Psyllid ID: psy4988

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------
Protein Sequence
MAPAPARMSAGSQIQMAPQSGLNAGHPIHSQDSNMSTGSSHSDKEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccHHHHHccccHHcccHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHcccccccccccccccccEEEccccccccccEEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHHHccccccEEEEEEEEEEcccEEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccEEccccccccccccccccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccEEcccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEEcccccccccccccccHHHccccccHHHHHHHHcccHHHHHHHHHHHHHcccccEEEcccEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccHHHHHHHHHEcccccccEEEEEEEcccccEEEEEEEcHHHHccHHHHHcHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccccEEEEcccccccEEEEEccccEEEccccccccccccEEccccccccccccEEEEEccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccccHcccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
mapaparmsagsqiqmapqsglnaghpihsqdsnmstgsshsdkevesvstpeklrpterkrkrkgddanmsvggplmkgggggnarpladskKINERQEEITAEREEIDRQKKLLnkkrptnaetgrkragsqsggagtqansagavgsggvagtptgpvtptapstptstlhngtdsatflkpeplpgmssqeyyEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHnedqsrfnnhpvlsdsyligyknLHIRELKRIhnedqsrfnnhpvlsDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYnihkaldhprvvkLYDVFEIDANSFCTvleycdghdldFYLKQHKTIAEREARSIVMQVVSALKYlneikppvihydlkpgnilltegnvcgeikitdfglskvmdeenynpdhgmdltsqgagtywylppecfvvgknppkisskvdvwsVGVIFYQClygkkpfghnqsqatILEENTILKATEVqfankptvsneAKGFIRSCLAYRKEDRIDVISLArhdylqppvpkhgrqsasssapvghspassgqnqnsggastqssAVQQSFATGlfsgmnassss
Flexible Loop (DISEMBL)
mapaparmsagsQIQMAPQSGLNAGHPIHSQDSNMSTgsshsdkevesvstpeklrpterkrkrkgddanmsvggplmkgggggnarpladskkinERQEeitaereeidrqkkllnkkrptnaetgrkragsqsggagtQANSAGAVGSGGVAGTPTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELkrihnedqsrfnnhpvlsdsYLIGYKNLHIRELKRIhnedqsrfnnhpVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVhqlnkdwkedkKANYIKHALREynihkaldhPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQfankptvsneakgfIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLfsgmnassss
Low Complexity Region (SEG)
MAPAPARMSAGSQIQMAPQSGLNAGHPIHSQDSNMSTGSSHSDKEVESVSTPEKLRPTERKRKRKGDDANMSVggplmkgggggNARPLADSKKINerqeeitaereeiDRQKKLLNKKRPTNAETGRKRagsqsggagtqansagavgsggvagtptgpvtptapstptstLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHspassgqnqnsggastqssaVQQSFATGLFSGMNASSSS
Disordered region (IsUnstruct)
*******************************************************************************************************************************************************************************************************************************************************NHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL***********************************************************
Disordered Region (DISOPRED)
********************************************************************************************************************************************************************************************************************************************************************************************LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQL**************HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP*********************************************************
Disordered Region (DISEMBL)
**************QMAPQSGLNAGHPIHSQ*************************************ANMSVGGPLMKGGGGGNARPLADSKKINERQEEITAEREEIDRQKKLLNKKR*******************************GVAGTPTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP*************************************VQQSFATGLFSGMNASSSS
Disordered Region (DISPRO)
**********************N****************S*SDK**ESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEITAEREEIDRQKKLLNKK**************************************************************FLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLE****************************************************RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQS***************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAPAPARMSAGSQIQMAPQSGLNAGHPIHSQDSNMSTGSSHSDKEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADxxxxxxxxxxxxxxxxxxxxxxxxxxxxRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	627	2.2.26 [Sep-21-2011]
Q86UE8	772	Serine/threonine-protein	yes	N/A	0.698	0.567	0.589	1e-161
O55047	718	Serine/threonine-protein	yes	N/A	0.663	0.579	0.585	1e-158
Q9UKI8	766	Serine/threonine-protein	no	N/A	0.749	0.613	0.543	1e-156
Q8C0V0	766	Serine/threonine-protein	no	N/A	0.749	0.613	0.542	1e-156
Q1ECX4	697	Serine/threonine-protein	yes	N/A	0.660	0.593	0.587	1e-156
Q08CW1	697	Serine/threonine-protein	no	N/A	0.663	0.596	0.581	1e-156
Q90ZY6	756	Serine/threonine-protein	no	N/A	0.681	0.564	0.577	1e-155
P34314	965	Serine/threonine-protein	yes	N/A	0.666	0.433	0.530	1e-139
Q39238	688	Serine/threonine-protein	yes	N/A	0.481	0.438	0.598	1e-107
Q5R7G9	628	NUAK family SNF1-like kin	no	N/A	0.405	0.404	0.326	1e-26

>sp|Q86UE8|TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2

 Score =  569 bits (1467), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 292/495 (58%), Positives = 352/495 (71%), Gaps = 57/495 (11%)

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE I ++REEI+RQ+K+L K++P         A  Q+  A  +     +  +G    T
Sbjct: 323 KQQERINSQREEIERQRKMLAKRKPP--------AMGQAPPATNEQKQRKSKTNGAENET 374

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
           P+   T    + P    H+            L  ++  EY+E +EI KLR   LKKE+A+
Sbjct: 375 PSSGNTELKDTAPALGAHS------------LLRLTLAEYHEQEEIFKLRLGHLKKEEAE 422

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRIHNED 
Sbjct: 423 IQAELERLERVRNLH---------------------------------IRELKRIHNEDN 449

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+HQLNK+W+++KK NY K
Sbjct: 450 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHK 509

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLDFYLKQHK ++E+EARS
Sbjct: 510 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARS 569

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITDFGLSK+MD+++YN   
Sbjct: 570 IIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD 629

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQCLYG+KPFGHNQSQ  
Sbjct: 630 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 689

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV  LA   YL P    H 
Sbjct: 690 ILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP----HI 745

Query: 577 RQSASSSAPVGHSPA 591
           R+S S+S+P G + A
Sbjct: 746 RKSVSTSSPAGAAIA 760

Serine/threonine-protein kinase involved in the process of chromatin assembly and probably also DNA replication, transcription, repair, and chromosome segregation. Phosphorylates the chromatin assembly factors ASF1A AND ASF1B. Phosphorylation of ASF1A prevents its proteasome-mediated degradation, thereby enhancing chromatin assembly.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O55047|TLK2_MOUSE Serine/threonine-protein kinase tousled-like 2 OS=Mus musculus GN=Tlk2 PE=1 SV=2

 Score =  559 bits (1440), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 290/495 (58%), Positives = 347/495 (70%), Gaps = 79/495 (15%)

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE I ++REEI+RQ+K+L K++P                         A+G       
Sbjct: 291 KQQERINSQREEIERQRKMLAKRKPP------------------------AMGQAP---- 322

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
              P T       + T  NG ++ T         ++  EY+E +EI KLR   LKKE+A+
Sbjct: 323 ---PATNEQKQRKSKT--NGAENET---------LTLAEYHEQEEIFKLRLGHLKKEEAE 368

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRIHNED 
Sbjct: 369 IQAELERLERVRNLH---------------------------------IRELKRIHNEDN 395

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+HQLNK+W+++KK NY K
Sbjct: 396 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHK 455

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLDFYLKQHK ++E+EARS
Sbjct: 456 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARS 515

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITDFGLSK+MD+++YN   
Sbjct: 516 IIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD 575

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQCLYG+KPFGHNQSQ  
Sbjct: 576 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 635

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV  LA   YL P    H 
Sbjct: 636 ILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP----HI 691

Query: 577 RQSASSSAPVGHSPA 591
           R+S S+S+P G + A
Sbjct: 692 RKSVSTSSPAGAAIA 706

Testis-specific isoforms may play a role in spermatogenesis. Highly expressed in embryos throughout development.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UKI8|TLK1_HUMAN Serine/threonine-protein kinase tousled-like 1 OS=Homo sapiens GN=TLK1 PE=1 SV=2

 Score =  553 bits (1425), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 297/546 (54%), Positives = 363/546 (66%), Gaps = 76/546 (13%)

Query: 40  SHSDKEVESVSTPEKLRPTERK---RKRKGDDANMSVGGPLMKGGGGGNARPLADSKKIN 96
           S S K +   ST EKL   E+    R R G    +  G    +    G A      + + 
Sbjct: 272 SMSKKLLIEKSTQEKLSSREKSMQDRLRLGHFTTVRHGASFTEQWTDGFA-----FQNLV 326

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE +  +RE+I+RQ+KLL K++P  A   +                            
Sbjct: 327 KQQEWVNQQREDIERQRKLLAKRKPPTANNSQ---------------------------- 358

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
              P T + P    +   NG ++  F++P     ++  EY+E +EI KLR   LKKE+A+
Sbjct: 359 --APSTNSEPKQRKNKAVNGAENDPFVRPNLPQLLTLAEYHEQEEIFKLRLGHLKKEEAE 416

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRI+NED 
Sbjct: 417 IQAELERLERVRNLH---------------------------------IRELKRINNEDN 443

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L++RYLLL LLG+GGFSEV+KAFDL EQRY A K+HQLNK W+++KK NY K
Sbjct: 444 SQFKDHPTLNERYLLLHLLGRGGFSEVYKAFDLYEQRYAAVKIHQLNKSWRDEKKENYHK 503

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D ++FCTVLEYC+G+DLDFYLKQHK ++E+EARS
Sbjct: 504 HACREYRIHKELDHPRIVKLYDYFSLDTDTFCTVLEYCEGNDLDFYLKQHKLMSEKEARS 563

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           IVMQ+V+AL+YLNEIKPP+IHYDLKPGNILL +G  CGEIKITDFGLSK+MD+++Y  D 
Sbjct: 564 IVMQIVNALRYLNEIKPPIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDSYGVD- 622

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GMDLTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIF+QCLYG+KPFGHNQSQ  
Sbjct: 623 GMDLTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQD 682

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP VS+EAK FIR CLAYRKEDR DV  LA   YL P    H 
Sbjct: 683 ILQENTILKATEVQFPVKPVVSSEAKAFIRRCLAYRKEDRFDVHQLANDPYLLP----HM 738

Query: 577 RQSASS 582
           R+S SS
Sbjct: 739 RRSNSS 744

Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly. Isoform 3 phosphorylates and enhances the stability of the t-SNARE SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects the cells from the ionizing radiation by faciliting the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8C0V0|TLK1_MOUSE Serine/threonine-protein kinase tousled-like 1 OS=Mus musculus GN=Tlk1 PE=2 SV=2

 Score =  551 bits (1421), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 296/546 (54%), Positives = 362/546 (66%), Gaps = 76/546 (13%)

Query: 40  SHSDKEVESVSTPEKLRPTERK---RKRKGDDANMSVGGPLMKGGGGGNARPLADSKKIN 96
           S S K +   ST EKL   E+    R R G    +  G    +    G A      + + 
Sbjct: 272 SMSKKLLIEKSTQEKLSSREKSMQDRLRLGHFTTVRHGASFTEQWTDGFA-----FQNLV 326

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE +  +RE+I+RQ+KLL K++P  A   +                            
Sbjct: 327 KQQEWVNQQREDIERQRKLLGKRKPPTANNSQ---------------------------- 358

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
              P T +      +   NG ++  F++P     ++  EY+E +EI KLR   LKKE+A+
Sbjct: 359 --APATNSEAKQRKTKAVNGAENDPFVRPNLPQLLTLAEYHEQEEIFKLRLGHLKKEEAE 416

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRI+NED 
Sbjct: 417 IQAELERLERVRNLH---------------------------------IRELKRINNEDN 443

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L++RYLLL LLG+GGFSEV+KAFDL EQRY A K+HQLNK W+++KK NY K
Sbjct: 444 SQFKDHPTLNERYLLLHLLGRGGFSEVYKAFDLYEQRYAAVKIHQLNKSWRDEKKENYHK 503

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D ++FCTVLEYC+G+DLDFYLKQHK ++E+EARS
Sbjct: 504 HACREYRIHKELDHPRIVKLYDYFSLDTDTFCTVLEYCEGNDLDFYLKQHKLMSEKEARS 563

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           IVMQ+V+AL+YLNEIKPP+IHYDLKPGNILL +G  CGEIKITDFGLSK+MD+++Y  D 
Sbjct: 564 IVMQIVNALRYLNEIKPPIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDSYGVD- 622

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GMDLTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIF+QCLYG+KPFGHNQSQ  
Sbjct: 623 GMDLTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQD 682

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP VS+EAK FIR CLAYRKEDR DV  LA   YL P    H 
Sbjct: 683 ILQENTILKATEVQFPVKPVVSSEAKAFIRRCLAYRKEDRFDVHQLANDPYLLP----HM 738

Query: 577 RQSASS 582
           R+S SS
Sbjct: 739 RRSNSS 744

Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly (By similarity). Isoform 3 protects the cells from the ionizing radiation by faciliting the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio GN=tlk2 PE=2 SV=2

 Score =  551 bits (1420), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 288/490 (58%), Positives = 342/490 (69%), Gaps = 76/490 (15%)

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE +  +REEI+RQ+KLL KK+P +A                             + T
Sbjct: 271 KQQERVNGQREEIERQRKLLIKKKPPSA-----------------------------SQT 301

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
           P   + P    + +    NG ++           +S  EY+E +EI KLR   LKKE+A+
Sbjct: 302 PPPNLEPNKRKSKS----NGAENEM---------LSLAEYHEQEEIFKLRLGHLKKEEAE 348

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q+E+E+LER RNLH                                 IRELKRIHNED 
Sbjct: 349 IQVELERLERVRNLH---------------------------------IRELKRIHNEDN 375

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+HQLNK+W+++KK NY K
Sbjct: 376 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHK 435

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLDFYLKQHK ++E+EARS
Sbjct: 436 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARS 495

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I+MQVV+ALKYLNEI+PP+IHYDLKPGNILL  G  CGEIKITDFGLSK+MD++NY  D 
Sbjct: 496 IIMQVVNALKYLNEIRPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDNYGVD- 554

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQCLYGKKPFGHNQSQ  
Sbjct: 555 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGKKPFGHNQSQQD 614

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP VS EAK FIR CL YRKEDRIDV  LA   YL P + K  
Sbjct: 615 ILQENTILKATEVQFPPKPGVSPEAKAFIRRCLVYRKEDRIDVHQLASDPYLLPHIRKSV 674

Query: 577 RQSASSSAPV 586
             + +SS  V
Sbjct: 675 AATGNSSMAV 684

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q08CW1|TLK2_XENTR Serine/threonine-protein kinase tousled-like 2 OS=Xenopus tropicalis GN=tlk2 PE=2 SV=1

 Score =  551 bits (1419), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 288/495 (58%), Positives = 341/495 (68%), Gaps = 79/495 (15%)

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE I  +REEI+RQ+K+L K++P                         A+G       
Sbjct: 270 KQQERINTQREEIERQRKMLAKRKPP------------------------AMGQ------ 299

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
            T P           T  NG ++           ++  EY+E +EI KLR   LKKE+A+
Sbjct: 300 -TPPANNEQKQRKNKT--NGAENE---------ALTLAEYHEQEEIFKLRLGHLKKEEAE 347

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRIHNED 
Sbjct: 348 IQAELERLERVRNLH---------------------------------IRELKRIHNEDN 374

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+HQLNK+W+++KK NY K
Sbjct: 375 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHK 434

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLDFYLKQHK + E+EARS
Sbjct: 435 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMTEKEARS 494

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITDFGLSK+MD+++YN   
Sbjct: 495 IIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVD 554

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQCLYG+KPFGHNQSQ  
Sbjct: 555 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 614

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV  LA   YL P    H 
Sbjct: 615 ILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP----HI 670

Query: 577 RQSASSSAPVGHSPA 591
           R+S S+S P   + A
Sbjct: 671 RKSVSTSIPANAAVA 685

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q90ZY6|TLK1B_DANRE Serine/threonine-protein kinase tousled-like 1-B OS=Danio rerio GN=tlk1b PE=2 SV=1

 Score =  547 bits (1410), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 290/502 (57%), Positives = 350/502 (69%), Gaps = 75/502 (14%)

Query: 97  ERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGT 156
           ++QE I  +REEI+RQ+KLL K++P++  + +    ++S    T+A              
Sbjct: 322 KQQEWINQQREEIERQRKLLAKRKPSSTPSSQSPTPNESKQRKTKAV------------- 368

Query: 157 PTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDAD 216
                             NG D+  FLKP     ++  EY+E +EI KLR   LKKE+A+
Sbjct: 369 ------------------NGADNDPFLKPSLPTLLTVAEYHEQEEIFKLRLGHLKKEEAE 410

Query: 217 LQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQ 276
           +Q E+E+LER RNLH                                 IRELKRI+NED 
Sbjct: 411 IQAELERLERVRNLH---------------------------------IRELKRINNEDS 437

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           S+F +HP L++RYLLL LLG+GGFSEV+KAFDL EQRY A K+HQLNK+W+E+KK NY K
Sbjct: 438 SQFKDHPTLNERYLLLHLLGRGGFSEVYKAFDLFEQRYAAVKIHQLNKNWREEKKENYHK 497

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
           HA REY IHK LDHPR+VKLYD F +D ++FCTVLE+C+G+DLDFYLKQHK ++E+EARS
Sbjct: 498 HACREYRIHKQLDHPRIVKLYDYFSLDTDTFCTVLEFCEGNDLDFYLKQHKLMSEKEARS 557

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           IVMQ+V+AL+YLNEIKP +IHYDLKPGNILL +G  CGEIKITDFGLSK+MD+++Y  D 
Sbjct: 558 IVMQIVNALRYLNEIKPSIIHYDLKPGNILLVDGTACGEIKITDFGLSKIMDDDSYGVD- 616

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GMDLTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIF+QCLYG+KPFGHNQSQ  
Sbjct: 617 GMDLTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFFQCLYGRKPFGHNQSQQD 676

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           IL+ENTILKATEVQF  KP  SNEAK FIR CLAYRKEDR DV  L    YL P    H 
Sbjct: 677 ILQENTILKATEVQFPAKPVASNEAKAFIRRCLAYRKEDRSDVHQLGSDSYLLP----HM 732

Query: 577 RQSASS----SAPVGHSPASSG 594
           R+S SS    + P   SPA SG
Sbjct: 733 RRSNSSGNLQATPA--SPAPSG 752

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P34314|TLK1_CAEEL Serine/threonine-protein kinase tousled-like 1 OS=Caenorhabditis elegans GN=tlk-1 PE=1 SV=3

 Score =  494 bits (1273), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 253/477 (53%), Positives = 318/477 (66%), Gaps = 59/477 (12%)

Query: 94  KINERQEEITAEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGV 153
           +++++ E+I AER EI     LL K++P               G G +     AV S   
Sbjct: 513 EMDKKTEQINAERNEIASASALLKKRKPL--------------GIGKEPKRPQAVNSQND 558

Query: 154 AGTPTGPVTPTAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKE 213
           +           PST ++T  NG D A F +PE    +  QEY E DEI KLR+  L+KE
Sbjct: 559 SNG-------MQPSTSSNT--NG-DDAIFRRPEEPKEIQYQEYIELDEIYKLRREHLRKE 608

Query: 214 DADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHN 273
           + DL +E E+LE+E                                 K  H+RELKR  N
Sbjct: 609 ETDLSMEKERLEKE---------------------------------KQHHVRELKRASN 635

Query: 274 EDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKAN 333
           E  S+FN+H +L  RYL+L LLGKGGFSEV KAFD++E RYVACK+H +NKDWKE+KKAN
Sbjct: 636 ESASQFNDHRLLHKRYLMLNLLGKGGFSEVWKAFDIEENRYVACKIHHVNKDWKEEKKAN 695

Query: 334 YIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE 393
           Y+KHA+RE +IHK+LDH R+VK YD+  ID +SFCTVLEY  G+DLDFYLKQ+++I+E+E
Sbjct: 696 YVKHAMREKDIHKSLDHCRIVKQYDLLTIDNHSFCTVLEYVPGNDLDFYLKQNRSISEKE 755

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           ARSI+MQVVSAL YLNE   P+IHYDLKP NILL  GN  G IKITDFGLSK+M+ E+ +
Sbjct: 756 ARSIIMQVVSALVYLNEKSTPIIHYDLKPANILLESGNTSGAIKITDFGLSKIMEGESDD 815

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
            D G++LTSQ AGTYWYLPPE F+V   PPKI+ KVDVWS+GVIFYQC+YGKKPFG++ +
Sbjct: 816 HDLGIELTSQFAGTYWYLPPETFIVP--PPKITCKVDVWSIGVIFYQCIYGKKPFGNDLT 873

Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           Q  ILE NTI+ A EV F +KP VS+ A+ FIR CL YRKEDR DV  LA+H+  +P
Sbjct: 874 QQKILEYNTIINAREVSFPSKPQVSSAAQDFIRRCLQYRKEDRADVFELAKHELFRP 930

Essential for appropriate transcription during embryonic development. May act during transcription elongation to activate the RNA polymerase II large subunit (ama-1) by phosphorylating the Ser-2 residues of the C-terminal domain 7-residue repeats. Does not phosphorylate histone H3.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39238|TSL_ARATH Serine/threonine-protein kinase TOUSLED OS=Arabidopsis thaliana GN=TOUSLED PE=1 SV=1

 Score =  388 bits (997), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 185/309 (59%), Positives = 232/309 (75%), Gaps = 7/309 (2%)

Query: 261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
           K L +RE+KRI +ED SRFN+ PVL+ RY LL LLGKGGFSEV+KA+DL + RYVACK+H
Sbjct: 381 KGLLMREMKRIRDEDGSRFNHFPVLNSRYALLNLLGKGGFSEVYKAYDLVDHRYVACKLH 440

Query: 321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
            LN  W E+KK +YI+HA RE  IHK+L H  +V+L+D F ID ++FCTVLEYC G DLD
Sbjct: 441 GLNAQWSEEKKQSYIRHANRECEIHKSLVHHHIVRLWDKFHIDMHTFCTVLEYCSGKDLD 500

Query: 381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             LK    + E+EAR I++Q+V  L YLN+    +IHYDLKPGN+L  E  V    K+TD
Sbjct: 501 AVLKATSNLPEKEARIIIVQIVQGLVYLNKKSQKIIHYDLKPGNVLFDEFGVA---KVTD 557

Query: 441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           FGLSK++ E+N     GM+LTSQGAGTYWYLPPECF + K  P ISSKVDVWSVGV+FYQ
Sbjct: 558 FGLSKIV-EDNVGS-QGMELTSQGAGTYWYLPPECFELNKT-PMISSKVDVWSVGVLFYQ 614

Query: 501 CLYGKKPFGHNQSQATILEENTILKATEVQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDV 559
            L+GK+PFGH+QSQ  IL E+TI+KA +V+F   +P +SNEAK  IR CL Y +EDR DV
Sbjct: 615 MLFGKRPFGHDQSQERILREDTIIKAKKVEFPVTRPAISNEAKDLIRRCLTYNQEDRPDV 674

Query: 560 ISLARHDYL 568
           +++A+  YL
Sbjct: 675 LTMAQDPYL 683

Required for correct initiation of floral organ primordia and for proper development of organ primordia. Phosphorylates in vitro ASF1B/SGA1, the C-terminal part of TKI1 and histone H3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5R7G9|NUAK2_PONAB NUAK family SNF1-like kinase 2 OS=Pongo abelii GN=NUAK2 PE=2 SV=1

 Score =  122 bits (305), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 141/285 (49%), Gaps = 31/285 (10%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  RY  L  LGKG + +V KA +    R VA K   + KD  +D++   + H  RE  I
Sbjct: 49  LRHRYEFLETLGKGTYGKVKKARE-SSGRLVAIK--SIRKDKIKDEQD--LMHIRREIEI 103

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
             +L+HP ++ +++VFE +++    V+EY    DL  Y+ + + ++EREAR    Q+VSA
Sbjct: 104 MSSLNHPHIIAIHEVFE-NSSKIVIVMEYASRGDLYDYISERQQLSEREARHFFRQIVSA 162

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y ++ +  V+H DLK  NILL   +  G IKI DFGLS +         H        
Sbjct: 163 VHYCHQNR--VVHRDLKLENILL---DANGNIKIADFGLSNLY--------HQGKFLQTF 209

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTI 523
            G+  Y  PE  V GK  P    +VD WS+GV+ Y  ++G  PF GH+           +
Sbjct: 210 CGSPLYASPE-IVNGK--PYTGPEVDSWSLGVLLYILVHGTMPFDGHDH--------KIL 258

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           +K        +P   ++A G IR  L      R  +  +A H ++
Sbjct: 259 VKQISNGAYREPPKPSDACGLIRWLLMVNPTRRATLEDVASHWWV 303

Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	627
328723550	838	PREDICTED: serine/threonine-protein kina	0.883	0.661	0.688	0.0
307211211	756	Serine/threonine-protein kinase tousled-	0.789	0.654	0.703	0.0
347963048	1379	AGAP000043-PA [Anopheles gambiae str. PE	0.859	0.390	0.670	0.0
189241920	732	PREDICTED: similar to mixed lineage prot	0.792	0.678	0.695	0.0
270015226	706	hypothetical protein TcasGA2_TC008538 [T	0.794	0.705	0.697	0.0
380013859	760	PREDICTED: serine/threonine-protein kina	0.789	0.651	0.700	0.0
110755587	793	PREDICTED: tousled-like kinase [Apis mel	0.789	0.624	0.700	0.0
345490845	951	PREDICTED: serine/threonine-protein kina	0.799	0.526	0.709	0.0
345490843	940	PREDICTED: serine/threonine-protein kina	0.799	0.532	0.709	0.0
383858081	807	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.789	0.613	0.697	0.0

>gi|328723550|ref|XP_001947282.2| PREDICTED: serine/threonine-protein kinase tousled-like 1-like [Acyrthosiphon pisum]

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/629 (68%), Positives = 472/629 (75%), Gaps = 75/629 (11%)

Query: 26  HPIHSQDSNMSTGSSHSDKEVESV-------STPEKLRPTER---KRKRKGDDANMSVGG 75
           H + SQ   +    SH +K ++ V       S  EK    +R    R R G      VG 
Sbjct: 258 HQLSSQQKTIEQHKSHINKCIDVVKKLLKEKSNIEKKEARQRCMQNRLRLGQFVTQRVGA 317

Query: 76  PLMKGGGGGNARPLADSKKINERQEEITAEREEIDRQKKLLNKKRPTNAETG-RKRAGSQ 134
              +    G A      ++++ RQEEIT+EREEIDRQKK+L KKRP+N+ETG RKRA SQ
Sbjct: 318 QFQENWTDGYA-----FQELSRRQEEITSEREEIDRQKKMLVKKRPSNSETGGRKRASSQ 372

Query: 135 SGGAGTQANSAGAVGSGGVAGTPTGPVT-PTAP--------STPTSTLHNGT-------D 178
           SG   + + +     +   + TP  P+T P+A         +T  + LHNGT       D
Sbjct: 373 SGTGSSSSTTNSVPINSTPSVTP--PITLPSASINNNQVTGATTGTVLHNGTVAPSSALD 430

Query: 179 SATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRI 238
           +ATFLKPE +PG+S QEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLH       
Sbjct: 431 TATFLKPEAVPGLSWQEYYEADEILKLRQSALKKEDADLQLEMEKLERERNLH------- 483

Query: 239 HNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKG 298
                                     IRELKRIHNEDQSRFNNHPVL+DRYLLLMLLGKG
Sbjct: 484 --------------------------IRELKRIHNEDQSRFNNHPVLNDRYLLLMLLGKG 517

Query: 299 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD 358
           GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK+LDHPRVVKLYD
Sbjct: 518 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKSLDHPRVVKLYD 577

Query: 359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 418
           VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY
Sbjct: 578 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 637

Query: 419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV 478
           DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV
Sbjct: 638 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV 697

Query: 479 GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVS 538
           GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVS
Sbjct: 698 GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVS 757

Query: 539 NEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQN 598
           NEAK FIR CLAYRKEDRIDV +L+RH+YLQPP+PKHGRQSA++            Q Q 
Sbjct: 758 NEAKSFIRCCLAYRKEDRIDVFTLSRHEYLQPPLPKHGRQSANNQQQQQQQQQQQQQQQQ 817

Query: 599 SGGASTQSSAVQQSFATGLFSGMNASSSS 627
              A+        +FA+G+F  MNASSSS
Sbjct: 818 QISAA--------NFASGMFGNMNASSSS 838

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307211211|gb|EFN87411.1| Serine/threonine-protein kinase tousled-like 2 [Harpegnathos saltator]

 Score =  775 bits (2000), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/584 (70%), Positives = 437/584 (74%), Gaps = 89/584 (15%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEI 
Sbjct: 262 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIA 316

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEID+QKKLL KKRP+N+ETGRKR                                 
Sbjct: 317 TEREEIDKQKKLLLKKRPSNSETGRKR--------------------------------- 343

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEK 223
              S P S+LHNGT+ ATFLKP+ +PG + QEYYEADEILKLRQSALKKEDADLQLEMEK
Sbjct: 344 ---SQPQSSLHNGTE-ATFLKPDAVPGYTWQEYYEADEILKLRQSALKKEDADLQLEMEK 399

Query: 224 LERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHP 283
           LERERNLH                                 IRELKRIHNEDQSRFN+HP
Sbjct: 400 LERERNLH---------------------------------IRELKRIHNEDQSRFNSHP 426

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           VL++RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN
Sbjct: 427 VLNERYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 486

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVVS
Sbjct: 487 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVVS 546

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ
Sbjct: 547 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 606

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
           GAGTYWYLPPECFV+GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI
Sbjct: 607 GAGTYWYLPPECFVIGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 666

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSS 583
           LKATEVQFANKPTVSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ S  
Sbjct: 667 LKATEVQFANKPTVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANSQQ 726

Query: 584 APVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                                Q    Q SF  G+FSGMNASSSS
Sbjct: 727 Q--------------QQQQQIQQQQQQSSFTIGMFSGMNASSSS 756

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|347963048|ref|XP_311117.5| AGAP000043-PA [Anopheles gambiae str. PEST] gi|333467384|gb|EAA06538.6| AGAP000043-PA [Anopheles gambiae str. PEST]

 Score =  774 bits (1999), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 420/626 (67%), Positives = 447/626 (71%), Gaps = 87/626 (13%)

Query: 44   KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
            K+  ++   E  +   + R R G      VG    +    G A      +++ +RQEEIT
Sbjct: 799  KQKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYAF-----QELAKRQEEIT 853

Query: 104  AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSG---GVAGTPTGP 160
            AEREEIDRQKKLL KKRPTN+E GRKR  S + G G           G   G AG  TG 
Sbjct: 854  AEREEIDRQKKLLMKKRPTNSEGGRKRNNSSATGGGAGGTGGAGDRGGTGPGSAGVGTGA 913

Query: 161  VTP-------------TAPSTPTSTLHNGTDSATFLKPEPLPGMSS----QEYYEADEIL 203
            V                      S LHNG DS TFLKP+P+   SS    QEYYE DEIL
Sbjct: 914  VVAMGSGGVVGASAGSVGSGGGGSALHNGNDS-TFLKPDPVVSSSSTFTLQEYYECDEIL 972

Query: 204  KLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNL 263
            KLRQSALKKEDADLQLEMEKLERERNLH                                
Sbjct: 973  KLRQSALKKEDADLQLEMEKLERERNLH-------------------------------- 1000

Query: 264  HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN 323
             IRELKRIHNEDQSRFNNHPVL+DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN
Sbjct: 1001 -IRELKRIHNEDQSRFNNHPVLNDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN 1059

Query: 324  KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL 383
            KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL
Sbjct: 1060 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL 1119

Query: 384  KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
            KQHKTI E+EARSI+MQVVSALKYLNEIKPP+IHYDLKPGNILLTEGNVCGEIKITDFGL
Sbjct: 1120 KQHKTIPEKEARSIIMQVVSALKYLNEIKPPIIHYDLKPGNILLTEGNVCGEIKITDFGL 1179

Query: 444  SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
            SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY
Sbjct: 1180 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 1239

Query: 504  GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAK FIR CLAYRKEDR+DV +LA
Sbjct: 1240 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKSFIRGCLAYRKEDRMDVFALA 1299

Query: 564  RHDYLQPPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAV-------------- 609
            +H+YLQPPV KH R S + +A  G      GQN +S G                      
Sbjct: 1300 KHEYLQPPVSKHNRSSNAQNAHAG------GQNSSSTGTGAGGGGGGGGGGGGGSGGSGG 1353

Query: 610  --------QQSFATGLFSGMNASSSS 627
                    Q SF+TG+F  MN SSSS
Sbjct: 1354 AGGNQIGQQTSFSTGMFGNMNQSSSS 1379

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189241920|ref|XP_967371.2| PREDICTED: similar to mixed lineage protein kinase [Tribolium castaneum]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/585 (69%), Positives = 436/585 (74%), Gaps = 88/585 (15%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  S+   E  +   + R R G      VG    +    G+A      +++  RQEEIT
Sbjct: 235 KEKSSIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGHA-----FQELARRQEEIT 289

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
           AEREEIDRQKKLL KKRP+N E+ RKR  S                              
Sbjct: 290 AEREEIDRQKKLLLKKRPSNNESSRKRNNS------------------------------ 319

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
                  + +HNGTDS  FLKP+ +PG ++ QEYYEADEILKLRQ+ALKKED+DLQLEME
Sbjct: 320 -------NAMHNGTDSG-FLKPDAVPGSLTLQEYYEADEILKLRQNALKKEDSDLQLEME 371

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFNNH
Sbjct: 372 KLERERNLH---------------------------------IRELKRIHNEDQSRFNNH 398

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVL+DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 399 PVLNDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 458

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSI+MQVV
Sbjct: 459 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIIMQVV 518

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 519 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 578

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 579 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 638

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKP V+NEAK FIRSCLAYRKEDRIDV+SLA+H+YLQPP+PKH R ++S 
Sbjct: 639 ILKATEVQFANKPAVTNEAKSFIRSCLAYRKEDRIDVLSLAKHEYLQPPMPKHSRVASSQ 698

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                       Q Q +G           SF+TGLF  MNASSSS
Sbjct: 699 QQQQQQQQQQQQQQQQAG-----------SFSTGLFGAMNASSSS 732

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270015226|gb|EFA11674.1| hypothetical protein TcasGA2_TC008538 [Tribolium castaneum]

 Score =  771 bits (1991), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/585 (69%), Positives = 435/585 (74%), Gaps = 87/585 (14%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  S+   E  +   + R R G      VG    +    G+A     S+    RQEEIT
Sbjct: 208 KEKSSIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGHAFQELASR----RQEEIT 263

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
           AEREEIDRQKKLL KKRP+N E+ RKR  S                              
Sbjct: 264 AEREEIDRQKKLLLKKRPSNNESSRKRNNS------------------------------ 293

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
                  + +HNGTDS  FLKP+ +PG ++ QEYYEADEILKLRQ+ALKKED+DLQLEME
Sbjct: 294 -------NAMHNGTDSG-FLKPDAVPGSLTLQEYYEADEILKLRQNALKKEDSDLQLEME 345

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFNNH
Sbjct: 346 KLERERNLH---------------------------------IRELKRIHNEDQSRFNNH 372

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVL+DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 373 PVLNDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 432

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSI+MQVV
Sbjct: 433 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIIMQVV 492

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 493 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 552

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 553 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 612

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKP V+NEAK FIRSCLAYRKEDRIDV+SLA+H+YLQPP+PKH R ++S 
Sbjct: 613 ILKATEVQFANKPAVTNEAKSFIRSCLAYRKEDRIDVLSLAKHEYLQPPMPKHSRVASSQ 672

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                       Q Q +G           SF+TGLF  MNASSSS
Sbjct: 673 QQQQQQQQQQQQQQQQAG-----------SFSTGLFGAMNASSSS 706

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380013859|ref|XP_003690963.1| PREDICTED: serine/threonine-protein kinase tousled-like 2-like [Apis florea]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/585 (70%), Positives = 436/585 (74%), Gaps = 90/585 (15%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEI 
Sbjct: 265 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIA 319

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEID+QKKLL KKRP+N+ETGRKR                                 
Sbjct: 320 TEREEIDKQKKLLLKKRPSNSETGRKR--------------------------------- 346

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
              S P  +LHNGT+ ATFLKP+ +PG  + QEYYEADEILKLRQSALKKEDADLQLEME
Sbjct: 347 ---SQPQPSLHNGTE-ATFLKPDAVPGSYTWQEYYEADEILKLRQSALKKEDADLQLEME 402

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFN+H
Sbjct: 403 KLERERNLH---------------------------------IRELKRIHNEDQSRFNSH 429

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 430 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 489

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVV
Sbjct: 490 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVV 549

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 550 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 609

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFV+GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 610 QGAGTYWYLPPECFVIGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 669

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKPTVSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ + 
Sbjct: 670 ILKATEVQFANKPTVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANNQ 729

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                                      Q SF+ G+FSGMNASSSS
Sbjct: 730 QQ--------------QQQQQQIQQQQQTSFSIGMFSGMNASSSS 760

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|110755587|ref|XP_624065.2| PREDICTED: tousled-like kinase [Apis mellifera]

 Score =  766 bits (1978), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/585 (70%), Positives = 436/585 (74%), Gaps = 90/585 (15%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEI 
Sbjct: 298 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIA 352

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEID+QKKLL KKRP+N+ETGRKR                                 
Sbjct: 353 TEREEIDKQKKLLLKKRPSNSETGRKR--------------------------------- 379

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
              S P  +LHNGT+ ATFLKP+ +PG  + QEYYEADEILKLRQSALKKEDADLQLEME
Sbjct: 380 ---SQPQPSLHNGTE-ATFLKPDAVPGSYTWQEYYEADEILKLRQSALKKEDADLQLEME 435

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFN+H
Sbjct: 436 KLERERNLH---------------------------------IRELKRIHNEDQSRFNSH 462

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 463 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 522

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVV
Sbjct: 523 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVV 582

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 583 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 642

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFV+GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 643 QGAGTYWYLPPECFVIGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 702

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKPTVSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ + 
Sbjct: 703 ILKATEVQFANKPTVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANNQ 762

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                                      Q SF+ G+FSGMNASSSS
Sbjct: 763 QQ--------------QQQQQQIQQQQQTSFSIGMFSGMNASSSS 793

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345490845|ref|XP_001601609.2| PREDICTED: serine/threonine-protein kinase tousled-like 2-like isoform 1 [Nasonia vitripennis]

 Score =  766 bits (1977), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/585 (70%), Positives = 443/585 (75%), Gaps = 84/585 (14%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEIT
Sbjct: 450 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIT 504

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEIDRQKKLL KKRP+N+ETGRKR+                                
Sbjct: 505 TEREEIDRQKKLLLKKRPSNSETGRKRS-------------------------------- 532

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
           + P+  TS LHNGT+ ATFLKP+ +PG  + QEYYEADEILKLRQSALKKEDADLQLEME
Sbjct: 533 SQPAQATS-LHNGTE-ATFLKPDAVPGSYTWQEYYEADEILKLRQSALKKEDADLQLEME 590

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFN+H
Sbjct: 591 KLERERNLH---------------------------------IRELKRIHNEDQSRFNSH 617

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVL++RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 618 PVLNERYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 677

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVV
Sbjct: 678 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVV 737

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 738 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 797

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 798 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 857

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKP+VSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ S 
Sbjct: 858 ILKATEVQFANKPSVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANSQ 917

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                         Q       Q    Q SF+TG+FSGMNASSSS
Sbjct: 918 QQ-----------QQQQQQQQIQQQQQQTSFSTGMFSGMNASSSS 951

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345490843|ref|XP_003426476.1| PREDICTED: serine/threonine-protein kinase tousled-like 2-like isoform 4 [Nasonia vitripennis]

 Score =  765 bits (1975), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/585 (70%), Positives = 443/585 (75%), Gaps = 84/585 (14%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEIT
Sbjct: 439 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIT 493

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEIDRQKKLL KKRP+N+ETGRKR+                                
Sbjct: 494 TEREEIDRQKKLLLKKRPSNSETGRKRS-------------------------------- 521

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
           + P+  TS LHNGT+ ATFLKP+ +PG  + QEYYEADEILKLRQSALKKEDADLQLEME
Sbjct: 522 SQPAQATS-LHNGTE-ATFLKPDAVPGSYTWQEYYEADEILKLRQSALKKEDADLQLEME 579

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFN+H
Sbjct: 580 KLERERNLH---------------------------------IRELKRIHNEDQSRFNSH 606

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVL++RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 607 PVLNERYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 666

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVV
Sbjct: 667 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVV 726

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 727 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 786

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 787 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 846

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKP+VSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ S 
Sbjct: 847 ILKATEVQFANKPSVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANSQ 906

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                         Q       Q    Q SF+TG+FSGMNASSSS
Sbjct: 907 QQ-----------QQQQQQQQIQQQQQQTSFSTGMFSGMNASSSS 940

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383858081|ref|XP_003704531.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase tousled-like 1-like [Megachile rotundata]

 Score =  765 bits (1975), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/585 (69%), Positives = 436/585 (74%), Gaps = 90/585 (15%)

Query: 44  KEVESVSTPEKLRPTERKRKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEIT 103
           KE  ++   E  +   + R R G      VG    +    G A      +++  RQEEI 
Sbjct: 312 KEKSNIEKKEARQKCMQNRLRLGQFVTQRVGATFQENWTDGYA-----FQELARRQEEIA 366

Query: 104 AEREEIDRQKKLLNKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTP 163
            EREEID+QKKLL KKRP+N+ETGRKR                                 
Sbjct: 367 TEREEIDKQKKLLLKKRPSNSETGRKR--------------------------------- 393

Query: 164 TAPSTPTSTLHNGTDSATFLKPEPLPG-MSSQEYYEADEILKLRQSALKKEDADLQLEME 222
              S P  +LHNGT+ ATFLKP+ +PG  + QEYYEADEILKLRQSALKKEDADLQLEME
Sbjct: 394 ---SQPQPSLHNGTE-ATFLKPDAVPGSYTWQEYYEADEILKLRQSALKKEDADLQLEME 449

Query: 223 KLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNH 282
           KLERERNLH                                 IRELKRIHNEDQSRFN+H
Sbjct: 450 KLERERNLH---------------------------------IRELKRIHNEDQSRFNSH 476

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           PVL++RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY
Sbjct: 477 PVLNERYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 536

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI EREARSIVMQVV
Sbjct: 537 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIPEREARSIVMQVV 596

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS
Sbjct: 597 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 656

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
           QGAGTYWYLPPECFV+GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT
Sbjct: 657 QGAGTYWYLPPECFVIGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 716

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASS 582
           ILKATEVQFANKPTVSNEAK FIRSCLAYRKE+RIDV++LARH+YLQPPVPKHGRQ+ + 
Sbjct: 717 ILKATEVQFANKPTVSNEAKSFIRSCLAYRKEERIDVLTLARHEYLQPPVPKHGRQANNQ 776

Query: 583 SAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMNASSSS 627
                                      Q SF+ G+FSGMNASSSS
Sbjct: 777 QQ--------------QQQQQQIQQQQQTSFSIGMFSGMNASSSS 807

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	627
FB|FBgn0086899	1489	tlk "Tousled-like kinase" [Dro	0.585	0.246	0.850	1.8e-217
UNIPROTKB|Q86UE8	772	TLK2 "Serine/threonine-protein	0.515	0.418	0.758	4.9e-171
MGI|MGI:1346023	718	Tlk2 "tousled-like kinase 2 (A	0.515	0.449	0.758	2.1e-170
UNIPROTKB|E1BBU6	750	TLK2 "Uncharacterized protein"	0.515	0.430	0.758	2.7e-170
UNIPROTKB|F1P773	750	TLK2 "Uncharacterized protein"	0.515	0.430	0.758	2.7e-170
UNIPROTKB|F1LPP2	750	Tlk2 "Protein Tlk2" [Rattus no	0.515	0.430	0.758	2.7e-170
UNIPROTKB|G3V6T3	718	Tlk2 "Tousled-like kinase 2 (A	0.515	0.449	0.758	2.7e-170
UNIPROTKB|F1RRU6	748	TLK2 "Uncharacterized protein"	0.515	0.431	0.758	7e-170
ZFIN|ZDB-GENE-060623-36	697	tlk2 "tousled-like kinase 2" [	0.518	0.466	0.757	7e-170
UNIPROTKB|E1C3U2	695	E1C3U2 "Uncharacterized protei	0.515	0.464	0.758	1.1e-169

FB|FBgn0086899 tlk "Tousled-like kinase" [Drosophila melanogaster (taxid:7227)]

 Score = 1667 (591.9 bits), Expect = 1.8e-217, Sum P(4) = 1.8e-217
 Identities = 313/368 (85%), Positives = 326/368 (88%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRI NEDQSRFNNHPVL+DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH
Sbjct:  1122 RNLHIRELKRILNEDQSRFNNHPVLNDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 1181

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD
Sbjct:  1182 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 1241

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHKTI EREARSI+MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD
Sbjct:  1242 FYLKQHKTIPEREARSIIMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 1301

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSKVMD+ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ
Sbjct:  1302 FGLSKVMDDENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 1361

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYGKKPFGHNQSQATILEENTILKATEVQF+NKPTVSNEAK FIR CLAYRKEDR+DV 
Sbjct:  1362 CLYGKKPFGHNQSQATILEENTILKATEVQFSNKPTVSNEAKSFIRGCLAYRKEDRMDVF 1421

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVGHXXXXXXXXXXXXXXXXXXXXV-QQSFATGLFS 619
             +LARH+Y+QPP+PKHGR S +                             Q SF+  +F 
Sbjct:  1422 ALARHEYIQPPIPKHGRGSLNQQQQAQQQQQQQQQQQQQQSSTSQANSTGQTSFSAHMFG 1481

Query:   620 GMNASSSS 627
              MN SSSS
Sbjct:  1482 NMNQSSSS 1489

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;NAS

GO:0006468 "protein phosphorylation" evidence=ISS;IDA;NAS

GO:0006325 "chromatin organization" evidence=IGI

GO:0045448 "mitotic cell cycle, embryonic" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0051726 "regulation of cell cycle" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0008360 "regulation of cell shape" evidence=IMP

GO:0007155 "cell adhesion" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0019730 "antimicrobial humoral response" evidence=IMP

GO:0007059 "chromosome segregation" evidence=IGI

UNIPROTKB|Q86UE8 TLK2 "Serine/threonine-protein kinase tousled-like 2" [Homo sapiens (taxid:9606)]

 Score = 1351 (480.6 bits), Expect = 4.9e-171, Sum P(4) = 4.9e-171
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   434 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 493

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   494 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 553

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   554 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 613

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   614 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 673

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   674 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 733

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   734 QLACDPYLLP----HIRKSVSTSSPAG 756

GO:0007049 "cell cycle" evidence=IEA

GO:0016568 "chromatin modification" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0035556 "intracellular signal transduction" evidence=IDA

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IDA

GO:0005882 "intermediate filament" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IMP

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0007059 "chromosome segregation" evidence=IMP

GO:0071480 "cellular response to gamma radiation" evidence=IDA

GO:0006974 "response to DNA damage stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010507 "negative regulation of autophagy" evidence=NAS

MGI|MGI:1346023 Tlk2 "tousled-like kinase 2 (Arabidopsis)" [Mus musculus (taxid:10090)]

 Score = 1351 (480.6 bits), Expect = 2.1e-170, Sum P(4) = 2.1e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   380 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 439

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   440 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 499

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   500 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 559

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   560 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 619

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   620 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 679

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   680 QLACDPYLLP----HIRKSVSTSSPAG 702

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005882 "intermediate filament" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006974 "response to DNA damage stimulus" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007059 "chromosome segregation" evidence=ISO

GO:0007275 "multicellular organismal development" evidence=IEA

GO:0007283 "spermatogenesis" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016568 "chromatin modification" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO

GO:0030154 "cell differentiation" evidence=IEA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=ISO

GO:0035556 "intracellular signal transduction" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO;IDA

GO:0071480 "cellular response to gamma radiation" evidence=ISO

UNIPROTKB|E1BBU6 TLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 1351 (480.6 bits), Expect = 2.7e-170, Sum P(4) = 2.7e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   412 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 471

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   472 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 531

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   532 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 591

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   592 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 651

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   652 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 711

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   712 QLACDPYLLP----HIRKSVSTSSPAG 734

GO:0071480 "cellular response to gamma radiation" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0007059 "chromosome segregation" evidence=IEA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0005882 "intermediate filament" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1P773 TLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1351 (480.6 bits), Expect = 2.7e-170, Sum P(4) = 2.7e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   412 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 471

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   472 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 531

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   532 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 591

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   592 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 651

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   652 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 711

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   712 QLACDPYLLP----HIRKSVSTSSPAG 734

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1LPP2 Tlk2 "Protein Tlk2" [Rattus norvegicus (taxid:10116)]

 Score = 1351 (480.6 bits), Expect = 2.7e-170, Sum P(4) = 2.7e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   412 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 471

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   472 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 531

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   532 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 591

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   592 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 651

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   652 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 711

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   712 QLACDPYLLP----HIRKSVSTSSPAG 734

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005882 "intermediate filament" evidence=IEA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007059 "chromosome segregation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0071480 "cellular response to gamma radiation" evidence=IEA

UNIPROTKB|G3V6T3 Tlk2 "Tousled-like kinase 2 (Arabidopsis) (Predicted), isoform CRA_b" [Rattus norvegicus (taxid:10116)]

 Score = 1351 (480.6 bits), Expect = 2.7e-170, Sum P(4) = 2.7e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   380 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 439

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   440 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 499

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   500 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 559

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   560 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 619

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   620 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 679

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   680 QLACDPYLLP----HIRKSVSTSSPAG 702

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

UNIPROTKB|F1RRU6 TLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1351 (480.6 bits), Expect = 7.0e-170, Sum P(4) = 7.0e-170
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   410 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 469

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   470 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 529

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   530 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 589

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   590 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 649

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   650 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 709

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   710 QLACDPYLLP----HIRKSVSTSSPAG 732

GO:0071480 "cellular response to gamma radiation" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0007059 "chromosome segregation" evidence=IEA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0005882 "intermediate filament" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

ZFIN|ZDB-GENE-060623-36 tlk2 "tousled-like kinase 2" [Danio rerio (taxid:7955)]

 Score = 1338 (476.1 bits), Expect = 7.0e-170, Sum P(4) = 7.0e-170
 Identities = 247/326 (75%), Positives = 279/326 (85%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   360 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 419

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   420 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 479

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQVV+ALKYLNEI+PP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   480 FYLKQHKLMSEKEARSIIMQVVNALKYLNEIRPPIIHYDLKPGNILLVNGTACGEIKITD 539

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD++NY  D GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   540 FGLSKIMDDDNYGVD-GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 598

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYGKKPFGHNQSQ  IL+ENTILKATEVQF  KP VS EAK FIR CL YRKEDRIDV 
Sbjct:   599 CLYGKKPFGHNQSQQDILQENTILKATEVQFPPKPGVSPEAKAFIRRCLVYRKEDRIDVH 658

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPV 586
              LA   YL P + K    + +SS  V
Sbjct:   659 QLASDPYLLPHIRKSVAATGNSSMAV 684

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

UNIPROTKB|E1C3U2 E1C3U2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1351 (480.6 bits), Expect = 1.1e-169, Sum P(4) = 1.1e-169
 Identities = 248/327 (75%), Positives = 283/327 (86%)

Query:   261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
             +NLHIRELKRIHNED S+F +HP L+DRYLLL LLG+GGFSEV+KAFDL EQRYVA K+H
Sbjct:   357 RNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIH 416

Query:   321 QLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
             QLNK+W+++KK NY KHA REY IHK LDHPR+VKLYD F +D +SFCTVLEYC+G+DLD
Sbjct:   417 QLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD 476

Query:   381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             FYLKQHK ++E+EARSI+MQ+V+ALKYLNEIKPP+IHYDLKPGNILL  G  CGEIKITD
Sbjct:   477 FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 536

Query:   441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
             FGLSK+MD+++YN   GM+LTSQGAGTYWYLPPECFVVGK PPKIS+KVDVWSVGVIFYQ
Sbjct:   537 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 596

Query:   501 CLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             CLYG+KPFGHNQSQ  IL+ENTILKATEVQF  KP V+ EAK FIR CLAYRKEDRIDV 
Sbjct:   597 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVTPEAKAFIRRCLAYRKEDRIDVQ 656

Query:   561 SLARHDYLQPPVPKHGRQSASSSAPVG 587
              LA   YL P    H R+S S+S+P G
Sbjct:   657 QLACDPYLLP----HIRKSVSTSSPAG 679

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001672 "regulation of chromatin assembly or disassembly" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005882 "intermediate filament" evidence=IEA

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0007059 "chromosome segregation" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0032435 "negative regulation of proteasomal ubiquitin-dependent protein catabolic process" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0071480 "cellular response to gamma radiation" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P34314	TLK1_CAEEL	2, ., 7, ., 1, 1, ., 1	0.5303	0.6666	0.4331	yes	N/A
Q1ECX4	TLK2_DANRE	2, ., 7, ., 1, 1, ., 1	0.5877	0.6602	0.5939	yes	N/A
Q86UE8	TLK2_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5898	0.6985	0.5673	yes	N/A
O55047	TLK2_MOUSE	2, ., 7, ., 1, 1, ., 1	0.5858	0.6634	0.5793	yes	N/A
Q39238	TSL_ARATH	2, ., 7, ., 1, 1, ., 1	0.5987	0.4816	0.4389	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	627
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-79
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-63
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-58
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-49
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-42
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-37
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-35
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-31
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-31
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-31
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-31
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-30
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-29
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-29
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-28
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-28
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-28
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-25
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-25
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-25
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-25
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-24
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-24
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-23
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-23
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-22
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-22
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-21
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-21
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-21
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-21
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-19
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-17
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-17
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-16
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-14
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-07
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-04
cd05155	235	cd05155, APH_ChoK_like_1, Uncharacterized bacteria	0.001
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.001
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  250 bits (640), Expect = 7e-79
 Identities = 98/280 (35%), Positives = 139/280 (49%), Gaps = 26/280 (9%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  LG+G F +V+ A D K  + VA KV  + K     K     +  LRE  I K L
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKV--IKKK----KIKKDRERILREIKILKKL 54

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +V+LYDVFE D +    V+EYC+G DL   LK+   ++E EAR  + Q++SAL+YL
Sbjct: 55  KHPNIVRLYDVFE-DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +     ++H DLKP NILL E    G +K+ DFGL++ +D          +  +   GT 
Sbjct: 114 HSKG--IVHRDLKPENILLDE---DGHVKLADFGLARQLDPG--------EKLTTFVGTP 160

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y+ PE              VD+WS+GVI Y+ L GK PF  +     + +   I K   
Sbjct: 161 EYMAPEVL----LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK--KIGKPKP 214

Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                +  +S EAK  IR  L    E R+      +H + 
Sbjct: 215 PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  210 bits (536), Expect = 1e-63
 Identities = 97/282 (34%), Positives = 137/282 (48%), Gaps = 24/282 (8%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y LL  LG G F  V+KA      + VA K        K  +K+   + A RE  I + L
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVK-----ILKKRSEKSKKDQTARREIRILRRL 55

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +V+L D FE D +    V+EYC+G DL  YL +   ++E EA+ I +Q++  L+YL
Sbjct: 56  SHPNIVRLIDAFE-DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +     +IH DLKP NILL E    G +KI DFGL+K + + + +            GT 
Sbjct: 115 HSNG--IIHRDLKPENILLDEN---GVVKIADFGLAKKLLKSSSSLTT-------FVGTP 162

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE--ENTILKA 526
           WY+ PE  V+         KVDVWS+GVI Y+ L GK PF   ++    L+     +   
Sbjct: 163 WYMAPE--VLLGGNG-YGPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPP 218

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            E       + S EAK  I+ CL      R     + +H + 
Sbjct: 219 LEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  194 bits (496), Expect = 2e-58
 Identities = 86/272 (31%), Positives = 118/272 (43%), Gaps = 59/272 (21%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+GGF  V+ A D K  + VA K+  + K+          +  LRE  I K L+HP +V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKI--IKKEDSSSLL----EELLREIEILKKLNHPNIV 54

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KLY VFE D N    V+EYC+G  L D   +    ++E E   I++Q++  L+YL+    
Sbjct: 55  KLYGVFE-DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG- 112

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL   N  G++K+ DFGLSK++  +         L     GT  Y+ P
Sbjct: 113 -IIHRDLKPENILLDSDN--GKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAP 162

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E           S K D+WS+GVI Y+                                 
Sbjct: 163 EVL---LGKGYYSEKSDIWSLGVILYEL-------------------------------- 187

Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
                 E K  IR  L    E R     +  H
Sbjct: 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  170 bits (433), Expect = 8e-49
 Identities = 89/263 (33%), Positives = 125/263 (47%), Gaps = 27/263 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LGKG F +V         +  A KV  L K  K+  K   ++H L E NI   ++HP +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKK--KKIIKRKEVEHTLTERNILSRINHPFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KL+  F+        VLEY  G +L  +L +    +E  AR    ++V AL+YL+ +   
Sbjct: 57  KLHYAFQ-TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG-- 113

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +I+ DLKP NILL      G IK+TDFGL+K +  E          T+   GT  YL PE
Sbjct: 114 IIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEG-------SRTNTFCGTPEYLAPE 163

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++GK        VD WS+GV+ Y+ L GK PF     +        ILK   ++F   
Sbjct: 164 -VLLGK---GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY---EKILKD-PLRF--P 213

Query: 535 PTVSNEAKGFIRSCLAYRKEDRI 557
             +S EA+  I   L      R+
Sbjct: 214 EFLSPEARDLISGLLQKDPTKRL 236

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  168 bits (429), Expect = 4e-48
 Identities = 83/269 (30%), Positives = 131/269 (48%), Gaps = 37/269 (13%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y ++  +GKG F +V+      + +    K   L+   +++++      AL E  I K 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERED-----ALNEVKILKK 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVS 403
           L+HP ++K Y+ FE +    C V+EY DG DL   +K+ K       E +     +Q+  
Sbjct: 56  LNHPNIIKYYESFE-EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           ALKYL+  K  ++H D+KP NI LT   +   +K+ DFG+SKV+          +DL   
Sbjct: 115 ALKYLHSRK--ILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSST-------VDLAKT 162

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE--N 521
             GT +YL PE     +N P  + K D+WS+G + Y+    K PF     +   L E   
Sbjct: 163 VVGTPYYLSPELC---QNKP-YNYKSDIWSLGCVLYELCTLKHPF-----EGENLLELAL 213

Query: 522 TILKATEVQFANKPT-VSNEAKGFIRSCL 549
            ILK    Q+   P+  S+E +  + S L
Sbjct: 214 KILKG---QYPPIPSQYSSELRNLVSSLL 239

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  162 bits (410), Expect = 2e-44
 Identities = 99/294 (33%), Positives = 150/294 (51%), Gaps = 25/294 (8%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  LG+G F EV+ A D K    VA KV  L K  K + K+  ++  LRE  I  +L
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKV--LAK--KLESKSKEVERFLREIQILASL 54

Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK---QHKTIAEREARSIVMQVVSA 404
           +HP  +VKLYD F+ +  S   V+EY DG  L+  LK   +   ++E EA  I+ Q++SA
Sbjct: 55  NHPPNIVKLYDFFQDE-GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL+     +IH D+KP NILL        +K+ DFGL+K++ +           ++  
Sbjct: 114 LEYLHSKG--IIHRDIKPENILLDRDG--RVVKLIDFGLAKLLPDPGSTSSIPALPSTS- 168

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-------GHNQSQATI 517
            GT  Y+ PE  ++G +    SS  D+WS+G+  Y+ L G  PF         +Q+   I
Sbjct: 169 VGTPGYMAPE-VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
           LE  T   A+ +  +N   +S  A   ++  LA   ++R+   S   HD L   
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281

Length = 384

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  153 bits (388), Expect = 3e-42
 Identities = 75/277 (27%), Positives = 118/277 (42%), Gaps = 31/277 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLG+G F  V+ A D      +A K  +L+ D +E+ +A       RE  I  +L HP +
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-----LEREIRILSSLQHPNI 61

Query: 354 VKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           V+ Y    + + N+    LEY  G  L   LK+   + E   R    Q++  L YL+   
Sbjct: 62  VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             ++H D+K  NIL+      G +K+ DFG +K + +         + T    GT +++ 
Sbjct: 122 --IVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIETG-----EGTGSVRGTPYWMA 171

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE     +         D+WS+G    +   GK P+    +    L    I  + E    
Sbjct: 172 PEVIRGEEY----GRAADIWSLGCTVIEMATGKPPWSELGNPMAAL--YKIGSSGEP--- 222

Query: 533 NKP----TVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
             P     +S EAK F+R CL    + R     L +H
Sbjct: 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  151 bits (384), Expect = 1e-41
 Identities = 91/296 (30%), Positives = 140/296 (47%), Gaps = 44/296 (14%)

Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNI-HKALD 349
            ++G+G FS V  A + +  +  A K+  L+K    KE KK  Y+K    E  +  +   
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKI--LDKRQLIKE-KKVKYVK---IEKEVLTRLNG 60

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP ++KLY  F+ D  +   VLEY    +L  Y++++ ++ E+  R    +++ AL+YL+
Sbjct: 61  HPGIIKLYYTFQ-DEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH 119

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT---SQGA- 465
                +IH DLKP NILL +      IKITDFG +KV+D  +    +  D T   SQ   
Sbjct: 120 SKG--IIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 466 ---------GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA 515
                    GT  Y+ PE  +  K         D+W++G I YQ L GK PF G N+   
Sbjct: 175 NRRRFASFVGTAEYVSPEL-LNEK---PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL- 229

Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI----SLARHDY 567
                 T  K  +++++  P    +AK  I   L    +DR+ V      L  H +
Sbjct: 230 ------TFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  139 bits (352), Expect = 3e-37
 Identities = 79/277 (28%), Positives = 118/277 (42%), Gaps = 27/277 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G    V+K       +  A K   ++ D        + K  LRE    ++ + P VV
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGD------EEFRKQLLRELKTLRSCESPYVV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           K Y  F         VLEY DG  L   LK+   I E     I  Q++  L YL+  +  
Sbjct: 63  KCYGAF-YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +IH D+KP N+L+   N  GE+KI DFG+SKV++         +D  +   GT  Y+ PE
Sbjct: 121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLEN-------TLDQCNTFVGTVTYMSPE 170

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ--SQATILEENTILKATEVQFA 532
                      S   D+WS+G+   +C  GK PF      S   +++   I         
Sbjct: 171 RI----QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--ICD-GPPPSL 223

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                S E + FI +CL    + R     L +H +++
Sbjct: 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  138 bits (351), Expect = 7e-37
 Identities = 75/223 (33%), Positives = 109/223 (48%), Gaps = 27/223 (12%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y  L  LG+G +  V+KA D K    VA K  +L+ + +E   +     ALRE ++ K L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPST----ALREISLLKEL 55

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKY 407
            HP +VKL DV          V EYCD  DL  YL +    ++    +SI+ Q++  L Y
Sbjct: 56  KHPNIVKLLDVI-HTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT--SQGA 465
            +  +  ++H DLKP NIL+      G +K+ DFGL++           G+ L   +   
Sbjct: 114 CHSHR--ILHRDLKPQNILINRD---GVLKLADFGLARA---------FGIPLRTYTHEV 159

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY  PE  +        S+ VD+WSVG IF + + GK  F
Sbjct: 160 VTLWYRAPEILL---GSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  133 bits (336), Expect = 5e-35
 Identities = 81/256 (31%), Positives = 115/256 (44%), Gaps = 19/256 (7%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           + KG +  V  A         A KV  + K     K  N +   L E +I      P VV
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV--IKKADMIRK--NQVDQVLTERDILSQAQSPYVV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KLY  F     +   V+EY  G DL   L+   ++ E  AR  + ++V AL+YL+     
Sbjct: 57  KLYYSF-QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG-- 113

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKV-MDEENYNPDHGMDLTSQGAGTYWYLPP 473
           +IH DLKP NIL+      G +K+TDFGLSKV +     N +       +  GT  Y+ P
Sbjct: 114 IIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  ++G+     S  VD WS+G I Y+ L G  PF     +        IL   ++++  
Sbjct: 171 E-VILGQGH---SKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---QNILNG-KIEWPE 222

Query: 534 KPTVSNEAKGFIRSCL 549
              VS+EA   I   L
Sbjct: 223 DVEVSDEAIDLISKLL 238

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  131 bits (331), Expect = 1e-34
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 27/270 (10%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + LL ++GKG F +V        ++  A K   +NK  K  +K   +++ L E  I + L
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKY--MNKQ-KCVEK-GSVRNVLNERRILQEL 57

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           +HP +V L+  F+ + N +  V++   G DL ++L Q    +E + +  + ++V AL+YL
Sbjct: 58  NHPFLVNLWYSFQDEENMY-LVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQGAGT 467
           +     +IH D+KP NILL E    G + ITDF ++ KV  +           T+  +GT
Sbjct: 117 HSKG--IIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDTL---------TTSTSGT 162

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
             Y+ PE           S  VD WS+GV  Y+CL GK+P+  +              A 
Sbjct: 163 PGYMAPEVL----CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218

Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            +      T S EA   I   L    + R+
Sbjct: 219 VL---YPATWSTEAIDAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (329), Expect = 3e-34
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 29/274 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKGGF EV+KA   +  + VA KV +L    KE K+       + E  I K   HP +V
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKI-----INEIQILKKCKHPNIV 60

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  + +  +    V+E+C G  L   LK   +T+ E +   +  +++  L+YL+    
Sbjct: 61  KYYGSY-LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH D+K  NILLT     GE+K+ DFGLS  +   +    + M       GT +++ P
Sbjct: 119 -IIHRDIKAANILLTSD---GEVKLIDFGLSAQL--SDTKARNTM------VGTPYWMAP 166

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+   P     K D+WS+G+   +   GK P+        + +  T          N
Sbjct: 167 E--VINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG---LRN 219

Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY 567
               S+E K F++ CL    E R     L +H +
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 1e-33
 Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 29/282 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            Y L  L+G+G F  V+K  +L+   +VA K   L K  +E      +K  ++E ++ K 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA-----LKSIMQEIDLLKN 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L HP +VK     E  ++S   +LEY +   L   +K+     E      V QV+  L Y
Sbjct: 56  LKHPNIVKYIGSIE-TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+E    VIH D+K  NIL T+    G +K+ DFG++  +++         D +    GT
Sbjct: 115 LHEQG--VIHRDIKAANILTTKD---GVVKLADFGVATKLND-----VSKDDASV--VGT 162

Query: 468 -YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
            YW + PE  V+  +    S+  D+WS+G    + L G  P+ ++ +    L    I++ 
Sbjct: 163 PYW-MAPE--VIEMSG--ASTASDIWSLGCTVIELLTGNPPY-YDLNPMAALFR--IVQD 214

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                     +S E K F+  C       R     L +H ++
Sbjct: 215 DHPPLP--EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (317), Expect = 2e-32
 Identities = 74/222 (33%), Positives = 109/222 (49%), Gaps = 28/222 (12%)

Query: 295 LGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LG+G F EV+K        K++  VA K   L    KED     I+  LRE  I + LDH
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKT--L----KEDASEQQIEEFLREARIMRKLDH 60

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLN 409
           P VVKL  V   +      V+EY +G DL  YL++++  ++  +  S  +Q+   ++YL 
Sbjct: 61  PNVVKLLGVC-TEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                 IH DL   N L+ E  V    KI+DFGLS+ + +++Y    G  L        W
Sbjct: 120 SK--NFIHRDLAARNCLVGENLVV---KISDFGLSRDLYDDDYYRKRGGKLP-----IRW 169

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGH 510
            + PE    G    K +SK DVWS GV+ ++    G++P+  
Sbjct: 170 -MAPESLKEG----KFTSKSDVWSFGVLLWEIFTLGEQPYPG 206

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 1e-31
 Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 36/229 (15%)

Query: 295 LGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LG+G F EV+K     K+ +     V  L    KED      K  L+E  + K L HP V
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK---------TIAEREARSIVMQVVSA 404
           V+L  V   +      VLEY +G DL  YL++ +         T++ ++  S  +Q+   
Sbjct: 59  VRLLGVC-TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           ++YL   K   +H DL   N L+ E  V    KI+DFGLS+ + +++Y          + 
Sbjct: 118 MEYLASKK--FVHRDLAARNCLVGEDLVV---KISDFGLSRDVYDDDYY-------RKKT 165

Query: 465 AG---TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
            G     W + PE    G      +SK DVWS GV+ ++    G  P+ 
Sbjct: 166 GGKLPIRW-MAPESLKDG----IFTSKSDVWSFGVLLWEIFTLGATPYP 209

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 3e-31
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 22/222 (9%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y  +  +G+G + +V+KA + K    VA K  ++  +   ++K  +   A+RE  + + L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK--KIRME---NEKEGFPITAIREIKLLQKL 55

Query: 349 DHPRVVKLYD-VFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALK 406
            HP +V+L + V      S   V EY D HDL   L   +    E + +  + Q++  L+
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+     ++H D+K  NIL+      G +K+ DFGL++      Y   +  D T+    
Sbjct: 115 YLHSNG--ILHRDIKGSNILINND---GVLKLADFGLAR-----PYTKRNSADYTN-RVI 163

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T WY PPE  ++G    +   +VD+WSVG I  +   GK  F
Sbjct: 164 TLWYRPPE-LLLGAT--RYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  124 bits (313), Expect = 3e-31
 Identities = 84/312 (26%), Positives = 129/312 (41%), Gaps = 47/312 (15%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY LL  +G G +  V  A D +  R VA K  +++  + +   A   K  LRE  + + 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDA---KRILREIKLLRH 55

Query: 348 LDHPRVVKLYDVFEIDA----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           L H  ++ L D+    +    N    V E  +  DL   +K  + + +   +  + Q++ 
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILR 114

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            LKYL+     VIH DLKP NIL+     C ++KI DFGL++ +D +    D    LT +
Sbjct: 115 GLKYLHSAN--VIHRDLKPSNILVNSN--C-DLKICDFGLARGVDPD---EDEKGFLT-E 165

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQ----ATI 517
              T WY  PE  ++  +  + +  +D+WSVG IF + L  K  F       Q      +
Sbjct: 166 YVVTRWYRAPE--LLL-SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222

Query: 518 L----EE--NTILKATEVQFANK-------------PTVSNEAKGFIRSCLAYRKEDRID 558
           L    EE    I       +                P  S EA   +   L +  + RI 
Sbjct: 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT 282

Query: 559 VISLARHDYLQP 570
                 H YL  
Sbjct: 283 ADEALAHPYLAQ 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 3e-31
 Identities = 90/290 (31%), Positives = 123/290 (42%), Gaps = 31/290 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D + ++ ++G+G F EV    D    +  A KV  L K   +  K N I H   E +I  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV--LRK--SDMIKRNQIAHVRAERDILA 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
             D P +VKLY  F+ D      V+EY  G DL   L +     E  AR  + ++V AL 
Sbjct: 57  DADSPWIVKLYYSFQ-DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM----DEENYNPDHGMDLTS 462
            ++++    IH D+KP NIL+      G IK+ DFGL K M    D E Y  D    L  
Sbjct: 116 SVHKLG--FIHRDIKPDNILIDA---DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 463 QGAGTYWYLPPE-----CFVVGKN---PPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
                      +        VG      P++        + D WS+GVI Y+ LYG  PF
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Query: 509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
             +  Q T      I     ++F   P VS EA   I   L    EDR+ 
Sbjct: 231 YSDTLQETYN--KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG 277

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (307), Expect = 3e-31
 Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 29/221 (13%)

Query: 295 LGKGGFSEVHKAF---DLKEQRY-VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LG+G F EV+K         +   VA K   L +D  E +   +    LRE  I + LDH
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKT--LKEDASEQQIEEF----LREARIMRKLDH 60

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYL 408
           P +VKL  V   +      V+EY  G DL  YL++++   ++  +  S  +Q+   ++YL
Sbjct: 61  PNIVKLLGVC-TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  IH DL   N L+ E  V    KI+DFGLS+ + +++Y    G  L        
Sbjct: 120 ESKN--FIHRDLAARNCLVGENLVV---KISDFGLSRDLYDDDYYKVKGGKLP-----IR 169

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           W + PE    G    K +SK DVWS GV+ ++    G++P+
Sbjct: 170 W-MAPESLKEG----KFTSKSDVWSFGVLLWEIFTLGEEPY 205

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (306), Expect = 6e-31
 Identities = 79/271 (29%), Positives = 116/271 (42%), Gaps = 38/271 (14%)

Query: 295 LGKGGFSEVHKA--FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LG+G F EV+K       E       V  L +   E+++  +    L E +I K L HP 
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKLSHPN 62

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +V+L  V          V EY  G DL  +L++H   +  ++   + +Q+   ++YL   
Sbjct: 63  IVRLLGVC-TQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL   N L+TE  V    KI+DFGLS+ + E++Y    G           W  
Sbjct: 122 N--FVHRDLAARNCLVTENLVV---KISDFGLSRDIYEDDYYRKRGGGKLPI----KWM- 171

Query: 472 PPECFVVGKNPPKISSKVDVWSVGV----IFYQCLYGKKPFG--HNQSQATILEENTILK 525
            PE    G    K +SK DVWS GV    IF     G++P+    N+    +LE+   L 
Sbjct: 172 APESLKDG----KFTSKSDVWSFGVLLWEIFT---LGEQPYPGMSNEEVLELLEDGYRLP 224

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
             E          +E    +  C AY  EDR
Sbjct: 225 RPE-------NCPDELYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 2e-30
 Identities = 95/292 (32%), Positives = 134/292 (45%), Gaps = 44/292 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            + LLGKG    V         +  A KV  L+K  KE  K N +K  L E  I   LDH
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKV--LDK--KEMIKRNKVKRVLTEQEILATLDH 60

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYL 408
           P +  LY  F+ +    C V++YC G +L   L++   K ++E  AR    +V+ AL+YL
Sbjct: 61  PFLPTLYASFQTETY-LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP-DHGMDLTSQGA-- 465
           + +   +++ DLKP NILL E    G I ++DF LSK  D E           + + +  
Sbjct: 120 HLLG--IVYRDLKPENILLHES---GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 466 -------------------GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKK 506
                              GT  Y+ PE  V+  +     S VD W++G++ Y+ LYG  
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPE--VISGDGH--GSAVDWWTLGILLYEMLYGTT 230

Query: 507 PF-GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
           PF G N+   T    N ILK  EV F   P VS+ A+  IR  L      R+
Sbjct: 231 PFKGSNR-DETF--SN-ILK-KEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  118 bits (299), Expect = 6e-30
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 42/293 (14%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +GKG F  V K     + + +  K  +++     +K+   +   + E NI + L
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMTEKEKQQL---VSEVNILREL 56

Query: 349 DHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDL----DFYLKQHKTIAEREARSIVMQVVS 403
            HP +V+ YD     +N +   V+EYC+G DL        K+ K I E     I+ Q++ 
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116

Query: 404 ALK---YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           AL      ++    V+H DLKP NI L   N    +K+ DFGL+K++  ++         
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFGLAKILGHDSS-------F 166

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILE 519
                GT +Y+ PE   +         K D+WS+G + Y+      PF   NQ Q     
Sbjct: 167 AKTYVGTPYYMSPE--QLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQLQL---- 218

Query: 520 ENTILKATEVQFANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                 A++++      +    S+E    I+S L    + R     L +   +
Sbjct: 219 ------ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  118 bits (298), Expect = 1e-29
 Identities = 88/306 (28%), Positives = 129/306 (42%), Gaps = 46/306 (15%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY +L  +G+G    V KA D +    VA K   L +   E    N    ALRE    +A
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR--LEGGIPN---QALREIKALQA 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALK 406
             HP VVKL DVF    + F  V+EY    DL   L+   + + E + +S +  ++  + 
Sbjct: 56  CQHPYVVKLLDVFP-HGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y++     ++H DLKP N+L++     G +KI DFGL+++  EE         L S    
Sbjct: 114 YMHANG--IMHRDLKPANLLISAD---GVLKIADFGLARLFSEE------EPRLYSHQVA 162

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHN-------------- 511
           T WY  PE  + G    K    VD+W+VG IF + L G   F G N              
Sbjct: 163 TRWYRAPE-LLYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT 219

Query: 512 QSQATILEENTILKATEVQFANK---------PTVSNEAKGFIRSCLAYRKEDRIDVISL 562
            ++ T     ++    ++ F            P  S EA   ++  L Y    R+     
Sbjct: 220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279

Query: 563 ARHDYL 568
            RH Y 
Sbjct: 280 LRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 6e-29
 Identities = 85/314 (27%), Positives = 132/314 (42%), Gaps = 61/314 (19%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VH-QLNKDWKEDKKANYIKHA-LREYNIH 345
           Y  L  +G+G +  V+KA DL   R+VA K V   L+++         I  + LRE  + 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--------IPLSTLREIALL 52

Query: 346 KALD---HPRVVKLYDVFEIDANSFCT----VLEYCDGHDLDFYLKQH--KTIAEREARS 396
           K L+   HP +V+L DV              V E+ D  DL  YL +     +     + 
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKD 111

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           ++ Q++  + +L+  +  ++H DLKP NIL+T     G++KI DFGL+++   E      
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD---GQVKIADFGLARIYSFE------ 160

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
            M LTS    T WY  PE   V       +  VD+WSVG IF + L+ ++P     S+A 
Sbjct: 161 -MALTSVVV-TLWYRAPE---VLLQSSYATP-VDMWSVGCIFAE-LFRRRPLFRGTSEAD 213

Query: 517 ----ILE-----------ENTILKATEVQFANK-------PTVSNEAKGFIRSCLAYRKE 554
               I +            N  L  +              P +  E    ++  L +   
Sbjct: 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH 273

Query: 555 DRIDVISLARHDYL 568
            RI      +H Y 
Sbjct: 274 KRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 78/303 (25%), Positives = 121/303 (39%), Gaps = 55/303 (18%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA D      VA K  ++   ++ +      K ALRE  + K L+HP ++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESE---GIPKTALREIKLLKELNHPNII 61

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KL DVF         V E+ D  DL   +K + + + E   +S + Q++  L + +    
Sbjct: 62  KLLDVFR-HKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--SH 117

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            ++H DLKP N+L+    V   +K+ DFGL++               T     T WY  P
Sbjct: 118 GILHRDLKPENLLINTEGV---LKLADFGLARSFG-----SPVRP-YTHYVV-TRWYRAP 167

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL-------- 524
           E  +        S+ VD+WSVG IF + L  +  F G ++    I +   I         
Sbjct: 168 ELLL---GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE----IDQLFKIFRTLGTPDP 220

Query: 525 ----KATEVQFANK---------------PTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
               K T +    K               P  S +A   +   L Y    RI       H
Sbjct: 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280

Query: 566 DYL 568
            Y 
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  113 bits (286), Expect = 3e-28
 Identities = 78/269 (28%), Positives = 118/269 (43%), Gaps = 36/269 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG GGF  V       + R  A K   + K    +      +H   E  I +  +HP +V
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC--VKKRHIVETGQQ--EHIFSEKEILEECNHPFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KLY  F+ D      ++EYC G +L   L+      E  AR  +  VV A +YL+     
Sbjct: 57  KLYRTFK-DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG-- 113

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +I+ DLKP N+LL      G +K+ DFG +K +  ++              GT  Y+ PE
Sbjct: 114 IIYRDLKPENLLLDSN---GYVKLVDFGFAKKL--KSGQKTWTF------CGTPEYVAPE 162

Query: 475 CFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE- 528
                     I +K     VD WS+G++ Y+ L G+ PFG +      +  + ILK    
Sbjct: 163 I---------ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-ILKGNGK 212

Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
           ++F N   +   AK  I+  L    E+R+
Sbjct: 213 LEFPNY--IDKAAKDLIKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  113 bits (285), Expect = 4e-28
 Identities = 78/282 (27%), Positives = 116/282 (41%), Gaps = 30/282 (10%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L  LG G    V K       + +A K  +L  +          K  LRE +I    + P
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI------QKQILRELDILHKCNSP 59

Query: 352 RVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLN 409
            +V  Y  F  + + S C  +EY DG  LD  LK+    I ER    I + V+  L YL+
Sbjct: 60  YIVGFYGAFYNNGDISIC--MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           E K  +IH D+KP NIL+      G+IK+ DFG+S  +            L     GT  
Sbjct: 118 E-KHKIIHRDVKPSNILVNSR---GQIKLCDFGVSGQLVN---------SLAKTFVGTSS 164

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENT-ILKAT 527
           Y+ PE           S K D+WS+G+   +   G+ P+   N     I E    I+   
Sbjct: 165 YMAPERI----QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220

Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +  +    S + + F+  CL     +R     L  H +++
Sbjct: 221 PPRLPSGK-FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  114 bits (287), Expect = 9e-28
 Identities = 96/324 (29%), Positives = 139/324 (42%), Gaps = 59/324 (18%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  RY+ L  LG G    V  A D    + VA K     K    D ++  +KHALRE  I
Sbjct: 3   LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK-----KIVLTDPQS--VKHALREIKI 55

Query: 345 HKALDHPRVVKLYDVF-------------EIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
            + LDH  +VK+Y+V                + NS   V EY +  DL   L+Q   ++E
Sbjct: 56  IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSE 113

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEE 450
             AR  + Q++  LKY++     V+H DLKP N+ + TE  V   +KI DFGL++++D  
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLV---LKIGDFGLARIVDPH 168

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-- 508
             +  +     S+G  T WY  P   +   +P   +  +D+W+ G IF + L GK  F  
Sbjct: 169 YSHKGY----LSEGLVTKWYRSPRLLL---SPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221

Query: 509 GHNQSQAT-ILE---------ENTILKATEVQFANK------------PTVSNEAKGFIR 546
            H   Q   ILE          N +L        N             P V+ EA  F+ 
Sbjct: 222 AHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLE 281

Query: 547 SCLAYRKEDRIDVISLARHDYLQP 570
             L +   DR+       H Y+  
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  110 bits (277), Expect = 3e-27
 Identities = 78/286 (27%), Positives = 133/286 (46%), Gaps = 41/286 (14%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACK---VHQLNKDWKEDKKANYIKHALREYNI 344
            + +L  LGKG +  V+K   L + ++ A K   +  +++  +ED        A+ E  I
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED--------AVNEIRI 52

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT----IAEREARSIVMQ 400
             +++HP ++   + F +D N  C V+EY    DL   + + K     I E+E   I +Q
Sbjct: 53  LASVNHPNIISYKEAF-LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  L+ L+E K  ++H DLK  NILL        +KI D G+SKV+ +         ++
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVAN---DLVKIGDLGISKVLKK---------NM 157

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                GT  Y+ PE   V K  P  S K D+WS+G + Y+      PF     +A  +++
Sbjct: 158 AKTQIGTPHYMAPE---VWKGRP-YSYKSDIWSLGCLLYEMATFAPPF-----EARSMQD 208

Query: 521 NTILKATEVQFANKPTV-SNEAKGFIRSCLAYRKEDRIDVISLARH 565
               K    ++   P + S + + FIRS L  + + R +   +   
Sbjct: 209 LR-YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  111 bits (280), Expect = 3e-27
 Identities = 85/270 (31%), Positives = 123/270 (45%), Gaps = 44/270 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D +  +  LG G F  V         +Y A K+  L+K   +  K   ++H L E  I +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI--LSKA--KIVKLKQVEHVLNEKRILQ 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           ++ HP +V LY  F+ D ++   V+EY  G +L  +L++     E  AR    QVV AL+
Sbjct: 57  SIRHPFLVNLYGSFQ-DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 407 YL--NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           YL   +I    ++ DLKP N+LL      G IKITDFG +K +    Y            
Sbjct: 116 YLHSLDI----VYRDLKPENLLLD---SDGYIKITDFGFAKRVKGRTYTL---------- 158

Query: 465 AGTYWYLPPECFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
            GT  YL PE          I SK     VD W++G++ Y+ L G  PF  +        
Sbjct: 159 CGTPEYLAPE---------IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-- 207

Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCL 549
              IL+  +V+F      S +AK  IR+ L
Sbjct: 208 -EKILEG-KVRFP--SFFSPDAKDLIRNLL 233

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  110 bits (277), Expect = 1e-26
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY     LG+G ++ V+KA D +  R VA K  +L +  +     N+   ALRE  + + 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT--ALREIKLLQE 58

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA--RSIVMQVVSAL 405
           L HP ++ L DVF   +N    V E+ +  DL+  +K  K+I    A  +S ++  +  L
Sbjct: 59  LKHPNIIGLLDVFGHKSN-INLVFEFMET-DLEKVIKD-KSIVLTPADIKSYMLMTLRGL 115

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +YL+     ++H DLKP N+L+      G +K+ DFGL++     N        +T Q  
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASD---GVLKLADFGLARSFGSPNRK------MTHQ-V 163

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
            T WY  PE     +        VD+WSVG IF
Sbjct: 164 VTRWYRAPELLFGAR---HYGVGVDMWSVGCIF 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 2e-26
 Identities = 70/223 (31%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 295 LGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LG G F  V K  + +K  + V   V  L    K++  A   K  LRE ++   LDHP +
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL----KQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V+L  V +        V+E      L  YLK+ + I   + + +  QV   + YL     
Sbjct: 59  VRLIGVCK--GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115

Query: 414 PVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTY-- 468
             +H DL   N+LL          KI+DFG+S+ +    + Y         +  AG +  
Sbjct: 116 -FVHRDLAARNVLLVNRHQA----KISDFGMSRALGAGSDYY--------RATTAGRWPL 162

Query: 469 -WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
            WY  PEC   G    K SSK DVWS GV  ++   YG KP+G
Sbjct: 163 KWY-APECINYG----KFSSKSDVWSYGVTLWEAFSYGAKPYG 200

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (269), Expect = 4e-26
 Identities = 80/284 (28%), Positives = 129/284 (45%), Gaps = 30/284 (10%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            + + +L  LG+G +  V+KA   +  + VA KV  + +D +E  K         E +I 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK---------EISIL 52

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQHKTIAEREARSIVMQVVSA 404
           K  D P +VK Y  +  +      V+EYC  G   D     +KT+ E E  +I+ Q +  
Sbjct: 53  KQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL+  K   IH D+K GNILL E    G+ K+ DFG+S  +          M   +  
Sbjct: 112 LEYLHSNK--KIHRDIKAGNILLNEE---GQAKLADFGVSGQL-------TDTMAKRNTV 159

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            GT +++ PE  V+ +     ++K D+WS+G+   +   GK P+        I     I 
Sbjct: 160 IGTPFWMAPE--VIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---MIP 212

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                  ++    S E   F++ CL    E+R   I L +H ++
Sbjct: 213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (267), Expect = 8e-26
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 29/287 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           R+     +G G F +V+ A +L     +A K  ++     +D     IK    E  + + 
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI-----QDNDPKTIKEIADEMKVLEL 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L HP +VK Y V E+        +EYC G  L+  L+  + + E   R   +Q++  L Y
Sbjct: 56  LKHPNLVKYYGV-EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAY 114

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+     ++H D+KP NI L      G IK+ DFG +  + + N         +   AGT
Sbjct: 115 LHSHG--IVHRDIKPANIFLDH---NGVIKLGDFGCAVKL-KNNTTTMGEEVQSL--AGT 166

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
             Y+ PE    GK      +  D+WS+G +  +   GK+P+           +N      
Sbjct: 167 PAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPW-SEL-------DNEFQIMF 217

Query: 528 EVQFANKPT------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            V   +KP       +S E K F+  CL    + R     L +H ++
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (265), Expect = 3e-25
 Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 61/297 (20%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G   EV+KA D    + VA K  +L K  KE      I     E  I K   HP +V
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKE-----LII---NEILIMKDCKHPNIV 78

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKP 413
             YD + +  +    V+EY DG  L   + Q+   + E +   +  +V+  L+YL+    
Sbjct: 79  DYYDSYLVG-DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQ 135

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA------GT 467
            VIH D+K  NILL++    G +K+ DFG                 LT + +      GT
Sbjct: 136 NVIHRDIKSDNILLSKD---GSVKLADFG-------------FAAQLTKEKSKRNSVVGT 179

Query: 468 -YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
            YW + PE  V+ +       KVD+WS+G++  +   G+ P+         L E   L+A
Sbjct: 180 PYW-MAPE--VIKRKD--YGPKVDIWSLGIMCIEMAEGEPPY---------LREPP-LRA 224

Query: 527 T---------EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
                      ++   K   S E K F+  CL    E R     L +H +L+   PK
Sbjct: 225 LFLITTKGIPPLKNPEK--WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (262), Expect = 4e-25
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 16/277 (5%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR-EYNIHKALDH 350
           L+GKG +  V+ A ++     +A K  +L      + D +   +  ALR E    K LDH
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             +V+ Y  FE         LEY  G  +   L+ +    E+  R    QV+  L YL+ 
Sbjct: 68  LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH- 125

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               ++H DLK  N+L+    +C   KI+DFG+SK  D+  Y+ D  M +     G+ ++
Sbjct: 126 -SKGILHRDLKADNLLVDADGIC---KISDFGISKKSDDI-YDNDQNMSMQ----GSVFW 176

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE  V+       S+KVD+WS+G +  +   G++P+   ++ A + +      A  + 
Sbjct: 177 MAPE--VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIP 234

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY 567
                 +S  A  F+ +C     ++R     L +H +
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  104 bits (261), Expect = 5e-25
 Identities = 89/291 (30%), Positives = 132/291 (45%), Gaps = 44/291 (15%)

Query: 289 YLLLMLLGKGGFSEVHKA-FDLKEQRYVACK---VHQLN--KDWKEDKKANYIKHALREY 342
           Y +L  LG G F  V+K       Q  +A K   VH     KD +E  K+  I   + E 
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS--IGDIVSEV 59

Query: 343 NIHK-ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSI 397
            I K  L HP +V+ Y  F ++ +    V++  +G  L  +     ++ +   E    +I
Sbjct: 60  TIIKEQLRHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            +Q+V AL+YL++ K  ++H DL P NI+L E +   ++ ITDFGL+K    E+      
Sbjct: 119 FVQMVLALRYLHKEKR-IVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESK----- 169

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             LTS   GT  Y  PE   + KN P    K DVW+ G I YQ    + PF         
Sbjct: 170 --LTSV-VGTILYSCPE---IVKNEP-YGEKADVWAFGCILYQMCTLQPPFYST------ 216

Query: 518 LEENTILKATEVQFA-----NKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
              N +  AT++  A      +   S +    I SCL    E R D+I ++
Sbjct: 217 ---NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (264), Expect = 5e-25
 Identities = 88/282 (31%), Positives = 143/282 (50%), Gaps = 32/282 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPR 352
           ++GKG F +V  A    E+++ A KV Q     K+ ++    KH + E N+  K + HP 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE----KHIMSERNVLLKNVKHPF 57

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +V L+  F+  A+    VL+Y +G +L ++L++ +   E  AR    ++ SAL YL+ + 
Sbjct: 58  LVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +++ DLKP NILL      G I +TDFGL K    EN   +     TS   GT  YL 
Sbjct: 117 --IVYRDLKPENILLDSQ---GHIVLTDFGLCK----ENIEHN---GTTSTFCGTPEYLA 164

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE  V+ K P      VD W +G + Y+ LYG  PF ++++ A +  +N + K  ++   
Sbjct: 165 PE--VLHKQP--YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMY-DNILNKPLQL--- 215

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYLQP 570
            KP ++N A+  +   L   +  R+    D + +  H +  P
Sbjct: 216 -KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  105 bits (263), Expect = 8e-25
 Identities = 88/284 (30%), Positives = 130/284 (45%), Gaps = 38/284 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPRV 353
           +GKG F +V  A    + ++ A KV  L K  K   K    KH + E N+  K + HP +
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQK--KAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V L+  F+  A+    VL+Y +G +L F+L++ ++  E  AR    ++ SAL YL+ +  
Sbjct: 59  VGLHYSFQ-TADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN- 116

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +I+ DLKP NILL      G + +TDFGL K    E          TS   GT  YL P
Sbjct: 117 -IIYRDLKPENILLDSQ---GHVVLTDFGLCK----EGIEHS---KTTSTFCGTPEYLAP 165

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEENTILKATEVQ 530
           E  V+ K P      VD W +G + Y+ LYG  PF      +    IL +   L      
Sbjct: 166 E--VLRKQP--YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL------ 215

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYLQP 570
              KP +S  A+  +   L   +  R+    D + +  H +   
Sbjct: 216 ---KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F +V+KA   +   + A K+ Q+     E++  +++     E +I     HP +V
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMV----EIDILSECKHPNIV 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
            LY+ +  + N    ++E+CDG  LD   L+  + + E + R +  Q++ AL +L+  K 
Sbjct: 66  GLYEAYFYE-NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK- 123

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DLK GNILLT     G++K+ DFG+S             +       GT +++ P
Sbjct: 124 -VIHRDLKAGNILLTLD---GDVKLADFGVSAKNKST-------LQKRDTFIGTPYWMAP 172

Query: 474 E---CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           E   C     NP     K D+WS+G+   + L   +P  H  +   +L +  ILK+    
Sbjct: 173 EVVACETFKDNP--YDYKADIWSLGITLIE-LAQMEPPHHELNPMRVLLK--ILKSEPPT 227

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                  S+    F++SCL    +DR     L +H ++ 
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (255), Expect = 2e-24
 Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 31/279 (11%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + +L  +GKG F  V K     ++R  A K   L+K  + +++      A+ E  +   L
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE-----AIDEARVLAKL 56

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALK 406
           D   +++ Y+ F +D      V+EY +  DL   LK    + + E +     +Q++  L 
Sbjct: 57  DSSYIIRYYESF-LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           +L+  K  ++H D+K  N+ L   +    +KI D G++K++ +         +  +   G
Sbjct: 116 HLHSKK--ILHRDIKSLNLFLDAYD---NVKIGDLGVAKLLSDNT-------NFANTIVG 163

Query: 467 TYWYLPPE-CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           T +YL PE C    ++ P  + K DVW++GV+ Y+C  GK PF  N   A IL+   I++
Sbjct: 164 TPYYLSPELC----EDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILK---IIR 215

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR 564
                 +     S +    I  CL      R D   L R
Sbjct: 216 GVFPPVSQM--YSQQLAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 33/236 (13%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +  + L+ ++G+G + +V+KA   K  + VA K+  + +D +E+     IK    EYNI 
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-----IKE---EYNIL 56

Query: 346 KAL-DHPRVVKLYDVF-----EIDANSFCTVLEYCDG---HDL-DFYLKQHKTIAEREAR 395
           +   +HP +   Y  F       + +    V+E C G    DL     K+ K + E    
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            I+ + +  L YL+E K  VIH D+K  NILLT+     E+K+ DFG+S  +D       
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKN---AEVKLVDFGVSAQLDSTLGR-- 169

Query: 456 HGMDLTSQGAGT-YWYLPPECFVVGKNP-PKISSKVDVWSVGVIFYQCLYGKKPFG 509
                 +   GT YW + PE     + P     ++ DVWS+G+   +   GK P  
Sbjct: 170 -----RNTFIGTPYW-MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  101 bits (252), Expect = 5e-24
 Identities = 70/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY+L   LGKG F  V+   D K       KV  L +    +   N    A +E  +   
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKV--LKEIPVGELNPNETVQANQEAQLLSK 58

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVS 403
           LDHP +VK +  F ++ ++FC + EYC+G DLD  L++ K    T++E +     +Q++ 
Sbjct: 59  LDHPAIVKFHASF-LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            + Y+++ +  ++H DLK  NI L + N+   +KI DFG+S+++           DL + 
Sbjct: 118 GVHYMHQRR--ILHRDLKAKNIFL-KNNL---LKIGDFGVSRLLMGS-------CDLATT 164

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ--CL 502
             GT +Y+ PE            SK D+WS+G I Y+  CL
Sbjct: 165 FTGTPYYMSPEAL----KHQGYDSKSDIWSLGCILYEMCCL 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  101 bits (252), Expect = 7e-24
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 38/270 (14%)

Query: 295 LGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LG G F  V K      K ++ VA K+ +      ++         LRE N+ + LD+P 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILK-----NDNNDPALKDELLREANVMQQLDNPY 57

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +V++  + E  A S+  V+E  +   L+ +L+++K + E+    +V QV   +KYL E  
Sbjct: 58  IVRMIGICE--AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE-ENYNPDHGMDLTSQGAGTY--- 468
              +H DL   N+LL   +     KI+DFGLSK +   ENY         ++  G +   
Sbjct: 116 --FVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENY-------YKAKTHGKWPVK 163

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKA 526
           WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   ++ T + E+     
Sbjct: 164 WY-APECM----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG---- 214

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
              +         E    ++ C  Y  ++R
Sbjct: 215 --ERMECPQRCPPEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 83/319 (26%), Positives = 133/319 (41%), Gaps = 75/319 (23%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHK 346
           Y ++  LG G F  V+ A + +    VA K    +    W+E      +   LRE    K
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEE-----CMN--LREV---K 49

Query: 347 AL----DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQV 401
           +L    +HP +VKL +VF  + +    V EY +G+       +  K  +E   RSI+ Q+
Sbjct: 50  SLRKLNEHPNIVKLKEVF-RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  L +++  K    H DLKP N+L++   V   +KI DFGL++ +   +  P      T
Sbjct: 109 LQGLAHIH--KHGFFHRDLKPENLLVSGPEV---VKIADFGLAREI--RSRPP-----YT 156

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-F-GHNQSQATILE 519
                T WY  PE  ++ ++    SS VD+W++G I  + LY  +P F G +       E
Sbjct: 157 DY-VSTRWYRAPE--ILLRS-TSYSSPVDIWALGCIMAE-LYTLRPLFPGSS-------E 204

Query: 520 ENTILKATEV-------------QFANK-----------------PTVSNEAKGFIRSCL 549
            + + K   V             + A+K                 P  S EA   I+  L
Sbjct: 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDML 264

Query: 550 AYRKEDRIDVISLARHDYL 568
            +  + R       +H Y 
Sbjct: 265 RWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  101 bits (252), Expect = 2e-23
 Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 32/279 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F +V    +    +Y A K+  L K+    K  + + H L E  + +   HP +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKI--LKKEVIIAK--DEVAHTLTESRVLQNTRHPFL 57

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
             L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++VSAL YL+    
Sbjct: 58  TALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD- 115

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V++ DLK  N++L +    G IKITDFGL K  +  +              GT  YL P
Sbjct: 116 -VVYRDLKLENLMLDKD---GHIKITDFGLCK--EGISDG-----ATMKTFCGTPEYLAP 164

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F  
Sbjct: 165 E--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---LILMEEIRFPR 216

Query: 534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDY 567
             T+S EAK  +   L    + R+     D   +  H +
Sbjct: 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 77/282 (27%), Positives = 119/282 (42%), Gaps = 36/282 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLG+G F  V+  +D+   R +A K    + D  E K    +     E  + K L H R+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETK--KEVNALECEIQLLKNLQHERI 66

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL--NEI 411
           V+ Y     D  +    +EY  G  +   LK +  + E   R    Q++  ++YL  N I
Sbjct: 67  VQYYGCLRDDE-TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA------ 465
               +H D+K  NIL    +  G +K+ DFG SK +            + S G       
Sbjct: 126 ----VHRDIKGANILR---DSAGNVKLGDFGASKRLQT----------ICSSGTGMKSVT 168

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT +++ PE  V+  +      K DVWSVG    + L  K P+   ++ A I +  T  +
Sbjct: 169 GTPYWMSPE--VI--SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--Q 222

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY 567
            T  Q      VS +A+ F+R       + R     L RH +
Sbjct: 223 PTNPQLP--SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 3e-23
 Identities = 90/286 (31%), Positives = 135/286 (47%), Gaps = 39/286 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY  L  +G G + +V  AFD K  R VA K  +L++ ++    A   K   RE  + K
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHA---KRTYRELRLLK 69

Query: 347 ALDHPRVVKLYDVFEIDA--NSFCTVLEYCDGH----DLDFYLKQHKTIAEREARSIVMQ 400
            +DH  V+ L DVF   +    F  V  Y   H    DL+  +K  K +++   + +V Q
Sbjct: 70  HMDHENVIGLLDVFTPASSLEDFQDV--YLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQ 126

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  LKY++     +IH DLKP NI + E   C E+KI DFGL++  D+E         +
Sbjct: 127 ILRGLKYIHSAG--IIHRDLKPSNIAVNED--C-ELKILDFGLARHTDDE---------M 172

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATI 517
           T     T WY  PE   +  N    +  VD+WSVG I  + L GK  F    H      I
Sbjct: 173 T-GYVATRWYRAPE---IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
           +    ++   + +   K + S  A+ +I+S     K+D  +V S A
Sbjct: 229 MN---LVGTPDEELLQKIS-SESARNYIQSLPQMPKKDFKEVFSGA 270

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 25/218 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG FS V+KA  L + R VA K  Q+ +    D KA   +  L+E ++ K LDHP V+
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFE--MMDAKAR--QDCLKEIDLLKQLDHPNVI 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYLNE 410
           K    F I+ N    VLE  D  DL   +K    Q + I ER      +Q+ SAL++++ 
Sbjct: 66  KYLASF-IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  ++H D+KP N+ +T     G +K+ D GL +    +           S   GT +Y
Sbjct: 125 KR--IMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKT------TAAHSL-VGTPYY 172

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           + PE   + +N     S  D+WS+G + Y+    + PF
Sbjct: 173 MSPE--RIHENGYNFKS--DIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 73/237 (30%), Positives = 114/237 (48%), Gaps = 35/237 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK---VHQLNKDWKEDKKANYIKHALREYN 343
             Y +L  LG+G F EV+KA  +K  R VA K   +H        ++K  +   ALRE  
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH--------NEKDGFPITALREIK 59

Query: 344 IHKALDHPRVVKLYDVF-------EIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREAR 395
           I K L HP VV L D+        +    S   V  Y D HDL   L+     + E + +
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIK 118

Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
             ++Q++  + YL+E    ++H D+K  NIL+   +  G +KI DFGL++  D    NP 
Sbjct: 119 CYMLQLLEGINYLHENH--ILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPK 173

Query: 456 HGM-----DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
            G        T+    T WY PPE  +  +     ++ VD+W +G +F + ++ ++P
Sbjct: 174 GGGGGGTRKYTNL-VVTRWYRPPELLLGERR---YTTAVDIWGIGCVFAE-MFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 22/223 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y +L ++G+G +  V K  +      VA K  + ++D ++ KK      ALRE  + +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT-----ALREVKVLR 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA-RSIVMQVVSAL 405
            L H  +V L + F      +  V EY +   L+  L+        +A RS + Q++ A+
Sbjct: 56  QLRHENIVNLKEAFRRKGRLY-LVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAI 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y +     +IH D+KP NIL++E  V   +K+ DFG ++ +     +P     LT   A
Sbjct: 114 AYCHSHN--IIHRDIKPENILVSESGV---LKLCDFGFARALRARPASP-----LTDYVA 163

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY  PE  V           VDVW++G I  + L G+  F
Sbjct: 164 -TRWYRAPELLV---GDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 98.5 bits (245), Expect = 2e-22
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 31/274 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY  L  +G G +  V  A D +    VA K  +L + ++ +  A   K A RE  + K
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFA---KRAYRELRLLK 69

Query: 347 ALDHPRVVKLYDVFEIDA-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
            + H  V+ L DVF  D      + F  V+ +  G DL   +K H+ ++E   + +V Q+
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQM 127

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  LKY++     +IH DLKPGN+ + E   C E+KI DFGL++  D E           
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNED--C-ELKILDFGLARQTDSE----------M 172

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
           +    T WY  PE  +   N    +  VD+WSVG I  + L GK  F  +     ++E  
Sbjct: 173 TGYVVTRWYRAPEVIL---NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229

Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKED 555
            +      +F  K   S +AK +++    +RK+D
Sbjct: 230 KVTGTPSKEFVQK-LQSEDAKNYVKKLPRFRKKD 262

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 97.2 bits (242), Expect = 5e-22
 Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 43/276 (15%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIK------HALREY 342
           L +LGKGG+ +V +   +      +  A KV          KKA  ++      H   E 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL---------KKATIVRNQKDTAHTKAER 51

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           NI +A+ HP +V L   F+     +  +LEY  G +L  +L++     E  A   + ++ 
Sbjct: 52  NILEAVKHPFIVDLIYAFQTGGKLY-LILEYLSGGELFMHLEREGIFMEDTACFYLSEIS 110

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            AL++L+  +  +I+ DLKP NILL   +  G +K+TDFGL K    E         +T 
Sbjct: 111 LALEHLH--QQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEG-------TVTH 158

Query: 463 QGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
              GT  Y+ PE  +  G         VD WS+G + Y  L G  PF     + TI   +
Sbjct: 159 TFCGTIEYMAPEILMRSGHG-----KAVDWWSLGALMYDMLTGAPPFTAENRKKTI---D 210

Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            ILK    +    P ++ EA+  ++  L      R+
Sbjct: 211 KILKG---KLNLPPYLTPEARDLLKKLLKRNPSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 28/223 (12%)

Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARS 396
           AL E  I   L HP ++  Y+ F +D N+    +EY +G  L D  ++Q   + E E   
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHF-MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL 104

Query: 397 IVM-QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
             + Q+VSA+ Y+++    ++H D+K  NI LT+  +   IK+ DFG+SK++       +
Sbjct: 105 WYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGL---IKLGDFGISKIL-----GSE 154

Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ 514
           + M  T    GT +Y+ PE    G    K + K D+W++G + Y+ L  K+ F   N   
Sbjct: 155 YSMAETV--VGTPYYMSPE-LCQGV---KYNFKSDIWALGCVLYELLTLKRTFDATNPL- 207

Query: 515 ATILEENTILKATEVQFANKPTV-SNEAKGFIRSCLAYRKEDR 556
                 N ++K  +  +    +V S+E    + S L    E R
Sbjct: 208 ------NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 95.0 bits (236), Expect = 7e-22
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 30/284 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY ++  +G+G F +++ A    +  +   K   L K   ++K+A+      +E  +   
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAK 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI--AEREARSIVMQVVSAL 405
           + HP +V  +  F+ +      V+EYCDG DL   + + + +  +E +  S  +Q+   L
Sbjct: 56  MKHPNIVTFFASFQ-ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K++++ K  ++H D+K  NI L++  +    K+ DFG+++ +++        M+L     
Sbjct: 115 KHIHDRK--ILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDS-------MELAYTCV 163

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT +YL PE   + +N P  ++K D+WS+G + Y+    K PF  N           +LK
Sbjct: 164 GTPYYLSPE---ICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLK 213

Query: 526 ATEVQFAN-KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             +  FA   P  S + +  I         DR  + S+ +  +L
Sbjct: 214 ICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 70/277 (25%), Positives = 130/277 (46%), Gaps = 26/277 (9%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y  L L+G+G +  V++   +   R VA K+  +N D  +D  ++ I+  +   +  +  
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKI--INLDTPDDDVSD-IQREVALLSQLRQS 59

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
             P + K Y  + +       ++EY +G  +   +K    IAE+    I+ +V+ ALKY+
Sbjct: 60  QPPNITKYYGSY-LKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYI 117

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  K  VIH D+K  NIL+T     G +K+ DFG++ ++++            S   GT 
Sbjct: 118 H--KVGVIHRDIKAANILVTNT---GNVKLCDFGVAALLNQ-------NSSKRSTFVGTP 165

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKAT 527
           +++ PE    GK      +K D+WS+G+  Y+   G  P+   +  +A +L    I K+ 
Sbjct: 166 YWMAPEVITEGK---YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML----IPKSK 218

Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR 564
             +       S   + F+ +CL    ++R+    L +
Sbjct: 219 PPRL-EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 24/278 (8%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPR 352
           ++GKG F +V  A    +  + A KV Q     K+ ++     H + E N+  K L HP 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ----NHIMAERNVLLKNLKHPF 57

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +V L+  F+  A     VL+Y +G +L F+L++ +   E  AR    +V SA+ YL+ + 
Sbjct: 58  LVGLHYSFQT-AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +I+ DLKP NILL   +  G + +TDFGL K    E   P+   + TS   GT  YL 
Sbjct: 117 --IIYRDLKPENILL---DSQGHVVLTDFGLCK----EGVEPE---ETTSTFCGTPEYLA 164

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE  V+ K P      VD W +G + Y+ LYG  PF       + + +N + K  ++   
Sbjct: 165 PE--VLRKEP--YDRTVDWWCLGAVLYEMLYGLPPF--YSRDVSQMYDNILHKPLQLPGG 218

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
                 +   G +      R   + D + +  H +  P
Sbjct: 219 KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 84/287 (29%), Positives = 132/287 (45%), Gaps = 42/287 (14%)

Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNI-HKALD 349
            +LGKG F +V  A         A KV  L KD   ++D     ++  + E  +   A  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDD----VECTMTEKRVLALAGK 54

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP + +L+  F+        V+EY +G DL F++++     E  AR    ++V  L++L+
Sbjct: 55  HPFLTQLHSCFQTKDR-LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 410 EIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           E    +I+ DLK  N+LL +EG+    IKI DFG+ K    E          TS   GT 
Sbjct: 114 ERG--IIYRDLKLDNVLLDSEGH----IKIADFGMCK----EGILGG---VTTSTFCGTP 160

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA--TILEENTILK 525
            Y+ PE  ++   P   +  VD W++GV+ Y+ L G+ PF G ++ +   +ILE+     
Sbjct: 161 DYIAPE--ILSYQPYGPA--VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY- 215

Query: 526 ATEVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
                    P  +S EAK  ++S L    E R+  +     D    P
Sbjct: 216 ---------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 32/240 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++ ++  +G+G + +V+KA D      VA K  +L     +++K  +   A+RE  I +
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILR 61

Query: 347 ALDHPRVVKLYDV---------FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARS 396
            L+H  +V L ++         F+ D  +F  V EY D HDL   L+      +E   +S
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGLVHFSEDHIKS 120

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
            + Q++  L Y +  K   +H D+K  NILL   N  G+IK+ DFGL+++ + E   P  
Sbjct: 121 FMKQLLEGLNYCH--KKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRP-- 173

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-FGHNQSQA 515
                +    T WY PPE  ++G+   +    +DVWS G I  + L+ KKP F  NQ  A
Sbjct: 174 ----YTNKVITLWYRPPE-LLLGEE--RYGPAIDVWSCGCILGE-LFTKKPIFQANQELA 225

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 38/287 (13%)

Query: 289 YLLLMLLGKGGFSEV----HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           Y  + ++GKG + EV    H+      ++YV  K++  N   +E K A       +E  +
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNASRRERKAAE------QEAQL 52

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVV 402
              L HP +V   + +E +      V+ +C+G DL   LK+ K   + E +     +Q+ 
Sbjct: 53  LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIA 112

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            AL+YL+E    ++H DLK  N+ LT  N+   IK+ D G+++V++ +        D+ S
Sbjct: 113 MALQYLHE--KHILHRDLKTQNVFLTRTNI---IKVGDLGIARVLENQC-------DMAS 160

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT +Y+ PE F    N P  + K DVW++G   Y+    K  F      +       
Sbjct: 161 TLIGTPYYMSPELF---SNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNS------L 210

Query: 523 ILKATEVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           + +  E +    P   S E    I + L+ R E R  V S+ R  Y+
Sbjct: 211 VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 32/291 (10%)

Query: 289 YLLLMLLGKGGFSEV---HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           + LL +LG G + +V    K       +  A KV  L K     +KA   +H   E  + 
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKV--LKKA-TIVQKAKTAEHTRTERQVL 58

Query: 346 KALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
           +A+   P +V L+  F+ D      +L+Y +G +L  +L Q +   E E R  + ++V A
Sbjct: 59  EAVRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L +L+++   +I+ D+K  NILL      G + +TDFGLSK    E        +     
Sbjct: 118 LDHLHQLG--IIYRDIKLENILLDSE---GHVVLTDFGLSKEFLAEE------EERAYSF 166

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEEN 521
            GT  Y+ PE  V+          VD WS+GV+ ++ L G  PF   G   SQ+ I    
Sbjct: 167 CGTIEYMAPE--VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SR 222

Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDYLQ 569
            ILK ++  F    T+S EA+ FI+  L    + R+       +  H + Q
Sbjct: 223 RILK-SKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V++A D      VA K  +++ +     +      +LRE  +   L HP +V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNE-----RDGIPISSLREITLLLNLRHPNIV 69

Query: 355 KLYDVFEIDA-NSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIK 412
           +L +V      +S   V+EYC+  DL   L    T  +E + + +++Q++  L+YL+E  
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-- 126

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +IH DLK  N+LLT+    G +KI DFGL++        P   M   +    T WY  
Sbjct: 127 NFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYG----LPAKPM---TPKVVTLWYRA 176

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
           PE  +        ++ +D+W+VG I  + L  K
Sbjct: 177 PELLLGCTTY---TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 71/245 (28%), Positives = 113/245 (46%), Gaps = 28/245 (11%)

Query: 285 LSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK------H 337
           +S+RY+     LG+G + +V KA+D    + VA K  ++ +    D   +         H
Sbjct: 6   ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIE-ISNDVTKDRQLVGMCGIH 64

Query: 338 --ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR 395
              LRE  I   + H  ++ L DV+ ++ +    V++     DL   + +   + E + +
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVK 122

Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            I++Q+++ L  L+  K   +H DL P NI +   N  G  KI DFGL++      Y+  
Sbjct: 123 CILLQILNGLNVLH--KWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDT 177

Query: 456 HGMDLTSQ-------GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              D T Q          T WY  PE  ++G    K    VD+WSVG IF + L GK  F
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPE-LLMGAE--KYHFAVDMWSVGCIFAELLTGKPLF 234

Query: 509 -GHNQ 512
            G N+
Sbjct: 235 PGENE 239

Length = 335

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 76/223 (34%), Positives = 113/223 (50%), Gaps = 36/223 (16%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQ----LNKDWKEDKKANYIKHALREYNIH-KAL 348
           ++GKG F +V  A    + +  A KV Q    LN+  KE K      H + E N+  K +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR--KEQK------HIMAERNVLLKNV 53

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +V L+  F+        VL++ +G +L F+L++ ++  E  AR    ++ SAL YL
Sbjct: 54  KHPFLVGLHYSFQT-TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM---DLTSQGA 465
           + I   +++ DLKP NILL   +  G + +TDFGL K           G+   D T+   
Sbjct: 113 HSIN--IVYRDLKPENILL---DSQGHVVLTDFGLCK----------EGIAQSDTTTTFC 157

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  YL PE  V+ K P    + VD W +G + Y+ LYG  PF
Sbjct: 158 GTPEYLAPE--VIRKQP--YDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 31/222 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +Y  L  +G+G F EV KA   K ++ VA K     K   E++K  +   ALRE  I +
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREIKILQ 66

Query: 347 ALDHPRVVKLYDVFEIDAN-------SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIV 398
            L H  VV L ++    A        SF  V E+C+ HDL   L   +      E + ++
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVM 125

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPDHG 457
             +++ L Y++  K  ++H D+K  NIL+T+  +   +K+ DFGL++     +N  P   
Sbjct: 126 KMLLNGLYYIHRNK--ILHRDMKAANILITKDGI---LKLADFGLARAFSLSKNSKP--- 177

Query: 458 MDLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVI 497
            +  +    T WY PPE  +  ++  PP     +D+W  G I
Sbjct: 178 -NRYTNRVVTLWYRPPELLLGERDYGPP-----IDMWGAGCI 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 5e-21
 Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 28/283 (9%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           +L  +G+GG+ +V  A        VA K   + K      K N ++H L E +I      
Sbjct: 5   ILTQVGQGGYGQVFLAKKKDTGEIVALKR--MKKSLLF--KLNEVRHVLTERDILTTTKS 60

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             +VKL   F+ D       +EY  G D    L     ++E  AR  + ++  A+  L+E
Sbjct: 61  EWLVKLLYAFQ-DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
           +    IH DLKP N L+      G IK+TDFGLSK            +   +   G+  Y
Sbjct: 120 LG--YIHRDLKPENFLIDAS---GHIKLTDFGLSK----------GIVTYANSVVGSPDY 164

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH---NQSQATILEENTILKAT 527
           + PE  + GK        VD WS+G + Y+ L G  PF     N++   +      L+  
Sbjct: 165 MAPE-VLRGK---GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-R 219

Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
            V    +  +S+EA   I   +         +  +  H + + 
Sbjct: 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 32/265 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + LL  +GKG F EV+KA D +  + VA KV  L +   ED+    I+   +E     
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDE----IEDIQQEIQFLS 54

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
               P + K Y  F +  +    ++EYC G      LK  K + E     I+ +V+  L+
Sbjct: 55  QCRSPYITKYYGSF-LKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLE 112

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+E     IH D+K  NILL+E    G++K+ DFG+S  +     +  +         G
Sbjct: 113 YLHEEG--KIHRDIKAANILLSEE---GDVKLADFGVSGQL-TSTMSKRNTF------VG 160

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTIL 524
           T +++ PE  V+ ++      K D+WS+G+   +   G+ P    H      ++ +N   
Sbjct: 161 TPFWMAPE--VIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP 216

Query: 525 KATEVQFANKPTVSNEAKGFIRSCL 549
                +F      S   K F+  CL
Sbjct: 217 SLEGNKF------SKPFKDFVSLCL 235

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 92.8 bits (230), Expect = 7e-21
 Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 27/277 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F +V+KA + +     A KV        + K    ++  + E +I  + DHP +V
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKV-------IDTKSEEELEDYMVEIDILASCDHPNIV 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KL D F  + N+   ++E+C G  +D   L+  + + E + R +  Q + AL YL+E K 
Sbjct: 66  KLLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK- 123

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLK GNIL T   + G+IK+ DFG+S          D  +       GT +++ P
Sbjct: 124 -IIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFI-------GTPYWMAP 172

Query: 474 ECFV--VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
           E  +    K+ P    K DVWS+G+   +    + P         +L+   I K+     
Sbjct: 173 EVVMCETSKDRP-YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKSEPPTL 228

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           A     S+E K F++ CL    + R     L +H ++
Sbjct: 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 25/276 (9%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLG G F  V++  +L +  + A K   L  D +  ++A  +K   +E  +   L HP +
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEA--VKQLEQEIALLSKLQHPNI 64

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V+     E + ++    LE   G  L   LK++ +  E   R    Q++  L+YL++   
Sbjct: 65  VQYLGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             +H D+K  NIL+ + N  G +K+ DFG++K + E                G+ +++ P
Sbjct: 123 -TVHRDIKGANILV-DTN--GVVKLADFGMAKQVVE--------FSFAKSFKGSPYWMAP 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  +  +         D+WS+G    +   GK P+   +  A + +     +   +    
Sbjct: 171 E-VIAQQGG--YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI---- 223

Query: 534 KP-TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            P  +S+EAK FI  CL      R     L  H ++
Sbjct: 224 -PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 83/277 (29%), Positives = 121/277 (43%), Gaps = 43/277 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G    V K          A K   +  D   D      K  LRE  I+K+   P +V
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKT--ITTDPNPD----LQKQILRELEINKSCKSPYIV 62

Query: 355 KLYDVFEIDANSFCTV-LEYCDGHDLDFYLKQHKT----IAEREARSIVMQVVSALKYLN 409
           K Y  F  +++S   + +EYC+G  LD   K+ K     I E+    I   V+  L YL+
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY- 468
             K  +IH D+KP NILLT     G++K+ DFG+S              +L +  AGT+ 
Sbjct: 123 SRK--IIHRDIKPSNILLTRK---GQVKLCDFGVSG-------------ELVNSLAGTFT 164

Query: 469 ---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE--NTI 523
              +Y+ PE  + GK P  I+S  DVWS+G+   +    + PF           E  + I
Sbjct: 165 GTSFYMAPE-RIQGK-PYSITS--DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220

Query: 524 LKATEVQFANKPTV----SNEAKGFIRSCLAYRKEDR 556
           +     +  ++P      S E K FI+ CL      R
Sbjct: 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 33/300 (11%)

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           F++ P  SD + ++  +GKG + +V K  + K     A K+     D  E+ +A      
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA------ 63

Query: 339 LREYNIHKAL-DHPRVVKLYDVF----EIDANSFCTVLEYCDGHDL-DF---YLKQHKTI 389
             EYNI KAL DHP VVK Y ++      + +    VLE C+G  + D    +LK+ + +
Sbjct: 64  --EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
            E     I+ + +  L++L+  K   IH D+K  NILLT     G +K+ DFG+S  +  
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTS 176

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPF 508
                       +   GT +++ PE     +       ++ DVWS+G+   +   G  P 
Sbjct: 177 TRLR-------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Query: 509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                   + +   I +            SNE   FIR CL    E R  V  L +H ++
Sbjct: 230 ADLHPMRALFK---IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 29/206 (14%)

Query: 298 GGFSEVHKAFDLKEQRYVACKVHQLNKDWK-EDKKANYIKHALREYNIHKALDHPRVVKL 356
           G +  V++A D K    VA K  +L    K E +K  +   +LRE NI   L HP +V +
Sbjct: 16  GTYGVVYRARDKKTGEIVALK--KL----KMEKEKEGFPITSLREINILLKLQHPNIVTV 69

Query: 357 YD-VFEIDANSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIK 412
            + V   + +    V+EY + HDL   ++  K     +E   + +++Q++S + +L++  
Sbjct: 70  KEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEV--KCLMLQLLSGVAHLHDNW 126

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             ++H DLK  N+LL   N  G +KI DFGL++    E  +P       +Q   T WY  
Sbjct: 127 --ILHRDLKTSNLLL---NNRGILKICDFGLAR----EYGSPLKPY---TQLVVTLWYRA 174

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIF 498
           PE  +      + S+ +D+WSVG IF
Sbjct: 175 PELLL---GAKEYSTAIDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 34/227 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D    +  +G G F  VH   D   + Y A KV  +     E  +    +H   E  + K
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRVLK 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            + HP +++L+   E D      ++EY  G +L  YL+     +         ++V AL+
Sbjct: 57  EVSHPFIIRLFWT-EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+  +  +++ DLKP NILL   +  G IK+TDFG +K +           D T    G
Sbjct: 116 YLHSKE--IVYRDLKPENILL---DKEGHIKLTDFGFAKKL----------RDRTWTLCG 160

Query: 467 TYWYLPPECFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPF 508
           T  YL PE          I SK     VD W++G++ Y+ L G  PF
Sbjct: 161 TPEYLAPEV---------IQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 85/312 (27%), Positives = 136/312 (43%), Gaps = 58/312 (18%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L  +G+G +  V K  + +  + VA K     K  + +      K ALRE  + K
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSAL 405
            L HP +V L +VF         V EYCD H +   L+++ + + E   + I+ Q + A+
Sbjct: 56  QLKHPNLVNLIEVFR-RKRKLHLVFEYCD-HTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            + ++     IH D+KP NIL+T+    G+IK+ DFG ++++         G D T   A
Sbjct: 114 NFCHKHN--CIHRDVKPENILITKQ---GQIKLCDFGFARIL-----TG-PGDDYTDYVA 162

Query: 466 GTYWYLPPECFV--VGKNPPKISSKVDVWSVGVIFYQCLYG------------------- 504
            T WY  PE  V      PP     VDVW++G +F + L G                   
Sbjct: 163 -TRWYRAPELLVGDTQYGPP-----VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKT 216

Query: 505 --------KKPFGHNQSQATI-LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKED 555
                   ++ F  NQ    + + E    +  E +F   P +S+ A  F++ CL     +
Sbjct: 217 LGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKF---PNISSPALSFLKGCLQMDPTE 273

Query: 556 RIDVISLARHDY 567
           R+    L  H Y
Sbjct: 274 RLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 81/266 (30%), Positives = 126/266 (47%), Gaps = 31/266 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP +
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHPFL 57

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
             L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+    
Sbjct: 58  TALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 115

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQGAGTYWYL 471
            V++ D+K  N++L +    G IKITDFGL K  + D                 GT  YL
Sbjct: 116 -VVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGAT---------MKTFCGTPEYL 162

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 163 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 214

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRI 557
               T+S EAK  +   L    + R+
Sbjct: 215 PR--TLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 25/218 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G FSEV++A  L +++ VA K  Q+ +    D KA   +  ++E ++ K L+HP V+
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFE--MMDAKAR--QDCVKEIDLLKQLNHPNVI 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD----FYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           K  D F I+ N    VLE  D  DL     ++ KQ + I ER      +Q+ SA+++++ 
Sbjct: 66  KYLDSF-IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  V+H D+KP N+ +T     G +K+ D GL +    +     H +       GT +Y
Sbjct: 125 RR--VMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKT-TAAHSL------VGTPYY 172

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           + PE   + +N     S  D+WS+G + Y+    + PF
Sbjct: 173 MSPE--RIHENGYNFKS--DIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 50/305 (16%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G+G FSEV KA   K  +Y A K   + K +K  ++ N     LRE    + L
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVN----NLREIQALRRL 54

Query: 349 -DHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
             HP +++L +V F+        V E  D +  +    + + + E+  +S + Q++ +L 
Sbjct: 55  SPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPDHGMDLTSQGA 465
           +++     + H D+KP NIL+ +      +K+ DFG  + +  +  Y         ++  
Sbjct: 115 HMHRNG--IFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPPY---------TEYI 159

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQ-SQATILEENTI 523
            T WY  PEC +          K+D+W+VG +F++ L     F G N+  Q   + +   
Sbjct: 160 STRWYRAPECLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG 216

Query: 524 LKATEVQ------------FANK---------PTVSNEAKGFIRSCLAYRKEDRIDVISL 562
               EV             F +K         P  S E    ++  LAY  ++RI     
Sbjct: 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276

Query: 563 ARHDY 567
            RH Y
Sbjct: 277 LRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 90.9 bits (225), Expect = 6e-20
 Identities = 83/280 (29%), Positives = 130/280 (46%), Gaps = 32/280 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F +V    +    +Y A K+ +      +D+    + H L E  + K   HP +
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE----VAHTLTESRVLKNTRHPFL 57

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
             L   F+   +  C V+EY +G +L F+L + +  +E   R    ++VSAL YL+  K 
Sbjct: 58  TSLKYSFQTK-DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK- 115

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +++ DLK  N++L +    G IKITDFGL K    E       M       GT  YL P
Sbjct: 116 -IVYRDLKLENLMLDKD---GHIKITDFGLCK----EGITDAATM---KTFCGTPEYLAP 164

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   +++F  
Sbjct: 165 E--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---LILMEDIKFPR 216

Query: 534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYL 568
             T+S +AK  +   L      R+     D   + RH + 
Sbjct: 217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 297 KGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA-NYIKHALRE-YNIHKALDHPRVV 354
           KG F  V+ A       Y A KV +     K D  A N + +   E   +    + P V 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLK-----KSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KLY  F+   +    V+EY +G D    +K    + E  A+  + +VV  ++ L+  +  
Sbjct: 61  KLYYSFQ-SKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH--QRG 117

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +IH D+KP N+L+ +    G +K+TDFGLS+   E   N            GT  YL PE
Sbjct: 118 IIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE---NKKF--------VGTPDYLAPE 163

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             ++G    K+S   D WS+G + ++ L+G  PF
Sbjct: 164 T-ILGVGDDKMS---DWWSLGCVIFEFLFGYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 28/225 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y  L  LG+G ++ V+K       + VA K  +L      ++ A +   A+RE ++ K
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE----HEEGAPFT--AIREASLLK 58

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSAL 405
            L H  +V L+D+      +   V EY D  DL  Y+            R  + Q++  L
Sbjct: 59  DLKHANIVTLHDIIHTK-KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS--KVMDEENYNPDHGMDLTSQ 463
            Y ++ +  V+H DLKP N+L++E    GE+K+ DFGL+  K +  + Y         S 
Sbjct: 117 AYCHQRR--VLHRDLKPQNLLISE---RGELKLADFGLARAKSVPSKTY---------SN 162

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY PP+  +        S+ +D+W VG IFY+   G+  F
Sbjct: 163 EVVTLWYRPPDVLLGSTE---YSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 63/185 (34%), Positives = 90/185 (48%), Gaps = 20/185 (10%)

Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER 392
           N I+    E +I    ++P VV ++  FE   +  C V+EY +G D    LK    +   
Sbjct: 43  NQIQQVFVERDILTFAENPFVVSMFCSFETKRH-LCMVMEYVEGGDCATLLKNIGALPVD 101

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV------ 446
            AR    + V AL+YL+     ++H DLKP N+L+T     G IK+TDFGLSK+      
Sbjct: 102 MARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLT 156

Query: 447 --MDEENYNPDHGMDLTSQGAGTYWYLPPECFVV-GKNPPKISSKVDVWSVGVIFYQCLY 503
             + E +   D    L  Q  GT  Y+ PE  +  G   P     VD W++G+I Y+ L 
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-----VDWWAMGIILYEFLV 211

Query: 504 GKKPF 508
           G  PF
Sbjct: 212 GCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 26/265 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LGKGGF EV         +  ACK  +L+K  K  KK    + AL E  I + +    +V
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK--KLDK--KRLKKRKGEQMALNEKKILEKVSSRFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEIK 412
            L   FE   +  C V+   +G DL +++         EAR+I    Q++  L++L++ +
Sbjct: 57  SLAYAFETKDD-LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +++ DLKP N+LL +    G ++I+D GL+  +                 AGT  Y+ 
Sbjct: 116 --IVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKK--------IKGRAGTPGYMA 162

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE              VD +++G   Y+ + G+ PF   + +    E         V++ 
Sbjct: 163 PEVLQGEV----YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP 218

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRI 557
           +K   S EAK    + L    E R+
Sbjct: 219 DK--FSPEAKDLCEALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 90.1 bits (223), Expect = 1e-19
 Identities = 85/264 (32%), Positives = 127/264 (48%), Gaps = 26/264 (9%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F +V    +    RY A K+ +      +D+ A    H L E  + +   HP +
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA----HTLTENRVLQNSRHPFL 57

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
             L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++VSAL YL+  K 
Sbjct: 58  TALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK- 115

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V++ DLK  N++L +    G IKITDFGL K    E       M       GT  YL P
Sbjct: 116 NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM---KTFCGTPEYLAP 165

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F  
Sbjct: 166 E--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---LILMEEIRFPR 217

Query: 534 KPTVSNEAKGFIRSCLAYRKEDRI 557
             T+S EAK  +   L    + R+
Sbjct: 218 --TLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 23/181 (12%)

Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKT-----IAE 391
           A RE  + + L H  VV L +VF   A+ S   + +Y + HDL   +K H+      I  
Sbjct: 49  ACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPP 107

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT-EGNVCGEIKITDFGLSKVMDEE 450
              +S++ Q+++ + YL+     V+H DLKP NIL+  EG   G +KI D GL+++    
Sbjct: 108 SMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--- 162

Query: 451 NYNPDHGMDLTSQGAG---TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
              P   +   +       T WY  PE  +  ++    +  +D+W++G IF + L  +  
Sbjct: 163 -NAP---LKPLADLDPVVVTIWYRAPELLLGARH---YTKAIDIWAIGCIFAELLTLEPI 215

Query: 508 F 508
           F
Sbjct: 216 F 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 88.3 bits (219), Expect = 5e-19
 Identities = 87/314 (27%), Positives = 126/314 (40%), Gaps = 56/314 (17%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +++RY+ L  +G G F  V  A D    + VA K     K  K        K   RE  +
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKL 62

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K L H  ++ L D+F         V E   G DL   L   + + ++  +  + Q++  
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRG 120

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           LKY++     V+H DLKP NIL+ E   C ++KI DFGL+++ D              Q 
Sbjct: 121 LKYVHSAG--VVHRDLKPSNILINEN--C-DLKICDFGLARIQD-------------PQM 162

Query: 465 AG---TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ------ 514
            G   T +Y  PE  +  +   K   +VD+WS G IF + L GK  F G +         
Sbjct: 163 TGYVSTRYYRAPEIMLTWQ---KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219

Query: 515 -----------ATILEENTIL------KATEVQFANK-PTVSNEAKGFIRSCLAYRKEDR 556
                       TI  ENT+       K   V F+ K       A   +   L +  + R
Sbjct: 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279

Query: 557 IDVISLARHDYLQP 570
           I       H YL P
Sbjct: 280 ISAAEALAHPYLAP 293

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 27/223 (12%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y  L  +G+G +  V KA + +    VA K  +L     +D        ALRE  + K 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKE 55

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALK 406
           L H  +V+LYDV   D      V EYCD  DL  Y    +  I     +S + Q++  L 
Sbjct: 56  LKHKNIVRLYDVLHSD-KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           + +     V+H DLKP N+L+   N  GE+K+ DFGL++           G+ +    A 
Sbjct: 114 FCHSHN--VLHRDLKPQNLLI---NKNGELKLADFGLAR---------AFGIPVRCYSAE 159

Query: 467 --TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
             T WY PP+     K     S+ +D+WS G IF +     +P
Sbjct: 160 VVTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 30/209 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA D      VA K  +L     E +       A+RE ++ K L+HP +V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA--EREARSIVMQVVSALKYLNEIK 412
           +L DV   +   +  V E+ D  DL  Y+             +S + Q++  + Y +  +
Sbjct: 62  RLLDVVHSENKLY-LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 413 PPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT--SQGAGTYW 469
             V+H DLKP N+L+  EG     +K+ DFGL++           G+ +   +    T W
Sbjct: 120 --VLHRDLKPQNLLIDREGA----LKLADFGLARAF---------GVPVRTYTHEVVTLW 164

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           Y  PE  +  +   + S+ VD+WS+G IF
Sbjct: 165 YRAPEILLGSR---QYSTPVDIWSIGCIF 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (218), Expect = 6e-19
 Identities = 81/281 (28%), Positives = 135/281 (48%), Gaps = 32/281 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI---HKALDHP 351
           +GKG F +V++      +R  A KV  L+K  KE      + H + E NI       + P
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV--LSK--KEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +V L   F+ D++ +  V +Y  G +L ++L++    +E  A+  + ++V AL++L+  
Sbjct: 57  FIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-- 113

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K  +++ DLKP NILL   +  G I + DFGLSK    +N         T+   GT  YL
Sbjct: 114 KYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDN-------KTTNTFCGTTEYL 163

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  +  K   K    VD WS+GV+ ++   G  PF    +Q    +    +   +V+F
Sbjct: 164 APEVLLDEKGYTK---HVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRF 216

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYL 568
             K  +S+E + F++  L    + R+    D + L  H + 
Sbjct: 217 P-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 87.7 bits (217), Expect = 9e-19
 Identities = 87/287 (30%), Positives = 130/287 (45%), Gaps = 54/287 (18%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L +RY  L  +G G +  V  A D +    VA K  +L++ ++ +  A   K A RE  +
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFA---KRAYRELTL 67

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYL------------KQHKTIAE 391
            K + H  V+ L DVF   A S           +  DFYL              H  ++E
Sbjct: 68  LKHMQHENVIGLLDVF-TSAVSG---------DEFQDFYLVMPYMQTDLQKIMGHP-LSE 116

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            + + +V Q++  LKY++     +IH DLKPGN+ + E   C E+KI DFGL++  D E 
Sbjct: 117 DKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNED--C-ELKILDFGLARHADAE- 170

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                     +    T WY  PE  +   N    +  VD+WSVG I  + L GK  F   
Sbjct: 171 ---------MTGYVVTRWYRAPEVIL---NWMHYNQTVDIWSVGCIMAEMLTGKTLF--- 215

Query: 512 QSQATILEENTILKATEV---QFANKPTVSNEAKGFIRSCLAYRKED 555
           + +  + +   ILK T V   +F  K      AK +I+S   Y ++D
Sbjct: 216 KGKDYLDQLTQILKVTGVPGPEFVQKLE-DKAAKSYIKSLPKYPRKD 261

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 22/279 (7%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREYNIHKALDHP 351
           L+G G F  V+   +      +A K  +L       +D+K + +    RE  + K L H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +V+      +DA+     LEY  G  +   L  +    E   R+ V Q++  L YL+  
Sbjct: 67  NIVQYLGS-SLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              +IH D+K  NIL+      G IKI+DFG+SK ++  + +        S     +W +
Sbjct: 126 G--IIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW-M 179

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH-NQSQATILEENTILKATEVQ 530
            PE  VV +     + K D+WS+G +  + L GK PF    Q QA       I K  E  
Sbjct: 180 APE--VVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IFKIGENA 228

Query: 531 FANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
               P+ +S+EA  F+          R     L +H +L
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y L+  +G G + +V+KA D+     VA KV +L  +  +D      +   +E ++ K
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL--EPGDD-----FEIIQQEISMLK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSAL 405
              HP +V  +  + +  +    V+EYC G  L D Y      ++E +   +  + +  L
Sbjct: 56  ECRHPNIVAYFGSY-LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGL 114

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+E     IH D+K  NILLTE    G++K+ DFG+S  +          +       
Sbjct: 115 AYLHETG--KIHRDIKGANILLTED---GDVKLADFGVSAQL-------TATIAKRKSFI 162

Query: 466 GT-YWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           GT YW + PE   V +       K D+W++G+
Sbjct: 163 GTPYW-MAPEVAAVERKGG-YDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 79/271 (29%), Positives = 124/271 (45%), Gaps = 36/271 (13%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYI-KHALREYNIHKALD 349
           +LGKG F +V  A       + A K   L KD     +D +   + +  L       A +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLA-----LAWE 54

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP +  L+  F+   + F  V+EY +G DL F+++      E  AR    +++  L++L+
Sbjct: 55  HPFLTHLFCTFQTKEHLF-FVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K  +I+ DLK  N+LL +    G IKI DFG+ K    EN N +      S   GT  
Sbjct: 114 --KKGIIYRDLKLDNVLLDKD---GHIKIADFGMCK----ENMNGE---GKASTFCGTPD 161

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y+ PE  + G+   K +  VD WS GV+ Y+ L G+ PF H +      +E+ +  +   
Sbjct: 162 YIAPE-ILKGQ---KYNESVDWWSFGVLLYEMLIGQSPF-HGE------DEDELFDSILN 210

Query: 530 QFANKP-TVSNEAKGFIRSCLAYRKEDRIDV 559
              + P  +S EAK  +          R+ V
Sbjct: 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGV 241

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 34/280 (12%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G FSEV++A  L +   VA K  Q+        +A+ IK    E ++ K L+HP V+
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPNVI 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD----FYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           K Y  F I+ N    VLE  D  DL      + KQ + I E+      +Q+ SAL++++ 
Sbjct: 66  KYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  V+H D+KP N+ +T     G +K+ D GL +    +     H +       GT +Y
Sbjct: 125 RR--VMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKT-TAAHSL------VGTPYY 172

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE   + +N     S  D+WS+G + Y+    + PF  ++     L +    K  +  
Sbjct: 173 MSPE--RIHENGYNFKS--DIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCD 224

Query: 531 FANKPT--VSNEAKGFIRSCLAYRKEDRID---VISLARH 565
           +   P+   S E +  +  C+    E R D   V  +A+ 
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 81/301 (26%), Positives = 126/301 (41%), Gaps = 28/301 (9%)

Query: 264 HIRELKRIHNEDQSRF-------NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVA 316
            +R+ K I N   SR+           + ++ + ++ ++G+G F EV        ++  A
Sbjct: 14  ALRKNKNIDNF-LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYA 72

Query: 317 CKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDG 376
            K   L+K   E  K +       E +I    +   +V+L+  F+ D      V+EY  G
Sbjct: 73  MK--LLSKF--EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYLYMVMEYMPG 127

Query: 377 HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            DL   L  +  I E+ AR    +VV AL  ++ +    IH D+KP N+LL   +  G +
Sbjct: 128 GDL-VNLMSNYDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL---DKSGHL 181

Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           K+ DFG    MD        GM       GT  Y+ PE             + D WSVGV
Sbjct: 182 KLADFGTCMKMDAN------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235

Query: 497 IFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
             Y+ L G  PF  +    T      +     + F +   +S +AK  I + L  R E R
Sbjct: 236 FLYEMLVGDTPFYADSLVGTY--SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDR-EVR 292

Query: 557 I 557
           +
Sbjct: 293 L 293

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 33/238 (13%)

Query: 288 RYLLLMLLGKGGFSEV----HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +Y +L ++G+G F       H   D   Q+Y         K+ +  K ++ ++ + +E  
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSD---QKYAM-------KEIRLPKSSSAVEDSRKEAV 50

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQV 401
           +   + HP +V   + FE D + +  V+EYCDG DL   +K    K   E       +Q+
Sbjct: 51  LLAKMKHPNIVAFKESFEADGHLY-IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
              +++++E +  V+H D+K  NI LT+    G++K+ DFG ++++              
Sbjct: 110 CLGVQHIHEKR--VLHRDIKSKNIFLTQN---GKVKLGDFGSARLLT-------SPGAYA 157

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
               GT +Y+PPE   + +N P  ++K D+WS+G I Y+    K PF  N  +  IL+
Sbjct: 158 CTYVGTPYYVPPE---IWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           +  L  LG+G ++ V+K  +      VA K   L      D +      A+RE ++ K L
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL------DAEEGTPSTAIREISLMKEL 55

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSAL 405
            H  +V+L+DV   + N    V EY D  DL  Y+  H     +     +S   Q++  +
Sbjct: 56  KHENIVRLHDVIHTE-NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT--SQ 463
            + +E +  V+H DLKP N+L+   N  GE+K+ DFGL++           G+ +   S 
Sbjct: 114 AFCHENR--VLHRDLKPQNLLI---NKRGELKLADFGLARAF---------GIPVNTFSN 159

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY  P+  +  +     S+ +D+WSVG I  + + G+  F
Sbjct: 160 EVVTLWYRAPDVLLGSRT---YSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 50/241 (20%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV-----HQLNKDWKEDKKANYIKHAL 339
           +  RY  L  +G+G +  V  A        VA K      HQ            + +  L
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----------FCQRTL 51

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAER 392
           RE  I +   H  ++ + D+  I   SF +          D Y+ Q       +K I  +
Sbjct: 52  REIKILRRFKHENIIGILDI--IRPPSFESFN--------DVYIVQELMETDLYKLIKTQ 101

Query: 393 E-----ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
                  +  + Q++  LKY++     V+H DLKP N+LL   N   ++KI DFGL+++ 
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL---NTNCDLKICDFGLARIA 156

Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           D E+   DH   LT   A T WY  PE  +  K     +  +D+WSVG I  + L  +  
Sbjct: 157 DPEH---DHTGFLTEYVA-TRWYRAPEIMLNSK---GYTKAIDIWSVGCILAEMLSNRPL 209

Query: 508 F 508
           F
Sbjct: 210 F 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 79/323 (24%), Positives = 126/323 (39%), Gaps = 65/323 (20%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-------VHQLNKDWKEDKKANYIKH 337
           +  RY  +  +G G +  V  A D +  + VA K       V  L             K 
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL------------AKR 50

Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTV-----LEYCDGHDLDFYLKQHKTIAER 392
            LRE  I +   H  ++ + D+       F  V     L   D H +  +  Q   + E 
Sbjct: 51  TLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI-IHSDQ--PLTEE 107

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
             R  + Q++  LKY++     VIH DLKP N+L+ E     E++I DFG+++ +   + 
Sbjct: 108 HIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED---CELRIGDFGMARGLS--SS 160

Query: 453 NPDHGMDLTSQGAGTYWYLPPEC-FVVGKNPPKISSKVDVWSVGVIF------YQCLYGK 505
             +H   +T   A T WY  PE    +    P+ ++ +D+WSVG IF       Q   GK
Sbjct: 161 PTEHKYFMTEYVA-TRWYRAPELLLSL----PEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215

Query: 506 KPFGHNQSQATIL---EENTI-------LKATEVQFANKPTV---------SNEAKGFIR 546
                 +   ++L    E  +       ++        K  V         S EA   + 
Sbjct: 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLS 275

Query: 547 SCLAYRKEDRIDVISLARHDYLQ 569
             L +  E+RI V    +H +L 
Sbjct: 276 QMLQFDPEERITVEQALQHPFLA 298

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSI 397
           L+E  I K L H ++V+LY V   +      V EY   G  LD +LK  +    R  + +
Sbjct: 49  LQEAQIMKKLRHDKLVQLYAVCS-EEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLV 106

Query: 398 VM--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            M  Q+   + YL       IH DL   NIL+ E  VC   KI DFGL+++++++ Y   
Sbjct: 107 DMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVC---KIADFGLARLIEDDEYTAR 161

Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            G     +     W   PE    G    + + K DVWS G++  + + YG+ P+
Sbjct: 162 EGAKFPIK-----W-TAPEAANYG----RFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 28/227 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +   L   +G+G F +V++  +   E   +A  V           +  +++ A     I 
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY----IM 61

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVV 402
           +  DHP +VKL  V  I  N    V+E     +L  YL+ +K     +  S+++   Q+ 
Sbjct: 62  RQFDHPHIVKLIGV--ITENPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLS 117

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           +AL YL   +   +H D+   N+L++    C  +K+ DFGLS+ +++E+Y         S
Sbjct: 118 TALAYLESKR--FVHRDIAARNVLVSS-PDC--VKLGDFGLSRYLEDESYYK------AS 166

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           +G     ++ PE      N  + +S  DVW  GV  ++ L  G KPF
Sbjct: 167 KGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 90/330 (27%), Positives = 135/330 (40%), Gaps = 84/330 (25%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK--------EDKKANYIKHAL 339
           +Y +L  LGKG +  V KA D + +  VA K        K         D +  +     
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALK--------KIFDAFRNATDAQRTF----- 54

Query: 340 REYNIHKAL-DHPRVVKLYDVFEIDANS-FCTVLEYCDGHDLDFYLK------QHKTIAE 391
           RE    + L DHP +VKL +V + + +     V EY +  DL   ++       HK    
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHK---- 109

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV---MD 448
              R I+ Q++ ALKY++     VIH DLKP NILL   N    +K+ DFGL++    ++
Sbjct: 110 ---RYIMYQLLKALKYIHSGN--VIHRDLKPSNILL---NSDCRVKLADFGLARSLSELE 161

Query: 449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E   NP     LT   A T WY  PE  ++G    + +  VD+WSVG I  + L GK  F
Sbjct: 162 ENPENP----VLTDYVA-TRWYRAPE-ILLGST--RYTKGVDMWSVGCILGEMLLGKPLF 213

Query: 509 GHNQSQATILEENTILKATEV-----------QFANK-----------------PTVSNE 540
                 +T+ +   I++                FA                   P  S++
Sbjct: 214 ---PGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDD 270

Query: 541 AKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           A   ++  L +    R+       H Y+  
Sbjct: 271 ALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 83/302 (27%), Positives = 125/302 (41%), Gaps = 58/302 (19%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           + ++G+G F EV            A K   L K   E  +   + H   E +I    D+P
Sbjct: 6   IKVIGRGAFGEVRLVQKKDTGHIYAMKK--LRK--SEMLEKEQVAHVRAERDILAEADNP 61

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            VVKLY  F+ D N    ++EY  G D+   L +  T  E E R  + + + A+  ++++
Sbjct: 62  WVVKLYYSFQ-DENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-------EENYN---PDHGMDLT 461
               IH D+KP N+LL      G IK++DFGL   +            +   P + +D  
Sbjct: 121 G--YIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 462 SQ---------------------GAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFY 499
           S+                       GT  Y+ PE F+  G N      + D WS+GVI Y
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK-----ECDWWSLGVIMY 230

Query: 500 QCLYGKKPFGHNQSQATILE----ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKED 555
           + L G  PF  +  Q T  +    + T+    EV       +S EAK  I+  L    E 
Sbjct: 231 EMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP------LSPEAKDLIKR-LCCEAER 283

Query: 556 RI 557
           R+
Sbjct: 284 RL 285

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 75/260 (28%), Positives = 116/260 (44%), Gaps = 40/260 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  V  A       Y A K   L K  +E  K   ++H  +E +I   L HP +V
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKC--LKK--REILKMKQVQHVAQEKSILMELSHPFIV 81

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            +   F+ D N    +LE+  G +L  +L++        A+    ++V A +YL+     
Sbjct: 82  NMMCSFQ-DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD-- 138

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +I+ DLKP N+LL      G +K+TDFG +K + +  +             GT  YL PE
Sbjct: 139 IIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPDRTFTL----------CGTPEYLAPE 185

Query: 475 CFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
                     I SK     VD W++GV+ Y+ + G  PF  + +   I E+  IL A  +
Sbjct: 186 V---------IQSKGHGKAVDWWTMGVLLYEFIAGYPPF-FDDTPFRIYEK--IL-AGRL 232

Query: 530 QFANKPTVSNEAKGFIRSCL 549
           +F N       A+  ++  L
Sbjct: 233 KFPN--WFDGRARDLVKGLL 250

Length = 329

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 78/280 (27%), Positives = 117/280 (41%), Gaps = 29/280 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRV 353
           LGKG +  V+K         +A K  +L  D   + K N I   + E +I HKA+  P +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQI---IMELDILHKAVS-PYI 61

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKT--IAEREARSIVMQVVSALKYLNE 410
           V  Y  F I+   +   +EY D   LD  Y     T  I E   R I   VV  LK+L E
Sbjct: 62  VDFYGAFFIEGAVY-MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  +IH D+KP N+L+   N  G++K+ DFG+S  +            L     G   Y
Sbjct: 121 -EHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS---------LAKTNIGCQSY 167

Query: 471 LPPECFVVG--KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
           + PE    G     P  + + DVWS+G+   +   G+ P+          + + I+    
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227

Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                    S++A+ F+  CL      R     L  H +L
Sbjct: 228 PTLP--SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 29/279 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F +V+KA + +     A KV        E K    ++  + E  I    +HP +V
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKV-------IETKSEEELEDYMVEIEILATCNHPYIV 72

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KL   F  D      ++E+C G  +D   L+  + + E + + I  Q++ AL+YL+ +K 
Sbjct: 73  KLLGAFYWD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK- 130

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLK GN+LLT     G+IK+ DFG+S     +N       D      GT +++ P
Sbjct: 131 -IIHRDLKAGNVLLTLD---GDIKLADFGVSA----KNVKTLQRRD---SFIGTPYWMAP 179

Query: 474 E---CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           E   C  +   P     K D+WS+G+   + +   +P  H  +   +L +  I K+    
Sbjct: 180 EVVMCETMKDTP--YDYKADIWSLGITLIE-MAQIEPPHHELNPMRVLLK--IAKSEPPT 234

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            +     S E + F+++ L    E R     L  H ++ 
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 31/281 (11%)

Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++LGKG +  V+ A DL  Q  +A K          ++ + Y++    E  +H  L H  
Sbjct: 14  VVLGKGTYGIVYAARDLSTQVRIAIKE-------IPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVVSALKYLN 409
           +V+ Y   + +   F   +E   G  L   L+      +   ++I+    Q++  LKYL+
Sbjct: 67  IVQ-YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           + +  ++H D+K  N+L+      G +KI+DFG SK +     NP      T    GT  
Sbjct: 126 DNQ--IVHRDIKGDNVLVN--TYSGVVKISDFGTSKRL--AGINP-----CTETFTGTLQ 174

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS-QATILEENTILKATE 528
           Y+ PE  V+ K P    +  D+WS+G    +   GK PF      QA + +        E
Sbjct: 175 YMAPE--VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232

Query: 529 VQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           +     P  +S EAK FI  C     + R     L +  +L
Sbjct: 233 I-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 73/287 (25%), Positives = 114/287 (39%), Gaps = 36/287 (12%)

Query: 287 DRYLLLM-LLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            R+L  +  LG+G F +V    +D L +       V  LN   +E  ++++     RE  
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF----EREIE 58

Query: 344 IHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQV 401
           I + LDH  +VK   V E     S   ++EY     L  YL++H+  I  +       Q+
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMD 459
              + YL   +   IH DL   NIL+ E      +KI+DFGL+KV+  D++ Y      +
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILV-ESEDL--VKISDFGLAKVLPEDKDYYYVKEPGE 173

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
                    WY  PEC        K SS  DVWS GV  Y+      P     ++   + 
Sbjct: 174 SPIF-----WY-APECL----RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223

Query: 520 ENTILKATEVQFANK----------PTVSNEAKGFIRSCLAYRKEDR 556
                +    +              P+  +E    ++ C     +DR
Sbjct: 224 GIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 32/223 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKALDHP 351
           +G+G + +V KA DLK   R+VA K  ++    +E    + I+    LR     +  +HP
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHL---ETFEHP 64

Query: 352 RVVKLYDVFEID----ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSAL 405
            VV+L+DV  +           V E+ D  DL  YL +     +     + ++ Q++  L
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   +           +   
Sbjct: 124 DFLHSHR--VVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQM--------ALTSVV 170

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY  PE  +        ++ VD+WSVG IF + ++ +KP 
Sbjct: 171 VTLWYRAPEVLL----QSSYATPVDLWSVGCIFAE-MFRRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 80/285 (28%), Positives = 120/285 (42%), Gaps = 56/285 (19%)

Query: 295 LGKGGFSEVHKA-FDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LG G F  V K  + + K+Q  VA KV       K + + +     +RE  I   LD+P 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKV------LKNENEKSVRDEMMREAEIMHQLDNPY 56

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +V++  V E  A +   V+E   G  L+ +L   K  I       ++ QV   +KYL   
Sbjct: 57  IVRMIGVCE--AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTY- 468
               +H DL   N+LL   +     KI+DFGLSK +  D+  Y         ++ AG + 
Sbjct: 115 N--FVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYY--------KARSAGKWP 161

Query: 469 --WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILK 525
             WY  PEC     N  K SS+ DVWS G+  ++   YG+KP+               +K
Sbjct: 162 LKWY-APECI----NFRKFSSRSDVWSYGITMWEAFSYGQKPYKK-------------MK 203

Query: 526 ATEV--------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL 562
             EV        +         E    ++ C  Y+ EDR +   +
Sbjct: 204 GPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYNIHKALD 349
            L +LG+G F +V  A   K     A K   L K D     +   +    R +    +  
Sbjct: 3   CLAVLGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP +V L+  F+ + +  C V+EY  G DL  ++      +E  A      VV  L+YL+
Sbjct: 61  HPFLVNLFACFQTE-DHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLH 118

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           E K  +++ DLK  N+LL      G +KI DFGL K    E        D TS   GT  
Sbjct: 119 ENK--IVYRDLKLDNLLLDTE---GFVKIADFGLCK----EGMGFG---DRTSTFCGTPE 166

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +L PE           +  VD W +GV+ Y+ L G+ PF
Sbjct: 167 FLAPEVLT----ETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 60/227 (26%), Positives = 117/227 (51%), Gaps = 32/227 (14%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKE----QRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +Y+ +  +G+G F    KA  +K     ++YV  +++      KE +++       +E  
Sbjct: 1   KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVA 51

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA--EREARSIVMQV 401
           +   + HP +V+  + FE + N +  V++YC+G DL   +   + +   E +     +Q+
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLY-IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI 110

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             ALK++++ K  ++H D+K  NI LT+    G IK+ DFG+++V++         ++L 
Sbjct: 111 CLALKHVHDRK--ILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNST-------VELA 158

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               GT +YL PE   + +N P  ++K D+W++G + Y+    K  F
Sbjct: 159 RTCIGTPYYLSPE---ICENRP-YNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 82.8 bits (204), Expect = 4e-17
 Identities = 65/216 (30%), Positives = 117/216 (54%), Gaps = 22/216 (10%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G +++V      K +R  A KV  + K+   +D+  ++++    ++   +A +HP 
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKV--VKKELVNDDEDIDWVQ--TEKHVFEQASNHPF 57

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +V L+  F+ ++  F  V+EY +G DL F++++ + + E  AR    ++  AL YL+E  
Sbjct: 58  LVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-- 114

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT  Y+ 
Sbjct: 115 RGIIYRDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSTFCGTPNYIA 164

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  + G++       VD W++GV+ ++ + G+ PF
Sbjct: 165 PE-ILRGED---YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 42/294 (14%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            +  L  +G G F  V+ A D++    VA K    +     +K  + IK    E    + 
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK----EVRFLQQ 71

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L HP  ++ Y    +  ++   V+EYC G   D      K + E E  +I    +  L Y
Sbjct: 72  LRHPNTIE-YKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+  +   IH D+K GNILLTE    G +K+ DFG + ++   N              GT
Sbjct: 131 LHSHE--RIHRDIKAGNILLTEP---GTVKLADFGSASLVSPAN-----------SFVGT 174

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP--FGHNQSQATI-LEENTIL 524
            +++ PE  ++  +  +   KVDVWS+G+   + L  +KP  F  N   A   + +N   
Sbjct: 175 PYWMAPEV-ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQN--- 229

Query: 525 KATEVQFANKPTV-----SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
                   + PT+     S+  + F+ SCL    +DR     L +H ++    P
Sbjct: 230 --------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 73/296 (24%), Positives = 110/296 (37%), Gaps = 49/296 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+ ++G G  + V+ A  L     VA K   L      +K    +    +E     
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL------EKCQTSVDELRKEVQAMS 54

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDG---HDLDFYLKQHKTIAEREARSIVMQVVS 403
             +HP VVK Y  F +  +    V+ Y  G    D+         + E    +++ +V+ 
Sbjct: 55  QCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            L+YL+      IH D+K GNILL E    G +KI DFG+S  + +       G D T +
Sbjct: 114 GLEYLH--SNGQIHRDIKAGNILLGED---GSVKIADFGVSASLAD-------GGDRTRK 161

Query: 464 G----AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN-------- 511
                 GT  ++ PE   V +       K D+WS G+   +   G  P+           
Sbjct: 162 VRKTFVGTPCWMAPE---VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218

Query: 512 --QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
             Q+    LE     K            S   +  I  CL      R     L +H
Sbjct: 219 TLQNDPPSLETGADYKK----------YSKSFRKMISLCLQKDPSKRPTAEELLKH 264

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 34/265 (12%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  V   + L E+R VA K  +     +ED           E  +   L HP++V
Sbjct: 12  IGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFI--------EEAQVMMKLSHPKLV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYLNEIKP 413
           +LY V   + +  C V E+ +   L  YL+  +    +E    + + V   + YL     
Sbjct: 63  QLYGVC-TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES--S 119

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   +K++DFG+++ + ++ Y    G     + +       P
Sbjct: 120 NVIHRDLAARNCLVGENQV---VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS------P 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE-NTILKATEVQF 531
           E F   K     SSK DVWS GV+ ++    GK P+  N+S + ++E  N   +  + + 
Sbjct: 171 EVFSFSK----YSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSEVVETINAGFRLYKPRL 225

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDR 556
           A++          ++ C   R EDR
Sbjct: 226 ASQSVYE-----LMQHCWKERPEDR 245

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 28/225 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y+ L  LG+G ++ V K      +  VA K  ++  + +E         A+RE ++ K
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALK--EIRLEHEEGAPCT----AIREVSLLK 59

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSAL 405
            L H  +V L+D+   D  S   V EY D  DL  Y+     I      +  + Q++  L
Sbjct: 60  DLKHANIVTLHDIVHTD-KSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS--KVMDEENYNPDHGMDLTSQ 463
            Y +  K  V+H DLKP N+L+ E    GE+K+ DFGL+  K +  + Y         S 
Sbjct: 118 AYCHRRK--VLHRDLKPQNLLINER---GELKLADFGLARAKSVPTKTY---------SN 163

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY PP+  +      + S+++D+W VG IF++   G+  F
Sbjct: 164 EVVTLWYRPPDVLL---GSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 65/219 (29%), Positives = 115/219 (52%), Gaps = 28/219 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KEDKKANYI---KHALREYNIHKALD 349
           ++G+G +++V      K +R  A KV  + K+   +D+  +++   KH         A +
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKV--IKKELVNDDEDIDWVQTEKHVFET-----ASN 54

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP +V L+  F+ ++  F  V+E+  G DL F++++ + + E  AR    ++  AL +L+
Sbjct: 55  HPFLVGLHSCFQTESRLF-FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH 113

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           E    +I+ DLK  N+LL   +  G IK+TD+G+ K    E   P    D TS   GT  
Sbjct: 114 E--RGIIYRDLKLDNVLL---DAEGHIKLTDYGMCK----EGIRPG---DTTSTFCGTPN 161

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           Y+ PE  + G++       VD W++GV+ ++ + G+ PF
Sbjct: 162 YIAPE-ILRGED---YGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 40/238 (16%)

Query: 341 EYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           E  +H+ + D+P  +KLY            +++Y    DL   LK+   ++E E + I+ 
Sbjct: 58  EPMVHQLMKDNPNFIKLYYSVTTL-KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+V AL  L++    +IH D+K  N+L         I + D+GL K++            
Sbjct: 117 QLVEALNDLHKHN--IIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP--------- 163

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPFGHNQSQ 514
             S   GT  Y  PE         KI         D W+VGV+ Y+ L GK PF  ++ +
Sbjct: 164 --SCYDGTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212

Query: 515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYL 568
              L+  ++LK  + +      VS  A  F++S L Y    R+    ++I   +H +L
Sbjct: 213 --ELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII---KHPFL 265

Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 80/320 (25%), Positives = 132/320 (41%), Gaps = 64/320 (20%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY L+  LG+G +  V  A + +        + ++   +   KK    K ALRE  + + 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKI-LAKRALRELKLLRH 57

Query: 348 L-DHPRVVKLYDVFEIDANSFCTVLEY-----CDGHDLDFYLKQHKTIAEREARSIVMQV 401
              H  +  LYD+  +   +F  +  Y      D H +   ++  + + +   +S + Q+
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQI---IRSGQPLTDAHFQSFIYQI 114

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  LKY++     V+H DLKPGN+L+       E+KI DFGL++      ++ + G    
Sbjct: 115 LCGLKYIHSAN--VLHRDLKPGNLLVNAD---CELKICDFGLAR-----GFSENPG---- 160

Query: 462 SQGAG-------TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQ 512
            + AG       T WY  PE  +  ++    +  +DVWSVG I  + L G+KP   G + 
Sbjct: 161 -ENAGFMTEYVATRWYRAPEIMLSFQS---YTKAIDVWSVGCILAE-LLGRKPVFKGKDY 215

Query: 513 -SQAT-ILE------ENTILKATEV-------QFANKPTV---------SNEAKGFIRSC 548
             Q   IL+      E T+ +              N P           +  A   +   
Sbjct: 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKL 275

Query: 549 LAYRKEDRIDVISLARHDYL 568
           LA+    RI V     H YL
Sbjct: 276 LAFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 81.6 bits (201), Expect = 9e-17
 Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 30/227 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 71

Query: 347 ALDHPRVVKLYDVFEIDANSF-----CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
            + H  V+ L DVF   A S        ++ +  G DL+  +K  K + +   + ++ Q+
Sbjct: 72  HMKHENVIGLLDVFT-PARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQI 129

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E         +T
Sbjct: 130 LRGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE---------MT 175

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 176 GYVA-TRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.8 bits (204), Expect = 1e-16
 Identities = 66/197 (33%), Positives = 99/197 (50%), Gaps = 23/197 (11%)

Query: 328 EDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-- 385
           ++++A Y   A  E +   A DH  +VK +D F+ D +    ++EY  G DL+  +KQ  
Sbjct: 105 DERQAAY---ARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQRL 160

Query: 386 --HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
             H    E E   +  Q+V AL  ++  K  ++H DLK  NI L      G IK+ DFG 
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMP---TGIIKLGDFGF 215

Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
           SK      Y+    +D+ S   GT +YL PE +       + S K D+WS+GVI Y+ L 
Sbjct: 216 SK-----QYSDSVSLDVASSFCGTPYYLAPELW----ERKRYSKKADMWSLGVILYELLT 266

Query: 504 GKKPFGHNQSQATILEE 520
             +PF    SQ  I+++
Sbjct: 267 LHRPF-KGPSQREIMQQ 282

Length = 478

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 23/272 (8%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             + +  L+G+G F EV    +       A KV + +    ++  + + +    E +I  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE----ERDILS 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE-ARSIVMQVVSAL 405
             + P + +L   F+ D ++   V+EY  G DL   L +++   + + A+  + ++V A+
Sbjct: 57  ISNSPWIPQLQYAFQ-DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
             ++++    +H D+KP N+L+      G IK+ DFG +  +          M  +    
Sbjct: 116 HSVHQMG--YVHRDIKPENVLIDR---TGHIKLADFGSAARLTAN------KMVNSKLPV 164

Query: 466 GTYWYLPPECFVVGKNPPKISSKV--DVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
           GT  Y+ PE         K +  V  D WS+GVI Y+ +YG+ PF    S  T    N I
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY---NNI 221

Query: 524 LKATE-VQFANKPTVSNEAKGFIRSCLAYRKE 554
           +     ++F   P VS++    I+S L  +KE
Sbjct: 222 MNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKE 253

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           YL L  LG+G ++ V+K       + VA KV  +  +            A+RE ++ K L
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE------EGVPFTAIREASLLKGL 60

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKY 407
            H  +V L+D+      +   V EY    DL  Y+ QH   +     R  + Q++  L Y
Sbjct: 61  KHANIVLLHDIIHT-KETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAY 118

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL--SKVMDEENYNPDHGMDLTSQGA 465
           ++     ++H DLKP N+L++     GE+K+ DFGL  +K +  + Y         S   
Sbjct: 119 IHGQH--ILHRDLKPQNLLIS---YLGELKLADFGLARAKSIPSQTY---------SSEV 164

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY PP+  +        SS +D+W  G IF + L G+  F
Sbjct: 165 VTLWYRPPDVLL---GATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 29/226 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKALDH 350
           +LGKG F +V  A      ++ A K   L KD     +D +   ++  +    +  A +H
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRV----LSLAWEH 55

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLN 409
           P +  LY  F+   N F  V+EY +G DL F+++  HK    R A     +++  L++L+
Sbjct: 56  PFLTHLYCTFQTKENLF-FVMEYLNGGDLMFHIQSCHKFDLPR-ATFYAAEIICGLQFLH 113

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +++ DLK  NILL   +  G IKI DFG+ K    EN   D     T    GT  
Sbjct: 114 S--KGIVYRDLKLDNILL---DTDGHIKIADFGMCK----ENMLGDAK---TCTFCGTPD 161

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ 514
           Y+ PE  ++G+   K ++ VD WS GV+ Y+ L G+ PF GH++ +
Sbjct: 162 YIAPE-ILLGQ---KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.9 bits (199), Expect = 1e-16
 Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 46/289 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKV-----HQLNKDWKEDKKANYIKHALREYNIHKALD 349
           +G G F  V+ A D++    VA K       Q N+ W++          ++E    + L 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD---------IIKEVRFLQKLR 73

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP  ++ Y    +  ++   V+EYC G   D      K + E E  ++    +  L YL+
Sbjct: 74  HPNTIQ-YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +IH D+K GNILL+E    G +K+ DFG + +M   N              GT +
Sbjct: 133 SHN--MIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPAN-----------XFVGTPY 176

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL-----EENTIL 524
           ++ PE  ++  +  +   KVDVWS+G+   + L  +KP   N +  + L      E+  L
Sbjct: 177 WMAPEV-ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPAL 234

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           ++           S   + F+ SCL    +DR     L +H ++    P
Sbjct: 235 QSGH--------WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 21/277 (7%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLG+G F  V+  +D+   R +A K  Q + +  E  K   +     E  + K L H R+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE--VSALECEIQLLKNLQHERI 66

Query: 354 VKLYDVFEIDANSFCTV-LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           V+ Y      A    T+ +EY  G  +   LK +  + E   R    Q++  + YL+   
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH--S 124

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             ++H D+K  NIL    +  G +K+ DFG SK +     +   G  + S     YW + 
Sbjct: 125 NMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMS---GTGIRSVTGTPYW-MS 177

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE  + G+       K DVWS+G    + L  K P+   ++ A I +  T  + T  Q  
Sbjct: 178 PEV-ISGEG---YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLP 231

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +   +S  A+ F+  C+      R     L RH + Q
Sbjct: 232 SH--ISEHARDFLG-CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 28/225 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y+ L  LG+G ++ V+K         VA K  ++  + +E         A+RE ++ K
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALK--EIRLEHEEGAPCT----AIREVSLLK 59

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
            L H  +V L+D+   +  S   V EY D  DL  YL     +I     +  + Q++  L
Sbjct: 60  DLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGL 117

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS--KVMDEENYNPDHGMDLTSQ 463
            Y +  K  V+H DLKP N+L+ E    GE+K+ DFGL+  K +  + Y         S 
Sbjct: 118 NYCHRRK--VLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTY---------SN 163

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY PP+  +        S+++D+W VG IFY+   G+  F
Sbjct: 164 EVVTLWYRPPDILL---GSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 35/283 (12%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACK---VHQLNKDWKEDKKANYIKHALREYNI 344
           +Y  + ++G+G F  VH      +Q+ V  K   V Q+ KD +          A  E  +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA--------AQNECQV 52

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVV 402
            K L HP +++ Y+ F  D  +   V+EY  G  L  Y+++     + E       +Q++
Sbjct: 53  LKLLSHPNIIEYYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            AL +++     ++H DLK  NILL +  +   +KI DFG+SK++  ++           
Sbjct: 112 LALHHVHT--KLILHRDLKTQNILLDKHKMV--VKIGDFGISKILSSKSK--------AY 159

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE    GK     + K D+W++G + Y+    K+ F      A +L+   
Sbjct: 160 TVVGTPCYISPE-LCEGK---PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK--- 212

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
           I+  T    +++   S + +  I S L      R  +  +   
Sbjct: 213 IMSGTFAPISDR--YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  V+K   + E   V  K+    K  +E+      K  L E  +  ++DHP VV
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKV--KIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKP 413
           +L  +    ++    + +      L  Y++ HK  I  +   +  +Q+   + YL E + 
Sbjct: 73  RLLGI--CLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWYL 471
            ++H DL   N+L+        +KITDFGL+K++  DE+ Y+ + G           W +
Sbjct: 130 -LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGK------VPIKW-M 178

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             E  +        + K DVWS GV  ++ + +G KP+
Sbjct: 179 ALESILHR----IYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 28/226 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  A+D + ++ VA K  +L++ ++    A   +   RE  + K
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHA---RRTYRELRLLK 69

Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     I+  +   ++    G DL+  +K  K +++   + ++ Q++
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLL 128

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E++I DFGL++  D+E         +T 
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNVAVNED--C-ELRILDFGLARQADDE---------MTG 174

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             A T WY  PE  +   N    +  VD+WSVG I  + L GK  F
Sbjct: 175 YVA-TRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 70/237 (29%), Positives = 109/237 (45%), Gaps = 32/237 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y+ L  LG+G ++ V K      +  VA K  +L  +  E         A+RE ++ K
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCT----AIREVSLLK 58

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-QVVSAL 405
            L H  +V L+D+   +      V EY D  DL  YL     +       I M Q++  L
Sbjct: 59  NLKHANIVTLHDIIHTE-RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS--KVMDEENYNPDHGMDLTSQ 463
            Y ++ K  ++H DLKP N+L+ E    GE+K+ DFGL+  K +  + Y         S 
Sbjct: 117 SYCHKRK--ILHRDLKPQNLLINEK---GELKLADFGLARAKSVPTKTY---------SN 162

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
              T WY PP+  +      + S+ +D+W VG I Y+   G+  F      +T+ EE
Sbjct: 163 EVVTLWYRPPDVLL---GSTEYSTPIDMWGVGCILYEMATGRPMF----PGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 49/224 (21%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G    V+KA+ L  +R +A KV  L      D      K  + E  I    D P ++
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL------DITVELQKQIMSELEILYKCDSPYII 62

Query: 355 KLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
             Y  F ++   S CT  E+ DG  LD Y    + I E     I + VV  L YL  +K 
Sbjct: 63  GFYGAFFVENRISICT--EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK- 115

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            ++H D+KP N+L+   N  G++K+ DFG+S               L +  A TY     
Sbjct: 116 -ILHRDVKPSNMLV---NTRGQVKLCDFGVST-------------QLVNSIAKTY----- 153

Query: 474 ECFVVGKN----PPKISSK-----VDVWSVGVIFYQCLYGKKPF 508
               VG N    P +IS +      DVWS+G+ F +   G+ P+
Sbjct: 154 ----VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 82/297 (27%), Positives = 123/297 (41%), Gaps = 58/297 (19%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++GKG F EV         +  A K    ++ +K+D+ A    H   E ++    D P V
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLA----HVKAERDVLAESDSPWV 63

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V LY  F+ DA     ++E+  G DL   L ++ T +E   R  + + V A++ ++  K 
Sbjct: 64  VSLYYSFQ-DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH--KL 120

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLS----KVMDEENY----------NPDHG-- 457
             IH D+KP NIL+  G   G IK++DFGLS    K  D   Y          N      
Sbjct: 121 GFIHRDIKPDNILIDRG---GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 458 ------MDLTSQG------------------AGTYWYLPPECFVVGKNPPKISSKVDVWS 493
                 ++LT                      GT  Y+ PE F+          + D WS
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL----QQGYGQECDWWS 233

Query: 494 VGVIFYQCLYGKKPFGHNQSQATILEENTILKATE-VQFANKPTVSNEAKGFIRSCL 549
           +G I ++CL G  PF    S  T      I+   E + F +   +S EA+  IR  +
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETY---RKIINWRETLYFPDDIHLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 46/289 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKV-----HQLNKDWKEDKKANYIKHALREYNIHKALD 349
           +G G F  V+ A +      VA K       Q N+ W++          ++E    + L 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD---------IIKEVKFLQQLK 79

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP  ++    +  +  ++  V+EYC G   D      K + E E  +I    +  L YL+
Sbjct: 80  HPNTIEYKGCYLKEHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +IH D+K GNILLTE    G++K+ DFG +      N              GT +
Sbjct: 139 S--HNMIHRDIKAGNILLTEP---GQVKLADFGSASKSSPAN-----------SFVGTPY 182

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           ++ PE  ++  +  +   KVDVWS+G+   + L  +KP         +   N +     +
Sbjct: 183 WMAPEV-ILAMDEGQYDGKVDVWSLGITCIE-LAERKP--------PLFNMNAMSALYHI 232

Query: 530 QFANKPTV-SNE----AKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
              + PT+ SNE     +GF+  CL    ++R     L RHD+++   P
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 26/218 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNIHK-ALDH 350
           +LGKG F +V  A   +  R  A KV  L KD   ++D     ++  + E  I   A +H
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDD----VECTMTEKRILSLARNH 55

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P + +LY  F+     F  V+E+ +G DL F++++ +   E  AR    ++ SAL +L++
Sbjct: 56  PFLTQLYCCFQTPDRLF-FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +I+ DLK  N+LL     C   K+ DFG+ K   E  +N   G   TS   GT  Y
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHC---KLADFGMCK---EGIFN---GK-TTSTFCGTPDY 162

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           + PE        P     VD W++GV+ Y+ L G  PF
Sbjct: 163 IAPEILQEMLYGP----SVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 38/234 (16%)

Query: 295 LGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +G G F EV +    L  ++ +   +  L     + ++ ++    L E +I    DHP +
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF----LTEASIMGQFDHPNI 67

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SALK 406
           ++L  V    +     + EY +   LD +L+++      + +  V Q+V       S +K
Sbjct: 68  IRLEGVV-TKSRPVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMK 120

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN--YNPDHGMDLTSQG 464
           YL+E+    +H DL   NIL+    VC   K++DFGLS+ +++    Y        T  G
Sbjct: 121 YLSEMN--YVHRDLAARNILVNSNLVC---KVSDFGLSRRLEDSEATYT-------TKGG 168

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPFGHNQSQATI 517
                +  PE         K +S  DVWS G++ ++   YG++P+    +Q  I
Sbjct: 169 KIPIRWTAPEAIAYR----KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 25/265 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LGKGGF EV         +  ACK  +L+K  K  KK +  K AL E  I + ++ P +V
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK--KLDK--KRLKKKSGEKMALLEKEILEKVNSPFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEIK 412
            L   FE   +  C V+   +G DL +++           R I    Q+   + +L+ + 
Sbjct: 57  NLAYAFESKTH-LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +++ D+KP N+LL +   C   +++D GL+  + +            +Q AGT  Y+ 
Sbjct: 116 --IVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKT--------ITQRAGTNGYMA 162

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA 532
           PE     K  P  S  VD +++G   Y+ + G+ PF  ++ +    E        EV+F 
Sbjct: 163 PEIL---KEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE 218

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRI 557
           ++   + E+K   R  LA + EDR+
Sbjct: 219 HQ-NFTEESKDICRLFLAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 24/226 (10%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +  +Y+ +  +G+G +  V  A + +    VA K  ++   +     A   K  LRE  +
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDA---KRTLREIKL 57

Query: 345 HKALDHPRVVKLYDVFE-IDANSFCTVLEYCDGHDLDFY--LKQHKTIAEREARSIVMQV 401
            + LDH  V+ + D+       +F  V    +  D D +  ++  +T+++   +  + Q+
Sbjct: 58  LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQL 117

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  LKY++     V+H DLKP N+LL   N   ++KI DFGL++   E+        D  
Sbjct: 118 LRGLKYIHSAN--VLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKG-------DFM 165

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           ++   T WY  PE  +   N  + ++ +DVWSVG IF + L G+KP
Sbjct: 166 TEYVVTRWYRAPELLL---NCSEYTTAIDVWSVGCIFAE-LLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 72/255 (28%), Positives = 114/255 (44%), Gaps = 30/255 (11%)

Query: 261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRY--VACK 318
           KNL + + K   +  + +  N     D +  +  LG G F  V  A   K + +  VA K
Sbjct: 5   KNLQLHKKKDSDSTKEPKRKNKMKYED-FNFIRTLGTGSFGRVILA-TYKNEDFPPVAIK 62

Query: 319 VHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD 378
             + +K  K+ +    + H   E  I   ++HP  V LY  F+ D +    VLE+  G +
Sbjct: 63  RFEKSKIIKQKQ----VDHVFSERKILNYINHPFCVNLYGSFK-DESYLYLVLEFVIGGE 117

Query: 379 LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI 438
              +L+++K            Q+V   +YL  +   +++ DLKP N+LL +    G IK+
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD---GFIKM 172

Query: 439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVI 497
           TDFG +KV+D   Y             GT  Y+ PE  + VG          D W++G+ 
Sbjct: 173 TDFGFAKVVDTRTYTL----------CGTPEYIAPEILLNVGH-----GKAADWWTLGIF 217

Query: 498 FYQCLYGKKPFGHNQ 512
            Y+ L G  PF  N+
Sbjct: 218 IYEILVGCPPFYANE 232

Length = 340

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 39/281 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+K  + K  + VA K  +L     E ++      A+RE ++ K L HP +V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL-----ESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ---HKTIAEREARSIVMQVVSALKYLNEI 411
            L DV  +  +    + E+    DL  YL      + +     +S + Q++  + + +  
Sbjct: 63  CLQDVL-MQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT--SQGAGTYW 469
           +  V+H DLKP N+L+      G IK+ DFGL++           G+ +   +    T W
Sbjct: 121 R--VLHRDLKPQNLLIDNK---GVIKLADFGLARAF---------GIPVRVYTHEVVTLW 166

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL---------EE 520
           Y  PE  +     P+ S+ VD+WS+G IF + +  KKP  H  S+   L           
Sbjct: 167 YRAPEVLLGS---PRYSTPVDIWSIGTIFAE-MATKKPLFHGDSEIDQLFRIFRILGTPT 222

Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS 561
             +          K T     KG +RS +    ED +D++ 
Sbjct: 223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 28/208 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK--QHKTIAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 63  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS--QGAGTYWY 470
             V+H DLKP N+L+   N  G IK+ DFGL++           G+ + +      T WY
Sbjct: 121 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAF---------GVPVRTYTHEVVTLWY 166

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIF 498
             PE  +  K     S+ VD+WS+G IF
Sbjct: 167 RAPEILLGCK---YYSTAVDIWSLGCIF 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.9 bits (197), Expect = 5e-16
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 24/242 (9%)

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  I + ++HP VVK +D+F+        +LE+ DG  L+          E+    +  
Sbjct: 121 REIEILRDVNHPNVVKCHDMFD-HNGEIQVLLEFMDGGSLE----GTHIADEQFLADVAR 175

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++S + YL+     ++H D+KP N+L+        +KI DFG+S+++ +        MD
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK---NVKIADFGVSRILAQT-------MD 223

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKV-DVWSVGVIFYQCLYGKKPF--GHNQSQAT 516
             +   GT  Y+ PE      N         D+WS+GV   +   G+ PF  G     A+
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           ++    + +  E       T S E + FI  CL      R   + L +H ++    P  G
Sbjct: 284 LMCAICMSQPPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339

Query: 577 RQ 578
           + 
Sbjct: 340 QG 341

Length = 353

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 63/233 (27%), Positives = 110/233 (47%), Gaps = 33/233 (14%)

Query: 294 LLGKGGFSEV-HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  +R +   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF----LSEASIMGQFDHPN 66

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           ++ L  V    +     V EY +   LD +L++H      + +  V+Q+V       S +
Sbjct: 67  IIHLEGVV-TKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASGM 119

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 120 KYLSDMG--YVHRDLAARNILVNSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 170

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 171 IPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 46/306 (15%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L L+G+G +  V K    +  + VA K    ++D K  KK      A+RE  + K
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI-----AMREIRMLK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +V L +VF         V E+ D   LD   K    + E   R  + Q++  ++
Sbjct: 56  QLRHENLVNLIEVFR-RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           + +     +IH D+KP NIL+++  V   +K+ DFG ++ +           ++ +    
Sbjct: 115 FCHSHN--IIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPG-------EVYTDYVA 162

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK----------------KPFGH 510
           T WY  PE  +VG    K    VD+W+VG +  + L G+                K  G+
Sbjct: 163 TRWYRAPE-LLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219

Query: 511 -NQSQATILEENTIL------KATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVIS 561
                  I ++N +       +  E++   K  P +S       + CL    +DR     
Sbjct: 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Query: 562 LARHDY 567
           L  H++
Sbjct: 280 LLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.1 bits (192), Expect = 8e-16
 Identities = 69/237 (29%), Positives = 112/237 (47%), Gaps = 33/237 (13%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y  +  +G G +  V+KA D     +VA K  ++     +  +       +RE  + K 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-----QTNEDGLPLSTVREVALLKR 55

Query: 348 L---DHPRVVKLYDV---FEIDANSFCT-VLEYCDGHDLDFYLKQHKT--IAEREARSIV 398
           L   DHP +V+L DV      D  +  T V E+ D  DL  YL +     +     + ++
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLM 114

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q +  L +L+     ++H DLKP NIL+T G   G++K+ DFGL+++   +       M
Sbjct: 115 RQFLRGLDFLHANC--IVHRDLKPENILVTSG---GQVKLADFGLARIYSCQ-------M 162

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
            LT     T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S+A
Sbjct: 163 ALTPV-VVTLWYRAPEVLL----QSTYATPVDMWSVGCIFAE-MFRRKPLFCGNSEA 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 78.2 bits (192), Expect = 1e-15
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +D Y  L  LG+G ++ V+K       + VA KV +L    +E++   +   A+RE ++ 
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL----QEEEGTPFT--AIREASLL 57

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSA 404
           K L H  +V L+D+      +   V EY    DL  Y+ +H   +     +  + Q++  
Sbjct: 58  KGLKHANIVLLHDIIHTK-ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG 115

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L Y+++    ++H DLKP N+L+++    GE+K+ DFGL++        P H     S  
Sbjct: 116 LSYIHQRY--ILHRDLKPQNLLISD---TGELKLADFGLARAKSV----PSHTY---SNE 163

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             T WY PP+  +      + S+ +D+W VG IF + + G   F
Sbjct: 164 VVTLWYRPPDVLL---GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 22/216 (10%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G +++V      K  +  A KV  + K+   +D+  ++++    ++   +A  +P 
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKV--VKKELVHDDEDIDWVQ--TEKHVFEQASSNPF 57

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +V L+  F+  +  F  V+EY +G DL F++++ + + E  AR    ++  AL +L+E  
Sbjct: 58  LVGLHSCFQTTSRLF-LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-- 114

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT  Y+ 
Sbjct: 115 RGIIYRDLKLDNVLLDAD---GHIKLTDYGMCK----EGLGPG---DTTSTFCGTPNYIA 164

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE         +    VD W++GV+ ++ + G+ PF
Sbjct: 165 PEIL----RGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E +I   ++HP +VKL+  F+ +   +  +L++  G DL   L +     E + +  + +
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 106

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +  AL +L+ +   +I+ DLKP NILL E    G IK+TDFGLSK               
Sbjct: 107 LALALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSK-------ESIDHEKK 154

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                GT  Y+ PE  VV  N    +   D WS GV+ ++ L G  PF     + T+   
Sbjct: 155 AYSFCGTVEYMAPE--VV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--- 207

Query: 521 NTILKATEVQFANKPTVSNEAKGFIR 546
             ILKA   +      +S EA+  +R
Sbjct: 208 TMILKA---KLGMPQFLSPEAQSLLR 230

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 34/231 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  VH     + +  VA K+ +     ++D    +I+ A     +   L HP +V
Sbjct: 12  LGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSEDD----FIEEA----KVMMKLSHPNLV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA-RSIVMQVVSALKYLNEIKP 413
           +LY V          V EY     L  YL++ K     E    +   V  A++YL     
Sbjct: 63  QLYGVC-TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG- 120

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPDHGMDLTSQGAG--TYWY 470
             IH DL   N L+ E NV   +K++DFGL++ V+D++ Y        +SQG      W 
Sbjct: 121 -FIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQ-YT-------SSQGTKFPVKWA 168

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE 520
            PPE F   +     SSK DVWS GV+ ++    GK P+    S + ++E 
Sbjct: 169 -PPEVFDYSR----FSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVES 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 88/320 (27%), Positives = 136/320 (42%), Gaps = 37/320 (11%)

Query: 254 DSYLIGYKNL--HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE 311
           D++L  YK+    IR+L R+  ED             Y ++ ++G+G F EV        
Sbjct: 22  DNFLNRYKDTINKIRDL-RMKAED-------------YEVVKVIGRGAFGEVQLVRHKST 67

Query: 312 QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL 371
           ++  A K+    +  K    A +      E +I    + P VV+L+  F+ D      V+
Sbjct: 68  RKVYAMKLLSKFEMIKRSDSAFF----WEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVM 122

Query: 372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN 431
           EY  G DL   L  +  + E+ AR    +VV AL  ++ +    IH D+KP N+LL +  
Sbjct: 123 EYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS- 178

Query: 432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV 491
             G +K+ DFG    M++E      GM       GT  Y+ PE             + D 
Sbjct: 179 --GHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAY 551
           WSVGV  Y+ L G  PF  +    T      +     + F +   +S EAK  I + L  
Sbjct: 231 WSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 288

Query: 552 R--KEDRIDVISLARHDYLQ 569
           R  +  R  V  + RH + +
Sbjct: 289 REVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 30/232 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y  L  +G+G + +V+KA D    + VA K  +L  D     +      ALRE ++ +
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-----EEGIPPTALREISLLQ 55

Query: 347 ALDH-PRVVKLYDVFEIDAN----SFCTVLEYCDGHDLDFYL-----KQHKTIAEREARS 396
            L     +V+L DV  ++      S   V EY D  DL  ++        + +  +  +S
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKS 114

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
            + Q++  + + +  K  V+H DLKP N+L+ +    G +KI D GL +       +  H
Sbjct: 115 FMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQK--GLLKIADLGLGRAFSIPVKSYTH 170

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            +        T WY  PE  +   +    S+ VD+WSVG IF +    +  F
Sbjct: 171 EIV-------TLWYRAPEVLLGSTH---YSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 55/180 (30%), Positives = 79/180 (43%), Gaps = 33/180 (18%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHKTIAE 391
           L E  I K L HP++++LY V        CT       V E      L  YL+     A 
Sbjct: 49  LAEAQIMKKLRHPKLIQLYAV--------CTLEEPIYIVTELMKYGSLLEYLQGGAGRAL 100

Query: 392 REARSIVM--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
           +  + I M  QV S + YL       IH DL   N+L+ E N+C   K+ DFGL++V+ E
Sbjct: 101 KLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNIC---KVADFGLARVIKE 155

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           + Y    G     +     W  P           + S K DVWS G++  + + YG+ P+
Sbjct: 156 DIYEAREGAKFPIK-----WTAPE-----AALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 79.8 bits (197), Expect = 2e-15
 Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 37/264 (14%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY ++ L+GKGG  EV+ A+D    R VA K  ++ +D  E+      K  LRE  I   
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLK--KRFLREAKIAAD 58

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREA----RS 396
           L HP +V +Y +   D +     + Y +G+ L   LK         K +AE+ +     S
Sbjct: 59  LIHPGIVPVYSI-CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG--LSKVMDEE---- 450
           I  ++ + ++Y++     V+H DLKP NILL    + GE+ I D+G  + K ++EE    
Sbjct: 118 IFHKICATIEYVHS--KGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 451 -NYNPDHGM--DLTSQG--AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
            + +  +     +T  G   GT  Y+ PE  +    P   S   D++++GVI YQ L   
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLL--GVPA--SESTDIYALGVILYQMLTLS 228

Query: 506 KPFGHNQSQATILEENTILKATEV 529
            P+   +    I   + IL   EV
Sbjct: 229 FPY-RRKKGRKISYRDVILSPIEV 251

Length = 932

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 70/236 (29%), Positives = 105/236 (44%), Gaps = 43/236 (18%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY +  ++GKG +  V  A D      VA K  ++N  ++    A  I   LRE  + + 
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRI---LREIKLLRL 55

Query: 348 LDHPRVVK---------------LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER 392
           L HP +V+               +Y VFE+  +    V++  D  DL     +H      
Sbjct: 56  LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND--DLT---PEHHQF--- 107

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
                + Q++ ALKY++     V H DLKP NIL    N   ++KI DFGL++V     +
Sbjct: 108 ----FLYQLLRALKYIHTAN--VFHRDLKPKNIL---ANADCKLKICDFGLARVA----F 154

Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           N        +    T WY  PE  + G    K +  +D+WS+G IF + L GK  F
Sbjct: 155 NDTPTAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.7 bits (188), Expect = 4e-15
 Identities = 72/284 (25%), Positives = 123/284 (43%), Gaps = 34/284 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  V+ A D++    VA K    +     +K  + IK    E    + + HP  +
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK----EVKFLQRIKHPNSI 88

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           + Y    +  ++   V+EYC G   D      K + E E  +I    +  L YL+     
Sbjct: 89  E-YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 145

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +IH D+K GNILLTE    G++K+ DFG + +    N              GT +++ PE
Sbjct: 146 MIHRDIKAGNILLTEP---GQVKLADFGSASIASPAN-----------SFVGTPYWMAPE 191

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE----ENTILKATEVQ 530
             ++  +  +   KVDVWS+G+   +    K P  +  + + +      E+  L++ E  
Sbjct: 192 V-ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE-- 248

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
                  S+  + F+ SCL    +DR     L +H ++    P+
Sbjct: 249 ------WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 32/276 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A D    R VA K   L K  + +   N       E  I +   HP +V
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHPNIV 79

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++Y  + +  +    V+E+ +G  L D  +  H  + E +  ++ + V+ AL +L+    
Sbjct: 80  EMYSSYLVG-DELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLAVLKALSFLHAQG- 135

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ P
Sbjct: 136 -VIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAP 184

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+ + P    ++VD+WS+G++  + + G+ P+ +       L+    ++        
Sbjct: 185 E--VISRLP--YGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIRDNLPPKLK 236

Query: 534 KP-TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
               VS   + F+   L      R     L  H +L
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 26/218 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNIHK-ALDH 350
           +LGKG F +V  A         A KV  L KD   ++D     +   + E  I   A  H
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDD----VDCTMTEKRILALAAKH 55

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +  L+  F+     F  V+EY +G DL F +++ +   E  +R    +V  AL +L+ 
Sbjct: 56  PFLTALHCCFQTKDRLF-FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VI+ DLK  NILL   +  G  K+ DFG+ K    E          T+   GT  Y
Sbjct: 114 -RHGVIYRDLKLDNILL---DAEGHCKLADFGMCK----EGILNG---VTTTTFCGTPDY 162

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           + PE         +    VD W++GV+ Y+ + G+ PF
Sbjct: 163 IAPEIL----QELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 28/284 (9%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKGGF EV         +  ACK  +L K  K  KK      AL E  I + ++   V
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACK--KLEK--KRIKKRKGEAMALNEKRILEKVNSRFV 62

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           V L   +E   ++ C VL   +G DL F++         E R+I    ++   L+ L   
Sbjct: 63  VSLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG-AGTYWY 470
           +  +++ DLKP NILL +    G I+I+D GL+  + E           T +G  GT  Y
Sbjct: 120 RERIVYRDLKPENILLDD---RGHIRISDLGLAVQIPEGE---------TVRGRVGTVGY 167

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE      N  K +   D W +G + Y+ + G+ PF   + +    E +  +K  + +
Sbjct: 168 MAPEVI----NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE 223

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
           ++ K   S +AK   R  L    ++R+           Q P+ K
Sbjct: 224 YSEK--FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 31/237 (13%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNIHKALD 349
           LM+LGKG F +V  A         A K+  L KD   ++D     ++  + E  +     
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDD----VECTMVEKRVLALPG 58

Query: 350 HPR-VVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            P  + +L+  F+ +D   F  V+EY +G DL ++++Q     E  A     ++   L +
Sbjct: 59  KPPFLTQLHSCFQTMDRLYF--VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+     +I+ DLK  N++L   +  G IKI DFG+ K    EN         T    GT
Sbjct: 117 LH--SKGIIYRDLKLDNVML---DAEGHIKIADFGMCK----ENIFGG---KTTRTFCGT 164

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILEEN 521
             Y+ PE  ++   P   S  VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N
Sbjct: 165 PDYIAPE--IIAYQPYGKS--VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 29/231 (12%)

Query: 346 KALDHPRVVKLYDVFEIDANSF-CT-VLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVV 402
           K+ D P +VK Y  F  D++ F C  ++  C    LD  LK+    I E     + + +V
Sbjct: 69  KSHDCPYIVKCYGYFITDSDVFICMELMSTC----LDKLLKRIQGPIPEDILGKMTVAIV 124

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            AL YL E K  VIH D+KP NILL      G +K+ DFG+S  + +            +
Sbjct: 125 KALHYLKE-KHGVIHRDVKPSNILLDAS---GNVKLCDFGISGRLVDSKAK--------T 172

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT----IL 518
           + AG   Y+ PE        PK   + DVWS+G+   +   G+ P+ + +++      IL
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +E          F      S +   F+  CL      R     L +H +++
Sbjct: 233 QEEPPSLPPNEGF------SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.4 bits (182), Expect = 1e-14
 Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 37/291 (12%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + L+ L+G G + +V+K   +K  +  A KV  +  D +E+ K        +E N+ K  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--------QEINMLKKY 59

Query: 349 DHPRVVKLYDVFEIDAN------SFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQ 400
            H R +  Y    I  N          V+E+C    +   +K  K  T+ E     I  +
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  L +L++ K  VIH D+K  N+LLTE     E+K+ DFG+S  +D         +  
Sbjct: 120 ILRGLSHLHQHK--VIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRT-------VGR 167

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISS-KVDVWSVGVIFYQCLYGKKPFG--HNQSQATI 517
            +   GT +++ PE     +NP      K D+WS+G+   +   G  P    H      +
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           +  N   +    +++ K       + FI SCL      R     L +H ++
Sbjct: 228 IPRNPAPRLKSKKWSKK------FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 76/283 (26%), Positives = 111/283 (39%), Gaps = 33/283 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G    V K   +     +A KV  +        K++  K  LRE  I      P +V
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHI------GAKSSVRKQILRELQIMHECRSPYIV 66

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
             Y  F ++ N+ C  +E+ D   LD   K+   I       I + VV  L YL  +   
Sbjct: 67  SFYGAF-LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR- 124

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           ++H D+KP NIL+   N  G+IK+ DFG+S     E  N      +     GT  Y+ PE
Sbjct: 125 IMHRDIKPSNILV---NSRGQIKLCDFGVSG----ELIN-----SIADTFVGTSTYMSPE 172

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG-HNQSQATILEENTILKATEVQFAN 533
               GK     + K DVWS+G+   +   GK PF   N       +   IL   + Q   
Sbjct: 173 RIQGGK----YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-QIVQ 227

Query: 534 KPT-------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +P           + + F+ +CL     +R     L       
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 79/300 (26%), Positives = 119/300 (39%), Gaps = 55/300 (18%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F EV     +      A K   L K   +    N   H   E +I    D+  VV
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT--LRK--ADVLMRNQAAHVKAERDILAEADNEWVV 64

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KLY  F+   N +  V++Y  G D+   L +     E  AR  + ++  A++ ++  K  
Sbjct: 65  KLYYSFQDKDNLY-FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH--KMG 121

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGL---------SKVMDEENYNPDHGMDLTSQGA 465
            IH D+KP NIL+      G IK+TDFGL         SK   + +++    M+ + + +
Sbjct: 122 FIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 466 ---------------------------GTYWYLPPECFV-VGKNPPKISSKVDVWSVGVI 497
                                      GT  Y+ PE  +  G          D WSVGVI
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-----QLCDWWSVGVI 233

Query: 498 FYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            Y+ L G+ PF    + A   +   I   T +   ++  +S EA   I   L    EDR+
Sbjct: 234 LYEMLVGQPPF-LADTPAET-QLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRL 290

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 35/221 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKT------LKEDTME--VEEFLKEAAVMKEIKHPNLV 65

Query: 355 KLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYL 408
           +L  V   +   F  + E+   G+ LD+  + ++     E  ++V+     Q+ SA++YL
Sbjct: 66  QLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSAMEYL 120

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
              K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +     
Sbjct: 121 E--KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK----- 170

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF 508
            +  PE         K S K DVW+ GV+ ++   YG  P+
Sbjct: 171 -WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 17/223 (7%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           ++ Y ++ ++G+G F EV        Q+  A K+    +  K    A +      E +I 
Sbjct: 42  AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF----WEERDIM 97

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
              + P VV+L+  F+ D      V+EY  G DL   L  +  + E+ A+    +VV AL
Sbjct: 98  AFANSPWVVQLFCAFQ-DDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
             ++ +   +IH D+KP N+LL +    G +K+ DFG    MDE       GM       
Sbjct: 156 DAIHSMG--LIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDET------GMVRCDTAV 204

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  Y+ PE             + D WSVGV  ++ L G  PF
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 74/267 (27%), Positives = 126/267 (47%), Gaps = 28/267 (10%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKGGF EV         +  ACK  +L K  K  KK      AL E  I + ++   V
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACK--KLEK--KRIKKRKGESMALNEKQILEKVNSRFV 62

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           V L   +E   ++ C VL   +G DL F++         E R++    ++   L+ L++ 
Sbjct: 63  VSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG-AGTYWY 470
           +  +++ DLKP NILL +    G I+I+D GL+  + E           T +G  GT  Y
Sbjct: 122 R--IVYRDLKPENILLDDH---GHIRISDLGLAVHVPE---------GQTIKGRVGTVGY 167

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE   V KN  + +   D W++G + Y+ + G+ PF   + +    E   ++K  + +
Sbjct: 168 MAPE---VVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE 223

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRI 557
           ++ K   S +A+   +  L    ++R+
Sbjct: 224 YSEK--FSPDARSLCKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 23/278 (8%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPR 352
           LLG+G F  V+  +D    R +A K  Q + +  E  K     +AL  E  + K L H R
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE---VNALECEIQLLKNLLHER 65

Query: 353 VVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           +V+ Y    +    +    +E+  G  +   LK +  + E   R    Q++  + YL+  
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH-- 123

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              ++H D+K  NIL    +  G +K+ DFG SK +     +      +T    GT +++
Sbjct: 124 SNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWM 176

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  + G+       K D+WSVG    + L  K P+   ++ A I +  T  + T    
Sbjct: 177 SPEV-ISGEG---YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPVL 230

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              P VS+  + F++      K  R     L RH ++ 
Sbjct: 231 P--PHVSDHCRDFLKRIFVEAKL-RPSADELLRHTFVH 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 43/281 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   ED+    I+   +E  +    D P V 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDE----IEDIQQEITVLSQCDSPYVT 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  +  D   +  ++EY  G   LD  L +   + E +  +I+ +++  L YL+  K 
Sbjct: 66  KYYGSYLKDTKLW-IIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    GE+K+ DFG++  + +     +  +       GT +++ P
Sbjct: 123 --IHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAP 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E            SK D+WS+G+   +   G+ P    H      ++ +N          
Sbjct: 171 EVI----KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN---------- 216

Query: 532 ANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            N PT+    S   K F+ +CL      R     L +H ++
Sbjct: 217 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 81/276 (29%), Positives = 132/276 (47%), Gaps = 33/276 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE-YNIH 345
           D + ++ ++G+G F EV        +R  A K+  LNK W+  K+A       RE  N+ 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LNK-WEMLKRAE--TACFREERNVL 55

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSA 404
              D   +  L+  F+ D N    V++Y  G DL   L K    + E  AR  + ++V A
Sbjct: 56  VNGDCQWITTLHYAFQ-DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           +  ++++    +H D+KP N+LL   ++ G I++ DFG    M+++      G   +S  
Sbjct: 115 IHSIHQLH--YVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQD------GTVQSSVA 163

Query: 465 AGTYWYLPPECFV-----VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
            GT  Y+ PE        +GK  P+     D WS+GV  Y+ LYG+ PF    +++ +  
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPE----CDWWSLGVCMYEMLYGETPF---YAESLVET 216

Query: 520 ENTILKATE-VQFANKPT-VSNEAKGFIRSCLAYRK 553
              I+   E  QF +  T VS EAK  I+  +  R+
Sbjct: 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 73/258 (28%), Positives = 116/258 (44%), Gaps = 26/258 (10%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKGGF EV         +  ACK  +L K  K  KK      AL E  I + ++   V
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACK--KLEK--KRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           V L   +E   ++ C VL   +G DL F++         E R++    ++   L+ L+  
Sbjct: 63  VSLAYAYETK-DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           +  +++ DLKP NILL +    G I+I+D GL+  + E         +      GT  Y+
Sbjct: 122 R--IVYRDLKPENILLDD---YGHIRISDLGLAVEIPEG--------ETIRGRVGTVGYM 168

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE   V KN  + +   D W +G + Y+ + GK PF   + +    E    +K  + ++
Sbjct: 169 APE---VVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224

Query: 532 ANKPTVSNEAKGFIRSCL 549
           + K   S  A+   R  L
Sbjct: 225 SEK--FSEAARSICRQLL 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F +V +      QR  A K   + K     +    + H L E  +   ++ P +V
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKT--IRKAHIVSRSE--VTHTLAERTVLAQVNCPFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            L   F+        VL + +G +L  +L++        AR    +++ AL+ L++    
Sbjct: 57  PLKFSFQ-SPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN-- 113

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VI+ DLKP NILL   +  G I + DFGL K+    N   D   D T+   GT  YL PE
Sbjct: 114 VIYRDLKPENILL---DYQGHIALCDFGLCKL----NMKDD---DKTNTFCGTPEYLAPE 163

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             ++G    K    VD W++GV+ Y+ L G  PF
Sbjct: 164 -LLLGHGYTKA---VDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 26/204 (12%)

Query: 330 KKANYIKHALREYNIHKALDH----PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ 385
           +KA   +H   E  +   L+H    P +V L+  F+ D      +L+Y +G +L  +L Q
Sbjct: 43  QKAKTTEHTRTERQV---LEHIRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQ 98

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   E+E +    ++V AL++L+++   +I+ D+K  NILL      G + +TDFGLSK
Sbjct: 99  RERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN---GHVVLTDFGLSK 153

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
              E+     +         GT  Y+ P+  +V          VD WS+GV+ Y+ L G 
Sbjct: 154 EFHEDEVERAYSF------CGTIEYMAPD--IVRGGDGGHDKAVDWWSMGVLMYELLTGA 205

Query: 506 KPF---GHNQSQATILEENTILKA 526
            PF   G   SQA I     ILK+
Sbjct: 206 SPFTVDGEKNSQAEISRR--ILKS 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 26/276 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE-YNIH 345
           D + +L ++G+G F EV         +  A K+  LNK W+  K+A       RE  ++ 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKI--LNK-WEMLKRAE--TACFREERDVL 55

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSA 404
              D   +  L+  F+ D N+   V++Y  G DL   L K    + E  AR  + ++V A
Sbjct: 56  VNGDRRWITNLHYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           +  ++++    +H D+KP N+LL   +  G I++ DFG    +  +      G   ++  
Sbjct: 115 IDSVHQLG--YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLAD------GTVQSNVA 163

Query: 465 AGTYWYLPPECF-VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            GT  Y+ PE    +     +   + D WS+GV  Y+ LYG+ PF    +++ +     I
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKI 220

Query: 524 LKATE-VQF-ANKPTVSNEAKGFIRSCLAYRKEDRI 557
           +   E  QF  +   VS EAK  IR  +    E R+
Sbjct: 221 MNHKEHFQFPPDVTDVSEEAKDLIRRLIC-SPETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 32/219 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKALDHPR 352
           LG G F EV +    K +  VA K+          K  + +K     +E    K L H  
Sbjct: 14  LGSGYFGEVWEGL-WKNRVRVAIKIL---------KSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVVSALKYLNE 410
           ++ L+ V  +       + E  +   L  +L+  +      A  I M  QV   + YL E
Sbjct: 64  LISLFAVCSVG-EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
                IH DL   NIL+ E  VC   K+ DFGL++++ E+ Y       L+S     Y +
Sbjct: 123 QN--SIHRDLAARNILVGEDLVC---KVADFGLARLIKEDVY-------LSSDKKIPYKW 170

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             PE    G      S+K DVWS G++ Y+   YG+ P+
Sbjct: 171 TAPEAASHGT----FSTKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 79/301 (26%), Positives = 116/301 (38%), Gaps = 65/301 (21%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPR 352
            +G+G F  V+K         +A K  +   D KE K+       L + + + ++ D P 
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKR------LLMDLDVVMRSSDCPY 64

Query: 353 VVKLYD-VF-EIDANSFCTVLEYCDGHDLDF-------YLKQHKTIAEREARSIVMQVVS 403
           +VK Y  +F E D    C  L      D+         Y      I E     I +  V 
Sbjct: 65  IVKFYGALFREGDC-WICMEL-----MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 404 ALKYL-NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS--------KVMDEENYNP 454
           AL YL  E+K  +IH D+KP NILL      G IK+ DFG+S        K  D      
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRN---GNIKLCDFGISGQLVDSIAKTRD------ 167

Query: 455 DHGMDLTSQGAGTYWYLPPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH--- 510
                     AG   Y+ PE      ++   + S  DVWS+G+  Y+   GK P+     
Sbjct: 168 ----------AGCRPYMAPERIDPSARDGYDVRS--DVWSLGITLYEVATGKFPYPKWNS 215

Query: 511 --NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             +Q    +  +  IL  +E     +   S     FI  CL   +  R     L  H ++
Sbjct: 216 VFDQLTQVVKGDPPILSNSE-----EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Query: 569 Q 569
           +
Sbjct: 271 K 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 29/263 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPR 352
           LLG+G F EV+  +D    R +A K    + D +E  K     +AL  E  + K L H R
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE---VNALECEIQLLKNLRHDR 65

Query: 353 VVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           +V+ Y    + +       +EY  G  +   LK +  + E   R    Q++  + YL+  
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-- 123

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              ++H D+K  NIL    +  G +K+ DFG SK +     +   G  + S     YW +
Sbjct: 124 SNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMS---GTGIKSVTGTPYW-M 176

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE      +      K DVWSV     + L  K P+   ++ A I            + 
Sbjct: 177 SPEVI----SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-----------KI 221

Query: 532 ANKPTVSNEAKGFIRSCLAYRKE 554
           A +PT      G   +C  + K+
Sbjct: 222 ATQPTKPMLPDGVSDACRDFLKQ 244

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 62/235 (26%), Positives = 112/235 (47%), Gaps = 35/235 (14%)

Query: 294 LLGKGGFSEVHKA---FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           ++G G F EV +       K + +VA K   L   + E ++ ++    L E +I    DH
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKT--LKSGYTEKQRRDF----LSEASIMGQFDH 64

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------S 403
           P ++ L  V    +     + E+ +   LD +L+Q+      + +  V+Q+V       +
Sbjct: 65  PNIIHLEGVV-TKSRPVMIITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAA 117

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            +KYL+E+    +H DL   NIL+    VC   K++DFGLS+ ++++  +P +   L   
Sbjct: 118 GMKYLSEMN--YVHRDLAARNILVNSNLVC---KVSDFGLSRFLEDDTSDPTYTSSLG-- 170

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
           G     +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 171 GKIPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 26/266 (9%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKGGF EV         +  ACK  +L K  K  KK      AL E  I + ++   V
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACK--RLEK--KRIKKRKGESMALNEKQILEKVNSQFV 62

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           V L   +E   ++ C VL   +G DL F++         E R++    +++  L+ L+  
Sbjct: 63  VNLAYAYETK-DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           +   ++ DLKP NILL +    G I+I+D GL+  + E         +      GT  Y+
Sbjct: 120 RENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEG--------ESIRGRVGTVGYM 168

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE      N  + +   D W +G + Y+ + G+ PF   + +    E +  +  TE  +
Sbjct: 169 APEVL----NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRI 557
           + K   S EAK   +  L    + R+
Sbjct: 225 SAK--FSEEAKSICKMLLTKDPKQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 40/285 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA K   L +  K++   N       E  + +   HP +V
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-------EILVMRENKHPNIV 79

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 80  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 135

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  NILL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPE 185

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI----LKAT--E 528
                   PK    VD+WS+G++  + + G+ P+         L EN +    L AT   
Sbjct: 186 VVTRKAYGPK----VDIWSLGIMAIEMVEGEPPY---------LNENPLRALYLIATNGT 232

Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
            +  N   +S   + F+  CL    E R     L +H +L+   P
Sbjct: 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 26/263 (9%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE---YNIHKALDH 350
           ++G+GGF EV+        +  A K   L+K   + K+   +  AL E    ++    D 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--ALNERIMLSLVSTGDC 56

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +V +   F    +  C +L+  +G DL ++L QH   +E+E R    +++  L++++ 
Sbjct: 57  PFIVCMTYAFHT-PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH- 114

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               V++ DLKP NILL E    G ++I+D GL+   D     P           GT+ Y
Sbjct: 115 -NRFVVYRDLKPANILLDEH---GHVRISDLGLA--CDFSKKKP-------HASVGTHGY 161

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKATEV 529
           + PE    G       S  D +S+G + ++ L G  PF  H       ++  T+    E+
Sbjct: 162 MAPEVLQKGT---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL 218

Query: 530 QFANKPTVSNEAKGFIRSCLAYR 552
             +  P + +  +G ++  ++ R
Sbjct: 219 PDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 34/235 (14%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLN---KDWKEDKKANYIKHALREYNIHKALDH 350
            LG G F  V      +   +       +    K  K DK ++ +   L+E  I  +LDH
Sbjct: 2   KLGDGSFGVV------RRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--SIVMQVVSALKYL 408
             +++LY V  +  +    V E      L   L++        +      +Q+ + ++YL
Sbjct: 56  ENLIRLYGV--VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD--EENYNPDHGMDLTSQGAG 466
            E K   IH DL   NILL   +   ++KI DFGL + +   E++Y  +  + +      
Sbjct: 114 -ESK-RFIHRDLAARNILLASDD---KVKIGDFGLMRALPQNEDHYVMEEHLKV------ 162

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILE 519
            + +  PE           S   DVW  GV  ++   YG++P+ G + SQ  IL+
Sbjct: 163 PFAWCAPESL----RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILK 211

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 31/237 (13%)

Query: 291 LLMLLGKGGFSEV---HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           LL +LG G + +V    K       +  A KV Q        +KA  ++H   E N+   
Sbjct: 4   LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ---KAALVQKAKTVEHTRTERNV--- 57

Query: 348 LDH----PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           L+H    P +V L+  F+ +A     +L+Y  G ++  +L Q    +E E R    +++ 
Sbjct: 58  LEHVRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL 116

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL++L+++   +++ D+K  NILL      G + +TDFGLSK    E        + T  
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEE------KERTYS 165

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATI 517
             GT  Y+ PE         K    VD WS+G++ ++ L G  PF   G   +Q+ +
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 31/228 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D+Y  +  +G+G +  V+KA D      +A K  +L +   ED+       A+RE ++ K
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ---EDEGVP--STAIREISLLK 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA------EREARSIVMQ 400
            + H  +V+L DV   +   +  V EY     LD  LK+H   +       R  ++ + Q
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLY-LVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  + Y +  +  V+H DLKP N+L+        +K+ DFGL++          H +  
Sbjct: 111 ILRGIAYCHSHR--VLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEVV- 165

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                 T WY  PE  +  ++    S+ VD+WSVG IF + +  K  F
Sbjct: 166 ------TLWYRAPEILLGSRH---YSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 34/282 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACK--VHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
            LG G FS  ++A D+K    +A K   +  N   ++++    ++   +E  +   L+HP
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR---KEIRLMARLNHP 63

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            ++++      D++ F   +E+  G  +   L ++    E    +   Q++  L YL+E 
Sbjct: 64  HIIRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 412 KPPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
           +  +IH D+K  N+L+   +  G+ ++I DFG +  +  +        +   Q  GT  +
Sbjct: 123 Q--IIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAG---EFQGQLLGTIAF 174

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG---HNQSQATILEENTILKAT 527
           + PE  V+       S   DVWSVG +  +    K P+    H+   A I +   I  AT
Sbjct: 175 MAPE--VLRGEQYGRSC--DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---IASAT 227

Query: 528 EVQFANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARH 565
                  P++    S   +     CL  + EDR     L +H
Sbjct: 228 T-----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 69/230 (30%), Positives = 102/230 (44%), Gaps = 35/230 (15%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
            +GKG F +V+K   LK    VA K          D K  +    L+E  I K  DHP +
Sbjct: 2   KIGKGNFGDVYKGV-LKGNTEVAVKT--CRSTLPPDLKRKF----LQEAEILKQYDHPNI 54

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA---LKYLNE 410
           VKL  V  +       V+E   G  L  +L++ K       + ++   + A   ++YL E
Sbjct: 55  VKLIGV-CVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYL-E 110

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY-- 468
            K   IH DL   N L+ E NV   +KI+DFG+S+   EE    + G+   S G      
Sbjct: 111 SKN-CIHRDLAARNCLVGENNV---LKISDFGMSR---EE----EGGIYTVSDGLKQIPI 159

Query: 469 -WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQA 515
            W   PE    G+     +S+ DVWS G++ ++    G  P+ G +  Q 
Sbjct: 160 KW-TAPEALNYGR----YTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 23/269 (8%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + +L ++G+G F EV         +  A K+  LNK W+  K+A        E ++    
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNK-WEMLKRAETACFR-EERDVLVNG 58

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           D+  +  L+  F+ + N +  +  Y  G  L    K    + E  AR  + ++V A+  +
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQGAGT 467
           +++    +H D+KP NIL+   ++ G I++ DFG   K+M++       G   +S   GT
Sbjct: 119 HQLH--YVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED-------GTVQSSVAVGT 166

Query: 468 YWYLPPECF-VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
             Y+ PE    +     K   + D WS+GV  Y+ LYG+ PF    +++ +     I+  
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNH 223

Query: 527 TE-VQFANKPT-VSNEAKGFIRSCLAYRK 553
            E  QF  + T VS +AK  IR  +  R+
Sbjct: 224 KERFQFPAQVTDVSEDAKDLIRRLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 68/269 (25%), Positives = 119/269 (44%), Gaps = 32/269 (11%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL----D 349
           ++G+GGF EV+        +  A K   L+K   + K+   +  AL E  I  +L    D
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--ALNE-RIMLSLVSTGD 55

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
            P +V +   F    +    +L+  +G DL ++L QH   +E E R    +++  L++++
Sbjct: 56  CPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                V++ DLKP NILL E    G ++I+D GL+          D          GT+ 
Sbjct: 115 --NRFVVYRDLKPANILLDEH---GHVRISDLGLA---------CDFSKKKPHASVGTHG 160

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y+ PE    G       S  D +S+G + ++ L G  PF  ++++    +++ I + T  
Sbjct: 161 YMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLT 213

Query: 530 QFANKP-TVSNEAKGFIRSCLAYRKEDRI 557
                P + S E +  +   L      R+
Sbjct: 214 MAVELPDSFSPELRSLLEGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 22/278 (7%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKG +  V+      + + +A K  +L+       +  Y K    E ++ K+L H  +
Sbjct: 7   VLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSLKHVNI 64

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V+ Y    +D N+    +E+  G  +   L +   + E        Q++  + YL+    
Sbjct: 65  VQ-YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--N 121

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H D+K  N++L      G IK+ DFG ++ +     +  H   L S     YW + P
Sbjct: 122 CVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW-MAP 177

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL---EENTILKATEVQ 530
           E      N      K D+WS+G   ++   GK P       A +        ++      
Sbjct: 178 EVI----NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDS 233

Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           F      S  A  F+ SCL   + +R   + L RHD+L
Sbjct: 234 F------SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 46/255 (18%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK-------KANYIKHAL----REYN 343
           LG+G F EVH       Q +   K    N +            + +   +A     +E  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFS-EKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-----------KTIAER 392
           I   L  P + +L  V  +D    C ++EY +  DL+ +L++H           K+++  
Sbjct: 72  ILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
               +  Q+ S ++YL  +    +H DL   N L+ +      IKI DFG+S+ +   +Y
Sbjct: 131 TLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYT---IKIADFGMSRNLYSSDY 185

Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV----IFYQCLYGKKPF 508
               G           W +  E  ++G    K ++K DVW+ GV    I   C   ++P+
Sbjct: 186 YRVQG----RAPLPIRW-MAWESVLLG----KFTTKSDVWAFGVTLWEILTLC--REQPY 234

Query: 509 GHNQSQATILEENTI 523
            H   Q  I  EN  
Sbjct: 235 EHLTDQQVI--ENAG 247

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 67/290 (23%)

Query: 312 QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVVKLY-DVFEIDANSFC 368
           Q  V+CK     + ++E K   + KH     N+  ALD   P  +  + +++ +      
Sbjct: 38  QNLVSCK-----RVFRELKMLCFFKHD----NVLSALDILQPPHIDPFEEIYVV------ 82

Query: 369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT 428
           T L   D H +   +   + ++    +  + Q++  LKYL+     ++H D+KPGN+L+ 
Sbjct: 83  TELMQSDLHKI---IVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN 137

Query: 429 EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSK 488
              V   +KI DFGL++V  EE   PD    +T Q   T +Y  PE  +        +S 
Sbjct: 138 SNCV---LKICDFGLARV--EE---PDESKHMT-QEVVTQYYRAPEILM---GSRHYTSA 185

Query: 489 VDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL------------------KATEVQ 530
           VD+WSVG IF + L  +  F   Q+Q+ I + + I                   +A  ++
Sbjct: 186 VDIWSVGCIFAELLGRRILF---QAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILR 242

Query: 531 FANKP-------TVSN----EAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +KP       T+S+    EA   +   L +  + RI       H YL 
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 71/292 (24%), Positives = 123/292 (42%), Gaps = 29/292 (9%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +D + ++  +GKG + +V+K  + K+    A K+     D  E+ +A        EYNI 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA--------EYNIL 72

Query: 346 KAL-DHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           ++L +HP VVK Y +F    ++       VLE C+G  +   +K      +R   +++  
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 401 VV-SALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
           ++  AL  L  +    +IH D+K  NILLT     G +K+ DFG+S  +           
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLR----- 184

Query: 459 DLTSQGAGTYWYLPPECFVVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
              +   GT +++ PE     +       ++ DVWS+G+   +   G  P        T+
Sbjct: 185 --RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            +   I +       +          FI  CL    E R  V  L  H +++
Sbjct: 243 FK---IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A D+   + VA K   L K  K++   N       E  + K L +P +V
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-------EILVMKELKNPNIV 79

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D F +    F  V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 80  NFLDSFLVGDELF-VVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ-- 135

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  N+LL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 136 VIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPE 185

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 186 VVTRKAYGPK----VDIWSLGIMAIEMVEGEPPY---------LNENPLRALYLIATNGT 232

Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  VH     + Q  VA K        +ED         + E  +   L HP++V
Sbjct: 12  LGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEED--------FIEEAKVMMKLSHPKLV 62

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYLNEIKP 413
           +LY V          V E+ +   L  YL+Q +    ++   S+   V   ++YL   + 
Sbjct: 63  QLYGVC-TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE--RN 119

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG--TYWYL 471
             IH DL   N L++   V   +K++DFG+++ + ++ Y        +S GA     W  
Sbjct: 120 SFIHRDLAARNCLVSSTGV---VKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWS- 168

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF 508
           PPE F    N  K SSK DVWS GV+ ++    GK PF
Sbjct: 169 PPEVF----NFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 43/227 (18%)

Query: 290 LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
            L   +GKG F +V         + VA K        K+D  A   +  L E ++   L 
Sbjct: 9   KLGATIGKGEFGDVMLG--DYRGQKVAVKC------LKDDSTA--AQAFLAEASVMTTLR 58

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKY 407
           HP +V+L  V  +  N    V EY     L  YL+      I   +     + V   ++Y
Sbjct: 59  HPNLVQLLGVV-LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L E     +H DL   N+L++E  V    K++DFGL+K   E +   D G          
Sbjct: 118 LEEKN--FVHRDLAARNVLVSEDLVA---KVSDFGLAK---EASQGQDSGK--------- 160

Query: 468 YWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
              LP     PE     K     S+K DVWS G++ ++   +G+ P+
Sbjct: 161 ---LPVKWTAPEALREKK----FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 68/215 (31%), Positives = 95/215 (44%), Gaps = 38/215 (17%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F EV K   LK++  VA K        KED         L E  I K  DHP +
Sbjct: 2   LLGKGNFGEVFKG-TLKDKTPVAVKT------CKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 354 VKLYDVFEIDANSFCT-------VLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSAL 405
           VKL  V        CT       V+E   G D L F  K+   +  ++     +   + +
Sbjct: 55  VKLIGV--------CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGM 106

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL E K   IH DL   N L+ E NV   +KI+DFG+S+  D+  Y+      +  +  
Sbjct: 107 AYL-ESK-NCIHRDLAARNCLVGENNV---LKISDFGMSRQEDDGIYSSSGLKQIPIK-- 159

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
               +  PE    G    + SS+ DVWS G++ ++
Sbjct: 160 ----WTAPEALNYG----RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 71/292 (24%), Positives = 123/292 (42%), Gaps = 40/292 (13%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y     +G+G    V+ A D+   + VA +   L +  K++   N I   +RE      
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENK---- 75

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
             +P +V   D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++
Sbjct: 76  --NPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEF 131

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+  +  VIH D+K  NILL    + G +K+TDFG    +  E           S   GT
Sbjct: 132 LHSNQ--VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGT 179

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
            +++ PE        PK    VD+WS+G++  + + G+ P+         L EN +    
Sbjct: 180 PYWMAPEVVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALY 226

Query: 528 EVQFANKPTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
            +     P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 19/173 (10%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI- 397
           L E N+ K L H ++V+LY V   +   +        G  LDF LK  +       + I 
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLID 107

Query: 398 -VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+   + Y+   +   IH DL+  N+L++E  +C   KI DFGL++V+++  Y    
Sbjct: 108 FSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMC---KIADFGLARVIEDNEYTARE 162

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           G     +      +  PE    G      + K DVWS G++ Y+ + YGK P+
Sbjct: 163 GAKFPIK------WTAPEAINFG----SFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 34/224 (15%)

Query: 291 LLMLLGKGGFSEV------HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LL  LG G F EV       +  D  E       V  L +   E  +++++  AL    I
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVEL---QVAVKTLPESCSEQDESDFLMEAL----I 62

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ---- 400
               +H  +V+L  V   +      +LE   G DL  +L++++   ER + S+ M+    
Sbjct: 63  MSKFNHQNIVRLIGV-SFERLPRFILLELMAGGDLKSFLRENRPRPERPS-SLTMKDLLF 120

Query: 401 ----VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
               V    KYL E     IH D+   N LLT        KI DFG+++ +   +Y    
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           G  +        W +PPE F+ G      +SK DVWS GV+ ++
Sbjct: 179 GRAMLP----IKW-MPPEAFLDGI----FTSKTDVWSFGVLLWE 213

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 29/217 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV   +       VA K        K+   +   +  L E N+ K L HPR+V
Sbjct: 14  LGAGQFGEVWMGY-YNGHTKVAIK------SLKQGSMS--PEAFLAEANLMKQLQHPRLV 64

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVVSALKYLNEIK 412
           +LY V  +       + EY +   L  +LK  + I     + I M  Q+   + ++    
Sbjct: 65  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
              IH DL+  NIL++E   C   KI DFGL++++++  Y    G     +      +  
Sbjct: 123 --YIHRDLRAANILVSETLCC---KIADFGLARLIEDNEYTAREGAKFPIK------WTA 171

Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           PE    G      + K DVWS G++  + + YG+ P+
Sbjct: 172 PEAINYG----TFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 22/171 (12%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+ K I E     +
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKEAKRIPEEILGKV 108

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDH 456
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S +++D        
Sbjct: 109 SIAVLRGLAYLRE-KHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS------- 157

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
              + +   GT  Y+ PE           S + D+WS+G+   +   G+ P
Sbjct: 158 ---MANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 49/242 (20%)

Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           +G+G F  V +A        +    VA K+       KE+  A+      RE  +    D
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM------LKEEASADMQADFQREAALMAEFD 66

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK------QHKT--------------- 388
           HP +VKL  V  +     C + EY    DL+ +L+      Q                  
Sbjct: 67  HPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 389 -IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
            ++  E   I  QV + + YL+E K   +H DL   N L+ E  V   +KI DFGLS+ +
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMV---VKIADFGLSRNI 180

Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKK 506
              +Y      D         W +PPE         + +++ DVW+ GV+ ++   YG +
Sbjct: 181 YSADYYKASENDAIP----IRW-MPPESIFYN----RYTTESDVWAYGVVLWEIFSYGMQ 231

Query: 507 PF 508
           P+
Sbjct: 232 PY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.0 bits (168), Expect = 4e-12
 Identities = 87/341 (25%), Positives = 147/341 (43%), Gaps = 54/341 (15%)

Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           +++ +SR N + V+         +G G F EV      + Q +   K     +  KE +K
Sbjct: 5   YDDGESRLNEYEVIKK-------IGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREK 56

Query: 332 ANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL-EYCDGHDLDFYLKQ-HKTI 389
           +  +     E N+ + L H  +V+  D F   AN    +L E+CD  DL   +++ +K  
Sbjct: 57  SQLVI----EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 390 AEREARSIV---MQVVSALKYLNEIK-----PPVIHYDLKPGNILLTEG----------- 430
            + E  +IV    Q++ AL Y + +K       V+H DLKP NI L+ G           
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 431 -NVCGE--IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS 487
            N+ G    KI DFGLSK +  E+        +     GT +Y  PE  +          
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLL--HETKSYDD 222

Query: 488 KVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRS 547
           K D+W++G I Y+   GK PF    + + ++ E  + +  ++    K   S E    I++
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKANNFSQLISE--LKRGPDLPIKGK---SKELNILIKN 277

Query: 548 CLAYRKEDRIDVISLARHDYLQ---PPVPKHGRQSASSSAP 585
            L    ++R   +    +  ++   PPV   G  +  ++AP
Sbjct: 278 LLNLSAKERPSALQCLGYQIIKNVGPPVGAAGGGAGVAAAP 318

Length = 1021

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 68/237 (28%), Positives = 116/237 (48%), Gaps = 31/237 (13%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LM+LGKG F +V  A         A K+ + +   ++D     ++  + E  +    D P
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD----VECTMVEKRVLALQDKP 60

Query: 352 R-VVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
             + +L+  F+ +D   F  V+EY +G DL ++++Q     E +A     ++   L +L+
Sbjct: 61  PFLTQLHSCFQTVDRLYF--VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD--LTSQGAGT 467
             +  +I+ DLK  N++L   +  G IKI DFG+ K         +H +D   T    GT
Sbjct: 119 --RRGIIYRDLKLDNVML---DSEGHIKIADFGMCK---------EHMVDGVTTRTFCGT 164

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILEEN 521
             Y+ PE  ++   P   S  VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N
Sbjct: 165 PDYIAPE--IIAYQPYGKS--VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 47/283 (16%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   ED+    I+   +E  +    D P V 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDE----IEDIQQEITVLSQCDSPYVT 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  + +       ++EY  G   LD  L +     E +  +++ +++  L YL+  K 
Sbjct: 66  KYYGSY-LKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    G++K+ DFG++  + +     +          GT +++ P
Sbjct: 123 --IHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA- 532
           E            SK D+WS+G+   +   G+ P             N+ +    V F  
Sbjct: 171 EVI----QQSAYDSKADIWSLGITAIELAKGEPP-------------NSDMHPMRVLFLI 213

Query: 533 ---NKPTVSNE----AKGFIRSCLAYRKEDRIDVISLARHDYL 568
              N PT++ E     K FI +CL      R     L +H ++
Sbjct: 214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 55/218 (25%), Positives = 105/218 (48%), Gaps = 21/218 (9%)

Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV +    +  ++ VA  +  L   + E ++ ++    L E +I     H  
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF----LSEASIMGQFSHHN 67

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +++L  V          + EY +   LD YL+ H    +  +   ++  + + +KYL+++
Sbjct: 68  IIRLEGVVT-KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL   NIL+     C   K++DFGLS+V++++   P+ G   TS G     + 
Sbjct: 127 N--YVHRDLAARNILVNSNLEC---KVSDFGLSRVLEDD---PE-GTYTTSGGKIPIRWT 177

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            PE         K +S  DVWS G++ ++ + +G++P+
Sbjct: 178 APEAIAY----RKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 31/140 (22%)

Query: 380 DFY---LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            FY     +  TI E     I + +V AL+YL+  K  VIH D+KP N+L+   N  G++
Sbjct: 88  KFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLI---NRNGQV 143

Query: 437 KITDFGLS--------KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSK 488
           K+ DFG+S        K +D                AG   Y+ PE      N      K
Sbjct: 144 KLCDFGISGYLVDSVAKTID----------------AGCKPYMAPERINPELNQKGYDVK 187

Query: 489 VDVWSVGVIFYQCLYGKKPF 508
            DVWS+G+   +   G+ P+
Sbjct: 188 SDVWSLGITMIELATGRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 29/230 (12%)

Query: 294 LLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKALD 349
           +LGKG F +V  A +LK +  Y A K   L KD     +D +   ++  +    +  A +
Sbjct: 2   VLGKGSFGKVLLA-ELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRV----LALAWE 54

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           +P +  LY  F+   + F  V+E+ +G DL F+++         A     ++V  L++L+
Sbjct: 55  NPFLTHLYCTFQTKEHLF-FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +I+ DLK  N++L      G IKI DFG+ K    EN     G +  S   GT  
Sbjct: 114 S--KGIIYRDLKLDNVMLDRD---GHIKIADFGMCK----ENV---FGDNRASTFCGTPD 161

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           Y+ PE  + G    K +  VD WS GV+ Y+ L G+ PF H   +  + E
Sbjct: 162 YIAPE-ILQGL---KYTFSVDWWSFGVLLYEMLIGQSPF-HGDDEDELFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 63/243 (25%), Positives = 107/243 (44%), Gaps = 43/243 (17%)

Query: 295 LGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           +G+G +  V+KA   D K+++  A K         + +       A RE  + + L HP 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK---------QIEGTGISMSACREIALLRELKHPN 59

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT---------IAEREARSIVMQVVS 403
           V+ L  VF   ++    +L     HDL   +K H+          +     +S++ Q++ 
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119

Query: 404 ALKYLNEIKPPVIHYDLKPGNIL-LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            + YL+     V+H DLKP NIL + EG   G +KI D G +++ +     P   +D   
Sbjct: 120 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LKPLADLDPV- 175

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK-------------KPFG 509
               T+WY  PE  +  ++  K    +D+W++G IF + L  +              PF 
Sbjct: 176 --VVTFWYRAPELLLGARHYTK---AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230

Query: 510 HNQ 512
           H+Q
Sbjct: 231 HDQ 233

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 30/226 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW--KEDKKANYIKHALREYNIHKALDHPR 352
           +G+G +  V+KA     +R    K  + ++D+  K+ +       A RE  + + L HP 
Sbjct: 9   VGRGTYGHVYKA-----KR----KDGKDDRDYALKQIEGTGISMSACREIALLRELKHPN 59

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE---------ARSIVMQVVS 403
           V+ L  VF   A+    +L     HDL   +K H+     +          +S++ Q++ 
Sbjct: 60  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 404 ALKYLNEIKPPVIHYDLKPGNIL-LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            + YL+     V+H DLKP NIL + EG   G +KI D G +++ +     P   +D   
Sbjct: 120 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LKPLADLDPV- 175

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T+WY  PE  +  ++  K    +D+W++G IF + L  +  F
Sbjct: 176 --VVTFWYRAPELLLGARHYTK---AIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 71/254 (27%), Positives = 110/254 (43%), Gaps = 44/254 (17%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L ++G+G F EV            A K+ +   D  E ++  +I+    E +I    D  
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIR---AERDILVEADSL 61

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            VVK++  F+   N +  ++E+  G D+   L +  T+ E E +  + + V A+  ++++
Sbjct: 62  WVVKMFYSFQDKLNLY-LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGL----SKVMDEENY-NPDHGM--DLTSQG 464
               IH D+KP N+LL      G +K++DFGL     K    E Y N +H +  D T Q 
Sbjct: 121 G--FIHRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 465 ---------------------AGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCL 502
                                 GT  Y+ PE F+  G N        D WS+GVI Y+ L
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-----KLCDWWSLGVIMYEML 230

Query: 503 YGKKPFGHNQSQAT 516
            G  PF     Q T
Sbjct: 231 IGYPPFCSETPQET 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 48/255 (18%)

Query: 295 LGKGGFSEVHK--------------AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           LG+G F EVH               + D+   + V   V  L +D  ++ + +++K    
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK---- 68

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-----------TI 389
           E  I   L  P +++L  V  I ++  C + EY +  DL+ +L +H+           TI
Sbjct: 69  EIKIMSRLKDPNIIRLLAVC-ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
           +      +  Q+ S +KYL+ +    +H DL   N L+ +      IKI DFG+S+ +  
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYT---IKIADFGMSRNLYS 182

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY--GKKP 507
            +Y    G     +      ++  E  ++G    K ++  DVW+ GV  ++ L    ++P
Sbjct: 183 GDYYRIQG-----RAVLPIRWMSWESILLG----KFTTASDVWAFGVTLWEILTLCKEQP 233

Query: 508 FGHNQSQATILEENT 522
           +     +  I  ENT
Sbjct: 234 YSQLSDEQVI--ENT 246

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 22/171 (12%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 108

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDH 456
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S +++D        
Sbjct: 109 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS------- 157

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
              + +   GT  Y+ PE           S + D+WS+G+   +   G+ P
Sbjct: 158 ---MANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 63/266 (23%), Positives = 101/266 (37%), Gaps = 56/266 (21%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           +RE  +    + P +V  Y  F  D       +E+ DG  LD  LK+   I E     I 
Sbjct: 47  IRELKVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAGRIPENILGKIS 105

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
           + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S            G 
Sbjct: 106 IAVLRGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVS------------GQ 149

Query: 459 DLTSQG---AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQS 513
            + S      GT  Y+ PE           + + D+WS+G+   +   G+ P      + 
Sbjct: 150 LIDSMANSFVGTRSYMSPERL----QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205

Query: 514 QATI-------LEENTILKATEVQFANKP-----------------------TVSNEAKG 543
              +        E     +       + P                         S+E + 
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD 265

Query: 544 FIRSCLAYRKEDRIDVISLARHDYLQ 569
           F+  CL    ++R D+  L +H +++
Sbjct: 266 FVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 49/243 (20%)

Query: 295 LGKGGFSEVHK--AFDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V K  AF LK +  Y    V  L    KE+  ++ ++  L E+N+ K ++HP
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML----KENASSSELRDLLSEFNLLKQVNHP 63

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA----------------EREAR 395
            V+KLY     D      ++EY     L  +L++ + +                   + R
Sbjct: 64  HVIKLYGACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 396 SIVM--------QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-V 446
           ++ M        Q+   ++YL E+K  ++H DL   N+L+ EG      KI+DFGLS+ V
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKM---KISDFGLSRDV 177

Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
            +E++Y         S+G     ++  E           +++ DVWS GV+ ++ +  G 
Sbjct: 178 YEEDSYVK------RSKGRIPVKWMAIESLF----DHIYTTQSDVWSFGVLLWEIVTLGG 227

Query: 506 KPF 508
            P+
Sbjct: 228 NPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 30/287 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y     +G+G    V+ A D+   + VA K   L +  K++   N I   +RE      
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL-VMRENK---- 74

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
             +P +V   D + +  +    V+EY  G  L   + +   + E +  ++  + + AL +
Sbjct: 75  --NPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDF 130

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+  +  VIH D+K  NILL    + G +K+TDFG    +  E           S   GT
Sbjct: 131 LHSNQ--VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGT 178

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKA 526
            +++ PE        PK    VD+WS+G++  + + G+ P+   N  +A  L    I   
Sbjct: 179 PYWMAPEVVTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATN 230

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
              +  N   +S   + F+  CL    + R     L +H +L+   P
Sbjct: 231 GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 31/254 (12%)

Query: 324 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY 382
           K  K +   N+I    +E  I + L H  +VK   +   D  N    ++E+     L  Y
Sbjct: 39  KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 98

Query: 383 LKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
           L ++K  I  ++     +Q+   + YL   +   +H DL   N+L+   +    +KI DF
Sbjct: 99  LPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQ---VKIGDF 153

Query: 442 GLSKVM--DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY 499
           GL+K +  D+E Y     +D     +  +WY  PEC +  K    I+S  DVWS GV  Y
Sbjct: 154 GLTKAIETDKEYYTVKDDLD-----SPVFWY-APECLIQSKF--YIAS--DVWSFGVTLY 203

Query: 500 QCL-YGK----------KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSC 548
           + L Y            K  G    Q T+     +L+    +    P    E    +R C
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE-EGKRLPRPPNCPEEVYQLMRKC 262

Query: 549 LAYRKEDRIDVISL 562
             ++   R    +L
Sbjct: 263 WEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LGKGGF EV         +  ACK  +LNK  K  KK    + A+ E  I   +    +V
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK--KLNK--KRLKKRKGYEGAMVEKRILAKVHSRFIV 56

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSIVMQVVSALKYLNE 410
            L   F+   +  C V+   +G DL +++    +++    E  A     Q++S L++L++
Sbjct: 57  SLAYAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 411 IKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
            +  +I+ DLKP N+LL  +GNV    +I+D GL+  + +       G   T   AGT  
Sbjct: 116 RR--IIYRDLKPENVLLDNDGNV----RISDLGLAVELKD-------GQSKTKGYAGTPG 162

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++ PE         +    VD +++GV  Y+ +  + PF
Sbjct: 163 FMAPELL----QGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 42/247 (17%)

Query: 290 LLLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +L   LG+G F +V            ++  VA K        KE    +  K   RE  +
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT------LKETASNDARKDFEREAEL 61

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------------KTIA 390
                H  +VK Y V   + +    V EY +  DL+ +L+ H                + 
Sbjct: 62  LTNFQHENIVKFYGVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
             +   I +Q+ S + YL       +H DL   N L+    V   +KI DFG+S+ +   
Sbjct: 121 LSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLV---VKIGDFGMSRDVYTT 175

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKP-F 508
           +Y    G  +        W +PPE  +      K +++ DVWS GV+ ++   YGK+P +
Sbjct: 176 DYYRVGGHTMLP----IRW-MPPESIMYR----KFTTESDVWSFGVVLWEIFTYGKQPWY 226

Query: 509 GHNQSQA 515
           G +  + 
Sbjct: 227 GLSNEEV 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 68/259 (26%), Positives = 110/259 (42%), Gaps = 44/259 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D +  L ++G+G F EV            A K+ +   D  E ++  +I+    E +I  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIR---AERDILV 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
             D   VVK++  F+ D  +   ++E+  G D+   L +  T++E   +  + + V A+ 
Sbjct: 57  EADGAWVVKMFYSFQ-DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL----SKVMDEENY-----NPDHG 457
            ++++    IH D+KP N+LL   +  G +K++DFGL     K    E Y     NP   
Sbjct: 116 AIHQLG--FIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 458 MDLTSQGA-------------------GTYWYLPPECFV-VGKNPPKISSKVDVWSVGVI 497
               +  +                   GT  Y+ PE F+  G N        D WS+GVI
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-----KLCDWWSLGVI 225

Query: 498 FYQCLYGKKPFGHNQSQAT 516
            Y+ L G  PF     Q T
Sbjct: 226 MYEMLIGYPPFCSETPQET 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 37/254 (14%)

Query: 295 LGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LG+G F +V+K       +R  A  V    K  KE+ +    +   +E  +   L HP +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSV--AIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS----------------I 397
           V L  V   +    C + EY    DL  +L ++   ++  A S                I
Sbjct: 71  VCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            +Q+ + ++YL+      +H DL   N L+ EG     +KI+DFGLS+    + Y+ D+ 
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLT---VKISDFGLSR----DIYSADY- 179

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKP-FGH-NQSQ 514
             + S+      ++PPE  + G    K +++ D+WS GV+ ++   YG +P +G  NQ  
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYG----KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235

Query: 515 ATILEENTILKATE 528
             ++    +L   E
Sbjct: 236 IEMIRSRQLLPCPE 249

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 70/254 (27%), Positives = 105/254 (41%), Gaps = 54/254 (21%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV  A  +      A K   L K  K+    N + H   E +I    D+  VV
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKT--LRK--KDVLNRNQVAHVKAERDILAEADNEWVV 64

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KLY  F+ D ++   V++Y  G D+   L + +   E  AR  + ++  A++ ++++   
Sbjct: 65  KLYYSFQ-DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG-- 121

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGL--------------------------SKVMD 448
            IH D+KP NIL+   ++ G IK+TDFGL                          S + D
Sbjct: 122 FIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 449 --------------EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV 494
                         E+     H   L     GT  Y+ PE  +        +   D WSV
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL----RKGYTQLCDWWSV 234

Query: 495 GVIFYQCLYGKKPF 508
           GVI ++ L G+ PF
Sbjct: 235 GVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 38/226 (16%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71

Query: 354 VKLYDVFEIDANSFCT-VLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
            +L  +         T ++ +  G  LD Y+++HK  I  +   +  +Q+   + YL E 
Sbjct: 72  CRLLGICLTSTVQLITQLMPF--GCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG------MDLTSQ 463
           +  ++H DL   N+L+        +KITDFGL+K++  DE+ Y+ + G      M L S 
Sbjct: 129 R--LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               Y                 + + DVWS GV  ++ + +G KP+
Sbjct: 184 LHRIY-----------------THQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           L+ ++G G + +V+K   +K  +  A KV  + +D +E+ K         E N+ K   H
Sbjct: 20  LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--------EINMLKKYSH 71

Query: 351 PR-VVKLYDVFEIDA-----NSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVV 402
            R +   Y  F   +     +    V+E+C    +   +K  K   + E     I  +++
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             L +L+  K  VIH D+K  N+LLTE     E+K+ DFG+S  +D         +   +
Sbjct: 132 RGLAHLHAHK--VIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRT-------VGRRN 179

Query: 463 QGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCLYGKKPF 508
              GT +++ PE     +NP      + D+WS+G+   +   G  P 
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 28/221 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +LG G F  V+K   + E   V   V    LN+         ++  AL    I  ++DHP
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL----IMASMDHP 69

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +V+L  V         T L    G  LD+  +    I  +   +  +Q+   + YL E 
Sbjct: 70  HLVRLLGVCLSPTIQLVTQL-MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG-MDLTSQGAGTY 468
           +  ++H DL   N+L+   N    +KITDFGL++++  DE+ YN D G M +        
Sbjct: 129 R--LVHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIK------- 176

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            ++  EC     +  K + + DVWS GV  ++ + +G KP+
Sbjct: 177 -WMALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 35/225 (15%)

Query: 287 DRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +R+L  +  LGKG F  V    +D L++       V +L         A +++   RE  
Sbjct: 3   ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIE 57

Query: 344 IHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVM-- 399
           I K+L H  +VK   V +     +   V+EY     L  YL++H+   ER + R +++  
Sbjct: 58  ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYA 114

Query: 400 -QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDH 456
            Q+   ++YL   +   +H DL   NIL+   N    +KI DFGL+KV+  D+E Y    
Sbjct: 115 SQICKGMEYLGSKR--YVHRDLATRNILVESEN---RVKIGDFGLTKVLPQDKEYYK--- 166

Query: 457 GMDLTSQG-AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
              +   G +  +WY P           K S   DVWS GV+ Y+
Sbjct: 167 ---VREPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYE 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 46/282 (16%)

Query: 295 LGKGGFSEVHKA---FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V  A     L EQ  +   V  L K+  E  + ++     RE  +   L H 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDF----QREAELLTVLQHQ 67

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARS----------- 396
            +V+ Y V   +      V EY    DL+ +L+ H    K +A  E  +           
Sbjct: 68  HIVRFYGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I  Q+ S + YL  +    +H DL   N L+ +G V   +KI DFG+S+ +   +Y    
Sbjct: 127 IASQIASGMVYLASLH--FVHRDLATRNCLVGQGLV---VKIGDFGMSRDIYSTDYYRVG 181

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G  +        W +PPE  +      K +++ D+WS GV+ ++   YGK+P+    +  
Sbjct: 182 GRTMLP----IRW-MPPESILY----RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232

Query: 516 TILEENTILKATEVQFANKP-TVSNEAKGFIRSCLAYRKEDR 556
            I     I +  E++   +P T   E    ++ C     + R
Sbjct: 233 AI---ECITQGRELE---RPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 68/280 (24%), Positives = 127/280 (45%), Gaps = 31/280 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A +    + VA K   L K  + +   N +   +R+Y+      H  VV
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-IMRDYH------HENVV 82

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            +Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL YL+     
Sbjct: 83  DMYNSYLV-GDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLSVLRALSYLH--NQG 138

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G IK++DFG    + +E       +       GT +++ PE
Sbjct: 139 VIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKE-------VPKRKSLVGTPYWMAPE 188

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             V+ + P    ++VD+WS+G++  + + G+ P+    ++  +     I      +  + 
Sbjct: 189 --VISRLP--YGTEVDIWSLGIMVIEMIDGEPPYF---NEPPLQAMRRIRDNLPPRVKDS 241

Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ---PP 571
             VS+  +GF+   L      R     L +H +L+   PP
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 54/250 (21%)

Query: 295 LGKGGFSEVHKA--------------FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           LG+G F EVH                F++++ R +   V  L  D  ++ + +++K    
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK---- 68

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------- 387
           E  I   L  P +++L  V  +D +  C + EY +  DL+ +L  H              
Sbjct: 69  EVKILSRLKDPNIIRLLGVC-VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 388 ------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
                  I+      + +Q+ S +KYL+ +    +H DL   N L+ E      IKI DF
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL---TIKIADF 182

Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC 501
           G+S+ +   +Y    G     +      ++  EC ++G    K ++  DVW+ GV  ++ 
Sbjct: 183 GMSRNLYAGDYYRIQG-----RAVLPIRWMAWECILMG----KFTTASDVWAFGVTLWEI 233

Query: 502 LY--GKKPFG 509
           L    ++P+G
Sbjct: 234 LMLCKEQPYG 243

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 37/231 (16%)

Query: 295 LGKGGFSEVHKA--FDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V  A  ++L  EQ  +   V  L     +D   N  K   RE  +   L H 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-----KDASDNARKDFHREAELLTNLQHE 67

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------------KTIAEREARSIV 398
            +VK Y V  ++ +    V EY    DL+ +L+ H               + + +   I 
Sbjct: 68  HIVKFYGVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q+ + + YL       +H DL   N L+ E  +   +KI DFG+S+ +   +Y    G 
Sbjct: 127 QQIAAGMVYL--ASQHFVHRDLATRNCLVGENLL---VKIGDFGMSRDVYSTDYYRVGGH 181

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            +         ++PPE  +      K +++ DVWS+GV+ ++   YGK+P+
Sbjct: 182 TMLP-----IRWMPPESIMY----RKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 70/236 (29%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    + VA K  +L++ ++    A   K A RE  + K 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHA---KRAYRELVLMKL 71

Query: 348 LDHPRVVKLYDVFE-----------------IDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
           ++H  ++ L +VF                  +DAN  C V++     DLD     H+ ++
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVIQM----DLD-----HERMS 121

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
                 ++ Q++  +K+L+     +IH DLKP NI++     C  +KI DFGL++     
Sbjct: 122 -----YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART---- 167

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGK--NPPKI------SSKVDVWSVGVIF 498
                         AGT + + P  +VV +    P++         VD+WSVG I 
Sbjct: 168 --------------AGTSFMMTP--YVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 6/166 (3%)

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  +   L HP +V L D  E        V EY  G  L   L     +   E   +++
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ AL   +     ++H DLKP NI++++  V    K+ DFG+  ++          + 
Sbjct: 87  QVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
            T++  GT  Y  PE     +  P ++   D+++ G+IF +CL G+
Sbjct: 145 RTTEVLGTPTYCAPEQL---RGEP-VTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 23/186 (12%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E  I K L H ++V+LY V  +       V EY     L  +LK  +  A +    + 
Sbjct: 49  LEEAQIMKKLRHDKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD 106

Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  QV + + Y+  +    IH DL+  NIL+ +G VC   KI DFGL++++++  Y    
Sbjct: 107 MAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVC---KIADFGLARLIEDNEYTARQ 161

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF-GHNQSQ 514
           G     +      +  PE  + G    + + K DVWS G++  + +  G+ P+ G N  +
Sbjct: 162 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211

Query: 515 ATILEE 520
             +LE+
Sbjct: 212 --VLEQ 215

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 20/173 (11%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQHKTIAE-REARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +        +   
Sbjct: 49  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 106

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 107 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 161

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF 508
           G     +      +  PE  + G    + + K DVWS G++  +    G+ P+
Sbjct: 162 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 72/256 (28%), Positives = 108/256 (42%), Gaps = 58/256 (22%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV  A  +  +   A K   L K  K+    N + H   E +I    D+  VV
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKT--LRK--KDVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           +LY  F+ D ++   V++Y  G D+   L +     E  AR  + ++  A++ ++++   
Sbjct: 65  RLYYSFQ-DKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG-- 121

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGL---------SKVMDEENYNPDHGMDLTSQGA 465
            IH D+KP NIL+      G IK+TDFGL         SK     ++     MD +++  
Sbjct: 122 FIHRDIKPDNILIDRD---GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE-- 176

Query: 466 GTYWYLPPEC-----------------------FVVGKNPPKISSKV----------DVW 492
              W  P  C                        +VG  P  I+ +V          D W
Sbjct: 177 ---WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG-TPNYIAPEVLLRTGYTQLCDWW 232

Query: 493 SVGVIFYQCLYGKKPF 508
           SVGVI Y+ L G+ PF
Sbjct: 233 SVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 55/222 (24%), Positives = 111/222 (50%), Gaps = 21/222 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +++ +L ++G+G +  V K    + +  VA K  + +++ +E K+       LRE  + +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT-----LRELKMLR 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L    +V+L + F      +  V EY + + L+   +    +   + RS + Q++ A+ 
Sbjct: 56  TLKQENIVELKEAFRRRGKLY-LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           + +  K  ++H D+KP N+L++  +V   +K+ DFG ++ + E + N ++     ++   
Sbjct: 115 WCH--KNDIVHRDIKPENLLISHNDV---LKLCDFGFARNLSEGS-NANY-----TEYVA 163

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T WY  PE  ++G    K    VD+WSVG I  +   G+  F
Sbjct: 164 TRWYRSPE-LLLGAPYGK---AVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 35/277 (12%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV+K  D + +  VA K+  L +   ED+    I+   +E  +    D P + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDE----IEDIQQEITVLSQCDSPYIT 65

Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           + Y  + +       ++EY  G   LD  L +   + E    +I+ +++  L YL+  + 
Sbjct: 66  RYYGSY-LKGTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    G++K+ DFG++  + +            +   GT +++ P
Sbjct: 123 --IHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAP 170

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E             K D+WS+G+   +   G+ P    H      ++ +N+     E Q+
Sbjct: 171 EVI----KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQY 225

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           + KP      K F+ +CL      R     L +H ++
Sbjct: 226 S-KPF-----KEFVEACLNKDPRFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 44/236 (18%)

Query: 295 LGKGGFSEVHKA--FDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  ++L   K++  VA K  +       D      K   RE  +   L 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-------DPTLAARKDFQREAELLTNLQ 65

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-------EREARS------ 396
           H  +VK Y V   D +    V EY    DL+ +L+ H   A        R+A+       
Sbjct: 66  HEHIVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 397 ---IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
              I  Q+ S + YL       +H DL   N L+    +   +KI DFG+S+ +   +Y 
Sbjct: 125 MLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLL---VKIGDFGMSRDVYSTDYY 179

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
              G  +         ++PPE  +      K +++ DVWS GVI ++   YGK+P+
Sbjct: 180 RVGGHTMLP-----IRWMPPESIMY----RKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 32/219 (14%)

Query: 295 LGKGGFSEVHKAFD---LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F  V++      +K +      +  +N++    ++  +    L E ++ K  +  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF----LNEASVMKEFNCH 69

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER----------EARSIVMQV 401
            VV+L  V          V+E     DL  YL+  +  AE           +   +  ++
Sbjct: 70  HVVRLLGVVS-TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
              + YL   K   +H DL   N ++ E       KI DFG+++ + E +Y    G    
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAEDLTV---KIGDFGMTRDIYETDYYRKGG---- 179

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
            +G     ++ PE    G      ++K DVWS GV+ ++
Sbjct: 180 -KGLLPVRWMAPESLKDGV----FTTKSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 18/143 (12%)

Query: 370 VLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
           VL+Y +  DL   +K      +T  E EA  + +QV+ A+ +++     +IH D+K  NI
Sbjct: 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANI 174

Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI 485
           LL      G +K+ DFG SK+     Y      D+     GT +Y+ PE   + +  P  
Sbjct: 175 LLCSN---GLVKLGDFGFSKM-----YAATVSDDVGRTFCGTPYYVAPE---IWRRKP-Y 222

Query: 486 SSKVDVWSVGVIFYQCLYGKKPF 508
           S K D++S+GV+ Y+ L  K+PF
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPF 245

Length = 496

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 37/233 (15%)

Query: 292 LMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +  LG+G F EV  A      +   +  V  K  Q  KD       N      RE ++ +
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD------ENLQSEFRRELDMFR 63

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR---------SI 397
            L H  VV+L  +   +A     +LEY D  DL  +L+  K+  E+            ++
Sbjct: 64  KLSHKNVVRLLGLCR-EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             Q+   + +L+  +   +H DL   N L++      E+K++   LSK    + YN ++ 
Sbjct: 123 CTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR---EVKVSLLSLSK----DVYNSEY- 172

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
             L +      W L PE           S+K DVWS GV+ ++    G+ PF 
Sbjct: 173 YKLRNALIPLRW-LAPEAVQED----DFSTKSDVWSFGVLMWEVFTQGELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 37/236 (15%)

Query: 294 LLGKGGFSEVHK--AFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            LG G F EV++  A D+        R VA K   L K   + +K  ++K A    ++  
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIR-VAVKT--LRKGATDQEKKEFLKEA----HLMS 54

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-------IAEREARSIVM 399
             +HP +VKL  V  +       ++E  +G DL  YL+  +        +  +E   I +
Sbjct: 55  NFNHPNIVKLLGVC-LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTE-GNVCGEI-KITDFGLSKVMDEENYNPDHG 457
            V     YL ++    IH DL   N L++E G     + KI DFGL++ + + +Y    G
Sbjct: 114 DVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHN 511
                +G     ++ PE  + GK     +++ DVWS GV+ ++ L  G++P+   N
Sbjct: 172 -----EGLLPVRWMAPESLLDGK----FTTQSDVWSFGVLMWEILTLGQQPYPALN 218

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 46/232 (19%)

Query: 292 LMLLGKGGFSEVHKAF---DLKEQRY-VACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           + +LG G F  V+K     D +  +  VA KV + N       KAN  K  L E  +   
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS----PKAN--KEILDEAYVMAG 65

Query: 348 LDHPRVVKLYDVFEIDANSFCT-VLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSAL 405
           +  P V +L  +         T ++ Y  G  LD Y++++K  I  ++  +  +Q+   +
Sbjct: 66  VGSPYVCRLLGICLTSTVQLVTQLMPY--GCLLD-YVRENKDRIGSQDLLNWCVQIAKGM 122

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG------ 457
            YL E++  ++H DL   N+L+   N    +KITDFGL++++  DE  Y+ D G      
Sbjct: 123 SYLEEVR--LVHRDLAARNVLVKSPN---HVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           M L S              ++ +   + + + DVWS GV  ++ + +G KP+
Sbjct: 178 MALES--------------ILHR---RFTHQSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 63/274 (22%), Positives = 123/274 (44%), Gaps = 28/274 (10%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A +    R VA K+  L K  + +   N +   +R+Y       H  VV
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQ------HQNVV 81

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y  + +       ++E+  G  L   + Q + + E +  ++   V+ AL YL+     
Sbjct: 82  EMYKSYLV-GEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHS--QG 137

Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT   + G +K++DFG    + ++       +       GT +++ PE
Sbjct: 138 VIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD-------VPKRKSLVGTPYWMAPE 187

Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             V+ + P    ++VD+WS+G++  + + G+ P+    S + +     +  +   +  N 
Sbjct: 188 --VISRTP--YGTEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRDSPPPKLKNA 240

Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             +S   + F+   L    ++R     L  H +L
Sbjct: 241 HKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 37/231 (16%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G F EV       +   VA K     +    D KA +    L+E  I K   HP +V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKF----LQEARILKQYSHPNIV 56

Query: 355 KLYDVFEIDANSFCT-------VLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALK 406
           +L  V        CT       V+E   G D L F   +   +  +E   +V    + ++
Sbjct: 57  RLIGV--------CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME 108

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL       IH DL   N L+TE NV   +KI+DFG+S+  ++  Y    GM    +   
Sbjct: 109 YLES--KHCIHRDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGM----KQIP 159

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQAT 516
             W   PE    G+     SS+ DVWS G++ ++    G  P+ +  +Q T
Sbjct: 160 VKW-TAPEALNYGR----YSSESDVWSFGILLWEAFSLGAVPYANLSNQQT 205

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 26/249 (10%)

Query: 330 KKANYIKHALRE--YN---IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK 384
           KK +  K   RE  +N   I +   H  VV++Y+ + +  +    V+E+ +G  L   + 
Sbjct: 51  KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGALT-DIV 108

Query: 385 QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
            H  + E +  ++ + V+ AL  L+     VIH D+K  +ILLT     G +K++DFG  
Sbjct: 109 THTRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHD---GRVKLSDFGFC 163

Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
             + +E       +       GT +++ PE  ++ + P     +VD+WS+G++  + + G
Sbjct: 164 AQVSKE-------VPRRKSLVGTPYWMAPE--LISRLP--YGPEVDIWSLGIMVIEMVDG 212

Query: 505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR 564
           + P+    ++  +     I      +  N   VS   KGF+   L      R     L +
Sbjct: 213 EPPYF---NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269

Query: 565 HDYLQPPVP 573
           H +L    P
Sbjct: 270 HPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 29/225 (12%)

Query: 294 LLGKGGFSEV-HKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREYNIHKALDH 350
           ++GKG F  V H      + + + C V  LN+  D +E      ++  L+E  I K   H
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE------VEQFLKEGIIMKDFSH 55

Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P V+ L  +      S   VL Y   G   +F   +      ++     +QV   ++YL 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA 115

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNP-DHGMDLTSQGAGT 467
             K   +H DL   N +L E      +K+ DFGL++ + D+E Y+  +H          T
Sbjct: 116 SKK--FVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYYSVHNH----------T 160

Query: 468 YWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLY-GKKPFGH 510
              LP +   +      K ++K DVWS GV+ ++ +  G  P+  
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI- 397
           L E N+ K L H ++VKL+ V  +       + E+     L  +LK  +   +   + I 
Sbjct: 49  LAEANVMKTLQHDKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 106

Query: 398 -VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+   + ++   +   IH DL+  NIL++   VC   KI DFGL++V+++  Y    
Sbjct: 107 FSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVC---KIADFGLARVIEDNEYTARE 161

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + YG+ P+    +  
Sbjct: 162 GAKFPIK------WTAPEAINFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211

Query: 516 TI--LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  LE    +   E           E    +  C   R E+R
Sbjct: 212 VIRALERGYRMPRPE-------NCPEELYNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 62/262 (23%), Positives = 110/262 (41%), Gaps = 47/262 (17%)

Query: 287 DRYLLLMLLGKGGFSEVH--KAFDLKE----------QRYVACKVHQLNKDWKEDKKANY 334
            +  L   LG+G F EVH  +A  L E           + V   V  L  D  +  + ++
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 335 IKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------- 387
           +K    E  I   L +P +++L  V  +  +  C + EY +  DL+ +L Q +       
Sbjct: 65  LK----EIKIMSRLKNPNIIRLLGVC-VSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                +++      + +Q+ S +KYL  +    +H DL   N L+        IKI DFG
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT---IKIADFG 174

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-- 500
           +S+ +   +Y    G     +      ++  E  ++G    K ++  DVW+ GV  ++  
Sbjct: 175 MSRNLYSGDYYRIQG-----RAVLPIRWMAWESILLG----KFTTASDVWAFGVTLWEMF 225

Query: 501 CLYGKKPFGHNQSQATILEENT 522
            L  ++P+     +  I  ENT
Sbjct: 226 TLCKEQPYSLLSDEQVI--ENT 245

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 31/238 (13%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKA 347
            LM+LGKG F +V  A         A K+  L KD     +D +   ++  +    +  +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRV----LALS 57

Query: 348 LDHPRVVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
              P + +L+  F+ +D   F  V+EY +G DL + ++Q     E  A     ++   L 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYF--VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           +L+     +I+ DLK  N++L      G IKI DFG+ K       N   G+  T    G
Sbjct: 116 FLHS--KGIIYRDLKLDNVMLDSE---GHIKIADFGMCK------ENMWDGVT-TKTFCG 163

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILEEN 521
           T  Y+ PE  ++   P      VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N
Sbjct: 164 TPDYIAPE--IIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 20/173 (11%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARS 396
           L+E  I K L H ++V LY V  +       V E+     L  +LK+   K +   +   
Sbjct: 49  LQEAQIMKKLRHDKLVPLYAV--VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+   + Y+  +    IH DL+  NIL+ +  VC   KI DFGL++++++  Y    
Sbjct: 107 MAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVC---KIADFGLARLIEDNEYTARQ 161

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF 508
           G     +      +  PE  + G    + + K DVWS G++  + +  G+ P+
Sbjct: 162 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 18/183 (9%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSI 397
           + E  +   L H ++V+LY V       +  V EY     L  YL++H K     +   +
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQRPIY-IVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              V   + YL   +   IH DL   N L+   +  G +K++DFGLS+ + ++ Y    G
Sbjct: 106 CKDVCEGMAYLESKQ--FIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVG 160

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQAT 516
                +      + PPE  +  K     SSK DVW+ GV+ ++    GK P+    +  T
Sbjct: 161 SKFPVR------WSPPEVLLYSK----FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210

Query: 517 ILE 519
           + +
Sbjct: 211 VEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 63/244 (25%), Positives = 100/244 (40%), Gaps = 66/244 (27%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79

Query: 348 LDHPRVVKLYDVFE-----------------IDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
           ++H  ++ L +VF                  +DAN  C V++    H+   YL       
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQMELDHERMSYL------- 131

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
                  + Q++  +K+L+     +IH DLKP NI++     C  +KI DFGL++     
Sbjct: 132 -------LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART---- 175

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYG 504
                         AGT + + P         P++         VD+WSVG I  + + G
Sbjct: 176 --------------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Query: 505 KKPF 508
              F
Sbjct: 222 GVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 60/246 (24%), Positives = 97/246 (39%), Gaps = 63/246 (25%)

Query: 287 DRYLLLMLLGKGGFSEVHKA--FDLKEQRYV-ACKVHQLNKDWKEDKKANYIKHALREYN 343
           DR  L   LG+G F +V KA    L          V  L    K+D     +   + E  
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEME 67

Query: 344 IHKAL-DHPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQH--------- 386
           + K +  H  ++ L  V        CT       V+EY    +L  +L+           
Sbjct: 68  MMKMIGKHKNIINLLGV--------CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119

Query: 387 -------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
                  +T+ +++  S   QV   +++L   K   IH DL   N+L+TE +V   +KI 
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHV---MKIA 174

Query: 440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKV-----DVWSV 494
           DFGL++ +   +Y        T+ G     ++ PE          +  +V     DVWS 
Sbjct: 175 DFGLARDIHHIDYYRK-----TTNGRLPVKWMAPEA---------LFDRVYTHQSDVWSF 220

Query: 495 GVIFYQ 500
           GV+ ++
Sbjct: 221 GVLLWE 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 6/96 (6%)

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +V LY   +  AN+   V+EY  G D+   L  +    E  A   + +V  AL YL+ 
Sbjct: 64  PFIVHLYYSLQ-SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH- 121

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV 446
            +  +IH DLKP N+L++     G IK+TDFGLSKV
Sbjct: 122 -RHGIIHRDLKPDNMLISNE---GHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 34/140 (24%), Positives = 54/140 (38%), Gaps = 21/140 (15%)

Query: 326 WKEDKKANYIKHALREYNIHKALDH--PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL 383
            K +          RE  I + L      V K+    E D  S+  ++E+ +G  LD   
Sbjct: 26  LKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYL-LMEWIEGETLDEVS 84

Query: 384 KQHKTIAEREARSIVMQVVSALKYLNEIKPPV-IHYDLKPGNILLTEGNVCGEIKITDFG 442
           ++ K         I  Q+   L  L+++   V  H DL PGNIL+ +G + G   I D+ 
Sbjct: 85  EEEKE-------DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG---IIDWE 134

Query: 443 LSKVMDEENYNPDHGMDLTS 462
            +              DL +
Sbjct: 135 YAGYGPPA-------FDLAA 147

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 21/162 (12%)

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSF-CTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           E +I +A++HP +++L   F    N F C +L      DL  YL   + IA  +  +I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTY--NKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIER 189

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTE-GNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            V+ A++YL+E +  +IH D+K  NI +   G+VC    + DFG +    + N N  +G 
Sbjct: 190 SVLRAIQYLHENR--IIHRDIKAENIFINHPGDVC----LGDFGAACFPVDINANKYYGW 243

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
                 AGT     PE  ++ ++P      VD+WS G++ ++
Sbjct: 244 ------AGTIATNAPE--LLARDP--YGPAVDIWSAGIVLFE 275

Length = 391

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 51/166 (30%), Positives = 69/166 (41%), Gaps = 19/166 (11%)

Query: 340 REYNIHKALDHPRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           +E NI K L H  +VK      E        ++EY     L  YL +HK +   +     
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFA 113

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH DL   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 114 QQICEGMAYLHSQH--YIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRE 168

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
             D     +  +WY   EC        K S   DVWS GV  Y+ L
Sbjct: 169 DGD-----SPVFWY-AVECL----KENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 25/219 (11%)

Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           +LG G F E+ +    L  +R +   +H L     + ++  ++  AL         DH  
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL----TLGQFDHSN 67

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +V+L  V     N+   V EY     LD +L++H+  +   +   ++  + S +KYL+E+
Sbjct: 68  IVRLEGVI-TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFG-LSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +H  L    +L+    VC   KI+ F  L +   E  Y        T  G     +
Sbjct: 127 G--YVHKGLAAHKVLVNSDLVC---KISGFRRLQEDKSEAIYT-------TMSGKSPVLW 174

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             PE           SS  DVWS G++ ++ + YG++P+
Sbjct: 175 AAPEAIQYHH----FSSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 39/221 (17%)

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           ++HP V+++ D   +     C VL +       +  K+ + +   +A  I  Q++  L+Y
Sbjct: 114 VNHPSVIRMKDTL-VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172

Query: 408 LNEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           L+  +  +IH D+K  NI +     VC    I D G ++      +       L    AG
Sbjct: 173 LHAQR--IIHRDVKTENIFINDVDQVC----IGDLGAAQ------FPVVAPAFLGL--AG 218

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-------------GHNQ 512
           T     PE  V+ ++  K +SK D+WS G++ ++ L Y    F              H+ 
Sbjct: 219 TVETNAPE--VLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274

Query: 513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRK 553
               I    + LK    +F   P  S   +GFI      R+
Sbjct: 275 LLKII----STLKVHPEEFPRDPG-SRLVRGFIEYASLERQ 310

Length = 357

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 69/259 (26%), Positives = 111/259 (42%), Gaps = 32/259 (12%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  AFD      VA K  +L++ ++    A   K A RE  + K 
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHA---KRAYRELVLLKC 76

Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +     H  +       ++ Q++  +
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++     N+       + +   
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLARTA-CTNF-------MMTPYV 183

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEENT 522
            T +Y  PE  ++G         VD+WSVG I  + + G   F    H      ++E   
Sbjct: 184 VTRYYRAPEV-ILGM---GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE--- 236

Query: 523 ILKATEVQFANK--PTVSN 539
            L     +F N+  PTV N
Sbjct: 237 QLGTPSAEFMNRLQPTVRN 255

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 35/209 (16%)

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS--- 396
           +E ++   L HP +V L  V        C + EY +  DL  +L      ++    S   
Sbjct: 56  QEASLMAELHHPNIVCLLGVV-TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114

Query: 397 --------------IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                         I +Q+ + ++YL+      +H DL   NIL+ E      +KI+D G
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQL---HVKISDLG 169

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           LS+    E Y+ D+   +  +      ++PPE  + GK     SS  D+WS GV+ ++  
Sbjct: 170 LSR----EIYSADY-YRVQPKSLLPIRWMPPEAIMYGK----FSSDSDIWSFGVVLWEIF 220

Query: 503 -YGKKPFG--HNQSQATILEENTILKATE 528
            +G +P+    NQ    ++ +  +L  +E
Sbjct: 221 SFGLQPYYGFSNQEVIEMVRKRQLLPCSE 249

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 16/103 (15%)

Query: 358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIH 417
            V+++D ++   V+EY +G  L       K   E     ++ +V   +  L++    ++H
Sbjct: 65  IVYDVDPDNGLIVMEYIEGELL-------KDALEEARPDLLREVGRLVGKLHKAG--IVH 115

Query: 418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
            DL   NI+L+ G +       DFGL +  DE     D  +DL
Sbjct: 116 GDLTTSNIILSGGRIY----FIDFGLGEFSDEVE---DKAVDL 151

Length = 204

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 66/234 (28%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 72

Query: 348 LDHPRVVKLYDVFE-----------------IDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
           ++H  ++ L +VF                  +DAN  C V++    H+   YL       
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYL------- 124

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
                  + Q++  +K+L+     +IH DLKP NI++     C  +KI DFGL++     
Sbjct: 125 -------LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART---- 168

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
                         AGT + + P         P++         VD+WSVG I 
Sbjct: 169 --------------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E   ++ L+HP V++      I++  +  VLE+C   DL  YL+ ++ +  + A+  V
Sbjct: 43  LQEVQPYRELNHPNVLQCLGQC-IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101

Query: 399 MQ-----VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           +Q     V S L +L+  +   IH DL   N  LT       +KI D+GL+     E Y 
Sbjct: 102 LQRMACEVASGLLWLH--QADFIHSDLALRNCQLTAD---LSVKIGDYGLA----LEQYP 152

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQ 500
            D+ +          W  P    + G++  P   + K ++WS+GV  ++
Sbjct: 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 33/221 (14%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  +GKG F +V     L + R     V    K  K D  A      L E ++   L H
Sbjct: 10  LLQTIGKGEFGDVM----LGDYRGNKVAV----KCIKNDATAQAF---LAEASVMTQLRH 58

Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYL 408
             +V+L  V   +      V EY   G  +D+   + +++   +      + V  A++YL
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  +H DL   N+L++E NV    K++DFGL+K            +  T+      
Sbjct: 119 EANN--FVHRDLAARNVLVSEDNVA---KVSDFGLTKEASSTQDTGKLPVKWTA------ 167

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 168 ----PEAL----REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 34/205 (16%)

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + H  ++ L   +    ++ C V+      DL  Y+ +   +   +A +I  
Sbjct: 135 REIDILKTISHRAIINLIHAYR-WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQR 192

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKITDFGLSKVMDEENYNP-DH 456
           +++ AL YL+     +IH D+K  NI L E    V G     DFG +  +D     P  +
Sbjct: 193 RLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLG-----DFGAACKLDAHPDTPQCY 245

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKIS------SKVDVWSVGVIFYQCLYGKKPFGH 510
           G       +GT          +  N P++       +K D+WS G++ ++          
Sbjct: 246 GW------SGT----------LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Query: 511 NQSQATILEENTILKATEVQFANKP 535
            Q +++  +  +I++  +V     P
Sbjct: 290 KQVKSSSSQLRSIIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           V + R+ +L LLG+G F +V +A+D K + Y A K+ +    +  D K       + +  
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEI--QFMEKVR 183

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
                D   ++K+   F+ +    C V+       LD+ +K H   + R    I+ Q   
Sbjct: 184 QADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGV 242

Query: 404 ALKYLN-EIKPPVIHYDLKPGNILLTEGN 431
           AL Y + E+   ++H DLKP NIL+   +
Sbjct: 243 ALDYFHTELH--LMHTDLKPENILMETSD 269

Length = 467

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--S 396
           L E  +   L H  +V+L  V  I  N    V+E     +L  +L+          +   
Sbjct: 47  LEETAVMTKLHHKNLVRLLGV--ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQ 104

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
             + V   ++YL   K  ++H DL   NIL++E  V    K++DFGL++V          
Sbjct: 105 FSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVA---KVSDFGLARV------GS-- 151

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            M + +      W   PE     K     SSK DVWS GV+ ++   YG+ P+
Sbjct: 152 -MGVDNSKLPVKW-TAPEALKHKK----FSSKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 27/211 (12%)

Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y L+  +G G + +V+KA +L      A K+ +L       +  +      +E  + K  
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-------EPGDDFSLIQQEIFMVKEC 63

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKT--IAEREARSIVMQVVSAL 405
            H  +V  +  + +        +EYC G  L D Y   H T  ++E +   +  + +  L
Sbjct: 64  KHCNIVAYFGSY-LSREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGL 119

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+      +H D+K  NILLT+    G++K+ DFG++  +          +       
Sbjct: 120 AYLHSKGK--MHRDIKGANILLTDN---GDVKLADFGVAAKITAT-------IAKRKSFI 167

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           GT +++ PE   V KN    +   D+W+VG+
Sbjct: 168 GTPYWMAPEVAAVEKN-GGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 24/137 (17%)

Query: 370 VLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL 427
           + EYC   DL  +L  K+   +   +  S   QV   + +L       IH DL   N+LL
Sbjct: 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLL 174

Query: 428 TEGNVCGEIKITDFGLSK-VMDEENYNPDHGMDLTSQGAG---TYWYLPPECFVVGKNPP 483
           T G +   +KI DFGL++ +M++ NY          +G       W  P   F       
Sbjct: 175 THGKI---VKICDFGLARDIMNDSNY--------VVKGNARLPVKWMAPESIF---NCVY 220

Query: 484 KISSKVDVWSVGVIFYQ 500
              S  DVWS G++ ++
Sbjct: 221 TFES--DVWSYGILLWE 235

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 37/202 (18%)

Query: 338 ALREYNIHKA-----LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL---KQHKTI 389
            LRE   H+A     L HP +V L  V   +      +  YC   DL  +L     H  +
Sbjct: 50  PLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDV 108

Query: 390 A----EREARS---------IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
                ++  +S         IV Q+ + +++L+     V+H DL   N+L+ +      +
Sbjct: 109 GSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL---NV 163

Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           KI+D GL +    E Y  D+   + +      W + PE  + GK     S   D+WS GV
Sbjct: 164 KISDLGLFR----EVYAADYYKLMGNSLLPIRW-MSPEAIMYGK----FSIDSDIWSYGV 214

Query: 497 IFYQCL-YGKKPFGHNQSQATI 517
           + ++   YG +P+    +Q  I
Sbjct: 215 VLWEVFSYGLQPYCGYSNQDVI 236

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 30/224 (13%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRY----VACKVHQLNKDWKEDKKANYIKHALREYNIH-K 346
           L LLG G F  VHK   + E       VA K  Q       D+        + ++ +   
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-------DRSGRQTFQEITDHMLAMG 64

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSAL 405
           +LDH  +V+L  +      S   V +      L  +++QH+ ++  +   +  +Q+   +
Sbjct: 65  SLDHAYIVRLLGI--CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL E +  ++H +L   NILL   ++   ++I DFG++ ++      PD      S+  
Sbjct: 123 YYLEEHR--MVHRNLAARNILLKSDSI---VQIADFGVADLL-----YPDDKKYFYSEHK 172

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               ++  E  + G    + + + DVWS GV  ++ + YG +P+
Sbjct: 173 TPIKWMALESILFG----RYTHQSDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 25/222 (11%)

Query: 275 DQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY 334
           D SR N      + + L+  +G G + +V+KA ++      A KV +L     ED     
Sbjct: 1   DLSRRNPQ----EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAV-- 52

Query: 335 IKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
                +E  + K   H  +V  +  + +  +     +E+C G  L         ++E + 
Sbjct: 53  ---VQQEIIMMKDCKHSNIVAYFGSY-LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQI 108

Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
             +  + +  L YL+      +H D+K  NILLT+    G +K+ DFG+S  +       
Sbjct: 109 AYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDN---GHVKLADFGVSAQITAT---- 159

Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
              +       GT +++ PE   V +     +   D+W+VG+
Sbjct: 160 ---IAKRKSFIGTPYWMAPEVAAVERK-GGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 44/249 (17%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           V  DR +L   LG+G F +V  A  +     K  R     V  L  D  E   ++ I   
Sbjct: 15  VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS-- 72

Query: 339 LREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK---------- 387
             E  + K +  H  ++ L      D   +  ++EY    +L  YL+  +          
Sbjct: 73  --EMEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYCYNP 129

Query: 388 ------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
                  ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DF
Sbjct: 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADF 184

Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQ 500
           GL++ +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++
Sbjct: 185 GLARDIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWE 234

Query: 501 CL-YGKKPF 508
               G  P+
Sbjct: 235 IFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 32/91 (35%), Positives = 54/91 (59%), Gaps = 13/91 (14%)

Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYN 453
           + ++ QV++ L+ L+ I   ++H D+KP N+L+T   V G++KI DFG +  M    N+N
Sbjct: 312 KGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFN 366

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPK 484
           P +GM L  +      Y PPE  V+ ++ P+
Sbjct: 367 PLYGM-LDPR------YSPPEELVMPQSCPR 390

Length = 507

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 25/102 (24%), Positives = 48/102 (47%), Gaps = 16/102 (15%)

Query: 359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 418
           V+++D ++   V+EY +G  L       K + E     ++ ++   +  L++    ++H 
Sbjct: 64  VYDVDPDNKTIVMEYIEGKPL-------KDVIEEGNDELLREIGRLVGKLHKAG--IVHG 114

Query: 419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           DL   NI++ +  +     + DFGL K  DE     D  +DL
Sbjct: 115 DLTTSNIIVRDDKLY----LIDFGLGKYSDEIE---DKAVDL 149

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 34/223 (15%)

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            + +  ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 182

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
               + +N D+    T+      W  P   F         + + DVWS GV+ ++     
Sbjct: 183 ----DVHNIDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEIF--- 230

Query: 506 KPFGHNQSQATILEENTILKATEVQFANKP-TVSNEAKGFIRSCL--------AYRK--E 554
              G       + E   +LK  E    +KP   ++E    +R C          +++  E
Sbjct: 231 TLGGSPYPGIPVEELFKLLK--EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Query: 555 DRIDVISLARHD-YLQPPVPKHGRQSASSSAPVGHSPASSGQN 596
           D   V+++   D YL   VP    +  S   P   S  SSG +
Sbjct: 289 DLDRVLTVTSTDEYLDLSVP---FEQYSPGCPDSPSSCSSGDD 328

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 39/235 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKA----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           DR +L   LG+G F +V +A     D            ++ KD   DK    +   + E 
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD---LADLISEM 68

Query: 343 NIHKALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
            + K +  H  ++ L  V   +   +  V EY    +L  +L+  +              
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVP 127

Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   +   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNV---MKIADFGLAR 182

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
            + + +Y        TS G     ++ PE           + + DVWS G++ ++
Sbjct: 183 GVHDIDYYKK-----TSNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWE 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 42/245 (17%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           D+  L   LG+G F +V  A  L     K +  V   V  L  D  E   ++ +     E
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 70

Query: 342 YNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------- 387
             + K +  H  ++ L      D   +  ++EY    +L  YL+  +             
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 388 ---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
               +  ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLA 184

Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-Y 503
           + ++  +Y        T+ G     ++ PE           + + DVWS GV+ ++    
Sbjct: 185 RDVNNIDYYKK-----TTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTL 235

Query: 504 GKKPF 508
           G  P+
Sbjct: 236 GGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 37/180 (20%)

Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY----IKHALREY----- 342
           + L+ +G  +E++    L  +  +           K      Y    +   +R       
Sbjct: 1   MKLIKRGAEAEIYLGDFLGIKAVI-----------KWRIPKRYRHPELDERIRRERTRRE 49

Query: 343 --NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
              + +A      V +  V+ +D  +F  V+EY +G  L   +  +       +R I   
Sbjct: 50  ARIMSRARK--AGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRL 107

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           V     +   I    IH DL   N++L+ G +     + DFGL++   +     D  +DL
Sbjct: 108 V--GKLHSAGI----IHGDLTTSNMILSGGKIY----LIDFGLAEFSKDLE---DRAVDL 154

Length = 211

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 57/233 (24%), Positives = 96/233 (41%), Gaps = 40/233 (17%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G+G F +V +A   K+   +   +  L +   E+   ++   A     + K   HP +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDF---AGELEVLCKLGHHPNI 65

Query: 354 VKLYDVFEIDANSFCTVLEYCD-GHDLDF------------YLKQH---KTIAEREARSI 397
           + L    E +       +EY   G+ LDF            + K+H    T+  ++    
Sbjct: 66  INLLGACE-NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              V + ++YL+E +   IH DL   N+L+ E       KI DFGLS+   EE Y     
Sbjct: 125 ASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS---KIADFGLSR--GEEVYVKK-- 175

Query: 458 MDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                    T   LP     +   N    ++K DVWS GV+ ++ +  G  P+
Sbjct: 176 ---------TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 22/106 (20%)

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +   +PD+  
Sbjct: 180 FQVARGMEFLASRK--CIHRDLAARNILLSENNV---VKICDFGLARDIYK---DPDY-- 229

Query: 459 DLTSQGAGTY---WYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQ 500
               +G       W  P   F       K+ +++ DVWS GV+ ++
Sbjct: 230 --VRKGDARLPLKWMAPESIF------DKVYTTQSDVWSFGVLLWE 267

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 23/114 (20%)

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + ++   PD+   
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENNV---VKICDFGLARDIYKD---PDY--- 230

Query: 460 LTSQGAGTY---WYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YGKKPF 508
              +G+      W  P   F       K+ +++ DVWS GV+ ++    G  P+
Sbjct: 231 -VRKGSARLPLKWMAPESIF------DKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.3 bits (103), Expect = 3e-04
 Identities = 24/103 (23%), Positives = 42/103 (40%), Gaps = 19/103 (18%)

Query: 359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 418
           ++++D      V+EY  G DL   L+ +  +  +    +      A  +   I    +H 
Sbjct: 403 IYDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVGEIV------AKLHKAGI----VHG 452

Query: 419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDE-ENYNPDHGMDL 460
           DL   N ++ +  +     + DFGL K  D  E    D  +DL
Sbjct: 453 DLTTSNFIVRDDRLY----LIDFGLGKYSDLIE----DKAVDL 487

Length = 535

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 32/230 (13%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHK--AFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           V  ++  LL  LG+G F  V++  A D+ K +      V  +N+     ++  +    L 
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF----LN 58

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE--------- 391
           E ++ K      VV+L  V          V+E     DL  YL+  +  AE         
Sbjct: 59  EASVMKGFTCHHVVRLLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117

Query: 392 -REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
            +E   +  ++   + YLN  K   +H DL   N ++        +KI DFG+++ + E 
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT---VKIGDFGMTRDIYET 172

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           +Y    G     +G     ++ PE    G      ++  D+WS GV+ ++
Sbjct: 173 DYYRKGG-----KGLLPVRWMAPESLKDG----VFTTSSDMWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 32/208 (15%)

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +V L+    +  +S   VL++ +G  L  ++ +   I E   +    ++V AL  L+ 
Sbjct: 45  PNMVCLHKYI-VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR 103

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFG-LSKVMDEENYNPDHGMDLTSQGAGTYW 469
               ++  DL P NILL   +  G I++T F   S+V D  +      M           
Sbjct: 104 --EGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCDGEAVENM----------- 147

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y  PE   VG    + +   D WS+G I ++ L GK      +   + +  +T L   E 
Sbjct: 148 YCAPE---VG-GISEETEACDWWSLGAILFELLTGKTLV---ECHPSGINTHTTLNIPEW 200

Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRI 557
                  VS EA+  ++  L +   +R+
Sbjct: 201 -------VSEEARSLLQQLLQFNPTERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 59/239 (24%), Positives = 87/239 (36%), Gaps = 52/239 (21%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY-IKHALREYNIHKALDHPR 352
           +LG+G F  V +   L +      KV    K  K D      I+  L E    K  DHP 
Sbjct: 6   ILGEGEFGSVMEG-QLSQDDGSQLKVAV--KTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 353 VVKLYDV-FEI-DANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ------- 400
           V+KL  V FE            +L +    DL  +L   +         + +Q       
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFMV 120

Query: 401 -VVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKITDFGLSKVMDEENYN----- 453
            +   ++YL+      IH DL   N +L E   VC    + DFGLSK +   +Y      
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDMTVC----VADFGLSKKIYSGDYYRQGRI 174

Query: 454 ---PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
              P   + + S     Y                 +SK DVW+ GV  ++    G+ P+
Sbjct: 175 AKMPVKWIAIESLADRVY-----------------TSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 48/237 (20%)

Query: 294 LLGKGGFSEVHKAFDLKEQ----RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           +LGKG F  V +A  LK +    + VA K+ + +     D     I+  LRE    K  D
Sbjct: 6   MLGKGEFGSVREAQ-LKSEDGSFQKVAVKMLKADIFSSSD-----IEEFLREAACMKEFD 59

Query: 350 HPRVVKLYDV---------FEIDANSFCTVLEYCDGHDLDFYLKQHK------TIAEREA 394
           HP V+KL  V           I       +L +    DL  +L   +      T+  +  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPM----VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115

Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKITDFGLSKVMDEENYN 453
              ++ + S ++YL+      IH DL   N +L E   VC    + DFGLSK +      
Sbjct: 116 VRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVC----VADFGLSKKI------ 163

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YGKKPF 508
             +  D   QG  +   LP +   +      + ++  DVW+ GV  ++ +  G+ P+
Sbjct: 164 --YSGDYYRQGCAS--KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 30/184 (16%)

Query: 339 LREYNIHKALDHPRVVKLYDV-FEIDAN----SFCTVLEYCDGHDLDFYL------KQHK 387
           L E    K  DHP V++L  V  +   +    S   +L +    DL  +L         +
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107

Query: 388 TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKITDFGLSKV 446
            +  +     +  + S ++YL+      IH DL   N +L E  NVC    + DFGLSK 
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVC----VADFGLSKK 161

Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQ-CLYG 504
           +    YN D+         G    +P +   +     ++ ++K DVWS GV  ++    G
Sbjct: 162 I----YNGDY------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211

Query: 505 KKPF 508
           + P+
Sbjct: 212 QTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|240176 cd05155, APH_ChoK_like_1, Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 17/37 (45%), Positives = 21/37 (56%), Gaps = 4/37 (10%)

Query: 413 PPV-IHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD 448
           PPV  H DL PGN+L+ +G +   I   DFG   V D
Sbjct: 163 PPVWFHGDLAPGNLLVQDGRLSAVI---DFGCLGVGD 196

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 235

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 295 LGKGGFSEVHKAFD---LKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKALD 349
           LG+G F  V++      +K++      +  +N+     ++  ++  A  ++E+N H    
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH---- 69

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE--------ARSIVM-- 399
              VV+L  V          ++E     DL  YL+  +   E           + I M  
Sbjct: 70  --HVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           ++   + YLN  K   +H DL   N ++ E      +KI DFG+++ + E +Y    G  
Sbjct: 127 EIADGMAYLNANK--FVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGG-- 179

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
              +G     ++ PE    G      ++  DVWS GV+ ++
Sbjct: 180 ---KGLLPVRWMSPESLKDGV----FTTYSDVWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 40/233 (17%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G+G F +V KA   K+   +   + ++ +   +D   ++   A     + K   HP +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF---AGELEVLCKLGHHPNI 58

Query: 354 VKLYDVFEIDANSFCTVLEYCD-GHDLDF------------YLKQH---KTIAEREARSI 397
           + L    E         +EY   G+ LDF            +   +    T++ ++    
Sbjct: 59  INLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              V   + YL++ +   IH DL   NIL+ E N     KI DFGLS+   +E Y     
Sbjct: 118 AADVARGMDYLSQKQ--FIHRDLAARNILVGE-NYVA--KIADFGLSR--GQEVYVKK-- 168

Query: 458 MDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                    T   LP     +   N    ++  DVWS GV+ ++ +  G  P+
Sbjct: 169 ---------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 23/114 (20%)

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + ++   PD+   
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENNV---VKICDFGLARDIYKD---PDY--- 235

Query: 460 LTSQGAGTY---WYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YGKKPF 508
              +G       W  P   F       ++ + + DVWS GV+ ++    G  P+
Sbjct: 236 -VRKGDARLPLKWMAPETIF------DRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 60/252 (23%), Positives = 101/252 (40%), Gaps = 46/252 (18%)

Query: 276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI 335
            +  N  P  +  Y L  ++G G F  V++A  +     VA K    +  +K        
Sbjct: 57  DNDINRSP--NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------- 107

Query: 336 KHALREYNIHKALDHPRVVKLYDVFEIDA------NSFCTV-LEYCDG--HD-LDFYLKQ 385
               RE  I K L+H  ++ L D +  +       N F  V +E+     H  +  Y + 
Sbjct: 108 ----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
           +  +     +    Q+  AL Y++     + H DLKP N LL + N    +K+ DFG +K
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQN-LLIDPNT-HTLKLCDFGSAK 219

Query: 446 VMDEENYNPDHGMDLTSQGAGTY----WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC 501
            +            L  Q + +Y    +Y  PE  +   N    ++ +D+WS+G I  + 
Sbjct: 220 NL------------LAGQRSVSYICSRFYRAPELMLGATN---YTTHIDLWSLGCIIAEM 264

Query: 502 LYGKKPFGHNQS 513
           + G   F    S
Sbjct: 265 ILGYPIFSGQSS 276

Length = 440

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	627
KOG1151|consensus	775		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0581|consensus	364		100.0
KOG0605|consensus	550		100.0
KOG0598|consensus	357		100.0
KOG0595|consensus	429		100.0
KOG0593|consensus	396		100.0
KOG0592|consensus	604		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
KOG0588|consensus	786		100.0
KOG0661|consensus	538		100.0
KOG0033|consensus	355		100.0
KOG0585|consensus	576		100.0
KOG0600|consensus	560		100.0
KOG0597|consensus	808		100.0
KOG0599|consensus	411		100.0
KOG0659|consensus	318		100.0
KOG0198|consensus	313		100.0
KOG0660|consensus	359		100.0
KOG0032|consensus	382		100.0
KOG0591|consensus	375		100.0
KOG0611|consensus	668		100.0
KOG0663|consensus	419		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0578|consensus	550		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0610|consensus	459		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0667|consensus	586		100.0
KOG0694|consensus	694		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582|consensus	516		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0580|consensus	281		100.0
KOG4717|consensus	864		100.0
KOG0192|consensus	362		100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0658|consensus	364		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0594|consensus	323		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0604|consensus	400		100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0201|consensus	467		100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0589|consensus	426		100.0
KOG0612|consensus	1317		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG1989|consensus	738		100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0607|consensus	463		100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0690|consensus	516		100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0579|consensus	1187		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG4279|consensus	1226		100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0586|consensus	596		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0584|consensus	632		100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0577|consensus	948		100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0197|consensus	468		100.0
KOG0608|consensus	1034		100.0
KOG0983|consensus	391		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0574|consensus	502		100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0596|consensus	677		100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1187|consensus	361		100.0
KOG0986|consensus	591		100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG2345|consensus	302		100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4721|consensus	904		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG4236|consensus	888		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0671|consensus	415		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0193|consensus	678		100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0662|consensus	292		100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0666|consensus	438		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0603|consensus	612		100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG1026|consensus	774		100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG4645|consensus	1509		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG1035|consensus	1351		100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0696|consensus	683		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0669|consensus	376		100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0194|consensus	474		100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0614|consensus	732		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1290|consensus	590		100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0670|consensus	752		100.0
KOG0668|consensus	338		100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0587|consensus	953		100.0
KOG1006|consensus	361		100.0
KOG1095|consensus	1025		100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4250|consensus	732		100.0
KOG0695|consensus	593		100.0
KOG1094|consensus	807		100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257|consensus	974		100.0
KOG0196|consensus	996		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199|consensus	1039		100.0
KOG4278|consensus	1157		100.0
KOG0664|consensus	449		100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0665|consensus	369		100.0
KOG1027|consensus	903		100.0
KOG1167|consensus	418		99.98
KOG0984|consensus	282		99.98
KOG3653|consensus	534		99.97
KOG0576|consensus	829		99.97
KOG2052|consensus	513		99.97
KOG0200|consensus	609		99.97
KOG1152|consensus	772		99.97
KOG1025|consensus	1177		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345|consensus	378		99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1024|consensus	563		99.95
KOG0590|consensus	601		99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1163|consensus	341		99.94
KOG1164|consensus	322		99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1165|consensus	449		99.92
KOG0603|consensus	612		99.9
KOG0606|consensus	1205		99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG0195|consensus	448		99.85
KOG4158|consensus	598		99.84
KOG1240|consensus	1431		99.83
PRK10345	210	hypothetical protein; Provisional	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1166|consensus	974		99.79
smart00090	237	RIO RIO-like kinase.	99.78
KOG1033|consensus	516		99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG0590|consensus	601		99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG1023|consensus	484		99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG0606|consensus	1205		99.58
KOG0601|consensus	524		99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
KOG1266|consensus	458		99.39
KOG0601|consensus	524		99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG1243|consensus	690		99.17
KOG3087|consensus	229		99.14
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
KOG3741|consensus	655		99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
KOG2137|consensus	700		98.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
COG4248	637	Uncharacterized protein with protein kinase and he	98.6
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.49
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.42
PRK09902	216	hypothetical protein; Provisional	98.37
KOG0576|consensus	829		98.36
KOG1235|consensus	538		98.35
KOG1035|consensus	1351		98.35
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.22
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.08
PF01636	239	APH: Phosphotransferase enzyme family This family	98.07
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
PLN02876	822	acyl-CoA dehydrogenase	97.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.85
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.66
KOG2270|consensus	520		97.63
PRK10593	297	hypothetical protein; Provisional	97.59
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.59
KOG1826|consensus	2724		97.59
KOG2268|consensus	465		97.5
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.47
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.24
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.22
PRK12396	409	5-methylribose kinase; Reviewed	97.07
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.01
KOG1093|consensus	725		96.88
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.86
PRK05231	319	homoserine kinase; Provisional	96.84
PLN02236	344	choline kinase	96.53
PLN02756	418	S-methyl-5-thioribose kinase	96.44
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.17
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.16
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.44
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.35
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.32
KOG1236|consensus	565		95.01
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.89
KOG2269|consensus	531		94.81
PTZ00384	383	choline kinase; Provisional	94.8
PRK06148	1013	hypothetical protein; Provisional	94.42
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.12
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.25
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	91.22
PHA03111	444	Ser/Thr kinase; Provisional	90.49

>KOG1151|consensus

Probab=100.00  E-value=4e-106  Score=825.46  Aligned_cols=465  Identities=63%  Similarity=1.032  Sum_probs=435.6

Q ss_pred             CCCcccccccCCCCCCCcchHh---hhccCCCCCcccCCCcccCCCCCCCCCCchhhHHHHHHHHHHHHHHHHHHHHHHH
Q psy4988          40 SHSDKEVESVSTPEKLRPTERK---RKRKGDDANMSVGGPLMKGGGGGNARPLADSKKINERQEEITAEREEIDRQKKLL  116 (627)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  116 (627)
                      +||+|+||++|++||++||+|+   |+|+|||+|||||++|++||+||     +||++|.|++|+|+++||+|+++||||
T Consensus       282 ~msKkLLIeKs~qEk~a~RdKsmqDrlRlGhFtTvRhGaSFteQWtDG-----~AFqnl~KqqE~iN~qReeIerqrklL  356 (775)
T KOG1151|consen  282 TMSKKLLIEKSKQEKMACRDKSMQDRLRLGHFTTVRHGASFTEQWTDG-----YAFQNLIKQQERINSQREEIERQRKLL  356 (775)
T ss_pred             HHHHHHhhhhhHHHHHhhhhhhhhhcccccceeeeecCccHhhhhhhh-----HHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            6999999999999999999999   99999999999999999999999     999999999999999999999999999


Q ss_pred             hccCCCCcccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCccCCCCCCCCCCchh
Q psy4988         117 NKKRPTNAETGRKRAGSQSGGAGTQANSAGAVGSGGVAGTPTGPVTPTAPSTPTSTL-HNGTDSATFLKPEPLPGMSSQE  195 (627)
Q Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~e  195 (627)
                      +||||+.+.    .         .+|++                  .++.-.++.++ .+|.|++-+. |+.+..++.+|
T Consensus       357 aKRKPp~~g----k---------vqap~------------------~~ne~kqrkskntNGaenifrr-peep~~ltlaE  404 (775)
T KOG1151|consen  357 AKRKPPAMG----K---------VQAPP------------------ATNEQKQRKSKNTNGAENIFRR-PEEPETLTLAE  404 (775)
T ss_pred             hccCCCCCC----c---------CCCCC------------------CccccccccccCCCcccccccC-CCCcccccHHH
Confidence            999999651    1         12222                  01111122333 5666666554 66777899999


Q ss_pred             hhHHHHHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhhccccccCCCCCCccchhcccccchHHHHHhhhccc
Q psy4988         196 YYEADEILKLRQSALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNED  275 (627)
Q Consensus       196 ~~~~~e~~k~r~~~lk~~e~~l~~e~~kle~er~~~~~~lk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~  275 (627)
                      |.+.+||+|+|..+|+++|++++.|+++||+.|+.|++++|++.+++                                 
T Consensus       405 YhEqeEIfKLRlgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEd---------------------------------  451 (775)
T KOG1151|consen  405 YHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNED---------------------------------  451 (775)
T ss_pred             HHhHHHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccc---------------------------------
Confidence            99999999999999999999999999999999999999999999887                                 


Q ss_pred             ccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      .+.|++++.+.+||.++.+||+|||++||+|+|....++||||++.+++.|.++++++|.+++.+|++|++.|+||.||+
T Consensus       452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            67888999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +||+|..|.+.||.|+|||+|.+|+.||+.++-+++.+++.|+.||+.||.||.+.+++|||.||||.||||..+..||.
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+||||++.++++.++...++++++.++||+||++||||+.++.++.+++++||||+|||+|+||+|+.||+++..+.
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      .++..++++++.++.||..|.|+.++++||++||++..++|.++.++..||||.|...+
T Consensus       692 dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr  750 (775)
T KOG1151|consen  692 DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR  750 (775)
T ss_pred             HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence            99999999999999999999999999999999999999999999999999999985543

>KOG0615|consensus

Probab=100.00  E-value=2.6e-57  Score=465.10  Aligned_cols=275  Identities=30%  Similarity=0.444  Sum_probs=232.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.+.|.+.+.||.|+||.|.+|+.+.+++.||||++.................+.+|++||++|+|||||+++++|+ .
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~-~  247 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE-V  247 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee-c
Confidence            478899999999999999999999999999999999976654332211222334679999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ....||||||++||+|.+++..++.+.+...+.+++|++.||.|||+.|  |+||||||+|||+..+...-.+||+|||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence            6777899999999999999999999999999999999999999999999  99999999999998774445899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |+.....        .++.+.||||.|.|||++.... ...+..++||||+|||||.||+|.+||.....+..+.+. ..
T Consensus       326 AK~~g~~--------sfm~TlCGTpsYvAPEVl~~kg-~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ-I~  395 (475)
T KOG0615|consen  326 AKVSGEG--------SFMKTLCGTPSYVAPEVLASKG-VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ-IL  395 (475)
T ss_pred             hhccccc--------eehhhhcCCccccChhheecCC-eecccchheeeeccceEEEEeccCCCcccccCCccHHHH-Hh
Confidence            9988643        4577889999999999986432 334556999999999999999999999766555433322 22


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........+.|..+++++.+||.+||..||+.||+++++|+||||+..
T Consensus       396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            233344446788999999999999999999999999999999999854

>KOG0575|consensus

Probab=100.00  E-value=8.2e-54  Score=459.14  Aligned_cols=256  Identities=36%  Similarity=0.564  Sum_probs=225.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      .+|...+.||+|||+.||.+.+..+|+.||+|++......    +.....++.+||+|++.|+|||||+++++|+ |.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~----k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-Ds~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK----KPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-DSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc----CcchHHHHHHHHHHHHhcCCCcEEeeeeEee-cCCc
Confidence            4799999999999999999999999999999998754332    3334567889999999999999999999999 7888


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||+|+|..++|..+++..+.++|.+++.++.||+.||.|||+++  |||||||..||||+++.   +|||+|||||+.
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~---~VKIgDFGLAt~  167 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENM---NVKIGDFGLATQ  167 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcC---cEEecccceeee
Confidence            9999999999999999999999999999999999999999999999  99999999999999984   899999999999


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +..+.       +...+.||||.|+|||++    +....+..+||||+|||||.||+|++||....-.+.+..    ++.
T Consensus       168 le~~~-------Erk~TlCGTPNYIAPEVl----~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~----Ik~  232 (592)
T KOG0575|consen  168 LEYDG-------ERKKTLCGTPNYIAPEVL----NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK----IKL  232 (592)
T ss_pred             ecCcc-------cccceecCCCcccChhHh----ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH----HHh
Confidence            87543       234567999999999999    456689999999999999999999999977655554432    223


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .+..+|  ..+|.++++||++||..||.+|||+.+||.|+||.
T Consensus       233 ~~Y~~P--~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  233 NEYSMP--SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             cCcccc--cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence            333343  48999999999999999999999999999999994

>KOG0581|consensus

Probab=100.00  E-value=1.2e-52  Score=428.31  Aligned_cols=261  Identities=30%  Similarity=0.448  Sum_probs=220.9

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++.+.++.||+|..|+||++.|+.+++.+|+|++.....      ....+++++|++|++.++|||||.+|++|..+..
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~  151 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID------PALQKQILRELEILRSCQSPYIVGFYGAFYSNGE  151 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence            3445567789999999999999999999999999865432      3446789999999999999999999999985554


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .++|+||||++|+|+.+++..++++|.....|+.+|++||.|||. ++  ||||||||+|||++..   |.|||||||.+
T Consensus       152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk---GeVKicDFGVS  226 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK---GEVKICDFGVS  226 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC---CCEEecccccc
Confidence            688999999999999999999999999999999999999999996 67  9999999999999987   79999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH-HH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS-QATILEE-NT  522 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~-~~~~~~~-~~  522 (627)
                      +.+...         +..+.+||..|||||.+.    +..|+.++||||||++|+||.+|++||..... ...+++. ..
T Consensus       227 ~~lvnS---------~a~tfvGT~~YMsPERi~----g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~  293 (364)
T KOG0581|consen  227 GILVNS---------IANTFVGTSAYMSPERIS----GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA  293 (364)
T ss_pred             HHhhhh---------hcccccccccccChhhhc----CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence            987643         356679999999999994    55799999999999999999999999976411 1122221 22


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      +.......+|.. .+|+++++||..||.+||.+||++.|++.|||+..-
T Consensus       294 Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  294 IVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             HhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            333334444432 589999999999999999999999999999999753

>KOG0605|consensus

Probab=100.00  E-value=1.2e-51  Score=436.14  Aligned_cols=277  Identities=30%  Similarity=0.481  Sum_probs=236.6

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      +.....+-.++|.++.+||+|+||+||+|..+.||.+||+|++.+...    ...+.+.+++.|-.||...++|+||+||
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M----~~~~Qv~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM----LKKNQVEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH----HhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence            334445567899999999999999999999999999999999875443    3445578899999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      ..|+ +..++||||||++||++..+|...+.|++..++.++.+++.||+.||++|  +|||||||+|+|||..   |++|
T Consensus       208 YsFQ-D~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~---GHiK  281 (550)
T KOG0605|consen  208 YSFQ-DKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK---GHIK  281 (550)
T ss_pred             EEec-CCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC---CCEe
Confidence            9998 88899999999999999999999999999999999999999999999999  9999999999999987   8999


Q ss_pred             EeecccccccccCCC-----------------CCCCCc-----c------------------ccccCCCCCccCCccccc
Q psy4988         438 ITDFGLSKVMDEENY-----------------NPDHGM-----D------------------LTSQGAGTYWYLPPECFV  477 (627)
Q Consensus       438 L~DFGla~~~~~~~~-----------------~~~~~~-----~------------------~~~~~~Gt~~Y~APE~l~  477 (627)
                      |+||||++-+.....                 .+....     .                  +....+|||.|||||+|.
T Consensus       282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll  361 (550)
T KOG0605|consen  282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL  361 (550)
T ss_pred             eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence            999999964432110                 000000     0                  011347999999999995


Q ss_pred             cCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC
Q psy4988         478 VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI  557 (627)
Q Consensus       478 ~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp  557 (627)
                          +..|+..||+|||||||||||.|.+||...+.+...-+  .+.+...+.||....++++++|||.+||+ ||++|.
T Consensus       362 ----~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rk--I~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  362 ----GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRK--IVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             ----cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence                45599999999999999999999999999888877643  34455667888889999999999999999 999998


Q ss_pred             C---HHHHHhccCCCCC
Q psy4988         558 D---VISLARHDYLQPP  571 (627)
Q Consensus       558 t---~~elL~hp~~~~~  571 (627)
                      -   ++||-.||||...
T Consensus       435 G~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  435 GSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             CcccHHHHhcCCccccC
Confidence            4   9999999999854

>KOG0598|consensus

Probab=100.00  E-value=8.1e-52  Score=422.12  Aligned_cols=261  Identities=33%  Similarity=0.508  Sum_probs=225.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +-.++|+++++||+|+||+||+++.+.+++.||+|++.+......    ..+++...|..||..++||.||+|+..|+ +
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-t   96 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK----KEVRHTKAERNILSKIKHPFIVKLIYSFQ-T   96 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh----hhHHHHHHHHHHHHhCCCCcEeeeEEecc-c
Confidence            346789999999999999999999999999999999876554322    33567889999999999999999999998 7


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|||+||+.||+|+..|.+.+.|+|..++.++.+|+.||.|||+++  ||||||||+|||||.+   |+++|+||||
T Consensus        97 ~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~---GHi~LtDFgL  171 (357)
T KOG0598|consen   97 EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ---GHIKLTDFGL  171 (357)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC---CcEEEecccc
Confidence            7889999999999999999999999999999999999999999999999  9999999999999998   7999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++......       ..+.+.|||+.|||||++.    ...|+..+|+|||||+|||||+|.+||...+....+-.   +
T Consensus       172 ~k~~~~~~-------~~t~tfcGT~eYmAPEil~----~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~---I  237 (357)
T KOG0598|consen  172 CKEDLKDG-------DATRTFCGTPEYMAPEILL----GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK---I  237 (357)
T ss_pred             chhcccCC-------CccccccCCccccChHHHh----cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH---H
Confidence            99654432       3466789999999999995    45799999999999999999999999987665544321   2


Q ss_pred             hhhhccccCCCC-CCCHHHHHHHHHhhhcCcCCCC----CHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKP-TVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~-~vs~el~~LI~~cL~~dP~~Rp----t~~elL~hp~~~~~  571 (627)
                      ....   .+..+ .++.++++||+++|..||++|.    ++.++-+||||...
T Consensus       238 ~~~k---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  238 LKGK---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             hcCc---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            2111   22223 4899999999999999999995    78999999999753

>KOG0595|consensus

Probab=100.00  E-value=4.8e-51  Score=419.71  Aligned_cols=265  Identities=32%  Similarity=0.530  Sum_probs=225.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+.+-     ....++.+..||.||+.++|||||.|+++++ +.
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-----~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~   81 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-----NKKLVELLLSEIKILKELKHPNIVRLLDCIE-DD   81 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-----CHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cC
Confidence            45789999999999999999999999999999999865532     1223456788999999999999999999988 67


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc---cceEEeec
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC---GEIKITDF  441 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~---g~vKL~DF  441 (627)
                      +.+|||||||.||+|.+|+...+.+++..++.++.||+.||++||+++  ||||||||+||||+.....   ..+||+||
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            789999999999999999999999999999999999999999999999  9999999999999875222   47999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.+...        .+..+.||+|.|||||++.    ...|+.|+|+||+|+|||+|++|+.||...+..+.+... 
T Consensus       160 GfAR~L~~~--------~~a~tlcGSplYMAPEV~~----~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-  226 (429)
T KOG0595|consen  160 GFARFLQPG--------SMAETLCGSPLYMAPEVIM----SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-  226 (429)
T ss_pred             chhhhCCch--------hHHHHhhCCccccCHHHHH----hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-
Confidence            999998754        3456779999999999995    556999999999999999999999999877766655422 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                        .+....-......++..+.+|+...|..+|.+|.+..+-+.|+++....
T Consensus       227 --~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  227 --KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             --hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence              2222222222345677788999999999999999999999999987543

>KOG0593|consensus

Probab=100.00  E-value=6.3e-51  Score=403.53  Aligned_cols=262  Identities=27%  Similarity=0.475  Sum_probs=221.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|+.+.++|+|+||+||+|+++.||+.||||.+.-...     ....-+-++|||++|++|.|||+|.|+++|. ....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-----d~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-rkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-----DPVVKKIALREIRMLKQLKHENLVNLIEVFR-RKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-----cHHHHHHHHHHHHHHHhcccchHHHHHHHHH-hcce
Confidence            578899999999999999999999999999999854332     2233345789999999999999999999998 6677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++||+|||+..-|..+-.....++.+.+..|++|++.|+.|||+++  +|||||||+||||..+   |.+||||||+|+.
T Consensus        76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~---gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN---GVVKLCDFGFART  150 (396)
T ss_pred             eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC---CcEEeccchhhHh
Confidence            8999999998777766666678999999999999999999999999  9999999999999998   6999999999998


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +....       +..+.++.|.||+|||.++   ....|+..+|||++||++.||++|.+.|.+.++-+.+..+...+..
T Consensus       151 L~~pg-------d~YTDYVATRWYRaPELLv---GDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~  220 (396)
T KOG0593|consen  151 LSAPG-------DNYTDYVATRWYRAPELLV---GDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN  220 (396)
T ss_pred             hcCCc-------chhhhhhhhhhccChhhhc---ccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc
Confidence            87432       2334568899999999987   3457999999999999999999999999988887777655444321


Q ss_pred             h---------------ccccCC----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         527 T---------------EVQFAN----------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       527 ~---------------~~~~~~----------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .               .+.+|.          .+.++.-+.||+..||..||.+|+++++++.|+||.
T Consensus       221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             cCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            1               011221          146788899999999999999999999999999995

>KOG0592|consensus

Probab=100.00  E-value=1.6e-49  Score=419.74  Aligned_cols=264  Identities=31%  Similarity=0.461  Sum_probs=224.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~  365 (627)
                      .+|.+.+.||+|+|++||+|.++.+++.|||||+.+.-..++    .-++-+.+|-.+|.+| .||.||+||-.|+ |..
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike----~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-D~~  147 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE----KKVKYVTREKEALTQLSGHPGIVKLYFTFQ-DEE  147 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh----cccchhhHHHHHHHHhhCCCCeEEEEEEee-ccc
Confidence            568889999999999999999999999999999865433222    2233456788889888 8999999999998 777


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+|+||+++|+|.++|+..+.|++..++.++.+|+.||+|||++|  ||||||||+|||||.+   +++||+|||.|+
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d---mhikITDFGsAK  222 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD---GHIKITDFGSAK  222 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC---CcEEEeeccccc
Confidence            88999999999999999999999999999999999999999999999  9999999999999998   699999999999


Q ss_pred             ccccCCCCCC---CC---ccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         446 VMDEENYNPD---HG---MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       446 ~~~~~~~~~~---~~---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      .+........   ..   .......+||..|.+||++    +....++.+|||+||||||+|+.|.+||...++...+. 
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL----~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq-  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL----NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ-  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHh----cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH-
Confidence            8876543211   11   1112457999999999999    46678999999999999999999999998766543332 


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                           +...+.+..++.+++.+.|||+++|..||.+|+|+.+|-+||||..
T Consensus       298 -----kI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  298 -----KIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             -----HHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence                 2234556666789999999999999999999999999999999974

>KOG0583|consensus

Probab=100.00  E-value=3.1e-49  Score=422.76  Aligned_cols=263  Identities=31%  Similarity=0.489  Sum_probs=221.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~  362 (627)
                      ...++|.+.+.||+|+||.|++|.+..+++.||||++........ . ....+.+.+|+.+++.+. ||||+++++++..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~-~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSK-S-QKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccccc-c-cccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            567899999999999999999999999999999997765422111 1 123345668999999999 9999999999984


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                       ...+|+|||||.||+|.+++...+++.|.+++.+|.||+.||+|||+++  |+||||||+|||++.+.  +++||+|||
T Consensus        92 -~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~--~~~Kl~DFG  166 (370)
T KOG0583|consen   92 -PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNE--GNLKLSDFG  166 (370)
T ss_pred             -CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCC--CCEEEeccc
Confidence             4558899999999999999999999999999999999999999999998  99999999999999974  589999999


Q ss_pred             cccccc-cCCCCCCCCccccccCCCCCccCCccccccCCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         443 LSKVMD-EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP-KISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       443 la~~~~-~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~-~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ++.... ..        ....+.|||+.|+|||++..   .. +.+.++||||||||||.|++|+.||...+....+.. 
T Consensus       167 ~s~~~~~~~--------~~l~t~cGsp~Y~aPEvl~~---~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-  234 (370)
T KOG0583|consen  167 LSAISPGED--------GLLKTFCGSPAYAAPEVLSG---KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-  234 (370)
T ss_pred             cccccCCCC--------CcccCCCCCcccCCHHHhCC---CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-
Confidence            999873 21        34566799999999999952   22 446899999999999999999999987544433322 


Q ss_pred             HHHhhhhccccCCCCCC-CHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         521 NTILKATEVQFANKPTV-SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~v-s~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                         +....+.+|.  .+ |.++++||++||..||.+|+++.+++.||||+.
T Consensus       235 ---i~~~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  235 ---IRKGEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ---HhcCCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence               2333444444  45 999999999999999999999999999999997

>KOG0616|consensus

Probab=100.00  E-value=2.4e-49  Score=391.75  Aligned_cols=258  Identities=33%  Similarity=0.506  Sum_probs=225.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .-.++|+++..||.|+||.|.+++++.++.++|+|++.....    .+...+++..+|..||+.+.||++|+|++.|. +
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v----VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV----VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-D  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH----HHHHHHHHHhhHHHHHhhccCceeEEEEEeec-c
Confidence            345779999999999999999999999999999999865443    34455778899999999999999999999998 7


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+||||||++||.|+.+++..++|++..++.++.||+.||+|||+++  ||+|||||+|||||.+   |.+||+|||+
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~---G~iKitDFGF  190 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN---GHIKITDFGF  190 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC---CcEEEEeccc
Confidence            8889999999999999999999999999999999999999999999998  9999999999999998   7999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |+.+...          +.+.||||.|+|||++.    ...|+.++|+|+|||++|||++|.+||...+....+.+   +
T Consensus       191 AK~v~~r----------T~TlCGTPeYLAPEii~----sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K---I  253 (355)
T KOG0616|consen  191 AKRVSGR----------TWTLCGTPEYLAPEIIQ----SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK---I  253 (355)
T ss_pred             eEEecCc----------EEEecCCccccChHHhh----cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH---H
Confidence            9987643          56779999999999994    55699999999999999999999999987776433321   1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                       ....+.||  ..++.++++||.++|+.|-.+|.     -..+|..||||...
T Consensus       254 -~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  254 -LEGKVKFP--SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             -HhCcccCC--cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence             12334444  57899999999999999999994     56789999999853

>KOG0588|consensus

Probab=100.00  E-value=2.5e-49  Score=425.60  Aligned_cols=259  Identities=31%  Similarity=0.477  Sum_probs=224.8

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..+-|++.+.||.|+-|.|.+|.|..||+.+|||++.......    ......+.+||-||+.+.||||+.||++|+ +.
T Consensus        10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s----~s~~~~IerEIviMkLi~HpnVl~LydVwe-~~   84 (786)
T KOG0588|consen   10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS----SSQPAGIEREIVIMKLIEHPNVLRLYDVWE-NK   84 (786)
T ss_pred             cccceeccccccCCCCceehhhhcccccceeEEEeeccccccc----cccccchhhhhHHHHHhcCCCeeeeeeeec-cC
Confidence            3467999999999999999999999999999999987653222    222346789999999999999999999998 77


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .++|+|+||++||.|++++...++|++.++.++++||+.||.|||..+  |+||||||+|+|||..+   +|||+|||+|
T Consensus        85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~---nIKIADFGMA  159 (786)
T KOG0588|consen   85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKN---NIKIADFGMA  159 (786)
T ss_pred             ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhccc---CEeeecccee
Confidence            889999999999999999999999999999999999999999999999  99999999999999984   6999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..-..+        .+..+.||+|.|.+||++.   ..++.+.++||||+|||||-||+|++||++++....++      
T Consensus       160 sLe~~g--------klLeTSCGSPHYA~PEIV~---G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLl------  222 (786)
T KOG0588|consen  160 SLEVPG--------KLLETSCGSPHYAAPEIVS---GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLL------  222 (786)
T ss_pred             ecccCC--------ccccccCCCcccCCchhhc---CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHH------
Confidence            875543        3456679999999999986   34567889999999999999999999998655443333      


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +.....|.-+..+|.++.+||++||.+||++|+|+++|++|||+..
T Consensus       223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            2233445555789999999999999999999999999999999863

>KOG0661|consensus

Probab=100.00  E-value=1.2e-49  Score=414.83  Aligned_cols=267  Identities=28%  Similarity=0.425  Sum_probs=224.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~  362 (627)
                      .+.+||.++++||.|+||+||+|..+.++..||||.+...-...++      ..-+||+..|++|+ |||||+|.+++..
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee------~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE------CMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH------HHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            4678999999999999999999999999999999987543322111      13468999999999 9999999999974


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ....+|+|||||+ .+|..+++. ++.|++..++.|+.||++||+|+|.+|  +.||||||+|||+..+   ..|||+||
T Consensus        81 ~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~---~~iKiaDF  154 (538)
T KOG0661|consen   81 NDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN---DVIKIADF  154 (538)
T ss_pred             cCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc---ceeEeccc
Confidence            4448999999998 467777764 568999999999999999999999999  9999999999999965   38999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |||+.+....        ..+.++.|.||+|||+++   ....|+.++|||++|||++|+.+-++.|.+.++.+.+.+..
T Consensus       155 GLARev~Skp--------PYTeYVSTRWYRAPEvLL---rs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc  223 (538)
T KOG0661|consen  155 GLAREVRSKP--------PYTEYVSTRWYRAPEVLL---RSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC  223 (538)
T ss_pred             ccccccccCC--------CcchhhhcccccchHHhh---hccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence            9999876542        234568999999999997   45679999999999999999999999999999988888776


Q ss_pred             HHhhhh---------------ccccCCC---------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         522 TILKAT---------------EVQFANK---------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       522 ~~~~~~---------------~~~~~~~---------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .++...               .+.||..         +..+.++.+||.+||.|||.+|||+.++|+||||+...+
T Consensus       224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            665332               2333322         347889999999999999999999999999999986544

>KOG0033|consensus

Probab=100.00  E-value=7.8e-50  Score=385.27  Aligned_cols=265  Identities=29%  Similarity=0.402  Sum_probs=227.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.+.|.+.+.||+|.|++||++.+..+|+.+|+|++...+-...     ..+++.+|++|-+.|+|||||+|.+.+. +
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-----~~e~l~rEarIC~~LqHP~IvrL~~ti~-~   81 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-----DFQKLEREARICRKLQHPNIVRLHDSIQ-E   81 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-----cHHHHHHHHHHHHhcCCCcEeehhhhhc-c
Confidence            467889999999999999999999999999999999875543222     3567889999999999999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ....|||+|++.|++|..-+.....++|..+..++.||+.+|.|+|.++  |||||+||+|+||......--+||+|||+
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccce
Confidence            5667899999999999887777788999999999999999999999999  99999999999998765556899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |..+...        .+....+|||.|||||++.    ..+|+..+|||+.|||||-||.|++||.+.+. ..+.+ ..+
T Consensus       160 Ai~l~~g--------~~~~G~~GtP~fmaPEvvr----kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye-~I~  225 (355)
T KOG0033|consen  160 AIEVNDG--------EAWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYE-QIK  225 (355)
T ss_pred             EEEeCCc--------cccccccCCCcccCHHHhh----cCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHH-HHh
Confidence            9988733        2334558999999999994    56799999999999999999999999976433 33332 334


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ........+.|+.+++++++||++||..||.+|+|+.|+|+|||+..
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            44556666789999999999999999999999999999999999874

>KOG0585|consensus

Probab=100.00  E-value=4.1e-48  Score=402.85  Aligned_cols=278  Identities=27%  Similarity=0.464  Sum_probs=227.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-------hHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-------KKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-------~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      ....+.|+++..||+|.||.|.+|++..+++.||||++.+.......       ....-+++..+||.||++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45667899999999999999999999999999999998754322211       11122457889999999999999999


Q ss_pred             EeeEEee-cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         356 LYDVFEI-DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       356 l~~~~~~-~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      |+++... ..+.+|||+|||..|.+...-....-|++.+++.|+.+++.||+|||.+|  ||||||||+|+||+.+   |
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~---g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD---G  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC---C
Confidence            9999853 23568999999999887654333233999999999999999999999999  9999999999999988   7


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      +|||+|||.+..+...... ... ......+|||.|+|||+...+......+.+.||||+||+||.|++|+.||.++...
T Consensus       248 ~VKIsDFGVs~~~~~~~~~-~~d-~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDE-GSD-DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             cEEeeccceeeecccCCcc-ccH-HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            9999999999876433111 111 22233699999999999876665667888999999999999999999999766544


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ...    .-+....+.||..+.+.++++|||.+||++||+.|+++.+|..|||....
T Consensus       326 ~l~----~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ELF----DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHH----HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            332    23345677888888899999999999999999999999999999998755

>KOG0600|consensus

Probab=100.00  E-value=8.2e-48  Score=403.82  Aligned_cols=267  Identities=27%  Similarity=0.458  Sum_probs=222.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +.-.+.|+.+++||+|+||.||+|++..+|+.||+|.+.....     ++.......|||.||++|+|||||+|.+....
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-----~~~~~~t~~REI~ILr~l~HpNIikL~eivt~  187 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-----KEGFPITAIREIKILRRLDHPNIIKLEEIVTS  187 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-----CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence            3445678888999999999999999999999999999876543     23345668899999999999999999998764


Q ss_pred             c-CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 D-ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~-~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . ...+|||+|||+ .||.-++.. .-.|++.++..|+.||+.||+|||+.|  |+|||||..|||||.+   |.+||+|
T Consensus       188 ~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~---G~LKiaD  261 (560)
T KOG0600|consen  188 KLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN---GVLKIAD  261 (560)
T ss_pred             cCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC---CCEEecc
Confidence            4 468999999998 477777765 358999999999999999999999998  9999999999999988   7999999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||||+++.......      .+..+-|.||+|||.++   ....|+.++|+||+||||.||+.|++.|.+.++.+.+-.+
T Consensus       262 FGLAr~y~~~~~~~------~T~rVvTLWYRpPELLL---G~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI  332 (560)
T KOG0600|consen  262 FGLARFYTPSGSAP------YTSRVVTLWYRPPELLL---GATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI  332 (560)
T ss_pred             ccceeeccCCCCcc------cccceEEeeccChHHhc---CCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence            99999887654321      23447899999999997   3457999999999999999999999999988887776555


Q ss_pred             HHHhhhhcc-ccC----------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         521 NTILKATEV-QFA----------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~-~~~----------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ..+...... .|+                      ....++..+.+|+..||+.||.+|.|+.++|.|+||.
T Consensus       333 fklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  333 FKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             HHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            444332211 111                      0124678899999999999999999999999999994

>KOG0597|consensus

Probab=100.00  E-value=3.6e-48  Score=409.06  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=221.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||+||+|+.+.+.+.||||++.+.....     ..++.+.+|++|++.++|||||.++++|+ ...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-----k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-----KELKNLRQEVRILRSLKHPNIVEMLESFE-TSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-----HHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccce
Confidence            56888899999999999999999999999999987655432     23567889999999999999999999999 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+|.|||.| +|+.++...+.++|+.++.|+.+++.||.|||+++  |+|||+||.||||+.+   +.+|+||||+|+.
T Consensus        76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~---~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG---GTLKLCDFGLARA  149 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC---Cceeechhhhhhh
Confidence            9999999997 99999999999999999999999999999999999  9999999999999998   6999999999998


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +....       .+.+..-|||.|||||.+    .+..|+..+|+||||||||||++|++||....    +......+..
T Consensus       150 m~~~t-------~vltsikGtPlYmAPElv----~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~  214 (808)
T KOG0597|consen  150 MSTNT-------SVLTSIKGTPLYMAPELV----EEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVKSILK  214 (808)
T ss_pred             cccCc-------eeeeeccCcccccCHHHH----cCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhc
Confidence            86532       345556899999999998    46789999999999999999999999995432    2222233333


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .++.+|.  .+|.++.+||..+|.+||.+|++..+++.|||+..
T Consensus       215 d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  215 DPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             CCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence            4444443  78999999999999999999999999999999764

>KOG0599|consensus

Probab=100.00  E-value=1.2e-48  Score=381.97  Aligned_cols=271  Identities=26%  Similarity=0.410  Sum_probs=229.8

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh-HhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE-DKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~-~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +.+.|.-.+.||.|..++|.++.++.++..+|+|++........ +..........+|+.||+++ .||+|++|.|+|+ 
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-   93 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-   93 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-
Confidence            34557777889999999999999999999999999876543222 22344556678899999988 6999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ....+++|+|+|+-|.|+++|...-.++|++.+.|+.|++.|++|||..+  ||||||||+|||+|++.   ++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~---~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNM---NIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecccc---ceEEeccc
Confidence            45567799999999999999999999999999999999999999999998  99999999999999984   89999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccC--CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG--KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      +|+.+....        .....||||.|+|||.+...  .+.+.|+..+|+|++|||||.||.|.+||.+....  ++-.
T Consensus       169 Fa~~l~~Ge--------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--lMLR  238 (411)
T KOG0599|consen  169 FACQLEPGE--------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--LMLR  238 (411)
T ss_pred             eeeccCCch--------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--HHHH
Confidence            999887543        24556999999999998543  35678999999999999999999999999765322  2222


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+.....+..+.|.++|.+.+|||.+||+.||.+|+|+.++|.||||.+.
T Consensus       239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            333444566678899999999999999999999999999999999999653

>KOG0659|consensus

Probab=100.00  E-value=3.8e-47  Score=371.18  Aligned_cols=262  Identities=28%  Similarity=0.479  Sum_probs=219.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|..+++||+|.||+||+|+|..+|+.||||.+.+....     ...-..++|||..|+.++|+|||.|+|+|- ....
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-----dGi~~talREIK~Lqel~h~nIi~LiD~F~-~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-----DGINRTALREIKLLQELKHPNIIELIDVFP-HKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-----cCccHHHHHHHHHHHHccCcchhhhhhhcc-CCCc
Confidence            5788899999999999999999999999999999876432     112346889999999999999999999997 6667


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +.||+||++ .+|...++.. ..|+..++..++.+++.||+|||++.  |+||||||.|+||+.+   |.+||+|||+|+
T Consensus        76 l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~---g~lKiADFGLAr  149 (318)
T KOG0659|consen   76 LSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD---GQLKIADFGLAR  149 (318)
T ss_pred             eEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC---CcEEeecccchh
Confidence            889999998 6899888765 57999999999999999999999998  9999999999999988   799999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+......       ....+-|.||+|||.+.+   ...|+..+||||.|||+.||+-|.+-|.+.++-+.+...-..+.
T Consensus       150 ~f~~p~~~-------~~~~V~TRWYRAPELLfG---sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG  219 (318)
T KOG0659|consen  150 FFGSPNRI-------QTHQVVTRWYRAPELLFG---SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG  219 (318)
T ss_pred             ccCCCCcc-------cccceeeeeccChHHhcc---chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence            98765422       122278999999999874   45799999999999999999999999988877766654433332


Q ss_pred             hh-ccccC---------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         526 AT-EVQFA---------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       526 ~~-~~~~~---------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .. +-.||                     ..+.++.++.||+.+||.+||.+|+++.|+|+|+||..
T Consensus       220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            21 11111                     11456788999999999999999999999999999974

>KOG0198|consensus

Probab=100.00  E-value=5.7e-47  Score=391.82  Aligned_cols=266  Identities=28%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ..+|...+.||+|+||.||++.+..+++.+|||.+.....+.       .+.+.+|+.+|++|+|||||++++......+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-------SESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-------HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            345788899999999999999999999999999987653322       4567899999999999999999997543444


Q ss_pred             -eEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 -SFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 -~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                       .++|+|||+++|+|.+++...+ .|++..++.+..||+.||.|||++|  ||||||||+||||+..+  +.+||+|||+
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~--~~~KlaDFG~  164 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSN--GDVKLADFGL  164 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCC--CeEEeccCcc
Confidence             7899999999999999999877 8999999999999999999999988  99999999999999832  6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN-QSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~-~~~~~~~~~~~  522 (627)
                      ++......    ..........||+.|||||++..   +.....++|||||||++.||+||+.||... .....++... 
T Consensus       165 a~~~~~~~----~~~~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig-  236 (313)
T KOG0198|consen  165 AKKLESKG----TKSDSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG-  236 (313)
T ss_pred             cccccccc----ccccccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh-
Confidence            98776411    01122334589999999999853   223345999999999999999999999753 2222222111 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                       ......  ..+..+|.++++||++||.+||++|||+.++|.|||+....+
T Consensus       237 -~~~~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  237 -REDSLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -ccCCCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence             111112  334569999999999999999999999999999999976544

>KOG0660|consensus

Probab=100.00  E-value=2.7e-47  Score=387.57  Aligned_cols=271  Identities=27%  Similarity=0.440  Sum_probs=221.7

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ..-.+..+|..++.||.|+||.|+.|.+..+++.||||.+...     -......++.+||+.+|+.++|+|||.+++++
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-----F~~~~~akRtlRElklLr~~~HeNIi~l~di~   90 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-----FENQIDAKRTLRELKLLRHLRHENIIGLLDIF   90 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-----hhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence            3345667888899999999999999999999999999987521     12334457889999999999999999999998


Q ss_pred             ee----cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         361 EI----DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       361 ~~----~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      ..    +-+.+|+|+|+|+ .+|...++.+..|++..+..+++||++||+|+|+.+  |+||||||.|||++.+   ..+
T Consensus        91 ~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~---c~l  164 (359)
T KOG0660|consen   91 RPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD---CDL  164 (359)
T ss_pred             ccccccccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC---CCE
Confidence            64    2345899999995 799999999888999999999999999999999998  9999999999999987   488


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||||||+|+.....     ......+.++-|.||.|||++.   +...|+..+||||+||||.|||+|++.|.+.+....
T Consensus       165 KI~DFGLAR~~~~~-----~~~~~mTeYVaTRWYRAPElll---~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q  236 (359)
T KOG0660|consen  165 KICDFGLARYLDKF-----FEDGFMTEYVATRWYRAPELLL---NSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ  236 (359)
T ss_pred             Eeccccceeecccc-----CcccchhcceeeeeecCHHHHh---ccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence            99999999988643     1113345678999999999986   566799999999999999999999999977665444


Q ss_pred             HHHHHHHhhhhc----------------cccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         517 ILEENTILKATE----------------VQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       517 ~~~~~~~~~~~~----------------~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +......+....                ..++         ..+.+++.+.+|+.+||.+||.+|+|++|+|.||||.+
T Consensus       237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence            322111111000                0011         12578999999999999999999999999999999974

>KOG0032|consensus

Probab=100.00  E-value=3.4e-46  Score=399.47  Aligned_cols=267  Identities=32%  Similarity=0.500  Sum_probs=230.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~  361 (627)
                      ..+.+.|.+.+.||.|.||.||+|.++.+|+.||+|++.........    ....+.+|+.||+++. |||||.++++|+
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~----~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE----DREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----cHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            45678899999999999999999999999999999998765442221    2356889999999998 999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-ccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-~g~vKL~D  440 (627)
                       +...+++|||+|.||.|++.+... .+++..+..++.||+.++.|||+.|  ||||||||+|||+..... .+.+|++|
T Consensus       107 -~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  107 -DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             -cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEee
Confidence             667889999999999999999776 5999999999999999999999988  999999999999987643 35899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++......        ......+||+.|+|||++    ....|+..+||||+||++|.|++|..||...+....... 
T Consensus       183 FGla~~~~~~--------~~~~~~~Gtp~y~APEvl----~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-  249 (382)
T KOG0032|consen  183 FGLAKFIKPG--------ERLHTIVGTPEYVAPEVL----GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-  249 (382)
T ss_pred             CCCceEccCC--------ceEeeecCCccccCchhh----cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-
Confidence            9999987652        234566999999999998    346799999999999999999999999988876666542 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       .......+..+.|+.++..+++||++||..||..|+|+.++|+|||+...
T Consensus       250 -i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  250 -ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             -HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence             22233345567788999999999999999999999999999999999864

>KOG0591|consensus

Probab=100.00  E-value=2.4e-48  Score=381.79  Aligned_cols=249  Identities=29%  Similarity=0.489  Sum_probs=205.9

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee-EEeecC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD-VFEIDA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~-~~~~~~  364 (627)
                      ...|+|+++||+|+||+||++.+..++..||.|-+.....     .....+....|+.+|++|+|||||++++ .|..+.
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-----d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-----DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-----cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            3468899999999999999999999999999998763321     2223456889999999999999999999 555455


Q ss_pred             CeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCC--CEEeccccCCcEEecCCCcccceEE
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKP--PVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~--~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      ..++||||||.+|+|..+++.    .+.++|..+|.++.|++.||.+||+.=+  .|+||||||.||+|+.+   |.|||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~---gvvKL  169 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN---GVVKL  169 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC---Cceee
Confidence            558999999999999998863    4689999999999999999999998433  39999999999999987   79999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +||||++++....       ......+|||+||+||.+.    ...|+.++||||+||++|||+.-+.||.+.+- ..+ 
T Consensus       170 GDfGL~r~l~s~~-------tfA~S~VGTPyYMSPE~i~----~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-~~L-  236 (375)
T KOG0591|consen  170 GDFGLGRFLSSKT-------TFAHSLVGTPYYMSPERIH----ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-LSL-  236 (375)
T ss_pred             ccchhHhHhcchh-------HHHHhhcCCCcccCHHHHh----cCCCCcchhHHHHHHHHHHHHhcCCCcccccH-HHH-
Confidence            9999999987653       3455679999999999994    66799999999999999999999999987622 222 


Q ss_pred             HHHHHhhhhccccC-CC-CCCCHHHHHHHHHhhhcCcCCCCCH
Q psy4988         519 EENTILKATEVQFA-NK-PTVSNEAKGFIRSCLAYRKEDRIDV  559 (627)
Q Consensus       519 ~~~~~~~~~~~~~~-~~-~~vs~el~~LI~~cL~~dP~~Rpt~  559 (627)
                        ..-+...  .++ .+ ..+|.++..||.-|++.||+.||+.
T Consensus       237 --~~KI~qg--d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  237 --CKKIEQG--DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             --HHHHHcC--CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence              1112222  332 22 4688999999999999999999985

>KOG0611|consensus

Probab=100.00  E-value=3.1e-47  Score=388.23  Aligned_cols=258  Identities=34%  Similarity=0.595  Sum_probs=221.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+..||.+.+.||+|+||.|.+|++...|+.||||.+.+.+.    +.+..+.++.+||+||..|+||||+.+|++|+ +
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI----kdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-N  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI----KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-N  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc----ccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-C
Confidence            456789999999999999999999999999999999876654    33344668999999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+.|||||..+|.|.+|+.+.+.|++.+++.||+||+.|+.|||.++  +||||||.+|||||.+   +++||+||||
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N---~NiKIADFGL  199 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN---NNIKIADFGL  199 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC---CCeeeeccch
Confidence            7778899999999999999999999999999999999999999999988  9999999999999998   5999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.++....        +..++||+|.|.+||++.   ..++-++.+|.|||||+||.|++|..||++.+-...+ ..  +
T Consensus       200 SNly~~~k--------fLqTFCGSPLYASPEIvN---G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-rQ--I  265 (668)
T KOG0611|consen  200 SNLYADKK--------FLQTFCGSPLYASPEIVN---GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-RQ--I  265 (668)
T ss_pred             hhhhcccc--------HHHHhcCCcccCCccccC---CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-HH--h
Confidence            99887654        456779999999999984   3345577999999999999999999999876443222 11  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                       ...  .+ ..+..+..+..||++||.+||++|.|+.+|..|=|+.
T Consensus       266 -s~G--aY-rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  266 -SRG--AY-REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -hcc--cc-cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence             111  11 2234567899999999999999999999999998875

>KOG0663|consensus

Probab=100.00  E-value=2.7e-46  Score=374.91  Aligned_cols=264  Identities=27%  Similarity=0.421  Sum_probs=218.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~  364 (627)
                      .+.|+.++.|++|+||.||+|.|+.|++.||+|.+...+..     .-+--..+|||.+|.+++|||||.+-.+..- +-
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-----~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-----EGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-----CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            35688889999999999999999999999999998765521     1222356899999999999999999998752 33


Q ss_pred             CeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      +.+|||||||+ .||..++..-+ +|...+++.++.|++.||+|||.+.  |+||||||+|+|+...   |.+||+|||+
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~---G~lKiaDFGL  223 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK---GILKIADFGL  223 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC---CcEEecccch
Confidence            56899999998 58888887654 8999999999999999999999999  9999999999999886   7999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |+.+.....      . .+..+-|.||+|||.+++   ...|+..+|+||+|||+.||+++++.|.+....+.+..+...
T Consensus       224 AR~ygsp~k------~-~T~lVVTLWYRaPELLLG---~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l  293 (419)
T KOG0663|consen  224 AREYGSPLK------P-YTPLVVTLWYRAPELLLG---AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL  293 (419)
T ss_pred             hhhhcCCcc------c-CcceEEEeeecCHHHhcC---CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence            999876531      1 233478999999999973   457999999999999999999999999888877766554444


Q ss_pred             hhhhc-cccC--------------CC-----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATE-VQFA--------------NK-----------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~-~~~~--------------~~-----------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +.... ..||              ..           ..+++...+|++.+|.+||.+|.|+.++|+|+||..
T Consensus       294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            32211 1111              00           125689999999999999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-45  Score=390.15  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=215.5

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||+++++|. +.+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI----LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-cCC
Confidence            4679999999999999999999999999999999864321    12233567889999999999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+|||||.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||+++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~---~~~kl~Dfg~~~  166 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK---GHVKVTDFGFAK  166 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC---CCEEEeeccCce
Confidence            88999999999999999998889999999999999999999999988  9999999999999987   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....          ...+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   + .
T Consensus       167 ~~~~~~----------~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i-~  228 (329)
T PTZ00263        167 KVPDRT----------FTLCGTPEYLAPEVIQ----SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---I-L  228 (329)
T ss_pred             EcCCCc----------ceecCChhhcCHHHHc----CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH---H-h
Confidence            764321          2347999999999984    44578999999999999999999999976554332211   1 1


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      ...+.+  +..++..+++||.+||+.||.+||+     +.+++.||||...
T Consensus       229 ~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        229 AGRLKF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             cCCcCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            122223  3458899999999999999999997     7999999999753

>KOG0578|consensus

Probab=100.00  E-value=1.4e-46  Score=400.50  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=226.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -..+|....+||+|+-|.||.|....+++.||||.+.+....+.+       -+++|+.+|+.++|+|||.+++.|.. .
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke-------LilnEi~Vm~~~~H~NiVnfl~Sylv-~  342 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE-------LLLNEILVMRDLHHPNIVNFLDSYLV-G  342 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh-------hhHHHHHHHHhccchHHHHHHHHhcc-c
Confidence            456788999999999999999999999999999999877654432       47899999999999999999999984 4


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+|||||+||+|.+.+.. ..++|.++..|.++++.||+|||..+  |||||||.+|||++.+   |.+||+|||++
T Consensus       343 deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~---g~vKltDFGFc  416 (550)
T KOG0578|consen  343 DELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD---GSVKLTDFGFC  416 (550)
T ss_pred             ceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC---CcEEEeeeeee
Confidence            778899999999999988765 45999999999999999999999988  9999999999999988   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       ...+.+|||+|||||++    ....|+.++||||||++++||+-|.+||-..+....   ...+.
T Consensus       417 aqi~~~~~-------KR~TmVGTPYWMAPEVv----trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---lyLIa  482 (550)
T KOG0578|consen  417 AQISEEQS-------KRSTMVGTPYWMAPEVV----TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIA  482 (550)
T ss_pred             eccccccC-------ccccccCCCCccchhhh----hhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---HHHHh
Confidence            98876532       34567999999999998    466799999999999999999999999976544333   23445


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ......+..+..+|+++++||.+||+.|+.+|+++.+||.||||...
T Consensus       483 ~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  483 TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            55666777788999999999999999999999999999999999543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.4e-45  Score=390.13  Aligned_cols=268  Identities=25%  Similarity=0.394  Sum_probs=215.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|.+..+++.||||++.....    ........+.+|+.++..++||||++++++|. +...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM----LEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-DKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH----HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCe
Confidence            479999999999999999999999999999999864321    12233456788999999999999999999998 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||+|++|..++...+.+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~---~~vkL~DFGla~~  150 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK---GHVKLSDFGLCTG  150 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC---CCEEEeeccCccc
Confidence            8999999999999999998889999999999999999999999988  9999999999999886   6899999999986


Q ss_pred             cccCCCCCC----------------------------CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         447 MDEENYNPD----------------------------HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       447 ~~~~~~~~~----------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      +........                            .........+||+.|+|||++.    ...++.++|||||||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~~DvwSlGvil  226 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc----CCCCCCchhhhhhHHHH
Confidence            542210000                            0000112458999999999984    44588999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcC---CCCCHHHHHhccCCCCC
Q psy4988         499 YQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE---DRIDVISLARHDYLQPP  571 (627)
Q Consensus       499 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~---~Rpt~~elL~hp~~~~~  571 (627)
                      |||++|+.||........+...  ......+.++....+++++++||.+||. +|.   .||++.++++||||...
T Consensus       227 ~ell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         227 YEMLIGYPPFCSETPQETYKKV--MNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHH--HcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            9999999999776554433221  1112334456556789999999999775 444   46899999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610|consensus

Probab=100.00  E-value=5.8e-46  Score=382.18  Aligned_cols=270  Identities=30%  Similarity=0.445  Sum_probs=226.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +-.++|++++.||.|.-|+||+|....++..+|+|++.+...    ...+-+.++..|-+||+.++||.++.||..|+ .
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l----~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-t  148 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL----ASRKKLKRAQTEREILSLLDHPFLPTLYASFE-T  148 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH----hhhhHHHHHHHHHHHHHhcCCCccchhhheee-c
Confidence            334567788889999999999999999999999999865433    22334567888999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      .+..|||||||+||+|..+++.+  +.|++..++.++.+|+.||+|||.+|  ||+|||||+||||.++   |+|.|+||
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred---GHIMLsDF  223 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED---GHIMLSDF  223 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC---CcEEeeec
Confidence            67889999999999999998765  68999999999999999999999999  9999999999999988   89999999


Q ss_pred             ccccccccC--CCC---------------------------CCC--------------------CccccccCCCCCccCC
Q psy4988         442 GLSKVMDEE--NYN---------------------------PDH--------------------GMDLTSQGAGTYWYLP  472 (627)
Q Consensus       442 Gla~~~~~~--~~~---------------------------~~~--------------------~~~~~~~~~Gt~~Y~A  472 (627)
                      .|+....-.  -..                           ...                    ........+||-.|+|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            998543210  000                           000                    0011224579999999


Q ss_pred             ccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcC
Q psy4988         473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYR  552 (627)
Q Consensus       473 PE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~d  552 (627)
                      ||++.    +...+.++|+|+|||+|||||+|..||.+.+..+.+.+.    -..++.|+..+.++..++|||+++|.+|
T Consensus       304 PEvI~----G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----v~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  304 PEVIR----GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----VGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             ceeee----cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----hcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            99994    556788999999999999999999999998888777532    2356788888899999999999999999


Q ss_pred             cCCCCC----HHHHHhccCCCCC
Q psy4988         553 KEDRID----VISLARHDYLQPP  571 (627)
Q Consensus       553 P~~Rpt----~~elL~hp~~~~~  571 (627)
                      |.+|.-    +.||-+||||...
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hhhhhccccchHHhhcCccccCC
Confidence            999998    9999999999853

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-45  Score=386.47  Aligned_cols=251  Identities=30%  Similarity=0.473  Sum_probs=208.7

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||+|.+..+++.||||++.....    .....+..+++|+.+++.++||||++++++|. +.+.+||||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~   76 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVI----IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-THDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-cCCEEEEEEeC
Confidence            59999999999999999999999999864321    12233456788999999999999999999998 66788999999


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN  453 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~  453 (627)
                      +++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++......  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~--  149 (323)
T cd05571          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDG--  149 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC---CCEEEeeCCCCcccccCC--
Confidence            999999999988889999999999999999999999988  9999999999999886   689999999997543211  


Q ss_pred             CCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       454 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                           ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||......... ..   .......  .
T Consensus       150 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~---~~~~~~~--~  214 (323)
T cd05571         150 -----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL---ILMEEIR--F  214 (323)
T ss_pred             -----CcccceecCccccChhhhc----CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HH---HHcCCCC--C
Confidence                 1123457999999999984    456889999999999999999999999765433222 11   1112222  3


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      +..+++++.+||.+||+.||++||     ++.++++||||...
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            356899999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-45  Score=381.07  Aligned_cols=254  Identities=27%  Similarity=0.440  Sum_probs=213.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||+++++++. +.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-DQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-cCCe
Confidence            479999999999999999999999999999999864321    11223456788999999999999999999887 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~---~~~kl~Dfg~~~~  150 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE---GHIKLTDFGFAKK  150 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC---CCEEEEecCcchh
Confidence            8999999999999999998889999999999999999999999988  9999999999999876   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +...          ....+||+.|+|||++.    ...++.++|||||||+||+|++|+.||............    ..
T Consensus       151 ~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i----~~  212 (291)
T cd05612         151 LRDR----------TWTLCGTPEYLAPEVIQ----SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI----LA  212 (291)
T ss_pred             ccCC----------cccccCChhhcCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh
Confidence            6432          12347999999999984    445789999999999999999999999766543322111    11


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~  570 (627)
                      ....+  ...++..+++||++||+.||.+||+     +.+++.||||..
T Consensus       213 ~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         213 GKLEF--PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCcCC--CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            12222  3457899999999999999999995     999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0667|consensus

Probab=100.00  E-value=2.5e-45  Score=397.84  Aligned_cols=268  Identities=28%  Similarity=0.454  Sum_probs=223.0

Q ss_pred             ccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-C----
Q psy4988         276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-H----  350 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-H----  350 (627)
                      .+.+..++++..||.|++.||+|+||.|.+|+|..|++.||||++...+        .+..+...|+.||..|+ |    
T Consensus       175 dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--------~f~~Q~~~Ei~iL~~ln~~d~~~  246 (586)
T KOG0667|consen  175 DYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--------RFLRQAQIEIRILELLNKHDPDD  246 (586)
T ss_pred             ceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--------HHHHHHHHHHHHHHHHhccCCCC
Confidence            4566677788889999999999999999999999999999999986443        34566788999999986 3    


Q ss_pred             -CceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         351 -PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       351 -pnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                       -|||+++|+|. ..+++|||+|++. .+|.++++.+  ..|+...++.|+.||+.||.+||+++  |||+||||+||||
T Consensus       247 ~~n~Vrm~d~F~-fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL  322 (586)
T KOG0667|consen  247 KYNIVRMLDYFY-FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILL  322 (586)
T ss_pred             CeeEEEeeeccc-cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheee
Confidence             38999999998 7889999999997 6899999876  47999999999999999999999998  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                      .+-..+ .|||+|||.|++.....+          +++-+..|+|||+|+    +.+|+.+.||||||||++||++|.+.
T Consensus       323 ~~~~r~-~vKVIDFGSSc~~~q~vy----------tYiQSRfYRAPEVIL----GlpY~~~IDmWSLGCIlAEL~tG~PL  387 (586)
T KOG0667|consen  323 KDPKRS-RIKVIDFGSSCFESQRVY----------TYIQSRFYRAPEVIL----GLPYDTAIDMWSLGCILAELFTGEPL  387 (586)
T ss_pred             ccCCcC-ceeEEecccccccCCcce----------eeeeccccccchhhc----cCCCCCccceeehhhhHHhHhcCccc
Confidence            876654 999999999998765432          447789999999996    55699999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhhhhc------------------------------------------------cccC-CC----
Q psy4988         508 FGHNQSQATILEENTILKATE------------------------------------------------VQFA-NK----  534 (627)
Q Consensus       508 f~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~-~~----  534 (627)
                      |.+.+..+.+.....++....                                                ...| ..    
T Consensus       388 fpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~  467 (586)
T KOG0667|consen  388 FPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLE  467 (586)
T ss_pred             cCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccc
Confidence            988887776654443321110                                                0000 00    


Q ss_pred             ---C-CCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         535 ---P-TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       535 ---~-~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                         . .--..+.|||.+||++||.+|+|+.++|+||||..
T Consensus       468 ~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  468 SGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             hhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence               0 11235789999999999999999999999999983

>KOG0694|consensus

Probab=100.00  E-value=9.8e-46  Score=400.97  Aligned_cols=261  Identities=30%  Similarity=0.478  Sum_probs=222.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~  361 (627)
                      .+-.++|.++.+||+|+||.|+++..+.++++||||++.+......+.    +.....|.+|+.... ||.++.|+.+|+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~----Ve~~~~EkrI~~la~~HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE----VESLMCEKRIFELANRHPFLVNLFSCFQ  439 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc----HHHHHHHHHHHHHhccCCeEeecccccc
Confidence            455688999999999999999999999999999999998776544433    456778888887774 999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       ..+++|+||||+.||++ .++...+.|++..++.|+..|+.||.|||+++  |||||||.+|||||.+   |++||+||
T Consensus       440 -T~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e---Gh~kiADF  512 (694)
T KOG0694|consen  440 -TKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE---GHVKIADF  512 (694)
T ss_pred             -cCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc---CcEEeccc
Confidence             67889999999999994 33445579999999999999999999999999  9999999999999998   89999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++..-..       -..+++.||||.|||||++    .+..|+..+|+|||||+|||||+|..||.+++.++..-.  
T Consensus       513 GlcKe~m~~-------g~~TsTfCGTpey~aPEil----~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds--  579 (694)
T KOG0694|consen  513 GLCKEGMGQ-------GDRTSTFCGTPEFLAPEVL----TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS--  579 (694)
T ss_pred             ccccccCCC-------CCccccccCChhhcChhhh----ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--
Confidence            999864321       1357889999999999999    466799999999999999999999999988777655432  


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                        +...++.+|.  .+|.++.++++++|.+||++|.-     +.+|..||||...
T Consensus       580 --I~~d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  580 --IVNDEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             --HhcCCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence              2234455554  58999999999999999999995     5789999999753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-45  Score=391.81  Aligned_cols=267  Identities=28%  Similarity=0.453  Sum_probs=214.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.++++||+|+||.||+|.+..+++.||||++.....    ........+.+|+++++.++|||||+++++|. +...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-DAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCe
Confidence            479999999999999999999999999999999854322    12233567888999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~---~~~kl~DfGla~~  150 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG---GHIKLSDFGLSTG  150 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC---CCEEEeecccccc
Confidence            8999999999999999988889999999999999999999999988  9999999999999876   6899999999974


Q ss_pred             cccCCCCC----------CC-C-----------------------------ccccccCCCCCccCCccccccCCCCCCCC
Q psy4988         447 MDEENYNP----------DH-G-----------------------------MDLTSQGAGTYWYLPPECFVVGKNPPKIS  486 (627)
Q Consensus       447 ~~~~~~~~----------~~-~-----------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~  486 (627)
                      +.......          .. .                             .......+||+.|+|||++.    ...++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~  226 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL----QQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc----cCCCC
Confidence            42210000          00 0                             00011247999999999984    44588


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCC---CCHHHHH
Q psy4988         487 SKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR---IDVISLA  563 (627)
Q Consensus       487 ~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~R---pt~~elL  563 (627)
                      .++||||||||||||++|..||........+...  ......+.++....++.++.+||.+||. +|.+|   +++.+++
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKI--INWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH--HccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999999999999766554333211  1112334555556789999999999998 77765   5999999


Q ss_pred             hccCCCC
Q psy4988         564 RHDYLQP  570 (627)
Q Consensus       564 ~hp~~~~  570 (627)
                      .||||..
T Consensus       304 ~hp~~~~  310 (377)
T cd05629         304 SHPFFRG  310 (377)
T ss_pred             cCCCcCC
Confidence            9999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-45  Score=390.40  Aligned_cols=268  Identities=29%  Similarity=0.462  Sum_probs=218.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||+||+|.+..+++.||||++.....    ........+.+|+.++..++||||++++++|. +.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM----LEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-DENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCe
Confidence            479999999999999999999999999999999864321    11233456788999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||++++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~  150 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK---GHIKLSDFGLCTG  150 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC---CCEEEeeccccee
Confidence            8999999999999999988889999999999999999999999988  9999999999999987   6899999999976


Q ss_pred             cccCCCCCCCC-------------------------------ccccccCCCCCccCCccccccCCCCCCCCcchhHHHHH
Q psy4988         447 MDEENYNPDHG-------------------------------MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVG  495 (627)
Q Consensus       447 ~~~~~~~~~~~-------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlG  495 (627)
                      +..........                               .......+||+.|+|||++.    ...++.++||||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG  226 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL----QTGYNKECDWWSLG  226 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc----CCCCCCeeeeecch
Confidence            54321100000                               00111347999999999984    44588999999999


Q ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHhccCCCCC
Q psy4988         496 VIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID---VISLARHDYLQPP  571 (627)
Q Consensus       496 viL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt---~~elL~hp~~~~~  571 (627)
                      |+||+|++|..||........+...  ......+.++....+++++.+||.+||. +|.+|++   +.+++.||||...
T Consensus       227 ~il~el~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQETYRKI--INWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHHHHHHHH--HcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999999876654433221  1112234455555789999999999996 9999998   9999999999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2e-44  Score=389.35  Aligned_cols=268  Identities=27%  Similarity=0.390  Sum_probs=215.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|.+++.||+|+||+||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||+++++|. +.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV----LNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-cCCEE
Confidence            58899999999999999999999999999999864321    12234567889999999999999999999998 67789


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +++||+|||+++.+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~---~~~kL~DFGl~~~~  151 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD---GHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC---CCEEEeeCcCCccc
Confidence            999999999999999998889999999999999999999999988  9999999999999876   68999999998644


Q ss_pred             ccCCCCC----------------------------------------CCCccccccCCCCCccCCccccccCCCCCCCCc
Q psy4988         448 DEENYNP----------------------------------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS  487 (627)
Q Consensus       448 ~~~~~~~----------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~  487 (627)
                      .......                                        ..........+||+.|+|||++.    ...++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~  227 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL----RKGYTQ  227 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc----CCCCCC
Confidence            2110000                                        00000112357999999999984    445889


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhh--cCcCCCCCHHHHHhc
Q psy4988         488 KVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLA--YRKEDRIDVISLARH  565 (627)
Q Consensus       488 k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~--~dP~~Rpt~~elL~h  565 (627)
                      ++||||||||||||++|..||............  ........++....+++++.+||.+||+  .++..|+++.+++.|
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV--INWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH--HccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999999999999999776554433221  1122234555556789999999999665  455569999999999


Q ss_pred             cCCCCC
Q psy4988         566 DYLQPP  571 (627)
Q Consensus       566 p~~~~~  571 (627)
                      |||...
T Consensus       306 p~f~~~  311 (381)
T cd05626         306 PFFSEV  311 (381)
T ss_pred             cccCCC
Confidence            999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-45  Score=375.21  Aligned_cols=261  Identities=21%  Similarity=0.391  Sum_probs=210.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++||||++++++|. +...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-----EEVKETTLRELKMLRTLKQENIVELKEAFR-RRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-----ccchhhHHHHHHHHHhCCCccccchhhhEe-cCCE
Confidence            4799999999999999999999999999999998654321     122356778999999999999999999997 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||++++.+..+......+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~  149 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN---DVLKLCDFGFARN  149 (287)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CcEEEeeccCccc
Confidence            8899999999888776666678999999999999999999999988  9999999999999876   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....      .......||+.|+|||++.    +..++.++|||||||+||+|++|+.||..................
T Consensus       150 ~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         150 LSEGSN------ANYTEYVATRWYRSPELLL----GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             cccccc------ccccccccccccCCcHHHc----CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            643221      1122347899999999984    345789999999999999999999999766544433222111100


Q ss_pred             ---------------hccccCC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 ---------------TEVQFAN-----------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ---------------~~~~~~~-----------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                     ....++.           ...++.++.+||++||++||++|||+.++++||||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                           0001111           12378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-44  Score=377.53  Aligned_cols=264  Identities=28%  Similarity=0.470  Sum_probs=206.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.......      ....+.+|+.+++.++||||+++++++. +..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~   76 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG------TPFTAIREASLLKGLKHANIVLLHDIIH-TKE   76 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc------cchhHHHHHHHHhhCCCCCcCeEEEEEe-cCC
Confidence            478999999999999999999999999999999986432211      1234678999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+.+ +|..++.. ...+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||++
T Consensus        77 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~---~~~kl~Dfg~~  150 (303)
T cd07869          77 TLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT---GELKLADFGLA  150 (303)
T ss_pred             eEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEECCCCcc
Confidence            78999999975 66666554 467999999999999999999999988  9999999999999876   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI-  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~-  523 (627)
                      +......       .......||+.|+|||++.   ....++.++|||||||+||+|++|..||.........+..... 
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  220 (303)
T cd07869         151 RAKSVPS-------HTYSNEVVTLWYRPPDVLL---GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV  220 (303)
T ss_pred             eeccCCC-------ccCCCCcccCCCCChHHHc---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence            7643221       1122347899999999874   2345788999999999999999999999765443322221111 


Q ss_pred             hhhh-ccc--------------c----C-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         524 LKAT-EVQ--------------F----A-------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       524 ~~~~-~~~--------------~----~-------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .... ...              +    +       ....+++++.+||.+||++||++|||+.+++.||||....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         221 LGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0000 000              0    0       0112457899999999999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0582|consensus

Probab=100.00  E-value=6.3e-45  Score=377.12  Aligned_cols=273  Identities=23%  Similarity=0.364  Sum_probs=227.3

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ..++.-.+.|.+...||.|.-++||+|+...++++||||++.+.+.      .+.+..+.+|+..++.++|||||+++.+
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc------~~~ld~l~kE~~~msl~~HPNIv~~~~s   92 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC------NNDLDALRKEVQTMSLIDHPNIVTYHCS   92 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh------hhhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence            3456677899999999999999999999999999999999876543      3346778999999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      |. ....+|+||.||.+|++.++++..  ..|.|..+..|+++++.||.|||.+|  .||||||+.||||+.+   |.||
T Consensus        93 Fv-v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d---G~Vk  166 (516)
T KOG0582|consen   93 FV-VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD---GTVK  166 (516)
T ss_pred             EE-ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC---CcEE
Confidence            98 567788999999999999999865  46999999999999999999999999  9999999999999998   7999


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||.+..+.+...  ....++ .+.+||++|||||+++.  ....|+.|+||||||++..||.+|..||....+...+
T Consensus       167 LadFgvsa~l~~~G~--R~~~rf-~tfvgtp~wmAPEvl~q--~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL  241 (516)
T KOG0582|consen  167 LADFGVSASLFDSGD--RQVTRF-NTFVGTPCWMAPEVLMQ--QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL  241 (516)
T ss_pred             EcCceeeeeecccCc--eeeEee-ccccCcccccChHHhhh--cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence            999999877665431  122233 66799999999999643  3456999999999999999999999999877666555


Q ss_pred             HHHHHHhhhh------ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         518 LEENTILKAT------EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       518 ~~~~~~~~~~------~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      +..  +.+..      .+.......++..++.||..||.+||.+|||+.++|+|+||+..
T Consensus       242 l~t--Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  242 LLT--LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             HHH--hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            432  11111      11222234567789999999999999999999999999999754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-44  Score=375.40  Aligned_cols=259  Identities=28%  Similarity=0.511  Sum_probs=207.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.++||.|+||.||+|.+..++..||||++.......      ....+.+|+.+++.++||||+++++++. +...
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~   77 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG------APCTAIREVSLLKNLKHANIVTLHDIIH-TERC   77 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC------cchhHHHHHHHHHhCCCCCEeeEEEEEc-CCCe
Confidence            57999999999999999999999999999999986432211      1235678999999999999999999987 5667


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++
T Consensus        78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~---~~~kl~DfG~~~  151 (288)
T cd07871          78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK---GELKLADFGLAR  151 (288)
T ss_pred             EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC---CCEEECcCccee
Confidence            8899999986 888877654 45899999999999999999999988  9999999999999887   689999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......|++.|+|||++.   ....++.++|||||||++|+|++|+.||........+........
T Consensus       152 ~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (288)
T cd07871         152 AKSVPT-------KTYSNEVVTLWYRPPDVLL---GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG  221 (288)
T ss_pred             eccCCC-------ccccCceecccccChHHhc---CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            654321       1122347899999999885   234578999999999999999999999977655444322211110


Q ss_pred             h---------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 A---------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~---------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .               ....++         ..+.++.++.+||.+||++||.+|||+.|+++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0               000111         123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.1e-45  Score=390.97  Aligned_cols=267  Identities=28%  Similarity=0.413  Sum_probs=215.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||++++++|. +.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV----LMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-DKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH----HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCE
Confidence            369999999999999999999999999999999853221    12223456788999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||++++|.+++...+.+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+|..
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~---~~ikL~DFG~a~~  150 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD---GHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC---CCEEEEeCCCCcc
Confidence            9999999999999999998889999999999999999999999988  9999999999999976   6899999999864


Q ss_pred             cccCCCCC------------------------------------CCCccccccCCCCCccCCccccccCCCCCCCCcchh
Q psy4988         447 MDEENYNP------------------------------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVD  490 (627)
Q Consensus       447 ~~~~~~~~------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~D  490 (627)
                      +.......                                    ..........+||+.|+|||++.    ...++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~D  226 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL----RTGYTQLCD  226 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc----CCCCCccee
Confidence            32100000                                    00000112347999999999984    456889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhccC
Q psy4988         491 VWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDY  567 (627)
Q Consensus       491 VwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp~  567 (627)
                      |||||||||+|++|+.||............  ........++....++.++.+||.+|+ .+|.+|+   ++.++++|||
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAETQLKV--INWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHHHHHHH--hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            999999999999999999876654433221  111223344555678999999999976 5999999   9999999999


Q ss_pred             CCC
Q psy4988         568 LQP  570 (627)
Q Consensus       568 ~~~  570 (627)
                      |..
T Consensus       304 ~~~  306 (376)
T cd05598         304 FKG  306 (376)
T ss_pred             cCC
Confidence            975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-44  Score=373.84  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=210.8

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |++.+.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|+||++++++|. +.+.+|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----KRKGEAMALNEKRILEKVNSRFVVSLAYAYE-TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-cCCeEE
Confidence            78899999999999999999999999999987643221    1122345778999999999999999999987 567889


Q ss_pred             EEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||++++|..++...  ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||++..
T Consensus        77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~---~~~kl~Dfg~~~~  151 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR---GHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC---CCEEEeeCCCcEE
Confidence            999999999998887543  46899999999999999999999988  9999999999999876   5899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +....        ......||+.|+|||++.    ...++.++|||||||+||+|++|+.||................. 
T Consensus       152 ~~~~~--------~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-  218 (285)
T cd05631         152 IPEGE--------TVRGRVGTVGYMAPEVIN----NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-  218 (285)
T ss_pred             cCCCC--------eecCCCCCCCccCHhhhc----CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-
Confidence            54321        112347999999999984    44688999999999999999999999976544322111111111 


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPPV  572 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~~  572 (627)
                       .........++.++.+||++||..||.+||+     +.++++||||....
T Consensus       219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence             1222334568999999999999999999997     89999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=383.55  Aligned_cols=259  Identities=27%  Similarity=0.384  Sum_probs=216.5

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.++..++||||++++++|. +.+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL----FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-DDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-cCCE
Confidence            469999999999999999999999999999999864321    12233567889999999999999999999997 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +||||||+++++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~~~kL~Dfg~a~~  150 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS---GHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC---CCEEEEeCcCCcc
Confidence            8999999999999999998889999999999999999999999988  9999999999999886   6899999999986


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ...          .....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+......  .
T Consensus       151 ~~~----------~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~  214 (333)
T cd05600         151 IVT----------YANSVVGSPDYMAPEVLR----GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--K  214 (333)
T ss_pred             ccc----------ccCCcccCccccChhHhc----CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--c
Confidence            543          123447999999999984    446889999999999999999999999776554433221111  1


Q ss_pred             hccccCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         527 TEVQFANK----PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~----~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....+..    ..+++++.+||.+||..+|.+||++.+++.||||...
T Consensus       215 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         215 ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            11111211    2578999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-44  Score=383.04  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=218.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++.....    ........+.+|+.+++.++||||++++++|. +.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL----LAQETVSFFEEERDILSISNSPWIPQLQYAFQ-DKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCe
Confidence            469999999999999999999999999999999864321    12233456778999999999999999999987 6678


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +||||||+++++|..++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~---~~~kL~Dfg~a~  150 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT---GHIKLADFGSAA  150 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC---CCEEeccCCCCe
Confidence            89999999999999999876 68999999999999999999999988  9999999999999976   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK--NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      .+.....      .......||+.|+|||++....  ....++.++||||||||||+|++|..||........+...  .
T Consensus       151 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i--~  222 (330)
T cd05601         151 RLTANKM------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI--M  222 (330)
T ss_pred             ECCCCCc------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH--H
Confidence            7653321      1122347999999999984211  1345788999999999999999999999766554433221  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......++..+.++.++.+||.+||. ||.+||++.+++.||||...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         223 NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            112234556666789999999999998 99999999999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-44  Score=391.26  Aligned_cols=267  Identities=28%  Similarity=0.412  Sum_probs=216.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.++++||+|+||+||+|.+..+++.||||++....    .........+.+|+.+++.++|||||+++++|. +.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-eCCEE
Confidence            6899999999999999999999999999999986322    122334567889999999999999999999998 66788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|||||++++|..++...+.+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++..+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~---g~~kL~DFGla~~~  151 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD---GHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---CCEEEeECCCCccc
Confidence            999999999999999988888999999999999999999999988  9999999999999986   68999999998643


Q ss_pred             ccCCCC----C------------------------------------CCCccccccCCCCCccCCccccccCCCCCCCCc
Q psy4988         448 DEENYN----P------------------------------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS  487 (627)
Q Consensus       448 ~~~~~~----~------------------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~  487 (627)
                      ......    .                                    ..........+||+.|+|||++.    ...++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~  227 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL----RTGYTQ  227 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc----CCCCCC
Confidence            210000    0                                    00000112357999999999984    445889


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHh
Q psy4988         488 KVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID---VISLAR  564 (627)
Q Consensus       488 k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt---~~elL~  564 (627)
                      ++||||||||||||++|+.||............  ........++....+++++.+||.+|+ .+|.+|++   +.++++
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV--INWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHH--HccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999999999999876554433222  112233455556678999999999976 59999997   999999


Q ss_pred             ccCCCCC
Q psy4988         565 HDYLQPP  571 (627)
Q Consensus       565 hp~~~~~  571 (627)
                      ||||...
T Consensus       305 hp~f~~~  311 (382)
T cd05625         305 HPFFKTI  311 (382)
T ss_pred             CCCcCCc
Confidence            9999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0580|consensus

Probab=100.00  E-value=5.9e-46  Score=358.25  Aligned_cols=257  Identities=31%  Similarity=0.464  Sum_probs=220.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -.++|.+.+.||+|-||.||+|+.+.++..||+|++.+...    ........+.+|++|...|+||||+++|++|. |.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi----~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-d~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI----LKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-DS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH----HHhcchhhhhheeEeecccCCccHHhhhhhee-cc
Confidence            35779999999999999999999999999999999865432    22233456789999999999999999999998 77


Q ss_pred             CeEEEEEeecCCCChHHHHH--hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLK--QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...||++||.+.|.|...|.  ...++++..+..++.|++.||.|+|..+  ||||||||+|+|++..   +.+||+|||
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~---~~lkiAdfG  169 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA---GELKIADFG  169 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC---CCeeccCCC
Confidence            88899999999999999998  5578999999999999999999999988  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      .+.....         ....+.|||..|+|||..    ++..++..+|+|++|++.||+|.|.+||......+.+.+   
T Consensus       170 wsV~~p~---------~kR~tlcgt~dyl~pEmv----~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr---  233 (281)
T KOG0580|consen  170 WSVHAPS---------NKRKTLCGTLDYLPPEMV----EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR---  233 (281)
T ss_pred             ceeecCC---------CCceeeecccccCCHhhc----CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH---
Confidence            9975432         224567999999999998    567789999999999999999999999976654333322   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                       +...+..+  +..++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus       234 -I~k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  234 -IRKVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -HHHccccC--CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence             22233333  4789999999999999999999999999999999863

>KOG4717|consensus

Probab=100.00  E-value=1.9e-45  Score=384.20  Aligned_cols=262  Identities=29%  Similarity=0.459  Sum_probs=223.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.+-|.+.+.||+|-|++|.+|++..+|..||||++.+.+...     ....++++|++.|+.++|||||+||++.. .
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-----~st~hlfqEVRCMKLVQHpNiVRLYEViD-T   88 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-----LSTGHLFQEVRCMKLVQHPNIVRLYEVID-T   88 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-----hhhhHHHHHHHHHHHhcCcCeeeeeehhc-c
Confidence            35667999999999999999999999999999999997665321     12357889999999999999999999987 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+|||+|+-++|+|++||..+ ..+.|+.++++|.||+.||.|||++.  +|||||||+||.+.+..  |-|||+|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKl--GlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKL--GLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeec--CceEeeecc
Confidence            55688999999999999998654 68999999999999999999999998  99999999999998765  799999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+....        ...+.||+..|.|||+++++.   +..+++||||||||||.|+||++||...++-+.+..+  
T Consensus       165 FSNkf~PG~--------kL~TsCGSLAYSAPEILLGDs---YDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--  231 (864)
T KOG4717|consen  165 FSNKFQPGK--------KLTTSCGSLAYSAPEILLGDS---YDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--  231 (864)
T ss_pred             ccccCCCcc--------hhhcccchhhccCchhhhcCc---cCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--
Confidence            998765442        235569999999999997443   4567899999999999999999999877666554321  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                          .+-.+..+..+|.++++||..||..||.+|.++++|..|+|+++..
T Consensus       232 ----mDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  232 ----MDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             ----hcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence                2334455668999999999999999999999999999999998653

>KOG0192|consensus

Probab=100.00  E-value=1.4e-44  Score=384.16  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeE-EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRY-VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~-VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      .+...+.+.||.|+||+||+|...  |.. ||||++........     ..+.|.+|+.+|.+++|||||+|++++....
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~-----~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDE-----SRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            344455566999999999999754  445 99999864332111     1678999999999999999999999997443


Q ss_pred             CeEEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ..++|||||+++|+|..++..  ...+++..+..|+.||++||+|||+.++ ||||||||+||||+.+.  .++||||||
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~--~~~KI~DFG  189 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKG--KTLKIADFG  189 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCC--CEEEECCCc
Confidence            378999999999999999987  6899999999999999999999999876 99999999999999883  389999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++......       ...+...||+.|||||++...  ...|+.++|||||||+||||+||+.||..........  ..
T Consensus       190 lsr~~~~~~-------~~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~--~v  258 (362)
T KOG0192|consen  190 LSREKVISK-------TSMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS--AV  258 (362)
T ss_pred             cceeecccc-------ccccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH--HH
Confidence            998765431       112225899999999999522  4579999999999999999999999998776632221  12


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ........+  +..+++.+..||.+||..||..||+..+++.
T Consensus       259 ~~~~~Rp~~--p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  259 VVGGLRPPI--PKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HhcCCCCCC--CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            222222222  3348899999999999999999999999874

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.1e-44  Score=384.39  Aligned_cols=272  Identities=26%  Similarity=0.401  Sum_probs=219.7

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ......++|++.+.||+|+||.||++.+..+++.||+|++......    .......+.+|+.+++.++||||++++++|
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI----KRSDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445668999999999999999999999999999999998642211    112234577899999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +...+|+|||||++++|..++... .+++..++.++.||+.||.|||+++  |+||||||+||||+.+   +.+||+|
T Consensus       113 ~-~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~---~~~kL~D  185 (370)
T cd05621         113 Q-DDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH---GHLKLAD  185 (370)
T ss_pred             E-cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC---CCEEEEe
Confidence            8 667889999999999999998654 6899999999999999999999988  9999999999999876   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++..+.....      ......+||+.|+|||++........++.++|||||||+||+|++|+.||........+.. 
T Consensus       186 FG~a~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~-  258 (370)
T cd05621         186 FGTCMKMDETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK-  258 (370)
T ss_pred             cccceecccCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence            999987643221      1123457999999999985432234578899999999999999999999976654433321 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                       .......+.++....++..+++||.+||..++.+  |+++.++++||||...
T Consensus       259 -i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         259 -IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence             1112223455666678999999999999865543  8999999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8e-44  Score=377.26  Aligned_cols=265  Identities=24%  Similarity=0.378  Sum_probs=213.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|++++.||+|+||.||++.+..++..||+|++.....      ......+.+|+++++.++||||+++++++. +
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~   74 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGAFY-S   74 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-E
Confidence            346889999999999999999999999999999999865321      223456889999999999999999999997 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+++||||+++++|.+++.....+++..+..++.|++.||.|||+.+ +||||||||+|||++.+   +.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~---~~~kl~Dfg~  150 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSR---GEIKLCDFGV  150 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCC---CcEEEccCcc
Confidence            6678899999999999999998889999999999999999999999841 39999999999999887   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN--  521 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~--  521 (627)
                      +..+....         .....||+.|+|||++.    +..++.++|||||||+||+|++|+.||.............  
T Consensus       151 ~~~~~~~~---------~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~  217 (331)
T cd06649         151 SGQLIDSM---------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP  217 (331)
T ss_pred             cccccccc---------cccCCCCcCcCCHhHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc
Confidence            97654321         23347999999999984    4458899999999999999999999996544322110000  


Q ss_pred             ----------------------------------------HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q psy4988         522 ----------------------------------------TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS  561 (627)
Q Consensus       522 ----------------------------------------~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~e  561 (627)
                                                              ...............+++++.+||.+||.+||++|||+.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e  297 (331)
T cd06649         218 VVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM  297 (331)
T ss_pred             ccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHH
Confidence                                                    0000000000011247889999999999999999999999


Q ss_pred             HHhccCCCCCC
Q psy4988         562 LARHDYLQPPV  572 (627)
Q Consensus       562 lL~hp~~~~~~  572 (627)
                      +++||||....
T Consensus       298 ll~h~~~~~~~  308 (331)
T cd06649         298 LMNHTFIKRSE  308 (331)
T ss_pred             HhcChHHhhcc
Confidence            99999998543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-44  Score=382.76  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=215.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCC-eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~-~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ..+..++|.+.+.||+|+||.||+|.+..++ ..||||++.....    ........+.+|+.+++.++|||||+++++|
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI----IKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            3455678999999999999999999876654 7899998864321    1223345688999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +.+.+|+||||+.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|
T Consensus       101 ~-~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~---~~ikL~D  174 (340)
T PTZ00426        101 K-DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD---GFIKMTD  174 (340)
T ss_pred             E-eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC---CCEEEec
Confidence            7 66788999999999999999998889999999999999999999999988  9999999999999876   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.+...          ....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+.. 
T Consensus       175 FG~a~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~-  239 (340)
T PTZ00426        175 FGFAKVVDTR----------TYTLCGTPEYIAPEILL----NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK-  239 (340)
T ss_pred             CCCCeecCCC----------cceecCChhhcCHHHHh----CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH-
Confidence            9999876432          12347999999999984    44578899999999999999999999976554322211 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                        +.. ....  .+..+++++.+||++||+.||.+|+     ++.++++||||...
T Consensus       240 --i~~-~~~~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        240 --ILE-GIIY--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             --Hhc-CCCC--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence              111 1222  2356889999999999999999996     89999999999753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-44  Score=375.83  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||+++++|. +.+.+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcCC
Confidence            7999999999999999999999999863221    12233567888999999999999999999987 667889999999


Q ss_pred             CCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         375 DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       375 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                      ++++|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++......   
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~---  147 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDD---  147 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC---CcEEEEECcccccCccCC---
Confidence            99999999988889999999999999999999999988  9999999999999887   689999999998643221   


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK  534 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (627)
                          ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||.......... .  +. ..  .+..+
T Consensus       148 ----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~-~--~~-~~--~~~~~  213 (312)
T cd05585         148 ----DKTNTFCGTPEYLAPELLL----GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR-K--IL-QE--PLRFP  213 (312)
T ss_pred             ----CccccccCCcccCCHHHHc----CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH-H--HH-cC--CCCCC
Confidence                1223457999999999984    4568899999999999999999999997655433221 1  11 11  22234


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhccCCCCC
Q psy4988         535 PTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDYLQPP  571 (627)
Q Consensus       535 ~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp~~~~~  571 (627)
                      ..+++++.+||.+||..||.+||   ++.+++.||||...
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            56889999999999999999997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-44  Score=382.69  Aligned_cols=268  Identities=32%  Similarity=0.478  Sum_probs=219.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.++..++||||++++++|. +.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM----IKRNQIAHVRAERDILADADSPWIVKLYYSFQ-DEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH----hhccHHHHHHHHHHHHHhcCCCCccchhhhee-cCCe
Confidence            479999999999999999999999999999999864321    11123456788999999999999999999997 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~---~~~kL~Dfg~~~~  150 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD---GHIKLADFGLCKK  150 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC---CCEEeecCCCCcc
Confidence            8999999999999999988889999999999999999999999988  9999999999999987   6899999999987


Q ss_pred             cccCCCCC----------------------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy4988         447 MDEENYNP----------------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       447 ~~~~~~~~----------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG  504 (627)
                      +.......                      ...........||+.|+|||++.    ...++.++||||||||||+|++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR----GTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc----CCCCCCceeeEecchhhhhhccC
Confidence            65432000                      00001123457999999999984    44688999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHhccCCCCC
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-VISLARHDYLQPP  571 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-~~elL~hp~~~~~  571 (627)
                      +.||............  ........++....+++++.+||.+||. ||.+||+ +.+++.||||...
T Consensus       227 ~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         227 FPPFYSDTLQETYNKI--INWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             CCCCCCCCHHHHHHHH--hccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            9999876644333221  1111334455555689999999999997 9999999 9999999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-44  Score=385.67  Aligned_cols=269  Identities=26%  Similarity=0.386  Sum_probs=220.2

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..-.++|.+.++||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||++++++|. 
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-  113 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM----IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-  113 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence            3456789999999999999999999999999999999853221    11122345678999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|+|||||++++|..++.. ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~---~~~kL~DfG  187 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS---GHLKLADFG  187 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC---CCEEEEecc
Confidence            67788999999999999998865 46899999999999999999999988  9999999999999987   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+.....      ......+||+.|+|||++........++.++|||||||+||+|++|+.||........+..  .
T Consensus       188 ~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--i  259 (370)
T cd05596         188 TCMKMDANGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--I  259 (370)
T ss_pred             ceeeccCCCc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH--H
Confidence            9987643221      1123457999999999985433334588999999999999999999999977654433221  1


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~  570 (627)
                      ......+.++....+|.++++||.+||..+|.+  |+++.++++||||..
T Consensus       260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         260 MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            112234556666678999999999999999987  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-43  Score=374.43  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=207.9

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||++.+..++..||||++.....    ........+.+|+.+++.++||||++++++|. +.+.+||||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~E~   76 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVI----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCEEEEEEeC
Confidence            59999999999999999999999999864321    11223456788999999999999999999998 56788999999


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN  453 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~  453 (627)
                      +++++|..++.....+++..++.++.||+.||.|||+++  ||||||||+|||++.+   +.+||+|||+++......  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~--  149 (323)
T cd05595          77 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDG--  149 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC---CCEEecccHHhccccCCC--
Confidence            999999999988889999999999999999999999988  9999999999999887   689999999987543221  


Q ss_pred             CCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       454 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                           ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||...........    .......  .
T Consensus       150 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----~~~~~~~--~  214 (323)
T cd05595         150 -----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIR--F  214 (323)
T ss_pred             -----CccccccCCcCcCCccccc----CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCC--C
Confidence                 1122347999999999984    44588999999999999999999999976544332211    1111222  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      +..+++++.+||.+||..||.+|+     ++.++++|+||...
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            346899999999999999999998     99999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.9e-44  Score=376.25  Aligned_cols=268  Identities=26%  Similarity=0.383  Sum_probs=208.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC---
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA---  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---  364 (627)
                      +|.+.++||+|+||.||+|.+..++..||||++.....     .......+.+|+.+++.++||||+++++++....   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-----HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-----cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence            69999999999999999999999999999998753211     1112346789999999999999999999875322   


Q ss_pred             -CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 -NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                       ..+|+|||||. ++|..++.....+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+
T Consensus        76 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~---~~~kL~Dfg~  149 (338)
T cd07859          76 FKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD---CKLKICDFGL  149 (338)
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC---CcEEEccCcc
Confidence             34789999996 689899988888999999999999999999999988  9999999999999887   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++........    ........||+.|+|||++...  ...++.++|||||||++|+|++|+.||........+......
T Consensus       150 ~~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~  223 (338)
T cd07859         150 ARVAFNDTPT----AIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL  223 (338)
T ss_pred             ccccccccCc----cccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence            9865432211    0112345799999999987421  245888999999999999999999999765432211100000


Q ss_pred             --------------------hhh----hccc-cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         524 --------------------LKA----TEVQ-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       524 --------------------~~~----~~~~-~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                                          ...    .... ....+.+++++.+||.+||..||++|||+.+++.||||....
T Consensus       224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                                000    0000 011235778999999999999999999999999999997543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0658|consensus

Probab=100.00  E-value=5.6e-45  Score=371.33  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=216.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..=.|.-.+++|.|+||.||+|....+++.||||.+-.++..+           -+|+.||+.++|||||+|+-+|....
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----------nrEl~im~~l~HpNIV~L~~~f~~~~   90 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----------NRELQIMRKLDHPNIVRLLYFFSSST   90 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----------cHHHHHHHhcCCcCeeeEEEEEEecC
Confidence            3346888999999999999999999999999999864443322           26999999999999999999886433


Q ss_pred             C----eEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         365 N----SFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       365 ~----~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +    ..++||||++ .+|..+++.    +..++.-.++-+.+||++||.|||+.+  |+||||||.|||+|.+.  |.+
T Consensus        91 ~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~t--g~L  165 (364)
T KOG0658|consen   91 ESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDT--GVL  165 (364)
T ss_pred             CCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCC--CeE
Confidence            2    3568999999 578777764    578999999999999999999999988  99999999999999886  899


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||||||.|+.+.....+        ..+..|..|+|||.+.   ....|+.+.||||.|||+.||+-|++.|.+.+..+.
T Consensus       166 KicDFGSAK~L~~~epn--------iSYicSRyYRaPELif---ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ  234 (364)
T KOG0658|consen  166 KICDFGSAKVLVKGEPN--------ISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ  234 (364)
T ss_pred             EeccCCcceeeccCCCc--------eeEEEeccccCHHHHc---CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence            99999999998765422        3346799999999997   345799999999999999999999999998887777


Q ss_pred             HHHHHHHhhhh-------------ccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         517 ILEENTILKAT-------------EVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       517 ~~~~~~~~~~~-------------~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      +.....++...             +..++          ....+++++.+|+.++|.++|.+|.++.+++.||||..-..
T Consensus       235 L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  235 LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            66554443221             11111          12457899999999999999999999999999999986543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-44  Score=378.57  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=208.3

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||++.+..+++.||||++......    .......+.+|+.+++.++||||++++++|. +.+.+|+||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~Ey   76 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-TKDRLCFVMEY   76 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCEEEEEEeC
Confidence            599999999999999999999999998643221    1223457888999999999999999999987 66788999999


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN  453 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~  453 (627)
                      +++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++......  
T Consensus        77 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~---~~~kL~DfG~~~~~~~~~--  149 (328)
T cd05593          77 VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDA--  149 (328)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC---CcEEEecCcCCccCCCcc--
Confidence            999999999988889999999999999999999999988  9999999999999976   689999999987543221  


Q ss_pred             CCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       454 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                           ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||......... ..   ......  ..
T Consensus       150 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~---~~~~~~--~~  214 (328)
T cd05593         150 -----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL---ILMEDI--KF  214 (328)
T ss_pred             -----cccccccCCcCccChhhhc----CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HH---hccCCc--cC
Confidence                 1123357999999999984    445789999999999999999999999765443222 11   111222  23


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      +..++.++.+||++||..||.+|+     ++.++++||||...
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            356899999999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-43  Score=374.14  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=210.8

Q ss_pred             CeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      +|++++.||+|+||.||++.+.   .+++.||||++.....   .........+..|+.++..+ +||||++++++|. +
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL---VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-T   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH---hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-c
Confidence            4899999999999999998764   4789999999864321   11223345678899999999 5999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+++|||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~---~~~kl~DfG~  151 (332)
T cd05614          77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE---GHVVLTDFGL  151 (332)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC---CCEEEeeCcC
Confidence            6778899999999999999988889999999999999999999999988  9999999999999987   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.+.....      ......+||+.|+|||++.   ....++.++||||||||||+|++|..||...............
T Consensus       152 ~~~~~~~~~------~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  222 (332)
T cd05614         152 SKEFLSEEK------ERTYSFCGTIEYMAPEIIR---GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR  222 (332)
T ss_pred             CccccccCC------CccccccCCccccCHHHhc---CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence            986543211      1123457999999999984   2234788999999999999999999999643221111111111


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      .  .....+.+..++..+.+||.+||..||++||     ++.++++||||...
T Consensus       223 ~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         223 I--LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             H--hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            1  1122233456899999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.7e-44  Score=381.27  Aligned_cols=268  Identities=26%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      +.|.+++.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.++..++||||++++++|. +.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM----LEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-DKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCE
Confidence            468999999999999999999999999999999864221    12233567788999999999999999999998 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~---~~vkL~DfG~~~~  150 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK---GHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC---CCEEEeeccCCcc
Confidence            8999999999999999998889999999999999999999999988  9999999999999876   6999999999976


Q ss_pred             cccCCCCCC----------------------------CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         447 MDEENYNPD----------------------------HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       447 ~~~~~~~~~----------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      +........                            .........+||+.|+|||++.    ...++.++|||||||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~~~~~DiwSlGvil  226 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc----CCCCCCcceecccccee
Confidence            532210000                            0001122357999999999984    45688999999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhccCCCCC
Q psy4988         499 YQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDYLQPP  571 (627)
Q Consensus       499 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp~~~~~  571 (627)
                      |+|++|+.||........+...  ......+.++....++.++++||.+|+ .||.+|+   ++.+++.||||...
T Consensus       227 yel~tG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         227 YEMLIGYPPFCSETPQETYRKV--MNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             eecccCCCCCCCCCHHHHHHHH--HcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            9999999999776654433221  111223445555568999999999977 5999998   58999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-43  Score=373.89  Aligned_cols=251  Identities=31%  Similarity=0.479  Sum_probs=207.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||++.+..+++.||||++.....    .....+..+.+|+.++..++||||++++++|. +...+||||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-~~~~~~lv~E~   76 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVMEY   76 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-cCCEEEEEEeC
Confidence            59999999999999999999999999864321    11223456778999999999999999999987 66788999999


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      +++++|..++.....+++..++.++.||+.||.|||+ .+  ||||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~---~~~kL~Dfg~~~~~~~~~-  150 (325)
T cd05594          77 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDG-  150 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC---CCEEEecCCCCeecCCCC-
Confidence            9999999999888899999999999999999999997 67  9999999999999987   689999999987543221 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||......... ..   .......  
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~---i~~~~~~--  214 (325)
T cd05594         151 ------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-EL---ILMEEIR--  214 (325)
T ss_pred             ------cccccccCCcccCCHHHHc----cCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HH---HhcCCCC--
Confidence                  1123347999999999984    445889999999999999999999999765443222 11   1112222  


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      .+..+++++.+||.+||++||.+|+     ++.++++||||...
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            2346899999999999999999997     99999999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-43  Score=372.76  Aligned_cols=253  Identities=30%  Similarity=0.465  Sum_probs=207.5

Q ss_pred             EEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEE
Q psy4988         293 MLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      +.||+|+||.||++.+.   .+++.||||++......   ........+.+|+.+++.++||||++++++|. +.+.+|+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~l   77 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV---RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-TGGKLYL   77 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH---hhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-cCCeEEE
Confidence            57999999999999864   47899999998643211   11223346778999999999999999999998 5677889


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      ||||+++++|..++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ---GHVKLTDFGLCKESIH  152 (323)
T ss_pred             EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC---CCEEEeeCcCCeeccc
Confidence            9999999999999998889999999999999999999999988  9999999999999887   6899999999975432


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ..       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +.   ..
T Consensus       153 ~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~---~~---~~  215 (323)
T cd05584         153 EG-------TVTHTFCGTIEYMAPEILM----RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK---IL---KG  215 (323)
T ss_pred             CC-------CcccccCCCccccChhhcc----CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH---HH---cC
Confidence            21       1123457999999999984    44578899999999999999999999976654433221   11   11


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      .+..++.+++++.+||.+||+.||++||     ++.+++.||||...
T Consensus       216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            2333456889999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.4e-43  Score=369.67  Aligned_cols=255  Identities=30%  Similarity=0.436  Sum_probs=206.3

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHH---HhcCCCCceeEEeeEEeecCC
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI---HKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~i---l~~l~HpnIV~l~~~~~~~~~  365 (627)
                      |.+++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+   ++.++||||++++++|. +.+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII----ARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-cCC
Confidence            78899999999999999999999999999998643211    11223445555554   46778999999999997 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~---~~~kL~Dfg~~~  149 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE---GFVKIADFGLCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC---CcEEeCcccCCc
Confidence            88999999999999888754 57999999999999999999999988  9999999999999987   689999999987


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +..
T Consensus       150 ~~~~~~-------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~---i~~  215 (324)
T cd05589         150 EGMGFG-------DRTSTFCGTPEFLAPEVLT----ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS---IVN  215 (324)
T ss_pred             cCCCCC-------CcccccccCccccCHhHhc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh
Confidence            543211       1123457999999999984    45688999999999999999999999976654433221   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                       ....  .+..++.++.+||.+||..||.+||     ++.++++||||...
T Consensus       216 -~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         216 -DEVR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             -CCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence             1122  2346889999999999999999999     79999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0594|consensus

Probab=100.00  E-value=5.4e-44  Score=364.47  Aligned_cols=265  Identities=26%  Similarity=0.446  Sum_probs=216.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR-VVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~  365 (627)
                      ..|..+++||+|+||+||+|+++.+|+.||+|.+.+.....     -.-...++|+.+++.|+|+| ||.|++++..+..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-----G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-----GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-----CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            34666677999999999999999999999999998765421     11235789999999999999 9999999986553


Q ss_pred             -----eEEEEEeecCCCChHHHHHhcc----CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         366 -----SFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       366 -----~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                           .+++|+||++ .+|..++....    .++...++.++.||+.||+|||+++  |+||||||+||||++.   |.+
T Consensus        86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~---G~l  159 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS---GVL  159 (323)
T ss_pred             ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC---CcE
Confidence                 7899999998 68999987654    5888999999999999999999999  9999999999999996   799


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+|+.+.-+.       ...+..++|.||+|||++++   ...|+..+||||+|||++||++++..|.+..+...
T Consensus       160 KlaDFGlAra~~ip~-------~~yt~evvTlWYRaPEvLlG---s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q  229 (323)
T KOG0594|consen  160 KLADFGLARAFSIPM-------RTYTPEVVTLWYRAPEVLLG---STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ  229 (323)
T ss_pred             eeeccchHHHhcCCc-------ccccccEEEeeccCHHHhcC---CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence            999999999665322       22334489999999999873   34699999999999999999999999998888766


Q ss_pred             HHHHHHHhhhhc--------------cccCCC----------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         517 ILEENTILKATE--------------VQFANK----------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       517 ~~~~~~~~~~~~--------------~~~~~~----------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      +...-.++....              ..|+.+          +..+....+|+.+||+++|.+|.++..+|.||||....
T Consensus       230 l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  230 LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            655544433221              112222          22345899999999999999999999999999998653

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.9e-43  Score=371.70  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC-ceeEEeeEEeecCCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP-RVVKLYDVFEIDANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIV~l~~~~~~~~~~  366 (627)
                      +|.+++.||+|+||.||+|.+..+++.||||++......    .......+..|+.++..+.|+ +|+.++++|. +.+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII----QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCE
Confidence            488999999999999999999999999999998643221    122345678899999999765 5888888887 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~---~~~kL~Dfg~~~~  150 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE---GHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC---CCEEEeecCccee
Confidence            8999999999999999988889999999999999999999999988  9999999999999986   6899999999875


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      .....       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+...   .  
T Consensus       151 ~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i---~--  214 (324)
T cd05587         151 NIFGG-------KTTRTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI---M--  214 (324)
T ss_pred             cCCCC-------CceeeecCCccccChhhhc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---H--
Confidence            32111       1123457999999999984    445789999999999999999999999766544333211   1  


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~~~~  571 (627)
                       ......+..++.++.+||.+||..||.+|++.     .++++||||...
T Consensus       215 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         215 -EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence             11222345689999999999999999999986     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-43  Score=391.77  Aligned_cols=265  Identities=23%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC------CCCceeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL------DHPRVVKLY  357 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIV~l~  357 (627)
                      ...++|.++++||+|+||+||+|.+..+++.||||++......        ...+..|+.+++.+      +|++|+.++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY--------TRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh--------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            3468899999999999999999999999999999998542211        12233455555444      456799999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCc----
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNV----  432 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~----  432 (627)
                      ++|..+..++|||||++ +++|.+++...+.+++..++.|+.||+.||.|||+ .+  ||||||||+||||+.+..    
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccc
Confidence            99986777899999998 56788888888899999999999999999999997 47  999999999999986531    


Q ss_pred             ---------ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh
Q psy4988         433 ---------CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY  503 (627)
Q Consensus       433 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt  503 (627)
                               ...+||+|||++......          ....+||+.|+|||++.    +..|+.++||||||||||||++
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~----~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVL----GLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc----------cccccCCccccCcHHhh----cCCCCcHHHHHHHHHHHHHHHh
Confidence                     125999999988643221          23458999999999984    4468999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhhhcccc--------------------C----------------CCCCCCHHHHHHHHH
Q psy4988         504 GKKPFGHNQSQATILEENTILKATEVQF--------------------A----------------NKPTVSNEAKGFIRS  547 (627)
Q Consensus       504 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~----------------~~~~vs~el~~LI~~  547 (627)
                      |++||........+.............+                    +                ......+.+.|||.+
T Consensus       341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            9999976654433222111110000000                    0                000124567899999


Q ss_pred             hhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         548 CLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       548 cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ||.+||.+|||+.|+|+||||..-.+
T Consensus       421 mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        421 LLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hCCcChhhCCCHHHHhcCccccccCC
Confidence            99999999999999999999986443

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-43  Score=370.58  Aligned_cols=250  Identities=32%  Similarity=0.509  Sum_probs=203.5

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH-HHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||+||+|.+..+++.||||++.....    ........++.|.. +++.++|||||+++++|. +.+.+|+|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-~~~~~~lv~e   76 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TADKLYFVLD   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-eCCEEEEEEc
Confidence            59999999999999999999999999864321    11122344555655 467899999999999997 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+.+++|..++.....+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~-  150 (323)
T cd05575          77 YVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIEHS-  150 (323)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC---CcEEEeccCCCcccccCC-
Confidence            9999999999988889999999999999999999999988  9999999999999887   689999999987543211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||.......... .  +.   .....
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~--i~---~~~~~  214 (323)
T cd05575         151 ------KTTSTFCGTPEYLAPEVLR----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD-N--IL---NKPLR  214 (323)
T ss_pred             ------CccccccCChhhcChhhhc----CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH-H--HH---cCCCC
Confidence                  1223457999999999984    4458899999999999999999999997654433221 1  11   11223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYLQP  570 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~~~  570 (627)
                      ..+.++.++.+||++||+.||.+||++    .+++.||||..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            345689999999999999999999987    69999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-43  Score=381.87  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=203.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|.+++.||+|+||.||+|.+..+++.||||...             ...+.+|+.+++.++|||||+++++|. .
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------------~~~~~~E~~il~~l~HpnIv~~~~~~~-~  154 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------------RGGTATEAHILRAINHPSIIQLKGTFT-Y  154 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------------hhhhHHHHHHHHhCCCCCCCCEeEEEE-E
Confidence            34568999999999999999999999999999999642             124678999999999999999999997 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ....|+|||++. ++|..++.....+++.+++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+
T Consensus       155 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~---~~vkL~DFG~  228 (391)
T PHA03212        155 NKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP---GDVCLGDFGA  228 (391)
T ss_pred             CCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC---CCEEEEeCCc
Confidence            567889999996 688888888888999999999999999999999988  9999999999999876   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS-------QAT  516 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~-------~~~  516 (627)
                      |+.......      ......+||+.|+|||++.    ...++.++||||||||||+|++|..||.....       ...
T Consensus       229 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  298 (391)
T PHA03212        229 ACFPVDINA------NKYYGWAGTIATNAPELLA----RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ  298 (391)
T ss_pred             ccccccccc------cccccccCccCCCChhhhc----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHH
Confidence            975432211      1123357999999999984    44589999999999999999999988743211       001


Q ss_pred             HHHHHHHhhh-----------------------hcc------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         517 ILEENTILKA-----------------------TEV------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       517 ~~~~~~~~~~-----------------------~~~------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      +.........                       ...      .+.....++.++.+||.+||++||.+|||+.++|+|||
T Consensus       299 l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        299 IKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             HHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence            1000000000                       000      00001135678999999999999999999999999999


Q ss_pred             CCC
Q psy4988         568 LQP  570 (627)
Q Consensus       568 ~~~  570 (627)
                      |..
T Consensus       379 f~~  381 (391)
T PHA03212        379 FQD  381 (391)
T ss_pred             hcc
Confidence            975

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.1e-43  Score=369.92  Aligned_cols=251  Identities=31%  Similarity=0.474  Sum_probs=202.8

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH-HHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +||+|+||.||+|.+..+++.||||++......    .......+..|+. +++.++|||||+++++|. +.+.+|+|||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e   76 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-TAEKLYFVLD   76 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCEEEEEEc
Confidence            599999999999999999999999998643221    1122334555554 678899999999999987 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ||++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~-  150 (321)
T cd05603          77 YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPE-  150 (321)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC---CCEEEccCCCCccCCCCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   689999999987532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||...+..... ..  +. ..  ...
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~--i~-~~--~~~  214 (321)
T cd05603         151 ------ETTSTFCGTPEYLAPEVLR----KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-DN--IL-HK--PLQ  214 (321)
T ss_pred             ------CccccccCCcccCCHHHhc----CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-HH--Hh-cC--CCC
Confidence                  1223457999999999984    445888999999999999999999999765443222 11  11 11  223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~~~~  571 (627)
                      .++..+.++.+||.+||+.||.+||++    .++++|+||.+.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence            335678999999999999999999865    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-43  Score=388.80  Aligned_cols=260  Identities=22%  Similarity=0.361  Sum_probs=205.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      ...+|.+.++||+|+||.||+|.+..+++.||||.+.....           ...+|+.+++.++|||||+++++|... 
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----------~~~~Ei~il~~l~h~niv~l~~~~~~~~  132 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----------YKNRELLIMKNLNHINIIFLKDYYYTEC  132 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----------hHHHHHHHHHhcCCCCCcceeeeEeecc
Confidence            34689999999999999999999999999999998753221           234699999999999999999887432 


Q ss_pred             ------CCeEEEEEeecCCCChHHHHH----hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         364 ------ANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       364 ------~~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                            ...+++||||+++ +|..++.    ....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+.  
T Consensus       133 ~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~--  207 (440)
T PTZ00036        133 FKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT--  207 (440)
T ss_pred             cccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCC--
Confidence                  1246799999996 5655543    3467999999999999999999999988  99999999999998653  


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+|+.+....        ......||+.|+|||++.   ....++.++|||||||+||+|++|.+||.+...
T Consensus       208 ~~vkL~DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  276 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQ--------RSVSYICSRFYRAPELML---GATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS  276 (440)
T ss_pred             CceeeeccccchhccCCC--------CcccCCCCcCccCHHHhc---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            479999999998764321        122347899999999985   234588999999999999999999999987665


Q ss_pred             HHHHHHHHHHhhh-------------hccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         514 QATILEENTILKA-------------TEVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       514 ~~~~~~~~~~~~~-------------~~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...+.........             ....++          .+...++++.+||.+||.+||.+|||+.+++.||||..
T Consensus       277 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence            5444332221110             011111          12246789999999999999999999999999999975


Q ss_pred             C
Q psy4988         571 P  571 (627)
Q Consensus       571 ~  571 (627)
                      .
T Consensus       357 ~  357 (440)
T PTZ00036        357 L  357 (440)
T ss_pred             h
Confidence            3

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-43  Score=376.31  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.++++||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++|+|||+++++|. +.+.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~  146 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE------DTVRRQICREIEILRDVNHPNVVKCHDMFD-HNGE  146 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc------HHHHHHHHHHHHHHHhCCCCCcceeeeEec-cCCe
Confidence            456778889999999999999999999999999854321      223456889999999999999999999987 6677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++|||||.+++|...    ..+.+..+..|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++.
T Consensus       147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---~~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA---KNVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC---CCEEEccccccee
Confidence            8899999999988643    34678888999999999999999988  9999999999999987   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      +....       .......||+.|+|||++.... .+..++.++|||||||+||+|++|+.||..............+. 
T Consensus       218 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-  289 (353)
T PLN00034        218 LAQTM-------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-  289 (353)
T ss_pred             ccccc-------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-
Confidence            64321       1123347999999999874321 12345678999999999999999999997432221111111111 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                       ..........++.++.+||.+||..||++||++.++++||||.....
T Consensus       290 -~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        290 -MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             -ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence             11122234568899999999999999999999999999999987543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4e-43  Score=372.41  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=212.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|++.++||.|+||.||++.+..++..||+|++.....      ......+.+|+++++.++|||||+++++|. +
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~   74 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGAFY-S   74 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHHCCCCcccceeEEEE-E
Confidence            456889999999999999999999999999999998865421      122346889999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||+. +  |+|+||||+|||++.+   +.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~---~~~kL~Dfg  149 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR---GEIKLCDFG  149 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC---CCEEEeeCC
Confidence            678889999999999999998888899999999999999999999974 5  9999999999999876   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN-  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~-  521 (627)
                      ++..+....         .....||+.|+|||++.    +..++.++|||||||++|+|++|+.||............. 
T Consensus       150 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~  216 (333)
T cd06650         150 VSGQLIDSM---------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC  216 (333)
T ss_pred             cchhhhhhc---------cccCCCCccccCHHHhc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC
Confidence            997654321         22347899999999984    4458889999999999999999999996543322110000 


Q ss_pred             ----------------------------------------HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q psy4988         522 ----------------------------------------TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS  561 (627)
Q Consensus       522 ----------------------------------------~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~e  561 (627)
                                                              .+.......+ ....++.++.+||.+||++||++|||+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~e  295 (333)
T cd06650         217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQ  295 (333)
T ss_pred             cccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccC-CCCCcCHHHHHHHHHhccCCcccCcCHHH
Confidence                                                    0000000000 01236789999999999999999999999


Q ss_pred             HHhccCCCCC
Q psy4988         562 LARHDYLQPP  571 (627)
Q Consensus       562 lL~hp~~~~~  571 (627)
                      ++.||||+..
T Consensus       296 ll~h~~~~~~  305 (333)
T cd06650         296 LMVHAFIKRS  305 (333)
T ss_pred             HhhCHHHhcC
Confidence            9999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-43  Score=373.10  Aligned_cols=251  Identities=28%  Similarity=0.432  Sum_probs=206.5

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +||+|+||.||+|.+..+++.||||++.....    ........+..|+.++..+ +||||++++++|. +.+.+|+|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-~~~~~~iv~E   76 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-TPDRLFFVME   76 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH----hhccHHHHHHHHHHHHHhccCCCchhceeeEEE-cCCEEEEEEc
Confidence            59999999999999999999999999864321    1122345677888888776 6999999999997 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 y~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~-  150 (320)
T cd05590          77 FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNG-  150 (320)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   689999999987543221 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +. ....  .
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---i~-~~~~--~  214 (320)
T cd05590         151 ------KTTSTFCGTPDYIAPEILQ----EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA---IL-NDEV--V  214 (320)
T ss_pred             ------CcccccccCccccCHHHHc----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---Hh-cCCC--C
Confidence                  1123457999999999984    45688899999999999999999999976654433211   11 1122  2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV------ISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~------~elL~hp~~~~~  571 (627)
                      .+..++.++.+||++||+.||.+||++      .+++.||||...
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            234588999999999999999999998      999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-43  Score=369.94  Aligned_cols=267  Identities=25%  Similarity=0.379  Sum_probs=211.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||.||++.+..+++.||||++.....    ........+.+|+.++..++|+||++++++|. +.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM----LKRAETACFREERDVLVNGDRRWITNLHYAFQ-DENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-cCCe
Confidence            479999999999999999999999999999999863221    22223456778999999999999999999998 6678


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+++++|..++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~---~~~kl~Dfg~~~  150 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN---GHIRLADFGSCL  150 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC---CCEEEEECCcee
Confidence            8999999999999999976 468999999999999999999999988  9999999999999876   689999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+.....      ......+||+.|+|||++.... ....++.++|||||||+||+|++|+.||........+...  ..
T Consensus       151 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i--~~  222 (331)
T cd05597         151 RLLADGT------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--MN  222 (331)
T ss_pred             ecCCCCC------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH--Hc
Confidence            6543221      1112246999999999985321 1235788999999999999999999999765544332211  11


Q ss_pred             hhhccccC-CCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFA-NKPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~-~~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                      ......++ ....++.++++||++||+.++..  |+++.+++.||||...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         223 HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            11112222 22458999999999999765443  8899999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.2e-43  Score=376.65  Aligned_cols=271  Identities=27%  Similarity=0.411  Sum_probs=218.3

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .....++|.+.+.||+|+||.||+|.+..+++.||+|++.....    ........+.+|+.+++.++||||++++++|.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34556899999999999999999999999999999999854221    11222345778999999999999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+|||||++++|..++.. ..+++..++.++.||+.||.|||+++  ||||||||+|||++.+   +.+||+||
T Consensus       114 -~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~---~~ikL~Df  186 (371)
T cd05622         114 -DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS---GHLKLADF  186 (371)
T ss_pred             -cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC---CCEEEEeC
Confidence             66788999999999999998865 46899999999999999999999988  9999999999999876   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+.....      ......+||+.|+|||++........++.++|||||||+||+|++|..||........+..  
T Consensus       187 G~a~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--  258 (371)
T cd05622         187 GTCMKMNKEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--  258 (371)
T ss_pred             CceeEcCcCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence            99987643221      1123457999999999985332234588999999999999999999999976655433221  


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                      .........++....++.++++||.+||..++.+  |+++.++++|+||...
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            1112223456666789999999999999844433  7899999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-43  Score=362.78  Aligned_cols=259  Identities=29%  Similarity=0.519  Sum_probs=201.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~  362 (627)
                      ++|.+++.||+|+||.||+|.+.. +++.||||++........     ....+.+|+.+++.+   +||||++++++|..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-----MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-----chHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            479999999999999999999865 578999998865432111     112345666666554   79999999998852


Q ss_pred             ----cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         363 ----DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       363 ----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                          ....+++||||++ ++|..++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~---~~~  149 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS---GQI  149 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC---CCE
Confidence                2356889999998 5888888653  46899999999999999999999988  9999999999999887   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+++.....        .......||+.|+|||++.    ...++.++|||||||+||+|++|++||........
T Consensus       150 kl~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~  217 (290)
T cd07862         150 KLADFGLARIYSFQ--------MALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  217 (290)
T ss_pred             EEccccceEeccCC--------cccccccccccccChHHHh----CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence            99999999865432        1223457899999999984    44588899999999999999999999987665544


Q ss_pred             HHHHHHHhhhh-ccccC--------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         517 ILEENTILKAT-EVQFA--------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       517 ~~~~~~~~~~~-~~~~~--------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      +.......... ...++                    ..+.++..+.+||.+||++||++|||+.++|+||||
T Consensus       218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            43322111000 00000                    113578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-43  Score=367.18  Aligned_cols=264  Identities=28%  Similarity=0.496  Sum_probs=209.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.++||+|+||.||+|.+..+++.||||++.......      ....+.+|+.+++.++||||+++++++. +.+
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~   77 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG------APCTAIREVSLLKDLKHANIVTLHDIVH-TDK   77 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC------cchhHHHHHHHHHhCCCCCcceEEEEEe-eCC
Confidence            367999999999999999999999999999999986543211      1234678999999999999999999997 566


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~---~~~kl~Dfg~~  151 (309)
T cd07872          78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER---GELKLADFGLA  151 (309)
T ss_pred             eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEECccccc
Confidence            78899999986 777776544 46899999999999999999999988  9999999999999986   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +......       .......+|+.|+|||++..   ...++.++|||||||++|+|++|+.||........+.......
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  221 (309)
T cd07872         152 RAKSVPT-------KTYSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL  221 (309)
T ss_pred             eecCCCc-------cccccccccccccCCHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            7653321       11123468999999998852   3457889999999999999999999997665443322221111


Q ss_pred             hh---------------hcccc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KA---------------TEVQF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~---------------~~~~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ..               ....+         ...+.++.++.+||.+||.+||.+|||+.+++.||||....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            00               00111         11235789999999999999999999999999999998543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-43  Score=373.31  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +||+|+||.||+|.+..+++.||||++.....    .....+..+.+|+.++..+ +||||++++++|. +.+.+|||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv~e   76 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELV----NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFVIE   76 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEEEe
Confidence            59999999999999999999999999864321    1122345677899999888 7999999999997 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ||++++|..++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~~-  150 (329)
T cd05588          77 FVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPG-  150 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC---CCEEECcCccccccccCC-
Confidence            9999999999988889999999999999999999999988  9999999999999886   689999999997532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHhh
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS-------QATILEENTILK  525 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~-------~~~~~~~~~~~~  525 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||.....       .......  ...
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~  218 (329)
T cd05588         151 ------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--VIL  218 (329)
T ss_pred             ------CccccccCCccccCHHHHc----CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--HHH
Confidence                  1233458999999999984    45688999999999999999999999953211       1111111  111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC------HHHHHhccCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID------VISLARHDYLQP  570 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt------~~elL~hp~~~~  570 (627)
                      ...  ...+..++.++.+||++||.+||.+|++      +.++++||||..
T Consensus       219 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         219 EKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            112  2233468899999999999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0604|consensus

Probab=100.00  E-value=6.2e-45  Score=360.29  Aligned_cols=261  Identities=29%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             cCCCeeEE-EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         285 LSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~-~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +.++|.|- ++||-|--|.|-.|+++.+++.+|+|++.-.            .++.+|++++-.. .|||||.++|+|+.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------------~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------------PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            45566664 6799999999999999999999999987422            2467899987665 69999999999863


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                         ....+.+|||.|+||.|+..+.+.+  .|+|.++..|+.||+.||.|||+++  |.||||||+|+|+......-.+|
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceE
Confidence               2345779999999999999998876  4999999999999999999999999  99999999999998765556899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT-  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~-  516 (627)
                      |+|||+|+......        ...+.|-||+|.|||++    ....|+..+|+||+|||+|-||||.+||........ 
T Consensus       205 LtDfGFAK~t~~~~--------~L~TPc~TPyYvaPevl----g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais  272 (400)
T KOG0604|consen  205 LTDFGFAKETQEPG--------DLMTPCFTPYYVAPEVL----GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_pred             ecccccccccCCCc--------cccCCcccccccCHHHh----CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence            99999998765322        23455899999999998    466799999999999999999999999954433221 


Q ss_pred             -HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         517 -ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       517 -~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       -.+.+.......+.-+.|..+|.+++|+|+++|..+|.+|.|+.++++|||+...
T Consensus       273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence             1222222333344445678999999999999999999999999999999999754

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.3e-43  Score=368.97  Aligned_cols=256  Identities=25%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~  366 (627)
                      +|.+++.||+|+||.||+|.+..+++.||||++.....    ........+..|..++..+ +|++|++++++|. +.+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV----IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-TMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-cCCE
Confidence            48899999999999999999999999999999864322    1122344567788888777 5899999999987 5678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~---~~~kL~DfG~~~~  150 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE---GHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC---CcEEEccCCCcee
Confidence            8999999999999999988889999999999999999999999988  9999999999999987   6899999999975


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      .....       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +. .
T Consensus       151 ~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~---i~-~  215 (323)
T cd05616         151 NMWDG-------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---IM-E  215 (323)
T ss_pred             cCCCC-------CccccCCCChhhcCHHHhc----CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH---HH-h
Confidence            43221       1123457999999999984    44589999999999999999999999976654433221   11 1


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~~~  570 (627)
                      ...  ..+..++.++.+||.+||+.||.+|+++     .+++.||||..
T Consensus       216 ~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         216 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             CCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            122  2334689999999999999999999984     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3e-43  Score=371.09  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=206.7

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +||+|+||.||+|.+..+++.||||++......    .......+..|+.++..+ +||||++++++|. +.+.+|+|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-~~~~~~lv~E   76 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-TKDRLFFVME   76 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh----hhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCeEEEEEe
Confidence            599999999999999999999999998643221    122345677888888865 7999999999998 6677899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~---~~~kL~Dfg~~~~~~~~~-  150 (321)
T cd05591          77 YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE---GHCKLADFGMCKEGILNG-  150 (321)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC---CCEEEeecccceecccCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   689999999997643221 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+...   . ....  .
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i---~-~~~~--~  214 (321)
T cd05591         151 ------VTTTTFCGTPDYIAPEILQ----ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI---L-HDDV--L  214 (321)
T ss_pred             ------ccccccccCccccCHHHHc----CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH---H-cCCC--C
Confidence                  1123457999999999984    456889999999999999999999999876654433211   1 1122  2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCC-------CHHHHHhccCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRI-------DVISLARHDYLQP  570 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rp-------t~~elL~hp~~~~  570 (627)
                      .+..++.++.+||.+||+.||.+||       ++.++++||||..
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            2345789999999999999999999       9999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=400.91  Aligned_cols=276  Identities=25%  Similarity=0.406  Sum_probs=220.7

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .+...+.+.++|.++++||+|+||+||+|.+..++..||+|++......     ......+.+|+.+++.|+|||||+++
T Consensus         4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-----e~~~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266          4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-----EREKSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-----HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            4556778889999999999999999999999999999999998654321     12245688999999999999999999


Q ss_pred             eEEee-cCCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCC-----CCEEeccccCCcEEe
Q psy4988         358 DVFEI-DANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIK-----PPVIHYDLKPGNILL  427 (627)
Q Consensus       358 ~~~~~-~~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~-----~~IvHrDLKP~NILl  427 (627)
                      ++|.. ....+|||||||++++|..+|..    ...+++..++.|+.||+.||.|||+.+     .+||||||||+||||
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            98853 34568999999999999998865    257999999999999999999999854     359999999999999


Q ss_pred             cCCC--------------cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHH
Q psy4988         428 TEGN--------------VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWS  493 (627)
Q Consensus       428 ~~~~--------------~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwS  493 (627)
                      +.+.              ..+.+||+|||++..+....        .....+||+.|+|||++...  ...++.++||||
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge--~~~~s~KSDVWS  228 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHE--TKSYDDKSDMWA  228 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhcc--CCCCCchhHHHH
Confidence            7531              12358999999998764322        12345799999999998521  235788999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         494 VGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       494 lGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ||||||+|++|..||........++...  ...  ..++ ...++.++.+||..||.++|.+||++.++|.|+||....+
T Consensus       229 LG~ILYELLTGk~PF~~~~~~~qli~~l--k~~--p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        229 LGCIIYELCSGKTPFHKANNFSQLISEL--KRG--PDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHHHHCCCCCCcCCcHHHHHHHH--hcC--CCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            9999999999999997655444433221  111  1111 2357899999999999999999999999999999975433

>KOG0201|consensus

Probab=100.00  E-value=3.3e-45  Score=379.13  Aligned_cols=258  Identities=28%  Similarity=0.477  Sum_probs=220.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ...|..+++||+|+||.||+|.+..+++.||||++.+...      +..+..+.+|+.+|..++++||.++|+.|. .+.
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~------~deIediqqei~~Ls~~~~~~it~yygsyl-~g~   84 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA------EDEIEDIQQEISVLSQCDSPNITEYYGSYL-KGT   84 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhc------chhhHHHHHHHHHHHhcCcchHHhhhhhee-ecc
Confidence            3457778999999999999999999999999999976543      233567889999999999999999999987 677


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .++++||||.||++.+.++....+.|..+..|+.+++.||.|||..+  .+|||||+.|||+..+   |.|||+|||.+.
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~---g~vkl~DfgVa~  159 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES---GDVKLADFGVAG  159 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc---CcEEEEecceee
Confidence            88999999999999999999888899999999999999999999988  9999999999999987   799999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....       ...+.+|||.|||||++.    ...|+.++||||||++.|||++|.+||....+...+.   .+.+
T Consensus       160 ql~~~~~-------rr~tfvGTPfwMAPEVI~----~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---lIpk  225 (467)
T KOG0201|consen  160 QLTNTVK-------RRKTFVGTPFWMAPEVIK----QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---LIPK  225 (467)
T ss_pred             eeechhh-------ccccccccccccchhhhc----cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---eccC
Confidence            8765432       235679999999999994    5579999999999999999999999997665522211   1222


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....+..  ..|+.+++||..||.+||+.||++.++|+|+|++..
T Consensus       226 ~~PP~L~~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  226 SAPPRLDG--DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CCCCcccc--ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            22222222  688999999999999999999999999999998753

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-42  Score=364.71  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA-LDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||.||+|.+..+++.||||++......    .......+..|..++.. ++||||++++++|. +.+.+|+|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E   76 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-TKEHLFFVME   76 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hcchHHHHHHHHHHHHhccCCCCccCeeEEEE-eCCEEEEEEC
Confidence            599999999999999999999999998643211    11123456678888775 48999999999998 5678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ||.+++|..++.....+++..+..++.||+.||+|||+++  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05620          77 FLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGD-  150 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC---CCEEeCccCCCeecccCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   589999999987532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+ +..   ......+ 
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-~~~---~~~~~~~-  215 (316)
T cd05620         151 ------NRASTFCGTPDYIAPEILQ----GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-ESI---RVDTPHY-  215 (316)
T ss_pred             ------CceeccCCCcCccCHHHHc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHH---HhCCCCC-
Confidence                  1223457999999999984    446889999999999999999999999765543322 211   1112222 


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH-HHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV-ISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~-~elL~hp~~~~~  571 (627)
                       +..++.++.+||.+||+.||.+||++ .+++.||||...
T Consensus       216 -~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         216 -PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence             23588999999999999999999998 578899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.2e-43  Score=360.79  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=203.6

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||+|+||+||++.+..+++.||||++.....    ........+..|+.+++.++||||++++++|. ....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL----KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH----hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-CCCeEEEEEeCC
Confidence            7999999999999999999999999754321    12223456778999999999999999999987 567788999999


Q ss_pred             CCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         375 DGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       375 ~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      ++++|..++..    ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..+...
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND---GNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEeeCccceecCCC
Confidence            99999887743    357999999999999999999999988  9999999999999876   68999999999876433


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ  530 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  530 (627)
                      ..       ......||+.|+|||++.    ...++.++|||||||+||+|++|+.||...................  .
T Consensus       151 ~~-------~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~  217 (280)
T cd05608         151 QS-------KTKGYAGTPGFMAPELLQ----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--S  217 (280)
T ss_pred             Cc-------cccccCCCcCccCHHHhc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--C
Confidence            21       123347899999999984    4458889999999999999999999997543321111111111111  1


Q ss_pred             cCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         531 FANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       531 ~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ...+..++.++.+||.+||+.||++||     ++.++++||||..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            223346889999999999999999999     8899999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-43  Score=371.62  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=203.8

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||.||+|.+..+++.||||++.....    ........+.+|+.++..+ +|||||+++++|. +.+.+|+|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~E   76 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELV----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVIE   76 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh----cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-eCCEEEEEEe
Confidence            59999999999999999999999999864321    1122345677888888766 8999999999997 5678889999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..++.|+.||+.||.|||+++  ||||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~---~~~kL~DfG~~~~~~~~~-  150 (329)
T cd05618          77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPG-  150 (329)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC---CCEEEeeCCccccccCCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   689999999997543211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHhh
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS-------QATILEENTILK  525 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~-------~~~~~~~~~~~~  525 (627)
                            ......+||+.|+|||++.    +..++.++|||||||+||+|++|+.||.....       ....+..  ...
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--~i~  218 (329)
T cd05618         151 ------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--VIL  218 (329)
T ss_pred             ------CccccccCCccccCHHHHc----CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH--HHh
Confidence                  1123457999999999984    45688899999999999999999999952111       0111111  111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC------HHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID------VISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt------~~elL~hp~~~~~  571 (627)
                      ..  ....+..++.++.+||.+||..||.+||+      +.++++||||...
T Consensus       219 ~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         219 EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            11  22234568899999999999999999998      5899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.9e-42  Score=363.07  Aligned_cols=251  Identities=27%  Similarity=0.410  Sum_probs=203.7

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA-LDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +||+|+||.||+|.+..+++.||||++......    .......+..|..++.. ++||||+++++++. ....+|+|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e   76 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-TKEHLFFVME   76 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhhHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEc
Confidence            599999999999999999999999998643221    11223345567777764 48999999999997 5678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          77 YLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD---GHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC---CCEEEccCcCCeECCCCC-
Confidence            9999999999988889999999999999999999999988  9999999999999887   589999999997643221 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    +..++.++|||||||+||+|++|..||........+...   .   .....
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i---~---~~~~~  214 (316)
T cd05592         151 ------GKASTFCGTPDYIAPEILK----GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI---L---NDRPH  214 (316)
T ss_pred             ------CccccccCCccccCHHHHc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---cCCCC
Confidence                  1223457999999999984    445889999999999999999999999776554332211   1   11122


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHH-HHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDVI-SLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~~-elL~hp~~~~~  571 (627)
                      .+..++.++.+||.+||..||.+||++. +++.||||...
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            2346889999999999999999999875 78899999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.7e-43  Score=366.93  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=206.2

Q ss_pred             EEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEE
Q psy4988         293 MLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      +.||+|+||.||++.+.   .+++.||||++.....     .......+.+|+.++++++||||++++++|. +.+.+|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-----KVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-TEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCEEEE
Confidence            56999999999999764   5789999999864321     1122345678999999999999999999998 5678889


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      ||||+.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++....
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSKESID  150 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC---CcEEEeeccCCcccCC
Confidence            9999999999999988888999999999999999999999988  9999999999999887   5899999999986543


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ..       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +.   ..
T Consensus       151 ~~-------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---i~---~~  213 (318)
T cd05582         151 HE-------KKAYSFCGTVEYMAPEVVN----RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---IL---KA  213 (318)
T ss_pred             CC-------CceecccCChhhcCHHHHc----CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH---HH---cC
Confidence            21       1123457999999999984    44578899999999999999999999976654433221   11   11


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      .+..+..+++++.+||++||+.||.+||+     +.+++.||||...
T Consensus       214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            22233468899999999999999999999     8889999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0589|consensus

Probab=100.00  E-value=1.3e-43  Score=375.82  Aligned_cols=259  Identities=30%  Similarity=0.476  Sum_probs=227.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .+.|..+++||+|+||.+++++++.+...|++|.+.+.......     ...+++|+.+++++.|||||.+++.|..++.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-----r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-----RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-----hHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            36789999999999999999999999999999999877653322     2367899999999999999999999996766


Q ss_pred             eEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+||||+||+||+|...+++.  ..|+++.+..++.||+.||.|||+..  |+|||||+.|||+..+   +.|||.|||+
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~---~~VkLgDfGl  152 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD---KKVKLGDFGL  152 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc---Cceeecchhh
Confidence            699999999999999998765  47999999999999999999999888  9999999999999998   4789999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |+.+..+.       .+..+.+||+.|+.||++    .+.+|+.|+|||||||++|||++-+++|...+....+.+....
T Consensus       153 aK~l~~~~-------~~a~tvvGTp~YmcPEil----~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~  221 (426)
T KOG0589|consen  153 AKILNPED-------SLASTVVGTPYYMCPEIL----SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG  221 (426)
T ss_pred             hhhcCCch-------hhhheecCCCcccCHHHh----CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence            99987653       356778999999999998    5678999999999999999999999999888776666544322


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                           ...|.+...+.+++.||..||..+|+.||++.++|.+|.+.+
T Consensus       222 -----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  222 -----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             -----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                 245667789999999999999999999999999999988764

>KOG0612|consensus

Probab=100.00  E-value=2.2e-44  Score=405.43  Aligned_cols=269  Identities=27%  Similarity=0.412  Sum_probs=229.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .-.++|.|+++||+|+||+|.+++++.+++.||+|++.+-...    +.....-|..|-.||..-+.++||.|+.+|+ |
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl----Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-D  146 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML----KRAETACFREERDIMVFGNSEWIVQLHYAFQ-D  146 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh----hchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-C
Confidence            4568899999999999999999999999999999997542211    1122345778999999999999999999998 8


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++|+||||++||+|..++....++|++.++.|+..|+.||.-||++|  +|||||||+|||||..   |+|||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~---GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS---GHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc---CcEeeccchh
Confidence            8899999999999999999999889999999999999999999999999  9999999999999987   8999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP-PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +-.+..+.      .-.....+|||.|++||++..-..+ ..|+..||+||+||++||||+|..||..+....++-++  
T Consensus       222 Clkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI--  293 (1317)
T KOG0612|consen  222 CLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI--  293 (1317)
T ss_pred             HHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH--
Confidence            98877543      2335566999999999999654334 78999999999999999999999999776655555332  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID---VISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt---~~elL~hp~~~~~  571 (627)
                      +.....+.||....||.++++||+++|+ +|+.|..   ++++-.||||...
T Consensus       294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            2223467788778899999999999885 6778888   9999999999753

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-42  Score=367.26  Aligned_cols=267  Identities=26%  Similarity=0.399  Sum_probs=211.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||+||++.+..+++.||||++.....    ........+.+|+.++..++|+||++++++|. +.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM----LKRAETACFREERNVLVNGDCQWITTLHYAFQ-DENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCE
Confidence            579999999999999999999999999999999853221    11222345778999999999999999999997 6678


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +||||||++|++|..++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||+++
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~---~~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN---GHIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC---CCEEEEecccee
Confidence            8999999999999999976 468999999999999999999999988  9999999999999876   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+.....      ......+||+.|+|||++..... ...++.++|||||||+||+|++|+.||........+...  ..
T Consensus       151 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i--~~  222 (331)
T cd05624         151 KMNQDGT------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--MN  222 (331)
T ss_pred             eccCCCc------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH--Hc
Confidence            7653321      11223479999999999853211 135788999999999999999999999766544333211  11


Q ss_pred             hhhccccCC-CCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFAN-KPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~-~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                      ......++. ...++.++++||.+||+.++.+  |+++.++++|+||...
T Consensus       223 ~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         223 HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            111122222 2457899999999999876654  5799999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=358.43  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=210.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|++.++||+|+||.||++.+..+++.||||++.....    ........+.+|+.+++.++||||++++++|. +.+.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh----hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-CCCeE
Confidence            48899999999999999999999999999999864321    11222345778999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+.+++|..++...  ..+++..+..++.||+.||.|||+.+  ||||||||+|||++++   +.++|+|||++.
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~~~~l~Dfg~~~  150 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY---GHIRISDLGLAV  150 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC---CCEEEeeCCCce
Confidence            9999999999999887643  46999999999999999999999988  9999999999999876   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....        .....|++.|+|||++.    ...++.++|||||||+||+|++|..||.................
T Consensus       151 ~~~~~~~--------~~~~~~~~~y~aPE~~~----~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~  218 (285)
T cd05605         151 EIPEGET--------IRGRVGTVGYMAPEVVK----NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK  218 (285)
T ss_pred             ecCCCCc--------cccccCCCCccCcHHhc----CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh
Confidence            7643211        12347899999999984    44588899999999999999999999976544322211111111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                        ......+..++..+.+||.+||..||.+||     ++.+++.||||...
T Consensus       219 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         219 --EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             --hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence              111222346889999999999999999999     89999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-42  Score=371.20  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|++.+.||+|+||.||++.+..++..||||++.....     .......+.+|+.+++.++||||++++++|...
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   92 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-----NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ   92 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-----chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            356899999999999999999999999999999999854321     112235677899999999999999999998643


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+||||++++ |...+.  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~~~-l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~---~~~kl  164 (359)
T cd07876          93 KSLEEFQDVYLVMELMDAN-LCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKI  164 (359)
T ss_pred             CCccccceeEEEEeCCCcC-HHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC---CCEEE
Confidence            3     3478999999864 555443  35899999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++......        ......||+.|+|||++.    +..++.++|||||||+||+|++|+.||...+....+.
T Consensus       165 ~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~  232 (359)
T cd07876         165 LDFGLARTACTNF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN  232 (359)
T ss_pred             ecCCCccccccCc--------cCCCCcccCCCCCchhcc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999997653321        123347899999999984    4568899999999999999999999997654332221


Q ss_pred             HHHHHhh------------------hhccc---------cC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         519 EENTILK------------------ATEVQ---------FA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       519 ~~~~~~~------------------~~~~~---------~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      .......                  .....         ++         .....++++.+||.+||++||++|||+.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  312 (359)
T cd07876         233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA  312 (359)
T ss_pred             HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence            1100000                  00000         00         011246789999999999999999999999


Q ss_pred             HhccCCCCC
Q psy4988         563 ARHDYLQPP  571 (627)
Q Consensus       563 L~hp~~~~~  571 (627)
                      |.||||...
T Consensus       313 l~hp~~~~~  321 (359)
T cd07876         313 LRHPYITVW  321 (359)
T ss_pred             hcCchhhhh
Confidence            999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-42  Score=365.05  Aligned_cols=267  Identities=25%  Similarity=0.388  Sum_probs=211.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.++||+|+||+||++.+..+++.||||++.....    ........+.+|+.++..++|+||++++++|. +.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM----LKRAETACFREERDVLVNGDNQWITTLHYAFQ-DENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCE
Confidence            479999999999999999999999999999999853221    12222345778999999999999999999997 6678


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~---~~~kL~DfG~a~  150 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN---GHIRLADFGSCL  150 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC---CCEEEeecchhe
Confidence            8999999999999999976 468999999999999999999999988  9999999999999876   689999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+.....      ......+||+.|+|||++.... ....++.++|||||||+||+|++|+.||........+...  ..
T Consensus       151 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i--~~  222 (332)
T cd05623         151 KLMEDGT------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--MN  222 (332)
T ss_pred             ecccCCc------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH--hC
Confidence            6543221      1122347999999999985321 1235788999999999999999999999766544333221  11


Q ss_pred             hhhccccCC-CCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFAN-KPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~-~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                      ......++. ...++.++++||++||+.++..  |+++.++++||||...
T Consensus       223 ~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            111122222 2468999999999999765544  7899999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-42  Score=367.28  Aligned_cols=250  Identities=30%  Similarity=0.477  Sum_probs=202.9

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH-HHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||+||+|.+..+++.||||++......    .......+..|.. +++.++||||++++++|. +.+.+|+|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-~~~~~~lv~e   76 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL----NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TTEKLYFVLD   76 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-cCCEEEEEEc
Confidence            599999999999999999999999998643221    1122334555655 467899999999999997 5677889999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~---~~~kL~DfG~~~~~~~~~-  150 (325)
T cd05604          77 FVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQS-  150 (325)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC---CCEEEeecCCcccCCCCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   689999999987532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   +..   ....
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~---~~~---~~~~  214 (325)
T cd05604         151 ------DTTTTFCGTPEYLAPEVIR----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN---ILH---KPLV  214 (325)
T ss_pred             ------CCcccccCChhhCCHHHHc----CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH---HHc---CCcc
Confidence                  1123457999999999984    44588899999999999999999999976554332211   111   1222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYLQP  570 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~~~  570 (627)
                      ..+.++.++.+||++||+.||.+||++    .+++.||||..
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            345688999999999999999999976    68999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-42  Score=363.06  Aligned_cols=251  Identities=29%  Similarity=0.422  Sum_probs=206.5

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||.||+|.+..++..||||++.....    ........+.+|+.++..+ +||||++++++|. +.+.+|+|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv~e   76 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVI----LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFVME   76 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEc
Confidence            59999999999999999999999999864321    1122344567888898877 7999999999987 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~-  150 (318)
T cd05570          77 YVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGG-  150 (318)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC---CcEEecccCCCeecCcCC-
Confidence            9999999999988889999999999999999999999988  9999999999999987   589999999987532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    +..++.++|||||||+||+|++|+.||...........   + .....  .
T Consensus       151 ------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~---i-~~~~~--~  214 (318)
T cd05570         151 ------VTTSTFCGTPDYIAPEILS----YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS---I-LEDEV--R  214 (318)
T ss_pred             ------CcccceecCccccCHHHhc----CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH---H-HcCCC--C
Confidence                  1123347999999999984    45688999999999999999999999976554332211   1 11122  2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~~~~  571 (627)
                      .+..++.++.+||++||..||.+||++     .+++.||||...
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            234688999999999999999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=368.05  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEeecCCeEEEEE
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      ||+|+||+||+|.+..+++.||||++.....    .....+..+..|..++..+   +||||+.++++|. +.+.+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI----VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH----hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-cCCeEEEEE
Confidence            7999999999999999999999999864221    1122344566677777655   6999999999998 667889999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      ||+.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||+++......
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT---GHIALCDFGLSKANLTDN  150 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC---CCEEEecCCcCcCCCCCC
Confidence            99999999999988889999999999999999999999988  9999999999999987   689999999997543221


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                             ......+||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+. .   .......+
T Consensus       151 -------~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~-~---i~~~~~~~  216 (330)
T cd05586         151 -------KTTNTFCGTTEYLAPEVLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR-N---IAFGKVRF  216 (330)
T ss_pred             -------CCccCccCCccccCHHHHc---CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH-H---HHcCCCCC
Confidence                   1123457999999999985   23347889999999999999999999997655433221 1   11122233


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCC----CHHHHHhccCCCC
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRI----DVISLARHDYLQP  570 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rp----t~~elL~hp~~~~  570 (627)
                      +. ..+++++.+||++||..||.+||    ++.++++||||..
T Consensus       217 ~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         217 PK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            32 35789999999999999999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.8e-42  Score=371.28  Aligned_cols=265  Identities=23%  Similarity=0.348  Sum_probs=209.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC---
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA---  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---  364 (627)
                      +|.+.++||+|+||.||++.+..+++.||||++.....     .....+.+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-----NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-----chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence            36788999999999999999999999999998753211     1122456889999999999999999999987433   


Q ss_pred             -CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 -NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                       ..+|+||||+. ++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~---~~~kL~Dfg~  149 (372)
T cd07853          76 FEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN---CVLKICDFGL  149 (372)
T ss_pred             cceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC---CCEEeccccc
Confidence             26889999997 578888887788999999999999999999999988  9999999999999987   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.......      .......+|+.|+|||++..   ...++.++||||||||||+|++|+.||........+......
T Consensus       150 a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  220 (372)
T cd07853         150 ARVEEPDES------KHMTQEVVTQYYRAPEILMG---SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL  220 (372)
T ss_pred             eeecccCcc------ccCCCCCcCCCcCCHHHHcC---CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            987543221      11223468999999999852   235788999999999999999999999766544332211110


Q ss_pred             hh-------------------hhcc-------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         524 LK-------------------ATEV-------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       524 ~~-------------------~~~~-------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ..                   ....       .+.....+++++.+||.+||++||.+|||+.+++.||||....
T Consensus       221 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            00                   0000       0112235688999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-42  Score=356.72  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=201.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEeec-
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEID-  363 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~~-  363 (627)
                      +|.+++.||+|+||+||+|.+..+++.||||++........     ....+.+|+.+++.+   +||||++++++|... 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~   75 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-----LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR   75 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-----CchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence            58999999999999999999999999999998865322111     012344566666554   799999999988632 


Q ss_pred             ---CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 ---ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ---~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                         ...+++||||+.+ +|..++...  ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||
T Consensus        76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~---~~~kl  149 (288)
T cd07863          76 TDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GQVKL  149 (288)
T ss_pred             CCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---CCEEE
Confidence               3457899999985 788877653  35899999999999999999999988  9999999999999887   58999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.+....        ......||+.|+|||++.    ...++.++|||||||++|+|++|++||........+.
T Consensus       150 ~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~  217 (288)
T cd07863         150 ADFGLARIYSCQM--------ALTPVVVTLWYRAPEVLL----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  217 (288)
T ss_pred             CccCccccccCcc--------cCCCccccccccCchHhh----CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence            9999998764321        122346899999999984    3458899999999999999999999997765554433


Q ss_pred             HHHHHhhhh-ccc-----------c---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         519 EENTILKAT-EVQ-----------F---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       519 ~~~~~~~~~-~~~-----------~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ......... ...           +         ...+.++.++.+||.+||++||.+|||+.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            222111000 000           0         0123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-42  Score=349.20  Aligned_cols=259  Identities=35%  Similarity=0.565  Sum_probs=209.9

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |++.+.||+|+||+||++.+..+++.||+|++........     ......+|+.+++.++||||+++++++. +...++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-----EREENIREIKILRRLRHPNIVQILDVFQ-DDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-----HHHHHHHHHHHHHHHTBTTBCHEEEEEE-ESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-----ccchhhhhhhcccccccccccccccccc-cccccc
Confidence            8899999999999999999999999999999876543221     1223456999999999999999999998 567788


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      +||||+.+++|..++.....+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++..+.
T Consensus        75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~---~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN---GEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT---SEEEESSGTTTEEST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc---ccccccccccccccc
Confidence            99999999999999998889999999999999999999999988  9999999999999976   689999999998642


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-hhh
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL-KAT  527 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~-~~~  527 (627)
                      ...       .......+++.|+|||++.   ....++.++||||||+++|+|++|..||................ ...
T Consensus       150 ~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~  219 (260)
T PF00069_consen  150 ENN-------ENFNPFVGTPEYMAPEVLQ---QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL  219 (260)
T ss_dssp             STT-------SEBSSSSSSGGGSCHHHHT---TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH
T ss_pred             ccc-------ccccccccccccccccccc---ccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence            111       2234457899999999984   25568999999999999999999999998763222221111111 111


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..........+.++.+||.+||+.||++||++.++++||||
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            11222222334899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.8e-42  Score=368.25  Aligned_cols=263  Identities=25%  Similarity=0.359  Sum_probs=205.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|++..+++.||||++.....     .......+.+|+.+++.++||||++++++|...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-----NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-----CchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            356899999999999999999999999999999998754321     112235678899999999999999999988532


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+||||+++ +|..++..  .+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kL  167 (364)
T cd07875          96 KSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKI  167 (364)
T ss_pred             ccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC---CcEEE
Confidence            2     357899999986 56666543  5889999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++......        ......||+.|+|||++.    +..++.++|||||||+||+|++|+.||........+.
T Consensus       168 ~DfG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  235 (364)
T cd07875         168 LDFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN  235 (364)
T ss_pred             EeCCCccccCCCC--------cccCCcccCCcCCHHHHh----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999998654321        123347899999999984    4568899999999999999999999997665433322


Q ss_pred             HHHHHhhh------------------hc--------------cccC----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         519 EENTILKA------------------TE--------------VQFA----NKPTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       519 ~~~~~~~~------------------~~--------------~~~~----~~~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      ........                  ..              ..++    .....+.++++||.+||..||.+|||+.++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~  315 (364)
T cd07875         236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  315 (364)
T ss_pred             HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence            11110000                  00              0000    011235689999999999999999999999


Q ss_pred             HhccCCCCC
Q psy4988         563 ARHDYLQPP  571 (627)
Q Consensus       563 L~hp~~~~~  571 (627)
                      |.||||...
T Consensus       316 L~hp~~~~~  324 (364)
T cd07875         316 LQHPYINVW  324 (364)
T ss_pred             hcCcccccc
Confidence            999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-42  Score=363.28  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=209.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  366 (627)
                      +|.+.+.||+|+||.||+|.+..+++.||||++......    .......+..|+.++..+. |++|++++++|. +.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-TVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHHhccCCCchhheeeEEe-cCCE
Confidence            377889999999999999999999999999998643221    1223456778888988886 577888999887 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..++.....+++.+++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~---~~ikL~Dfg~~~~  150 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE---GHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC---CCEEEeccccccc
Confidence            8999999999999999988889999999999999999999999988  9999999999999987   6899999999975


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      .....       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +. .
T Consensus       151 ~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---i~-~  215 (323)
T cd05615         151 HMVDG-------VTTRTFCGTPDYIAPEIIA----YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS---IM-E  215 (323)
T ss_pred             cCCCC-------ccccCccCCccccCHHHHc----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HH-h
Confidence            43221       1123457999999999984    44588999999999999999999999976654433211   11 1


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      ..  ...+..++.++.+||.+||+.||.+|++     ..+++.||||...
T Consensus       216 ~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         216 HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CC--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            12  2233468899999999999999999997     5789999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-42  Score=365.98  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=203.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKL  356 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l  356 (627)
                      ++-.++|++.++||+|+||.||+|.+.     .+++.||||++.....      ......+.+|+.++..+ +|||||++
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~   76 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT------ASEHKALMSELKILIHIGNHLNVVNL   76 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc------hHHHHHHHHHHHHHHHhccCcceeeE
Confidence            455689999999999999999999753     3467899998753321      12235688999999999 89999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc--------------------------------------------------
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------------------------------------------------  386 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------  386 (627)
                      +++|......+++|||||++|+|.+++...                                                  
T Consensus        77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (338)
T cd05102          77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS  156 (338)
T ss_pred             EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence            999875666789999999999999998642                                                  


Q ss_pred             ------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         387 ------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       387 ------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                                  ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.+...... 
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~---~~~kl~DfG~a~~~~~~~~~-  230 (338)
T cd05102         157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDY-  230 (338)
T ss_pred             cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC---CcEEEeecccccccccCcch-
Confidence                        24778899999999999999999988  9999999999999876   58999999999865432110 


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                          .......+++.|+|||++.    ...++.++|||||||+||||++ |..||........+...  +....  ....
T Consensus       231 ----~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--~~~~~--~~~~  298 (338)
T cd05102         231 ----VRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--LKDGT--RMRA  298 (338)
T ss_pred             ----hcccCCCCCccccCcHHhh----cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--HhcCC--CCCC
Confidence                1122335678899999984    4458899999999999999996 99999765543333221  11111  1223


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +..+++++.+||.+||..||.+|||+.+++.
T Consensus       299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         299 PENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-42  Score=365.58  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||.||+|.+..+++.||||++.....    .....+..+.+|+.++.++ +||||+.++++|. +.+.+|+|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e   76 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV----HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-TTSRLFLVIE   76 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-eCCEEEEEEe
Confidence            69999999999999999999999999864322    1223355678899999888 6999999999997 6678899999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ||++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~-  150 (327)
T cd05617          77 YVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPG-  150 (327)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC---CCEEEeccccceeccCCC-
Confidence            9999999999988889999999999999999999999988  9999999999999887   589999999997532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhhhh
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-----ATILEENTILKAT  527 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~  527 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||......     ......  .....
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~  218 (327)
T cd05617         151 ------DTTSTFCGTPNYIAPEILR----GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ--VILEK  218 (327)
T ss_pred             ------CceecccCCcccCCHHHHC----CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH--HHHhC
Confidence                  1123457999999999984    456889999999999999999999999532211     111111  11111


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCC------HHHHHhccCCCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRID------VISLARHDYLQPP  571 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt------~~elL~hp~~~~~  571 (627)
                        ....+..++..+.+||.+||.+||.+|++      +.+++.||||...
T Consensus       219 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         219 --PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence              22234468899999999999999999998      5799999999754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG1989|consensus

Probab=100.00  E-value=1.7e-42  Score=386.43  Aligned_cols=261  Identities=27%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee--
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI--  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~--  362 (627)
                      ..+++|.+.|.+|||+.||+|.+...+..||+|.+....       +...+.+.+||++|+.|. |+|||.++|....  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-------e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-------EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-------HHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            346889999999999999999999888999999876541       233567889999999996 9999999993211  


Q ss_pred             --c--CCeEEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         363 --D--ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       363 --~--~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                        +  ...++|+||||.|+.|-+++..  ..+|+|.++++|+.|+++||.+||.+.++|||||||-+||||..+   ++.
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~---g~~  185 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD---GNY  185 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC---CCE
Confidence              1  2357899999999999998874  357999999999999999999999999999999999999999988   689


Q ss_pred             EEeecccccccccCCCCCCCCccc---cccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDL---TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      ||||||.|+-....-.. .....+   .-....|+.|+|||++.... +..++.|+|||+|||+||-||+...||+....
T Consensus       186 KLCDFGSatt~~~~~~~-~~e~~~ve~eI~k~TTp~YRsPEMIDlys-g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTS-AQEVNYVEEEIEKYTTPQYRSPEMIDLYS-GLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             EeCcccccccccCCCcc-HHHHHHHHHHHHhhCCccccChHHHhhhc-CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            99999999643221100 000000   00124699999999986543 66799999999999999999999999976533


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ..        +......||..+.+++.+++||+.||+.||.+||++.|++.+-
T Consensus       264 la--------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  264 LA--------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ee--------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            21        1224567788889999999999999999999999999998753

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-42  Score=363.13  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=203.9

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA-LDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||+||+|.+..+++.||||++.......    ......+..|..++.. ++||||++++++|. +...+|+|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~e   76 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-TKENLFFVME   76 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----cchHHHHHHHHHHHHhccCCCcCcceEEEEE-eCCEEEEEEe
Confidence            5999999999999999999999999986432111    1223456677788875 58999999999998 5677889999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 y~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~-  150 (316)
T cd05619          77 YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGD-  150 (316)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC---CCEEEccCCcceECCCCC-
Confidence            9999999999988888999999999999999999999988  9999999999999987   589999999997532211 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+ ...   ......+ 
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-~~i---~~~~~~~-  215 (316)
T cd05619         151 ------AKTCTFCGTPDYIAPEILL----GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-QSI---RMDNPCY-  215 (316)
T ss_pred             ------CceeeecCCccccCHHHHc----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-HHH---HhCCCCC-
Confidence                  1123457999999999984    445889999999999999999999999765543322 111   1111222 


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHH-HHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDVI-SLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~~-elL~hp~~~~~  571 (627)
                       +..++.++.+||.+||+.||.+||++. +++.||||...
T Consensus       216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             -CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence             235889999999999999999999996 89999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6e-42  Score=357.19  Aligned_cols=264  Identities=28%  Similarity=0.491  Sum_probs=209.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||.|+||.||+|.+..++..||+|.+........      ...+.+|+.+++.++||||+++++++. +.+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~   77 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA------PCTAIREVSLLKDLKHANIVTLHDIIH-TEK   77 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc------hhHHHHHHHHHHhcCCCCcceEEEEEe-cCC
Confidence            3679999999999999999999999999999999865432111      234678999999999999999999997 667


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+++ +|..++.. ...+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        78 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~---~~~kl~dfg~~  151 (301)
T cd07873          78 SLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER---GELKLADFGLA  151 (301)
T ss_pred             eEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC---CcEEECcCcch
Confidence            88999999985 78777764 457899999999999999999999988  9999999999999987   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .......       .......+++.|+|||++.   ....++.++|||||||+||+|++|++||...+....+.......
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~---~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~  221 (301)
T cd07873         152 RAKSIPT-------KTYSNEVVTLWYRPPDILL---GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL  221 (301)
T ss_pred             hccCCCC-------CcccccceeecccCcHHHh---CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            7654321       1112236789999999875   23457889999999999999999999997665443322111111


Q ss_pred             hh---------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KA---------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~---------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ..               ....++         ..+.+++++++||.+||++||.+|||+.+++.||||....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             CCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            00               000111         1235788999999999999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.2e-42  Score=362.31  Aligned_cols=250  Identities=33%  Similarity=0.518  Sum_probs=203.1

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH-HHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||+||+|.+..+++.||||++......    .......+..|.. +++.++||||++++++|. +.+.+|+|||
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-~~~~~~lv~e   76 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-TADKLYFVLD   76 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-cCCeEEEEEe
Confidence            599999999999999999999999998643221    1112234444544 567899999999999997 6677889999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      |+++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++...... 
T Consensus        77 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~---~~~kl~DfG~a~~~~~~~-  150 (325)
T cd05602          77 YINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHN-  150 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC---CCEEEccCCCCcccccCC-
Confidence            9999999999998889999999999999999999999988  9999999999999876   689999999997543221 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                            ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   +.   .....
T Consensus       151 ------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~---~~~~~  214 (325)
T cd05602         151 ------GTTSTFCGTPEYLAPEVLH----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---IL---NKPLQ  214 (325)
T ss_pred             ------CCcccccCCccccCHHHHc----CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---HH---hCCcC
Confidence                  1133457999999999984    45688999999999999999999999976554433211   11   11223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHH----HHHhccCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDVI----SLARHDYLQP  570 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~~----elL~hp~~~~  570 (627)
                      ..+.++..+.+||.+||+.||.+|+++.    ++++|+||.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            3457899999999999999999999865    8999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0607|consensus

Probab=100.00  E-value=2.5e-43  Score=351.19  Aligned_cols=270  Identities=26%  Similarity=0.415  Sum_probs=217.0

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      +.||+|+|+.|--+....++..||||++.+...       ....++++|++++.+. .|+||++|+++|+ +...|||||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-------HsR~RvfREVe~f~~Cqgh~nilqLiefFE-dd~~FYLVf  155 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-------HSRSRVFREVETFYQCQGHKNILQLIEFFE-DDTRFYLVF  155 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc-------hHHHHHHHHHHHHHHhcCCccHHHHHHHhc-ccceEEEEE
Confidence            569999999999999999999999999875532       1245789999999998 5999999999998 777899999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      |-|.||.|...|.+...|+|.++..++.+|+.||.|||..|  |.||||||+|||..+.+.-..||||||.|..-+....
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            99999999999999999999999999999999999999988  9999999999999876555589999999886544322


Q ss_pred             CC-CCCCccccccCCCCCccCCcccccc-CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q psy4988         452 YN-PDHGMDLTSQGAGTYWYLPPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA---------TILEE  520 (627)
Q Consensus       452 ~~-~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~---------~~~~~  520 (627)
                      .. +....+ ..+.+|+..|||||+... ......|+.++|.||||||||-||+|.+||.+....+         ....+
T Consensus       234 ~~spastP~-L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  234 DCSPASTPE-LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCcc-ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence            11 122222 234589999999998632 1235679999999999999999999999995432211         11111


Q ss_pred             HHHhhh--hccccC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         521 NTILKA--TEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       521 ~~~~~~--~~~~~~--~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ......  ....||  .|..+|.+++|||..+|..|+.+|.++.++++|||++...+
T Consensus       313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            111111  223343  57789999999999999999999999999999999986544

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.1e-42  Score=367.36  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||++++++|....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   89 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-----ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence            56899999999999999999999999999999998754321     1222456778999999999999999999986432


Q ss_pred             -----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 -----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                           ..+|+||||+++ +|..++.  ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~---~~~kl~  161 (355)
T cd07874          90 SLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKIL  161 (355)
T ss_pred             cccccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC---CCEEEe
Confidence                 347899999986 4555554  35899999999999999999999988  9999999999999887   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++......        ......||+.|+|||++.    +..++.++|||||||+||+|++|+.||........+..
T Consensus       162 Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  229 (355)
T cd07874         162 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_pred             eCcccccCCCcc--------ccCCccccCCccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999998654321        123347899999999984    44588999999999999999999999976554332221


Q ss_pred             HHHHhhh--------------------h---ccc---------c----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         520 ENTILKA--------------------T---EVQ---------F----ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       520 ~~~~~~~--------------------~---~~~---------~----~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      .......                    .   ...         +    ......+.++++||.+||..||++|||+.+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell  309 (355)
T cd07874         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL  309 (355)
T ss_pred             HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence            1100000                    0   000         0    01123467889999999999999999999999


Q ss_pred             hccCCCCC
Q psy4988         564 RHDYLQPP  571 (627)
Q Consensus       564 ~hp~~~~~  571 (627)
                      .||||...
T Consensus       310 ~hp~~~~~  317 (355)
T cd07874         310 QHPYINVW  317 (355)
T ss_pred             cCcchhcc
Confidence            99999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-42  Score=366.09  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=206.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+++.||.|+||.||+|.+..++..||||++.....     .......+.+|+.+++.++||||++++++|....
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-----SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-----hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            46789999999999999999999999999999998754321     1223456778999999999999999999885322


Q ss_pred             -----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 -----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                           ..+|++++++ +++|..++.. ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+
T Consensus        88 ~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~---~~~kl~  160 (343)
T cd07878          88 SIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED---CELRIL  160 (343)
T ss_pred             cccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC---CCEEEc
Confidence                 3478999988 5788877653 57999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.....          .....||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+..
T Consensus       161 Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  227 (343)
T cd07878         161 DFGLARQADDE----------MTGYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR  227 (343)
T ss_pred             CCccceecCCC----------cCCccccccccCchHhc---CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999865432          12347899999999985   234588899999999999999999999976554332221


Q ss_pred             HHHHhhhhc-------------------cccC------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKATE-------------------VQFA------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~-------------------~~~~------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .........                   ...+      ....+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            111100000                   0000      012456788999999999999999999999999999753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=344.37  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=213.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      +.|.+.+.||.|+||.||+|.+..+++.||||++.......  .....+..+.+|+.++++++||||+++++++. +...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP--ETKKEVNALECEIQLLKNLQHERIVQYYGCLR-DDET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-cCCe
Confidence            45889999999999999999999999999999986543221  12223567889999999999999999999998 5568


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||+++.
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~---~~~~l~dfg~~~~  153 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA---GNVKLGDFGASKR  153 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEeeccccee
Confidence            8999999999999999988888999999999999999999999988  9999999999999876   6899999999976


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +......    ........|+..|+|||++.    ...++.++|||||||++|+|++|+.||........+...  .  .
T Consensus       154 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~--~  221 (263)
T cd06625         154 LQTICSS----GTGMKSVTGTPYWMSPEVIS----GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--A--T  221 (263)
T ss_pred             ccccccc----cccccCCCcCccccCcceec----cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH--h--c
Confidence            5432110    00112346889999999984    344889999999999999999999999765443332211  1  1


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .......+..++.++.+||++||..+|.+|||+.++++|+||
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            112223344688999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-41  Score=351.93  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=208.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|++.+.||+|+||.||++.+..+++.||||.+......    .......+.+|+.+++.++|+||+.+++.+. +.+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----KRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEE
Confidence            377889999999999999999999999999987643221    1222345678999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.+   +.++|+|||++.
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~---~~~~l~Dfg~~~  150 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH---GHIRISDLGLAV  150 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC---CCEEEeecccee
Confidence            9999999999999888643  36999999999999999999999988  9999999999999986   589999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......        .....|++.|+|||++.    ...++.++|||||||++|+|++|+.||.................
T Consensus       151 ~~~~~~~--------~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~  218 (285)
T cd05630         151 HVPEGQT--------IKGRVGTVGYMAPEVVK----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK  218 (285)
T ss_pred             ecCCCcc--------ccCCCCCccccChHHHc----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh
Confidence            6543210        12237899999999984    44588999999999999999999999975433211111111111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      ....  .....+++++.+||.+||+.||++|||     +.++++||||...
T Consensus       219 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         219 EVQE--EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hhhh--hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            1111  123468899999999999999999999     9999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0690|consensus

Probab=100.00  E-value=1.6e-43  Score=352.99  Aligned_cols=261  Identities=30%  Similarity=0.494  Sum_probs=224.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+-.++|..+++||+|.||.|-+++.+.++++||+|++.+.-....    +.+.+.+.|-++|+..+||.+..|-..|+ 
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak----dEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-  238 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK----DEVAHTLTENRVLQNCRHPFLTSLKYSFQ-  238 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh----HHhhhhhhHHHHHHhccCcHHHHhhhhhc-
Confidence            3556778899999999999999999999999999999875544322    23567888999999999999999998898 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ..+.+|+||||+.||.|+.+|.....|++..++.+-..|+.||.|||+.+  ||.||||.+|+|||++   |++||+|||
T Consensus       239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD---GHIKitDFG  313 (516)
T KOG0690|consen  239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD---GHIKITDFG  313 (516)
T ss_pred             cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC---CceEeeecc
Confidence            67889999999999999999999999999999999999999999999988  9999999999999998   799999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      |++.--..       -..+.+.||||.|+|||++    ....|+.++|+|.+||++|||+||++||...+. ..+.+   
T Consensus       314 LCKE~I~~-------g~t~kTFCGTPEYLAPEVl----eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFe---  378 (516)
T KOG0690|consen  314 LCKEEIKY-------GDTTKTFCGTPEYLAPEVL----EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFE---  378 (516)
T ss_pred             cchhcccc-------cceeccccCChhhcCchhh----ccccccceeehhhhhHHHHHHHhccCcccccch-hHHHH---
Confidence            99753221       1346788999999999999    466799999999999999999999999964332 33322   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ++...++.||.  .++++++.|+..+|.+||.+|.     ++.++.+|+||..
T Consensus       379 LIl~ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  379 LILMEDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHhhhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            23345566664  6999999999999999999998     7899999999864

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=378.96  Aligned_cols=263  Identities=25%  Similarity=0.334  Sum_probs=213.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||+||+|.+..+++.||||++......     ......+.+|+.++..++|+||+++++.|...
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-----EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-----HHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3457999999999999999999999999999999998654332     12244678899999999999999998877532


Q ss_pred             C-------CeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         364 A-------NSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       364 ~-------~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                      .       ..+++||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+  
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~--  179 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN--  179 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC--
Confidence            2       1368999999999999988643    47999999999999999999999988  9999999999999987  


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ  512 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~  512 (627)
                       +.+||+|||+++.+......     ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||....
T Consensus       180 -~~vkL~DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~----~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        180 -GLVKLGDFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWR----RKPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             -CCEEEEecccCeeccccccc-----cccccccCCcceeCHHHhC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence             58999999999876532211     1233458999999999984    4458999999999999999999999997655


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ....+. ..  ..  ....+.++.+++++.+||.+||+.||.+||++.++++|||+..
T Consensus       250 ~~~~~~-~~--~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        250 MEEVMH-KT--LA--GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHHHHH-HH--hc--CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            433221 11  11  1112234578999999999999999999999999999999753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-41  Score=351.01  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=200.2

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||+|+||.||++.+..+++.||+|.+.....    ........+..|+++++.++||||++++++|. +...+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL----KKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-SKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHh----hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-cCCeEEEEEecC
Confidence            7999999999999999999999998853221    11112234567999999999999999999997 667889999999


Q ss_pred             CCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         375 DGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       375 ~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ++++|..++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.++|+|||++..+.... 
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~---~~~~l~Dfg~~~~~~~~~-  149 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGK-  149 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC---CCEEEeeceeeeecCCCc-
Confidence            999999887654  35899999999999999999999988  9999999999999986   589999999998764321 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                             ......|++.|+|||++.    ...++.++|||||||+||+|++|+.||......................+ 
T Consensus       150 -------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  217 (277)
T cd05607         150 -------TITQRAGTNGYMAPEILK----EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-  217 (277)
T ss_pred             -------eeeccCCCCCccCHHHHc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-
Confidence                   112346899999999984    33488999999999999999999999965433211111111111111111 


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYLQPP  571 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~~~~  571 (627)
                      ....++.++++||.+||.+||.+||++    .+++.|+||...
T Consensus       218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         218 EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            123688999999999999999999999    678899999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-41  Score=376.26  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=209.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC-CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~-~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+.....       .....+.+|+.+++.++|||||+++++|. +.
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~  137 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-------RQAAYARSELHCLAACDHFGIVKHFDDFK-SD  137 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCCCEeEEEEEEE-EC
Confidence            34599999999999999999998887 78899997643321       12245678999999999999999999998 56


Q ss_pred             CeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      +.+||||||+++++|..++..    ...+++.++..++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|
T Consensus       138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~---~~~kL~D  212 (478)
T PTZ00267        138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT---GIIKLGD  212 (478)
T ss_pred             CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC---CcEEEEe
Confidence            788899999999999987753    346899999999999999999999988  9999999999999976   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.+.....     .......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+ ..
T Consensus       213 Fgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-~~  282 (478)
T PTZ00267        213 FGFSKQYSDSVS-----LDVASSFCGTPYYLAPELWE----RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-QQ  282 (478)
T ss_pred             CcCceecCCccc-----cccccccCCCccccCHhHhC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH
Confidence            999987654321     12234457999999999984    456899999999999999999999999765443322 11


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .  ....  ..+.+..++.++.+||.+||..||++||++.+++.|+|+.
T Consensus       283 ~--~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        283 V--LYGK--YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             H--HhCC--CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            1  1111  1122346889999999999999999999999999999974

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-41  Score=367.94  Aligned_cols=262  Identities=21%  Similarity=0.293  Sum_probs=205.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ..++..+|.+++.||+|+||.||+|...  .++..||||.+....            ...+|+.+++.++|||||+++++
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------------~~~~E~~il~~l~h~~iv~~~~~  154 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------------TPGREIDILKTISHRAIINLIHA  154 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------------cHHHHHHHHHhcCCCCccceeee
Confidence            3456678999999999999999999754  356889999875321            24579999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      |. ....+|+||||+. ++|..++.....+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       155 ~~-~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~---~~~~l~  227 (392)
T PHA03207        155 YR-WKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP---ENAVLG  227 (392)
T ss_pred             Ee-eCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC---CCEEEc
Confidence            97 5677889999997 578888877788999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ---AT  516 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~---~~  516 (627)
                      |||+++.+......     .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||......   ..
T Consensus       228 DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~  298 (392)
T PHA03207        228 DFGAACKLDAHPDT-----PQCYGWSGTLETNSPELLA----LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ  298 (392)
T ss_pred             cCccccccCccccc-----ccccccccccCccCHhHhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH
Confidence            99999876543211     1123457999999999984    445889999999999999999999999654321   11


Q ss_pred             HHHHHHHhhhhccccC----------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         517 ILEENTILKATEVQFA----------------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~----------------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      +.............++                            ....++.++.+||.+||.+||.+||++.++|.||||
T Consensus       299 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        299 LRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             HHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence            1111100000000000                            012356789999999999999999999999999999


Q ss_pred             CCC
Q psy4988         569 QPP  571 (627)
Q Consensus       569 ~~~  571 (627)
                      ...
T Consensus       379 ~~~  381 (392)
T PHA03207        379 TKE  381 (392)
T ss_pred             hcc
Confidence            753

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.4e-41  Score=346.54  Aligned_cols=259  Identities=26%  Similarity=0.462  Sum_probs=204.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||+|.+..++..||||++......     ......+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-----EGVPSTAIREISLLKELQHPNIVCLQDVLM-QESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-----CCchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeE
Confidence            488999999999999999999999999999988643221     112245678999999999999999999997 56788


Q ss_pred             EEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      |+||||+. ++|..++...   ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~---~~~~l~dfg~~  148 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK---GVIKLADFGLA  148 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC---CcEEECcccce
Confidence            99999998 5787777542   56999999999999999999999988  9999999999999886   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .......       .......+++.|+|||++.   ....++.++|||||||++|+|++|+.||................
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~  218 (285)
T cd07861         149 RAFGIPV-------RVYTHEVVTLWYRAPEVLL---GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRIL  218 (285)
T ss_pred             eecCCCc-------ccccCCcccccccChHHhc---CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            7654321       1112236789999999874   23357889999999999999999999997665433322211100


Q ss_pred             h--------------hhcccc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 K--------------ATEVQF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~--------------~~~~~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .              .....+         .....+++++.+||++||+.||.+|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             CCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0              000000         0123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-41  Score=354.73  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=192.1

Q ss_pred             EEecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cCCeEEE
Q psy4988         293 MLLGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DANSFCT  369 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~~l  369 (627)
                      .+||+|+||+||+|.+.  .+++.||||.+.....         ...+.+|+.+++.++|||||+++++|.. ....+|+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            57999999999999865  4678999998754321         1246789999999999999999999863 3456889


Q ss_pred             EEeecCCCChHHHHHhc---------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC-CcccceEEe
Q psy4988         370 VLEYCDGHDLDFYLKQH---------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKIT  439 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~-~~~g~vKL~  439 (627)
                      ||||+.+ +|..++...         ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+ ...+.+||+
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            9999975 777776432         25899999999999999999999988  9999999999999532 223689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-----  514 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-----  514 (627)
                      |||+++.+.....    .........||+.|+|||++..   ...++.++|||||||++|+|++|++||......     
T Consensus       155 DfG~a~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  227 (317)
T cd07868         155 DMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLG---ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  227 (317)
T ss_pred             ecCceeccCCCCc----cccccCCccccccccCCHHHcC---CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc
Confidence            9999987653221    1112234578999999999852   345889999999999999999999999643321     


Q ss_pred             ----HHHHHHHHHhh---------------------hh-cccc----------CCCCCCCHHHHHHHHHhhhcCcCCCCC
Q psy4988         515 ----ATILEENTILK---------------------AT-EVQF----------ANKPTVSNEAKGFIRSCLAYRKEDRID  558 (627)
Q Consensus       515 ----~~~~~~~~~~~---------------------~~-~~~~----------~~~~~vs~el~~LI~~cL~~dP~~Rpt  558 (627)
                          ..+........                     .. ...+          ......+.++.+||++||++||.+|||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  307 (317)
T cd07868         228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  307 (317)
T ss_pred             cccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC
Confidence                00000000000                     00 0000          001124567899999999999999999


Q ss_pred             HHHHHhccCC
Q psy4988         559 VISLARHDYL  568 (627)
Q Consensus       559 ~~elL~hp~~  568 (627)
                      +.|+|+||||
T Consensus       308 ~~e~l~hp~f  317 (317)
T cd07868         308 SEQAMQDPYF  317 (317)
T ss_pred             HHHHhcCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-41  Score=342.15  Aligned_cols=265  Identities=26%  Similarity=0.438  Sum_probs=214.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchh--hHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK--EDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~--~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      +|.+...||.|+||.||+|.+..+++.||||.+.......  ..........+.+|+.++++++||||+++++++. +..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL-DAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCC
Confidence            5788899999999999999999999999999876543221  1223345567889999999999999999999987 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+++++|..++.....+++..+..++.|++.||.|||+.+  |+|+||+|+|||++++   +.++|+|||+++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~---~~~~l~dfg~~~  154 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK---GGIKISDFGISK  154 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC---CCEEecccCCCc
Confidence            78899999999999999988889999999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+......... ........|+..|+|||++.    ...++.++|||||||++|+|++|..||........+....   .
T Consensus       155 ~~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~  226 (267)
T cd06628         155 KLEANSLSTKT-NGARPSLQGSVFWMAPEVVK----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---E  226 (267)
T ss_pred             ccccccccCCc-cccccccCCCcCccChhHhc----cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---c
Confidence            77533211111 01112346899999999984    3457889999999999999999999997654443332211   1


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .  .....+..++.++.+||.+||+.||.+||++.+++.||||
T Consensus       227 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         227 N--ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             c--CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            1  1112234678999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-41  Score=349.51  Aligned_cols=259  Identities=28%  Similarity=0.509  Sum_probs=202.8

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+......     ......+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-----~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-----ccCccchhHHHHHHHhcCCCCeeeHHHHhc-cCCce
Confidence            589999999999999999999999999999998653221     112235678999999999999999999997 66788


Q ss_pred             EEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++|+||+++ +|..++.. ...+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||+++.
T Consensus        75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~---~~~~l~dfg~~~~  148 (284)
T cd07839          75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN---GELKLADFGLARA  148 (284)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC---CcEEECccchhhc
Confidence            999999985 67666654 567999999999999999999999988  9999999999999987   5899999999986


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN-TILK  525 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~-~~~~  525 (627)
                      +....       .......+++.|+|||++.   ....++.++|||||||++|+|++|..||.........+... ....
T Consensus       149 ~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         149 FGIPV-------RCYSAEVVTLWYRPPDVLF---GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             cCCCC-------CCcCCCccccCCcChHHHh---CCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            54321       1112336789999999884   23347889999999999999999999864433322222111 0000


Q ss_pred             h------------hc-ccc----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 A------------TE-VQF----------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~------------~~-~~~----------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .            .. ..+          ...+.+++++.+||.+||..||.+|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0            00 000          1123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-41  Score=372.55  Aligned_cols=257  Identities=20%  Similarity=0.263  Sum_probs=200.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ....|.+.+.||+|+||.||+|.+..+++.||||....             ..+.+|++++++|+|||||++++++. ..
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------------~~~~~E~~iL~~L~HpnIv~l~~~~~-~~  232 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------------ASSVHEARLLRRLSHPAVLALLDVRV-VG  232 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------------cCHHHHHHHHHHCCCCCCCcEEEEEE-EC
Confidence            45689999999999999999999999999999996321             23568999999999999999999987 55


Q ss_pred             CeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...|||||++. ++|..++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+
T Consensus       233 ~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~---~~vkL~DFGl  306 (461)
T PHA03211        233 GLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP---EDICLGDFGA  306 (461)
T ss_pred             CEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC---CCEEEcccCC
Confidence            67789999996 5777777553 57999999999999999999999988  9999999999999876   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-h------HHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ-S------QAT  516 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~-~------~~~  516 (627)
                      ++.+......     ......+||+.|+|||++.    +..++.++||||||||||||++|..|+.... .      ...
T Consensus       307 a~~~~~~~~~-----~~~~~~~GT~~Y~APE~~~----~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~  377 (461)
T PHA03211        307 ACFARGSWST-----PFHYGIAGTVDTNAPEVLA----GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ  377 (461)
T ss_pred             ceeccccccc-----ccccccCCCcCCcCHHHHc----CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH
Confidence            9876432211     1122357999999999984    4458899999999999999999876652211 1      111


Q ss_pred             HHHHHHHhhhhcc-----------------------------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         517 ILEENTILKATEV-----------------------------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       517 ~~~~~~~~~~~~~-----------------------------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      +............                             .+.....++.++.+||.+||.+||.+|||+.|||+|||
T Consensus       378 l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        378 ILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             HHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence            1111110000000                             01111245678999999999999999999999999999


Q ss_pred             CCC
Q psy4988         568 LQP  570 (627)
Q Consensus       568 ~~~  570 (627)
                      |+.
T Consensus       458 f~~  460 (461)
T PHA03211        458 FQS  460 (461)
T ss_pred             cCC
Confidence            974

>KOG0579|consensus

Probab=100.00  E-value=2.5e-43  Score=374.77  Aligned_cols=262  Identities=26%  Similarity=0.447  Sum_probs=220.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .|.|.|+..||.|+||.||+|.++.++-..|.|+|...       ....+..++-||+||..++||+||+|++.|. ..+
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-------seEELEDylVEIeILa~CdHP~ivkLl~ayy-~en  102 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-------SEEELEDYLVEIEILAECDHPVIVKLLSAYY-FEN  102 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-------chhHHhhhhhhhhhhhcCCChHHHHHHHHHh-ccC
Confidence            46688889999999999999999999988999987543       2333567889999999999999999999887 446


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .++|+.|||+||-.+.++-. ...|.+.++..+.+|++.||+|||+.+  |||||||..|||++.+   |.|+|+|||.+
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld---GdirLADFGVS  177 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD---GDIRLADFGVS  177 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec---CcEeeeccccc
Confidence            67899999999999887654 568999999999999999999999998  9999999999999987   79999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCcccccc-CCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      .......       .....+.|||+|||||++.. .....+|++++||||||++|.||.-+.+|...-+....+++.   
T Consensus       178 AKn~~t~-------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---  247 (1187)
T KOG0579|consen  178 AKNKSTR-------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---  247 (1187)
T ss_pred             ccchhHH-------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH---
Confidence            6543221       22345689999999998753 335678999999999999999999999998766665555433   


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .+..+..+..+...+..+.||+.+||.+||..||++.++|+||||+.
T Consensus       248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            33444555566678899999999999999999999999999999983

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7e-41  Score=346.83  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=210.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|++.+.||+|+||+||+|.+..+++.||||++.....    ........+.+|+.+++.++|+||+.++++|. +.+.+
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI----KKRKGESMALNEKQILEKVNSQFVVNLAYAYE-TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh----hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-cCCEE
Confidence            37788999999999999999999999999999864322    11222345778999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+.+++|..++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.+   +.+||+|||++.
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~---~~~kl~Dfg~~~  150 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY---GHIRISDLGLAV  150 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC---CCEEEecCCcce
Confidence            9999999999999888643  46999999999999999999999988  9999999999999887   589999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......        ......|++.|+|||++.    ...++.++|||||||++|+|++|..||................ 
T Consensus       151 ~~~~~~--------~~~~~~g~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~-  217 (285)
T cd05632         151 KIPEGE--------SIRGRVGTVGYMAPEVLN----NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-  217 (285)
T ss_pred             ecCCCC--------cccCCCCCcCccChHHhc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-
Confidence            654221        112347899999999984    4458889999999999999999999997654433222111111 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                       ..........++.++.+||.+||..||++||+     +.+++.|+||...
T Consensus       218 -~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         218 -LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             -hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence             11122234568899999999999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.6e-41  Score=351.63  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=208.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++.+.||+|+||.||++.+..++..||+|++.....      ......+.+|+++++.++||||++++++|. +.+.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK------PAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCE
Confidence            469999999999999999999999999999998764321      223456889999999999999999999997 5678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+++++|..++.....+++..+..++.||+.||.|||+ .+  |+|+||||+|||++.+   +.+||+|||++.
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~---~~~~l~dfg~~~  148 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR---GEIKLCDFGVSG  148 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC---CcEEEccCCCcc
Confidence            88999999999999999888899999999999999999999997 46  9999999999999886   589999999987


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH--
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI--  523 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~--  523 (627)
                      .+....         .....|++.|+|||++.    +..++.++|||||||++|+|++|+.||...............  
T Consensus       149 ~~~~~~---------~~~~~~~~~~~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  215 (308)
T cd06615         149 QLIDSM---------ANSFVGTRSYMSPERLQ----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVS  215 (308)
T ss_pred             cccccc---------cccCCCCcCccChhHhc----CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccc
Confidence            653321         23347899999999873    445788999999999999999999999644322111000000  


Q ss_pred             -------------------------------hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 -------------------------------LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 -------------------------------~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                                                     ........ ....++.++.+||.+||..||++|||+.+++.||||..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                                           00000001 11236789999999999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-41  Score=349.84  Aligned_cols=267  Identities=25%  Similarity=0.414  Sum_probs=214.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...+.|+++++||.|+||.||+|.+..++..|++|++....       ......+.+|+.+++.++||||++++++|. .
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   80 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-------EEELEDYMVEIEILATCNHPYIVKLLGAFY-W   80 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-e
Confidence            34577999999999999999999999999999999975432       223456888999999999999999999987 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+|+||||+++++|..++.. ...+++..++.++.||+.+|.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~---~~~kl~dfg  155 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD---GDIKLADFG  155 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC---CCEEEccCc
Confidence            5678899999999999887754 457999999999999999999999988  9999999999999876   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      ++.......       .......+++.|+|||++.... ....++.++|||||||++|+|++|..||........+... 
T Consensus       156 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-  227 (292)
T cd06644         156 VSAKNVKTL-------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-  227 (292)
T ss_pred             cceeccccc-------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH-
Confidence            987643221       1112346889999999984321 2345788999999999999999999999765543332221 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                        .............++.++.+||.+||..||++||++.++++||||.....
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         228 --AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             --hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence              11112222334567889999999999999999999999999999976443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.4e-41  Score=345.62  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=204.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++.++||+|+||.||+|.+..++..||||++.....      ......+.+|+.++++++||||++++++|. ..+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT------VELQKQIMSELEILYKCDSPYIIGFYGAFF-VENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-ECCE
Confidence            368889999999999999999999999999999864321      112346889999999999999999999998 4567


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||+++++|..+    ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~---~~~~l~dfg~~~~  144 (279)
T cd06619          74 ISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR---GQVKLCDFGVSTQ  144 (279)
T ss_pred             EEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC---CCEEEeeCCccee
Confidence            8899999999998654    35789999999999999999999988  9999999999999987   6899999999986


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHH-HH
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI---LEE-NT  522 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~~  522 (627)
                      +....         ....+||..|+|||++.    ...++.++|||||||++|+|++|..||.........   ... ..
T Consensus       145 ~~~~~---------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  211 (279)
T cd06619         145 LVNSI---------AKTYVGTNAYMAPERIS----GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC  211 (279)
T ss_pred             ccccc---------ccCCCCChhhcCceeec----CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence            64321         23347899999999984    445889999999999999999999999643221110   000 01


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      +....... .....++.++.+||.+||+.||.+||++.+++.||||...
T Consensus       212 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         212 IVDEDPPV-LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HhccCCCC-CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            11111111 1123578899999999999999999999999999999743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.1e-41  Score=345.37  Aligned_cols=261  Identities=28%  Similarity=0.489  Sum_probs=210.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++...||+|+||.||+|.+..+++.||+|++.......     ...+.+.+|+.+++.++||||++++++|. +...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-----VIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-----cccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCE
Confidence            57999999999999999999999999999999876432211     11235678999999999999999999998 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||++++.|..++.....+++..++.++.||+.+|.|||+.+  |+|+||||+|||++.+   +.++|+|||++..
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~---~~~~l~dfg~~~~  149 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ---GQIKLCDFGFARI  149 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC---CcEEECcccccee
Confidence            8899999999999888877778999999999999999999999988  9999999999999877   5899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......++..|+|||++..   ...++.++|||||||++|+|++|..||......+...........
T Consensus       150 ~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07847         150 LTGPGD-------DYTDYVATRWYRAPELLVG---DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD  219 (286)
T ss_pred             cCCCcc-------cccCcccccccCCHHHHhC---CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            654321       1123367899999998752   245788999999999999999999999766554433222111100


Q ss_pred             h---------------ccccCC----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 T---------------EVQFAN----------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ~---------------~~~~~~----------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .               ....+.          .+.++..+.+||.+||..||++||++.+++.||||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0               000000          13568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-40  Score=337.18  Aligned_cols=255  Identities=28%  Similarity=0.454  Sum_probs=209.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|++++.||+|+||.||++.+..+++.||||.+......     ......+.+|+.+++.++||||+++++.+..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-----RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL   75 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-----HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence            489999999999999999999999999999998643221     122446788999999999999999999886555678


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+++++|.+++...  ..+++.+++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++.
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~---~~~~l~df~~~~  150 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT---NIIKVGDLGIAR  150 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC---CcEEEecccceE
Confidence            8999999999999998763  46899999999999999999999988  9999999999999876   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       .......|++.|+|||++.    ...++.++|||||||++|+|++|+.||...........   +..
T Consensus       151 ~~~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~  216 (257)
T cd08223         151 VLENQC-------DMASTLIGTPYYMSPELFS----NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR---IIE  216 (257)
T ss_pred             EecccC-------CccccccCCcCccChhHhc----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHh
Confidence            764321       1123447899999999984    44578899999999999999999999976544332211   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..  .......+++++.+||.+||+.||.+||++.+++.||||
T Consensus       217 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         217 GK--LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cC--CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            11  112234688999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-41  Score=362.40  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ...|.+++.||+|+||.||+|.+..++..||+|+....             ....|+.+++.++|||||+++++|. +..
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------~~~~E~~~l~~l~h~~iv~~~~~~~-~~~  130 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------TTLIEAMLLQNVNHPSVIRMKDTLV-SGA  130 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------ccHHHHHHHHhCCCCCCcChhheEE-eCC
Confidence            34799999999999999999999999999999985321             2346899999999999999999997 567


Q ss_pred             eEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..|+||||+.+ +|..++. ....+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||++
T Consensus       131 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~---~~~kl~DfG~a  204 (357)
T PHA03209        131 ITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV---DQVCIGDLGAA  204 (357)
T ss_pred             eeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEEecCccc
Confidence            78899999975 6666665 4568999999999999999999999988  9999999999999887   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChH---------
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-FGHNQSQ---------  514 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P-f~~~~~~---------  514 (627)
                      +......        ......||+.|+|||++.    ...++.++|||||||+||||+++..| |......         
T Consensus       205 ~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~  272 (357)
T PHA03209        205 QFPVVAP--------AFLGLAGTVETNAPEVLA----RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH  272 (357)
T ss_pred             cccccCc--------ccccccccccccCCeecC----CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHH
Confidence            7543211        122347999999999984    44588999999999999999975544 4322111         


Q ss_pred             HHHHHHHHHhhhhccccC----------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         515 ATILEENTILKATEVQFA----------------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~----------------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ..+.............++                            ....++.++.+||.+||++||.+|||+.++|+||
T Consensus       273 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp  352 (357)
T PHA03209        273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP  352 (357)
T ss_pred             HHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence            011110000000000111                            1124677888999999999999999999999999


Q ss_pred             CCCC
Q psy4988         567 YLQP  570 (627)
Q Consensus       567 ~~~~  570 (627)
                      ||+.
T Consensus       353 ~f~~  356 (357)
T PHA03209        353 MFAQ  356 (357)
T ss_pred             hhcc
Confidence            9974

>KOG4279|consensus

Probab=100.00  E-value=3.9e-42  Score=369.10  Aligned_cols=255  Identities=28%  Similarity=0.406  Sum_probs=216.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      -+||+|+||+||-|+|..+...+|||-+...       ...+.+-+..||.++++|+|.|||++++++. ++.++-|.||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-enGf~kIFME  652 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-------DSREVQPLHEEIALHSTLRHKNIVRYLGSVS-ENGFFKIFME  652 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-------cchhhccHHHHHHHHHHHhhHhHHHHhhccC-CCCeEEEEee
Confidence            3799999999999999999999999987532       2334566889999999999999999999986 6678889999


Q ss_pred             ecCCCChHHHHHhc-cCc--CHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         373 YCDGHDLDFYLKQH-KTI--AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       373 ~~~gg~L~~~l~~~-~~l--~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      -++||+|..+|... +++  .|..+-.+.+||+.||.|||++.  |||||||-+|||++--  +|.+||+|||.++.+..
T Consensus       653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTy--SGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTY--SGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeec--cceEEecccccchhhcc
Confidence            99999999999865 567  78889999999999999999998  9999999999999754  48999999999998765


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      -+       ..+.+..||.-|||||++..|  ...|+.++|||||||++.||.||++||-...+....+-   .......
T Consensus       729 in-------P~TETFTGTLQYMAPEvIDqG--~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---kVGmyKv  796 (1226)
T KOG4279|consen  729 IN-------PCTETFTGTLQYMAPEVIDQG--PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---KVGMYKV  796 (1226)
T ss_pred             CC-------ccccccccchhhhChHhhccC--CcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---hhcceec
Confidence            43       456778999999999999655  45699999999999999999999999965444332221   1223334


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+.+..+|.+++.||.+|+..||.+||++.++|.+||++..
T Consensus       797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            455566789999999999999999999999999999999876

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-40  Score=340.33  Aligned_cols=265  Identities=22%  Similarity=0.369  Sum_probs=212.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++.+.||.|+||+||+|.+ .+++.||||.+........ ........+.+|+++++.++|+||++++++|. +...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   77 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVL-AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-DDNTI   77 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchh-hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-cCCeE
Confidence            478889999999999999976 5788999998875543222 22334567889999999999999999999997 56788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++||||+++++|..++.....+++..+..++.||+.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~  152 (265)
T cd06631          78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN---GIIKLIDFGCARRL  152 (265)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC---CeEEeccchhhHhh
Confidence            999999999999999988888999999999999999999999988  9999999999999876   68999999999865


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ....... ..........|+..|+|||++.    ...++.++|||||||++|+|++|..||............   ....
T Consensus       153 ~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~  224 (265)
T cd06631         153 AWVGLHG-THSNMLKSMHGTPYWMAPEVIN----ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GAHR  224 (265)
T ss_pred             hhccccc-cccccccccCCCccccChhhhc----CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---hhcc
Confidence            4221110 0111223457899999999984    445788999999999999999999999765443332211   1111


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .........++.++.+||++||..+|.+||++.+++.||||
T Consensus       225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11122344688999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.7e-41  Score=355.92  Aligned_cols=268  Identities=20%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             EEEEeccc--CceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         291 LLMLLGKG--GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       291 i~~~LG~G--~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      ++++||+|  +|++||++.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|. +.+.+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-----NEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-----HHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCEEE
Confidence            45779999  7899999999999999999998654321     112345667999999999999999999997 557788


Q ss_pred             EEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.++|+||+.+..
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~  150 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD---GKVYLSGLRSNLS  150 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC---CcEEEcccchhhc
Confidence            999999999999998653  46999999999999999999999988  9999999999999987   5899999987654


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ...................++..|+|||++...  ...++.++|||||||++|+|++|+.||........+.........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  228 (327)
T cd08227         151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  228 (327)
T ss_pred             cccccccccccccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcc
Confidence            332111100001112233678889999998521  235889999999999999999999999755443322221110000


Q ss_pred             ----------hc------------------------------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         527 ----------TE------------------------------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       527 ----------~~------------------------------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                                ..                              ...+....+++++.+||.+||++||++|||+.++++||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p  308 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS  308 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence                      00                              00011224578899999999999999999999999999


Q ss_pred             CCCCC
Q psy4988         567 YLQPP  571 (627)
Q Consensus       567 ~~~~~  571 (627)
                      ||...
T Consensus       309 ~f~~~  313 (327)
T cd08227         309 FFKQI  313 (327)
T ss_pred             hhhhc
Confidence            99753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-41  Score=345.07  Aligned_cols=260  Identities=21%  Similarity=0.338  Sum_probs=209.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++......       ....+.+|+.+++.++||||+++++++. +.+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~   79 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-------DFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRD   79 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCC
Confidence            35788888999999999999999999999999998654221       1235678999999999999999999987 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+++++|.+++...+.+++.+++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~---~~~~l~dfg~~~  154 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN---GHVKLADFGVSA  154 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEECcceeee
Confidence            78899999999999999988889999999999999999999999988  9999999999999876   589999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......|++.|+|||++... ....++.++|||||||++|+|++|..||........+... ....
T Consensus       155 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-~~~~  225 (267)
T cd06645         155 QITATI-------AKRKSFIGTPYWMAPEVAAVE-RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-TKSN  225 (267)
T ss_pred             EccCcc-------cccccccCcccccChhhhccc-cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-hccC
Confidence            654321       112334789999999987422 1334788999999999999999999999654433322211 1111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      .....+.....++..+.+||.+||..||++||++.+++.|||
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            111112222357889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0586|consensus

Probab=100.00  E-value=7.3e-42  Score=367.43  Aligned_cols=258  Identities=29%  Similarity=0.453  Sum_probs=220.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -...|.+...||+|.|+.|.+|++..++..||||++.....     .....+++.+|++||+.|+|||||+|+.+.+ ..
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-----n~~~~~k~~rev~imk~l~HPnIvkl~~v~~-t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-----NPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-TE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-----ChHHHHHHHHHHHHHHhcCCcceeeeeeeee-ec
Confidence            34569999999999999999999999999999999875543     2233456889999999999999999999998 55


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+.++.+++++..++++.+.+++.++.|++.|++|||+.+  |||||||.+||||+.+.   ++||+|||++
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~m---nikIaDfgfS  202 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENM---NIKIADFGFS  202 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccccc---ceeeeccccc
Confidence            678899999999999999999999999999999999999999999988  99999999999999984   7999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .++...        .+..+.||++.|.|||++.+   ..+.++.+|+||+|++||.|++|.+||++.....  +....+.
T Consensus       203 ~~~~~~--------~~lqt~cgsppyAaPEl~~g---~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr~rvl~  269 (596)
T KOG0586|consen  203 TFFDYG--------LMLQTFCGSPPYAAPELFNG---KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LRPRVLR  269 (596)
T ss_pred             eeeccc--------ccccccCCCCCccChHhhcC---cccCCcceehhhhhhhheeeeecccccCCccccc--ccchhee
Confidence            988744        34566799999999999853   3367889999999999999999999997654322  1122222


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                          ..+..+-.++.++++||+++|..+|.+|++++++..|.|+..
T Consensus       270 ----gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  270 ----GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             ----eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence                223333457899999999999999999999999999999753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-40  Score=345.00  Aligned_cols=255  Identities=33%  Similarity=0.490  Sum_probs=213.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||++.+..+++.||||++.....    ........+.+|+++++.++||||+++++++. +.+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI----VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-DDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh----hhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCe
Confidence            479999999999999999999999999999999864321    12233567889999999999999999999987 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+|+||+|.|||++.+   +.+||+|||++..
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~---~~~kl~dfg~~~~  150 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD---GYIKITDFGFAKR  150 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC---CCEEEeeCCCccc
Confidence            8899999999999999988889999999999999999999999988  9999999999999887   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ....          ....+|++.|+|||++.    ...++.++||||||+++|+|++|..||......... ..  +.  
T Consensus       151 ~~~~----------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~--~~--  211 (290)
T cd05580         151 VKGR----------TYTLCGTPEYLAPEIIL----SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-EK--IL--  211 (290)
T ss_pred             cCCC----------CCCCCCCccccChhhhc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH--Hh--
Confidence            6432          22347899999999884    335788999999999999999999999765532221 11  11  


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                       .........++..+.+||.+||..||.+|+     ++.++++||||...
T Consensus       212 -~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         212 -EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             -cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence             112223345789999999999999999999     99999999999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0584|consensus

Probab=100.00  E-value=2.7e-42  Score=371.12  Aligned_cols=262  Identities=26%  Similarity=0.465  Sum_probs=220.1

Q ss_pred             CCee-EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         287 DRYL-LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       287 ~rY~-i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      +||. ...+||+|+|-+||+|+|..+|..||---+.....   .......++|..|+.+|+.|+|||||++|++|.... 
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~---~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV---TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHh---hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            4443 45789999999999999999999988654433221   233445678999999999999999999999987433 


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+.+|+|++..|+|..|+++.+.+..+.++.|++||+.||.|||++.|||||||||.+||+|+.+.  |.|||+|+|||
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~--G~VKIGDLGLA  193 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL--GEVKIGDLGLA  193 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc--CceeecchhHH
Confidence            3478999999999999999999999999999999999999999999999999999999999999875  89999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +......         .....|||.|||||++     ...|+..+||||||++|+||+|+.+||..+.....|++...-.
T Consensus       194 tl~r~s~---------aksvIGTPEFMAPEmY-----EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG  259 (632)
T KOG0584|consen  194 TLLRKSH---------AKSVIGTPEFMAPEMY-----EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG  259 (632)
T ss_pred             HHhhccc---------cceeccCccccChHHH-----hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence            9887543         2235899999999987     3569999999999999999999999999999888887654432


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+. .|..  --.+++++||.+||.. .++|+++.++|.||||...
T Consensus       260 iKP~-sl~k--V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  260 IKPA-ALSK--VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             CCHH-Hhhc--cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            2221 1111  1247999999999999 9999999999999999875

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.3e-41  Score=342.58  Aligned_cols=260  Identities=25%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++......        ...+.+|+.+++.+ +||||++++++|...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--------EEEIKQEINMLKKYSHHRNIATYYGAFIKK   75 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--------HHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence            356788899999999999999999999999999998643211        13567899999988 799999999998643


Q ss_pred             -----CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         364 -----ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       364 -----~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                           ...+|+||||+++++|..++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+
T Consensus        76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~---~~~  150 (272)
T cd06637          76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN---AEV  150 (272)
T ss_pred             CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC---CCE
Confidence                 24688999999999999998763  46899999999999999999999988  9999999999999987   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +|+|||++..+....       .......|++.|+|||++.... ....++.++|||||||+||+|++|..||.......
T Consensus       151 ~l~Dfg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~  223 (272)
T cd06637         151 KLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  223 (272)
T ss_pred             EEccCCCceeccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            999999998654321       1123347899999999985321 13458889999999999999999999996544332


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ....   . ............++.++.+||.+||..||.+|||+.+++.||||
T Consensus       224 ~~~~---~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         224 ALFL---I-PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHH---H-hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2211   1 11111222234678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-40  Score=340.37  Aligned_cols=268  Identities=25%  Similarity=0.416  Sum_probs=212.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh---HhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE---DKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~---~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+........   ......++.+.+|+.+++.++||||+++++++. ..
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET-TE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec-cC
Confidence            58899999999999999999999999999998764322111   122334567888999999999999999999887 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+++||||+++++|..++.....+++..++.++.||+.||.|||+.+  ++|+||+|+||+++.+   +.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~---~~~~l~d~~~~  155 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD---GICKISDFGIS  155 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC---CeEEEeecccc
Confidence            778899999999999999988889999999999999999999999988  9999999999999976   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +........     .......|+..|+|||++...  ...++.++||||||+++|+|++|..||........+.......
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDN-----DQNMSMQGSVFWMAPEVIHSY--SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR  228 (272)
T ss_pred             ccccccccc-----cccccccCCccccCHHHhccc--cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc
Confidence            765432110     112334689999999987422  1247889999999999999999999996544433332211111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ............++.++.+||.+||..+|.+||++.++++||||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            11111111224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.3e-41  Score=342.41  Aligned_cols=260  Identities=21%  Similarity=0.331  Sum_probs=208.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......       ....+.+|+.+++.++||||+++++++. ..+
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~~e~~~l~~~~h~~ii~~~~~~~-~~~   79 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-------DFSLIQQEIFMVKECKHCNIVAYFGSYL-SRE   79 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-------hHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCC
Confidence            46799999999999999999999999999999998643221       1235678999999999999999999997 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++.
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~---~~~~l~dfg~~~  154 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN---GDVKLADFGVAA  154 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC---CCEEECcCccce
Confidence            78899999999999999988888999999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....       ......|++.|+|||.+... ....++.++|||||||++|+|++|..||.............. ..
T Consensus       155 ~~~~~~~-------~~~~~~~~~~y~~PE~~~~~-~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-~~  225 (267)
T cd06646         155 KITATIA-------KRKSFIGTPYWMAPEVAAVE-KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-SN  225 (267)
T ss_pred             eeccccc-------ccCccccCccccCHhHcccc-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-CC
Confidence            7643211       11234688999999987422 233467899999999999999999999964433222111000 00


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      .....+.....++..+.+||++||..||++||++.++++|+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         226 FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            011112222457899999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-40  Score=345.76  Aligned_cols=260  Identities=23%  Similarity=0.403  Sum_probs=213.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ...+|.+.+.||.|+||.||+|.+..++..||||.+......       ....+.+|+.+++.++||||++++++|. +.
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-------~~~~~~~e~~~l~~~~h~~v~~~~~~~~-~~   89 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------KKELIINEILVMRENKNPNIVNYLDSYL-VG   89 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-------hHHHHHHHHHHHHhCCCCCEeeEEEEEE-eC
Confidence            446899999999999999999999999999999988654321       1245778999999999999999999987 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+++++|..++.. ..+++.++..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~---~~~kl~dfg~~  163 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFC  163 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC---CCEEECccccc
Confidence            788999999999999998865 46899999999999999999999988  9999999999999876   58999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ........       ......|++.|+|||++.    ...++.++|||||||++|+|++|+.||........+...   .
T Consensus       164 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~  229 (296)
T cd06654         164 AQITPEQS-------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A  229 (296)
T ss_pred             hhcccccc-------ccCcccCCccccCHHHHc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---h
Confidence            86543211       112347899999999884    445788999999999999999999999766554333221   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ............++..+.+||.+||..||.+||++.+++.||||....
T Consensus       230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            111112233456889999999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-40  Score=339.85  Aligned_cols=268  Identities=21%  Similarity=0.353  Sum_probs=213.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|+..+.||+|+||.||++.+..++..||||++....... .........+.+|+.+++.++|||||++++++. +.+.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   78 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSHF   78 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc-hhHHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCeE
Confidence            4778899999999999999999999999999986443211 122334577889999999999999999999997 66788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+.  ..+||+|||++..+
T Consensus        79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~  154 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTG--QRLRIADFGAAARL  154 (268)
T ss_pred             EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC--CEEEEccccccccc
Confidence            899999999999999988889999999999999999999999988  99999999999998653  36999999999877


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      .......   ........|+..|+|||++.    ...++.++|||||||++|+|++|..||................. .
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~~~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~  226 (268)
T cd06630         155 AAKGTGA---GEFQGQLLGTIAFMAPEVLR----GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-A  226 (268)
T ss_pred             ccccccC---CccccccccccceeCHhHhc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-c
Confidence            5432110   11123346899999999984    44578899999999999999999999964432211111111100 1


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ......+..++.++.+||.+||..+|.+||++.++++||||.
T Consensus       227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            111222345789999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0577|consensus

Probab=100.00  E-value=6.7e-42  Score=362.40  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=211.9

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.-++.||.|+||-||.|++..+.+.||||.+......    ...-.+.++.|+.+|.++.|||+|.+-+||. .....|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ----s~EKWqDIlKEVrFL~~l~HPntieYkgCyL-re~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ----SNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-REHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc----cHHHHHHHHHHHHHHHhccCCCcccccceee-ccchHH
Confidence            44456699999999999999999999999987654332    2233567999999999999999999999997 445677


Q ss_pred             EEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ||||||-| +-.+++. ..+++-+.++..|..+.+.||.|||+++  .||||||..||||.+.   |.|||+|||.|..+
T Consensus       103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~---g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEP---GLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCC---Ceeeeccccchhhc
Confidence            99999985 5566664 3468999999999999999999999999  9999999999999988   79999999999876


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ..           ...++|||+|||||+|+--. ...|+-++||||||+++.||.-.++|+...+....++.+   ....
T Consensus       177 ~P-----------AnsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNe  241 (948)
T KOG0577|consen  177 AP-----------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNE  241 (948)
T ss_pred             Cc-----------hhcccCCccccchhHheecc-ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcC
Confidence            54           34569999999999986443 556999999999999999999999998766554444322   1112


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ...+ .....|+.+..||..||.+-|.+|||.+++|.|+|+....|
T Consensus       242 sPtL-qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  242 SPTL-QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             CCCC-CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            2222 24567899999999999999999999999999999875533

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-41  Score=345.37  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=210.5

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||.||++.+..++..||+|.+.....      ......+.+|+.++++++||||++++++|. ..+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD------ESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC------HHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCe
Confidence            468899999999999999999999999999998764321      122356889999999999999999999987 5677


Q ss_pred             EEEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +++||||+++++|..++...   ..+++..+..++.||+.||.|||+ .+  |+|+||||+|||++.+   +.+||+|||
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~---~~~~l~dfg  148 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN---GQVKLCDFG  148 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC---CCEEEeecC
Confidence            88999999999999888763   379999999999999999999996 46  9999999999999986   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK--NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ++..+....         .....+++.|+|||++....  ....++.++|||||||+||+|++|..||............
T Consensus       149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  219 (286)
T cd06622         149 VSGNLVASL---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL  219 (286)
T ss_pred             CcccccCCc---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence            997654321         23346889999999874322  1234688999999999999999999999654433222111


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+.....  ...++.++.++.+||.+||..+|.+||++.+++.||||...
T Consensus       220 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         220 SAIVDGDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             HHHhhcCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            11111111  12234588999999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=346.17  Aligned_cols=267  Identities=32%  Similarity=0.492  Sum_probs=216.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||+|.+..+++.||||.+.......    ......+.+|+++++.++||||+++++++. +...
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----RNKVKRVLTEQEILATLDHPFLPTLYASFQ-TETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch----HHHHHHHHHHHHHHHhCCCCCchhheeeee-cCCE
Confidence            47999999999999999999999999999999986543221    223567889999999999999999999987 6678


Q ss_pred             EEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +|+||||+.+++|..++...  ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~---~~~~l~dfg~~  150 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES---GHIMLSDFDLS  150 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC---CCEEEeecchh
Confidence            89999999999999998754  57999999999999999999999988  9999999999999986   68999999998


Q ss_pred             cccccCCCCCCC----------------------CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDH----------------------GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL  502 (627)
Q Consensus       445 ~~~~~~~~~~~~----------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell  502 (627)
                      ............                      .........||..|+|||++.    +..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS----GDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc----CCCCCchHHHHHHHHHHHHHh
Confidence            765432111000                      000112346899999999984    445788999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC----HHHHHhccCCCCC
Q psy4988         503 YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID----VISLARHDYLQPP  571 (627)
Q Consensus       503 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt----~~elL~hp~~~~~  571 (627)
                      +|..||........+...    ......++....++.++.+||.+||+.||++||+    +.+++.||||+..
T Consensus       227 ~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         227 YGTTPFKGSNRDETFSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             hCCCCCCCCchHHHHHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            999999766554443221    1222334444457899999999999999999999    9999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-40  Score=345.77  Aligned_cols=259  Identities=24%  Similarity=0.453  Sum_probs=201.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcC----------------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLK----------------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL  348 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~----------------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l  348 (627)
                      ..++|.+.++||+|+||.||+|.+..                ++..||||++.....      ......+.+|+.++..+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l   76 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN------KNARNDFLKEVKILSRL   76 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC------HHHHHHHHHHHHHHhhc
Confidence            35789999999999999999997532                345799998864322      12345688999999999


Q ss_pred             CCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc-------------------cCcCHHHHHHHHHHHHHHHHHHH
Q psy4988         349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------------------KTIAEREARSIVMQVVSALKYLN  409 (627)
Q Consensus       349 ~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~~l~e~~~~~i~~qi~~aL~yLH  409 (627)
                      +|||||+++++|. +.+.+|+||||+.+++|.+++...                   ..+++..+..|+.||+.||.|||
T Consensus        77 ~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          77 KDPNIIRLLGVCV-DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             CCCCeeEEEEEEe-cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999997 556788999999999999988643                   23678889999999999999999


Q ss_pred             hCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcch
Q psy4988         410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKV  489 (627)
Q Consensus       410 ~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~  489 (627)
                      +.+  |+||||||+|||++.+   +.+||+|||+++.+.....     ........+++.|+|||++.    ...++.++
T Consensus       156 ~~~--ivH~dlkp~Nill~~~---~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~  221 (304)
T cd05096         156 SLN--FVHRDLATRNCLVGEN---LTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECIL----MGKFTTAS  221 (304)
T ss_pred             HCC--ccccCcchhheEEcCC---ccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHh----cCCCCchh
Confidence            988  9999999999999986   6899999999986643321     11223345688999999984    34588999


Q ss_pred             hHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhhh--hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         490 DVWSVGVIFYQCLY--GKKPFGHNQSQATILEENTILKA--TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       490 DVwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |||||||++|+|++  +..||........+.........  ........+.++..+.+||.+||..||.+|||+.+|..
T Consensus       222 Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         222 DVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             hhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            99999999999986  66788765544333222111111  11122234567899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.7e-40  Score=344.62  Aligned_cols=261  Identities=25%  Similarity=0.423  Sum_probs=215.0

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ...+|.+.+.||.|+||.||+|.+..+++.||||.+......       ....+.+|+.+++.++||||++++++|. +.
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-------KKELIINEILVMKELKNPNIVNFLDSFL-VG   88 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-------hHHHHHHHHHHHHhcCCCceeeeeeeEe-cC
Confidence            346799999999999999999999999999999988643221       1245788999999999999999999987 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+|+||+++++|..++.. ..+++.++..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~---~~~kl~dfg~~  162 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD---GSVKLTDFGFC  162 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEccCccc
Confidence            788999999999999998865 46999999999999999999999988  9999999999999876   68999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ........       ......|++.|+|||.+.    ...++.++|||||||++|+|++|..||............   .
T Consensus       163 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~  228 (296)
T cd06655         163 AQITPEQS-------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A  228 (296)
T ss_pred             hhcccccc-------cCCCcCCCccccCcchhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H
Confidence            86643321       122346899999999884    445788999999999999999999999776554333211   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ......+..+..+++.+.+||++||..||.+||++.+++.||||....+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         229 TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            1112223344568899999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-40  Score=334.33  Aligned_cols=254  Identities=29%  Similarity=0.486  Sum_probs=209.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|.+.+.||+|+||.||+|.+..+++.|++|.+......     ......+.+|+.+++.++||||+++++++. +.+.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----RREREEAIDEARVLAKLDSSYIIRYYESFL-DKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----HHHHHHHHHHHHHHHhcCCCCeehheeeec-cCCEE
Confidence            478899999999999999999999999999988643221     223456889999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||+++
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~---~~~~l~df~~~~  149 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY---DNVKIGDLGVAK  149 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC---CCEEEcccccce
Confidence            9999999999999998764  57899999999999999999999988  9999999999999986   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       .......|++.|+|||++.    ...++.++|||||||++|+|++|+.||...........   +..
T Consensus       150 ~~~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~  215 (256)
T cd08529         150 LLSDNT-------NFANTIVGTPYYLSPELCE----DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK---IIR  215 (256)
T ss_pred             eccCcc-------chhhccccCccccCHHHhc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHc
Confidence            765432       1123346899999999984    44578899999999999999999999976653322211   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...  .+....++.++.++|.+||+.+|++||++.+++.|||+
T Consensus       216 ~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         216 GVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCC--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            111  11122678899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0197|consensus

Probab=100.00  E-value=1.1e-41  Score=362.33  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=206.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ..+.+++.||+|-||+||+|... ....||||.+......        ...|++|++||++|+|+|||+|+++|. ....
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~--------~~~f~~Ea~iMk~L~H~~lV~l~gV~~-~~~p  275 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS--------PEAFLREAQIMKKLRHEKLVKLYGVCT-KQEP  275 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC--------hhHHHHHHHHHHhCcccCeEEEEEEEe-cCCc
Confidence            34556778999999999999753 4458999998654322        135889999999999999999999998 4457


Q ss_pred             EEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +|||||||+.|+|.++|+.  ...+...+.+.++.|||+|++||++++  +|||||-..||||+++   ..+||+|||||
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~---~~vKIsDFGLA  350 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED---LVVKISDFGLA  350 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC---ceEEEcccccc
Confidence            8899999999999999986  568999999999999999999999998  9999999999999998   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.+.++.|....+.      --.+.|.|||++.    ...++.++|||||||+||||+| |+.||......+.+...   
T Consensus       351 r~~~d~~Y~~~~~~------kfPIkWtAPEa~~----~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l---  417 (468)
T KOG0197|consen  351 RLIGDDEYTASEGG------KFPIKWTAPEALN----YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL---  417 (468)
T ss_pred             cccCCCceeecCCC------CCCceecCHHHHh----hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH---
Confidence            97776665433222      3356799999995    4559999999999999999995 99999877665554221   


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        .....++.+..+|+++-+++..||+.+|++|||.+.+..
T Consensus       418 --e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  418 --ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             --hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence              234567778899999999999999999999999997753

>KOG0608|consensus

Probab=100.00  E-value=3.1e-41  Score=359.48  Aligned_cols=270  Identities=26%  Similarity=0.394  Sum_probs=221.0

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -..-|..++.||-|+||+|.++....|...||+|.+++..    ....+.+.++..|-.||..-+.++||+||..|+ |.
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD----Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQ-Dk  701 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD----VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DK  701 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH----HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-cC
Confidence            3445888999999999999999999999999999876432    234455678888999999999999999999998 78


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+||+|++||++..+|.+-+.|+|..++.++.++.+||+++|..|  +|||||||+|||||.+   |+|||+||||+
T Consensus       702 dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd---GHIKLTDFGLC  776 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD---GHIKLTDFGLC  776 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC---Cceeeeecccc
Confidence            889999999999999999999999999999999999999999999999  9999999999999998   79999999999


Q ss_pred             cccccC---CCC------CCCCccc--------------------------cccCCCCCccCCccccccCCCCCCCCcch
Q psy4988         445 KVMDEE---NYN------PDHGMDL--------------------------TSQGAGTYWYLPPECFVVGKNPPKISSKV  489 (627)
Q Consensus       445 ~~~~~~---~~~------~~~~~~~--------------------------~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~  489 (627)
                      +-+.-.   .|.      -...++.                          ....+||+.|+|||++.    ...|+..|
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~----r~g~~q~c  852 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA----RTGYTQLC  852 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc----ccCccccc
Confidence            643211   100      0000000                          11346999999999994    56689999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhcc
Q psy4988         490 DVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHD  566 (627)
Q Consensus       490 DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp  566 (627)
                      |+||.|||||||++|++||-.+.......+.  +.+...+.++....+|.++.+||.+++ .++++|.   -.+++-.||
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv--~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHp  929 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQYKV--INWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHP  929 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcceeee--eehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCc
Confidence            9999999999999999999777665554332  333445677777889999999999754 5667776   466799999


Q ss_pred             CCCCC
Q psy4988         567 YLQPP  571 (627)
Q Consensus       567 ~~~~~  571 (627)
                      ||...
T Consensus       930 fFkgI  934 (1034)
T KOG0608|consen  930 FFKGI  934 (1034)
T ss_pred             ccccc
Confidence            99865

>KOG0983|consensus

Probab=100.00  E-value=4.9e-41  Score=328.92  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=209.8

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      ++..||.|+.|+||++..+.++...|||.+......      +..++++..+.++... ++|+||+.+++|..+.+ ++|
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk------ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-V~I  168 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK------EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-VFI  168 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCH------HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-HHH
Confidence            445699999999999999999999999998765432      2245778888876655 59999999999986655 458


Q ss_pred             EEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         370 VLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       370 V~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      .||.|.. .++.+++ -.++++|..+-++...++.||.||.+. ++|||||+||+|||||+.   |+|||||||++-.+.
T Consensus       169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~---GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDER---GNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccC---CCEEeecccccceee
Confidence            8999874 3444444 457899999999999999999999774 359999999999999987   799999999998877


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE  528 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  528 (627)
                      +...        .+..+|.+.|||||.+... +.+.|+.++||||||++|+||.||+.||..++.+...+..  ++....
T Consensus       244 dSkA--------htrsAGC~~YMaPERidp~-~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk--vln~eP  312 (391)
T KOG0983|consen  244 DSKA--------HTRSAGCAAYMAPERIDPP-DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK--VLNEEP  312 (391)
T ss_pred             cccc--------cccccCCccccCccccCCC-CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH--HHhcCC
Confidence            6532        2344899999999998543 3678999999999999999999999999887776665543  233334


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ..++....+|+.+.+|+..||.+|+.+||.+.++|+|||+.
T Consensus       313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            55555566999999999999999999999999999999975

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-40  Score=346.14  Aligned_cols=262  Identities=24%  Similarity=0.412  Sum_probs=213.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ...+|.+++.||.|+||.||++.+..+++.||||.+......       ....+.+|+.+++.++||||++++++|. ..
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~   88 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-------KKELIINEILVMRENKNPNIVNYLDSYL-VG   88 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-------hHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            457899999999999999999999999999999998654321       1235778999999999999999999997 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+++++|..++.. ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~---~~~~l~Dfg~~  162 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFC  162 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEECcCccc
Confidence            788899999999999998865 56899999999999999999999988  9999999999999876   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ........       ......+++.|+|||.+.    ...++.++|||||||++|+|++|..||........+..   ..
T Consensus       163 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~  228 (297)
T cd06656         163 AQITPEQS-------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA  228 (297)
T ss_pred             eEccCCcc-------CcCcccCCccccCHHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---ec
Confidence            86543321       122346899999999984    44578899999999999999999999976544322211   11


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      ............++..+.+||.+||..||.+||++.+++.||||....+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         229 TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            11111222334678899999999999999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-40  Score=336.12  Aligned_cols=261  Identities=25%  Similarity=0.382  Sum_probs=212.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||.|+||+||+|.+..++..||||++.......      ....+.+|+.+++.++|+||+++++.+. +.+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------SVDELRKEVQAMSQCNHPNVVKYYTSFV-VGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch------HHHHHHHHHHHHHhcCCCCEEEEEEEEe-eCCE
Confidence            47999999999999999999998899999999986433211      3457889999999999999999999887 5678


Q ss_pred             EEEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      +++||||+++++|..++...   ..+++..++.++.||+.||.|||+.+  |+|+||||+||+++++   +.++|+|||+
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~---~~~~l~df~~  148 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED---GSVKIADFGV  148 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC---CCEEEcccch
Confidence            88999999999999999764   46899999999999999999999988  9999999999999987   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +..+.......   ........|+..|+|||++...   ..++.++|||||||++|+|++|+.||........+....  
T Consensus       149 ~~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--  220 (267)
T cd06610         149 SASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--  220 (267)
T ss_pred             HHHhccCcccc---ccccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh--
Confidence            98776433211   0122334689999999998522   357889999999999999999999997655443322211  


Q ss_pred             hhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                       ......+..   ...+++++.+||.+||..||++||++.+++.||||
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         221 -QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence             111111221   23678999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-40  Score=337.62  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=209.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-CCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-ANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~  366 (627)
                      .|.+.+.||+|+||.||+|.+..++..||+|++.......  ........+.+|+.+++.++||||+++++++... ...
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP--ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc--hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence            5888999999999999999999999999999876543211  1223345688899999999999999999988643 456


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++..
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~---~~~~l~dfg~~~~  155 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA---GNVKLGDFGASKR  155 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC---CCEEEccCCCccc
Confidence            8899999999999999988888999999999999999999999988  9999999999999876   5899999999986


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.......    .......++..|+|||++.    ...++.++|||||||++|+|++|+.||........+....  ...
T Consensus       156 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~--~~~  225 (266)
T cd06651         156 LQTICMSG----TGIRSVTGTPYWMSPEVIS----GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA--TQP  225 (266)
T ss_pred             cccccccC----CccccCCccccccCHHHhC----CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh--cCC
Confidence            54321100    1112246899999999984    4457889999999999999999999997654433332211  111


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..  ...+..+++.+.+|| +||..+|++||++.++++||||++
T Consensus       226 ~~--~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~  266 (266)
T cd06651         226 TN--PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL  266 (266)
T ss_pred             CC--CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence            11  112235678899999 577789999999999999999963

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=335.20  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=211.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||.|+||.||+|.+..+++.|+||++......       ..+.+.+|+.+++.++||||+++++++. +.+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~   73 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-------DFEIIQQEISMLKECRHPNIVAYFGSYL-RRD   73 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-------hHHHHHHHHHHHHhCCCCChhceEEEEE-eCC
Confidence            36899999999999999999999999999999998654321       3457889999999999999999999887 667


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+++++|..++... ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.+   +.+||+|||++
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~---~~~~l~d~g~~  148 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED---GDVKLADFGVS  148 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC---CCEEECccccc
Confidence            889999999999999998776 78999999999999999999999988  9999999999999986   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+....       .......++..|+|||.+.... ...++.++|||||||++|+|++|..||.............. .
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~-~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~  219 (262)
T cd06613         149 AQLTATI-------AKRKSFIGTPYWMAPEVAAVER-KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-S  219 (262)
T ss_pred             hhhhhhh-------hccccccCCccccCchhhcccc-cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-c
Confidence            8764321       0112346889999999884321 13678899999999999999999999976654443322111 1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      ............++.++.+||++||..||.+|||+.+++.|+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         220 NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             cCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            0011112223456788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=343.93  Aligned_cols=263  Identities=28%  Similarity=0.479  Sum_probs=214.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||.|+||.||++.+..++..||+|++....       ......+.+|+.+++.++||||+++++++. +..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~   75 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-------EEELEDFMVEIDILSECKHPNIVGLYEAYF-YEN   75 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-------HHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCC
Confidence            367999999999999999999998899999999986432       122456888999999999999999999997 567


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+++++|..++... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~---~~~~l~d~g~~  150 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD---GDVKLADFGVS  150 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC---CCEEEccCccc
Confidence            788999999999999998764 57999999999999999999999988  9999999999999887   68999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ........       ......|++.|+|||++.... ....++.++|||||||++|+|++|+.||........+..   +
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~---~  220 (280)
T cd06611         151 AKNKSTLQ-------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK---I  220 (280)
T ss_pred             hhhccccc-------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH---H
Confidence            76543211       122346899999999875321 234578899999999999999999999976544333322   1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......+..+..++.++.+||.+||+.+|.+||++.++++||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         221 LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             hcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            121222333345688999999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.9e-40  Score=334.33  Aligned_cols=264  Identities=26%  Similarity=0.451  Sum_probs=216.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      ||.+.+.||+|+||.||++.+..+++.||||++......     ......+.+|+.+++.++|+||+++++++. +.+.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-----PKTIKEIADEMKVLELLKHPNLVKYYGVEV-HREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----hHHHHHHHHHHHHHHhCCCCChhheeeeEe-cCCEE
Confidence            689999999999999999999999999999998755332     344678899999999999999999999876 66788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||+|+|||++.+   +.+||+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~---~~~kl~d~g~~~~~  149 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN---GVIKLGDFGCAVKL  149 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEccccccccc
Confidence            999999999999999988778999999999999999999999988  9999999999999986   68999999999877


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ........   .......+++.|+|||++.... ...++.++||||||+++|+|++|..||............  .....
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~  223 (264)
T cd06626         150 KNNTTTMG---EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGH  223 (264)
T ss_pred             CCCCCccc---ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCC
Confidence            54432111   1012346889999999985322 234788999999999999999999999654333222211  11123


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...++....++..+.+||.+||..+|.+||++.+++.|||+
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            33445555678999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.1e-40  Score=341.76  Aligned_cols=260  Identities=28%  Similarity=0.467  Sum_probs=210.5

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |++.+.||.|+||.||++.+..++..|++|.+....       ......+.+|+.+++.++||||++++++|. ..+.++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~   78 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-------EEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLW   78 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-eCCEEE
Confidence            678888999999999999999999999999875432       122456788999999999999999999987 567788


Q ss_pred             EEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      +||||+++++|..++.. ...+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++...
T Consensus        79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~---~~~kl~dfg~~~~~  153 (282)
T cd06643          79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD---GDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC---CCEEEccccccccc
Confidence            99999999999888754 467999999999999999999999988  9999999999999876   58999999999765


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ....       .......+++.|+|||++.... ....++.++|||||||++|+|++|..||.............   ..
T Consensus       154 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~  223 (282)
T cd06643         154 TRTI-------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KS  223 (282)
T ss_pred             cccc-------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hc
Confidence            4321       1122346899999999974221 23457889999999999999999999997655443332221   11


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......+..++.++.+||.+||..||.+||++.++++||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            111223344678999999999999999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574|consensus

Probab=100.00  E-value=1.4e-43  Score=350.03  Aligned_cols=254  Identities=27%  Similarity=0.518  Sum_probs=218.0

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.++++||+|+||.||+|+++.+|..||||.+....+         +++++.||.|+.+++.|+||++|+.|. ....++
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---------LQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLW  104 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---------LQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLW  104 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---------HHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceE
Confidence            5678889999999999999999999999998765433         567899999999999999999999876 455688


Q ss_pred             EEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ||||||..|++.+.+. ++++|++.++..|+...+.||+|||..+  -||||||..||||+-+   |++||+|||.|-.+
T Consensus       105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~---G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD---GIAKLADFGVAGQL  179 (502)
T ss_pred             eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc---chhhhhhccccchh
Confidence            9999999999999886 4579999999999999999999999988  8999999999999877   79999999999877


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      .+.       +....+..|||.|||||++.    .-.|++++||||||++..||.-|++||.+..+...+.   .+....
T Consensus       180 TDT-------MAKRNTVIGTPFWMAPEVI~----EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~P  245 (502)
T KOG0574|consen  180 TDT-------MAKRNTVIGTPFWMAPEVIE----EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKP  245 (502)
T ss_pred             hhh-------HHhhCccccCcccccHHHHH----HhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCC
Confidence            542       33456678999999999994    4569999999999999999999999997655543321   233334


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ...|..+...|+++.|||+.||.++|++|-|+.++++|+|+...
T Consensus       246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            45555556678999999999999999999999999999998754

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.6e-40  Score=338.81  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=209.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      ..++|.+.+.||.|+||.||++.+..+++.||||++......        ...+.+|+.++.++ +||||++++++|...
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~--------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV--------DEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH--------HHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            468899999999999999999999999999999997543211        23466788999988 899999999998643


Q ss_pred             C----CeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         364 A----NSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       364 ~----~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      .    ..+++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~---~~  166 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE---GG  166 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC---CC
Confidence            2    458899999999999988753    457899999999999999999999988  9999999999999886   58


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      +||+|||++..+......       .....|+..|+|||++.... ....++.++|||||||++|+|++|+.||......
T Consensus       167 ~kl~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             EEEeecccchhccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            999999999876532211       12246899999999874321 1224688999999999999999999999765544


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ..+...   .......+.....++..+.+||.+||.+||++||++.+++.||||+
T Consensus       240 ~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         240 KTLFKI---PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHH---hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            333221   1111222233345778999999999999999999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0596|consensus

Probab=100.00  E-value=2.6e-41  Score=357.29  Aligned_cols=263  Identities=29%  Similarity=0.484  Sum_probs=205.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~  364 (627)
                      ...|+++++||.||-+.||++..- +.+.||+|.+...     ......+.-+..|+..|.+| +|.+||+||||-. ..
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-----~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-~d  432 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-----EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-TD  432 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-----hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-cC
Confidence            346999999999999999999754 4455666644321     23344567899999999999 4999999999754 67


Q ss_pred             CeEEEEEeecCCCChHHHHHhccC-cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ..+||||||- ..+|..+|+.... ++...++.|..|++.|+.++|.+|  |||.||||.|+||-+    |.+||+|||+
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk----G~LKLIDFGI  505 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK----GRLKLIDFGI  505 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe----eeEEeeeech
Confidence            7899999964 4799999987754 444688999999999999999999  999999999999987    5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCC-------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-------NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-------~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      |..+..+...     -.....+||+.||+||.+....       ....++.++||||||||||+|++|+.||+.......
T Consensus       506 A~aI~~DTTs-----I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a  580 (677)
T KOG0596|consen  506 ANAIQPDTTS-----IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA  580 (677)
T ss_pred             hcccCccccc-----eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH
Confidence            9988765432     2334569999999999985322       123477899999999999999999999975433222


Q ss_pred             HHHHHHHhhh-hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         517 ILEENTILKA-TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       517 ~~~~~~~~~~-~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      -  ...+... .++.|+.-+. ..++.++++.||.+||.+||++.++|+|||+++
T Consensus       581 K--l~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  581 K--LHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             H--HHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            1  1222222 3345554332 234999999999999999999999999999987

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-40  Score=342.21  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=209.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.++||+|+||.||+|.+..+++.||||++.......     ...+.+.+|+++++.++||||++++++|. +...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-----MVKKIAMREIRMLKQLRHENLVNLIEVFR-RKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-----hhhHHHHHHHHHHHhcCCcchhhHHHhcc-cCCe
Confidence            47999999999999999999999899999999875432211     22345778999999999999999999997 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..+......+++..++.++.||+.||.|||+.+  |+|+||+|+||+++++   +.++|+|||++..
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~---~~~~l~dfg~~~~  149 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS---GVVKLCDFGFART  149 (286)
T ss_pred             EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC---CcEEEEeeeeeee
Confidence            8999999999999888777677999999999999999999999988  9999999999999887   5899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......++..|+|||++..   ...++.++|||||||++|+|++|.+||........+.........
T Consensus       150 ~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07846         150 LAAPGE-------VYTDYVATRWYRAPELLVG---DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN  219 (286)
T ss_pred             ccCCcc-------ccCcccceeeccCcHHhcc---ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCC
Confidence            644321       1223468899999998842   234778999999999999999999999765543322111110000


Q ss_pred             ---------------hcccc----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 ---------------TEVQF----------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ---------------~~~~~----------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                     .....          ...+.++..+.+||.+||..+|.+||++.+++.||||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             CchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                           00000          1124678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.2e-40  Score=339.75  Aligned_cols=266  Identities=29%  Similarity=0.459  Sum_probs=210.2

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEee
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYD  358 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~  358 (627)
                      .......++|.+++.||+|+||.||+|.+..+++.||||++......        ...+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--------DEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--------HHHHHHHHHHHHHHhcCCCeeeeee
Confidence            33456788999999999999999999999999999999987532211        13466799999998 6999999999


Q ss_pred             EEee----cCCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC
Q psy4988         359 VFEI----DANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       359 ~~~~----~~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~  430 (627)
                      ++..    +.+.+++||||+++++|..++..    ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~  160 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC
Confidence            8742    34568999999999999988752    357899999999999999999999988  9999999999999987


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                         +.+||+|||+++.+.....       ......|++.|+|||++.... ....++.++|||||||++|+|++|+.||.
T Consensus       161 ---~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         161 ---GGVKLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             ---CCEEEccCCceeecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence               5799999999987643221       112336899999999874221 12447889999999999999999999997


Q ss_pred             CCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .......+...   .............++.++.+||.+||+.||.+|||+.+++.|+||
T Consensus       231 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         231 DLHPMRALFKI---PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCchhHHHhhc---cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            65443332211   111111222233467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=336.82  Aligned_cols=261  Identities=27%  Similarity=0.448  Sum_probs=210.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      ..++|.+.+.||.|+||.||+|.+..+++.|++|++.....        ....+.+|+.+++++ +|+||++++++|...
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   75 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--------EEEEIKEEYNILRKYSNHPNIATFYGAFIKK   75 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence            46899999999999999999999999999999999865432        124578899999999 799999999998632


Q ss_pred             -----CCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         364 -----ANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       364 -----~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                           ...+++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+  |+|+||+|+||+++.+   +
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~---~  150 (275)
T cd06608          76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN---A  150 (275)
T ss_pred             CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC---C
Confidence                 3358899999999999998764    358999999999999999999999988  9999999999999986   5


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      .++|+|||++.......       .......|++.|+|||++.... ....++.++|||||||+||+|++|..||.....
T Consensus       151 ~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  223 (275)
T cd06608         151 EVKLVDFGVSAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP  223 (275)
T ss_pred             eEEECCCccceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence            89999999997654321       1123346899999999875321 234578899999999999999999999975544


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...+..   +.......+.....++.++.+||.+||..||.+|||+.+++.|||+
T Consensus       224 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         224 MRALFK---IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHH---hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            333322   1121222223333477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-39  Score=333.46  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=210.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-CC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-AN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~  365 (627)
                      ..|.+.+.||+|+||.||++.+..+++.||||.+.......  .....+..+.+|+.+++.++||||+++++++... ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   79 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP--ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER   79 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc--ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence            46899999999999999999999999999999876433211  1122356788899999999999999999988643 35


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++.
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~---~~~~l~Dfg~~~  154 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV---GNVKLGDFGASK  154 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC---CCEEECcCcccc
Confidence            67899999999999999988788999999999999999999999988  9999999999999876   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.......    .......|+..|+|||++.    ...++.++|||||||++|+|++|+.||........+...  .  
T Consensus       155 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~--  222 (265)
T cd06652         155 RLQTICLSG----TGMKSVTGTPYWMSPEVIS----GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--A--  222 (265)
T ss_pred             ccccccccc----cccccCCCCccccChhhhc----CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH--h--
Confidence            654321110    1122346899999999984    345788999999999999999999999765433333211  1  


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ........+..++..+.++|.+|| .+|.+||++.+++.|||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         223 TQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence            111112223467889999999999 4999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5e-40  Score=341.46  Aligned_cols=265  Identities=28%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||+|.+..+++.||||.+.......  ........+..|+.+++.++|+||+++++++. +.+.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE--AKDGINFTALREIKLLQELKHPNIIGLLDVFG-HKSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc--ccchhhHHHHHHHHHHhhcCCCCChhhhheee-cCCEE
Confidence            5889999999999999999999999999999986543211  11223345678999999999999999999998 56788


Q ss_pred             EEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++||||+ +++|..++.... .+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||+++.
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~---~~~~l~dfg~~~~  151 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD---GVLKLADFGLARS  151 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC---CCEEEccceeeee
Confidence            9999999 889999998766 8999999999999999999999988  9999999999999986   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......       ......+++.|+|||++.   ....++.++|||||||++|+|++|.+||........+.........
T Consensus       152 ~~~~~~-------~~~~~~~~~~y~aPE~~~---~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         152 FGSPNR-------KMTHQVVTRWYRAPELLF---GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             ccCCCc-------cccccccceeeeCHHHHh---CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence            654321       112235688999999874   2335788999999999999999998888665543332221111000


Q ss_pred             h-cccc---------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         527 T-EVQF---------------------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       527 ~-~~~~---------------------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      . ...+                     .....++.++.+||.+||.+||.+||++.+++.|+||...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence            0 0000                     0113457899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.2e-40  Score=339.36  Aligned_cols=260  Identities=28%  Similarity=0.441  Sum_probs=201.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||+|+||.||+|.+..++..||||++.......      ....+.+|+.+++.++|+||+++++++. +..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~   76 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG------VPFTAIREASLLKGLKHANIVLLHDIIH-TKE   76 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC------CcHHHHHHHHHHHhcCCCCEeEEEEEEe-cCC
Confidence            367999999999999999999999999999999986443211      1124568999999999999999999987 567


Q ss_pred             eEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+. ++|..++. ....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~---~~~~l~Dfg~~  150 (291)
T cd07870          77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL---GELKLADFGLA  150 (291)
T ss_pred             eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC---CcEEEeccccc
Confidence            7889999997 55655554 3457889999999999999999999988  9999999999999876   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-H
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT-I  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~-~  523 (627)
                      +.......       ......+++.|+|||++..   ...++.++|||||||+||+|++|..||.........+.... .
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  220 (291)
T cd07870         151 RAKSIPSQ-------TYSSEVVTLWYRPPDVLLG---ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV  220 (291)
T ss_pred             cccCCCCC-------CCCCccccccccCCceeec---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHH
Confidence            76433211       1122357899999998742   23477899999999999999999999976554333222110 0


Q ss_pred             hh---------------hhccccC-----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LK---------------ATEVQFA-----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~---------------~~~~~~~-----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..               .....+.           .....+.++.+||.+||..||++|||+.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00               0000000           001235789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.9e-40  Score=337.51  Aligned_cols=261  Identities=32%  Similarity=0.512  Sum_probs=208.5

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||+|.+..++..||||++......     ......+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-----GGIPNQALREIKALQACQHPYVVKLLDVFP-HGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-----chhhHHHHHHHHHHHhCCCCCCcceeeEEe-cCCee
Confidence            589999999999999999999999999999998654321     122356889999999999999999999997 56788


Q ss_pred             EEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++||||+ +++|..++.. ...+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+   +.++|+|||++..
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~---~~~~l~dfg~~~~  148 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD---GVLKIADFGLARL  148 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC---CcEEEeeeeeccc
Confidence            9999999 9999998864 457999999999999999999999988  9999999999999986   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......      .......|+..|+|||++.   ....++.++|||||||++|+|++|.+||........+.........
T Consensus       149 ~~~~~~------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07832         149 FSEEEP------RLYSHQVATRWYRAPELLY---GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT  219 (286)
T ss_pred             ccCCCC------CccccccCcccccCceeee---ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence            654321      1122347899999999874   2345688999999999999999998888665543322211111000


Q ss_pred             ---------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         527 ---------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       527 ---------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                                     ....++         ..+.++.++.+||.+||..||.+||++.+++.||||.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                           000111         1135678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-39  Score=340.59  Aligned_cols=267  Identities=26%  Similarity=0.424  Sum_probs=211.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      +.|.+++.||+|+||.||++.+..+++.||||.+.....    ........+.+|+.+++.++||||+++++++. +.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL----ILRNQIQQVFVERDILTFAENPFVVSMFCSFE-TKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-cCCE
Confidence            468999999999999999999999999999998754321    11223456788999999999999999999987 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||++|++|..++.....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~---~~~~l~dfg~~~~  150 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM---GHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC---CCEEEeeCCCccc
Confidence            8999999999999999988889999999999999999999999988  9999999999999876   6899999999874


Q ss_pred             cccCCCCC--------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         447 MDEENYNP--------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       447 ~~~~~~~~--------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      ........        ...........|+..|+|||.+.    ...++.++|||||||+||+|++|..||....... +.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~  225 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LF  225 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence            22110000        00000112246788999999984    3457899999999999999999999997654432 22


Q ss_pred             HHHHHhhhhccccC-CCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHhccCCCCC
Q psy4988         519 EENTILKATEVQFA-NKPTVSNEAKGFIRSCLAYRKEDRID---VISLARHDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~~~~~-~~~~vs~el~~LI~~cL~~dP~~Rpt---~~elL~hp~~~~~  571 (627)
                      .....   ....++ ....++.++.+||.+||..||++||+   +.+++.||||...
T Consensus       226 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         226 GQVIS---DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HHHHh---cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            21111   111122 12357899999999999999999998   7999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-40  Score=334.05  Aligned_cols=254  Identities=29%  Similarity=0.507  Sum_probs=210.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||.|+||.||+|.+..++..|++|.+.....         ...+.+|+.+++.++||||+++++++. +..
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~   71 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---------LQEIIKEISILKQCDSPYIVKYYGSYF-KNT   71 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---------HHHHHHHHHHHHhCCCCcEeeeeeeee-cCC
Confidence            3679999999999999999999998899999999753211         456889999999999999999999998 557


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||++
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~---~~~~l~dfg~~  146 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE---GQAKLADFGVS  146 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC---CcEEEcccccc
Confidence            78899999999999999875 457899999999999999999999988  9999999999999986   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       ......|+..|+|||++.    +..++.++||||||||+|+|++|+.||............   .
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~  212 (256)
T cd06612         147 GQLTDTMA-------KRNTVIGTPFWMAPEVIQ----EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---P  212 (256)
T ss_pred             hhcccCcc-------ccccccCCccccCHHHHh----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---c
Confidence            87654321       122335889999999984    446889999999999999999999999765443332211   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ......+.....++.++.+||.+||+.||.+|||+.+++.||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            11112223334578899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.4e-40  Score=339.24  Aligned_cols=259  Identities=26%  Similarity=0.450  Sum_probs=205.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|++++.||.|+||.||+|.+..++..||||.+.......     .....+.+|++++++++||||+++++++. +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-----GVPSTAIREISLLKELNHPNIVKLLDVIH-TENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-----ccchHHHHHHHHHHhcCCCCCcchhhhcc-cCCcE
Confidence            3889999999999999999999999999999876432211     12245778999999999999999999987 66778


Q ss_pred             EEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++||||+. ++|..++..  ...+++..++.++.||+.||.|||+.+  |+|+||+|+|||++.+   +.+||+|||++.
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~---~~~~l~dfg~~~  148 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE---GAIKLADFGLAR  148 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEEeeccchh
Confidence            89999997 578888764  357899999999999999999999988  9999999999999987   589999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....       ......+++.|+|||++..   ...++.++|||||||++|+|++|+.||........+........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  218 (284)
T cd07860         149 AFGVPVR-------TYTHEVVTLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG  218 (284)
T ss_pred             hcccCcc-------ccccccccccccCCeEEec---CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            6543211       1122357889999998742   23467899999999999999999999977665443332211110


Q ss_pred             hh--------------ccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 AT--------------EVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~--------------~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..              ...++         ..+.++.++++||.+||+.||.+|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         219 TPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             CCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00              00111         123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-39  Score=329.79  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=209.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++.+.||+|+||.||+|.+..++..||||.+......     ......+.+|+.+++.++||||+++++.+. ..+.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-----KDERLAAQNECQVLKLLSHPNIIEYYENFL-EDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-----cHHHHHHHHHHHHHhhCCCCchhheeeeEe-cCCEE
Confidence            589999999999999999999999999999998654321     122456889999999999999999999887 66788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++||||+++++|.+++...  ..+++..+..++.+++.+|.|||+++  |+|+||||+|||++.+.  +.+||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~--~~~~l~d~~~~~  150 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHK--MVVKIGDFGISK  150 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC--CEEEEccCCCce
Confidence            9999999999999999764  35899999999999999999999988  99999999999998654  468999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......        .....|+..|+|||++.    ...++.++||||||+++|+|++|..||............   ..
T Consensus       151 ~~~~~~~--------~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~---~~  215 (256)
T cd08220         151 ILSSKSK--------AYTVVGTPCYISPELCE----GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI---MS  215 (256)
T ss_pred             ecCCCcc--------ccccccCCcccCchhcc----CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH---Hh
Confidence            7654321        12346899999999984    445788999999999999999999999766544332221   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                        ....+....++.++.+||.+||..||.+|||+.+++.||||
T Consensus       216 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         216 --GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             --cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence              11112234588999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.7e-40  Score=345.44  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             EEEecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cCCeEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DANSFC  368 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~~  368 (627)
                      ..+||+|+||.||+|.+..  ++..||+|.+.....         ...+.+|+.+++.++|||||+++++|.. +...+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW   76 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence            3579999999999998654  668999998753321         1246789999999999999999998853 345688


Q ss_pred             EEEeecCCCChHHHHHh---------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC-CcccceEE
Q psy4988         369 TVLEYCDGHDLDFYLKQ---------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKI  438 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~---------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~-~~~g~vKL  438 (627)
                      +||||+.+ +|..++..         ...+++..++.++.||+.||.|||+.+  ||||||||+|||+..+ ...+.+||
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          77 LLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEE
Confidence            99999985 66666542         125889999999999999999999988  9999999999999532 12368999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA---  515 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~---  515 (627)
                      +|||+++.+......    ........||+.|+|||++.   ....++.++|||||||+||+|++|.+||.......   
T Consensus       154 ~DfG~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~  226 (317)
T cd07867         154 ADMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS  226 (317)
T ss_pred             eeccceeccCCCccc----ccccCcceecccccCcHHhc---CCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccc
Confidence            999999876543211    11123457899999999985   23457899999999999999999999996433210   


Q ss_pred             ------HHHHHHHHhh------------h---hcc-----------------ccCCCCCCCHHHHHHHHHhhhcCcCCCC
Q psy4988         516 ------TILEENTILK------------A---TEV-----------------QFANKPTVSNEAKGFIRSCLAYRKEDRI  557 (627)
Q Consensus       516 ------~~~~~~~~~~------------~---~~~-----------------~~~~~~~vs~el~~LI~~cL~~dP~~Rp  557 (627)
                            .+........            .   ...                 ........+..+.+||.+||+.||.+||
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~  306 (317)
T cd07867         227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI  306 (317)
T ss_pred             ccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc
Confidence                  0000000000            0   000                 0001123456788999999999999999


Q ss_pred             CHHHHHhccCC
Q psy4988         558 DVISLARHDYL  568 (627)
Q Consensus       558 t~~elL~hp~~  568 (627)
                      |+.|+|+||||
T Consensus       307 t~~e~l~hp~f  317 (317)
T cd07867         307 TSEQALQDPYF  317 (317)
T ss_pred             CHHHHhcCCCC
Confidence            99999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-40  Score=338.40  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=211.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||.|+||.||+|.+..+++.||||++......      .....+.+|+.+++.++||||+++++++. +...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE------DEIEDIQQEIQFLSQCRSPYITKYYGSFL-KGSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc------hHHHHHHHHHHHHHHcCCCCeeeeeEEEE-ECCe
Confidence            4788999999999999999999999999999998654321      12345778999999999999999999987 5578


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+|+||+++++|..++... .+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||+++.
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~  147 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE---GDVKLADFGVSGQ  147 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC---CCEEEccccccee
Confidence            89999999999999998765 8999999999999999999999988  9999999999999987   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......+++.|+|||++.    ...++.++|||||||++|+|++|..||........+..   +...
T Consensus       148 ~~~~~~-------~~~~~~~~~~y~~PE~~~----~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~  213 (274)
T cd06609         148 LTSTMS-------KRNTFVGTPFWMAPEVIK----QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---IPKN  213 (274)
T ss_pred             eccccc-------ccccccCCccccChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH---hhhc
Confidence            754321       122346889999999984    33488999999999999999999999976553332211   1111


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ....++. ..++.++.+||.+||..||++|||+.+++.||||...
T Consensus       214 ~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         214 NPPSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             CCCCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            1111111 1278899999999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.9e-40  Score=340.83  Aligned_cols=245  Identities=18%  Similarity=0.240  Sum_probs=198.9

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--c-CCeEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--D-ANSFCT  369 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~-~~~~~l  369 (627)
                      ..||+|+++.||+|.+  +++.||||++.....    .....++.+.+|+.++++++|||||++++++..  + ...+++
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l   99 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL   99 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence            4599999999999975  789999999864322    122335678899999999999999999999864  2 346889


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      |||||++++|..++.....+++.....++.|++.||.|||+. +  ++||||||+|||++.+   +.+||+|||+++.+.
T Consensus       100 v~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~---~~~kl~dfg~~~~~~  174 (283)
T PHA02988        100 ILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN---YKLKIICHGLEKILS  174 (283)
T ss_pred             EEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC---CcEEEcccchHhhhc
Confidence            999999999999999888999999999999999999999984 6  8899999999999987   689999999998654


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE  528 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  528 (627)
                      ...          ....|++.|+|||++...  ...++.++|||||||++|||++|..||......... .. ....  .
T Consensus       175 ~~~----------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~-~~-i~~~--~  238 (283)
T PHA02988        175 SPP----------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-DL-IINK--N  238 (283)
T ss_pred             ccc----------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH-HH-HHhc--C
Confidence            321          123689999999998421  246899999999999999999999999866543322 11 1111  1


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..++.+..+++++++||.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            223333468899999999999999999999999985

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.2e-40  Score=338.71  Aligned_cols=263  Identities=28%  Similarity=0.453  Sum_probs=204.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  365 (627)
                      ++|.+.+.||.|+||.||+|.+..+++.||||++......     ......+.+|+.+++.+. ||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~   75 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-----EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK   75 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-----cCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence            4799999999999999999999999999999987543221     112345778999999995 6999999999874433


Q ss_pred             ----eEEEEEeecCCCChHHHHHhc-----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         366 ----SFCTVLEYCDGHDLDFYLKQH-----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       366 ----~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                          .+|+||||+++ +|..++...     ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+.  +.+
T Consensus        76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~--~~~  150 (295)
T cd07837          76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQK--GLL  150 (295)
T ss_pred             CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCC--CeE
Confidence                37899999996 787777542     35899999999999999999999988  99999999999999833  689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||++..+.....       ......+++.|+|||++..   ...++.++|||||||+||+|++|..||........
T Consensus       151 kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~  220 (295)
T cd07837         151 KIADLGLGRAFSIPVK-------SYTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ  220 (295)
T ss_pred             EEeecccceecCCCcc-------ccCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            9999999986543210       1112357889999998842   34578899999999999999999999976655443


Q ss_pred             HHHHHHHhhhh-ccc------------cC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         517 ILEENTILKAT-EVQ------------FA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       517 ~~~~~~~~~~~-~~~------------~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      +.......... ...            ++         ..+.++.++.+||.+||.+||.+||++.+++.||||+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            33221111000 000            00         1135789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1187|consensus

Probab=100.00  E-value=2e-40  Score=353.92  Aligned_cols=269  Identities=27%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             ccccchHHHHHhhhcccccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHH
Q psy4988         259 GYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA  338 (627)
Q Consensus       259 ~~~~~~~~el~~~~~~~~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~  338 (627)
                      ....|.+.|+++++++|..              ...||+|+||.||+|.. .++..||||.+.......       .++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~--------------~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~-------~~eF  118 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSE--------------SNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG-------EREF  118 (361)
T ss_pred             CcceeeHHHHHHHHhCCch--------------hcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc-------hhHH
Confidence            4567889999999977653              34699999999999974 555999999765433210       2359


Q ss_pred             HHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhC-CCCE
Q psy4988         339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEI-KPPV  415 (627)
Q Consensus       339 ~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~-~~~I  415 (627)
                      .+|+.++.+++|||||+|++||.......+|||||+++|+|.++|....  .++|..+.+|+.++++||.|||.. .++|
T Consensus       119 ~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i  198 (361)
T KOG1187|consen  119 LNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPI  198 (361)
T ss_pred             HHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence            9999999999999999999999833335889999999999999998665  899999999999999999999984 3489


Q ss_pred             EeccccCCcEEecCCCcccceEEeeccccccccc-CCCCCCCCccccccC-CCCCccCCccccccCCCCCCCCcchhHHH
Q psy4988         416 IHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE-ENYNPDHGMDLTSQG-AGTYWYLPPECFVVGKNPPKISSKVDVWS  493 (627)
Q Consensus       416 vHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~-~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~~~~~~~~~k~DVwS  493 (627)
                      |||||||.|||||.+   .++||+|||+|+.... ..        ..... .||..|+|||++..    ...+.++||||
T Consensus       199 iHrDiKssNILLD~~---~~aKlsDFGLa~~~~~~~~--------~~~~~~~gt~gY~~PEy~~~----g~lt~KsDVyS  263 (361)
T KOG1187|consen  199 IHRDIKSSNILLDED---FNAKLSDFGLAKLGPEGDT--------SVSTTVMGTFGYLAPEYAST----GKLTEKSDVYS  263 (361)
T ss_pred             ecCCCCHHHeeECCC---CCEEccCccCcccCCcccc--------ceeeecCCCCccCChhhhcc----CCcCccccccc
Confidence            999999999999988   4899999999966543 21        11112 79999999999853    45899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC--hHHHHHH--HHH-----HhhhhccccCCCCCCC--HH---HHHHHHHhhhcCcCCCCCH
Q psy4988         494 VGVIFYQCLYGKKPFGHNQ--SQATILE--ENT-----ILKATEVQFANKPTVS--NE---AKGFIRSCLAYRKEDRIDV  559 (627)
Q Consensus       494 lGviL~elltG~~Pf~~~~--~~~~~~~--~~~-----~~~~~~~~~~~~~~vs--~e---l~~LI~~cL~~dP~~Rpt~  559 (627)
                      |||+|+||++|+.+.+...  ....+..  ...     +....+..+.. ...+  .+   +..+..+|+..+|.+||++
T Consensus       264 FGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  264 FGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             chHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence            9999999999999887542  1111111  011     11111112110 1222  23   4566779999999999999


Q ss_pred             HHHHhc
Q psy4988         560 ISLARH  565 (627)
Q Consensus       560 ~elL~h  565 (627)
                      .+++..
T Consensus       343 ~~Vv~~  348 (361)
T KOG1187|consen  343 SQVVKE  348 (361)
T ss_pred             HHHHHH
Confidence            998653

>KOG0986|consensus

Probab=100.00  E-value=1.9e-41  Score=350.96  Aligned_cols=265  Identities=27%  Similarity=0.446  Sum_probs=223.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .++-.+.|..-++||+||||+||-+....||+.||+|.+.+...    ++..-....+.|-.||.+++.+.||.|-.+|+
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi----Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI----KKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH----HHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            56667889999999999999999999999999999998754332    22223346788999999999999999998898


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                       ..+.+||||..|.||+|..+|.+.+  .|++..++.++.+|+.||++||+.+  ||.|||||+|||||+.   |+|.|+
T Consensus       256 -Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~---GhvRIS  329 (591)
T KOG0986|consen  256 -TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDH---GHVRIS  329 (591)
T ss_pred             -CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccC---CCeEee
Confidence             6788999999999999999998766  8999999999999999999999988  9999999999999998   799999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |+|||..+.+..        .....+||..|||||++.    ...|+...|+|||||+||||+.|+.||.........-+
T Consensus       330 DLGLAvei~~g~--------~~~~rvGT~GYMAPEvl~----ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE  397 (591)
T KOG0986|consen  330 DLGLAVEIPEGK--------PIRGRVGTVGYMAPEVLQ----NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE  397 (591)
T ss_pred             ccceEEecCCCC--------ccccccCcccccCHHHHc----CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH
Confidence            999999886543        223449999999999994    44599999999999999999999999965544433323


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ...........++  ..+|+++++|.+.+|++||++|.     .++++-+||||..
T Consensus       398 vdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  398 VDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            3333344455555  57999999999999999999998     4668999999975

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-39  Score=329.50  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=207.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cCCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~  366 (627)
                      +|.+++.||.|+||.||++.+..++..||+|++......     ......+..|+.+++.++||||+++++++.. ....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-----EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-----HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence            588999999999999999999999999999988643221     1223567889999999999999999998753 3456


Q ss_pred             EEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHH-----hCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLN-----EIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH-----~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      ++++|||+++++|..++..    ...+++..++.++.||+.||.|||     +.+  |+|+||||+|||++.+   +.+|
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~---~~~k  150 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN---NNVK  150 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC---CCEE
Confidence            7899999999999999865    367999999999999999999999     766  9999999999999976   6999


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||++........       ......|++.|+|||++.    ...++.++||||||+++|+|++|..||...... .+
T Consensus       151 l~d~g~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~  218 (265)
T cd08217         151 LGDFGLAKILGHDSS-------FAKTYVGTPYYMSPEQLN----HMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-QL  218 (265)
T ss_pred             EecccccccccCCcc-------cccccccCCCccChhhhc----CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-HH
Confidence            999999987754321       122346899999999984    344788999999999999999999999765532 22


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...  +....  .......++.++.+||.+||..+|.+||++.+++.|||+
T Consensus       219 ~~~--~~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         219 ASK--IKEGK--FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHH--HhcCC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            211  11111  112234678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.1e-39  Score=341.29  Aligned_cols=266  Identities=25%  Similarity=0.398  Sum_probs=208.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+.+.||.|+||.||+|.+..+++.||+|++.......     .....+.+|+.+++.++|+||+++++++....
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-----GIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-----CCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3467999999999999999999999999999999986543211     11224567999999999999999999986433


Q ss_pred             -CeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         365 -NSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       365 -~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                       +.+++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        80 ~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~---~~~kL~dfg  153 (309)
T cd07845          80 LDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK---GCLKIADFG  153 (309)
T ss_pred             CCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---CCEEECccc
Confidence             568899999985 77777764 467999999999999999999999988  9999999999999876   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+.....       ......+++.|+|||++..   ...++.++|||||||++|+|++|+.||........+.....
T Consensus       154 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~  223 (309)
T cd07845         154 LARTYGLPAK-------PMTPKVVTLWYRAPELLLG---CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ  223 (309)
T ss_pred             eeeecCCccC-------CCCcccccccccChhhhcC---CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9987653210       1122246888999998752   24578899999999999999999999987665544332222


Q ss_pred             Hhhhh---------------ccccCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKAT---------------EVQFAN---------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~---------------~~~~~~---------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....               ......         ...+++++.+||.+||.+||++|||+.+++.||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            11100               000000         12358899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-40  Score=337.29  Aligned_cols=262  Identities=27%  Similarity=0.471  Sum_probs=211.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++.+.||.|+||.||+|.+..+++.||||++.....     .......+.+|+++++.++|+||++++++|. +.+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-----DEDVKKTALREVKVLRQLRHENIVNLKEAFR-RKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-----cccchhHHHHHHHHHHhcCCCCeeehhheEE-ECCE
Confidence            479999999999999999999999999999998754321     1223456889999999999999999999997 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||++++.+..++.....+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+   +.+||+|||++..
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~---~~~kl~d~g~~~~  149 (288)
T cd07833          75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES---GVLKLCDFGFARA  149 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC---CCEEEEeeecccc
Confidence            8899999999888877777678999999999999999999999988  9999999999999986   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....      .......++..|+|||++..   ...++.++||||||++||+|++|+.||........+.........
T Consensus       150 ~~~~~~------~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  220 (288)
T cd07833         150 LRARPA------SPLTDYVATRWYRAPELLVG---DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP  220 (288)
T ss_pred             cCCCcc------ccccCcccccCCcCCchhcC---CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            654321      01223478899999999852   226788999999999999999999999766554433322211100


Q ss_pred             hc---------------ccc-----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 TE---------------VQF-----------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ~~---------------~~~-----------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..               ..+           .....++.++.+||++||..+|++||++.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00               000           0112358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.2e-40  Score=334.59  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=211.8

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++.+.||.|+||.||+|.+..++..||+|++.....    ......+.+.+|++++++++||||++++++|. +...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC----VEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-DEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh----cchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-CCCeE
Confidence            48999999999999999999999999999999864322    11223567889999999999999999999987 66788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|+||+.+++|..++.....+++..+..++.||+.||.|||+.+  |+|+||+|+|||++++   +.++|+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~  150 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ---GHVHITDFNIATKV  150 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC---CCEEEeeccccccc
Confidence            999999999999999988789999999999999999999999988  9999999999999987   68999999999876


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ--ATILEENTILK  525 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~  525 (627)
                      ....        ......|+..|+|||++.    ...++.++||||||+++|+|++|..||......  ..+...  . .
T Consensus       151 ~~~~--------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-~  215 (258)
T cd05578         151 TPDT--------LTTSTSGTPGYMAPEVLC----RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK--Q-E  215 (258)
T ss_pred             CCCc--------cccccCCChhhcCHHHHc----ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH--h-c
Confidence            5432        112346889999999984    344788999999999999999999999766542  222111  1 1


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH--HHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV--ISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~--~elL~hp~~  568 (627)
                      .  .....+..++.++.+||.+||..||.+||+.  .++++||||
T Consensus       216 ~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         216 T--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             c--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            1  2223345678999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-39  Score=329.50  Aligned_cols=254  Identities=23%  Similarity=0.427  Sum_probs=209.0

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++.+.||.|+||.||++.+..+++.||||.+......     ......+.+|+.+++.++||||+++++++. +.+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-----PKEREESRKEVAVLSNMKHPNIVQYQESFE-ENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-----hHHHHHHHHHHHHHHhCCCCCeeeeEeeec-CCCeE
Confidence            589999999999999999999999999999987643221     112346788999999999999999999987 66788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++||||+.+++|..++...  ..+++..++.++.||+.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||++.
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~---~~~~l~d~~~~~  149 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD---GTIKLGDFGIAR  149 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC---CCEEEeecccee
Confidence            9999999999999988754  36899999999999999999999988  9999999999999886   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....       ......|++.|+|||++.    ...++.++|||||||++|+|++|..||............   ..
T Consensus       150 ~~~~~~~-------~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~~  215 (256)
T cd08218         150 VLNSTVE-------LARTCIGTPYYLSPEICE----NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---IR  215 (256)
T ss_pred             ecCcchh-------hhhhccCCccccCHHHhC----CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH---hc
Confidence            7654221       122346889999999984    345788999999999999999999999765544333221   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .  ...+....++.++.+||.+||+.+|.+||++.+++.||||
T Consensus       216 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         216 G--SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             C--CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            1  1112234678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.7e-40  Score=336.69  Aligned_cols=258  Identities=29%  Similarity=0.453  Sum_probs=209.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++.+.||.|+||.||++.+..+++.||+|++......      .....+.+|+++++.++||||+++++++. ..+.
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE------AIQKQILRELDILHKCNSPYIVGFYGAFY-NNGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh------HHHHHHHHHHHHHHHCCCCchhhhheeee-cCCE
Confidence            3577888999999999999999999999999988654321      22456889999999999999999999987 5578


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +++|+||+++++|.+++... ..+++..+..++.||+.||.|||+ .+  |+|+||||+||+++.+   +.++|+|||++
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~---~~~~l~d~g~~  148 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR---GQIKLCDFGVS  148 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC---CCEEEeecccc
Confidence            89999999999999999876 789999999999999999999999 88  9999999999999986   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH-HH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-ATILEE-NT  522 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-~~~~~~-~~  522 (627)
                      ..+....         .....++..|+|||++.    +..++.++|||||||++|+|++|..||...... ...... ..
T Consensus       149 ~~~~~~~---------~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  215 (265)
T cd06605         149 GQLVNSL---------AKTFVGTSSYMAPERIQ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY  215 (265)
T ss_pred             hhhHHHH---------hhcccCChhccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH
Confidence            7664321         11147889999999984    446889999999999999999999999654211 111111 11


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .........+.. .++.++.+||.+||..||.+|||+.+++.||||+.
T Consensus       216 ~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         216 IVNEPPPRLPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HhcCCCCCCChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            111111111111 27889999999999999999999999999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.4e-40  Score=337.49  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI-  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~-  362 (627)
                      ..+.|++.+.||.|+||.||+|.+..+++.||+|++.....        ....+..|+.+++++ +||||++++++|.. 
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--------EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34689999999999999999999999999999999754321        123567788999888 79999999999852 


Q ss_pred             ----cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         363 ----DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       363 ----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                          ....+|+||||+++++|..++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~---~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN---AEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCE
Confidence                245789999999999999988753  45889999999999999999999988  9999999999999986   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +|+|||++.......       .......|++.|+|||++.... ....++.++|||||||++|+|++|..||.......
T Consensus       161 ~l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         161 KLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             EEeeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999987654321       1122346899999999875321 13457889999999999999999999996554433


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .+...   ....... .....++.++.+||++||..||.+|||+.+++.||||
T Consensus       234 ~~~~~---~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         234 ALFLI---PRNPPPK-LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             hhhhH---hhCCCCC-CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            32211   1111111 1223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-39  Score=336.07  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=203.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHH-HhcCCCCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ++|.+.+.||+|+||.||++.+..+++.||||++........      ...+..|+.+ ++.++|||||++++++. ..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~e~~~~~~~~~~~~iv~~~~~~~-~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE------QKRLLMDLDISMRSVDCPYTVTFYGALF-REG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH------HHHHHHHHHHHHHHcCCCCeeeeeEEEe-cCC
Confidence            468999999999999999999999999999998865432111      1234556664 66779999999999997 556


Q ss_pred             eEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .+|+||||++ ++|..++..    ...+++..++.++.||+.||.|||+. +  |+||||||+|||++.+   +.+||+|
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~---~~~kl~d  147 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN---GQVKLCD  147 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC---CCEEEee
Confidence            7889999998 577766643    34789999999999999999999986 6  9999999999999887   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++..+....        ......|+..|+|||++........++.++|||||||+||+|++|+.||.........+. 
T Consensus       148 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-  218 (283)
T cd06617         148 FGISGYLVDSV--------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-  218 (283)
T ss_pred             ccccccccccc--------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-
Confidence            99998654321        112236889999999885433335578899999999999999999999964332211111 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                       .........++ ...+|.++.+||.+||..+|.+||++.+++.||||....
T Consensus       219 -~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         219 -QVVEEPSPQLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -HHHhcCCCCCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence             11111112222 235789999999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.9e-40  Score=349.60  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||++++++|..+
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-----NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ   87 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-----ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence            356889999999999999999999999999999998753221     112234577899999999999999999998633


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+||||+.+ +|..++...  +++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||
T Consensus        88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~---~~~kL  159 (353)
T cd07850          88 KSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKI  159 (353)
T ss_pred             CCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC---CCEEE
Confidence            2     357899999975 777776543  999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++......        ......+++.|+|||++.    ...++.++|||||||+||+|++|+.||...+....+.
T Consensus       160 ~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~  227 (353)
T cd07850         160 LDFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN  227 (353)
T ss_pred             ccCccceeCCCCC--------CCCCCcccccccCHHHHh----CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999998764321        122346889999999984    4568899999999999999999999997554332221


Q ss_pred             HHHHHhhhh--------------------------------ccccCC-----CCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q psy4988         519 EENTILKAT--------------------------------EVQFAN-----KPTVSNEAKGFIRSCLAYRKEDRIDVIS  561 (627)
Q Consensus       519 ~~~~~~~~~--------------------------------~~~~~~-----~~~vs~el~~LI~~cL~~dP~~Rpt~~e  561 (627)
                      .........                                ...++.     ....+.++.+||.+||+.||++|||+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  307 (353)
T cd07850         228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD  307 (353)
T ss_pred             HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence            111000000                                000000     1134667899999999999999999999


Q ss_pred             HHhccCCCCCCC
Q psy4988         562 LARHDYLQPPVP  573 (627)
Q Consensus       562 lL~hp~~~~~~~  573 (627)
                      +|.||||.....
T Consensus       308 iL~~~~~~~~~~  319 (353)
T cd07850         308 ALQHPYINVWYD  319 (353)
T ss_pred             HhcChhHhhccC
Confidence            999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-39  Score=332.90  Aligned_cols=253  Identities=21%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      -.++|++.+.||+|+||.||+|.+.   ..+..||+|++.....      ......+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS------DKQRRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC------HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            3467999999999999999999765   4567899998764322      122356889999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       ..+.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.+   +.++|+|
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~---~~~~l~d  150 (266)
T cd05064          77 -RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD---LVCKISG  150 (266)
T ss_pred             -cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC---CcEEECC
Confidence             567788999999999999998764 57999999999999999999999988  9999999999999886   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~  519 (627)
                      ||++........      .......++..|+|||++.    ...++.++|||||||++|+|+ +|..||........+ .
T Consensus       151 fg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-~  219 (266)
T cd05064         151 FRRLQEDKSEAI------YTTMSGKSPVLWAAPEAIQ----YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-K  219 (266)
T ss_pred             Ccccccccccch------hcccCCCCceeecCHHHHh----hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-H
Confidence            998765432211      1112234678899999984    445889999999999999977 599999766544322 1


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .  +.  .....+.+..++..+.+|+.+||..+|.+||++.++++
T Consensus       220 ~--~~--~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         220 A--VE--DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             H--HH--CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            1  11  11223445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-40  Score=338.65  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=210.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||+||++.+..++..||+|++.....      ......+.+|+++++.++||||+++++++. +.+
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   76 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK------SSVRKQILRELQIMHECRSPYIVSFYGAFL-NEN   76 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc------chHHHHHHHHHHHHHHcCCCCcceEeeeEe-cCC
Confidence            3578889999999999999999999999999998764321      223456889999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+++||||+++++|..++...+.+++..+..++.+++.+|.|||+ .+  |+|+||||+|||++.+   +.++|+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~---~~~~l~d~gl~  151 (284)
T cd06620          77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR---GQIKLCDFGVS  151 (284)
T ss_pred             EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC---CcEEEccCCcc
Confidence            889999999999999999888889999999999999999999997 46  9999999999999876   58999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-------HH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-------TI  517 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~-------~~  517 (627)
                      .......         .....|+..|+|||++.    ...++.++|||||||++|+|++|..||.......       .+
T Consensus       152 ~~~~~~~---------~~~~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~  218 (284)
T cd06620         152 GELINSI---------ADTFVGTSTYMSPERIQ----GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI  218 (284)
T ss_pred             cchhhhc---------cCccccCcccCCHHHHc----cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH
Confidence            7553221         12347899999999984    3357889999999999999999999997544321       11


Q ss_pred             HHH-HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         518 LEE-NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       518 ~~~-~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ... ..+.......++ ...++.++.+||.+||..||.+||++.++++|+||...
T Consensus       219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         219 LDLLQQIVQEPPPRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHHhhccCCCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            110 111111111111 12377899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=337.13  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=202.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||.|+||.||+|.+..+++.||||.+........      ...+.+|+.+++.++||||+++++++. +.+
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------PFTAIREASLLKDLKHANIVTLHDIIH-TKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------chhHHHHHHHHhhCCCcceeeEEEEEe-cCC
Confidence            3689999999999999999999999999999999865432111      124668999999999999999999987 667


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++
T Consensus        77 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~---~~~kl~dfg~~  150 (291)
T cd07844          77 TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER---GELKLADFGLA  150 (291)
T ss_pred             eEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC---CCEEECccccc
Confidence            88999999985 888887654 47899999999999999999999988  9999999999999987   58999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE-NTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~~~  523 (627)
                      +.......       ......++..|+|||++..   ...++.++|||||||++|+|++|+.||.........+.. ...
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  220 (291)
T cd07844         151 RAKSVPSK-------TYSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV  220 (291)
T ss_pred             cccCCCCc-------cccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHh
Confidence            75432110       0112256889999998742   234788999999999999999999999655422221111 000


Q ss_pred             hhh---------------hcccc---------CCCCCCC--HHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LKA---------------TEVQF---------ANKPTVS--NEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~~---------------~~~~~---------~~~~~vs--~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...               ....+         ...+.++  .++.+||.+||++||.+||++.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000               00000         0011344  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=345.59  Aligned_cols=268  Identities=25%  Similarity=0.422  Sum_probs=207.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+.++||+|+||.||+|.+..++..||||++.....      ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------QTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc------chhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            56889999999999999999999999999999998753211      123456778999999999999999999875322


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                          ..+|+|+||+.+ +|..++. ...+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~---~~~kl~d  149 (336)
T cd07849          77 FESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN---CDLKICD  149 (336)
T ss_pred             ccccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC---CCEEECc
Confidence                357899999985 7776664 357999999999999999999999988  9999999999999887   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.........    .......||+.|+|||.+.   ....++.++|||||||++|+|++|+.||........+...
T Consensus       150 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~  222 (336)
T cd07849         150 FGLARIADPEHDHT----GFLTEYVATRWYRAPEIML---NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI  222 (336)
T ss_pred             ccceeecccccccc----CCcCCcCcCCCccChHHhh---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99998764332111    1123347899999999874   2345788999999999999999999999654432221111


Q ss_pred             HHHhhh--------------------hcc----cc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         521 NTILKA--------------------TEV----QF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       521 ~~~~~~--------------------~~~----~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ......                    ...    .+ ...+.++.++.+||.+||+.||++|||+.+++.||||..-.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            000000                    000    00 01135688999999999999999999999999999998543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-39  Score=328.29  Aligned_cols=254  Identities=27%  Similarity=0.422  Sum_probs=210.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++++.||.|+||.||.+.+..+++.|++|.+......     ......+.+|+.++++++|+||++++++|. +...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-----EKERRDALNEIVILSLLQHPNIIAYYNHFM-DDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-----hhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-cCCeE
Confidence            589999999999999999999999999999987644321     122456789999999999999999999998 56788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++|||||++++|..++...  ..+++..+..++.|++.+|.|||+.+  |+|+||+|+||+++.+   +.+||+|||++.
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~---~~~kl~d~~~~~  149 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA---GLIKLGDFGISK  149 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC---CCEEECcCcceE
Confidence            8999999999999999765  46899999999999999999999988  9999999999999987   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......       ......|++.|+|||++.    +..++.++||||||+++|+|++|..||............   ..
T Consensus       150 ~~~~~~~-------~~~~~~~~~~y~ape~~~----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~~  215 (256)
T cd08221         150 ILGSEYS-------MAETVVGTPYYMSPELCQ----GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI---VQ  215 (256)
T ss_pred             Ecccccc-------cccccCCCccccCHhhcC----CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hc
Confidence            7654321       123346899999999884    344788999999999999999999999765544333221   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                       ... .+....++.++.+||.+||..+|.+||++.++++|+|+
T Consensus       216 -~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         216 -GNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -CCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence             111 12225678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-39  Score=329.45  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=210.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|+..+.||.|+||.||+|.+..++..|+||++.......  ......+.+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ--TGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-EEDNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc--cchHHHHHHHHHHHHHHhcCCCCchheeeeEe-cCCeE
Confidence            5778889999999999999998899999999986543211  12233567889999999999999999999887 66778


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++||||+++++|..++.....+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.+   +.+||+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~---~~~kl~d~~~~~~~  152 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN---GVVKLADFGMAKQV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEccCccceec
Confidence            899999999999999988888999999999999999999999988  9999999999999876   58999999999876


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ....        ......|++.|+|||.+..   ...++.++|+|||||++|+|++|..||.............   ...
T Consensus       153 ~~~~--------~~~~~~~~~~y~~pe~~~~---~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~  218 (258)
T cd06632         153 VEFS--------FAKSFKGSPYWMAPEVIAQ---QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG---RSK  218 (258)
T ss_pred             cccc--------cccccCCCcceeCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH---hcc
Confidence            4322        1233468999999999842   1237889999999999999999999997655333322211   101


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                       .....+..++.++.+||.+||..+|.+||++.+++.|||+
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence             1112234678999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.9e-40  Score=353.36  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=201.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKL  356 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l  356 (627)
                      ..-.++|++.+.||+|+||.||+|.+...     ...||||++......      .....+.+|+.+++.+ +|||||++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT------DEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH------HHHHHHHHHHHHHHhhccCCceeeE
Confidence            44567899999999999999999986543     357999998644321      1235688999999999 89999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc--------------------------------------------------
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------------------------------------------------  386 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------  386 (627)
                      +++|. +...+|+|||||++++|.+++...                                                  
T Consensus       108 ~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         108 LGACT-HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             eeEec-CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            99987 566788999999999999988542                                                  


Q ss_pred             --------------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         387 --------------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       387 --------------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                                          ..+++..++.|+.||+.||.|||+.+  |+||||||+|||++++   +.+||+|||+++.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~---~~~kL~DfGla~~  261 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG---RVAKICDFGLARD  261 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC---CeEEEeeceeeee
Confidence                                24788899999999999999999988  9999999999999876   5899999999986


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      +.....     ........+++.|+|||++.    ...++.++|||||||+||+|++ |+.||........+....  . 
T Consensus       262 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--~-  329 (374)
T cd05106         262 IMNDSN-----YVVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--K-  329 (374)
T ss_pred             ccCCcc-----eeeccCCCCccceeCHHHhc----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH--H-
Confidence            543211     11122234567899999984    4458999999999999999997 999997654333222211  1 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       ..........+++++.+||.+||+.||.+|||+.++++
T Consensus       330 -~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         330 -RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             11122233457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-39  Score=336.82  Aligned_cols=264  Identities=26%  Similarity=0.426  Sum_probs=206.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||.|+||.||+|.+..+++.||||.+......     ......+.+|+.+++.++||||+++++++. +...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-----EGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-----ccchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCe
Confidence            5799999999999999999999999999999987543221     112345778999999999999999999997 6678


Q ss_pred             EEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +|+||||+++ +|..++....  .+++..++.++.||+.||.|||+.+  |+|+||+|+|||++...  +.+||+|||++
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~--~~~kl~dfg~~  150 (294)
T PLN00009         76 LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRT--NALKLADFGLA  150 (294)
T ss_pred             EEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCC--CEEEEcccccc
Confidence            8899999975 6777665443  3688899999999999999999988  99999999999998653  47999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .......       .......+++.|+|||++..   ...++.++|||||||++|+|++|+.||........+.+.....
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~  220 (294)
T PLN00009        151 RAFGIPV-------RTFTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL  220 (294)
T ss_pred             cccCCCc-------cccccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            7654321       11122367899999998742   2357889999999999999999999997765544443321111


Q ss_pred             hhh-c-------------cccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         525 KAT-E-------------VQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~-~-------------~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ... .             ..++         ..+.+++++.+||.+||+.+|++||++.+++.||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            100 0             0000         124578999999999999999999999999999999754

>KOG2345|consensus

Probab=100.00  E-value=3.2e-41  Score=326.83  Aligned_cols=269  Identities=25%  Similarity=0.383  Sum_probs=213.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +-.+||+|.+.||+|||+-||++.+..+++.||+|.+.....       +.+...++|++..++++||||++++++...+
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-------~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~   90 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-------EDIEEALREIDNHRKFNSPNVLRLVDHQLRE   90 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-------HHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence            345799999999999999999999999999999999876542       2245789999999999999999999976422


Q ss_pred             ----CCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         364 ----ANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       364 ----~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                          ....|||+.|...|+|.+.+..    ...++|.+++.|+.+|++||++||+..+++.||||||.|||+.+.   +.
T Consensus        91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~---~~  167 (302)
T KOG2345|consen   91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS---GL  167 (302)
T ss_pred             hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC---Cc
Confidence                2347899999999999888753    237999999999999999999999998899999999999999985   68


Q ss_pred             eEEeecccccccccCCCCCCCCcccc--ccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLT--SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~--~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      ++|.|||.++...-......+...+.  ..-..|..|+|||.|... .+..++.++|||||||+||.|++|.-||.....
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~  246 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-SHCTITERTDIWSLGCTLYAMMFGESPFERIYQ  246 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc-cCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence            99999999986553321111111111  012479999999998543 466789999999999999999999999942211


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +-.-  ...-.......+|....+|..+..||++||+.||.+||++.+++.+
T Consensus       247 ~GgS--laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  247 QGGS--LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cCCe--EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0000  0001122346677778899999999999999999999999999875

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-39  Score=336.03  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=198.3

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHH---HHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY---NIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .||+|+||.||++.+..+++.||||++..........    ...+.+|.   .++...+||||+.++++|. ..+.+++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----ETLALNERIMLSLVSTGDCPFIVCMTYAFH-TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH----HHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-cCCeEEEE
Confidence            3899999999999999999999999886543211111    11223333   3444558999999999987 55678899


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      |||+++++|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.++|+|||++......
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~---~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH---GHVRISDLGLACDFSKK  150 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC---CCEEEccCCcceecccc
Confidence            999999999999988889999999999999999999999988  9999999999999877   58999999999765432


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ  530 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  530 (627)
                      .         .....||+.|+|||.+.   .+..++.++|||||||+||+|++|..||.......... ......  ...
T Consensus       151 ~---------~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~--~~~  215 (279)
T cd05633         151 K---------PHASVGTHGYMAPEVLQ---KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL--TVN  215 (279)
T ss_pred             C---------ccCcCCCcCccCHHHhc---CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh--cCC
Confidence            1         12236899999999874   23457889999999999999999999996543221111 111111  112


Q ss_pred             cCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         531 FANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       531 ~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      ...+..++.++.+||.+||..||.+||     ++.++++||||...
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            223346889999999999999999999     69999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-39  Score=346.42  Aligned_cols=266  Identities=27%  Similarity=0.429  Sum_probs=209.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+.+.||+|+||+||+|.+..+++.||||.+......     ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-----RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-----cchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            457899999999999999999999999999999987543211     112345678999999999999999999886332


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                          ..+|+||||+. ++|..++.....+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~---~~~kL~D  151 (337)
T cd07858          78 REAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN---CDLKICD  151 (337)
T ss_pred             ccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC---CCEEECc
Confidence                34789999997 688888888889999999999999999999999988  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++......       .......++..|+|||.+..   ...++.++|||||||++|+|++|+.||...+....+...
T Consensus       152 fg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  221 (337)
T cd07858         152 FGLARTTSEKG-------DFMTEYVVTRWYRAPELLLN---CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI  221 (337)
T ss_pred             CccccccCCCc-------ccccccccccCccChHHHhc---CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence            99998664321       11233468999999998752   234788999999999999999999999655432211111


Q ss_pred             HHHh--------------------hh----hccc-cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTIL--------------------KA----TEVQ-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~--------------------~~----~~~~-~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ....                    ..    .... ....+.+++++.+||++||+.||++|||+.++++||||...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0000                    00    0000 01124688999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.6e-40  Score=353.12  Aligned_cols=257  Identities=21%  Similarity=0.322  Sum_probs=201.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEE-----cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFD-----LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLY  357 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~-----~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~  357 (627)
                      .-.++|.+.+.||+|+||.||+|.+     ..++..||||++......      .....+.+|+.++..+ +|||||+++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL------TEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc------HHHHHHHHHHHHHHHhcCCcceeeee
Confidence            3456899999999999999999964     345778999998543221      1234678999999999 899999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhcc--------------------------------------------------
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHK--------------------------------------------------  387 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------------------------------------------  387 (627)
                      ++|. +....++|||||++|+|..++....                                                  
T Consensus       106 ~~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         106 GACT-VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeec-cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            9997 5667889999999999999886421                                                  


Q ss_pred             -------------------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         388 -------------------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       388 -------------------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                                               .+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~---~~~kl~DfG  259 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG---RITKICDFG  259 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC---CcEEEecCc
Confidence                                     4788899999999999999999988  9999999999999876   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEEN  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~  521 (627)
                      +++.+......     .......+++.|+|||++.    ...++.++|||||||+||+|++ |..||........+....
T Consensus       260 ~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~  330 (375)
T cd05104         260 LARDIRNDSNY-----VVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI  330 (375)
T ss_pred             cceeccCcccc-----cccCCCCCCcceeChhHhc----CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence            99876533210     1122234567899999984    4458899999999999999997 899997654433332211


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        ..  ......+...+.++.+||.+||..||++||++.++++.
T Consensus       331 --~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         331 --KE--GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             --Hh--CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence              11  11122234567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5e-40  Score=342.00  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=209.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .+.|.....||.|+||.||++.+..++..||||.+.....       .....+.+|+.+++.++||||+++++.|. ..+
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~   92 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-------QRRELLFNEVVIMRDYHHENVVDMYNSYL-VGD   92 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-------HHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCC
Confidence            3455566779999999999999999999999998754221       12345788999999999999999999987 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+||||+++++|..++.. ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.++|+|||++.
T Consensus        93 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~---~~~kL~dfg~~~  166 (292)
T cd06658          93 ELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD---GRIKLSDFGFCA  166 (292)
T ss_pred             eEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC---CCEEEccCcchh
Confidence            88999999999999998754 57999999999999999999999988  9999999999999887   589999999997


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......|++.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +..
T Consensus       167 ~~~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~  232 (292)
T cd06658         167 QVSKEV-------PKRKSLVGTPYWMAPEVIS----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRD  232 (292)
T ss_pred             hccccc-------ccCceeecCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh
Confidence            654321       1122346899999999983    44578899999999999999999999976554333221   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....++....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            2222333444678999999999999999999999999999999844

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-39  Score=336.30  Aligned_cols=267  Identities=26%  Similarity=0.427  Sum_probs=203.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+.++||+|+||.||+|.+..+++.||||++.......     .....+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   84 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-----GFPITALREIKILQLLKHENVVNLIEICRTKA   84 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-----CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence            3457999999999999999999999999999999876432211     11234568999999999999999999876432


Q ss_pred             -------CeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         365 -------NSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       365 -------~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                             ..+++||||+.+ +|..++... ..+++.+++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~---~~~  158 (310)
T cd07865          85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD---GIL  158 (310)
T ss_pred             ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC---CcE
Confidence                   346899999985 677666543 47999999999999999999999988  9999999999999887   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||++..+.......   ........++..|+|||++..   ...++.++||||||+++|+|++|+.||........
T Consensus       159 kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~  232 (310)
T cd07865         159 KLADFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLG---ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ  232 (310)
T ss_pred             EECcCCCcccccCCcccC---CCCccCcccCccccCcHHhcC---CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999998765432111   111223467899999998742   23467899999999999999999999976654433


Q ss_pred             HHHHHHHhhhh---------------ccccCC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         517 ILEENTILKAT---------------EVQFAN-----------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       517 ~~~~~~~~~~~---------------~~~~~~-----------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ......+....               ...++.           ....+..+.+||.+||..||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            22111111000               000000           01235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.9e-39  Score=332.83  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=204.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|++.+.||.|+||.||+|.+..++..||||++......      .....+.+|+.+++.++||||++++++|. +.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE------GTPSTAIREISLMKELKHENIVRLHDVIH-TENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc------cchHHHHHHHHHHHhhcCCCEeeeeeeEe-eCCcE
Confidence            488999999999999999999999999999998654321      11235678999999999999999999998 55678


Q ss_pred             EEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ++||||+++ +|..++...   ..+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+   +.++|+|||++
T Consensus        74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~---~~~~l~d~g~~  147 (284)
T cd07836          74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR---GELKLADFGLA  147 (284)
T ss_pred             EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC---CcEEEeecchh
Confidence            899999996 787777653   36899999999999999999999988  9999999999999876   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .......       .......+++.|++||++..   ...++.++|||||||++|+|++|..||........+.......
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (284)
T cd07836         148 RAFGIPV-------NTFSNEVVTLWYRAPDVLLG---SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM  217 (284)
T ss_pred             hhhcCCc-------cccccccccccccChHHhcC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            7654321       11122367899999998752   2357889999999999999999999997665544332211110


Q ss_pred             hh------------h--ccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 KA------------T--EVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~~------------~--~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..            .  ...++         ..+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         218 GTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             CCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00            0  00000         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-39  Score=333.23  Aligned_cols=256  Identities=28%  Similarity=0.470  Sum_probs=199.5

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeec-CCe
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEID-ANS  366 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~-~~~  366 (627)
                      |.++++||+|+||.||+|.+..+++.||||++........      .....+|+.++.++. ||||+++++++..+ .+.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE------QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch------hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            6789999999999999999999999999998754321111      123457888898885 99999999998743 167


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.    +.+||+|||+++
T Consensus        75 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~----~~~kl~dfg~~~  147 (282)
T cd07831          75 LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD----DILKLADFGSCR  147 (282)
T ss_pred             EEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC----CCeEEEeccccc
Confidence            8999999985 66666654 457999999999999999999999988  999999999999988    489999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.....        .....+++.|+|||++..   ...++.++|||||||+||+|++|..||...+....+........
T Consensus       148 ~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~  216 (282)
T cd07831         148 GIYSKPP--------YTEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG  216 (282)
T ss_pred             ccccCCC--------cCCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC
Confidence            7643221        122367899999998642   33578899999999999999999999976654433222211110


Q ss_pred             h--------------hccccCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 A--------------TEVQFAN---------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~--------------~~~~~~~---------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .              ....++.         .+.++.++.+||.+||.+||++||++.+++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0              0111111         13568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=346.88  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=205.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      |++-.++|++.+.||.|+||.||+|.+..     +++.||||++.....      ......+.+|+.++.++ +||||++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT------ASEYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC------HHHHHHHHHHHHHHHhhccCcchhh
Confidence            45567899999999999999999997543     457899998754322      12235678899999999 8999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc-------------------------------------------------
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------------------------------------------------  386 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------  386 (627)
                      ++++|..+...+++||||+++++|.+++...                                                 
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9999876777888999999999999988532                                                 


Q ss_pred             ------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         387 ------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       387 ------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                                  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.+...... 
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~---~~vkL~DfG~a~~~~~~~~~-  229 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN---NVVKICDFGLARDIYKDPDY-  229 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC---CcEEEeccccchhcccCcch-
Confidence                        26789999999999999999999988  9999999999999976   58999999999876432211 


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                          .......++..|+|||++.    ...++.++|||||||+||+|++ |..||........+...  +...  .....
T Consensus       230 ----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--~~~~--~~~~~  297 (337)
T cd05054         230 ----VRKGDARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--LKEG--TRMRA  297 (337)
T ss_pred             ----hhccCCCCCccccCcHHhc----CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--Hhcc--CCCCC
Confidence                1122335678899999884    4568999999999999999997 99999764433332211  1111  11222


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...+++++.+++.+||+.+|++||++.++++|
T Consensus       298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            34578899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.7e-40  Score=346.49  Aligned_cols=269  Identities=26%  Similarity=0.454  Sum_probs=211.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  362 (627)
                      +.++|.+.+.||.|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||++++++|..  
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-----VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-----cccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            35789999999999999999999999999999998764321     11234567789999999999999999998853  


Q ss_pred             -cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 -DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 -~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+||||+. ++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~---~~~kl~df  151 (334)
T cd07855          78 ADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED---CELRIGDF  151 (334)
T ss_pred             CCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CcEEeccc
Confidence             2346789999997 589888887788999999999999999999999988  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |++..+......   .........|+..|+|||++..   ...++.++|||||||++|+|++|+.||........+....
T Consensus       152 g~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~  225 (334)
T cd07855         152 GMARGLSSSPTE---HKYFMTEYVATRWYRAPELLLS---LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL  225 (334)
T ss_pred             ccceeecccCcC---CCcccccccccccccChHHhcC---CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence            999876533211   1112234478999999999742   2357889999999999999999999996654332221111


Q ss_pred             HHhhhh----------------ccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKAT----------------EVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~----------------~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ......                ...++         ..+.++.++.+||++||+.+|.+||++.+++.||||..
T Consensus       226 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             HHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence            000000                00000         11457899999999999999999999999999999974

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-39  Score=327.38  Aligned_cols=255  Identities=25%  Similarity=0.444  Sum_probs=208.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||++.+..++..||+|.+.......     .....+.+|+.+++.++|+||+++++++. +...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-----KEKEASKKEVILLAKMKHPNIVTFFASFQ-ENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-----hhhHHHHHHHHHHHhCCCCChhhhhheec-cCCeE
Confidence            5889999999999999999999999999999986532111     11345678999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++|+||+++++|.+++....  .+++..+..++.||+.||.|||+.+  |+|+||||.|||++.+.  ..+||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~--~~~~l~d~~~~~  150 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNG--MVAKLGDFGIAR  150 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCC--CeEEecccccch
Confidence            99999999999999987643  5799999999999999999999988  99999999999998763  357999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......|++.|+|||++.    ...++.++|||||||++|+|++|..||........+...   ..
T Consensus       151 ~~~~~~-------~~~~~~~~~~~~~ape~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~  216 (257)
T cd08225         151 QLNDSM-------ELAYTCVGTPYYLSPEICQ----NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI---CQ  216 (257)
T ss_pred             hccCCc-------ccccccCCCccccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hc
Confidence            765322       1122346899999999874    345788999999999999999999999765544333211   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                        ....+..+.++.++.++|.+||..+|++|||+.+++.||||
T Consensus       217 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         217 --GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence              11122335678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-39  Score=332.76  Aligned_cols=256  Identities=22%  Similarity=0.364  Sum_probs=200.2

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||+|.+..+++.||||++........ ............+.+++..+||||+.++++|. +.+.+|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCEEEEEEec
Confidence            38999999999999999999999999865432111 11111112223344556678999999999998 56788899999


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN  453 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~  453 (627)
                      +.|++|..++.....+++..++.++.|++.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..+....  
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~---~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC---CCEEEccCcCccccCccC--
Confidence            999999999988889999999999999999999999988  9999999999999987   589999999997654321  


Q ss_pred             CCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       454 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                             ....+|+..|+|||++..   ...++.++|||||||+||+|++|+.||............ ......  ....
T Consensus       152 -------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~  218 (278)
T cd05606         152 -------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTM--AVEL  218 (278)
T ss_pred             -------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhcc--CCCC
Confidence                   123478999999999852   335788999999999999999999999755322111111 111111  2223


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      +..++.++.+||.+||..+|.+||     ++.++++||||...
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            345789999999999999999999     99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.1e-39  Score=328.19  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      ...||+|+||.||+|.+..++..||||.+.....       ...+.+.+|+.+++.++|+||+++++++. ..+.+++|+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   84 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-------RYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGFFKIFM   84 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-------HHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCEEEEEE
Confidence            3579999999999999999999999998754321       12346789999999999999999999987 567889999


Q ss_pred             eecCCCChHHHHHhc-cCc--CHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         372 EYCDGHDLDFYLKQH-KTI--AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       372 E~~~gg~L~~~l~~~-~~l--~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      ||+++++|..++... ..+  ++..+..++.||+.||.|||+.+  |+||||||+|||++.+.  +.++|+|||++..+.
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~--~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCC--CeEEEecchhheecc
Confidence            999999999998764 455  88899999999999999999988  99999999999998643  589999999997654


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE  528 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  528 (627)
                      ....       ......|++.|+|||++...  ...++.++|||||||++|+|++|..||..............   ...
T Consensus       161 ~~~~-------~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~---~~~  228 (268)
T cd06624         161 GINP-------CTETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG---MFK  228 (268)
T ss_pred             cCCC-------ccccCCCCccccChhhhccc--cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh---hhc
Confidence            3221       11223689999999997422  23478899999999999999999999965433222111111   111


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .....+..+++++.+||.+||..+|.+|||+.+++.||||
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            1112234678999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4721|consensus

Probab=100.00  E-value=2.7e-41  Score=356.66  Aligned_cols=239  Identities=26%  Similarity=0.401  Sum_probs=203.2

Q ss_pred             eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEE
Q psy4988         290 LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      .-++.||.|+-|-||+|.  -.++.||||.+.-              .-..+|.-|++|+|||||.|.++|. ....|||
T Consensus       127 sELeWlGSGaQGAVF~Gr--l~netVAVKKV~e--------------lkETdIKHLRkLkH~NII~FkGVCt-qsPcyCI  189 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGR--LHNETVAVKKVRE--------------LKETDIKHLRKLKHPNIITFKGVCT-QSPCYCI  189 (904)
T ss_pred             hhhhhhccCcccceeeee--ccCceehhHHHhh--------------hhhhhHHHHHhccCcceeeEeeeec-CCceeEE
Confidence            345679999999999996  4578999996521              0113677899999999999999997 7788999


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      |||||..|-|...|+....+.......+..+|+.|+.|||.++  |||||||.-||||.-++   .|||+|||.++...+
T Consensus       190 iMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDD---VVKISDFGTSKELSD  264 (904)
T ss_pred             eeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccc---eEEeccccchHhhhh
Confidence            9999999999999999999999999999999999999999999  99999999999999874   899999999987764


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ..        ..-.++||..|||||+|.    ..+.+.|+|||||||||||||||..||.+-.....|.    -+....+
T Consensus       265 ~S--------TkMSFaGTVaWMAPEvIr----nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVGsNsL  328 (904)
T KOG4721|consen  265 KS--------TKMSFAGTVAWMAPEVIR----NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVGSNSL  328 (904)
T ss_pred             hh--------hhhhhhhhHhhhCHHHhh----cCCcccccceehhHHHHHHHHhcCCCccccchheeEE----eccCCcc
Confidence            32        123459999999999994    5678999999999999999999999997654433321    1233456


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      .++.+..+++-++=||+.||.-.|..||++.++|.|-
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            6777788999999999999999999999999999883

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.2e-39  Score=331.28  Aligned_cols=261  Identities=29%  Similarity=0.453  Sum_probs=207.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~  365 (627)
                      ++|...+.||.|+||.||++.+..+++.||+|++.....      ......+.+|+++++.++||||++++++|.. +.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            578999999999999999999999999999998864322      1234568889999999999999999998853 344


Q ss_pred             eEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      .+|+||||+++++|.+++..    ...+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+||
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~---~~~~l~df  149 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK---GQVKLCDF  149 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC---CeEEEeec
Confidence            68899999999999887653    356899999999999999999999988  9999999999999876   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----HHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS----QATI  517 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~----~~~~  517 (627)
                      |++.......         .....++..|+|||.+.    ...++.++|||||||++|+|++|..||.....    ....
T Consensus       150 g~~~~~~~~~---------~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (287)
T cd06621         150 GVSGELVNSL---------AGTFTGTSFYMAPERIQ----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL  216 (287)
T ss_pred             cccccccccc---------cccccCCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence            9987654321         12336788999999884    44588899999999999999999999975521    1111


Q ss_pred             HHHHHHhhhhccccCC----CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         518 LEENTILKATEVQFAN----KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~----~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ..  .........++.    ....++++.+||.+||..||.+|||+.+++.||||.....
T Consensus       217 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         217 LS--YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             HH--HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence            11  111111111111    1235678999999999999999999999999999965443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.8e-39  Score=329.27  Aligned_cols=251  Identities=29%  Similarity=0.487  Sum_probs=206.1

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||.|+||.||+|.+..++..||||++.......    ....+.+.+|+.+++.++||||+++++++. +.+.+|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE----TGQQEHIFSEKEILEECNHPFIVKLYRTFK-DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-cCCccEEEEecC
Confidence            689999999999999999999999986543221    123456889999999999999999999987 667889999999


Q ss_pred             CCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         375 DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       375 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                      ++++|.+++.....+++..+..++.||+.||.|||+.+  ++|+||+|+||+++.+   +.++|+|||++..+....   
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC---CCEEEeeCCcccccCccc---
Confidence            99999999988888999999999999999999999988  9999999999999886   689999999998765432   


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhhhhccccCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-ATILEENTILKATEVQFAN  533 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~  533 (627)
                           ......|++.|++||.+.    ...++.++||||||+++|+|++|..||...... ...... .........  .
T Consensus       148 -----~~~~~~~~~~~~~PE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~--~  215 (262)
T cd05572         148 -----KTWTFCGTPEYVAPEIIL----NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-ILKGNGKLE--F  215 (262)
T ss_pred             -----ccccccCCcCccChhHhc----CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-HhccCCCCC--C
Confidence                 112346899999999874    345788999999999999999999999766521 121111 111112222  2


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQP  570 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~  570 (627)
                      +..+++++.+||.+||..||.+||+     +.++++||||..
T Consensus       216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            3345899999999999999999999     999999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=333.12  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=205.2

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.+.+.||.|++|.||+|.+..++..||||++......     ......+.+|+.+++.++||||+++++++. +...+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-----EGVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-----ccchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEE
Confidence            67789999999999999999999999999998654321     112235778999999999999999999987 667889


Q ss_pred             EEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +||||++ ++|..++....  .+++..+..++.||+.||.|||+.+  ++|+||+|+|||++.+   +.++|+|||++..
T Consensus        75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~---~~~~l~df~~~~~  148 (283)
T cd07835          75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE---GALKLADFGLARA  148 (283)
T ss_pred             EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC---CcEEEeecccccc
Confidence            9999996 58888887665  7999999999999999999999988  9999999999999986   6899999999976


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......+++.|+|||++..   ...++.++|||||||++|+|++|+.||........+.........
T Consensus       149 ~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (283)
T cd07835         149 FGVPVR-------TYTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGT  218 (283)
T ss_pred             cCCCcc-------ccCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            543211       1122356889999998742   234688999999999999999999999776554433221111000


Q ss_pred             --------------hcccc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 --------------TEVQF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 --------------~~~~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                    ....+         ...+.++.++.+||.+||+.||.+|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             CChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                          00000         1124678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-39  Score=331.58  Aligned_cols=257  Identities=20%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .+..++|++.+.||+|+||.||+|.+..     ++..||||++......      .....+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~e~~~l~~l~~~~iv~~~   75 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM------RERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH------HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            4667889999999999999999998642     4578999987533221      1234688999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhcc----------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      +++. +...+++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+  |+|+||||+|||+
T Consensus        76 ~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~  152 (277)
T cd05062          76 GVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV  152 (277)
T ss_pred             EEEc-CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE
Confidence            9987 6667889999999999999986532          3577889999999999999999988  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKK  506 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~  506 (627)
                      +.+   +.++|+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+||+|++ |..
T Consensus       153 ~~~---~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~  220 (277)
T cd05062         153 AED---FTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQ  220 (277)
T ss_pred             cCC---CCEEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhh----cCCcCchhHHHHHHHHHHHHHcCCCC
Confidence            976   68999999999865432211     0111235678899999984    4458899999999999999998 789


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||........+ ..  +....  .......++..+.+||.+||+.||++||++.+++.+
T Consensus       221 p~~~~~~~~~~-~~--~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         221 PYQGMSNEQVL-RF--VMEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCHHHHH-HH--HHcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99765443222 11  11111  112234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-39  Score=332.79  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=203.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCC-----eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQ-----RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~-----~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ++|++++.||+|+||.||+|.+...+     ..||+|.+.....      ......+.+|+.++..++||||+++++++.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   78 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE------PKVQQEFRQEAELMSDLQHPNIVCLLGVCT   78 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC------HHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence            46889999999999999999876655     7899998753321      223456889999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                       +...+|++|||+++++|.+++...                ..+++..++.++.||+.||.|||+.+  |+|+||||+||
T Consensus        79 -~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Ni  155 (283)
T cd05048          79 -KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNC  155 (283)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceE
Confidence             566788999999999999998754                45888999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++++   +.++|+|||+++........     .......+++.|+|||.+.    ...++.++|||||||+||||++ |
T Consensus       156 l~~~~---~~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~sDv~slG~il~el~~~g  223 (283)
T cd05048         156 LVGEG---LTVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEIFSYG  223 (283)
T ss_pred             EEcCC---CcEEECCCcceeeccccccc-----cccCCCcccccccCHHHhc----cCcCchhhhHHHHHHHHHHHHcCC
Confidence            99886   58999999999865433211     1223346788999999884    3458899999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..||...........   +...  ...+....+++++.+|+.+||+.||.+||++.+++++
T Consensus       224 ~~p~~~~~~~~~~~~---i~~~--~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         224 LQPYYGFSNQEVIEM---IRSR--QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCCCHHHHHHH---HHcC--CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999976554432211   1111  1122345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.6e-39  Score=331.06  Aligned_cols=249  Identities=27%  Similarity=0.429  Sum_probs=197.1

Q ss_pred             CCeeEEEEe--cccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLL--GKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~L--G~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      +.|.+.+.+  |.|+||.||++.+..++..+|+|++.......            .|+.+...+ +||||++++++|. .
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------------~e~~~~~~~~~h~~iv~~~~~~~-~   80 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------------IEPMVHQLMKDNPNFIKLYYSVT-T   80 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------------hhHHHHHHhhcCCCEEEEEEEEe-c
Confidence            345555555  99999999999999999999999975432110            022222212 7999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+|+||||+++++|..++.....+++.+++.++.||+.||.|||+.+  |+||||||+|||++.+.  +.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~--~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAK--DRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCC--CeEEEecCcc
Confidence            5688999999999999999988789999999999999999999999988  99999999999998873  3899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +......           ....|+..|+|||++.    ...++.++|||||||++|+|++|..||............  .
T Consensus       157 ~~~~~~~-----------~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~--~  219 (267)
T PHA03390        157 CKIIGTP-----------SCYDGTLDYFSPEKIK----GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES--L  219 (267)
T ss_pred             ceecCCC-----------ccCCCCCcccChhhhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH--H
Confidence            9765432           1236899999999984    445788999999999999999999999754332211111  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHhccCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-VISLARHDYLQ  569 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-~~elL~hp~~~  569 (627)
                      ........+....+++.+.+||.+||+.||.+||+ ++++++||||.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        220 LKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            11112222334468999999999999999999996 69999999996

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=341.29  Aligned_cols=266  Identities=24%  Similarity=0.405  Sum_probs=201.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      +|.+.++||+|+||.||+|.+..  ++..||||++.....    ........+.+|+.+++.++||||++++++|. +. 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE----QYTGISQSACREIALLRELKHENVVSLVEVFL-EHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc----cccCccHHHHHHHHHHHhcCCCCccceEEEEe-CCC
Confidence            58999999999999999999988  899999999875331    01112345678999999999999999999997 44 


Q ss_pred             -CeEEEEEeecCCCChHHHHHhc-----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC-CcccceE
Q psy4988         365 -NSFCTVLEYCDGHDLDFYLKQH-----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIK  437 (627)
Q Consensus       365 -~~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~-~~~g~vK  437 (627)
                       ..+|+||||+++ +|..++...     ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+ ...+.+|
T Consensus        76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEE
Confidence             678999999986 565555322     36899999999999999999999988  9999999999999871 1126899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA--  515 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~--  515 (627)
                      |+|||+++.+......    ........+++.|+|||++.   ....++.++|||||||+||+|++|++||.......  
T Consensus       153 l~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  225 (316)
T cd07842         153 IGDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK  225 (316)
T ss_pred             ECCCccccccCCCccc----ccccCCccccccccCHHHHh---CCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence            9999999876543211    11123347899999999874   23357889999999999999999999996544322  


Q ss_pred             -------HHHHHHHHhh----------------------hhccccC---------CCCCCCHHHHHHHHHhhhcCcCCCC
Q psy4988         516 -------TILEENTILK----------------------ATEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRI  557 (627)
Q Consensus       516 -------~~~~~~~~~~----------------------~~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rp  557 (627)
                             .+......+.                      .....++         .+...+.++.+||.+||.+||++||
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  305 (316)
T cd07842         226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI  305 (316)
T ss_pred             cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence                   0000000000                      0000000         1115677899999999999999999


Q ss_pred             CHHHHHhccCC
Q psy4988         558 DVISLARHDYL  568 (627)
Q Consensus       558 t~~elL~hp~~  568 (627)
                      |+.+++.||||
T Consensus       306 s~~eil~~~~f  316 (316)
T cd07842         306 TAEEALEHPYF  316 (316)
T ss_pred             CHHHHhcCCCC
Confidence            99999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.3e-39  Score=330.75  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=204.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      -.+.|.+.+.||+|+||.||+|.+..     +...||+|.+.....      ......+.+|+.+++.++|+||++++++
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS------EQDESDFLMEALIMSKFNHQNIVRLIGV   77 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34679999999999999999999887     778999998653322      1112458889999999999999999998


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhcc-------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHK-------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                      +. +...+++||||+++++|.+++....       .+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+..
T Consensus        78 ~~-~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          78 SF-ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             Ec-cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCC
Confidence            87 5566789999999999999987653       5899999999999999999999988  999999999999987543


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHN  511 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~  511 (627)
                      ...+||+|||+++.+....+..     .......++.|+|||++.    ...++.++|||||||+||+|++ |..||...
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYYR-----KGGRAMLPIKWMPPEAFL----DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             CcceEeccCccccccCCcccee-----cCCCCCccHhhCCHHHHh----cCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            3479999999998764322110     011223456899999984    3458999999999999999996 99999765


Q ss_pred             ChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...... ..  +....  .......++..+.+||.+||..+|++||++.++++|
T Consensus       226 ~~~~~~-~~--~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         226 TNQEVM-EF--VTGGG--RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CHHHHH-HH--HHcCC--cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            544322 11  11111  222345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.6e-39  Score=326.22  Aligned_cols=257  Identities=30%  Similarity=0.460  Sum_probs=212.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      +.|.+.+.||.|+||.||+|.+..+++.|+||++......      .....+.+|+.++..++||||+++++++. ..+.
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE------EFRKQLLRELKTLRSCESPYVVKCYGAFY-KEGE   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-cCCe
Confidence            3688999999999999999999999999999998654321      23456889999999999999999999987 5578


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+++++|..++.....+++..++.++.||+.||.|||+ .+  ++|+||+|+||+++.+   +.++|+|||++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~---~~~~l~df~~~~  148 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK---GEVKIADFGISK  148 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC---CCEEEccCccce
Confidence            89999999999999999888899999999999999999999999 88  9999999999999887   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHH
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ--SQATILEENTI  523 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~  523 (627)
                      .+......       .....++..|+|||.+.    ...++.++||||||+++|+|++|..||....  ........  +
T Consensus       149 ~~~~~~~~-------~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~--~  215 (264)
T cd06623         149 VLENTLDQ-------CNTFVGTVTYMSPERIQ----GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA--I  215 (264)
T ss_pred             ecccCCCc-------ccceeecccccCHhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH--H
Confidence            76543211       12346889999999984    3468889999999999999999999997664  22222211  1


Q ss_pred             hhhhccccCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~-vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ....  ....... ++..+.+||.+||..+|.+||++.+++.||||+.
T Consensus       216 ~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         216 CDGP--PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             hcCC--CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            1111  1122233 7899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-39  Score=335.91  Aligned_cols=262  Identities=25%  Similarity=0.397  Sum_probs=208.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .....+|.+.+.||+|+||.||+|.+..+++.||||++.......    ......+.+|+.+++.++||||++++++|. 
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-   85 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-   85 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-
Confidence            345577999999999999999999999999999999885433221    223456889999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+..|+||||+.+ +|.+++. ....+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+||
T Consensus        86 ~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~---~~~kL~df  159 (307)
T cd06607          86 REHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP---GTVKLADF  159 (307)
T ss_pred             eCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC---CCEEEeec
Confidence            56678899999985 5555554 4567999999999999999999999988  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |++......           ....+++.|+|||++... ....++.++|||||||++|+|++|..||........+... 
T Consensus       160 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~-~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-  226 (307)
T cd06607         160 GSASLVSPA-----------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-  226 (307)
T ss_pred             CcceecCCC-----------CCccCCccccCceeeecc-CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-
Confidence            999765322           223688899999987422 2345788999999999999999999999765443332211 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        .......+ ....++.++.+||.+||..||.+||++.+++.||||...
T Consensus       227 --~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         227 --AQNDSPTL-SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             --hcCCCCCC-CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence              11111111 122467899999999999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.1e-39  Score=332.28  Aligned_cols=258  Identities=24%  Similarity=0.416  Sum_probs=209.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|...+.||.|+||.||++.+..+++.|+||++.....       .....+.+|+.+++.++||||+++++++. ..+..
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~   91 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-------QRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDEL   91 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-------hHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeE
Confidence            35556789999999999999999999999998754322       11345788999999999999999999987 56778


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|+||+.+++|.+++.. ..+++..+..++.||+.||.|||+++  |+||||+|+||+++.+   +.++|+|||++...
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~~l~d~g~~~~~  165 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD---GRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC---CcEEEcccccchhh
Confidence            899999999999999877 67999999999999999999999988  9999999999999987   68999999998765


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ....       .......|++.|+|||++.    ...++.++|||||||++|+|++|..||........+..   +....
T Consensus       166 ~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~  231 (285)
T cd06648         166 SKEV-------PRRKSLVGTPYWMAPEVIS----RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNL  231 (285)
T ss_pred             ccCC-------cccccccCCccccCHHHhc----CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcC
Confidence            4321       1112346899999999984    34578899999999999999999999976543322211   11111


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .........++..+.+||++||..+|.+||++.+++.||||....+
T Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         232 PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            1222223347899999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.2e-39  Score=332.39  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||+|+||+||+|.+..+++.||||++.....    ........+..|+.+++.++||||++++++|. ..+.+|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL----KKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh----hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEecC
Confidence            6899999999999999999999999864321    11222445678999999999999999999997 567789999999


Q ss_pred             CCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         375 DGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       375 ~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ++++|..++....  .+++..++.++.|++.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||++....... 
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~---~~~~l~dfg~~~~~~~~~-  149 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGK-  149 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC---CCEEEccCcchhhhccCC-
Confidence            9999999987665  7999999999999999999999988  9999999999999987   589999999997654321 


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                             ......++..|+|||++.    ...++.++|||||||++|+|++|+.||..............  ........
T Consensus       150 -------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~  216 (277)
T cd05577         150 -------KIKGRAGTPGYMAPEVLQ----GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTLEMAVE  216 (277)
T ss_pred             -------ccccccCCCCcCCHHHhc----CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--cccccccc
Confidence                   112336788999999984    33478899999999999999999999965543111111111  11112223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ....+++++.+||.+||..||.+||     ++.+++.||||..
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            3346789999999999999999999     9999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.4e-39  Score=334.66  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=205.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-C
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-N  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-~  365 (627)
                      +.|.+.+.||.|+||.||+|.+..+++.||||.+......     ......+.+|+.+++.++||||+++++++..+. .
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-----EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-----ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence            4688899999999999999999999999999998654321     122345678999999999999999999886332 7


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~---~~~~l~d~g~~  153 (293)
T cd07843          80 KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR---GILKICDFGLA  153 (293)
T ss_pred             cEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC---CcEEEeecCce
Confidence            78999999985 888887654 46999999999999999999999988  9999999999999987   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       ......+++.|+|||++..   ...++.++|||||||++|+|++|..||........+.......
T Consensus       154 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~  223 (293)
T cd07843         154 REYGSPLK-------PYTQLVVTLWYRAPELLLG---AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL  223 (293)
T ss_pred             eeccCCcc-------ccccccccccccCchhhcC---CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            87654321       1122367899999998852   2346889999999999999999999997665443332211110


Q ss_pred             hh---------------h----------ccccCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 KA---------------T----------EVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~~---------------~----------~~~~~~~~~-vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..               .          .+.-..... +++.+.+||++||..||++|||+.|++.||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            00               0          000000111 58899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-39  Score=335.88  Aligned_cols=260  Identities=25%  Similarity=0.433  Sum_probs=212.3

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||.|+||.||++.+..++..||||.+.....       .....+.+|+.+++.++||||++++++|. +.+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~   89 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-------PKKELIINEILVMRENKHPNIVNYLDSYL-VGD   89 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-------hHHHHHHHHHHHHhhcCCCCeeehhheee-eCC
Confidence            4789999999999999999999988999999998753221       11346788999999999999999999997 566


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+|+||+++++|..++.. ..+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+   +.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~---~~~kL~dfg~~~  163 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFCA  163 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC---CCEEEccCccee
Confidence            78899999999999998875 46899999999999999999999988  9999999999999886   589999999987


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......       ......|++.|+|||++.    ...++.++|||||||++|+|++|+.||........+..   ...
T Consensus       164 ~~~~~~~-------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~~  229 (293)
T cd06647         164 QITPEQS-------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT  229 (293)
T ss_pred             ccccccc-------ccccccCChhhcCchhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hhc
Confidence            6543321       112346899999999984    34578899999999999999999999976544332211   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .....+..+..++..+.+||++||..+|.+||++.+++.|+||....+
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            122233344567889999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-39  Score=337.18  Aligned_cols=269  Identities=28%  Similarity=0.430  Sum_probs=203.9

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      .++|.+.++||.|+||.||+|.+..+++.||||++........     ....+.+|+++++.++||||+++++++.... 
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-----FPITALREIKILKKLKHPNVVPLIDMAVERPD   81 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-----cchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence            5789999999999999999999999999999998865332111     1124568999999999999999999875332 


Q ss_pred             ------CeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         365 ------NSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       365 ------~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                            ..+++||||+.+ +|...+. ....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++
T Consensus        82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~---~~~~  155 (311)
T cd07866          82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ---GILK  155 (311)
T ss_pred             cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---CCEE
Confidence                  347899999985 5655554 3458999999999999999999999988  9999999999999987   6899


Q ss_pred             EeecccccccccCCCCCCC----CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         438 ITDFGLSKVMDEENYNPDH----GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      |+|||++............    .........+++.|+|||++..   ...++.++|||||||++|+|++|++||.....
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999876543221110    0111223467899999998742   33578899999999999999999999976554


Q ss_pred             HHHHHHHHHHhhh-hcccc------------------C-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         514 QATILEENTILKA-TEVQF------------------A-----NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       514 ~~~~~~~~~~~~~-~~~~~------------------~-----~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ............. ....+                  +     ....++.++.+||.+||..||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            4322211111000 00000                  0     012355788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.4e-39  Score=329.83  Aligned_cols=262  Identities=30%  Similarity=0.479  Sum_probs=213.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  365 (627)
                      ++|.+.+.||.|+||.||+|.+..++..||||++.......    ......+.+|+.+++.++ ||||++++++|. +.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK----EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-DEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc----hHHHHHHHHHHHHHHhcccCCCchhHHHHhc-CCc
Confidence            47999999999999999999999999999999986533221    122356778999999998 999999999987 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+.+++|.+++.....+++..++.++.||+.||.|||+.+  ++|+||+|+||+++.+   +.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~---~~~~l~df~~~~  150 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD---MHIKITDFGTAK  150 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC---CCEEecCCcccc
Confidence            78899999999999999998889999999999999999999999988  9999999999999876   689999999998


Q ss_pred             ccccCCCCCCC-------------CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4988         446 VMDEENYNPDH-------------GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ  512 (627)
Q Consensus       446 ~~~~~~~~~~~-------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~  512 (627)
                      ...........             .........++..|+|||++.    ...++.++||||||+++|+|++|..||....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN----EKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            76543321000             011223346889999999874    3447889999999999999999999997665


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCC
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYL  568 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~  568 (627)
                      ....+...      ..........++..+.+||.+||..||.+||++    .++++||||
T Consensus       227 ~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         227 EYLTFQKI------LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHH------HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            33322111      122333345678999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-38  Score=320.57  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=212.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC--C
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA--N  365 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~  365 (627)
                      +|.+.+.||+|+||.||+|.+..+++.|+||++......     ......+.+|+.++++++||||+++++++. +.  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-----EEELEALEREIRILSSLQHPNIVRYYGSER-DEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-cCCCC
Confidence            488899999999999999999999999999998655432     233567889999999999999999999987 44  6


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++|+||+++++|.+++.....+++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.+   +.++|+|||.+.
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~---~~~~l~d~~~~~  149 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD---GVVKLADFGCAK  149 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC---CCEEEcccccEE
Confidence            78899999999999999988889999999999999999999999988  9999999999999986   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ........     .......++..|+|||.+.    ...++.++||||||++||+|++|..||............  . .
T Consensus       150 ~~~~~~~~-----~~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~-~  217 (260)
T cd06606         150 RLGDIETG-----EGTGSVRGTPYWMAPEVIR----GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--I-G  217 (260)
T ss_pred             eccccccc-----ccccCCCCCccccCHhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh--c-c
Confidence            87654310     0122346899999999984    334888999999999999999999999766522222111  1 1


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ........+..++.++.+||.+||+.||.+||++.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            1111122334568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.4e-39  Score=324.47  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.++||.|+||.||++.+..++..||+|.+......      ...+.+.+|+.+++.++||||++++++|. +.+.+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS------SAVEDSRKEAVLLAKMKHPNIVAFKESFE-ADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch------HHHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCEE
Confidence            588999999999999999999999999999998654321      12346778999999999999999999997 66788


Q ss_pred             EEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |+||||+++++|..++...  ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++++   +.++|+|||++.
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~---~~~~l~dfg~~~  148 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN---GKVKLGDFGSAR  148 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC---CcEEEcccCcce
Confidence            9999999999999888643  46899999999999999999999988  9999999999999886   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......|++.|+|||++.    ...++.++||||||+++|+|++|..||........+...   ..
T Consensus       149 ~~~~~~-------~~~~~~~~~~~~~aPE~~~----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~---~~  214 (255)
T cd08219         149 LLTSPG-------AYACTYVGTPYYVPPEIWE----NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV---CQ  214 (255)
T ss_pred             eecccc-------cccccccCCccccCHHHHc----cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH---hc
Confidence            764322       1123347899999999984    445888999999999999999999999765443332211   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .  ...+....++..+.+||.+||+.||.+||++.+++.-
T Consensus       215 ~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 G--SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C--CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1  1112234678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4236|consensus

Probab=100.00  E-value=7.7e-41  Score=350.39  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=213.1

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +.||.|-||+||-|.++++|+.||||++.+..-....  +   ..+..|+.||..++||.||.|--.|+ ..+.+++|||
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--e---sqlR~EVaILq~l~HPGiV~le~M~E-T~ervFVVME  643 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--E---SQLRNEVAILQNLHHPGIVNLECMFE-TPERVFVVME  643 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCch--H---HHHHHHHHHHHhcCCCCeeEEEEeec-CCceEEEEeh
Confidence            6799999999999999999999999999765433221  1   35678999999999999999999998 5667779999


Q ss_pred             ecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         373 YCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       373 ~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      -+.|.-|..+|. +.++|++.....++.||+.||.|||-++  |||+||||+||||........+||||||+|+++.+..
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            998766666664 4579999999999999999999999988  9999999999999887666799999999999998754


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                              +....+|||.|+|||++.    ...|+...|+||+|||+|.-|.|..||..+.+-...+.+    ...-...
T Consensus       722 --------FRrsVVGTPAYLaPEVLr----nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN----AaFMyPp  785 (888)
T KOG4236|consen  722 --------FRRSVVGTPAYLAPEVLR----NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN----AAFMYPP  785 (888)
T ss_pred             --------hhhhhcCCccccCHHHHh----hccccccccceeeeEEEEEEecccccCCCccchhHHhhc----cccccCC
Confidence                    346679999999999995    445899999999999999999999999655432222111    1112222


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..|..++.++.|||..+|+..-++|.+++..|.|||++.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            357789999999999999999999999999999999974

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-39  Score=342.76  Aligned_cols=266  Identities=18%  Similarity=0.269  Sum_probs=201.6

Q ss_pred             Eeccc--CceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         294 LLGKG--GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       294 ~LG~G--~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      .||+|  +||+||+|.+..+++.||||++......     ....+.+.+|+.+++.++|||||+++++|. ....+|+||
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~~v~   78 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-----EEHLKALQNEVVLSHFFRHPNIMTSWTVFT-TGSWLWVIS   78 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCCcceEeeeEe-cCCceEEEE
Confidence            46766  9999999999999999999998654321     123467888999999999999999999998 567788999


Q ss_pred             eecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         372 EYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       372 E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      ||+.+++|..++...  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.+   +.++|+||+.+.....
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~  153 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD---GLVSLSGLSHLYSLVR  153 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC---CcEEEechHHHhhhhc
Confidence            999999999998764  35899999999999999999999988  9999999999999876   5899999986644322


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh----
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK----  525 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~----  525 (627)
                      ................++..|+|||++...  ...++.++|||||||++|+|++|..||........+........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL  231 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence            111100000111123456789999998532  23478899999999999999999999976554433322111000    


Q ss_pred             -------------------------------------hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 -------------------------------------ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 -------------------------------------~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                                           ......+....+++.+.+||++||++||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                                                 0001111223467789999999999999999999999999999


Q ss_pred             CCCC
Q psy4988         569 QPPV  572 (627)
Q Consensus       569 ~~~~  572 (627)
                      ....
T Consensus       312 ~~~~  315 (328)
T cd08226         312 KQVK  315 (328)
T ss_pred             HHHH
Confidence            7543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-39  Score=334.49  Aligned_cols=265  Identities=26%  Similarity=0.413  Sum_probs=206.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.......     .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-----GFPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-----CchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            45678999999999999999999999999999999986543211     1123567899999999999999999988633


Q ss_pred             C---------CeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         364 A---------NSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       364 ~---------~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      .         ..+|+|+||+++ +|..++.. ...+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+   
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~---  152 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK---  152 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---
Confidence            2         378999999997 56565554 357999999999999999999999988  9999999999999987   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||++..+......      ......++..|+|||++.   ....++.++|||||||++|+|++|++||.....
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~---~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~  223 (302)
T cd07864         153 GQIKLADFGLARLYNSEESR------PYTNKVITLWYRPPELLL---GEERYGPAIDVWSCGCILGELFTKKPIFQANQE  223 (302)
T ss_pred             CcEEeCcccccccccCCccc------ccccceeccCccChHHhc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            58999999999876543211      112225688899999874   223467899999999999999999999976655


Q ss_pred             HHHHHHHHHHhhhh-cccc-----------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         514 QATILEENTILKAT-EVQF-----------------------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       514 ~~~~~~~~~~~~~~-~~~~-----------------------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ...+.......... ...+                       .....++..+.+||.+||..||.+||++.+++.||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         224 LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            44332222211110 0000                       0123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=331.63  Aligned_cols=257  Identities=25%  Similarity=0.498  Sum_probs=207.5

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeEEeecC
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---HPRVVKLYDVFEIDA  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~~  364 (627)
                      .|.+.+.||.|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.+.   ||||++++++|. +.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-KG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-eC
Confidence            47788899999999999999999999999998764322      112345778999998886   999999999987 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~---~~~~l~dfg~~  148 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT---GNVKLCDFGVA  148 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC---CCEEEccCCce
Confidence            778899999999999998865 47999999999999999999999988  9999999999999986   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       ......|+..|+|||++.   .+..++.++|||||||++|+|++|..||........+..   ..
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~---~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~  215 (277)
T cd06917         149 ALLNQNSS-------KRSTFVGTPYWMAPEVIT---EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IP  215 (277)
T ss_pred             eecCCCcc-------ccccccCCcceeCHHHhc---cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---cc
Confidence            87654321       112336899999999885   234578899999999999999999999976544332211   11


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ......++ ...++.++.+||.+||..||.+||++.+++.|+||+..
T Consensus       216 ~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         216 KSKPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             cCCCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            11111111 12378899999999999999999999999999999653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-39  Score=337.47  Aligned_cols=255  Identities=23%  Similarity=0.396  Sum_probs=207.2

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.....||.|+||.||+|.+..+++.||||++......       ....+.+|+.+++.++||||++++++|. ..+.+|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~   94 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-------RRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELW   94 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-------hHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEE
Confidence            33445699999999999999999999999998543221       1245778999999999999999999987 567788


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      +||||+++++|..++.. ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++..+.
T Consensus        95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~  168 (297)
T cd06659          95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD---GRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC---CcEEEeechhHhhcc
Confidence            99999999999987755 57899999999999999999999988  9999999999999887   689999999997654


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE  528 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  528 (627)
                      ....       ......|++.|+|||++.    ...++.++|||||||++|+|++|+.||........+..   +.....
T Consensus       169 ~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~  234 (297)
T cd06659         169 KDVP-------KRKSLVGTPYWMAPEVIS----RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPP  234 (297)
T ss_pred             cccc-------cccceecCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhccCC
Confidence            3221       122347899999999984    34578899999999999999999999976544333211   111122


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+.....++.++.+||++||+.+|.+||++.+++.||||...
T Consensus       235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            2233345678999999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-39  Score=334.76  Aligned_cols=260  Identities=27%  Similarity=0.387  Sum_probs=200.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCe
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANS  366 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~  366 (627)
                      +|...+.||+|+||.||++.+..+++.||||.+......      .....+.+|+.++.++. |||||++++++. +...
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-~~~~   77 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-REGD   77 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-cCCc
Confidence            455667799999999999999999999999987643321      22456788999999996 999999999887 5566


Q ss_pred             EEEEEeecCCCChHHHH---H--hccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         367 FCTVLEYCDGHDLDFYL---K--QHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l---~--~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .+++|||+.. ++..+.   .  ....+++..+..++.|++.||+|||+. +  |+||||||+|||++.+   +.+||+|
T Consensus        78 ~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~---~~~kl~d  151 (288)
T cd06616          78 CWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN---GNIKLCD  151 (288)
T ss_pred             EEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC---CcEEEee
Confidence            7799999875 444332   2  246799999999999999999999974 6  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++..+.....        .....|++.|+|||++.... ...++.++|||||||++|+|++|+.||.........+  
T Consensus       152 fg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--  220 (288)
T cd06616         152 FGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL--  220 (288)
T ss_pred             cchhHHhccCCc--------cccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH--
Confidence            999976543211        12236899999999985321 2368889999999999999999999996544211111  


Q ss_pred             HHHhhhh--ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKAT--EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~--~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......  ......+..++.++.+||.+||..||.+|||+.+++.||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             hhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            1111111  11122234588999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-38  Score=330.63  Aligned_cols=263  Identities=21%  Similarity=0.353  Sum_probs=205.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      |++..++|.+.+.||+|+||.||+|.+..     .+..||||.+......      .....+.+|+.+++.++||||+++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~   74 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL------RERIEFLNEASVMKGFTCHHVVRL   74 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence            35667899999999999999999997652     3568999986533221      112357789999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc----------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEE
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL  426 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NIL  426 (627)
                      ++++. +...+|+||||+++++|.+++...          ..++...+..++.||+.||.|||+++  |+||||||+|||
T Consensus        75 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nil  151 (288)
T cd05061          75 LGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCM  151 (288)
T ss_pred             EEEEc-CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEE
Confidence            99987 566788999999999999999753          23466788999999999999999988  999999999999


Q ss_pred             ecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q psy4988         427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GK  505 (627)
Q Consensus       427 l~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~  505 (627)
                      ++.+   +.++|+|||+++.+......     .......++..|+|||++.    ...++.++|||||||++|+|++ |.
T Consensus       152 i~~~---~~~~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~----~~~~~~~~DvwslG~~l~el~~~~~  219 (288)
T cd05061         152 VAHD---FTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLK----DGVFTTSSDMWSFGVVLWEITSLAE  219 (288)
T ss_pred             EcCC---CcEEECcCCccccccccccc-----cccCCCcccccccCHHHhc----cCCCChHhHHHHHHHHHHHHHhCCC
Confidence            9986   58999999999865432211     1112234577899999984    3457889999999999999998 78


Q ss_pred             CCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh------ccCCCC
Q psy4988         506 KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR------HDYLQP  570 (627)
Q Consensus       506 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~------hp~~~~  570 (627)
                      .||....... +...  +....  .......++..+.+||.+||+.||.+|||+.++++      ||||..
T Consensus       220 ~p~~~~~~~~-~~~~--~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         220 QPYQGLSNEQ-VLKF--VMDGG--YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCHHH-HHHH--HHcCC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            9997654433 2211  11111  12223456789999999999999999999999986      888864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-39  Score=362.76  Aligned_cols=274  Identities=17%  Similarity=0.219  Sum_probs=195.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCC-CeEEEEEEeecCcc----------hhhHhHHHHHHHHHHHHHHHhcCCC
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKD----------WKEDKKANYIKHALREYNIHKALDH  350 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-~~~VAVKii~~~~~----------~~~~~~~~~~~~~~~Ei~il~~l~H  350 (627)
                      ...+.++|++++.||+|+||+||+|..... +..+++|.+.....          ............+.+|+.+++.++|
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence            345678999999999999999999875442 22233331110000          0000112234567899999999999


Q ss_pred             CceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc-----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       351 pnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                      ||||++++++. +.+..|+|+|++.+ +|..++...     .......++.|+.||+.||.|||+++  ||||||||+||
T Consensus       223 pnIv~l~~~~~-~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILR-SEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEE-ECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence            99999999998 55667899999974 565555432     23456778899999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK  505 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~  505 (627)
                      ||+.+   +.+||+|||+++.+.....      ......+||+.|+|||++.    +..++.++||||||||||||++|.
T Consensus       299 Ll~~~---~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        299 FLNCD---GKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILA----GDGYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             EECCC---CCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhc----CCCCCcHHHHHHHHHHHHHHHHCC
Confidence            99886   6899999999987654321      1123357999999999984    445889999999999999999987


Q ss_pred             CC-CCCCC--hHHHHHHHHHHhhhhccccC--------------------------CCCCCCHHHHHHHHHhhhcCcCCC
Q psy4988         506 KP-FGHNQ--SQATILEENTILKATEVQFA--------------------------NKPTVSNEAKGFIRSCLAYRKEDR  556 (627)
Q Consensus       506 ~P-f~~~~--~~~~~~~~~~~~~~~~~~~~--------------------------~~~~vs~el~~LI~~cL~~dP~~R  556 (627)
                      .+ |....  ....+.+....+......++                          ....++.++.+||.+||.+||.+|
T Consensus       366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R  445 (501)
T PHA03210        366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR  445 (501)
T ss_pred             CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence            64 43222  12222221111110000010                          112356788899999999999999


Q ss_pred             CCHHHHHhccCCCCCC
Q psy4988         557 IDVISLARHDYLQPPV  572 (627)
Q Consensus       557 pt~~elL~hp~~~~~~  572 (627)
                      ||+.|+|.||||....
T Consensus       446 psa~elL~hp~f~~~~  461 (501)
T PHA03210        446 PGAAELLALPLFSAEE  461 (501)
T ss_pred             cCHHHHhhChhhhcCC
Confidence            9999999999997643

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.5e-39  Score=326.04  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=203.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||+|.+..+++.||||.+.......    ......+.+|+.+++.++||||+++++++. +.+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD----AKARQDCVKEIDLLKQLNHPNVIKYLDSFI-EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC----HHHHHHHHHHHHHHHhCCCcceeeeeeeEE-ECCe
Confidence            57999999999999999999999999999999875432211    223456788999999999999999999987 5567


Q ss_pred             EEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +++||||+++++|..++..    ...+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~---~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT---GVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC---CCEEECccc
Confidence            8899999999999988753    345899999999999999999999988  9999999999999886   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-ATILEEN  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~  521 (627)
                      ++..+.....       ......|++.|+|||++.    ...++.++||||||+++|+|++|+.||...... ..+... 
T Consensus       152 ~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~-  219 (267)
T cd08228         152 LGRFFSSKTT-------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK-  219 (267)
T ss_pred             cceeccchhH-------HHhcCCCCccccChhhhc----cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH-
Confidence            9987653221       112346889999999884    345788999999999999999999999654332 122111 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        .............++..+.+||.+||..+|.+||++.++++.
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         220 --IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             --HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence              111111111123577899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=322.93  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=210.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-CC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-AN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~  365 (627)
                      .+|.+.+.||+|+||.||+|.+..++..||+|++.......  ........+.+|+.+++.++||||+++++++... ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   79 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ--ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEK   79 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc--hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCC
Confidence            46999999999999999999999999999999875432111  1123356788999999999999999999988643 35


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+||+++.+   +.++|+|||+++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~---~~~~l~dfg~~~  154 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA---GNVKLGDFGASK  154 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC---CCEEECcccccc
Confidence            68899999999999999988788999999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ........   . .......|+..|+|||++.    ...++.++|||||||++|+|++|+.||........+...   . 
T Consensus       155 ~~~~~~~~---~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~-  222 (264)
T cd06653         155 RIQTICMS---G-TGIKSVTGTPYWMSPEVIS----GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---A-  222 (264)
T ss_pred             cccccccc---C-ccccccCCcccccCHhhhc----CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---H-
Confidence            76432110   0 0112346899999999984    345788999999999999999999999765444433221   1 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ........+..+++++.+||.+||. +|..||++.+++.|||.
T Consensus       223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            1111222345788999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0671|consensus

Probab=100.00  E-value=1.4e-40  Score=339.72  Aligned_cols=270  Identities=24%  Similarity=0.405  Sum_probs=213.8

Q ss_pred             cccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC--C---
Q psy4988         277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH--P---  351 (627)
Q Consensus       277 ~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--p---  351 (627)
                      ..|..++.+.+||.++..||+|+||.|-.+.|..++..|||||+..        ...|....+-|++++.++.+  |   
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--------V~kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--------VDKYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--------HHHHhhHHHHHHHHHHHHHhcCCCCc
Confidence            4556677889999999999999999999999999999999999853        23345567779999999932  2   


Q ss_pred             -ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         352 -RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       352 -nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                       .+|++.+||+ -.++.|||+|.+. -++.++++.+  .+++...++.|.+||+.+++|||+.+  |+|.||||+|||+.
T Consensus       151 ~rcv~m~~wFd-yrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfv  226 (415)
T KOG0671|consen  151 FRCVQMRDWFD-YRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFV  226 (415)
T ss_pred             eEEEeeehhhh-ccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEe
Confidence             4889999997 5678999999884 6889999875  47899999999999999999999999  99999999999995


Q ss_pred             CCCc-----------------ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhH
Q psy4988         429 EGNV-----------------CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV  491 (627)
Q Consensus       429 ~~~~-----------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DV  491 (627)
                      +...                 ...|+|+|||.|++..+..          +..+.|..|.|||+++    +..++.+|||
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViL----gLGwS~pCDv  292 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVIL----GLGWSQPCDV  292 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchhee----ccCcCCccCc
Confidence            3210                 1369999999998865432          4457899999999996    5569999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh-----------------ccccCCC--------------------
Q psy4988         492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT-----------------EVQFANK--------------------  534 (627)
Q Consensus       492 wSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--------------------  534 (627)
                      ||+||||+||++|...|....+.+.+.-...++...                 .+.|+..                    
T Consensus       293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~  372 (415)
T KOG0671|consen  293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM  372 (415)
T ss_pred             eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence            999999999999999998776555432222222111                 1111110                    


Q ss_pred             ---CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         535 ---PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       535 ---~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                         ..---++.|||++||.+||.+|+|+.|+|.||||....
T Consensus       373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence               00112478999999999999999999999999998643

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.3e-39  Score=329.66  Aligned_cols=253  Identities=24%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .++|.+.+.||+|+||.||+|.+..     ++..||||++.....      ......+.+|+++++.++||||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   77 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS------NDARKDFEREAELLTNFQHENIVKFYGVC   77 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC------HHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence            3568888999999999999998753     468899998754322      11235788999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc--------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH--------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL  426 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NIL  426 (627)
                      . +...+++||||+++++|..++...              ..+++..+..++.||+.||.|||+.+  |+||||||+|||
T Consensus        78 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nil  154 (280)
T cd05049          78 T-EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCL  154 (280)
T ss_pred             e-cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEE
Confidence            8 557788999999999999999754              34789999999999999999999988  999999999999


Q ss_pred             ecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CC
Q psy4988         427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GK  505 (627)
Q Consensus       427 l~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~  505 (627)
                      ++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+||+|++ |.
T Consensus       155 i~~~---~~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~e~~~~g~  222 (280)
T cd05049         155 VGYD---LVVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEIFTYGK  222 (280)
T ss_pred             EcCC---CeEEECCcccceecccCcce-----ecCCCCcccceecChhhhc----cCCcchhhhHHHHHHHHHHHHhcCC
Confidence            9987   69999999999865432211     1122335678999999984    4458899999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         506 KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       506 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .||........+...   .. . ........++.++.+||++||..||.+||++.+++.
T Consensus       223 ~p~~~~~~~~~~~~~---~~-~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         223 QPWYGLSNEEVIECI---TQ-G-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCCHHHHHHHH---Hc-C-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999765544332211   11 1 111223468899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.5e-39  Score=336.14  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeE----EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRY----VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~----VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ..+|++.+.||+|+||.||+|.+..++..    ||||++.....      ....+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~g~~~   79 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------PKANKEILDEAYVMASVDNPHVCRLLGICL   79 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence            35799999999999999999988766654    89998753221      223456888999999999999999999986


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .  ...++|+||+++++|.+++... ..+++..+..++.||+.||+|||+.+  ||||||||+|||++.+   +.+||+|
T Consensus        80 ~--~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~---~~~kl~D  152 (316)
T cd05108          80 T--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP---QHVKITD  152 (316)
T ss_pred             C--CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC---CcEEEcc
Confidence            3  3466999999999999998764 46899999999999999999999988  9999999999999887   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+......     .......++..|+|||++.    ...++.++|||||||+||||++ |..||....... +..
T Consensus       153 fG~a~~~~~~~~~-----~~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~  222 (316)
T cd05108         153 FGLAKLLGADEKE-----YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISS  222 (316)
T ss_pred             ccccccccCCCcc-----eeccCCccceeecChHHhc----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH
Confidence            9999876543211     0111224567899999984    4568899999999999999997 999997654332 211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         +. .....++..+.++.++.++|.+||..||.+||++.+++.+
T Consensus       223 ---~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         223 ---IL-EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ---HH-hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               11 1222344455678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.2e-39  Score=347.79  Aligned_cols=258  Identities=22%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~  355 (627)
                      +..-.++|++.++||+|+||.||+|.+...     ...||||++.....      ....+.+++|+.+++++. |||||+
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~~Ei~~l~~l~~HpnIv~  105 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR------SSEKQALMSELKIMTHLGPHLNIVN  105 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC------hHHHHHHHHHHHHHHhcCCCCCeee
Confidence            344568899999999999999999987543     35799998854322      122356889999999996 999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc-------------------------------------------------
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------------------------------------------------  386 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------------------------------------  386 (627)
                      ++++|. +...+|||||||++++|.+++...                                                 
T Consensus       106 l~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         106 LLGACT-KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             EEEEEc-cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            999997 667788999999999999887542                                                 


Q ss_pred             -----------------------------------------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q psy4988         387 -----------------------------------------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYD  419 (627)
Q Consensus       387 -----------------------------------------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrD  419 (627)
                                                                     ..+++..+..++.||+.||.|||+.+  |+|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~d  262 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRD  262 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence                                                           24778889999999999999999988  99999


Q ss_pred             ccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       420 LKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      |||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+||
T Consensus       263 ikp~Nill~~~---~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwSlGvil~  330 (400)
T cd05105         263 LAARNVLLAQG---KIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIF----DNLYTTLSDVWSYGILLW  330 (400)
T ss_pred             CChHhEEEeCC---CEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhc----CCCCCchhhHHHHHHHHH
Confidence            99999999986   58999999999876432211     1122335778899999984    445889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         500 QCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       500 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +|++ |..||........+...  +..  ...++....++.++.+||.+||..||++||++.++.+
T Consensus       331 ellt~g~~P~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         331 EIFSLGGTPYPGMIVDSTFYNK--IKS--GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHCCCCCCcccchhHHHHHH--Hhc--CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            9996 99999765433333221  111  1223344578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=326.78  Aligned_cols=256  Identities=21%  Similarity=0.346  Sum_probs=204.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      ++..++|.+.+.||+|+||.||+|.+...     +..||||.+.....      ......+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~   75 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS------MRERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC------HHHHHHHHHHHHHHHhCCCCceeEEE
Confidence            45668899999999999999999987654     48899999753321      11234678899999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhc----------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQH----------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      +++. +...+++||||+++++|..++...          ..+++..+..++.||+.||.|||+.+  |+||||||+|||+
T Consensus        76 ~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill  152 (277)
T cd05032          76 GVVS-TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV  152 (277)
T ss_pred             EEEc-CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE
Confidence            9987 557788999999999999998643          24688899999999999999999988  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKK  506 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~  506 (627)
                      +.+   +.+||+|||+++.+......     .......++..|+|||.+.    ...++.++|||||||++|+|++ |..
T Consensus       153 ~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~t~g~~  220 (277)
T cd05032         153 AED---LTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLK----DGVFTTKSDVWSFGVVLWEMATLAEQ  220 (277)
T ss_pred             cCC---CCEEECCcccchhhccCccc-----ccCCCCCccccccCHHHHh----cCCCCcccchHHHHHHHHHhhccCCC
Confidence            987   68999999999876543211     1123345788999999884    3457889999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ||......... ...  ..  ......+..++.++.+||.+||+.+|++|||+.+++.
T Consensus       221 p~~~~~~~~~~-~~~--~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         221 PYQGLSNEEVL-KFV--ID--GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCccCCHHHHH-HHH--hc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99765443322 211  11  1122233457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6.2e-39  Score=330.24  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=209.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ..|..++.||.|+||.||+|.+..++..||||++.....      ......+.+|+.+++.++||||+++++++. +.+.
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   76 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KGTK   76 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCE
Confidence            457788889999999999999999999999999864322      122457889999999999999999999987 5678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+  ++|+||+|+|||++.+   +.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~  150 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ---GDVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC---CCEEEccccccee
Confidence            8999999999999998865 57899999999999999999999988  9999999999999976   5899999999977


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......++..|+|||++.    ...++.++|||||||++|+|++|..||...........   +...
T Consensus       151 ~~~~~~-------~~~~~~~~~~y~apE~~~----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~~~  216 (277)
T cd06640         151 LTDTQI-------KRNTFVGTPFWMAPEVIQ----QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---IPKN  216 (277)
T ss_pred             ccCCcc-------ccccccCcccccCHhHhc----cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---hhcC
Confidence            643221       112236889999999984    34578899999999999999999999976543322211   1000


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                        ........++..+.+||.+||..+|.+||++.+++.|+||....
T Consensus       217 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         217 --NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             --CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence              01112235678899999999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-38  Score=324.08  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +....|.+.+.||+|+||.||+|.+..+++.||+|++.....        ....+.+|+.+++.++||||+++++++. .
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   73 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------EVEEFLKEAAVMKEIKHPNLVQLLGVCT-R   73 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--------HHHHHHHHHHHHHhCCCCChhheEEEEc-C
Confidence            345669999999999999999999999999999998753211        1346788999999999999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++++   +.+||+||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~---~~~kl~df  148 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN---HLVKVADF  148 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC---CcEEeCCC
Confidence            56788999999999999998653  36899999999999999999999988  9999999999999876   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++.........      ......+++.|+|||++.    ...++.++|||||||+||+|++ |..||.......... .
T Consensus       149 ~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~  217 (263)
T cd05052         149 GLSRLMTGDTYT------AHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-L  217 (263)
T ss_pred             ccccccccceee------ccCCCCCccccCCHHHhc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-H
Confidence            999876543211      111223467899999883    4458889999999999999998 999997654433221 1


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        +..  .........++.++.+||.+||..||++||++.++++.
T Consensus       218 --~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         218 --LEK--GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             --HHC--CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence              111  12233345688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=339.40  Aligned_cols=263  Identities=30%  Similarity=0.457  Sum_probs=208.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+++.||+|+||.||++.+..++..||||++.....     .......+.+|+.+++.++||||++++++|..+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-----SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-----chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            57899999999999999999999999999999998753221     1223346778999999999999999999987443


Q ss_pred             -----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 -----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                           ..+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.++|+
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~---~~~kl~  160 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED---CELKIL  160 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEe
Confidence                 2468999999 6788887764 57999999999999999999999988  9999999999999876   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++.......          ....+++.|+|||++..   ...++.++|||||||++|+|++|..||........+..
T Consensus       161 dfg~~~~~~~~~----------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         161 DFGLARQTDSEM----------TGYVVTRWYRAPEVILN---WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             ecccccccccCc----------cccccCCcccCHHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999997654321          22367899999998842   23478899999999999999999999976654333222


Q ss_pred             HHHHhhh---------------------hcc----ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         520 ENTILKA---------------------TEV----QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       520 ~~~~~~~---------------------~~~----~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .......                     ...    .....+.++.++.+||.+||+.||.+|||+.+++.||||....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            1110000                     000    0011246788999999999999999999999999999998543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.1e-39  Score=338.47  Aligned_cols=278  Identities=26%  Similarity=0.428  Sum_probs=212.4

Q ss_pred             ccCCCeeE-EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhH-------HHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         284 VLSDRYLL-LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK-------ANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       284 ~l~~rY~i-~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      .+.++|.. .+.||.|+||+||+|.+..+++.||||++...........       ......+.+|+.+++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            46678875 4779999999999999999999999999865432211100       001124678999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ++++|. ..+.+|+||||+. ++|..++.....+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.
T Consensus        85 ~~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~---~~  157 (335)
T PTZ00024         85 LVDVYV-EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK---GI  157 (335)
T ss_pred             eeEEEe-cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC---CC
Confidence            999987 6678899999998 589999888888999999999999999999999988  9999999999999887   58


Q ss_pred             eEEeecccccccccCCCCCC-------CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy4988         436 IKITDFGLSKVMDEENYNPD-------HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF  508 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf  508 (627)
                      ++|+|||++..+....+...       ..........+++.|+|||++..   ...++.++|||||||++|+|++|..||
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG---AEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhccc---CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999987652211100       00011122357889999999852   234788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhhhh-ccccC---------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         509 GHNQSQATILEENTILKAT-EVQFA---------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~-~~~~~---------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ........+.......... ...++                     .....+.++.+||.+||..+|++||++.+++.||
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            8766544332221111100 00000                     0134578899999999999999999999999999


Q ss_pred             CCCCC
Q psy4988         567 YLQPP  571 (627)
Q Consensus       567 ~~~~~  571 (627)
                      ||+..
T Consensus       315 ~~~~~  319 (335)
T PTZ00024        315 YFKSD  319 (335)
T ss_pred             ccCCC
Confidence            99854

>KOG0193|consensus

Probab=100.00  E-value=3.4e-40  Score=352.75  Aligned_cols=263  Identities=21%  Similarity=0.347  Sum_probs=210.5

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      .+|++..+...+...||.|.||+||+|.+..   .||||++.......     +..+.|..|+.++++-+|.||+-+.++
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-----~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-----EQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-----HHHHHHHHHHHHHhhcchhhheeeehh
Confidence            5678888899999999999999999998754   49999987654322     256789999999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      |- ... +.||.-+|+|.+|..+|... ..|.....+.|+.||++|+.|||.++  |||||||..||+|.++   +.|||
T Consensus       457 ~~-~p~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~---~kVkI  529 (678)
T KOG0193|consen  457 CM-NPP-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED---LKVKI  529 (678)
T ss_pred             hc-CCc-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC---CcEEE
Confidence            86 333 48999999999999999754 57999999999999999999999988  9999999999999987   59999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +||||+..-..-.     +..-..+..|...|||||+++... ..+|+..+||||||||+|||++|.+||.....+..+.
T Consensus       530 gDFGLatvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd-~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif  603 (678)
T KOG0193|consen  530 GDFGLATVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQD-DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF  603 (678)
T ss_pred             ecccceeeeeeec-----cccccCCCccchhhhcHHHHhhcc-cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE
Confidence            9999997643321     112233457899999999997554 6679999999999999999999999998443333322


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..-.-....+ ........+.++++|+..||.+++++||...+||.
T Consensus       604 mVGrG~l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  604 MVGRGYLMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             EecccccCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            1100000011 11122356679999999999999999999999987

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.2e-39  Score=340.05  Aligned_cols=266  Identities=32%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +..+|.+.+.||.|+||.||+|.+..++..||||++.....       ...+.+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   75 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG   75 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence            46899999999999999999999999999999998865432       22356788999999999999999998775332


Q ss_pred             -------------CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         365 -------------NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       365 -------------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                                   ..+|+||||++ ++|..++.. ..+++..++.++.||+.||.|||+.+  |+||||||+|||++...
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~  151 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCC
Confidence                         35789999998 488877754 57999999999999999999999988  99999999999998653


Q ss_pred             cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy4988         432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN  511 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~  511 (627)
                        +.+||+|||+++.+......    ........++..|+|||++.   ....++.++|||||||++|+|++|+.||...
T Consensus       152 --~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         152 --LVLKIGDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLL---SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             --ceEEECCcccceecCCcccc----ccccccccccccccCHHHHh---CccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              57899999999866432111    11122336899999999874   2345788999999999999999999999765


Q ss_pred             ChHHHHHHHHHHh------------h---------hhcccc---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         512 QSQATILEENTIL------------K---------ATEVQF---ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       512 ~~~~~~~~~~~~~------------~---------~~~~~~---~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      .............            .         ......   ...+.++.++.+||++||..||.+|||+.+++.|||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~  302 (342)
T cd07854         223 HELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY  302 (342)
T ss_pred             CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence            4433221110000            0         000000   011357889999999999999999999999999999


Q ss_pred             CCC
Q psy4988         568 LQP  570 (627)
Q Consensus       568 ~~~  570 (627)
                      |+.
T Consensus       303 ~~~  305 (342)
T cd07854         303 MSC  305 (342)
T ss_pred             ccc
Confidence            974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=318.66  Aligned_cols=254  Identities=28%  Similarity=0.471  Sum_probs=212.9

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||++.+..+++.|+||.+......     ......+.+|++++++++||||+++++++. +.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-----EEALKSIMQEIDLLKNLKHPNIVKYIGSIE-TSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----HHHHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEE
Confidence            588999999999999999999999999999998654321     234567889999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++||||+++++|.+++.....+++..+..++.|++.+|.|||+.+  |+|+||||+||+++.+   +.++|+|||++...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~  149 (254)
T cd06627          75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD---GVVKLADFGVATKL  149 (254)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC---CCEEEeccccceec
Confidence            899999999999999988889999999999999999999999988  9999999999999985   68999999999877


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ......       .....++..|+|||.+.    ...++.++||||||+++|+|++|..||............   .  .
T Consensus       150 ~~~~~~-------~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~--~  213 (254)
T cd06627         150 NDVSKD-------DASVVGTPYWMAPEVIE----MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---V--Q  213 (254)
T ss_pred             CCCccc-------ccccccchhhcCHhhhc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---h--c
Confidence            643211       22346899999999874    334788999999999999999999999765543332221   1  1


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ......+..++.++.+||.+||..+|++||++.+++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            12223345688999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=324.12  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=198.7

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHH-HhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      +.||.|+||.||+|.+..+++.||||++.......    ......+..|..+ ...++||||++++++|. +.+.+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA----KNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH----HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-cCCeEEEEE
Confidence            45999999999999999999999999875432111    1122334445444 45568999999999997 667889999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      ||+++++|..++.....+++..+..++.||+.||.|||+.+  |+|+||+|.|||++.+   +.++|+|||++.....  
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC---CcEEEeecccceeccc--
Confidence            99999999999988889999999999999999999999988  9999999999999886   5899999999876432  


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                               .....|++.|+|||.+.    ...++.++||||||++||+|++|..||........+...  .........
T Consensus       150 ---------~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~  214 (260)
T cd05611         150 ---------NKKFVGTPDYLAPETIL----GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPE  214 (260)
T ss_pred             ---------cccCCCCcCccChhhhc----CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcccCCCC
Confidence                     12236889999999984    334788999999999999999999999765544322111  111111111


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhccCCCC
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDYLQP  570 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp~~~~  570 (627)
                      .....++.++.+||.+||+.||++||   ++.+++.||||..
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence            12235789999999999999999999   5589999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0662|consensus

Probab=100.00  E-value=6.5e-40  Score=303.59  Aligned_cols=261  Identities=28%  Similarity=0.494  Sum_probs=212.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|.-.++||+|+||+||+|++..+++.||+|.++++.....     .-...++||.+++.+.|.|||+++++.. ..+.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-----vpssalreicllkelkhknivrl~dvlh-sdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-----VPSSALREICLLKELKHKNIVRLHDVLH-SDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-----CcHHHHHHHHHHHHhhhcceeehhhhhc-cCcee
Confidence            45566789999999999999999999999999987654222     1235889999999999999999999987 45667


Q ss_pred             EEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .+|+|||. .+|..+.. .++.++...++.++.|+++||.|+|+++  ++||||||.|+||+.+   |.+||+|||+++.
T Consensus        77 tlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n---gelkladfglara  150 (292)
T KOG0662|consen   77 TLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN---GELKLADFGLARA  150 (292)
T ss_pred             EEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC---CcEEecccchhhh
Confidence            89999998 56766664 4688999999999999999999999998  9999999999999988   7999999999998


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      +.-..       ...+..+-|.||.+|.++.+.   .-|+...|+||.|||+.|+. .|++.|.+.+-.+.+......+.
T Consensus       151 fgipv-------rcysaevvtlwyrppdvlfga---kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg  220 (292)
T KOG0662|consen  151 FGIPV-------RCYSAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_pred             cCCce-------EeeeceeeeeeccCcceeeee---ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence            76432       223334679999999999743   36899999999999999998 68888988777666654443332


Q ss_pred             hh-ccccCC----------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         526 AT-EVQFAN----------------------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       526 ~~-~~~~~~----------------------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .. +-.||.                      -+.++...+||++++|..+|..|++++.+++||||..
T Consensus       221 ~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence            21 111111                      1345566789999999999999999999999999964

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-38  Score=330.32  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCC----------------eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQ----------------RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD  349 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~----------------~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~  349 (627)
                      .++|++++.||+|+||.||+|.+...+                ..||+|++......      .....+.+|+++++.++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~~e~~~l~~l~   77 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD------NAREDFLKEVKILSRLS   77 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH------HHHHHHHHHHHHHHhcC
Confidence            468999999999999999999876644                56899987644321      23457889999999999


Q ss_pred             CCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc-----------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-----------TIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       350 HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      ||||++++++|. +...+++||||+.+++|..++....           .+++..++.++.||+.||.|||+.+  |+|+
T Consensus        78 ~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~  154 (296)
T cd05051          78 DPNIARLLGVCT-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHR  154 (296)
T ss_pred             CCCEeEEEEEEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccc
Confidence            999999999987 4577889999999999999997765           7899999999999999999999988  9999


Q ss_pred             cccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       419 DLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      ||||+|||++.+   +.++|+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||++
T Consensus       155 dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l  222 (296)
T cd05051         155 DLATRNCLVGKN---YTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVL----LGKFTTKSDVWAFGVTL  222 (296)
T ss_pred             ccchhceeecCC---CceEEccccceeecccCcce-----eecCcCCCCceecCHHHhh----cCCCCccchhhhhHHHH
Confidence            999999999987   68999999999865433211     1223345688999999984    33588999999999999


Q ss_pred             HHHHh--CCCCCCCCChHHHHHHHHHHhh--hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         499 YQCLY--GKKPFGHNQSQATILEENTILK--ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       499 ~ellt--G~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |+|++  +..||........+........  ......+....++.++.+||.+||+.||.+|||+.+++.
T Consensus       223 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         223 WEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            99997  7888876554443322211111  111222334567899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-38  Score=323.41  Aligned_cols=252  Identities=23%  Similarity=0.392  Sum_probs=202.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+-.++|+++++||+|+||.||+|.+ .++..||||.+.....        ..+.+.+|+.+++.++|+||+++++++. 
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   71 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM--------SVQAFLEEANLMKTLQHDKLVRLYAVVT-   71 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch--------hHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence            34567899999999999999999985 4567799998653221        1346788999999999999999999887 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      +.+.+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  ++|+||||+|||++.+   +.+||+|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~---~~~~l~d  146 (261)
T cd05072          72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES---LMCKIAD  146 (261)
T ss_pred             CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC---CcEEECC
Confidence            567788999999999999998653  56899999999999999999999988  9999999999999987   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||++.........      ......++..|+|||++.    ...++.++|||||||++|+|++ |..||...........
T Consensus       147 fg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05072         147 FGLARVIEDNEYT------AREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA  216 (261)
T ss_pred             CccceecCCCcee------ccCCCccceecCCHHHhc----cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence            9999876532211      112234677899999984    4457889999999999999998 9999976544432221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   ..  ...++....++.++.+||.+||..+|++||++.++++
T Consensus       217 ~---~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         217 L---QR--GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             H---Hc--CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            1   11  1223444568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-38  Score=367.35  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.++||+|+||.||+|.+..+++.||||++......    ......++.+|+.+++.++|||||++++++. +.+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~----~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE----NPLLKKRFLREAKIAADLIHPGIVPVYSICS-DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc----CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCCE
Confidence            6899999999999999999999999999999998643221    1223457889999999999999999999987 5677


Q ss_pred             EEEEEeecCCCChHHHHHhc-----------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-----------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      .|+||||++|++|.+++...           ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d---g~  151 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF---GE  151 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC---CC
Confidence            88999999999999988641           24566788999999999999999988  9999999999999887   68


Q ss_pred             eEEeecccccccccCCCCC-----------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy4988         436 IKITDFGLSKVMDEENYNP-----------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~-----------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG  504 (627)
                      +||+|||+++.........           ..........+||+.|+|||++.    +..++.++|||||||+||+|++|
T Consensus       152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~----g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL----GVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc----CCCCCcHhHHHHHHHHHHHHHHC
Confidence            9999999998763211000           00011122357999999999984    44588999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +.||........... ....  ....+.....+++.+.+++.+||+.||.+||+..+.+.+
T Consensus       228 ~~PF~~~~~~ki~~~-~~i~--~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        228 SFPYRRKKGRKISYR-DVIL--SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             CCCCCCcchhhhhhh-hhcc--ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999976443322211 1111  111222334688999999999999999999887776643

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-39  Score=333.70  Aligned_cols=255  Identities=24%  Similarity=0.429  Sum_probs=205.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      +.|.+.+.||.|+||.||+|.+..++..||||++.....      ......+.+|+.+++.++||||++++++|. +.+.
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   76 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYITRYYGSYL-KGTK   76 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------hHHHHHHHHHHHHHHcCCCCccHhhhcccc-cCCc
Confidence            346667779999999999999999999999998754321      122456889999999999999999999987 5677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~  150 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ---GDVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC---CCEEEcccccccc
Confidence            8899999999999988864 57899999999999999999999988  9999999999999876   5899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....       ......|+..|+|||++.    ...++.++|||||||++|+|++|..||...........   +...
T Consensus       151 ~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~~~~  216 (277)
T cd06642         151 LTDTQI-------KRNTFVGTPFWMAPEVIK----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---IPKN  216 (277)
T ss_pred             ccCcch-------hhhcccCcccccCHHHhC----cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---hhcC
Confidence            653221       112236889999999984    44578899999999999999999999965433222211   1111


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...  .....++.++.+||.+||..+|.+||++.+++.||||..
T Consensus       217 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         217 SPP--TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             CCC--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            111  112357789999999999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.8e-38  Score=316.14  Aligned_cols=252  Identities=30%  Similarity=0.515  Sum_probs=209.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|.+.+.||.|+||.||++.+..++..|++|++.....       .....+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   72 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-------EKKEKIINEIQILKKCKHPNIVKYYGSYL-KKDEL   72 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cCCeE
Confidence            47889999999999999999998999999999864332       23456889999999999999999999987 55778


Q ss_pred             EEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||.|||..+  ++|+||+|+||+++.+   +.++|+|||++..
T Consensus        73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~---~~~~l~d~~~~~~  147 (253)
T cd05122          73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD---GEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC---CeEEEeecccccc
Confidence            8999999999999998776 68999999999999999999999988  9999999999999986   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......        .....++..|+|||++.    ...++.++||||||++||+|++|..||........+.....   .
T Consensus       148 ~~~~~~--------~~~~~~~~~~~~PE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~  212 (253)
T cd05122         148 LSDTKA--------RNTMVGTPYWMAPEVIN----GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---N  212 (253)
T ss_pred             cccccc--------ccceecCCcccCHHHHc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---c
Confidence            654321        22346899999999984    33478899999999999999999999976644433332211   1


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      ....++....++.++.+||.+||..||.+|||+.+++.|||
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            12222333335899999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-38  Score=321.79  Aligned_cols=248  Identities=27%  Similarity=0.394  Sum_probs=198.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||++... ++..||+|.+......        ...+.+|+.+++.++||||++++++|. +...
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   73 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS--------EEDFIEEAKVMMKLSHPKLVQLYGVCT-QQKP   73 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc--------HHHHHHHHHHHHHCCCCCceeEEEEEc-cCCC
Confidence            46889999999999999999764 4567999986533211        235778999999999999999999987 5667


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+|+||||+||+++.+   +.+||+|||+++
T Consensus        74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~---~~~kl~d~g~~~  148 (256)
T cd05114          74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST---GVVKVSDFGMTR  148 (256)
T ss_pred             EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC---CeEEECCCCCcc
Confidence            88999999999999998753 56899999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+......      ......++..|+|||++.    ...++.++||||||++||+|++ |+.||........+....   
T Consensus       149 ~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~---  215 (256)
T cd05114         149 YVLDDEYT------SSSGAKFPVKWSPPEVFN----FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS---  215 (256)
T ss_pred             ccCCCcee------ccCCCCCchhhCChhhcc----cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence            65432211      111224567899999984    3457889999999999999999 999997665443332211   


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...  ....+...+.++.+||.+||..||.+||++.++++
T Consensus       216 ~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         216 RGF--RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCC--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            111  12223456789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.8e-38  Score=317.92  Aligned_cols=254  Identities=31%  Similarity=0.523  Sum_probs=210.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.+.||.|+||.||++.+..++..|++|++......     ......+.+|+++++.++|||++++++.+. +...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-----EKEREDALNEVKILKKLNHPNIIKYYESFE-EKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-----hHHHHHHHHHHHHHHhcCCCChhheEEEEe-cCCEE
Confidence            588999999999999999999999999999998654321     122456788999999999999999999987 55788


Q ss_pred             EEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ++|+||+++++|..++...    ..+++..+..++.+|+.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||+
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~---~~~~l~d~~~  149 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN---GLVKLGDFGI  149 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC---CcEEECCccc
Confidence            9999999999999998764    78999999999999999999999988  9999999999999986   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.......       .......|++.|+|||.+.    ...++.++||||||+++|+|++|..||....... +...  .
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~--~  215 (258)
T cd08215         150 SKVLSSTV-------DLAKTVVGTPYYLSPELCQ----NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-LALK--I  215 (258)
T ss_pred             eeecccCc-------ceecceeeeecccChhHhc----cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-HHHH--H
Confidence            98765432       1223347899999999874    4457889999999999999999999997654322 2211  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ....  ..+....++.++.++|.+||..+|.+|||+.+++.||||
T Consensus       216 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         216 LKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             hcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            1111  112233678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.9e-38  Score=325.99  Aligned_cols=253  Identities=22%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEc----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDL----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +.|++.+.||+|+||.||+|.+.    .++..||||.+.....      ......+.+|+.+++.++||||+++++++. 
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-   77 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN------PQQWGEFQQEASLMAELHHPNIVCLLGVVT-   77 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC------HHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-
Confidence            56889999999999999999853    4567899998753221      122456788999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                      ....+|+||||+++++|.+++...                 ..+++..+..++.||+.||.|||+.+  |+||||||+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ni  155 (283)
T cd05090          78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNI  155 (283)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceE
Confidence            566788999999999999998532                 24788999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++.+   +.+||+|||+++.+......     .......++..|+|||++.    ...++.++|||||||+||+|++ |
T Consensus       156 li~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~~g  223 (283)
T cd05090         156 LIGEQ---LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIM----YGKFSSDSDIWSFGVVLWEIFSFG  223 (283)
T ss_pred             EEcCC---CcEEeccccccccccCCcce-----ecccCCCccceecChHHhc----cCCCCchhhhHHHHHHHHHHHcCC
Confidence            99976   58999999999876433211     1123335678899999884    3458899999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..||...... .+.....  .  ....+.+..++..+.+||.+||+.||.+||++.+++++
T Consensus       224 ~~p~~~~~~~-~~~~~~~--~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         224 LQPYYGFSNQ-EVIEMVR--K--RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCCCHH-HHHHHHH--c--CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9999765432 2222111  1  11223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-38  Score=337.03  Aligned_cols=266  Identities=29%  Similarity=0.427  Sum_probs=211.5

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC---
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA---  364 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---  364 (627)
                      +|.+.+.||.|+||.||+|.+..++..||||++.....     .....+.+.+|+.+++.++||||+++++++....   
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-----DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-----cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence            68999999999999999999999999999998764321     1223456888999999999999999999987443   


Q ss_pred             -CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 -NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 -~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                       ..+|+||||++ ++|..++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||+
T Consensus        76 ~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~---~~~~L~dfg~  149 (330)
T cd07834          76 FNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN---CDLKICDFGL  149 (330)
T ss_pred             ccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEcccCc
Confidence             36889999998 488888888789999999999999999999999988  9999999999999987   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.........    ........+++.|+|||++..   ...++.++|||||||++|+|++|..||........+......
T Consensus       150 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~  222 (330)
T cd07834         150 ARGVDPDEDE----KGFLTEYVVTRWYRAPELLLS---SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV  222 (330)
T ss_pred             eEeecccccc----cccccccccccCcCCceeeec---ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence            9876543210    011233468999999999852   226888999999999999999999999766544332221111


Q ss_pred             hhhhcc------------------------c-cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEV------------------------Q-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~------------------------~-~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ......                        . ....+.++.++.+||.+||++||.+||++.+++.||||...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            100000                        0 00123478899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=320.57  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++..++|++.+.||+|+||.||+|.+. ++..||||.+.....        ....+.+|+.++++++||||+++++++. 
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   71 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--------DPKDFLAEAQIMKKLRHPKLIQLYAVCT-   71 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--------cHHHHHHHHHHHHHCCCCCccceeEEEe-
Confidence            355678999999999999999999864 457899998754321        1235778999999999999999999887 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      ..+.+|+||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~~l~d  146 (261)
T cd05068          72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN---NICKVAD  146 (261)
T ss_pred             cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC---CCEEECC
Confidence            5667889999999999999987644  7999999999999999999999988  9999999999999987   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+.......      ......+..|+|||++.    ...++.++|||||||++|+|++ |+.||........+..
T Consensus       147 fg~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05068         147 FGLARVIKEDIYEA------REGAKFPIKWTAPEAAL----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ  216 (261)
T ss_pred             cceEEEccCCcccc------cCCCcCceeccCccccc----cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99998775332110      11112346799999884    4458889999999999999998 9999976554333221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   ..  ....+....++..+.+||.+||..+|.+||++.+++.
T Consensus       217 ~---~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         217 V---DQ--GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             H---Hc--CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1   11  1122334567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=325.39  Aligned_cols=260  Identities=26%  Similarity=0.454  Sum_probs=205.1

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-CCeE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-ANSF  367 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~  367 (627)
                      |.+.+.||.|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||+++++++..+ ...+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-----KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc-----cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence            6789999999999999999999999999999875431     112234677899999999999999999998744 2678


Q ss_pred             EEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  ++|+||||+|||++++   +.+||+|||++..
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~---~~~~l~d~g~~~~  149 (287)
T cd07840          76 YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND---GVLKLADFGLARP  149 (287)
T ss_pred             EEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC---CCEEEccccceee
Confidence            899999985 788877654 58999999999999999999999988  9999999999999987   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......      .......++..|+|||++..   ...++.++|||||||++|+|++|+.||........+.........
T Consensus       150 ~~~~~~------~~~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07840         150 YTKRNS------ADYTNRVITLWYRPPELLLG---ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS  220 (287)
T ss_pred             ccCCCc------ccccccccccccCCceeeEc---cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            654321      01122357889999998742   234788999999999999999999999766644333221111100


Q ss_pred             h-ccccCC-----------------------CCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 T-EVQFAN-----------------------KPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 ~-~~~~~~-----------------------~~~-vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      . ...++.                       ... ++.++.+||++||..||.+||++.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0 000000                       011 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.4e-38  Score=320.53  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .||+|+||.||+|.+..+++.||||++.....      ......+.+|+++++.++||||++++++|. +...+++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~   74 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP------PDLKAKFLQEARILKQYSHPNIVRLIGVCT-QKQPIYIVMEL   74 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCeEEEEee
Confidence            59999999999999999999999998643211      122356889999999999999999999987 56678899999


Q ss_pred             cCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         374 CDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       374 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      +++++|.+++... ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++........
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC---CcEEECccccCcccccccc
Confidence            9999999998754 46899999999999999999999988  9999999999999876   5899999999976543211


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                      ...     .....++..|+|||++.    ...++.++|||||||++|+|++ |..||..........   .+..  ....
T Consensus       150 ~~~-----~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~---~~~~--~~~~  215 (252)
T cd05084         150 AST-----GGMKQIPVKWTAPEALN----YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE---AIEQ--GVRL  215 (252)
T ss_pred             ccc-----CCCCCCceeecCchhhc----CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH---HHHc--CCCC
Confidence            100     01112356799999984    4458889999999999999997 999996554432211   1111  1122


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +.+..++..+.+||.+||..||.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-38  Score=337.45  Aligned_cols=271  Identities=29%  Similarity=0.461  Sum_probs=210.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      .+.++|.+.+.||.|+||.||+|.+..++..||||.+......     ......+.+|+.+++++ +||||++++++|..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-----ATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-----chhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            4678899999999999999999999999999999987532111     11234567899999999 99999999998863


Q ss_pred             c-CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 D-ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~-~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      . ...+|+||||+++ +|..++... .+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+||
T Consensus        79 ~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~---~~~kl~d~  151 (337)
T cd07852          79 ENDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD---CRVKLADF  151 (337)
T ss_pred             CCCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CcEEEeec
Confidence            3 4468899999984 888888765 8899999999999999999999988  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |++..+.......  .........||+.|+|||++..   ...++.++|||||||++|+|++|+.||........+....
T Consensus       152 g~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~  226 (337)
T cd07852         152 GLARSLSELEENP--ENPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII  226 (337)
T ss_pred             cchhccccccccc--cCcchhcccccccccCceeeec---cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9998765432211  1112233478999999998752   3457889999999999999999999996554333221110


Q ss_pred             HHh--------------------hh-hcc----ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TIL--------------------KA-TEV----QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~--------------------~~-~~~----~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ...                    .. ...    .....+.++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            000                    00 000    001113478999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.5e-38  Score=326.62  Aligned_cols=265  Identities=27%  Similarity=0.401  Sum_probs=208.7

Q ss_pred             CeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      .|++.+.||.|+||.||+|.+.   .++..||+|++......   .......++.+|+.+++.+ +|+||+.++++|. .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV---QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-T   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh---hcchHHHHHHHHHHHHHhcccCCChhceeeEee-c
Confidence            3889999999999999999875   47899999997543211   1122235677899999999 5999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~---~~~kl~dfg~  151 (290)
T cd05613          77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN---GHVVLTDFGL  151 (290)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC---CCEEEeeCcc
Confidence            5678899999999999999988888999999999999999999999988  9999999999999886   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +........      .......|+..|+|||++...  ...++.++|||||||+||+|++|..||...............
T Consensus       152 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  223 (290)
T cd05613         152 SKEFHEDEV------ERAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR  223 (290)
T ss_pred             ceecccccc------cccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence            987643321      112234689999999997422  234678899999999999999999999643322111111111


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      ....  ..+....++..+.+||.+||..||.+||     ++.+++.||||...
T Consensus       224 ~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         224 ILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             hhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            1111  1223345789999999999999999997     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-38  Score=335.27  Aligned_cols=264  Identities=28%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-----hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            356899999999999999999999999999999998754321     111234577899999999999999999988632


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|++++++ +++|..++.. ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.+   +.+||
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~---~~~kl  161 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED---CELKI  161 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC---CCEEE
Confidence            2     3467888887 6788877764 46999999999999999999999988  9999999999999987   58999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.....          .....++..|+|||++.   ....++.++|||||||++|+|++|+.||........+.
T Consensus       162 ~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  228 (345)
T cd07877         162 LDFGLARHTDDE----------MTGYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  228 (345)
T ss_pred             eccccccccccc----------ccccccCCCccCHHHHh---CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999765321          12346889999999874   22357889999999999999999999996554332221


Q ss_pred             HHHHHhh--------------------h----hccccC-CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         519 EENTILK--------------------A----TEVQFA-NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       519 ~~~~~~~--------------------~----~~~~~~-~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .......                    .    ....+. .....++++.+||.+||..||.+||++.+++.||||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence            1100000                    0    000000 0123578999999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-38  Score=323.96  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||.|+||.||+|.+..+++.||||.+.....    ........+.+|+.+++.++||||++++++|. +.+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL----MDAKARADCIKEIDLLKQLNHPNVIKYYASFI-EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh----hhHHHHHHHHHHHHHHHHccCCchhhhhheeE-eCCe
Confidence            468888999999999999999999999999998764322    11223457889999999999999999999987 5667


Q ss_pred             EEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +++||||+++++|..++..    ...+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~---~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT---GVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CCEEECcch
Confidence            8899999999999998863    356899999999999999999999988  9999999999999876   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+.....       ......|+..|+|||++.    ...++.++||||||+++|+|++|..||............. 
T Consensus       152 ~~~~~~~~~~-------~~~~~~~~~~~~ape~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-  219 (267)
T cd08229         152 LGRFFSSKTT-------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-  219 (267)
T ss_pred             hhhccccCCc-------ccccccCCcCccCHHHhc----CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh-
Confidence            9887643221       112346899999999984    4457889999999999999999999996543321111111 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      + ............++.++.+||.+||..||.+|||+.+|+.
T Consensus       220 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         220 I-EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             h-hcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            1 1111111112357889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-38  Score=322.16  Aligned_cols=258  Identities=30%  Similarity=0.443  Sum_probs=207.1

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||.|+||.||++.+..+++.|+||++.....    ........+.+|+++++.++||||+++++++. +...+|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-GKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh----hhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-cCcEEEEEEecC
Confidence            6899999999999998999999998754322    11234567889999999999999999999887 667889999999


Q ss_pred             CCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         375 DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       375 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                      ++++|..++.....+++..+..++.||+.||.|||+.+  |+|+||+|+|||++.+   +.++|+|||++..........
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccc
Confidence            99999999988789999999999999999999999988  9999999999999987   589999999987654321100


Q ss_pred             -CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC
Q psy4988         455 -DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN  533 (627)
Q Consensus       455 -~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  533 (627)
                       ...........++..|+|||++.    ...++.++||||||+++|+|++|..||............    ......++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~  222 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVIL----GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI----LNGKIEWPE  222 (265)
T ss_pred             cccccccccCcccCccccCHHHhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCcCCCc
Confidence             00001122346888999999984    334788999999999999999999999766544332111    112233333


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCH---HHHHhccCCCC
Q psy4988         534 KPTVSNEAKGFIRSCLAYRKEDRIDV---ISLARHDYLQP  570 (627)
Q Consensus       534 ~~~vs~el~~LI~~cL~~dP~~Rpt~---~elL~hp~~~~  570 (627)
                      ...++.++.+||.+||+.+|.+|||+   .++++||||..
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            33458999999999999999999999   99999999973

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-38  Score=328.10  Aligned_cols=257  Identities=24%  Similarity=0.399  Sum_probs=204.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKL  356 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l  356 (627)
                      .+-.++|.+.+.||+|+||.||++.+...     ...||+|++.....      ......+.+|+.+++.+ +||||+++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC------HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            34567899999999999999999987644     47899998764322      11234688899999999 79999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHh----------------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQ----------------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                      ++++. +...+++||||+++++|..++..                ...+++..++.++.||+.||.|||+.+  |+||||
T Consensus        82 ~~~~~-~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dl  158 (293)
T cd05053          82 LGVCT-QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDL  158 (293)
T ss_pred             EEEEc-CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence            99987 56678899999999999999864                246899999999999999999999988  999999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      ||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||++|+
T Consensus       159 kp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~e  226 (293)
T cd05053         159 AARNVLVTED---HVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWE  226 (293)
T ss_pred             ceeeEEEcCC---CeEEeCccccccccccccce-----eccCCCCCCccccCHHHhc----cCCcCcccceeehhhHHHH
Confidence            9999999876   68999999999876543211     1112234567899999873    4558899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         501 CLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       501 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |++ |..||......... ..  +.  .......+..++.++.+||.+||..||.+|||+.+++.+
T Consensus       227 l~~~g~~p~~~~~~~~~~-~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         227 IFTLGGSPYPGIPVEELF-KL--LK--EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HhcCCCCCCCCCCHHHHH-HH--HH--cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            997 99999765443322 11  11  111223344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.4e-38  Score=324.75  Aligned_cols=255  Identities=26%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      -|.+++.||.|+||.||+|.+..++..||||++.....      ......+.+|+.+++.++||||++++++|. +.+.+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   77 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA------EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKL   77 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeE
Confidence            36788899999999999999999999999998753321      123456888999999999999999999997 56778


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ++||||+++++|..++.. ..+++..+..++.|++.+|.|||+.+  |+|+||||+||+++.+   +.++|+|||++..+
T Consensus        78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~  151 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH---GEVKLADFGVAGQL  151 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC---CCEEEeecccceec
Confidence            899999999999988864 57899999999999999999999988  9999999999999876   58999999999766


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      .....       ......++..|+|||.+.    ...++.++|||||||++|+|++|..||.......... .  +....
T Consensus       152 ~~~~~-------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~--~~~~~  217 (277)
T cd06641         152 TDTQI-------KRNTFVGTPFWMAPEVIK----QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-L--IPKNN  217 (277)
T ss_pred             ccchh-------hhccccCCccccChhhhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-H--HhcCC
Confidence            43221       112346889999999884    3457889999999999999999999996544322211 1  11111


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .  ......++.++.+||.+||..+|.+||++.++++||||...
T Consensus       218 ~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 P--PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             C--CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            1  11223578899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-38  Score=337.09  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=205.0

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+...||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||++++++|....
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-----SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-----cccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            45789999999999999999999999999999998754321     1122345788999999999999999999986332


Q ss_pred             -----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 -----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                           ..+|+|+||+.. +|..++  ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~---~~~kL~  159 (342)
T cd07879          88 SGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED---CELKIL  159 (342)
T ss_pred             cCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEe
Confidence                 346899999974 666654  346899999999999999999999988  9999999999999986   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.....          .....+++.|+|||++..   ...++.++|||||||+||+|++|+.||........+..
T Consensus       160 dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~  226 (342)
T cd07879         160 DFGLARHADAE----------MTGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  226 (342)
T ss_pred             eCCCCcCCCCC----------CCCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999764321          122367899999998742   23478899999999999999999999976554332221


Q ss_pred             HHHHhhhh-------------------ccccC------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         520 ENTILKAT-------------------EVQFA------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       520 ~~~~~~~~-------------------~~~~~------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ........                   ...++      ..+.++.++.+||.+||+.||.+||++.+++.||||....+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            11100000                   00000      12357788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-38  Score=326.87  Aligned_cols=260  Identities=28%  Similarity=0.441  Sum_probs=214.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...+.|.+...||.|+||.||++.+..++..|++|++.....        ....+.+|+.+++.++|+||++++++|. .
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~   86 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--------NKELIINEILIMKDCKHPNIVDYYDSYL-V   86 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------hHHHHHHHHHHHHHCCCCCeeEEEEEEE-E
Confidence            456779999999999999999999998999999999864432        2346788999999999999999999998 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+|+|+||+++++|.+++.... .+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~---~~~~l~d~~  161 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD---GSVKLADFG  161 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC---CCEEECccc
Confidence            577889999999999999998876 8999999999999999999999988  9999999999999976   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++........       ......+++.|+|||++.    ...++.++||||||||||+|++|..||............  
T Consensus       162 ~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--  228 (286)
T cd06614         162 FAAQLTKEKS-------KRNSVVGTPYWMAPEVIK----RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--  228 (286)
T ss_pred             hhhhhccchh-------hhccccCCcccCCHhHhc----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence            9876543211       112235788999999874    445789999999999999999999999765444332211  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       .......+.....++.++.+||.+||+.+|.+||++.+++.|+||...
T Consensus       229 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         229 -TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             -HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence             111112223333478999999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=321.96  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             eeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      |.+.+.||+|+||.||+|.+..+   +..||||++......     ......+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   75 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-----YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASS   75 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-----HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCc
Confidence            56788999999999999987653   478999998643221     222456889999999999999999999875332 


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhc------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                          ..+++||||+++++|..++...      ..+++..+..++.|++.||.|||+.+  |+||||||+|||++++   +
T Consensus        76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~---~  150 (273)
T cd05035          76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED---M  150 (273)
T ss_pred             cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC---C
Confidence                2378999999999999888542      36899999999999999999999988  9999999999999886   5


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQS  513 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~  513 (627)
                      .+||+|||+++.+......     .......++..|+|||.+.    ...++.++|||||||++|||++ |..||.....
T Consensus       151 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~  221 (273)
T cd05035         151 TVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN  221 (273)
T ss_pred             eEEECCccceeeccccccc-----cccccccCCccccCHhhcc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence            8999999999876543221     1112234577899999873    4458889999999999999998 9999976554


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...+ ..  +....  .......++.++.+||.+||..||.+||++.+++.+
T Consensus       222 ~~~~-~~--~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         222 HEIY-DY--LRHGN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHHH-HH--HHcCC--CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322 11  11111  222345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-38  Score=320.49  Aligned_cols=246  Identities=28%  Similarity=0.481  Sum_probs=196.4

Q ss_pred             EecccCceEEEEEEE--cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         294 LLGKGGFSEVHKAFD--LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~--~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      +||+|+||.||+|.+  ..++..||||++.....     .......+.+|+.+++.++||||+++++++.  ...+++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~   74 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-----DPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVM   74 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-----cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEE
Confidence            489999999999964  45789999998754321     1234567889999999999999999999875  45678999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||.|||++.+   +.+||+|||+++.+....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~---~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADE  149 (257)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC---CeEEECCCccccccCCCC
Confidence            99999999999988888999999999999999999999988  9999999999999986   589999999998765332


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQ  530 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  530 (627)
                      ..    ........+++.|+|||++.    ...++.++|||||||++|||++ |..||...........   +...  ..
T Consensus       150 ~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---i~~~--~~  216 (257)
T cd05116         150 NY----YKAKTHGKWPVKWYAPECMN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---IESG--ER  216 (257)
T ss_pred             Ce----eeecCCCCCCccccCHhHhc----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHCC--CC
Confidence            10    00112234568999999883    3457889999999999999997 9999976544332211   1111  12


Q ss_pred             cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       531 ~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .+.+..++.++.+||.+||..||.+||++.+|..
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            2334568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.4e-38  Score=319.29  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=202.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||.|+||.||+|.+..+++.||+|.+.......    ......+.+|+.++++++|+||++++++|. +.+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD----AKARQDCLKEIDLLKQLDHPNVIKYLASFI-ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc----hhhHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCe
Confidence            57999999999999999999999899999999876433211    122456889999999999999999999997 5677


Q ss_pred             EEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +++||||+++++|..++..    ...+++..+..++.+|+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~---~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT---GVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC---CcEEEeccc
Confidence            8899999999999998864    346899999999999999999999988  9999999999999876   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+.....       ......+++.|+|||.+.    +..++.++|||||||++|+|++|..||.........+... 
T Consensus       152 ~~~~~~~~~~-------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-  219 (267)
T cd08224         152 LGRFFSSKTT-------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-  219 (267)
T ss_pred             eeeeccCCCc-------ccceecCCccccCHHHhc----cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh-
Confidence            9986543221       112336889999999884    4458889999999999999999999996443221111111 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +........+ ...++.++.+||.+||..+|.+||++.+++.
T Consensus       220 ~~~~~~~~~~-~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         220 IEKCDYPPLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hhcCCCCCCC-hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            1111111111 1257789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.8e-38  Score=327.74  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-.+.|.+.+.||.|+||.||+|.+..+++.||||++......      .....+.+|+.++..+ +||||++++++|. 
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-   84 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK------EENKRILMDLDVVLKSHDCPYIVKCYGYFI-   84 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh------HHHHHHHHHHHHHHhccCCCchHhhheeee-
Confidence            4457899999999999999999999988999999998643221      1134566777766666 5999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      +...+|+||||+.+ +|..++.. ...+++..+..++.||+.||.|||+ .+  |+||||+|+|||++.+   +.+||+|
T Consensus        85 ~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~---~~~kL~d  158 (296)
T cd06618          85 TDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS---GNVKLCD  158 (296)
T ss_pred             cCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC---CCEEECc
Confidence            56678899999975 66666554 4679999999999999999999997 46  9999999999999876   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++..+.....        .....+++.|+|||++........++.++|||||||+||+|++|+.||.........+..
T Consensus       159 fg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  230 (296)
T cd06618         159 FGISGRLVDSKA--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK  230 (296)
T ss_pred             cccchhccCCCc--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH
Confidence            999976643221        112357889999999853322345788999999999999999999999654333222221


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ........++....++.++.+||.+||..||.+||++.+++.||||...
T Consensus       231 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         231 --ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             --HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence              1111122233333578999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.3e-38  Score=326.01  Aligned_cols=252  Identities=25%  Similarity=0.417  Sum_probs=200.5

Q ss_pred             CCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+.|.+.+.||+|+||.||++.+.     .++..||||.+....       ......+.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------DNARKDFHREAELLTNLQHEHIVKFYGVC   76 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            357899999999999999999753     346779999875321       12245688999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc-------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK-------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      . +.+.+++||||+++++|..++...+             .+++..++.++.||+.||+|||+.+  |+||||||+|||+
T Consensus        77 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili  153 (288)
T cd05093          77 V-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV  153 (288)
T ss_pred             e-cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE
Confidence            7 5677889999999999999987543             4899999999999999999999988  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKK  506 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~  506 (627)
                      +.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||++|+|++ |..
T Consensus       154 ~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~il~~l~t~g~~  221 (288)
T cd05093         154 GEN---LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSLGVVLWEIFTYGKQ  221 (288)
T ss_pred             ccC---CcEEeccCCccccccCCcee-----ecCCCCCccccccCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            887   68999999999866432210     1122335678899999884    4568889999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ||........+. .  +....  .......++.++.+||.+||+.||.+|||+.+++.
T Consensus       222 p~~~~~~~~~~~-~--i~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         222 PWYQLSNNEVIE-C--ITQGR--VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCHHHHHH-H--HHcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            997665443221 1  11111  12223457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-38  Score=320.64  Aligned_cols=254  Identities=22%  Similarity=0.374  Sum_probs=202.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .++|.+.+.||+|+||.||+|.+..+   ...||||++.....      ......+.+|+.+++.++||||+++++++. 
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   75 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS------DKQRLDFLTEASIMGQFDHPNIIRLEGVVT-   75 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC------hHHHHHHHHHHHHHHhCCCCCcceEeEEEe-
Confidence            35799999999999999999987654   56899998754321      112346788999999999999999999887 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.++|+||
T Consensus        76 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~---~~~~l~df  150 (266)
T cd05033          76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN---LVCKVSDF  150 (266)
T ss_pred             cCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC---CCEEECcc
Confidence            567788999999999999998764 47999999999999999999999988  9999999999999987   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+......     .......+++.|+|||.+.    ...++.++||||||+++|+|++ |..||......... ..
T Consensus       151 g~~~~~~~~~~~-----~~~~~~~~~~~y~~Pe~~~----~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-~~  220 (266)
T cd05033         151 GLSRRLEDSEAT-----YTTKGGKIPIRWTAPEAIA----YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KA  220 (266)
T ss_pred             chhhcccccccc-----eeccCCCCCccccChhhhc----cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-HH
Confidence            999887522110     1112234577899999884    4458889999999999999997 99999655433222 11


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        +..  ....+....++..+.+||.+||..+|++||++.+++++
T Consensus       221 --~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         221 --VED--GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --HHc--CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              111  11223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5e-38  Score=319.98  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|+++++||.|+||.||+|.+ .+++.||||.+......        ...+.+|+.+++.++||||+++++++. 
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS--------PEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc--------HHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            46778999999999999999999985 46788999987643321        235788999999999999999999875 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       ...+++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.+   +.++|+|
T Consensus        72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~---~~~~l~d  145 (260)
T cd05067          72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET---LCCKIAD  145 (260)
T ss_pred             -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC---CCEEEcc
Confidence             35678999999999999988653  46899999999999999999999988  9999999999999987   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||++.........      ......++..|+|||++.    ...++.++|||||||++|+|++ |+.||...........
T Consensus       146 fg~~~~~~~~~~~------~~~~~~~~~~y~~pe~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  215 (260)
T cd05067         146 FGLARLIEDNEYT------AREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN  215 (260)
T ss_pred             CcceeecCCCCcc------cccCCcccccccCHHHhc----cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence            9999876532211      112234678899999884    4457889999999999999998 9999976554332211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   ..  ....+....++.++.+||.+||..+|++||++++++.
T Consensus       216 ~---~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         216 L---ER--GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             H---Hc--CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1   11  1122334567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.4e-38  Score=330.85  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEE--EEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYV--ACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~V--AVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      ++|.+.+.||+|+||.||+|.+..++..+  |+|.+....      .......+.+|+.++.++ +||||+++++++. +
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-~   79 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------SKDDHRDFAGELEVLCKLGHHPNIINLLGACE-H   79 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC------CHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-C
Confidence            57899999999999999999988777654  665543211      112245678899999999 8999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      .+.+++||||+++++|.+++....                .+++..++.++.||+.||+|||+.+  |+||||||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili  157 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV  157 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence            667889999999999999987542                5789999999999999999999988  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKK  506 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~  506 (627)
                      +.+   +.+||+|||++.......        ......++..|+|||++.    ...++.++|||||||+||+|++ |..
T Consensus       158 ~~~---~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~  222 (303)
T cd05088         158 GEN---YVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGT  222 (303)
T ss_pred             cCC---CcEEeCccccCcccchhh--------hcccCCCcccccCHHHHh----ccCCcccccchhhhhHHHHHHhcCCC
Confidence            876   589999999986432110        011123467899999883    4457889999999999999998 999


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||......... ..  ..  .......+..++.++.+||.+||..+|.+||++.+++.+
T Consensus       223 p~~~~~~~~~~-~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         223 PYCGMTCAELY-EK--LP--QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcccCChHHHH-HH--Hh--cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99655443322 11  11  111222334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-38  Score=338.33  Aligned_cols=265  Identities=29%  Similarity=0.439  Sum_probs=209.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+...||.|+||.||+|.+..++..||||++.....     .......+.+|+.+++.++||||+++++++..+
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-----SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA   86 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-----hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence            357889999999999999999999999999999998754321     112235677899999999999999999987633


Q ss_pred             CC-----eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 AN-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~~-----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      ..     .+|+|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~---~~~kL  159 (343)
T cd07851          87 SSLEDFQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED---CELKI  159 (343)
T ss_pred             ccccccccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC---CCEEE
Confidence            32     4789999994 689888865 57999999999999999999999988  9999999999999986   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||++......          .....++..|+|||.+..   ...++.++|||||||++|+|++|+.||........+.
T Consensus       160 ~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~  226 (343)
T cd07851         160 LDFGLARHTDDE----------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK  226 (343)
T ss_pred             cccccccccccc----------ccCCcccccccCHHHHhC---CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            999999865432          123367899999998742   2357889999999999999999999997655443322


Q ss_pred             HHHHHhhhhc------------------c------cc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         519 EENTILKATE------------------V------QF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       519 ~~~~~~~~~~------------------~------~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ..........                  .      .+ .....++.++.+||++||..||.+|||+.+|+.||||.....
T Consensus       227 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         227 RIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             HHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence            1111110000                  0      00 011246889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.5e-38  Score=329.12  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCc
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPR  352 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  352 (627)
                      .+.+..++|.+.+.||+|+||.||++.+..       +...||+|++.....      ......+.+|+.+++.+ +|||
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~e~~~l~~l~~h~~   85 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKHKN   85 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC------hHHHHHHHHHHHHHHHhcCCCC
Confidence            345667899999999999999999998643       235799998764321      11234678899999999 7999


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      |+++++++. +.+.+|+||||+++++|.+++...                ..+++.+++.++.||+.||.|||+.+  |+
T Consensus        86 i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~  162 (307)
T cd05098          86 IINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CI  162 (307)
T ss_pred             EeeEEEEEe-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence            999999987 556788999999999999999753                24889999999999999999999988  99


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      ||||||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||
T Consensus       163 H~dlkp~Nill~~~---~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~  230 (307)
T cd05098         163 HRDLAARNVLVTED---NVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGV  230 (307)
T ss_pred             cccccHHheEEcCC---CcEEECCCcccccccccchh-----hccccCCCccceeChHHhc----cCCCCcHHHHHHHHH
Confidence            99999999999977   58999999999866432211     1112223567899999884    445789999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         497 IFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       497 iL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +||+|++ |..||....... +....  ..  ......+..++.++.+||.+||..+|.+||++.+++.+
T Consensus       231 ~l~el~~~g~~p~~~~~~~~-~~~~~--~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         231 LLWEIFTLGGSPYPGVPVEE-LFKLL--KE--GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCCCCCCCcCCHHH-HHHHH--Hc--CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9999998 889996554322 22111  11  11223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.5e-38  Score=337.01  Aligned_cols=258  Identities=23%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEE-----cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFD-----LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLY  357 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~-----~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~  357 (627)
                      .-.++|++.+.||+|+||.||+|.+     ..+++.||||++.....      ......+.+|+.++.++ +|||||+++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~~   77 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNVVNLL   77 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC------hHHHHHHHHHHHHHHhccCCccHhhhc
Confidence            4467899999999999999999984     34678999999864322      12245688999999999 689999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhc---------------------------------------------------
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQH---------------------------------------------------  386 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------  386 (627)
                      +++......+++|||||++++|.+++...                                                   
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            98876667788999999999999988642                                                   


Q ss_pred             ----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         387 ----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       387 ----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                                      ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~---~~~kl~dfg~~~~~~~~  232 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN---NVVKICDFGLARDIYKD  232 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC---CcEEEEecccccccccC
Confidence                            23678888999999999999999988  9999999999999976   58999999999875432


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ...     .......+++.|+|||++.    ...++.++|||||||+||+|++ |..||........+...  ...... 
T Consensus       233 ~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--~~~~~~-  300 (343)
T cd05103         233 PDY-----VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTR-  300 (343)
T ss_pred             cch-----hhcCCCCCCcceECcHHhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH--HhccCC-
Confidence            110     0112234677899999884    4458889999999999999996 99999765433332211  111111 


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       ...+..+++++.+++.+||+.||.+|||+.++++|
T Consensus       301 -~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             22223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.6e-38  Score=321.35  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=200.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|.+.++||+|+||.||+|.+..+ ..||||++......        ...+.+|+.+++.++||||+++++++.  
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~--------~~~~~~E~~~l~~l~~~~i~~~~~~~~--   71 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAVVS--   71 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC--------HHHHHHHHHHHHhCCCCCcceEEEEEC--
Confidence            4567899999999999999999987655 45999987642221        135788999999999999999999875  


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+||
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~---~~~~L~df  146 (262)
T cd05071          72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN---LVCKVADF  146 (262)
T ss_pred             CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC---CcEEeccC
Confidence            34578999999999999999753  46899999999999999999999988  9999999999999986   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+......      ......++..|+|||++.    ...++.++|||||||++|+|++ |..||........+.. 
T Consensus       147 g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-  215 (262)
T cd05071         147 GLARLIEDNEYT------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-  215 (262)
T ss_pred             Cceeeccccccc------cccCCcccceecCHhHhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-
Confidence            999876543211      112235677899999873    4458899999999999999999 8889976654433221 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        +..  ....+....++..+.+||.+||+.||.+||++.+++.
T Consensus       216 --~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         216 --VER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             --Hhc--CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence              111  1122334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-38  Score=327.98  Aligned_cols=258  Identities=22%  Similarity=0.398  Sum_probs=200.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC--------------CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE--------------QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP  351 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~--------------~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp  351 (627)
                      .++|++.+.||+|+||.||+|.+..+              ...||||++.....      ......+.+|++++++++||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~ei~~l~~l~h~   77 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT------KTARNDFLKEIKIMSRLKNP   77 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC------HHHHHHHHHHHHHHHhCCCC
Confidence            46899999999999999999987543              23589998764322      11234688999999999999


Q ss_pred             ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q psy4988         352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYD  419 (627)
Q Consensus       352 nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrD  419 (627)
                      ||+++++++. ..+.+++||||+++++|.+++....            .+++..+..++.||+.||.|||+.+  |+|+|
T Consensus        78 ~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d  154 (295)
T cd05097          78 NIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD  154 (295)
T ss_pred             CcCeEEEEEc-CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence            9999999987 5667889999999999999986432            3688899999999999999999988  99999


Q ss_pred             ccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       420 LKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      |||+|||++.+   +.+||+|||++..+.....     ........+++.|+|||++.    ...++.++|||||||++|
T Consensus       155 lkp~Nill~~~---~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~~l~  222 (295)
T cd05097         155 LATRNCLVGNH---YTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESIL----LGKFTTASDVWAFGVTLW  222 (295)
T ss_pred             cChhhEEEcCC---CcEEecccccccccccCcc-----eeccCcCcCceeecChhhhc----cCCcCchhhHHHHHHHHH
Confidence            99999999876   5899999999986543221     11122335578899999884    345889999999999999


Q ss_pred             HHHh--CCCCCCCCChHHHHHHHHHHhhh--hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         500 QCLY--GKKPFGHNQSQATILEENTILKA--TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       500 ellt--G~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +|++  +..||........+.........  ........+.+++.+.+||++||..||.+||++.++++
T Consensus       223 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         223 EMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9987  67888765544333221111111  11222334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.1e-38  Score=329.53  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=206.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .+.|...+.||+|+||.||+|.+..++..|+||++......    .......+.+|+.+++.++||||+++++++. +..
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~   94 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ----TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-KEH   94 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC----chHHHHHHHHHHHHHHhCCCCCCccEEEEEE-eCC
Confidence            34577788899999999999999999999999998644321    1223456788999999999999999999987 567


Q ss_pred             eEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..|+||||+.+ +|.+++. ....+++..+..++.||+.+|.|||+.+  |+|+||+|+||+++.+   +.+||+|||++
T Consensus        95 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~---~~~kL~dfg~~  168 (313)
T cd06633          95 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP---GQVKLADFGSA  168 (313)
T ss_pred             EEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC---CCEEEeecCCC
Confidence            78899999975 5656554 4567999999999999999999999988  9999999999999876   58999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .....           .....|+..|+|||++.... ...++.++|||||||++|+|++|..||.............   
T Consensus       169 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---  233 (313)
T cd06633         169 SKSSP-----------ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---  233 (313)
T ss_pred             cccCC-----------CCCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---
Confidence            64321           12347899999999974221 3457889999999999999999999997655433332211   


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      . ..........++..+++||.+||+++|.+||++.+++.||||....
T Consensus       234 ~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         234 Q-NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             h-cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            1 1111112235678899999999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.6e-38  Score=329.68  Aligned_cols=261  Identities=25%  Similarity=0.412  Sum_probs=208.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ...|...+.||+|+||.||++.+..++..||||++.......    ......+.+|+.+++.++|||||++++++. +.+
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   98 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS----NEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-REH   98 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc----hHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCC
Confidence            344778889999999999999999999999999986543221    233456889999999999999999999987 566


Q ss_pred             eEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+++||||+.+ +|.+++. ....+++..+..++.||+.||.|||+.+  |+|+||+|+||+++.+   +.+||+|||++
T Consensus        99 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~---~~~kl~dfg~~  172 (317)
T cd06635          99 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP---GQVKLADFGSA  172 (317)
T ss_pred             eEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC---CCEEEecCCCc
Confidence            78899999986 5666554 4567999999999999999999999988  9999999999999876   68999999998


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ......           ....|++.|+|||++... ....++.++|||||||++|+|++|..||........+...   .
T Consensus       173 ~~~~~~-----------~~~~~~~~y~aPE~~~~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~  237 (317)
T cd06635         173 SIASPA-----------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---A  237 (317)
T ss_pred             cccCCc-----------ccccCCccccChhhhhcC-CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---H
Confidence            754321           233689999999997432 2345788999999999999999999999765433332211   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      . ..........+++.+.+||.+||..+|.+||++.+++.|+|+....+
T Consensus       238 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         238 Q-NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             h-ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            1 11112223457889999999999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-38  Score=332.51  Aligned_cols=261  Identities=21%  Similarity=0.273  Sum_probs=199.1

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCC
Q psy4988         299 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD  378 (627)
Q Consensus       299 ~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~  378 (627)
                      +++.||++.+..+++.||||++.....     ....+..+.+|+.+++.++||||++++++|. +.+.++++|||+++++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-~~~~~~~~~e~~~~~~   85 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC-----SKEDLKLLQQEIITSRQLQHPNILPYVTSFI-VDSELYVVSPLMAYGS   85 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc-----chhHHHHHHHHHHHHHhcCCcchhhhhheee-cCCeEEEEEeccCCCC
Confidence            456666666777999999999865421     1223567889999999999999999999997 5677889999999999


Q ss_pred             hHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCC
Q psy4988         379 LDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH  456 (627)
Q Consensus       379 L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~  456 (627)
                      |.+++...  ..+++..+..++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||.+..+.........
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC---CceEEecCccceeeccccccccc
Confidence            99998753  46899999999999999999999988  9999999999999976   68999999998766433221111


Q ss_pred             CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh----------
Q psy4988         457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA----------  526 (627)
Q Consensus       457 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~----------  526 (627)
                      .........++..|+|||++...  ...++.++|||||||++|+|++|..||........+.........          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence            11223344678899999998421  134788999999999999999999999766554443322110000          


Q ss_pred             ------------------hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         527 ------------------TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       527 ------------------~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                                        ..........++.++.+||.+||.+||++|||+.++++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                              0000111123457899999999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=317.47  Aligned_cols=246  Identities=29%  Similarity=0.456  Sum_probs=202.7

Q ss_pred             EecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .||+|+||.||+|.+...   +..|+||++.......      ....+.+|+.+++.++|+||+++++++. +...+++|
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv   74 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE------ERKDFLKEARVMKKLGHPNVVRLLGVCT-EEEPLYLV   74 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh------HHHHHHHHHHHHhhcCCCChheeeeeec-CCCceEEE
Confidence            599999999999998866   8999999986543211      3457889999999999999999999987 56778899


Q ss_pred             EeecCCCChHHHHHhc---------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         371 LEYCDGHDLDFYLKQH---------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      |||+++++|..++...         ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+||
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~---~~~~l~df  149 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED---LVVKISDF  149 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC---CcEEEccc
Confidence            9999999999999875         78999999999999999999999988  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++........     ........+++.|+|||.+.    ...++.++|||||||++|+|++ |..||......... ..
T Consensus       150 g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~  219 (262)
T cd00192         150 GLSRDVYDDDY-----YRKKTGGKLPIRWMAPESLK----DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-EY  219 (262)
T ss_pred             ccccccccccc-----cccccCCCcCccccCHHHhc----cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-HH
Confidence            99987764321     11123346789999999884    3368899999999999999998 69999776443322 11


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        +..  .........++.++.++|.+||..||.+||++.+++.+
T Consensus       220 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         220 --LRK--GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --HHc--CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              111  22233445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-38  Score=324.33  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             CCCe-eEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         286 SDRY-LLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       286 ~~rY-~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+|| ++++.||+|+||+||++.    ...++..||||++.....      ......+.+|+++++.++||||+++++++
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG------QQNTSGWKKEINILKTLYHENIVKYKGCC   75 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC------hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4566 899999999999998764    345788999999764321      11234678899999999999999999987


Q ss_pred             eec-CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EID-ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~-~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      ... ...+++||||+++++|.+++... .+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~---~~~~l~  149 (283)
T cd05080          76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND---RLVKIG  149 (283)
T ss_pred             ecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC---CcEEEe
Confidence            643 34578999999999999998764 6999999999999999999999988  9999999999999886   589999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT-IL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~-~~  518 (627)
                      |||+++.+......    ........++..|+|||++.    ...++.++|||||||++|+|++|..||........ ..
T Consensus       150 dfg~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~  221 (283)
T cd05080         150 DFGLAKAVPEGHEY----YRVREDGDSPVFWYAVECLK----ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI  221 (283)
T ss_pred             ecccccccCCcchh----hccCCCCCCCceeeCHhHhc----ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh
Confidence            99999876532210    11122235677899999884    34578999999999999999999999864332111 00


Q ss_pred             HHH-------HHh--hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EEN-------TIL--KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~-------~~~--~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...       ...  .......+....++.++.+|+.+||..||++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         222 GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000       000  0001122334567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.1e-38  Score=318.86  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=198.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||++.+.. +..||||.+..... .       ...+.+|+.+++.++||||+++++++. +...
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   73 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-S-------EDEFIEEAKVMMKLSHEKLVQLYGVCT-KQRP   73 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-c-------HHHHHHHHHHHhcCCCCCeeeEEEEEc-cCCC
Confidence            568999999999999999997643 45699998753321 1       235788999999999999999999987 5567


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+  |+|+||||.|||++.+   +.+||+|||+++
T Consensus        74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~---~~~kl~d~g~~~  148 (256)
T cd05113          74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ---GCVKVSDFGLSR  148 (256)
T ss_pred             cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC---CCEEECCCccce
Confidence            88999999999999998764 47899999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+....+.      ......++..|+|||++.    ...++.++|||||||+||+|++ |..||...........   +.
T Consensus       149 ~~~~~~~~------~~~~~~~~~~y~~pe~~~----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~---~~  215 (256)
T cd05113         149 YVLDDEYT------SSVGSKFPVRWSPPEVLL----YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK---VS  215 (256)
T ss_pred             ecCCCcee------ecCCCccChhhCCHHHHh----cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---Hh
Confidence            76443211      011224567899999984    3458889999999999999998 9999976554332211   11


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..  .........+..+.+||.+||..||.+||++.+++.+
T Consensus       216 ~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         216 QG--LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             cC--CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            11  1122234568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-38  Score=319.49  Aligned_cols=249  Identities=26%  Similarity=0.374  Sum_probs=198.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      .+|.+.+.||+|+||.||++.+. ++..+|||++......        ...+.+|+.+++.++||||+++++++. +...
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   73 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--------EDDFIEEAKVMMKLSHPNLVQLYGVCT-KQRP   73 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--------HHHHHHHHHHHHhCCCCCEEEEEEEEc-CCCc
Confidence            35788899999999999999875 5678999987532211        124778999999999999999999987 5667


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~---~~~kl~dfg~~~  148 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED---NVVKVSDFGLAR  148 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC---CcEEECCcccce
Confidence            88999999999999998753 57899999999999999999999988  9999999999999986   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ........      ......++..|+|||++.    ...++.++|||||||+||+|++ |..||...........   +.
T Consensus       149 ~~~~~~~~------~~~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~  215 (256)
T cd05059         149 YVLDDQYT------SSQGTKFPVKWAPPEVFD----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---VS  215 (256)
T ss_pred             eccccccc------ccCCCCCCccccCHHHhc----cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---HH
Confidence            66432211      011123456799999884    4458889999999999999998 8999976554433221   11


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .  .........++.++.+||.+||..+|++|||+.++++.
T Consensus       216 ~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         216 A--GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             c--CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            1  11223345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.8e-38  Score=319.54  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=200.4

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|++.++||+|+||.||+|.+. ++..||+|.+......        ...+.+|+.++++++||||+++++++. 
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--------~~~~~~E~~~l~~l~~~~i~~~~~~~~-   71 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--------PESFLEEAQIMKKLRHDKLVQLYAVVS-   71 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--------HHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence            456788999999999999999999754 5667999987643321        135788999999999999999999875 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++++   +.++|+|
T Consensus        72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~---~~~~l~d  145 (260)
T cd05070          72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG---LVCKIAD  145 (260)
T ss_pred             -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC---ceEEeCC
Confidence             34577999999999999998753  46899999999999999999999988  9999999999999986   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||++..+......      ......++..|+|||++.    ...++.++|||||||++|+|++ |..||......... .
T Consensus       146 fg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-~  214 (260)
T cd05070         146 FGLARLIEDNEYT------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-E  214 (260)
T ss_pred             ceeeeeccCcccc------cccCCCCCccccChHHHh----cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-H
Confidence            9999876432211      111224567899999874    4457889999999999999999 89999765443322 1


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .  +..  ....+.+..++..+.+||.+||..||.+|||+.+++.
T Consensus       215 ~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         215 Q--VER--GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             H--HHc--CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            1  111  1223334567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1e-37  Score=330.38  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=207.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||.|+||.||+|.+..+++.||||++......     ....+.+.+|+.+++.++|||||+++++|...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-----PVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-----cchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            4678999999999999999999999999999999987543211     11234577899999999999999999999755


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+.+  |+|+||+|.|||++.+   +.++|+|||+
T Consensus        82 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~---~~~~l~dfg~  154 (328)
T cd07856          82 LEDIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN---CDLKICDFGL  154 (328)
T ss_pred             CCcEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC---CCEEeCcccc
Confidence            677889999995 578877764 56899999999999999999999988  9999999999999876   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +......          .....++..|+|||++..   ...++.++|||||||++|+|++|+.||...............
T Consensus       155 ~~~~~~~----------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~  221 (328)
T cd07856         155 ARIQDPQ----------MTGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL  221 (328)
T ss_pred             ccccCCC----------cCCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9754321          122367889999998742   245788999999999999999999999765432221111110


Q ss_pred             hh--------------------hhcc--ccC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LK--------------------ATEV--QFA---NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~--------------------~~~~--~~~---~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..                    ....  ..+   ..+.++.++.+||.+||+.+|++||++.+++.||||...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         222 LGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             hCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence            00                    0000  000   113578899999999999999999999999999999643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-37  Score=317.58  Aligned_cols=250  Identities=22%  Similarity=0.347  Sum_probs=199.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|.+...||+|+||.||+|.+..+ ..||+|++......        ...+.+|+.+++.++||||+++++++.  
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~--   71 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM--------PEAFLQEAQIMKKLRHDKLVPLYAVVS--   71 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc--------HHHHHHHHHHHHhCCCCCeeeEEEEEc--
Confidence            4567899999999999999999987555 46899987543221        235778999999999999999999875  


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      .+..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++++   +.++|+||
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~---~~~~l~df  146 (260)
T cd05069          72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN---LVCKIADF  146 (260)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC---CeEEECCC
Confidence            34578999999999999998754  35899999999999999999999988  9999999999999987   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++..+......      ......++..|+|||.+.    ...++.++|||||||+||+|++ |..||........... 
T Consensus       147 g~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-  215 (260)
T cd05069         147 GLARLIEDNEYT------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-  215 (260)
T ss_pred             ccceEccCCccc------ccCCCccchhhCCHHHhc----cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence            999876432211      111224677899999873    4458889999999999999999 9999976554433211 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        +..  ....+....++..+.+||.+||..||.+||++.++++
T Consensus       216 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         216 --VER--GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             --HHc--CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              111  1222334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-38  Score=321.62  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ..+|.+.++||.|+||.||+|.+.. +..||+|++.....       .....+.+|+.+++.++||||+++++++. +..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~   75 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-------LKQQDFQKEVQALKRLRHKHLISLFAVCS-VGE   75 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-------hhHHHHHHHHHHHhcCCCcchhheeeeEe-cCC
Confidence            4568899999999999999999877 89999999764321       11335778999999999999999999987 667


Q ss_pred             eEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~---~~~kl~d~g~  150 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED---LVCKVADFGL  150 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC---ceEEEccccc
Confidence            789999999999999999753  46899999999999999999999988  9999999999999987   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      +..+....+.       .....+++.|+|||.+.    ...++.++|||||||++|+|++ |+.||........+...  
T Consensus       151 ~~~~~~~~~~-------~~~~~~~~~~~~PE~~~----~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~--  217 (261)
T cd05148         151 ARLIKEDVYL-------SSDKKIPYKWTAPEAAS----HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI--  217 (261)
T ss_pred             hhhcCCcccc-------ccCCCCceEecCHHHHc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--
Confidence            9876543221       12335677899999884    3457889999999999999998 89999765543333211  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       .  .....+....+++++.++|.+||..||.+|||+.+++.
T Consensus       218 -~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         218 -T--AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -H--hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             1  12233445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6e-38  Score=320.98  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=196.0

Q ss_pred             eEEEEecccCceEEEEEEEcCCCe--EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec----
Q psy4988         290 LLLMLLGKGGFSEVHKAFDLKEQR--YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID----  363 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~~~~~--~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~----  363 (627)
                      .+.+.||+|+||.||+|.+..++.  .||||.+.....     .......+.+|+.+++.++||||+++++++...    
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-----TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            467889999999999999877765  689998754321     122245788899999999999999999976321    


Q ss_pred             -CCeEEEEEeecCCCChHHHHHh------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         364 -ANSFCTVLEYCDGHDLDFYLKQ------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       364 -~~~~~lV~E~~~gg~L~~~l~~------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                       ....++||||+.+++|..++..      ...+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~  151 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN---MNV  151 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC---CCE
Confidence             1246799999999999988742      235899999999999999999999988  9999999999999876   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~  515 (627)
                      ||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||++|+|++ |..||.......
T Consensus       152 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  222 (272)
T cd05075         152 CVADFGLSKKIYNGDYY-----RQGRIAKMPVKWIAIESLA----DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE  222 (272)
T ss_pred             EECCCCcccccCcccce-----ecCCcccCCcccCCHHHcc----CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999876543211     0112235677899999984    4568899999999999999998 899997654332


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       +...  +...  ..++..+.++..+.+||.+||+.||.+|||+.+++++
T Consensus       223 -~~~~--~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         223 -IYDY--LRQG--NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -HHHH--HHcC--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             2221  1111  1223345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.6e-38  Score=330.92  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=205.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCC--CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee--
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKE--QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI--  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~--~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--  362 (627)
                      +|.+.+.||+|+||.||++.+..+  +..||||++.....     .....+.+.+|+.+++++ +||||+++++++..  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   75 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-----KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP   75 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-----cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence            588999999999999999999888  89999998753211     111235677899999999 59999999987542  


Q ss_pred             -cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 -DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 -~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       ....+++++||+. ++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        76 ~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~---~~~kl~Df  149 (332)
T cd07857          76 GNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD---CELKICDF  149 (332)
T ss_pred             ccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC---CCEEeCcC
Confidence             2245778999987 589888888889999999999999999999999988  9999999999999887   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+.......   ........||+.|+|||++.   ....++.++|||||||++|+|++|..||........+....
T Consensus       150 g~a~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~---~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~  223 (332)
T cd07857         150 GLARGFSENPGEN---AGFMTEYVATRWYRAPEIML---SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQIL  223 (332)
T ss_pred             CCceecccccccc---cccccCcccCccccCcHHHh---CCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHH
Confidence            9998765432110   11123347899999999874   23457889999999999999999999997654322211100


Q ss_pred             HHh------------------------hhhcccc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TIL------------------------KATEVQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~------------------------~~~~~~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ...                        ......+ ...+.++.++.+||.+||++||.+|||+.+++.||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            000                        0000001 1123468899999999999999999999999999999644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.5e-38  Score=326.41  Aligned_cols=258  Identities=21%  Similarity=0.323  Sum_probs=204.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      .+...++|.+.+.||+|+||.||++.+.     .++..||||++.....      ......+.+|+.+++++ +||||++
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH------SSEREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC------hHHHHHHHHHHHHHHhccCCCCcce
Confidence            4456678999999999999999999753     3456899998754322      12235688999999999 7999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      +++++. ..+.+++||||+.+++|..++....  .+++.++..++.||+.||.|||+.+  |+|+||||+|||++.+   
T Consensus       104 ~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~---  177 (302)
T cd05055         104 LLGACT-IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG---  177 (302)
T ss_pred             EEEEEe-cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC---
Confidence            999987 5667889999999999999987543  3899999999999999999999988  9999999999999876   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQ  512 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~  512 (627)
                      +.++|+|||+++.+.....     ........+++.|+|||++.    ...++.++|||||||++|+|++ |..||....
T Consensus       178 ~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         178 KIVKICDFGLARDIMNDSN-----YVVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             CeEEECCCcccccccCCCc-----eeecCCCCcccccCCHhhhc----cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            5899999999986543211     01112235678899999884    4457889999999999999998 999997665


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ....+....  .  ..........++.++.+||.+||..+|++|||+.+++.
T Consensus       249 ~~~~~~~~~--~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         249 VDSKFYKLI--K--EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             chHHHHHHH--H--cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            444332211  1  11122333467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0666|consensus

Probab=100.00  E-value=1.6e-39  Score=323.05  Aligned_cols=270  Identities=25%  Similarity=0.393  Sum_probs=205.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..|.++..||+|+||.||+|...+++.    .+|||.+.-.+....     .-..+.||+.+++.++|||||.|..+|..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-----iS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-----ISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-----cCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            458899999999999999997665533    789998765543221     12467899999999999999999999986


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC-Ccccce
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEI  436 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~-~~~g~v  436 (627)
                      ....++|++||.+ .+|...++-     ...++...++.|++||+.|+.|||++-  |+||||||.|||+..+ ...|.|
T Consensus        99 ~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen   99 HDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             cCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence            5778899999998 577777753     257999999999999999999999999  9999999999999654 224799


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ--  514 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~--  514 (627)
                      ||+|||+++.+.....    ...-....+-|+||+|||.+++   ...|+.++|||++|||+.|||+-.+.|.+....  
T Consensus       176 KIaDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLG---a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~  248 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLG---ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK  248 (438)
T ss_pred             EeecccHHHHhhcccc----ccccCCceEEEEEecChHHhcc---cccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence            9999999999876532    1212334578999999999974   446999999999999999999988888433211  


Q ss_pred             -------HHHHHHHHHhhh-hccccCC------------------------------CCCCCHHHHHHHHHhhhcCcCCC
Q psy4988         515 -------ATILEENTILKA-TEVQFAN------------------------------KPTVSNEAKGFIRSCLAYRKEDR  556 (627)
Q Consensus       515 -------~~~~~~~~~~~~-~~~~~~~------------------------------~~~vs~el~~LI~~cL~~dP~~R  556 (627)
                             +.+.....++.. ....||.                              +..-++.+.+|+.+||++||-+|
T Consensus       249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR  328 (438)
T KOG0666|consen  249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR  328 (438)
T ss_pred             cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence                   111111111110 0011110                              11134558899999999999999


Q ss_pred             CCHHHHHhccCCCCC
Q psy4988         557 IDVISLARHDYLQPP  571 (627)
Q Consensus       557 pt~~elL~hp~~~~~  571 (627)
                      +|+.++++|+||...
T Consensus       329 Ita~qAleh~yF~~d  343 (438)
T KOG0666|consen  329 ITAEQALEHPYFTED  343 (438)
T ss_pred             ccHHHHhcccccccC
Confidence            999999999999753

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-37  Score=321.00  Aligned_cols=252  Identities=22%  Similarity=0.359  Sum_probs=199.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .++|+++++||.|+||+||+|.+..+++    .||||++.....      ......+.+|+.+++.+.||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS------PKANKEILDEAYVMAGVGSPYVCRLLGICL   79 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC------HHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence            4679999999999999999999877766    489998754322      122346788999999999999999999886


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       . ...+++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++++   +.+||+|
T Consensus        80 -~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~---~~~kL~d  152 (279)
T cd05109          80 -T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP---NHVKITD  152 (279)
T ss_pred             -C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC---CcEEECC
Confidence             3 3466999999999999998764 57999999999999999999999988  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+......     .......+++.|+|||.+.    ...++.++|||||||+||||++ |..||....... +..
T Consensus       153 fG~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~  222 (279)
T cd05109         153 FGLARLLDIDETE-----YHADGGKVPIKWMALESIL----HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPD  222 (279)
T ss_pred             CCceeecccccce-----eecCCCccchhhCCHHHhc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH
Confidence            9999876532211     0111224567899999984    4458899999999999999998 999996544322 211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        .+..  ....+....++.++.+||.+||..||++||++.+++.
T Consensus       223 --~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         223 --LLEK--GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             --HHHC--CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              1111  1122334568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=322.25  Aligned_cols=271  Identities=16%  Similarity=0.203  Sum_probs=194.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHH----HHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKA----NYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      +..++|.+.++||+|+||.||+|.+..+   +..+|+|+.............    ........++..+..++|+||+.+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            5668999999999999999999998877   778888875443321111100    011223345556677899999999


Q ss_pred             eeEEeecCC---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         357 YDVFEIDAN---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       357 ~~~~~~~~~---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      ++++.....   ..++++|++.. ++...+.....+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~---  162 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN---  162 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---
Confidence            987653322   33678887753 56666666556789999999999999999999988  9999999999999876   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.++|+|||+|+.+..................||+.|+|||++.    +..++.++|||||||+||+|++|..||.....
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~----~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN----GACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            58999999999876432211111111123347999999999984    45689999999999999999999999976633


Q ss_pred             HHHHHHHH--HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         514 QATILEEN--TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       514 ~~~~~~~~--~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...+....  .........-...+..+.++.+|+..|+..+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             chHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22222111  1111111011112356789999999999999999999999875

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=316.73  Aligned_cols=245  Identities=30%  Similarity=0.445  Sum_probs=196.4

Q ss_pred             EecccCceEEEEEEEcCCC---eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~---~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      +||+|+||.||+|.+...+   ..||+|++......      .....+.+|+.+++.++|||||++++++.  .+.+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v   73 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLV   73 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccch------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEE
Confidence            5999999999999876655   78999987644321      23456888999999999999999999875  4567899


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      |||+++++|.+++.....+++..+..++.|++.||.|||..+  |+|+||||+|||++.+   +.+||+|||+++.+...
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~  148 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR---HQAKISDFGMSRALGAG  148 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC---CcEEeccccccceeecC
Confidence            999999999999988888999999999999999999999988  9999999999999887   68999999999876533


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ...    ........++..|+|||++.    ...++.++|||||||++|+|++ |..||......... ..  +..  ..
T Consensus       149 ~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~-~~--~~~--~~  215 (257)
T cd05060         149 SDY----YRATTAGRWPLKWYAPECIN----YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AM--LES--GE  215 (257)
T ss_pred             Ccc----cccccCccccccccCHHHhc----CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH-HH--HHc--CC
Confidence            211    01111223456899999884    4458889999999999999997 99999765543322 11  111  11


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..+....++..+.+||.+||..||.+||++.+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22344568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-37  Score=359.65  Aligned_cols=151  Identities=30%  Similarity=0.452  Sum_probs=134.5

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.++++||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||++++++. +..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI----NKNMVHQVQAERDALALSKSPFIVHLYYSLQ-SAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-ECC
Confidence            36899999999999999999999999999999998643321    2233456888999999999999999999887 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+||||||+.+++|..++...+.+++..++.|+.||+.||.|||..+  ||||||||+||||+.+   +.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~---g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE---GHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC---CCEEEEeCCCCc
Confidence            88999999999999999988888999999999999999999999988  9999999999999876   689999999986


Q ss_pred             c
Q psy4988         446 V  446 (627)
Q Consensus       446 ~  446 (627)
                      .
T Consensus       153 ~  153 (669)
T cd05610         153 V  153 (669)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-37  Score=320.45  Aligned_cols=256  Identities=21%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcC----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLK----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      +-.++|.+.+.||+|+||.||+|.+..    ++..|++|++....      .......+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~   76 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA------SEIQVTLLLQESCLLYGLSHQNILPILHV   76 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            346789999999999999999999876    36889999875322      12234568899999999999999999998


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc--------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH--------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      +..+...+++++||+++++|..++...        ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++++ 
T Consensus        77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-  153 (280)
T cd05043          77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-  153 (280)
T ss_pred             EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-
Confidence            775567788999999999999998653        45899999999999999999999988  9999999999999876 


Q ss_pred             cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q psy4988         432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGH  510 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~  510 (627)
                        +.+||+|||+++.+.......     ......++..|+|||++.    ...++.++|||||||++|++++ |+.||..
T Consensus       154 --~~~kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         154 --LQVKITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLV----NKEYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             --CcEEECCCCCcccccCCceEE-----eCCCCCcchhccCHHHHh----cCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence              589999999998764432210     111234677899999984    4457899999999999999998 9999976


Q ss_pred             CChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..... +...  +..  ...+.....+++++.++|.+||..||++|||+.+++.
T Consensus       223 ~~~~~-~~~~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         223 IDPFE-MAAY--LKD--GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCHHH-HHHH--HHc--CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            54432 2111  111  1223334567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-37  Score=316.05  Aligned_cols=244  Identities=23%  Similarity=0.362  Sum_probs=197.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||+|+||.||++..  .+..||+|.+....         ..+.+.+|+.+++.++|+||+++++++..+.+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            45799999999999999999965  47889999874322         13457889999999999999999998765667


Q ss_pred             eEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+  |+||||||+|||++++   +.+||+|||+
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~---~~~kl~dfg~  148 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED---NVAKVSDFGL  148 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC---CcEEecCCcc
Confidence            7889999999999999987643  4899999999999999999999988  9999999999999887   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      +......          .....++..|+|||++.    ...++.++|||||||++|+|++ |+.||...........   
T Consensus       149 ~~~~~~~----------~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~---  211 (256)
T cd05082         149 TKEASST----------QDTGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---  211 (256)
T ss_pred             ceecccc----------CCCCccceeecCHHHHc----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---
Confidence            8765322          12224567899999883    4458889999999999999997 9999975543322211   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +..  .........++..+.+||.+||..+|++|||+.++++
T Consensus       212 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         212 VEK--GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             Hhc--CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            111  1122233567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-38  Score=320.11  Aligned_cols=256  Identities=29%  Similarity=0.470  Sum_probs=203.2

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      ||.+.+.||+|+||.||++.+...+..+++|++........  .......+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL--NPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc--CcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCce
Confidence            68999999999999999999988888788887654322111  1112235667999999999999999999987 56678


Q ss_pred             EEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      |+||||+++++|..++..    ...+++..++.++.|++.||.|||+.+  |+|+||||+||+++.+    .++|+|||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~~----~~~l~d~g~  151 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNN----LLKIGDFGV  151 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeecC----CEeecccCc
Confidence            899999999999988753    357999999999999999999999988  9999999999999753    699999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +..+....       .......|++.|+|||.+.    ...++.++||||||+++|+|++|..||...........   .
T Consensus       152 ~~~~~~~~-------~~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~  217 (260)
T cd08222         152 SRLLMGSC-------DLATTFTGTPYYMSPEALK----HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---I  217 (260)
T ss_pred             eeecCCCc-------ccccCCCCCcCccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---H
Confidence            98764322       1223346889999999873    34578899999999999999999999965443222211   1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ....  .......++.++.+||.+||..||++||++.+++.||||
T Consensus       218 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         218 VEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            1111  111234678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-37  Score=323.70  Aligned_cols=258  Identities=23%  Similarity=0.417  Sum_probs=200.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcC----------------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLK----------------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD  349 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~----------------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~  349 (627)
                      .++|++.++||+|+||.||++.+..                +...||||++.....      ......+.+|+.+++.++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~E~~~l~~l~   77 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN------KNARNDFLKEIKIMSRLK   77 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC------HHHHHHHHHHHHHHHhCC
Confidence            4679999999999999999985432                345799998754321      222456889999999999


Q ss_pred             CCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc-----------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-----------TIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       350 HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      ||||+++++++. +...+++||||+++++|..++....           .+++..+..++.||+.||.|||+.+  |+|+
T Consensus        78 ~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~  154 (296)
T cd05095          78 DPNIIRLLAVCI-TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR  154 (296)
T ss_pred             CCCcceEEEEEe-cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence            999999999987 5567889999999999999987542           4778899999999999999999988  9999


Q ss_pred             cccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       419 DLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      ||||+|||++.+   +.++|+|||+++.+......     .......+++.|++||++.    ...++.++|||||||+|
T Consensus       155 dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~----~~~~~~~~DiwSlG~~l  222 (296)
T cd05095         155 DLATRNCLVGKN---YTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESIL----LGKFTTASDVWAFGVTL  222 (296)
T ss_pred             cCChheEEEcCC---CCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHh----cCCccchhhhhHHHHHH
Confidence            999999999876   58999999999866432211     1122234567899999874    33588999999999999


Q ss_pred             HHHHh--CCCCCCCCChHHHHHHHHHHhh--hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         499 YQCLY--GKKPFGHNQSQATILEENTILK--ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       499 ~ellt--G~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |||++  |..||........+........  .....++....++..+.+||.+||..||.+||++.+++.
T Consensus       223 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         223 WEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99998  7889965544433321111111  112223444567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=322.46  Aligned_cols=258  Identities=29%  Similarity=0.454  Sum_probs=204.4

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.+.+.||.|++|.||+|.+..+++.|++|.+......     ......+.+|+.+++.++||||+++++++. +...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-----EGIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-----chhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEE
Confidence            56788999999999999999999999999987543321     122356778999999999999999999987 567888


Q ss_pred             EEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      +||||+++ +|..++.. ...+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|||++...
T Consensus        75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~---~~~~l~df~~~~~~  148 (283)
T cd05118          75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE---GVLKLADFGLARSF  148 (283)
T ss_pred             EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC---CcEEEeeeeeeEec
Confidence            99999986 77776655 468999999999999999999999988  9999999999999976   58999999999876


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh-
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA-  526 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-  526 (627)
                      ....       .......++..|+|||.+..   ...++.++||||||+++|+|++|+.||...+....+......... 
T Consensus       149 ~~~~-------~~~~~~~~~~~~~~PE~~~~---~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         149 GSPV-------RPYTHYVVTRWYRAPELLLG---DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             CCCc-------ccccCccCcccccCcHHHhc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            5432       01122367889999999852   235788999999999999999999999766543332221111000 


Q ss_pred             --------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 --------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 --------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                    ....++         ..+.++.++.+||.+||.+||.+||++.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                          000010         123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.4e-38  Score=326.82  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=205.6

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      ..+||+|+||.||++.+..++..||||.+.....       .....+.+|+.+++.++|+||++++++|. +.+.+++||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   96 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-------QRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVM   96 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-------hHHHHHHHHHHHHHhcCCcchhheeeEEE-eCCEEEEEE
Confidence            3569999999999999999999999998754321       12345788999999999999999999997 567888999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      ||+++++|.+++.. ..+++..++.++.|++.+|.|||+.+  |+|+||+|+||+++.+   +.++|+|||++..+....
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CCEEEcccccceeccccc
Confidence            99999999987754 57899999999999999999999988  9999999999999987   589999999987654321


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                      .       ......|++.|+|||.+.    ...++.++|||||||++|+|++|..||........+..   ........+
T Consensus       171 ~-------~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~  236 (292)
T cd06657         171 P-------RRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNLPPKL  236 (292)
T ss_pred             c-------cccccccCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhhCCccc
Confidence            0       112246899999999873    34578899999999999999999999976544332211   111112223


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .....++..+.+||.+||..||.+||++.+++.||||....+
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            333467899999999999999999999999999999986554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0603|consensus

Probab=100.00  E-value=6.3e-39  Score=346.51  Aligned_cols=247  Identities=30%  Similarity=0.470  Sum_probs=206.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      .+.+.|.+...||.|+|+.|..+.+..+++.++||++.....           ...+|+.++... +||||+++.+++. 
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----------~~~~e~~~~~~~~~h~niv~~~~v~~-  386 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----------DNQDEIPISLLVRDHPNIVKSHDVYE-  386 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc-----------ccccccchhhhhcCCCcceeecceec-
Confidence            356789999999999999999999999999999999875522           133466665555 7999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +..+.|+|||++.|+.|.+.+.....+. .++..|+.+|+.||.|||++|  ||||||||+|||++.+  .++++|||||
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~--~g~lrltyFG  461 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGS--AGHLRLTYFG  461 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCC--CCcEEEEEec
Confidence            7778889999999999988887766666 888899999999999999988  9999999999999622  2799999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      .++.+...          ..+.|-|..|.|||++.    ...|+.+|||||||++||+||+|+.||.....+..+..   
T Consensus       462 ~a~~~~~~----------~~tp~~t~~y~APEvl~----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---  524 (612)
T KOG0603|consen  462 FWSELERS----------CDTPALTLQYVAPEVLA----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---  524 (612)
T ss_pred             hhhhCchh----------hcccchhhcccChhhhc----cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---
Confidence            99887654          12337789999999984    66799999999999999999999999976665533322   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .+..  ..+  ...+|+++++||++||+.||.+|+++.+++.||||
T Consensus       525 ~i~~--~~~--s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  525 RIQM--PKF--SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hhcC--Ccc--ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            1111  122  25799999999999999999999999999999999

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-37  Score=322.43  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=199.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .+|.+.+.||+|+||.||+|.+.     .+...|++|.+.....       ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------AARKDFQREAELLTNLQHEHIVKFYGVCG   77 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-------HHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence            46889999999999999999754     3456789998643221       22346788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                       +...+++||||+++++|.+++...                ..+++..++.++.||+.||.|||+.+  |+||||||+||
T Consensus        78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni  154 (291)
T cd05094          78 -DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNC  154 (291)
T ss_pred             -cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceE
Confidence             566788999999999999998754                24899999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++.+   +.++|+|||+++........     .......++..|+|||++.    ...++.++|||||||++|+|++ |
T Consensus       155 l~~~~---~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~t~g  222 (291)
T cd05094         155 LVGAN---LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVILWEIFTYG  222 (291)
T ss_pred             EEccC---CcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhc----cCCCCchhhHHHHHHHHHHHHhCC
Confidence            99987   58999999999865432211     1122345788999999884    4458889999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..||........+ ..  +..  ..........+..+.+||.+||+.||.+||++.++++
T Consensus       223 ~~p~~~~~~~~~~-~~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         223 KQPWFQLSNTEVI-EC--ITQ--GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCCCCCHHHHH-HH--HhC--CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            9999765543322 11  111  1111223456889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-37  Score=325.61  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=201.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCcee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVV  354 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV  354 (627)
                      ....++|.+.+.||+|+||.||+|.+..       ....||+|++.....      ......+.+|+.+++.+ +||||+
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv   81 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT------DKDLADLISEMELMKLIGKHKNII   81 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC------hHHHHHHHHHHHHHHhccCCCCee
Confidence            4456789999999999999999997642       356799998753322      12245678899999999 699999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      ++++++. +...+|+||||+++++|..++...                ..+++..+..++.||+.||.|||+.+  |+||
T Consensus        82 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~  158 (314)
T cd05099          82 NLLGVCT-QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHR  158 (314)
T ss_pred             eEEEEEc-cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence            9999987 566788999999999999999653                34889999999999999999999988  9999


Q ss_pred             cccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       419 DLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      ||||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||++
T Consensus       159 dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~~l  226 (314)
T cd05099         159 DLAARNVLVTED---NVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILM  226 (314)
T ss_pred             cccceeEEEcCC---CcEEEccccccccccccccc-----cccccCCCCccccCHHHHc----cCCcCccchhhHHHHHH
Confidence            999999999876   58999999999876532211     1112224557899999984    34588899999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         499 YQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       499 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |+|++ |..||........+ ...  ...  ........++.++.+||.+||..||.+||++.+++.
T Consensus       227 ~el~~~g~~p~~~~~~~~~~-~~~--~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         227 WEIFTLGGSPYPGIPVEELF-KLL--REG--HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHhCCCCCCCCCCHHHHH-HHH--HcC--CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99998 89999765443322 111  111  112223467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=315.30  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=203.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++..++|.+.++||.|+||.||+|.+. ++..||||.+......        ...+.+|+.+++.++||||+++++++. 
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~-   71 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS--------PEAFLQEAQIMKKLRHDKLVQLYAVCS-   71 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC--------HHHHHHHHHHHhhCCCCCEeeeeeeee-
Confidence            466789999999999999999999865 5578999987643321        235788999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      +...+++||||+++++|..++...  ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~---~~~~l~d  146 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN---LVCKIAD  146 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC---CCEEECc
Confidence            556788999999999999999764  37899999999999999999999988  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+....+.      ......++..|+|||.+.    ...++.++|||||||++|+|++ |+.||........+..
T Consensus       147 ~g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  216 (261)
T cd05034         147 FGLARLIEDDEYT------AREGAKFPIKWTAPEAAN----YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ  216 (261)
T ss_pred             cccceeccchhhh------hhhccCCCccccCHHHhc----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999876542211      111223567899999884    4458889999999999999998 9999976554433221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   .  .....+....++.++.++|.+||..+|.+||++.+++.
T Consensus       217 ~---~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         217 V---E--RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             H---H--cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            1   1  11223344567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.9e-38  Score=324.10  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=199.5

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .+|.+.+.||+|+||.||+|.+..+     +..||||++.....      ......+.+|+.++..++|||||++++++.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~   78 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE------GPLREEFKHEAMMRSRLQHPNIVCLLGVVT   78 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC------HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            4577788899999999999987643     57899999764321      123456788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                       +....++++||+.+++|..++...                ..+++..+..++.|++.||.|||+.+  |+||||||+||
T Consensus        79 -~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Ni  155 (283)
T cd05091          79 -KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNV  155 (283)
T ss_pred             -CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhhe
Confidence             556688999999999999998532                35888999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++++   +.+||+|||+++.+......     .......+++.|+|||.+.    ...++.++|||||||+||||++ |
T Consensus       156 l~~~~---~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~~~g  223 (283)
T cd05091         156 LVFDK---LNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIM----YGKFSIDSDIWSYGVVLWEVFSYG  223 (283)
T ss_pred             EecCC---CceEecccccccccccchhe-----eeccCccCCccccCHHHHh----cCCCCcchhHHHHHHHHHHHHcCC
Confidence            99876   58999999999876433211     1223345678999999984    3347889999999999999997 8


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..||........+ ..  +....  ..+....++.++.+||.+||+.+|.+||++.+++..
T Consensus       224 ~~p~~~~~~~~~~-~~--i~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         224 LQPYCGYSNQDVI-EM--IRNRQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCCCCCCHHHHH-HH--HHcCC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            8899765544322 11  11111  112335688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=319.36  Aligned_cols=257  Identities=28%  Similarity=0.494  Sum_probs=199.2

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEeecCC
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~~~~  365 (627)
                      |.+.+.||.|+||.||+|.+..++..||||++.......     .....+.+|+.+++++   +||||+++++++.....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   75 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT   75 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-----hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence            678999999999999999998889999999986443211     1123455677776655   69999999999874332


Q ss_pred             ----eEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         366 ----SFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       366 ----~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                          .+++||||+.+ +|.+++....  .+++..++.++.||+.||.|||+.+  |+|+||+|+|||++.+   +.+||+
T Consensus        76 ~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~---~~~~l~  149 (287)
T cd07838          76 DRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD---GQVKIA  149 (287)
T ss_pred             CCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC---CCEEEe
Confidence                38899999985 7888876543  5999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++..+.....        .....++..|+|||++.    ...++.++|||||||++|+|++|.+||........+..
T Consensus       150 dfg~~~~~~~~~~--------~~~~~~~~~~~~PE~~~----~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~  217 (287)
T cd07838         150 DFGLARIYSFEMA--------LTSVVVTLWYRAPEVLL----QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK  217 (287)
T ss_pred             ccCcceeccCCcc--------cccccccccccChHHhc----cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH
Confidence            9999987643321        12235789999999984    34578899999999999999999999976655443322


Q ss_pred             HHHHhhh-hcccc-----------C---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         520 ENTILKA-TEVQF-----------A---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       520 ~~~~~~~-~~~~~-----------~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ....... ....+           +         ..+.++.++.+||.+||+.||.+||++.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         218 IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            2111100 00000           0         012456888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-37  Score=321.87  Aligned_cols=265  Identities=28%  Similarity=0.404  Sum_probs=207.5

Q ss_pred             CeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      .|.+.+.||+|+||.||++.+.   .+++.||||++......   ........+.+|+.++..+ +||||++++++|. .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~---~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~-~   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV---QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ-T   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH---hhhhHHHHHHHHHHHHHhccCCcchhhhheeee-c
Confidence            4889999999999999999864   46789999998643221   2223345678899999999 5999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+||||+++++|..++.....+++..++.++.|++.+|.|||+.+  ++|+||||.|||++.+   +.++|+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~---~~~~l~dfg~  151 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE---GHVVLTDFGL  151 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC---CCEEEEECcc
Confidence            6778899999999999999987788999999999999999999999988  9999999999999886   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.+.....      .......|+..|+|||++...  ....+.++||||||+++|+|++|..||.............. 
T Consensus       152 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-  222 (288)
T cd05583         152 SKEFLAEEE------ERAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-  222 (288)
T ss_pred             ccccccccc------cccccccCCccccCHHHhcCC--CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-
Confidence            876543221      112234689999999987422  12367899999999999999999999964332211111111 


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID---VISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt---~~elL~hp~~~~~  571 (627)
                       .......+.+..++.++.+||.+||+.||++|||   +.++++||||...
T Consensus       223 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         223 -RILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             -HHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence             1111223344567899999999999999999998   5678999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-37  Score=324.12  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCe--EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQR--YVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~--~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      ++|.+.+.||+|+||.||+|.+..++.  .+++|.+.....      ....+.+.+|+.++.++ +||||+++++++. +
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS------ENDHRDFAGELEVLCKLGHHPNIINLLGACE-N   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC------HHHHHHHHHHHHHHHhhcCCCchhheEEEEc-c
Confidence            679999999999999999999877764  468887642111      12235688899999999 7999999999987 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      ...+|+||||+++++|.+++....                .+++..++.++.||+.||+|||+.+  ||||||||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill  152 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV  152 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence            567889999999999999986532                5889999999999999999999988  9999999999999


Q ss_pred             cCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q psy4988         428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKK  506 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~  506 (627)
                      +.+   +.+||+|||++.......        .......+..|+|||++.    ...++.++|||||||+||+|++ |..
T Consensus       153 ~~~---~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~il~el~t~g~~  217 (297)
T cd05089         153 GEN---LASKIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLN----YSVYTTKSDVWSFGVLLWEIVSLGGT  217 (297)
T ss_pred             CCC---CeEEECCcCCCcccccee--------ccCCCCcCccccCchhhc----cCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            886   589999999986432110        011123356799999884    4458899999999999999997 999


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||.......... .  +..  .........++.++.+||.+||..||.+||++.++++.
T Consensus       218 pf~~~~~~~~~~-~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         218 PYCGMTCAELYE-K--LPQ--GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHH-H--Hhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            997655443221 1  111  12223344688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-37  Score=316.21  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=201.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCe---EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQR---YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ..++|...+.||+|+||.||+|.+..++.   .||||.+.....      ......+..|+++++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT------EKQRQDFLSEASIMGQFSHHNIIRLEGVVT   76 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC------HHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence            34678899999999999999999876554   799998754322      112356788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       +.+.+++||||+++++|..++... ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~---~~~kl~d  150 (268)
T cd05063          77 -KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN---LECKVSD  150 (268)
T ss_pred             -cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC---CcEEECC
Confidence             566788999999999999998754 57899999999999999999999988  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||++..........    ........++.|+|||++.    ...++.++|||||||++|+|++ |..||...........
T Consensus       151 fg~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~  222 (268)
T cd05063         151 FGLSRVLEDDPEGT----YTTSGGKIPIRWTAPEAIA----YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA  222 (268)
T ss_pred             Cccceecccccccc----eeccCCCcCceecCHHHhh----cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            99998765322110    0011123456799999984    3457899999999999999997 9999965544332211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                         +..  ....+....++.++.+||.+||..+|.+||++.++++
T Consensus       223 ---i~~--~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         223 ---IND--GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ---Hhc--CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               111  1233344467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-37  Score=321.20  Aligned_cols=252  Identities=24%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             CCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ..+|++.++||+|+||.||++...     .++..||+|.+....       ......+.+|+++++.++|+||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------ESARQDFQREAELLTVLQHQHIVRFYGVC   76 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-------HHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence            457888999999999999999643     356789999865322       12245688999999999999999999988


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc---------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK---------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                      . +...+++||||+++++|.+++....               .+++..++.++.||+.||.|||+.+  |+||||||+||
T Consensus        77 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~ni  153 (280)
T cd05092          77 T-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNC  153 (280)
T ss_pred             e-cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhE
Confidence            7 5677889999999999999987543               4889999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++++   +.+||+|||+++.+.....     ........+++.|+|||++.    ...++.++|||||||++|+|++ |
T Consensus       154 l~~~~---~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g  221 (280)
T cd05092         154 LVGQG---LVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESIL----YRKFTTESDIWSFGVVLWEIFTYG  221 (280)
T ss_pred             EEcCC---CCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhc----cCCcCchhhHHHHHHHHHHHHcCC
Confidence            99876   5899999999976543211     01122234578899999884    4458899999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .+||........+..   ....  ........+++.+.+||.+||+.||.+||++.+++.
T Consensus       222 ~~p~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         222 KQPWYQLSNTEAIEC---ITQG--RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCccCCHHHHHHH---HHcC--ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999965544333211   1111  122333468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.6e-37  Score=314.08  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=207.6

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|.+.++||.|+||.||++.+..++..||||.+.......     .....+.+|+.+++.++||||+++++++. +...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-----KEREDAVNEIRILASVNHPNIISYKEAFL-DGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-----HHHHHHHHHHHHHHhCCCCCchhhhhhhc-cCCEE
Confidence            5889999999999999999999999999999986433221     22346778999999999999999999987 56788


Q ss_pred             EEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ++||||+++++|..++..    ...+++..+..++.|++.||.|||+.+  |+|+||+|.||+++.+   +.+||+|||+
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~---~~~kl~d~g~  149 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN---DLVKIGDLGI  149 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC---CcEEEeeccc
Confidence            999999999999998865    357899999999999999999999988  9999999999999986   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.......         .....+++.|+|||.+.    ...++.++|+||||+++|+|++|+.||......... ..  .
T Consensus       150 ~~~~~~~~---------~~~~~~~~~~~~Pe~~~----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~--~  213 (256)
T cd08530         150 SKVLKKNM---------AKTQIGTPHYMAPEVWK----GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-YK--V  213 (256)
T ss_pred             hhhhccCC---------cccccCCccccCHHHHC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH--H
Confidence            98765431         22346889999999984    445788999999999999999999999765543221 11  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..  ....+....++.++.++|.+||..+|.+||++.+++.||++
T Consensus       214 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         214 QR--GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             hc--CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            11  11112223578899999999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1026|consensus

Probab=100.00  E-value=8.2e-39  Score=355.46  Aligned_cols=258  Identities=25%  Similarity=0.445  Sum_probs=214.1

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCcee
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV  354 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV  354 (627)
                      ....+-....++.+.||+|+||+||+|.-..     +...||||.++..      ......++|.||++++..|+|||||
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~------a~~~~~~dF~REaeLla~l~H~nIV  552 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK------AENQARQDFRREAELLAELQHPNIV  552 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc------ccHHHHHHHHHHHHHHHhccCCCeE
Confidence            3344455667888999999999999997443     4578999987532      2233567899999999999999999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------c----CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------K----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~----~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                      +|+++|. +++.+|+|+|||..|||..+|...          .    .|+..+.+.|+.||+.|+.||-++.  +|||||
T Consensus       553 rLlGVC~-~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDL  629 (774)
T KOG1026|consen  553 RLLGVCR-EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDL  629 (774)
T ss_pred             EEEEEEc-cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccch
Confidence            9999997 778889999999999999999642          1    2888999999999999999999988  999999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      -..|+||.++   -.|||+||||++.+...+|...     .....-.+.|||||.|+.++    |+.++|||||||||||
T Consensus       630 ATRNCLVge~---l~VKIsDfGLsRdiYssDYYk~-----~~~t~lPIRWMppEsIly~k----FTteSDVWs~GVvLWE  697 (774)
T KOG1026|consen  630 ATRNCLVGEN---LVVKISDFGLSRDIYSSDYYKV-----RGNTLLPIRWMPPESILYGK----FTTESDVWSFGVVLWE  697 (774)
T ss_pred             hhhhceeccc---eEEEecccccchhhhhhhhhcc-----cCCceeeeecCCHHHhhcCc----ccchhhhhhhhhhhhh
Confidence            9999999998   4899999999998776655422     22234577899999997554    9999999999999999


Q ss_pred             HH-hCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         501 CL-YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       501 ll-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      ++ +|+-||.+-..++.+..    +....+ ++.+..++.++.+|+..||+.+|.+||++.||-
T Consensus       698 IFsyG~QPy~glSn~EVIe~----i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  698 IFSYGKQPYYGLSNQEVIEC----IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             hhccccCcccccchHHHHHH----HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99 69999988877776532    233344 677788999999999999999999999999984

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-38  Score=321.64  Aligned_cols=256  Identities=28%  Similarity=0.420  Sum_probs=202.0

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  367 (627)
                      |.+.+.||.|+||+||+|.+..+++.|+||.+........      .....+|+..++.++ ||||+++++++. +.+.+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE------ECMNLREVKSLRKLNEHPNIVKLKEVFR-ENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh------HHHHHHHHHHHHhccCCCCchhHHHHhh-cCCcE
Confidence            6788999999999999999988999999998754322111      123457899999999 999999999997 56778


Q ss_pred             EEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++||||+ +++|..++....  .+++..+..++.||+.+|.|||+.+  |+|+||+|+|||++.+   +.++|+|||+++
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~---~~~~l~d~~~~~  147 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP---EVVKIADFGLAR  147 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC---CCEEEeecccce
Confidence            8999999 678888887654  7899999999999999999999988  9999999999999986   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......        .....++..|+|||++..   ...++.++||||||+++|+|++|+.||........+........
T Consensus       148 ~~~~~~~--------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  216 (283)
T cd07830         148 EIRSRPP--------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG  216 (283)
T ss_pred             eccCCCC--------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcC
Confidence            7653221        123468899999998752   33578899999999999999999999976654433322111110


Q ss_pred             h---------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         526 A---------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       526 ~---------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .               ....++         ..+..+.++.+||++||..||.+|||+.+++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             CCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0               000000         012346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-37  Score=316.96  Aligned_cols=254  Identities=23%  Similarity=0.374  Sum_probs=201.3

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCC---eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~---~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .++|++.+.||+|+||.||+|.+..++   ..||||.+.....      ......+.+|+.+++.++||||+++++++. 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   75 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT-   75 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence            357899999999999999999876544   3789998753221      112456788999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|+||||+++++|..++... ..+++.++..++.||+.||.|||+.+  |+||||||+|||++.+   +.++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~---~~~~l~df  150 (267)
T cd05066          76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN---LVCKVSDF  150 (267)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC---CeEEeCCC
Confidence            567788999999999999998764 57899999999999999999999988  9999999999999876   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++..+......    ........++..|+|||++.    ...++.++|||||||++|+|++ |..||........... 
T Consensus       151 g~~~~~~~~~~~----~~~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~-  221 (267)
T cd05066         151 GLSRVLEDDPEA----AYTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA-  221 (267)
T ss_pred             Ccccccccccce----eeecCCCccceeecCHhHhc----cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH-
Confidence            999876543211    01112223467899999984    3458899999999999999886 9999976544332211 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        +..  ...++....++..+.+||.+||+.+|.+||++.+++.
T Consensus       222 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         222 --IEE--GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --HhC--CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence              111  1223444567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-37  Score=329.13  Aligned_cols=260  Identities=22%  Similarity=0.359  Sum_probs=204.4

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCC-------CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCc
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE-------QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPR  352 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-------~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  352 (627)
                      ++++...+|++.+.||+|+||.||+|.+...       ...||+|++.....      ......+.+|+.+++++ +|||
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~   79 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT------DKDLSDLVSEMEMMKMIGKHKN   79 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC------HHHHHHHHHHHHHHHhhcCCCC
Confidence            4566778899999999999999999986532       34789998753221      12345788999999999 7999


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      |++++++|. +.+.+++||||+++++|.+++...                ..+++..+..++.||+.||.|||+.+  |+
T Consensus        80 iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--iv  156 (334)
T cd05100          80 IINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CI  156 (334)
T ss_pred             eeeeeEEEc-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            999999987 556788999999999999998753                24788899999999999999999988  99


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      ||||||+|||++.+   +.+||+|||+++.+......     .......++..|+|||++.    ...++.++|||||||
T Consensus       157 H~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~  224 (334)
T cd05100         157 HRDLAARNVLVTED---NVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGV  224 (334)
T ss_pred             ccccccceEEEcCC---CcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhc----cCCcCchhhhHHHHH
Confidence            99999999999877   58999999999876532211     1112234567899999984    445888999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         497 IFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       497 iL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      +||+|++ |..||...........   +..  .........++.++.+||.+||..+|.+||++.+++.+-
T Consensus       225 il~el~~~g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         225 LLWEIFTLGGSPYPGIPVEELFKL---LKE--GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHH---HHc--CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            9999998 8999976544332211   111  122233446788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-37  Score=323.90  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=203.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-------CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCce
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-------KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRV  353 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-------~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI  353 (627)
                      +.+..++|.+.+.||+|+||.||+|.+.       .++..||||++.....      ......+.+|+.+++.+ +||||
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~i   83 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHKNI   83 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc------hHHHHHHHHHHHHHHhhccCCCc
Confidence            4466789999999999999999999753       2456899998753211      12245688999999999 89999


Q ss_pred             eEEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       354 V~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      +++++++. +...+++||||+++++|..++...                ..+++..+..++.||+.||.|||+.+  |+|
T Consensus        84 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH  160 (304)
T cd05101          84 INLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIH  160 (304)
T ss_pred             hheeEEEe-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eee
Confidence            99999987 556788999999999999998753                24788899999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+
T Consensus       161 ~dlkp~Nili~~~---~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~  228 (304)
T cd05101         161 RDLAARNVLVTEN---NVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVL  228 (304)
T ss_pred             cccccceEEEcCC---CcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhc----cCCCCchhhHHHHHHH
Confidence            9999999999876   58999999999876543211     1122335678899999884    4458899999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||+|++ |..||.......... .  +..  .........++.++.+||.+||..+|.+||++.++++.
T Consensus       229 l~el~~~g~~p~~~~~~~~~~~-~--~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         229 MWEIFTLGGSPYPGIPVEELFK-L--LKE--GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHcCCCCCcccCCHHHHHH-H--HHc--CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            999998 889997654433221 1  111  11222334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-37  Score=320.02  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeE----EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRY----VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~----VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++|++++.||+|+||+||+|.+..+++.    |++|.+....      .......+..|+.+++.++|||||++++++. 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS------GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc------chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            5788999999999999999998877764    6666653211      1223456778888999999999999999875 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       ...+++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~---~~~kl~Df  153 (279)
T cd05111          80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD---SIVQIADF  153 (279)
T ss_pred             -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC---CcEEEcCC
Confidence             34567899999999999999754 57999999999999999999999988  9999999999999876   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+......     .......++..|+|||++.    ...++.++|||||||++|||++ |..||......... . 
T Consensus       154 g~~~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~-  222 (279)
T cd05111         154 GVADLLYPDDKK-----YFYSEHKTPIKWMALESIL----FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-D-  222 (279)
T ss_pred             ccceeccCCCcc-----cccCCCCCcccccCHHHhc----cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H-
Confidence            999876432211     1123346788999999984    3458899999999999999997 99999765443221 1 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        +... ....+....++.++.+++.+||..||.+|||+.+++.
T Consensus       223 --~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         223 --LLEK-GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --HHHC-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              1111 1122233346788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-37  Score=316.48  Aligned_cols=254  Identities=22%  Similarity=0.385  Sum_probs=201.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCe---EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQR---YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ..|.+.+.||+|+||.||+|.+..++.   .||||++.....      ......+..|+.+++.++||||+++++++. +
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~   76 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT-K   76 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCcCcceEEEEEC-C
Confidence            468999999999999999999887664   699998754321      222456889999999999999999999987 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+++||||+++++|..++.. .+.+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~---~~~kl~dfg  151 (269)
T cd05065          77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN---LVCKVSDFG  151 (269)
T ss_pred             CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC---CcEEECCCc
Confidence            6678899999999999999875 357899999999999999999999988  9999999999999876   589999999


Q ss_pred             cccccccCCCCCCCCccccccC--CCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQG--AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~--~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ++..+.......    ......  ..+..|+|||++.    ...++.++|||||||++|||++ |..||...........
T Consensus       152 ~~~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~  223 (269)
T cd05065         152 LSRFLEDDTSDP----TYTSSLGGKIPIRWTAPEAIA----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA  223 (269)
T ss_pred             cccccccCcccc----ccccccCCCcceeecCHhHhc----cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            998765432111    111111  2245799999984    4458889999999999999885 9999976554332211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         +.  .....+....++..+.++|.+||..+|.+||++.+++..
T Consensus       224 ---i~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         224 ---IE--QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             ---HH--cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               11  122334455788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-37  Score=318.37  Aligned_cols=249  Identities=30%  Similarity=0.511  Sum_probs=194.3

Q ss_pred             eEEEEecccCceEEEEEEEc----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         290 LLLMLLGKGGFSEVHKAFDL----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .+.+.||.|.||.||+|...    ..+..|+||++.....      ......+++|++++++++||||+++++++. +..
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~   74 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS------EEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENE   74 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS------HHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc------cccceeeeeccccccccccccccccccccc-ccc
Confidence            46789999999999999887    4578899999843221      122467889999999999999999999998 666


Q ss_pred             eEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++|||||++++|.+++...  ..+++..+..|+.||+.||.|||+.+  |||+||++.|||++.+   +.+||+|||+
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~---~~~Kl~~f~~  149 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN---GQVKLSDFGL  149 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT---TEEEEESTTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc---cccccccccc
Confidence            688999999999999999886  78999999999999999999999988  9999999999999987   5999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      +........     ............|+|||++..    ..++.++||||||+++|||++ |+.||........+ ..  
T Consensus       150 ~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-~~--  217 (259)
T PF07714_consen  150 SRPISEKSK-----YKNDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-EK--  217 (259)
T ss_dssp             GEETTTSSS-----EEESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-HH--
T ss_pred             ccccccccc-----ccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc-cc--
Confidence            987632211     112233457889999999853    338999999999999999999 78999766443322 22  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +...  ...+....++..+.+||..||..||.+||++.++++
T Consensus       218 ~~~~--~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  218 LKQG--QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHTT--EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccc--ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1222  223334568999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.9e-37  Score=314.80  Aligned_cols=244  Identities=29%  Similarity=0.466  Sum_probs=192.6

Q ss_pred             ecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         295 LGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      ||+|+||.||+|.+.  .++..||||++.....      ......+.+|+.+++.++||||++++++++  ...+++|||
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e   74 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE------KSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVME   74 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccC------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEE
Confidence            899999999999765  4566799998754321      223456889999999999999999999885  456789999


Q ss_pred             ecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC
Q psy4988         373 YCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN  451 (627)
Q Consensus       373 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~  451 (627)
                      |+++++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..+....
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ---HYAKISDFGLSKALGADD  149 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC---CcEEeccCCccccccCCc
Confidence            9999999999875 457999999999999999999999988  9999999999999876   589999999998654332


Q ss_pred             CCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccc
Q psy4988         452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQ  530 (627)
Q Consensus       452 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  530 (627)
                      ..    ........+++.|+|||++.    ...++.++|||||||++|+|++ |..||...........   +....  .
T Consensus       150 ~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~--~  216 (257)
T cd05115         150 SY----YKARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---IEQGK--R  216 (257)
T ss_pred             cc----eeccCCCCCCcccCCHHHHc----cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---HHCCC--C
Confidence            11    01111223467899999984    4457889999999999999995 9999976554432211   11111  2


Q ss_pred             cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       531 ~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ......+++++.+||.+||.+||++||++.++++
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-37  Score=321.19  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=197.8

Q ss_pred             CeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +|++.+.||+|+||.||+|.+..     ....|++|++......      .....+.+|+.+++.++|||||++++.|. 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-   73 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS------SELRDLLSEFNLLKQVNHPHVIKLYGACS-   73 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH------HHHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence            47888999999999999998753     3367899987543221      12356889999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc------------------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH------------------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      ..+.+++||||+.+++|.+++...                        ..+++..++.++.||+.||.|||+.+  ||||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~  151 (290)
T cd05045          74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHR  151 (290)
T ss_pred             cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehh
Confidence            556678999999999999988642                        24788999999999999999999988  9999


Q ss_pred             cccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       419 DLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      ||||+|||++++   +.+||+|||+++.+......     .......++..|+|||++.    ...++.++|||||||++
T Consensus       152 dikp~nill~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~~l  219 (290)
T cd05045         152 DLAARNVLVAEG---RKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLF----DHIYTTQSDVWSFGVLL  219 (290)
T ss_pred             hhhhheEEEcCC---CcEEeccccccccccCccch-----hcccCCCCCccccCHHHHc----cCCcchHhHHHHHHHHH
Confidence            999999999886   58999999999865432210     0112235677899999873    44588999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         499 YQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       499 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |+|++ |..||........ ...  ..  .....+....++.++.+||.+||+.+|.+||++.+++.
T Consensus       220 ~el~t~g~~p~~~~~~~~~-~~~--~~--~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         220 WEIVTLGGNPYPGIAPERL-FNL--LK--TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhcCCCCCCCCCHHHH-HHH--Hh--CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99998 9999976544332 211  11  11223334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-37  Score=326.79  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=206.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ...+|...+.||+|+||.||+|.+..++..||||.+......    ......++.+|+.+++.++|+||+++++++. +.
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   87 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-RE   87 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-cC
Confidence            345577888899999999999999999999999987643221    1223456788999999999999999999987 56


Q ss_pred             CeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ..+++||||+.+ +|.+++. ....+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.++|+|||+
T Consensus        88 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~---~~~kl~dfg~  161 (308)
T cd06634          88 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP---GLVKLGDFGS  161 (308)
T ss_pred             CeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC---CcEEECCccc
Confidence            778899999985 6666654 4457899999999999999999999988  9999999999999876   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +......           ....|++.|+|||++.... ...++.++|||||||++|+|++|..||............   
T Consensus       162 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---  226 (308)
T cd06634         162 ASIMAPA-----------NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---  226 (308)
T ss_pred             ceeecCc-----------ccccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH---
Confidence            8765432           2236889999999974321 234788999999999999999999999654433222211   


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ... .........++..+.+||.+||..+|.+||++.+++.|||+...
T Consensus       227 ~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         227 AQN-ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             hhc-CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            111 11111233678899999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=313.40  Aligned_cols=247  Identities=35%  Similarity=0.511  Sum_probs=205.4

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||.|+||.||++.+..+++.||||++.....    ........+..|+.+++.++||||+++++++. +...+|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI----IKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh----cchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-cCCeeEEEEecC
Confidence            6899999999999988999999999865432    11223557888999999999999999999987 667888999999


Q ss_pred             CCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         375 DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       375 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                      ++++|.+++.....+++..+..++.||+.||.|||+.+  ++|+||+|+||+++.+   +.++|+|||++.......   
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~---  147 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEG---  147 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC---CcEEEeecCcceecccCC---
Confidence            99999999988888999999999999999999999988  9999999999999987   589999999998765432   


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK  534 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (627)
                          .......++..|++||.+.    ...++.++|+||||+++|+|++|..||....... ....  +.   ...+..+
T Consensus       148 ----~~~~~~~~~~~~~~Pe~~~----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~--~~---~~~~~~~  213 (250)
T cd05123         148 ----SRTNTFCGTPEYLAPEVLL----GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEK--IL---KDPLRFP  213 (250)
T ss_pred             ----CcccCCcCCccccChHHhC----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHH--Hh---cCCCCCC
Confidence                1123346899999999984    3447889999999999999999999996654322 2111  11   1233444


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCH---HHHHhccCC
Q psy4988         535 PTVSNEAKGFIRSCLAYRKEDRIDV---ISLARHDYL  568 (627)
Q Consensus       535 ~~vs~el~~LI~~cL~~dP~~Rpt~---~elL~hp~~  568 (627)
                      ..++.++.+||++||..||.+||++   .+++.||||
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            5678999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-37  Score=319.31  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=198.9

Q ss_pred             CCeeEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+|++++.||+|+||.||++.    +..+++.||||.+....       ....+.+.+|+++++.++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-------AEHLRDFEREIEILKSLQHDNIVKYKGVCYS   76 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence            478999999999999999997    44578999999875432       1224567899999999999999999998643


Q ss_pred             -cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 -DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 -~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       +...+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~---~~~~l~d  151 (284)
T cd05081          77 AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE---NRVKIGD  151 (284)
T ss_pred             CCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC---CeEEECC
Confidence             345688999999999999998764 46899999999999999999999988  9999999999999887   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH----
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT----  516 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~----  516 (627)
                      ||+++.+......    ........++..|+|||++.    ...++.++|||||||++|||++|..|+........    
T Consensus       152 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~  223 (284)
T cd05081         152 FGLTKVLPQDKEY----YKVREPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG  223 (284)
T ss_pred             CcccccccCCCcc----eeecCCCCCceEeeCHHHhc----cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc
Confidence            9999876532210    01112224456799999984    34578899999999999999998877643221100    


Q ss_pred             -------HH-HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         517 -------IL-EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       517 -------~~-~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                             .. ...... .....++....++.++.+||.+||..+|++|||+.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         224 NDKQGQMIVYHLIELL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             cccccccchHHHHHHH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                   00 000001 1112334455788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-38  Score=321.26  Aligned_cols=258  Identities=32%  Similarity=0.531  Sum_probs=205.5

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.+.+.||.|+||.||+|.+..+++.||||++.....     .......+..|+.+++.++|+||+++++++. +...++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-----EEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-----cccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceE
Confidence            6678889999999999999999999999999865431     1122345678999999999999999999987 557788


Q ss_pred             EEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      +||||+++ +|..++... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||+++.+   +.++|+|||+++..
T Consensus        75 ~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~---~~~~l~d~g~~~~~  148 (282)
T cd07829          75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD---GVLKLADFGLARAF  148 (282)
T ss_pred             EEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC---CCEEEecCCccccc
Confidence            99999984 899998876 58999999999999999999999988  9999999999999986   68999999999876


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh-
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA-  526 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~-  526 (627)
                      .....       ......++..|+|||++..   ...++.++|||||||++|+|++|..||........+......... 
T Consensus       149 ~~~~~-------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07829         149 GIPLR-------TYTHEVVTLWYRAPEILLG---SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP  218 (282)
T ss_pred             CCCcc-------ccCccccCcCcCChHHhcC---CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence            53321       1122356788999999852   235788999999999999999999999776544333222111100 


Q ss_pred             -------------hccccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         527 -------------TEVQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       527 -------------~~~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                                   ....++         ..+.++..+.+||++||..||++||++.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                         000111         113457899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-37  Score=312.57  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||.|+||.||+|.+  .++.||||.+.....        ..+++.+|+.+++.++|+||+++++++. +..
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~   73 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--------AAQAFLAEASVMTTLRHPNLVQLLGVVL-QGN   73 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--------HHHHHHHHHHHHHhcCCcceeeeEEEEc-CCC
Confidence            45788999999999999999975  478999999854321        3467889999999999999999999987 577


Q ss_pred             eEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||+
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~---~~~~l~d~g~  148 (256)
T cd05039          74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED---LVAKVSDFGL  148 (256)
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC---CCEEEccccc
Confidence            7889999999999999997665  7999999999999999999999988  9999999999999876   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++......          .....+..|+|||++.    ...++.++||||||+++|+|++ |..||......... ..  
T Consensus       149 ~~~~~~~~----------~~~~~~~~~~ape~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~--  211 (256)
T cd05039         149 AKEASQGQ----------DSGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PH--  211 (256)
T ss_pred             cccccccc----------ccCCCcccccCchhhc----CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HH--
Confidence            98763221          1224567899999884    3457889999999999999997 99999765433222 11  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +..  .........+++++.+||.+||..+|.+||++.+++.
T Consensus       212 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         212 VEK--GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             Hhc--CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            111  1122233467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4645|consensus

Probab=100.00  E-value=1.3e-39  Score=371.21  Aligned_cols=267  Identities=25%  Similarity=0.416  Sum_probs=220.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.-||.-..+||.|.||.||-|.+..+|+..|||-+......     ...+..+.+|+.++..++|||+|++|++=. +.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-----~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-HR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-----HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-HR 1306 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-----cccCcchHHHHHHHHhccCccccccCceee-cH
Confidence            445778888999999999999999999999999987654332     233456788999999999999999999754 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ...+|.||||.+|+|.+++...+..+|...+.+..|++.||.|||++|  ||||||||.||||+.+   |.+|++|||.|
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~---g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN---GLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC---CcEEeecccce
Confidence            778899999999999999999888999999999999999999999999  9999999999999998   79999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+......  .+.. .....||+.|||||+|.+.. .....-+.||||||||+.||+||+.||..-+....|+-.  +.
T Consensus      1382 ~ki~~~~~~--~~~e-l~~~~GT~~YMAPEvit~t~-~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~--V~ 1455 (1509)
T KOG4645|consen 1382 VKIKNNAQT--MPGE-LQSMMGTPMYMAPEVITGTK-GKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH--VA 1455 (1509)
T ss_pred             eEecCchhc--CCHH-HHhhcCCchhcCchhhcccc-cCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH--Hh
Confidence            988754211  1112 23458999999999996543 344567899999999999999999999766655554322  22


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      -.....+|.  .+|.+..|||.+||+.||..|.++.|++.|.|-..
T Consensus      1456 ~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1456 AGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             ccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            222334444  49999999999999999999999999999998653

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-37  Score=320.36  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=198.9

Q ss_pred             eeEEEEecccCceEEEEEEE----cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         289 YLLLMLLGKGGFSEVHKAFD----LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~----~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      |++++.||+|+||.||+|..    ..++..||||.+.....      ......+.+|+.+++.++||||+++++++..+ 
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG------GNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc------HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            68899999999999999974    45789999998754321      12235688999999999999999999988754 


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+++||||+++++|..++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.++|+|||
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~---~~~~l~dfg  154 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE---HQVKIGDFG  154 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC---CCEEECCCc
Confidence            35678999999999999998664 46899999999999999999999988  9999999999999876   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-------
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-------  515 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~-------  515 (627)
                      +++.+......    ........++..|+|||++.    ...++.++|||||||++|+|++++.|+.......       
T Consensus       155 ~~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~  226 (284)
T cd05079         155 LTKAIETDKEY----YTVKDDLDSPVFWYAPECLI----QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT  226 (284)
T ss_pred             cccccccCccc----eeecCCCCCCccccCHHHhc----cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc
Confidence            99876532210    11222346778899999884    3457889999999999999999887653221100       


Q ss_pred             ----HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 ----TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ----~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                          ......... .....++.+..++..+.+||.+||+.||.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         227 HGQMTVTRLVRVL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cccccHHHHHHHH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                000000000 1112234455789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.8e-37  Score=316.85  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ++|+++..||.|+||.||+|....     +...|++|.+.....      ......+.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   78 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD------ENLQSEFRRELDMFRKLSHKNVVRLLGLCR   78 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc------hHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence            578999999999999999998654     356799998753221      223456889999999999999999999886


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc---------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK---------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                       +...+|+||||+++++|..++....         .+++..+..++.||+.||.|||+.+  |+||||||+|||++.+  
T Consensus        79 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~--  153 (275)
T cd05046          79 -EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ--  153 (275)
T ss_pred             -CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC--
Confidence             5677889999999999999998665         6999999999999999999999988  9999999999999886  


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHN  511 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~  511 (627)
                       +.++|+|||+++......+.      ......++..|+|||.+.    ...++.++|||||||++|+|++ |..||...
T Consensus       154 -~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~  222 (275)
T cd05046         154 -REVKVSLLSLSKDVYNSEYY------KLRNALIPLRWLAPEAVQ----EDDFSTKSDVWSFGVLMWEVFTQGELPFYGL  222 (275)
T ss_pred             -CcEEEcccccccccCccccc------ccCCceeEEeecChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence             58999999998754332211      112235678899999884    3347789999999999999998 88999654


Q ss_pred             ChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .....+. .   .......++....++..+.+||.+||..||.+||++.+++.+
T Consensus       223 ~~~~~~~-~---~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         223 SDEEVLN-R---LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             chHHHHH-H---HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            4332221 1   122233344445788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.8e-37  Score=316.10  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=188.9

Q ss_pred             EecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      .||+|+||.||+|....  ....||||.+.....      ......+++|+.+++.++||||++++++|. +...+|+||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT------PDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCC------hHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEE
Confidence            59999999999996433  445788887643321      112346788999999999999999999987 567788999


Q ss_pred             eecCCCChHHHHHhcc-----CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         372 EYCDGHDLDFYLKQHK-----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ||+++++|.+++....     .+++..++.++.||+.||.|||+++  |+||||||+|||++.+   +.+||+|||++..
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~---~~~kl~dfg~~~~  149 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD---LSVKIGDYGLALE  149 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC---CcEEEeccccccc
Confidence            9999999999987643     3467888999999999999999988  9999999999999987   5899999999875


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCC---CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK---NPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      .....+.     .......+++.|+|||++....   ....++.++|||||||+||+|++ |..||........+...  
T Consensus       150 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--  222 (269)
T cd05042         150 QYPEDYY-----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--  222 (269)
T ss_pred             cccchhe-----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--
Confidence            4332211     0112235677899999874321   23457889999999999999998 88899765544332221  


Q ss_pred             HhhhhccccC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFA---NKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~---~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       .......++   ....++..+.+++..|+ .||++|||+.+++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         223 -VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -hhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence             111111111   22367889999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG1035|consensus

Probab=100.00  E-value=1.7e-38  Score=360.72  Aligned_cols=267  Identities=27%  Similarity=0.429  Sum_probs=204.3

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee---
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI---  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---  362 (627)
                      ..+|+.+..||+||||.||+++++-+|+.||||.|.+...      .....++++|+.++.+|+|||||++|..|..   
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s------~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS------DKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchH------HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            3457788999999999999999999999999999876542      1224578999999999999999999822100   


Q ss_pred             --------------------------------------------------------------------------------
Q psy4988         363 --------------------------------------------------------------------------------  362 (627)
Q Consensus       363 --------------------------------------------------------------------------------  362 (627)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             -----c----------------------C--------CeEEEEEeecCCCChHHHHHhccCc-CHHHHHHHHHHHHHHHH
Q psy4988         363 -----D----------------------A--------NSFCTVLEYCDGHDLDFYLKQHKTI-AEREARSIVMQVVSALK  406 (627)
Q Consensus       363 -----~----------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~e~~~~~i~~qi~~aL~  406 (627)
                           +                      .        ..+||-||||+..+|.+++..+... .-..++++|++|+.||.
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence                 0                      0        2468999999998888888876655 57889999999999999


Q ss_pred             HHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc----c--C-----CCCCCCCccccccCCCCCccCCccc
Q psy4988         407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD----E--E-----NYNPDHGMDLTSQGAGTYWYLPPEC  475 (627)
Q Consensus       407 yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~----~--~-----~~~~~~~~~~~~~~~Gt~~Y~APE~  475 (627)
                      |+|+.|  ||||||||.||+||.+   +.|||+|||+|+...    .  .     ...........+..+||..|+|||+
T Consensus       712 YIH~~g--iIHRDLKP~NIFLd~~---~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  712 YIHDQG--IIHRDLKPRNIFLDSR---NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHhCc--eeeccCCcceeEEcCC---CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            999998  9999999999999977   589999999998722    0  0     0001111112344689999999999


Q ss_pred             cccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC--CCCCCCHHHHHHHHHhhhcCc
Q psy4988         476 FVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRK  553 (627)
Q Consensus       476 l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~vs~el~~LI~~cL~~dP  553 (627)
                      +.... ...|+.|+|+||||||||||+   .||....+...++...   ....+.++  .+..--++-..+|++||..||
T Consensus       787 l~~~~-~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~L---R~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  787 LSDTS-SNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNL---RKGSIPEPADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             hcccc-cccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhc---ccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence            85332 246999999999999999999   6787665555444332   22222222  011223456789999999999


Q ss_pred             CCCCCHHHHHhccCCCC
Q psy4988         554 EDRIDVISLARHDYLQP  570 (627)
Q Consensus       554 ~~Rpt~~elL~hp~~~~  570 (627)
                      .+|||+.|+|++.||.+
T Consensus       860 ~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  860 SKRPTATELLNSELLPP  876 (1351)
T ss_pred             ccCCCHHHHhhccCCCc
Confidence            99999999999999985

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-37  Score=336.27  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=203.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~  355 (627)
                      +.+-.++|.+.++||+|+||.||+|.+.     .++..||||++......      .....+.+|+.++..+. |||||+
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~~E~~~l~~l~~H~niv~  105 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS------SEKQALMSELKIMSHLGPHLNIVN  105 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh------hHHHHHHHHHHHHHhcCCCCCeEE
Confidence            4556678999999999999999999853     35678999998643221      12346789999999997 999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhcc------------------------------------------------
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------------------------------------------  387 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------  387 (627)
                      ++++|. ....+++|||||++|+|.+++...+                                                
T Consensus       106 ~~~~~~-~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         106 LLGACT-KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             EEEEEc-cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            999987 5567889999999999999986431                                                


Q ss_pred             --------------------------------------------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         388 --------------------------------------------------TIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       388 --------------------------------------------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                                                                        .+++..++.|+.||+.||.|||+.+  |+|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH  262 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVH  262 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCc
Confidence                                                              3677788999999999999999987  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+
T Consensus       263 rdlkp~NiLl~~~---~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslGvi  330 (401)
T cd05107         263 RDLAARNVLICEG---KLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIF----NNLYTTLSDVWSFGIL  330 (401)
T ss_pred             ccCCcceEEEeCC---CEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhc----CCCCCcHhHHHHHHHH
Confidence            9999999999876   58999999999865432110     1112235788999999984    3457889999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||||++ |..||........+...  +..  ....+.+..++.++.+||.+||..+|.+||++.+|+..
T Consensus       331 l~e~l~~g~~P~~~~~~~~~~~~~--~~~--~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         331 LWEIFTLGGTPYPELPMNEQFYNA--IKR--GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCCCCCCCchHHHHHH--HHc--CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999998 89999654433332211  111  12233345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.2e-37  Score=314.23  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=201.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      -.++|.+.+.||+|+||.||+|.+...   ...||||.......      ....+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   77 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS------PSVREKFLQEAYIMRQFDHPHIVKLIGVIT   77 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC------HHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence            356799999999999999999987654   45789998754322      122356888999999999999999999886


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       + ..+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+  ++|+||||+|||++.+   +.+||+|
T Consensus        78 -~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~---~~~~l~d  150 (270)
T cd05056          78 -E-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP---DCVKLGD  150 (270)
T ss_pred             -C-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC---CCeEEcc
Confidence             3 45679999999999999997643 6899999999999999999999988  9999999999999986   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++........      ......+++.|+|||.+.    ...++.++|||||||++|+|++ |..||...........
T Consensus       151 ~g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~  220 (270)
T cd05056         151 FGLSRYLEDESYY------KASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR  220 (270)
T ss_pred             Cceeeecccccce------ecCCCCccccccChhhhc----cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999876543211      112234567899999873    4457899999999999999985 9999976655433322


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .   ..  ....+.+..++.++.+||.+||..+|.+|||+.+++..
T Consensus       221 ~---~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         221 I---EN--GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             H---Hc--CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1   11  11223445788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-37  Score=318.55  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=199.8

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      -.++|.+...||+|+||.||+|.+..     ++..||||++.....      ......+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~ei~~l~~l~h~~iv~~~~~   76 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDHPNIVKLLGV   76 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC------HHHHHHHHHHHHHHHhcCCCchheEEEE
Confidence            35679999999999999999998753     678999998764321      1223568889999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc----------------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH----------------------KTIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      +. +...+|+||||+++++|..++...                      ..+++..++.++.||+.||.|||+.+  |+|
T Consensus        77 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H  153 (288)
T cd05050          77 CA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVH  153 (288)
T ss_pred             Ec-CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence            87 566788999999999999998643                      24788899999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.++|+|||++..+......     ........++.|+|||.+.    ...++.++|||||||+
T Consensus       154 ~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~i  221 (288)
T cd05050         154 RDLATRNCLVGEN---MVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIF----YNRYTTESDVWAYGVV  221 (288)
T ss_pred             ccccHhheEecCC---CceEECccccceecccCccc-----cccCCCccChhhcCHHHHh----cCCCCchhHHHHHHHH
Confidence            9999999999876   68999999999765433211     1112224567899999874    4458899999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +|+|++ |..||.......... .  +....  .++....++.++.+||.+||..||.+|||+.++++
T Consensus       222 l~el~~~~~~p~~~~~~~~~~~-~--~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         222 LWEIFSYGMQPYYGMAHEEVIY-Y--VRDGN--VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHH-H--HhcCC--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999997 888986554433221 1  11111  12223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.1e-37  Score=312.19  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             EecccCceEEEEEEEcC-CC--eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLK-EQ--RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~-~~--~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      +||+|+||.||+|.+.. .+  ..||||++......      ...+.+.+|+.++++++|||||++++++. + ..+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~~~~v   73 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------DIMDDFLKEAAIMHSLDHENLIRLYGVVL-T-HPLMMV   73 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH------HHHHHHHHHHHHHhhcCCCCccceeEEEc-C-CeEEEE
Confidence            58999999999998765 33  36999987644321      44567889999999999999999999987 4 788999


Q ss_pred             EeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         371 LEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      |||+++++|..++....  .+++..++.++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||+++.+.
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~  148 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD---DKVKIGDFGLMRALP  148 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC---CEEEecccccccccc
Confidence            99999999999997654  6899999999999999999999988  9999999999999987   689999999998775


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      .....    ........++..|+|||++.    ...++.++|||||||++|+|++ |..||.......... ....   .
T Consensus       149 ~~~~~----~~~~~~~~~~~~y~~pE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~---~  216 (257)
T cd05040         149 QNEDH----YVMEEHLKVPFAWCAPESLR----TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK-KIDK---E  216 (257)
T ss_pred             ccccc----eecccCCCCCceecCHHHhc----ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHh---c
Confidence            42211    11122346788999999883    4558889999999999999998 999997655443222 1111   1


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...+.....++..+.+||.+||..+|.+||++.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            1222333467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0696|consensus

Probab=100.00  E-value=1.3e-38  Score=325.85  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=217.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-..+|..+.+||+|+||.|.+|..+.+.+.||||++..+.....+.    ++-.+.|-++|... +-|.+|+|+.+|+ 
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD----vectm~EKrvLAL~~kppFL~qlHScFQ-  420 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD----VECTMVEKRVLALPGKPPFLVQLHSCFQ-  420 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc----ccceehhhhheecCCCCchHHHHHHHhh-
Confidence            33457889999999999999999999999999999987665443332    22345577777766 4678999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .-+.+|+||||+.||+|...+++.+++.|..+..++.+|+.||-|||+.+  ||.||||.+|||||.+   |+|||+|||
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e---GHiKi~DFG  495 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE---GHIKIADFG  495 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC---CceEeeecc
Confidence            66788999999999999999999999999999999999999999999988  9999999999999988   799999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.---+       ...+.+.||||.|+|||++.    ..+|+..+|+||+||+|||||.|++||++.+..+.+..+  
T Consensus       496 mcKEni~~-------~~TTkTFCGTPdYiAPEIi~----YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--  562 (683)
T KOG0696|consen  496 MCKENIFD-------GVTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--  562 (683)
T ss_pred             cccccccC-------CcceeeecCCCcccccceEE----ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--
Confidence            99753221       13467789999999999995    456999999999999999999999999988776554322  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~~~  570 (627)
                        ....+.+  +..+|.|+.++...+|.+.|.+|.-+     .+|-.||||..
T Consensus       563 --~ehnvsy--PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  563 --MEHNVSY--PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             --HHccCcC--cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence              1223333  45799999999999999999999843     67889999863

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.5e-37  Score=314.17  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=188.7

Q ss_pred             EecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         294 LLGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      .||+|+||.||+|...  .+...+|+|.+......      .....+.+|+.+++.++||||+++++++. +...+++||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   74 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV------QEQMKFLEEAQPYRSLQHSNLLQCLGQCT-EVTPYLLVM   74 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh------HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCCcEEEE
Confidence            5899999999999754  35577999987544321      11246788999999999999999999987 556788999


Q ss_pred             eecCCCChHHHHHhc-----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         372 EYCDGHDLDFYLKQH-----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       372 E~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ||+++++|.+++...     ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+   +.+||+|||+++.
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~---~~~kL~dfg~~~~  149 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD---LTVKIGDYGLSHN  149 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC---CcEEECCcccccc
Confidence            999999999998643     24567788899999999999999988  9999999999999986   6899999999975


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCC---CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN---PPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      .......     .......+++.|+|||++.....   ...++.++|||||||++|+|++ |..||............  
T Consensus       150 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--  222 (269)
T cd05087         150 KYKEDYY-----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--  222 (269)
T ss_pred             ccCccee-----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH--
Confidence            4432211     01122467889999998842211   1246789999999999999996 99999765544332211  


Q ss_pred             HhhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       .......++.   ....++.+.+++.+|+ .+|.+|||+.+|+.
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         223 -VREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -hhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             1111111111   1246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.6e-37  Score=311.15  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=201.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +++..++|.+.++||+|+||.||++.+ ..+..||||.+.....        ....+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM--------SVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChh--------HHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            356788999999999999999999975 4556799998753211        1346788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                       + ..+++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+  ++|+||||+||+++.+   +.+||+
T Consensus        72 -~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~---~~~~l~  144 (260)
T cd05073          72 -K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS---LVCKIA  144 (260)
T ss_pred             -C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC---CcEEEC
Confidence             3 6678999999999999998753  46788999999999999999999988  9999999999999886   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||++..+......      ......++..|+|||++.    ...++.++|||||||++|+|++ |..||..........
T Consensus       145 d~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~  214 (260)
T cd05073         145 DFGLARVIEDNEYT------AREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR  214 (260)
T ss_pred             CCcceeeccCCCcc------cccCCcccccccCHhHhc----cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999866432211      112234667899999984    4458889999999999999998 999997654433221


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   +..  ....+....++.++.+|+.+||..+|++||++.+++.
T Consensus       215 ~---~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         215 A---LER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             H---HhC--CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            1   111  1222334568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.7e-37  Score=309.60  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=198.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      .+|++.+.||.|+||.||++.+. .+..+|||++......        ...+.+|+++++.++||||+++++++. +...
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   73 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--------EEDFIEEAQVMMKLSHPKLVQLYGVCT-ERSP   73 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--------HHHHHHHHHHHHhCCCCCeeeEEEEEc-cCCc
Confidence            47899999999999999999875 4678999987533221        124778999999999999999999987 5667


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+.+++|.+++... ..+++..++.++.|++.+|.|||+.+  |+|+||||+||+++.+   +.++|+|||++.
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~---~~~~l~d~g~~~  148 (256)
T cd05112          74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN---QVVKVSDFGMTR  148 (256)
T ss_pred             eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC---CeEEECCCccee
Confidence            88999999999999998764 56899999999999999999999988  9999999999999876   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .........      .....++..|+|||++.    ...++.++|||||||++|+|++ |..||........+ ...  .
T Consensus       149 ~~~~~~~~~------~~~~~~~~~~~aPe~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~--~  215 (256)
T cd05112         149 FVLDDQYTS------STGTKFPVKWSSPEVFS----FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-ETI--N  215 (256)
T ss_pred             ecccCcccc------cCCCccchhhcCHhHhc----cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-HHH--h
Confidence            664332110      11123567899999884    3458889999999999999998 99999755443222 111  1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .  ..........+.++.+|+.+||..+|.+||++.+++++
T Consensus       216 ~--~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         216 A--GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             C--CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            1  11222233468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.9e-37  Score=308.07  Aligned_cols=244  Identities=26%  Similarity=0.431  Sum_probs=193.8

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      +||.|+||.||+|.+ .++..||+|++.....      ......+.+|+++++.++||||+++++++. +...+++||||
T Consensus         2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~   73 (250)
T cd05085           2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP------QELKIKFLSEARILKQYDHPNIVKLIGVCT-QRQPIYIVMEL   73 (250)
T ss_pred             ccCCCCCceEEEEEe-cCCcEEEEEecCCcCC------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-cCCccEEEEEC
Confidence            599999999999985 5688999998754321      112346788999999999999999999987 55678899999


Q ss_pred             cCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         374 CDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       374 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      +++++|..++... ..+++..+..++.|++.+|.|||+.+  ++|+||||+|||++.+   +.+||+|||++........
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN---NVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC---CeEEECCCccceecccccc
Confidence            9999999988653 46899999999999999999999988  9999999999999876   5899999999976543221


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                      .      ......+++.|+|||++.    ...++.++|||||||++|+|++ |..||...........   +....  ..
T Consensus       149 ~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~---~~~~~--~~  213 (250)
T cd05085         149 S------SSGLKQIPIKWTAPEALN----YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ---VEKGY--RM  213 (250)
T ss_pred             c------cCCCCCCcccccCHHHhc----cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HHcCC--CC
Confidence            1      111224567899999984    4457889999999999999998 9999976544432211   11111  22


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .....++..+.+||.+||..+|.+||++.++++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            2334688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0669|consensus

Probab=100.00  E-value=1e-39  Score=316.38  Aligned_cols=270  Identities=26%  Similarity=0.423  Sum_probs=214.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-  362 (627)
                      ...+.|.-+.+||+|.||+||+|+..++++.||+|++-.     +.+++-+-...++|+.||..|.|+|++.++++|.. 
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlm-----eneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLM-----ENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHH-----hccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            345678888899999999999999999999999987532     22333344568899999999999999999988742 


Q ss_pred             ------cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         363 ------DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       363 ------~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                            +...+|+||.+|+ .+|.-+|... .+|+..++..++.+++.||.|+|+.+  |+|||+|++|+||+.+   |.
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d---gi  162 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD---GI  162 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC---ce
Confidence                  2345899999998 5788887655 68999999999999999999999999  9999999999999997   69


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++.+......  .... .+..+-|.||++||.+++   ...|+++.|||..||||.||+++.+.|.++..+.
T Consensus       163 lklADFGlar~fs~~~n~--~kpr-ytnrvvTLwYrppEllLG---~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq  236 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNV--VKPR-YTNRVVTLWYRPPELLLG---DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ  236 (376)
T ss_pred             EEeeccccccceeccccc--CCCC-cccceeeeecCCHHHhhc---ccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence            999999999876543211  1112 223467999999999974   4469999999999999999999999999988887


Q ss_pred             HHHHHHHHhhhhcc-ccCCC----------------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         516 TILEENTILKATEV-QFANK----------------------------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       516 ~~~~~~~~~~~~~~-~~~~~----------------------------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      .+.....+...... .||.-                            -.-.+++.||+..+|.+||.+|++++++++|.
T Consensus       237 ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  237 QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            76554443322110 01100                            01245788999999999999999999999999


Q ss_pred             CCCC
Q psy4988         567 YLQP  570 (627)
Q Consensus       567 ~~~~  570 (627)
                      ||..
T Consensus       317 ~F~k  320 (376)
T KOG0669|consen  317 FFWK  320 (376)
T ss_pred             hhhc
Confidence            9963

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.4e-37  Score=313.82  Aligned_cols=241  Identities=20%  Similarity=0.304  Sum_probs=186.7

Q ss_pred             EecccCceEEEEEEEcC------------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         294 LLGKGGFSEVHKAFDLK------------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~------------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .||+|+||.||+|....            ....|+||++....       ......+.+|+.+++.++|||||++++++.
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~   74 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-------RDISLAFFETASMMRQVSHKHIVLLYGVCV   74 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            58999999999997432            23358888764321       122346788999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc----ccce
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV----CGEI  436 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~----~g~v  436 (627)
                       +....++||||+++++|..++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+..    ...+
T Consensus        75 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          75 -RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             -cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCcee
Confidence             556678999999999999988753 57999999999999999999999988  999999999999986431    1138


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~  515 (627)
                      +|+|||++..+...           ....++..|+|||++.   ....++.++|||||||+||+|+ .|..||.......
T Consensus       152 ~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         152 KLSDPGIPITVLSR-----------QECVERIPWIAPECVE---DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             EeCCCCCCccccCc-----------ccccccccccChhhhc---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence            99999998765321           1236788999999874   2345888999999999999998 5888886543221


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .    ....   ...+......+.++.+||.+||..||.+||++.+|+++
T Consensus       218 ~----~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         218 K----ERFY---EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             H----HHHH---hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            1    1111   11122223456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.3e-37  Score=315.58  Aligned_cols=241  Identities=20%  Similarity=0.271  Sum_probs=186.8

Q ss_pred             EecccCceEEEEEEEcCC------------------------CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC
Q psy4988         294 LLGKGGFSEVHKAFDLKE------------------------QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD  349 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~------------------------~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~  349 (627)
                      .||+|+||.||+|....+                        ...||||++...       .......+.+|+.+++.++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-------~~~~~~~~~~~~~~~~~l~   74 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-------HRDIALAFFETASLMSQVS   74 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-------HHHHHHHHHHHHHHHhcCC
Confidence            499999999999975322                        245888886422       1123356788999999999


Q ss_pred             CCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       350 HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                      ||||+++++++. +....++||||+++++|..++.. .+.+++..+..++.||+.||.|||+.+  |+||||||+|||++
T Consensus        75 h~niv~~~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~  151 (274)
T cd05076          75 HIHLAFVHGVCV-RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLA  151 (274)
T ss_pred             CCCeeeEEEEEE-eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEe
Confidence            999999999987 55677899999999999999865 467999999999999999999999988  99999999999998


Q ss_pred             CCCc----ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-h
Q psy4988         429 EGNV----CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-Y  503 (627)
Q Consensus       429 ~~~~----~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-t  503 (627)
                      ....    ...+||+|||++......           ....++..|+|||++.   ....++.++|||||||++|||+ +
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~---~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVP---GGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             ccCcccCccceeeecCCccccccccc-----------cccccCCcccCchhhc---CCCCCCcHHHHHHHHHHHHHHHhC
Confidence            6421    235899999998654321           1225788899999884   2345789999999999999985 7


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       504 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |..||..........    ... ....  .....+.++.+||.+||+.+|.+|||+.+++++
T Consensus       218 g~~p~~~~~~~~~~~----~~~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         218 GEVPLKERTPSEKER----FYE-KKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCCCccccChHHHHH----HHH-hccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            999997654332211    111 1111  122356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.9e-37  Score=315.91  Aligned_cols=241  Identities=25%  Similarity=0.358  Sum_probs=188.0

Q ss_pred             EecccCceEEEEEEEcCCCeE-------EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRY-------VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~-------VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      .||.|+||.||+|.+...+..       ||+|++...       .......+.+|+.+++.++|||||++++++. ....
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~   73 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-------HRNYSESFFEAASMMSQLSHKHLVLNYGVCV-CGDE   73 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch-------hHHHHHHHHHHHHHHHhCCCCChhheeeEEE-eCCC
Confidence            599999999999988665444       888876322       1223456788999999999999999999997 4456


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-----ccceEEee
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-----CGEIKITD  440 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-----~g~vKL~D  440 (627)
                      .++||||+++++|..++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+..     .+.++|+|
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecc
Confidence            77999999999999999764 46899999999999999999999988  999999999999987632     12479999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK-KPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~-~Pf~~~~~~~~~~~  519 (627)
                      ||++..+...           ....+++.|+|||++.   ....++.++|||||||++|+|++|. .||.......... 
T Consensus       152 ~g~~~~~~~~-----------~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-  216 (258)
T cd05078         152 PGISITVLPK-----------EILLERIPWVPPECIE---NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-  216 (258)
T ss_pred             cccccccCCc-----------hhccccCCccCchhcc---CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-
Confidence            9998754321           2236888999999985   2235788999999999999999984 6665443322211 


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         ... ...  ..+...+.++.+||.+||+.||.+|||+.++++.
T Consensus       217 ---~~~-~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         217 ---FYE-DRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ---HHH-ccc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence               111 111  2223466899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0194|consensus

Probab=100.00  E-value=1e-37  Score=336.71  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=206.5

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCe---E-EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQR---Y-VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~-VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .|++..++-.+.++||+|+||+||+|.....+.   . ||||.......    .....+..+++|.++++.++|||||+|
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~----~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE----LTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc----ccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            344555666677899999999999998766422   3 89998764221    223446789999999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ||+.. +...++||||+|.||+|.++|+..+ .++..+...++.+.+.||+|||+++  +|||||-.+|+|++.+   +.
T Consensus       227 yGVa~-~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~---~~  300 (474)
T KOG0194|consen  227 YGVAV-LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK---GV  300 (474)
T ss_pred             EEEEc-CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC---Ce
Confidence            99887 6677889999999999999999887 5999999999999999999999998  9999999999999987   36


Q ss_pred             eEEeecccccccccCCCCCCCCccccc-cCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTS-QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQS  513 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~-~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~  513 (627)
                      +||+|||+++.-..  +.      ... ..--...|+|||.+.    ...|+.++|||||||++||+++ |..||.+...
T Consensus       301 vKISDFGLs~~~~~--~~------~~~~~~klPirWLAPEtl~----~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~  368 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQ--YV------MKKFLKKLPIRWLAPETLN----TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN  368 (474)
T ss_pred             EEeCccccccCCcc--ee------eccccccCcceecChhhhc----cCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence            89999999876431  11      111 112467899999995    4479999999999999999997 8889987766


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ......    +.......+.+...+.++..++.+|+..||++||++.++.+
T Consensus       369 ~~v~~k----I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  369 YEVKAK----IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHH----HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            543221    11222333444577889999999999999999999999875

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.1e-37  Score=310.51  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=191.0

Q ss_pred             EecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .||+|+||.||+|.+..   ....||||.+.....      ......+.+|+.+++.++||||+++++++.......++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   75 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV   75 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCC------HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence            58999999999998654   346799998643221      122456788999999999999999999876556667899


Q ss_pred             EeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         371 LEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      |||+.+++|..++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~---~~~kl~dfg~~~~~~~  150 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES---FTVKVADFGLARDIYD  150 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC---CcEEECCccccccccC
Confidence            9999999999998764 45678888999999999999999988  9999999999999886   5899999999986643


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhhhhc
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG-KKPFGHNQSQATILEENTILKATE  528 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~  528 (627)
                      .....   ........++..|+|||++.    ...++.++|||||||++|||++| .+||....... +...  +.... 
T Consensus       151 ~~~~~---~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~--~~~~~-  219 (262)
T cd05058         151 KEYYS---VHNHTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-ITVY--LLQGR-  219 (262)
T ss_pred             Cccee---ecccccCcCCccccChhHhc----cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH--HhcCC-
Confidence            32110   11112335678899999884    34588899999999999999995 66675443322 2211  11111 


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       ..+....++..+.+||.+||..+|++||++.+++..
T Consensus       220 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         220 -RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             122233568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=312.10  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=201.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .++|++.+.||+|+||.||+|.+..++.    .||+|++.....      ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------PKANKEILDEAYVMASVDHPHVVRLLGICL   79 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4679999999999999999999877655    589998754432      223456888999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .  ..+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        80 ~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~---~~~kL~d  152 (279)
T cd05057          80 S--SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP---QHVKITD  152 (279)
T ss_pred             c--CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC---CeEEECC
Confidence            3  6788999999999999998764 57999999999999999999999988  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+......     .......++..|+|||.+.    ...++.++|||||||++|+|++ |..||......... .
T Consensus       153 fg~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~  222 (279)
T cd05057         153 FGLAKLLDVDEKE-----YHAEGGKVPIKWMALESIL----HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-D  222 (279)
T ss_pred             CcccccccCcccc-----eecCCCcccccccCHHHhh----cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-H
Confidence            9999876532210     0011123467899999873    3457889999999999999998 99999765543322 1


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .  +..  ...++.....+.++.++|.+||..||.+||++.++++
T Consensus       223 ~--~~~--~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         223 L--LEK--GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             H--HhC--CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1  111  1223344457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=312.36  Aligned_cols=242  Identities=22%  Similarity=0.343  Sum_probs=189.0

Q ss_pred             EecccCceEEEEEEEcCCCe--EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQR--YVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~--~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .||+|+||.||+|.+..++.  .+++|.+.....      ......+.+|+.++.++ +||||++++++|. ....+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv   74 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLA   74 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC------HHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-cCCCceEE
Confidence            58999999999999888775  457777642211      12234678899999999 7999999999997 55668899


Q ss_pred             EeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         371 LEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      |||+++++|.+++....                .+++..++.++.|++.||+|||+.+  |+||||||+|||++.+   +
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~---~  149 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN---Y  149 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC---C
Confidence            99999999999987543                4789999999999999999999988  9999999999999987   5


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQS  513 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~  513 (627)
                      .+||+|||++.......        .......+..|+|||++.    ...++.++|||||||+||+|++ |..||.....
T Consensus       150 ~~kl~dfgl~~~~~~~~--------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~  217 (270)
T cd05047         150 VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  217 (270)
T ss_pred             eEEECCCCCccccchhh--------hccCCCCccccCChHHHc----cCCCCchhhHHHHHHHHHHHHcCCCCCccccCH
Confidence            89999999986332110        011123466799999883    4458889999999999999996 9999965543


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .... ..  +..  .........++.++.+||.+||..||.+||++.+++.
T Consensus       218 ~~~~-~~--~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         218 AELY-EK--LPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHH-HH--HhC--CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3222 11  111  1122233457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-36  Score=307.91  Aligned_cols=248  Identities=30%  Similarity=0.461  Sum_probs=200.2

Q ss_pred             eEEEEecccCceEEEEEEEcCCC----eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         290 LLLMLLGKGGFSEVHKAFDLKEQ----RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~~~~----~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ++.+.||.|+||.||++.+...+    ..||+|++......      .....+..|+.+++.++|+||+++++++. +.+
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~   74 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE------QQIEEFLREARIMRKLDHPNIVKLLGVCT-EEE   74 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh------HHHHHHHHHHHHHHhcCCCchheEEEEEc-CCC
Confidence            46788999999999999988766    99999998544321      13457888999999999999999999987 457


Q ss_pred             eEEEEEeecCCCChHHHHHhccC--cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+++||||+++++|.+++.....  +++..+..++.||+.||.|||+.+  |+|+||||+||+++.+   +.++|+|||+
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~---~~~~l~dfg~  149 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN---LVVKISDFGL  149 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC---CeEEEcccCC
Confidence            78899999999999999976554  999999999999999999999988  9999999999999987   5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++.........      .....+++.|+|||.+.    ...++.++|||||||++|+|++ |..||......... ... 
T Consensus       150 ~~~~~~~~~~~------~~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-~~~-  217 (258)
T smart00219      150 SRDLYDDDYYK------KKGGKLPIRWMAPESLK----DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-EYL-  217 (258)
T ss_pred             ceecccccccc------cccCCCcccccChHHhc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH-
Confidence            98776442211      11224788999999883    4457889999999999999998 88998764433222 111 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       ....  .......++.++.++|.+||..||.+|||+.+++.
T Consensus       218 -~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      218 -KKGY--RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -hcCC--CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence             1111  12233458899999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-37  Score=310.44  Aligned_cols=229  Identities=24%  Similarity=0.297  Sum_probs=187.2

Q ss_pred             cCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCC
Q psy4988         298 GGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH  377 (627)
Q Consensus       298 G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg  377 (627)
                      |.||.||++.+..+++.||+|.+.....            +.+|...+....||||+++++++. +.+.+|+||||++++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------------~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------------YSRERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------------hhhHHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCC
Confidence            8999999999999999999999854321            223444455667999999999987 667889999999999


Q ss_pred             ChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCC
Q psy4988         378 DLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG  457 (627)
Q Consensus       378 ~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~  457 (627)
                      +|.+++.....+++..+..++.|++.||.|||+.+  |+||||||+|||++.+   +.++|+|||++..+....      
T Consensus        71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~~------  139 (237)
T cd05576          71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDSC------  139 (237)
T ss_pred             CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC---CCEEEecccchhcccccc------
Confidence            99999988788999999999999999999999988  9999999999999987   589999999887654321      


Q ss_pred             ccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCC
Q psy4988         458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTV  537 (627)
Q Consensus       458 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~v  537 (627)
                          ....++..|+|||++.    ...++.++||||+||++|+|++|..||......        .....  .+..+..+
T Consensus       140 ----~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~~--~~~~~~~~  201 (237)
T cd05576         140 ----DGEAVENMYCAPEVGG----ISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTHT--TLNIPEWV  201 (237)
T ss_pred             ----ccCCcCccccCCcccC----CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccccc--ccCCcccC
Confidence                1225677899999873    445788999999999999999999988532211        00011  11223457


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCC
Q psy4988         538 SNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYL  568 (627)
Q Consensus       538 s~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~  568 (627)
                      ++.+++||.+||+.||.+||++     .++++||||
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            8999999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614|consensus

Probab=100.00  E-value=2e-38  Score=331.77  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=219.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      .++.++..||-|+||.|=++........+|+|++.+......    ....++..|-+||..++.|.||+||..|. +..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt----kQqeHv~sEr~Im~~~~s~fIvrLYrTfr-d~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT----KQQEHVFSERNIMMECRSDFIVRLYRTFR-DSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch----hHHHHHHhHHHHHHhcCchHHHHHHHHhc-cchh
Confidence            445677789999999999997666666699998865443322    22457888999999999999999999998 7788


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|++||-|=||.|...+...+.|.+..++.|+..++.|++|||+++  ||+|||||+|+|||.+   |-+||.|||+|+.
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~---Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR---GYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC---CceEEeehhhHHH
Confidence            8999999999999999999999999999999999999999999998  9999999999999988   7899999999999


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +...        ..+.+.||||.|.|||+++    ....+.++|.||||+++||||+|.+||...+....+   +.+++.
T Consensus       570 i~~g--------~KTwTFcGTpEYVAPEIIL----nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY---n~ILkG  634 (732)
T KOG0614|consen  570 IGSG--------RKTWTFCGTPEYVAPEIIL----NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY---NLILKG  634 (732)
T ss_pred             hccC--------CceeeecCCcccccchhhh----ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHhh
Confidence            8754        3467889999999999996    334688999999999999999999999887765554   233333


Q ss_pred             -hccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCC
Q psy4988         527 -TEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQP  570 (627)
Q Consensus       527 -~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~  570 (627)
                       ..+.||  ..++..+.+||++++..+|.+|.-     +.+|-+|.||..
T Consensus       635 id~i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  635 IDKIEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             hhhhhcc--cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence             334555  578999999999999999999985     899999999974

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-36  Score=312.52  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=201.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEc----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDL----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..|.+.+.||+|+||.||+|...    .++..||||++......      .....+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~   77 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------QHRSDFEREIEILRTLDHENIVKYKGVCEK   77 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence            46788899999999999999854    34889999998644321      234578899999999999999999998863


Q ss_pred             -cCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         363 -DANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       363 -~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       ....+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.++|+|
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~---~~~~l~d  152 (284)
T cd05038          78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE---DLVKISD  152 (284)
T ss_pred             CCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC---CCEEEcc
Confidence             2456889999999999999997654 6999999999999999999999988  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH---
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI---  517 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~---  517 (627)
                      ||++.........    ........++..|+|||++.    ...++.++|||||||++|+|++|..||.........   
T Consensus       153 fg~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~  224 (284)
T cd05038         153 FGLAKVLPEDKDY----YYVKEPGESPIFWYAPECLR----TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG  224 (284)
T ss_pred             cccccccccCCcc----eeccCCCCCcccccCcHHHc----cCCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence            9999877532110    01112234566799999884    345788999999999999999999998644322100   


Q ss_pred             -------HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 -------LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 -------~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                             .............++....++.++.+|+.+||..+|.+|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         225 IAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                   00000011112233444567789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1290|consensus

Probab=100.00  E-value=1.2e-36  Score=318.18  Aligned_cols=155  Identities=29%  Similarity=0.411  Sum_probs=129.2

Q ss_pred             HHHHHhhhcccccccCCCCccC-CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH
Q psy4988         265 IRELKRIHNEDQSRFNNHPVLS-DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN  343 (627)
Q Consensus       265 ~~el~~~~~~~~~~~~~~~~l~-~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~  343 (627)
                      -+..+.+....+.++..+++|. .||.+.++||.|-|++||+|+|..+.++||+||.....        .|.+..+.||.
T Consensus        55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--------hYtEaAlDEIk  126 (590)
T KOG1290|consen   55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--------HYTEAALDEIK  126 (590)
T ss_pred             ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--------HHHHHHHHHHH
Confidence            3445667777788888888999 99999999999999999999999999999999986433        34556888999


Q ss_pred             HHhcCC-----C---CceeEEeeEEee---cCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhC
Q psy4988         344 IHKALD-----H---PRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEI  411 (627)
Q Consensus       344 il~~l~-----H---pnIV~l~~~~~~---~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~  411 (627)
                      +|++++     |   ..||+|+|.|..   ++.++|||+|++....|..++. .++.++...++.|++||+.||.|||..
T Consensus       127 lL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e  206 (590)
T KOG1290|consen  127 LLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE  206 (590)
T ss_pred             HHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence            999882     3   379999999965   4568999999997554444443 346899999999999999999999984


Q ss_pred             CCCEEeccccCCcEEec
Q psy4988         412 KPPVIHYDLKPGNILLT  428 (627)
Q Consensus       412 ~~~IvHrDLKP~NILl~  428 (627)
                       ++|||.||||+||||.
T Consensus       207 -cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  207 -CGIIHTDLKPENVLLC  222 (590)
T ss_pred             -cCccccCCCcceeeee
Confidence             5699999999999993

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=305.17  Aligned_cols=244  Identities=25%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      +||.|+||.||+|.+.. ++.||+|++......      .....+.+|+++++.++||||+++++++. +...+++||||
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~   73 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP------DLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVMEL   73 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCH------HHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEEc
Confidence            59999999999999877 999999987644321      23456889999999999999999999987 56778899999


Q ss_pred             cCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCC
Q psy4988         374 CDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       374 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      +.+++|..++.. ...+++..+..++.+++.+|.|||+.+  |+||||||+|||++.+   +.+||+|||++.......+
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC---CcEEEeeccccccccCCcc
Confidence            999999999865 357899999999999999999999988  9999999999999887   5899999999986543221


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcccc
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQF  531 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  531 (627)
                      ...     .....++..|+|||.+.    ...++.++|||||||++|+|++ |..||..........   .+..  ....
T Consensus       149 ~~~-----~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~~~~--~~~~  214 (251)
T cd05041         149 TVS-----DGLKQIPIKWTAPEALN----YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---RIES--GYRM  214 (251)
T ss_pred             eec-----cccCcceeccCChHhhc----cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---HHhc--CCCC
Confidence            100     11123466799999884    3458899999999999999998 899996554332211   1111  1122


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       532 ~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +.+..++.++.+||.+||..+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            334567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-36  Score=308.14  Aligned_cols=239  Identities=23%  Similarity=0.316  Sum_probs=188.1

Q ss_pred             EecccCceEEEEEEEcCCC----------eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         294 LLGKGGFSEVHKAFDLKEQ----------RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~----------~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .||+|+||.||+|.+..++          ..|++|++.....        ....+.+|+.+++.++||||+++++++.. 
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   72 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--------DSLAFFETASLMSQLSHKHLVKLYGVCVR-   72 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--------hHHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence            5999999999999998776          3578887643221        13568889999999999999999999874 


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC----cccceEE
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN----VCGEIKI  438 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~----~~g~vKL  438 (627)
                       ...++||||+++++|..++.... .+++..+..++.||+.||.|||+.+  |+||||||+|||++.+.    ....+||
T Consensus        73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEe
Confidence             55789999999999999998766 7999999999999999999999988  99999999999998763    1126999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||++..+...           ....++..|+|||++...  ...++.++|||||||++|+|++ |..||.........
T Consensus       150 ~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~  216 (259)
T cd05037         150 SDPGIPITVLSR-----------EERVERIPWIAPECIRNG--QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE  216 (259)
T ss_pred             CCCCcccccccc-----------cccccCCCccChhhhcCC--CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH
Confidence            999999865431           123567889999998422  1368899999999999999999 68888655422211


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      . .  ..  .....+  ......+.+||.+||..+|.+|||+.++++
T Consensus       217 ~-~--~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         217 R-F--YQ--DQHRLP--MPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             H-H--Hh--cCCCCC--CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1 1  11  111111  123378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-36  Score=316.50  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=198.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .++|++.+.||+|+||.||+|.+..++.    .||+|++.....      ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG------PKANVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            3568889999999999999999887776    468887643221      122345788999999999999999999886


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       . ...++|+||+++++|.+++.... .+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        80 -~-~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~---~~~kL~D  152 (303)
T cd05110          80 -S-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP---NHVKITD  152 (303)
T ss_pred             -C-CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC---CceEEcc
Confidence             3 34669999999999999987654 6899999999999999999999988  9999999999999876   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||+++.+......     .......++..|+|||++.    ...++.++|||||||++|+|++ |..||........ ..
T Consensus       153 fg~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~----~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~  222 (303)
T cd05110         153 FGLARLLEGDEKE-----YNADGGKMPIKWMALECIH----YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PD  222 (303)
T ss_pred             ccccccccCcccc-----cccCCCccccccCCHHHhc----cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence            9999876532211     1122235678899999883    4558899999999999999996 9999965543221 11


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         ... ....++..+..+..+.+||.+||..+|++||++.+++..
T Consensus       223 ---~~~-~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         223 ---LLE-KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ---HHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               111 122233445678899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-36  Score=306.88  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=194.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||++.  .+++.||||++....         ....+.+|+.+++.++||||+++++++..  +.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~   72 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---------TAQAFLEETAVMTKLHHKNLVRLLGVILH--NG   72 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CC
Confidence            569999999999999999985  578899999875321         12467889999999999999999999863  34


Q ss_pred             EEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +++||||+.+++|..++....  .+++..+..++.|++.||.|||+.+  ++||||||+|||++.+   +.+||+|||++
T Consensus        73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~---~~~kl~Dfg~~  147 (254)
T cd05083          73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED---GVAKVSDFGLA  147 (254)
T ss_pred             cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC---CcEEECCCccc
Confidence            689999999999999987543  5899999999999999999999988  9999999999999886   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~  523 (627)
                      .......          .....+..|+|||++.    ...++.++|||||||++|+|++ |+.||...........   +
T Consensus       148 ~~~~~~~----------~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~  210 (254)
T cd05083         148 RVGSMGV----------DNSKLPVKWTAPEALK----HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---V  210 (254)
T ss_pred             eeccccC----------CCCCCCceecCHHHhc----cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H
Confidence            7643211          1123457899999884    3458889999999999999997 9999976554332211   1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..  .........++.++.+||.+||..+|.+||++.+++.
T Consensus       211 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         211 EK--GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             hC--CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11  1222234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0670|consensus

Probab=100.00  E-value=2.7e-38  Score=331.48  Aligned_cols=269  Identities=27%  Similarity=0.392  Sum_probs=217.3

Q ss_pred             cccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-----
Q psy4988         275 DQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-----  349 (627)
Q Consensus       275 ~~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----  349 (627)
                      .++++..++++.++|.+....|+|-|++|..|.|..-+..||||||..+.        .+.+.-++|++||++|+     
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--------~M~KtGl~EleiLkKL~~AD~E  491 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--------VMHKTGLKELEILKKLNDADPE  491 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--------HHhhhhhHHHHHHHHhhccCch
Confidence            36667777889999999999999999999999999999999999997543        33456788999999994     


Q ss_pred             -CCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         350 -HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       350 -HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                       --|+|.|+-.|. ..+++|||+|-+. .+|..+|+..+   .|....++.|+.|++.||..|-.++  |+|.||||+||
T Consensus       492 dk~Hclrl~r~F~-hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNi  567 (752)
T KOG0670|consen  492 DKFHCLRLFRHFK-HKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNI  567 (752)
T ss_pred             hhhHHHHHHHHhh-hcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccce
Confidence             347899999887 7899999999886 68888888764   6889999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK  505 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~  505 (627)
                      |+++..  ..+||||||.|.++.+....         .+.-+..|.|||+++    +..|++..|+||+||+||||.||+
T Consensus       568 LVNE~k--~iLKLCDfGSA~~~~eneit---------PYLVSRFYRaPEIiL----G~~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  568 LVNESK--NILKLCDFGSASFASENEIT---------PYLVSRFYRAPEIIL----GLPYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             EeccCc--ceeeeccCcccccccccccc---------HHHHHHhccCcceee----cCcccCCccceeeceeeEEeeccc
Confidence            999876  58999999999888765432         224567899999996    567999999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhhhh-----------------cccc---------------------C---------C-----
Q psy4988         506 KPFGHNQSQATILEENTILKAT-----------------EVQF---------------------A---------N-----  533 (627)
Q Consensus       506 ~Pf~~~~~~~~~~~~~~~~~~~-----------------~~~~---------------------~---------~-----  533 (627)
                      ..|.+......+--...+....                 .+.|                     |         .     
T Consensus       633 IlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~  712 (752)
T KOG0670|consen  633 ILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLP  712 (752)
T ss_pred             eecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCC
Confidence            9998776655432111100000                 0000                     0         0     


Q ss_pred             --CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         534 --KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       534 --~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                        .+.+-..+.+||.+||..||++|.|+.++|.||||+.
T Consensus       713 deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  713 DEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             chhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence              0112235889999999999999999999999999974

>KOG0668|consensus

Probab=100.00  E-value=3.2e-38  Score=302.27  Aligned_cols=260  Identities=23%  Similarity=0.466  Sum_probs=210.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee-c
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI-D  363 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~-~  363 (627)
                      .++|++.+++|+|-|++||.|.+..+++.++||++..-+          .+.+.+|+.||..|. |||||+|+++... .
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            478999999999999999999999999999999985322          246889999999997 9999999998763 2


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .....||+||+.+.+...+   ...|+..+++.++.+++.||.|||++|  |+|||+||.|++||...  ..++|+|+||
T Consensus       107 SktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~--rkLrlIDWGL  179 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHEL--RKLRLIDWGL  179 (338)
T ss_pred             ccCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhh--ceeeeeecch
Confidence            3457899999998766544   456899999999999999999999999  99999999999999875  5899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-ATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~  522 (627)
                      |.++....-        -...+.+..|.-||.++   .-..|+...|+|||||+|..|++.+.||.+..+. +.+.+...
T Consensus       180 AEFYHp~~e--------YnVRVASRyfKGPELLV---dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  180 AEFYHPGKE--------YNVRVASRYFKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             HhhcCCCce--------eeeeeehhhcCCchhee---echhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            998765421        12336788999999987   4567999999999999999999999998654433 33433333


Q ss_pred             Hhhhhc---------cc----c------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATE---------VQ----F------------------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~---------~~----~------------------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ++...+         +.    |                  ....-+++++.|||.++|.+|..+|+|+.|++.||||.+.
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            322111         00    0                  1112367999999999999999999999999999999865


Q ss_pred             CC
Q psy4988         572 VP  573 (627)
Q Consensus       572 ~~  573 (627)
                      ..
T Consensus       329 ~~  330 (338)
T KOG0668|consen  329 RE  330 (338)
T ss_pred             HH
Confidence            43

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-36  Score=310.25  Aligned_cols=248  Identities=24%  Similarity=0.402  Sum_probs=193.7

Q ss_pred             EecccCceEEEEEEEcCCC------eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQ------RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~------~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .||+|+||.||+|.+....      ..||||.+.....      ......+.+|+.+++.++||||+++++++. +...+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   74 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQ   74 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccc------hhhHHHHHHHHHHHHhcCCCCeeeEeeeec-CCCCe
Confidence            5999999999999876544      7899998643211      122446888999999999999999999987 55678


Q ss_pred             EEEEeecCCCChHHHHHhc-------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceEE
Q psy4988         368 CTVLEYCDGHDLDFYLKQH-------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKI  438 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vKL  438 (627)
                      ++||||+++++|..++...       ..+++..+..++.||+.||.|||+.+  |+|+||||+|||++.+.  ....++|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEE
Confidence            8999999999999998642       34788999999999999999999988  99999999999998763  1127999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+......     .......++..|+|||++.    ...++.++|||||||++|+|++ |..||.........
T Consensus       153 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~  223 (269)
T cd05044         153 GDFGLARDIYKSDYY-----RKEGEGLLPVRWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL  223 (269)
T ss_pred             CCccccccccccccc-----ccCcccCCCccccCHHHHc----cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence            999999866433211     1112235678899999984    3457899999999999999998 99999765443322


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...   .  ....+.....++..+.+||.+||..+|.+||++.++++
T Consensus       224 ~~~---~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         224 QHV---T--AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHH---h--cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            111   1  11223334568899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.5e-36  Score=307.70  Aligned_cols=252  Identities=18%  Similarity=0.282  Sum_probs=186.4

Q ss_pred             EecccCceEEEEEEEcCC--CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKE--QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~--~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      .||+|+||.||++.....  ...+++|.+.....      ......+.+|+.+++.++|||||+++++|. +...+|+||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS------SKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC------hHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEE
Confidence            599999999999975433  33456666543322      112457889999999999999999999987 567788999


Q ss_pred             eecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         372 EYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       372 E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      ||+++++|..++...    ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++...
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~---~~~~l~Dfg~~~~~  149 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD---LTVKVGDYGIGPSR  149 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC---ccEEeccccccccc
Confidence            999999999998753    34677788899999999999999988  9999999999999876   68999999998653


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCC---CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK---NPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ....+.     ......+++..|+|||++....   ....++.++|||||||++|+|++ |..||........+... ..
T Consensus       150 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~  223 (268)
T cd05086         150 YKEDYI-----ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-IK  223 (268)
T ss_pred             Ccchhh-----hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hh
Confidence            222110     1122346889999999874211   12346789999999999999996 57788655443333221 11


Q ss_pred             hhhhc-cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         524 LKATE-VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       524 ~~~~~-~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..... ........+++.+.++|..|| .+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         224 DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            11111 111122357889999999999 78999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-36  Score=307.90  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhh---HhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEee
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKE---DKKANYIKHALREYNIHKA-LDHPRVVKLYDVFEI  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~---~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~  362 (627)
                      .|.+.+.||+|+||.||++.+.. .++.||||.+........   ......+..+.+|+.++.+ ++||||++++++|. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            37788899999999999999887 688999998764321110   1223345667889998865 79999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +.+.+++||||+++++|.+++..    ...+++..++.++.|++.+|.|||+ .+  |+|+||||.|||++.+   +.+|
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~---~~~~  154 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED---DKVT  154 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC---CcEE
Confidence            56788899999999999888743    3579999999999999999999996 56  9999999999999887   5899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||++.......        ......|+..|+|||++.    ...++.++||||||+++|+|++|+.||.........
T Consensus       155 l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~----~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~  222 (269)
T cd08528         155 ITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVK----NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA  222 (269)
T ss_pred             Eecccceeeccccc--------ccccccCcccCcChhhhc----CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence            99999998754321        123347899999999984    345789999999999999999999999655433222


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..   +.. ..........++.++.+||.+||..||.+||++.++..+
T Consensus       223 ~~---~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         223 TK---IVE-AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HH---Hhh-ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            11   111 111111223578999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0587|consensus

Probab=100.00  E-value=1e-36  Score=337.04  Aligned_cols=267  Identities=25%  Similarity=0.440  Sum_probs=225.1

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDV  359 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~  359 (627)
                      ..+.-.+.|.|.+.||.|.+|.||++.++.+++.+||||+.......+        ++..|++|++.+ +|||++.+|++
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de--------EiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE--------EIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH--------HHHHHHHHHHhccCCCCcceEEEE
Confidence            345567889999999999999999999999999999999876554332        355688999877 69999999999


Q ss_pred             Eee----cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         360 FEI----DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       360 ~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      |..    .++.+|||||||.||+.-++++..  .++.|..+..|+..++.||.+||...  +||||||-.|||++.+   
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e---  159 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN---  159 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc---
Confidence            843    346799999999999999998754  58999999999999999999999988  9999999999999998   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ  512 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~  512 (627)
                      +.|||+|||++..++...       ....+.+|||.|||||++.... ....|+..+|+||||++..||--|.+|+.+..
T Consensus       160 ~~VKLvDFGvSaQldsT~-------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  160 AEVKLVDFGVSAQLDSTV-------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             CcEEEeeeeeeeeeeccc-------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            799999999998876532       3356679999999999986543 34468889999999999999999999998776


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ....+.   .+.....+.+..+...+.++.+||..||.+|.+.||++.++|.|||+..
T Consensus       233 PmraLF---~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  233 PMRALF---LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhhhhc---cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            654432   2334445555556678899999999999999999999999999999873

>KOG1006|consensus

Probab=100.00  E-value=1.1e-38  Score=311.44  Aligned_cols=256  Identities=29%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA-LDHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      -+..||.|+||+|++..++.+|+..|||.++.....++      .++++.|.+...+ -+.||||++|+++- ....+||
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke------q~rll~e~d~~mks~~cp~IVkfyGa~F-~EGdcWi  140 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE------QKRLLMEHDTVMKSSNCPNIVKFYGALF-SEGDCWI  140 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH------HHHHHHHHHHHHhhcCCcHHHHHhhhhh-cCCceee
Confidence            34569999999999999999999999999987765222      3567888876554 47999999999876 4455779


Q ss_pred             EEeecCCCChHHHHH-----hccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         370 VLEYCDGHDLDFYLK-----QHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       370 V~E~~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .||+|+ .+|+.+-+     ....++|..+-.|...++.||+||-. ++  ||||||||+||||+..   |.|||||||+
T Consensus       141 CMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~---G~vKLCDFGI  214 (361)
T KOG1006|consen  141 CMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRH---GDVKLCDFGI  214 (361)
T ss_pred             eHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecC---CCEeeecccc
Confidence            999997 56655432     44689999999999999999999965 45  9999999999999987   7999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +-.+.+..        ..+..+|...|||||.+..  ....|+.++||||||++|||+.||.+||..-++....+.....
T Consensus       215 cGqLv~Si--------AkT~daGCrpYmAPERi~p--~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~  284 (361)
T KOG1006|consen  215 CGQLVDSI--------AKTVDAGCRPYMAPERIDP--SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI  284 (361)
T ss_pred             hHhHHHHH--------HhhhccCCccccChhccCC--ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence            98776542        1233489999999998853  2335899999999999999999999999765543333222211


Q ss_pred             hhhhccccCC-CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         524 LKATEVQFAN-KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       524 ~~~~~~~~~~-~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .....+.+.. ...++..+..||.-||.+|.++||...+++.+||+.
T Consensus       285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            1112222221 135899999999999999999999999999999985

>KOG1095|consensus

Probab=100.00  E-value=1.3e-36  Score=348.87  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=208.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCe-----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQR-----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~-----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      -.+...+...||+|.||+||.|......-     .||||.+.....      ...+..|++|..+|++++|||||+++++
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~------~~~~~~Fl~Ea~~m~~f~HpNiv~liGv  763 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS------EQEVSDFLKEALLMSKFDHPNIVSLIGV  763 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC------HHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence            35678889999999999999998765322     377776643322      2335689999999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc-------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH-------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                      +. +....+|++|||.||+|..+|++.       ..|+..+...|+.||++|++||++++  +|||||-..|+||+..  
T Consensus       764 ~l-~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~--  838 (1025)
T KOG1095|consen  764 CL-DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER--  838 (1025)
T ss_pred             ec-CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc--
Confidence            97 467778999999999999999865       36899999999999999999999988  9999999999999987  


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHN  511 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~  511 (627)
                       ..|||+|||+|+.+....|....+.     ..-...|||||.|.    ...++.++|||||||+|||+++ |..||...
T Consensus       839 -r~VKIaDFGlArDiy~~~yyr~~~~-----a~lPvkWm~PEsl~----d~iFtskSDvWsFGVllWEifslG~~PY~~~  908 (1025)
T KOG1095|consen  839 -RVVKIADFGLARDIYDKDYYRKHGE-----AMLPVKWMPPESLK----DGIFTSKSDVWSFGVLLWEIFSLGATPYPSR  908 (1025)
T ss_pred             -CcEEEcccchhHhhhhchheeccCc-----cccceecCCHHHHh----hcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence             5999999999996655544322211     12246799999995    4569999999999999999996 99999877


Q ss_pred             ChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .+.+.+...   ....  .++.+..+++.+.+++..||..+|++||+...|++
T Consensus       909 ~n~~v~~~~---~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  909 SNFEVLLDV---LEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             chHHHHHHH---HhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            666554321   1222  66677789999999999999999999999999986

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.2e-36  Score=305.79  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=195.0

Q ss_pred             eeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      |.+.+.||+|+||.||+|.+..   ++..||||++......     ......+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   75 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-----SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRA   75 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-----hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCC
Confidence            5678889999999999998654   5789999998643321     112456888999999999999999999875322 


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhc------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                          ...++++||+.+++|..++...      ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.+   +
T Consensus        76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~---~  150 (273)
T cd05074          76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN---M  150 (273)
T ss_pred             CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC---C
Confidence                1347899999999998877432      25789999999999999999999988  9999999999999876   5


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQS  513 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~  513 (627)
                      .+||+|||+++.+......     .......+++.|++||.+.    ...++.++|||||||++|+|++ |+.||.....
T Consensus       151 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~----~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~  221 (273)
T cd05074         151 TVCVADFGLSKKIYSGDYY-----RQGCASKLPVKWLALESLA----DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN  221 (273)
T ss_pred             CEEECcccccccccCCcce-----ecCCCccCchhhcCHhHHh----cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence            8999999999876432210     1112234567899999883    4457889999999999999998 8999975544


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ... ...  +....  .+...+..+..+.+|+.+||..+|.+||++.+++.+
T Consensus       222 ~~~-~~~--~~~~~--~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         222 SEI-YNY--LIKGN--RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             HHH-HHH--HHcCC--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            322 111  11111  122334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.7e-36  Score=342.07  Aligned_cols=265  Identities=19%  Similarity=0.252  Sum_probs=178.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCC----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKE----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ..++|.+.++||+|+||.||+|.+..+    +..||||.+.....     .+    ....|  .+....+.+++.++..|
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e----~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VE----IWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hH----HHHHH--HHHhhchhhHHHHHHhh
Confidence            457899999999999999999999988    99999998643211     00    01111  11222222332222221


Q ss_pred             -----eecCCeEEEEEeecCCCChHHHHHhccC--------------------cCHHHHHHHHHHHHHHHHHHHhCCCCE
Q psy4988         361 -----EIDANSFCTVLEYCDGHDLDFYLKQHKT--------------------IAEREARSIVMQVVSALKYLNEIKPPV  415 (627)
Q Consensus       361 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~e~~~~~i~~qi~~aL~yLH~~~~~I  415 (627)
                           ..+...++|||||+++++|.+++.....                    ..+..+..|+.||+.||.|||+.+  |
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--I  276 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--I  276 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--E
Confidence                 1245678899999999999998864321                    123456789999999999999988  9


Q ss_pred             EeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCC-------------
Q psy4988         416 IHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP-------------  482 (627)
Q Consensus       416 vHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-------------  482 (627)
                      |||||||+||||+.+.  +.+||+|||+|+.+.....      ......++|+.|+|||.+......             
T Consensus       277 iHRDLKP~NILl~~~~--~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s  348 (566)
T PLN03225        277 VHRDVKPQNIIFSEGS--GSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS  348 (566)
T ss_pred             EeCcCCHHHEEEeCCC--CcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence            9999999999998643  5899999999986643211      123445889999999976422111             


Q ss_pred             -----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh--------hhhccc--------cCCCCCCCHHH
Q psy4988         483 -----PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL--------KATEVQ--------FANKPTVSNEA  541 (627)
Q Consensus       483 -----~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~--------~~~~~~vs~el  541 (627)
                           ..++.++||||||||||||+++..|+...  ...+.......        ......        +.........+
T Consensus       349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  426 (566)
T PLN03225        349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAG  426 (566)
T ss_pred             chhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHH
Confidence                 12456779999999999999987776432  11111110000        000000        00011123456


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         542 KGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       542 ~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .+||.+||++||++|||+.++|+||||....
T Consensus       427 ~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        427 WELLKSMMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             HHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence            6999999999999999999999999998643

>KOG4250|consensus

Probab=100.00  E-value=4e-37  Score=334.88  Aligned_cols=251  Identities=31%  Similarity=0.449  Sum_probs=194.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC--
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA--  364 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--  364 (627)
                      .-|...+.||+|+||.||+++++.+|+.||||.+......      ..+....+|++||++|+|||||+++++=+...  
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~------r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~   86 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL------RPRERWCREIEILKKLNHPNIVKLFDIEETKFLG   86 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc------chHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence            3455667899999999999999999999999987654321      22456789999999999999999999754322  


Q ss_pred             ---CeEEEEEeecCCCChHHHHHh---ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC-cccceE
Q psy4988         365 ---NSFCTVLEYCDGHDLDFYLKQ---HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN-VCGEIK  437 (627)
Q Consensus       365 ---~~~~lV~E~~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~-~~g~vK  437 (627)
                         ....+|||||.||+|+.++..   ...|++.+++.++.+++.||.|||++|  ||||||||.||++-.+. .....|
T Consensus        87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyK  164 (732)
T KOG4250|consen   87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYK  164 (732)
T ss_pred             cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEe
Confidence               234699999999999999964   358999999999999999999999998  99999999999986543 223679


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA--  515 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~--  515 (627)
                      |||||.|+.+.++.        .....+||..|++||.+-   +...|+.-+|.|||||++|+++||..||-......  
T Consensus       165 LtDfG~Arel~d~s--------~~~S~vGT~~YLhPel~E---~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~  233 (732)
T KOG4250|consen  165 LTDFGAARELDDNS--------LFTSLVGTEEYLHPELYE---RQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN  233 (732)
T ss_pred             eecccccccCCCCC--------eeeeecCchhhcChHHHh---hccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc
Confidence            99999999887653        345669999999999983   24679999999999999999999999995443332  


Q ss_pred             --HHHHHHHHhhh------------hc----cccCCCCCCCHHH----HHHHHHhhhcCcCCCC
Q psy4988         516 --TILEENTILKA------------TE----VQFANKPTVSNEA----KGFIRSCLAYRKEDRI  557 (627)
Q Consensus       516 --~~~~~~~~~~~------------~~----~~~~~~~~vs~el----~~LI~~cL~~dP~~Rp  557 (627)
                        ..... ...+.            .+    ..+|.+..++..+    ...+..+|+++|++|.
T Consensus       234 ~~~~~~~-~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  234 KEIMWHI-ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             chhhhhh-hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence              11111 11100            01    1233344455443    3456778999999998

>KOG0695|consensus

Probab=100.00  E-value=1.3e-36  Score=304.35  Aligned_cols=264  Identities=25%  Similarity=0.417  Sum_probs=212.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVF  360 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~  360 (627)
                      +.+-.++|.++.+||+|+|+.|.++.++.+.+.||+|++.+.- ..+++..++   +..|-.+..+. +||.+|-|..+|
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-~nddedidw---vqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-VNDDEDIDW---VQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHh-cCCcccchh---HHhhHHHHHhccCCCeEEehhhhh
Confidence            3455678999999999999999999999999999999975432 222222222   33455555443 799999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      + ....+++|.||++||+|...++++..|+++.++.+..+|+.||.|||+.|  ||.||||.+|||||..   |++||+|
T Consensus       321 q-tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae---ghikltd  394 (593)
T KOG0695|consen  321 Q-TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE---GHIKLTD  394 (593)
T ss_pred             c-ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC---Cceeecc
Confidence            8 45567799999999999999999999999999999999999999999998  9999999999999988   7999999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC------CChH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH------NQSQ  514 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~------~~~~  514 (627)
                      +|+++.--.+       -+.+++.||||.|+|||++.    +..|+..+|+|+|||+++||+.|+.||+-      ..+.
T Consensus       395 ygmcke~l~~-------gd~tstfcgtpnyiapeilr----geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt  463 (593)
T KOG0695|consen  395 YGMCKEGLGP-------GDTTSTFCGTPNYIAPEILR----GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT  463 (593)
T ss_pred             cchhhcCCCC-------CcccccccCCCcccchhhhc----ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch
Confidence            9999753322       25688999999999999994    66799999999999999999999999951      1122


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC------HHHHHhccCCCC
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID------VISLARHDYLQP  570 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt------~~elL~hp~~~~  570 (627)
                      +.++-...+    +.+...+..+|-.+..+++..|.+||.+|.-      ..++-.|+||..
T Consensus       464 edylfqvil----ekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  464 EDYLFQVIL----EKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hHHHHHHHh----hhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            222222111    2223334467778889999999999999974      578889999973

>KOG1094|consensus

Probab=100.00  E-value=4.5e-36  Score=318.57  Aligned_cols=258  Identities=24%  Similarity=0.422  Sum_probs=210.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -.++..+.++||+|-||+|.+|. ...+..||||+++....      .+....|.+|+++|.+|+|||||.|+++|.. .
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~------~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-D  607 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDAT------KNARNDFLKEIKILSRLKHPNIVELLGVCVQ-D  607 (807)
T ss_pred             chhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccc------hhHHHHHHHHHHHHhccCCCCeeEEEeeeec-C
Confidence            35677889999999999999997 44579999999865433      2335689999999999999999999999984 4


Q ss_pred             CeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+|+|+||+++|+|..++..+  ..+.-....+|+.||+.|++||.+.+  +|||||.+.|+|+|.+   .++||+|||
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e---~~iKiadfg  682 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE---FTIKIADFG  682 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc---ccEEecCcc
Confidence            6788999999999999999876  34455566789999999999999999  9999999999999998   599999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL--YGKKPFGHNQSQATILEE  520 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell--tG~~Pf~~~~~~~~~~~~  520 (627)
                      +++-+....|...     ....+-.+.|||+|.++.++    ++.++|||+|||+|||++  |...||....+.+.+.+.
T Consensus       683 msR~lysg~yy~v-----qgr~vlpiRwmawEsillgk----FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~  753 (807)
T KOG1094|consen  683 MSRNLYSGDYYRV-----QGRAVLPIRWMAWESILLGK----FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA  753 (807)
T ss_pred             cccccccCCceee-----ecceeeeeeehhHHHHHhcc----ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh
Confidence            9997766555422     23335578999999997554    899999999999999976  789999776665554333


Q ss_pred             HHHhhh--hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKA--TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~--~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..+...  ....+..++.++..+..||.+|+.+|-++||+.+++..
T Consensus       754 ~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  754 GEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             hhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            333222  22344556778999999999999999999999999854

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.1e-35  Score=321.81  Aligned_cols=276  Identities=21%  Similarity=0.268  Sum_probs=194.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEc----------------CCCeEEEEEEeecCcchhhHhHH-------HHHHHHHHH
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDL----------------KEQRYVACKVHQLNKDWKEDKKA-------NYIKHALRE  341 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~----------------~~~~~VAVKii~~~~~~~~~~~~-------~~~~~~~~E  341 (627)
                      -.++|.+.++||+|+||+||+|.+.                ..++.||||.+............       ........|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999753                24568999998654321111000       001223457


Q ss_pred             HHHHhcCCCCce-----eEEeeEEee-------cCCeEEEEEeecCCCChHHHHHhc-----------------------
Q psy4988         342 YNIHKALDHPRV-----VKLYDVFEI-------DANSFCTVLEYCDGHDLDFYLKQH-----------------------  386 (627)
Q Consensus       342 i~il~~l~HpnI-----V~l~~~~~~-------~~~~~~lV~E~~~gg~L~~~l~~~-----------------------  386 (627)
                      +.++.++.|.++     ++++++|..       +....+|||||+++++|.+++...                       
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677777643       234578999999999999888632                       


Q ss_pred             -cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCC
Q psy4988         387 -KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA  465 (627)
Q Consensus       387 -~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~  465 (627)
                       ..+++..++.|+.||+.+|.|||+.+  |+||||||+|||++.+   +.+||+|||++..+.....      .......
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~------~~~~~g~  371 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGIN------FNPLYGM  371 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC---CcEEEEeCcCccccccCCc------cCccccC
Confidence             12356788999999999999999988  9999999999999987   5899999999976543211      0111234


Q ss_pred             CCCccCCccccccCCCCC------------------CCCcchhHHHHHHHHHHHHhCCC-CCCCCChHHHH-------HH
Q psy4988         466 GTYWYLPPECFVVGKNPP------------------KISSKVDVWSVGVIFYQCLYGKK-PFGHNQSQATI-------LE  519 (627)
Q Consensus       466 Gt~~Y~APE~l~~~~~~~------------------~~~~k~DVwSlGviL~elltG~~-Pf~~~~~~~~~-------~~  519 (627)
                      +|+.|+|||.+.......                  ....++||||+|||||+|++|.. ||.........       +.
T Consensus       372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~  451 (507)
T PLN03224        372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN  451 (507)
T ss_pred             CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence            589999999875321100                  11235799999999999999986 77432111111       11


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCc---CCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRK---EDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP---~~Rpt~~elL~hp~~~~~  571 (627)
                      ...........+..+..+++.++|||.+||..+|   .+|+|+.|+|+||||.+.
T Consensus       452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            1112223345566677889999999999999876   689999999999999763

>KOG4257|consensus

Probab=100.00  E-value=1.3e-35  Score=316.51  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=208.3

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcC--C--CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK--E--QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~--~--~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      +.++-.....+.++||.|-||.||+|....  .  .-.||||....+..      .+..+.|+.|.-||+.++|||||+|
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t------~d~tekflqEa~iMrnfdHphIikL  456 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT------PDDTEKFLQEASIMRNFDHPHIIKL  456 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC------hhhHHHHHHHHHHHHhCCCcchhhe
Confidence            444555666777899999999999997543  2  34577776544322      2224679999999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++|.  ....+||||+++-|.|..||+.+ ..|+......+..||+.||.|||+.+  +|||||-..|||+...   .-
T Consensus       457 IGv~~--e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp---~C  529 (974)
T KOG4257|consen  457 IGVCV--EQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP---QC  529 (974)
T ss_pred             eeeee--ccceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc---ce
Confidence            99997  45678999999999999999876 47999999999999999999999988  9999999999999987   37


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQ  514 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~  514 (627)
                      |||+||||++.+.++.|..      .+...-.+.|||||-+    +...++.++|||-|||++||+| .|..||.+-.+.
T Consensus       530 VKLaDFGLSR~~ed~~yYk------aS~~kLPIKWmaPESI----NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs  599 (974)
T KOG4257|consen  530 VKLADFGLSRYLEDDAYYK------ASRGKLPIKWMAPESI----NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS  599 (974)
T ss_pred             eeecccchhhhccccchhh------ccccccceeecCcccc----chhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence            9999999999998776531      2233456789999998    6778999999999999999988 699999776655


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      +.+...     .....+|.++.+++.+..|+.+||+++|.+||+..++.
T Consensus       600 DVI~~i-----EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  600 DVIGHI-----ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ceEEEe-----cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            544221     12345677789999999999999999999999887753

>KOG0196|consensus

Probab=100.00  E-value=2.6e-35  Score=321.60  Aligned_cols=263  Identities=22%  Similarity=0.375  Sum_probs=217.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCC---eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~---~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +-.....|.++||.|.||+||+|..+..+   ..||||.+.....      +.....|+.|..||-+++||||++|.++.
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt------ekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT------EKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc------HHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            44556788999999999999999877654   5799998754332      22346799999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . ....++||.|||++|.|+.+|..+ +.|+.-+...+++.|+.|++||-+++  +|||||-..|||++.+.   ..||+
T Consensus       700 T-ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL---vCKVs  773 (996)
T KOG0196|consen  700 T-KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL---VCKVS  773 (996)
T ss_pred             e-cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce---EEEec
Confidence            6 677888999999999999999754 68999999999999999999999999  99999999999999985   67999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~  518 (627)
                      ||||++++.++...    ..-+...--...|.|||.|.    ...++.++||||+||+|||.+ +|..||.+..+++.+.
T Consensus       774 DFGLSRvledd~~~----~ytt~GGKIPiRWTAPEAIa----~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk  845 (996)
T KOG0196|consen  774 DFGLSRVLEDDPEA----AYTTLGGKIPIRWTAPEAIA----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK  845 (996)
T ss_pred             cccceeecccCCCc----cccccCCccceeecChhHhh----hcccCchhhccccceEEEEecccCCCcccccchHHHHH
Confidence            99999988654311    01111112256899999994    556999999999999999977 8999998888777664


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc--cCCCCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH--DYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h--p~~~~~  571 (627)
                      ...     ....+|.+.+++..+..|+..||++|...||...||+.+  .++..|
T Consensus       846 aIe-----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  846 AIE-----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHH-----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            332     345678888999999999999999999999999999863  455544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.5e-34  Score=283.06  Aligned_cols=243  Identities=40%  Similarity=0.610  Sum_probs=198.8

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCC
Q psy4988         299 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD  378 (627)
Q Consensus       299 ~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~  378 (627)
                      +||.||+|.+..+++.||+|++........      ...+.+|+.+++.++|+||+++++++. ....+++|+||+++++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK------RERILREISILKKLKHPNIVRLYDVFE-DEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH------HHHHHHHHHHHHhCCCCcHHHHHhhee-eCCEEEEEEeCCCCCC
Confidence            589999999988899999999865433211      356888999999999999999999987 4567889999999999


Q ss_pred             hHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCc
Q psy4988         379 LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM  458 (627)
Q Consensus       379 L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~  458 (627)
                      |..++.....+++..++.++.+++.+|.|||+.+  |+|+||+|.||+++.+   +.++|+|||++.......       
T Consensus        74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~-------  141 (244)
T smart00220       74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED---GHVKLADFGLARQLDPGG-------  141 (244)
T ss_pred             HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC---CcEEEccccceeeecccc-------
Confidence            9999987767999999999999999999999988  9999999999999987   689999999998775432       


Q ss_pred             cccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC-CCCC
Q psy4988         459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN-KPTV  537 (627)
Q Consensus       459 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~v  537 (627)
                       ......+++.|++||++.    ...++.++||||||+++|+|++|..||........+...   .......... ...+
T Consensus       142 -~~~~~~~~~~~~~pE~~~----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  213 (244)
T smart00220      142 -LLTTFVGTPEYMAPEVLL----GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKI  213 (244)
T ss_pred             -ccccccCCcCCCCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccC
Confidence             123347899999999984    445788999999999999999999999763333333221   1111111111 1127


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         538 SNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       538 s~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      +.++.+||.+||..+|.+||++.++++||||
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199|consensus

Probab=100.00  E-value=1.6e-34  Score=311.60  Aligned_cols=257  Identities=24%  Similarity=0.366  Sum_probs=209.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +...+.++||+|.||+||+|.+..   +.-.||||++.......      ....|++|+.+|.+|+|||+|+||++.. +
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------~mddflrEas~M~~L~H~hliRLyGvVl-~  182 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------IMDDFLREASHMLKLQHPHLIRLYGVVL-D  182 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch------hHHHHHHHHHHHHhccCcceeEEeeeec-c
Confidence            345567789999999999998765   23568999987554322      3567999999999999999999999987 3


Q ss_pred             CCeEEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       ....||||++++|+|.+.|..  ...|.......|+.||+.|+.||.+++  +|||||-..||||...   ..||||||
T Consensus       183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp---rtVKI~DF  256 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP---RTVKICDF  256 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc---ceeeeecc
Confidence             556799999999999999976  346888899999999999999999988  9999999999999886   48999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~  520 (627)
                      ||.+.+......    +.+....--.+.|.|||++    +...++.++|||+|||+||||+ +|..||.+......+ +.
T Consensus       257 GLmRaLg~ned~----Yvm~p~rkvPfAWCaPEsL----rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-~~  327 (1039)
T KOG0199|consen  257 GLMRALGENEDM----YVMAPQRKVPFAWCAPESL----RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-KN  327 (1039)
T ss_pred             cceeccCCCCcc----eEecCCCcCcccccCHhHh----ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-Hh
Confidence            999988754321    1233333456789999999    4667999999999999999999 589999877654433 22


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .   . ....++.+..+++++.+++..||..+|.+|||...|...-++.
T Consensus       328 i---D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  328 I---D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             c---c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            1   1 3345677778999999999999999999999999997554443

>KOG4278|consensus

Probab=100.00  E-value=4.9e-34  Score=303.71  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .-.-+.....+||-|-||.||.|.+++-.-.||||.+.-+.        --+.+|+.|..+|+.+.|||+|+|+++|. .
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--------MeveEFLkEAAvMKeikHpNLVqLLGVCT-~  334 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-H  334 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--------hhHHHHHHHHHHHHhhcCccHHHHhhhhc-c
Confidence            33445566789999999999999999999999999864222        22568999999999999999999999997 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ...||||.|||..|+|.+||.+-  .-++--..+.++.||..|++||...+  +|||||-..|.|+.++   ..|||+||
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn---hiVKvADF  409 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN---HIVKVADF  409 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc---ceEEeecc
Confidence            66788999999999999999754  34666777899999999999999988  9999999999999998   48999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++++..+.|..+-+..      -.+.|.|||-+.    ...++.++|||+|||+|||+. +|--||.+.+....+   
T Consensus       410 GLsRlMtgDTYTAHAGAK------FPIKWTAPEsLA----yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY---  476 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAK------FPIKWTAPESLA----YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---  476 (1157)
T ss_pred             chhhhhcCCceecccCcc------CcccccCccccc----ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH---
Confidence            999999988776554332      356799999884    345889999999999999998 588899765433222   


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                       . +.........+..+++.+..|++.||+|+|.+||+..++-
T Consensus       477 -~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  477 -G-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             -H-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence             1 1112334455668999999999999999999999998873

>KOG0664|consensus

Probab=100.00  E-value=2.5e-35  Score=288.48  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=202.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC----eE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN----SF  367 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~----~~  367 (627)
                      -+.||.|+||+||.+.|..+++.||+|.+..-     .......+++.+|+.+|.-++|.||+..+|+.+...-    .+
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-----fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-----FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchH-----HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            35699999999999999999999999976321     1223345789999999999999999999998763221    24


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|.|+|. .+|..++..-..++.+.+.-+++||++||+|||+.+  |+||||||.|+|++.|   ..+||||||+|+..
T Consensus       133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN---CvLKICDFGLARve  206 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN---CILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC---ceEEeccccccccc
Confidence            67888887 588888888889999999999999999999999998  9999999999999987   48999999999987


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      +.+...     . .+.-+-|.+|+|||++++   ...|+.++||||+|||+.|||..+..|.....-+.+.-...++...
T Consensus       207 e~d~~~-----h-MTqEVVTQYYRAPEiLMG---aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  207 DQRDRL-----N-MTHEVVTQYYRAPELLMG---ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             chhhhh-----h-hHHHHHHHHhccHHHhhc---chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence            654321     2 233367899999999973   4569999999999999999999999997655544332221111110


Q ss_pred             c-------------------c---cc------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         528 E-------------------V---QF------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       528 ~-------------------~---~~------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .                   .   .+      .....-..+..+++..+|.+||.+|.+..+++.|+|+...
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            0                   0   01      1112334578889999999999999999999999998653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.9e-33  Score=334.60  Aligned_cols=243  Identities=19%  Similarity=0.255  Sum_probs=181.1

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.....||+|+||.||+|.+..++..||||.+.....           ....|+.++++++|||||+++++|. +...+|
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~l~~l~HpnIv~~~~~~~-~~~~~~  759 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----------IPSSEIADMGKLQHPNIVKLIGLCR-SEKGAY  759 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----------ccHHHHHHHhhCCCCCcceEEEEEE-cCCCCE
Confidence            4456789999999999999999999999998753221           1124678899999999999999997 556778


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      +||||+++++|.+++.   .+++..+..|+.||+.||.|||.. .++||||||||+|||++.+.   .++++ ||.....
T Consensus       760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~---~~~~~-~~~~~~~  832 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD---EPHLR-LSLPGLL  832 (968)
T ss_pred             EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC---ceEEE-ecccccc
Confidence            9999999999999996   389999999999999999999943 23499999999999998763   55554 6655433


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhh
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-TILEEN-TILK  525 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~-~~~~  525 (627)
                      ...           ....||+.|+|||++.    ...++.++|||||||+||||++|+.||....... .+.... ....
T Consensus       833 ~~~-----------~~~~~t~~y~aPE~~~----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~  897 (968)
T PLN00113        833 CTD-----------TKCFISSAYVAPETRE----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS  897 (968)
T ss_pred             ccC-----------CCccccccccCccccc----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence            211           1236899999999984    4568999999999999999999999995332111 111000 0000


Q ss_pred             h------hcccc----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         526 A------TEVQF----ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       526 ~------~~~~~----~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .      .+...    ........++.+++.+||+.||++|||+.++++.
T Consensus       898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0      00000    0001122357789999999999999999999875

>KOG0665|consensus

Probab=100.00  E-value=6.2e-34  Score=285.05  Aligned_cols=260  Identities=27%  Similarity=0.367  Sum_probs=202.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ....||.-+..+|.|.- .|..|.|..+++.||+|.+......     ....++..+|..++..+.|+|||+++.+|...
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-----~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-----QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-----CccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            35578999999999998 8888999999999999987654221     11235678999999999999999999998643


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+|||||. .+|...+.  -.++-+.+..|++|+++|+.|||+.+  |+||||||+||++..+   ..+||
T Consensus        88 ~~l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~---~~lKi  159 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD---CTLKI  159 (369)
T ss_pred             ccHHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch---hheee
Confidence            3     24689999998 46666655  35778889999999999999999999  9999999999999887   58999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+|+.....        -..+..+.|..|.|||++.    +..|...+||||+|||+.||++|...|.+..--+...
T Consensus       160 ~dfg~ar~e~~~--------~~mtpyVvtRyyrapevil----~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~  227 (369)
T KOG0665|consen  160 LDFGLARTEDTD--------FMMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN  227 (369)
T ss_pred             ccchhhcccCcc--------cccCchhheeeccCchhee----ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence            999999865432        1345568899999999996    3348999999999999999999999996544322222


Q ss_pred             HHHHHhhh---------------------------hccccCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         519 EENTILKA---------------------------TEVQFAN---------KPTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       519 ~~~~~~~~---------------------------~~~~~~~---------~~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      +....+..                           ....||+         .+.-+..+.+|+.+||..||++|.+++++
T Consensus       228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da  307 (369)
T KOG0665|consen  228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA  307 (369)
T ss_pred             HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence            21111100                           0011111         11234568899999999999999999999


Q ss_pred             HhccCCC
Q psy4988         563 ARHDYLQ  569 (627)
Q Consensus       563 L~hp~~~  569 (627)
                      |+||||.
T Consensus       308 L~HPY~~  314 (369)
T KOG0665|consen  308 LRHPYIK  314 (369)
T ss_pred             hcCCeee
Confidence            9999997

>KOG1027|consensus

Probab=100.00  E-value=6.1e-34  Score=313.88  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=189.9

Q ss_pred             EEEecccCceE-EEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeEEE
Q psy4988         292 LMLLGKGGFSE-VHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       292 ~~~LG~G~fG~-Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~~l  369 (627)
                      .+++|.|+-|+ ||+|.  ..++.||||.+-          .....-+.+||..|+.-+ |||||++|+. +.+....||
T Consensus       514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YI  580 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGV--YEGREVAVKRLL----------EEFFDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYI  580 (903)
T ss_pred             HHHcccCCCCcEEEEEe--eCCceehHHHHh----------hHhHHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEE
Confidence            35689998865 79985  678999999752          223445789999998884 9999999875 447778899


Q ss_pred             EEeecCCCChHHHHHhcc----CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc--ccceEEeeccc
Q psy4988         370 VLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV--CGEIKITDFGL  443 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~--~g~vKL~DFGl  443 (627)
                      ..|+|. .+|.++++...    ....-..+.++.|++.||++||+.+  ||||||||.||||+..+.  ...++|+|||+
T Consensus       581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            999998 69999998741    1122456889999999999999998  999999999999987422  24899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG-KKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++.+..+...    ....+...||-.|+|||++....    -+.++||||||||+|+.++| ..||+.....+.     .
T Consensus       658 sKkl~~~~sS----~~r~s~~sGt~GW~APE~L~~~~----~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-----N  724 (903)
T KOG1027|consen  658 SKKLAGGKSS----FSRLSGGSGTSGWQAPEQLREDR----KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-----N  724 (903)
T ss_pred             ccccCCCcch----hhcccCCCCcccccCHHHHhccc----cCcccchhhcCceEEEEecCCccCCCchHHhhh-----h
Confidence            9998765422    22356778999999999996433    45699999999999999976 999976544322     1


Q ss_pred             Hhhh-hc-cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKA-TE-VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~-~~-~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ++.. .. ..+.....  .++.+||.+||+++|..||++.++|.||+|=.
T Consensus       725 Il~~~~~L~~L~~~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  725 ILTGNYTLVHLEPLPD--CEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             hhcCccceeeeccCch--HHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            1111 11 11111111  28999999999999999999999999999843

>KOG1167|consensus

Probab=99.98  E-value=6.9e-33  Score=286.84  Aligned_cols=269  Identities=25%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYD  358 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~  358 (627)
                      +.+.+.|.++++||+|+|++||++.+..   ..++||+|.+.....         ..++..|+++|..+ .+.||+++.+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---------p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---------PSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---------chHHHHHHHHHHHhccchhhhcchh
Confidence            3566789999999999999999999888   899999998876544         23588899999999 4999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      ++. ..+..++||||++..+..++...   ++..+++.+++.++.||.++|..|  ||||||||.|+|.+...  +.-.|
T Consensus       103 ~~r-nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t--~rg~L  174 (418)
T KOG1167|consen  103 CFR-NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRT--QRGVL  174 (418)
T ss_pred             hhc-cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCcccccccccc--CCceE
Confidence            987 66778899999999888877654   779999999999999999999998  99999999999998865  68899


Q ss_pred             eecccccccccCC------------CCC-------------------------CCCccccccCCCCCccCCccccccCCC
Q psy4988         439 TDFGLSKVMDEEN------------YNP-------------------------DHGMDLTSQGAGTYWYLPPECFVVGKN  481 (627)
Q Consensus       439 ~DFGla~~~~~~~------------~~~-------------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~  481 (627)
                      +|||||.......            ..+                         .......-..+||++|.|||++.   .
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~---k  251 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF---R  251 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh---h
Confidence            9999997321110            000                         00000011346999999999986   3


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhhh-----------h--------------------cc
Q psy4988         482 PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI-LEENTILKA-----------T--------------------EV  529 (627)
Q Consensus       482 ~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~-~~~~~~~~~-----------~--------------------~~  529 (627)
                      -+..++++||||.||||..+++++.||....++... .+...+...           .                    .+
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence            445788999999999999999999999544333222 111111100           0                    00


Q ss_pred             -------------ccCCC-CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         530 -------------QFANK-PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       530 -------------~~~~~-~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                                   ....+ ...+..+.+|+.+||+.||.+|.|++++|+||||.+.
T Consensus       332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence                         00011 1235578999999999999999999999999999854

>KOG0984|consensus

Probab=99.98  E-value=1.6e-32  Score=259.83  Aligned_cols=213  Identities=29%  Similarity=0.398  Sum_probs=173.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDA  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~  364 (627)
                      .|...-+..||+|++|.|=+.++..+|...|||.+...-..+      ..++.++|+++..+. .+|.+|.+|+.+. +.
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q------~q~r~L~dldi~~r~~~CPf~V~FyGa~~-re  117 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ------EQKRLLMDLDIIMRTVDCPFTVHFYGALF-RE  117 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH------HHHHHHHhhhhhccCCCCCeEEEeehhhh-cc
Confidence            344445567999999999999999999999999987654422      235678898876554 7999999999876 45


Q ss_pred             CeEEEEEeecCCCChHHH----HHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 NSFCTVLEYCDGHDLDFY----LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~----l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      ...+|.||.|. .+|+.+    ++..+.++|..+-+|+..|+.||.|||++ ..|||||+||+||||+.+   |+|||||
T Consensus       118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~---GqVKiCD  192 (282)
T KOG0984|consen  118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYD---GQVKICD  192 (282)
T ss_pred             ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccC---CcEEEcc
Confidence            56779999997 566654    34567999999999999999999999985 349999999999999987   7999999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      ||++-.+.+...        .+..+|...|||||.+....+...|+-++||||||++++||.++++||.........+
T Consensus       193 FGIsG~L~dSiA--------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL  262 (282)
T KOG0984|consen  193 FGISGYLVDSIA--------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL  262 (282)
T ss_pred             cccceeehhhhH--------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence            999988765421        2224899999999999766666689999999999999999999999997655544443

>KOG3653|consensus

Probab=99.97  E-value=8.4e-32  Score=281.38  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=185.4

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc--CCCCceeEEeeEEee---
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA--LDHPRVVKLYDVFEI---  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~~~~---  362 (627)
                      ...++++||+|.||.||+|.  -+++.||||++...          ..+.+..|-+|.+.  +.|+||++++++-..   
T Consensus       211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~----------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ----------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             chhhHHHhhcCccceeehhh--ccCceeEEEecCHH----------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            45567789999999999995  45699999997521          13467788888764  579999999987541   


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-------CCCCEEeccccCCcEEecCCCcccc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-------IKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-------~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +.-.++||+||.+.|+|-+||+.+ .++|....+|+..+++||+|||+       .+++|+|||||..||||..+   ++
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D---lT  354 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND---LT  354 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC---Cc
Confidence            123688999999999999999874 79999999999999999999996       34579999999999999988   58


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCC--CCCCcchhHHHHHHHHHHHHhCCCC------
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP--PKISSKVDVWSVGVIFYQCLYGKKP------  507 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~--~~~~~k~DVwSlGviL~elltG~~P------  507 (627)
                      ..|+|||||..+......     .-+-..+||..|||||++-+.-+-  ...-.+.||||+|.|||||++...-      
T Consensus       355 ccIaDFGLAl~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v  429 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV  429 (534)
T ss_pred             EEeeccceeEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence            899999999988743321     112235899999999998533221  1222468999999999999975433      


Q ss_pred             ------CC---CCChHHHHHHHHHHhhhhccccCC-C--CCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         508 ------FG---HNQSQATILEENTILKATEVQFAN-K--PTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       508 ------f~---~~~~~~~~~~~~~~~~~~~~~~~~-~--~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                            |.   +..+...-+....+.+.....++. |  ..--..+++.|..||..|++-|.|+.=+.
T Consensus       430 p~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  430 PEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             CcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence                  32   111111111122222222222222 1  12235688999999999999999987654

>KOG0576|consensus

Probab=99.97  E-value=3.8e-33  Score=300.59  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=221.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -.++|.++..+|.|+||.||+|+|+.+++..|||++.+....       .+.-+.+|+-+++..+|||||-+++.+. ..
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-------d~~~iqqei~~~~dc~h~nivay~gsyl-r~   84 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-------DFSGIQQEIGMLRDCRHPNIVAYFGSYL-RR   84 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-------cccccccceeeeecCCCcChHHHHhhhh-hh
Confidence            468899999999999999999999999999999999876542       1345678999999999999999999886 45


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..++++||||.||+|.+.-.-.+.+++.++..+.+..+.+|+|||+.+  =+|||||-.|||+.+.   |.+|++|||.+
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~---gDvklaDfgvs  159 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE---GDVKLADFGVS  159 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc---CceeecccCch
Confidence            668899999999999998887889999999999999999999999988  8999999999999987   79999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+....       .......||++|||||+-.... ...|...||||++|++..|+---++|..+......+ .....-
T Consensus       160 aqitati-------~KrksfiGtpywmapEvaaver-kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS  230 (829)
T KOG0576|consen  160 AQITATI-------AKRKSFIGTPYWMAPEVAAVER-KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKS  230 (829)
T ss_pred             hhhhhhh-------hhhhcccCCccccchhHHHHHh-cccccccccccccccchhhhhhcCCcccccchHHHH-HHhhcc
Confidence            7665322       1234458999999999986654 456899999999999999999888886544433322 222222


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........++...++.+.+|++.+|.++|.+||+++.+|.|||...+
T Consensus       231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            33445556667788999999999999999999999999999998654

>KOG2052|consensus

Probab=99.97  E-value=3.3e-31  Score=275.14  Aligned_cols=267  Identities=20%  Similarity=0.311  Sum_probs=193.1

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc--CCCCceeE
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA--LDHPRVVK  355 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~  355 (627)
                      ++.....+....++.+.||+|.||+||+|.  ..|+.||||++.....          ..+.+|.+|...  |+|+||+.
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srdE----------~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRDE----------RSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeecc--ccCCceEEEEecccch----------hhhhhHHHHHHHHHhccchhhh
Confidence            333445567789999999999999999995  4589999999864321          357788888764  59999999


Q ss_pred             EeeEEeecCC---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh------CCCCEEeccccCCcEE
Q psy4988         356 LYDVFEIDAN---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE------IKPPVIHYDLKPGNIL  426 (627)
Q Consensus       356 l~~~~~~~~~---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~------~~~~IvHrDLKP~NIL  426 (627)
                      +++.-..+.+   .++||.+|.+.|+|.+||.. ..++.+....++..++.||++||.      -+|.|.|||||..|||
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL  348 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  348 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence            9987554443   47999999999999999998 689999999999999999999994      2457999999999999


Q ss_pred             ecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCC--CCcchhHHHHHHHHHHHHhC
Q psy4988         427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPK--ISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       427 l~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~--~~~k~DVwSlGviL~elltG  504 (627)
                      +.++   +...|+|||||-........   -.......+||..|||||++....+...  .-..+||||||.||||+...
T Consensus       349 VKkn---~~C~IADLGLAv~h~~~t~~---idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  349 VKKN---GTCCIADLGLAVRHDSDTDT---IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             EccC---CcEEEeeceeeEEecccCCc---ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            9998   57899999999776654311   1122345699999999999853322111  12368999999999999842


Q ss_pred             ----------CCCCCCCCh-HHHHHHHHHHhhhh--ccccCCCCCCC---HHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         505 ----------KKPFGHNQS-QATILEENTILKAT--EVQFANKPTVS---NEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       505 ----------~~Pf~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~vs---~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                                ++||.+-.+ +..+.+.+.+.-..  ...+|..-.-.   ..+..|++.||..||.-|.|+.-+-
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence                      567742221 11222222222111  12222211112   2456789999999999999886654

>KOG0200|consensus

Probab=99.97  E-value=9.8e-31  Score=297.94  Aligned_cols=257  Identities=26%  Similarity=0.444  Sum_probs=202.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCce
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRV  353 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI  353 (627)
                      +++..+...+.+.||+|.||.||+|.-..       ....||||.+......      ...+.+..|+.+|+.+. ||||
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~------~~~~~~~~El~~m~~~g~H~ni  364 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS------SEKKDLMSELNVLKELGKHPNI  364 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc------HHHHHHHHHHHHHHHhcCCcch
Confidence            44555556677799999999999996431       2567999987544332      23457889999999995 9999


Q ss_pred             eEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       354 V~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      |.+++++.. ...+++|+|||..|+|..++...+                .++..+...++.||+.|++||++..  +||
T Consensus       365 v~llG~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vH  441 (609)
T KOG0200|consen  365 VNLLGACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVH  441 (609)
T ss_pred             hhheeeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccc
Confidence            999999874 677889999999999999998765                4889999999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCC--CCccCCccccccCCCCCCCCcchhHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG--TYWYLPPECFVVGKNPPKISSKVDVWSVG  495 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~G--t~~Y~APE~l~~~~~~~~~~~k~DVwSlG  495 (627)
                      |||-..|||+..+   ..+||+|||+|+......+..      .....|  ...|||||.+.    ...|+.++||||||
T Consensus       442 RDLAaRNVLi~~~---~~~kIaDFGlar~~~~~~~y~------~~~~~~~LP~kWmApEsl~----~~~ft~kSDVWSfG  508 (609)
T KOG0200|consen  442 RDLAARNVLITKN---KVIKIADFGLARDHYNKDYYR------TKSSAGTLPVKWMAPESLF----DRVFTSKSDVWSFG  508 (609)
T ss_pred             hhhhhhhEEecCC---CEEEEccccceeccCCCCceE------ecCCCCccceeecCHHHhc----cCcccccchhhHHH
Confidence            9999999999998   489999999999765543211      111233  34599999994    56799999999999


Q ss_pred             HHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         496 VIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       496 viL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |+||||++ |..||.+......+.+  .+...  .....+..+++++.++++.||..+|++||+..++..
T Consensus       509 I~L~EifsLG~~PYp~~~~~~~l~~--~l~~G--~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  509 ILLWEIFTLGGTPYPGIPPTEELLE--FLKEG--NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhhCCCCCCCCCCcHHHHHH--HHhcC--CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            99999995 8999977443344432  22222  233344567999999999999999999999999864

>KOG1152|consensus

Probab=99.97  E-value=4e-32  Score=288.49  Aligned_cols=202  Identities=27%  Similarity=0.469  Sum_probs=173.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcc----hhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeE
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD----WKEDKKANYIKHALREYNIHKALD---HPRVVKLYDV  359 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~----~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~  359 (627)
                      ..|..++.||.|+||.|++|.++.+...|+||++.+.+.    |..+.+.   -.+--||.||..|+   |+||++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL---GtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL---GTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc---CccchhHHHHHHhhhcCccchhhhhhe
Confidence            359999999999999999999999999999999865442    2222111   12345999999997   9999999999


Q ss_pred             EeecCCeEEEEEeec-CCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYC-DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~-~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      |+ +.++|||+||-. +|.+|++++.....++|.++..|+.||+.|+++||+.+  |||||||-+||.++.+   |.+||
T Consensus       638 FE-ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~---g~~kl  711 (772)
T KOG1152|consen  638 FE-DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN---GFVKL  711 (772)
T ss_pred             ee-cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC---CeEEE
Confidence            99 778889999966 56799999999999999999999999999999999998  9999999999999988   79999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                      +|||.|.+....-         ....+||..|.|||++.   ...+.+..-|||+||++||.+++...||.
T Consensus       712 idfgsaa~~ksgp---------fd~f~gtv~~aapevl~---g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP---------FDVFVGTVDYAAPEVLG---GEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCC---------cceeeeeccccchhhhC---CCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999998776543         23458999999999985   23456778899999999999999999984

>KOG1025|consensus

Probab=99.97  E-value=6.4e-31  Score=288.08  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=201.1

Q ss_pred             EEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ..++||.|+||+||+|.+...++    +||||++......+      ...+++.|+-+|.+|+|||+++|++++..  ..
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~------~s~e~LdeAl~masldHpnl~RLLgvc~~--s~  771 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK------ASIELLDEALRMASLDHPNLLRLLGVCML--ST  771 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch------hhHHHHHHHHHHhcCCCchHHHHhhhccc--ch
Confidence            35779999999999999877654    57888876544322      23578999999999999999999999873  33


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +.||++|++.|.|.++++.+ ..+-....+.|..||++||.|||.++  +|||||-..|||+..-   .+|||.|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP---~hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP---NHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC---CeEEEEecchhh
Confidence            77999999999999999865 58999999999999999999999988  9999999999999987   499999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+..+....     ......-.+.|||=|.+.    ...|+.++|||||||++|||+ +|..|+.+....+.    ..++
T Consensus       847 ll~~d~~ey-----~~~~gK~pikwmale~i~----~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----~dll  913 (1177)
T KOG1025|consen  847 LLAPDEKEY-----SAPGGKVPIKWMALESIR----IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----PDLL  913 (1177)
T ss_pred             ccCcccccc-----cccccccCcHHHHHHHhh----ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----hHHH
Confidence            887654221     123334567899999984    566999999999999999998 59999976544332    2222


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +.. ..++.++..+-++.-++-+||..|+..||++.++..
T Consensus       914 e~g-eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  914 EKG-ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             hcc-ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            222 237777889999999999999999999999988754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.4e-29  Score=242.29  Aligned_cols=213  Identities=40%  Similarity=0.639  Sum_probs=182.5

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeec
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC  374 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~  374 (627)
                      ||.|.+|.||++.+..+++.++||++.......      ....+.+|+.+++.+.|++|+++++++. .....++||||+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------LLEELLREIEILKKLNHPNIVKLYGVFE-DENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh------HHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeEEEEEecC
Confidence            689999999999988889999999986543311      2356889999999999999999999987 446788999999


Q ss_pred             CCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC-CCcccceEEeecccccccccCCC
Q psy4988         375 DGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE-GNVCGEIKITDFGLSKVMDEENY  452 (627)
Q Consensus       375 ~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~-~~~~g~vKL~DFGla~~~~~~~~  452 (627)
                      ++++|..++... ..+++..++.++.+++.+|.|||+.+  ++|+||+|.||+++. +   +.++|+|||.+........
T Consensus        74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~---~~~~l~d~~~~~~~~~~~~  148 (215)
T cd00180          74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDN---GKVKLADFGLSKLLTSDKS  148 (215)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCC---CcEEEecCCceEEccCCcc
Confidence            999999998875 57999999999999999999999988  999999999999998 4   5899999999987654321


Q ss_pred             CCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC
Q psy4988         453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA  532 (627)
Q Consensus       453 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  532 (627)
                             ......+...|++||.+...   ..++.+.|+|+||+++|+|                               
T Consensus       149 -------~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         149 -------LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             -------hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH-------------------------------
Confidence                   12234678899999988421   2678899999999999999                               


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                            ..+.++|.+||..||.+||++.++++|+
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                  5789999999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345|consensus

Probab=99.97  E-value=1e-30  Score=256.29  Aligned_cols=265  Identities=22%  Similarity=0.345  Sum_probs=199.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~  363 (627)
                      +.|.|.|.+.||+|.||.+-+|.|+.++..+++|.+.....        .++.|.+|+..--.| .|.|||.-|++--..
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--------TQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--------hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            56789999999999999999999999999999998764322        245688887765555 489999999864446


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.|++++||++-|+|..-+.. ..+-|.....++.|++.||.|||+.+  |||||||.+||||-..+. .+|||||||+
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df-~rvKlcDFG~  169 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADF-YRVKLCDFGL  169 (378)
T ss_pred             CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCc-cEEEeeeccc
Confidence            6788899999999999887765 46889999999999999999999998  999999999999965443 4999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT-ILEEN  521 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~  521 (627)
                      .+..+...          ....-+..|.+||...... ......+..|||.||+|+|.+|+|++||......+. +.+-.
T Consensus       170 t~k~g~tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  170 TRKVGTTV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             ccccCcee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            98654321          1123466789998764332 233456789999999999999999999964332222 11111


Q ss_pred             HHhhhhccccC-CCCCCCHHHHHHHHHhhhcCcCCC---CCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFA-NKPTVSNEAKGFIRSCLAYRKEDR---IDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~-~~~~vs~el~~LI~~cL~~dP~~R---pt~~elL~hp~~~~~  571 (627)
                      ..........| ....+++.+..+.++-|..++++|   -++.......|....
T Consensus       240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            12222222222 124578899999999999999999   566666666776543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=5.4e-28  Score=238.66  Aligned_cols=201  Identities=41%  Similarity=0.670  Sum_probs=171.7

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      |.+.+.||.|+||.||++.+..+++.||||++......      .....+.+|+..++.++|+||+++++++. ....++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------KQREEFLREIRILKKLKHPNIVKLYGVFE-DPEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------HHHHHHHHHHHHHHhCCCCChhhheeeee-cCCceE
Confidence            56788999999999999999888999999998754332      13457888999999999999999999887 556788


Q ss_pred             EEEeecCCCChHHHHHhccC-cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      +++||+++++|..++..... +++..+..++.+++.+|.|||+.+  ++|+||+|.||+++.+   +.++|+|||++..+
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~  148 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD---GLVKLADFGLARFI  148 (225)
T ss_pred             EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEeeCceeeEe
Confidence            99999999999999987766 899999999999999999999988  9999999999999987   58999999999877


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH  510 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~  510 (627)
                      .....      .......++..|++||.+.   ....++.++|||+||+++|+|++|+.||..
T Consensus       149 ~~~~~------~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      149 HRDLA------ALLKTVKGTPFYLAPEVLL---GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCccc------ccccceeccCCcCCHhHhc---CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            54320      0123346888999999874   244577799999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=6.6e-29  Score=292.49  Aligned_cols=211  Identities=15%  Similarity=0.184  Sum_probs=148.8

Q ss_pred             cCCC-CceeEEeeEEee------cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         347 ALDH-PRVVKLYDVFEI------DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       347 ~l~H-pnIV~l~~~~~~------~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      .+.| +||+.++++|..      +...++++|||+. ++|..++.. ...+++.+++.|+.||+.||.|||+++  ||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr  104 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH  104 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence            4455 588888888721      2245778889875 699999965 356999999999999999999999988  9999


Q ss_pred             cccCCcEEecCC----------------CcccceEEeecccccccccCCCC------CCCC---ccccccCCCCCccCCc
Q psy4988         419 DLKPGNILLTEG----------------NVCGEIKITDFGLSKVMDEENYN------PDHG---MDLTSQGAGTYWYLPP  473 (627)
Q Consensus       419 DLKP~NILl~~~----------------~~~g~vKL~DFGla~~~~~~~~~------~~~~---~~~~~~~~Gt~~Y~AP  473 (627)
                      ||||+||||+..                ...+.+||+|||+++........      ....   .......+||++|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999642                11246778888877653211000      0000   0001124689999999


Q ss_pred             cccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCc
Q psy4988         474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRK  553 (627)
Q Consensus       474 E~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP  553 (627)
                      |++.    ...|+.++||||||||||||++|..||.........+..    ...   .+........+.+++.+||.+||
T Consensus       185 E~~~----~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~L~~~P  253 (793)
T PLN00181        185 EEDN----GSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH----RVL---PPQILLNWPKEASFCLWLLHPEP  253 (793)
T ss_pred             hhhc----cCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH----hhc---ChhhhhcCHHHHHHHHHhCCCCh
Confidence            9984    445899999999999999999999987532211111100    000   01111224567899999999999


Q ss_pred             CCCCCHHHHHhccCCCCC
Q psy4988         554 EDRIDVISLARHDYLQPP  571 (627)
Q Consensus       554 ~~Rpt~~elL~hp~~~~~  571 (627)
                      .+||++.++++||||...
T Consensus       254 ~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        254 SCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhCcChHHHhhchhhhhh
Confidence            999999999999999753

>KOG1024|consensus

Probab=99.95  E-value=6.4e-28  Score=246.61  Aligned_cols=258  Identities=21%  Similarity=0.261  Sum_probs=206.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeE-----EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRY-----VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~-----VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      -.+..+|+++..++-+|.||.||.|++.....+     |-||.+      +.....-.+..++.|--.+..+.|||+..+
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv------k~~AS~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV------KQHASQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH------HhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence            345667888889999999999999987654433     334432      223334446678889999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHh--------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQ--------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~--------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                      .+++..+....+.++.++.-++|..++..        -..++..+...++.|++.|++|||+++  |||.||-..|.+||
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID  430 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh
Confidence            99988788888899999999999999872        135778888999999999999999988  99999999999999


Q ss_pred             CCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q psy4988         429 EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKP  507 (627)
Q Consensus       429 ~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~P  507 (627)
                      +.   -.|||+|=.+++.+...+|+.-.     ..-.-...||+||.+.    ...|+.++|||||||+||||++ |+.|
T Consensus       431 d~---LqVkltDsaLSRDLFP~DYhcLG-----DnEnRPvkWMslEal~----n~~yssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  431 DQ---LQVKLTDSALSRDLFPGDYHCLG-----DNENRPVKWMSLEALQ----NSHYSSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             hh---eeEEeccchhccccCcccccccC-----CCCCCcccccCHHHHh----hhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence            87   59999999999998877766322     2224467899999995    4569999999999999999996 9999


Q ss_pred             CCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         508 FGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       508 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +...++.+...   .+.  ....+..+-++++++..++..||..+|++||+.+|+..
T Consensus       499 yaeIDPfEm~~---ylk--dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  499 YAEIDPFEMEH---YLK--DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ccccCHHHHHH---HHh--ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            97666544321   122  23344555679999999999999999999999999864

>KOG0590|consensus

Probab=99.94  E-value=3.6e-28  Score=274.30  Aligned_cols=274  Identities=23%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             ccCCCe-eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         284 VLSDRY-LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY-~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+.+.| .....+|.|++|.|+.+........++.|..... ....+....+...+..|+.+-..|.|||++..++.+..
T Consensus       314 ~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  314 GFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE  392 (601)
T ss_pred             ccccccCCccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh
Confidence            344556 4568899999999999888887777777765422 11223333444457889999999999999988887763


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                       ...+.-+||||++ +|+.++.....+...++..++.|++.||+|||++|  |.||||||+|+|+..+   |.+||+|||
T Consensus       393 -~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~---g~lki~Dfg  465 (601)
T KOG0590|consen  393 -IDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN---GILKIIDFG  465 (601)
T ss_pred             -cccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC---CceEEeecC
Confidence             3333344999999 99999998889999999999999999999999999  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      .+..+.-..-   .........+|+..|+|||++..   ..+....+||||.|+|++.|++|+.||......+.......
T Consensus       466 ~~~vf~~~~e---~~~~~~~g~~gS~pY~apE~~~~---~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~  539 (601)
T KOG0590|consen  466 AASVFRYPWE---KNIHESSGIVGSDPYLAPEVLTG---KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN  539 (601)
T ss_pred             cceeeccCcc---hhhhhhcCcccCCcCcCcccccc---cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc
Confidence            9987653321   11234556789999999999852   22344578999999999999999999965443322110000


Q ss_pred             ---HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ---ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ---~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                         ...........+..++.+.+.+|.+||++||.+|.|+.+|++.+||+..
T Consensus       540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence               0111111222334577889999999999999999999999999999854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=5.7e-25  Score=224.78  Aligned_cols=268  Identities=35%  Similarity=0.516  Sum_probs=203.8

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC-ceeEEeeEEeecCCeE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP-RVVKLYDVFEIDANSF  367 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIV~l~~~~~~~~~~~  367 (627)
                      |.+...||.|+|+.||++.+.   ..+++|++........    .....+.+|+.++..+.|+ +|+++++++. .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS----KEVERFLREIQILASLNHPPNIVKLYDFFQ-DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch----hHHHHHHHHHHHHHHccCCcceeeEEEEEe-cCCEE
Confidence            788999999999999999877   7889998865443221    2456788999999999988 7999999995 55557


Q ss_pred             EEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +++++|+.++++..++....   .+++..+..++.|++.+|.|+|+.+  ++||||||+|||++...  ..++++|||++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~--~~~~l~dfg~~  149 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDG--RVVKLIDFGLA  149 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCC--CeEEEeccCcc
Confidence            89999999999997777665   7999999999999999999999988  99999999999999873  26999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS---QATILEEN  521 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~---~~~~~~~~  521 (627)
                      ..+.......... .......||..|++||.+.... ...+....|+||+|++++++++|..||.....   ........
T Consensus       150 ~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         150 KLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             eecCCCCcccccc-ccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            8665433211000 1235568999999999984210 14678899999999999999999999866553   22222111


Q ss_pred             HHhhhhccccCCCCCC----CHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~v----s~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ................    ...+.+++..|+..+|..|.+..+...++|...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            1111000111111111    257899999999999999999999998876654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.1e-26  Score=222.67  Aligned_cols=163  Identities=24%  Similarity=0.322  Sum_probs=125.6

Q ss_pred             CChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCC
Q psy4988         377 HDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD  455 (627)
Q Consensus       377 g~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~  455 (627)
                      |+|.+++... ..+++.+++.|+.||+.||.|||+.+        ||+|||++.+   +.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~---~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD---GLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc---cceee--ccceEeecccc----
Confidence            6788888764 56999999999999999999999865        9999999887   57888  99998764321    


Q ss_pred             CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhcccc---C
Q psy4988         456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF---A  532 (627)
Q Consensus       456 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~  532 (627)
                              ..||+.|+|||++.    ...++.++|||||||+||||++|+.||.........+..... .......   +
T Consensus        64 --------~~g~~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  130 (176)
T smart00750       64 --------SRVDPYFMAPEVIQ----GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN-GMPADDPRDRS  130 (176)
T ss_pred             --------CCCcccccChHHhc----CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-HhccCCccccc
Confidence                    26899999999984    445889999999999999999999999655433222221111 1111100   1


Q ss_pred             CCCCCCH--HHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         533 NKPTVSN--EAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       533 ~~~~vs~--el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ....++.  ++.+||.+||..||.+||++.+++.|+|+.
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            1122334  699999999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163|consensus

Probab=99.94  E-value=1.1e-25  Score=217.92  Aligned_cols=263  Identities=17%  Similarity=0.244  Sum_probs=203.1

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH-PRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~  361 (627)
                      .+..+.|.++++||.|+||.+|+|....+|+.||||+-.......         ++..|..+.+.|++ ..|..+..++ 
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---------qL~yEskvY~iL~~g~GiP~i~~y~-   80 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---------QLLYESKVYRILQGGVGIPHIRHYG-   80 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---------chhHHHHHHHHhccCCCCchhhhhc-
Confidence            356789999999999999999999999999999999865443321         35667777777764 3444444444 


Q ss_pred             ecCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .+..+-.+||+++. .+|++++. +...|+..+++.++.|++.-|+|+|..+  +|||||||+|+|+.-+..|..+.|+|
T Consensus        81 ~e~~ynvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   81 TEKDYNVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             cccccceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEe
Confidence            36677779999985 68887764 6788999999999999999999999988  99999999999999887788999999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||||+.+.+.....+.+..-....+||..|.+--...    +...+...|+-|+|.+|.++.-|..||.+-.......+.
T Consensus       158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~----g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL----GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             ccchhhhccccccccCccccCCccceeeeehhhhhhh----hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            9999998876655555555566678999998876653    334677899999999999999999999766554433322


Q ss_pred             HHHhhhh-cc-ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         521 NTILKAT-EV-QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       521 ~~~~~~~-~~-~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      ..+.... .. .-.....+|.|+.-.+..|-..--++-|+..-+
T Consensus       234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl  277 (341)
T KOG1163|consen  234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL  277 (341)
T ss_pred             HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence            2222111 00 001234678899999999998888888987654

>KOG1164|consensus

Probab=99.93  E-value=3.1e-24  Score=226.95  Aligned_cols=263  Identities=19%  Similarity=0.160  Sum_probs=192.1

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCC-eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC----CCceeEEeeEEee
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD----HPRVVKLYDVFEI  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~-~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~----HpnIV~l~~~~~~  362 (627)
                      +|.+.++||+|+||.||++.+..++ ..+|+|+..........       .+..|+.++..+.    -+++..+++.+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~   91 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-------VLKIEIQVLKKLEKKNGPSHFPKLLDHGRS   91 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-------cchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence            8999999999999999999988875 78999987654321110       2445777777775    2588888888743


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceEE
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKI  438 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vKL  438 (627)
                      .....+|||+++. .+|.++....  +.|+...+..|+.|++.+|.+||+.|  +|||||||+|+++....  ....+.|
T Consensus        92 ~~~~~~iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~l  168 (322)
T KOG1164|consen   92 TEDFNFIVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYL  168 (322)
T ss_pred             CCceeEEEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEE
Confidence            4556779999884 7888877544  58999999999999999999999998  99999999999998653  1247999


Q ss_pred             eeccccc--ccccCCCCCCCCccc-cccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         439 TDFGLSK--VMDEENYNPDHGMDL-TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       439 ~DFGla~--~~~~~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      .|||+++  .+............. .....||..|.++.+.    .+...+.+.|+||++.++.+|+.|..||.......
T Consensus       169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H----~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH----LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHh----CCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            9999998  332221110011111 2334699999999987    45668889999999999999999999996655432


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ............... ......+.++..+...+-..+..++|+...+...
T Consensus       245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  245 LKSKFEKDPRKLLTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hHHHHHHHhhhhccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            222211111111111 0223456788888888888999999999888654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.9e-25  Score=233.50  Aligned_cols=178  Identities=21%  Similarity=0.226  Sum_probs=133.0

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE-Eee
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK-LYD  358 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~-l~~  358 (627)
                      ..+.+.++|.+.+.||+|+||+||+|++.. +++.||||++.....+..  .......+.+|+++|+.++|+|||. +++
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~--~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS--KPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc--cHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            345788999999999999999999998876 788889998653211100  1123456889999999999999985 443


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc-cCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL-KPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL-KP~NILl~~~~~~g~vK  437 (627)
                      +     ...|||||||+|++|... ..   ..   ...++.|++.+|.|||+.+  |||||| ||+|||++.+   +.+|
T Consensus        90 ~-----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~---~~ik  152 (365)
T PRK09188         90 T-----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD---GEAA  152 (365)
T ss_pred             c-----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC---CCEE
Confidence            2     346899999999999632 11   11   1468899999999999988  999999 9999999865   5899


Q ss_pred             EeecccccccccCCCCCCC-CccccccCCCCCccCCccccc
Q psy4988         438 ITDFGLSKVMDEENYNPDH-GMDLTSQGAGTYWYLPPECFV  477 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~APE~l~  477 (627)
                      |+|||+|+.+......... ...-.....+++.|+|||.+.
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999999987654311110 001113457899999999884

>KOG1165|consensus

Probab=99.92  E-value=2.7e-24  Score=216.58  Aligned_cols=261  Identities=18%  Similarity=0.232  Sum_probs=197.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      ++.-.|++.++||+|+||+.|.|.+..++++||||.-.......         ++..|++..+.| ..++|...|.+-. 
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP---------QLrdEYr~YKlL~g~~GIP~vYYFGq-   94 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP---------QLRDEYRTYKLLGGTEGIPQVYYFGQ-   94 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCcc---------hHHHHHHHHHHHcCCCCCCceeeecc-
Confidence            45667999999999999999999999999999999865443321         345577777766 4688888776443 


Q ss_pred             cCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceEEe
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKIT  439 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vKL~  439 (627)
                      ++.+-.||+|++. -+|++++. +..+|+.+.+..|+.|++.-|+|+|++.  +|.|||||+|+||....  ....|.|+
T Consensus        95 eG~~NiLVidLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   95 EGKYNILVIDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             ccchhhhhhhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEE
Confidence            6666679999985 68888775 6679999999999999999999999988  99999999999997531  12379999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.+.+.....+....-.....||..||+=-..+    +...+...|+-|||-+++++|-|.+||.+-.......+
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl----GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccc----cchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            99999999888766666666667778999999876653    55678899999999999999999999976544332222


Q ss_pred             HHHHhhh---hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         520 ENTILKA---TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       520 ~~~~~~~---~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      ...+...   ..+. .....++.++...++-.-..+-.+-|+.+-+
T Consensus       248 YeKIGe~Kr~T~i~-~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl  292 (449)
T KOG1165|consen  248 YEKIGETKRSTPIE-VLCEGFPEEFATYLRYVRRLDFFETPDYDYL  292 (449)
T ss_pred             HHHhccccccCCHH-HHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence            2222111   1111 0113466777777777777777777876543

>KOG0603|consensus

Probab=99.90  E-value=6.2e-25  Score=238.21  Aligned_cols=239  Identities=29%  Similarity=0.420  Sum_probs=194.2

Q ss_pred             ecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeEEEE
Q psy4988         295 LGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      +|.|+||.|+++...   ..+..+|+|+...........     .+...|..++..++ ||.+|++...|+.+ ...+++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-----~~t~~er~il~~~~~~~f~v~lhyafqt~-~kl~l~   75 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-----THTKQERIILAFVHNTPFLVKLHYAFQTD-GKLYLI   75 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-----cccccHHHHHhhccCCCceeeeeeeeccc-cchhHh
Confidence            799999999987432   357789999876543322211     14455777888887 99999999999854 556799


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      ++|..|++|...+.....+.+.....+...++.+++++|+.+  |+|||+|++||+++.+   |++++.|||+++..-..
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~---Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE---GHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc---CccccCCchhhhHhHhh
Confidence            999999999999999999999999999999999999999999  9999999999999998   79999999999976543


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ  530 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  530 (627)
                      ..           .|||..|||||++.      .....+|+||||+++|+|++|..||..     .+.  ..+   ....
T Consensus       151 ~~-----------~cgt~eymApEI~~------gh~~a~D~ws~gvl~felltg~~pf~~-----~~~--~~I---l~~~  203 (612)
T KOG0603|consen  151 KI-----------ACGTYEYRAPEIIN------GHLSAADWWSFGVLAFELLTGTLPFGG-----DTM--KRI---LKAE  203 (612)
T ss_pred             hh-----------cccchhhhhhHhhh------ccCCcccchhhhhhHHHHhhCCCCCch-----HHH--HHH---hhhc
Confidence            21           19999999999984      356789999999999999999999976     111  111   1223


Q ss_pred             cCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         531 FANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       531 ~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      +..+..++.++.++++.++..+|..|.-     +.++++|+||+..
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence            4445578899999999999999999974     5789999999753

>KOG0606|consensus

Probab=99.88  E-value=6.3e-23  Score=232.10  Aligned_cols=228  Identities=26%  Similarity=0.418  Sum_probs=164.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|..++.|..|+||-||++.|+.+.+.+|+|+-+ .         +.   ++|-  |+.....|.+|          
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q---------~l---ilRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q---------NL---ILRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-c---------ch---hhhc--cccccCCccee----------
Confidence            4567899999999999999999999999999997521 0         10   1111  22222233222          


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                                  |+-...++.-+.++...        +.+++|||+.+  |||||+||+|.||..-   |++|++|||++
T Consensus       136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m---GhiKlTDfgLs  190 (1205)
T KOG0606|consen  136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM---GHIKLTDFGLS  190 (1205)
T ss_pred             ------------chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec---ccccccchhhh
Confidence                        45555666656666544        88999999988  9999999999999986   79999999998


Q ss_pred             cccccCC----CCCC---CCccc-cccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         445 KVMDEEN----YNPD---HGMDL-TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       445 ~~~~~~~----~~~~---~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      +...-..    +..+   ....+ ....||||.|+|||++.    ...|+..+|+|++|+|+||++.|+.||.++...+.
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil----rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel  266 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL  266 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh----hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence            7532111    0000   00011 23569999999999985    44589999999999999999999999998876654


Q ss_pred             HHHHHHHhhhhccccC-CCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHhccCCCC
Q psy4988         517 ILEENTILKATEVQFA-NKPTVSNEAKGFIRSCLAYRKEDRI---DVISLARHDYLQP  570 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~-~~~~vs~el~~LI~~cL~~dP~~Rp---t~~elL~hp~~~~  570 (627)
                      +-..   +. ..+.|+ ....+++|++++|.++|..+|..|.   ...++-+|+||+.
T Consensus       267 fg~v---is-d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  267 FGQV---IS-DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             Hhhh---hh-hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            4221   11 222332 2356789999999999999999996   5667778999863

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.9e-22  Score=195.87  Aligned_cols=147  Identities=19%  Similarity=0.195  Sum_probs=111.4

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHh-------------------HHHHHHHHHHHHHHHhcCCCCc
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK-------------------KANYIKHALREYNIHKALDHPR  352 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~-------------------~~~~~~~~~~Ei~il~~l~Hpn  352 (627)
                      ...||+|+||.||+|.+. +|+.||||++..........                   .........+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            356999999999999986 89999999987543211100                   0001123346999999998877


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccccCCcEEecCCC
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL-NEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yL-H~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      |.....+.. . . .+|||||++|+++...+.....+++..+..++.||+.+|.|| |+.+  ||||||||+|||++.  
T Consensus        81 v~~p~~~~~-~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~~--  153 (190)
T cd05147          81 IPCPEPILL-K-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYHD--  153 (190)
T ss_pred             CCCCcEEEe-c-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEEC--
Confidence            644333222 2 2 269999999988766544557899999999999999999999 7888  999999999999984  


Q ss_pred             cccceEEeecccccccc
Q psy4988         432 VCGEIKITDFGLSKVMD  448 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~  448 (627)
                        +.++|+|||+|....
T Consensus       154 --~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 --GKLYIIDVSQSVEHD  168 (190)
T ss_pred             --CcEEEEEccccccCC
Confidence              479999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.9e-21  Score=199.30  Aligned_cols=238  Identities=24%  Similarity=0.329  Sum_probs=152.4

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC----------CCceeEEee
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD----------HPRVVKLYD  358 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~----------HpnIV~l~~  358 (627)
                      +.....||.|+|+.||.+.|..+++.+|||+.........    ..++.+.+|.-....+.          |-.++..+|
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~----~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA----NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT----THHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccch----HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            4567889999999999999999999999999877663222    22444555543333321          223333333


Q ss_pred             EEeec-----------CCe-----EEEEEeecCCCChHHHHH---hcc----CcCHHHHHHHHHHHHHHHHHHHhCCCCE
Q psy4988         359 VFEID-----------ANS-----FCTVLEYCDGHDLDFYLK---QHK----TIAEREARSIVMQVVSALKYLNEIKPPV  415 (627)
Q Consensus       359 ~~~~~-----------~~~-----~~lV~E~~~gg~L~~~l~---~~~----~l~e~~~~~i~~qi~~aL~yLH~~~~~I  415 (627)
                      .....           ...     ++++|+-+. ++|..++.   ...    .+.......+..|++..+++||..|  |
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--l  166 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--L  166 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--e
Confidence            32211           112     357788775 67777654   221    2233334566699999999999999  9


Q ss_pred             EeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC----CCCCCCcchhH
Q psy4988         416 IHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK----NPPKISSKVDV  491 (627)
Q Consensus       416 vHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~~~~~~~k~DV  491 (627)
                      ||+||+|+|+|++.+   |.++|+||+.........         .. ...+..|.|||......    ....++.+.|.
T Consensus       167 VHgdi~~~nfll~~~---G~v~Lg~F~~~~r~g~~~---------~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da  233 (288)
T PF14531_consen  167 VHGDIKPENFLLDQD---GGVFLGDFSSLVRAGTRY---------RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDA  233 (288)
T ss_dssp             EEST-SGGGEEE-TT---S-EEE--GGGEEETTEEE---------EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH
T ss_pred             EecccceeeEEEcCC---CCEEEcChHHHeecCcee---------ec-cCCCcccCChhhhhhhcccCcccceeeeccCH
Confidence            999999999999997   799999999887654321         11 23457899999764211    23357889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCC
Q psy4988         492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR  556 (627)
Q Consensus       492 wSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~R  556 (627)
                      |+||++||.|+|+..||+.......          ....|.....+++.++.||+.+|++||.+|
T Consensus       234 W~LG~~ly~lWC~~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  234 WQLGITLYSLWCGRLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHSS-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHHccCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9999999999999999976543221          111455555899999999999999999988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=3.4e-22  Score=199.11  Aligned_cols=176  Identities=13%  Similarity=0.188  Sum_probs=133.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHH------HHHHHHHHhcCCCCceeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH------ALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIV~l~  357 (627)
                      ++.++|+++++||.|+||.||++.+  ++..+|||++.......    +..+..      +.+|+..+.++.||+|..+.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~----~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~  101 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRT----ERFLKSFVKGDYYENLIVQTDRVRSEGLASLN  101 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCch----HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence            5789999999999999999999754  46789999986443221    222223      56899999999999999999


Q ss_pred             eEEeecC-------CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC
Q psy4988         358 DVFEIDA-------NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       358 ~~~~~~~-------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~  430 (627)
                      +++....       ...+|||||++|.+|.++..    +++    .+..+|+.+|..||..|  |+||||||+|||++.+
T Consensus       102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~  171 (232)
T PRK10359        102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             EeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC
Confidence            9876332       34689999999999987632    333    34669999999999998  9999999999999876


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL  502 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell  502 (627)
                         + ++|+|||..........                    -+.+.   ....|+.++|||||||+|..+.
T Consensus       172 ---g-i~liDfg~~~~~~e~~a--------------------~d~~v---ler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 ---G-LRIIDLSGKRCTAQRKA--------------------KDRID---LERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ---C-EEEEECCCcccccchhh--------------------HHHHH---HHhHhcccccccceeEeehHHH
Confidence               5 99999998876533210                    01111   1223567899999999987554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.3e-21  Score=189.50  Aligned_cols=148  Identities=20%  Similarity=0.157  Sum_probs=113.0

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-------------------hHHHHHHHHHHHHHHHhcCCCCc
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-------------------KKANYIKHALREYNIHKALDHPR  352 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-------------------~~~~~~~~~~~Ei~il~~l~Hpn  352 (627)
                      ...||+|+||.||+|.+. +|+.||||++.........                   ........+.+|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999998765311000                   00001123457999999999998


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCC
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~  431 (627)
                      |.....+.. ..  .||||||++|+++.........+++..+..++.|++.+|.+||. .|  |+||||||+|||++ + 
T Consensus        81 i~~p~~~~~-~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~-  153 (190)
T cd05145          81 VPVPEPILL-KK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D-  153 (190)
T ss_pred             CCCceEEEe-cC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C-
Confidence            755444333 22  36999999988654443344678899999999999999999999 88  99999999999998 3 


Q ss_pred             cccceEEeeccccccccc
Q psy4988         432 VCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~  449 (627)
                        +.++|+|||++..+..
T Consensus       154 --~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 --GKPYIIDVSQAVELDH  169 (190)
T ss_pred             --CCEEEEEcccceecCC
Confidence              5899999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195|consensus

Probab=99.85  E-value=1.2e-21  Score=192.58  Aligned_cols=286  Identities=14%  Similarity=0.228  Sum_probs=211.7

Q ss_pred             HHHHHHHHHhhhccccccCCCCCCccchhcccccchHHHHHhhhcccccccCCCCccCCCeeEEEEecccCceEEEEEEE
Q psy4988         229 NLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFD  308 (627)
Q Consensus       229 ~~~~~~lk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~  308 (627)
                      +++.++.+++...++.+-.+.....+..+..+..+++.+|.                     ++.+|.+.-.|+.|+|++
T Consensus       153 ek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~ln---------------------l~tkl~e~hsgelwrgrw  211 (448)
T KOG0195|consen  153 EKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLN---------------------LITKLAESHSGELWRGRW  211 (448)
T ss_pred             HHhCCCCCcccccccccccccccccccccccccCcchhhhh---------------------hhhhhccCCCcccccccc
Confidence            34556677777777777766666666666666666665554                     344578888899999965


Q ss_pred             cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc-
Q psy4988         309 LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-  387 (627)
Q Consensus       309 ~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-  387 (627)
                      .  +..+++|++..... .    ...-+.|..|+-.|+-+.||||+.+++.|. ....+.++..||+-++|...+.... 
T Consensus       212 q--gndivakil~vr~~-t----~risrdfneefp~lrifshpnilpvlgacn-sppnlv~isq~mp~gslynvlhe~t~  283 (448)
T KOG0195|consen  212 Q--GNDIVAKILNVREV-T----ARISRDFNEEFPALRIFSHPNILPVLGACN-SPPNLVIISQYMPFGSLYNVLHEQTS  283 (448)
T ss_pred             c--Ccchhhhhhhhhhc-c----hhhcchhhhhCcceeeecCCchhhhhhhcc-CCCCceEeeeeccchHHHHHHhcCcc
Confidence            4  55667787654321 1    122345778888999999999999999998 4566779999999999999998764 


Q ss_pred             -CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCC
Q psy4988         388 -TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG  466 (627)
Q Consensus       388 -~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~G  466 (627)
                       .++..++.+++.+|++|+.|||+..+-|.-.-|....|+||++.. -++-.+|--++....              ....
T Consensus       284 vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlt-arismad~kfsfqe~--------------gr~y  348 (448)
T KOG0195|consen  284 VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSFQEV--------------GRAY  348 (448)
T ss_pred             EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhh-hheecccceeeeecc--------------cccc
Confidence             467789999999999999999999776777789999999999853 244556654443221              1245


Q ss_pred             CCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHH
Q psy4988         467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIR  546 (627)
Q Consensus       467 t~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~  546 (627)
                      .|.||+||.+...... ..-.++|+|||.++||||.|...||..-.+.+.-.+.    ....+....++.++..+..|+.
T Consensus       349 ~pawmspealqrkped-~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~hm~klm~  423 (448)
T KOG0195|consen  349 SPAWMSPEALQRKPED-LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISRHMNKLMN  423 (448)
T ss_pred             CcccCCHHHHhcCchh-cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccHHHHHHHH
Confidence            7899999998633211 2335799999999999999999999876665544332    1223445566799999999999


Q ss_pred             HhhhcCcCCCCCHHHHH
Q psy4988         547 SCLAYRKEDRIDVISLA  563 (627)
Q Consensus       547 ~cL~~dP~~Rpt~~elL  563 (627)
                      -|+.-||.+||..+.++
T Consensus       424 icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  424 ICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHhcCCCCcCCCcceeh
Confidence            99999999999887764

>KOG4158|consensus

Probab=99.84  E-value=9.6e-21  Score=194.76  Aligned_cols=266  Identities=23%  Similarity=0.263  Sum_probs=175.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCe-----------------------------------EEEEEEeecCcchhhHh
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQR-----------------------------------YVACKVHQLNKDWKEDK  330 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~-----------------------------------~VAVKii~~~~~~~~~~  330 (627)
                      .|+|.|...||+|.-..||.|....++.                                   +.|||++-.-...  ..
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~--s~  233 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD--SG  233 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC--Cc
Confidence            4679999999999999999986544221                                   2466654322111  12


Q ss_pred             HHHHHHHHHHHHH------H--------Hhc--------CCCCceeEEeeEEeec-------------------------
Q psy4988         331 KANYIKHALREYN------I--------HKA--------LDHPRVVKLYDVFEID-------------------------  363 (627)
Q Consensus       331 ~~~~~~~~~~Ei~------i--------l~~--------l~HpnIV~l~~~~~~~-------------------------  363 (627)
                      ....++..-+|.-      .        .+.        -.|||||.++.+|...                         
T Consensus       234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g  313 (598)
T KOG4158|consen  234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG  313 (598)
T ss_pred             hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence            2223333333321      1        111        1699999999887531                         


Q ss_pred             -CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC-CCcccceEEeec
Q psy4988         364 -ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE-GNVCGEIKITDF  441 (627)
Q Consensus       364 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~-~~~~g~vKL~DF  441 (627)
                       ...+|+||...+ .+|..|+.. ...+....+-|+.|+++|+.|||.+|  |.|||||.+||||.- ++.+..++|+||
T Consensus       314 ~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  314 EPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             CCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEccc
Confidence             245689998776 578887765 45777888899999999999999998  999999999999843 334568999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccC--CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG--KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |++-.-+.....-....+ .-...|.-.-||||++..-  .+-.-.-.++|.|+.|.+.||++....||.....  ..++
T Consensus       390 GCcLAd~~hGlqlpy~S~-~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~  466 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESD-EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLD  466 (598)
T ss_pred             ceeeeccccccccccccc-cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heec
Confidence            987432221111000000 1122578889999998422  1111123478999999999999999999965221  1121


Q ss_pred             HHHHhhhhcccc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         520 ENTILKATEVQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       520 ~~~~~~~~~~~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      ...   ..+-++ +.+..+++.+.+||..+|+.||++|++..-+.
T Consensus       467 ~r~---Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  467 TRT---YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             hhh---hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence            111   112222 23457899999999999999999999876544

>KOG1240|consensus

Probab=99.83  E-value=2.2e-21  Score=219.62  Aligned_cols=260  Identities=22%  Similarity=0.253  Sum_probs=180.7

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      .|...+.||.+.|=.|.+|.+.+ |. |+||++......-   ...-+.+-++|++ ...++|||++.+.-+.+.+ ..-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~---sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTI---SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-KAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCC---CchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-HHH
Confidence            67788899999999999997643 43 8999987554211   1122334455666 6667999999988776533 445


Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |||-+|.. .+|.+.+.....+.+-+.+.|+.||+.||.-+|..|  |+|+|||.+||||+.=+   .+.|+||-.-+-.
T Consensus        97 ylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWN---W~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   97 YLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWN---WLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeec---hhhhhcccccCCc
Confidence            58888887 578888888888899999999999999999999999  99999999999999753   7899999766533


Q ss_pred             ccCCCCCCCCccccccCCCCCccCCccccccC-------CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVG-------KNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       448 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      .-...++..-.-+..+..--..|+|||.|...       ...+..+++.||||+||+++||++ |++||.-.    .++.
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~a  246 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLA  246 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHh
Confidence            22221221111112222344579999998642       122237789999999999999986 79999421    1211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .+... ......-...--+..++.||..|++.||++|.++++.|+.
T Consensus       247 Yr~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  247 YRSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11110 0000000000012368899999999999999999999974

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.1e-20  Score=183.10  Aligned_cols=137  Identities=20%  Similarity=0.205  Sum_probs=107.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-----CCCceeEEeeEEeecCC--
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-----DHPRVVKLYDVFEIDAN--  365 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~--  365 (627)
                      ..||+|+||.||.  +..+... +||++......       ....+.+|+.+++.+     +||||++++++++++..  
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCe-EEEEEeccccc-------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            5699999999995  6777666 69988654221       124578999999999     67999999999986642  


Q ss_pred             e-EEEEEee--cCCCChHHHHHhccCcCHHHHHHHHHHHHHHH-HHHHhCCCCEEeccccCCcEEecCCC-cccceEEee
Q psy4988         366 S-FCTVLEY--CDGHDLDFYLKQHKTIAEREARSIVMQVVSAL-KYLNEIKPPVIHYDLKPGNILLTEGN-VCGEIKITD  440 (627)
Q Consensus       366 ~-~~lV~E~--~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL-~yLH~~~~~IvHrDLKP~NILl~~~~-~~g~vKL~D  440 (627)
                      . +.+|+||  +.+++|.+++++. .+++.  ..++.+++.++ +|||+++  ||||||||+|||++... ....++|+|
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            3 4589999  5589999999764 56666  36688888888 9999998  99999999999998542 224899999


Q ss_pred             cccc
Q psy4988         441 FGLS  444 (627)
Q Consensus       441 FGla  444 (627)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=3.3e-20  Score=181.53  Aligned_cols=197  Identities=18%  Similarity=0.084  Sum_probs=140.1

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~~l  369 (627)
                      +...|+.|+||+||++..  .+..|+.+.+.....|....   ....+.+|+++|++|. |++|++++++     +..|+
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~---~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~l   75 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGV---AWWLARREALALRQLDGLPRTPRLLHW-----DGRHL   75 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhH---HHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEE
Confidence            457799999999998753  67788877766555443211   1225778999999995 5889999886     22579


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc-cCCcEEecCCCcccceEEeecccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL-KPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL-KP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      +|||+.|.+|...+..       ....++.|++.+|.+||+.|  |||||| ||+|||++.+   +.++|+|||+|....
T Consensus        76 vmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~---g~i~LIDFG~A~~~~  143 (218)
T PRK12274         76 DRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED---GSPAVIDFQLAVRGN  143 (218)
T ss_pred             EEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC---CCEEEEECCCceecC
Confidence            9999999998654321       12457889999999999998  999999 7999999875   689999999998654


Q ss_pred             cCCCCCC--CCccc----cccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy4988         449 EENYNPD--HGMDL----TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN  511 (627)
Q Consensus       449 ~~~~~~~--~~~~~----~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~  511 (627)
                      .......  ...++    ......++.|+.|+......  ..--...++++.|+-+|.++|+..++..+
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            3210000  00000    11123688899998643211  11224679999999999999999997543

>KOG1166|consensus

Probab=99.79  E-value=3.3e-19  Score=205.92  Aligned_cols=204  Identities=21%  Similarity=0.226  Sum_probs=159.2

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEe
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---HPRVVKLY  357 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~  357 (627)
                      ..++-.+.|.|-+.||+|+||.||+|.+.. ++.||||+-.....|...-..          +++.+|+   -+-|..+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~----------q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL----------QVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH----------HHHHhhchhhhcchHHHH
Confidence            345667899999999999999999999777 999999998777776543222          2333333   23344444


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC----cc
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN----VC  433 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~----~~  433 (627)
                      .++.. .+..+||+||.+.|+|.+++...+.+++..+..|+.|++..|++||..+  |||+||||+|+||....    ..
T Consensus       761 ~a~~~-~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  761 SAHVF-QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             HHHcc-CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcc
Confidence            44442 3344599999999999999998899999999999999999999999998  99999999999995321    12


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                      .-++|+|||.+..+.--.   . + ......++|-.+-.+|+.    .+..+++.+|.|.|..+++.||+|++-
T Consensus       838 ~~l~lIDfG~siDm~lfp---~-~-~~F~~~~~td~f~C~EM~----~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFP---D-G-TKFKAVWHTDLFDCIEMR----EGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cceEEEecccceeeeEcC---C-C-cEEeeeeccccchhHHHh----cCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            469999999997654211   0 0 123345789999999987    577899999999999999999999754

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=7.1e-19  Score=177.89  Aligned_cols=151  Identities=19%  Similarity=0.122  Sum_probs=113.6

Q ss_pred             CeeEEEEecccCceEEEEEE-EcCCCeEEEEEEeecCcchhh-----------------HhHHHHHHHHHHHHHHHhcCC
Q psy4988         288 RYLLLMLLGKGGFSEVHKAF-DLKEQRYVACKVHQLNKDWKE-----------------DKKANYIKHALREYNIHKALD  349 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~-~~~~~~~VAVKii~~~~~~~~-----------------~~~~~~~~~~~~Ei~il~~l~  349 (627)
                      -|.+.+.||+|+||.||+|. +..+++.||||++........                 .........+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            37788999999999999998 778999999999875431000                 000111234568999999997


Q ss_pred             CC--ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe
Q psy4988         350 HP--RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL  427 (627)
Q Consensus       350 Hp--nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl  427 (627)
                      +.  .+.+++++   . . .+|||||++|.+|..+......+....+..++.||+.+|.+||+.+ .|+||||||+|||+
T Consensus       109 ~~~i~~p~~~~~---~-~-~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli  182 (237)
T smart00090      109 EAGVPVPKPIAW---R-R-NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV  182 (237)
T ss_pred             hcCCCCCeeeEe---c-C-ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE
Confidence            53  23344432   2 2 3699999999888766544556777788899999999999999854 39999999999999


Q ss_pred             cCCCcccceEEeecccccccc
Q psy4988         428 TEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       428 ~~~~~~g~vKL~DFGla~~~~  448 (627)
                      + +   +.++|+|||++....
T Consensus       183 ~-~---~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-D---GKVVIIDVSQSVELD  199 (237)
T ss_pred             E-C---CCEEEEEChhhhccC
Confidence            8 3   589999999987543

>KOG1033|consensus

Probab=99.76  E-value=1.9e-19  Score=192.41  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=165.3

Q ss_pred             CeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee------
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD------  358 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~------  358 (627)
                      .+.+.+.++..+++.++...-...   .+.++.+.....       .........+++-.+....|-+..-+.+      
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d-------~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~  317 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD-------SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLF  317 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhcc-------chhhhhhhhhhhhheeccccCCcccccCCCCchh
Confidence            344555566666666665543332   333333332221       1122334455666665555444444433      


Q ss_pred             -EEee----cCCeEEEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC
Q psy4988         359 -VFEI----DANSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       359 -~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~  430 (627)
                       .+..    ...++||.|++|.-.+|.+||....   ..+.-....++.|++.+++|   ++  .+|+|+||.||++..+
T Consensus       318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d  392 (516)
T KOG1033|consen  318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD  392 (516)
T ss_pred             hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc
Confidence             1110    1235789999999999999997543   56778889999999999999   56  9999999999999887


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFG  509 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~  509 (627)
                         ..+||.|||+.......... .....-.+..+||.+||+||.+    .+..|+.++||||||+|||||+. =..+|.
T Consensus       393 ---~q~kIgDFgl~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi----~g~~y~~kvdIyaLGlil~EL~~~f~T~~e  464 (516)
T KOG1033|consen  393 ---DQLKIGDFGLVTSQDKDETV-APAAASHTQQVGTLLYMSPEQI----RGQQYSEKVDIYALGLILAELLIQFSTQFE  464 (516)
T ss_pred             ---hhhhhhhhhheeecccCCcc-cchhhhhhhcccccccCCHHHH----hhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence               48999999999887654310 0111223456899999999999    46679999999999999999995 223331


Q ss_pred             CCChHHHHHHHHHHhhhhccccC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         510 HNQSQATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                            .+   ..........+|  .+... ++-.+|+.+||...|.+||++.+...|.|++
T Consensus       465 ------r~---~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  465 ------RI---ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ------HH---HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                  11   111111122222  11111 3456899999999999999888888888763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=6.5e-18  Score=167.06  Aligned_cols=141  Identities=22%  Similarity=0.254  Sum_probs=111.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh-HhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE-DKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      +.||+|++|.||+|.+  .+..|+||+......... .........+.+|+.++..+.|++|+....++. +....++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-DPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-eCCCCEEEE
Confidence            4699999999999976  677899997653321111 111122345788999999999998877666655 345567999


Q ss_pred             eecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       372 E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ||++|.+|.+++.....    ....++.+++.+|.+||+.+  |+|+||+|.|||++ +   +.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~---~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G---GKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C---CCEEEEECCcccC
Confidence            99999999998865332    78899999999999999988  99999999999998 3   5899999999865

>KOG0590|consensus

Probab=99.76  E-value=3.1e-20  Score=210.02  Aligned_cols=267  Identities=25%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeec
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEID  363 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~  363 (627)
                      ...|.+.+.||+|+|+.|-.+.+.. ....+|+|.+....     .......++..|+.+.+.+. |.|++.+++... +
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-----~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~   92 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-----KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-S   92 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-----CccchhhhcCccccccccccccccccccCCccC-C
Confidence            3457788889999999999887644 45567777654433     22233445667888888887 999999999876 6


Q ss_pred             CCeEEEEEeecCCCChHHHH-Hhcc-CcCHHHHHHHHHHHHHHHHHHH-hCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         364 ANSFCTVLEYCDGHDLDFYL-KQHK-TIAEREARSIVMQVVSALKYLN-EIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l-~~~~-~l~e~~~~~i~~qi~~aL~yLH-~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      ...++++++|..|+++...+ .... ..+...+..++.|+..+|.|+| ..+  +.|+||||+|.+++....  .+++.|
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~--~l~~~d  168 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGS--ALKIAD  168 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCC--cccCCC
Confidence            77788999999999999988 5554 7888899999999999999999 777  999999999999998731  899999


Q ss_pred             cccccccccCCCCCCCCccccccCCC-CCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~G-t~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      ||+|..+....    .........+| ++.|+|||.+..   ........|+||+|+++.-+++|..||...........
T Consensus       169 f~~At~~~~~~----g~~~~~~~~~g~s~~y~a~E~~~~---~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~  241 (601)
T KOG0590|consen  169 FGLATAYRNKN----GAERSLKDRCGSSPPYGAPEHLSG---KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS  241 (601)
T ss_pred             chhhccccccC----CcceeeecccCCCCCCCCcccccc---hhhcCCCcccccccccccccccCCCCccccccccccce
Confidence            99998876521    11123344578 999999999852   23567789999999999999999999975544332211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .. ...........|..++....+++.++|..+|..|.+..++-.++|+..
T Consensus       242 ~~-~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 SW-KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ee-cccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            10 011112234566788999999999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.7e-17  Score=162.61  Aligned_cols=138  Identities=17%  Similarity=0.169  Sum_probs=105.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchh-hHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEe
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK-EDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      .||+|+||.||++.  .++..|+||+........ .........++.+|++++..+.|++|.....++. +.+..++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEE
Confidence            38999999999997  467889999865432111 1112222356788999999998886544433333 3445679999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |++|++|.+++.....       .++.+++.+|.+||+.+  |+|+||+|.|||++ +   +.++|+|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~---~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D---DKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C---CcEEEEECCCCcCC
Confidence            9999999988765321       78999999999999988  99999999999998 3   58999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2.4e-17  Score=186.15  Aligned_cols=147  Identities=21%  Similarity=0.220  Sum_probs=111.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcc-hhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD-WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~-~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .....|...++||+|+||+||++.+...  .+++|+...... ...........++.+|+++++.++|++|+..+.++. 
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-  406 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-  406 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-
Confidence            3345566789999999999999976443  445554322211 111112222456889999999999999988776665 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +....++||||++|++|.+++.        ....++.+++.+|.|||+.+  |+||||||+|||++.    +.++|+|||
T Consensus       407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~~----~~~~liDFG  472 (535)
T PRK09605        407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVRD----DRLYLIDFG  472 (535)
T ss_pred             eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEEC----CcEEEEeCc
Confidence            4445679999999999998875        35679999999999999988  999999999999943    489999999


Q ss_pred             ccccc
Q psy4988         443 LSKVM  447 (627)
Q Consensus       443 la~~~  447 (627)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=1.2e-17  Score=164.14  Aligned_cols=144  Identities=27%  Similarity=0.249  Sum_probs=108.4

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHh--HH-------------HHHHHHHHHHHHHhcCCCCc-
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK--KA-------------NYIKHALREYNIHKALDHPR-  352 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~--~~-------------~~~~~~~~Ei~il~~l~Hpn-  352 (627)
                      |.+.+.||.|+||.||++.+. +++.||||++..........  ..             .....+.+|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777889999999999999864 79999999976543110000  00             01123567899999998774 


Q ss_pred             -eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         353 -VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       353 -IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                       +...++.     ...++||||++|++|..+...      .....++.+++.+|.++|+.+  |+|+||||+|||++.+ 
T Consensus        96 ~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~-  161 (198)
T cd05144          96 PVPKPIDW-----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDD-  161 (198)
T ss_pred             CCCceeec-----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCC-
Confidence             4444432     234799999999998765431      345678999999999999988  9999999999999875 


Q ss_pred             cccceEEeeccccccccc
Q psy4988         432 VCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~  449 (627)
                        +.++|+|||++..+..
T Consensus       162 --~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 --EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             --CcEEEEECCccccCCC
Confidence              6899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023|consensus

Probab=99.72  E-value=1.8e-17  Score=180.34  Aligned_cols=210  Identities=20%  Similarity=0.270  Sum_probs=154.6

Q ss_pred             HhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCC
Q psy4988         345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG  423 (627)
Q Consensus       345 l~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~  423 (627)
                      |+.+.|.|+.++++.+. +...+++|.+||.-|+|.+.+.. ...+++.....++++|+.||.|||..- -.+|+-|+..
T Consensus         1 l~~l~h~n~~~f~g~~~-~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASV-DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEe-cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence            46789999999999987 66888899999999999999986 467888999999999999999999854 2399999999


Q ss_pred             cEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCC---CCcchhHHHHHHHHHH
Q psy4988         424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPK---ISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       424 NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~---~~~k~DVwSlGviL~e  500 (627)
                      |.++|..   ..+||+|||+........ .  .  .......-...|.|||.+........   .+.+.||||||+++||
T Consensus        79 nClvd~~---w~lklt~~Gl~~~~~~~~-~--~--~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   79 NCLVDSR---WVLKLTDFGLNSLLEETA-E--P--EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             cceeeee---EEEEechhhhcccccccc-c--c--cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            9999988   589999999998764310 0  0  00111123557999999864322222   5778999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhhh--hc---cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         501 CLYGKKPFGHNQSQATILEENTILKA--TE---VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       501 lltG~~Pf~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +++..-||..........+....+..  ..   ........+.+++..+++.||..+|.+||++.++-.
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            99999999754333221111111111  11   111111145568999999999999999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=3.4e-16  Score=151.77  Aligned_cols=143  Identities=24%  Similarity=0.308  Sum_probs=97.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHH---------------HH--HHHHHHHHHHhcCCCCc--
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKAN---------------YI--KHALREYNIHKALDHPR--  352 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~---------------~~--~~~~~Ei~il~~l~Hpn--  352 (627)
                      .+.||+|+||.||+|.+. +++.||||++.............               ..  .....|+..+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            456999999999999876 88999999986543221111100               00  01134666666664432  


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHH-HHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCC
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~  430 (627)
                      +.+++++     ...++||||++++.+.. .+... ... ..++.++.+++.++.++|. .+  |+|+||||+|||++ +
T Consensus        81 ~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~  150 (187)
T cd05119          81 VPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCceEec-----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C
Confidence            4444432     23479999999854321 11111 111 6788999999999999999 88  99999999999999 3


Q ss_pred             CcccceEEeecccccccc
Q psy4988         431 NVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~  448 (627)
                         +.++|+|||.+....
T Consensus       151 ---~~~~liDfg~a~~~~  165 (187)
T cd05119         151 ---GKVYIIDVPQAVEID  165 (187)
T ss_pred             ---CcEEEEECccccccc
Confidence               589999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=1.6e-15  Score=153.77  Aligned_cols=142  Identities=16%  Similarity=0.166  Sum_probs=104.2

Q ss_pred             EEec-ccCceEEEEEEEcCCCeEEEEEEeecCcchhhHh------HHHHHHHHHHHHHHHhcCCCCce--eEEeeEEeec
Q psy4988         293 MLLG-KGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK------KANYIKHALREYNIHKALDHPRV--VKLYDVFEID  363 (627)
Q Consensus       293 ~~LG-~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~------~~~~~~~~~~Ei~il~~l~HpnI--V~l~~~~~~~  363 (627)
                      ..|| .||.|+||.+..  .+..++||.+..........      .......+.+|+.++..|.|++|  +..+++...+
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3577 788888888864  37789999875322111100      01123567889999999998775  6777765433


Q ss_pred             CCeE---EEEEeecCC-CChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 ANSF---CTVLEYCDG-HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ~~~~---~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      ....   +|||||++| .+|..++.. ..+++.    .+.+|+.+|.+||+.|  |+||||||.|||++.+   +.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~---~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPD---GKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC---CCEEEE
Confidence            3322   599999997 688888765 355654    3678999999999998  9999999999999876   489999


Q ss_pred             ecccccc
Q psy4988         440 DFGLSKV  446 (627)
Q Consensus       440 DFGla~~  446 (627)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=7.8e-15  Score=135.03  Aligned_cols=134  Identities=25%  Similarity=0.254  Sum_probs=107.7

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeecCCeEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH--PRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~~~~~~  368 (627)
                      +++.||.|.++.||++.+..  ..++||+......         ...+.+|+.++..+.|  .++++++.++. ..+..+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-~~~~~~   69 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---------GADREREVAILQLLARKGLPVPKVLASGE-SDGWSY   69 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc---------hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCccE
Confidence            45779999999999998643  7899998754322         2357788899998876  58888888776 446678


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC-CCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK-PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~-~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++|||+.+..+..+       +......++.+++.+|.+||... .+++|+||+|.|||++..   +.++|+|||++..
T Consensus        70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~---~~~~l~Df~~~~~  138 (155)
T cd05120          70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG---KILGIIDWEYAGY  138 (155)
T ss_pred             EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC---cEEEEEecccccC
Confidence            99999998877654       55677788999999999999852 249999999999999974   5899999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606|consensus

Probab=99.58  E-value=1.1e-15  Score=173.90  Aligned_cols=272  Identities=24%  Similarity=0.286  Sum_probs=200.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .-.+.+.+.+-+-.|+|+.++.+.-..++...++|++.+......    +.++.+.++-.++-...||-++.....|- .
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~----~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~  875 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT----NDYESIRSKSNILITPRSPAVVRSFPSFP-C  875 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc----ccccccCCccCccccCCCCceecccCCCC-C
Confidence            355677888899999999999998777787888887654322111    11233444545555556787877665543 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ....+||++|+.+++|...+...+..+.+-++.++..+..+++|||...  ++|+|++|.|+|+..+   ++.++.|||+
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~---gh~~l~~~~t  950 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD---GHRPLTDFGT  950 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc---CCcccCcccc
Confidence            4567799999999999999999899999999999999999999999977  8999999999999887   6999999984


Q ss_pred             ccccccCC---------------------CCCCCC---ccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         444 SKVMDEEN---------------------YNPDHG---MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       444 a~~~~~~~---------------------~~~~~~---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      ......-.                     ......   ........||+.|.+||.+.    +......+|+|++|++++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l----g~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL----GRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc----cccCCCcchhhhhhhhhh
Confidence            43221110                     000000   01122346999999999985    344677899999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHH---HHHhccCCCCCC
Q psy4988         500 QCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI---SLARHDYLQPPV  572 (627)
Q Consensus       500 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~---elL~hp~~~~~~  572 (627)
                      +.++|.+||.....+..+   ..+..............+.++++++.++|..+|.+|..+.   ++-.|+||++..
T Consensus      1027 e~l~g~pp~na~tpq~~f---~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIF---ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             hhhcCCCCCCCcchhhhh---hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            999999999877766554   1222222222223345788999999999999999999988   788899998653

>KOG0601|consensus

Probab=99.48  E-value=4.1e-14  Score=154.38  Aligned_cols=263  Identities=20%  Similarity=0.259  Sum_probs=194.5

Q ss_pred             cCCCeeEEEEecc--cCceEEEEEEE--cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeE
Q psy4988         285 LSDRYLLLMLLGK--GGFSEVHKAFD--LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDV  359 (627)
Q Consensus       285 l~~rY~i~~~LG~--G~fG~Vy~a~~--~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~  359 (627)
                      +...+.+...+|.  |.+|.||.+..  ..++..+|+|.-.........     -.+-++|+.-.++++ |+|.|+.+..
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-----~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-----SKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-----cccccchhhcccccCccccccccCcc
Confidence            3455667788999  99999999987  788999999973322111111     112346777777775 9999999988


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHH----HHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVS----ALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~----aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      ++ .....++-+|+|. .+|..+...-. -+++..++.++.+...    ||.++|+..  |+|-|+||.||++..+.  .
T Consensus       187 ~e-~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~--~  260 (524)
T KOG0601|consen  187 WE-GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDW--T  260 (524)
T ss_pred             cc-cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccccc--c
Confidence            87 6677779999997 66666665544 4899999999999999    999999988  99999999999998873  3


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--C
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN--Q  512 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~--~  512 (627)
                      ..+++|||+...+............  ....|...|++||..     ..-++...|||++|.++.+..++..++...  .
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~--~r~~~~~~Y~~ke~~-----~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVS--KRPEGDCIYAAKELL-----NGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             eeecCCcceeEEccCCccccceeee--ecCCCCceEeChhhh-----ccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            7799999999998877644332221  223678889999987     345788999999999999999887766332  1


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ....+ ..  ..    +........+.++...+..|+..+|..|++.+.+.+|+++....
T Consensus       334 ~W~~~-r~--~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~  386 (524)
T KOG0601|consen  334 SWSQL-RQ--GY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL  386 (524)
T ss_pred             Ccccc-cc--cc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence            11111 00  00    11111234566677789999999999999999999999987543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=3.8e-13  Score=147.84  Aligned_cols=148  Identities=22%  Similarity=0.259  Sum_probs=97.3

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhH---------------------------HHHHH------HHH
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK---------------------------ANYIK------HAL  339 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~---------------------------~~~~~------~~~  339 (627)
                      +.||.|++|.||+|.. .+|+.||||+.+......-..+                           ..+..      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3499999999999985 5789999999764421111000                           00011      234


Q ss_pred             HHHHHHhcC----CCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHH-HHHHHHhCCC
Q psy4988         340 REYNIHKAL----DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVS-ALKYLNEIKP  413 (627)
Q Consensus       340 ~Ei~il~~l----~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~-aL~yLH~~~~  413 (627)
                      +|...+.++    .|.+-|.+-.++..-....+|||||++|.+|.++.... ..+   ....++..++. .+..+|..| 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g-  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG-  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC-
Confidence            455544444    33333444344432233457999999999998876432 122   23446666655 467889888 


Q ss_pred             CEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                       ++|+|+||.|||++.+   +.++|+|||++..+..
T Consensus       278 -~~H~D~hPgNilv~~~---g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 -FFHADLHPGNIFVLKD---GKIIALDFGIVGRLSE  309 (437)
T ss_pred             -ceeCCCCcccEEECCC---CcEEEEeCCCeeECCH
Confidence             9999999999999876   6899999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=2.4e-12  Score=125.87  Aligned_cols=146  Identities=19%  Similarity=0.184  Sum_probs=101.7

Q ss_pred             EEecccCceEEEEEEEcC------CCeEEEEEEeecCcc-hhh-------H-----------hHHHHHHHHHHHHHHHhc
Q psy4988         293 MLLGKGGFSEVHKAFDLK------EQRYVACKVHQLNKD-WKE-------D-----------KKANYIKHALREYNIHKA  347 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~------~~~~VAVKii~~~~~-~~~-------~-----------~~~~~~~~~~~Ei~il~~  347 (627)
                      ..||.|--+.||.|....      .+..+|||+...... ++.       +           .......-..+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999997653      357999999764321 100       0           000111123379999988


Q ss_pred             CCC--CceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHH-HhCCCCEEeccccCCc
Q psy4988         348 LDH--PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL-NEIKPPVIHYDLKPGN  424 (627)
Q Consensus       348 l~H--pnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yL-H~~~~~IvHrDLKP~N  424 (627)
                      +..  -++..++++    .. -+|||||+.+..+....-....+++..+..++.+++.+|.+| |..+  |||+||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~-~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KK-HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cC-CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence            842  455566653    12 358999998764432222233566677888899999999999 8888  9999999999


Q ss_pred             EEecCCCcccceEEeeccccccccc
Q psy4988         425 ILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       425 ILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      ||+++    +.++|+|||.+....+
T Consensus       156 IL~~~----~~v~iIDF~qav~~~h  176 (197)
T cd05146         156 MLWHD----GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EEEEC----CcEEEEECCCceeCCC
Confidence            99975    4799999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=1.1e-12  Score=146.26  Aligned_cols=149  Identities=21%  Similarity=0.203  Sum_probs=97.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchh---------------------------hHhHHHHHHHHHH-----
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK---------------------------EDKKANYIKHALR-----  340 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~---------------------------~~~~~~~~~~~~~-----  340 (627)
                      +.||.|++|.||+|..+.+|+.||||+++......                           .....++.+.+.+     
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            56999999999999988889999999987542110                           0001122223333     


Q ss_pred             -HHHHHhcC----CCCceeEEeeEEeecCCeEEEEEeecCCCChHHH--HHhcc----CcCHHHHHHHHHHHHHHHHHHH
Q psy4988         341 -EYNIHKAL----DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY--LKQHK----TIAEREARSIVMQVVSALKYLN  409 (627)
Q Consensus       341 -Ei~il~~l----~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~--l~~~~----~l~e~~~~~i~~qi~~aL~yLH  409 (627)
                       |...+.++    .+.+.|.+-.+|..-....+|||||+.|+.+.++  +...+    .+.+..+..++.||+       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence             33333333    2444444444443223445699999999999764  33333    355566666666665       


Q ss_pred             hCCCCEEeccccCCcEEecCCC-cccceEEeecccccccccC
Q psy4988         410 EIKPPVIHYDLKPGNILLTEGN-VCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       410 ~~~~~IvHrDLKP~NILl~~~~-~~g~vKL~DFGla~~~~~~  450 (627)
                      ..|  ++|+|+||.|||++.+. ..+.++++|||++..+...
T Consensus       278 ~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            356  99999999999998762 1238999999999877543

>KOG1266|consensus

Probab=99.39  E-value=6.3e-14  Score=142.05  Aligned_cols=205  Identities=22%  Similarity=0.309  Sum_probs=139.5

Q ss_pred             hcCCCCceeEEeeEEee----cCCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         346 KALDHPRVVKLYDVFEI----DANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       346 ~~l~HpnIV~l~~~~~~----~~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      -.+.|-|||+++.|+..    +.....++.||+..|+|..+|++    ...+......+|..||+.||.|||+..|+|+|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            34568999999988752    23346789999999999999874    35788888899999999999999999999999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      +++..+-|++..+   |-|||.- +.-..+... .+... ..-+....+-++|.+||.=.    ....+.++|||+||..
T Consensus       202 gnlTc~tifiq~n---gLIkig~-~ap~s~h~s-~~~~~-~~Ek~~~~~~~g~~a~~sg~----~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  202 GNLTCDTIFIQHN---GLIKIGS-VAPDSTHPS-VNSTR-EAEKSVNTSLPGFSAPESGT----TTNTTGASDIYKFGMC  271 (458)
T ss_pred             CCcchhheeecCC---ceEEecc-cCccccchh-hhhhh-HhhhhccccCCccccCCcCc----ccccccchhhhhhhHH
Confidence            9999999999966   5666532 111111000 00000 00112235788999999642    2335668999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         498 FYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       498 L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..+|..+..--......... +. .+.. ..+...+     .--.++|.+||+-.|..||++.+++.||.+
T Consensus       272 AlemailEiq~tnseS~~~~-ee-~ia~-~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  272 ALEMAILEIQSTNSESKVEV-EE-NIAN-VIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHHHHHheeccCCCcceeeh-hh-hhhh-heeeccC-----ccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            99999887654332222111 11 1110 0011111     123568999999999999999999999974

>KOG0601|consensus

Probab=99.33  E-value=9.5e-13  Score=143.76  Aligned_cols=254  Identities=17%  Similarity=0.179  Sum_probs=184.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc-CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~-~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      ....+|.++..||.|.|+.||.+... .++..|++|.+......... +    ..-+.|+-+...+ .|.+++.++..|.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-d----i~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-D----IFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-h----hcchhhhhHhhHhhcccccCCCCCCcc
Confidence            34567889999999999999987644 57888999976433221111 1    1234566666655 4888888887776


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      .. ...||-.|||.++++...+.....+.+...+.+..|++.++.++|+..  ++|+|+||.||++..+.  +.-++.||
T Consensus       337 ~~-r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~--~~~~~~~~  411 (524)
T KOG0601|consen  337 QL-RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDG--FFSKLGDF  411 (524)
T ss_pred             cc-ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccch--hhhhcccc
Confidence            33 445589999999999888866678999999999999999999999988  99999999999998863  57799999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccC-CccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYL-PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~-APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+....          ......-++. .+|++.   ....+..+.|++|||..+++.+++...-.......     
T Consensus       412 ~~~t~~~~~~----------~~~~~~~r~~p~~~~~~---e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-----  473 (524)
T KOG0601|consen  412 GCWTRLAFSS----------GVFHHIDRLYPIAEILL---EDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-----  473 (524)
T ss_pred             ccccccceec----------ccccccccccccchhhc---cccccccccccccccccccccccCcccCcccccce-----
Confidence            9997532211          1112333444 355554   45567889999999999999998865432211111     


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                          ....-..+..+....++..+...++..++..|+.+.++..|.-|.
T Consensus       474 ----~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  474 ----TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----eeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                112223444455668888999999999999999999998887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=4.6e-12  Score=120.46  Aligned_cols=129  Identities=18%  Similarity=0.190  Sum_probs=92.2

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCcee-EEeeEEeecCCeEEEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV-KLYDVFEIDANSFCTV  370 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV-~l~~~~~~~~~~~~lV  370 (627)
                      ++.|+.|.++.||++...  +..|+||+.......        ...+.+|+.+++.+.+.+++ +++.++.   ...++|
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~P~~~~~~~---~~~~lv   69 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL--------LINRENEAENSKLAAEAGIGPKLYYFDP---ETGVLI   69 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc--------ccCHHHHHHHHHHHHHhCCCCceEEEeC---CCCeEE
Confidence            456899999999999753  778999986433210        11345688888877654444 4444332   234699


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCC---CEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP---PVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~---~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      |||++|.++...        ......++.+++.+|..||..+.   .++|+|++|.|||++.    +.++|+|||.+.
T Consensus        70 ~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~----~~~~liDf~~a~  135 (170)
T cd05151          70 TEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD----GRLWLIDWEYAG  135 (170)
T ss_pred             EEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC----CeEEEEeccccc
Confidence            999999887643        11123567899999999998761   3599999999999983    479999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=2.4e-10  Score=108.81  Aligned_cols=134  Identities=24%  Similarity=0.299  Sum_probs=96.9

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH--hHHHHHHHHHHHHHHHhcCCCC--ceeEEeeEEeecCCeEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED--KKANYIKHALREYNIHKALDHP--RVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~--~~~~~~~~~~~Ei~il~~l~Hp--nIV~l~~~~~~~~~~~~l  369 (627)
                      .|.+|+-+.+|.+..  -+..+++|.- ..+.+...  ...-...+..+|..++.++.--  ++..+|++   +.+...|
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv---D~~~~~I   76 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV---DPDNGLI   76 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE---cCCCCEE
Confidence            478999999999854  3445667753 33322221  1122234567899999877532  33344443   4555669


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||++|..|.+++...       ...++..|-.-+.-||..+  |||+||.+.||++..+    .+.++||||+.+
T Consensus        77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~----~i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG----RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC----cEEEEECCcccc
Confidence            99999999999888765       2567788888899999998  9999999999999875    599999999974

>KOG1243|consensus

Probab=99.17  E-value=4.7e-10  Score=124.05  Aligned_cols=181  Identities=19%  Similarity=0.215  Sum_probs=130.1

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      ...-++.+.+-.|..+.++.+|.|.+......       .....+.+-+..|+.++||||+++++.++ ....+|||+|-
T Consensus        19 ~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTEr   90 (690)
T KOG1243|consen   19 ETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-------EVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTER   90 (690)
T ss_pred             cccCCCcccccccceeccCCceEEEEEeCCCc-------hhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeec
Confidence            33334444332466678899999998865543       11234667888899999999999999998 45578899998


Q ss_pred             cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCC
Q psy4988         374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN  453 (627)
Q Consensus       374 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~  453 (627)
                      +.  -|..++++.   ....+...+.||+.||.|||.. +.++|++|.-+-|+++..   |..||.+|.++.....-.. 
T Consensus        91 V~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~---GeWkLggle~v~~~~~~~~-  160 (690)
T KOG1243|consen   91 VR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNES---GEWKLGGLELVSKASGFNA-  160 (690)
T ss_pred             cc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCC---CcEEEeeeEEEeccccCCc-
Confidence            85  566777663   4777888899999999999853 249999999999999987   7999999998865432210 


Q ss_pred             CCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy4988         454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       454 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG  504 (627)
                            ......---.|..|+.+.    .  -....|.|-|||++++++.|
T Consensus       161 ------~~~~~~~~~s~~~P~~~~----~--s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 ------PAKSLYLIESFDDPEEID----P--SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ------ccccchhhhcccChhhcC----c--cccchhhhhHHHHHHHHhCc
Confidence                  000001122366676542    1  12357999999999999998

>KOG3087|consensus

Probab=99.14  E-value=6.1e-10  Score=105.63  Aligned_cols=151  Identities=19%  Similarity=0.166  Sum_probs=104.6

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcch-hhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~-~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      .+..|-+|+-+.|+++.  ..|+...||.-...... ..-...-..++..+|.+++.++.--.|.-..-+|. |.+.-+|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-DTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-ecCCCeE
Confidence            46778999999999995  56888888853322211 11122223456778999998875333322222233 3444468


Q ss_pred             EEeecCC-CChHHHHHhcc-CcCHHHH-HHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         370 VLEYCDG-HDLDFYLKQHK-TIAEREA-RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       370 V~E~~~g-g~L~~~l~~~~-~l~e~~~-~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||++| .++.+++.... .-.++.. ..++..|-..|.-||..+  |||+||..+||||..+.....+.|+|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999997 47777775432 2233333 789999999999999998  99999999999998876555679999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=4.5e-10  Score=111.19  Aligned_cols=145  Identities=20%  Similarity=0.234  Sum_probs=104.2

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeecC--CeEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH--PRVVKLYDVFEIDA--NSFC  368 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~~--~~~~  368 (627)
                      +.|+.|.++.||++... ++..|+||+.......      .....+.+|+.+++.+.+  .++.+++.+.....  +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            56899999999999753 3578999986543221      012356789999988865  34566666654221  2567


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI-------------------------------------  411 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-------------------------------------  411 (627)
                      +||||++|.++...+.. ..+++.....++.+++.+|.+||+.                                     
T Consensus        77 ~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          77 YVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99999999888765432 4577777788888888888888852                                     


Q ss_pred             -----------------CCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         412 -----------------KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       412 -----------------~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                                       ...+||+|++|.|||++.+. .+.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE-PRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC-CcEEEEEecccccc
Confidence                             13479999999999998841 14689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741|consensus

Probab=99.10  E-value=3.3e-09  Score=114.07  Aligned_cols=212  Identities=18%  Similarity=0.186  Sum_probs=152.4

Q ss_pred             eEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee---cCCeEEEEEeecCC-
Q psy4988         301 SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI---DANSFCTVLEYCDG-  376 (627)
Q Consensus       301 G~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---~~~~~~lV~E~~~g-  376 (627)
                      .+.|+++...+|..|++|.++..+.....       ....-+++++++.|+|||++.++|..   ....++|||+|.++ 
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN-------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcc-------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            57899999999999999998544332221       12345678999999999999999863   33568999999987 


Q ss_pred             CChHHHHH---------------hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         377 HDLDFYLK---------------QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       377 g~L~~~l~---------------~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      .+|.++-.               .+..++|..+|.|+.||..||.++|+.|  +.-+-|.|.+||++.+.   +++|.-.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~---RIriS~C  437 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM---RIRISGC  437 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc---eEEEecc
Confidence            45554432               1235789999999999999999999998  88899999999999763   7888888


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI-LEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~-~~~  520 (627)
                      |+...+..+.                   .+|  +       .--.+-|.=-||.+++-|.||..--...+..... ++.
T Consensus       438 ~i~Dvl~~d~-------------------~~~--l-------e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~  489 (655)
T KOG3741|consen  438 GIMDVLQEDP-------------------TEP--L-------ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR  489 (655)
T ss_pred             cceeeecCCC-------------------Ccc--h-------hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH
Confidence            8776654331                   111  1       1123569999999999999996542111111111 110


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                                  ....++.++.++|..+...++++ -++.+++.|
T Consensus       490 ------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 ------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                        11357788999999888888886 677777754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=5.4e-09  Score=101.80  Aligned_cols=133  Identities=26%  Similarity=0.357  Sum_probs=84.2

Q ss_pred             EEEEEEEcCCCeEEEEEEeecCcc-h------------------hhHhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeEE
Q psy4988         302 EVHKAFDLKEQRYVACKVHQLNKD-W------------------KEDKKANYIKHALREYNIHKALDHP--RVVKLYDVF  360 (627)
Q Consensus       302 ~Vy~a~~~~~~~~VAVKii~~~~~-~------------------~~~~~~~~~~~~~~Ei~il~~l~Hp--nIV~l~~~~  360 (627)
                      .||.|.. .++..||||+...... +                  .............+|+++|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899975 5678999999764311 0                  0111122234567899999999755  456666542


Q ss_pred             eecCCeEEEEEeecC--CCChHHHHHhccCcCHHHHHHHHHHHHHHHHH-HHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         361 EIDANSFCTVLEYCD--GHDLDFYLKQHKTIAEREARSIVMQVVSALKY-LNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~y-LH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                         .+  +|||||++  |..+..+....  ++......++.+++..+.. +|..|  |||+||.+.|||++++    .+.
T Consensus        80 ---~~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~----~~~  146 (188)
T PF01163_consen   80 ---RN--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG----KVY  146 (188)
T ss_dssp             ---TT--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT----CEE
T ss_pred             ---CC--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc----eEE
Confidence               22  48999999  65565443322  2245667788888886655 57888  9999999999999975    799


Q ss_pred             Eeecccccccc
Q psy4988         438 ITDFGLSKVMD  448 (627)
Q Consensus       438 L~DFGla~~~~  448 (627)
                      |+|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=4.4e-08  Score=100.82  Aligned_cols=140  Identities=15%  Similarity=0.101  Sum_probs=92.7

Q ss_pred             EEEEEEEcCCCeEEEEEEeecCcchhhHhHH-----HHHHHHHHHHHHHhcCCCCc--eeEEeeEEeec----CCeEEEE
Q psy4988         302 EVHKAFDLKEQRYVACKVHQLNKDWKEDKKA-----NYIKHALREYNIHKALDHPR--VVKLYDVFEID----ANSFCTV  370 (627)
Q Consensus       302 ~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~-----~~~~~~~~Ei~il~~l~Hpn--IV~l~~~~~~~----~~~~~lV  370 (627)
                      .|++..  ..|+.|.||... ...|....+.     .-...+.+|+..+.+|..-+  +..++.+++..    ...-+||
T Consensus        37 rvvr~~--~~g~~~~vKr~~-~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHR-GTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             eEEEEE--ECCEEEEEEEec-CCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            355543  357789999653 2222211100     00113677888777663222  22333333321    1235699


Q ss_pred             EeecCCC-ChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC----CcccceEEeeccc
Q psy4988         371 LEYCDGH-DLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG----NVCGEIKITDFGL  443 (627)
Q Consensus       371 ~E~~~gg-~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~----~~~g~vKL~DFGl  443 (627)
                      ||++++. +|.+++..  ....+......++.+|+..+.-||..|  |+|+||++.|||++.+    .....+.|+||+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            9999986 89888754  345667788899999999999999999  9999999999999852    2225899999998


Q ss_pred             ccc
Q psy4988         444 SKV  446 (627)
Q Consensus       444 a~~  446 (627)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            853

>KOG2137|consensus

Probab=98.85  E-value=1.5e-09  Score=120.48  Aligned_cols=164  Identities=20%  Similarity=0.298  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCC-CC-CCCCccccccCCCCCccCCccccc
Q psy4988         400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN-YN-PDHGMDLTSQGAGTYWYLPPECFV  477 (627)
Q Consensus       400 qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~-~~-~~~~~~~~~~~~Gt~~Y~APE~l~  477 (627)
                      +++.||.|+|.. .++||+.|.|++|.++.+   +.+||+.|+++....... |. ....+.+.....-...|.|||++.
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~---~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNAN---GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccC---cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            444899999985 569999999999999987   689999999886554421 10 111122222334566799999984


Q ss_pred             cCCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCC
Q psy4988         478 VGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR  556 (627)
Q Consensus       478 ~~~~~~~~~~k~DVwSlGviL~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~R  556 (627)
                          ....+.++|+||+||++|.+. .|+.-|.........-.........  .+.....++.++++=|.++|..+...|
T Consensus       183 ----~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--~~~~s~~~p~el~~~l~k~l~~~~~~r  256 (700)
T KOG2137|consen  183 ----GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--AFGYSNNLPSELRESLKKLLNGDSAVR  256 (700)
T ss_pred             ----cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--cccccccCcHHHHHHHHHHhcCCcccC
Confidence                455788999999999999998 5666664443322222122121111  222335789999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCC
Q psy4988         557 IDVISLARHDYLQPPVP  573 (627)
Q Consensus       557 pt~~elL~hp~~~~~~~  573 (627)
                      |++..++.-+||..+.-
T Consensus       257 p~~~~l~~~~ff~D~~~  273 (700)
T KOG2137|consen  257 PTLDLLLSIPFFSDPGL  273 (700)
T ss_pred             cchhhhhcccccCCchh
Confidence            99999999999986643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.75  E-value=3.8e-08  Score=99.13  Aligned_cols=143  Identities=25%  Similarity=0.265  Sum_probs=100.5

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH---------------hHHHHHHHHHHHHHHHhcCCCC--
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED---------------KKANYIKHALREYNIHKALDHP--  351 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~---------------~~~~~~~~~~~Ei~il~~l~Hp--  351 (627)
                      +.+..+||-|--+.||.|.+. .+..+|||+++.....-..               .-.-....+.+|+++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            446788999999999999865 7889999997654211000               0011234567899999998654  


Q ss_pred             ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       352 nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      .|.+.+++     +.-++||||++|..|...-     +....+..|+..|+.-+..+-..|  |||+|+.+-|||++++ 
T Consensus       172 ~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d-  238 (304)
T COG0478         172 KVPKPIAW-----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED-  238 (304)
T ss_pred             CCCCcccc-----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC-
Confidence            66666653     3346999999997665432     234455556666666666555667  9999999999999997 


Q ss_pred             cccceEEeeccccccc
Q psy4988         432 VCGEIKITDFGLSKVM  447 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~  447 (627)
                        |.+.|+||--+...
T Consensus       239 --g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 --GDIVVIDWPQAVPI  252 (304)
T ss_pred             --CCEEEEeCcccccC
Confidence              68999999665443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=1.3e-07  Score=93.66  Aligned_cols=108  Identities=19%  Similarity=0.205  Sum_probs=82.3

Q ss_pred             HHHHHHHHHhcCCC--CceeEEeeEEeecC---CeEEEEEeecCCC-ChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh
Q psy4988         337 HALREYNIHKALDH--PRVVKLYDVFEIDA---NSFCTVLEYCDGH-DLDFYLKQHKTIAEREARSIVMQVVSALKYLNE  410 (627)
Q Consensus       337 ~~~~Ei~il~~l~H--pnIV~l~~~~~~~~---~~~~lV~E~~~gg-~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~  410 (627)
                      ++.+|+..+..|..  -.+...+.+.+...   ...+||+|++++. +|.+++.....++......++.+++..+.-||.
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            46677777666632  22344444443211   2347999999984 799998875567888889999999999999999


Q ss_pred             CCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       411 ~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .|  |+|+||++.|||++.+.....+.|+||+.++.
T Consensus       137 ~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             Cc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99  99999999999999875334799999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.60  E-value=9.6e-07  Score=93.30  Aligned_cols=245  Identities=12%  Similarity=0.115  Sum_probs=149.3

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHh-cCCCCceeEEeeE-----E-eec
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK-ALDHPRVVKLYDV-----F-EID  363 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~-----~-~~~  363 (627)
                      +...||+|+-+.+|-.-   .-...+.|+.+...-....          +.+..|. .-.||-+-.-+.|     + -..
T Consensus        15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~a----------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQA----------QKVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCccccCCccceeeecc---hhhchhheeecCCCchHHH----------HHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            34669999999999642   2222345766544332111          1222233 3356644331111     1 112


Q ss_pred             CCeEEEEEeecCCCChHHHH-------HhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         364 ANSFCTVLEYCDGHDLDFYL-------KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l-------~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      .....++|..+.|..--..+       .......|..+.++++.|+.+...||..|  .+-+|+.++|||+.++   +.|
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~---~~V  156 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD---SKV  156 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC---ceE
Confidence            33367888888875322222       12235778999999999999999999998  9999999999999987   588


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccC-CCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC--
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG-KNPPKISSKVDVWSVGVIFYQCLYG-KKPFGHNQ--  512 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~~~~~k~DVwSlGviL~elltG-~~Pf~~~~--  512 (627)
                      .|+|-..-.....+        ......+|...|.+||.-..+ -.+..-+...|.|.|||++|++|.| +.||.+..  
T Consensus       157 ~LVdsDsfqi~~ng--------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~  228 (637)
T COG4248         157 VLVDSDSFQINANG--------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI  228 (637)
T ss_pred             EEEcccceeeccCC--------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence            88875432221111        122344899999999975311 1233456678999999999999987 99995432  


Q ss_pred             -----hHH-HHHHHHHHh-------hhhccccCCCCCCCHHHHHHHHHhhhcC--cCCCCCHHH
Q psy4988         513 -----SQA-TILEENTIL-------KATEVQFANKPTVSNEAKGFIRSCLAYR--KEDRIDVIS  561 (627)
Q Consensus       513 -----~~~-~~~~~~~~~-------~~~~~~~~~~~~vs~el~~LI~~cL~~d--P~~Rpt~~e  561 (627)
                           ..+ .|..-....       ......-..+..+++.+..|..+|++..  +.-|||+..
T Consensus       229 ~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         229 SDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             CCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                 111 111100000       0000111123457889999999999753  567998764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=4.3e-07  Score=101.20  Aligned_cols=146  Identities=23%  Similarity=0.296  Sum_probs=88.4

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH---------------------------hHHHHHHH------HHH
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED---------------------------KKANYIKH------ALR  340 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~---------------------------~~~~~~~~------~~~  340 (627)
                      .|+.++.|.||+|.. .+|+.||||+.+..-...-.                           ...++.+.      +.+
T Consensus       132 PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         132 PIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             chhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            399999999999984 56999999997643211111                           01111112      223


Q ss_pred             HHHHHhcC-----CCCceeEEeeEEeecCCeEEEEEeecCCCChHHHH--HhccCcCHHHHHHHHHHHHHHHHHHHhCCC
Q psy4988         341 EYNIHKAL-----DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKYLNEIKP  413 (627)
Q Consensus       341 Ei~il~~l-----~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~  413 (627)
                      |..-+.++     +.|+| .+-.+|..-...-.|+|||++|..+.+..  +. ..++.+.+...+.++.----+-  .| 
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~--dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLR--DG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHh--cC-
Confidence            33333333     23333 33333332223335999999998888774  33 4455433333333322222222  36 


Q ss_pred             CEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                       ++|.|.+|.||+++.+   +.+.+.|||+...+.+
T Consensus       286 -ffHaDpHpGNi~v~~~---g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 -FFHADPHPGNILVRSD---GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -ccccCCCccceEEecC---CcEEEEcCcceecCCH
Confidence             9999999999999988   7999999999977654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.49  E-value=1.9e-06  Score=85.27  Aligned_cols=147  Identities=18%  Similarity=0.257  Sum_probs=91.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHH-----HHHHHHHHHHHhcCCCCceeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY-----IKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      ++.+.|.+.+++-......|.+-  ..++..+.+|.........+......     ..+.+..+..+....--.++.++-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            46678999999988777777665  45678889998654322111111111     112222223333223233333332


Q ss_pred             EEee----cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         359 VFEI----DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       359 ~~~~----~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      +.+.    -...++|||||++|..|.++..    +++    .+...|+.+|.-||+.|  ++|+|+.|.|+++.++    
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~----  171 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN----  171 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC----
Confidence            2221    1234568999999988766532    233    24566778899999998  9999999999999975    


Q ss_pred             ceEEeecccccc
Q psy4988         435 EIKITDFGLSKV  446 (627)
Q Consensus       435 ~vKL~DFGla~~  446 (627)
                      .++++||+..+.
T Consensus       172 ~i~iID~~~k~~  183 (229)
T PF06176_consen  172 GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEEECccccc
Confidence            699999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.42  E-value=3e-06  Score=84.78  Aligned_cols=144  Identities=25%  Similarity=0.269  Sum_probs=96.5

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHH------------------HHHHHHHHHHhcCC--CC
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI------------------KHALREYNIHKALD--HP  351 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~------------------~~~~~Ei~il~~l~--Hp  351 (627)
                      ...|..|--+.||+|.. .++..||||+.......-.. ...++                  .-..+|+.-|+++.  +-
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~-~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKR-IRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhh-HHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            34678888899999964 67899999997654321111 11111                  11235777777663  44


Q ss_pred             ceeEEeeEEeecCCeEEEEEeecCCCCh-HHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecC
Q psy4988         352 RVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       352 nIV~l~~~~~~~~~~~~lV~E~~~gg~L-~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~  429 (627)
                      .+.+-+.++.    . .|||||++...+ .-.|+. -.+...++..+..+++..+.-|-. .+  +||+||..=|||+.+
T Consensus       131 rvP~Pi~~~~----n-VLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~~  202 (268)
T COG1718         131 RVPEPIAFRN----N-VLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVHD  202 (268)
T ss_pred             CCCCceeecC----C-eEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEEC
Confidence            5555565542    2 489999976411 112222 233444788899999999988866 66  999999999999995


Q ss_pred             CCcccceEEeeccccccccc
Q psy4988         430 GNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       430 ~~~~g~vKL~DFGla~~~~~  449 (627)
                          +.+.|+|||-|....+
T Consensus       203 ----~~p~iID~~QaV~~~h  218 (268)
T COG1718         203 ----GEPYIIDVSQAVTIDH  218 (268)
T ss_pred             ----CeEEEEECccccccCC
Confidence                4899999998876543

>PRK09902 hypothetical protein; Provisional

Probab=98.37  E-value=3.3e-06  Score=83.23  Aligned_cols=143  Identities=17%  Similarity=0.108  Sum_probs=97.1

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEee--cCcchhhHhHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeec--C--Ce
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQ--LNKDWKEDKKANYIKHALREYNIHKALDH--PRVVKLYDVFEID--A--NS  366 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~--~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~--~--~~  366 (627)
                      -|+||.+-|+....  .|..+-||.-.  ....+.-   ..-...|.+|+..+..|..  -.+.++. ++...  .  ..
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~---P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r   99 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRY---PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR   99 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccC---CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence            46799999998642  33467788643  1111110   1112468889888887742  1244444 22211  1  12


Q ss_pred             EEEEEeecCC-CChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         367 FCTVLEYCDG-HDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       367 ~~lV~E~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      -+||+|-++| .+|.+++...  .+.+......++.+|+..|.-||+.|  +.|+|+.+.|||++.+. .-.|+++||.-
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g-~~~v~lIDlEk  176 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEG-KAEAGFLDLEK  176 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCC-CeeEEEEEhhc
Confidence            4689997765 6888887653  35678888899999999999999998  99999999999998553 13599999976


Q ss_pred             ccc
Q psy4988         444 SKV  446 (627)
Q Consensus       444 a~~  446 (627)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            653

>KOG0576|consensus

Probab=98.36  E-value=9.1e-08  Score=105.44  Aligned_cols=243  Identities=16%  Similarity=0.125  Sum_probs=161.9

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeEEeecCCeE
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR-VVKLYDVFEIDANSF  367 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~~~  367 (627)
                      |...+-+++|+++.+|+.+...+...+ .+++...            ....-++++|.+++||| .|..++-++ .....
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------------l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~  309 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------------LSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYL  309 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------------hhhHHHHHHHHHccCCCCcccccccCC-ccccc
Confidence            444556899999999999877666555 7765432            12334788999999999 666666554 44567


Q ss_pred             EEEEeecCCC--ChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         368 CTVLEYCDGH--DLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       368 ~lV~E~~~gg--~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++++++|.++  .........-.+.+-+...+.+.-..+|+|||+.-  =+|+|    |||..++    ..+..||+...
T Consensus       310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~~----~~~~~~~~v~~  379 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSEE----EVKLLDFAVPP  379 (829)
T ss_pred             chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccccc----ccccccccCCc
Confidence            8999999987  22221122234455556677778888999999863  48999    9988774    78999999987


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....        ..++..+|+.++|||+..    ...+....|+|++++--.+|--|-+|-.........     +..
T Consensus       380 ~L~~~~--------~~~t~~~~~~~~~pev~~----~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~-----~g~  442 (829)
T KOG0576|consen  380 QLTRTM--------KPRTAIGTPEPLAPEVIQ----ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPM-----IGN  442 (829)
T ss_pred             ccCccc--------ccccCCCCCCCCCchhhc----ccccccCCCccCCCcchhhcCCCCCCCCCCccccCC-----CCC
Confidence            765421        245568999999999874    445888999999998777777777765321100000     000


Q ss_pred             hh-ccccCCCCCCCHHH-HHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         526 AT-EVQFANKPTVSNEA-KGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       526 ~~-~~~~~~~~~vs~el-~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .. ...+......++.. .++...|+..-|..|+....++.|.+|....
T Consensus       443 ~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  443 GPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            00 00000000001111 1477889999999999999999998887543

>KOG1235|consensus

Probab=98.35  E-value=1.7e-06  Score=96.23  Aligned_cols=153  Identities=19%  Similarity=0.195  Sum_probs=90.6

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHh------------------------HHHHHH------HHHHHH
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK------------------------KANYIK------HALREY  342 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~------------------------~~~~~~------~~~~Ei  342 (627)
                      +.||.-+.|.||+|..+ +|+.||||+.+..-...-..                        ..+..+      .|.+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            45999999999999855 49999999965332110000                        000011      122333


Q ss_pred             H----HHhcCCCCc---eeEEeeEEeecCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCC
Q psy4988         343 N----IHKALDHPR---VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPP  414 (627)
Q Consensus       343 ~----il~~l~Hpn---IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~  414 (627)
                      +    +.+.+.|-+   -|.+-.++..-...-.|+||||+|..+.+... ....++...+...+.++..-+-+.|  |  
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~--G--  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT--G--  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc--C--
Confidence            2    223334545   22233334322334569999999976655432 1234555555544444443333333  5  


Q ss_pred             EEeccccCCcEEecCC-CcccceEEeecccccccccC
Q psy4988         415 VIHYDLKPGNILLTEG-NVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       415 IvHrDLKP~NILl~~~-~~~g~vKL~DFGla~~~~~~  450 (627)
                      ++|+|-+|.|||++.+ .....+.+.|||+...+...
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            9999999999999953 12368999999999876543

>KOG1035|consensus

Probab=98.35  E-value=1.3e-05  Score=94.17  Aligned_cols=209  Identities=18%  Similarity=0.242  Sum_probs=141.9

Q ss_pred             HHHHHHHHHHHhcCCCCceeEEeeEEeecCC---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC
Q psy4988         335 IKHALREYNIHKALDHPRVVKLYDVFEIDAN---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI  411 (627)
Q Consensus       335 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~  411 (627)
                      +....-|+..+.+..|+|++.++.|-.....   ...+..++|...++...+..-..++...++.+..+++.||.|+|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            3344457777888999999999887642221   1234568899999999999989999999999999999999999997


Q ss_pred             CCCEEeccccCC---cEEecCCCcccceEEe--ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCC
Q psy4988         412 KPPVIHYDLKPG---NILLTEGNVCGEIKIT--DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKIS  486 (627)
Q Consensus       412 ~~~IvHrDLKP~---NILl~~~~~~g~vKL~--DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~  486 (627)
                      .  +.|.=|...   +...+..   +.+.+.  ||+.++.+......        ....-+..|.+||....  +.....
T Consensus       306 ~--l~~v~L~~s~~~~~~~~~e---~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~--~~~~~~  370 (1351)
T KOG1035|consen  306 S--LEHVVLSASSSKESTVDGE---GVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKE--NTAKKS  370 (1351)
T ss_pred             c--cceeEEecccccccccCcc---ceeecchhhhcccccCCCcccc--------hhhcCcccccccccccc--ccchhh
Confidence            5  555444444   2222222   456666  89888776554321        11234556777876531  122233


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         487 SKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       487 ~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ...|+|.+|..+..+..|..+-........              +...... .+..+++.+|+.-++++|+.+.+++.|+
T Consensus       371 r~~dL~~lgll~~~~~~~~~i~~~~~~~~~--------------~l~~~~~-~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  371 RLTDLWCLGLLLLQLSQGEDISEKSAVPVS--------------LLDVLST-SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhHHHHHHHHHhhhhhcCcccccccchhh--------------hhccccc-hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            346999999999999987665421111111              1110011 2678889999999999999999999999


Q ss_pred             CCCCCCC
Q psy4988         567 YLQPPVP  573 (627)
Q Consensus       567 ~~~~~~~  573 (627)
                      |..++..
T Consensus       436 f~~~~~~  442 (1351)
T KOG1035|consen  436 FLRFPTD  442 (1351)
T ss_pred             hcccccc
Confidence            9986654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.22  E-value=1.5e-05  Score=80.18  Aligned_cols=135  Identities=18%  Similarity=0.217  Sum_probs=77.0

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc--eeEEeeEEeecCCeEEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR--VVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--IV~l~~~~~~~~~~~~lV  370 (627)
                      ..||.|..+.||+.    .+..+++|+......         .....+|+++++.+..-.  +.+.+++.. +.+.+.+|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---------~~~i~~E~~~l~~l~~~glpvP~~~~~~~-~~~~~glv   72 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---------KETIKREFDASRKVFSLGIPTPHPFDLVE-DGGRLGLI   72 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---------HHHHHHHHHHHHHHHHcCCCCCceEEEEe-cCCeeeee
Confidence            45899999999984    244577888643221         123567888887774322  344555544 55667899


Q ss_pred             EeecCCCC-hHHHH--------------Hh-----c----cCcCHHHHH-HHHH----------HHHH-HHHHHH--hCC
Q psy4988         371 LEYCDGHD-LDFYL--------------KQ-----H----KTIAEREAR-SIVM----------QVVS-ALKYLN--EIK  412 (627)
Q Consensus       371 ~E~~~gg~-L~~~l--------------~~-----~----~~l~e~~~~-~i~~----------qi~~-aL~yLH--~~~  412 (627)
                      ||+++|.+ +...+              ..     +    ......... .+..          .+.. ...+|.  ...
T Consensus        73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            99999963 11111              00     0    011111100 0000          1111 122222  222


Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +.++|+|+.|.||+++++   + +.|+||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~~~---~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGK---G-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEcCC---C-cEEEechhcC
Confidence            358999999999999875   4 8999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.21  E-value=1.6e-05  Score=77.85  Aligned_cols=133  Identities=22%  Similarity=0.264  Sum_probs=94.2

Q ss_pred             CCeeEEEEecccCc-eEEEEEEEcCCCeEEEEEEeec---Ccc-hh----------hHhHHHHHHHHHHHHHHHhcC---
Q psy4988         287 DRYLLLMLLGKGGF-SEVHKAFDLKEQRYVACKVHQL---NKD-WK----------EDKKANYIKHALREYNIHKAL---  348 (627)
Q Consensus       287 ~rY~i~~~LG~G~f-G~Vy~a~~~~~~~~VAVKii~~---~~~-~~----------~~~~~~~~~~~~~Ei~il~~l---  348 (627)
                      ..++.++.||.|.- |.||++.  -+|+.||+|++..   ... +.          ......+..-|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 9999995  4678999999321   100 00          001124455677787776666   


Q ss_pred             CCCce--eEEeeEEeecC-----------------CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHH
Q psy4988         349 DHPRV--VKLYDVFEIDA-----------------NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN  409 (627)
Q Consensus       349 ~HpnI--V~l~~~~~~~~-----------------~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH  409 (627)
                      .+.++  |++++|+..+.                 ..+.||.||++...         .+    ...-+.+|++-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            45566  99999984431                 23578899887643         12    2334567788888999


Q ss_pred             hCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       410 ~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..|  |+=+|+++.|..        .-||+|||.+
T Consensus       182 k~g--I~~~Dv~~~ny~--------~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLG--IVPRDVKPRNYR--------GGKLVDFSSS  206 (207)
T ss_pred             HCC--eeeccCcccccc--------CCEEEecccC
Confidence            988  999999999986        2399999865

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.08  E-value=3.5e-05  Score=78.05  Aligned_cols=74  Identities=14%  Similarity=-0.002  Sum_probs=46.5

Q ss_pred             ecccCc-eEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeEEEEEe
Q psy4988         295 LGKGGF-SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       295 LG~G~f-G~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      |-.|.. ..||+...  .+..+.||+.....          ...+.+|+.+++.+. +--+.+++++.. ..+..++|||
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e   72 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP----------TYELEREAERLRWLAGKLPVPEVIDYGS-DDGRAWLLTS   72 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc----------ccchHHHHHHHHHHHhcCCCCeEEEEEe-cCCccEEEEE
Confidence            444444 88999854  34678889864321          113456777777663 334556666665 3345679999


Q ss_pred             ecCCCChHH
Q psy4988         373 YCDGHDLDF  381 (627)
Q Consensus       373 ~~~gg~L~~  381 (627)
                      +++|..|..
T Consensus        73 ~i~G~~l~~   81 (244)
T cd05150          73 AVPGVPAAA   81 (244)
T ss_pred             eeCCccHhH
Confidence            999987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.07  E-value=6.1e-05  Score=74.66  Aligned_cols=79  Identities=16%  Similarity=0.066  Sum_probs=50.8

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeEEee--cCCeE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP--RVVKLYDVFEI--DANSF  367 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIV~l~~~~~~--~~~~~  367 (627)
                      ++.|+.|..+.||+.....  ..+++|+....         .....+.+|+.+++.+...  .+.+++.+...  .....
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~   70 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP   70 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence            4679999999999997544  48899986432         1123455677777666422  24455543321  23346


Q ss_pred             EEEEeecCCCChHH
Q psy4988         368 CTVLEYCDGHDLDF  381 (627)
Q Consensus       368 ~lV~E~~~gg~L~~  381 (627)
                      +++|++++|..+..
T Consensus        71 ~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   71 YLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEEEEESSEEHHH
T ss_pred             eEEEEEeccccccc
Confidence            89999999987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=0.0001  Score=72.52  Aligned_cols=142  Identities=21%  Similarity=0.348  Sum_probs=90.5

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH---------hHHHHHHHHHHHHHHHhcC------CCCceeEEe
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED---------KKANYIKHALREYNIHKAL------DHPRVVKLY  357 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~---------~~~~~~~~~~~Ei~il~~l------~HpnIV~l~  357 (627)
                      ..||.|+.=.||.   .......+||+..........         ......+...+|+.-...+      .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4599999999996   344556789998765400000         0011123445555544444      388999999


Q ss_pred             eEEeecCCeEEEEEeecCC------CChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         358 DVFEIDANSFCTVLEYCDG------HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      ++.+++.. ..+|+|.+.+      -+|.+++.. +.+++ .....+.   .-..||-+.+  |+.+||+|.||++....
T Consensus        84 G~veT~~G-~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   84 GFVETNLG-LGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEEecCCc-eEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEecC
Confidence            99986555 4688887643      367788754 34665 4444444   4445666666  99999999999998765


Q ss_pred             ccc-ceEEee-ccccc
Q psy4988         432 VCG-EIKITD-FGLSK  445 (627)
Q Consensus       432 ~~g-~vKL~D-FGla~  445 (627)
                      ... .+.|+| ||...
T Consensus       156 ~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCceEEEEEeCCCCcc
Confidence            433 688888 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=7.4e-05  Score=89.08  Aligned_cols=149  Identities=18%  Similarity=0.234  Sum_probs=86.8

Q ss_pred             EEEecccCceEEEEEEEcCCC--eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCce--eEEeeEEeecC--
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQ--RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRV--VKLYDVFEIDA--  364 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~--~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--V~l~~~~~~~~--  364 (627)
                      +..|+.|.+..+|+......+  ..+++|+.........      ...+.+|+.+++.+. |.+|  .+++.++....  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            577899999999998654332  3566776432211110      124668999999885 6654  67777665221  


Q ss_pred             CeEEEEEeecCCCChHH--------------------HH---Hhc--c--Cc-----C----HHHHHHHHH---------
Q psy4988         365 NSFCTVLEYCDGHDLDF--------------------YL---KQH--K--TI-----A----EREARSIVM---------  399 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~--------------------~l---~~~--~--~l-----~----e~~~~~i~~---------  399 (627)
                      +..|+||||++|..+.+                    .+   +.-  .  .+     +    ..++..+..         
T Consensus       117 G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~  196 (822)
T PLN02876        117 GTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEG  196 (822)
T ss_pred             CCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhccc
Confidence            34679999999864321                    01   000  0  00     0    112221111         


Q ss_pred             ------HHHHHHHHHHhCC---------CCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         400 ------QVVSALKYLNEIK---------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       400 ------qi~~aL~yLH~~~---------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                            .+...+.+|..+-         +.+||+|+++.|||++.+.. ..+-|.||.++..-
T Consensus       197 ~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~-~v~aVLDWE~a~~G  258 (822)
T PLN02876        197 KPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTED-RVIGILDWELSTLG  258 (822)
T ss_pred             CCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCC-eEEEEEeeeccccC
Confidence                  1233456664322         24999999999999986431 24679999988653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.85  E-value=8.1e-05  Score=75.10  Aligned_cols=30  Identities=40%  Similarity=0.626  Sum_probs=24.6

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .+||+|+.|.|||++.+   +..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~---~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDG---RLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECC---CEEEEEeCcccCc
Confidence            49999999999999865   3456999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.69  E-value=0.00078  Score=73.24  Aligned_cols=78  Identities=23%  Similarity=0.234  Sum_probs=50.4

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecC-----cchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeEEeec
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN-----KDWKEDKKANYIKHALREYNIHKALD---HPRVVKLYDVFEID  363 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~-----~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~  363 (627)
                      .+.||.|.+..||++.+...++.|+||.-...     ..|.-     ...+...|.+.|..+.   -.++.+++.+   +
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl-----~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---D  102 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPL-----TLDRARIEAEALKIQAKYVPDLVPKVYHY---D  102 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccc-----cHHHHHHHHHHHHHHHhhCCCCCCeEEEE---C
Confidence            46799999999999987544468999974211     11111     1234556777776652   3456677665   3


Q ss_pred             CCeEEEEEeecCCC
Q psy4988         364 ANSFCTVLEYCDGH  377 (627)
Q Consensus       364 ~~~~~lV~E~~~gg  377 (627)
                      ....++||||+++.
T Consensus       103 ~~~~~lVME~L~~~  116 (401)
T PRK09550        103 EELAVTVMEDLSDH  116 (401)
T ss_pred             CCCCEEEEecCCCc
Confidence            44456999999874

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.66  E-value=0.00054  Score=68.81  Aligned_cols=75  Identities=24%  Similarity=0.284  Sum_probs=44.8

Q ss_pred             EEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc-eeEEeeEEeecCCeEEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR-VVKLYDVFEIDANSFCT  369 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~~~~l  369 (627)
                      ++.|..|-...||++.... .+..|++|+........        ....+|+.+++.+...+ +.+++..+.  .   .+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---~~   69 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--------IDRERELRIHKLLSKHGLAPKLYATFQ--N---GL   69 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C---cE
Confidence            4567788888999986432 35678899764321110        11235777777774322 344444332  2   37


Q ss_pred             EEeecCCCCh
Q psy4988         370 VLEYCDGHDL  379 (627)
Q Consensus       370 V~E~~~gg~L  379 (627)
                      ||||++|..+
T Consensus        70 l~e~i~G~~l   79 (235)
T cd05157          70 IYEFIPGRTL   79 (235)
T ss_pred             EEEeeCCCcC
Confidence            9999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270|consensus

Probab=97.63  E-value=0.00036  Score=73.51  Aligned_cols=149  Identities=19%  Similarity=0.177  Sum_probs=96.5

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchh------------------hHhHHHHHHH-HHHHHHHHhcCCCC
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK------------------EDKKANYIKH-ALREYNIHKALDHP  351 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~------------------~~~~~~~~~~-~~~Ei~il~~l~Hp  351 (627)
                      |-..|..|--+.||.|. ..+|..+||||....-..-                  ......+++- +..|++-|++|...
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            44678899999999996 5678889999864321100                  0011111211 23577777777544


Q ss_pred             ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       352 nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      .|.-.--+..  .++ .|||+|+.....-.-.-..-.++...+..+-.+++.-+.-|-.. +.+||.||.--|+|+.+  
T Consensus       227 GIP~PePIlL--k~h-VLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyhd--  300 (520)
T KOG2270|consen  227 GIPCPEPILL--KNH-VLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYHD--  300 (520)
T ss_pred             CCCCCCceee--ecc-eEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEEC--
Confidence            4321111111  233 48999997543322222335678888999999999999888442 34999999999999987  


Q ss_pred             cccceEEeecccccccc
Q psy4988         432 VCGEIKITDFGLSKVMD  448 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~  448 (627)
                        |.+.|+|-+-+...+
T Consensus       301 --G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  301 --GKLYIIDVSQSVEHD  315 (520)
T ss_pred             --CEEEEEEccccccCC
Confidence              489999998775443

>PRK10593 hypothetical protein; Provisional

Probab=97.59  E-value=0.00092  Score=70.12  Aligned_cols=77  Identities=13%  Similarity=0.108  Sum_probs=49.4

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC---CceeEEeeEEeec--CCe
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH---PRVVKLYDVFEID--ANS  366 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIV~l~~~~~~~--~~~  366 (627)
                      .+.||.|..+.||.... .++ .+.||+......         ...+..|...++.|.-   ..|.++++++...  .+.
T Consensus        19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~---------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         19 VECISEQPYAALWALYD-SQG-NPMPLMARSFST---------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeecCCccceeEEEEEc-CCC-CEEEEEeccccc---------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            45699999999999743 233 466777432100         1246678888877642   3566777665422  344


Q ss_pred             EEEEEeecCCCCh
Q psy4988         367 FCTVLEYCDGHDL  379 (627)
Q Consensus       367 ~~lV~E~~~gg~L  379 (627)
                      .+||||+++|..+
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            6799999998654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.59  E-value=0.00031  Score=67.09  Aligned_cols=127  Identities=24%  Similarity=0.240  Sum_probs=83.7

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE-EeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK-LYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~-l~~~~~~~~~~~~l  369 (627)
                      ..+.|++|++|.||++..  .+..+|+|+-..+..         ...+..|.++|..+.-.++.. +|.+-   .+  ++
T Consensus        26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~---------r~~l~kEakiLeil~g~~~~p~vy~yg---~~--~i   89 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP---------RRNLEKEAKILEILAGEGVTPEVYFYG---ED--FI   89 (201)
T ss_pred             hhhhhhcccccEEEEeec--cCceEEEEEecCCcc---------hhhHHHHHHHHHHhhhcCCCceEEEec---hh--hh
Confidence            456799999999999964  466999998654332         235777889888887655543 33332   22  25


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEecccc-CC-cEEecCCCcccceEEeecccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLK-PG-NILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLK-P~-NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .|||+.|-.|.......   .    ++-+..++..---|-..|  |-|..|. |. ||++.+    +.+.|+||..|+.
T Consensus        90 ~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~----~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVND----RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEecC----CcEEEEEccchhh
Confidence            69999998887654321   1    222334444444455557  9999886 44 555544    3789999998874

>KOG1826|consensus

Probab=97.59  E-value=2.9e-05  Score=93.00  Aligned_cols=215  Identities=12%  Similarity=-0.014  Sum_probs=142.2

Q ss_pred             HHHHHHHHhcCCCCceeEEeeEEee-cCCeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhC-
Q psy4988         338 ALREYNIHKALDHPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEI-  411 (627)
Q Consensus       338 ~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-  411 (627)
                      .+.|.+-++...|++++..+.-... .....+.+++||.+|.++..+-..    ..+...-+.....+.+.+..-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445555666789998877664432 223457899999999999988543    2344444444444447777777653 


Q ss_pred             --CCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcch
Q psy4988         412 --KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKV  489 (627)
Q Consensus       412 --~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~  489 (627)
                        +.-.||++||+-|.+|..+   .++|+.+||+.+...+..       .......+++.|+.|++.    +.-.++.++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtn---y~v~~gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~----N~ik~t~rs 1421 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN---YNVKLGKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIK----NEIKFTKRS 1421 (2724)
T ss_pred             cCCccchhhhhhhhccceecC---CcccccccccccccCchH-------hhhhhhhCCHHHHHHHHH----HHHhhhhHH
Confidence              3357999999999999987   489999999998433221       234455789999999988    566688889


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         490 DVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       490 DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      |+|..++.+|+...|..+|-.-   ....-...+....  .+....-.|.++-.....+|-+....||.-...+.-+.|.
T Consensus      1422 dilr~s~~ly~rs~~n~~fi~f---lq~~Lkgiidn~t--f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1422 DILRRSLSLYLRSDGNAYFIFF---LQPALKGIIDNHT--FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHHHHHHHhcccHHHHHH---HHHHHcCcccccc--cccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            9999999999999998887210   0000011111111  1111122234455555666667777899998888888776


Q ss_pred             CC
Q psy4988         570 PP  571 (627)
Q Consensus       570 ~~  571 (627)
                      ..
T Consensus      1497 ~~ 1498 (2724)
T KOG1826|consen 1497 VG 1498 (2724)
T ss_pred             cc
Confidence            44

>KOG2268|consensus

Probab=97.50  E-value=6.8e-05  Score=77.63  Aligned_cols=144  Identities=24%  Similarity=0.282  Sum_probs=97.8

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH--hHHHH-------------HHHHHHHHHHHhcCC-CCc
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED--KKANY-------------IKHALREYNIHKALD-HPR  352 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~--~~~~~-------------~~~~~~Ei~il~~l~-Hpn  352 (627)
                      |.+.+.||-|--+.||.+-+ ..|+..++|++++....-..  .+.+|             .....+|+..|+.|. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56778899999999999964 56888999987654321110  01111             123567888888884 322


Q ss_pred             -eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         353 -VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       353 -IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                       |.+.+|     .+.-|+|||++.|..|...-+      ...+..+...+..-|.-|-.+|  +||+|..--||+++++ 
T Consensus       173 pVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~dd-  238 (465)
T KOG2268|consen  173 PVPKPID-----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKDD-  238 (465)
T ss_pred             CCCCccc-----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcC--ceecccchheeEEecC-
Confidence             333333     445679999999877654321      1234456666667777777778  9999999999999976 


Q ss_pred             cccceEEeeccccccccc
Q psy4988         432 VCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~  449 (627)
                        +.++++||--.....+
T Consensus       239 --~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  239 --DKIVVIDFPQMVSTSH  254 (465)
T ss_pred             --CCEEEeechHhhccCC
Confidence              5899999976544433

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.47  E-value=0.00038  Score=67.99  Aligned_cols=101  Identities=23%  Similarity=0.215  Sum_probs=79.1

Q ss_pred             HHHHHHhcCCC-CceeEEeeEEeecCCeEEEEEeecCCCChHH---HHHhccCcCHHHHHHHHHHHHHHHHHHHhCCC-C
Q psy4988         340 REYNIHKALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSALKYLNEIKP-P  414 (627)
Q Consensus       340 ~Ei~il~~l~H-pnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~---~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~-~  414 (627)
                      .|.-++..+.+ +++.+++|+|.    .+ +|.||.+.+.+..   .+......+|..+..|+.+++..+.+|+..-. .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~-~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RF-YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CE-EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47788888875 69999999884    23 6889998765532   12233457899999999999999999986311 3


Q ss_pred             EEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       415 IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      +.-.|++|+|+-++++   +++|++|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~---~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDD---GRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCC---CcEEEEechhcchhH
Confidence            8889999999999976   689999998876554

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.24  E-value=0.0015  Score=69.78  Aligned_cols=75  Identities=20%  Similarity=0.293  Sum_probs=46.6

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEee----c-CcchhhHhHHHHHHHHHHHHHHHhcCC--CC-ceeEEeeEEeecCC
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQ----L-NKDWKEDKKANYIKHALREYNIHKALD--HP-RVVKLYDVFEIDAN  365 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~----~-~~~~~~~~~~~~~~~~~~Ei~il~~l~--Hp-nIV~l~~~~~~~~~  365 (627)
                      .||.|....||++.+...++.|+||--.    . ...|.-.     +.+..-|...|+...  -| .+.++|.+   +..
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~-----~~R~~~E~~~L~~~~~~~P~~vP~vy~~---D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT-----LDRARIESSALIRQGEHVPHLVPRIFHF---DTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC-----ccHHHHHHHHHHHhhccCccccCeEEEE---ccc
Confidence            4899999999999875444689999632    1 1122222     234445777776553  34 45555543   455


Q ss_pred             eEEEEEeecCC
Q psy4988         366 SFCTVLEYCDG  376 (627)
Q Consensus       366 ~~~lV~E~~~g  376 (627)
                      ...+|||+++.
T Consensus        74 ~~~~vMEdL~~   84 (370)
T TIGR01767        74 MAVTVMEDLSH   84 (370)
T ss_pred             cceehHhhCcc
Confidence            66699999965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.22  E-value=0.0013  Score=67.27  Aligned_cols=134  Identities=16%  Similarity=0.164  Sum_probs=71.8

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce-eEEeeEEeecCCeEEEEEee
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV-VKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-V~l~~~~~~~~~~~~lV~E~  373 (627)
                      +..|-...+|+..  .++..+++|+.........       ....+|+.+++.+..-.+ .+++..+   .+  ++||||
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~i~~~---~~--~~v~e~   69 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALG-------VDRQREYQILQALSALGLAPKPILVN---EH--WLLVEW   69 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccccccc-------CcHHHHHHHHHHHHhcCCCCceEEEe---CC--EEEEEe
Confidence            4567778899875  4566788887432211100       023457777777753323 2333322   22  489999


Q ss_pred             cCCCChHHH--------------HH---hc----cCcCHH-HHHHHHHHH---------HHHHHHHHhC------CCCEE
Q psy4988         374 CDGHDLDFY--------------LK---QH----KTIAER-EARSIVMQV---------VSALKYLNEI------KPPVI  416 (627)
Q Consensus       374 ~~gg~L~~~--------------l~---~~----~~l~e~-~~~~i~~qi---------~~aL~yLH~~------~~~Iv  416 (627)
                      ++|..+...              +.   ..    ..++.. .+..+..++         ...+..+-..      ...++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            998665311              11   00    111211 111221111         1112222111      12489


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccc
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      |+|+.|.|||++.+    .+.|+||..|..
T Consensus       150 H~Dl~~~Nil~~~~----~~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQ----GLKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCC----CCEEEeccccCc
Confidence            99999999999875    378999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.07  E-value=0.0045  Score=66.96  Aligned_cols=77  Identities=21%  Similarity=0.307  Sum_probs=50.4

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEE----eecCcchhhHhHHHHHHHHHHHHHHHhcCC--CC-ceeEEeeEEeecC
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKV----HQLNKDWKEDKKANYIKHALREYNIHKALD--HP-RVVKLYDVFEIDA  364 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKi----i~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--Hp-nIV~l~~~~~~~~  364 (627)
                      .+.||.|.-..||++.+...++.|+||-    +.....|.-.     ..+..-|.++|+.+.  .| .+.++|.+   |.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~-----~~R~~~E~~aL~~~~~~~P~~VP~vy~~---D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLS-----TNRIRIESDVLQLEEELAPGLVPKVYLF---DS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCC-----hHHHHHHHHHHHHHHhhCCCcCCeEEEE---Cc
Confidence            6789999999999998744456789985    2222333332     234555777777653  34 45555543   55


Q ss_pred             CeEEEEEeecCC
Q psy4988         365 NSFCTVLEYCDG  376 (627)
Q Consensus       365 ~~~~lV~E~~~g  376 (627)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            666799999965

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.02  E-value=0.003  Score=65.52  Aligned_cols=31  Identities=35%  Similarity=0.578  Sum_probs=25.1

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .+||+|++|.|||++++.  ...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~--~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDA--RVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCC--CEEEEECcHhccc
Confidence            489999999999998741  2456999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.01  E-value=0.0045  Score=64.73  Aligned_cols=31  Identities=32%  Similarity=0.497  Sum_probs=25.9

Q ss_pred             CCEEeccccCCcEEecCC---CcccceEEeeccccc
Q psy4988         413 PPVIHYDLKPGNILLTEG---NVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~---~~~g~vKL~DFGla~  445 (627)
                      ..++|+|+.|.|||++.+   .  +.+.|+||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~--~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSET--KKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCC--CcEEEEeeCCCC
Confidence            369999999999999863   2  378999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093|consensus

Probab=96.88  E-value=0.0057  Score=67.14  Aligned_cols=163  Identities=20%  Similarity=0.233  Sum_probs=97.6

Q ss_pred             HHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       337 ~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      .++-...+++.+.|+|....+++.........+|||++. .+|.+++.... +-.....            -|  +  +.
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------~~--~--~~   89 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------AH--G--VL   89 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------cc--c--cc
Confidence            466778899999999999999987755666789999996 68888877643 2111110            11  1  33


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      |-               +.++++| -++.                      . |  |=         ...+|+||||+|.
T Consensus        90 ~~---------------~~~~~td-~~~t----------------------~-~--~~---------~~~pKsdVwsl~~  119 (725)
T KOG1093|consen   90 HL---------------NIIYITD-HFLT----------------------K-Y--PS---------PIGPKSDVWSLGF  119 (725)
T ss_pred             ee---------------hhhhccc-cccc----------------------c-C--CC---------CCCcchhhhhHHH
Confidence            31               2345555 0000                      0 0  11         1224899999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhhh--------hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         497 IFYQCLYGKKPFGHNQSQATILEENTILKA--------TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       497 iL~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      |+.++..|...|..-...............        .+-.  ..-.++..+..+...|+-..|..||...++.+++-|
T Consensus       120 i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~--~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~  197 (725)
T KOG1093|consen  120 IILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHL--IQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSF  197 (725)
T ss_pred             HHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHH--HHHhhhHhHHHHhccCCccccccccchhHHhcCccH
Confidence            999999988776422221111100000000        0000  001234556788889999999999988888887765


Q ss_pred             C
Q psy4988         569 Q  569 (627)
Q Consensus       569 ~  569 (627)
                      .
T Consensus       198 ~  198 (725)
T KOG1093|consen  198 T  198 (725)
T ss_pred             H
Confidence            4

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.87  E-value=0.0051  Score=64.04  Aligned_cols=139  Identities=13%  Similarity=0.033  Sum_probs=75.5

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC--ceeEEeeE-----EeecC
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP--RVVKLYDV-----FEIDA  364 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp--nIV~l~~~-----~~~~~  364 (627)
                      ++.|..|....+|+...  ++..+++|+.... .         ...+..|+.++..|.+-  .+.+++..     +....
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-~---------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV-S---------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCC-C---------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            45677787789998753  3446888986431 1         11244566666555322  23443331     11122


Q ss_pred             CeEEEEEeecCCCChHH----HH----------Hhc-cCc----------CHHHH----------HHHHHHHHHHHHHHH
Q psy4988         365 NSFCTVLEYCDGHDLDF----YL----------KQH-KTI----------AEREA----------RSIVMQVVSALKYLN  409 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~----~l----------~~~-~~l----------~e~~~----------~~i~~qi~~aL~yLH  409 (627)
                      +..++|++|++|..+..    ..          ... ..+          .+...          ......+..++.++.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            34578999999876421    11          000 000          00000          011112333444444


Q ss_pred             h-----CCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         410 E-----IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       410 ~-----~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .     ....+||+|+.|.|||++.+   +.+.|+||+.+.
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~iIDfe~a~  204 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGD---ELSGVIDFYFAC  204 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCC---ceEEEeehhhhc
Confidence            3     22359999999999999975   356899998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.86  E-value=0.006  Score=64.08  Aligned_cols=30  Identities=33%  Similarity=0.443  Sum_probs=25.6

Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .++||+|+.+.||+++.+   +.+.|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~---~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGD---SVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECC---ceEEEeeccccc
Confidence            459999999999999876   356899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.84  E-value=0.021  Score=60.19  Aligned_cols=30  Identities=30%  Similarity=0.303  Sum_probs=24.9

Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .++||+|+.|.|||++.+   ...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~---~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGD---RLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECC---ceEEEEeccccc
Confidence            359999999999999865   245799999875

>PLN02236 choline kinase

Probab=96.53  E-value=0.03  Score=59.99  Aligned_cols=145  Identities=17%  Similarity=0.184  Sum_probs=79.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcC----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCcee-EEeeEEe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLK----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV-KLYDVFE  361 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV-~l~~~~~  361 (627)
                      +...-+..|-.|-.-.+|++....    .++.|++|+......       ..+. -.+|+.+++.+..-++. ++++.+.
T Consensus        36 ~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-------~~id-R~~E~~~~~~l~~~gl~P~~~~~~~  107 (344)
T PLN02236         36 DEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-------LFFD-RDDEIRTFECMSRHGQGPRLLGRFP  107 (344)
T ss_pred             cCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-------eeec-hHHHHHHHHHHHHcCCCCceEEEEC
Confidence            334445566668888999986332    246888998654321       1111 24577777776433332 4455543


Q ss_pred             ecCCeEEEEEeecCCCChHHH-------H----------Hhcc------CcCHHHHHHHHHH-----------------H
Q psy4988         362 IDANSFCTVLEYCDGHDLDFY-------L----------KQHK------TIAEREARSIVMQ-----------------V  401 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~-------l----------~~~~------~l~e~~~~~i~~q-----------------i  401 (627)
                       + .   .|++|+++..|...       +          +.-.      ...+..+..++.+                 +
T Consensus       108 -~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l  182 (344)
T PLN02236        108 -N-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL  182 (344)
T ss_pred             -C-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence             2 2   57899987665321       0          0000      0112223233211                 1


Q ss_pred             HHHHHHH----Hh--CCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         402 VSALKYL----NE--IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       402 ~~aL~yL----H~--~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ...+..|    ..  ....++|+||++.|||+++..  +.+.|+||..|..
T Consensus       183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~--~~~~lID~Eya~~  231 (344)
T PLN02236        183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEET--RAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCC--CcEEEEeehhccc
Confidence            1122222    11  112489999999999998643  4799999988753

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.44  E-value=0.044  Score=59.72  Aligned_cols=76  Identities=13%  Similarity=0.143  Sum_probs=47.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEee-----cCcchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeEEee
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQ-----LNKDWKEDKKANYIKHALREYNIHKALD---HPRVVKLYDVFEI  362 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~-----~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~  362 (627)
                      ..+.||.|....||+..+  .+..|+||.-.     ....|.-.     ..+...|...|+.+.   ..++.++|.++. 
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~-----~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMT-----KERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCC-----ccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            367799999999999876  34568899743     11122211     223344555555443   346777777654 


Q ss_pred             cCCeEEEEEeecCC
Q psy4988         363 DANSFCTVLEYCDG  376 (627)
Q Consensus       363 ~~~~~~lV~E~~~g  376 (627)
                        ...++||||+++
T Consensus       108 --d~~vlvME~L~~  119 (418)
T PLN02756        108 --TMALIGMRYLEP  119 (418)
T ss_pred             --CCCEEEEeecCC
Confidence              334589999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.17  E-value=0.045  Score=57.75  Aligned_cols=32  Identities=28%  Similarity=0.632  Sum_probs=27.7

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      .+||+|+.+.||||+.+.   .+=|+||+++..-+
T Consensus       199 ~lvHGD~~~gNlii~~~~---~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR---PTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCC---eeEEEeccccccCC
Confidence            599999999999999884   58999999997643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.16  E-value=0.068  Score=56.92  Aligned_cols=31  Identities=32%  Similarity=0.575  Sum_probs=25.9

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .++|.||.+.|||++++.  +.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~--~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDE--GKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCC--CcEEEEcccccCC
Confidence            379999999999997543  4799999998853

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.44  E-value=0.13  Score=53.97  Aligned_cols=29  Identities=17%  Similarity=0.186  Sum_probs=25.5

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      ++||+|+.+.|||++.+   +.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~---~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDET---RGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCC---CCEEEEEhhhcc
Confidence            59999999999999876   478999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.35  E-value=0.072  Score=55.60  Aligned_cols=74  Identities=20%  Similarity=0.109  Sum_probs=41.7

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEeecCCeE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~~~~~~  367 (627)
                      -.+.|+.|....+|+..  .++..+.||+-.....          ..|..|..-|+.|   .--.+.+++.+...+... 
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~----------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~-   87 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR----------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA-   87 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC----------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC-
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhH----------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc-
Confidence            35679999999999975  7788899998652111          1345566666655   344566777776644444 


Q ss_pred             EEEEeecCCC
Q psy4988         368 CTVLEYCDGH  377 (627)
Q Consensus       368 ~lV~E~~~gg  377 (627)
                      +|||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            6999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.32  E-value=0.051  Score=54.02  Aligned_cols=86  Identities=16%  Similarity=0.291  Sum_probs=61.0

Q ss_pred             HHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       338 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      +..+++|+.++.  .|++|..   .+...+.+++|+|--....             ...++..=+.+|.-.|+.....+|
T Consensus       105 y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i~-------------~~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  105 YFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKIN-------------FSNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCcccc-------------hhHHHHHhHHHHHHhhccCCCeec
Confidence            566788888764  6788773   2455688999999632111             112223335678888976667999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccc
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +|..|+|||-|..   |.+||.|=+..
T Consensus       167 GD~np~NiM~D~~---G~lKlVDP~~L  190 (308)
T PF07387_consen  167 GDCNPDNIMCDKF---GYLKLVDPVCL  190 (308)
T ss_pred             CCCChhheeecCC---CCEEecChhhh
Confidence            9999999999987   79999997643

The function of this family is unknown.

>KOG1236|consensus

Probab=95.01  E-value=0.068  Score=57.57  Aligned_cols=61  Identities=25%  Similarity=0.293  Sum_probs=42.8

Q ss_pred             EEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCC
Q psy4988         368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~  431 (627)
                      .||-+|..|..+..+++.. ..++.....++.=.+.||--+-- -+  ++|.||.|.||++..+.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK  382 (565)
T ss_pred             eeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence            4666788888888887653 45555666666666666644432 24  99999999999996543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.89  E-value=0.093  Score=55.81  Aligned_cols=76  Identities=25%  Similarity=0.342  Sum_probs=56.5

Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +..+.|++|++.. +.+...    ....+.++..|+++.+..+.-+.. +.++-||||.-.||||++    |+|.|+||-
T Consensus       297 e~~y~yl~~kdhg-t~is~i----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId~----GnvtLIDfk  366 (488)
T COG5072         297 ETLYLYLHFKDHG-TPISII----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILIDE----GNVTLIDFK  366 (488)
T ss_pred             CceEEEEEEecCC-ceeeee----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeeec----CceEEEEee
Confidence            4455678888764 333221    234567888999998888877765 356999999999999994    689999999


Q ss_pred             cccccc
Q psy4988         443 LSKVMD  448 (627)
Q Consensus       443 la~~~~  448 (627)
                      +++.-.
T Consensus       367 lsRl~~  372 (488)
T COG5072         367 LSRLSY  372 (488)
T ss_pred             eeeccc
Confidence            998543

>KOG2269|consensus

Probab=94.81  E-value=0.013  Score=61.04  Aligned_cols=140  Identities=24%  Similarity=0.264  Sum_probs=88.8

Q ss_pred             EEEEecccCceEEEEEEE-------cC---CCeEEEEEEeecCcchhhHhHHHHH------------------HHHH--H
Q psy4988         291 LLMLLGKGGFSEVHKAFD-------LK---EQRYVACKVHQLNKDWKEDKKANYI------------------KHAL--R  340 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~-------~~---~~~~VAVKii~~~~~~~~~~~~~~~------------------~~~~--~  340 (627)
                      |..+|..|--++|+.|+-       ..   ..+.+|||++...-.. ......|+                  ..+.  +
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnE-FKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk  334 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNE-FKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK  334 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHH-HhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence            345688899999998842       11   2456889986432110 00011111                  1222  2


Q ss_pred             HHHHHhcC-----CCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHH-HhCCCC
Q psy4988         341 EYNIHKAL-----DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL-NEIKPP  414 (627)
Q Consensus       341 Ei~il~~l-----~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yL-H~~~~~  414 (627)
                      |+.-|.++     .+|-+|.|--       + .|||-|+...-+..-.-..-.|+..+.+....|++.++.-| |...  
T Consensus       335 EmhNL~RMq~~GlpcP~vV~lkk-------h-vLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~--  404 (531)
T KOG2269|consen  335 EMHNLSRMQKHGLPCPQVVKLKK-------H-VLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECL--  404 (531)
T ss_pred             HHHHHHHHHhcCCCCCceeeeec-------c-eEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhh--
Confidence            33333333     4677776532       2 38999987544432222234588999999999999999888 6666  


Q ss_pred             EEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       415 IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +||-||.--|||...+    .+.++|-.-+.
T Consensus       405 LVHADlSEyN~Lw~~g----Kvw~IDVsQsv  431 (531)
T KOG2269|consen  405 LVHADLSEYNLLWTPG----KVWVIDVSQSV  431 (531)
T ss_pred             eeecchhhhhheecCC----ceEEEechhcc
Confidence            9999999999999874    78999986553

>PTZ00384 choline kinase; Provisional

Probab=94.80  E-value=0.42  Score=51.97  Aligned_cols=82  Identities=18%  Similarity=0.268  Sum_probs=46.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCC-e-----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce-eEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQ-R-----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV-VKLYD  358 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~-~-----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-V~l~~  358 (627)
                      ......++.|..|--..+|++...... .     .|.+++.....        ...-.-.+|+.+++.+...++ .++++
T Consensus        49 ~~~~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~--------~l~IdR~~E~~i~~~Ls~~glgP~l~~  120 (383)
T PTZ00384         49 NPEFIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN--------SLVIDNDLQYNIAKLLGDNNFGPKIIG  120 (383)
T ss_pred             CcccEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC--------ceEeccHHHHHHHHHHHhCCCCCeEEE
Confidence            334445566766888899998643321 2     24444321110        011122468888888865444 44555


Q ss_pred             EEeecCCeEEEEEeecCCCChH
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLD  380 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~  380 (627)
                      .|.   +  ++|+||++|..|.
T Consensus       121 ~f~---~--g~l~efIeGr~l~  137 (383)
T PTZ00384        121 RFG---D--FTIQEWVEGNTMG  137 (383)
T ss_pred             ecC---C--EEEEEEeccccCC
Confidence            543   1  4899999987653

>PRK06148 hypothetical protein; Provisional

Probab=94.42  E-value=0.81  Score=56.11  Aligned_cols=38  Identities=32%  Similarity=0.420  Sum_probs=28.0

Q ss_pred             HHhCCCCEEeccccCCcEEecCCCcccceE-Eeecccccc
Q psy4988         408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIK-ITDFGLSKV  446 (627)
Q Consensus       408 LH~~~~~IvHrDLKP~NILl~~~~~~g~vK-L~DFGla~~  446 (627)
                      |......|||.|+.+.|||++.+.. +.+. |+|||.+..
T Consensus       198 l~~Lp~~vIHgDln~~NiLv~~~~~-~~isGiIDFgDa~~  236 (1013)
T PRK06148        198 LAALPAQVIHNDANDYNILVDADDG-ERISGLIDFGDAVH  236 (1013)
T ss_pred             HhcCCcceECCCCCcccEEEcCCCC-cceEEEEECccccc
Confidence            3344446999999999999997632 1454 999998853

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.12  E-value=0.49  Score=47.49  Aligned_cols=73  Identities=21%  Similarity=0.146  Sum_probs=41.8

Q ss_pred             ecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEEeecCCeEEEEE
Q psy4988         295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVFEIDANSFCTVL  371 (627)
Q Consensus       295 LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~~~~~~~~~lV~  371 (627)
                      +--|..-+.|...  .....|-||+-.          ......|..|+.-|..|   +--+|.+++.+-. +..+-|+||
T Consensus        24 v~gG~inea~~v~--dg~~~~FvK~n~----------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~-~~~~sylVl   90 (286)
T COG3001          24 VSGGDINEAWRLR--DGTDPFFVKCNQ----------REQLSMFTAEADGLELLARSNTITVPKVIAVGA-SRDHSYLVL   90 (286)
T ss_pred             cCCccccceeEee--cCCcceEEEecc----------hhhHHHHHHHHHHHHHHHhcCCccccceEEecC-CCCeeEEEE
Confidence            4444444445442  234567888732          22234455665555444   3345556666554 667778999


Q ss_pred             eecCCCChH
Q psy4988         372 EYCDGHDLD  380 (627)
Q Consensus       372 E~~~gg~L~  380 (627)
                      ||++-+.++
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999886654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.25  E-value=0.26  Score=51.42  Aligned_cols=29  Identities=31%  Similarity=0.446  Sum_probs=24.6

Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++|+|+.+.|||++.+    .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~----~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDN----EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeCC----cEEEEECcccc
Confidence            359999999999999863    57899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=91.22  E-value=0.66  Score=47.47  Aligned_cols=77  Identities=17%  Similarity=0.075  Sum_probs=51.3

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEEEee
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY  373 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~  373 (627)
                      .+-.|..+.|+.+. ..+|..+++|+........         ........|+..+=...|++++.   +...-.|++|.
T Consensus         9 ~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~~~---------~E~~g~~~L~~w~G~GaVrll~~---d~~~~AlLLEr   75 (253)
T PF04655_consen    9 PPAHGSSSLVVPVR-RADGTPAVLKLAPPHAEAE---------HEARGEAALRWWNGRGAVRLLAA---DPERGALLLER   75 (253)
T ss_pred             CCCCCcceEEEEEE-cCCCCeEEEEecCCcccch---------hhhhHHhHhheeCCCCceeeecc---ccccchhhhhh
Confidence            46678999999997 5779999999864322111         11112255777777788999986   33445688999


Q ss_pred             c-CCCChHHHH
Q psy4988         374 C-DGHDLDFYL  383 (627)
Q Consensus       374 ~-~gg~L~~~l  383 (627)
                      + ++.+|.++.
T Consensus        76 l~~g~~L~~~~   86 (253)
T PF04655_consen   76 LDPGRSLASLP   86 (253)
T ss_pred             ccCCCchhhcc
Confidence            9 555675543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PHA03111 Ser/Thr kinase; Provisional

Probab=90.49  E-value=0.44  Score=50.16  Aligned_cols=39  Identities=28%  Similarity=0.413  Sum_probs=28.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCC-C-CEEeccccCCcEEecCC
Q psy4988         392 REARSIVMQVVSALKYLNEIK-P-PVIHYDLKPGNILLTEG  430 (627)
Q Consensus       392 ~~~~~i~~qi~~aL~yLH~~~-~-~IvHrDLKP~NILl~~~  430 (627)
                      +-++.++.||+.-.-++-++. + .++|-||||+|||+-+.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            456778889887765554332 1 49999999999999654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	627
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-29
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-29
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-26
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-26
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-25
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-24
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-24
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-24
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-24
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-24
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-23
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-23
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-23
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-23
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-23
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-22
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-22
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-22
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-22
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-22
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-22
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-22
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-21
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-21
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-21
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-21
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-21
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-21
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-21
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-21
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-21
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-21
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-21
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-21
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-21
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-21
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-21
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-21
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-20
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-20
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-20
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-20
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-20
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-20
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-20
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-20
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-20
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-20
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-20
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-20
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-20
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-20
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-20
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-20
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-20
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-20
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-19
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-19
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-19
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-19
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-19
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-19
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-19
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-19
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-19
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-19
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-19
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-19
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-19
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-19
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-19
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-19
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-19
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-19
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-19
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-19
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-18
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-18
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-18
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-18
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-18
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-18
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-18
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-18
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-18
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-18
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-17
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-17
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-16
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-16
3soa_A	444	Full-Length Human Camkii Length = 444		1e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-16
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-16
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-16
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-16
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-16
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-16
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-16
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-16
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-16
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-16
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-16
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-16
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-16
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-16
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-15
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-15
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-15
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-14
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-14
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-14
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-14
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-14
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-14
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-14
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-05
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		6e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  130 bits (328), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 100/292 (34%), Positives = 139/292 (47%), Gaps = 35/292 (11%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
             ++RY ++ +LGKG F EV K  D   Q+  A KV  +NK   ++K  + I   LRE  
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTI---LREVE 73
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           + K LDHP ++KL+++ E D++SF  V E   G +L   + + K  +E +A  I+ QV S
Sbjct: 74  LLKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            + Y++  K  ++H DLKP NILL       +IKI DFGLS    +     D        
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR------- 183
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENT 522
             GT +Y+ PE             K DVWS GVI Y  L G  PF G N        E  
Sbjct: 184 -IGTAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYD 229
Query: 523 ILKATEV-----QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           ILK  E            T+S++AK  IR  L +    RI       H ++Q
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 139/291 (47%), Gaps = 35/291 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            ++RY ++ +LGKG F EV K  D   Q+  A KV  +NK   ++K  + I   LRE  +
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTI---LREVEL 74
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K LDHP ++KL+++ E D++SF  V E   G +L   + + K  +E +A  I+ QV S 
Sbjct: 75  LKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y++  K  ++H DLKP NILL       +IKI DFGLS    +     D         
Sbjct: 134 ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-------- 183
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTI 523
            GT +Y+ PE             K DVWS GVI Y  L G  PF G N        E  I
Sbjct: 184 IGTAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDI 230
Query: 524 LKATEV-----QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           LK  E            T+S++AK  IR  L +    RI       H ++Q
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 139/291 (47%), Gaps = 35/291 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            ++RY ++ +LGKG F EV K  D   Q+  A KV  +NK   ++K  + I   LRE  +
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTI---LREVEL 74
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K LDHP ++KL+++ E D++SF  V E   G +L   + + K  +E +A  I+ QV S 
Sbjct: 75  LKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y++  K  ++H DLKP NILL       +IKI DFGLS    +     D         
Sbjct: 134 ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-------- 183
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTI 523
            GT +Y+ PE             K DVWS GVI Y  L G  PF G N        E  I
Sbjct: 184 IGTAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDI 230
Query: 524 LKATEV-----QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           LK  E            T+S++AK  IR  L +    RI       H ++Q
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
            + SDRY    +LGKG F EV    D    +  A KV    Q+ +  K DK++      L
Sbjct: 45  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKES-----LL 97
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  + K LDHP ++KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ 
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 156
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S + Y++  K  ++H DLKP N+LL   +    I+I DFGLS   +      D    
Sbjct: 157 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 211
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATIL 518
                 GT +Y+ PE             K DVWS GVI Y  L G  PF G N       
Sbjct: 212 -----IGTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGAN------- 254
Query: 519 EENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  ILK  E      +      VS  AK  IR  L Y    RI       H+++Q
Sbjct: 255 -EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
            + SDRY    +LGKG F EV    D    +  A KV    Q+ +  K DK++      L
Sbjct: 46  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKES-----LL 98
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  + K LDHP ++KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ 
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 157
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S + Y++  K  ++H DLKP N+LL   +    I+I DFGLS   +      D    
Sbjct: 158 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 212
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATIL 518
                 GT +Y+ PE             K DVWS GVI Y  L G  PF G N       
Sbjct: 213 -----IGTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGAN------- 255
Query: 519 EENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  ILK  E      +      VS  AK  IR  L Y    RI       H+++Q
Sbjct: 256 -EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 132/296 (44%), Gaps = 40/296 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
            + SDRY    +LGKG F EV    D    +  A KV    Q+ +  K DK++      L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKES-----LL 74
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  + K LDHP ++KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ 
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S + Y++  K  ++H DLKP N+LL   +    I+I DFGLS   +      D    
Sbjct: 134 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 188
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATIL 518
                 GT +Y+ PE             K DVWS GVI Y  L G  PF G N       
Sbjct: 189 -----IGTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGAN------- 231
Query: 519 EENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  ILK  E      +      VS  AK  IR  L Y    RI       H+++Q
Sbjct: 232 -EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 100/295 (33%), Positives = 132/295 (44%), Gaps = 40/295 (13%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALR 340
           + SDRY    +LGKG F EV    D    +  A KV    Q+ +  K DK++      LR
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKES-----LLR 81
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  + K LDHP ++KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ Q
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 140
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           V+S + Y++  K  ++H DLKP N+LL   +    I+I DFGLS   +      D     
Sbjct: 141 VLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---- 194
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILE 519
                GT +Y+ PE             K DVWS GVI Y  L G  PF G N        
Sbjct: 195 ----IGTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGAN-------- 237
Query: 520 ENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           E  ILK  E      +      VS  AK  IR  L Y    RI       H+++Q
Sbjct: 238 EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 130/296 (43%), Gaps = 40/296 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
            + SDRY    +LGKG F EV    D    +  A KV    Q+ +  K DK++      L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKES-----LL 74
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE  + K LDHP + KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ 
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S + Y +  K  ++H DLKP N+LL   +    I+I DFGLS   +      D    
Sbjct: 134 QVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--- 188
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATIL 518
                 GT +Y+ PE             K DVWS GVI Y  L G  PF G N       
Sbjct: 189 -----IGTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGAN------- 231
Query: 519 EENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  ILK  E      +      VS  AK  IR  L Y    RI       H+++Q
Sbjct: 232 -EYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 34/279 (12%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LLGKG F+ V++A  +     VA K+     D K   KA  ++    E  IH  L HP +
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKM----IDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIK 412
           ++LY+ FE D+N    VLE C   +++ YLK   K  +E EAR  + Q+++ + YL+   
Sbjct: 74  LELYNYFE-DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-- 130
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLS---KVMDEENYNPDHGMDLTSQGAGTYW 469
             ++H DL   N+LLT       IKI DFGL+   K+  E++Y             GT  
Sbjct: 131 HGILHRDLTLSNLLLTRNM---NIKIADFGLATQLKMPHEKHYTL----------CGTPN 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y+ PE  +  ++   + S  DVWS+G +FY  L G+ PF  +  +      NT+ K    
Sbjct: 178 YISPE--IATRSAHGLES--DVWSLGCMFYTLLIGRPPFDTDTVK------NTLNKVVLA 227
Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +     +S EAK  I   L     DR+ + S+  H ++
Sbjct: 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 15/286 (5%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
           L D Y++   LG G   EV  AF+ K  + VA K+    K      ++A+   +   E  
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E   +    Q++ 
Sbjct: 74  ILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L   
Sbjct: 132 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------LMRT 181
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  +V       +  VD WS+GVI + CL G  PF  +++Q ++ ++ T 
Sbjct: 182 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 240
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 241 GKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 15/286 (5%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
           L D Y++   LG G   EV  AF+ K  + VA K+    K      ++A+   +   E  
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E   +    Q++ 
Sbjct: 68  ILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L   
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------LMRT 175
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  +V       +  VD WS+GVI + CL G  PF  +++Q ++ ++ T 
Sbjct: 176 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 235 GKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 15/286 (5%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
           L D Y++   LG G   EV  AF+ K  + VA K+    K      ++A+   +   E  
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E   +    Q++ 
Sbjct: 68  ILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L   
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------LMRT 175
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  +V       +  VD WS+GVI + CL G  PF  +++Q ++ ++ T 
Sbjct: 176 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 235 GKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 15/286 (5%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
           L D Y++   LG G   EV  AF+ K  + VA K+    K      ++A+   +   E  
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E   +    Q++ 
Sbjct: 68  ILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L   
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------LMRT 175
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  +V       +  VD WS+GVI + CL G  PF  +++Q ++ ++ T 
Sbjct: 176 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 235 GKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 15/286 (5%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
           L D Y++   LG G   EV  AF+ K  + VA K+    K      ++A+   +   E  
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E   +    Q++ 
Sbjct: 67  ILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L   
Sbjct: 125 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------LMRT 174
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  +V       +  VD WS+GVI + CL G  PF  +++Q ++ ++ T 
Sbjct: 175 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 233
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 234 GKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALRE 341
           + + Y  +  LG G + EV    +       A KV    Q +K    D   N  K     
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 342 YN---IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           YN   + K+LDHP ++KL+DVFE D   F  V E+ +G +L   +       E +A +I+
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q++S + YL+  K  ++H D+KP NILL   N    IKI DFGLS       ++ D+ +
Sbjct: 153 KQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-----FSKDYKL 205
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT +Y+ PE         K + K DVWS GVI Y  L G  PFG    Q    
Sbjct: 206 ---RDRLGTAYYIAPEVL-----KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---- 253
Query: 519 EENTILKATE-----VQFANKPTVSNEAKGFIRSCLAY 551
               I+K  E       F +   +S+EAK  I+  L Y
Sbjct: 254 ---DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTY 288

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 114/229 (49%), Gaps = 24/229 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL++ R VA KV  L  D   D   ++     RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDP--SFYLRFRREAQN 65
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NI+++  N    +K+ DFG+++ +       D G  +T
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNA---VKVMDFGIARAI------ADSGNSVT 174
Query: 462 SQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A  GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 175 QTAAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 114/229 (49%), Gaps = 24/229 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL++ R VA KV  L  D   D   ++     RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDP--SFYLRFRREAQN 65
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NI+++  N    +K+ DFG+++ +       D G  +T
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNA---VKVMDFGIARAI------ADSGNSVT 174
Query: 462 SQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A  GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 175 QTAAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 114/227 (50%), Gaps = 20/227 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL++ R VA KV  L  D   D   ++     RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARDP--SFYLRFRREAQN 65
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NIL++  N    +K+ DFG+++ + +      + +  T
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANILISATNA---VKVVDFGIARAIADSG----NSVXQT 176
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 177 AAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 143/297 (48%), Gaps = 17/297 (5%)
Query: 274 EDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKA 332
           +DQS +     L D Y++   LG G   EV  AF+ K  + VA ++    K      ++A
Sbjct: 124 DDQSVYPK--ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA 181
Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER 392
           +   +   E  I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E 
Sbjct: 182 DPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
             +    Q++ A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E + 
Sbjct: 240 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
                  L     GT  YL PE  +V       +  VD WS+GVI + CL G  PF  ++
Sbjct: 297 -------LMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348
Query: 513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +Q ++ ++ T  K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 349 TQVSLKDQITSGKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 143/297 (48%), Gaps = 17/297 (5%)
Query: 274 EDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKA 332
           +DQS +     L D Y++   LG G   EV  AF+ K  + VA ++    K      ++A
Sbjct: 138 DDQSVYPK--ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA 195
Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER 392
           +   +   E  I K L+HP ++K+ + F  DA  +  VLE  +G +L   +  +K + E 
Sbjct: 196 DPALNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA 253
Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
             +    Q++ A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E + 
Sbjct: 254 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 310
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
                  L     GT  YL PE  +V       +  VD WS+GVI + CL G  PF  ++
Sbjct: 311 -------LMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362
Query: 513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +Q ++ ++ T  K   +       VS +A   ++  L    + R       RH +LQ
Sbjct: 363 TQVSLKDQITSGKYNFIP-EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 24/229 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL+  R VA KV  L  D   D   ++     RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDP--SFYLRFRREAQN 65
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NI+++  N    +K+ DFG+++ +       D G  +T
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNA---VKVMDFGIARAI------ADSGNSVT 174
Query: 462 SQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A  GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 175 QTAAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 150/295 (50%), Gaps = 31/295 (10%)
Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VHQLNKDWKEDKKANYIK 336
           R+     + D Y    +LG G FSEV  A D + Q+ VA K + +   + KE    N I 
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
                  +HK + HP +V L D++E   + +  +++   G +L   + +     ER+A  
Sbjct: 69  ------VLHK-IKHPNIVALDDIYESGGHLYL-IMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           ++ QV+ A+KYL+++   ++H DLKP N+L    +   +I I+DFGLSK+ D  +     
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----- 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
              + S   GT  Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF ++++ A 
Sbjct: 174 ---VLSTACGTPGYVAPE--VLAQKP--YSKAVDCWSIGVIAYILLCGYPPF-YDENDAK 225
Query: 517 ILEENTILKATEVQFANKP---TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           + E+  ILKA E +F + P    +S+ AK FIR  +    E R       +H ++
Sbjct: 226 LFEQ--ILKA-EYEF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/229 (32%), Positives = 113/229 (49%), Gaps = 24/229 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL+  R VA KV  L  D   D   ++     RE   
Sbjct: 27  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDP--SFYLRFRREAQN 82
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 83  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NI+++  N    +K+ DFG+++ +       D G  +T
Sbjct: 143 CQALNFSHQNG--IIHRDVKPANIMISATNA---VKVMDFGIARAI------ADSGNSVT 191
Query: 462 SQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A  GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 192 QTAAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 147/291 (50%), Gaps = 33/291 (11%)
Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           N H   SD +  L ++GKG F +V  A    E+ + A KV Q     K+ ++    KH +
Sbjct: 32  NPHAKPSD-FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE----KHIM 86
Query: 340 REYNIH-KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
            E N+  K + HP +V L+  F+  A+    VL+Y +G +L ++L++ +   E  AR   
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYA 145
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            ++ SAL YL+ +   +++ DLKP NILL      G I +TDFGL K   E N       
Sbjct: 146 AEIASALGYLHSLN--IVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHN------- 193
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             TS   GT  YL PE  V+ K P      VD W +G + Y+ LYG  PF ++++ A + 
Sbjct: 194 STTSTFCGTPEYLAPE--VLHKQP--YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMY 248
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            +N + K  ++    KP ++N A+  +   L   +  R+     A+ D+++
Sbjct: 249 -DNILNKPLQL----KPNITNSARHLLEGLLQKDRTKRLG----AKDDFME 290

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 149/294 (50%), Gaps = 29/294 (9%)
Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           R+     + D Y    +LG G FSEV  A D + Q+ VA K   + K+  E K+ +    
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC--IAKEALEGKEGS---- 62
Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
              E  +   + HP +V L D++E   + +  +++   G +L   + +     ER+A  +
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + QV+ A+KYL+++   ++H DLKP N+L    +   +I I+DFGLSK+ D  +      
Sbjct: 122 IFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS------ 173
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             + S   GT  Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF ++++ A +
Sbjct: 174 --VLSTACGTPGYVAPE--VLAQKP--YSKAVDCWSIGVIAYILLCGYPPF-YDENDAKL 226
Query: 518 LEENTILKATEVQFANKP---TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            E+  ILKA E +F + P    +S+ AK FIR  +    E R       +H ++
Sbjct: 227 FEQ--ILKA-EYEF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 149/294 (50%), Gaps = 29/294 (9%)
Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           R+     + D Y    +LG G FSEV  A D + Q+ VA K   + K+  E K+ +    
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC--IAKEALEGKEGS---- 62
Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
              E  +   + HP +V L D++E   + +  +++   G +L   + +     ER+A  +
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + QV+ A+KYL+++   ++H DLKP N+L    +   +I I+DFGLSK+ D  +      
Sbjct: 122 IFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS------ 173
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             + S   GT  Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF ++++ A +
Sbjct: 174 --VLSTACGTPGYVAPE--VLAQKP--YSKAVDCWSIGVIAYILLCGYPPF-YDENDAKL 226
Query: 518 LEENTILKATEVQFANKP---TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            E+  ILKA E +F + P    +S+ AK FIR  +    E R       +H ++
Sbjct: 227 FEQ--ILKA-EYEF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 149/294 (50%), Gaps = 29/294 (9%)
Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           R+     + D Y    +LG G FSEV  A D + Q+ VA K   + K+  E K+ +    
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC--IAKEALEGKEGS---- 62
Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
              E  +   + HP +V L D++E   + +  +++   G +L   + +     ER+A  +
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLY-LIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + QV+ A+KYL+++   ++H DLKP N+L    +   +I I+DFGLSK+ D  +      
Sbjct: 122 IFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS------ 173
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             + S   GT  Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF ++++ A +
Sbjct: 174 --VLSTACGTPGYVAPE--VLAQKP--YSKAVDCWSIGVIAYILLCGYPPF-YDENDAKL 226
Query: 518 LEENTILKATEVQFANKP---TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            E+  ILKA E +F + P    +S+ AK FIR  +    E R       +H ++
Sbjct: 227 FEQ--ILKA-EYEF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 112/229 (48%), Gaps = 24/229 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LSDRY L  +LG GG SEVH A DL+  R VA KV  L  D   D   ++     RE   
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDP--SFYLRFRREAQN 65
Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             AL+HP +V +Y   E +  +      V+EY DG  L   +     +  + A  ++   
Sbjct: 66  AAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             AL + ++    +IH D+KP NI+++  N    +K+ DFG+++ +       D G  +T
Sbjct: 126 CQALNFSHQNG--IIHRDVKPANIMISATNA---VKVMDFGIARAI------ADSGNSVT 174
Query: 462 SQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              A  GT  YL PE          + ++ DV+S+G + Y+ L G+ PF
Sbjct: 175 QTAAVIGTAQYLSPE----QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + HP ++ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHPNIITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+       +  + G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------HEIEDGV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
               +    + +F ++   S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITAVSYDFDEEFFSQ--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA----LR 340
           LS+ Y  +  LG G + EV    D         KV  + +  K  +K +    +    L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRD---------KVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  + K LDHP ++KLYD FE D  ++  V+E   G +L   +       E +A  I+ Q
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFE-DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ 144
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           V+S + YL+  K  ++H DLKP N+LL        IKI DFGLS V + +    +     
Sbjct: 145 VLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---- 198
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                GT +Y+ PE         K   K DVWS+GVI +  L G  PFG  Q+   IL +
Sbjct: 199 ----LGTAYYIAPEVL-----RKKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRK 248
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
               K T         VS  AK  I+  L +  + RI       H +++    K
Sbjct: 249 VEKGKYT-FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y ++  LG+G F +V  A+     + VA K+  +NK  K   K++      RE +  + L
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKI--INK--KVLAKSDMQGRIEREISYLRLL 71
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLYDV +   +    V+EY  G++L  Y+ Q   ++E+EAR    Q++SA++Y 
Sbjct: 72  RHPHIIKLYDVIK-SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  K  ++H DLKP N+LL E      +KI DFGLS +M + N+             G+ 
Sbjct: 130 HRHK--IVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNF--------LKTSCGSP 176
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y  PE  + GK       +VDVWS GVI Y  L  + PF  +     +L +N     + 
Sbjct: 177 NYAAPEV-ISGK--LYAGPEVDVWSCGVILYVMLCRRLPF--DDESIPVLFKNI----SN 227
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             +     +S  A G I+  L     +RI +  + + D+ +  +P++
Sbjct: 228 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEY 274

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y ++  LG+G F +V  A+     + VA K+  +NK  K   K++      RE +  + L
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKI--INK--KVLAKSDMQGRIEREISYLRLL 70
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLYDV +   +    V+EY  G++L  Y+ Q   ++E+EAR    Q++SA++Y 
Sbjct: 71  RHPHIIKLYDVIK-SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  K  ++H DLKP N+LL E      +KI DFGLS +M + N+             G+ 
Sbjct: 129 HRHK--IVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNF--------LKTSCGSP 175
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y  PE  + GK       +VDVWS GVI Y  L  + PF  +     +L +N     + 
Sbjct: 176 NYAAPEV-ISGK--LYAGPEVDVWSCGVILYVMLCRRLPF--DDESIPVLFKNI----SN 226
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             +     +S  A G I+  L     +RI +  + + D+ +  +P++
Sbjct: 227 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEY 273

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 133/294 (45%), Gaps = 42/294 (14%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA-----L 339
           LSDRY  +  LG G + EV    D         K+    +  K  KK++    +     L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKD---------KLTGAERAIKIIKKSSVTTTSNSGALL 52
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  + K LDHP ++KLY+ FE D  ++  V+E   G +L   +   +  +E +A  I+ 
Sbjct: 53  DEVAVLKQLDHPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S   YL+  K  ++H DLKP N+LL   +    IKI DFGLS      ++     M 
Sbjct: 112 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGKM- 163
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
              +  GT +Y+ PE         K   K DVWS GVI Y  L G  PFG    Q     
Sbjct: 164 --KERLGTAYYIAPEVL-----RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE---- 212
Query: 520 ENTILKATEV-QFANKP----TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              ILK  E  +F+  P     VS+EAK  ++  L Y    RI       H ++
Sbjct: 213 ---ILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y ++  LG+G F +V  A+     + VA K+  +NK  K   K++      RE +  + L
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKI--INK--KVLAKSDMQGRIEREISYLRLL 61
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLYDV +   +    V+EY  G++L  Y+ Q   ++E+EAR    Q++SA++Y 
Sbjct: 62  RHPHIIKLYDVIK-SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  K  ++H DLKP N+LL E      +KI DFGLS +M + N+             G+ 
Sbjct: 120 HRHK--IVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNF--------LKTSCGSP 166
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y  PE  + GK       +VDVWS GVI Y  L  + PF  +     +L +N     + 
Sbjct: 167 NYAAPEV-ISGK--LYAGPEVDVWSCGVILYVMLCRRLPF--DDESIPVLFKNI----SN 217
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             +     +S  A G I+  L     +RI +  + + D+ +  +P++
Sbjct: 218 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEY 264

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y ++  LG+G F +V  A+     + VA K+  +NK  K   K++      RE +  + L
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKI--INK--KVLAKSDMQGRIEREISYLRLL 65
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLYDV +   +    V+EY  G++L  Y+ Q   ++E+EAR    Q++SA++Y 
Sbjct: 66  RHPHIIKLYDVIK-SKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  K  ++H DLKP N+LL E      +KI DFGLS +M + N+             G+ 
Sbjct: 124 HRHK--IVHRDLKPENLLLDEHL---NVKIADFGLSNIMTDGNF--------LKTSCGSP 170
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y  PE  + GK       +VDVWS GVI Y  L  + PF  +     +L +N     + 
Sbjct: 171 NYAAPEV-ISGK--LYAGPEVDVWSCGVILYVMLCRRLPF--DDESIPVLFKNI----SN 221
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             +     +S  A G I+  L     +RI +  + + D+ +  +P++
Sbjct: 222 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEY 268

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 124/261 (47%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   R VA K+    QLN           ++   RE  I 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--------PTSLQKLFREVRIM 65
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  ++EY  G ++  YL  H  + E+EARS   Q+VSA+
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYL-IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 124
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++ +  ++H DLK  N+LL   +    IKI DFG S       +     +D      
Sbjct: 125 QYCHQKR--IVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTVGGKLDTF---C 171
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   +       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 172 GSPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 225
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 226 GKYRIPFYMSTDCENLLKRFL 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 92/321 (28%), Positives = 139/321 (43%), Gaps = 57/321 (17%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  RY+ L  LG GG   V  A D    + VA K     K    D ++  +KHALRE  I
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQS--VKHALREIKI 61
Query: 345 HKALDHPRVVKLYDVFE-------------IDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
            + LDH  +VK++++                + NS   V EY +  DL   L+Q   + E
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLE 119
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
             AR  + Q++  LKY++     V+H DLKP N+ +   ++   +KI DFGL+++MD   
Sbjct: 120 EHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLV--LKIGDFGLARIMDPHY 175
Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--G 509
            +  H     S+G  T WY  P   +   +P   +  +D+W+ G IF + L GK  F   
Sbjct: 176 SHKGH----LSEGLVTKWYRSPRLLL---SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228
Query: 510 HNQSQATILEENT----------ILKATEVQFANK------------PTVSNEAKGFIRS 547
           H   Q  ++ E+           +L    V   N             P +S EA  F+  
Sbjct: 229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ 288
Query: 548 CLAYRKEDRIDVISLARHDYL 568
            L +   DR+       H Y+
Sbjct: 289 ILTFSPMDRLTAEEALSHPYM 309

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 133/294 (45%), Gaps = 42/294 (14%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA-----L 339
           LSDRY  +  LG G + EV    D         K+    +  K  KK++    +     L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKD---------KLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  + K LDHP ++KLY+ FE D  ++  V+E   G +L   +   +  +E +A  I+ 
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+S   YL+  K  ++H DLKP N+LL   +    IKI DFGLS      ++     M 
Sbjct: 129 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGKM- 180
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
              +  GT +Y+ PE         K   K DVWS GVI Y  L G  PFG    Q     
Sbjct: 181 --KERLGTAYYIAPEVL-----RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQE---- 229
Query: 520 ENTILKATEV-QFANKP----TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              ILK  E  +F+  P     VS+EAK  ++  L Y    RI       H ++
Sbjct: 230 ---ILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 123/261 (47%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   R VA K+    QLN           ++   RE  I 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--------PTSLQKLFREVRIM 68
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  ++EY  G ++  YL  H  + E+EARS   Q+VSA+
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYL-IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++ +  ++H DLK  N+LL   +    IKI DFG S       +     +D      
Sbjct: 128 QYCHQKR--IVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTVGGKLDAF---C 174
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G   Y  PE F   +       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 175 GAPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 228
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 229 GKYRIPFYMSTDCENLLKRFL 249

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 118/228 (51%), Gaps = 26/228 (11%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D ++    LG G F +VH    L E+R  +  + ++ K   +D+    ++    E  +
Sbjct: 20  IDDLFIFKRKLGSGAFGDVH----LVEER--SSGLERVIKTINKDRSQVPMEQIEAEIEV 73
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSIVMQ 400
            K+LDHP ++K+++VFE D ++   V+E C+G +L   +     + K ++E     ++ Q
Sbjct: 74  LKSLDHPNIIKIFEVFE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++AL Y +     V+H DLKP NIL  + +    IKI DFGL+++   + +        
Sbjct: 133 MMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-------- 182
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++  AGT  Y+ PE F        ++ K D+WS GV+ Y  L G  PF
Sbjct: 183 STNAAGTALYMAPEVF-----KRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 126/261 (48%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA K+    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN--------SSSLQKLFREVRIM 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTFGNKLDTF---C 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   K       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYMSTDCENLLKKFL 248

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 126/261 (48%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA K+    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN--------SSSLQKLFREVRIM 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFS-----NEFTFGNKLDTF---C 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   K       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYMSTDCENLLKKFL 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 127/261 (48%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA ++    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN--------SSSLQKLFREVRIM 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D   +  
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTFGNKLD---EFC 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   K       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYMSTDCENLLKKFL 248

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 127/291 (43%), Gaps = 32/291 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHK 346
           Y++   LG+G F +V  A   K Q+ VA K    QL K      K++      RE +  K
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK------KSDMHMRVEREISYLK 64
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L HP ++KLYDV     +    V+EY  G   D Y+ + K + E E R    Q++ A++
Sbjct: 65  LLRHPHIIKLYDVITTPTD-IVMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y +  K  ++H DLKP N+LL +      +KI DFGLS +M + N+             G
Sbjct: 123 YCHRHK--IVHRDLKPENLLLDDNL---NVKIADFGLSNIMTDGNF--------LKTSCG 169
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           +  Y  PE   V         +VDVWS G++ Y  L G+ PF            N   K 
Sbjct: 170 SPNYAAPE---VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE------FIPNLFKKV 220
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGR 577
               +     +S  A+  IR  +      RI +  + R  +    +P + R
Sbjct: 221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLR 271

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 121/244 (49%), Gaps = 32/244 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
           P    RY+    LGKGGF++ ++  D+  +   A KV     L K  +++K +       
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------ 91
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  IHK+LD+P VV  +  FE D +    VLE C    L    K+ K + E EAR  + 
Sbjct: 92  -EIAIHKSLDNPHVVGFHGFFE-DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q +  ++YL+  +  VIH DLK GN+ L +     ++KI DFGL+  ++   ++ +   D
Sbjct: 150 QTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM---DVKIGDFGLATKIE---FDGERKKD 201
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           L     GT  Y+ PE      +    S +VD+WS+G I Y  L GK PF     + + L+
Sbjct: 202 L----CGTPNYIAPEVLCKKGH----SFEVDIWSLGCILYTLLVGKPPF-----ETSCLK 248
Query: 520 ENTI 523
           E  I
Sbjct: 249 ETYI 252

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 125/261 (47%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA K+    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN--------SSSLQKLFREVRIM 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTFGNKLD---AFC 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G   Y  PE F   +       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GAPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYMSTDCENLLKKFL 248

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 126/261 (48%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA ++    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLN--------SSSLQKLFREVRIM 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTFGNKLDTF---C 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   K       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYMSTDCENLLKKFL 248

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 121/244 (49%), Gaps = 32/244 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
           P    RY+    LGKGGF++ ++  D+  +   A KV     L K  +++K +       
Sbjct: 22  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------ 75
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  IHK+LD+P VV  +  FE D +    VLE C    L    K+ K + E EAR  + 
Sbjct: 76  -EIAIHKSLDNPHVVGFHGFFE-DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 133
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q +  ++YL+  +  VIH DLK GN+ L +     ++KI DFGL+  ++   ++ +   D
Sbjct: 134 QTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM---DVKIGDFGLATKIE---FDGERKKD 185
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           L     GT  Y+ PE      +    S +VD+WS+G I Y  L GK PF     + + L+
Sbjct: 186 L----CGTPNYIAPEVLCKKGH----SFEVDIWSLGCILYTLLVGKPPF-----ETSCLK 232
Query: 520 ENTI 523
           E  I
Sbjct: 233 ETYI 236

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + H  V+ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++       G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------GV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
               +    + +F ++   S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITAVSYDFDEEFFSQ--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
Query: 576 GRQSASS 582
              SA S
Sbjct: 283 ALSSAWS 289

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
Query: 576 GRQSASS 582
              SA S
Sbjct: 283 ALSSAWS 289

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 62  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 121 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 167
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 168 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 224 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
Query: 576 GRQSASS 582
              SA S
Sbjct: 282 ALSSAWS 288

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 126/261 (48%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA K+    QLN        ++ ++   RE  I 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN--------SSSLQKLFREVRIM 60
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAV 119
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 120 QYCHQ--KFIVHRDLKAENLLL---DADMNIKIADFGFSN-----EFTFGNKLD---TFC 166
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G+  Y  PE F   +       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 167 GSPPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 220
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 221 GKYRIPFYMSTDCENLLKKFL 241

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 131/281 (46%), Gaps = 36/281 (12%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLN--KDWKEDKKANYIKHALREYNIHKALDHP 351
           +LG G F +VHK  +      +A K+ +    KD +E K          E ++   LDH 
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN---------EISVMNQLDHA 146
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
            +++LYD FE   N    V+EY DG +L D  + +   + E +    + Q+   ++++++
Sbjct: 147 NLIQLYDAFE-SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
           +   ++H DLKP NIL    +   +IKI DFGL++      Y P   + +     GT  +
Sbjct: 206 MY--ILHLDLKPENILCVNRD-AKQIKIIDFGLAR-----RYKPREKLKVN---FGTPEF 254
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA--TILEENTILKAT 527
           L PE      N   +S   D+WSVGVI Y  L G  PF G N ++    IL     L+  
Sbjct: 255 LAPEVV----NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE 310
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           E Q      +S EAK FI   L   K  RI      +H +L
Sbjct: 311 EFQ-----DISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
Query: 576 GRQSASS 582
              SA S
Sbjct: 283 ALSSAWS 289

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + H  V+ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++       G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------GV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
              ++    + +F +    S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITSVSYDFDEEFFSH--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 125/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 62  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 121 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 167
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 168 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 223
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 224 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
Query: 576 GRQSASS 582
              SA S
Sbjct: 282 ALSSAWS 288

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + H  V+ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++       G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------GV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
              ++    + +F +    S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITSVSYDFDEEFFSH--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + H  V+ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++       G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------GV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
               +    + +F ++   S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITAVSYDFDEEFFSQ--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 143/296 (48%), Gaps = 32/296 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F+ V K  +       A K  +  +  K  ++    +   RE +I K + HP V+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            L++V+E +      +LE   G +L  +L + +++ E EA   + Q+++ + YL+ ++  
Sbjct: 78  TLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 134
Query: 415 VIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGMDLTSQGA---GTYWY 470
           + H+DLKP NI+L + NV    IKI DFGL+           H +D  ++     GT  +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKIDFGNEFKNIFGTPAF 183
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+      + A   +
Sbjct: 184 VAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYE 235
Query: 531 FANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSA 584
           F ++     S  AK FIR  L    + R+ +    +H +++   PK  +Q+ S  A
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---PKDTQQALSRKA 288

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 18/232 (7%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I + + H  V+ L+DV+E +      +LE   G +L  +L Q ++++E EA S + 
Sbjct: 64  REVSILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++       G+
Sbjct: 123 QILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------GV 173
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           +  +   GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q T+ 
Sbjct: 174 EFKNI-FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
              ++    + +F +    S  AK FIR  L      R+ +    RH ++ P
Sbjct: 229 NITSVSYDFDEEFFSH--TSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/227 (34%), Positives = 116/227 (51%), Gaps = 29/227 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y L   +GKG F++V  A  +   R VA K+    QLN           ++   RE  I 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLN--------PTSLQKLFREVRIM 68
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V+EY  G ++  YL  H  + E+EAR+   Q+VSA+
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYL-VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV 127
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL +G++   IKI DFG S       +   + +D      
Sbjct: 128 QYCHQ--KYIVHRDLKAENLLL-DGDM--NIKIADFGFSN-----EFTVGNKLDTF---C 174
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHN 511
           G+  Y  PE F   K       +VDVWS+GVI Y  + G  PF G N
Sbjct: 175 GSPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 31/251 (12%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           T+      + A   +F ++     S  AK FIR  L    + R+ +    +H +++   P
Sbjct: 225 TLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---P 277
Query: 574 KHGRQSASSSA 584
           K  +Q+ S  A
Sbjct: 278 KDTQQALSRKA 288

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 31/251 (12%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           T+      + A   +F ++     S  AK FIR  L    + R+ +    +H +++   P
Sbjct: 225 TLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---P 277
Query: 574 KHGRQSASSSA 584
           K  +Q+ S  A
Sbjct: 278 KDTQQALSRKA 288

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
           P    RY+    LGKGGF++ ++  D+  +   A KV     L K  +++K +       
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------ 91
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  IHK+LD+P VV  +  FE D +    VLE C    L    K+ K + E EAR  + 
Sbjct: 92  -EIAIHKSLDNPHVVGFHGFFE-DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q +  ++YL+  +  VIH DLK GN+ L +     ++KI DFGL+  ++ +        +
Sbjct: 150 QTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDG-------E 197
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
                 GT  Y+ PE      +    S +VD+WS+G I Y  L GK PF     + + L+
Sbjct: 198 RKKTLCGTPNYIAPEVLCKKGH----SFEVDIWSLGCILYTLLVGKPPF-----ETSCLK 248
Query: 520 ENTI 523
           E  I
Sbjct: 249 ETYI 252

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 31/251 (12%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           T+      + A   +F ++     S  AK FIR  L    + R+ +    +H +++   P
Sbjct: 225 TLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---P 277
Query: 574 KHGRQSASSSA 584
           K  +Q+ S  A
Sbjct: 278 KDTQQALSRKA 288

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 127/251 (50%), Gaps = 31/251 (12%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           T+      + A   +F ++     S  AK FIR  L    + R+ +    +H +++   P
Sbjct: 225 TLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK---P 277
Query: 574 KHGRQSASSSA 584
           K  +Q+ S  A
Sbjct: 278 KDTQQALSRKA 288

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHAL 339
           P    RY+    LGKGGF++ ++  D+  +   A KV     L K  +++K +       
Sbjct: 38  PRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST------ 91
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            E  IHK+LD+P VV  +  FE D +    VLE C    L    K+ K + E EAR  + 
Sbjct: 92  -EIAIHKSLDNPHVVGFHGFFE-DDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q +  ++YL+  +  VIH DLK GN+ L +     ++KI DFGL+  ++ +        +
Sbjct: 150 QTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM---DVKIGDFGLATKIEFDG-------E 197
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
                 GT  Y+ PE      +    S +VD+WS+G I Y  L GK PF     + + L+
Sbjct: 198 RKKXLCGTPNYIAPEVLCKKGH----SFEVDIWSLGCILYTLLVGKPPF-----ETSCLK 248
Query: 520 ENTI 523
           E  I
Sbjct: 249 ETYI 252

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 123/261 (47%), Gaps = 32/261 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIH 345
           Y LL  +GKG F++V  A  +   + VA K+    QLN        ++ ++   RE  I 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLN--------SSSLQKLFREVRIX 67
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           K L+HP +VKL++V E +   +  V EY  G ++  YL  H    E+EAR+   Q+VSA+
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYL-VXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAV 126
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +Y ++    ++H DLK  N+LL   +    IKI DFG S       +   + +D      
Sbjct: 127 QYCHQ--KFIVHRDLKAENLLL---DADXNIKIADFGFSN-----EFTFGNKLDAF---C 173
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           G   Y  PE F   K       +VDVWS+GVI Y  + G  PF G N  +   L E  + 
Sbjct: 174 GAPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLR 227
Query: 525 KATEVQFANKPTVSNEAKGFI 545
               + F       N  K F+
Sbjct: 228 GKYRIPFYXSTDCENLLKKFL 248

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSAXKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 121/237 (51%), Gaps = 28/237 (11%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           T+      + A   +F ++     S  AK FIR  L    + R+ +    +H +++P
Sbjct: 225 TLAN----VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 24/235 (10%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 24/235 (10%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 139/299 (46%), Gaps = 31/299 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           H V  + +  L LLGKG F +V    +    RY A K+ +      +D+    + H L E
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTE 198
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             + +   HP +  L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           VSAL YL+  K  V++ DLK  N++L +    G IKITDFGL K    E       M   
Sbjct: 258 VSALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM--- 306
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  YL PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E  
Sbjct: 307 KTFCGTPEYLAPE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE-- 359
Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPPVPKH 575
            ++   E++F    T+  EAK  +   L    + R+     D   + +H +    V +H
Sbjct: 360 -LILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 95
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 96  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 152
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 153 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANSFVGTAQYVSP 204
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 205 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 235

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/299 (30%), Positives = 139/299 (46%), Gaps = 31/299 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           H V  + +  L LLGKG F +V    +    RY A K+ +      +D+    + H L E
Sbjct: 146 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTE 201
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             + +   HP +  L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++
Sbjct: 202 NRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 260
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           VSAL YL+  K  V++ DLK  N++L +    G IKITDFGL K    E       M   
Sbjct: 261 VSALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM--- 309
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  YL PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E  
Sbjct: 310 KTFCGTPEYLAPE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE-- 362
Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPPVPKH 575
            ++   E++F    T+  EAK  +   L    + R+     D   + +H +    V +H
Sbjct: 363 -LILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 418

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 92
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 93  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 149
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 150 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 202 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 92
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 93  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 149
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 150 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 202 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 97
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 98  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 154
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 155 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 206
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 207 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 95
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 96  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 152
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 153 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 204
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 205 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 92
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 93  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 149
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 150 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANAFVGTAQYVSP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 202 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 69
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 70  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 126
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 127 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 179 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 71  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 127
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 128 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 179
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 180 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 72
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 73  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 130 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 181
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 182 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 212

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 99
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 100 VKLYFCFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 156
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 157 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 208
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 209 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 239

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 71
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 72  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 129 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 181 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 211

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 91
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 92  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 148
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 149 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANSFVGTAQYVSP 200
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 201 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 231

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 124/247 (50%), Gaps = 24/247 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE +I K + HP V+ L++V+E +      + E   G +L  +L + +++ E EA   + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYE-NKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q+++ + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+           H +
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----------HKI 168
Query: 459 DLTSQGA---GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           D  ++     GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF  +  Q 
Sbjct: 169 DFGNEFKNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           T+   + +    E ++ +    S  AK FIR  L    + R+ +    +H +++P   + 
Sbjct: 225 TLANVSAVNYEFEDEYFS--NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
Query: 576 GRQSASS 582
              SA S
Sbjct: 283 ALSSAWS 289

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 76
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 77  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 134 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 185
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 186 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 216

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 91
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 92  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 148
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 149 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 200
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 201 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 231

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 94
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y     L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 95  VKLYFTFQDDEKLYFG-LSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 151
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 152 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANSFVGTAQYVSP 203
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 204 E-LLTEKSASKSS---DLWALGCIIYQLVAGLPPF 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 131/280 (46%), Gaps = 28/280 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G FS   K    K  +  A K+  ++K  + + +       L E        HP +V
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKI--ISKRMEANTQKEITALKLCE-------GHPNIV 69
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           KL++VF    ++F  V+E  +G +L   +K+ K  +E EA  I+ ++VSA+ +++++   
Sbjct: 70  KLHEVFHDQLHTF-LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG-- 126
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           V+H DLKP N+L T+ N   EIKI DFG +++   +N  P            T  Y  PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP------LKTPCFTLHYAAPE 179
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT---EVQF 531
                 N        D+WS+GVI Y  L G+ PF  +    T      I+K     +  F
Sbjct: 180 LL----NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 532 ANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +    VS EAK  I+  L      R+ +  L  +++LQ
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+G FS    A +L   R  A K+ +     KE+K    + +  RE ++   LDHP  
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRLDHPFF 92
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           VKLY  F+ D   +   L Y    +L  Y+++  +  E   R    ++VSAL+YL+    
Sbjct: 93  VKLYFTFQDDEKLYFG-LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH--GK 149
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLKP NILL E      I+ITDFG +KV+     +P+      +   GT  Y+ P
Sbjct: 150 GIIHRDLKPENILLNEDM---HIQITDFGTAKVL-----SPESKQARANXFVGTAQYVSP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K+  K S   D+W++G I YQ + G  PF
Sbjct: 202 E-LLTEKSACKSS---DLWALGCIIYQLVAGLPPF 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 97  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 154
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P    D      GT  YLPP
Sbjct: 155 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPSSRRD---DLCGTLDYLPP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 202 E-MIEGR---MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 251
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 252 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           V  + +  L LLGKG F +V    +    RY A K+ +      +D+    + H L E  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTENR 61
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           + +   HP +  L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++VS
Sbjct: 62  VLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 120
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL YL+  K  V++ DLK  N++L +    G IKITDFGL K    E       M     
Sbjct: 121 ALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM---KX 169
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   +
Sbjct: 170 FCGTPEYLAPE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---L 221
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPPVPKH 575
           +   E++F    T+  EAK  +   L    + R+     D   + +H +    V +H
Sbjct: 222 ILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 276

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           V  + +  L LLGKG F +V    +    RY A K+ +      +D+    + H L E  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTENR 62
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           + +   HP +  L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++VS
Sbjct: 63  VLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 121
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL YL+  K  V++ DLK  N++L +    G IKITDFGL K    E       M     
Sbjct: 122 ALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM---KX 170
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   +
Sbjct: 171 FCGTPEYLAPE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---L 222
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPPVPKH 575
           +   E++F    T+  EAK  +   L    + R+     D   + +H +    V +H
Sbjct: 223 ILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 277

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           V  + +  L LLGKG F +V    +    RY A K+ +      +D+    + H L E  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----VAHTLTENR 60
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           + +   HP +  L   F+   +  C V+EY +G +L F+L + +  +E  AR    ++VS
Sbjct: 61  VLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 119
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL YL+  K  V++ DLK  N++L +    G IKITDFGL K    E       M     
Sbjct: 120 ALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK----EGIKDGATM---KX 168
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  YL PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   +
Sbjct: 169 FCGTPEYLAPE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE---L 220
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPPVPKH 575
           +   E++F    T+  EAK  +   L    + R+     D   + +H +    V +H
Sbjct: 221 ILMEEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 275

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 68
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 69  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 125
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 126 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KTFCGTPEYL 175
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 176 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 227
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 228 PR--TLSPEAKSLLAGLL 243

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           N  V  D + +L  +GKG F +V        ++  A K   +NK  ++  + N +++  +
Sbjct: 9   NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKY--MNK--QKCVERNEVRNVFK 64
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I + L+HP +V L+  F+ + + F  V++   G DL ++L+Q+    E   +  + +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMF-MVVDLLLGGDLRYHLQQNVHFKEETVKLFICE 123
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +V AL YL   +  +IH D+KP NILL E    G + ITDF ++ ++  E          
Sbjct: 124 LVMALDYLQNQR--IIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRETQ-------- 170
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            +  AGT  Y+ PE F   K     S  VD WS+GV  Y+ L G++P+
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGA-GYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 65
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 123 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KXFCGTPEYL 172
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 173 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 224
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 225 PR--TLSPEAKSLLAGLL 240

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 22/233 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE NI + + HP ++ L+D+FE +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 57  REVNILREIRHPNIITLHDIFE-NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 115
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  +  + H+DLKP NI+L + NV    IK+ DFG++  ++  N   +   
Sbjct: 116 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-- 171
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF     Q T+ 
Sbjct: 172 ------FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETL- 220
Query: 519 EENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              T + A    F  +     S  AK FIR  L    + R+ +     H +++
Sbjct: 221 ---TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 65
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 123 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KTFCGTPEYL 172
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 173 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 224
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 225 PR--TLSPEAKSLLAGLL 240

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 65
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 123 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KXFCGTPEYL 172
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 173 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 224
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 225 PR--TLSPEAKSLLAGLL 240

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 22/233 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE NI + + HP ++ L+D+FE +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 78  REVNILREIRHPNIITLHDIFE-NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 136
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  +  + H+DLKP NI+L + NV    IK+ DFG++  ++  N   +   
Sbjct: 137 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-- 192
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF     Q T+ 
Sbjct: 193 ------FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETL- 241
Query: 519 EENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              T + A    F  +     S  AK FIR  L    + R+ +     H +++
Sbjct: 242 ---TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 65
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 123 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KTFCGTPEYL 172
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 173 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 224
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 225 PR--TLSPEAKSLLAGLL 240

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 22/233 (9%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE NI + + HP ++ L+D+FE +      +LE   G +L  +L + +++ E EA   + 
Sbjct: 64  REVNILREIRHPNIITLHDIFE-NKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGM 458
           Q++  + YL+  +  + H+DLKP NI+L + NV    IK+ DFG++  ++  N   +   
Sbjct: 123 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI-- 178
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF     Q T+ 
Sbjct: 179 ------FGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETL- 227
Query: 519 EENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              T + A    F  +     S  AK FIR  L    + R+ +     H +++
Sbjct: 228 ---TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 97  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 154
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 155 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 201
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 202 E-MIEGR---MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 251
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 252 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 112
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 113 QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     GT
Sbjct: 171 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGT 219
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 280 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 132/290 (45%), Gaps = 46/290 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVL-----FKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +++Y+ F  D      +LE+    +L   L++H    E+ + + + ++  AL Y +E K 
Sbjct: 78  LRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 135
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG-AGTYWYLP 472
            VIH D+KP N+L+      GE+KI DFG S           H   L  +   GT  YLP
Sbjct: 136 -VIHRDIKPENLLM---GYKGELKIADFGWSV----------HAPSLRRRXMCGTLDYLP 181
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEENTILKATEV 529
           PE  + GK       KVD+W  GV+ Y+ L G  PF    H ++   I+          V
Sbjct: 182 PE-MIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---------NV 228
Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-------PPV 572
                P +S+ +K  I   L Y    R+ +  +  H +++       PPV
Sbjct: 229 DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 278

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 72  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P    D      GT  YLPP
Sbjct: 130 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPSSRRDTL---CGTLDYLPP 176
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 177 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 226
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 70
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 71  FLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 127
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 128 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KXFCGTPEYL 177
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 178 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 229
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 230 PR--TLSPEAKSLLAGLL 245

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 125/258 (48%), Gaps = 27/258 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           L LLGKG F +V    +    RY A K+ +      +D+ A    H + E  + +   HP
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----HTVTESRVLQNTRHP 65
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+  
Sbjct: 66  FLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V++ D+K  N++L +    G IKITDFGL K    E  +    M       GT  YL
Sbjct: 123 SRDVVYRDIKLENLMLDKD---GHIKITDFGLCK----EGISDGATM---KXFCGTPEYL 172
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
            PE  V+  N       VD W +GV+ Y+ + G+ PF +NQ    + E   ++   E++F
Sbjct: 173 APE--VLEDN--DYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE---LILMEEIRF 224
Query: 532 ANKPTVSNEAKGFIRSCL 549
               T+S EAK  +   L
Sbjct: 225 PR--TLSPEAKSLLAGLL 240

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 136/298 (45%), Gaps = 46/298 (15%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIH 345
           D + ++  LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVL-----FKSQLEKEGVEHQLRREIEIQ 68
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
             L HP ++++Y+ F  D      +LE+    +L   L++H    E+ + + + ++  AL
Sbjct: 69  SHLRHPNILRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG- 464
            Y +E K  VIH D+KP N+L+      GE+KI DFG S           H   L  +  
Sbjct: 128 HYCHERK--VIHRDIKPENLLM---GYKGELKIADFGWSV----------HAPSLRRRXM 172
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEEN 521
            GT  YLPPE  + GK       KVD+W  GV+ Y+ L G  PF    H ++   I+   
Sbjct: 173 CGTLDYLPPE-MIEGKTH---DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--- 225
Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-------PPV 572
                  V     P +S+ +K  I   L Y    R+ +  +  H +++       PPV
Sbjct: 226 ------NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 35/292 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 72  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       S   GT  YLPP
Sbjct: 130 -VIHRDIKPENLLL---GSAGELKIADFGWS------CHAPSSRRTTLS---GTLDYLPP 176
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 177 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 226
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP----PVPKHGRQSAS 581
              V+  A+  I   L +    R  +  +  H ++      P     ++SAS
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESAS 278

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/331 (27%), Positives = 144/331 (43%), Gaps = 39/331 (11%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
           +G   +  ++  + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A 
Sbjct: 3   MGSGAMGSQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 62
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEY 373
           K+ Q                A RE  +H +A   P +V++ DV+E + A   C   V+E 
Sbjct: 63  KMLQ------------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 110
Query: 374 CDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN 431
            DG +L   ++    +   EREA  I+  +  A++YL+ I   + H D+KP N+L T   
Sbjct: 111 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKR 168
Query: 432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV 491
               +K+TDFG +K     N        LT+     Y Y+ PE  V+G  P K     D+
Sbjct: 169 PNAILKLTDFGFAKETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDM 216
Query: 492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCL 549
           WS+GVI Y  L G  PF  N   A      T ++  + +F N     VS E K  IR+ L
Sbjct: 217 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 276
Query: 550 AYRKEDRIDVISLARHDYLQ-----PPVPKH 575
                 R+ +     H ++      P  P H
Sbjct: 277 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 307

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 90/324 (27%), Positives = 144/324 (44%), Gaps = 39/324 (12%)
Query: 265 IRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK 324
           +++  + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q   
Sbjct: 1   MQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--- 57
Query: 325 DWKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLD 380
              +  KA       RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L 
Sbjct: 58  ---DCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 108
Query: 381 FYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI 438
             ++    +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+
Sbjct: 109 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKL 166
Query: 439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           TDFG +K     N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI 
Sbjct: 167 TDFGFAKETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIM 214
Query: 499 YQCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDR 556
           Y  L G  PF  N   A      T ++  + +F N     VS E K  IR+ L      R
Sbjct: 215 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 274
Query: 557 IDVISLARHDYLQ-----PPVPKH 575
           + +     H ++      P  P H
Sbjct: 275 MTITEFMNHPWIMQSTKVPQTPLH 298

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 87/316 (27%), Positives = 155/316 (49%), Gaps = 40/316 (12%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
           +G +NL+ + ++         FNN  +L+ + L     G+G F+ V +       +  A 
Sbjct: 13  LGTENLYFQSMEN--------FNNFYILTSKEL-----GRGKFAVVRQCISKSTGQEYAA 59
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH 377
           K  +  +   +D +A  I H +    + K+   PRV+ L++V+E + +    +LEY  G 
Sbjct: 60  KFLK-KRRRGQDCRAE-ILHEIAVLELAKSC--PRVINLHEVYE-NTSEIILILEYAAGG 114
Query: 378 DLDFYL---KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG 434
           ++ F L   +  + ++E +   ++ Q++  + YL++    ++H DLKP NILL+     G
Sbjct: 115 EI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLG 171
Query: 435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV 494
           +IKI DFG+S+ +        H  +L  +  GT  YL PE  ++  +P  I++  D+W++
Sbjct: 172 DIKIVDFGMSRKI-------GHACEL-REIMGTPEYLAPE--ILNYDP--ITTATDMWNI 219
Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTI-LKATEVQFANKPTVSNEAKGFIRSCLAYRK 553
           G+I Y  L    PF    +Q T L  + + +  +E  F+   +VS  A  FI+S L    
Sbjct: 220 GIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS---SVSQLATDFIQSLLVKNP 276
Query: 554 EDRIDVISLARHDYLQ 569
           E R        H +LQ
Sbjct: 277 EKRPTAEICLSHSWLQ 292

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 112
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 113 QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     GT
Sbjct: 171 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGT 219
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 280 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY    ++   L++     E+   + + ++ +AL Y +  + 
Sbjct: 76  LRLYGYFH-DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR- 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 134 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 181 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 230
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 231 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 128/276 (46%), Gaps = 31/276 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVL-----FKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 75  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR- 132
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P    D      GT  YLPP
Sbjct: 133 -VIHRDIKPENLLLGSN---GELKIADFGWSV------HAPSSRRDTL---CGTLDYLPP 179
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L G  PF  +  Q       T  + + V+F  
Sbjct: 180 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGMPPFEAHTYQ------ETYRRISRVEFTF 229
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              V+  A+  I   L +    R+ +  +  H +++
Sbjct: 230 PDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       ++  GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTELCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 141/323 (43%), Gaps = 39/323 (12%)
Query: 266 RELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
           ++  + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q    
Sbjct: 3   QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---- 58
Query: 326 WKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDF 381
                       A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L  
Sbjct: 59  --------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 110
Query: 382 YLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
            ++    +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+T
Sbjct: 111 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 168
Query: 440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY 499
           DFG +K     N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y
Sbjct: 169 DFGFAKETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMY 216
Query: 500 QCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRI 557
             L G  PF  N   A      T ++  + +F N     VS E K  IR+ L      R+
Sbjct: 217 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 276
Query: 558 DVISLARHDYLQ-----PPVPKH 575
            +     H ++      P  P H
Sbjct: 277 TITEFMNHPWIMQSTKVPQTPLH 299

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 90/335 (26%), Positives = 147/335 (43%), Gaps = 41/335 (12%)
Query: 260 YKNLHIRELKRIHNEDQSRFNNHPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQR 313
           Y    I +  + + +   ++   PV      + D Y +L  LG G F  VH+  +    R
Sbjct: 18  YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGR 77
Query: 314 YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY 373
               K   +N  +  DK          E +I   L HP+++ L+D FE D      +LE+
Sbjct: 78  VFVAKF--INTPYPLDKYT-----VKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEF 129
Query: 374 CDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV 432
             G +L D    +   ++E E  + + Q    LK+++E    ++H D+KP NI+  E   
Sbjct: 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIM-CETKK 186
Query: 433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVW 492
              +KI DFGL+  +     NPD  + +T+  A    +  PE  +V + P  +    D+W
Sbjct: 187 ASSVKIIDFGLATKL-----NPDEIVKVTTATAE---FAAPE--IVDREP--VGFYTDMW 234
Query: 493 SVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLA 550
           ++GV+ Y  L G  PF       T+      +K  + +F      +VS EAK FI++ L 
Sbjct: 235 AIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 290
Query: 551 YRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAP 585
                R+ V     HD L+ P  K    + +S  P
Sbjct: 291 KEPRKRLTV-----HDALEHPWLKGDHSNLTSRIP 320

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 88  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 145
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 146 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 192
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 193 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 242
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 243 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P    D      GT  YLPP
Sbjct: 132 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPSSRRD---DLCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 137/278 (49%), Gaps = 31/278 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACK-VHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           LG G FSEV  A +    +  A K + +     KE    N       E  + + + H  +
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN-------EIAVLRKIKHENI 82
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           V L D++E   N    V++   G +L   + +     E++A +++ QV+ A+ YL+ +  
Sbjct: 83  VALEDIYE-SPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRM-- 139
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            ++H DLKP N+L    +   +I I+DFGLSK+        +   D+ S   GT  Y+ P
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--------EGKGDVMSTACGTPGYVAP 191
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  V+ + P   S  VD WS+GVI Y  L G  PF ++++ + + E+  ILKA E +F +
Sbjct: 192 E--VLAQKP--YSKAVDCWSIGVIAYILLCGYPPF-YDENDSKLFEQ--ILKA-EYEF-D 242
Query: 534 KP---TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            P    +S+ AK FIR+ +      R      ARH ++
Sbjct: 243 SPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 65
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 66  QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     GT
Sbjct: 124 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGT 172
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 233 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 89/323 (27%), Positives = 141/323 (43%), Gaps = 39/323 (12%)
Query: 266 RELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
           ++  + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q    
Sbjct: 1   QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---- 56
Query: 326 WKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDF 381
                       A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L  
Sbjct: 57  --------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 108
Query: 382 YLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
            ++    +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+T
Sbjct: 109 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 166
Query: 440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY 499
           DFG +K     N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y
Sbjct: 167 DFGFAKETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMY 214
Query: 500 QCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRI 557
             L G  PF  N   A      T ++  + +F N     VS E K  IR+ L      R+
Sbjct: 215 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 274
Query: 558 DVISLARHDYLQ-----PPVPKH 575
            +     H ++      P  P H
Sbjct: 275 TITEFMNHPWIMQSTKVPQTPLH 297

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 29/299 (9%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           F +  V    Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNE 76
Query: 339 LREYNIHKALDHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +   N  K   H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S 
Sbjct: 77  IAYLN--KLQQHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSY 132
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              ++ A+  +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD  
Sbjct: 133 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDXX 181
Query: 458 MDLTSQGAGTYWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
             +     GT  Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF  
Sbjct: 182 XVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +Q + L    I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 242 IINQISKLHA-IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 76  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S      +       DL     GT  YLPP
Sbjct: 134 -VIHRDIKPENLLLGSA---GELKIADFGWSV-----HAPSSRRTDL----CGTLDYLPP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 181 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 230
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 231 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY    ++   L++     E+   + + ++ +AL Y +  + 
Sbjct: 76  LRLYGYFH-DATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR- 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P           GT  YLPP
Sbjct: 134 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPSSRRXXLX---GTLDYLPP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 181 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 230
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 231 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S      +       DL     GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV-----HAPSSRRTDL----CGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 76  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 134 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 181 EX-IEGRXH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 230
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 231 PDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 72  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S      +       DL     GT  YLPP
Sbjct: 130 -VIHRDIKPENLLLGSA---GELKIADFGWSV-----HAPSSRRTDL----CGTLDYLPP 176
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 177 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 226
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 134/305 (43%), Gaps = 39/305 (12%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++ D  +   +LG G   +V + F+ + Q   A K+ Q                A RE  
Sbjct: 65  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------------DCPKARREVE 112
Query: 344 IH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH--KTIAEREARSI 397
           +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++    +   EREA  I
Sbjct: 113 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 172
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           +  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K     N      
Sbjct: 173 MKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------ 224
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L G  PF  N   A  
Sbjct: 225 -SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 278
Query: 518 LEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-----P 570
               T ++  + +F N     VS E K  IR+ L      R+ +     H ++      P
Sbjct: 279 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 338
Query: 571 PVPKH 575
             P H
Sbjct: 339 QTPLH 343

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 76  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 133
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 134 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 180
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 181 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 230
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 231 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 29/299 (9%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           F +  V    Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNE 76
Query: 339 LREYNIHKALDHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +   N  K   H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S 
Sbjct: 77  IAYLN--KLQQHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSY 132
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              ++ A+  +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD  
Sbjct: 133 WKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTT 181
Query: 458 MDLTSQGAGTYWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
             +     GT  Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF  
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +Q + L    I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 242 IINQISKLHA-IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 138/317 (43%), Gaps = 39/317 (12%)
Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q          
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------- 52
Query: 332 ANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH- 386
                 A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++   
Sbjct: 53  --DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 387 -KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
                N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L G 
Sbjct: 169 ETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGY 216
Query: 506 KPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +    
Sbjct: 217 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 276
Query: 564 RHDYLQ-----PPVPKH 575
            H ++      P  P H
Sbjct: 277 NHPWIMQSTKVPQTPLH 293

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 132 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 134/305 (43%), Gaps = 39/305 (12%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++ D  +   +LG G   +V + F+ + Q   A K+ Q                A RE  
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------------DCPKARREVE 106
Query: 344 IH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH--KTIAEREARSI 397
           +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++    +   EREA  I
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           +  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K     N      
Sbjct: 167 MKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------ 218
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L G  PF  N   A  
Sbjct: 219 -SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272
Query: 518 LEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-----P 570
               T ++  + +F N     VS E K  IR+ L      R+ +     H ++      P
Sbjct: 273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
Query: 571 PVPKH 575
             P H
Sbjct: 333 QTPLH 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 140/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 112
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 113 QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     G 
Sbjct: 171 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGA 219
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 280 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S      +       DL     GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV-----HAPSSRRTDL----CGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 132 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRAALCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 138/317 (43%), Gaps = 39/317 (12%)
Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q          
Sbjct: 1   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------- 50
Query: 332 ANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH- 386
                 A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++   
Sbjct: 51  --DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 108
Query: 387 -KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K
Sbjct: 109 DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
                N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L G 
Sbjct: 167 ETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGY 214
Query: 506 KPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +    
Sbjct: 215 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 274
Query: 564 RHDYLQ-----PPVPKH 575
            H ++      P  P H
Sbjct: 275 NHPWIMQSTKVPQTPLH 291

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 68
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 69  QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 126
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     GT
Sbjct: 127 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGT 175
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 235
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 236 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/319 (27%), Positives = 139/319 (43%), Gaps = 39/319 (12%)
Query: 270 RIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED 329
           + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q        
Sbjct: 1   QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------- 52
Query: 330 KKANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQ 385
                   A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++ 
Sbjct: 53  ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108
Query: 386 H--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
              +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG 
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
           +K     N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L 
Sbjct: 167 AKETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLC 214
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVIS 561
           G  PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +  
Sbjct: 215 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 274
Query: 562 LARHDYLQ-----PPVPKH 575
              H ++      P  P H
Sbjct: 275 FMNHPWIMQSTKVPQTPLH 293

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 75  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 132
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 133 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 179
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 180 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 229
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 230 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/318 (27%), Positives = 138/318 (43%), Gaps = 39/318 (12%)
Query: 271 IHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK 330
            H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q         
Sbjct: 1   FHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------- 51
Query: 331 KANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH 386
                  A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++  
Sbjct: 52  ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 108
Query: 387 --KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
             +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +
Sbjct: 109 GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 166
Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
           K     N        LT+     Y Y+ PE  V+G  P K     D+WS+GVI Y  L G
Sbjct: 167 KETTSHN-------SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCG 214
Query: 505 KKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISL 562
             PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +   
Sbjct: 215 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 274
Query: 563 ARHDYLQ-----PPVPKH 575
             H ++      P  P H
Sbjct: 275 MNHPWIMQSTKVPQTPLH 292

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 70  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 127
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 128 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 174
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 175 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 224
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 225 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRAALCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 73  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 130
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P           GT  YLPP
Sbjct: 131 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRXXLCGTLDYLPP 177
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 178 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 227
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 228 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 128/276 (46%), Gaps = 31/276 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVL-----FKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 75  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR- 132
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 133 -VIHRDIKPENLLLGSN---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 179
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L G  PF  +  Q       T  + + V+F  
Sbjct: 180 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGMPPFEAHTYQ------ETYRRISRVEFTF 229
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              V+  A+  I   L +    R+ +  +  H +++
Sbjct: 230 PDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 129 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRTXLCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y +L  +G GG S+V +  + K+Q Y    +  +N +  +++  +  ++ +   N  K  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYA---IKYVNLEEADNQTLDSYRNEIAYLN--KLQ 64
Query: 349 DHP-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++++LYD +EI       V+E C   DL+ +LK+ K+I   E +S    ++ A+  
Sbjct: 65  QHSDKIIRLYD-YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 122
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           +++    ++H DLKP N L+ +G     +K+ DFG++  M      PD    +     GT
Sbjct: 123 IHQ--HGIVHSDLKPANFLIVDG----MLKLIDFGIANQM-----QPDTTSVVKDSQVGT 171
Query: 468 YWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L  
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 231
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    E++F + P    + +  ++ CL    + RI +  L  H Y+Q
Sbjct: 232 -IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 132 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 147/314 (46%), Gaps = 32/314 (10%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
           +G +NL+ + +K+   E  +R  N     D + ++  LG G F +V+KA + +     A 
Sbjct: 13  LGTENLYFQSMKQY--EHVTRDLNP---EDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH 377
           KV        + K    ++  + E +I  + DHP +VKL D F  + N+   ++E+C G 
Sbjct: 68  KV-------IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGG 119
Query: 378 DLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            +D   L+  + + E + + +  Q + AL YL++ K  +IH DLK GNIL T   + G+I
Sbjct: 120 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT---LDGDI 174
Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV--VGKNPPKISSKVDVWSV 494
           K+ DFG+S     +N       D      GT +++ PE  +    K+ P    K DVWS+
Sbjct: 175 KLADFGVSA----KNTRTIQRRD---SFIGTPYWMAPEVVMCETSKDRP-YDYKADVWSL 226
Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE 554
           G+   +    + P         +L+   I K+     A     S+  K F++ CL    +
Sbjct: 227 GITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 283
Query: 555 DRIDVISLARHDYL 568
            R     L +H ++
Sbjct: 284 ARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 146/314 (46%), Gaps = 32/314 (10%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
           +G +NL+ + +K+   E  +R  N     D + ++  LG G F +V+KA + +     A 
Sbjct: 13  LGTENLYFQSMKQY--EHVTRDLNP---EDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH 377
           KV        + K    ++  + E +I  + DHP +VKL D F  + N+   ++E+C G 
Sbjct: 68  KV-------IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGG 119
Query: 378 DLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            +D   L+  + + E + + +  Q + AL YL++ K  +IH DLK GNIL T   + G+I
Sbjct: 120 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT---LDGDI 174
Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV--VGKNPPKISSKVDVWSV 494
           K+ DFG+S          D  +       GT +++ PE  +    K+ P    K DVWS+
Sbjct: 175 KLADFGVSAKNTRXIQRRDSFI-------GTPYWMAPEVVMCETSKDRP-YDYKADVWSL 226
Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE 554
           G+   +    + P         +L+   I K+     A     S+  K F++ CL    +
Sbjct: 227 GITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 283
Query: 555 DRIDVISLARHDYL 568
            R     L +H ++
Sbjct: 284 ARWTTSQLLQHPFV 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/317 (27%), Positives = 138/317 (43%), Gaps = 39/317 (12%)
Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q          
Sbjct: 1   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------- 50
Query: 332 ANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH- 386
                 A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++   
Sbjct: 51  --DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 108
Query: 387 -KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K
Sbjct: 109 DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
                N          ++   T +Y+ PE  V+G  P K     D+WS+GVI Y  L G 
Sbjct: 167 ETTSHNS--------LTEPCYTPYYVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGY 214
Query: 506 KPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +    
Sbjct: 215 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 274
Query: 564 RHDYLQ-----PPVPKH 575
            H ++      P  P H
Sbjct: 275 NHPWIMQSTKVPQTPLH 291

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 146/314 (46%), Gaps = 32/314 (10%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
           +G +NL+ + +K+   E  +R  N     D + ++  LG G F +V+KA + +     A 
Sbjct: 13  LGTENLYFQSMKQY--EHVTRDLNP---EDFWEIIGELGDGAFGKVYKAQNKETSVLAAA 67
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH 377
           KV        + K    ++  + E +I  + DHP +VKL D F  + N+   ++E+C G 
Sbjct: 68  KV-------IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGG 119
Query: 378 DLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            +D   L+  + + E + + +  Q + AL YL++ K  +IH DLK GNIL T   + G+I
Sbjct: 120 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT---LDGDI 174
Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV--VGKNPPKISSKVDVWSV 494
           K+ DFG+S          D  +       GT +++ PE  +    K+ P    K DVWS+
Sbjct: 175 KLADFGVSAKNTRXIQRRDXFI-------GTPYWMAPEVVMCETSKDRP-YDYKADVWSL 226
Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE 554
           G+   +    + P         +L+   I K+     A     S+  K F++ CL    +
Sbjct: 227 GITLIEMAEIEPPHHELNPMRVLLK---IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVD 283
Query: 555 DRIDVISLARHDYL 568
            R     L +H ++
Sbjct: 284 ARWTTSQLLQHPFV 297

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 68  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 125
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 126 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRTTLCGTLDYLPP 172
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 173 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 222
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 223 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 127/259 (49%), Gaps = 29/259 (11%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           ++ + +LG G FSEV         +  A K  + +  +++    N       E  + K +
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN-------EIAVLKKI 63
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            H  +V L D++E     +  V++   G +L   + +     E++A  ++ QV+SA+KYL
Sbjct: 64  KHENIVTLEDIYE-STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +E    ++H DLKP N+L        +I ITDFGLSK+  E+N        + S   GT 
Sbjct: 123 HE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQN-------GIMSTACGTP 171
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF + ++++ + E+   +K   
Sbjct: 172 GYVAPE--VLAQKP--YSKAVDCWSIGVITYILLCGYPPF-YEETESKLFEK---IKEGY 223
Query: 529 VQFANK--PTVSNEAKGFI 545
            +F +     +S  AK FI
Sbjct: 224 YEFESPFWDDISESAKDFI 242

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 80
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 81  QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 140 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKTL----CGTPNY 187
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 188 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A +   +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  D+     +LEY     +   L++     E+   + + ++ +AL Y +  K 
Sbjct: 71  LRLYGYFH-DSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P       +   GT  YLPP
Sbjct: 129 -VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPS---SRRAALCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q      +T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------DTYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 71  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 128
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P           GT  YLPP
Sbjct: 129 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRXXLCGTLDYLPP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 176 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 225
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 226 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 76
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 77  QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 136 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKTL----CGTPNY 183
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 184 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI DFG S       + P           GT  YLPP
Sbjct: 132 -VIHRDIKPENLLL---GSAGELKIADFGWSV------HAPS---SRRXXLCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 73  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 130
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI +FG S       + P       +   GT  YLPP
Sbjct: 131 -VIHRDIKPENLLLGSA---GELKIANFGWSV------HAPS---SRRTTLCGTLDYLPP 177
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 178 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 227
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 228 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 76
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 77  QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 136 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKTL----CGTPNY 183
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 184 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 227

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + + +  +A KV      +K   +   ++H LR E  I   L HP +
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL Y +  + 
Sbjct: 74  LRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 131
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH D+KP N+LL      GE+KI +FG S       + P       +   GT  YLPP
Sbjct: 132 -VIHRDIKPENLLLGSA---GELKIANFGWSV------HAPS---SRRTTLCGTLDYLPP 178
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFAN 533
           E  + G+       KVD+WS+GV+ Y+ L GK PF  N  Q       T  + + V+F  
Sbjct: 179 E-MIEGRMH---DEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEFTF 228
Query: 534 KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              V+  A+  I   L +    R  +  +  H ++
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 100
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 101 QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 160 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKVL----CGTPNY 207
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 208 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 98
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 99  QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 158 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKVL----CGTPNY 205
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 206 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 249

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 29/283 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y L   +G+G + EV  A     +   A K  ++ K + ED     +    +E  I K+L
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVED-----VDRFKQEIEIMKSL 80
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           DHP +++LY+ FE D      V+E C G +L   +   +   E +A  I+  V+SA+ Y 
Sbjct: 81  DHPNIIRLYETFE-DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +++   V H DLKP N L    +    +K+ DFGL+       + P   M       GT 
Sbjct: 140 HKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-----RFKPGKMM---RTKVGTP 189
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
           +Y+ P+       P     + D WS GV+ Y  L G  PF        +L+    ++   
Sbjct: 190 YYVSPQVLEGLYGP-----ECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK----IREGT 240
Query: 529 VQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             F  K    VS +A+  IR  L    + RI  +    H++ +
Sbjct: 241 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 29/283 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y L   +G+G + EV  A     +   A K  ++ K + ED     +    +E  I K+L
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVED-----VDRFKQEIEIMKSL 63
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           DHP +++LY+ FE D      V+E C G +L   +   +   E +A  I+  V+SA+ Y 
Sbjct: 64  DHPNIIRLYETFE-DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +++   V H DLKP N L    +    +K+ DFGL+       + P   M       GT 
Sbjct: 123 HKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-----RFKPGKMM---RTKVGTP 172
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
           +Y+ P+       P     + D WS GV+ Y  L G  PF        +L+    ++   
Sbjct: 173 YYVSPQVLEGLYGP-----ECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLK----IREGT 223
Query: 529 VQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             F  K    VS +A+  IR  L    + RI  +    H++ +
Sbjct: 224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 28/291 (9%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           H  + D Y +   LG G F  VH+  +       A K   +    + DK+        +E
Sbjct: 46  HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKET-----VRKE 98
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQ 400
                 L HP +V L+D FE D N    + E+  G +L +    +H  ++E EA   + Q
Sbjct: 99  IQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           V   L +++E     +H DLKP NI+ T      E+K+ DFGL+  +D     P   + +
Sbjct: 158 VCKGLCHMHENN--YVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLD-----PKQSVKV 209
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
           T+   GT  +  PE   V +  P +    D+WSVGV+ Y  L G  PFG      T+   
Sbjct: 210 TT---GTAEFAAPE---VAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262
Query: 521 NTI-LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
            +      +  F+    +S + K FIR  L      R+ +     H +L P
Sbjct: 263 KSCDWNMDDSAFSG---ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 310

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/228 (34%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LGKGGF++  +  D   +   A K+     L K  + +K +        E +IH++L H
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------MEISIHRSLAH 74
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
             VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +YL+ 
Sbjct: 75  QHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  VIH DLK GN+ L E     E+KI DFGL+  ++   Y+ +    L     GT  Y
Sbjct: 134 NR--VIHRDLKLGNLFLNEDL---EVKIGDFGLATKVE---YDGERKKVL----CGTPNY 181
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  V+ K     S +VDVWS+G I Y  L GK PF  +  + T L
Sbjct: 182 IAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 25/291 (8%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +  D Y L  ++GKG FS V +  + +  +  A K+  + K       +   +   RE +
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST--EDLKREAS 78
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVM 399
           I   L HP +V+L + +  D   +  V E+ DG DL F + +        +E  A   + 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLY-MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++ AL+Y ++    +IH D+KP N+LL        +K+ DFG++  + E          
Sbjct: 138 QILEALRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG-------- 187
Query: 460 LTSQG-AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           L + G  GT  ++ PE  VV + P      VDVW  GVI +  L G  PF   + +   L
Sbjct: 188 LVAGGRVGTPHFMAPE--VVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTKER---L 240
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  I    ++       +S  AK  +R  L     +RI V     H +L+
Sbjct: 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 126/295 (42%), Gaps = 36/295 (12%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV----HQLNKDWKEDKKANYIKH 337
           H  + D Y +   LG G F  VH+  +       A K     H+ +K+            
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----------T 200
Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARS 396
             +E      L HP +V L+D FE D N    + E+  G +L +    +H  ++E EA  
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
            + QV   L +++E     +H DLKP NI+ T      E+K+ DFGL+  +D     P  
Sbjct: 260 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLD-----PKQ 311
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
            + +T+   GT  +  PE   V +  P +    D+WSVGV+ Y  L G  PFG      T
Sbjct: 312 SVKVTT---GTAEFAAPE---VAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364
Query: 517 ILEENTI-LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           +    +      +  F+    +S + K FIR  L      R+ +     H +L P
Sbjct: 365 LRNVKSCDWNMDDSAFSG---ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 123/272 (45%), Gaps = 31/272 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A D +    VA K     K ++  +   + K A RE  + K + H  V+
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 355 KLYDVFEIDAN-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
            L DVF  D        F  V+ +  G DL   +K H+ + E   + +V Q++  L+Y++
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +IH DLKPGN+ + E   C E+KI DFGL++  D E                T W
Sbjct: 146 AAG--IIHRDLKPGNLAVNED--C-ELKILDFGLARQADSEMXG----------XVVTRW 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y  PE  +   N  + +  VD+WSVG I  + + GK  F  +     + E   +      
Sbjct: 191 YRAPEVIL---NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247
Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS 561
           +F  +   S+EAK +++      K+D   +++
Sbjct: 248 EFVQR-LQSDEAKNYMKGLPELEKKDFASILT 278

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++++RY ++  LG GG S V+ A D      VA K   +    KE+     +K   RE +
Sbjct: 8   IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET----LKRFEREVH 63
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
               L H  +V + DV E D + +  V+EY +G  L  Y++ H  ++   A +   Q++ 
Sbjct: 64  NSSQLSHQNIVSMIDVDEED-DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            +K+ ++++  ++H D+KP NIL+        +KI DFG++K + E +      +  T+ 
Sbjct: 123 GIKHAHDMR--IVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETS------LTQTNH 171
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE---- 519
             GT  Y  PE               D++S+G++ Y+ L G+ PF    + +  ++    
Sbjct: 172 VLGTVQYFSPE----QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD 227
Query: 520 -----------------ENTILKATEVQFANKPTVSNEAKGFIRSCL 549
                             N IL+ATE   AN+     E K  + S L
Sbjct: 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 27/299 (9%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY-NIHKALDHPR 352
           LLG+G +++V  A  L+  +  A K+        E +  +      RE   +++   +  
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKI-------IEKQAGHSRSRVFREVETLYQCQGNKN 72
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
           +++L + FE D   F  V E   G  +  ++++ K   EREA  +V  V +AL +L+   
Sbjct: 73  ILELIEFFE-DDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH--T 129
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN-YNPDHGMDLTSQGAGTYWYL 471
             + H DLKP NIL         +KI DF L   M   N   P    +LT+   G+  Y+
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP-CGSAEYM 188
Query: 472 PPECFVVGKNPPKISSK-VDVWSVGVIFYQCLYGKKPF--------GHNQSQATILEENT 522
            PE   V  +      K  D+WS+GV+ Y  L G  PF        G ++ +   + +N 
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 248
Query: 523 ILKATE---VQFANKPT--VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
           + ++ +    +F +K    +S+EAK  I   L    + R+    + +H ++Q   P+ G
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG 307

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 475
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 476 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 525
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 526 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 579 SEVTAMLE 586

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 419 LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 476
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 477 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 526
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 527 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 580 SEVTAMLE 587

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG GGF  V +         VA K  +     +E    N  +  L E  I K L+HP VV
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRERWCL-EIQIMKKLNHPNVV 75
Query: 355 KLYDVFE----IDANSF-CTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSALK 406
              +V +    +  N      +EYC+G DL  YL Q +    + E   R+++  + SAL+
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+E +  +IH DLKP NI+L  G      KI D G +K +D+         +L ++  G
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--------ELCTEFVG 185
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           T  YL PE         K +  VD WS G + ++C+ G +PF  N
Sbjct: 186 TLQYLAPELL----EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG GGF  V +         VA K  +     +E    N  +  L E  I K L+HP VV
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRERWCL-EIQIMKKLNHPNVV 76
Query: 355 KLYDVFE----IDANSF-CTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSALK 406
              +V +    +  N      +EYC+G DL  YL Q +    + E   R+++  + SAL+
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+E +  +IH DLKP NI+L  G      KI D G +K +D+         +L ++  G
Sbjct: 137 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--------ELCTEFVG 186
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           T  YL PE         K +  VD WS G + ++C+ G +PF  N
Sbjct: 187 TLQYLAPELL----EQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y+L   LG G F +V           VA K+  LN+  ++ +  + +    RE    K  
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI--LNR--QKIRSLDVVGKIKREIQNLKLF 68
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLY V     + F  V+EY  G +L  Y+ +H  + E EAR +  Q++SA+ Y 
Sbjct: 69  RHPHIIKLYQVISTPTDFF-MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  +  V+H DLKP N+LL   +     KI DFGLS +M +  +  D          G+ 
Sbjct: 128 H--RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRD--------SCGSP 174
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y  PE   V         +VD+WS GVI Y  L G  PF
Sbjct: 175 NYAAPE---VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 24/228 (10%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + +L  LG G F  VH        RY A KV  L K+     K   ++H   E  +   +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQ--VEHTNDERLMLSIV 63
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +++++  F+ DA     +++Y +G +L   L++ +      A+    +V  AL+YL
Sbjct: 64  THPFIIRMWGTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +     +I+ DLKP NILL +    G IKITDFG +K      Y PD    +T    GT 
Sbjct: 123 H--SKDIIYRDLKPENILLDKN---GHIKITDFGFAK------YVPD----VTYXLCGTP 167
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
            Y+ PE  VV   P   +  +D WS G++ Y+ L G  PF  + +  T
Sbjct: 168 DYIAPE--VVSTKP--YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 129/305 (42%), Gaps = 39/305 (12%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++ D  +   +LG G   +V + F+ + Q   A K  Q                A RE  
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ------------DCPKARREVE 106
Query: 344 IH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH--KTIAEREARSI 397
           +H +A   P +V++ DV+E + A   C   V E  DG +L   ++    +   EREA  I
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
              +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K     N      
Sbjct: 167 XKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------ 218
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             LT+     Y Y+ PE  V+G  P K     D WS+GVI Y  L G  PF  N   A  
Sbjct: 219 -SLTTPCYTPY-YVAPE--VLG--PEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAIS 272
Query: 518 LEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-----P 570
               T ++  + +F N     VS E K  IR+ L      R  +     H ++      P
Sbjct: 273 PGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTKVP 332
Query: 571 PVPKH 575
             P H
Sbjct: 333 QTPLH 337

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G FSEV++A  L +   VA K  Q+        +A+ IK    E ++ K L+HP V+
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPNVI 95
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD----FYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           K Y  F I+ N    VLE  D  DL      + KQ + I ER      +Q+ SAL++++ 
Sbjct: 96  KYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  V+H D+KP N+ +T     G +K+ D GL +    +     H +       GT +Y
Sbjct: 155 RR--VMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKT-TAAHSL------VGTPYY 202
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE   + +N    + K D+WS+G + Y+    + PF  ++     L +    K  +  
Sbjct: 203 MSPE--RIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCD 254
Query: 531 FANKPT--VSNEAKGFIRSCLAYRKEDRIDV 559
           +   P+   S E +  +  C+    E R DV
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 24/261 (9%)
Query: 250 PVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDL 309
           P   + Y  G     I E K   N  +S   +  +    + LL ++G+G +++V      
Sbjct: 15  PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLK 74
Query: 310 KEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF 367
           K  R  A +V   +L  D   D+  ++++    ++   +A +HP +V L+  F+ ++  F
Sbjct: 75  KTDRIYAMRVVKKELVND---DEDIDWVQ--TEKHVFEQASNHPFLVGLHSCFQTESRLF 129
Query: 368 CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL 427
             V+EY +G DL F++++ + + E  AR    ++  AL YL+E    +I+ DLK  N+LL
Sbjct: 130 F-VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLL 186
Query: 428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS 487
              +  G IK+TD+G+ K    E   P    D TS   GT  Y+ PE  + G++      
Sbjct: 187 ---DSEGHIKLTDYGMCK----EGLRPG---DTTSTFCGTPNYIAPEI-LRGED---YGF 232
Query: 488 KVDVWSVGVIFYQCLYGKKPF 508
            VD W++GV+ ++ + G+ PF
Sbjct: 233 SVDWWALGVLMFEMMAGRSPF 253

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+    K    D      +   RE  I
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-----FQKLEREARI 81
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + ++  +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQ 463
           + Y +     ++H +LKP N+LL        +K+ DFGL+ +V D E +   HG      
Sbjct: 141 IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGF----- 190
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +   
Sbjct: 191 -AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ--- 241
Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +KA    + +    TV+ EAK  I S L    + RI
Sbjct: 242 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 54  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 111
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 112 HQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 161
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 162 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 214
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 215 SEVTAMLE 222

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y+L   LG G F +V           VA K+  LN+  ++ +  + +    RE    K  
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI--LNR--QKIRSLDVVGKIKREIQNLKLF 68
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLY V     + F  V+EY  G +L  Y+ +H  + E EAR +  Q++SA+ Y 
Sbjct: 69  RHPHIIKLYQVISTPTDFF-MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  +  V+H DLKP N+LL   +     KI DFGLS +M +  +             G+ 
Sbjct: 128 H--RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEF--------LRTSCGSP 174
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y  PE   V         +VD+WS GVI Y  L G  PF
Sbjct: 175 NYAAPE---VISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 123
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 124 HQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 173
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 174 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 227 SEVTAMLE 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 117
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 118 HQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 167
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 168 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 220
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 221 SEVTAMLE 228

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 37/306 (12%)
Query: 266 RELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
           R+LK++   D+      P   + + +L  LG+G +  V+KA   +  + VA K   +  D
Sbjct: 13  RQLKKL---DEDSLTKQP--EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD 67
Query: 326 WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLK 384
            +E          ++E +I +  D P VVK Y  +         V+EYC  G   D    
Sbjct: 68  LQE---------IIKEISIMQQCDSPHVVKYYGSY-FKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 385 QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
           ++KT+ E E  +I+   +  L+YL+ ++   IH D+K GNILL   N  G  K+ DFG++
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFMRK--IHRDIKAGNILL---NTEGHAKLADFGVA 172
Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCLY 503
             + +        M   +   GT +++ PE    +G N        D+WS+G+   +   
Sbjct: 173 GQLTDX-------MAKRNXVIGTPFWMAPEVIQEIGYN-----CVADIWSLGITAIEMAE 220
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
           GK P+        I    T    T   F      S+    F++ CL    E R     L 
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPT---FRKPELWSDNFTDFVKQCLVKSPEQRATATQLL 277
Query: 564 RHDYLQ 569
           +H +++
Sbjct: 278 QHPFVR 283

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 113
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 114 HQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 163
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 164 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 217 SEVTAMLE 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 74  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 131
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 132 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 181
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 182 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 234
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 235 SEVTAMLE 242

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 133
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 134 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 183
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 184 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 237 SEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/188 (35%), Positives = 100/188 (53%), Gaps = 25/188 (13%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 133
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM-DEENYNPDHG 457
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  +ENY     
Sbjct: 134 HQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENY----- 183
Query: 458 MDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQ 512
               +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G   
Sbjct: 184 --YKAQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 236
Query: 513 SQATILEE 520
           S+ T + E
Sbjct: 237 SEVTAMLE 244

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/189 (34%), Positives = 99/189 (52%), Gaps = 27/189 (14%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E  A S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 117
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDH 456
            QV   +KYL E     +H DL   N+LL   +     KI+DFGLSK +  DE  Y    
Sbjct: 118 HQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENXYK--- 169
Query: 457 GMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHN 511
                +Q  G +   WY  PEC     N  K SSK DVWS GV+ ++   YG+KP+ G  
Sbjct: 170 -----AQTHGKWPVKWY-APECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219
Query: 512 QSQATILEE 520
            S+ T + E
Sbjct: 220 GSEVTAMLE 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 62/308 (20%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V K  +    + VA K    ++D    KK      ALRE  + K L HP +V
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-----ALREIRMLKQLKHPNLV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDG---HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            L +VF         V EYCD    H+LD Y    + + E   +SI  Q + A+ + +  
Sbjct: 66  NLLEVFR-RKRRLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   IH D+KP NIL+T+ +V   IK+ DFG ++++   +       D       T WY 
Sbjct: 120 KHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPS-------DYYDDEVATRWYR 169
Query: 472 PPECFV--VGKNPPKISSKVDVWSVGVIFYQCLYG------------------------- 504
            PE  V      PP     VDVW++G +F + L G                         
Sbjct: 170 SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224
Query: 505 --KKPFGHNQSQATI-LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS 561
             ++ F  NQ  + + + +   ++  E++F   P +S  A G ++ CL     +R+    
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKF---PNISYPALGLLKGCLHMDPTERLTCEQ 281
Query: 562 LARHDYLQ 569
           L  H Y +
Sbjct: 282 LLHHPYFE 289

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 33/293 (11%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           SDRY L+  +G G F       D +    VA K  +  +   E+ K        RE   H
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVK--------REIINH 69
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++L HP +V+  +V  +       V+EY  G +L   +      +E EAR    Q++S +
Sbjct: 70  RSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ-- 463
            Y + ++  V H DLK  N LL +G+    +KI DFG SK              L SQ  
Sbjct: 129 SYAHAMQ--VAHRDLKLENTLL-DGSPAPRLKIADFGYSK-----------ASVLHSQPK 174
Query: 464 -GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  +  +   K++   DVWS GV  Y  L G  PF   +         T
Sbjct: 175 SAVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT 229
Query: 523 ILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I +   VQ+A  +   +S E +  I          RI +  +  H++    +P
Sbjct: 230 IHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 117/220 (53%), Gaps = 24/220 (10%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKAL 348
           LL ++G+G +++V      K  R  A KV   +L  D   D+  ++++    ++   +A 
Sbjct: 24  LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND---DEDIDWVQT--EKHVFEQAS 78
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           +HP +V L+  F+ ++  F  V+EY +G DL F++++ + + E  AR    ++  AL YL
Sbjct: 79  NHPFLVGLHSCFQTESRLF-FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +E    +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT 
Sbjct: 138 HE--RGIIYRDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSXFCGTP 185
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y+ PE  + G++       VD W++GV+ ++ + G+ PF
Sbjct: 186 NYIAPEI-LRGED---YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + LL +LGKGG+ +V +   +           ++ K     + A    H   E NI + +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +V L   F+     +  +LEY  G +L   L++     E  A   + ++  AL +L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYL-ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           ++    +I+ DLKP NI+L   N  G +K+TDFGL K          H   +T    GT 
Sbjct: 138 HQ--KGIIYRDLKPENIML---NHQGHVKLTDFGLCK-------ESIHDGTVTHXFCGTI 185
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKAT 527
            Y+ PE  +   +    +  VD WS+G + Y  L G  PF G N+ +       TI K  
Sbjct: 186 EYMAPEILMRSGH----NRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKIL 234
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
           + +    P ++ EA+  ++  L      R+
Sbjct: 235 KCKLNLPPYLTQEARDLLKKLLKRNAASRL 264

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + LL +LGKGG+ +V +   +           ++ K     + A    H   E NI + +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP +V L   F+     +  +LEY  G +L   L++     E  A   + ++  AL +L
Sbjct: 79  KHPFIVDLIYAFQTGGKLYL-ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           ++    +I+ DLKP NI+L   N  G +K+TDFGL K          H   +T    GT 
Sbjct: 138 HQ--KGIIYRDLKPENIML---NHQGHVKLTDFGLCK-------ESIHDGTVTHTFCGTI 185
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKAT 527
            Y+ PE  +   +    +  VD WS+G + Y  L G  PF G N+ +       TI K  
Sbjct: 186 EYMAPEILMRSGH----NRAVDWWSLGALMYDMLTGAPPFTGENRKK-------TIDKIL 234
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
           + +    P ++ EA+  ++  L      R+
Sbjct: 235 KCKLNLPPYLTQEARDLLKKLLKRNAASRL 264

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 117/220 (53%), Gaps = 24/220 (10%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKAL 348
           LL ++G+G +++V      K  R  A KV   +L  D   D+  ++++    ++   +A 
Sbjct: 9   LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND---DEDIDWVQ--TEKHVFEQAS 63
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           +HP +V L+  F+ ++  F  V+EY +G DL F++++ + + E  AR    ++  AL YL
Sbjct: 64  NHPFLVGLHSCFQTESRLFF-VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +E    +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT 
Sbjct: 123 HE--RGIIYRDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSXFCGTP 170
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y+ PE  + G++       VD W++GV+ ++ + G+ PF
Sbjct: 171 NYIAPEI-LRGED---YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 88/309 (28%), Positives = 143/309 (46%), Gaps = 52/309 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY------------ 334
           ++Y L   +GKG +  V  A++  +  Y A KV  L+K  K  ++A +            
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV--LSKK-KLIRQAGFPRRPPPRGTRPA 69
Query: 335 ----------IKHALREYNIHKALDHPRVVKLYDVFEIDANS--FCTVLEYCDGHDLDFY 382
                     I+   +E  I K LDHP VVKL +V + D N      V E  +   +   
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD-DPNEDHLYMVFELVNQGPV-ME 127
Query: 383 LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
           +   K ++E +AR     ++  ++YL+  K  +IH D+KP N+L+ E    G IKI DFG
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED---GHIKIADFG 182
Query: 443 LSKVMDEENYNPDHGMD-LTSQGAGTYWYLPPECFVVGKNPPKISS--KVDVWSVGVIFY 499
           +S        N   G D L S   GT  ++ PE         KI S   +DVW++GV  Y
Sbjct: 183 VS--------NEFKGSDALLSNTVGTPAFMAPESL---SETRKIFSGKALDVWAMGVTLY 231
Query: 500 QCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV 559
             ++G+ PF   +    I+  ++ +K+  ++F ++P ++ + K  I   L    E RI V
Sbjct: 232 CFVFGQCPFMDER----IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 560 ISLARHDYL 568
             +  H ++
Sbjct: 288 PEIKLHPWV 296

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+    K       A   +   RE  I
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-----LSARDFQKLEREARI 58
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + ++  +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQ 463
           + Y +     ++H +LKP N+LL        +K+ DFGL+ +V D E +   HG      
Sbjct: 118 IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGF----- 167
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +   
Sbjct: 168 -AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQ--- 218
Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +KA    + +    TV+ EAK  I S L    + RI
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 117/220 (53%), Gaps = 24/220 (10%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKAL 348
           LL ++G+G +++V      K  R  A KV   +L  D   D+  ++++    ++   +A 
Sbjct: 13  LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND---DEDIDWVQ--TEKHVFEQAS 67
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
           +HP +V L+  F+ ++  F  V+EY +G DL F++++ + + E  AR    ++  AL YL
Sbjct: 68  NHPFLVGLHSCFQTESRLFF-VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +E    +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT 
Sbjct: 127 HERG--IIYRDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSXFCGTP 174
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y+ PE  + G++       VD W++GV+ ++ + G+ PF
Sbjct: 175 NYIAPEI-LRGED---YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 33/293 (11%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           SDRY L+  +G G F       D +    VA K  +  +   E+ K        RE   H
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK--------REIINH 68
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++L HP +V+  +V  +       V+EY  G +L   +      +E EAR    Q++S +
Sbjct: 69  RSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 127
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ-- 463
            Y + ++  V H DLK  N LL +G+    +KI DFG SK              L SQ  
Sbjct: 128 SYCHAMQ--VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----------SSVLHSQPK 173
Query: 464 -GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  +  +   K++   DVWS GV  Y  L G  PF   +         T
Sbjct: 174 STVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT 228
Query: 523 ILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I +   VQ+A  +   +S E +  I          RI +  +  H++    +P
Sbjct: 229 IHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 281

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+    K       A   +   RE  I
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-----LSARDFQKLEREARI 57
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + ++  +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 58  CRKLQHPNIVRLHDSIQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 116
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQ 463
           + Y +     ++H +LKP N+LL        +K+ DFGL+ +V D E +   HG      
Sbjct: 117 IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGF----- 166
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +   
Sbjct: 167 -AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQ--- 217
Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +KA    + +    TV+ EAK  I S L    + RI
Sbjct: 218 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 253

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 27/287 (9%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            ++ Y L   LGKG FS V +    L  Q Y A  ++      ++ +K        RE  
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE------REAR 62
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I + L HP +V+L+D    + + +  + +   G +L   +   +  +E +A   + Q++ 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHY-LIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A+ + +++   V+H +LKP N+LL        +K+ DFGL+  ++ E      G      
Sbjct: 122 AVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF----- 173
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            AGT  YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++   
Sbjct: 174 -AGTPGYLSPE--VLRKDP--YGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQ--- 224
Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           +KA    F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 91
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 151 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 199
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 200 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 249 ----IIGGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 91
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 151 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 199
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 200 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 249 ----IIGGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 92/186 (49%), Gaps = 23/186 (12%)
Query: 338 ALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
            L+E +I  K   HP +++L D +E +   F  V +     +L  YL +  T++E+E R 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 397 I---VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           I   +++V+ AL  LN     ++H DLKP NILL +      IK+TDFG S  +D     
Sbjct: 129 IMRALLEVICALHKLN-----IVHRDLKPENILLDDDM---NIKLTDFGFSCQLDP---- 176
Query: 454 PDHGMDLTSQGAGTYWYLPPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
              G  L S   GT  YL PE     +  N P    +VD+WS GVI Y  L G  PF H 
Sbjct: 177 ---GEKLRSV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232
Query: 512 QSQATI 517
           +    +
Sbjct: 233 KQMLML 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 90
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 150 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 198
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 199 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 248 ----IIGGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 28/276 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+    K       A   +   RE  I
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-----LSARDFQKLEREARI 58
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + ++  +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHY-LVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTSQ 463
           + Y +     ++H +LKP N+LL        +K+ DFGL+ +V D E +   HG      
Sbjct: 118 IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGF----- 167
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +   
Sbjct: 168 -AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQ--- 218
Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +KA    + +    TV+ EAK  I S L    + RI
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 90
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 150 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 198
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 199 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 248 ----IIGGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 97
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 157 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 205
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 206 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 254
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 255 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 47/264 (17%)
Query: 259 GYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC- 317
           G +NL+ + +K +H            + D Y++  L+G+G +  V+ A+D   ++ VA  
Sbjct: 10  GRENLYFQGIKNVH------------VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK 57
Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID----ANSFCTVLEY 373
           KV+++ +D  + K+       LRE  I   L    +++LYD+   D     +    VLE 
Sbjct: 58  KVNRMFEDLIDCKR------ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111
Query: 374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC 433
            D  DL    K    + E   ++I+  ++    +++E    +IH DLKP N LL +   C
Sbjct: 112 ADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQD--C 166
Query: 434 GEIKITDFGLSKVMD-----------EENYNPD-HGMDLTSQGAG---TYWYLPPECFVV 478
             +K+ DFGL++ ++           EEN  P  H  +L  Q      T WY  PE  ++
Sbjct: 167 S-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 479 GKNPPKISSKVDVWSVGVIFYQCL 502
            +N  K    +D+WS G IF + L
Sbjct: 226 QENYTK---SIDIWSTGCIFAELL 246

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 78
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 138 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 186
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 187 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 236 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           +N   LSD + +   LG+G  S V++      Q+  A KV +   D          K  +
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----------KKIV 95
Query: 340 R-EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           R E  +   L HP ++KL ++FE        VLE   G +L   + +    +ER+A   V
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFE-TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q++ A+ YL+E    ++H DLKP N+L         +KI DFGLSK+++ +        
Sbjct: 155 KQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV------- 205
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            L     GT  Y  PE        P    +VD+WSVG+I Y  L G +PF
Sbjct: 206 -LMKTVCGTPGYCAPEILRGCAYGP----EVDMWSVGIITYILLCGFEPF 250

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 77
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 137 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 185
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 186 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 234
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 235 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 92/186 (49%), Gaps = 23/186 (12%)
Query: 338 ALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
            L+E +I  K   HP +++L D +E +   F  V +     +L  YL +  T++E+E R 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 397 I---VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           I   +++V+ AL  LN     ++H DLKP NILL +      IK+TDFG S  +D     
Sbjct: 129 IMRALLEVICALHKLN-----IVHRDLKPENILLDDDM---NIKLTDFGFSCQLD----- 175
Query: 454 PDHGMDLTSQGAGTYWYLPPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           P   +    +  GT  YL PE     +  N P    +VD+WS GVI Y  L G  PF H 
Sbjct: 176 PGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232
Query: 512 QSQATI 517
           +    +
Sbjct: 233 KQMLML 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 90
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 150 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 198
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 199 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 248 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 105
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 164
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 165 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 213
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 214 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 262
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 263 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 29/288 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           ++D Y L   LGKG FS V +   +   +  A K+    K    D +        RE  I
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-----KLEREARI 56
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D    +   +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHY-LVFDLVTGGELFEDIVAREYYSEADASHCIQQILES 115
Query: 405 LKY--LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           + +  LN I    +H DLKP N+LL   +    +K+ DFGL+ +  + +     G     
Sbjct: 116 VNHCHLNGI----VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGF---- 166
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
             AGT  YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++  
Sbjct: 167 --AGTPGYLSPE--VLRKDP--YGKPVDMWACGVILYILLVGYPPFW-DEDQHRLYQQ-- 217
Query: 523 ILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +KA    F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 218 -IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 110
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 111 VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 169
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 170 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 218
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 219 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 267
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 268 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 62
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERMEPVQDLFDFITERGALQEELARSFFW 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 122 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 170
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 171 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 219
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 220 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 125/293 (42%), Gaps = 33/293 (11%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           SDRY L+  +G G F       D +    VA K  +     + +K A  +K   RE   H
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-----RGEKIAANVK---REIINH 69
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++L HP +V+  +V  +       V+EY  G +L   +      +E EAR    Q++S +
Sbjct: 70  RSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ-- 463
            Y + ++  V H DLK  N LL +G+    +KI DFG SK              L SQ  
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----------SSVLHSQPK 174
Query: 464 -GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  +  +   K++   DVWS GV  Y  L G  PF   +         T
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT 229
Query: 523 ILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I +   VQ+A  +   +S E +  I          RI +  +  H++    +P
Sbjct: 230 IHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 91
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 151 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 199
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 200 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 249 ----IIGGQVFFRQR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 92/186 (49%), Gaps = 23/186 (12%)
Query: 338 ALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS 396
            L+E +I  K   HP +++L D +E +   F  V +     +L  YL +  T++E+E R 
Sbjct: 57  TLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 115
Query: 397 I---VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           I   +++V+ AL  LN     ++H DLKP NILL +      IK+TDFG S  +D     
Sbjct: 116 IMRALLEVICALHKLN-----IVHRDLKPENILLDDDM---NIKLTDFGFSCQLD----- 162
Query: 454 PDHGMDLTSQGAGTYWYLPPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           P   +    +  GT  YL PE     +  N P    +VD+WS GVI Y  L G  PF H 
Sbjct: 163 PGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 219
Query: 512 QSQATI 517
           +    +
Sbjct: 220 KQMLML 225

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 63
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 123 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 171
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 172 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 220
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 221 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A+D + ++ VA K  +L++ ++    A   +   RE  + K L H  V+
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHA---RRTYRELRLLKHLKHENVI 90
Query: 355 KLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
            L DVF     I+  S   ++    G DL+  +K  + +++   + +V Q++  LKY++ 
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIH- 148
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +IH DLKP N+ + E +   E++I DFGL++  DEE           +    T WY
Sbjct: 149 -SAGIIHRDLKPSNVAVNEDS---ELRILDFGLARQADEE----------MTGYVATRWY 194
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             PE  +   N    +  VD+WSVG I  + L GK  F
Sbjct: 195 RAPEIML---NWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 91
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 151 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 199
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 200 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 248
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 249 ----IIGGQVFFRQR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 90
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 150 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 198
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 199 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 247
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 248 ----IIGGQVFFRQR--VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 124/288 (43%), Gaps = 35/288 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWK--EDKKANYIKHALREYNI 344
           Y L  LLGKGGF  V     L ++  VA KV   N+   W    D     ++ AL  + +
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL-WKV 91
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
                HP V++L D FE     F  VLE      DL  Y+ +   + E  +R    QVV+
Sbjct: 92  GAGGGHPGVIRLLDWFETQ-EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A+++ +     V+H D+K  NIL+     C   K+ DFG   ++ +E Y         + 
Sbjct: 151 AIQHCHSRG--VVHRDIKDENILIDLRRGCA--KLIDFGSGALLHDEPY---------TD 197
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  Y PPE     +     +    VWS+G++ Y  + G  PF  +Q    ILE    
Sbjct: 198 FDGTRVYSPPEWISRHQY---HALPATVWSLGILLYDMVCGDIPFERDQE---ILE---- 247
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
               E+ F     VS +    IR CLA +   R  +  +    ++Q P
Sbjct: 248 ---AELHFPAH--VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 105
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 164
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 165 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 213
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 214 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 262
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 263 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 63
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 123 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 171
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 172 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 220
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 221 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 63
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 123 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 171
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 172 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 220
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 221 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 115/243 (47%), Gaps = 40/243 (16%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC-KVHQLNKDWKEDKKANYIKHALREYN 343
           + DRY +  L+G G +  V +A+D  E+R VA  K+ ++ +D  + K+       LRE  
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR------ILREIA 104
Query: 344 IHKALDHPRVVKLYD-VFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           I   L+H  VVK+ D V   D   F     VLE  D  D     +    + E   ++++ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLY 163
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPD--- 455
            ++  +KY++     ++H DLKP N L+ +   C  +K+ DFGL++ +D  EN N     
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQD--CS-VKVCDFGLARTVDYPENGNSQLPI 218
Query: 456 -------------HGMDLTSQGAG---TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY 499
                        H  +L  Q  G   T WY  PE  ++ +N    +  +DVWS+G IF 
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN---YTEAIDVWSIGCIFA 275
Query: 500 QCL 502
           + L
Sbjct: 276 ELL 278

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 62
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 122 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 170
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 171 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 219
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 220 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 27/283 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           Y L   LGKG FS V +    L  Q Y A  ++      ++ +K        RE  I + 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE------REARICRL 77
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L HP +V+L+D    + + +  + +   G +L   +   +  +E +A   + Q++ A+ +
Sbjct: 78  LKHPNIVRLHDSISEEGHHY-LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 136
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
            +++   V+H DLKP N+LL        +K+ DFGL+  ++ E      G       AGT
Sbjct: 137 CHQMG--VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF------AGT 187
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
             YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++   +KA 
Sbjct: 188 PGYLSPE--VLRKDP--YGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQ---IKAG 239
Query: 528 EVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 240 AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 25/291 (8%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +  D Y L  ++GKG FS V +  + +  +  A K+  + K       +   +   RE +
Sbjct: 23  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST--EDLKREAS 80
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVM 399
           I   L HP +V+L + +  D   +  V E+ DG DL F + +        +E  A   + 
Sbjct: 81  ICHMLKHPHIVELLETYSSDGMLY-MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++ AL+Y ++    +IH D+KP  +LL        +K+  FG++  + E          
Sbjct: 140 QILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-------- 189
Query: 460 LTSQG-AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           L + G  GT  ++ PE  VV + P      VDVW  GVI +  L G  PF   + +   L
Sbjct: 190 LVAGGRVGTPHFMAPE--VVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTKER---L 242
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  I    ++       +S  AK  +R  L     +RI V     H +L+
Sbjct: 243 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 77
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 137 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 185
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 186 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 234
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 235 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 78
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 138 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 186
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 187 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 236 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           Y+L   LG G F +V           VA K+  LN+  ++ +  + +    RE    K  
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKI--LNR--QKIRSLDVVGKIRREIQNLKLF 73
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            HP ++KLY V    ++ F  V+EY  G +L  Y+ ++  + E+E+R +  Q++S + Y 
Sbjct: 74  RHPHIIKLYQVISTPSDIF-MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +  +  V+H DLKP N+LL   +     KI DFGLS +M +  +             G+ 
Sbjct: 133 H--RHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEF--------LRXSCGSP 179
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            Y  PE   V         +VD+WS GVI Y  L G  PF
Sbjct: 180 NYAAPE---VISGRLYAGPEVDIWSSGVILYALLCGTLPF 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 78
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 138 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 186
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 187 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 235
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 236 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L+K ++    A   K   RE  + K
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSKPFQSIIHA---KRTYRELRLLK 88
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 147
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 192
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 193 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A+D + ++ VA K  +L++ ++    A   +   RE  + K L H  V+
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHA---RRTYRELRLLKHLKHENVI 90
Query: 355 KLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
            L DVF     I+  S   ++    G DL+  +K  + +++   + +V Q++  LKY++ 
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK-CQALSDEHVQFLVYQLLRGLKYIH- 148
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +IH DLKP N+ + E +   E++I DFGL++  DEE           +    T WY
Sbjct: 149 -SAGIIHRDLKPSNVAVNEDS---ELRILDFGLARQADEE----------MTGYVATRWY 194
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             PE  +   N    +  VD+WSVG I  + L GK  F
Sbjct: 195 RAPEIML---NWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 85
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 86  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 144
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 145 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 193
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 194 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 242
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 243 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E +   E+KI DFGL +  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDS---ELKILDFGLCRHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 25/291 (8%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +  D Y L  ++GKG FS V +  + +  +  A K+  + K       +   +   RE +
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST--EDLKREAS 78
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVM 399
           I   L HP +V+L + +  D   +  V E+ DG DL F + +        +E  A   + 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLY-MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++ AL+Y ++    +IH D+KP  +LL        +K+  FG++  + E          
Sbjct: 138 QILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-------- 187
Query: 460 LTSQG-AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           L + G  GT  ++ PE  VV + P      VDVW  GVI +  L G  PF   + +   L
Sbjct: 188 LVAGGRVGTPHFMAPE--VVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTKER---L 240
Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E  I    ++       +S  AK  +R  L     +RI V     H +L+
Sbjct: 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 61
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 120
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 121 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 169
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 170 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 218
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 219 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 82
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 141
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E +   E+KI DFGL++  D+E           +
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDS---ELKILDFGLARHTDDE----------MT 186
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 187 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 82
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 141
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 186
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 187 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E     E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDX---ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 29/288 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           ++D Y L   LGKG FS V +   +   +  A K+    K    D +        RE  I
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ-----KLEREARI 56
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D    +   +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHY-LVFDLVTGGELFEDIVAREYYSEADASHCIQQILES 115
Query: 405 LKY--LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           + +  LN I    +H DLKP N+LL   +    +K+ DFGL+ +  + +     G     
Sbjct: 116 VNHCHLNGI----VHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGF---- 166
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
             AGT  YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++  
Sbjct: 167 --AGTPGYLSPE--VLRKDP--YGKPVDMWACGVILYILLVGYPPFW-DEDQHRLYQQ-- 217
Query: 523 ILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +KA    F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 218 -IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 96
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 155
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 200
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 201 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 58
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 118 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 166
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 167 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 215
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +   +V F  +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 216 ----IIGGQVFFRQR--VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 78
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 137
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E +   E+KI DFGL++  D+E           +
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDS---ELKILDFGLARHTDDE----------MT 182
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 183 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 95
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 154
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 199
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 200 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 58
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 118 QVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 166
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 167 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 215
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 216 ---IIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 86
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 145
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 190
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 191 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G GGF +V++AF + ++  V    H  ++D      +  I++  +E  +   L HP +
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDED-----ISQTIENVRQEAKLFAMLKHPNI 68
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL-NEIK 412
           + L  V   + N  C V+E+  G  L+  L   K I      +  +Q+   + YL +E  
Sbjct: 69  IALRGVCLKEPN-LCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 413 PPVIHYDLKPGNILLTE----GNVCGEI-KITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
            P+IH DLK  NIL+ +    G++  +I KITDFGL++                   AG 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---------KMSAAGA 177
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           Y ++ PE           S   DVWS GV+ ++ L G+ PF
Sbjct: 178 YAWMAPEVI----RASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 88
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 147
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 192
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 193 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 88
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 147
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 192
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 193 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 96
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 155
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E            
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MX 200
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 201 GXVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 95
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 154
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 199
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 200 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 82
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 141
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 186
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 187 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 96
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 155
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 200
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 201 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MA 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GFVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 131/280 (46%), Gaps = 39/280 (13%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-EYNIHKALDHPRV 353
           LGKG F  V+ A + K    VA KV      +K   +   ++H LR E  I   L HP +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVL-----FKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           ++LY+ F  D      +LEY    +L   L++  T  E+   +I+ ++  AL Y +  K 
Sbjct: 86  LRLYNYF-YDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK- 143
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG-AGTYWYLP 472
            VIH D+KP N+LL       E+KI DFG S           H   L  +   GT  YLP
Sbjct: 144 -VIHRDIKPENLLLGLKG---ELKIADFGWSV----------HAPSLRRKTMCGTLDYLP 189
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATILEENTILKATEV 529
           PE  + G+     + KVD+W +GV+ Y+ L G  PF    HN++   I++ +    A   
Sbjct: 190 PE-MIEGRMH---NEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA--- 242
Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                 +V   A+  I   L +   +R+ +  ++ H +++
Sbjct: 243 ------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPWVR 276

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 99
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 158
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 203
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 204 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 136/305 (44%), Gaps = 49/305 (16%)
Query: 276 QSRFNNHPVLSDRYLLL---------MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW 326
           +S F++   L D+ L L         + LG G F  V +      ++ +   +  L +  
Sbjct: 316 ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG- 374
Query: 327 KEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQ 385
              +KA+  +  +RE  I   LD+P +V+L  V +  A +   V+E   G  L  F + +
Sbjct: 375 --TEKAD-TEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGGGPLHKFLVGK 429
Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            + I       ++ QV   +KYL E     +H +L   N+LL   +     KI+DFGLSK
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYA---KISDFGLSK 484
Query: 446 VM--DEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
            +  D+  Y        T++ AG +   WY  PEC     N  K SS+ DVWS GV  ++
Sbjct: 485 ALGADDSYY--------TARSAGKWPLKWY-APECI----NFRKFSSRSDVWSYGVTMWE 531
Query: 501 CL-YGKKPFGHNQSQATI--LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            L YG+KP+   +    +  +E+   ++         P    E    +  C  Y+ EDR 
Sbjct: 532 ALSYGQKPYKKMKGPEVMAFIEQGKRMECP-------PECPPELYALMSDCWIYKWEDRP 584
Query: 558 DVISL 562
           D +++
Sbjct: 585 DFLTV 589

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 81
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 140
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E     E+KI DFGL++  D+E           +
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDX---ELKILDFGLARHTDDE----------MT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 186 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MA 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GFVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 34/229 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---H 350
           +G+G + +V KA DLK   R+VA K  ++     +  +       +RE  + + L+   H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 351 PRVVKLYDVFEID----ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSA 404
           P VV+L+DV  +           V E+ D  DL  YL +     +     + ++ Q++  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   +       M LTS  
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ-------MALTSV- 179
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
             T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S
Sbjct: 180 VVTLWYRAPEVLLQS----SYATPVDLWSVGCIFAE-MFRRKPLFRGSS 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 40/277 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  V +      ++ +   +  L +     +KA+  +  +RE  I   LD+P +V
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKAD-TEEMMREAQIMHQLDNPYIV 73
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +L  V +  A +   V+E   G  L  F + + + I       ++ QV   +KYL E   
Sbjct: 74  RLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE--K 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTY--- 468
             +H DL   N+LL   +     KI+DFGLSK +  D+  Y        T++ AG +   
Sbjct: 130 NFVHRDLAARNVLLVNRHYA---KISDFGLSKALGADDSYY--------TARSAGKWPLK 178
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI--LEENTILK 525
           WY  PEC     N  K SS+ DVWS GV  ++ L YG+KP+   +    +  +E+   ++
Sbjct: 179 WY-APECI----NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233
Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL 562
                    P    E    +  C  Y+ EDR D +++
Sbjct: 234 CP-------PECPPELYALMSDCWIYKWEDRPDFLTV 263

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 83
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++          H  D  +
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLAR----------HTADEMT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 188 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 83
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++          H  D  +
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLAR----------HTADEMT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 188 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALREY 342
           L  +Y +  LLG GGF  V+    + +   VA K  + ++  DW E      +     E 
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEV 58
Query: 343 NIHKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVM 399
            + K +      V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y       
Sbjct: 118 QVLEAVRHCHNXG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY------- 166
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +   GT  Y PPE     +   + ++   VWS+G++ Y  + G  PF H++       
Sbjct: 167 --TDFDGTRVYSPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE------ 215
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              I++    Q   +  VS E +  IR CLA R  DR     +  H ++Q
Sbjct: 216 ---IIRG---QVFFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 82
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 141
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 186
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 187 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 33/293 (11%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           SDRY L+  +G G F       D +    VA K  +  +   E+ K        RE   H
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK--------REIINH 69
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++L HP +V+  +V  +       V+EY  G +L   +      +E EAR    Q++S +
Sbjct: 70  RSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ-- 463
            Y + ++  V H DLK  N LL +G+    +KI  FG SK              L SQ  
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLL-DGSPAPRLKICAFGYSK-----------SSVLHSQPK 174
Query: 464 -GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  +  +   K++   DVWS GV  Y  L G  PF   +         T
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT 229
Query: 523 ILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I +   VQ+A  +   +S E +  I          RI +  +  H++    +P
Sbjct: 230 IHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 87
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 146
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E     E+KI DFGL++  D+E           +
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDX---ELKILDFGLARHTDDE----------MT 191
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 192 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 83
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++          H  D  +
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLAR----------HTADEMT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 188 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GXVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 78
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 137
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 182
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 183 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 81
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 140
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 186 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 33/293 (11%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           SDRY L+  +G G F       D +    VA K  +  +   E+ K        RE   H
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVK--------REIINH 69
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++L HP +V+  +V  +       V+EY  G +L   +      +E EAR    Q++S +
Sbjct: 70  RSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ-- 463
            Y + ++  V H DLK  N LL +G+    +KI  FG SK              L SQ  
Sbjct: 129 SYCHAMQ--VCHRDLKLENTLL-DGSPAPRLKICAFGYSK-----------SSVLHSQPK 174
Query: 464 -GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  +  +   K++   DVWS GV  Y  L G  PF   +         T
Sbjct: 175 DTVGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKT 229
Query: 523 ILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I +   VQ+A  +   +S E +  I          RI +  +  H++    +P
Sbjct: 230 IHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 81
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 140
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E     E+KI DFGL++  D+E           +
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDX---ELKILDFGLARHTDDE----------MT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 186 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 78
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 137
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 182
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 183 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 72
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 131
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 176
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 177 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 72
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 131
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MA 176
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 177 GFVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 83
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 188 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A+D + ++ VA K  +L++ ++    A   +   RE  + K L H  V+
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVK--KLSRPFQSLIHA---RRTYRELRLLKHLKHENVI 82
Query: 355 KLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
            L DVF     I+  S   ++    G DL+  +K  + +++   + +V Q++  LKY++ 
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK-CQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +IH DLKP N+ + E   C E++I DFGL++  DEE           +    T WY
Sbjct: 142 AG--IIHRDLKPSNVAVNED--C-ELRILDFGLARQADEE----------MTGYVATRWY 186
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             PE  +   N    +  VD+WSVG I  + L GK  F
Sbjct: 187 RAPEIML---NWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 81
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 140
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 186 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 29/278 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  ++D+K    +A K  +L++ ++    A   K   RE  + K
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK--KLSRPFQSIIHA---KRTYRELRLLK 105
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 164
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 209
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F         L++  
Sbjct: 210 GYVATRWYRAPEIML---NWMHYNMTVDIWSVGCIMAELLTGRTLFP-GTDHINQLQQIM 265
Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
            L  T          S+EA+ +I S     K +  DV 
Sbjct: 266 RLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVF 303

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 87
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 146
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 191
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 192 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 75
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 134
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 135 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 179
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 180 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 78
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 137
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 182
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 183 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 34/239 (14%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 71  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 128
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +        
Sbjct: 129 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-------- 176
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             + +   GT  Y+ PE           S + D+WS+G+   +   G+ P G       I
Sbjct: 177 -SMANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAI 231
Query: 518 LEENTILKATEVQFANKP-------TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E    +        N+P         S E + F+  CL     +R D+  L  H +++
Sbjct: 232 FELLDYI-------VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 134/324 (41%), Gaps = 53/324 (16%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  +Y L   +G+G +  V  A + + +   A K+   NK  + + K   ++    E  +
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD--VERIKTEVRL 81
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYC-DGHDLDFY--------------------- 382
            K L HP + +LY+V+E D    C V+E C  GH LD                       
Sbjct: 82  MKKLHHPNIARLYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 383 ----------------LKQHKTIAERE--ARSIVMQVVSALKYLNEIKPPVIHYDLKPGN 424
                            ++     +RE    +I+ Q+ SAL YL+     + H D+KP N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPEN 198
Query: 425 ILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPK 484
            L +  N   EIK+ DFGLSK   + N    +GM   +  AGT +++ PE  V+      
Sbjct: 199 FLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGM---TTKAGTPYFVAPE--VLNTTNES 252
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGF 544
              K D WS GV+ +  L G  PF       TI     + K    +  N   +S  A+  
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKLCFENPNYNVLSPLARDL 310
Query: 545 IRSCLAYRKEDRIDVISLARHDYL 568
           + + L    ++R D +   +H ++
Sbjct: 311 LSNLLNRNVDERFDAMRALQHPWI 334

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 74
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 133
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 134 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 178
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 179 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 73
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 132
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 177
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 178 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 72
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 131
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 176
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 177 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 34/229 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---H 350
           +G+G + +V KA DLK   R+VA K  ++     +  +       +RE  + + L+   H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 351 PRVVKLYDVFEID----ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSA 404
           P VV+L+DV  +           V E+ D  DL  YL +     +     + ++ Q++  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   +       M LTS  
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ-------MALTSV- 179
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
             T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S
Sbjct: 180 VVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAE-MFRRKPLFRGSS 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 112/229 (48%), Gaps = 34/229 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---H 350
           +G+G + +V KA DLK   R+VA K  ++     +  +       +RE  + + L+   H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 351 PRVVKLYDVFEID----ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSA 404
           P VV+L+DV  +           V E+ D  DL  YL +     +     + ++ Q++  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   +       M LTS  
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ-------MALTSV- 179
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
             T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S
Sbjct: 180 VVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAE-MFRRKPLFRGSS 223

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 99
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 158
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E            
Sbjct: 159 RGLKYIH--SADIIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MX 203
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 204 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 73
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 132
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 177
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 178 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 127/286 (44%), Gaps = 25/286 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            +D Y L   LGKG FS V +       +  A K+    K    D +        RE  I
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-----LEREARI 83
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D    +   +  V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHY-LVFDLVTGGELFEDIVAREYYSEADASHCIHQILES 142
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + ++++    ++H DLKP N+LL        +K+ DFGL+  +  E      G       
Sbjct: 143 VNHIHQ--HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGF------ 193
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
           AGT  YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++   +
Sbjct: 194 AGTPGYLSPE--VLRKDP--YGKPVDIWACGVILYILLVGYPPFW-DEDQHKLYQQ---I 245
Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           KA    F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 246 KAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 72
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQIL 131
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DFGL++  D+E           +
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFGLARHTDDE----------MT 176
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 177 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 24/282 (8%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE--YNIHKALDHP 351
           ++G+G  S V +          A K+ ++  +    ++   ++ A R   + + +   HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            ++ L D +E  +  F  V +     +L  YL +   ++E+E RSI+  ++ A+ +L+  
Sbjct: 161 HIITLIDSYESSSFMFL-VFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              ++H DLKP NILL +     +I+++DFG S  ++     P   +    +  GT  YL
Sbjct: 220 N--IVHRDLKPENILLDDNM---QIRLSDFGFSCHLE-----PGEKL---RELCGTPGYL 266
Query: 472 PPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
            PE     + +  P    +VD+W+ GVI +  L G  PF H +    IL    I++  + 
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRMIMEG-QY 322
Query: 530 QFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           QF++      S+  K  I   L    E R+      +H + +
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           + RY  L  LG+G F+ V+KA D    + VA K  +L    + + K    + ALRE  + 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREIKLL 66
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSA 404
           + L HP ++ L D F   +N    V ++ +  DL+  +K +   +     ++ ++  +  
Sbjct: 67  QELSHPNIIGLLDAFGHKSN-ISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL++    ++H DLKP N+LL E  V   +K+ DFGL+K     N    H +      
Sbjct: 125 LEYLHQHW--ILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYXHQVV----- 174
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             T WY  PE     +        VD+W+VG I  + L  + PF
Sbjct: 175 --TRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 254 DSYLIGYKNL--HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE 311
           D++L  YK+    IR+L R+  ED             Y ++ ++G+G F EV        
Sbjct: 53  DNFLSRYKDTINKIRDL-RMKAED-------------YEVVKVIGRGAFGEVQLVRHKST 98
Query: 312 QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL 371
           ++  A K+    +  K    A + +    E +I    + P VV+L+  F+ D      V+
Sbjct: 99  RKVYAMKLLSKFEMIKRSDSAFFWE----ERDIMAFANSPWVVQLFYAFQ-DDRYLYMVM 153
Query: 372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN 431
           EY  G DL   L  +  + E+ AR    +VV AL  ++ +    IH D+KP N+LL +  
Sbjct: 154 EYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS- 209
Query: 432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV 491
             G +K+ DFG    M++E      GM       GT  Y+ PE             + D 
Sbjct: 210 --GHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAY 551
           WSVGV  Y+ L G  PF  +    T      +     + F +   +S EAK  I + L  
Sbjct: 262 WSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 319
Query: 552 RK 553
           R+
Sbjct: 320 RE 321

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI D+GL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDYGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y+ L  LG+G ++ V+K         VA K  ++  + +E         A+RE ++ K
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK--EIRLEHEEGAPCT----AIREVSLLK 55
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSAL 405
            L H  +V L+D+   +  S   V EY D  DL  YL     I      +  + Q++  L
Sbjct: 56  DLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y +  K  V+H DLKP N+L+ E    GE+K+ DFGL++         D+ +       
Sbjct: 114 AYCHRQK--VLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYDNEV------- 161
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY PP+  +   +    S+++D+W VG IFY+   G+  F
Sbjct: 162 VTLWYRPPDILLGSTD---YSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 127/317 (40%), Gaps = 60/317 (18%)
Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+ Q          
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------- 52
Query: 332 ANYIKHALREYNIH-KALDHPRVVKLYDVFE-IDANSFC--TVLEYCDGHDLDFYLKQH- 386
                 A RE  +H +A   P +V++ DV+E + A   C   V+E  DG +L   ++   
Sbjct: 53  --DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 387 -KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
               E Y+                                    D+WS+GVI Y  L G 
Sbjct: 169 ETTGEKYD---------------------------------KSCDMWSLGVIMYILLCGY 195
Query: 506 KPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            PF  N   A      T ++  + +F N     VS E K  IR+ L      R+ +    
Sbjct: 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
Query: 564 RHDYLQ-----PPVPKH 575
            H ++      P  P H
Sbjct: 256 NHPWIMQSTKVPQTPLH 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 254 DSYLIGYKNL--HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE 311
           D++L  YK+    IR+L R+  ED             Y ++ ++G+G F EV        
Sbjct: 48  DNFLSRYKDTINKIRDL-RMKAED-------------YEVVKVIGRGAFGEVQLVRHKST 93
Query: 312 QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL 371
           ++  A K+    +  K    A + +    E +I    + P VV+L+  F+ D      V+
Sbjct: 94  RKVYAMKLLSKFEMIKRSDSAFFWE----ERDIMAFANSPWVVQLFYAFQ-DDRYLYMVM 148
Query: 372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN 431
           EY  G DL   L  +  + E+ AR    +VV AL  ++ +    IH D+KP N+LL +  
Sbjct: 149 EYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS- 204
Query: 432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV 491
             G +K+ DFG    M++E      GM       GT  Y+ PE             + D 
Sbjct: 205 --GHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAY 551
           WSVGV  Y+ L G  PF  +    T      +     + F +   +S EAK  I + L  
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 314
Query: 552 RK 553
           R+
Sbjct: 315 RE 316

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKEIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFGL+K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGLAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 133/306 (43%), Gaps = 28/306 (9%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+          +E
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE 217
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
            +  K  +        + +     +   L      RI +  + +  +   P+ K  ++  
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 581 SSSAPV 586
            +S  V
Sbjct: 278 VTSGGV 283

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKGGF  VHK   +K++  VA K   L     E +     +   RE  I   L+HP +V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKYLNEIK 412
           KLY +     N    V+E+    DL   L  K H      + R +++ +   ++Y+    
Sbjct: 87  KLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR-LMLDIALGIEYMQNQN 142
Query: 413 PPVIHYDLKPGNILLTE----GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           PP++H DL+  NI L        VC   K+ DFGLS+            +   S   G +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCA--KVADFGLSQ----------QSVHSVSGLLGNF 190
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++ PE   +G      + K D +S  +I Y  L G+ PF
Sbjct: 191 QWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G ++ V+K  +     YVA K      + K D +      A+RE ++ K L H  +V
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALK------EVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVMQVVSALKYL 408
           +LYDV   + N    V E+ D +DL  Y+         + +     +    Q++  L + 
Sbjct: 67  RLYDVIHTE-NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +E K  ++H DLKP N+L+   N  G++K+ DFGL++            ++  S    T 
Sbjct: 125 HENK--ILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIP-------VNTFSSEVVTL 172
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           WY  P+  +  +     S+ +D+WS G I  + + GK  F
Sbjct: 173 WYRAPDVLMGSRT---YSTSIDIWSCGCILAEMITGKPLF 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +     +ED         + E  +   L HP++V
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--------FIEEAEVMMKLSHPKLV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 66  QLYGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 122
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 123 SVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------P 173
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+ +    T  +  
Sbjct: 174 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIS----TGFRLY 224
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 225 KPRLASTHVYQIMNHCWKERPEDR 248

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 254 DSYLIGYKNL--HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE 311
           D++L  YK+    IR+L R+  ED             Y ++ ++G+G F EV        
Sbjct: 53  DNFLSRYKDTINKIRDL-RMKAED-------------YEVVKVIGRGAFGEVQLVRHKST 98
Query: 312 QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVL 371
           ++  A K+    +  K    A + +    E +I    + P VV+L+  F+ D      V+
Sbjct: 99  RKVYAMKLLSKFEMIKRSDSAFFWE----ERDIMAFANSPWVVQLFYAFQ-DDRYLYMVM 153
Query: 372 EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN 431
           EY  G DL   L  +  + E+ AR    +VV AL  ++ +    IH D+KP N+LL +  
Sbjct: 154 EYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS- 209
Query: 432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDV 491
             G +K+ DFG    M++E      GM       GT  Y+ PE             + D 
Sbjct: 210 --GHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 492 WSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAY 551
           WSVGV  Y+ L G  PF  +    T      +     + F +   +S EAK  I + L  
Sbjct: 262 WSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 319
Query: 552 RK 553
           R+
Sbjct: 320 RE 321

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--FVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 133/306 (43%), Gaps = 28/306 (9%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+          +E
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE 217
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
            +  K  +        + +     +   L      RI +  + +  +   P+ K  ++  
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 581 SSSAPV 586
            +S  V
Sbjct: 278 VTSGGV 283

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 133/306 (43%), Gaps = 28/306 (9%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+          +E
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE 217
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
            +  K  +        + +     +   L      RI +  + +  +   P+ K  ++  
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 581 SSSAPV 586
            +S  V
Sbjct: 278 VTSGGV 283

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 133/306 (43%), Gaps = 28/306 (9%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+          +E
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QE 217
Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
            +  K  +        + +     +   L      RI +  + +  +   P+ K  ++  
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 581 SSSAPV 586
            +S  V
Sbjct: 278 VTSGGV 283

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V KA + +    VA K  +L     +D        ALRE  + K L H  +V
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKELKHKNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE-ARSIVMQVVSALKYLNEIKP 413
           +L+DV   D      V E+CD  DL  Y        + E  +S + Q++  L + +    
Sbjct: 65  RLHDVLHSD-KKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG--TYWYL 471
            V+H DLKP N+L+   N  GE+K+ DFGL++           G+ +    A   T WY 
Sbjct: 122 -VLHRDLKPQNLLI---NRNGELKLADFGLARAF---------GIPVRCYSAEVVTLWYR 168
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PP+     K     S+ +D+WS G IF +     +P 
Sbjct: 169 PPDVLFGAK---LYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI  FGL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILGFGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 78
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 79  IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 131
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 132 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 182
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 183 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMXGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY  +  LG+G + EV+KA D      VA K  +L     E ++      A+RE ++ K
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLK 88
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +++L  V   + +    + EY + +DL  Y+ ++  ++ R  +S + Q+++ + 
Sbjct: 89  ELQHRNIIELKSVIHHN-HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGE--IKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + +  +   +H DLKP N+LL+  +      +KI DFGL++          H +      
Sbjct: 147 FCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----- 199
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
             T WY PPE  +  ++    S+ VD+WS+  I+ + L
Sbjct: 200 --TLWYRPPEILLGSRH---YSTSVDIWSIACIWAEML 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 95
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 96  IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 148
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 149 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 199
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 200 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 248

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +     +ED         + E  +   L HP++V
Sbjct: 13  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--------FIEEAEVMMKLSHPKLV 63
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 64  QLYGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 120
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 121 CVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------P 171
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+ +    T  +  
Sbjct: 172 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIS----TGFRLY 222
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDR 246

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +     +ED         + E  +   L HP++V
Sbjct: 15  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--------FIEEAEVMMKLSHPKLV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 66  QLYGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 122
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 123 CVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------P 173
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+ +    T  +  
Sbjct: 174 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIS----TGFRLY 224
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 225 KPRLASTHVYQIMNHCWKERPEDR 248

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKEIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G I++TDFGL+K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQ---GYIQVTDFGLAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 105
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 106 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 158
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 159 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 209
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 210 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +     +ED         + E  +   L HP++V
Sbjct: 18  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--------FIEEAEVMMKLSHPKLV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 69  QLYGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 125
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 126 CVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SP 176
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+ +    T  +  
Sbjct: 177 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIS----TGFRLY 227
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 228 KPRLASTHVYQIMNHCWRERPEDR 251

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 35/244 (14%)
Query: 294 LLGKGGFSEV-HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G   EV +    +  QR V   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFDHPN 111
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V          V EY +   LD +L+ H      + +  +MQ+V       + +
Sbjct: 112 IIRLEGVV-TRGRLAMIVTEYMENGSLDTFLRTH------DGQFTIMQLVGMLRGVGAGM 164
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +YL+++    +H DL   N+L+    VC   K++DFGLS+V+++   +PD     T    
Sbjct: 165 RYLSDLG--YVHRDLAARNVLVDSNLVC---KVSDFGLSRVLED---DPDAAXTTTGGKI 216
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGH--NQSQATILEENT 522
              W   PE           SS  DVWS GV+ ++ L YG++P+ +  N+   + +EE  
Sbjct: 217 PIRW-TAPEAIAF----RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271
Query: 523 ILKA 526
            L A
Sbjct: 272 RLPA 275

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 164 LNKMXGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 2   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 52
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 53  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 111
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 112 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 161
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 162 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMXGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI DF L++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDFYLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 35/244 (14%)
Query: 294 LLGKGGFSEV-HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G   EV +    +  QR V   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFDHPN 111
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V          V EY +   LD +L+ H      + +  +MQ+V       + +
Sbjct: 112 IIRLEGVV-TRGRLAMIVTEYMENGSLDTFLRTH------DGQFTIMQLVGMLRGVGAGM 164
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +YL+++    +H DL   N+L+    VC   K++DFGLS+V+++   +PD     T    
Sbjct: 165 RYLSDLG--YVHRDLAARNVLVDSNLVC---KVSDFGLSRVLED---DPDAAYTTTGGKI 216
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGH--NQSQATILEENT 522
              W   PE           SS  DVWS GV+ ++ L YG++P+ +  N+   + +EE  
Sbjct: 217 PIRW-TAPEAIAF----RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271
Query: 523 ILKA 526
            L A
Sbjct: 272 RLPA 275

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 38/290 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY-IKHALR---EYN 343
           ++ LL +LG+G F +V        ++       QL    K  KKA   ++  +R   E +
Sbjct: 25  QFELLKVLGQGSFGKVFLV-----KKISGSDARQLYA-MKVLKKATLKVRDRVRTKMERD 78
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I   ++HP +VKL+  F+ +   +  +L++  G DL   L +     E + +  + ++  
Sbjct: 79  ILVEVNHPFIVKLHYAFQTEGKLYL-ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL +L+ +   +I+ DLKP NILL E    G IK+TDFGLSK       + DH     S 
Sbjct: 138 ALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSK------ESIDHEKKAYS- 185
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  Y+ PE      N    +   D WS GV+ ++ L G  PF     + T+     I
Sbjct: 186 FCGTVEYMAPEVV----NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMI 238
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYL 568
           LKA   +      +S EA+  +R        +R+      V  + RH + 
Sbjct: 239 LKA---KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +            AG
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGRTWXL----------AG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIH 345
           ++L  +LGKG F +V  A   K  ++ A K   L KD     +D +   ++  +    + 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRV----LS 72
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
            A +HP +  ++  F+   N F  V+EY +G DL ++++         A     +++  L
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLF-FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++L+     +++ DLK  NILL +    G IKI DFG+ K    EN   D     T+   
Sbjct: 132 QFLH--SKGIVYRDLKLDNILLDKD---GHIKIADFGMCK----ENMLGDAK---TNXFC 179
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           GT  Y+ PE  ++G+   K +  VD WS GV+ Y+ L G+ PF H Q +  + 
Sbjct: 180 GTPDYIAPEI-LLGQ---KYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELF 227

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  +G G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G D+  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G IK+ DFG +K +             T    G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIKVADFGFAKRVKGR----------TWXLCG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E +I   ++HP VVKL+  F+ +   +  +L++  G DL   L +     E + +  + +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYL-ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPDHGMD 459
           +   L +L+ +   +I+ DLKP NILL E    G IK+TDFGLSK  +D E         
Sbjct: 139 LALGLDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSKEAIDHEKK------- 186
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
                 GT  Y+ PE      N    S   D WS GV+ ++ L G  PF     + T+  
Sbjct: 187 -AYSFCGTVEYMAPEVV----NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETM-- 239
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
              ILKA   +      +S EA+  +R+       +R+
Sbjct: 240 -TLILKA---KLGMPQFLSTEAQSLLRALFKRNPANRL 273

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +             T    G
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGR----------TWXLCG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMXGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI D GL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDAGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 82
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 141
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 142 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTL----------CG 186
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 187 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK------KISPFEHQTYCQRTLREIQILLR 97
Query: 348 LDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVSAL 405
             H  V+ + D+       +   V    D  + D Y L + + ++       + Q++  L
Sbjct: 98  FRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGL 157
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KY++     V+H DLKP N+L+   N   ++KI DFGL+++ D E+   DH   LT +  
Sbjct: 158 KYIHSAN--VLHRDLKPSNLLI---NTTCDLKICDFGLARIADPEH---DHTGFLT-EXV 208
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 209 ATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  +G G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G D+  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G IK+ DFG +K +             T    G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIKVADFGFAKRVKGR----------TWXLCG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 112/228 (49%), Gaps = 27/228 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKALDH 350
           +LGKG F +V  A   K  ++ A K   L KD     +D +   ++  +    +  A +H
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRV----LSLAWEH 78
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +  ++  F+   N F  V+EY +G DL ++++         A     +++  L++L+ 
Sbjct: 79  PFLTHMFCTFQTKENLF-FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH- 136
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +++ DLK  NILL +    G IKI DFG+ K    EN   D     T++  GT  Y
Sbjct: 137 -SKGIVYRDLKLDNILLDKD---GHIKIADFGMCK----ENMLGDAK---TNEFCGTPDY 185
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           + PE  ++G+   K +  VD WS GV+ Y+ L G+ PF H Q +  + 
Sbjct: 186 IAPEI-LLGQ---KYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELF 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 38/290 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY-IKHALR---EYN 343
           ++ LL +LG+G F +V        ++       QL    K  KKA   ++  +R   E +
Sbjct: 25  QFELLKVLGQGSFGKVFLV-----KKISGSDARQLYA-MKVLKKATLKVRDRVRTKMERD 78
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I   ++HP +VKL+  F+ +   +  +L++  G DL   L +     E + +  + ++  
Sbjct: 79  ILVEVNHPFIVKLHYAFQTEGKLYL-ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL +L+ +   +I+ DLKP NILL E    G IK+TDFGLSK       + DH     S 
Sbjct: 138 ALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSK------ESIDHEKKAYSF 186
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  Y+ PE      N    +   D WS GV+ ++ L G  PF     + T+     I
Sbjct: 187 -CGTVEYMAPEVV----NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMI 238
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYL 568
           LKA   +      +S EA+  +R        +R+      V  + RH + 
Sbjct: 239 LKA---KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +      ED   ++I+ A     +   L HP++V
Sbjct: 35  IGSGQFGLVHLGYWLNKDK-VAIKTIK-EGSMSED---DFIEEA----EVMMKLSHPKLV 85
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 86  QLYGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 142
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 143 CVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------P 193
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+     +T  +  
Sbjct: 194 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVED----ISTGFRLY 244
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 245 KPRLASTHVYQIMNHCWKERPEDR 268

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKGGF  VHK   +K++  VA K   L     E +     +   RE  I   L+HP +V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKYLNEIK 412
           KLY +     N    V+E+    DL   L  K H      + R +++ +   ++Y+    
Sbjct: 87  KLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR-LMLDIALGIEYMQNQN 142
Query: 413 PPVIHYDLKPGNILLTE----GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           PP++H DL+  NI L        VC   K+ DFG S+            +   S   G +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCA--KVADFGTSQ----------QSVHSVSGLLGNF 190
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++ PE   +G      + K D +S  +I Y  L G+ PF
Sbjct: 191 QWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 38/290 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY-IKHALR---EYN 343
           ++ LL +LG+G F +V        ++       QL    K  KKA   ++  +R   E +
Sbjct: 26  QFELLKVLGQGSFGKVFLV-----KKISGSDARQLYA-MKVLKKATLKVRDRVRTKMERD 79
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           I   ++HP +VKL+  F+ +   +  +L++  G DL   L +     E + +  + ++  
Sbjct: 80  ILVEVNHPFIVKLHYAFQTEGKLYL-ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 138
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL +L+ +   +I+ DLKP NILL E    G IK+TDFGLSK       + DH     S 
Sbjct: 139 ALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFGLSK------ESIDHEKKAYSF 187
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  Y+ PE      N    +   D WS GV+ ++ L G  PF     + T+     I
Sbjct: 188 -CGTVEYMAPEVV----NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM---TMI 239
Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYL 568
           LKA   +      +S EA+  +R        +R+      V  + RH + 
Sbjct: 240 LKA---KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ YQ   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYQMAAGYPPFFADQ 242

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGL++V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLARVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI D GL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDGGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 32/264 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH  + L + + VA K  +     +ED         + E  +   L HP++V
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--------FIEEAEVMMKLSHPKLV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKP 413
           +LY V  ++    C V E+ +   L  YL+ Q    A      + + V   + YL E   
Sbjct: 67  QLYGVC-LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--A 123
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            VIH DL   N L+ E  V   IK++DFG+++ + ++ Y    G     + A       P
Sbjct: 124 CVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS------P 174
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFA 532
           E F    +  + SSK DVWS GV+ ++    GK P+  N+S + ++E+ +    T  +  
Sbjct: 175 EVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDIS----TGFRLY 225
Query: 533 NKPTVSNEAKGFIRSCLAYRKEDR 556
                S      +  C   R EDR
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDR 249

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRIQQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  VLEY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G IK+ DFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIKVADFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 35/282 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVA-CKVH--QLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +G+G F  V+K  D +    VA C++   +L K  ++  K         E    K L HP
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK--------EEAEXLKGLQHP 85
Query: 352 RVVKLYDVFEIDANSF-CTVL--EYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYL 408
            +V+ YD +E       C VL  E      L  YLK+ K    +  RS   Q++  L++L
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +   PP+IH DLK  NI +T     G +KI D GL+ +                   GT 
Sbjct: 146 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL---------KRASFAKAVIGTP 194
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            +  PE +       K    VDV++ G    +    + P+   Q+ A I    T    + 
Sbjct: 195 EFXAPEXY-----EEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVT----SG 245
Query: 529 VQFANKPTVS-NEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           V+ A+   V+  E K  I  C+   K++R  +  L  H + Q
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 28/226 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY  L  +G G +  V  AFD K    VA K  +L++ ++    A   K   RE  + K
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHA---KRTYRELRLLK 76
Query: 347 ALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            + H  V+ L DVF     ++  +   ++ +  G DL+  +K  K + +   + ++ Q++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQIL 135
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             LKY++     +IH DLKP N+ + E   C E+KI D GL++  D+E           +
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILDRGLARHTDDE----------MT 180
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T WY  PE  +   N    +  VD+WSVG I  + L G+  F
Sbjct: 181 GYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLMIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           + L+ L+G G + +V+K   +K  +  A KV  +  D +E+ K        +E N+ K  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--------QEINMLKKY 77
Query: 349 DHPRVVKLYDVFEIDAN------SFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQ 400
            H R +  Y    I  N          V+E+C    +   +K  K  T+ E     I  +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  L +L++ K  VIH D+K  N+LLTE     E+K+ DFG+S  +D         +  
Sbjct: 138 ILRGLSHLHQHK--VIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRT-------VGR 185
Query: 461 TSQGAGTYWYLPPECFVVGKNP-PKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATI 517
            +   GT +++ PE     +NP      K D+WS+G+   +   G  P    H      +
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +  N   +    +++ K       + FI SCL      R     L +H +++
Sbjct: 246 IPRNPAPRLKSKKWSKK------FQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +             T    G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR----------TWXLCG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 24/220 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKGGF  VHK   +K++  VA K   L     E +     +   RE  I   L+HP +V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKYLNEIK 412
           KLY +     N    V+E+    DL   L  K H      + R +++ +   ++Y+    
Sbjct: 87  KLYGLMH---NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLR-LMLDIALGIEYMQNQN 142
Query: 413 PPVIHYDLKPGNILLTE----GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           PP++H DL+  NI L        VC   K+ DF LS+            +   S   G +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCA--KVADFSLSQ----------QSVHSVSGLLGNF 190
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++ PE   +G      + K D +S  +I Y  L G+ PF
Sbjct: 191 QWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +             T    G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR----------TWXLCG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMXGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P + KL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V EY +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEYMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGL +V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLGRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    AE  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P + KL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  V+ A D++    VA K    +     +K  + IK    E    + L HP  +
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK----EVRFLQKLRHPNTI 117
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           +    + +  ++   V+EYC G   D      K + E E  ++    +  L YL+     
Sbjct: 118 QYRGCY-LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +IH D+K GNILL+E    G +K+ DFG + +M   N              GT +++ PE
Sbjct: 175 MIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPAN-----------XFVGTPYWMAPE 220
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++  +  +   KVDVWS+G+   + L  +KP   N +  + L      ++  +Q  + 
Sbjct: 221 V-ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPALQSGH- 277
Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL---QPP 571
              S   + F+ SCL    +DR     L +H ++   +PP
Sbjct: 278 --WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 117
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 177 YLHSLD--LIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGATWTL----------CG 221
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 222 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V KA + +    VA K  +L     +D        ALRE  + K L H  +V
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKELKHKNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE-ARSIVMQVVSALKYLNEIKP 413
           +L+DV   D      V E+CD  DL  Y        + E  +S + Q++  L + +    
Sbjct: 65  RLHDVLHSD-KKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG--TYWYL 471
            V+H DLKP N+L+   N  GE+K+ +FGL++           G+ +    A   T WY 
Sbjct: 122 -VLHRDLKPQNLLI---NRNGELKLANFGLARAF---------GIPVRCYSAEVVTLWYR 168
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PP+     K     S+ +D+WS G IF +     +P 
Sbjct: 169 PPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 83
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 142
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ E    G I++TDFG +K +    +             G
Sbjct: 143 YLHSLD--LIYRDLKPENLLIDEQ---GYIQVTDFGFAKRVKGRTWXL----------CG 187
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 188 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 229

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 353 VVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V++L D FE   +SF  +LE  +   DL  ++ +   + E  ARS   QV+ A+++ +  
Sbjct: 118 VIRLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
              V+H D+K  NIL+      GE+K+ DFG   ++ +  Y         +   GT  Y 
Sbjct: 177 G--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVY---------TDFDGTRVYS 223
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
           PPE     +   + ++   VWS+G++ Y  + G  PF H++          I++    Q 
Sbjct: 224 PPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDIPFEHDEE---------IIRG---QV 268
Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 269 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 117
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 177 YLHSLD--LIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGRTWXL----------CG 221
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 222 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G   EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 3   PFVED-WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 53
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+K L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 54  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 112
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 113 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 163 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P + KL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 98  AVNFPFLTKLEFSFKDNSNLYM-VMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G IK+TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLMIDQQ---GYIKVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  +G G F  V     ++   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G IK+ DFG +K +             T    G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIKVADFGFAKRVKGR----------TWXLCG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L ++Y  L  +G+G +  V+KA D  + R VA K  +L+    ED+       A+RE ++
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA---EDEGIP--STAIREISL 72
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVS 403
            K L HP +V L DV          V E+ +  DL   L ++KT + + + +  + Q++ 
Sbjct: 73  LKELHHPNIVSLIDVIH-SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            + + ++ +  ++H DLKP N+L+   N  G +K+ DFGL++       +  H +     
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEV----- 180
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY  P+  +  K   K S+ VD+WS+G IF + + GK  F
Sbjct: 181 --VTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V E  +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEXMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--AVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 19/268 (7%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           ++ Y ++ ++G+G F EV        Q+  A K+    +  K    A +      E +I 
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFF----WEERDIM 129
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
              + P VV+L+  F+ D      V+EY  G DL   L  +  + E+ A+    +VV AL
Sbjct: 130 AFANSPWVVQLFCAFQ-DDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLAL 187
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
             ++ +   +IH D+KP N+LL +    G +K+ DFG    MDE       GM       
Sbjct: 188 DAIHSMG--LIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDET------GMVHCDTAV 236
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  Y+ PE             + D WSVGV  ++ L G  PF  +    T      +  
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY--SKIMDH 294
Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRK 553
              + F     +S  AK  I + L  R+
Sbjct: 295 KNSLCFPEDAEISKHAKNLICAFLTDRE 322

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L ++Y  L  +G+G +  V+KA D  + R VA K  +L+    ED+       A+RE ++
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA---EDEGIP--STAIREISL 72
Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVS 403
            K L HP +V L DV          V E+ +  DL   L ++KT + + + +  + Q++ 
Sbjct: 73  LKELHHPNIVSLIDVIH-SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            + + ++ +  ++H DLKP N+L+   N  G +K+ DFGL++       +  H +     
Sbjct: 131 GVAHCHQHR--ILHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEV----- 180
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY  P+  +  K   K S+ VD+WS+G IF + + GK  F
Sbjct: 181 --VTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGRTWXL----------XG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 29/280 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  V+ A D++    VA K    +     +K  + IK    E    + L HP  +
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK----EVRFLQKLRHPNTI 78
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           +    + +  ++   V+EYC G   D      K + E E  ++    +  L YL+     
Sbjct: 79  QYRGCY-LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           +IH D+K GNILL+E    G +K+ DFG + +M   N              GT +++ PE
Sbjct: 136 MIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPAN-----------XFVGTPYWMAPE 181
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++  +  +   KVDVWS+G+   +    K P  +  + + +      +   E      
Sbjct: 182 V-ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQS 236
Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL---QPP 571
              S   + F+ SCL    +DR     L +H ++   +PP
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 121/236 (51%), Gaps = 26/236 (11%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           ++Y+ L  +G+G F +       ++ R YV  +++      KE +++       RE  + 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR------REVAVL 77
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI--VMQVVS 403
             + HP +V+  + FE +  S   V++YC+G DL   +   K +  +E + +   +Q+  
Sbjct: 78  ANMKHPNIVQYRESFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           ALK++++ K  ++H D+K  NI LT+    G +++ DFG+++V++         ++L   
Sbjct: 137 ALKHVHDRK--ILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNST-------VELARA 184
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             GT +YL PE   + +N P  ++K D+W++G + Y+    K  F     +  +L+
Sbjct: 185 CIGTPYYLSPE---ICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 29/288 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL--REY 342
           ++D Y L   +GKG FS V +   L       C  H+        KK +   H    RE 
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKL-------CTGHEYAAKIINTKKLSARDHQKLEREA 54
Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            I + L H  +V+L+D    +   +  V +   G +L   +   +  +E +A   + Q++
Sbjct: 55  RICRLLKHSNIVRLHDSISEEGFHY-LVFDLVTGGELFEDIVAREYYSEADASHCIQQIL 113
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
            A+ + +++   V+H DLKP N+LL        +K+ DFGL+ +  + +     G     
Sbjct: 114 EAVLHCHQMG--VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGF---- 166
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
             AGT  YL PE              VD+W+ GVI Y  L G  PF  ++ Q  + ++  
Sbjct: 167 --AGTPGYLSPEVL----RKEAYGKPVDIWACGVILYILLVGYPPFW-DEDQHKLYQQ-- 217
Query: 523 ILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +KA    F +    TV+ EAK  I   L      RI      +H ++
Sbjct: 218 -IKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+++ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLIIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-IISKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 201
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 202 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 89
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 148
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +             T    G
Sbjct: 149 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR----------TWXLCG 193
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 194 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 117
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 176
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 177 YLHSLD--LIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKGRTWXL----------CG 221
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 222 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 25/228 (10%)
Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK--DWKEDKKANYIKHALR 340
           P + D + L+  LG+G + EV  A +   +  VA K+  + +  D  E+ K        +
Sbjct: 4   PFVED-WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--------K 54
Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
           E  I+  L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q
Sbjct: 55  EICINAMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++ + YL+ I   + H D+KP N+LL E +    +KI+DFGL+ V    N        L
Sbjct: 114 LMAGVVYLHGIG--ITHRDIKPENLLLDERD---NLKISDFGLATVFRYNNRE-----RL 163
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++  GT  Y+ PE     K     +  VDVWS G++    L G+ P+
Sbjct: 164 LNKMCGTLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 52/300 (17%)
Query: 284 VLSDRYLLLMLLGKGGFSE----VHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           V SD Y++   +G G +SE    VHKA +++   Y    + +  +D  E+     I+  L
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNME---YAVKVIDKSKRDPSEE-----IEILL 75
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           R Y       HP ++ L DV++ D      V E   G +L   + + K  +EREA  ++ 
Sbjct: 76  R-YG-----QHPNIITLKDVYD-DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVMDEENYNPDHGM 458
            +   ++YL+     V+H DLKP NIL  + +   E ++I DFG +K +  EN     G+
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN-----GL 181
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSK------VDVWSVGVIFYQCLYGKKPFGHNQ 512
            +T             C+      P++  +       D+WS+G++ Y  L G  PF +  
Sbjct: 182 LMTP------------CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 513 SQATILEENTILKATEVQF----ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           S      E  + +    +F     N  TVS  AK  +   L      R+    + +H ++
Sbjct: 230 SDT---PEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 55  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 112
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +E       
Sbjct: 113 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDE------- 161
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
             + ++  GT  Y+ PE           S + D+WS+G+   +   G+ P    +    I
Sbjct: 162 --MANEFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYP----RPPMAI 211
Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            E    +             S E + F+  CL     +R D+  L  H +++
Sbjct: 212 FELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 263

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 78
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V E  +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 79  IIRLEGVVT-KSKPVMIVTEXMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 131
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 132 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 182
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 183 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 231

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 107
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           +++L  V    +     V E  +   LD +L++H      +A+  V+Q+V       S +
Sbjct: 108 IIRLEGVVT-KSKPVMIVTEXMENGSLDSFLRKH------DAQFTVIQLVGMLRGIASGM 160
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V++++   P+     T  G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLEDD---PEAAYT-TRGGK 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 212 IPIRWTSPEAIAY----RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 23/238 (9%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  +R VA  +  L   + E ++ ++    L E +I    DHP 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDF----LCEASIMGQFDHPN 105
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           VV L  V          V+E+ +   LD +L++H       +   ++  + + ++YL ++
Sbjct: 106 VVHLEGVV-TRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADM 164
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL   NIL+    VC   K++DFGLS+V+++   +P+     T       W  
Sbjct: 165 G--YVHRDLAARNILVNSNLVC---KVSDFGLSRVIED---DPEAVYTTTGGKIPVRWTA 216
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI--LEENTILKA 526
           P           K +S  DVWS G++ ++ + YG++P+    +Q  I  +EE   L A
Sbjct: 217 PEAI-----QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPA 269

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 89
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYM-VMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 148
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +             T    G
Sbjct: 149 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR----------TWXLCG 193
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 194 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++LGKG +  V+   DL  Q  +A K          ++ + Y +    E  +HK L H  
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKE-------IPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 353 VVKLYDVFEIDANSFCTV-LEYCDGHDLDFYLKQHKTIAEREARSI---VMQVVSALKYL 408
           +V+    F    N F  + +E   G  L   L+      +   ++I     Q++  LKYL
Sbjct: 81  IVQYLGSF--SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           ++ +  ++H D+K  N+L+      G +KI+DFG SK +     NP      T    GT 
Sbjct: 139 HDNQ--IVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL--AGINP-----CTETFTGTL 187
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH-NQSQATILEENTILKAT 527
            Y+ PE  ++ K P       D+WS+G    +   GK PF    + QA + +        
Sbjct: 188 QYMAPE--IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 528 EVQFANKPTVSNEAKGFIRSCL 549
           E+      ++S EAK FI  C 
Sbjct: 246 EI----PESMSAEAKAFILKCF 263

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F +V+KA + +     A KV +      E++  +YI     E  I    DHP +V
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIV----EIEILATCDHPYIV 79
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KL   +  D   +  ++E+C G  +D   L+  + + E + + +  Q++ AL +L+  + 
Sbjct: 80  KLLGAYYHDGKLW-IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR- 137
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLK GN+L+T   + G+I++ DFG+S     +N       D      GT +++ P
Sbjct: 138 -IIHRDLKAGNVLMT---LEGDIRLADFGVSA----KNLKTLQKRD---SFIGTPYWMAP 186
Query: 474 E---CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           E   C  +   P     K D+WS+G+   +    + P         +L+   I K+    
Sbjct: 187 EVVMCETMKDTP--YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKSDPPT 241
Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                  S E + F++  L    E R     L  H ++
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 111/240 (46%), Gaps = 28/240 (11%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + LL +LG G + +V     +           ++ K     +KA   +H   E  +  
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-- 111
Query: 347 ALDH----PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            L+H    P +V L+  F+ +      +L+Y +G +L  +L Q +   E E +  V ++V
Sbjct: 112 -LEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDL 460
            AL++L+  K  +I+ D+K  NILL   +  G + +TDFGLSK  V DE     D     
Sbjct: 170 LALEHLH--KLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDF---- 220
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQATI 517
                GT  Y+ P+  +V          VD WS+GV+ Y+ L G  PF   G   SQA I
Sbjct: 221 ----CGTIEYMAPD--IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLY-MVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I  A
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLA 79
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 138 GLKYIHSAN--VLHRDLKPSNLLL---NTTSDLKICDFGLARVAD-----PDHDHTGFLT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 188 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 91
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++     E  AR    Q+V   +
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 150
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 151 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 195
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 196 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 237

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 52/300 (17%)
Query: 284 VLSDRYLLLMLLGKGGFSE----VHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           V SD Y++   +G G +SE    VHKA +++   Y    + +  +D  E+     I+  L
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNME---YAVKVIDKSKRDPSEE-----IEILL 75
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           R Y       HP ++ L DV++ D      V E   G +L   + + K  +EREA  ++ 
Sbjct: 76  R-YG-----QHPNIITLKDVYD-DGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVMDEENYNPDHGM 458
            +   ++YL+     V+H DLKP NIL  + +   E ++I DFG +K +  EN     G+
Sbjct: 129 TIGKTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN-----GL 181
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSK------VDVWSVGVIFYQCLYGKKPFGHNQ 512
            +T             C+      P++  +       D+WS+G++ Y  L G  PF +  
Sbjct: 182 LMTP------------CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 513 SQATILEENTILKATEVQF----ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           S      E  + +    +F     N  TVS  AK  +   L      R+    + +H ++
Sbjct: 230 SDT---PEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 115/238 (48%), Gaps = 29/238 (12%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LM+LGKG F +V  A     +   A K+ + +   ++D     ++  + E  +   LD 
Sbjct: 23  FLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDD----VECTMVEKRVLALLDK 78
Query: 351 P-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P  + +L+  F+   +    V+EY +G DL ++++Q     E +A     ++   L +L+
Sbjct: 79  PPFLTQLHSCFQT-VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD--LTSQGAGT 467
             K  +I+ DLK  N++L      G IKI DFG+ K         +H MD   T +  GT
Sbjct: 138 --KRGIIYRDLKLDNVMLDSE---GHIKIADFGMCK---------EHMMDGVTTREFCGT 183
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA--TILEENT 522
             Y+ PE  ++   P      VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N 
Sbjct: 184 PDYIAPE--IIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 24/222 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T  YL PE  ++ K   K    VD W++GV+ Y+   G  PF
Sbjct: 201 TPEYLAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPF 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 22/176 (12%)
Query: 341 EYNIHKALDHPRVVKLYD-VFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREAR 395
           E N+ + L HP +V+ YD + +    +   V+EYC+G DL   +    K+ + + E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 396 SIVMQVVSALKYLNEIKP---PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
            ++ Q+  ALK  +        V+H DLKP N+ L        +K+ DFGL++++     
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARIL----- 166
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +H  D   +  GT +Y+ PE      N    + K D+WS+G + Y+      PF
Sbjct: 167 --NHDEDFAKEFVGTPYYMSPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F +V+KA + +     A KV +      E++  +YI     E  I    DHP +V
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYI----VEIEILATCDHPYIV 71
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KL   +  D   +  ++E+C G  +D   L+  + + E + + +  Q++ AL +L+  + 
Sbjct: 72  KLLGAYYHDGKLW-IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR- 129
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            +IH DLK GN+L+T   + G+I++ DFG+S     +N       D      GT +++ P
Sbjct: 130 -IIHRDLKAGNVLMT---LEGDIRLADFGVSA----KNLKTLQKRD---SFIGTPYWMAP 178
Query: 474 E---CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           E   C  +   P     K D+WS+G+   +    + P         +L+   I K+    
Sbjct: 179 EVVMCETMKDTP--YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKSDPPT 233
Query: 531 FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
                  S E + F++  L    E R     L  H ++
Sbjct: 234 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 25/228 (10%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQ----LNKDWKEDKKANYIKHALRE 341
           S +Y  +  LG G F  V  A D ++ + V  K  +    L   W ED K   +     E
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT---LE 79
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLE-YCDGHDLDFYLKQHKTIAEREARSIVMQ 400
             I   ++H  ++K+ D+FE +   F  V+E +  G DL  ++ +H  + E  A  I  Q
Sbjct: 80  IAILSRVEHANIIKVLDIFE-NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +VSA+ YL      +IH D+K  NI++ E      IK+ DFG +  ++           L
Sbjct: 139 LVSAVGYLR--LKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGK--------L 185
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                GT  Y  PE  V+  NP +   ++++WS+GV  Y  ++ + PF
Sbjct: 186 FYTFCGTIEYCAPE--VLMGNPYR-GPELEMWSLGVTLYTLVFEENPF 230

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 19/227 (8%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  +R +   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEASIMGQFDHPN 95
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           V+ L  V    +     + E+ +   LD +L+Q+       +   ++  + + +KYL ++
Sbjct: 96  VIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL   NIL+    VC   K++DFGLS+ ++++  +P +   L   G     + 
Sbjct: 155 N--YVHRDLAARNILVNSNLVC---KVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 207
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
            PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 208 APEAI----QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 250

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +   + +   K+        E +        +RE +I K L H  +V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKP 413
           KLYDV          V E+ D  DL   L   +   E   A+S ++Q+++ + Y ++ + 
Sbjct: 64  KLYDVIH-TKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  GE+KI DFGL++          H +        T WY  P
Sbjct: 121 -VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIV-------TLWYRAP 169
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +  +  K   K S+ +D+WSVG IF + + G   F
Sbjct: 170 DVLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 281 NHPVL--SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           + P++  SDRY  +  +G G F       D   +  VA K  +        + A   ++ 
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE--------RGAAIDENV 63
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
            RE   H++L HP +V+  +V  +       ++EY  G +L   +      +E EAR   
Sbjct: 64  QREIINHRSLRHPNIVRFKEVI-LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF 122
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q++S + Y + ++  + H DLK  N LL +G+    +KI DFG SK             
Sbjct: 123 QQLLSGVSYCHSMQ--ICHRDLKLENTLL-DGSPAPRLKICDFGYSK-----------SS 168
Query: 459 DLTSQ---GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            L SQ     GT  Y+ PE  +  +   KI+   DVWS GV  Y  L G  PF
Sbjct: 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA---DVWSCGVTLYVMLVGAYPF 218

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++LGKG +  V+   DL  Q  +A K          ++ + Y +    E  +HK L H  
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKE-------IPERDSRYSQPLHEEIALHKHLKHKN 66
Query: 353 VVKLYDVFEIDANSFCTV-LEYCDGHDLDFYLKQHKTIAEREARSI---VMQVVSALKYL 408
           +V+    F    N F  + +E   G  L   L+      +   ++I     Q++  LKYL
Sbjct: 67  IVQYLGSFS--ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           ++ +  ++H D+K  N+L+      G +KI+DFG SK +     NP      T    GT 
Sbjct: 125 HDNQ--IVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL--AGINP-----CTETFTGTL 173
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH-NQSQATILEENTILKAT 527
            Y+ PE  ++ K P       D+WS+G    +   GK PF    + QA + +        
Sbjct: 174 QYMAPE--IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 231
Query: 528 EVQFANKPTVSNEAKGFIRSCL 549
           E+      ++S EAK FI  C 
Sbjct: 232 EI----PESMSAEAKAFILKCF 249

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 25/268 (9%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE-YNIHKALD 349
           ++ ++G+G F EV        +R  A K+  LNK W+  K+A       RE  ++    D
Sbjct: 94  IIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNK-WEMLKRAE--TACFREERDVLVNGD 148
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYL 408
              +  L+  F+ D N    V++Y  G DL   L + +  + E  AR  + ++V A+  +
Sbjct: 149 CQWITALHYAFQ-DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +++    +H D+KP N+LL   +V G I++ DFG    M+      D G   +S   GT 
Sbjct: 208 HQLH--YVHRDIKPDNVLL---DVNGHIRLADFGSCLKMN------DDGTVQSSVAVGTP 256
Query: 469 WYLPPECF-VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
            Y+ PE    +     K   + D WS+GV  Y+ LYG+ PF    +++ +     I+   
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNHE 313
Query: 528 E-VQFANKPT-VSNEAKGFIRSCLAYRK 553
           E  QF +  T VS EAK  I+  +  R+
Sbjct: 314 ERFQFPSHVTDVSEEAKDLIQRLICSRE 341

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +   + +   K+        E +        +RE +I K L H  +V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKP 413
           KLYDV          V E+ D  DL   L   +   E   A+S ++Q+++ + Y ++ + 
Sbjct: 64  KLYDVIH-TKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  GE+KI DFGL++          H +        T WY  P
Sbjct: 121 -VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVV-------TLWYRAP 169
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +  +  K   K S+ +D+WSVG IF + + G   F
Sbjct: 170 DVLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 28/239 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +   N    
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---- 161
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
                   GT  Y+ PE           S + D+WS+G+   +   G+ P     ++   
Sbjct: 162 -----SFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212
Query: 518 LEENTILKATEVQFANKP-------TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                I +  +    N+P         S E + F+  CL     +R D+  L  H +++
Sbjct: 213 RPPMAIFELLD-YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T  YL P   ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEYLAP-AIILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 24/225 (10%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 97
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
             H  ++ + D+     I+      ++ +  G DL + L + + ++       + Q++  
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL-YKLLKTQHLSNDHICYFLYQILRG 156
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTSQ 463
           LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      ++
Sbjct: 157 LKYIHSAN--VLHRDLKPSNLLL---NTTXDLKICDFGLARVAD-----PDHDHTGFLTE 206
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 207 YVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 119/262 (45%), Gaps = 38/262 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A D +    VA K  +L++ ++ +    + K A RE  + K + H  V+
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSE---IFAKRAYRELLLLKHMQHENVI 104
Query: 355 KLYDVFEIDAN-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
            L DVF   ++      F  V+ +      D         +E + + +V Q++  LKY++
Sbjct: 105 GLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGMEFSEEKIQYLVYQMLKGLKYIH 161
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                V+H DLKPGN+ + E   C E+KI DFGL++  D E           +    T W
Sbjct: 162 SAG--VVHRDLKPGNLAVNED--C-ELKILDFGLARHADAE----------MTGYVVTRW 206
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y  PE  +   +    +  VD+WSVG I  + L GK  F   + +  + +   ILK T V
Sbjct: 207 YRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLF---KGKDYLDQLTQILKVTGV 260
Query: 530 ---QFANKPTVSNEAKGFIRSC 548
              +F  K      AK +I+S 
Sbjct: 261 PGTEFVQKLN-DKAAKSYIQSL 281

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +   + +   K+        E +        +RE +I K L H  +V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKP 413
           KLYDV          V E+ D  DL   L   +   E   A+S ++Q+++ + Y ++ + 
Sbjct: 64  KLYDVIH-TKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  GE+KI DFGL++          H +        T WY  P
Sbjct: 121 -VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEVV-------TLWYRAP 169
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +  +  K   K S+ +D+WSVG IF + + G   F
Sbjct: 170 DVLMGSK---KYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE-YNIHKALD 349
           ++ ++G+G F EV        +R  A K+  LNK W+  K+A       RE  ++    D
Sbjct: 78  IIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNK-WEMLKRAE--TACFREERDVLVNGD 132
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSALKYL 408
              +  L+  F+ D N    V++Y  G DL   L K    + E  AR  + ++V A+  +
Sbjct: 133 CQWITALHYAFQ-DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +++    +H D+KP N+LL   +V G I++ DFG    M+      D G   +S   GT 
Sbjct: 192 HQLH--YVHRDIKPDNVLL---DVNGHIRLADFGSCLKMN------DDGTVQSSVAVGTP 240
Query: 469 WYLPPECF-VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
            Y+ PE    +     K   + D WS+GV  Y+ LYG+ PF    +++ +     I+   
Sbjct: 241 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNHE 297
Query: 528 E-VQFANKPT-VSNEAKGFIRSCLAYRK 553
           E  QF +  T VS EAK  I+  +  R+
Sbjct: 298 ERFQFPSHVTDVSEEAKDLIQRLICSRE 325

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I  A
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLA 79
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 138 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 188 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 40/240 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC-KVHQLNKDWKEDKKANYIKHALREYNIH 345
           D Y +  L+G+G +  V+ A+D    + VA  KV+++ +D  + K+       LRE  I 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKR------ILREITIL 81
Query: 346 KALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
             L    +++L+D+      +  +    VLE  D  DL    K    + E+  ++I+  +
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNL 140
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN---------- 451
           +   K+++E    +IH DLKP N LL +   C  +KI DFGL++ ++ +           
Sbjct: 141 LLGEKFIHE--SGIIHRDLKPANCLLNQD--CS-VKICDFGLARTINSDKDIHIVNDLEE 195
Query: 452 ---------YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
                    +N +    LTS    T WY  PE  ++ +N    ++ +D+WS G IF + L
Sbjct: 196 KEENEEPGPHNKNLKKQLTSH-VVTRWYRAPELILLQEN---YTNSIDIWSTGCIFAELL 251

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 31/238 (13%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYN 343
           + RY  +  +G G +  V+KA D     +VA K  ++  + +E    + ++    LR   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGEEGLPISTVREVALLRRL- 60
Query: 344 IHKALDHPRVVKLYDVFEIDANS----FCTVLEYCDGHDLDFYLKQHKT--IAEREARSI 397
             +A +HP VV+L DV              V E+ D  DL  YL +     +     + +
Sbjct: 61  --EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 117
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + Q +  L +L+     ++H DLKP NIL+T G   G +K+ DFGL+++     Y+    
Sbjct: 118 MRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GTVKLADFGLARI-----YSYQMA 167
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           +D       T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S+A
Sbjct: 168 LDPV---VVTLWYRAPEVLLQS----TYATPVDMWSVGCIFAE-MFRRKPLFCGNSEA 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 30/239 (12%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           + RY  +  +G G +  V+KA D     +VA K  ++                +RE  + 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVALL 65
Query: 346 K---ALDHPRVVKLYDVFEIDANS----FCTVLEYCDGHDLDFYLKQHKT--IAEREARS 396
           +   A +HP VV+L DV              V E+ D  DL  YL +     +     + 
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKD 124
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           ++ Q +  L +L+     ++H DLKP NIL+T G   G +K+ DFGL+++         +
Sbjct: 125 LMRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GTVKLADFGLARIY-------SY 172
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
            M LT     T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S+A
Sbjct: 173 QMALTPV-VVTLWYRAPEVLLQS----TYATPVDMWSVGCIFAE-MFRRKPLFCGNSEA 225

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 37/242 (15%)
Query: 351 PRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSAL 405
           P +V + DV+E           ++E  +G +L   +++   +   EREA  I+  + +A+
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-----VMDEENYNPDHGMDL 460
           ++L+     + H D+KP N+L T       +K+TDFG +K      +    Y P      
Sbjct: 142 QFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP------ 193
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                   +Y+ PE  V+G  P K     D+WS+GVI Y  L G  PF  N  QA     
Sbjct: 194 --------YYVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 521 NTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-----PPVP 573
              ++  +  F N     VS +AK  IR  L     +R+ +     H ++      P  P
Sbjct: 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
Query: 574 KH 575
            H
Sbjct: 302 LH 303

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G +  V  A D +    VA K  +L++ ++ +    + K A RE  + K + H  V+
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSE---IFAKRAYRELLLLKHMQHENVI 86
Query: 355 KLYDVFEIDAN-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
            L DVF   ++      F  V+ +      D         +E + + +V Q++  LKY++
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                V+H DLKPGN+ + E   C E+KI DFGL++  D E           +    T W
Sbjct: 144 SAG--VVHRDLKPGNLAVNED--C-ELKILDFGLARHADAE----------MTGYVVTRW 188
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           Y  PE  +   +    +  VD+WSVG I  + L GK  F   + +  + +   ILK T V
Sbjct: 189 YRAPEVILSWMH---YNQTVDIWSVGCIMAEMLTGKTLF---KGKDYLDQLTQILKVTGV 242
Query: 530 ---QFANKPTVSNEAKGFIRS 547
              +F  K      AK +I+S
Sbjct: 243 PGTEFVQKLN-DKAAKSYIQS 262

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 43/281 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   E +         +E  +    D P V 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPYVT 83
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  +  D      ++EY  G   LD  L +   + E +  +I+ +++  L YL+  K 
Sbjct: 84  KYYGSYLKDTK-LWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    GE+K+ DFG++  + +            +   GT +++ P
Sbjct: 141 --IHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK-------RNXFVGTPFWMAP 188
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E            SK D+WS+G+   +   G+ P    H      ++ +N          
Sbjct: 189 EVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---------- 234
Query: 532 ANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            N PT+    S   K F+ +CL      R     L +H ++
Sbjct: 235 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 27/237 (11%)
Query: 351 PRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSAL 405
           P +V + DV+E           ++E  +G +L   +++   +   EREA  I+  + +A+
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++L+     + H D+KP N+L T       +K+TDFG +K         +   +      
Sbjct: 123 QFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---------ETTQNALQTPC 171
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
            T +Y+ PE  V+G  P K     D+WS+GVI Y  L G  PF  N  QA        ++
Sbjct: 172 YTPYYVAPE--VLG--PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 227
Query: 526 ATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ-----PPVPKH 575
             +  F N     VS +AK  IR  L     +R+ +     H ++      P  P H
Sbjct: 228 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLH 284

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 32/238 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y  L  +G+G F EV KA   K  + VA     L K   E++K  +   ALRE  I + 
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVA-----LKKVLMENEKEGFPITALREIKILQL 73
Query: 348 LDHPRVVKLYDVFEIDAN-------SFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
           L H  VV L ++    A+       S   V ++C+ HDL   L          E + ++ 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPDHGM 458
            +++ L Y++  K  ++H D+K  N+L+T     G +K+ DFGL++     +N  P+   
Sbjct: 133 MLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 459 DLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
           +       T WY PPE  +  ++  PP     +D+W  G I  + ++ + P     ++
Sbjct: 188 NRVV----TLWYRPPELLLGERDYGPP-----IDLWGAGCIMAE-MWTRSPIMQGNTE 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 38/246 (15%)
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP ++ L DV++ D      V E   G +L   + + K  +EREA +++  +   ++YL+
Sbjct: 75  HPNIITLKDVYD-DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                V+H DLKP NIL  + +   E I+I DFG +K +  EN     G+ +T       
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-----GLLMTP------ 180
Query: 469 WYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
                 C+      P++       +  D+WS+GV+ Y  L G  PF +         E  
Sbjct: 181 ------CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEI 231
Query: 523 ILKATEVQFANKP----TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL----QPPVPK 574
           + +    +F+       +VS+ AK  +   L      R+    + RH ++    Q P  +
Sbjct: 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291
Query: 575 HGRQSA 580
             RQ A
Sbjct: 292 LNRQDA 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D +  + +LGKG F +V  A   +     A KV + +   ++D     ++  + E  I  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD----VECTMTEKRILS 78
Query: 347 -ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
            A +HP + +L+  F+     F  V+E+ +G DL F++++ +   E  AR    +++SAL
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLF-FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            +L++    +I+ DLK  N+LL     C   K+ DFG+ K   E   N   G+  T+   
Sbjct: 138 MFLHD--KGIIYRDLKLDNVLLDHEGHC---KLADFGMCK---EGICN---GVT-TATFC 185
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  Y+ PE        P     VD W++GV+ Y+ L G  PF
Sbjct: 186 GTPDYIAPEILQEMLYGP----AVDWWAMGVLLYEMLCGHAPF 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D++  +  LG G F  V      +   + A K+  L+K  ++  K   I+H L E  I +
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDK--QKVVKLKQIEHTLNEKRILQ 96
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           A++ P +VKL   F+ ++N +  V+EY  G ++  +L++    +E  AR    Q+V   +
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ +   +I+ DLKP N+L+ +    G I++TDFG +K +    +             G
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWXL----------CG 200
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
           T   L PE  ++ K   K    VD W++GV+ Y+   G  PF  +Q
Sbjct: 201 TPEALAPEI-ILSKGYNK---AVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  +R +   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPN 84
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           ++ L  V    +     V EY +   LD +LK++      + +  V+Q+V       + +
Sbjct: 85  IIHLEGVVT-KSKPVMIVTEYMENGSLDTFLKKN------DGQFTVIQLVGMLRGISAGM 137
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGLS+V+++   +P+     T  G 
Sbjct: 138 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLSRVLED---DPEAAYT-TRGGK 188
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 189 IPIRWTAPEAIAF----RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      +  +R +   +  L   + + ++ ++    L E +I    DHP 
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF----LSEASIMGQFDHPN 91
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           ++ L  V          + EY +   LD +L+++      + R  V+Q+V       S +
Sbjct: 92  IIHLEGVVT-KCKPVMIITEYMENGSLDAFLRKN------DGRFTVIQLVGMLRGIGSGM 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFG+S+V+++   +P+     T  G 
Sbjct: 145 KYLSDMS--AVHRDLAARNILVNSNLVC---KVSDFGMSRVLED---DPEAAYT-TRGGK 195
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 196 IPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 244

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 31/238 (13%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYN 343
           + RY  +  +G G +  V+KA D     +VA K  ++  + +E    + ++    LR   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGEEGLPISTVREVALLRRL- 60
Query: 344 IHKALDHPRVVKLYDVFEIDANS----FCTVLEYCDGHDLDFYLKQHKT--IAEREARSI 397
             +A +HP VV+L DV              V E+ D  DL  YL +     +     + +
Sbjct: 61  --EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 117
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + Q +  L +L+     ++H DLKP NIL+T G   G +K+ DFGL+++         + 
Sbjct: 118 MRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GTVKLADFGLARIY-------SYQ 165
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           M L      T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S+A
Sbjct: 166 MALAPV-VVTLWYRAPEVLLQS----TYATPVDMWSVGCIFAE-MFRRKPLFCGNSEA 217

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+ D  DL  ++       I     +S + Q++  L + +  +
Sbjct: 69  KLLDVIHTE-NKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 127 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 174
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 43/281 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   E +         +E  +    D P V 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPYVT 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  +  D      ++EY  G   LD  L +   + E +  +I+ +++  L YL+  K 
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    GE+K+ DFG++  + +            +   GT +++ P
Sbjct: 126 --IHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK-------RNXFVGTPFWMAP 173
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E            SK D+WS+G+   +   G+ P    H      ++ +N          
Sbjct: 174 EVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---------- 219
Query: 532 ANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            N PT+    S   K F+ +CL      R     L +H ++
Sbjct: 220 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 43/281 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   E +         +E  +    D P V 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPYVT 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  +  D      ++EY  G   LD  L +   + E +  +I+ +++  L YL+  K 
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    GE+K+ DFG++  + +            +   GT +++ P
Sbjct: 126 --IHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAP 173
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E            SK D+WS+G+   +   G+ P    H      ++ +N          
Sbjct: 174 EVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---------- 219
Query: 532 ANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            N PT+    S   K F+ +CL      R     L +H ++
Sbjct: 220 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 43/281 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   E +         +E  +    D P V 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPYVT 88
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  +  D   +  ++EY  G   LD  L +   + E +  +I+ +++  L YL+  K 
Sbjct: 89  KYYGSYLKDTKLWI-IMEYLGGGSALD--LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    GE+K+ DFG++  + +            +   GT +++ P
Sbjct: 146 --IHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAP 193
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG--HNQSQATILEENTILKATEVQF 531
           E            SK D+WS+G+   +   G+ P    H      ++ +N          
Sbjct: 194 EVI----KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN---------- 239
Query: 532 ANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            N PT+    S   K F+ +CL      R     L +H ++
Sbjct: 240 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKP 413
           KL DV   + N    V E+      DF      T I     +S + Q++  L + +  + 
Sbjct: 69  KLLDVIHTE-NKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 126
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  P
Sbjct: 127 -VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRAP 175
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 176 EILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYXQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTXDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTXDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 74
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 182
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 183 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      +  +R +   +  L   + + ++ ++    L E +I    DHP 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF----LSEASIMGQFDHPN 76
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           ++ L  V          + EY +   LD +L+++      + R  V+Q+V       S +
Sbjct: 77  IIHLEGVVT-KCKPVMIITEYMENGSLDAFLRKN------DGRFTVIQLVGMLRGIGSGM 129
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFG+S+V++++   P+     T  G 
Sbjct: 130 KYLSDMS--YVHRDLAARNILVNSNLVC---KVSDFGMSRVLEDD---PEAAYT-TRGGK 180
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 181 IPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 67
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKP 413
           KL DV   + N    V E+      DF      T I     +S + Q++  L + +  + 
Sbjct: 68  KLLDVIHTE-NKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 125
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  P
Sbjct: 126 -VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRAP 174
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 EILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPF-------EHQTYCQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 77
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 136 GLKYIHSAN--VLHRDLKPSNLLL---NTTXDLKIXDFGLARVAD-----PDHDHTGFLT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 186 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 38/289 (13%)
Query: 270 RIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED 329
           R+H ED             + +L ++G+G F EV         +  A K+  LNK W+  
Sbjct: 70  RLHRED-------------FEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNK-WEML 113
Query: 330 KKANYIKHALRE-YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT 388
           K+A       RE  ++    D   +  L+  F+ D N +  +  Y  G  L    K    
Sbjct: 114 KRAE--TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR 171
Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG-LSKVM 447
           + E  AR  + ++V A+  ++++    +H D+KP NIL+   ++ G I++ DFG   K+M
Sbjct: 172 LPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226
Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPKISSKVDVWSVGVIFYQCLYGKK 506
           ++       G   +S   GT  Y+ PE    +     +   + D WS+GV  Y+ LYG+ 
Sbjct: 227 ED-------GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 507 PFGHNQSQATILEENTILKATE-VQFANKPT-VSNEAKGFIRSCLAYRK 553
           PF    +++ +     I+   E  QF  + T VS  AK  IR  +  R+
Sbjct: 280 PF---YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSRE 325

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 131/307 (42%), Gaps = 46/307 (14%)
Query: 275 DQSRFNNHPV-LSD-RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA 332
           DQS F    V L + R  +  +L +GGF+ V++A D+   R  A K  +L  + +E  +A
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRA 71
Query: 333 NYIKHALREYNIHKALD-HPRVVKLYDVFEIDANS-------FCTVLEYCDGHDLDFY-- 382
                 ++E    K L  HP +V+      I           F  + E C G  ++F   
Sbjct: 72  -----IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK 126
Query: 383 LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
           ++    ++      I  Q   A+++++  KPP+IH DLK  N+LL+     G IK+ DFG
Sbjct: 127 MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFG 183
Query: 443 LSKVMDEENYNPDHGMDLTSQGA--------GTYWYLPPECFVVGKNPPKISSKVDVWSV 494
            +  +   ++ PD+      +           T  Y  PE   +  N P I  K D+W++
Sbjct: 184 SATTI---SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWAL 239
Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYR 552
           G I Y   + + PF          E+   L+    +++  P  T        IR+ L   
Sbjct: 240 GCILYLLCFRQHPF----------EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 553 KEDRIDV 559
            E+R+ +
Sbjct: 290 PEERLSI 296

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 81
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 189
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 190 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 82
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 140
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 141 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 190
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 191 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 73
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 131
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 132 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 181
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 182 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 74
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 182
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 183 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 77
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 136 GLKYIHSAN--VLHRDLKPSNLLL---NTTXDLKICDFGLARVAD-----PDHDHTGFLT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 186 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 79
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 138 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 187
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 188 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 341 EYNIHKALDHPRVVKLYD-VFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREAR 395
           E N+ + L HP +V+ YD + +    +   V+EYC+G DL   +    K+ + + E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 396 SIVMQVVSALKYLNEIKP---PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
            ++ Q+  ALK  +        V+H DLKP N+ L        +K+ DFGL++++     
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARIL----- 166
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +H         GT +Y+ PE      N    + K D+WS+G + Y+      PF
Sbjct: 167 --NHDTSFAKTFVGTPYYMSPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 46/262 (17%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           + +LG+G F +V KA +  + RY A K     K    ++K + I   L E  +  +L+H 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTI---LSEVMLLASLNHQ 62
Query: 352 RVVKLYDVFEIDAN------------SFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIV 398
            VV+ Y  +    N            +    +EYC+   L D    ++      E   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK---------VMDE 449
            Q++ AL Y++     +IH DLKP NI + E      +KI DFGL+K          +D 
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDS 177
Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
           +N  P    +LTS   GT  Y+  E           + K+D++S+G+IF++ +Y   PF 
Sbjct: 178 QNL-PGSSDNLTS-AIGTAMYVATEVL---DGTGHYNEKIDMYSLGIIFFEMIY---PFS 229
Query: 510 HNQSQATILEENTILKATEVQF 531
               +  IL++   L++  ++F
Sbjct: 230 TGMERVNILKK---LRSVSIEF 248

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 341 EYNIHKALDHPRVVKLYD-VFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREAR 395
           E N+ + L HP +V+ YD + +    +   V+EYC+G DL   +    K+ + + E    
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 396 SIVMQVVSALKYLNEIKP---PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
            ++ Q+  ALK  +        V+H DLKP N+ L        +K+ DFGL++++     
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ---NVKLGDFGLARIL----- 166
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +H         GT +Y+ PE      N    + K D+WS+G + Y+      PF
Sbjct: 167 --NHDTSFAKAFVGTPYYMSPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 77
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 136 GLKYIHSAN--VLHRDLKPSNLLL---NTTXDLKICDFGLARVAD-----PDHDHTGFLT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 186 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 85
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 143
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 144 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 193
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 194 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 77
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 136 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 186 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      +  +R +   +  L   + + ++ ++    L E +I    DHP 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF----LSEASIMGQFDHPN 70
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------SAL 405
           ++ L  V          + EY +   LD +L+++      + R  V+Q+V       S +
Sbjct: 71  IIHLEGVVT-KCKPVMIITEYMENGSLDAFLRKN------DGRFTVIQLVGMLRGIGSGM 123
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFG+S+V++++   P+     T  G 
Sbjct: 124 KYLSDMS--YVHRDLAARNILVNSNLVC---KVSDFGMSRVLEDD---PEAAYT-TRGGK 174
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
               +  PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 175 IPIRWTAPEAIAY----RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 77
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 136 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 185
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 186 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 XEXVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 26/226 (11%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I   
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLR 97
Query: 348 LDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVVS 403
             H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++ 
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILR 155
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLTS 462
            LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      +
Sbjct: 156 GLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFLT 205
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 206 EYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 81
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 189
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            +   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 190 XEXVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV      L  +R +   +  L   + E ++ ++    L E +I    DHP 
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDF----LSEASIMGQFDHPN 69
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           V+ L  V    +     + E+ +   LD +L+Q+       +   ++  + + +KYL ++
Sbjct: 70  VIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H  L   NIL+    VC   K++DFGLS+ ++++  +P +   L   G     + 
Sbjct: 129 N--YVHRALAARNILVNSNLVC---KVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWT 181
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
            PE         K +S  DVWS G++ ++ + YG++P+    +Q  I
Sbjct: 182 APEAI----QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           RY  L  +G+G +  V  A+D L + R    K+          +   Y +  LRE  I  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILL 80
Query: 347 ALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
              H  ++ + D+     I+      +++  D  + D Y L + + ++       + Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQ--DLMETDLYKLLKCQHLSNDHICYFLYQIL 138
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG-MDLT 461
             LKY++     V+H DLKP N+LL   N   ++KI DFGL++V D     PDH      
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLL---NTTCDLKICDFGLARVAD-----PDHDHTGFL 188
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           ++   T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 189 TEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G F EV KA   K  + VA     L K   E++K  +   ALRE  I + L H  VV
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVA-----LKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 355 KLYDVFEIDAN-------SFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALK 406
            L ++    A+       S   V ++C+ HDL   L          E + ++  +++ L 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPDHGMDLTSQGA 465
           Y++  K  ++H D+K  N+L+T     G +K+ DFGL++     +N  P+   +      
Sbjct: 139 YIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYXNRVV--- 190
Query: 466 GTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
            T WY PPE  +  ++  PP     +D+W  G I  + ++ + P     ++
Sbjct: 191 -TLWYRPPELLLGERDYGPP-----IDLWGAGCIMAE-MWTRSPIMQGNTE 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 32/238 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y  L  +G+G F EV KA   K  + VA     L K   E++K  +   ALRE  I + 
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVA-----LKKVLMENEKEGFPITALREIKILQL 73
Query: 348 LDHPRVVKLYDVFEIDAN-------SFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
           L H  VV L ++    A+       S   V ++C+ HDL   L          E + ++ 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPDHGM 458
            +++ L Y++  K  ++H D+K  N+L+T     G +K+ DFGL++     +N  P+   
Sbjct: 133 MLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 459 DLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
           +       T WY PPE  +  ++  PP     +D+W  G I  + ++ + P     ++
Sbjct: 188 NRVV----TLWYRPPELLLGERDYGPP-----IDLWGAGCIMAE-MWTRSPIMQGNTE 235

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 32/238 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y  L  +G+G F EV KA   K  + VA     L K   E++K  +   ALRE  I + 
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVA-----LKKVLMENEKEGFPITALREIKILQL 73
Query: 348 LDHPRVVKLYDVFEIDAN-------SFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
           L H  VV L ++    A+       S   V ++C+ HDL   L          E + ++ 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD-EENYNPDHGM 458
            +++ L Y++  K  ++H D+K  N+L+T     G +K+ DFGL++     +N  P+   
Sbjct: 133 MLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 459 DLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
           +       T WY PPE  +  ++  PP     +D+W  G I  + ++ + P     ++
Sbjct: 188 NRVV----TLWYRPPELLLGERDYGPP-----IDLWGAGCIMAE-MWTRSPIMQGNTE 235

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKP 413
           KL DV   + N    V E+      DF      T I     +S + Q++  L + +  + 
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  P
Sbjct: 124 -VLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRAP 172
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           E  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 EILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 31/238 (13%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYN 343
           + RY  +  +G G +  V+KA D     +VA K  ++  + +E    + ++    LR   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGEEGLPISTVREVALLRRL- 60
Query: 344 IHKALDHPRVVKLYDVFEIDANS----FCTVLEYCDGHDLDFYLKQHKT--IAEREARSI 397
             +A +HP VV+L DV              V E+ D  DL  YL +     +     + +
Sbjct: 61  --EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 117
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + Q +  L +L+     ++H DLKP NIL+T G   G +K+ DFGL+++         + 
Sbjct: 118 MRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GTVKLADFGLARIY-------SYQ 165
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA 515
           M L      T WY  PE  +        ++ VD+WSVG IF + ++ +KP     S+A
Sbjct: 166 MALFPV-VVTLWYRAPEVLLQS----TYATPVDMWSVGCIFAE-MFRRKPLFCGNSEA 217

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+ K I E     +
Sbjct: 62  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +        
Sbjct: 120 SIAVLRGLAYLRE-KHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-------- 167
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             + +   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 168 -SMANSFVGTRSYMAPERL----QGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 46/262 (17%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           + +LG+G F +V KA +  + RY A K     K    ++K + I   L E  +  +L+H 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTI---LSEVMLLASLNHQ 62
Query: 352 RVVKLYDVFEIDAN------------SFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIV 398
            VV+ Y  +    N            +    +EYC+   L D    ++      E   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK---------VMDE 449
            Q++ AL Y++     +IH DLKP NI + E      +KI DFGL+K          +D 
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDS 177
Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
           +N  P    +LTS   GT  Y+  E           + K+D++S+G+IF++ +Y   PF 
Sbjct: 178 QNL-PGSSDNLTS-AIGTAMYVATEVL---DGTGHYNEKIDMYSLGIIFFEMIY---PFS 229
Query: 510 HNQSQATILEENTILKATEVQF 531
               +  IL++   L++  ++F
Sbjct: 230 TGMERVNILKK---LRSVSIEF 248

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK-HALREYNIHKALDHPR 352
           +LG+G  + V    +L   +  A K+ +        K+  +I+    RE  +       R
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE--------KQPGHIRSRVFREVEMLYQCQGHR 71
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
            V     F  + + F  V E   G  +  ++ + +   E EA  +V  V SAL +L+   
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH--N 129
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGL-SKVMDEENYNPDHGMDLTSQGAGTYWYL 471
             + H DLKP NIL    N    +KI DFGL S +    + +P    +L +   G+  Y+
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP-CGSAEYM 188
Query: 472 PPECFVVGKNPPKISSK-VDVWSVGVIFYQCLYGKKPF--------GHNQSQATILEENT 522
            PE          I  K  D+WS+GVI Y  L G  PF        G ++ +A    +N 
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 523 ILKATE---VQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           + ++ +    +F +K    +S  AK  I   L    + R+    + +H ++Q   P++
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP ++ L DV++ D      V E   G +L   + + K  +EREA +++  +   ++YL+
Sbjct: 75  HPNIITLKDVYD-DGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                V+H DLKP NIL  + +   E I+I DFG +K +  EN     G+          
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-----GL---------- 176
Query: 469 WYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
             L   C+      P++       +  D+WS+GV+ Y  L G  PF +         E  
Sbjct: 177 --LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDT---PEEI 231
Query: 523 ILKATEVQFANKP----TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL----QPPVPK 574
           + +    +F+       +VS+ AK  +   L      R+    + RH ++    Q P  +
Sbjct: 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291
Query: 575 HGRQSA 580
             RQ A
Sbjct: 292 LNRQDA 297

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 69  KLLDVIHTE-NKLYLVFEFLH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 127 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYRA 174
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 142/329 (43%), Gaps = 44/329 (13%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            N H  ++D + +  ++G+GGF EV+        +  A K   L+K   + K+   +  A
Sbjct: 181 LNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--A 235
Query: 339 LRE---YNIHKALDHPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
           L E    ++    D P +V +   F   D  SF  +L+  +G DL ++L QH   +E + 
Sbjct: 236 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEADM 293
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           R    +++  L++++     V++ DLKP NILL E    G ++I+D GL+          
Sbjct: 294 RFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH---GHVRISDLGLA---------C 339
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           D          GT+ Y+ PE    G       S  D +S+G + ++ L G  PF  H   
Sbjct: 340 DFSKKKPHASVGTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 396
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGFIR-------SCLAYRKED--------RID 558
               ++  T+  A E+  +  P + +  +G ++        CL    ++         +D
Sbjct: 397 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 456
Query: 559 VISLARHDYLQPPVPKHGRQSASSSAPVG 587
              +    Y  P +P  G  +A+ +  +G
Sbjct: 457 WQMVFLQKYPPPLIPPRGEVNAADAFDIG 485

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 142/329 (43%), Gaps = 44/329 (13%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            N H  ++D + +  ++G+GGF EV+        +  A K   L+K   + K+   +  A
Sbjct: 182 LNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--A 236
Query: 339 LRE---YNIHKALDHPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
           L E    ++    D P +V +   F   D  SF  +L+  +G DL ++L QH   +E + 
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           R    +++  L++++     V++ DLKP NILL E    G ++I+D GL+          
Sbjct: 295 RFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH---GHVRISDLGLA---------C 340
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           D          GT+ Y+ PE    G       S  D +S+G + ++ L G  PF  H   
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGFIR-------SCLAYRKED--------RID 558
               ++  T+  A E+  +  P + +  +G ++        CL    ++         +D
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
Query: 559 VISLARHDYLQPPVPKHGRQSASSSAPVG 587
              +    Y  P +P  G  +A+ +  +G
Sbjct: 458 WQMVFLQKYPPPLIPPRGEVNAADAFDIG 486

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 73  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 131 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 178
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 179 PEILLGXKY---YSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 69
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 70  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 128 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 175
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 176 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 26/281 (9%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
               PV  + +    +LGKGGF EV         +  ACK  +  +  K   +A     A
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA----MA 231
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI- 397
           L E  I + ++   VV L   +E   ++ C VL   +G DL F++         EAR++ 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 398 -VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              ++   L+ L+  +  +++ DLKP NILL +    G I+I+D GL+  + E       
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH---GHIRISDLGLAVHVPE------- 338
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           G  +  +  GT  Y+ PE   V KN  + +   D W++G + Y+ + G+ PF   + +  
Sbjct: 339 GQTIKGR-VGTVGYMAPE---VVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393
Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
             E   ++K    +++ +   S +A+      L     +R+
Sbjct: 394 REEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERL 432

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGXKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 142/329 (43%), Gaps = 44/329 (13%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            N H  ++D + +  ++G+GGF EV+        +  A K   L+K   + K+   +  A
Sbjct: 182 LNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--A 236
Query: 339 LRE---YNIHKALDHPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
           L E    ++    D P +V +   F   D  SF  +L+  +G DL ++L QH   +E + 
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           R    +++  L++++     V++ DLKP NILL E    G ++I+D GL+          
Sbjct: 295 RFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH---GHVRISDLGLA---------C 340
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           D          GT+ Y+ PE    G       S  D +S+G + ++ L G  PF  H   
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGFIR-------SCLAYRKED--------RID 558
               ++  T+  A E+  +  P + +  +G ++        CL    ++         +D
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
Query: 559 VISLARHDYLQPPVPKHGRQSASSSAPVG 587
              +    Y  P +P  G  +A+ +  +G
Sbjct: 458 WQMVFLQKYPPPLIPPRGEVNAADAFDIG 486

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/329 (24%), Positives = 142/329 (43%), Gaps = 44/329 (13%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            N H  ++D + +  ++G+GGF EV+        +  A K   L+K   + K+   +  A
Sbjct: 182 LNIHLTMND-FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETL--A 236
Query: 339 LRE---YNIHKALDHPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
           L E    ++    D P +V +   F   D  SF  +L+  +G DL ++L QH   +E + 
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           R    +++  L++++     V++ DLKP NILL E    G ++I+D GL+          
Sbjct: 295 RFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEH---GHVRISDLGLA---------C 340
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           D          GT+ Y+ PE    G       S  D +S+G + ++ L G  PF  H   
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGFIR-------SCLAYRKED--------RID 558
               ++  T+  A E+  +  P + +  +G ++        CL    ++         +D
Sbjct: 398 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
Query: 559 VISLARHDYLQPPVPKHGRQSASSSAPVG 587
              +    Y  P +P  G  +A+ +  +G
Sbjct: 458 WQMVFLQKYPPPLIPPRGEVNAADAFDIG 486

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 56/300 (18%)
Query: 295 LGKGGFSEVHKAFD---LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +G+G F  V +A     L  + +    V  L ++   D +A++     RE  +    D+P
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEFDNP 110
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ----------HKTIAER--------- 392
            +VKL  V  +     C + EY    DL+ +L+           H  ++ R         
Sbjct: 111 NIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 393 -----EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
                E   I  QV + + YL+E K   +H DL   N L+ E  V   +KI DFGLS+ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMV---VKIADFGLSRNI 224
Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKK 506
              +Y    G D     A    ++PPE         + +++ DVW+ GV+ ++   YG +
Sbjct: 225 YSADYYKADGND-----AIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 507 PFGHNQSQATI--LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR 564
           P+     +  I  + +  IL   E    N P    E    +R C +    DR    S+ R
Sbjct: 276 PYYGMAHEEVIYYVRDGNILACPE----NCPL---ELYNLMRLCWSKLPADRPSFCSIHR 328

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 67  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 125 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 172
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 69  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 127 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYRA 174
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 73  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 130
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 131 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRA 178
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 179 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 67
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 68  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 126 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 173
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 174 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 40/285 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA +   L +  K++   N I   +RE        +P +V
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK------NPNIV 80
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 81  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  NILL    + G +K+TDFG    +  E           S+  GT +++ PE
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSEMVGTPYWMAPE 186
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 187 VVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALYLIATNGT 233
Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 69  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 127 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 174
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 67
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 68  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 126 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 173
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 174 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEHVH-QDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 67  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 125 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 172
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 69
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 70  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 127
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 128 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYRA 175
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 176 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 67
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 68  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 126 --VLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 173
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 174 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 67  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 125 --VLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 172
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 114 IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 171
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +   N    
Sbjct: 172 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---- 223
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 224 -----SFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 68
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 69  KLLDVIHTE-NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 127 --VLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 174
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 175 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 26/281 (9%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
               PV  + +    +LGKGGF EV         +  ACK  +  +  K   +A     A
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA----MA 231
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSI- 397
           L E  I + ++   VV L   +E   ++ C VL   +G DL F++         EAR++ 
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 398 -VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              ++   L+ L+  +  +++ DLKP NILL +    G I+I+D GL+  + E       
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLDDH---GHIRISDLGLAVHVPE------- 338
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           G  +  +  GT  Y+ PE   V KN  + +   D W++G + Y+ + G+ PF   + +  
Sbjct: 339 GQTIKGR-VGTVGYMAPE---VVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393
Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
             E   ++K    +++ +   S +A+      L     +R+
Sbjct: 394 REEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERL 432

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 67  KLLDVIHTE-NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 125 --VLHRDLKPENLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 172
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G+G F  V KA    + R     + Q+  +   ++KA  ++  LR+ +    ++HP +
Sbjct: 16  VVGRGAFGVVCKA----KWRAKDVAIKQIESE--SERKAFIVE--LRQLS---RVNHPNI 64
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI---AEREARSIVMQVVSALKYLNE 410
           VKLY       N  C V+EY +G  L   L   + +       A S  +Q    + YL+ 
Sbjct: 65  VKLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 411 IKP-PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           ++P  +IH DLKP N+LL  G     +KI DFG +          D    +T+      W
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTAC---------DIQTHMTNNKGSAAW 170
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            + PE F  G N    S K DV+S G+I ++ +  +KPF
Sbjct: 171 -MAPEVFE-GSN---YSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA +   L +  K++   N I   +RE        +P +V
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK------NPNIV 81
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 82  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  NILL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 138 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSXMVGTPYWMAPE 187
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 188 VVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALYLIATNGT 234
Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 235 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 136
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +        
Sbjct: 137 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-------- 184
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             + +   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 185 -SMANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA +   L +  K++   N I   +RE        +P +V
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK------NPNIV 80
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 81  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  NILL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSXMVGTPYWMAPE 186
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 187 VVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALYLIATNGT 233
Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA +      VA K  +L+ +            A+RE ++ K L+HP +V
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIV 66
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 67  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 125 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYXHEV-------VTLWYRA 172
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 173 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 101/237 (42%), Gaps = 31/237 (13%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +Y L+  LGKG +  V K+ D +    VA K     K +   + +   +   RE  I   
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMILTE 64
Query: 348 LD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSAL 405
           L  H  +V L +V   D +    V    D  + D +      I E    + +V Q++  +
Sbjct: 65  LSGHENIVNLLNVLRADNDR--DVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV--------------MDEEN 451
           KYL+     ++H D+KP NILL   N    +K+ DFGLS+               ++E  
Sbjct: 123 KYLHS--GGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            N D    + +    T WY  PE  +      K +  +D+WS+G I  + L GK  F
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILL---GSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G+G F  V KA    + R     + Q+  +   ++KA  ++  LR+ +    ++HP +
Sbjct: 15  VVGRGAFGVVCKA----KWRAKDVAIKQIESE--SERKAFIVE--LRQLS---RVNHPNI 63
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI---AEREARSIVMQVVSALKYLNE 410
           VKLY       N  C V+EY +G  L   L   + +       A S  +Q    + YL+ 
Sbjct: 64  VKLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 411 IKP-PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           ++P  +IH DLKP N+LL  G     +KI DFG +          D    +T+      W
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTAC---------DIQTHMTNNKGSAAW 169
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            + PE F  G N    S K DV+S G+I ++ +  +KPF
Sbjct: 170 -MAPEVFE-GSN---YSEKCDVFSWGIILWEVITRRKPF 203

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA +   L +  K++   N I   +RE        +P +V
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK------NPNIV 80
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 81  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  NILL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPE 186
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 187 VVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALYLIATNGT 233
Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 45/263 (17%)
Query: 288 RYLL----LMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           RYL     +  LG+GGF  V +A + + +  Y   ++   N++   +K        +RE 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-------VMREV 54
Query: 343 NIHKALDHPRVVKLYDVFEIDANS------------FCTVLEYCDGHDLDFYLKQHKTIA 390
                L+HP +V+ ++ + ++ N+                ++ C   +L  ++    TI 
Sbjct: 55  KALAKLEHPGIVRYFNAW-LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 391 ERE---ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
           ERE      I +Q+  A+++L+     ++H DLKP NI  T  +V   +K+ DFGL   M
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAM 168
Query: 448 DEEN-----YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           D++        P       +   GT  Y+ PE  + G +    S KVD++S+G+I ++ L
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ-IHGNS---YSHKVDIFSLGLILFELL 224
Query: 503 YGKKPFGHNQSQATILEENTILK 525
           Y   PF     +   L +   LK
Sbjct: 225 Y---PFSTQMERVRTLTDVRNLK 244

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--------- 388
           A RE  + + L HP V+ L  VF   A+    +L     HDL   +K H+          
Sbjct: 65  ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL-LTEGNVCGEIKITDFGLSKVM 447
           +     +S++ Q++  + YL+     V+H DLKP NIL + EG   G +KI D G +++ 
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           +    +P   +        T+WY  PE  +  ++    +  +D+W++G IF + L  +  
Sbjct: 183 N----SPLKPLADLDPVVVTFWYRAPELLLGARH---YTKAIDIWAIGCIFAELLTSEPI 235
Query: 508 F 508
           F
Sbjct: 236 F 236

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 114/244 (46%), Gaps = 51/244 (20%)
Query: 295 LGKGGFSEVHKA--FDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V KA  F LK +  Y    V  L    KE+   + ++  L E+N+ K ++HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFNVLKQVNHP 86
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-------------------ER 392
            V+KLY     D      ++EY     L  +L++ + +                    ER
Sbjct: 87  HVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 393 -----EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-V 446
                +  S   Q+   ++YL E+K  ++H DL   NIL+ EG    ++KI+DFGLS+ V
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR---KMKISDFGLSRDV 200
Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YG 504
            +E++Y         SQG      +P +   +      I +++ DVWS GV+ ++ +  G
Sbjct: 201 YEEDSYVK------RSQGR-----IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 505 KKPF 508
             P+
Sbjct: 250 GNPY 253

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D Y ++  +G G +  V  A     +R +  +   + K           K  LRE  I
Sbjct: 52  VGDEYEIIETIGNGAYGVVSSA-----RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 106
Query: 345 HKALDHPRVVKLYDVFE--IDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQ 400
            K   H  ++ + D+    +    F +V    D  + D +   H +  +     R  + Q
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  LKY++  +  VIH DLKP N+L+ E   C E+KI DFG+++ +     +P      
Sbjct: 167 LLRGLKYMHSAQ--VIHRDLKPSNLLVNEN--C-ELKIGDFGMARGL---CTSPAEHQYF 218
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++   T WY  PE  +   +  + +  +D+WSVG IF + L  ++ F
Sbjct: 219 MTEYVATRWYRAPELML---SLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 49/243 (20%)
Query: 295 LGKGGFSEVHKA--FDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V KA  F LK +  Y    V  L    KE+   + ++  L E+N+ K ++HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFNVLKQVNHP 86
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-------------------ER 392
            V+KLY     D      ++EY     L  +L++ + +                    ER
Sbjct: 87  HVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 393 -----EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
                +  S   Q+   ++YL E+K  ++H DL   NIL+ EG    ++KI+DFGLS+ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR---KMKISDFGLSRDV 200
Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YGK 505
            EE+          SQG      +P +   +      I +++ DVWS GV+ ++ +  G 
Sbjct: 201 YEEDSXVKR-----SQGR-----IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250
Query: 506 KPF 508
            P+
Sbjct: 251 NPY 253

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +   N    
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---- 161
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 162 -----SFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D Y ++  +G G +  V  A     +R +  +   + K           K  LRE  I
Sbjct: 53  VGDEYEIIETIGNGAYGVVSSA-----RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKI 107
Query: 345 HKALDHPRVVKLYDVFE--IDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQ 400
            K   H  ++ + D+    +    F +V    D  + D +   H +  +     R  + Q
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  LKY++  +  VIH DLKP N+L+ E   C E+KI DFG+++ +     +P      
Sbjct: 168 LLRGLKYMHSAQ--VIHRDLKPSNLLVNEN--C-ELKIGDFGMARGL---CTSPAEHQYF 219
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            ++   T WY  PE  +      + +  +D+WSVG IF + L  ++ F
Sbjct: 220 MTEYVATRWYRAPELMLSLH---EYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +   N    
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMAN---- 161
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 162 -----SFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA     +  +  +V  L K   + +       A+RE ++ K L+HP +V
Sbjct: 11  IGEGTYGVVYKA-----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 66  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 124 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 171
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 172 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G +  V+KA     +  +  +V  L K   + +       A+RE ++ K L+HP +V
Sbjct: 10  IGEGTYGVVYKA-----RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIK 412
           KL DV   + N    V E+    DL  ++       I     +S + Q++  L + +  +
Sbjct: 65  KLLDVIHTE-NKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             V+H DLKP N+L+   N  G IK+ DFGL++          H +        T WY  
Sbjct: 123 --VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEV-------VTLWYRA 170
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  +  K     S+ VD+WS+G IF + +  +  F
Sbjct: 171 PEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 444 ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLIL 495
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  N C  +K+ DFGLS+ M++  Y    
Sbjct: 496 YAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDC--VKLGDFGLSRYMEDSTYYK-- 548
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 549 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 29/290 (10%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           L  +YL+  LLG+G + +V +  D +   R     + +       + +AN  K    E  
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK----EIQ 58
Query: 344 IHKALDHPRVVKLYDV-FEIDANSFCTVLEYC-DGHDLDFYLKQHKTIAEREARSIVMQV 401
           + + L H  V++L DV +  +      V+EYC  G          K     +A     Q+
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  L+YL+     ++H D+KPGN+LLT G   G +KI+  G++     E  +P    D  
Sbjct: 119 IDGLEYLHSQG--IVHKDIKPGNLLLTTG---GTLKISALGVA-----EALHPFAADDTC 168
Query: 462 SQGAGTYWYLPPECFVVGKNPPKISS-KVDVWSVGVIFYQCLYGKKPF-GHNQSQATILE 519
               G+  + PPE   +       S  KVD+WS GV  Y    G  PF G N  +   L 
Sbjct: 169 RTSQGSPAFQPPE---IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LF 222
Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           EN    +  +     P +S+  KG     L Y    R  +  + +H + +
Sbjct: 223 ENIGKGSYAIPGDCGPPLSDLLKGM----LEYEPAKRFSIRQIRQHSWFR 268

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 107/254 (42%), Gaps = 29/254 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH+A        VA K+       ++D  A  +   LRE  I K L HP +V
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILM-----EQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-----EREARSIVMQVVSALKYLN 409
                     N    V EY     L  Y   HK+ A     ER   S+   V   + YL+
Sbjct: 98  LFMGAVTQPPN-LSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
              PP++H DLK  N+L+ +      +K+ DFGLS++              +   AGT  
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGLSRLKASXFLX-------SKXAAGTPE 204
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           ++ PE   V ++ P  + K DV+S GVI ++    ++P+G+      +       K  E+
Sbjct: 205 WMAPE---VLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 530 QFANKPTVSNEAKG 543
                P V+   +G
Sbjct: 261 PRNLNPQVAAIIEG 274

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +        
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-------- 157
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             + +   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 158 -SMANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSI 397
           +RE  +    + P +V  Y  F  D   S C  +E+ DG  LD  LK+   I E+    +
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISIC--MEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            + V+  L YL E K  ++H D+KP NIL+   N  GEIK+ DFG+S  + +        
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-------- 157
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             + +   GT  Y+ PE           S + D+WS+G+   +   G+ P 
Sbjct: 158 -SMANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 67  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 118
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  N C  +K+ DFGLS+ M++  Y    
Sbjct: 119 YAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDC--VKLGDFGLSRYMEDSTYYK-- 171
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 172 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
           + K+ D P +V+ +  F  + + F   +E           +    I ER    + + +V 
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENYNPDHGMDLTS 462
           AL YL E K  VIH D+KP NILL E    G+IK+ DFG+S +++D++  +         
Sbjct: 136 ALYYLKE-KHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDKAKD--------- 182
Query: 463 QGAGTYWYLPPECFVVGKNPPKISS-----KVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
           + AG   Y+ PE      +PP  +      + DVWS+G+   +   G+ P+ + ++   +
Sbjct: 183 RSAGCAAYMAPERI----DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           L +  +L+            S + + F++ CL      R     L  H +++
Sbjct: 239 LTK--VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 66  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 117
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  N C  +K+ DFGLS+ M++  Y    
Sbjct: 118 YAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDC--VKLGDFGLSRYMEDSTYYK-- 170
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 171 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV+     K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 91
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V  ++   F  V EY    +L  YL++       E  ++V+     Q+ SA++YL 
Sbjct: 92  QLLGVCTLEP-PFYIVTEYMPYGNLLDYLRE---CNREEVTAVVLLYMATQISSAMEYLE 147
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E +V   +K+ DFGLS++M  + Y    G     +      
Sbjct: 148 --KKNFIHRDLAARNCLVGENHV---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 196
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQAT-ILEENTILKA 526
           +  PE           S K DVW+ GV+ ++   YG  P+ G + SQ   +LE+   ++ 
Sbjct: 197 WTAPESLAYN----TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQ 252
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E      P V       +R+C  +   DR
Sbjct: 253 PE---GCPPKVYE----LMRACWKWSPADR 275

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 444 ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLIL 495
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 496 YAYQLSTALAYLESKR--FVHRDIAARNVLVSATDC---VKLGDFGLSRYMEDSTYYK-- 548
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 549 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 593

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 69  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 120
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 121 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYK-- 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 174 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK-HALREYNIHKALDHPR 352
           +LG+G  + V    +L   +  A K+ +        K+  +I+    RE  +       R
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE--------KQPGHIRSRVFREVEMLYQCQGHR 71
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
            V     F  + + F  V E   G  +  ++ + +   E EA  +V  V SAL +L+   
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH--N 129
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGL-SKVMDEENYNPDHGMDLTSQGAGTYWYL 471
             + H DLKP NIL    N    +KI DF L S +    + +P    +L +   G+  Y+
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP-CGSAEYM 188
Query: 472 PPECFVVGKNPPKISSK-VDVWSVGVIFYQCLYGKKPF--------GHNQSQATILEENT 522
            PE          I  K  D+WS+GVI Y  L G  PF        G ++ +A    +N 
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 523 ILKATE---VQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           + ++ +    +F +K    +S  AK  I   L    + R+    + +H ++Q   P++
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  ++E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 78  QLLGVCTREP-PFYIIIEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 134 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 182
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 183 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 239 PE-------GCPEKVYELMRACWQWNPSDR 261

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 92  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 143
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 144 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYK-- 196
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 197 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  ++E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIIIEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 61  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 112
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  N C  +K+ DFGLS+ M++  Y    
Sbjct: 113 YAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDC--VKLGDFGLSRYMEDSTYYK-- 165
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 166 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 29/254 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH+A        VA K+       ++D  A  +   LRE  I K L HP +V
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILM-----EQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-----EREARSIVMQVVSALKYLN 409
                     N    V EY     L  Y   HK+ A     ER   S+   V   + YL+
Sbjct: 98  LFMGAVTQPPN-LSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
              PP++H +LK  N+L+ +      +K+ DFGLS++      +       +   AGT  
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLS-------SKSAAGTPE 204
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           ++ PE   V ++ P  + K DV+S GVI ++    ++P+G+      +       K  E+
Sbjct: 205 WMAPE---VLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 530 QFANKPTVSNEAKG 543
                P V+   +G
Sbjct: 261 PRNLNPQVAAIIEG 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 40/285 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V+ A D+   + VA +   L +  K++   N I   +RE        +P +V
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENK------NPNIV 81
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
              D + +  +    V+EY  G  L   + +   + E +  ++  + + AL++L+  +  
Sbjct: 82  NYLDSYLV-GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH ++K  NILL    + G +K+TDFG    +  E           S   GT +++ PE
Sbjct: 138 VIHRNIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK-------RSTMVGTPYWMAPE 187
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
                   PK    VD+WS+G++  + + G+ P+         L EN +     +     
Sbjct: 188 VVTRKAYGPK----VDIWSLGIMAIEMIEGEPPY---------LNENPLRALYLIATNGT 234
Query: 535 PTVSNEAK------GFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           P + N  K       F+  CL    E R     L +H +L+   P
Sbjct: 235 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 64  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 115
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYK-- 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 169 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  ++E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIIIEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 64  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKY--SLDLASLIL 115
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYK-- 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 169 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 25/230 (10%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVAC-KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV +       +  +C  +  L   + E ++  +    L E +I    +HP 
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREF----LSEASIMGQFEHPN 78
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYL 408
           +++L  V   ++     + E+ +   LD +L+    Q   I   +   ++  + S ++YL
Sbjct: 79  IIRLEGVV-TNSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYL 134
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
            E+    +H DL   NIL+    VC   K++DFGLS+ ++E + +P     L   G    
Sbjct: 135 AEMS--YVHRDLAARNILVNSNLVC---KVSDFGLSRFLEENSSDPTETSSLG--GKIPI 187
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
            +  PE         K +S  D WS G++ ++ + +G++P+    +Q  I
Sbjct: 188 RWTAPEAIAFR----KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI 233

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 46/262 (17%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           + +LG+G F +V KA +  + RY A K     K    ++K + I   L E  +  +L+H 
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTI---LSEVXLLASLNHQ 62
Query: 352 RVVKLYDVFEIDAN------------SFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIV 398
            VV+ Y  +    N            +     EYC+   L D    ++      E   + 
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK---------VMDE 449
            Q++ AL Y++     +IH +LKP NI + E      +KI DFGL+K          +D 
Sbjct: 123 RQILEALSYIHS--QGIIHRNLKPXNIFIDESR---NVKIGDFGLAKNVHRSLDILKLDS 177
Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
           +N  P    +LTS   GT  Y+  E           + K+D +S+G+IF++ +Y   PF 
Sbjct: 178 QNL-PGSSDNLTS-AIGTAXYVATEVL---DGTGHYNEKIDXYSLGIIFFEXIY---PFS 229
Query: 510 HNQSQATILEENTILKATEVQF 531
               +  IL++   L++  ++F
Sbjct: 230 TGXERVNILKK---LRSVSIEF 248

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 279
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 280 QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH +L   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 336 --KKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 384
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 385 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 440
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 441 PE-------GCPEKVYELMRACWQWNPSDR 463

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K   L +D  E      ++  L+E  + K + HP +V
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTME------VEEFLKEAAVMKEIKHPNLV 318
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 319 QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH +L   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 375 --KKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 423
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 424 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 479
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 480 PE-------GCPEKVYELMRACWQWNPSDR 502

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 106/230 (46%), Gaps = 25/230 (10%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVAC-KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G G F EV +       +  +C  +  L   + E ++  +    L E +I    +HP 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREF----LSEASIMGQFEHPN 76
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYL 408
           +++L  V   ++     + E+ +   LD +L+    Q   I   +   ++  + S ++YL
Sbjct: 77  IIRLEGVVT-NSMPVMILTEFMENGALDSFLRLNDGQFTVI---QLVGMLRGIASGMRYL 132
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
            E+    +H DL   NIL+    VC   K++DFGLS+ ++E + +P +   L   G    
Sbjct: 133 AEMS--YVHRDLAARNILVNSNLVC---KVSDFGLSRFLEENSSDPTYTSSLG--GKIPI 185
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
            +  PE         K +S  D WS G++ ++ + +G++P+    +Q  I
Sbjct: 186 RWTAPEAIAFR----KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI 231

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 49/243 (20%)
Query: 295 LGKGGFSEVHKA--FDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V KA  F LK +  Y    V  L    KE+   + ++  L E+N+ K ++HP
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFNVLKQVNHP 86
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA-------------------ER 392
            V+KLY     D      ++EY     L  +L++ + +                    ER
Sbjct: 87  HVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 393 -----EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
                +  S   Q+   ++YL E+   ++H DL   NIL+ EG    ++KI+DFGLS+ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAEGR---KMKISDFGLSRDV 200
Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-YGK 505
            EE+          SQG      +P +   +      I +++ DVWS GV+ ++ +  G 
Sbjct: 201 YEEDSXVKR-----SQGR-----IPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250
Query: 506 KPF 508
            P+
Sbjct: 251 NPY 253

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 78  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 134 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 182
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 183 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 239 PE-------GCPEKVYELMRACWQWNPSDR 261

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 64  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLIL 115
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M++  Y    
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSATDC---VKLGDFGLSRYMEDSTYYK-- 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 169 ----ASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 78  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 134 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 182
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 183 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 239 PE-------GCPEKVYELMRACWQWNPSDR 261

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 73
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 74  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 130 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAPAGAKFPIK------ 178
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 179 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 235 PE-------GCPEKVYELMRACWQWNPSDR 257

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/322 (25%), Positives = 144/322 (44%), Gaps = 39/322 (12%)
Query: 259 GYKNLHIRELKRIHNEDQSRFNNHPVLSD----RYLL-LMLLGKGGFSEVHKAFDLKEQR 313
           G +NL+ + + R+ +E Q R     V+S      YL   + +G+G    V  A +    +
Sbjct: 13  GRENLYFQSMSRVSHE-QFRAALQLVVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGK 71
Query: 314 YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEY 373
            VA K   L K  + +   N +   +R+Y+      H  VV +Y  + +  +    V+E+
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVV-IMRDYH------HDNVVDMYSSYLV-GDELWVVMEF 123
Query: 374 CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC 433
            +G  L   +  H  + E +  ++ + V+ AL YL+     VIH D+K  +ILLT     
Sbjct: 124 LEGGALT-DIVTHTRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSD--- 177
Query: 434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWS 493
           G IK++DFG    + +E       +       GT +++ PE  V+ + P    ++VD+WS
Sbjct: 178 GRIKLSDFGFCAQVSKE-------VPKRKXLVGTPYWMAPE--VISRLP--YGTEVDIWS 226
Query: 494 VGVIFYQCLYGKKP-FGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYR 552
           +G++  + + G+ P F     QA       I  +   +  +   VS+  +GF+   L   
Sbjct: 227 LGIMVIEMIDGEPPYFNEPPLQAM----RRIRDSLPPRVKDLHKVSSVLRGFLDLMLVRE 282
Query: 553 KEDRIDVISLARHDYLQ---PP 571
              R     L  H +L+   PP
Sbjct: 283 PSQRATAQELLGHPFLKLAGPP 304

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           +LL  +LG+G  + V +    K     A KV      +        +   +RE+ + K L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKV------FNNISFLRPVDVQMREFEVLKKL 64
Query: 349 DHPRVVKLYDVFEIDANSF-CTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSA 404
           +H  +VKL+ + E         ++E+C    L   L++      + E E   ++  VV  
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI-KITDFGLSKVM-DEENYNPDHGMDLTS 462
           + +L E    ++H ++KPGNI+   G     + K+TDFG ++ + D+E +   +G     
Sbjct: 125 MNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG----- 177
Query: 463 QGAGTYWYLPPECF---VVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T  YL P+ +   V+ K+   K  + VD+WS+GV FY    G  PF
Sbjct: 178 ----TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 76
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 77  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 133 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 181
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 182 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 238 PE-------GCPEKVYELMRACWQWNPSDR 260

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 78  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 134 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 182
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 183 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 239 PE-------GCPEKVYELMRACWQWNPSDR 261

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 294 LLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           ++G G F EV+K   LK    ++ V   +  L   + E ++ ++    L E  I     H
Sbjct: 51  VIGAGEFGEVYKGM-LKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQFSH 105
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV-------S 403
             +++L  V          + EY +   LD +L+      E++    V+Q+V       +
Sbjct: 106 HNIIRLEGVIS-KYKPMMIITEYMENGALDKFLR------EKDGEFSVLQLVGMLRGIAA 158
Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            +KYL  +    +H DL   NIL+    VC   K++DFGLS+V++++          TS 
Sbjct: 159 GMKYLANMN--YVHRDLAARNILVNSNLVC---KVSDFGLSRVLEDD----PEATYTTSG 209
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           G     +  PE      +  K +S  DVWS G++ ++ + YG++P+
Sbjct: 210 GKIPIRWTAPEAI----SYRKFTSASDVWSFGIVMWEVMTYGERPY 251

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 85
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 86  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 141
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 142 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 191 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 246
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 247 PE-------GCPEKVYELMRACWQWNPSDR 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 74
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 75  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 131 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAPAGAKFPIK------ 179
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 180 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 236 PE-------GCPEKVYELMRACWQWNPSDR 258

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 211
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 212 EMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG-- 267
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 268 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 317
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +      +     I      +  N 
Sbjct: 318 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDNLPPRLKNL 370
Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             VS   KGF+   L      R     L +H +L
Sbjct: 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 74
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 75  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 131 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 179
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 180 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 236 PE-------GCPEKVYELMRACWQWNPSDR 258

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 74
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 75  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 131 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 179
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 180 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 235
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 236 PE-------GCPEKVYELMRACWQWNPSDR 258

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +S  + L  LLG+G +  V  A        VA K        +   K  +    LRE  I
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 345 HKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
            K   H  ++ ++++   D+  +F  V    +    D + +   + +++   +  + Q +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE---ENYNPDHGMD 459
            A+K L+     VIH DLKP N+L+   N   ++K+ DFGL++++DE   +N  P     
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
             ++   T WY  PE  +      K S  +DVWS G I  + L+ ++P
Sbjct: 178 GMTEXVATRWYRAPEVMLTSA---KYSRAMDVWSCGCILAE-LFLRRP 221

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
           +LL  +LG+G  + V +    K     A KV      +        +   +RE+ + K L
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKV------FNNISFLRPVDVQMREFEVLKKL 64
Query: 349 DHPRVVKLYDVFEIDANSF-CTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSA 404
           +H  +VKL+ + E         ++E+C    L   L++      + E E   ++  VV  
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI-KITDFGLSKVM-DEENYNPDHGMDLTS 462
           + +L E    ++H ++KPGNI+   G     + K+TDFG ++ + D+E +   +G     
Sbjct: 125 MNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYG----- 177
Query: 463 QGAGTYWYLPPECF---VVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPF 508
               T  YL P+ +   V+ K+   K  + VD+WS+GV FY    G  PF
Sbjct: 178 ----TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +LG G F  V+K   + E   V   V    LN+         ++  AL    I  ++DHP
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL----IMASMDHP 100
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +V+L  V         T L    G  L++  +    I  +   +  +Q+   + YL E 
Sbjct: 101 HLVRLLGVCLSPTIQLVTQL-MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 159
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG-MDLTSQGAGTY 468
           +  ++H DL   N+L+   N    +KITDFGL++++  DE+ YN D G M +        
Sbjct: 160 R--LVHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIK------- 207
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            ++  EC     +  K + + DVWS GV  ++ + +G KP+
Sbjct: 208 -WMALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY +  L+GKG F +V KA+D  EQ +VA K+ +       +KKA ++  A  E  + +
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKA-FLNQAQIEVRLLE 86
Query: 347 ALD-HPRVVKLYDVFE----IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQ 400
            ++ H   +K Y V      +  N  C V E    +  D     + + ++    R    Q
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 146
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           + +AL +L   +  +IH DLKP NILL        IKI DFG S  + +  Y        
Sbjct: 147 MCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIY-------- 197
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             Q   + +Y  PE  V+   P  ++  +D+WS+G I  +   G+  F
Sbjct: 198 --QXIQSRFYRSPE--VLLGMPYDLA--IDMWSLGCILVEMHTGEPLF 239

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 72
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 73  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + Y    G     +      
Sbjct: 129 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIK------ 177
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 178 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 234 PE-------GCPEKVYELMRACWQWNPSDR 256

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 28/233 (12%)
Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++ +  +R  L   +G+G F +VH+   +  E   +A  +        +  +  +++ AL
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
                 +  DHP +VKL  V  I  N    ++E C   +L  +L+  K     +  S+++
Sbjct: 64  ----TMRQFDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLIL 115
Query: 400 ---QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+ +AL YL   +   +H D+   N+L++  +    +K+ DFGLS+ M+      D 
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC---VKLGDFGLSRYME------DS 164
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                S+G     ++ PE      N  + +S  DVW  GV  ++ L +G KPF
Sbjct: 165 TXXKASKGKLPIKWMAPESI----NFRRFTSASDVWMFGVCMWEILMHGVKPF 213

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +S  + L  LLG+G +  V  A        VA K        +   K  +    LRE  I
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 345 HKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
            K   H  ++ ++++   D+  +F  V    +    D + +   + +++   +  + Q +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE---ENYNPDHGMD 459
            A+K L+     VIH DLKP N+L+   N   ++K+ DFGL++++DE   +N  P     
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
             ++   T WY  PE  +      K S  +DVWS G I  + L+ ++P
Sbjct: 178 GMTEYVATRWYRAPEVMLTSA---KYSRAMDVWSCGCILAE-LFLRRP 221

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY +  L+GKG F +V KA+D  EQ +VA K+ +       +KKA ++  A  E  + +
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKA-FLNQAQIEVRLLE 105
Query: 347 ALD-HPRVVKLYDVFE----IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQ 400
            ++ H   +K Y V      +  N  C V E    +  D     + + ++    R    Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           + +AL +L   +  +IH DLKP NILL        IKI DFG S  + +  Y        
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIY-------- 216
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             Q   + +Y  PE  V+   P  ++  +D+WS+G I  +   G+  F
Sbjct: 217 --QXIQSRFYRSPE--VLLGMPYDLA--IDMWSLGCILVEMHTGEPLF 258

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +LG G F  V+K   + E   V   V    LN+         ++  AL    I  ++DHP
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL----IMASMDHP 77
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
            +V+L  V         T L    G  L++  +    I  +   +  +Q+   + YL E 
Sbjct: 78  HLVRLLGVCLSPTIQLVTQL-MPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 136
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG-MDLTSQGAGTY 468
           +  ++H DL   N+L+   N    +KITDFGL++++  DE+ YN D G M +        
Sbjct: 137 R--LVHRDLAARNVLVKSPN---HVKITDFGLARLLEGDEKEYNADGGKMPIK------- 184
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            ++  EC     +  K + + DVWS GV  ++ + +G KP+
Sbjct: 185 -WMALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPY 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 70
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 71  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  + +    G     +      
Sbjct: 127 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTFTAHAGAKFPIK------ 175
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE         K S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 176 WTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 232 PE-------GCPEKVYELMRACWQWNPSDR 254

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY +  L+GKG F +V KA+D  EQ +VA K+ +       +KKA ++  A  E  + +
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKA-FLNQAQIEVRLLE 105
Query: 347 ALD-HPRVVKLYDVFE----IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQ 400
            ++ H   +K Y V      +  N  C V E    +  D     + + ++    R    Q
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           + +AL +L   +  +IH DLKP NILL        IKI DFG S  + +  Y        
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRXA-IKIVDFGSSCQLGQRIY-------- 216
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             Q   + +Y  PE  V+   P  ++  +D+WS+G I  +   G+  F
Sbjct: 217 --QXIQSRFYRSPE--VLLGMPYDLA--IDMWSLGCILVEMHTGEPLF 258

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 134
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 135 EMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG-- 190
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 191 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 240
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +      +     I      +  N 
Sbjct: 241 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDNLPPRLKNL 293
Query: 535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             VS   KGF+   L      R     L +H +L
Sbjct: 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 294 LLGKGGFSEVHK-AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           +LG+G F EV++  +   +   +   V    KD   D K  ++  A+    I K LDHP 
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV----IMKNLDHPH 86
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV---MQVVSALKYLN 409
           +VKL  + E +      ++E     +L  YL+++K     +  ++V   +Q+  A+ YL 
Sbjct: 87  IVKLIGIIEEEPTWI--IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLE 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
            I    +H D+   NIL+        +K+ DFGLS+ +++E+Y       L  +      
Sbjct: 143 SIN--CVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTRLPIK------ 191
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
           ++ PE      N  + ++  DVW   V  ++ L +GK+PF   +++  I
Sbjct: 192 WMSPESI----NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 335 IKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAER 392
           ++  L E N+ K L H ++V+LY V   +   +        G  LDF LK  +   +   
Sbjct: 52  VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDF-LKSDEGGKVLLP 110
Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
           +      Q+   + Y+   +   IH DL+  N+L++E  +C   KI DFGL++V+++  Y
Sbjct: 111 KLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMC---KIADFGLARVIEDNEY 165
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG-- 509
               G     +      +  PE    G      + K DVWS G++ Y+ + YGK P+   
Sbjct: 166 TAREGAKFPIK------WTAPEAINFG----CFTIKSDVWSFGILLYEIVTYGKIPYPGR 215
Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            N    T L +   +   E    N P   +E    ++ C   + E+R         DYLQ
Sbjct: 216 TNADVMTALSQGYRMPRVE----NCP---DELYDIMKMCWKEKAEER------PTFDYLQ 262

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 70
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 71  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  +      G     +      
Sbjct: 127 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTXTAHAGAKFPIK------ 175
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE     K     S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 176 WTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 232 PE-------GCPEKVYELMRACWQWNPSDR 254

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 73
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  ++E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 74  QLLGVCTREP-PFYIIIEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  +      G     +      
Sbjct: 130 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTXTAHAGAKFPIK------ 178
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE     K     S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 179 WTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 234
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 235 PE-------GCPEKVYELMRACWQWNPSDR 257

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +S  + L  LLG+G +  V  A        VA K        +   K  +    LRE  I
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 345 HKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY-LKQHKTIAEREARSIVMQVV 402
            K   H  ++ ++++   D+  +F  V    +    D + +   + +++   +  + Q +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE---ENYNPDHGMD 459
            A+K L+     VIH DLKP N+L+   N   ++K+ DFGL++++DE   +N  P     
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
              +   T WY  PE  +      K S  +DVWS G I  + L+ ++P
Sbjct: 178 GMVEFVATRWYRAPEVMLTSA---KYSRAMDVWSCGCILAE-LFLRRP 221

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 120/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 70
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  ++E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 71  QLLGVCTREP-PFYIIIEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE 126
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  +      G     +      
Sbjct: 127 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTXTAHAGAKFPIK------ 175
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE     K     S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 176 WTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 232 PE-------GCPEKVYELMRACWQWNPSDR 254

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 294 LLGKGGFSEVHK-AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           +LG+G F EV++  +   +   +   V    KD   D K  ++  A+    I K LDHP 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV----IMKNLDHPH 74
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV---MQVVSALKYLN 409
           +VKL  + E +      ++E     +L  YL+++K     +  ++V   +Q+  A+ YL 
Sbjct: 75  IVKLIGIIEEEPTWI--IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLE 130
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
            I    +H D+   NIL+        +K+ DFGLS+ +++E+Y       L  +      
Sbjct: 131 SIN--CVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
           ++ PE      N  + ++  DVW   V  ++ L +GK+PF   +++  I
Sbjct: 180 WMSPESI----NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 47/283 (16%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV K  D + Q+ VA K+  L +   E +         +E  +    D   V 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSSYVT 84
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           K Y  + +  +    ++EY  G   LD  L +     E +  +++ +++  L YL+  K 
Sbjct: 85  KYYGSY-LKGSKLWIIMEYLGGGSALD--LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    G++K+ DFG++  + +            +   GT +++ P
Sbjct: 142 --IHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIK-------RNTFVGTPFWMAP 189
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA- 532
           E            SK D+WS+G+   +   G+ P             N+ +    V F  
Sbjct: 190 EVI----QQSAYDSKADIWSLGITAIELAKGEPP-------------NSDMHPMRVLFLI 232
Query: 533 ---NKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              N PT+    +   K FI +CL      R     L +H ++
Sbjct: 233 PKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 294 LLGKGGFSEVHK-AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           +LG+G F EV++  +   +   +   V    KD   D K  ++  A+    I K LDHP 
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV----IMKNLDHPH 70
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV---MQVVSALKYLN 409
           +VKL  + E +      ++E     +L  YL+++K     +  ++V   +Q+  A+ YL 
Sbjct: 71  IVKLIGIIEEEPTWI--IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLE 126
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
            I    +H D+   NIL+        +K+ DFGLS+ +++E+Y       L  +      
Sbjct: 127 SIN--CVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTRLPIK------ 175
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
           ++ PE      N  + ++  DVW   V  ++ L +GK+PF   +++  I
Sbjct: 176 WMSPE----SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 91
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 92  EMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG-- 147
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 148 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 197
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +             LKA ++   N 
Sbjct: 198 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------LKAMKMIRDNL 243
Query: 535 PT-------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           P        VS   KGF+   L      R     L +H +L
Sbjct: 244 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 89
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 90  EMYNSYLV-GDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQG-- 145
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 146 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 195
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +             LKA ++   N 
Sbjct: 196 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------LKAMKMIRDNL 241
Query: 535 PT-------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           P        VS   KGF+   L      R     L +H +L
Sbjct: 242 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G + EV++    K    VA K        KED     ++  L+E  + K + HP +V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL------KEDTME--VEEFLKEAAVMKEIKHPNLV 77
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM-----QVVSALKYLN 409
           +L  V   +   F  + E+    +L  YL++      +E  ++V+     Q+ SA++YL 
Sbjct: 78  QLLGVCTREP-PFYIITEFMTYGNLLDYLRE---CNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             K   IH DL   N L+ E ++   +K+ DFGLS++M  +      G     +      
Sbjct: 134 --KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTXTAHAGAKFPIK------ 182
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF-GHNQSQA-TILEENTILKA 526
           +  PE     K     S K DVW+ GV+ ++   YG  P+ G + SQ   +LE++  ++ 
Sbjct: 183 WTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            E           +    +R+C  +   DR
Sbjct: 239 PE-------GCPEKVYELMRACWQWNPSDR 261

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 84
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 85  EMYNSYLV-GDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLH--AQG 140
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 141 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 190
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +             LKA ++   N 
Sbjct: 191 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------LKAMKMIRDNL 236
Query: 535 P-------TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           P        VS   KGF+   L      R     L +H +L
Sbjct: 237 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 118/299 (39%), Gaps = 37/299 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L  ++G G  + V  A+   ++  VA K   L      +K    +   L+E     
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL------EKCQTSMDELLKEIQAMS 68
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-----KQHKT--IAEREARSIVM 399
              HP +V  Y  F +    +  +     G  LD         +HK+  + E    +I+ 
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           +V+  L+YL+  K   IH D+K GNILL E    G ++I DFG+S  +         G D
Sbjct: 129 EVLEGLEYLH--KNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLAT-------GGD 176
Query: 460 LTSQG-----AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           +T         GT  ++ PE   V +       K D+WS G+   +   G  P+  +   
Sbjct: 177 ITRNKVRKTFVGTPCWMAPE---VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGF---IRSCLAYRKEDRIDVISLARHDYLQ 569
           +  +L       + E    +K  +    K F   I  CL    E R     L RH + Q
Sbjct: 234 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 27/181 (14%)
Query: 335 IKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAER 392
           ++  L E N+ K L H ++V+LY V   +   +        G  LDF LK  +   +   
Sbjct: 51  VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDF-LKSDEGGKVLLP 109
Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
           +      Q+   + Y+   +   IH DL+  N+L++E  +C   KI DFGL++V+++  Y
Sbjct: 110 KLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMC---KIADFGLARVIEDNEY 164
Query: 453 NPDHGMDLTSQGAGTYWYLPPE----CFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKP 507
               G     +     W  P      CF +  N         VWS G++ Y+ + YGK P
Sbjct: 165 TAREGAKFPIK-----WTAPEAINFGCFTIKSN---------VWSFGILLYEIVTYGKIP 210
Query: 508 F 508
           +
Sbjct: 211 Y 211

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQR-YVACKVHQLNKDWKEDKKANYIKHALREYN 343
           L ++Y++   LG+G F  VH+  +   ++ Y+A  V     D    KK         E +
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---------EIS 53
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQ 400
           I     H  ++ L++ FE        + E+  G  LD + + + +   + ERE  S V Q
Sbjct: 54  ILNIARHRNILHLHESFE-SMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQ 110
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           V  AL++L+     + H+D++P NI+  +      IKI +FG ++ +      P     L
Sbjct: 111 VCEALQFLH--SHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQL-----KPGDNFRL 162
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                    Y  PE          +S+  D+WS+G + Y  L G  PF    +Q  I  E
Sbjct: 163 LFTAPE---YYAPEV----HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII--E 213
Query: 521 NTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
           N I+ A E  F  +    +S EA  F+   L   ++ R+      +H +L+  + +
Sbjct: 214 N-IMNA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G    V  A      + VA K   L K  + +   N       E  I +   H  VV
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-------EVVIMRDYQHENVV 80
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
           ++Y+ + +  +    V+E+ +G  L   +  H  + E +  ++ + V+ AL  L+     
Sbjct: 81  EMYNSYLV-GDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG-- 136
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
           VIH D+K  +ILLT     G +K++DFG    + +E       +       GT +++ PE
Sbjct: 137 VIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE-------VPRRKXLVGTPYWMAPE 186
Query: 475 CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK 534
             ++ + P     +VD+WS+G++  + + G+ P+ +             LKA ++   N 
Sbjct: 187 --LISRLP--YGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------LKAMKMIRDNL 232
Query: 535 P-------TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           P        VS   KGF+   L      R     L +H +L
Sbjct: 233 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 20/234 (8%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D + +L ++G+G FSEV      +  +  A K+  +NK W   K+   +     E ++  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNK-WDMLKRGE-VSCFREERDVLV 116
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSAL 405
             D   + +L+  F+ D N    V+EY  G DL   L K  + I    AR  + ++V A+
Sbjct: 117 NGDRRWITQLHFAFQ-DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
             ++ +    +H D+KP NILL   + CG I++ DFG    +  +      G   +    
Sbjct: 176 DSVHRLG--YVHRDIKPDNILL---DRCGHIRLADFGSCLKLRAD------GTVRSLVAV 224
Query: 466 GTYWYLPPECF---VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
           GT  YL PE       G        + D W++GV  Y+  YG+ PF  + +  T
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 118/299 (39%), Gaps = 37/299 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L  ++G G  + V  A+   ++  VA K   L      +K    +   L+E     
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL------EKCQTSMDELLKEIQAMS 63
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-----KQHKT--IAEREARSIVM 399
              HP +V  Y  F +    +  +     G  LD         +HK+  + E    +I+ 
Sbjct: 64  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           +V+  L+YL+  K   IH D+K GNILL E    G ++I DFG+S  +         G D
Sbjct: 124 EVLEGLEYLH--KNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLAT-------GGD 171
Query: 460 LTSQG-----AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQS 513
           +T         GT  ++ PE   V +       K D+WS G+   +   G  P+  +   
Sbjct: 172 ITRNKVRKTFVGTPCWMAPE---VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 228
Query: 514 QATILEENTILKATEVQFANKPTVSNEAKGF---IRSCLAYRKEDRIDVISLARHDYLQ 569
           +  +L       + E    +K  +    K F   I  CL    E R     L RH + Q
Sbjct: 229 KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 20/173 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 368 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 422
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF 508
           G     +      +  PE  + G    + + K DVWS G++  +    G+ P+
Sbjct: 423 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 275 DQSRFNNHPV-----LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED 329
           D  +   HPV      + RY ++  LG G FS V   +D++ +R+VA KV +        
Sbjct: 14  DYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVK-------- 65
Query: 330 KKANYIKHALREYNIHKAL--------DHPRVVKLYDVFEIDANS---FCTVLEYCDGHD 378
              +Y + AL E  + K +        +   VV+L D F+I   +    C V E    H 
Sbjct: 66  SAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHL 125
Query: 379 LDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT 428
           L + +K  ++ +  R  +SI+ QV+  L YL+  K  +IH D+KP NIL+ 
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHS-KCKIIHTDIKPENILMC 175

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 302 EVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV 359
           +V++A D   +R VA K+    L+ D        +     RE      L  P VV ++D 
Sbjct: 49  DVYEAEDTVRERIVALKLXSETLSSD------PVFRTRXQREARTAGRLQEPHVVPIHDF 102
Query: 360 FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYD 419
            EID   +       +G DL   L++   +A   A +IV Q+ SAL   +       H D
Sbjct: 103 GEIDGQLYVDX-RLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRD 159
Query: 420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG--AGTYWYLPPECFV 477
           +KP NIL++  +      + DFG++    +E         LT  G   GT +Y  PE F 
Sbjct: 160 VKPENILVSADDFA---YLVDFGIASATTDEK--------LTQLGNTVGTLYYXAPERF- 207
Query: 478 VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ 512
              +    + + D++++  + Y+CL G  P+  +Q
Sbjct: 208 ---SESHATYRADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 123/295 (41%), Gaps = 33/295 (11%)
Query: 228 RNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRE---LKRIHNEDQSRFNNHP- 283
           R+  I+ L  ++  +   F + P+L D  L   + L  +    L R   +D+   N+   
Sbjct: 57  RHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDL 116
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           VL ++      +G+G F EV       +   VA K     +    D KA +    L+E  
Sbjct: 117 VLGEQ------IGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKF----LQEAR 164
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVV 402
           I K   HP +V+L  V          V+E   G D L F   +   +  +    +V    
Sbjct: 165 ILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           + ++YL       IH DL   N L+TE NV   +KI+DFG+S+   +  Y    G+    
Sbjct: 224 AGMEYLE--SKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVYAASGGL---- 274
Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQAT 516
           +     W  P        N  + SS+ DVWS G++ ++    G  P+ +  +Q T
Sbjct: 275 RQVPVKWTAPE-----ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
            N  V +D    +M LG+G +  V K   +   + +A K  +   + +E K+       L
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL------L 97
Query: 340 REYNIH-KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY---LKQHKTIAEREAR 395
            + +I  + +D P  V  Y     + + +   +E  D     FY   + + +TI E    
Sbjct: 98  MDLDISMRTVDCPFTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILG 156
Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNP 454
            I + +V AL++L+  K  VIH D+KP N+L+   N  G++K+ DFG+S  ++D      
Sbjct: 157 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDSVAKTI 212
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG----- 509
           D         AG   Y+ PE      N    S K D+WS+G+   +    + P+      
Sbjct: 213 D---------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 263
Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
             Q +  + E +  L A +         S E   F   CL    ++R     L +H + 
Sbjct: 264 FQQLKQVVEEPSPQLPADK--------FSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V+EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 87/178 (48%), Gaps = 20/178 (11%)
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER--EARSIVMQVVSALK 406
           +HP V++ Y   E D       +E C    L  Y++Q K  A    E  +++ Q  S L 
Sbjct: 76  EHPNVIR-YFCTEKDRQFQYIAIELCAA-TLQEYVEQ-KDFAHLGLEPITLLQQTTSGLA 132
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIK--ITDFGLSKVMDEENYNPDHGMDLTSQG 464
           +L+ +   ++H DLKP NIL++  N  G+IK  I+DFGL K +        H     S  
Sbjct: 133 HLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR----HSFSRRSGV 186
Query: 465 AGTYWYLPPECFV--VGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHN-QSQATIL 518
            GT  ++ PE       +NP   +  VD++S G +FY  +  G  PFG + Q QA IL
Sbjct: 187 PGTEGWIAPEMLSEDCKENP---TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 295 LGKGGFSEVHKA--FDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           LG+G F +V  A  ++L  EQ  +   V  L     +D   N  K   RE  +   L H 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL-----KDASDNARKDFHREAELLTNLQHE 75
Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------------KTIAEREARSIV 398
            +VK Y V  ++ +    V EY    DL+ +L+ H               + + +   I 
Sbjct: 76  HIVKFYGVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q+ + + YL       +H DL   N L+ E  +   +KI DFG+S+ +   +Y    G 
Sbjct: 135 QQIAAGMVYLA--SQHFVHRDLATRNCLVGENLL---VKIGDFGMSRDVYSTDYYRVGGH 189
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            +         ++PPE  +      K +++ DVWS+GV+ ++   YGK+P+
Sbjct: 190 TMLPIR-----WMPPESIMY----RKFTTESDVWSLGVVLWEIFTYGKQPW 231

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L L+G+G +  V K  +    R VA K    + D K  KK      A+RE  + K
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI-----AMREIKLLK 79
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +V L +V +     +  V E+ D   LD        +  +  +  + Q+++ + 
Sbjct: 80  QLRHENLVNLLEVCK-KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           + +     +IH D+KP NIL+++  V   +K+ DFG ++ +           ++      
Sbjct: 139 FCHS--HNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPG-------EVYDDEVA 186
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T WY  PE  V      K    VDVW++G +  +   G+  F
Sbjct: 187 TRWYRAPELLV---GDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKA 347
            LM+LGKG F +V  +         A K+  L KD     +D +   ++  +    +   
Sbjct: 345 FLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRV----LALP 398
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
              P + +L+  F+   +    V+EY +G DL ++++Q     E  A     ++   L +
Sbjct: 399 GKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L      +I+ DLK  N++L      G IKI DFG+ K       N   G+  T    GT
Sbjct: 458 LQS--KGIIYRDLKLDNVMLDSE---GHIKIADFGMCK------ENIWDGV-TTKXFCGT 505
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILEENT 522
             Y+ PE  ++   P      VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N 
Sbjct: 506 PDYIAPE--IIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 295 LGKGGF-----SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F     +E H     +++  VA K     K+  E  + ++     RE  +   L 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA---LKEASESARQDF----QREAELLTMLQ 101
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----KTIAERE-----------A 394
           H  +V+ + V   +      V EY    DL+ +L+ H    K +A  E            
Sbjct: 102 HQHIVRFFGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
            ++  QV + + YL  +    +H DL   N L+ +G V   +KI DFG+S+ +   +Y  
Sbjct: 161 LAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV---VKIGDFGMSRDIYSTDYYR 215
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             G  +        W +PPE  +      K +++ DVWS GV+ ++   YGK+P+
Sbjct: 216 VGGRTMLP----IRW-MPPESILY----RKFTTESDVWSFGVVLWEIFTYGKQPW 261

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 66  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 124 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 178
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 179 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 228
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 229 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 264

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV  A   K  + VA K  +          +  ++  L E N+ K L H ++V
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMK--------PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 355 KLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           KL+ V  +       + E+   G  LDF LK  +   +   + I    Q+   + ++ + 
Sbjct: 247 KLHAV--VTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               IH DL+  NIL++   VC   KI DFGL++V+++  Y    G     +      + 
Sbjct: 304 N--YIHRDLRAANILVSASLVC---KIADFGLARVIEDNEYTAREGAKFPIK------WT 352
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            PE    G      + K DVWS G++  + + YG+ P+
Sbjct: 353 APEAINFG----SFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E ++   I  Q    + YL+     +IH DLK  NI
Sbjct: 82  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNI 139
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI 485
            L E N    +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  + P  
Sbjct: 140 FLHEDNT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNP-Y 190
Query: 486 SSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           S + DV++ G++ Y+ + G+ P+ +  ++  I+E
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V+EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV  A   K  + VA K  +          +  ++  L E N+ K L H ++V
Sbjct: 23  LGAGQFGEVWMATYNKHTK-VAVKTMK--------PGSMSVEAFLAEANVMKTLQHDKLV 73
Query: 355 KLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           KL+ V  +       + E+   G  LDF LK  +   +   + I    Q+   + ++ + 
Sbjct: 74  KLHAV--VTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               IH DL+  NIL++   VC   KI DFGL++V+++  Y    G     +      + 
Sbjct: 131 N--YIHRDLRAANILVSASLVC---KIADFGLARVIEDNEYTAREGAKFPIK------WT 179
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            PE    G      + K DVWS G++  + + YG+ P+
Sbjct: 180 APEAINFG----SFTIKSDVWSFGILLMEIVTYGRIPY 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY +   L  +LK       R  + + 
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 116 MSAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 170
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 171 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 202

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 339
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 340 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 371

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 62  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 120 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 174
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 175 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 225 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 260

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 339
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 340 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 371

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 61  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 119 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 174 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 223
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 224 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 259

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 17/116 (14%)
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           + I+  V+++  Y++  K  + H D+KP NIL+ +    G +K++DFG S+ M       
Sbjct: 154 KCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN---GRVKLSDFGESEYM------- 202
Query: 455 DHGMDLTSQGA-GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
              +D   +G+ GTY ++PPE F          +KVD+WS+G+  Y   Y   PF 
Sbjct: 203 ---VDKKIKGSRGTYEFMPPEFF--SNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
            P+  D +L   +LG+GGF EV         +  ACK        +  K+  Y + A+ E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK---RLKKRKGY-QGAMVE 235
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSI 397
             I   +    +V L   FE   +  C V+   +G D+ +++    + +    E  A   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             Q+VS L++L++    +I+ DLKP N+LL +    G ++I+D GL+  +         G
Sbjct: 295 TAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVRISDLGLAVELKA-------G 342
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T   AGT  ++ PE  ++G+   +    VD +++GV  Y+ +  + PF
Sbjct: 343 QTKTKGYAGTPGFMAPE-LLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 364 ANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSALKYLNEIKPPVIHYDLKP 422
           A     V ++C+G  L  +L   +T  E ++   I  Q    + YL+     +IH DLK 
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKS 148
Query: 423 GNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP 482
            NI L E N    +KI DFGL+   ++  ++  H  +   Q +G+  ++ PE   +  + 
Sbjct: 149 NNIFLHEDNT---VKIGDFGLAT--EKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSN 200
Query: 483 PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           P  S + DV++ G++ Y+ + G+ P+ +  ++  I+E
Sbjct: 201 P-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 20/173 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E  I K L H ++V+LY V  +       V EY +   L  +LK  +  A +    + 
Sbjct: 52  LEEAQIMKKLKHDKLVQLYAV--VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVD 109
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  QV + + Y+  +    IH DL+  NIL+  G +C   KI DFGL++++++       
Sbjct: 110 MAAQVAAGMAYIERMN--YIHRDLRSANILVGNGLIC---KIADFGLARLIEDNEXTARQ 164
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF 508
           G     +      +  PE  + G    + + K DVWS G++  + +  G+ P+
Sbjct: 165 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILLTELVTKGRVPY 207

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 294 LLGKGGFSEV-HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++GKG F  V H  +  + Q  + C +  L++      +   ++  LRE  + + L+HP 
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPN 83
Query: 353 VVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +          +L Y C G  L F     +    ++  S  +QV   ++YL E 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPDHGMDLTSQGAGTYWY 470
           K   +H DL   N +L E      +K+ DFGL++ ++D E Y         S     +  
Sbjct: 144 K--FVHRDLAARNCMLDESFT---VKVADFGLARDILDREYY---------SVQQHRHAR 189
Query: 471 LPPECFVV-GKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGH 510
           LP +   +      + ++K DVWS GV+ ++ L  G  P+ H
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
            P+  D +L   +LG+GGF EV         +  ACK        +  K+  Y + A+ E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK---RLKKRKGY-QGAMVE 235
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSI 397
             I   +    +V L   FE   +  C V+   +G D+ +++    + +    E  A   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             Q+VS L++L++    +I+ DLKP N+LL +    G ++I+D GL+  +         G
Sbjct: 295 TAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVRISDLGLAVELKA-------G 342
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T   AGT  ++ PE  ++G+   +    VD +++GV  Y+ +  + PF
Sbjct: 343 QTKTKGYAGTPGFMAPE-LLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
            P+  D +L   +LG+GGF EV         +  ACK        +  K+  Y + A+ E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK---RLKKRKGY-QGAMVE 235
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSI 397
             I   +    +V L   FE   +  C V+   +G D+ +++    + +    E  A   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             Q+VS L++L++    +I+ DLKP N+LL +    G ++I+D GL+  +         G
Sbjct: 295 TAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVRISDLGLAVELKA-------G 342
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T   AGT  ++ PE  ++G+   +    VD +++GV  Y+ +  + PF
Sbjct: 343 QTKTKGYAGTPGFMAPE-LLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            LM+LGKG F +V  +         A K+ + +   ++D     ++  + E  +      
Sbjct: 24  FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----VECTMVEKRVLALPGK 79
Query: 351 P-RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P  + +L+  F+   +    V+EY +G DL ++++Q     E  A     ++   L +L 
Sbjct: 80  PPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                +I+ DLK  N++L      G IKI DFG+ K       N   G+  T    GT  
Sbjct: 139 --SKGIIYRDLKLDNVMLDSE---GHIKIADFGMCK------ENIWDGVT-TKXFCGTPD 186
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA--TILEENT 522
           Y+ PE  ++   P      VD W+ GV+ Y+ L G+ PF G ++ +   +I+E N 
Sbjct: 187 YIAPE--IIAYQP--YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA-LREYNIHKALDHPRV 353
           LG+G F EV         R VA K           K  N    A L+E  + K L H ++
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTL---------KPGNMSPEAFLQEAQVMKKLRHEKL 242
Query: 354 VKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEI 411
           V+LY V  +       V EY   G  LDF   +  K +   +   +  Q+ S + Y+  +
Sbjct: 243 VQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 300
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL+  NIL+ E  VC   K+ DFGL +++++  Y    G     +      + 
Sbjct: 301 N--YVHRDLRAANILVGENLVC---KVADFGLGRLIEDNEYTARQGAKFPIK------WT 349
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIF 498
            PE  + G    + + K DVWS G++ 
Sbjct: 350 APEAALYG----RFTIKSDVWSFGILL 372

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 295 LGKGGF-----SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F     +E H     +++  VA K     K+  E  + ++     RE  +   L 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA---LKEASESARQDF----QREAELLTMLQ 78
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----KTIAERE-----------A 394
           H  +V+ + V   +      V EY    DL+ +L+ H    K +A  E            
Sbjct: 79  HQHIVRFFGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
            ++  QV + + YL  +    +H DL   N L+ +G V   +KI DFG+S+ +   +Y  
Sbjct: 138 LAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV---VKIGDFGMSRDIYSTDYYR 192
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             G  +         ++PPE  +      K +++ DVWS GV+ ++   YGK+P+
Sbjct: 193 VGGRTMLPIR-----WMPPESILY----RKFTTESDVWSFGVVLWEIFTYGKQPW 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 295 LGKGGF-----SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F     +E H     +++  VA K     K+  E  + ++     RE  +   L 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA---LKEASESARQDF----QREAELLTMLQ 72
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----KTIAERE-----------A 394
           H  +V+ + V   +      V EY    DL+ +L+ H    K +A  E            
Sbjct: 73  HQHIVRFFGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
            ++  QV + + YL  +    +H DL   N L+ +G V   +KI DFG+S+ +   +Y  
Sbjct: 132 LAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV---VKIGDFGMSRDIYSTDYYR 186
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             G  +         ++PPE  +      K +++ DVWS GV+ ++   YGK+P+
Sbjct: 187 VGGRTMLPIR-----WMPPESILY----RKFTTESDVWSFGVVLWEIFTYGKQPW 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 365 NSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPG 423
           ++   V ++C+G  L  +L   +T  +  +   I  Q    + YL+     +IH D+K  
Sbjct: 104 DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSN 161
Query: 424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP 483
           NI L EG     +KI DFGL+ V    +     G     Q  G+  ++ PE   +  N P
Sbjct: 162 NIFLHEGLT---VKIGDFGLATVKSRWS-----GSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 484 KISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S + DV+S G++ Y+ + G+ P+ H  ++  I+
Sbjct: 214 -FSFQSDVYSYGIVLYELMTGELPYSHINNRDQII 247

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 54  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 111
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 112 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 166
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 167 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 198

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
            P+  D +L   +LG+GGF EV         +  ACK        +  K+  Y + A+ E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK---RLKKRKGY-QGAMVE 235
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSI 397
             I   +    +V L   FE   +  C V+   +G D+ +++    + +    E  A   
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTD-LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             Q+VS L++L++    +I+ DLKP N+LL +    G ++I+D GL+  +         G
Sbjct: 295 TAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVRISDLGLAVELKA-------G 342
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              T   AGT  ++ PE  ++G+   +    VD +++GV  Y+ +  + PF
Sbjct: 343 QTKTKGYAGTPGFMAPE-LLLGE---EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 114 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 169 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 219 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 254

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E ++   I  Q    + YL+     +IH DLK  NI
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNI 151
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI 485
            L E N    +KI DFGL+   ++  ++  H  +   Q +G+  ++ PE   +  + P  
Sbjct: 152 FLHEDNT---VKIGDFGLAT--EKSRWSGSHQFE---QLSGSILWMAPEVIRMQDSNP-Y 202
Query: 486 SSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
           S + DV++ G++ Y+ + G+ P+ +  ++  I+E
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 50  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 107
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 108 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 162
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 163 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 194

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 52  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 109
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 110 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 164
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 165 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 196

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDH 350
           +M LG+G +  V K   +   + +A K  +   + +E K+       L + +I  + +D 
Sbjct: 12  IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL------LMDLDISMRTVDC 65
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY---LKQHKTIAEREARSIVMQVVSALKY 407
           P  V  Y     + + +   +E  D     FY   + + +TI E     I + +V AL++
Sbjct: 66  PFTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+  K  VIH D+KP N+L+   N  G++K+ DFG+S  + +     D   D+    AG 
Sbjct: 125 LHS-KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVD-----DVAKDID---AGC 172
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             Y+ PE      N    S K D+WS+G+   +    + P+
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 51  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 108
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 109 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 163
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 164 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 213
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 214 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 249

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--------SIVMQ 400
           DHP V++ Y   E         LE C+ +  D  L + K +++   +        S++ Q
Sbjct: 85  DHPNVIRYY-CSETTDRFLYIALELCNLNLQD--LVESKNVSDENLKLQKEYNPISLLRQ 141
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLT----------EGNVCGEIKITDFGLSKVMDEE 450
           + S + +L+ +K  +IH DLKP NIL++           G     I I+DFGL K +D  
Sbjct: 142 IASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFG 509
                  ++     +GT  +  PE  +      +++  +D++S+G +FY  L  GK PFG
Sbjct: 200 QXXFRXNLN---NPSGTSGWRAPE-LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              S+ + +    I    E++  +  ++  EA   I   + +    R   + + RH    
Sbjct: 256 DKYSRESNIIRG-IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 314
Query: 570 P 570
           P
Sbjct: 315 P 315

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--------SIVMQ 400
           DHP V++ Y   E         LE C+ +  D  L + K +++   +        S++ Q
Sbjct: 85  DHPNVIRYY-CSETTDRFLYIALELCNLNLQD--LVESKNVSDENLKLQKEYNPISLLRQ 141
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLT----------EGNVCGEIKITDFGLSKVMDEE 450
           + S + +L+ +K  +IH DLKP NIL++           G     I I+DFGL K +D  
Sbjct: 142 IASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFG 509
                  ++     +GT  +  PE  +      +++  +D++S+G +FY  L  GK PFG
Sbjct: 200 QXXFRXNLN---NPSGTSGWRAPE-LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              S+ + +    I    E++  +  ++  EA   I   + +    R   + + RH    
Sbjct: 256 DKYSRESNIIRG-IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 314
Query: 570 P 570
           P
Sbjct: 315 P 315

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD 284
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 285 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 339
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 340 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 371

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY +   L  +LK       R  + + 
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD 115
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  +    
Sbjct: 116 MSAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEWTARQ 170
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 171 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 202

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 31/244 (12%)
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--------SIVMQ 400
           DHP V++ Y   E         LE C+ +  D  L + K +++   +        S++ Q
Sbjct: 67  DHPNVIRYY-CSETTDRFLYIALELCNLNLQD--LVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLT----------EGNVCGEIKITDFGLSKVMDEE 450
           + S + +L+ +K  +IH DLKP NIL++           G     I I+DFGL K +D  
Sbjct: 124 IASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKN---PPKISSKVDVWSVGVIFYQCLY-GKK 506
             +    ++     +GT  +  PE      N     +++  +D++S+G +FY  L  GK 
Sbjct: 182 QSSFRTNLN---NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
           PFG   S+ + +    I    E++  +  ++  EA   I   + +    R   + + RH 
Sbjct: 239 PFGDKYSRESNIIRG-IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297
Query: 567 YLQP 570
              P
Sbjct: 298 LFWP 301

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K + H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKIRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 47/283 (16%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F EV+K  D   +  VA K+  L +   E +         +E  +    D P + 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ------QEITVLSQCDSPYIT 80
Query: 355 KLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           + +  + + +     ++EY  G   LD  L +   + E    +I+ +++  L YL+  + 
Sbjct: 81  RYFGSY-LKSTKLWIIMEYLGGGSALD--LLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             IH D+K  N+LL+E    G++K+ DFG++  + +            +   GT +++ P
Sbjct: 138 --IHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQIK-------RNXFVGTPFWMAP 185
Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA- 532
           E             K D+WS+G+   +   G+ P             N+ L    V F  
Sbjct: 186 EVI----KQSAYDFKADIWSLGITAIELAKGEPP-------------NSDLHPMRVLFLI 228
Query: 533 ---NKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
              + PT+    S   K F+ +CL      R     L +H ++
Sbjct: 229 PKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--------SIVMQ 400
           DHP V++ Y   E         LE C+ +  D  L + K +++   +        S++ Q
Sbjct: 67  DHPNVIRYY-CSETTDRFLYIALELCNLNLQD--LVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLT----------EGNVCGEIKITDFGLSKVMDEE 450
           + S + +L+ +K  +IH DLKP NIL++           G     I I+DFGL K +D  
Sbjct: 124 IASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKN---PPKISSKVDVWSVGVIFYQCLY-GKK 506
                  ++     +GT  +  PE      N     +++  +D++S+G +FY  L  GK 
Sbjct: 182 QXXFRXNLN---NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
           PFG   S+ + +    I    E++  +  ++  EA   I   + +    R   + + RH 
Sbjct: 239 PFGDKYSRESNIIRG-IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297
Query: 567 YLQP 570
              P
Sbjct: 298 LFWP 301

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL   NIL+ E  VC   K+ DFGL++++++  Y    
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLAAANILVGENLVC---KVADFGLARLIEDNEYTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 68
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 129 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 179
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 180 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 25/228 (10%)
Query: 281 NHPVLSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           N     +R+L  L  LGKG F  V    +D L++       V +L    +E     +++ 
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRD 75
Query: 338 ALREYNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREAR 395
             RE  I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +  
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
               Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++     
Sbjct: 136 QYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK---- 186
Query: 456 HGMDLTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
               +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 187 EXXKVKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 61
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG 457
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+  D+E +     
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            +     +  +WY P           K S   DVWS GV+ Y+  
Sbjct: 177 GE-----SPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 25/228 (10%)
Query: 281 NHPVLSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           N     +R+L  L  LGKG F  V    +D L++       V +L    +E     +++ 
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRD 75
Query: 338 ALREYNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREAR 395
             RE  I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +  
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 135
Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
               Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++     
Sbjct: 136 QYTSQICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK---- 186
Query: 456 HGMDLTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
               +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 187 EXXKVKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 229

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 39/298 (13%)
Query: 228 RNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRE---LKRIHNEDQSRFNNHP- 283
           R+  I+ L  ++  +   F + P+L D  L   + L  +    L R   +D+   N+   
Sbjct: 57  RHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDL 116
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           VL ++      +G+G F EV       +   VA K     +    D KA +    L+E  
Sbjct: 117 VLGEQ------IGRGNFGEVFSGRLRADNTLVAVK--SCRETLPPDLKAKF----LQEAR 164
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD-LDFYLKQHKTIAEREARSIVMQVV 402
           I K   HP +V+L  V          V+E   G D L F   +   +  +    +V    
Sbjct: 165 ILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           + ++YL       IH DL   N L+TE NV   +KI+DFG+S+   EE      G+   S
Sbjct: 224 AGMEYLE--SKCCIHRDLAARNCLVTEKNV---LKISDFGMSR---EEA----DGVXAAS 271
Query: 463 QG---AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQAT 516
            G       W  P        N  + SS+ DVWS G++ ++    G  P+ +  +Q T
Sbjct: 272 GGLRQVPVKWTAPE-----ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 92
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 153 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 203
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 204 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 242

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 64
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 125 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 175
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 176 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 61
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 172
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 173 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 60
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 121 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 171
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 172 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 61
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 172
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 173 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 59
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 60  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 119
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 120 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 170
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 171 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 67
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 128 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 178
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 179 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 66
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 127 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 177
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 178 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 216

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 65
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 126 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 176
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 177 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 62
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL++HK  I   +      
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG 457
           Q+   ++YL   +   IH +L   NIL+   N    +KI DFGL+KV+  D+E Y     
Sbjct: 123 QICKGMEYLGTKR--YIHRNLATRNILVENEN---RVKIGDFGLTKVLPQDKEYYKVKEP 177
Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            +     +  +WY P           K S   DVWS GV+ Y+  
Sbjct: 178 GE-----SPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 52  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 109
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH +L+  NIL+++   C   KI DFGL++++++  Y    
Sbjct: 110 MAAQIAEGMAFIEERN--YIHRNLRAANILVSDTLSC---KIADFGLARLIEDNEYTARE 164
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 165 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 214
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 215 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 250

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCD-GHDLDFYLKQH-KTIAEREARS 396
           L+E  + K L H ++V+LY V  +       V+EY   G  LDF   +  K +   +   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           +  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++       
Sbjct: 119 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEXTARQ 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 174 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 64  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 122 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 176
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 177 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 226
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 227 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 62  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 120 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 174
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 175 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 224
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 225 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 260

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 83  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 141 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 183
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATE 528
           +P +   +     +I + + DVWS GV  ++ + +G KP+    +     E ++IL+  E
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 239
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            +    P  + +    +R C     + R
Sbjct: 240 -RLPQPPICTIDVYMIMRKCWMIDADSR 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 65  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 123 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 177
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 178 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 227
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 228 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 263

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 114 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDAEXTARE 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 169 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 219 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 254

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V   V  +        KAN  K  L E  +  ++D+P V
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN--KEILDEAYVMASVDNPHV 113
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 114 CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 171
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 172 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 214
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 254

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 114 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 169 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 219 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 254

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 89
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 90  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 148 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 190
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATE 528
           +P +   +     +I + + DVWS GV  ++ + +G KP+    +     E ++IL+  E
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 246
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            +    P  + +    +R C     + R
Sbjct: 247 -RLPQPPICTIDVYMIMRKCWMIDADSR 273

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 64
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVM 399
             I K+L H  +VK   V +     +   ++E+     L  YL++HK  I   +      
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 125 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 175
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 176 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 214

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           + + RY ++  LG G FS V  ++D++ +++VA KV +           +Y + AL E  
Sbjct: 34  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK--------SAEHYTETALDEIR 85
Query: 344 IHKAL--------DHPRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQ-HKTIAE 391
           + K++        +   VV+L D F+I   +    C V E    H L + +K  ++ +  
Sbjct: 86  LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPL 145
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT 428
              + I+ QV+  L YL+  K  +IH D+KP NILL+
Sbjct: 146 PCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLS 181

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G F EVH+  D  +Q    C V          KK         E      L  PR+V
Sbjct: 82  LGRGSFGEVHRMED--KQTGFQCAV----------KKVRLEVFRAEELMACAGLTSPRIV 129
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            LY     +       +E  +G  L   +K+   + E  A   + Q +  L+YL+  +  
Sbjct: 130 PLYGAVR-EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR-- 186
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG--AGTYWYLP 472
           ++H D+K  N+LL+         + DFG +  +  +      G DL +     GT  ++ 
Sbjct: 187 ILHGDVKADNVLLSSDG--SHAALCDFGHAVCLQPDGL----GKDLLTGDYIPGTETHMA 240
Query: 473 PECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           PE  V+G++     +KVDVWS   +    L G  P+
Sbjct: 241 PE-VVLGRS---CDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 58  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 115
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 116 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 170
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 171 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 220
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 221 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 256

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 118/254 (46%), Gaps = 28/254 (11%)
Query: 258 IGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLL---MLLGKGGFSEVHKAFDLKEQRY 314
           +G +NL+ +     H + ++         D  LLL   + +G+G    V  A +    R 
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 315 VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYC 374
           VA K+  L K  + +   N       E  I +   H  VV++Y  + +       ++E+ 
Sbjct: 73  VAVKMMDLRKQQRRELLFN-------EVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFL 124
Query: 375 DGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG 434
            G  L   + Q + + E +  ++   V+ AL YL+     VIH D+K  +ILLT   + G
Sbjct: 125 QGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLT---LDG 178
Query: 435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV 494
            +K++DFG    + ++   P           GT +++ PE  V+ ++    +++VD+WS+
Sbjct: 179 RVKLSDFGFCAQISKDV--PKR-----KXLVGTPYWMAPE--VISRS--LYATEVDIWSL 227
Query: 495 GVIFYQCLYGKKPF 508
           G++  + + G+ P+
Sbjct: 228 GIMVIEMVDGEPPY 241

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATE 528
           +P +   +     +I + + DVWS GV  ++ + +G KP+    +     E ++IL+  E
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 236
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            +    P  + +    +R C     + R
Sbjct: 237 -RLPQPPICTIDVYMIMRKCWMIDADSR 263

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 57  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 114
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 115 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 169
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 170 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 219
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 220 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 255

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L+E  + K L H ++V+LY V  +       V EY     L  +LK       R  + + 
Sbjct: 51  LQEAQVMKKLRHEKLVQLYAV--VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 108
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+ S + Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++       
Sbjct: 109 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEXTARQ 163
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           G     +      +  PE  + G    + + K DVWS G++ 
Sbjct: 164 GAKFPIK------WTAPEAALYG----RFTIKSDVWSFGILL 195

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 112/226 (49%), Gaps = 30/226 (13%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+        +  K N IK   RE  I +
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI-------LKPVKKNKIK---REIKILE 86
Query: 347 AL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSA 404
            L   P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ A
Sbjct: 87  NLRGGPNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKA 143
Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + 
Sbjct: 144 LDYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRV 192
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
           A  Y +  PE  V   +       +D+WS+G +    ++ K+PF H
Sbjct: 193 ASRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ K L H R+V+LY V  +       + EY +   L  +LK    I     + + 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 399 M--QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           M  Q+   + ++ E     IH DL+  NIL+++   C   KI DFGL++++++       
Sbjct: 114 MAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEXTARE 168
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQA 515
           G     +      +  PE    G      + K DVWS G++  + + +G+ P+    +  
Sbjct: 169 GAKFPIK------WTAPEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            I  +N       V+  N P    E    +R C   R EDR
Sbjct: 219 VI--QNLERGYRMVRPDNCP---EELYQLMRLCWKERPEDR 254

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           + + RY ++  LG G FS V  ++D++ +++VA KV +           +Y + AL E  
Sbjct: 18  LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK--------SAEHYTETALDEIR 69
Query: 344 IHKAL--------DHPRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQ-HKTIAE 391
           + K++        +   VV+L D F+I   +    C V E    H L + +K  ++ +  
Sbjct: 70  LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPL 129
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT 428
              + I+ QV+  L YL+  K  +IH D+KP NILL+
Sbjct: 130 PCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLS 165

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 26/280 (9%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRV 353
           +G+G +  V+K       + +A K  +   D KE K+       L + ++  ++ D P +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL------LMDLDVVMRSSDCPYI 83
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSALKYLNE 410
           V+ Y     + + +  +       D  +   Y      I E     I +  V AL +L E
Sbjct: 84  VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +IH D+KP NILL      G IK+ DFG+S  + +            ++ AG   Y
Sbjct: 144 -NLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAK--------TRDAGCRPY 191
Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQ 530
           + PE      +      + DVWS+G+  Y+   G+ P+    S    L +  ++K    Q
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ--VVKGDPPQ 249
Query: 531 FANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +N      S     F+  CL   +  R     L +H ++
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 112/290 (38%), Gaps = 26/290 (8%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 79
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 139 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHXVMQEHRKVPFAW 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 191 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 241
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGR 577
           E +         +    +  C A++ EDR   ++L   D+L    P   R
Sbjct: 242 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDMR 288

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + +   V  K+    K  +E+      K  L E  +   +  P V
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENV--KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 354 VKLYDVFEIDANSFCT-VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T ++ Y  G  LD   +    +  ++  +  MQ+   + YL +++
Sbjct: 82  SRLLGICLTSTVQLVTQLMPY--GCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHG------MDLTSQG 464
             ++H DL   N+L+   N    +KITDFGL++++  DE  Y+ D G      M L S  
Sbjct: 140 --LVHRDLAARNVLVKSPN---HVKITDFGLARLLDIDETEYHADGGKVPIKWMALES-- 192
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                       ++ +   + + + DVWS GV  ++ + +G KP+
Sbjct: 193 ------------ILRR---RFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 285 LSDRYL-LLMLLGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             +R+L  L  LGKG F  V    +D L++       V +L    +E     +++   RE
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFERE 64
Query: 342 YNIHKALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVM 399
             I K+L H  +VK   V +     +   ++EY     L  YL+ H + I   +      
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   ++YL   +   IH DL   NIL+   N    +KI DFGL+KV+ ++         
Sbjct: 125 QICKGMEYLGTKR--YIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDK----EXXK 175
Query: 460 LTSQGAG-TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           +   G    +WY P           K S   DVWS GV+ Y+  
Sbjct: 176 VKEPGESPIFWYAPESL-----TESKFSVASDVWSFGVVLYELF 214

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 17/142 (11%)
Query: 371 LEYCDGHDLDFYLKQHKTIAERE---ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL 427
           ++ C   +L  ++ +  ++ +RE      I +Q+  A+++L+     ++H DLKP NI  
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFF 197
Query: 428 TEGNVCGEIKITDFGLSKVMDEEN-----YNPDHGMDLTSQGAGTYWYLPPECFVVGKNP 482
           T  +V   +K+ DFGL   MD++        P           GT  Y+ PE  + G N 
Sbjct: 198 TMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ-IHGNN- 252
Query: 483 PKISSKVDVWSVGVIFYQCLYG 504
              S KVD++S+G+I ++ LY 
Sbjct: 253 --YSHKVDIFSLGLILFELLYS 272

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGICLTSTVQLITQL-MPFGXLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 44/236 (18%)
Query: 295 LGKGGFSEVHKA--FDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  ++L   K++  VA K         +D      K   RE  +   L 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKA-------LKDPTLAARKDFQREAELLTNLQ 75
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-------REARS------ 396
           H  +VK Y V   D +    V EY    DL+ +L+ H   A        R+A+       
Sbjct: 76  HEHIVKFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 397 ---IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
              I  Q+ S + YL       +H DL   N L+    +   +KI DFG+S+ +   +Y 
Sbjct: 135 MLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLL---VKIGDFGMSRDVYSTDYY 189
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
              G  +         ++PPE  +      K +++ DVWS GVI ++   YGK+P+
Sbjct: 190 RVGGHTMLPIR-----WMPPESIMY----RKFTTESDVWSFGVILWEIFTYGKQPW 236

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 87  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 145 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 187
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 85
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 86  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 144 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 186
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 83  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 141 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 183
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 82  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 140 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 182
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 83  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 141 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 183
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G F EVH+  D  +Q    C V          KK       + E      L  PR+V
Sbjct: 80  LGRGSFGEVHRMKD--KQTGFQCAV----------KKVRLEVFRVEELVACAGLSSPRIV 127
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            LY     +       +E  +G  L   +KQ   + E  A   + Q +  L+YL+  +  
Sbjct: 128 PLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 184
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDF---------GLSKVMDEENYNPDHGMDLTSQGA 465
           ++H D+K  N+LL+         + DF         GL K +   +Y P           
Sbjct: 185 ILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIP----------- 231
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  ++ PE  V+GK      +KVD+WS   +    L G  P+
Sbjct: 232 GTETHMAPE-VVMGK---PCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG+G F EVH+  D  +Q    C V          KK         E      L  PR+V
Sbjct: 101 LGRGSFGEVHRMED--KQTGFQCAV----------KKVRLEVFRAEELMACAGLTSPRIV 148
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            LY     +       +E  +G  L   +K+   + E  A   + Q +  L+YL+  +  
Sbjct: 149 PLYGAVR-EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR-- 205
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDF---------GLSKVMDEENYNPDHGMDLTSQGA 465
           ++H D+K  N+LL+         + DF         GL K +   +Y P           
Sbjct: 206 ILHGDVKADNVLLSSDG--SHAALCDFGHAVCLQPDGLGKSLLTGDYIP----------- 252
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  ++ PE  V+G++     +KVDVWS   +    L G  P+
Sbjct: 253 GTETHMAPE-VVLGRS---CDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 104
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 105 CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 163 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 205
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 112/290 (38%), Gaps = 26/290 (8%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 79
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 80  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 139 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 191 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 241
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGR 577
           E +         +    +  C A++ EDR   ++L   D+L    P   R
Sbjct: 242 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDMR 288

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKV 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD---ATLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVGVI  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKV 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD---ATLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVGVI  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLF 225

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 26/281 (9%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 69
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 129 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHXVMQEHRKVPFAW 180
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 181 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 231
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           E +         +    +  C A++ EDR   ++L   D+L
Sbjct: 232 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFL 269

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 76
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 77  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 135 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 177
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 114/290 (39%), Gaps = 26/290 (8%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 73
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 133 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 184
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ  IL +  I K  
Sbjct: 185 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHK--IDKEG 235
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGR 577
           E +         +    +  C A++ EDR   ++L   D+L    P   R
Sbjct: 236 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDMR 282

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 132/316 (41%), Gaps = 46/316 (14%)
Query: 279 FNNHPVLSD--RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           F  H V+ D   YL +  LG+GGFS V     L +  + A K    ++  ++D++     
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDRE----- 71
Query: 337 HALREYNIHKALDHPRVVKL--YDVFEIDANSFCTVLEYCDGHDLDFYLK---------- 384
            A RE ++H+  +HP +++L  Y + E  A     +L       L F+ +          
Sbjct: 72  EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL-------LPFFKRGTLWNEIERL 124
Query: 385 --QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
             +   + E +   +++ +   L+ ++       H DLKP NILL +    G+  + D G
Sbjct: 125 KDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDE---GQPVLMDLG 179
Query: 443 LSKVMDEENYNPDHGMDLTSQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
                          + L    A   T  Y  PE F V ++   I  + DVWS+G + Y 
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV-QSHCVIDERTDVWSLGCVLYA 238
Query: 501 CLYGKKPFGHNQSQATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRID 558
            ++G+ P+          + +++  A + Q +    P  S+     + S +      R  
Sbjct: 239 MMFGEGPY-----DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293
Query: 559 V-ISLARHDYLQPPVP 573
           + + L++ + LQPP P
Sbjct: 294 IPLLLSQLEALQPPAP 309

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 32/259 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  AFD      VA K  +L++ ++    A   K A RE  + K 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHA---KRAYRELVLLKC 77
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +     H  +       ++ Q++  +
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 137
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++     N+       + +   
Sbjct: 138 KHLH--SAGIIHRDLKPSNIVVKSD--C-TLKILDFGLARTAS-TNF-------MMTPYV 184
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
            T +Y  PE  ++G         VD+WSVG I  + + G   F   Q    I + N +++
Sbjct: 185 VTRYYRAPEV-ILGMG---YKENVDIWSVGCIMGELVKGSVIF---QGTDHIDQWNKVIE 237
Query: 526 -----ATEVQFANKPTVSN 539
                + E   A +PTV N
Sbjct: 238 QLGTPSAEFMAALQPTVRN 256

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 74  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 132 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 174
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 35/242 (14%)
Query: 272 HNEDQSRFNN--HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KE 328
           +++DQ  +    H  ++ RY +L ++GKG F +V KA+D K  ++VA K+ +  K + ++
Sbjct: 80  YDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ 139
Query: 329 DKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK- 387
             +   I   LR+ +    ++   V+ + + F    N  C   E     +L   +K++K 
Sbjct: 140 AAEEIRILEHLRKQDKDNTMN---VIHMLENFTF-RNHICMTFELLS-MNLYELIKKNKF 194
Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                 +  + A SI +Q + AL      K  +IH DLKP NILL +    G IK+ DFG
Sbjct: 195 QGFSLPLVRKFAHSI-LQCLDALH-----KNRIIHCDLKPENILLKQQGRSG-IKVIDFG 247
Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            S    +  Y              + +Y  PE  ++G    +    +D+WS+G I  + L
Sbjct: 248 SSCYEHQRVYTXIQ----------SRFYRAPEV-ILGA---RYGMPIDMWSLGCILAELL 293
Query: 503 YG 504
            G
Sbjct: 294 TG 295

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + PE        P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 82  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 140 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 182
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATE 528
           +P +   +     +I + + DVWS GV  ++ + +G KP+    +     E ++IL+  E
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 238
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            +    P  + +    +R C     + R
Sbjct: 239 -RLPQPPICTIDVYMIMRKCWMIDADSR 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G F EVH+  D  +Q    C V          KK       + E      L  PR+V
Sbjct: 66  VGRGSFGEVHRMKD--KQTGFQCAV----------KKVRLEVFRVEELVACAGLSSPRIV 113
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            LY     +       +E  +G  L   +KQ   + E  A   + Q +  L+YL+  +  
Sbjct: 114 PLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 170
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDF---------GLSKVMDEENYNPDHGMDLTSQGA 465
           ++H D+K  N+LL+         + DF         GL K +   +Y P           
Sbjct: 171 ILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIP----------- 217
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  ++ PE  V+GK      +KVD+WS   +    L G  P+
Sbjct: 218 GTETHMAPE-VVMGK---PCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 35/242 (14%)
Query: 272 HNEDQSRFNN--HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KE 328
           +++DQ  +    H  ++ RY +L ++GKG F +V KA+D K  ++VA K+ +  K + ++
Sbjct: 80  YDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ 139
Query: 329 DKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK- 387
             +   I   LR+ +    ++   V+ + + F    N  C   E     +L   +K++K 
Sbjct: 140 AAEEIRILEHLRKQDKDNTMN---VIHMLENFTF-RNHICMTFELLS-MNLYELIKKNKF 194
Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                 +  + A SI +Q + AL      K  +IH DLKP NILL +    G IK+ DFG
Sbjct: 195 QGFSLPLVRKFAHSI-LQCLDALH-----KNRIIHCDLKPENILLKQQGRSG-IKVIDFG 247
Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            S    +  Y              + +Y  PE  ++G    +    +D+WS+G I  + L
Sbjct: 248 SSCYEHQRVYTXIQ----------SRFYRAPEV-ILGA---RYGMPIDMWSLGCILAELL 293
Query: 503 YG 504
            G
Sbjct: 294 TG 295

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 81  CRLLGI--CLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 139 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 181
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 26/281 (9%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 73
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 74  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 133 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 184
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 185 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 235
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           E +         +    +  C A++ EDR   ++L   D+L
Sbjct: 236 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFL 273

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G F EVH+  D  +Q    C V          KK       + E      L  PR+V
Sbjct: 82  VGRGSFGEVHRMKD--KQTGFQCAV----------KKVRLEVFRVEELVACAGLSSPRIV 129
Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPP 414
            LY     +       +E  +G  L   +KQ   + E  A   + Q +  L+YL+  +  
Sbjct: 130 PLYGAVR-EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 186
Query: 415 VIHYDLKPGNILLTEGNVCGEIKITDF---------GLSKVMDEENYNPDHGMDLTSQGA 465
           ++H D+K  N+LL+         + DF         GL K +   +Y P           
Sbjct: 187 ILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIP----------- 233
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT  ++ PE  V+GK      +KVD+WS   +    L G  P+
Sbjct: 234 GTETHMAPE-VVMGK---PCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 26/281 (9%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 69
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 129 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 180
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 181 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 231
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           E +         +    +  C A++ EDR   ++L   D+L
Sbjct: 232 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFL 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 27/252 (10%)
Query: 324 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY 382
           K  K +   N+I    +E  I + L H  +VK   +   D  N    ++E+     L  Y
Sbjct: 56  KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 383 LKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
           L ++K  I  ++     +Q+   + YL   +   +H DL   N+L+   +   ++KI DF
Sbjct: 116 LPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH---QVKIGDF 170
Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC 501
           GL+K ++ +        D  S     +WY  PEC +  K    I+S  DVWS GV  ++ 
Sbjct: 171 GLTKAIETDKEXXTVKDDRDSP---VFWY-APECLMQSKF--YIAS--DVWSFGVTLHEL 222
Query: 502 L-----------YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLA 550
           L              K  G    Q T+      LK  + +    P   +E    +R C  
Sbjct: 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWE 281
Query: 551 YRKEDRIDVISL 562
           ++  +R    +L
Sbjct: 282 FQPSNRTSFQNL 293

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 26/281 (9%)
Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N   +LD
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAMHSLD 69
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           H  +++LY V         T L    G  LD   K              +QV   + YL 
Sbjct: 70  HRNLIRLYGVVLTPPMKMVTELAPL-GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   IH DL   N+LL   ++   +KI DFGL + + +   N DH +    +     W
Sbjct: 129 SKR--FIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 180
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATILEENTILKAT 527
             P             S   D W  GV  ++   YG++P+ G N SQ      + I K  
Sbjct: 181 CAPESL-----KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEG 231
Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           E +         +    +  C A++ EDR   ++L   D+L
Sbjct: 232 E-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFL 269

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 35/242 (14%)
Query: 272 HNEDQSRFNN--HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KE 328
           +++DQ  +    H  ++ RY +L ++GKG F +V KA+D K  ++VA K+ +  K + ++
Sbjct: 80  YDDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ 139
Query: 329 DKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK- 387
             +   I   LR+ +    ++   V+ + + F    N  C   E     +L   +K++K 
Sbjct: 140 AAEEIRILEHLRKQDKDNTMN---VIHMLENFTF-RNHICMTFELLS-MNLYELIKKNKF 194
Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                 +  + A SI +Q + AL      K  +IH DLKP NILL +    G IK+ DFG
Sbjct: 195 QGFSLPLVRKFAHSI-LQCLDALH-----KNRIIHCDLKPENILLKQQGRSG-IKVIDFG 247
Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            S    +  Y              + +Y  PE  ++G    +    +D+WS+G I  + L
Sbjct: 248 SSCYEHQRVYXXIQ----------SRFYRAPEV-ILGA---RYGMPIDMWSLGCILAELL 293
Query: 503 YG 504
            G
Sbjct: 294 TG 295

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 32/259 (12%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  AFD      VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHA---KRAYRELVLLKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +     H  +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++     N+       + +   
Sbjct: 140 KHLH--SAGIIHRDLKPSNIVVKSD---CTLKILDFGLARTAC-TNF-------MMTPYV 186
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
            T +Y  PE  ++G      ++ VD+WSVG I  + + G   F   Q    I + N +++
Sbjct: 187 VTRYYRAPE-VILGMG---YAANVDIWSVGCIMGELVKGCVIF---QGTDHIDQWNKVIE 239
Query: 526 -----ATEVQFANKPTVSN 539
                + E   A +PTV N
Sbjct: 240 QLGTPSAEFMAALQPTVRN 258

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 84  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 142 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 184
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 83  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 141 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 183
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 82  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 140 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 182
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 81  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 139 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 181
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 27/252 (10%)
Query: 324 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFY 382
           K  K +   N+I    +E  I + L H  +VK   +   D  N    ++E+     L  Y
Sbjct: 44  KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 103
Query: 383 LKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
           L ++K  I  ++     +Q+   + YL   +   +H DL   N+L+   +   ++KI DF
Sbjct: 104 LPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH---QVKIGDF 158
Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC 501
           GL+K ++ +        D  S     +WY  PEC +  K    I+S  DVWS GV  ++ 
Sbjct: 159 GLTKAIETDKEXXTVKDDRDSP---VFWY-APECLMQSKF--YIAS--DVWSFGVTLHEL 210
Query: 502 L-----------YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLA 550
           L              K  G    Q T+      LK  + +    P   +E    +R C  
Sbjct: 211 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWE 269
Query: 551 YRKEDRIDVISL 562
           ++  +R    +L
Sbjct: 270 FQPSNRTSFQNL 281

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 112 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSRGS 166
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 167 KFPVRWS------PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 105 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 162
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 163 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 214
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 215 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 246

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 23/237 (9%)
Query: 276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI 335
           Q    N  V +D    +  LG+G +  V K   +   +  A K  +   + +E K+    
Sbjct: 23  QGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRL--- 79
Query: 336 KHALREYNIH-KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY---LKQHKTIAE 391
              L + +I  + +D P  V  Y     + + +    E  D     FY   + + +TI E
Sbjct: 80  ---LXDLDISXRTVDCPFTVTFYGALFREGDVW-ICXELXDTSLDKFYKQVIDKGQTIPE 135
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
                I + +V AL++L+  K  VIH D+KP N+L+   N  G++K  DFG+S  + +  
Sbjct: 136 DILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLI---NALGQVKXCDFGISGYLVD-- 189
Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              D   D+    AG   Y  PE      N    S K D+WS+G+   +    + P+
Sbjct: 190 ---DVAKDI---DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 163
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 164 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 215
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 216 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKV 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD---ATLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD---ATLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + PE        P++         VD+WSVG I 
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 87  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 145 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 187
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +L  G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 87  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 145 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 187
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 83/203 (40%), Gaps = 30/203 (14%)
Query: 340 REYNIHKALDHPRVVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           +E +I + L H  ++K     E   A S   V+EY     L  YL +H +I   +     
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH DL   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEXYRVRE 195
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ----CLYGKKP----- 507
             D     +  +WY  PEC        K     DVWS GV  Y+    C   + P     
Sbjct: 196 DGD-----SPVFWY-APECL----KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245
Query: 508 --FGHNQSQATILEENTILKATE 528
              G  Q Q T+L    +L+  E
Sbjct: 246 ELIGIAQGQMTVLRLTELLERGE 268

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 127 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 181
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 182 KFPVRWS------PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 110
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 171 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 217
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 56/113 (49%), Gaps = 14/113 (12%)
Query: 397 IVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
           I +     L YL++   P +IH D+K  NILL E     E  + DFGL+K+MD   Y   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMD---YKDX 197
Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           H   +     GT  ++ PE    GK+    S K DV+  GV+  + + G++ F
Sbjct: 198 H---VXXAVRGTIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAF 243

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 119/268 (44%), Gaps = 31/268 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 82  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 140 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 182
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATE 528
           +P +   +     +I + + DVWS GV  ++ + +G KP+    +     E ++IL+  E
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEKGE 238
Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDR 556
            +    P  + +    +R C     + R
Sbjct: 239 -RLPQPPICTIDVYMIMRKCWMIDADSR 265

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +L  G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKV 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD---ATLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 31/271 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           L+GKG F +V+     +    VA ++  + +D  ED+    +K   RE   ++   H  V
Sbjct: 40  LIGKGRFGQVYHG---RWHGEVAIRLIDIERD-NEDQ----LKAFKREVMAYRQTRHENV 91
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE-REARSIVMQVVSALKYLNEIK 412
           V L+    +       +   C G  L   ++  K + +  + R I  ++V  + YL+   
Sbjct: 92  V-LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--A 148
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP 472
             ++H DLK  N+    G V     ITDFGL  +            D      G   +L 
Sbjct: 149 KGILHKDLKSKNVFYDNGKVV----ITDFGLFSI--SGVLQAGRREDKLRIQNGWLCHLA 202
Query: 473 PECFVVGKNPPK-------ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           PE  ++ +  P         S   DV+++G I+Y+    + PF    ++A I +  T +K
Sbjct: 203 PE--IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDR 556
               Q      +S+     +  C A+ +E+R
Sbjct: 261 PNLSQIGMGKEISD----ILLFCWAFEQEER 287

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 110
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 111 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 165
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 166 KFPVRWS------PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 111
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 172 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 218
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +         T L    G  LD Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 80  CRLLGICLTSTVQLITQL-MPFGCLLD-YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 138 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 180
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 118 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 172
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 173 KFPVRWS------PPEVLMY----SKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 40/231 (17%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 81
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 142 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 178
Query: 466 GTYWYLPPECFVVGK--NPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P  FVV +    P++         VD+WSVG I  + + G   F
Sbjct: 179 GTSFMMVP--FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 107 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 161
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 162 KFPVRWS------PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 84
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 144
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 145 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 191
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 90
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 151 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 197
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 92
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 153 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 199
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 29/261 (11%)
Query: 259 GYKNLHIRELKRIH------NEDQSRFNNHPVLSDRYLLLM---LLGKGGFSEVHKAFDL 309
           G +NL+ +    +H      N +  +   H V+    L++    ++G+G F  V+    L
Sbjct: 52  GSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 310 -KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC 368
             + + + C V  LN+     + + ++   +    I K   HP V+ L  +      S  
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 369 TVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL 427
            VL Y    DL +F   +      ++     +QV   +K+L   K   +H DL   N +L
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML 225
Query: 428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV-GKNPPKIS 486
            E      +K+ DFGL++ M ++ ++  H       GA     LP +   +      K +
Sbjct: 226 DEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----LPVKWMALESLQTQKFT 274
Query: 487 SKVDVWSVGVIFYQCLYGKKP 507
           +K DVWS GV+ ++ +    P
Sbjct: 275 TKSDVWSFGVLLWELMTRGAP 295

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 92
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 153 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 199
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 16/171 (9%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ + ++ Y    G 
Sbjct: 112 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 166
Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               + +      PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 167 KFPVRWS------PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 41/261 (15%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           VLS RY ++  LG+G F +V +  D K   R+VA K+ +    + E  ++      L   
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI--QVLEHL 68
Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER--EARSIVMQ 400
           N        R V++ + FE   +  C V E       DF +K++  +  R    R +  Q
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGH-ICIVFELLGLSTYDF-IKENGFLPFRLDHIRKMAYQ 126
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGN----------------VCGEIKITDFGLS 444
           +  ++ +L+  K  + H DLKP NIL  + +                +  +IK+ DFG  
Sbjct: 127 ICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182
Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCLY 503
                  Y+ +H   L S    T  Y  PE  + +G + P      DVWS+G I  +   
Sbjct: 183 ----SATYDDEHHSTLVS----TRHYRAPEVILALGWSQP-----CDVWSIGCILIEYYL 229
Query: 504 GKKPFGHNQSQATILEENTIL 524
           G   F  + S+  +     IL
Sbjct: 230 GFTVFPTHDSKEHLAMMERIL 250

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 91
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 152 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 198
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V +A  L E   VA K    +K +K            RE  I + + HP V
Sbjct: 47  VIGNGSFGVVFQA-KLVESDEVAIKKVLQDKRFKN-----------RELQIMRIVKHPNV 94
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDG---HDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           V L   F     + D      VLEY           Y K  +T+     +  + Q++ +L
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++ I   + H D+KP N+LL   +  G +K+ DFG +K++     N            
Sbjct: 155 AYIHSIG--ICHRDIKPQNLLLDPPS--GVLKLIDFGSAKILIAGEPN--------VSXI 202
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            + +Y  PE      N    ++ +D+WS G +  + + G+  F
Sbjct: 203 CSRYYRAPELIFGATN---YTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 89
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 149
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 150 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 196
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 80/203 (39%), Gaps = 30/203 (14%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           RE  I + L H  +VK     E     S   V+EY     L  YL +H  +   +     
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFA 118
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH  L   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 119 QQICEGMAYLH--AQHYIHRALAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRE 173
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ----CLYGKKP----- 507
             D     +  +WY  PEC        K     DVWS GV  Y+    C   + P     
Sbjct: 174 DGD-----SPVFWY-APECL----KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFT 223
Query: 508 --FGHNQSQATILEENTILKATE 528
              GH Q Q T+L    +L+  E
Sbjct: 224 ELIGHTQGQMTVLRLTELLERGE 246

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 364 ANSFCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKP 422
           A     V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK 
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKS 132
Query: 423 GNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKN 481
            NI L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KN
Sbjct: 133 NNIFLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKN 184
Query: 482 PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           P    S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 185 PYSFQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 90
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
           L+H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 91  LNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 150 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 208 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 80/203 (39%), Gaps = 30/203 (14%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           RE  I + L H  +VK     E     S   V+EY     L  YL +H  +   +     
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-CVGLAQLLLFA 117
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH  L   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 118 QQICEGMAYLH--AQHYIHRALAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRE 172
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ----CLYGKKP----- 507
             D     +  +WY  PEC        K     DVWS GV  Y+    C   + P     
Sbjct: 173 DGD-----SPVFWY-APECL----KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFT 222
Query: 508 --FGHNQSQATILEENTILKATE 528
              GH Q Q T+L    +L+  E
Sbjct: 223 ELIGHTQGQMTVLRLTELLERGE 245

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     + + ++   +    I K   HP 
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPN 87
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ Y   H       GA     L
Sbjct: 148 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYSVH----NKTGAK----L 194
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 80  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 137
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 138 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 189
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 190 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDCT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + PE        P++         VD+WSVG I 
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIM 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 140
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 141 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 192
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 193 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 163
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+   ++  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 164 FLHEDLT---VKIGDFGLAT--EKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 215
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 216 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 140
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 141 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 192
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 193 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 98  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 155
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+   ++  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 156 FLHEDLT---VKIGDFGLAT--EKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 207
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 208 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 239

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 80
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 177
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIFYQCLYGKKPF 508
           GT + + P         P++         VD+WSVG I  + + G   F
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L + + E  + +++  AL    I   
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL----IISK 104
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 105 FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 164 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 222 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 135
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+ V  +  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 136 FLHEDLT---VKIGDFGLATV--KSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 187
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 188 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 336 KHALREYNIHKALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
           K  LRE  +     HP ++ L D+F    E   +    V E            Q   I+ 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
           +  +  +  ++  L  L+E    V+H DL PGNILL + N   +I I DF L++  D  +
Sbjct: 134 QHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNN---DITICDFNLAR-EDTAD 187
Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            N  H +          WY  PE  +  K   K+   VD+WS G +  +    K  F
Sbjct: 188 ANKTHYV-------THRWYRAPELVMQFKGFTKL---VDMWSAGCVMAEMFNRKALF 234

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 104
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
           L+H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 105 LNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 164 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 222 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 336 KHALREYNIHKALDHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
           K  LRE  +     HP ++ L D+F    E   +    V E            Q   I+ 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
           +  +  +  ++  L  L+E    V+H DL PGNILL + N   +I I DF L++  D  +
Sbjct: 134 QHIQYFMYHILLGLHVLHE--AGVVHRDLHPGNILLADNN---DITICDFNLAR-EDTAD 187
Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            N  H +          WY  PE  +  K   K+   VD+WS G +  +    K  F
Sbjct: 188 ANKTHYV-------THRWYRAPELVMQFKGFTKL---VDMWSAGCVMAEMFNRKALF 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +L  G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 87  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFGL+K++  +E+ Y+ + G             
Sbjct: 145 --LVHRDLAARNVLVKTPQ---HVKITDFGLAKLLGAEEKEYHAEGGK------------ 187
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 93
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 154 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMLDKEFDSVH----NKTGAK----L 200
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 82  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 140 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 182
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     + + ++   +    I K   HP 
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPN 97
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 158 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----L 204
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     + + ++   +    I K   HP 
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPN 93
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 154 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----L 200
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 92
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 153 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----L 199
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 295 LGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LGKG F  V    +D L +       V QL      D++ ++     RE  I KAL    
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDF----QREIQILKALHSDF 72
Query: 353 VVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVVSALKYL 408
           +VK   V +     S   V+EY     L  +L++H+  A  +A  +++   Q+   ++YL
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYL 130
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
              +   +H DL   NIL+        +KI DFGL+K++  +    D+ +      +  +
Sbjct: 131 GSRR--CVHRDLAARNILVESE---AHVKIADFGLAKLLPLDK---DYYVVREPGQSPIF 182
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           WY P     +  N    S + DVWS GV+ Y+
Sbjct: 183 WYAPES---LSDN--IFSRQSDVWSFGVVLYE 209

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     + + ++   +    I K   HP 
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPN 92
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 153 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----L 199
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 295 LGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LGKG F  V    +D L +       V QL      D++ ++     RE  I KAL    
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDF----QREIQILKALHSDF 73
Query: 353 VVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVVSALKYL 408
           +VK   V +     S   V+EY     L  +L++H+  A  +A  +++   Q+   ++YL
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYL 131
Query: 409 NEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
              +   +H DL   NIL+ +E +V    KI DFGL+K++  +    D+ +      +  
Sbjct: 132 GSRR--CVHRDLAARNILVESEAHV----KIADFGLAKLLPLDK---DYYVVREPGQSPI 182
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           +WY P     +  N    S + DVWS GV+ Y+
Sbjct: 183 FWYAPES---LSDN--IFSRQSDVWSFGVVLYE 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 61  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 116
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 117 FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 176 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 234 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 282

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 295 LGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LGKG F  V    +D L +       V QL      D++ ++     RE  I KAL    
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDF----QREIQILKALHSDF 85
Query: 353 VVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVVSALKYL 408
           +VK   V +     S   V+EY     L  +L++H+  A  +A  +++   Q+   ++YL
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYL 143
Query: 409 NEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
              +   +H DL   NIL+ +E +V    KI DFGL+K++  +    D+ +      +  
Sbjct: 144 GSRR--CVHRDLAARNILVESEAHV----KIADFGLAKLLPLDK---DYYVVREPGQSPI 194
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           +WY P     +  N    S + DVWS GV+ Y+
Sbjct: 195 FWYAPES---LSDN--IFSRQSDVWSFGVVLYE 222

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG G F  V+K   + E   V  K+    K+ +E       K  L E  +  ++D+P V
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIK 412
            +L  +     ++   +++      L  Y+++HK  I  +   +  +Q+   + YL + +
Sbjct: 84  CRLLGI--CLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTYWY 470
             ++H DL   N+L+        +KITDFG +K++  +E+ Y+ + G             
Sbjct: 142 --LVHRDLAARNVLVKTPQ---HVKITDFGRAKLLGAEEKEYHAEGGK------------ 184
Query: 471 LPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-YGKKPF 508
           +P +   +     +I + + DVWS GV  ++ + +G KP+
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 88  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 198
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 199 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 248
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 249 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 288

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 80  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 190
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 191 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 240
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 241 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 280

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 117
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD---CTLKILDFGLART------------------A 214
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 77  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 132
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 187
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 188 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 237
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 238 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     + + ++   +    I K   HP 
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI----IMKDFSHPN 90
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+L   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++ ++  H       GA     L
Sbjct: 151 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVH----NKTGAK----L 197
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 90
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 91  FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 150 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 208 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 41  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 96
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 97  FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 156 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 214 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 262

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              V ++C+G  L  +L   +T  E  +   I  Q    + YL+     +IH DLK  NI
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNI 135
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF-VVGKNPPK 484
            L E      +KI DFGL+   ++  ++  H  +   Q +G+  ++ PE   +  KNP  
Sbjct: 136 FLHEDLT---VKIGDFGLAT--EKSRWSGSHQFE---QLSGSILWMAPEVIRMQDKNPYS 187
Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             S  DV++ G++ Y+ + G+ P+ +  ++  I+
Sbjct: 188 FQS--DVYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 52  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 107
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 108 FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +    Y    G  +
Sbjct: 167 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 225 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 273

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 88  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 198
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
               + ++ D     T+      W  P   F       +I + + DVWS GV+ ++    
Sbjct: 199 ----DIHHIDXXKKTTNGRLPVKWMAPEALF------DRIYTHQSDVWSFGVLLWEIFTL 248
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 249 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 288

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 51  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 106
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 107 FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 166 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 224 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 81  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 191
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 192 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 241
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 242 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 281

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 130
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 131 FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +    Y    G  +
Sbjct: 190 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 248 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 47/272 (17%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE---------- 328
           F   P    RY+L+  LG G FS V  A D+    +VA K+ + +K + E          
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 329 --DKKANYIKHALREYNIHKALDH-----PRVVKLYDVFEIDANSFCTVLEYCDGHDLDF 381
             +   N  + ++   +I K LDH     P  V +  VFE+   +   +++         
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY------- 123
Query: 382 YLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL----TEGNVCGEIK 437
              +H+ I     + I  Q++  L Y++  +  +IH D+KP N+L+    +  N+  +IK
Sbjct: 124 ---EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI-QIK 178
Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I D G +   DE   N             T  Y  PE  +            D+WS   +
Sbjct: 179 IADLGNACWYDEHYTN----------SIQTREYRSPEVLL----GAPWGCGADIWSTACL 224
Query: 498 FYQCLYGKKPFGHNQSQATILEENTILKATEV 529
            ++ + G   F  ++  +   +++ I +  E+
Sbjct: 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 18/174 (10%)
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALK 406
           L HP++VK Y V   +   +  V EY     L  YL+ H K +   +   +   V   + 
Sbjct: 60  LSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           +L   +   IH DL   N L+ + ++C  +K++DFG+++ + ++ Y    G     + + 
Sbjct: 119 FLESHQ--FIHRDLAARNCLV-DRDLC--VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILE 519
                 PE F    +  K SSK DVW+ G++ ++    GK P+    +   +L+
Sbjct: 174 ------PEVF----HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDXT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 74/324 (22%), Positives = 134/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     VA K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+L+   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVLIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQAR 333

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 90
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 91  FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 150 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 208 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 109/252 (43%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 163
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 164 S--QGIMHRDVKPHNVMID--HELRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 211
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 212 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 268
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 269 LNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 328
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 329 TALEAMTHPYFQ 340

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 72
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVKSDXT---LKILDFGLART------------------A 169
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 47/272 (17%)
Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE---------- 328
           F   P    RY+L+  LG G FS V  A D+    +VA K+ + +K + E          
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 329 --DKKANYIKHALREYNIHKALDH-----PRVVKLYDVFEIDANSFCTVLEYCDGHDLDF 381
             +   N  + ++   +I K LDH     P  V +  VFE+   +   +++         
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY------- 123
Query: 382 YLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL----TEGNVCGEIK 437
              +H+ I     + I  Q++  L Y++  +  +IH D+KP N+L+    +  N+  +IK
Sbjct: 124 ---EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI-QIK 178
Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I D G +   DE   N             T  Y  PE  +            D+WS   +
Sbjct: 179 IADLGNACWYDEHYTN----------SIQTREYRSPEVLL----GAPWGCGADIWSTACL 224
Query: 498 FYQCLYGKKPFGHNQSQATILEENTILKATEV 529
            ++ + G   F  ++  +   +++ I +  E+
Sbjct: 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 115/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V  A  +     K  R     V  L  D  E   ++ I      
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 73  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 183
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 184 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 233
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 234 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 273

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 14/113 (12%)
Query: 397 IVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
           I +     L YL++   P +IH D+K  NILL E     E  + DFGL+K+MD   Y   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMD---YKDX 189
Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           H   +     G   ++ PE    GK+    S K DV+  GV+  + + G++ F
Sbjct: 190 H---VXXAVRGXIGHIAPEYLSTGKS----SEKTDVFGYGVMLLELITGQRAF 235

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 88  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 143
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 198
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 199 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 248
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 249 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 288

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 89
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 90  FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 149 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 207 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKX 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDXT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 26  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 81
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  +LE   G DL  +L+       Q  ++A  +   +   
Sbjct: 82  FNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 141 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 199 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 247

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 143 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 191 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 308 TALEAMTHPYFQ 319

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 143
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 144 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 191
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 192 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 309 TALEAMTHPYFQ 320

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------------- 387
             I K   H  ++ L      D   +  ++EY    +L  YL+  +              
Sbjct: 129 KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 239
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS-KVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 240 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 289
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 290 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 329

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKX 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDXT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 143 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 191 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 308 TALEAMTHPYFQ 319

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 287 DRYLLLMLLGKGGFSEV--HKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR +L   LG+G F +V   +A  L   K  R     V  L  D  E   ++ I      
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ---------------- 385
             I K   H  ++ L      D   +  ++EY    +L  YL+                 
Sbjct: 88  KMIGK---HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            + ++ ++  S   QV   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV---MKIADFGLAR 198
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVGVIFYQCL-Y 503
            +   +Y        T+ G     ++ PE         +I + + DVWS GV+ ++    
Sbjct: 199 DIHHIDYYKK-----TTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTL 248
Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSC 548
           G  P+        + E   +LK  E    +KP+  +NE    +R C
Sbjct: 249 GGSPY----PGVPVEELFKLLK--EGHRMDKPSNCTNELYMMMRDC 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 20/217 (9%)
Query: 294 LLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+          +   L E  I K   HP 
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPN 91
Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +KYL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           K   +H DL   N +L E      +K+ DFGL++ M ++     H       GA     L
Sbjct: 152 K--FVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEXXSVH----NKTGAK----L 198
Query: 472 PPECFVV-GKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
           P +   +      K ++K DVWS GV+ ++ +    P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 80
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 177
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 117
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD---CTLKILDFGLART------------------A 214
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  +GKG F +V        +  V C         K D  A      L E ++   L H
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAF---LAEASVMTQLRH 73
Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYL 408
             +V+L  V   +      V EY   G  +D+   + +++   +      + V  A++YL
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  +H DL   N+L++E NV    K++DFGL+K   E +   D G       A   
Sbjct: 134 E--GNNFVHRDLAARNVLVSEDNVA---KVSDFGLTK---EASSTQDTGKLPVKWTA--- 182
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 183 ----PEAL----REKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 143 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 191 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 308 TALEAMTHPYFQ 319

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/331 (22%), Positives = 138/331 (41%), Gaps = 60/331 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGRQSASSSA 584
           + R+       H Y  P V +  +  A ++ 
Sbjct: 310 QSRLTAREAMEHPYFYPVVKEQSQPCADNAV 340

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 78
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 139 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 175
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 176 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 214

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 39/260 (15%)
Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           VLS RY ++  LG+G F +V +  D K   R+VA K+ +    + E  ++      L   
Sbjct: 11  VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI--QVLEHL 68
Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAER--EARSIVMQ 400
           N        R V++ + FE      C V E       DF +K++  +  R    R +  Q
Sbjct: 69  NTTDPNSTFRCVQMLEWFE-HHGHICIVFELLGLSTYDF-IKENGFLPFRLDHIRKMAYQ 126
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGN----------------VCGEIKITDFGLS 444
           +  ++ +L+  K  + H DLKP NIL  + +                +  +IK+ DFG S
Sbjct: 127 ICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S 183
Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
              D+E++        ++     ++  P     +G + P      DVWS+G I  +   G
Sbjct: 184 ATYDDEHH--------STLVXXRHYRAPEVILALGWSQP-----CDVWSIGCILIEYYLG 230
Query: 505 KKPFGHNQSQATILEENTIL 524
              F  + S+  +     IL
Sbjct: 231 FTVFPTHDSKEHLAMMERIL 250

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSD--CT-LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 80
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++     C  +KI DFGL++                   A
Sbjct: 141 KHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLART------------------A 177
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 144
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 145 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 192
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 193 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 249
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 250 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 309
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 310 TALEAMTHPYFQ 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 143
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 144 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 191
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 192 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 248
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 249 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 308
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 309 TALEAMTHPYFQ 320

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 37/201 (18%)
Query: 339 LREYNIHKA-----LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ---HKTIA 390
           LRE   H+A     L HP VV L  V   D      +  YC   DL  +L     H  + 
Sbjct: 72  LREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 391 ----EREARS---------IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
               +R  +S         +V Q+ + ++YL+     V+H DL   N+L+ +      +K
Sbjct: 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL---NVK 185
Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I+D GL +    E Y  D+   L +      W + PE  + GK     S   D+WS GV+
Sbjct: 186 ISDLGLFR----EVYAADYYKLLGNSLLPIRW-MAPEAIMYGK----FSIDSDIWSYGVV 236
Query: 498 FYQCL-YGKKPFGHNQSQATI 517
            ++   YG +P+    +Q  +
Sbjct: 237 LWEVFSYGLQPYCGYSNQDVV 257

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 22/174 (12%)
Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           + E  +   L H ++V+LY V       F       +G  L++  +       ++   + 
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPDHG 457
             V  A++YL       +H DL   N L+ +  V   +K++DFGLS+ V+D+E       
Sbjct: 127 KDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE------- 174
Query: 458 MDLTSQGAG--TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            + +S G+     W  PPE  +  K     SSK D+W+ GV+ ++    GK P+
Sbjct: 175 -ETSSVGSKFPVRWS-PPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 143 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 191 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 308 TALEAMTHPYFQ 319

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F EV  A   K  + VA K  +          +  ++  L E N+ K L H ++V
Sbjct: 190 LGAGQFGEVWMATYNKHTK-VAVKTMK--------PGSMSVEAFLAEANVMKTLQHDKLV 240
Query: 355 KLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSI--VMQVVSALKYLNEI 411
           KL+ V  +       + E+   G  LDF LK  +   +   + I    Q+   + ++ + 
Sbjct: 241 KLHAV--VTKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 297
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               IH DL+  NIL++   VC   KI DFGL++V          G     +      + 
Sbjct: 298 N--YIHRDLRAANILVSASLVC---KIADFGLARV----------GAKFPIK------WT 336
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            PE    G      + K DVWS G++  + + YG+ P+
Sbjct: 337 APEAINFG----SFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 73
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVKSD---CTLKILDFGLART------------------A 170
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 209

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSAL 405
           HP +V L   F  + N    + +Y +  +L  +L        +++  +   I +     L
Sbjct: 94  HPHLVSLIG-FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     +IH D+K  NILL E  V    KITDFG+SK   E +        L     
Sbjct: 153 HYLH--TRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELDQT-----HLXXVVK 202
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
           GT  Y+ PE F+ G+    ++ K DV+S GV+ ++ L  +
Sbjct: 203 GTLGYIDPEYFIKGR----LTEKSDVYSFGVVLFEVLCAR 238

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 73
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVKSD---CTLKILDFGLART------------------A 170
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 209

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/252 (22%), Positives = 108/252 (42%), Gaps = 51/252 (20%)
Query: 351 PRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL Y +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 142
Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
                ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A  Y 
Sbjct: 143 --SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVASRY- 190
Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI---------- 517
           +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +          
Sbjct: 191 FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG 247
Query: 518 ---------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRKEDRI 557
                    +E +  L+A   + + KP            VS EA  F+   L Y  ++R+
Sbjct: 248 LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERL 307
Query: 558 DVISLARHDYLQ 569
             +    H Y Q
Sbjct: 308 TALEAMTHPYFQ 319

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKG F +  K    +    +  K  +L + + E+ +  ++K    E  + + L+HP V
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMK--ELIR-FDEETQRTFLK----EVKVMRCLEHPNV 69
Query: 354 VKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYLNEI 411
           +K   V   D   +F T  EY  G  L   +K   +      R S    + S + YL+ +
Sbjct: 70  LKFIGVLYKDKRLNFIT--EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG------- 464
              +IH DL   N L+ E      + + DFGL+++M +E   P+    L           
Sbjct: 128 N--IIHRDLNSHNCLVRENK---NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
            G  +++ PE      N      KVDV+S G++  + +
Sbjct: 183 VGNPYWMAPEMI----NGRSYDEKVDVFSFGIVLCEII 216

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 89
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  ++E   G DL  +L+       Q  ++A  +   +   
Sbjct: 90  FNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 149 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 207 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 84
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 145 KHLHSAG--IIHRDLKPSNIVVKSDCT---LKILDFGLART------------------A 181
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 182 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIM 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 72
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 133 KHLHSAG--IIHRDLKPSNIVVKSD---CTLKILDFGLART------------------A 169
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  +GKG F +V        +  V C         K D  A      L E ++   L H
Sbjct: 10  LLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAF---LAEASVMTQLRH 58
Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYL 408
             +V+L  V   +      V EY   G  +D+   + +++   +      + V  A++YL
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  +H DL   N+L++E NV    K++DFGL+K   E +   D G       A   
Sbjct: 119 E--GNNFVHRDLAARNVLVSEDNVA---KVSDFGLTK---EASSTQDTGKLPVKWTA--- 167
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 168 ----PEAL----REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D    R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHA---KRAYRELVLMKX 79
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDXT---LKILDFGLART------------------A 176
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 37/201 (18%)
Query: 339 LREYNIHKA-----LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ---HKTIA 390
           LRE   H+A     L HP VV L  V   D      +  YC   DL  +L     H  + 
Sbjct: 55  LREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 391 ----EREARS---------IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
               +R  +S         +V Q+ + ++YL+     V+H DL   N+L+ +      +K
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL---NVK 168
Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I+D GL +    E Y  D+   L +      W + PE  + GK     S   D+WS GV+
Sbjct: 169 ISDLGLFR----EVYAADYYKLLGNSLLPIRW-MAPEAIMYGK----FSIDSDIWSYGVV 219
Query: 498 FYQCL-YGKKPFGHNQSQATI 517
            ++   YG +P+    +Q  +
Sbjct: 220 LWEVFSYGLQPYCGYSNQDVV 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 27/238 (11%)
Query: 291 LLMLLGKGGFSEVHK---AFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++   +    +   +   V  L +   E  + +++  AL    I   
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL----IISK 104
Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK-------QHKTIAEREARSIVMQ 400
            +H  +V+   V       F  ++E   G DL  +L+       Q  ++A  +   +   
Sbjct: 105 FNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +    +YL E     IH D+   N LLT        KI DFG+++ +   +Y    G  +
Sbjct: 164 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
                    ++PPE F+ G      +SK D WS GV+ ++    G  P+    +Q  +
Sbjct: 222 LPVK-----WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSAL 405
           HP +V L   F  + N    + +Y +  +L  +L        +++  +   I +     L
Sbjct: 94  HPHLVSLIG-FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     +IH D+K  NILL E  V    KITDFG+SK   E          L     
Sbjct: 153 HYLH--TRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELGQT-----HLXXVVK 202
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
           GT  Y+ PE F+ G+    ++ K DV+S GV+ ++ L  +
Sbjct: 203 GTLGYIDPEYFIKGR----LTEKSDVYSFGVVLFEVLCAR 238

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  +GKG F +V        +  V C         K D  A      L E ++   L H
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAF---LAEASVMTQLRH 245
Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYL 408
             +V+L  V   +      V EY   G  +D+   + +++   +      + V  A++YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  +H DL   N+L++E NV    K++DFGL+K   E +   D G       A   
Sbjct: 306 E--GNNFVHRDLAARNVLVSEDNVA---KVSDFGLTK---EASSTQDTGKLPVKWTA--- 354
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 355 ----PEAL----REKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D   LL L+G+G +  V+K     ++R VA KV           + N+I     E NI++
Sbjct: 13  DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFAN------RQNFIN----EKNIYR 60
Query: 347 A--LDHPRVVKLYDVFE-IDANS---FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
              ++H  + +     E + A+    +  V+EY     L  YL  H +      R +   
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR-LAHS 119
Query: 401 VVSALKYL-------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS-KVMDEENY 452
           V   L YL       +  KP + H DL   N+L+     C    I+DFGLS ++      
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC---VISDFGLSMRLTGNRLV 176
Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS---KVDVWSVGVIFYQCL 502
            P    +      GT  Y+ PE      N     S   +VD++++G+I+++  
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           RY  L  +G G    V  A+D   +R VA K  +L++ ++    A   K A RE  + K 
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHA---KRAYRELVLMKC 73
Query: 348 LDHPRVVKLYDVF--EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           ++H  ++ L +VF  +     F  V    +  D +        +       ++ Q++  +
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           K+L+     +IH DLKP NI++        +KI DFGL++                   A
Sbjct: 134 KHLHSAG--IIHRDLKPSNIVVKSDCT---LKILDFGLART------------------A 170
Query: 466 GTYWYLPPECFVVGKNPPKI------SSKVDVWSVGVIF 498
           GT + + P         P++         VD+WSVG I 
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIM 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 47/228 (20%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           L+G GGF +V KA   +  + YV  +V   N            + A RE      LDH  
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVN 65
Query: 353 VV---KLYDVFEID----------ANSFCTV--LEYCDGHDLDFYLKQHK--TIAEREAR 395
           +V     +D F+ D          + + C    +E+CD   L+ ++++ +   + +  A 
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            +  Q+   + Y++  K  +I+ DLKP NI L +     ++KI DFGL   +  +     
Sbjct: 126 ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTK---QVKIGDFGLVTSLKNDGKR-- 178
Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
                  +  GT  Y+ PE      +      +VD++++G+I  + L+
Sbjct: 179 ------XRSKGTLRYMSPEQI----SSQDYGKEVDLYALGLILAELLH 216

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 82/203 (40%), Gaps = 30/203 (14%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           +E +I + L H  ++K     E     S   V+EY     L  YL +H +I   +     
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 123
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH +L   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 124 QQICEGMAYLHSQH--YIHRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRE 178
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ----CLYGKKP----- 507
             D     +  +WY  PEC        K     DVWS GV  Y+    C   + P     
Sbjct: 179 DGD-----SPVFWY-APECL----KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 228
Query: 508 --FGHNQSQATILEENTILKATE 528
              G  Q Q T+L    +L+  E
Sbjct: 229 ELIGIAQGQMTVLRLTELLERGE 251

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 395 RSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           +  + Q++ ++  L+     V H D+KP N+L+ E +  G +K+ DFG +K +     N 
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD--GTLKLCDFGSAKKLSPSEPNV 189
Query: 455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
            +          + +Y  PE  + G      ++ VD+WSVG IF + + G+  F  + S 
Sbjct: 190 AY--------ICSRYYRAPE-LIFGNQ--HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 515 ATILEENTIL 524
             + E   +L
Sbjct: 239 GQLHEIVRVL 248

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 73/328 (22%), Positives = 135/328 (41%), Gaps = 60/328 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGRQSAS 581
           + R+       H Y    V    R  +S
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQARMGSS 337

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 33/221 (14%)
Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  +GKG F +V        +  V C         K D  A      L E ++   L H
Sbjct: 16  LLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAF---LAEASVMTQLRH 64
Query: 351 PRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREAR-SIVMQVVSALKYL 408
             +V+L  V   +      V EY   G  +D+   + +++   +      + V  A++YL
Sbjct: 65  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 124
Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
                  +H DL   N+L++E NV    K++DFGL+K   E +   D G       A   
Sbjct: 125 E--GNNFVHRDLAARNVLVSEDNVA---KVSDFGLTK---EASSTQDTGKLPVKWTA--- 173
Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               PE           S+K DVWS G++ ++   +G+ P+
Sbjct: 174 ----PEAL----REAAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 82/203 (40%), Gaps = 30/203 (14%)
Query: 340 REYNIHKALDHPRVVKLYDVFEIDAN-SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           +E +I + L H  ++K     E     S   V+EY     L  YL +H +I   +     
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 123
Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE--ENYNPDH 456
            Q+   + YL+      IH +L   N+LL    +   +KI DFGL+K + E  E Y    
Sbjct: 124 QQICEGMAYLHAQH--YIHRNLAARNVLLDNDRL---VKIGDFGLAKAVPEGHEYYRVRE 178
Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ----CLYGKKP----- 507
             D     +  +WY  PEC        K     DVWS GV  Y+    C   + P     
Sbjct: 179 DGD-----SPVFWY-APECL----KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 228
Query: 508 --FGHNQSQATILEENTILKATE 528
              G  Q Q T+L    +L+  E
Sbjct: 229 ELIGIAQGQMTVLRLTELLERGE 251

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 295 LGKGGFSEVHKA-FD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LGKG F  V    +D L +       V QL      D++ ++     RE  I KAL    
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDF----QREIQILKALHSDF 69
Query: 353 VVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM---QVVSALKYL 408
           +VK   V +         V+EY     L  +L++H+  A  +A  +++   Q+   ++YL
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYL 127
Query: 409 NEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
              +   +H DL   NIL+ +E +V    KI DFGL+K++  +    D  +      +  
Sbjct: 128 GSRR--CVHRDLAARNILVESEAHV----KIADFGLAKLLPLDK---DXXVVREPGQSPI 178
Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           +WY P     +  N    S + DVWS GV+ Y+
Sbjct: 179 FWYAPES---LSDN--IFSRQSDVWSFGVVLYE 206

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 111
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 172 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 219
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 220 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 275

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 154
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 215 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 262
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 263 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 318

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 73/326 (22%), Positives = 134/326 (41%), Gaps = 60/326 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGRQS 579
           + R+       H Y    V    R S
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQARMS 335

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 113
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 174 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 221
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 222 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 277

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 109
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 170 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 217
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 218 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 66/268 (24%)
Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           S +Y L   LG G F  V + FD++  +  A K     K  ++ +  N      RE +I 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRYKN------RELDIM 54
Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHD-------------------------LD 380
           K LDH  ++KL D F    +      +  D H+                         L+
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 381 FYLKQ-----HKTIAE--REARSIVMQVVS--------ALKYLNEIKPPVIHYDLKPGNI 425
             ++      HK +    R  RSI M ++S        A+ +++ +   + H D+KP N+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNL 172
Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI 485
           L+   +    +K+ DFG +K +           + +     + +Y  PE  +      + 
Sbjct: 173 LVNSKD--NTLKLCDFGSAKKLIPS--------EPSVAXICSRFYRAPELMLGAT---EY 219
Query: 486 SSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
           +  +D+WS+G +F + + GK  F    S
Sbjct: 220 TPSIDLWSIGCVFGELILGKPLFSGETS 247

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 109
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 170 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 215
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 216 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 524 L 524
           L
Sbjct: 273 L 273

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 103
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 164 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 211
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 212 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 80
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 141 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 188
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 189 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 244

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           L +RY ++  LG+G F  V +  D +     VA K+ +  + +KE  +     + L + N
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEI--NVLEKIN 88
Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE--REARSIVMQV 401
                +    V+++D F+   +  C   E       DF LK +  +     + R +  Q+
Sbjct: 89  EKDPDNKNLCVQMFDWFDYHGH-MCISFELLGLSTFDF-LKDNNYLPYPIHQVRHMAFQL 146
Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNV----------------CGEIKITDFGLSK 445
             A+K+L++ K  + H DLKP NIL    +                    +++ DFG S 
Sbjct: 147 CQAVKFLHDNK--LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG-SA 203
Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCLYG 504
             D E++         S    T  Y  PE  + +G + P      DVWS+G I ++   G
Sbjct: 204 TFDHEHH---------STIVSTRHYRAPEVILELGWSQP-----CDVWSIGCIIFEYYVG 249
Query: 505 KKPF 508
              F
Sbjct: 250 FTLF 253

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 67/134 (50%), Gaps = 19/134 (14%)
Query: 377 HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
            D D + K+  T+ +  + S   QV   +++L+  K   IH DL   NILL+E NV   +
Sbjct: 186 EDSDGFYKEPITMEDLISYSF--QVARGMEFLSSRK--CIHRDLAARNILLSENNV---V 238
Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKI-SSKVDVWSVG 495
           KI DFGL++ + +   NPD+     ++     W  P   F       KI S+K DVWS G
Sbjct: 239 KICDFGLARDIYK---NPDYVRKGDTR-LPLKWMAPESIF------DKIYSTKSDVWSYG 288
Query: 496 VIFYQCL-YGKKPF 508
           V+ ++    G  P+
Sbjct: 289 VLLWEIFSLGGSPY 302

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 60/241 (24%)
Query: 294 LLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           L+G GGF +V KA   +  + YV  +V   N            + A RE      LDH  
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN------------EKAEREVKALAKLDHVN 66
Query: 353 VV---KLYDVFEID-----------------------ANSFCTV--LEYCDGHDLDFYLK 384
           +V     +D F+ D                       + + C    +E+CD   L+ +++
Sbjct: 67  IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 385 QHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
           + +   + +  A  +  Q+   + Y++  K  +IH DLKP NI L +     ++KI DFG
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLVDTK---QVKIGDFG 181
Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           L   +  +           ++  GT  Y+ PE      +      +VD++++G+I  + L
Sbjct: 182 LVTSLKNDGKR--------TRSKGTLRYMSPEQI----SSQDYGKEVDLYALGLILAELL 229
Query: 503 Y 503
           +
Sbjct: 230 H 230

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 88
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 149 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSY--------I 196
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 197 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 87
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 148 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 193
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 194 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250
Query: 524 L 524
           L
Sbjct: 251 L 251

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E+  ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D+    T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D+  + T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDYYKNTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS---------- 181
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 182 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 524 L 524
           L
Sbjct: 239 L 239

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/327 (22%), Positives = 134/327 (40%), Gaps = 60/327 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGRQSA 580
           + R+       H Y    V    R  +
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQARMGS 336

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K     K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS---------- 181
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 182 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 524 L 524
           L
Sbjct: 239 L 239

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/316 (21%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y ++  +G+G +SEV +  ++       C +       K  K     K       +  
Sbjct: 31  DDYEVVRKVGRGKYSEVFEGINVNNNE--KCII-------KILKPVKKKKIKREIKILQN 81
Query: 347 ALDHPRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
            +  P +VKL D+  +  + +   + EY +  D       + T+ + + R  + +++ AL
Sbjct: 82  LMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKV---LYPTLTDYDIRYYIYELLKAL 138
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y +     ++H D+KP N+++       ++++ D+GL+     E Y+P  G +   + A
Sbjct: 139 DYCH--SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA-----EFYHP--GKEYNVRVA 187
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATI------ 517
             Y +  PE  V   +       +D+WS+G +F   ++ K+PF  GH+     +      
Sbjct: 188 SRY-FKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 243
Query: 518 -------------LEENTILKATEVQFANKP-----------TVSNEAKGFIRSCLAYRK 553
                        +E +  L+A   + + KP            VS EA  F+   L Y  
Sbjct: 244 GTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDH 303
Query: 554 EDRIDVISLARHDYLQ 569
           ++R+  +    H Y Q
Sbjct: 304 QERLTALEAMTHPYFQ 319

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 94
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 155 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 200
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 201 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 257
Query: 524 L 524
           L
Sbjct: 258 L 258

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 83
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 144 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 189
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 190 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 246
Query: 524 L 524
           L
Sbjct: 247 L 247

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 87
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 148 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 193
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 194 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 250
Query: 524 L 524
           L
Sbjct: 251 L 251

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 87
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIV----- 398
            + H   VV L             ++E+C   +L  YL  K+++ +  +EA   +     
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIYK 202
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
              +PD+      +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 203 ---DPDY----VRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 250
Query: 506 KPF 508
            P+
Sbjct: 251 SPY 253

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 95
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 96  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 149
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 150 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 198
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 199 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 254
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 255 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 314
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 315 QSRLTAREAMEHPYFYTVVKDQAR 338

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSY--------I 183
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 184 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQAR 333

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 89
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 90  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 143
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 144 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 192
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 193 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 308
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 309 QSRLTAREAMEHPYFYTVVKDQAR 332

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQAR 333

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQAR 333

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 79
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 140 AYIHSFG--ICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVS---------- 185
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 186 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 242
Query: 524 L 524
           L
Sbjct: 243 L 243

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS---------- 181
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 182 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 524 L 524
           L
Sbjct: 239 L 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS---------- 181
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 182 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 524 L 524
           L
Sbjct: 239 L 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K    +K +K            RE  I + LDH  +
Sbjct: 28  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMRKLDHCNI 76
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK--VMDEENYNPDHGMDLTSQ 463
            Y++     + H D+KP N+LL        +K+ DFG +K  V  E N +          
Sbjct: 137 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVS---------- 182
Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
              + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +
Sbjct: 183 XICSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 239
Query: 524 L 524
           L
Sbjct: 240 L 240

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+GGF  V+K + +        K+  +     E+ K  +     +E  +     H  +V
Sbjct: 39  MGEGGFGVVYKGY-VNNTTVAVKKLAAMVDITTEELKQQFD----QEIKVMAKCQHENLV 93
Query: 355 KLYDVFEIDANSFCTVLEYC-DGHDLDFY--LKQHKTIAEREARSIVMQVVSALKYLNEI 411
           +L   F  D +  C V  Y  +G  LD    L     ++      I     + + +L+E 
Sbjct: 94  ELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN 152
Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               IH D+K  NILL E       KI+DFGL++  ++          + S+  GT  Y+
Sbjct: 153 HH--IHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTV-----MXSRIVGTTAYM 202
Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
            PE         +I+ K D++S GV+  + + G
Sbjct: 203 APEAL-----RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 76
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIV 398
            + H   VV L             ++E+C   +L  YL+        +K   E   +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIXK 191
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
           +        D   +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 192 DP-------DXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 506 KPF 508
            P+
Sbjct: 240 SPY 242

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D     T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K     K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSY--------I 183
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 184 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 34/239 (14%)
Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           ++G G F  V++A        VA K     K +K            RE  I + LDH  +
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----------RELQIMRKLDHCNI 75
Query: 354 VKLYDVF-----EIDANSFCTVLEYCDGHDLDF---YLKQHKTIAEREARSIVMQVVSAL 405
           V+L   F     + D      VL+Y           Y +  +T+     +  + Q+  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y++     + H D+KP N+LL        +K+ DFG +K +     N  +         
Sbjct: 136 AYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSY--------I 183
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            + +Y  PE  + G      +S +DVWS G +  + L G+  F  +     ++E   +L
Sbjct: 184 CSRYYRAPE-LIFGAT--DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 24/165 (14%)
Query: 382 YLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL--------------L 427
           +L    +++ +E R  ++ +  ALK +++    ++H D+KP N L              L
Sbjct: 107 FLDILNSLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGL 164
Query: 428 TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG-----AGTYWYLPPECFVVGKNP 482
            +G    +I++  F  S+   E        + L+ +      AGT  +  PE  V+ K P
Sbjct: 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE--VLTKCP 222
Query: 483 PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
            + ++ +D+WS GVIF   L G+ PF       T L +   ++ +
Sbjct: 223 NQ-TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS 266

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIITLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D+    T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 95/243 (39%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 85
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIV 398
            + H   VV L             ++E+C   +L  YL+        +K   E   +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIXK 200
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
           +        D   +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 201 DP-------DXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 506 KPF 508
            P+
Sbjct: 249 SPY 251

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 122
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIV 398
            + H   VV L             ++E+C   +L  YL+        +K   E   +  +
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIYK 237
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
              +PD+      +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 238 ---DPDY----VRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 285
Query: 506 KPF 508
            P+
Sbjct: 286 SPY 288

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 145
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 146 HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 205 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 255
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D+    T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIINLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D     T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDXXKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 89
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 90  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 143
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 144 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 192
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H
Sbjct: 193 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 92/234 (39%), Gaps = 40/234 (17%)
Query: 295 LGKGGFSEV--HKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DH 350
           LG G F +V    AF L KE   +   V  L      D+K    +  + E  I   L  H
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK----EALMSELKIMSHLGQH 109
Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ--------------HKTIAEREARS 396
             +V L             + EYC   DL  +L++              + T++ R+   
Sbjct: 110 ENIVNLLGACT-HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNPD 455
              QV   + +L       IH D+   N+LLT G+V    KI DFGL++ +M++ NY   
Sbjct: 169 FSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMNDSNYIVK 223
Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               L  +     W  P   F         + + DVWS G++ ++    G  P+
Sbjct: 224 GNARLPVK-----WMAPESIF-----DCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 72/324 (22%), Positives = 132/324 (40%), Gaps = 60/324 (18%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 90
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ  +T+ + + R  + +++ AL
Sbjct: 91  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLRQTLTDYDIRFYMYEILKAL 144
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 145 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 193
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H       L     + 
Sbjct: 194 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 249
Query: 526 ATE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRK 553
            TE                                V   N+  VS EA  F+   L Y  
Sbjct: 250 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 309
Query: 554 EDRIDVISLARHDYLQPPVPKHGR 577
           + R+       H Y    V    R
Sbjct: 310 QSRLTAREAMEHPYFYTVVKDQAR 333

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   ++      N+  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE------NLRG 88
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSAL 405
               P ++ L D+ + D  S    L +   ++ DF  KQ ++T+ + + R  + +++ AL
Sbjct: 89  G---PNIITLADIVK-DPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKAL 142
Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y + +   ++H D+KP N+++   +   ++++ D+GL+     E Y+P  G +   + A
Sbjct: 143 DYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EFYHP--GQEYNVRVA 191
Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
             Y +  PE  V   +       +D+WS+G +    ++ K+PF H
Sbjct: 192 SRY-FKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/330 (20%), Positives = 132/330 (40%), Gaps = 58/330 (17%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+ +  K  K  ++   +++     NI K
Sbjct: 38  DDYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIK 97
Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            +D         V +  + +   V EY +  D     + ++ + + + R  + +++ AL 
Sbjct: 98  LID--------TVKDPVSKTPALVFEYINNTDFK---QLYQILTDFDIRFYMYELLKALD 146
Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y +     ++H D+KP N+++       ++++ D+GL+     E Y+P    ++      
Sbjct: 147 YCH--SKGIMHRDVKPHNVMIDHQQ--KKLRLIDWGLA-----EFYHPAQEYNVR---VA 194
Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           + ++  PE  V   +       +D+WS+G +    ++ ++PF H Q     L     +  
Sbjct: 195 SRYFKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLG 251
Query: 527 TE--------------------------------VQFANKPTVSNEAKGFIRSCLAYRKE 554
           TE                                +   N+  VS EA   +   L Y  +
Sbjct: 252 TEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQ 311
Query: 555 DRIDVISLARHDYLQPPVPKHGRQSASSSA 584
            R+       H Y  P V +  + SA ++ 
Sbjct: 312 QRLTAKEAMEHPYFYPVVKEQSQPSADNAV 341

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 40/236 (16%)
Query: 295 LGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG+G F +V  A  +     K +  V   V  L  D  E   ++ +        I K   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--- 99
Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAERE 393
           H  ++ L      D   +  ++EY    +L  YL+  +                 +  ++
Sbjct: 100 HKNIIHLLGACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
             S   Q+   ++YL   K   IH DL   N+L+TE NV   +KI DFGL++ ++    N
Sbjct: 159 LVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV---MKIADFGLARDIN----N 209
Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            D+    T+      W  P   F         + + DVWS GV+ ++    G  P+
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 45/262 (17%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKK--ANYIKHALRE 341
           L +RY ++  LG+G F +V +  D  + +  VA K+ +    ++E  +   N +K    +
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 85
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVM 399
              +K L     V + D F    +  C   E    +  +F LK++  +       R +  
Sbjct: 86  DKENKFL----CVLMSDWFNFHGH-MCIAFELLGKNTFEF-LKENNFQPYPLPHVRHMAY 139
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLT---------EGNVCGE-------IKITDFGL 443
           Q+  AL++L+E +  + H DLKP NIL           E   C E       I++ DFG 
Sbjct: 140 QLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 196
Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCL 502
           S   D E++         +    T  Y PPE  + +G   P      DVWS+G I ++  
Sbjct: 197 SATFDHEHH---------TTIVATRHYRPPEVILELGWAQP-----CDVWSIGCILFEYY 242
Query: 503 YGKKPFGHNQSQATILEENTIL 524
            G   F  ++++  ++    IL
Sbjct: 243 RGFTLFQTHENREHLVMMEKIL 264

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 85
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIV 398
            + H   VV L             ++E+C   +L  YL+        +K   E   +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIYK 200
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
              +PD+      +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 201 ---DPDY----VRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 506 KPF 508
            P+
Sbjct: 249 SPY 251

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 45/262 (17%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKK--ANYIKHALRE 341
           L +RY ++  LG+G F +V +  D  + +  VA K+ +    ++E  +   N +K    +
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVM 399
              +K L     V + D F    +  C   E    +  +F LK++  +       R +  
Sbjct: 77  DKENKFL----CVLMSDWFNFHGH-MCIAFELLGKNTFEF-LKENNFQPYPLPHVRHMAY 130
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLT---------EGNVCGE-------IKITDFGL 443
           Q+  AL++L+E +  + H DLKP NIL           E   C E       I++ DFG 
Sbjct: 131 QLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187
Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCL 502
           S   D E++         +    T  Y PPE  + +G   P      DVWS+G I ++  
Sbjct: 188 SATFDHEHH---------TTIVATRHYRPPEVILELGWAQP-----CDVWSIGCILFEYY 233
Query: 503 YGKKPFGHNQSQATILEENTIL 524
            G   F  ++++  ++    IL
Sbjct: 234 RGFTLFQTHENREHLVMMEKIL 255

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 112/262 (42%), Gaps = 45/262 (17%)
Query: 285 LSDRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKK--ANYIKHALRE 341
           L +RY ++  LG+G F +V +  D  + +  VA K+ +    ++E  +   N +K    +
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 108
Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVM 399
              +K L     V + D F    +  C   E    +  +F LK++  +       R +  
Sbjct: 109 DKENKFL----CVLMSDWFNFHGH-MCIAFELLGKNTFEF-LKENNFQPYPLPHVRHMAY 162
Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLT---------EGNVCGE-------IKITDFGL 443
           Q+  AL++L+E +  + H DLKP NIL           E   C E       I++ DFG 
Sbjct: 163 QLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 219
Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPKISSKVDVWSVGVIFYQCL 502
           S   D E++         +    T  Y PPE  + +G   P      DVWS+G I ++  
Sbjct: 220 SATFDHEHH---------TTIVATRHYRPPEVILELGWAQP-----CDVWSIGCILFEYY 265
Query: 503 YGKKPFGHNQSQATILEENTIL 524
            G   F  ++++  ++    IL
Sbjct: 266 RGFTLFQTHENREHLVMMEKIL 287

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 39/243 (16%)
Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   + K  KE    +  +  + E  I  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILI 76
Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIV 398
            + H   VV L             + E+C   +L  YL+        +K   E   +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 399 ---------MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                     QV   +++L   K   IH DL   NILL+E NV   +KI DFGL++ + +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV---VKICDFGLARDIXK 191
Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
           +        D   +G       W  P   F         + + DVWS GV+ ++    G 
Sbjct: 192 DP-------DXVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 506 KPF 508
            P+
Sbjct: 240 SPY 242
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	627
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-72
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-69
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-66
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-60
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-58
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-58
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-57
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-57
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-57
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-56
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-56
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-56
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-55
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-55
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-55
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-55
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-55
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-55
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-55
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-54
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-54
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-54
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-54
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-54
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-54
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-54
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-53
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-53
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-53
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-53
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-53
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-52
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-52
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-52
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-52
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-52
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-52
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-52
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-51
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-51
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-51
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-51
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-50
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-50
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-50
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-47
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-47
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-47
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-46
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-45
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-45
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-44
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-43
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-43
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-42
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-42
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-41
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-41
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-40
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-40
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-40
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-39
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-39
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-38
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-37
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-37
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-36
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-35
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-35
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-34
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-34
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-34
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-33
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-33
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-33
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-33
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-32
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-32
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-32
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-31
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-31
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-31
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-31
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-31
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-30
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-30
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-30
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-30
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-28
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-27
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-27
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-26
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-25
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-19
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-18
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-18
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-17
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-06
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-04
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	2e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	7e-04

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  235 bits (601), Expect = 1e-72
 Identities = 80/320 (25%), Positives = 139/320 (43%), Gaps = 31/320 (9%)

Query: 273 NEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA 332
             +   F +  V    Y +L  +G GG S+V +  + ++++  A K   L +   +    
Sbjct: 14  GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT--- 69

Query: 333 NYIKHALREYNIHKALDHP--RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
             +     E      L     ++++LYD           V+E  +  DL+ +LK+ K+I 
Sbjct: 70  --LDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVMECGNI-DLNSWLKKKKSID 125

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
             E +S    ++ A+  +++    ++H DLKP N L+ +G     +K+ DFG++  M  +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPD 179

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLY 503
                  +   SQ  GT  Y+PPE           GK+  KIS K DVWS+G I Y   Y
Sbjct: 180 ----TTSVVKDSQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
           GK PF    +Q + L    I    E++F        + +  ++ CL    + RI +  L 
Sbjct: 235 GKTPFQQIINQISKL-HAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELL 291

Query: 564 RHDYLQPPVPKHGRQSASSS 583
            H Y+Q       + +  ++
Sbjct: 292 AHPYVQIQTHPVNQMAKGTT 311

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  226 bits (579), Expect = 6e-69
 Identities = 77/338 (22%), Positives = 142/338 (42%), Gaps = 31/338 (9%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            Y +L  +G GG S+V +  + ++++  A K   L +   +      +     E      
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-----LDSYRNEIAYLNK 63

Query: 348 LDHP--RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           L     ++++LYD           V+E  +  DL+ +LK+ K+I   E +S    ++ A+
Sbjct: 64  LQQHSDKIIRLYDYEI-TDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAV 121

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
             +++    ++H DLKP N L+ +G     +K+ DFG++  M  +       +   SQ  
Sbjct: 122 HTIHQHG--IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPD----TTSVVKDSQ-V 170

Query: 466 GTYWYLPPECFV-------VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           GT  Y+PPE           GK+  KIS K DVWS+G I Y   YGK PF    +Q + L
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230

Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQ 578
               I+     +         + +  ++ CL    + RI +  L  H Y+Q       + 
Sbjct: 231 HA--IIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287

Query: 579 SASSSAPVGHSPASSGQNQNSGGASTQSSAVQQSFATG 616
           +  ++  + +         +       +  + + ++ G
Sbjct: 288 AKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  220 bits (563), Expect = 4e-66
 Identities = 79/317 (24%), Positives = 136/317 (42%), Gaps = 31/317 (9%)

Query: 276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI 335
            S      V    Y +L  +G GG S+V +  + ++++  A K   L +   +      +
Sbjct: 45  SSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT-----L 98

Query: 336 KHALREYNIHKALDHP--RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE 393
                E      L     ++++LYD           V+E  +  DL+ +LK+ K+I   E
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVMECGNI-DLNSWLKKKKSIDPWE 156

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
            +S    ++ A+  +++    ++H DLKP N L+ +G     +K+ DFG++  M  +   
Sbjct: 157 RKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM----LKLIDFGIANQMQPD--- 207

Query: 454 PDHGMDLTSQGAGTYWYLPPECF-------VVGKNPPKISSKVDVWSVGVIFYQCLYGKK 506
               +   SQ  G   Y+PPE           GK+  KIS K DVWS+G I Y   YGK 
Sbjct: 208 -TTSVVKDSQ-VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

Query: 507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
           PF    +Q + L    I    E++F        + +  ++ CL    + RI +  L  H 
Sbjct: 266 PFQQIINQISKLHAI-IDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322

Query: 567 YLQPPVPKHGRQSASSS 583
           Y+Q       + +  ++
Sbjct: 323 YVQIQTHPVNQMAKGTT 339

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  206 bits (527), Expect = 2e-60
 Identities = 89/328 (27%), Positives = 148/328 (45%), Gaps = 23/328 (7%)

Query: 247 NNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKA 306
                L+++  I       +           +      L D Y++   LG G   EV  A
Sbjct: 95  GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154

Query: 307 FDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID 363
           F+ K  + VA ++  ++K        ++A+   +   E  I K L+HP ++K+ + F+  
Sbjct: 155 FERKTCKKVAIRI--ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 210

Query: 364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG 423
           A  +  VLE  +G +L   +  +K + E   +    Q++ A++YL+E    +IH DLKP 
Sbjct: 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPE 268

Query: 424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP 483
           N+LL+       IKITDFG SK++ E +        L     GT  YL PE  +V     
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETS--------LMRTLCGTPTYLAPE-VLVSVGTA 319

Query: 484 KISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKP--TVSNEA 541
             +  VD WS+GVI + CL G  PF  +++Q ++ ++  I    +  F  +    VS +A
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ--ITSG-KYNFIPEVWAEVSEKA 376

Query: 542 KGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              ++  L    + R       RH +LQ
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  196 bits (500), Expect = 3e-58
 Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 36/299 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y +L  +G G +    K     + + +  K        + +K+       + E N+ +
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-----LVSEVNLLR 60

Query: 347 ALDHPRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQV 401
            L HP +V+ YD   +    +   V+EYC+G DL   + +       + E     ++ Q+
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 402 VSALKYL---NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             ALK     ++    V+H DLKP N+ L        +K+ DFGL+++++       H  
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILN-------HDT 170

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATI 517
                  GT +Y+ PE   + +     + K D+WS+G + Y+      PF   +Q +   
Sbjct: 171 SFAKTFVGTPYYMSPE--QMNRMS--YNEKSDIWSLGCLLYELCALMPPFTAFSQKE--- 223

Query: 518 LEENTILKATEVQFANKPTV-SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
                  K  E +F   P   S+E    I   L  +   R  V  +  +  +      H
Sbjct: 224 ----LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  197 bits (503), Expect = 3e-58
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 25/291 (8%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD---WKEDKKANYIKHALRE 341
           L D Y++   LG G   EV  AF+ K  + VA K+  ++K        ++A+   +   E
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKI--ISKRKFAIGSAREADPALNVETE 65

Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQ 400
             I K L+HP ++K+ + F+  A  +  VLE  +G +L F  +  +K + E   +    Q
Sbjct: 66  IEILKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGEL-FDKVVGNKRLKEATCKLYFYQ 122

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++ A++YL+E    +IH DLKP N+LL+       IKITDFG SK++ E +        L
Sbjct: 123 MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--------L 172

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                GT  YL PE   V       +  VD WS+GVI + CL G  PF  +++Q ++ ++
Sbjct: 173 MRTLCGTPTYLAPEVL-VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231

Query: 521 NTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             I    +  F  +    VS +A   ++  L    + R       RH +LQ
Sbjct: 232 --ITSG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  196 bits (500), Expect = 2e-57
 Identities = 71/348 (20%), Positives = 141/348 (40%), Gaps = 39/348 (11%)

Query: 274 EDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKAN 333
            D    N +    ++Y+ L  +G+G F +       ++ R    K   +++   ++++  
Sbjct: 11  VDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE- 69

Query: 334 YIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAE 391
               + RE  +   + HP +V+  + FE +  S   V++YC+G DL   +   K     E
Sbjct: 70  ----SRREVAVLANMKHPNIVQYRESFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            +     +Q+  ALK++++ K  ++H D+K  NI LT+    G +++ DFG+++V+    
Sbjct: 125 DQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD---GTVQLGDFGIARVL---- 175

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GH 510
              +  ++L     GT +YL PE  +    P   ++K D+W++G + Y+    K  F   
Sbjct: 176 ---NSTVELARACIGTPYYLSPE--ICENKP--YNNKSDIWALGCVLYELCTLKHAFEAG 228

Query: 511 NQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +           +LK     F       S + +  +         DR  V S+    ++ 
Sbjct: 229 SMKNL-------VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281

Query: 570 PPVPKH------GRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQ 611
             + K         +    +     S     +   SG  S      Q+
Sbjct: 282 KRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  194 bits (496), Expect = 2e-57
 Identities = 74/318 (23%), Positives = 128/318 (40%), Gaps = 50/318 (15%)

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
            R+      +  +  + +LG+G F +V KA +  + RY A K   +     E+K    + 
Sbjct: 2   LRY------ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRH--TEEK----LS 47

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCT------------VLEYCDGHDLDFYLK 384
             L E  +  +L+H  VV+ Y  +    N                 +EYC+   L   + 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107

Query: 385 QHKTIAER-EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
                 +R E   +  Q++ AL Y++     +IH DLKP NI + E      +KI DFGL
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES---RNVKIGDFGL 162

Query: 444 SKVMDE-------ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           +K +         ++ N     D  +   GT  Y+  E   V       + K+D++S+G+
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE---VLDGTGHYNEKIDMYSLGI 219

Query: 497 IFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKE 554
           IF++ +Y   PF     +  IL+    L++  ++F            K  IR  + +   
Sbjct: 220 IFFEMIY---PFSTGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273

Query: 555 DRIDVISLARHDYLQPPV 572
            R    +L    +L    
Sbjct: 274 KRPGARTLLNSGWLPVKH 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  193 bits (493), Expect = 4e-57
 Identities = 85/307 (27%), Positives = 129/307 (42%), Gaps = 28/307 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            RY+    LGKGGF++  +  D   +   A K+  + K      K +  +    E +IH+
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI--VPK--SLLLKPHQREKMSMEISIHR 70

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           +L H  VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +
Sbjct: 71  SLAHQHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+  +  VIH DLK GN+ L E     E+KI DFGL+  ++      D          G
Sbjct: 130 YLHRNR--VIHRDLKLGNLFLNED---LEVKIGDFGLATKVE-----YDGERKKVL--CG 177

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE  V+ K     S +VDVWS+G I Y  L GK PF                + 
Sbjct: 178 TPNYIAPE--VLSKK--GHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYL-----RI 227

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP-PVPKHGRQSASSSAP 585
            + +++    ++  A   I+  L      R  +  L   ++     +P     +  +  P
Sbjct: 228 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 287

Query: 586 VGHSPAS 592
                 S
Sbjct: 288 RFSIAPS 294

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  191 bits (488), Expect = 2e-56
 Identities = 61/312 (19%), Positives = 115/312 (36%), Gaps = 56/312 (17%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             +  + L+G GGF +V KA    + +    K  + N +            A RE     
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----------KAEREVKALA 59

Query: 347 ALDHPRVVKLYDVFE---------------IDANSFCTVLEYCDGHDLDFYLKQHK--TI 389
            LDH  +V     ++                        +E+CD   L+ ++++ +   +
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
            +  A  +  Q+   + Y++  K  +I+ DLKP NI L +     ++KI DFGL   +  
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT---KQVKIGDFGLVTSL-- 172

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
                 +    T    GT  Y+ PE   +         +VD++++G+I  + L+      
Sbjct: 173 -----KNDGKRTRS-KGTLRYMSPE--QISSQD--YGKEVDLYALGLILAELLHVCDTA- 221

Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              S              +           + K  ++  L+ + EDR +   + R   + 
Sbjct: 222 FETS-------KFFTDLRDGII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272

Query: 570 PPVP-KHGRQSA 580
              P K+ R +A
Sbjct: 273 KKSPEKNERHTA 284

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  192 bits (490), Expect = 3e-56
 Identities = 90/308 (29%), Positives = 137/308 (44%), Gaps = 28/308 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            RY+    LGKGGF++  +  D   +   A K+  + K      K +  +    E +IH+
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI--VPK--SLLLKPHQREKMSMEISIHR 96

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           +L H  VV  +  FE D +    VLE C    L    K+ K + E EAR  + Q+V   +
Sbjct: 97  SLAHQHVVGFHGFFE-DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+  +  VIH DLK GN+ L E     E+KI DFGL+  ++      D          G
Sbjct: 156 YLHRNR--VIHRDLKLGNLFLNED---LEVKIGDFGLATKVE-----YDGERKKVL--CG 203

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE  V+ K     S +VDVWS+G I Y  L GK PF     + + L+E T L+ 
Sbjct: 204 TPNYIAPE--VLSKKG--HSFEVDVWSIGCIMYTLLVGKPPF-----ETSCLKE-TYLRI 253

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP-PVPKHGRQSASSSAP 585
            + +++    ++  A   I+  L      R  +  L   ++     +P     +  +  P
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 313

Query: 586 VGHSPASS 593
                 SS
Sbjct: 314 RFSIAPSS 321

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  191 bits (488), Expect = 4e-56
 Identities = 66/299 (22%), Positives = 122/299 (40%), Gaps = 30/299 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            YL +  LG+GGFS V     L +  + A K  ++    ++D++      A RE ++H+ 
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALK--RILCHEQQDREE-----AQREADMHRL 82

Query: 348 LDHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQHKT----IAEREARSIVMQ 400
            +HP +++L      +  +      +L +     L   +++ K     + E +   +++ 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +   L+ ++       H DLKP NILL +    G+  + D G               + L
Sbjct: 143 ICRGLEAIH--AKGYAHRDLKPTNILLGDE---GQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 461 TSQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
               A   T  Y  PE F V  +   I  + DVWS+G + Y  ++G+ P+          
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPY-----DMVFQ 251

Query: 519 EENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH-DYLQPPVPK 574
           + +++  A + Q +    P  S+     + S +      R  +  L    + LQPP P 
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  189 bits (483), Expect = 9e-56
 Identities = 79/302 (26%), Positives = 136/302 (45%), Gaps = 27/302 (8%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL-REYN 343
           + D Y +   LG G F+ V K       +  A K   + K      +    +  + RE N
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVV 402
           I + + HP ++ L+D+FE +      +LE   G +L F +L + +++ E EA   + Q++
Sbjct: 61  ILREIRHPNIITLHDIFE-NKTDVVLILELVSGGEL-FDFLAEKESLTEDEATQFLKQIL 118

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGMDLT 461
             + YL+  +  + H+DLKP NI+L + NV    IK+ DFG++  ++          +  
Sbjct: 119 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--------NEF 168

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF   +++   L   
Sbjct: 169 KNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPF-LGETKQETLTN- 222

Query: 522 TILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQS 579
            I       F  +     S  AK FIR  L    + R+ +     H +++    ++ R  
Sbjct: 223 -ISAV-NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

Query: 580 AS 581
            S
Sbjct: 281 DS 282

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  190 bits (485), Expect = 1e-55
 Identities = 68/295 (23%), Positives = 122/295 (41%), Gaps = 35/295 (11%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L ++Y++   LG+G F  VH+  +   ++    K            K        +E +I
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF--------VKVKGTDQVLVKKEISI 54

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVS 403
                H  ++ L++ FE        + E+  G D+ +        + ERE  S V QV  
Sbjct: 55  LNIARHRNILHLHESFE-SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLT--EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           AL++L+     + H+D++P NI+      +    IKI +FG ++ +      P       
Sbjct: 114 ALQFLHSHN--IGHFDIRPENIIYQTRRSS---TIKIIEFGQARQLK-----PGDNF--- 160

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
                   Y  PE  V   +   +S+  D+WS+G + Y  L G  PF   ++   I+E  
Sbjct: 161 RLLFTAPEYYAPE--VHQHDV--VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIEN- 214

Query: 522 TILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
            I+ A E  F  +    +S EA  F+   L   ++ R+      +H +L+  + +
Sbjct: 215 -IMNA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  188 bits (479), Expect = 4e-55
 Identities = 91/288 (31%), Positives = 136/288 (47%), Gaps = 27/288 (9%)

Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H+  +         ++RY ++ +LGKG F EV K  D   Q+  A KV        +D  
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 332 ANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
                  LRE  + K LDHP ++KL+++ E D++SF  V E   G +L   + + K  +E
Sbjct: 67  T-----ILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            +A  I+ QV S + Y+++    ++H DLKP NILL       +IKI DFGLS    +  
Sbjct: 121 HDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                         GT +Y+ PE  V+         K DVWS GVI Y  L G  PF + 
Sbjct: 178 -------TKMKDRIGTAYYIAPE--VLRG---TYDEKCDVWSAGVILYILLSGTPPF-YG 224

Query: 512 QSQATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +++  IL+   +    +  F      T+S++AK  IR  L +    RI
Sbjct: 225 KNEYDILKR--VETG-KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  193 bits (493), Expect = 4e-55
 Identities = 94/310 (30%), Positives = 142/310 (45%), Gaps = 27/310 (8%)

Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H+  +         ++RY ++ +LGKG F EV K  D   Q+  A KV        +D  
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 332 ANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
                  LRE  + K LDHP ++KL+++ E D++SF  V E   G +L   + + K  +E
Sbjct: 67  T-----ILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSE 120

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            +A  I+ QV S + Y+++    ++H DLKP NILL       +IKI DFGLS    +  
Sbjct: 121 HDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                         GT +Y+ PE  V+         K DVWS GVI Y  L G  PF + 
Sbjct: 178 -------TKMKDRIGTAYYIAPE--VLRGT---YDEKCDVWSAGVILYILLSGTPPF-YG 224

Query: 512 QSQATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +++  IL+   +    +  F      T+S++AK  IR  L +    RI       H ++Q
Sbjct: 225 KNEYDILKR--VETG-KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

Query: 570 PPVPKHGRQS 579
               +    S
Sbjct: 282 KYSSETPTIS 291

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  188 bits (480), Expect = 6e-55
 Identities = 63/306 (20%), Positives = 114/306 (37%), Gaps = 48/306 (15%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
             +  +LL  +LG+G  + V +    K     A KV   N      +  +      RE+ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNI-SFLRPVDVQM---REFE 59

Query: 344 IHKALDHPRVVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIA---EREARSIVM 399
           + K L+H  +VKL+ + E         ++E+C    L   L++        E E   ++ 
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKITDFGLSKVMDEENYNPDHGM 458
            VV  + +L E    ++H ++KPGNI+   G +     K+TDFG ++ +++         
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-------DE 170

Query: 459 DLTSQGAGTYWYLPPE----CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHN 511
              S   GT  YL P+      +   +  K  + VD+WS+GV FY    G  PF      
Sbjct: 171 QFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 512 QSQATILEENTILKATEVQFANK--------------------PTVSNEAKGFIRSCLAY 551
           +    ++ +    K +      +                      +       + + L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 552 RKEDRI 557
            +E   
Sbjct: 290 DQEKCW 295

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  188 bits (480), Expect = 6e-55
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 27/291 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL-REYN 343
           + D Y +   LG G F+ V K  +       A K   + K      +    +  + RE +
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVSREEIEREVS 67

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVV 402
           I + + H  V+ L+DV+E +      +LE   G +L F +L Q ++++E EA S + Q++
Sbjct: 68  ILRQVLHHNVITLHDVYE-NRTDVVLILELVSGGEL-FDFLAQKESLSEEEATSFIKQIL 125

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++            
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--------VEF 175

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF    ++   L   
Sbjct: 176 KNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN- 229

Query: 522 TILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
            I       F  +     S  AK FIR  L      R+ +    RH ++ P
Sbjct: 230 -ITSV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  192 bits (491), Expect = 8e-55
 Identities = 95/287 (33%), Positives = 136/287 (47%), Gaps = 26/287 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SDRY    +LGKG F EV    D    +  A KV  ++K  ++ K+    +  LRE  +
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKV--ISK--RQVKQKTDKESLLREVQL 79

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K LDHP ++KLY+ FE D   F  V E   G +L   +   K  +E +A  I+ QV+S 
Sbjct: 80  LKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y+++ K  ++H DLKP N+LL   +    I+I DFGLS   +                
Sbjct: 139 ITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--------KKMKDK 188

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            GT +Y+ PE  V+         K DVWS GVI Y  L G  PF +  ++  IL++  + 
Sbjct: 189 IGTAYYIAPE--VLHGT---YDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKK--VE 240

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           K  +  F       VS  AK  IR  L Y    RI       H+++Q
Sbjct: 241 KG-KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  186 bits (476), Expect = 9e-55
 Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 28/295 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + +  LLGKG F+ V++A  +     VA K+  ++K  K   KA  ++    E  IH 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM--IDK--KAMYKAGMVQRVQNEVKIHC 66

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSAL 405
            L HP +++LY+ FE D+N    VLE C   +++ YLK   K  +E EAR  + Q+++ +
Sbjct: 67  QLKHPSILELYNYFE-DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     ++H DL   N+LLT       IKI DFGL+  +        H    T    
Sbjct: 126 LYLHSHG--ILHRDLTLSNLLLTRN---MNIKIADFGLATQLK-----MPHEKHYTL--C 173

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  Y+ PE  +  ++      + DVWS+G +FY  L G+ PF    +    L      K
Sbjct: 174 GTPNYISPE--IATRSA--HGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLN-----K 223

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
                +     +S EAK  I   L     DR+ + S+  H ++        +   
Sbjct: 224 VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  187 bits (477), Expect = 9e-55
 Identities = 66/303 (21%), Positives = 121/303 (39%), Gaps = 43/303 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             +  +  LG+GGF  V +A +  +    A K  +L       +K       +RE     
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK------VMREVKALA 58

Query: 347 ALDHPRVVKLYDVFEIDANSF-----------CTVLEYCDGHDLDFYLKQHKTIAEREAR 395
            L+HP +V+ ++ +     +               ++ C   +L  ++    TI ERE  
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 396 SIV---MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN- 451
             +   +Q+  A+++L+     ++H DLKP NI  T       +K+ DFGL   MD++  
Sbjct: 119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEE 173

Query: 452 ----YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP 507
                 P       +   GT  Y+ PE   +  N    S KVD++S+G+I ++ LY   P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPE--QIHGNS--YSHKVDIFSLGLILFELLY---P 226

Query: 508 FGHNQSQATILEENTILKATEVQFANKPT-VSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
           F     +   L          ++F    T         ++  L+    +R + I++  + 
Sbjct: 227 FSTQMERVRTLT-----DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281

Query: 567 YLQ 569
             +
Sbjct: 282 VFE 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  189 bits (483), Expect = 1e-54
 Identities = 78/322 (24%), Positives = 138/322 (42%), Gaps = 40/322 (12%)

Query: 264 HIRELKRIHNEDQSRFNNHPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVAC 317
            I +  + + +   ++   PV      + D Y +L  LG G F  VH+  +    R    
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 318 KVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH 377
           K   +N  +  DK          E +I   L HP+++ L+D FE D      +LE+  G 
Sbjct: 82  KF--INTPYPLDKYT-----VKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLSGG 133

Query: 378 DL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT--EGNVCG 434
           +L D    +   ++E E  + + Q    LK+++E    ++H D+KP NI+    + +   
Sbjct: 134 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKAS--- 188

Query: 435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV 494
            +KI DFGL+  ++ +         +      T  +  PE  +V + P  +    D+W++
Sbjct: 189 SVKIIDFGLATKLNPDE--------IVKVTTATAEFAAPE--IVDREP--VGFYTDMWAI 236

Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYR 552
           GV+ Y  L G  PF   +     L+   + +  + +F      +VS EAK FI++ L   
Sbjct: 237 GVLGYVLLSGLSPF-AGEDDLETLQN--VKRC-DWEFDEDAFSSVSPEAKDFIKNLLQKE 292

Query: 553 KEDRIDVISLARHDYLQPPVPK 574
              R+ V     H +L+     
Sbjct: 293 PRKRLTVHDALEHPWLKGDHSN 314

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  188 bits (479), Expect = 2e-54
 Identities = 80/327 (24%), Positives = 132/327 (40%), Gaps = 57/327 (17%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  +Y L   +G+G +  V  A + + +   A K+  +NK+         ++    E  +
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKI--MNKNKIRQINPKDVERIKTEVRL 81

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL------------------------- 379
            K L HP + +LY+V+E D    C V+E C G  L                         
Sbjct: 82  MKKLHHPNIARLYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140

Query: 380 ---------------DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGN 424
                           F         E+   +I+ Q+ SAL YL+     + H D+KP N
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPEN 198

Query: 425 ILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPK 484
            L +      EIK+ DFGLSK   + N    +GM   +  AGT +++ PE  V+      
Sbjct: 199 FLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGM---TTKAGTPYFVAPE--VLNTTNES 252

Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKP--TVSNEAK 542
              K D WS GV+ +  L G  PF    + A  + +  +L   ++ F N     +S  A+
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPF-PGVNDADTISQ--VLNK-KLCFENPNYNVLSPLAR 308

Query: 543 GFIRSCLAYRKEDRIDVISLARHDYLQ 569
             + + L    ++R D +   +H ++ 
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWIS 335

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  191 bits (488), Expect = 3e-54
 Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 27/275 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           LS+ Y  +  LG G + EV    D       A K+ +                 L E  +
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-----LLEEVAV 89

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K LDHP ++KLYD FE D  ++  V+E   G +L   +       E +A  I+ QV+S 
Sbjct: 90  LKLLDHPNIMKLYDFFE-DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + YL++    ++H DLKP N+LL        IKI DFGLS V + +            + 
Sbjct: 149 VTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--------KKMKER 198

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            GT +Y+ PE  V+ K       K DVWS+GVI +  L G  PF   Q+   IL +  + 
Sbjct: 199 LGTAYYIAPE--VLRKK---YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRK--VE 250

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           K  +  F +     VS  AK  I+  L +  + RI
Sbjct: 251 KG-KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  187 bits (476), Expect = 3e-54
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 27/291 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL-REYN 343
           + D Y     LG G F+ V K  +       A K   + K   +  +    +  + RE +
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVV 402
           I K + HP V+ L++V+E +      +LE   G +L F +L + +++ E EA   + Q++
Sbjct: 67  ILKEIQHPNVITLHEVYE-NKTDVILILELVAGGEL-FDFLAEKESLTEEEATEFLKQIL 124

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCG-EIKITDFGLSKVMDEENYNPDHGMDLT 461
           + + YL+ ++  + H+DLKP NI+L + NV    IKI DFGL+        +  +     
Sbjct: 125 NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-----IDFGNEF--- 174

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF    ++   L   
Sbjct: 175 KNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN- 228

Query: 522 TILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
            +      +F ++     S  AK FIR  L    + R+ +    +H +++P
Sbjct: 229 -VSAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  184 bits (470), Expect = 6e-54
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 26/275 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+  +N      +    ++   RE  I
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLE---REARI 58

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + + +    V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 59  CRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y +     ++H +LKP N+LL        +K+ DFGL+  +++         +     
Sbjct: 118 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--------EAWHGF 167

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
           AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +  I 
Sbjct: 168 AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ--IK 220

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
                 + +    TV+ EAK  I S L    + RI
Sbjct: 221 AG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  187 bits (476), Expect = 6e-54
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 27/291 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL-REYN 343
           + D Y +   LG G F+ V K  +       A K   + K      +    +  + RE +
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVCREEIEREVS 67

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVV 402
           I + + HP ++ L+DV+E +      +LE   G +L F +L Q ++++E EA S + Q++
Sbjct: 68  ILRQVLHPNIITLHDVYE-NRTDVVLILELVSGGEL-FDFLAQKESLSEEEATSFIKQIL 125

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVMDEENYNPDHGMDLT 461
             + YL+  K  + H+DLKP NI+L + N+    IK+ DFGL+  +++            
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--------VEF 175

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  ++ PE  +V   P  +  + D+WS+GVI Y  L G  PF    ++   L   
Sbjct: 176 KNIFGTPEFVAPE--IVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN- 229

Query: 522 TILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
            I       F  +     S  AK FIR  L      R+ +    RH ++ P
Sbjct: 230 -ITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  184 bits (469), Expect = 7e-54
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 29/275 (10%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           ++  Y L   +G+G + EV  A     +   A K   + K          +    +E  I
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK--IPK-----YFVEDVDRFKQEIEI 59

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K+LDHP +++LY+ FE D      V+E C G +L   +   +   E +A  I+  V+SA
Sbjct: 60  MKSLDHPNIIRLYETFE-DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y +++   V H DLKP N L    +    +K+ DFGL+         P   M      
Sbjct: 119 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-----PGKMM---RTK 168

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            GT +Y+ P+  V+         + D WS GV+ Y  L G  PF    + + ++ +  I 
Sbjct: 169 VGTPYYVSPQ--VLEG---LYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLK--IR 220

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +     F  K    VS +A+  IR  L    + RI
Sbjct: 221 EG-TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  184 bits (469), Expect = 8e-54
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 31/278 (11%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D ++    LG G F +VH   +         K   +NKD    +    ++    E  +
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT--INKD----RSQVPMEQIEAEIEV 73

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DF---YLKQHKTIAEREARSIVMQ 400
            K+LDHP ++K+++VFE D ++   V+E C+G +L +       + K ++E     ++ Q
Sbjct: 74  LKSLDHPNIIKIFEVFE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +++AL Y +     V+H DLKP NIL  + +    IKI DFGL+++        D     
Sbjct: 133 MMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-----SDEHS-- 183

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
            +  AGT  Y+ PE  V  +    ++ K D+WS GV+ Y  L G  PF    S   + ++
Sbjct: 184 -TNAAGTALYMAPE--VFKR---DVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQK 236

Query: 521 NTILKATEVQFANKP-TVSNEAKGFIRSCLAYRKEDRI 557
                  E  +A +   ++ +A   ++  L    E R 
Sbjct: 237 --ATYK-EPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  183 bits (468), Expect = 1e-53
 Identities = 85/299 (28%), Positives = 129/299 (43%), Gaps = 33/299 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + +   LGKG F  V+ A + + +  +A KV  L K   + +KA       RE  I  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFK--AQLEKAGVEHQLRREVEIQS 64

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L HP +++LY  F      +  +LEY     +   L++     E+   + + ++ +AL 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYL-ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y +  +  VIH D+KP N+LL      GE+KI DFG S       + P           G
Sbjct: 124 YCHSKR--VIHRDIKPENLLLGSA---GELKIADFGWSV------HAPSSRRT-DL--CG 169

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  YLPPE  ++         KVD+WS+GV+ Y+ L GK PF  N  Q T      I + 
Sbjct: 170 TLDYLPPE--MIEGRM--HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRISRV 222

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH----DYLQPPVPKHGRQSAS 581
            E  F     V+  A+  I   L +    R  +  +  H         P     ++SAS
Sbjct: 223 -EFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  184 bits (469), Expect = 2e-53
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 31/276 (11%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +   ++ + +LG G FSEV         +  A K   + K       +        E  +
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKSPAFRDSS-----LENEIAV 59

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQVVS 403
            K + H  +V L D++E     +  V++   G +L F  + +     E++A  ++ QV+S
Sbjct: 60  LKKIKHENIVTLEDIYE-STTHYYLVMQLVSGGEL-FDRILERGVYTEKDASLVIQQVLS 117

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           A+KYL+E    ++H DLKP N+L        +I ITDFGLSK+               S 
Sbjct: 118 AVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---------ST 166

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  Y+ PE  V+ + P   S  VD WS+GVI Y  L G  PF + ++++ + E+  I
Sbjct: 167 ACGTPGYVAPE--VLAQKP--YSKAVDCWSIGVITYILLCGYPPF-YEETESKLFEK--I 219

Query: 524 LKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
            +    +F +     +S  AK FI   L     +R 
Sbjct: 220 KEG-YYEFESPFWDDISESAKDFICHLLEKDPNERY 254

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  185 bits (472), Expect = 3e-53
 Identities = 82/280 (29%), Positives = 128/280 (45%), Gaps = 32/280 (11%)

Query: 285 LSDRYLL--LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           ++  Y +    +LG G F +VHK  +      +A K+  +     +DK+         E 
Sbjct: 85  VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKE-----EVKNEI 137

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQV 401
           ++   LDH  +++LYD FE   N    V+EY DG +L D  + +   + E +    + Q+
Sbjct: 138 SVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
              +++++++   ++H DLKP NIL    +   +IKI DFGL++      Y P   +   
Sbjct: 197 CEGIRHMHQMY--ILHLDLKPENILCVNRDA-KQIKIIDFGLARR-----YKPREKL--- 245

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  +L PE  VV  +   +S   D+WSVGVI Y  L G  PF    + A  L   
Sbjct: 246 KVNFGTPEFLAPE--VVNYDF--VSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNN- 299

Query: 522 TILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDV 559
            IL        ++    +S EAK FI   L   K  RI  
Sbjct: 300 -ILAC-RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA 337

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  184 bits (469), Expect = 5e-53
 Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 27/286 (9%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
             ++  +  D Y L  ++GKG FS V +  + +  +  A K+  ++            + 
Sbjct: 15  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI--VDVAKFTSSPGLSTED 72

Query: 338 ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA----ERE 393
             RE +I   L HP +V+L + +         V E+ DG DL F + +         E  
Sbjct: 73  LKREASICHMLKHPHIVELLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           A   + Q++ AL+Y ++    +IH D+KP  +LL        +K+  FG++  + E    
Sbjct: 132 ASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
                 +     GT  ++ PE  VV + P      VDVW  GVI +  L G  PF   + 
Sbjct: 188 -----LVAGGRVGTPHFMAPE--VVKREP--YGKPVDVWGCGVILFILLSGCLPFYGTKE 238

Query: 514 QATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           +  + E   I+K  + +   +    +S  AK  +R  L     +RI
Sbjct: 239 R--LFEG--IIKG-KYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  185 bits (471), Expect = 7e-53
 Identities = 63/306 (20%), Positives = 114/306 (37%), Gaps = 48/306 (15%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
             +  +LL  +LG+G  + V +    K     A KV   N      +  +      RE+ 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKV--FNNI-SFLRPVDVQM---REFE 59

Query: 344 IHKALDHPRVVKLYDVFEID-ANSFCTVLEYCDGHDLDFYLKQHKTIA---EREARSIVM 399
           + K L+H  +VKL+ + E         ++E+C    L   L++        E E   ++ 
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEG-NVCGEIKITDFGLSKVMDEENYNPDHGM 458
            VV  + +L E    ++H ++KPGNI+   G +     K+TDFG ++ +++         
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-------DE 170

Query: 459 DLTSQGAGTYWYLPPE----CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHN 511
              S   GT  YL P+      +   +  K  + VD+WS+GV FY    G  PF      
Sbjct: 171 QFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 512 QSQATILEENTILKATEVQFANK--------------------PTVSNEAKGFIRSCLAY 551
           +    ++ +    K +      +                      +       + + L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 552 RKEDRI 557
            +E   
Sbjct: 290 DQEKCW 295

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  189 bits (481), Expect = 1e-52
 Identities = 87/374 (23%), Positives = 139/374 (37%), Gaps = 43/374 (11%)

Query: 226 RERNLHIR-------ELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSR 278
              N H +           I  +++ R   + V     ++  K            +   +
Sbjct: 83  IAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQ 142

Query: 279 FNNHPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA 332
           +   PV      + D Y +   LG G F  VH+  +       A K   +    + DK+ 
Sbjct: 143 YYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDKET 200

Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAE 391
                  +E      L HP +V L+D FE D N    + E+  G +L +    +H  ++E
Sbjct: 201 -----VRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSE 254

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            EA   + QV   L +++E     +H DLKP NI+ T      E+K+ DFGL+       
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRS-NELKLIDFGLTAH----- 306

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
            +P   +       GT  +  PE  V    P  +    D+WSVGV+ Y  L G  PF   
Sbjct: 307 LDPKQSV---KVTTGTAEFAAPE--VAEGKP--VGYYTDMWSVGVLSYILLSGLSPF-GG 358

Query: 512 QSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           ++    L    +    +    +     +S + K FIR  L      R+ +     H +L 
Sbjct: 359 ENDDETLRN--VKSC-DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

Query: 570 PPVPKHGRQSASSS 583
           P           SS
Sbjct: 416 PGNAPGRDSQIPSS 429

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  183 bits (467), Expect = 2e-52
 Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            SD Y +   LGKG FS V +          A K+    K    D +        RE  I
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----LEREARI 81

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D  + + +    V +   G +L   +   +  +E +A   + Q++ +
Sbjct: 82  CRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y +     ++H +LKP N+LL        +K+ DFGL+  +++         +     
Sbjct: 141 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--------EAWHGF 190

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
           AGT  YL PE  V+ K+P   S  VD+W+ GVI Y  L G  PF  ++ Q  +  +  I 
Sbjct: 191 AGTPGYLSPE--VLKKDP--YSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ--IK 243

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
                 + +    TV+ EAK  I S L    + RI
Sbjct: 244 AG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  184 bits (469), Expect = 3e-52
 Identities = 65/314 (20%), Positives = 118/314 (37%), Gaps = 28/314 (8%)

Query: 266 RELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
                  ++     +   V    +    +LG G    +     + + R VA K  ++  +
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVK--RILPE 59

Query: 326 WKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLK 384
                       A RE  + +  D HP V++ +   + D       +E C     ++  +
Sbjct: 60  --------CFSFADREVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIELCAATLQEYVEQ 110

Query: 385 QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE--IKITDFG 442
           +       E  +++ Q  S L +L+ +   ++H DLKP NIL++  N  G+    I+DFG
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG 168

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           L K +    ++        S   GT  ++ PE  +        +  VD++S G +FY  +
Sbjct: 169 LCKKLAVGRHS----FSRRSGVPGTEGWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVI 223

Query: 503 -YGKKPFGH-NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI 560
             G  PFG   Q QA IL     L         +      A+  I   +A   + R    
Sbjct: 224 SEGSHPFGKSLQRQANILLGACSLDCLH----PEKHEDVIARELIEKMIAMDPQKRPSAK 279

Query: 561 SLARHDYLQPPVPK 574
            + +H +      +
Sbjct: 280 HVLKHPFFWSLEKQ 293

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  184 bits (470), Expect = 3e-52
 Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 25/275 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
            ++ Y L   LGKG FS V +   +   +  A  +    K    D +        RE  I
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----LEREARI 63

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            + L HP +V+L+D    +      + +   G +L   +   +  +E +A   + Q++ A
Sbjct: 64  CRLLKHPNIVRLHDSIS-EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + + +++   V+H +LKP N+LL        +K+ DFGL+  ++ E              
Sbjct: 123 VLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-------QAWFGF 173

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
           AGT  YL PE  V+ K+P      VD+W+ GVI Y  L G  PF  ++ Q  + ++  I 
Sbjct: 174 AGTPGYLSPE--VLRKDP--YGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQ--IK 226

Query: 525 KATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
                 F +    TV+ EAK  I   L      RI
Sbjct: 227 AG-AYDFPSPEWDTVTPEAKDLINKMLTINPSKRI 260

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  186 bits (474), Expect = 4e-52
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 28/281 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNKDWKEDKKANYIKHA--- 338
           + + Y  +  LG G + EV    +       A KV    Q +K    D   N  K     
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
             E ++ K+LDHP ++KL+DVFE D   F  V E+ +G +L   +       E +A +I+
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q++S + YL++    ++H D+KP NILL   N    IKI DFGLS    ++        
Sbjct: 153 KQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-------- 202

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT +Y+ PE  V+ K     + K DVWS GVI Y  L G  PF   Q+   I+
Sbjct: 203 YKLRDRLGTAYYIAPE--VLKKK---YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDII 256

Query: 519 EENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
           ++  + K  +  F       +S+EAK  I+  L Y    R 
Sbjct: 257 KK--VEKG-KYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  184 bits (468), Expect = 5e-52
 Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 41/312 (13%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L +  +   +LG G    V       + R VA K   +  D        +   AL E  +
Sbjct: 13  LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR--MLID--------FCDIALMEIKL 61

Query: 345 HKALD-HPRVVKLYDVFEIDANSFCTVLEYCDG--HDL----DFYLKQHKTIAEREARSI 397
               D HP V++ Y             LE C+    DL    +   +  K   E    S+
Sbjct: 62  LTESDDHPNVIRYYCSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE----------IKITDFGLSKVM 447
           + Q+ S + +L+ +K  +IH DLKP NIL++  +              I I+DFGL K +
Sbjct: 121 LRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 448 DEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP---KISSKVDVWSVGVIFYQCL-Y 503
           D    +    +   +  +GT  +  PE      N     +++  +D++S+G +FY  L  
Sbjct: 179 DSGQSSFRTNL---NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 504 GKKPFGH-NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL 562
           GK PFG     ++ I+    I    E++  +  ++  EA   I   + +    R   + +
Sbjct: 236 GKHPFGDKYSRESNII--RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

Query: 563 ARHDYLQPPVPK 574
            RH    P   K
Sbjct: 294 LRHPLFWPKSKK 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  179 bits (457), Expect = 8e-52
 Identities = 59/343 (17%), Positives = 110/343 (32%), Gaps = 41/343 (11%)

Query: 238 IHNEDQSRFNNHPVLSDSYLIGYKNLHIREL-------KRIHNEDQSRFNNHPVLSDRYL 290
           +H+             + Y      L  R +       + + +               + 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ 60

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-D 349
            L  LG G + EV K    ++ R  A K  +    ++  K        L E   H+ +  
Sbjct: 61  RLSRLGHGSYGEVFKVRSKEDGRLYAVK--RSMSPFRGPKD---RARKLAEVGSHEKVGQ 115

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYL 408
           HP  V+L   +E +        E C    L  + +    ++ E +    +   + AL +L
Sbjct: 116 HPCCVRLEQAWE-EGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           +     ++H D+KP NI L      G  K+ DFGL   +                  G  
Sbjct: 174 HSQG--LVHLDVKPANIFLGPR---GRCKLGDFGLLVELGT--------AGAGEVQEGDP 220

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
            Y+ PE   + +      +  DV+S+G+   +     +     +    +      L    
Sbjct: 221 RYMAPE---LLQGSY--GTAADVFSLGLTILEVACNMELPHGGEGWQQLR--QGYLPPE- 272

Query: 529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
                   +S+E +  +   L    + R    +L     L+ P
Sbjct: 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  180 bits (458), Expect = 1e-51
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 30/279 (10%)

Query: 285 LSDRYLLLM-LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            ++ Y+L    LG+G F+ V +       +  A K  +  +  ++ +        L E  
Sbjct: 26  FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-----ILHEIA 80

Query: 344 IHKALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYL-KQHKTIAEREARSIVMQ 400
           + +     PRV+ L++V+E + +    +LEY  G ++    L +  + ++E +   ++ Q
Sbjct: 81  VLELAKSCPRVINLHEVYE-NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  + YL++    ++H DLKP NILL+     G+IKI DFG+S+ +             
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--------E 189

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
             +  GT  YL PE  ++  +P  I++  D+W++G+I Y  L    PF   +        
Sbjct: 190 LREIMGTPEYLAPE--ILNYDP--ITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLN 244

Query: 521 NTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
             I +   V ++ +   +VS  A  FI+S L    E R 
Sbjct: 245 --ISQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  178 bits (455), Expect = 1e-51
 Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 27/281 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREY 342
             + Y    +LG+G  S V +       +  A K+  +        +         L+E 
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74

Query: 343 NIHKALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQ 400
           +I + +  HP +++L D +E     F  V +     +L F YL +  T++E+E R I+  
Sbjct: 75  DILRKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIMRA 132

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  +  L+++   ++H DLKP NILL +      IK+TDFG S  +D          + 
Sbjct: 133 LLEVICALHKLN--IVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPG--------EK 179

Query: 461 TSQGAGTYWYLPPE--CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
             +  GT  YL PE     +  N P    +VD+WS GVI Y  L G  PF H + Q  +L
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLML 238

Query: 519 EENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
               I+     QF +      S+  K  +   L  + + R 
Sbjct: 239 RM--IMSG-NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  178 bits (453), Expect = 3e-51
 Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 31/294 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             + +   +G+G FSEV++A  L +   VA K  Q+        +A+     ++E ++ K
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD----CIKEIDLLK 87

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVV 402
            L+HP V+K Y  F I+ N    VLE  D  DL   +K  K     I ER      +Q+ 
Sbjct: 88  QLNHPNVIKYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SAL++++  +  V+H D+KP N+ +T     G +K+ D GL +                 
Sbjct: 147 SALEHMHSRR--VMHRDIKPANVFITAT---GVVKLGDLGLGRFF-------SSKTTAAH 194

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT +Y+ PE   + +N    + K D+WS+G + Y+    + PF  ++     L    
Sbjct: 195 SLVGTPYYMSPE--RIHENG--YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---- 246

Query: 523 ILKATEVQFANKPT--VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
             K  +  +   P+   S E +  +  C+    E R DV  +            
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  179 bits (455), Expect = 5e-51
 Identities = 84/281 (29%), Positives = 126/281 (44%), Gaps = 31/281 (11%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           +N   LSD + +   LG+G  S V++      Q+  A KV  L K    DKK        
Sbjct: 46  SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV--LKK--TVDKKI-----VR 96

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIV 398
            E  +   L HP ++KL ++FE        VLE   G +L F  + +    +ER+A   V
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFE-TPTEISLVLELVTGGEL-FDRIVEKGYYSERDAADAV 154

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q++ A+ YL+E    ++H DLKP N+L         +KI DFGLSK+++ +        
Sbjct: 155 KQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-------- 204

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
            L     GT  Y  PE  ++         +VD+WSVG+I Y  L G +PF   +    + 
Sbjct: 205 VLMKTVCGTPGYCAPE--ILRGCA--YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260

Query: 519 EENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
               IL   E  F +     VS  AK  +R  +    + R+
Sbjct: 261 RR--ILNC-EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  177 bits (452), Expect = 1e-50
 Identities = 75/312 (24%), Positives = 128/312 (41%), Gaps = 42/312 (13%)

Query: 261 KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVH 320
           + + +  + +  + +  +F      +D Y +   +G G +S   +          A K+ 
Sbjct: 2   QTVGVHSIVQQLHRNSIQF------TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI- 54

Query: 321 QLNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL 379
            ++K  K D           E  I  +   HP ++ L DV++ D      V E   G +L
Sbjct: 55  -IDKS-KRDPT--------EEIEILLRYGQHPNIITLKDVYD-DGKYVYVVTELMKGGEL 103

Query: 380 DF-YLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL-TEGNVCGEIK 437
               + + K  +EREA +++  +   ++YL+     V+H DLKP NIL   E      I+
Sbjct: 104 -LDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIR 160

Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I DFG +K +  EN        L      T  ++ PE  V+ +      +  D+WS+GV+
Sbjct: 161 ICDFGFAKQLRAEN-------GLLMTPCYTANFVAPE--VLERQG--YDAACDIWSLGVL 209

Query: 498 FYQCLYGKKPF--GHNQSQATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRK 553
            Y  L G  PF  G + +   IL    I    +   +     +VS+ AK  +   L    
Sbjct: 210 LYTMLTGYTPFANGPDDTPEEILAR--IGSG-KFSLSGGYWNSVSDTAKDLVSKMLHVDP 266

Query: 554 EDRIDVISLARH 565
             R+    + RH
Sbjct: 267 HQRLTAALVLRH 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  175 bits (446), Expect = 4e-50
 Identities = 73/308 (23%), Positives = 114/308 (37%), Gaps = 30/308 (9%)

Query: 285 LSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
             D Y L   +LG+G  + V    +L   +  A K+  + K     +         RE  
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI--IEKQPGHIRS-----RVFREVE 62

Query: 344 IHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           +      H  V++L + FE + + F  V E   G  +  ++ + +   E EA  +V  V 
Sbjct: 63  MLYQCQGHRNVLELIEFFE-EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA 121

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           SAL +L+     + H DLKP NIL    N    +KI DF L   +               
Sbjct: 122 SALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 463 QGAGTYWYLPPECFVVGKNPPKISS---KVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
              G+  Y+ PE  VV     + S    + D+WS+GVI Y  L G  PF          +
Sbjct: 180 TPCGSAEYMAPE--VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237

Query: 520 ENTILKATEVQFANK-------------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
                 A +                     +S  AK  I   L    + R+    + +H 
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297

Query: 567 YLQPPVPK 574
           ++Q   P+
Sbjct: 298 WVQGCAPE 305

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  174 bits (443), Expect = 5e-50
 Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 37/296 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D + +   LGKG F  V+ A + + +  +A KV  L K   + +K        RE  I  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKV--LFK--SQLEKEGVEHQLRREIEIQS 69

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L HP ++++Y+ F  D      +LE+    +L   L++H    E+ + + + ++  AL 
Sbjct: 70  HLRHPNILRMYNYFH-DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y +E K  VIH D+KP N+L+      GE+KI DFG S                     G
Sbjct: 129 YCHERK--VIHRDIKPENLLMGYK---GELKIADFGWSVHAPSL---------RRRTMCG 174

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  YLPPE  ++         KVD+W  GV+ Y+ L G  PF  + S         I+  
Sbjct: 175 TLDYLPPE--MIEGKT--HDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRR--IVNV 227

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH--------DYLQPPVPK 574
            +++F   P +S+ +K  I   L Y    R+ +  +  H          L P    
Sbjct: 228 -DLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  174 bits (444), Expect = 9e-50
 Identities = 91/347 (26%), Positives = 145/347 (41%), Gaps = 51/347 (14%)

Query: 285 LSDRYLLLML---LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
               Y L +    LG+G FS   K    K  +  A K+  ++K  + + +        +E
Sbjct: 6   FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI--ISKRMEANTQ--------KE 55

Query: 342 YNIHKALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
               K  + HP +VKL++VF  D      V+E  +G +L   +K+ K  +E EA  I+ +
Sbjct: 56  ITALKLCEGHPNIVKLHEVFH-DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           +VSA+ +++++   V+H DLKP N+L T+ N   EIKI DFG +++   +N         
Sbjct: 115 LVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-------QP 165

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
                 T  Y  PE  ++ +N        D+WS+GVI Y  L G+ PF  +    T    
Sbjct: 166 LKTPCFTLHYAAPE--LLNQNG--YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221

Query: 521 NTILKAT---EVQFANKP--TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             I+K     +  F  +    VS EAK  I+  L      R+ +  L  +++LQ      
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ------ 275

Query: 576 GRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQSFATGLFSGMN 622
                        S  SS          +  +AV        F   N
Sbjct: 276 -----------DGSQLSSNPLMTPDILGSSGAAVHTCVKAT-FHAFN 310

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  176 bits (447), Expect = 1e-49
 Identities = 69/280 (24%), Positives = 127/280 (45%), Gaps = 26/280 (9%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNK-DWKEDKKANYIKHALREYN 343
              +Y    ++G+G  S V +          A K+ ++       ++     +   RE +
Sbjct: 92  FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151

Query: 344 IHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF-YLKQHKTIAEREARSIVMQV 401
           I + +  HP ++ L D +E  ++    V +     +L F YL +   ++E+E RSI+  +
Sbjct: 152 ILRQVAGHPHIITLIDSYE-SSSFMFLVFDLMRKGEL-FDYLTEKVALSEKETRSIMRSL 209

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           + A+ +L+     ++H DLKP NILL +     +I+++DFG S  ++          +  
Sbjct: 210 LEAVSFLHANN--IVHRDLKPENILLDDN---MQIRLSDFGFSCHLEPG--------EKL 256

Query: 462 SQGAGTYWYLPPE--CFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
            +  GT  YL PE     + +  P    +VD+W+ GVI +  L G  PF  ++ Q  +L 
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF-WHRRQILMLR 315

Query: 520 ENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
              I++  + QF++      S+  K  I   L    E R+
Sbjct: 316 M--IMEG-QYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  174 bits (442), Expect = 2e-49
 Identities = 75/336 (22%), Positives = 132/336 (39%), Gaps = 53/336 (15%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           +   R  +  +L +GGF+ V++A D+   R  A K  +L  + +E  +A      ++E  
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALK--RLLSNEEEKNRA-----IIQEVC 77

Query: 344 IHKAL-DHPRVVKLYDVFEIDANS-------FCTVLEYCDGHDLDFYLK--QHKTIAERE 393
             K L  HP +V+      I           F  + E C G  ++F  K      ++   
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
              I  Q   A+++++  KPP+IH DLK  N+LL+     G IK+ DFG +  +   ++ 
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKLCDFGSATTI---SHY 191

Query: 454 PDHGMDLTSQGA--------GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
           PD+      +           T  Y  PE   +  N P I  K D+W++G I Y   + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ 250

Query: 506 KPFGHNQSQATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
            PF          E+   L+    +++     T        IR+ L    E+R+ +  + 
Sbjct: 251 HPF----------EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

Query: 564 RH-------DYLQP--PVPKHGRQSASSSAPVGHSP 590
                      + P  P+ +   Q+    +      
Sbjct: 301 HQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  171 bits (434), Expect = 6e-48
 Identities = 42/324 (12%), Positives = 87/324 (26%), Gaps = 52/324 (16%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV-----HQLNKDWKEDKKANYIKHALREYNIHKAL 348
            L  G  S V    D++     A KV          + +   +A +    L   +  +A 
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 349 DHPRVVKLYDVFEI----------------DANSFCTVLEYCDG------HDLDFYLKQH 386
           D  R++   D   +                   ++  ++             LDF     
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 387 KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV 446
                     +  Q++     L      ++H    P N+ +      G + + D      
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD---GRLMLGDVSALWK 243

Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKK 506
           +                 +    Y P E   +  +    +  ++ W +G+  Y+      
Sbjct: 244 VGT----------RGPASSVPVTYAPRE--FLNASTATFTHALNAWQLGLSIYRVWCLFL 291

Query: 507 PFGH---NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
           PFG        +       +     + F +   + +  K  I   L + +  R+  +   
Sbjct: 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351

Query: 564 RHDYLQPPVPKHGRQSASSSAPVG 587
                        +   SSS   G
Sbjct: 352 ETPEFL-----QLQNEISSSLSTG 370

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  167 bits (424), Expect = 5e-47
 Identities = 78/302 (25%), Positives = 121/302 (40%), Gaps = 43/302 (14%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD----WKEDKKANYIK 336
           +       Y L  LLGKGGF  V     L ++  VA KV  + ++    W     +    
Sbjct: 25  DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV--IPRNRVLGWSPLSDSVTCP 82

Query: 337 HALREYNIHKALD----HPRVVKLYDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAE 391
               E  +   +     HP V++L D FE     F  VLE      DL  Y+ +   + E
Sbjct: 83  ---LEVALLWKVGAGGGHPGVIRLLDWFE-TQEGFMLVLERPLPAQDLFDYITEKGPLGE 138

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
             +R    QVV+A+++ +     V+H D+K  NIL+      G  K+ DFG   ++ +E 
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRR--GCAKLIDFGSGALLHDEP 194

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           Y             GT  Y PPE ++        +    VWS+G++ Y  + G  PF   
Sbjct: 195 YT-------DF--DGTRVYSPPE-WISRH--QYHALPATVWSLGILLYDMVCGDIPFER- 241

Query: 512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
                   +  IL+A   +      VS +    IR CLA +   R  +  +    ++Q P
Sbjct: 242 --------DQEILEA---ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290

Query: 572 VP 573
             
Sbjct: 291 AE 292

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  174 bits (443), Expect = 7e-47
 Identities = 70/247 (28%), Positives = 102/247 (41%), Gaps = 28/247 (11%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           +        + +   LG GGF  V +         VA K     ++          +   
Sbjct: 7   SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ--CRQE----LSPKNRERWC 60

Query: 340 REYNIHKALDHPRVVKLYDVFE-----IDANSFCTVLEYCDGHDLDFYLKQHKTIA---E 391
            E  I K L+HP VV   +V +        +     +EYC+G DL  YL Q +      E
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
              R+++  + SAL+YL+E +  +IH DLKP NI+L  G      KI D G +K +D+  
Sbjct: 121 GPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                    T    GT  YL PE     K   K +  VD WS G + ++C+ G +PF  N
Sbjct: 179 L-------CTEF-VGTLQYLAPELL-EQK---KYTVTVDYWSFGTLAFECITGFRPFLPN 226

Query: 512 QSQATIL 518
                  
Sbjct: 227 WQPVQWH 233

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  167 bits (425), Expect = 8e-47
 Identities = 61/326 (18%), Positives = 120/326 (36%), Gaps = 50/326 (15%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV---HQLNK-------DWKEDKKANYIK 336
           + Y ++  L +G F+++      K+ ++ A K      L K       +  +    +   
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 337 HALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------KT 388
               E  I   + +   +    +   + +    + EY +   +  + +            
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIIT-NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD 448
           I  +  + I+  V+++  Y++  K  + H D+KP NIL+ +    G +K++DFG S    
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKN---GRVKLSDFGES---- 199

Query: 449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
              Y  D  +   S   GTY ++PPE            +KVD+WS+G+  Y   Y   PF
Sbjct: 200 --EYMVDKKIK-GS--RGTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

Query: 509 GHNQSQATILE--------------ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE 554
               S   +                        +    +   +SNE   F++  L     
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312

Query: 555 DRIDVISLARHDYLQPPVPKHGRQSA 580
           +RI      +H++L     +  R+ +
Sbjct: 313 ERITSEDALKHEWLADTNIEDLREFS 338

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  165 bits (421), Expect = 2e-46
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 41/306 (13%)

Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD----WK 327
           H    +       L  +Y +  LLG GGF  V+    + +   VA K   + KD    W 
Sbjct: 28  HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH--VEKDRISDWG 85

Query: 328 EDKKANYIKHALREYNIHKALDH--PRVVKLYDVFEIDANSFCTVLEYCDGH-DLDFYLK 384
           E      +     E  + K +      V++L D FE   +SF  +LE  +   DL  ++ 
Sbjct: 86  ELPNGTRVP---MEVVLLKKVSSGFSGVIRLLDWFE-RPDSFVLILERPEPVQDLFDFIT 141

Query: 385 QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
           +   + E  ARS   QV+ A+++ +     V+H D+K  NIL+      GE+K+ DFG  
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSG 197

Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
            ++ +  Y             GT  Y PPE ++             VWS+G++ Y  + G
Sbjct: 198 ALLKDTVYT-------DF--DGTRVYSPPE-WIRYH--RYHGRSAAVWSLGILLYDMVCG 245

Query: 505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR 564
             PF H         +  I++    Q   +  VS+E +  IR CLA R  DR     +  
Sbjct: 246 DIPFEH---------DEEIIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

Query: 565 HDYLQP 570
           H ++Q 
Sbjct: 294 HPWMQD 299

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  163 bits (415), Expect = 1e-45
 Identities = 71/285 (24%), Positives = 116/285 (40%), Gaps = 42/285 (14%)

Query: 285 LSDRYLLLM-LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++D Y L   +LG G   +V + F  +  +  A K+  L        +        +E +
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL--LYD--SPKAR--------QEVD 73

Query: 344 IH-KALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDL--DFYLKQHKTIAEREARSI 397
            H +A   P +V + DV+E           ++E  +G +L      +  +   EREA  I
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           +  + +A+++L+     + H D+KP N+L T       +K+TDFG +K   +        
Sbjct: 134 MRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----- 186

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF---GHNQSQ 514
                    T +Y+ PE  V+G    K     D+WS+GVI Y  L G  PF         
Sbjct: 187 ----QTPCYTPYYVAPE--VLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238

Query: 515 ATILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
             +     I    +  F N     VS +AK  IR  L     +R+
Sbjct: 239 PGMKRR--IRLG-QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL 280

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  161 bits (410), Expect = 3e-45
 Identities = 72/297 (24%), Positives = 113/297 (38%), Gaps = 61/297 (20%)

Query: 272 HNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKK 331
           H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+  L        +
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQD--CPKAR 58

Query: 332 ANYIKHALREYNIHKAL-DHPRVVKLYDVFE---IDANSFCTVLEYCDGHDL--DFYLKQ 385
                   RE  +H      P +V++ DV+E           V+E  DG +L      + 
Sbjct: 59  --------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
               E Y+                                    D+WS+GVI Y  L G 
Sbjct: 169 ETTGEKYDK---------------------------------SCDMWSLGVIMYILLCGY 195

Query: 506 KPFGHNQSQAT---ILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKEDRI 557
            PF  N   A    +     I    + +F N     VS E K  IR+ L      R+
Sbjct: 196 PPFYSNHGLAISPGMKTR--IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  161 bits (409), Expect = 4e-44
 Identities = 80/303 (26%), Positives = 127/303 (41%), Gaps = 40/303 (13%)

Query: 266 RELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
           ++  + H +   +   + ++ D  +   +LG G   +V + F+ + Q   A K+  L   
Sbjct: 41  QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQD- 97

Query: 326 WKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE---IDANSFCTVLEYCDGHDL-- 379
                +        RE  +H      P +V++ DV+E           V+E  DG +L  
Sbjct: 98  -CPKAR--------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 148

Query: 380 DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
               +  +   EREA  I+  +  A++YL+ I   + H D+KP N+L T       +K+T
Sbjct: 149 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT 206

Query: 440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY 499
           DFG +K     N        LT+    T +Y+ PE  V+G    K     D+WS+GVI Y
Sbjct: 207 DFGFAKETTSHN-------SLTTP-CYTPYYVAPE--VLGPE--KYDKSCDMWSLGVIMY 254

Query: 500 QCLYGKKPFGHNQSQAT---ILEENTILKATEVQFANKP--TVSNEAKGFIRSCLAYRKE 554
             L G  PF  N   A    +     I    + +F N     VS E K  IR+ L     
Sbjct: 255 ILLCGYPPFYSNHGLAISPGMKTR--IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311

Query: 555 DRI 557
            R+
Sbjct: 312 QRM 314

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  158 bits (401), Expect = 5e-44
 Identities = 70/280 (25%), Positives = 112/280 (40%), Gaps = 29/280 (10%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
            +G+G F  V+K  D +    VA    Q  K  K +      +    E  + K L HP +
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-----RQRFKEEAEMLKGLQHPNI 87

Query: 354 VKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           V+ YD +E           V E      L  YLK+ K +  +  RS   Q++  L++L+ 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT-YW 469
             PP+IH DLK  NI +T     G +KI D GL+ +                   GT  +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPT--GSVKIGDLGLATLKRA---------SFAKAVIGTPEF 196

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
            + PE   + +   K    VDV++ G+   +    + P+   Q+ A I      + +   
Sbjct: 197 -MAPE---MYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVK 247

Query: 530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +       E K  I  C+   K++R  +  L  H + Q
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  157 bits (400), Expect = 1e-43
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 30/288 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            Y LL  +GKG F++V  A  +   R VA K+  ++K          ++   RE  I K 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKI--IDK---TQLNPTSLQKLFREVRIMKI 70

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L+HP +VKL++V E +   +  ++EY  G ++  YL  H  + E+EARS   Q+VSA++Y
Sbjct: 71  LNHPNIVKLFEVIETEKTLYL-IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
            ++ +  ++H DLK  N+LL        IKI DFG S             +D      G 
Sbjct: 130 CHQKR--IVHRDLKAENLLLDAD---MNIKIADFGFSNEF-----TVGGKLD-AF--CGA 176

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKA 526
             Y  PE F   +       +VDVWS+GVI Y  + G  PF G N  +   L E  +L+ 
Sbjct: 177 PPYAAPELF---QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRER-VLRG 229

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
              ++     +S + +  ++  L      R  +  + +  ++     +
Sbjct: 230 ---KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  156 bits (396), Expect = 3e-43
 Identities = 78/312 (25%), Positives = 133/312 (42%), Gaps = 42/312 (13%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD-------------- 325
           +   V  ++Y L   +GKG +  V  A++  +  Y A KV  L+K               
Sbjct: 6   SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV--LSKKKLIRQAGFPRRPPP 63

Query: 326 -------WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGH 377
                      +    I+   +E  I K LDHP VVKL +V +    +    V E  +  
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123

Query: 378 DLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
            +   +   K ++E +AR     ++  ++YL+  K  +IH D+KP N+L+ E    G IK
Sbjct: 124 PV-MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGE---DGHIK 177

Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I DFG+S      +        L S   GT  ++ PE  +           +DVW++GV 
Sbjct: 178 IADFGVSNEFKGSD-------ALLSNTVGTPAFMAPES-LSETRKIFSGKALDVWAMGVT 229

Query: 498 FYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            Y  ++G+ PF  ++    +  +  I     ++F ++P ++ + K  I   L    E RI
Sbjct: 230 LYCFVFGQCPF-MDERIMCLHSK--IKSQ-ALEFPDQPDIAEDLKDLITRMLDKNPESRI 285

Query: 558 DVISLARHDYLQ 569
            V  +  H ++ 
Sbjct: 286 VVPEIKLHPWVT 297

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (394), Expect = 6e-43
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 20/225 (8%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           ++++RY ++  LG GG S V+ A D      VA K   +    +E      +K   RE +
Sbjct: 8   IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA--IFIPPREK--EETLKRFEREVH 63

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
               L H  +V + DV E D   +  V+EY +G  L  Y++ H  ++   A +   Q++ 
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            +K+ ++++  ++H D+KP NIL+        +KI DFG++K + E        +  T+ 
Sbjct: 123 GIKHAHDMR--IVHRDIKPQNILIDSN---KTLKIFDFGIAKALSET------SLTQTNH 171

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             GT  Y  PE    G+         D++S+G++ Y+ L G+ PF
Sbjct: 172 VLGTVQYFSPEQ-AKGE---ATDECTDIYSIGIVLYEMLVGEPPF 212

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  156 bits (395), Expect = 1e-42
 Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 41/307 (13%)

Query: 274 EDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD------WK 327
           E +         S +Y  +  LG G F  V  A D ++ + V  K   + K+      W 
Sbjct: 11  ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF--IKKEKVLEDCWI 68

Query: 328 EDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLE-YCDGHDLDFYLKQH 386
           ED K   +     E  I   ++H  ++K+ D+FE +   F  V+E +  G DL  ++ +H
Sbjct: 69  EDPKLGKVT---LEIAILSRVEHANIIKVLDIFE-NQGFFQLVMEKHGSGLDLFAFIDRH 124

Query: 387 KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV 446
             + E  A  I  Q+VSA+ YL      +IH D+K  NI++ E      IK+ DFG +  
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED---FTIKLIDFGSAAY 179

Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKK 506
           ++            T    GT  Y  PE   +G   P    ++++WS+GV  Y  ++ + 
Sbjct: 180 LE-----RGKLFY-TF--CGTIEYCAPEVL-MGN--PYRGPELEMWSLGVTLYTLVFEEN 228

Query: 507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD 566
           PF          E    ++A          VS E    +   L    E R  +  L    
Sbjct: 229 PF---------CELEETVEA---AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 567 YLQPPVP 573
           ++  PV 
Sbjct: 277 WVTQPVN 283

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  153 bits (389), Expect = 4e-42
 Identities = 74/230 (32%), Positives = 114/230 (49%), Gaps = 24/230 (10%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            LSDRY L  +LG GG SEVH A DL++ R VA KV  L  D   D   ++     RE  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV--LRADLARD--PSFYLRFRREAQ 64

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCT---VLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
              AL+HP +V +YD  E +  +      V+EY DG  L   +     +  + A  ++  
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
              AL + ++    +IH D+KP NI+++       +K+ DFG+++ + +       G  +
Sbjct: 125 ACQALNFSHQNG--IIHRDVKPANIMISAT---NAVKVMDFGIARAIADS------GNSV 173

Query: 461 TSQGA--GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T   A  GT  YL PE    G     + ++ DV+S+G + Y+ L G+ PF
Sbjct: 174 TQTAAVIGTAQYLSPEQ-ARGD---SVDARSDVYSLGCVLYEVLTGEPPF 219

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  152 bits (387), Expect = 9e-42
 Identities = 77/332 (23%), Positives = 147/332 (44%), Gaps = 25/332 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + L+  LG+G + EV  A +   +  VA K+  ++      +  +  ++  +E  I+K
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI--VDMK----RAVDCPENIKKEICINK 60

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q+++ + 
Sbjct: 61  MLNHENVVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 407 YLNEIKPPVIHYDLKPGNILLTE-GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           YL+ I   + H D+KP N+LL E  N    +KI+DFGL+ V      N +  ++      
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDN----LKISDFGLATVFRYN--NRERLLN-KM--C 168

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  Y+ PE   + K     +  VDVWS G++    L G+ P+  +Q   +  E +   +
Sbjct: 169 GTLPYVAPE---LLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKE 223

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAP 585
             +        + +     +   L      RI +  + +  +   P+ K  ++   +S  
Sbjct: 224 K-KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGG 282

Query: 586 VGHSPASSGQNQNSGGASTQSSAVQQSFATGL 617
           V  SP+   ++  S    +  ++  ++  +G 
Sbjct: 283 VSESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  154 bits (390), Expect = 2e-41
 Identities = 53/372 (14%), Positives = 112/372 (30%), Gaps = 62/372 (16%)

Query: 277 SRFNNHPVLSDRYLLLM---LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED---- 329
             F     L +R   L+   +LG+       +A D +        V    +    +    
Sbjct: 65  QPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQ 124

Query: 330 --KKANYIKHALREYNIHKALDHPRVVKLYDVFEI-----------DANSFCTVLEY--- 373
             ++   ++      N  +A  H R +  +D+ +            D      +  +   
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 374 ----CDGHD----LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
                +       L  +   HK++       + +QV+  L  L+     ++H  L+P +I
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDI 242

Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV-VGKNPPK 484
           +L +    G + +T F                +    +G                 +P  
Sbjct: 243 VLDQR---GGVFLTGFEHLVRDGAS------AVSPIGRGFAPPETTAERMLPFGQHHPTL 293

Query: 485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGF 544
           ++   D W++G+  Y       P   + +              E  F +   +    +  
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------EWIFRSCKNIPQPVRAL 343

Query: 545 IRSCLAYRKEDRIDVISLARH-------DYLQPPVPKHGRQSASSSAPVGHSPASSGQNQ 597
           +   L Y KEDR+  +              L   +P +      +    G +P S     
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPT--REGGAPPSGTSQP 401

Query: 598 NSGGASTQSSAV 609
           +  GA+   +A+
Sbjct: 402 DEAGAAEAVTAI 413

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  151 bits (383), Expect = 3e-41
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 24/223 (10%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            Y L  L+G+GG  +V++A D   +R VA K+  +++    D    +     RE      
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKL--MSETLSSD--PVFRTRMQREARTAGR 90

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L  P VV ++D  EID   +   +   +G DL   L++   +A   A +IV Q+ SAL  
Sbjct: 91  LQEPHVVPIHDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA-- 465
            +       H D+KP NIL++         + DFG++    +E         LT  G   
Sbjct: 150 AHAAG--ATHRDVKPENILVSAD---DFAYLVDFGIASATTDEK--------LTQLGNTV 196

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           GT +Y+ PE F         + + D++++  + Y+CL G  P+
Sbjct: 197 GTLYYMAPERFSES----HATYRADIYALTCVLYECLTGSPPY 235

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  150 bits (380), Expect = 4e-41
 Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 25/290 (8%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + L+  LG+G + EV  A +   +  VA K+  ++      +  +  ++  +E  I+K
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI--VDMK----RAVDCPENIKKEICINK 60

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L+H  VVK Y     + N     LEYC G +L   ++    + E +A+    Q+++ + 
Sbjct: 61  MLNHENVVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 407 YLNEIKPPVIHYDLKPGNILLTE-GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           YL+ I   + H D+KP N+LL E  N    +KI+DFGL+ V      N +  ++      
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDN----LKISDFGLATVFRYN--NRERLLN-KM--C 168

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  Y+ PE   + K     +  VDVWS G++    L G+ P+  +Q   +  E +   +
Sbjct: 169 GTLPYVAPE---LLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKE 223

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
             +        + +     +   L      RI +  + +  +   P+ K 
Sbjct: 224 K-KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  149 bits (377), Expect = 9e-41
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 19/229 (8%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKGGF  VHK   +K++  VA K   L     E +     +   RE  I   L+HP +V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSALKYLNEIKP 413
           KLY +     N    V+E+    DL   L  +   I       +++ +   ++Y+    P
Sbjct: 87  KLYGLM---HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143

Query: 414 PVIHYDLKPGNILLTEGNVCGE--IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
           P++H DL+  NI L   +       K+ DFGLS+                S   G + ++
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----------VSGLLGNFQWM 193

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILE 519
            PE     +     + K D +S  +I Y  L G+ PF  ++  +   + 
Sbjct: 194 APETIGAEEES--YTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  148 bits (377), Expect = 1e-40
 Identities = 71/285 (24%), Positives = 123/285 (43%), Gaps = 25/285 (8%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +YL+  LLG+G + +V +  D +     A K+  L K  K  +  N   +  +E  + + 
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKI--LKKK-KLRRIPNGEANVKKEIQLLRR 62

Query: 348 LDHPRVVKLYDVFEIDANS-FCTVLEYCDG--HDLDFYLKQHKTIAEREARSIVMQVVSA 404
           L H  V++L DV   +       V+EYC     ++   + + +     +A     Q++  
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDG 121

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL+     ++H D+KPGN+LLT G   G +KI+  G+++ +    +  D     TSQG
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLTTG---GTLKISALGVAEALHP--FAADDTCR-TSQG 173

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
             +  + PPE  +          KVD+WS GV  Y    G  PF    +   + E   I 
Sbjct: 174 --SPAFQPPE--IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFEN--IG 226

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           K     +A            ++  L Y    R  +  + +H + +
Sbjct: 227 KG---SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  148 bits (375), Expect = 2e-40
 Identities = 82/296 (27%), Positives = 127/296 (42%), Gaps = 27/296 (9%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++  V    Y+L   LG G F +V           VA K+  LN+   + +  + +    
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKI--LNRQ--KIRSLDVVGKIK 59

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE    K   HP ++KLY V     + F  V+EY  G +L  Y+ +H  + E EAR +  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFM-VMEYVSGGELFDYICKHGRVEEMEARRLFQ 118

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++SA+ Y +     V+H DLKP N+LL         KI DFGLS      N   D    
Sbjct: 119 QILSAVDYCHRHM--VVHRDLKPENVLLDAH---MNAKIADFGLS------NMMSDGEFL 167

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
            TS   G+  Y  PE  + G+       +VD+WS GVI Y  L G  PF  ++   T+ +
Sbjct: 168 RTS--CGSPNYAAPE-VISGR--LYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFK 221

Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           +  I       F     ++      +   L      R  +  +  H++ +  +P +
Sbjct: 222 K--IRGG---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSY 272

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  148 bits (377), Expect = 2e-40
 Identities = 82/284 (28%), Positives = 125/284 (44%), Gaps = 36/284 (12%)

Query: 271 IHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK 330
           + +             D +    +LG+G FS V  A +L   R  A K+  L K  +   
Sbjct: 15  LQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVVLARELATSREYAIKI--LEK--RHII 69

Query: 331 KANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
           K N + +  RE ++   LDHP  VKLY  F+ D       L Y    +L  Y+++  +  
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGSFD 128

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
           E   R    ++VSAL+YL+     +IH DLKP NILL E      I+ITDFG +KV+  E
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED---MHIQITDFGTAKVLSPE 183

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGK 505
           +          +   GT  Y+ PE          ++ K      D+W++G I YQ + G 
Sbjct: 184 SKQ-----ARANSFVGTAQYVSPEL---------LTEKSACKSSDLWALGCIIYQLVAGL 229

Query: 506 KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
            PF    ++  I ++  I+K  E  F        +A+  +   L
Sbjct: 230 PPF-RAGNEYLIFQK--IIKL-EYDF--PEKFFPKARDLVEKLL 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  148 bits (375), Expect = 9e-40
 Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 23/306 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY  +  +G G F       D   +  VA K   + +    D+    ++   RE   H+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDEN---VQ---REIINHR 71

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           +L HP +V+  +V          ++EY  G +L   +      +E EAR    Q++S + 
Sbjct: 72  SLRHPNIVRFKEVIL-TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y + ++  + H DLK  N LL +G+    +KI DFG SK          H    ++   G
Sbjct: 131 YCHSMQ--ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSV------LHSQPKST--VG 179

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE   V           DVWS GV  Y  L G  PF   +      +    + +
Sbjct: 180 TPAYIAPE---VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSSAPV 586
            +    +   +S E    I          RI +  +  H +    +P      +++ +  
Sbjct: 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQF 296

Query: 587 GHSPAS 592
                 
Sbjct: 297 QEPEQP 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  145 bits (369), Expect = 1e-39
 Identities = 57/316 (18%), Positives = 109/316 (34%), Gaps = 57/316 (18%)

Query: 276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI 335
           +SR+      +  +  L  +G G F  V K     +    A K  +       D++    
Sbjct: 6   KSRY------TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQN--- 56

Query: 336 KHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIA 390
             ALRE   H  L  H  VV+ +  +  + +      EYC+G  L   + ++        
Sbjct: 57  --ALREVYAHAVLGQHSHVVRYFSAWA-EDDHMLIQNEYCNGGSLADAISENYRIMSYFK 113

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI-------------- 436
           E E + +++QV   L+Y++ +   ++H D+KP NI ++  ++                  
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171

Query: 437 --KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV 494
             KI D G    +               +  G   +L  E  V+ +N      K D++++
Sbjct: 172 MFKIGDLGHVTRISSPQ----------VE-EGDSRFLANE--VLQENYTH-LPKADIFAL 217

Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKE 554
            +        +    +      I +    L             S E    ++  +    E
Sbjct: 218 ALTVVCAAGAEPLPRNGDQWHEIRQGR--LPRIPQVL------SQEFTELLKVMIHPDPE 269

Query: 555 DRIDVISLARHDYLQP 570
            R   ++L +H  L  
Sbjct: 270 RRPSAMALVKHSVLLS 285

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  147 bits (374), Expect = 2e-39
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 24/260 (9%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           +L  +GKG F +V        ++  A K   +NK    ++    +++  +E  I + L+H
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNE--VRNVFKELQIMQGLEH 74

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +V L+  F+ D      V++   G DL ++L+Q+    E   +  + ++V AL YL  
Sbjct: 75  PFLVNLWYSFQ-DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  +IH D+KP NILL E    G + ITDF ++ ++  E           +  AGT  Y
Sbjct: 134 QR--IIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRE--------TQITTMAGTKPY 180

Query: 471 LPPECFVVGKNPPKISSK-VDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           + PE  +         S  VD WS+GV  Y+ L G++P+    S ++    +T      V
Sbjct: 181 MAPE--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VV 237

Query: 530 QFANKPTVSNEAKGFIRSCL 549
            +      S E    ++  L
Sbjct: 238 TY--PSAWSQEMVSLLKKLL 255

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  148 bits (376), Expect = 2e-39
 Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 28/311 (9%)

Query: 248 NHPVLSDSYLIGYKNLHIRELKRIHNEDQ---------SRFNNHPVLSDRYLLLMLLGKG 298
           N   L D       +L    L++  N D          ++  +  + ++ Y ++ ++G+G
Sbjct: 21  NSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRG 80

Query: 299 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD 358
            F EV        ++  A K+  L+K   E  K +       E +I    + P VV+L+ 
Sbjct: 81  AFGEVQLVRHKSTRKVYAMKL--LSK--FEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 418
            F+ D      V+EY  G DL   L  +  + E+ AR    +VV AL  ++ +    IH 
Sbjct: 137 AFQ-DDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHR 192

Query: 419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVV 478
           D+KP N+LL +    G +K+ DFG    M++E      GM       GT  Y+ PE    
Sbjct: 193 DVKPDNMLLDK---SGHLKLADFGTCMKMNKE------GMVRCDTAVGTPDYISPEVLKS 243

Query: 479 GKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVS 538
                    + D WSVGV  Y+ L G  PF  +    T      +     + F +   +S
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNHKNSLTFPDDNDIS 301

Query: 539 NEAKGFIRSCL 549
            EAK  I + L
Sbjct: 302 KEAKNLICAFL 312

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  147 bits (371), Expect = 4e-39
 Identities = 45/311 (14%), Positives = 96/311 (30%), Gaps = 61/311 (19%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV---------------------HQLNKDWKEDKKA 332
           +LG+       +A D +        V                      +L +  K  K+A
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFE-IDANSFCTVLEYCD------GHDLDFYLKQ 385
                 +  +++ K     +++++      +   S   +           G  L  +   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
           HK++       + +QV+  L  L+     ++H  L+P +I+L +    G + +T F    
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR---GGVFLTGFEHLV 254

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPE-------CFVVGKNPPKISSKVDVWSVGVIF 498
                      G  + S    +  + PPE                 ++   D W++G++ 
Sbjct: 255 ---------RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 499 YQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
           Y       P   + +              E  F +   +    +  +   L Y KEDR+ 
Sbjct: 304 YWIWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLL 353

Query: 559 VISLARHDYLQ 569
            +        +
Sbjct: 354 PLQAMETPEYE 364

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  145 bits (368), Expect = 9e-39
 Identities = 55/330 (16%), Positives = 107/330 (32%), Gaps = 50/330 (15%)

Query: 254 DSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKA-----FD 308
              +  Y N    + K    + ++ F    + S    +  LLG+G F++V++A      D
Sbjct: 35  SKPVSSYPNTFEWQCKLPAIKPKTEF---QLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91

Query: 309 LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC 368
            K ++    KV +    W+            +     K       +K Y       N   
Sbjct: 92  AKNKQKFVLKVQKPANPWE-------FYIGTQLMERLKPSMQHMFMKFYSAHL-FQNGSV 143

Query: 369 TVLEYCDGHDLDFYLKQHK-----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG 423
            V E      L   +  +K      + +    S  M+++  ++ +++ +  +IH D+KP 
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPD 201

Query: 424 NILL--------TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPEC 475
           N +L         E ++   + + D G S  M            + +    T  +   E 
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVE- 255

Query: 476 FVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKP 535
            ++   P     ++D + V    Y  L+G      N+      E          +     
Sbjct: 256 -MLSNKPWNY--QIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL-------FRRLPHL 305

Query: 536 TVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
            + NE   F    L       +  + L R 
Sbjct: 306 DMWNE---FFHVMLNIPDCHHLPSLDLLRQ 332

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  144 bits (366), Expect = 1e-38
 Identities = 62/290 (21%), Positives = 100/290 (34%), Gaps = 28/290 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
                   +G+G F EVH+  D +     A K  +L     E            E     
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------------ELVACA 105

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L  PR+V LY     +       +E  +G  L   +KQ   + E  A   + Q +  L+
Sbjct: 106 GLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 407 YLNEIKPPVIHYDLKPGNILLT-EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           YL+  +  ++H D+K  N+LL+ +G+      + DFG +  +  +               
Sbjct: 165 YLHTRR--ILHGDVKADNVLLSSDGS---RAALCDFGHALCLQPDGLGKSLLTGDYIP-- 217

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  ++ PE  VV   P    +KVD+WS   +    L G  P+         L+   I  
Sbjct: 218 GTETHMAPE--VVMGKPC--DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IAS 270

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
                    P+ +      I+  L      R   + L R           
Sbjct: 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  143 bits (362), Expect = 2e-38
 Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 23/291 (7%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
            +    +    L  +G G   +V K    K    +A K  + + + +E       K  L 
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE------NKRILM 72

Query: 341 EYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           + ++  K+ D P +V+ +  F  +       +E           +    I ER    + +
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITN-TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
            +V AL YL E K  VIH D+KP NILL E    G+IK+ DFG+S  +            
Sbjct: 132 AIVKALYYLKE-KHGVIHRDVKPSNILLDER---GQIKLCDFGISGRL-------VDDKA 180

Query: 460 LTSQGAGTYWYLPPECFVVGKNP-PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                AG   Y+ PE         P    + DVWS+G+   +   G+ P+ + ++   +L
Sbjct: 181 KDRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               +L+            S + + F++ CL      R     L  H +++
Sbjct: 240 T--KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  142 bits (360), Expect = 5e-38
 Identities = 59/353 (16%), Positives = 114/353 (32%), Gaps = 84/353 (23%)

Query: 277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV-------HQLNKDWKED 329
           SR+         +  +  +G+GGF  V +A +  +    A K            K  +E 
Sbjct: 2   SRYL------TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREV 55

Query: 330 KKANYIKH--------------------------------------------ALREYNIH 345
           K    ++H                                               +    
Sbjct: 56  KALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAERE---ARSIVMQVV 402
                   V                ++ C   +L  ++ +  ++ +RE      I +Q+ 
Sbjct: 116 DPFSTKNTVGQLQPSSPK-VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN-----YNPDHG 457
            A+++L+     ++H DLKP NI  T       +K+ DFGL   MD++        P   
Sbjct: 175 EAVEFLHSKG--LMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI 517
               +   GT  Y+ PE   +  N    S KVD++S+G+I ++ LY        + +   
Sbjct: 230 YATHTGQVGTKLYMSPE--QIHGNN--YSHKVDIFSLGLILFELLYSFST-QMERVR--- 281

Query: 518 LEENTILKATEVQFANKPTV-SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                I     ++F    T    +    ++  L+    +R +   +  +   +
Sbjct: 282 ----IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  144 bits (366), Expect = 1e-37
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 27/296 (9%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           ++  V    Y+L   LG G F +V           VA K+  LN+   + +  + +    
Sbjct: 9   HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKI--LNRQ--KIRSLDVVGKIR 64

Query: 340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
           RE    K   HP ++KLY V    ++ F  V+EY  G +L  Y+ ++  + E+E+R +  
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFM-VMEYVSGGELFDYICKNGRLDEKESRRLFQ 123

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++S + Y +     V+H DLKP N+LL         KI DFGLS +M     +    + 
Sbjct: 124 QILSGVDYCHRHM--VVHRDLKPENVLLDAH---MNAKIADFGLSNMM-----SDGEFLR 173

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
            TS   G+  Y  PE    G+       +VD+WS GVI Y  L G  PF  +    T+ +
Sbjct: 174 -TS--CGSPNYAAPEVI-SGR--LYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFK 226

Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
           +  I       F     ++      ++  L      R  +  +  H++ +  +PK+
Sbjct: 227 K--ICDG---IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKY 277

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  146 bits (370), Expect = 3e-37
 Identities = 94/468 (20%), Positives = 168/468 (35%), Gaps = 62/468 (13%)

Query: 195 EYYEADEILKLRQSALKKEDADLQLEMEKLERERNL--HIRELKRIHNEDQSRFNNHPVL 252
           E  E +E   +    +       +L        ++   H++            F  +   
Sbjct: 93  EKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEE 152

Query: 253 SDSYLIGY---KNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDL 309
               L G    K +   +  R         N H  ++D + +  ++G+GGF EV+     
Sbjct: 153 ICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMND-FSVHRIIGRGGFGEVYGCRKA 211

Query: 310 KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI---HKALDHPRVVKLYDVFEIDANS 366
              +  A K   L+K  K  K       AL E  +       D P +V +   F    + 
Sbjct: 212 DTGKMYAMKC--LDK--KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDK 266

Query: 367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL 426
              +L+  +G DL ++L QH   +E + R    +++  L++++     V++ DLKP NIL
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 324

Query: 427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKIS 486
           L E    G ++I+D GL+    +                GT+ Y+ PE  V+ K     S
Sbjct: 325 LDEH---GHVRISDLGLACDFSK---------KKPHASVGTHGYMAPE--VLQKGVAYDS 370

Query: 487 SKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIR 546
           S  D +S+G + ++ L G  PF  ++++     +   L    V+     + S E +  + 
Sbjct: 371 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVEL--PDSFSPELRSLLE 426

Query: 547 SCLAYRKEDRI-----DVISLARHDY-------------LQPP-VPKHGRQSASSSAPVG 587
             L      R+         +    +               PP +P  G  +A+ +  +G
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 486

Query: 588 H--------SPASSG-QNQNSGGASTQSSAVQQSFATGLFSGMNASSS 626
                           Q        T S   QQ  A  +F  +NA + 
Sbjct: 487 SFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETD 534

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  138 bits (351), Expect = 1e-36
 Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 28/288 (9%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            Y++   LG+G F +V  A   K Q+ VA K   +++  +  KK++      RE +  K 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKF--ISR--QLLKKSDMHMRVEREISYLKL 65

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           L HP ++KLYDV     +    V+EY  G   D Y+ + K + E E R    Q++ A++Y
Sbjct: 66  LRHPHIIKLYDVITTPTDIVM-VIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIICAIEY 123

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
            +  K  ++H DLKP N+LL +      +KI DFGLS +M        + +  TS   G+
Sbjct: 124 CHRHK--IVHRDLKPENLLLDDN---LNVKIADFGLSNIM-----TDGNFLK-TS--CGS 170

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT 527
             Y  PE   V         +VDVWS G++ Y  L G+ PF  ++    + ++  +    
Sbjct: 171 PNYAAPE---VINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKK--VNSC- 223

Query: 528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
              +     +S  A+  IR  +      RI +  + R  +    +P +
Sbjct: 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDY 269

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  139 bits (353), Expect = 2e-36
 Identities = 78/325 (24%), Positives = 127/325 (39%), Gaps = 39/325 (12%)

Query: 242 DQSRFNNHPVLSDSYLIGYKNLHIRELKRIHN---------EDQSRFNNHPVLSDRYLLL 292
           D       P L D  L  ++ L   EL +                R     +  D + +L
Sbjct: 8   DPGFLGLEP-LLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEIL 66

Query: 293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
            ++G+G FSEV      +  +  A K+  +NK   +  K   +     E ++    D   
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKW--DMLKRGEVSCFREERDVLVNGDRRW 122

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEI 411
           + +L+  F+ D N    V+EY  G DL   L +  + I    AR  + ++V A+  ++ +
Sbjct: 123 ITQLHFAFQ-DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H D+KP NILL     CG I++ DFG    +  +      G   +    GT  YL
Sbjct: 182 G--YVHRDIKPDNILLDR---CGHIRLADFGSCLKLRAD------GTVRSLVAVGTPDYL 230

Query: 472 PPECFVVGKNPPKISSK----VDVWSVGVIFYQCLYGKKPF---GHNQSQATILEENTIL 524
            PE  +        +       D W++GV  Y+  YG+ PF      ++   I+     L
Sbjct: 231 SPE-ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289

Query: 525 KATEVQFANKPTVSNEAKGFIRSCL 549
                       V  EA+ FI+  L
Sbjct: 290 SLPL----VDEGVPEEARDFIQRLL 310

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (346), Expect = 2e-36
 Identities = 68/293 (23%), Positives = 115/293 (39%), Gaps = 26/293 (8%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           +  V +D    +M LG+G +  V K   +   + +A K  +   + +E       K  L 
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE------QKRLLM 54

Query: 341 EYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY---LKQHKTIAEREARS 396
           + +I  + +D P  V  Y             +E  D     FY   + + +TI E     
Sbjct: 55  DLDISMRTVDCPFTVTFYGAL-FREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK 113

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I + +V AL++L+  K  VIH D+KP N+L+      G++K+ DFG+S  +         
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLV-------D 162

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
            +      AG   Y+ PE      N    S K D+WS+G+   +    + P+    S  T
Sbjct: 163 DVAKDID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY---DSWGT 218

Query: 517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             ++   +             S E   F   CL    ++R     L +H +  
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  136 bits (345), Expect = 5e-36
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 26/225 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G G F  VH+A +      VA K+  L +   +D  A  +   LRE  I K L HP +V
Sbjct: 45  IGAGSFGTVHRA-EWHGS-DVAVKI--LME---QDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL---KQHKTIAEREARSIVMQVVSALKYLNEI 411
                      +   V EY     L   L      + + ER   S+   V   + YL+  
Sbjct: 98  LFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
            PP++H +LK  N+L+ +       K+ DFGLS++      +       +   AGT  ++
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTV---KVCDFGLSRLKASTFLS-------SKSAAGTPEWM 206

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA 515
            PE     ++ P  + K DV+S GVI ++    ++P+   N +Q 
Sbjct: 207 APEVL---RDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (344), Expect = 5e-36
 Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 37/286 (12%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LGKG +  V+   DL  Q  +A K           + + Y +    E  +HK L H  +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE-------RDSRYSQPLHEEIALHKHLKHKNI 81

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREA--RSIVMQVVSALKYLNE 410
           V+       +       +E   G  L      +   + + E        Q++  LKYL++
Sbjct: 82  VQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            +  ++H D+K  N+L+   +  G +KI+DFG SK +   N         T    GT  Y
Sbjct: 141 NQ--IVHRDIKGDNVLINTYS--GVLKISDFGTSKRLAGIN-------PCTETFTGTLQY 189

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH-NQSQATILEENTILKATEV 529
           + PE  ++ K P       D+WS+G    +   GK PF    + QA + +   +      
Sbjct: 190 MAPE--IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK---VGMFKV- 243

Query: 530 QFANKPTV----SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
                P +    S EAK FI  C     + R     L   ++L+  
Sbjct: 244 ----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  133 bits (337), Expect = 2e-35
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 27/228 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G GGF +V++A        VA K      D  ++  +  I++  +E  +   L HP ++
Sbjct: 15  IGIGGFGKVYRA-FWIGD-EVAVKA--ARHD-PDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP- 413
            L  V  +   + C V+E+  G  L+  L   + I      +  +Q+   + YL++    
Sbjct: 70  ALRGVC-LKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 414 PVIHYDLKPGNILLTEGNVCGE-----IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
           P+IH DLK  NIL+ +    G+     +KITDFGL++                   AG Y
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---------MSAAGAY 178

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA 515
            ++ PE     +     S   DVWS GV+ ++ L G+ PF G +    
Sbjct: 179 AWMAPEVI---RASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  140 bits (355), Expect = 3e-35
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 35/230 (15%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           +++ +Y +   +  GG   ++ A D     R V  K    + D      A     A+ E 
Sbjct: 77  IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD------AEAQAMAMAER 130

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCT----VLEYCDGHDLDFYLKQHKTIAEREARSIV 398
                + HP +V++++  E            V+EY  G  L     Q   +   EA + +
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYL 188

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
           ++++ AL YL+ I   +++ DLKP NI+LTE  +    K+ D G    ++          
Sbjct: 189 LEILPALSYLHSI--GLVYNDLKPENIMLTEEQL----KLIDLGAVSRINS--------- 233

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                  GT  +  PE   + +  P +++  D+++VG             
Sbjct: 234 --FGYLYGTPGFQAPE---IVRTGPTVAT--DIYTVGRTLAALTLDLPTR 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  134 bits (339), Expect = 5e-35
 Identities = 72/316 (22%), Positives = 117/316 (37%), Gaps = 35/316 (11%)

Query: 262 NLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQ 321
           ++      +I  E    F      ++    L  +G+G +  V+K       + +A K  +
Sbjct: 2   SIESSGKLKISPEQHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR 56

Query: 322 LNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD 380
              D KE       K  L + ++  ++ D P +V+ Y             +E        
Sbjct: 57  STVDEKE------QKQLLMDLDVVMRSSDCPYIVQFYGAL-FREGDCWICMELMSTSFDK 109

Query: 381 FYLK----QHKTIAEREARSIVMQVVSALKYL-NEIKPPVIHYDLKPGNILLTEGNVCGE 435
           FY          I E     I +  V AL +L   +K  +IH D+KP NILL      G 
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS---GN 164

Query: 436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVG 495
           IK+ DFG+S  +          +  T   AG   Y+ PE      +      + DVWS+G
Sbjct: 165 IKLCDFGISGQLV-------DSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

Query: 496 VIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTV--SNEAKGFIRSCLAYRK 553
           +  Y+   G+ P+    S    L    ++K    Q +N      S     F+  CL   +
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQLT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274

Query: 554 EDRIDVISLARHDYLQ 569
             R     L +H ++ 
Sbjct: 275 SKRPKYKELLKHPFIL 290

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  138 bits (348), Expect = 9e-35
 Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 28/272 (10%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
             PV  + +    +LGKGGF EV         +  ACK   L K     KK      AL 
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKK--RIKKRKGEAMALN 233

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA--EREARSIV 398
           E  I + ++   VV L   +E   ++ C VL   +G DL F++         E  A    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYE-TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            ++   L+ L+  +  +++ DLKP NILL +    G I+I+D GL+  + E         
Sbjct: 293 AEICCGLEDLHRER--IVYRDLKPENILLDDH---GHIRISDLGLAVHVPEG-------- 339

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATI 517
                  GT  Y+ PE  VV       S   D W++G + Y+ + G+ PF    +     
Sbjct: 340 QTIKGRVGTVGYMAPE--VVKNERYTFS--PDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
             E  + +    ++      S +A+      L
Sbjct: 396 EVERLVKEV-PEEY--SERFSPQARSLCSQLL 424

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  132 bits (334), Expect = 1e-34
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +G+G F  V KA   + +  VA K  +   + K           + E      ++HP +V
Sbjct: 16  VGRGAFGVVCKA-KWRAK-DVAIKQIESESERKA---------FIVELRQLSRVNHPNIV 64

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL---KQHKTIAEREARSIVMQVVSALKYLNEI 411
           KLY       N  C V+EY +G  L   L   +         A S  +Q    + YL+ +
Sbjct: 65  KLYGAC---LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 412 KP-PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
           +P  +IH DLKP N+LL  G     +KI DFG +  +            +T+   G+  +
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQTH---------MTN-NKGSAAW 169

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
           + PE F   +     S K DV+S G+I ++ +  +KPF  
Sbjct: 170 MAPEVF---EGSN-YSEKCDVFSWGIILWEVITRRKPFDE 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  135 bits (341), Expect = 1e-34
 Identities = 80/334 (23%), Positives = 134/334 (40%), Gaps = 34/334 (10%)

Query: 232 IRELKRIHNEDQSRFNNHPV----LSDSYLIGYKNLHIRELKRIHNEDQ---------SR 278
           +R+L++   +  ++ N        L D  +  Y   +   L+R  N  +         S+
Sbjct: 6   LRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSK 65

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
                +  + + +L ++G+G F EV         +  A K+  LNK   E  K       
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNKW--EMLKRAETACF 121

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI-AEREARSI 397
             E ++    D   +  L+  F+ D N+   V++Y  G DL   L + +    E  AR  
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQ-DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + ++V A+  ++++    +H D+KP NIL+      G I++ DFG    + E+      G
Sbjct: 181 LAEMVIAIDSVHQLH--YVHRDIKPDNILMDM---NGHIRLADFGSCLKLMED------G 229

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSK-VDVWSVGVIFYQCLYGKKPFGHNQSQAT 516
              +S   GT  Y+ PE     +          D WS+GV  Y+ LYG+ PF       T
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289

Query: 517 ILEENTILKATEVQF-ANKPTVSNEAKGFIRSCL 549
                 +      QF      VS  AK  IR  +
Sbjct: 290 Y--GKIMNHKERFQFPTQVTDVSENAKDLIRRLI 321

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  133 bits (336), Expect = 2e-34
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 41/295 (13%)

Query: 260 YKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV 319
            K    +  +    + ++   N   L   +  +  LG G F  V      +   + A K+
Sbjct: 15  VKEFLAKAKEDFLKKWETPSQNTAQLDQ-FDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73

Query: 320 HQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL 379
             L+K      K   I+H L E  I +A++ P +VKL   F+ D ++   V+EY  G ++
Sbjct: 74  --LDKQKVVKLKQ--IEHTLNEKRILQAVNFPFLVKLEFSFK-DNSNLYMVMEYVAGGEM 128

Query: 380 DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
             +L++    +E  AR    Q+V   +YL+ +   +I+ DLKP N+L+ +    G I++T
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ---GYIQVT 183

Query: 440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSK-----VDVWSV 494
           DFG +K +             T    GT   L PE          I SK     VD W++
Sbjct: 184 DFGFAKRVK----------GRTWTLCGTPEALAPEI---------ILSKGYNKAVDWWAL 224

Query: 495 GVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
           GV+ Y+   G  PF  +Q          I+   +V+F      S++ K  +R+ L
Sbjct: 225 GVLIYEMAAGYPPFFADQPIQIY---EKIVSG-KVRF--PSHFSSDLKDLLRNLL 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (336), Expect = 2e-34
 Identities = 71/346 (20%), Positives = 121/346 (34%), Gaps = 62/346 (17%)

Query: 262 NLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQ 321
            L  ++ KR+      +     +  D +  +  LG G    V K         +A K+  
Sbjct: 8   ELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 67

Query: 322 LNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF 381
           L                +RE  +    + P +V  Y  F  D       +E+ DG  LD 
Sbjct: 68  LEIKPAI------RNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQ 120

Query: 382 YLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
            LK+   I E+    + + V+  L YL E    ++H D+KP NIL+      GEIK+ DF
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSR---GEIKLCDF 176

Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC 501
           G+S  + +          + +   GT  Y+ PE           S + D+WS+G+   + 
Sbjct: 177 GVSGQLID---------SMANSFVGTRSYMSPERL----QGTHYSVQSDIWSMGLSLVEM 223

Query: 502 LYGKKPFGHNQSQATILEENTILKATEVQFANKPTV------------------------ 537
             G+ P     ++   L     ++    +   +P                          
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283

Query: 538 --------------SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                         S E + F+  CL     +R D+  L  H +++
Sbjct: 284 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  133 bits (336), Expect = 4e-34
 Identities = 82/318 (25%), Positives = 146/318 (45%), Gaps = 31/318 (9%)

Query: 239 HNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKG 298
           ++       + P   + Y  G     I E K   N  +S   +  +    + LL ++G+G
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRG 63

Query: 299 GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLY 357
            +++V      K  R  A +V  + K+   D +   I     E ++  +A +HP +V L+
Sbjct: 64  SYAKVLLVRLKKTDRIYAMRV--VKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLH 119

Query: 358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIH 417
             F+ + +    V+EY +G DL F++++ + + E  AR    ++  AL YL+E    +I+
Sbjct: 120 SCFQTE-SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 176

Query: 418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFV 477
            DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT  Y+ PE  +
Sbjct: 177 RDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSTFCGTPNYIAPE--I 224

Query: 478 VGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT------ILKATEVQF 531
           +       S  VD W++GV+ ++ + G+ PF    S     +         IL+  +++ 
Sbjct: 225 LRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRI 281

Query: 532 ANKPTVSNEAKGFIRSCL 549
               ++S +A   ++S L
Sbjct: 282 --PRSLSVKAASVLKSFL 297

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  130 bits (329), Expect = 7e-34
 Identities = 57/273 (20%), Positives = 99/273 (36%), Gaps = 37/273 (13%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           +GKG F +V+      E   VA ++  ++ +       + +K   RE   ++   H  VV
Sbjct: 41  IGKGRFGQVYHGRWHGE---VAIRL--IDIE---RDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSALKYLNEIKP 413
                  +       +   C G  L   +      +   + R I  ++V  + YL+    
Sbjct: 93  LFMGAC-MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AK 149

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
            ++H DLK  N+    G V     ITDFGL  +                   G   +L P
Sbjct: 150 GILHKDLKSKNVFYDNGKV----VITDFGLFSISGVLQAGRREDK--LRIQNGWLCHLAP 203

Query: 474 ECFVVGKNPPKI-----SSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE 528
           E         +      S   DV+++G I+Y+    + PF    ++A I          +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW---------Q 254

Query: 529 VQFANKPTVSN-----EAKGFIRSCLAYRKEDR 556
           +    KP +S      E    +  C A+ +E+R
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  133 bits (337), Expect = 2e-33
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 29/274 (10%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
             P+  D +L   +LG+GGF EV         +  ACK   LNK  K  KK    + A+ 
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNK--KRLKKRKGYQGAMV 234

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARS 396
           E  I   +    +V L   FE      C V+   +G D+ +++    + +    E  A  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFE-TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
              Q+VS L++L++    +I+ DLKP N+LL +    G ++I+D GL+     E      
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVRISDLGLAV----ELKAGQ- 343

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA 515
               T   AGT  ++ PE  ++       S  VD +++GV  Y+ +  + PF    +   
Sbjct: 344 --TKTKGYAGTPGFMAPE--LLLGEEYDFS--VDYFALGVTLYEMIAARGPFRARGEKVE 397

Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
               +  +L+   V +      S  +K F  + L
Sbjct: 398 NKELKQRVLEQ-AVTY--PDKFSPASKDFCEALL 428

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  128 bits (324), Expect = 4e-33
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 40/264 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           +L  LG G F  VH        RY A KV  L K+     +   ++H   E  +   + H
Sbjct: 10  ILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKE--IVVRLKQVEHTNDERLMLSIVTH 65

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +++++  F+ DA     +++Y +G +L   L++ +      A+    +V  AL+YL+ 
Sbjct: 66  PFIIRMWGTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +I+ DLKP NILL +    G IKITDFG +K +           D+T    GT  Y
Sbjct: 125 KD--IIYRDLKPENILLDKN---GHIKITDFGFAKYVP----------DVTYTLCGTPDY 169

Query: 471 LPPECFVVGKNPPKISSK-----VDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           + PE          +S+K     +D WS G++ Y+ L G  PF ++ +     E+  IL 
Sbjct: 170 IAPEV---------VSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEK--ILN 217

Query: 526 ATEVQFANKPTVSNEAKGFIRSCL 549
           A E++F   P  + + K  +   +
Sbjct: 218 A-ELRF--PPFFNEDVKDLLSRLI 238

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  128 bits (324), Expect = 7e-33
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 31/266 (11%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALD 349
           LL ++G+G +++V      K  R  A KV  + K+   D +   I     E ++  +A +
Sbjct: 13  LLRVIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDED--IDWVQTEKHVFEQASN 68

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP +V L+  F+ + +    V+EY +G DL F++++ + + E  AR    ++  AL YL+
Sbjct: 69  HPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           E    +I+ DLK  N+LL      G IK+TD+G+ K    E   P    D TS   GT  
Sbjct: 128 ERG--IIYRDLKLDNVLLDSE---GHIKLTDYGMCK----EGLRPG---DTTSTFCGTPN 175

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT------I 523
           Y+ PE  ++       S  VD W++GV+ ++ + G+ PF    S     +         I
Sbjct: 176 YIAPE--ILRGEDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCL 549
           L+  +++     ++S +A   ++S L
Sbjct: 232 LEK-QIRI--PRSLSVKAASVLKSFL 254

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  128 bits (324), Expect = 8e-33
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 29/278 (10%)

Query: 273 NEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA 332
           N+++        + D ++L  +LGKG F +V  A   K  ++ A K   L KD       
Sbjct: 4   NKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDD 60

Query: 333 NYIKHALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAE 391
             ++  + E  +   A +HP +  ++  F+    +   V+EY +G DL ++++       
Sbjct: 61  --VECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKENLFFVMEYLNGGDLMYHIQSCHKFDL 117

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
             A     +++  L++L+     +++ DLK  NILL +    G IKI DFG+ K    EN
Sbjct: 118 SRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD---GHIKIADFGMCK----EN 168

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
              D     T+   GT  Y+ PE  ++       S  VD WS GV+ Y+ L G+ PF H 
Sbjct: 169 MLGD---AKTNTFCGTPDYIAPE--ILLGQKYNHS--VDWWSFGVLLYEMLIGQSPF-HG 220

Query: 512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
           Q +  +    +I       +     +  EAK  +    
Sbjct: 221 QDEEELFH--SIRMD-NPFY--PRWLEKEAKDLLVKLF 253

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  128 bits (323), Expect = 8e-33
 Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 31/263 (11%)

Query: 291 LLMLLGKGGFSEV---HKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           LL +LGKGG+ +V    K       +  A KV  L K     + A    H   E NI + 
Sbjct: 21  LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV--LKKA-MIVRNAKDTAHTKAERNILEE 77

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
           + HP +V L   F+        +LEY  G +L   L++     E  A   + ++  AL +
Sbjct: 78  VKHPFIVDLIYAFQ-TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136

Query: 408 LNEIKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           L++    +I+ DLKP NI+L  +G+    +K+TDFGL K    E+ +      +T    G
Sbjct: 137 LHQKG--IIYRDLKPENIMLNHQGH----VKLTDFGLCK----ESIHDG---TVTHTFCG 183

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE  ++ ++    +  VD WS+G + Y  L G  PF     + TI   + ILK 
Sbjct: 184 TIEYMAPE--ILMRSGHNRA--VDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILKC 236

Query: 527 TEVQFANKPTVSNEAKGFIRSCL 549
            ++     P ++ EA+  ++  L
Sbjct: 237 -KLNL--PPYLTQEARDLLKKLL 256

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  128 bits (323), Expect = 1e-32
 Identities = 84/260 (32%), Positives = 126/260 (48%), Gaps = 29/260 (11%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            L LLGKG F +V    +    RY A K+  L K+    K    + H + E  + +   H
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDE--VAHTVTESRVLQNTRH 64

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+YL+ 
Sbjct: 65  PFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 411 IKPPVIHYDLKPGNILL-TEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
               V++ D+K  N++L  +G+    IKITDFGL K    E  +            GT  
Sbjct: 124 RD--VVYRDIKLENLMLDKDGH----IKITDFGLCK----EGISDG---ATMKTFCGTPE 170

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           YL PE  V+  N    +  VD W +GV+ Y+ + G+ PF +NQ    + E   IL   E+
Sbjct: 171 YLAPE--VLEDNDYGRA--VDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILME-EI 222

Query: 530 QFANKPTVSNEAKGFIRSCL 549
           +F    T+S EAK  +   L
Sbjct: 223 RF--PRTLSPEAKSLLAGLL 240

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  129 bits (327), Expect = 1e-32
 Identities = 89/280 (31%), Positives = 129/280 (46%), Gaps = 26/280 (9%)

Query: 270 RIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED 329
               E       H V  + +  L LLGKG F +V    +    RY A K+  L K+    
Sbjct: 131 AEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVA 188

Query: 330 KKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI 389
           K    + H L E  + +   HP +  L   F+   +  C V+EY +G +L F+L + +  
Sbjct: 189 KDE--VAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVMEYANGGELFFHLSRERVF 245

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
           +E  AR    ++VSAL YL+  K  V++ DLK  N++L +    G IKITDFGL K    
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKD---GHIKITDFGLCK---- 297

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
           E               GT  YL PE  V+  N    +  VD W +GV+ Y+ + G+ PF 
Sbjct: 298 EGIKDG---ATMKTFCGTPEYLAPE--VLEDNDYGRA--VDWWGLGVVMYEMMCGRLPF- 349

Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
           +NQ    + E   IL   E++F    T+  EAK  +   L
Sbjct: 350 YNQDHEKLFE--LILME-EIRF--PRTLGPEAKSLLSGLL 384

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  127 bits (321), Expect = 1e-32
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 33/287 (11%)

Query: 267 ELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVH---KAFDLKEQRYVACKVHQLN 323
            +K I      +  +      ++ LL +LG+G F +V    K      ++  A KV  L 
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV--LK 61

Query: 324 KDW-KEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY 382
           K   K   +         E +I   ++HP +VKL+  F+        +L++  G DL   
Sbjct: 62  KATLKVRDRV----RTKMERDILVEVNHPFIVKLHYAFQ-TEGKLYLILDFLRGGDLFTR 116

Query: 383 LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
           L +     E + +  + ++  AL +L+ +   +I+ DLKP NILL E    G IK+TDFG
Sbjct: 117 LSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFG 171

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           LSK    E+ + +          GT  Y+ PE  VV +     S   D WS GV+ ++ L
Sbjct: 172 LSK----ESIDHE---KKAYSFCGTVEYMAPE--VVNRRGHTQS--ADWWSFGVLMFEML 220

Query: 503 YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
            G  PF   + +   +    ILKA ++       +S EA+  +R   
Sbjct: 221 TGTLPF-QGKDRKETMT--MILKA-KLGM--PQFLSPEAQSLLRMLF 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  125 bits (315), Expect = 2e-32
 Identities = 30/229 (13%), Positives = 70/229 (30%), Gaps = 35/229 (15%)

Query: 295 LGKGGFSEVHKAFDLKEQRY----VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           L +    E+ K       R+    +  KV  L      D      +    E    +   H
Sbjct: 18  LNENHSGELWKG------RWQGNDIVVKV--LKV---RDWSTRKSRDFNEECPRLRIFSH 66

Query: 351 PRVVKLY-DVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSALKY 407
           P V+ +        A     +  +     L   L    +  + + +A    + +   + +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L+ ++P +  + L   ++++ E       +I+   +                        
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTA---RISMADVKFSFQSPG------------RMYA 171

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQA 515
             ++ PE     K         D+WS  V+ ++ +  + PF   +  + 
Sbjct: 172 PAWVAPEAL-QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  127 bits (322), Expect = 2e-32
 Identities = 88/260 (33%), Positives = 133/260 (51%), Gaps = 28/260 (10%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALD 349
            L ++GKG F +V  A    E+ + A KV  L K     KK    KH + E N+  K + 
Sbjct: 42  FLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKE--EKHIMSERNVLLKNVK 97

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP +V L+  F+  A+    VL+Y +G +L ++L++ +   E  AR    ++ SAL YL+
Sbjct: 98  HPFLVGLHFSFQ-TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
            +   +++ DLKP NILL      G I +TDFGL K    EN   +     TS   GT  
Sbjct: 157 SLN--IVYRDLKPENILLDSQ---GHIVLTDFGLCK----ENIEHN---STTSTFCGTPE 204

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEV 529
           YL PE  V+ K P   +  VD W +G + Y+ LYG  PF ++++ A + +   IL    +
Sbjct: 205 YLAPE--VLHKQPYDRT--VDWWCLGAVLYEMLYGLPPF-YSRNTAEMYD--NILNK-PL 256

Query: 530 QFANKPTVSNEAKGFIRSCL 549
           Q   KP ++N A+  +   L
Sbjct: 257 QL--KPNITNSARHLLEGLL 274

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  124 bits (314), Expect = 4e-32
 Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 29/228 (12%)

Query: 295 LGKGGFSEVHKAFDLKEQRY---VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +G G F  V+K       ++   VA K+  LN           ++    E  + +   H 
Sbjct: 32  IGSGSFGTVYKG------KWHGDVAVKM--LNVT---APTPQQLQAFKNEVGVLRKTRHV 80

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNE 410
            ++         A     V ++C+G  L  +L   +T    ++   I  Q    + YL+ 
Sbjct: 81  NILLFMGY--STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH- 137

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               +IH DLK  NI L E N     KI DFGL+      + +         Q +G+  +
Sbjct: 138 -AKSIIHRDLKSNNIFLHEDNTV---KIGDFGLATEKSRWSGS-----HQFEQLSGSILW 188

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATI 517
           + PE  +  ++    S + DV++ G++ Y+ + G+ P+   N     I
Sbjct: 189 MAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  124 bits (315), Expect = 5e-32
 Identities = 78/310 (25%), Positives = 131/310 (42%), Gaps = 50/310 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  +  +G+G +  V K  +    + VA K    ++D    KK      ALRE  + K
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-----ALREIRMLK 57

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L HP +V L +VF         V EYCD H +   L +++  + E   +SI  Q + A+
Sbjct: 58  QLKHPNLVNLLEVFRRK-RRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            + ++     IH D+KP NIL+T+      IK+ DFG ++++   +           + A
Sbjct: 116 NFCHKHN--CIHRDVKPENILITK---HSVIKLCDFGFARLLTGPSDY------YDDEVA 164

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF----------------- 508
            T WY  PE  +VG    +    VDVW++G +F + L    P                  
Sbjct: 165 -TRWYRSPE-LLVGD--TQYGPPVDVWAIGCVFAE-LLSGVPLWPGKSDVDQLYLIRKTL 219

Query: 509 G----HNQSQATILEENTILKATEVQFANK-----PTVSNEAKGFIRSCLAYRKEDRIDV 559
           G     +Q   +  +  + +K  + +         P +S  A G ++ CL     +R+  
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC 279

Query: 560 ISLARHDYLQ 569
             L  H Y +
Sbjct: 280 EQLLHHPYFE 289

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  124 bits (313), Expect = 2e-31
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 27/265 (10%)

Query: 291 LLMLLGKGGFSEVH---KAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HK 346
           LL +LG G + +V    K       +  A KV  L K     +KA   +H   E  +   
Sbjct: 58  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKA-TIVQKAKTTEHTRTERQVLEH 114

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
               P +V L+  F+        +L+Y +G +L  +L Q +   E E +  V ++V AL+
Sbjct: 115 IRQSPFLVTLHYAFQ-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV-MDEENYNPDHGMDLTSQGA 465
           +L+++   +I+ D+K  NILL      G + +TDFGLSK  + +E        +      
Sbjct: 174 HLHKLG--IIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADET-------ERAYDFC 221

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
           GT  Y+ P+  +V          VD WS+GV+ Y+ L G  PF    +  +       IL
Sbjct: 222 GTIEYMAPD--IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279

Query: 525 KATEVQFANKPTVSNEAKGFIRSCL 549
           K+ E  +     +S  AK  I+  L
Sbjct: 280 KS-EPPY--PQEMSALAKDLIQRLL 301

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  122 bits (309), Expect = 3e-31
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 23/223 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +Y  L  +G+G +  V KA + +    VA K  +L+ D  E   ++    ALRE  + K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSS----ALREICLLK 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L H  +V+L+DV          V E+CD  DL  Y       +     +S + Q++  L
Sbjct: 57  ELKHKNIVRLHDVL-HSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            + +     V+H DLKP N+L+      GE+K+ +FGL++        P       S   
Sbjct: 115 GFCHSRN--VLHRDLKPQNLLINRN---GELKLANFGLARAFG----IPVRCY---SAEV 162

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY PP+     K     S+ +D+WS G IF +     +P 
Sbjct: 163 VTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPL 202

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  122 bits (309), Expect = 4e-31
 Identities = 76/321 (23%), Positives = 124/321 (38%), Gaps = 54/321 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            RY  +  +G G +  V+KA D     +VA K  ++                +RE  + +
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG--GGGGGGLPISTVREVALLR 66

Query: 347 AL---DHPRVVKLYDVFEIDANSFCT----VLEYCDGHDLDFYLKQHKT--IAEREARSI 397
            L   +HP VV+L DV              V E+ D  DL  YL +     +     + +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 125

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           + Q +  L +L+     ++H DLKP NIL+T G   G +K+ DFGL+++   +       
Sbjct: 126 MRQFLRGLDFLHANC--IVHRDLKPENILVTSG---GTVKLADFGLARIYSYQ------- 173

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-- 515
           M LT     T WY  PE  ++       ++ VD+WSVG IF + ++ +KP     S+A  
Sbjct: 174 MALTPV-VVTLWYRAPE-VLLQS---TYATPVDMWSVGCIFAE-MFRRKPLFCGNSEADQ 227

Query: 516 ---------TILEEN----------TILKATEVQFANK-PTVSNEAKGFIRSCLAYRKED 555
                       E++                     +  P +       +   L +    
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287

Query: 556 RIDVISLARHDYLQ--PPVPK 574
           RI      +H YL      P+
Sbjct: 288 RISAFRALQHSYLHKDEGNPE 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  123 bits (311), Expect = 4e-31
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 21/224 (9%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           + RY  L  LG+G F+ V+KA D    + VA K  +L    +     N    ALRE  + 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT--ALREIKLL 66

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSA 404
           + L HP ++ L D F    ++   V ++ +  DL+  +K +   +     ++ ++  +  
Sbjct: 67  QELSHPNIIGLLDAFGHK-SNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL++    ++H DLKP N+LL E    G +K+ DFGL+K       +P+     T Q 
Sbjct: 125 LEYLHQHW--ILHRDLKPNNLLLDEN---GVLKLADFGLAKSFG----SPNRAY--THQV 173

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             T WY  PE     +        VD+W+VG I  + L  + PF
Sbjct: 174 V-TRWYRAPELLFGAR---MYGVGVDMWAVGCILAE-LLLRVPF 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (306), Expect = 5e-31
 Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 39/226 (17%)

Query: 295 LGKGGFSEVHKAF--DLKEQRYVA---CKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           LG G F  V K +    K  + VA    K    +   K++         L E N+ + LD
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE--------LLAEANVMQQLD 76

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           +P +V++  +   +A S+  V+E  +   L+ YL+Q++ + ++    +V QV   +KYL 
Sbjct: 77  NPYIVRMIGI--CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGT 467
           E     +H DL   N+LL   +     KI+DFGLSK +  DE  Y         +Q  G 
Sbjct: 135 ESN--FVHRDLAARNVLLVTQHYA---KISDFGLSKALRADENYY--------KAQTHGK 181

Query: 468 Y---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
           +   WY  PEC        K SSK DVWS GV+ ++   YG+KP+ 
Sbjct: 182 WPVKWY-APECINYY----KFSSKSDVWSFGVLMWEAFSYGQKPYR 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  122 bits (308), Expect = 5e-31
 Identities = 83/327 (25%), Positives = 126/327 (38%), Gaps = 65/327 (19%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK----KANYIKHALR 340
           L  RY+ L  LG GG   V  A D    + VA K           K        +KHALR
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----------KIVLTDPQSVKHALR 57

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAERE 393
           E  I + LDH  +VK++++     +     +      +   Y+ Q          + +  
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN-SVYIVQEYMETDLANVLEQGP 116

Query: 394 -----ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD 448
                AR  + Q++  LKY++     V+H DLKP N+ +   +    +KI DFGL+++MD
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTED-L-VLKIGDFGLARIMD 172

Query: 449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
               +  H   L+     T WY  P   +   +P   +  +D+W+ G IF + L GK  F
Sbjct: 173 PHYSHKGH---LSEGLV-TKWYRSPRLLL---SPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

Query: 509 -G---HNQSQATILE------ENTILKATE--------------VQFANK-PTVSNEAKG 543
            G     Q Q  ILE      E    +                        P +S EA  
Sbjct: 226 AGAHELEQMQ-LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD 284

Query: 544 FIRSCLAYRKEDRIDVISLARHDYLQP 570
           F+   L +   DR+       H Y+  
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYMSI 311

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  122 bits (308), Expect = 7e-31
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 22/224 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DRY  +  LG+G + EV+KA D      VA K  +L  + +E         A+RE ++ K
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGT----AIREVSLLK 88

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +++L  V     +    + EY + +DL  Y+ ++  ++ R  +S + Q+++ + 
Sbjct: 89  ELQHRNIIELKSVI-HHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVC--GEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + +  +   +H DLKP N+LL+  +      +KI DFGL++        P       +  
Sbjct: 147 FCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG----IPIRQF---THE 197

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             T WY PPE  +  +     S+ VD+WS+  I+ + +  K P 
Sbjct: 198 IITLWYRPPEILLGSR---HYSTSVDIWSIACIWAE-MLMKTPL 237

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (304), Expect = 1e-30
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 24/221 (10%)

Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           L   +G+G F +VH+  +   E   +A  +        +  +  +    L+E    +  D
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQFD 74

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYL 408
           HP +VKL  V  I  N    ++E C   +L  +L+  K ++          Q+ +AL YL
Sbjct: 75  HPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 409 NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY 468
              +   +H D+   N+L++  +     K+ DFGLS+ M++  Y       L  +     
Sbjct: 133 ESKR--FVHRDIAARNVLVSSNDCV---KLGDFGLSRYMEDSTYYKASKGKLPIK----- 182

Query: 469 WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           W   PE         + +S  DVW  GV  ++ L +G KPF
Sbjct: 183 WM-APESINFR----RFTSASDVWMFGVCMWEILMHGVKPF 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (304), Expect = 2e-30
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 41/299 (13%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           ++ + ++  LG G F +V+KA + +     A KV +      E++  +YI     E  I 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIV----EIEIL 70

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
              DHP +VKL   +  D      ++E+C G  +    L+  + + E + + +  Q++ A
Sbjct: 71  ATCDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG----LSKVMDEENYNPDHGMDL 460
           L +L+  +  +IH DLK GN+L+T     G+I++ DFG      K + + +         
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRD--------- 175

Query: 461 TSQGAGT-YWYLPPECFVVGKNPPKIS---SKVDVWSVGVIFYQCLYGKKP-FGHNQSQA 515
           +    GT YW + PE  VV     K +    K D+WS+G+   +    + P    N  + 
Sbjct: 176 SF--IGTPYW-MAPE--VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230

Query: 516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
            +     I K+           S E + F++  L    E R     L  H ++      
Sbjct: 231 LLK----IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  121 bits (307), Expect = 2e-30
 Identities = 70/280 (25%), Positives = 117/280 (41%), Gaps = 29/280 (10%)

Query: 271 IHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK 330
           +   D +   +   L+D +  LM+LGKG F +V  +         A K+  L KD     
Sbjct: 5   VSKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQD 61

Query: 331 KANYIKHALREYNI-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTI 389
               ++  + E  +       P + +L+  F+   +    V+EY +G DL ++++Q    
Sbjct: 62  DD--VECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVGRF 118

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
            E  A     ++   L +L      +I+ DLK  N++L      G IKI DFG+ K    
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE---GHIKIADFGMCK---- 169

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG 509
           EN         T    GT  Y+ PE  ++   P   S  VD W+ GV+ Y+ L G+ PF 
Sbjct: 170 ENIWDG---VTTKTFCGTPDYIAPE--IIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFE 222

Query: 510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCL 549
                       +I++   V +    ++S EA    +  +
Sbjct: 223 GEDEDELF---QSIMEH-NVAY--PKSMSKEAVAICKGLM 256

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  119 bits (302), Expect = 2e-30
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 25/223 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L  +G+G +  V+KA +       A K  +L K+  E   +      +RE +I K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPST----TIREISILK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L H  +VKLYDV          V E+ D  DL   L   +  +    A+S ++Q+++ +
Sbjct: 56  ELKHSNIVKLYDVIHTK-KRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y ++ +  V+H DLKP N+L+      GE+KI DFGL++        P       +   
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLINRE---GELKIADFGLARAFG----IPVRKY---THEI 161

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY  P+  +  K   K S+ +D+WSVG IF + +    P 
Sbjct: 162 VTLWYRAPDVLMGSK---KYSTTIDIWSVGCIFAE-MVNGTPL 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  120 bits (303), Expect = 2e-30
 Identities = 67/243 (27%), Positives = 117/243 (48%), Gaps = 26/243 (10%)

Query: 268 LKRIHNEDQSRFNNHPV-LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW 326
           +   H+    R N +   L ++Y  L  +G+G +  V+KA D  + R VA K  +L+ + 
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAE- 58

Query: 327 KEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH 386
            E   +     A+RE ++ K L HP +V L DV          V E+ +  DL   L ++
Sbjct: 59  DEGIPST----AIREISLLKELHHPNIVSLIDVI-HSERCLTLVFEFME-KDLKKVLDEN 112

Query: 387 KT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
           KT + + + +  + Q++  + + ++ +  ++H DLKP N+L+      G +K+ DFGL++
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD---GALKLADFGLAR 167

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
                   P       +    T WY  P+  +  K   K S+ VD+WS+G IF + +   
Sbjct: 168 AFG----IPVRSY---THEVVTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAE-MITG 216

Query: 506 KPF 508
           KP 
Sbjct: 217 KPL 219

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  121 bits (306), Expect = 2e-30
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 34/263 (12%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALD 349
            + +LGKG F +V  A   +     A KV  L KD         ++  + E  I   A +
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDD--VECTMTEKRILSLARN 82

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN 409
           HP + +L+  F+   +    V+E+ +G DL F++++ +   E  AR    +++SAL +L+
Sbjct: 83  HPFLTQLFCCFQTP-DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
           +    +I+ DLK  N+LL      G  K+ DFG+ K    E          T+   GT  
Sbjct: 142 DKG--IIYRDLKLDNVLLDHE---GHCKLADFGMCK----EGICNG---VTTATFCGTPD 189

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILEENTILKA 526
           Y+ PE  ++ +     +  VD W++GV+ Y+ L G  PF   N+      IL +      
Sbjct: 190 YIAPE--ILQEMLYGPA--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------ 239

Query: 527 TEVQFANKPTVSNEAKGFIRSCL 549
            EV +     +  +A G ++S +
Sbjct: 240 -EVVY--PTWLHEDATGILKSFM 259

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  120 bits (302), Expect = 2e-30
 Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 36/235 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHK-- 346
           LL  +GKG + EV +    + +  VA K+   +  K W             RE  ++   
Sbjct: 12  LLECVGKGRYGEVWRG-SWQGE-NVAVKIFSSRDEKSWF------------RETELYNTV 57

Query: 347 ALDHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
            L H  ++          +S      +  Y +   L  YL+   T+       IV+ + S
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIAS 116

Query: 404 ALKYL------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            L +L       + KP + H DLK  NIL+ +   C    I D GL+ +  +     D G
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC---CIADLGLAVMHSQSTNQLDVG 173

Query: 458 MDLTSQGAGTYWYLPPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
               +   GT  Y+ PE     +  +      +VD+W+ G++ ++        G 
Sbjct: 174 N---NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  120 bits (304), Expect = 3e-30
 Identities = 69/317 (21%), Positives = 126/317 (39%), Gaps = 51/317 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L L+G+G +  V K  +    R VA K    + D K  KK      A+RE  + K
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI-----AMREIKLLK 79

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L H  +V L +V +     +  V E+ D H +   L+     +  +  +  + Q+++ +
Sbjct: 80  QLRHENLVNLLEVCKKK-KRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            + +     +IH D+KP NIL+++    G +K+ DFG ++ +               + A
Sbjct: 138 GFCHSHN--IIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGEV------YDDEVA 186

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA---------- 515
            T WY  PE  +VG    K    VDVW++G +  + ++  +P     S            
Sbjct: 187 -TRWYRAPE-LLVGD--VKYGKAVDVWAIGCLVTE-MFMGEPLFPGDSDIDQLYHIMMCL 241

Query: 516 -TILEEN----------TILKATEVQFANK-----PTVSNEAKGFIRSCLAYRKEDRIDV 559
             ++  +            ++  E++         P +S       + CL    + R   
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301

Query: 560 ISLARHDYLQP-PVPKH 575
             L  HD+ Q     + 
Sbjct: 302 AELLHHDFFQMDGFAER 318

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (306), Expect = 3e-30
 Identities = 82/351 (23%), Positives = 133/351 (37%), Gaps = 61/351 (17%)

Query: 183 LKPEPLPGMSSQEYY-------EADEILK------LRQSALKKEDADLQLEMEKLERERN 229
           + PE    +  Q +Y       E  E+L       +R+S  K+   +  L +      R+
Sbjct: 2   MIPEVQKPLHEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQ---EYVLSVLWDGLPRH 58

Query: 230 LHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLSDRY 289
             I+ L  ++  +   F + P+L D  L   + L  +    +H           V  D++
Sbjct: 59  FIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLH---------RAVPKDKW 109

Query: 290 L-------LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
           +       L   +G+G F EV       +   VA K        +E    +     L+E 
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC------RETLPPDLKAKFLQEA 163

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQV 401
            I K   HP +V+L  V          V+E   G D   +L+     +  +    +V   
Sbjct: 164 RILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
            + ++YL       IH DL   N L+TE NV    KI+DFG+S+   +  Y         
Sbjct: 223 AAGMEYLESKC--CIHRDLAARNCLVTEKNVL---KISDFGMSREEADGVYA-------A 270

Query: 462 SQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           S G       W   PE    G    + SS+ DVWS G++ ++    G  P+
Sbjct: 271 SGGLRQVPVKW-TAPEALNYG----RYSSESDVWSFGILLWETFSLGASPY 316

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  118 bits (299), Expect = 4e-30
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 34/226 (15%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L  +LG+G F EV++        E+  VA K     KD   D K  +    + E  I K 
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKF----MSEAVIMKN 69

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALK 406
           LDHP +VKL  +  I+      ++E     +L  YL+++K ++         +Q+  A+ 
Sbjct: 70  LDHPHIVKLIGI--IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL  I    +H D+   NIL+         K+ DFGLS+ +++E+Y              
Sbjct: 128 YLESIN--CVHRDIAVRNILVASPECV---KLGDFGLSRYIEDEDY--------YKASVT 174

Query: 467 TY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                W   PE         + ++  DVW   V  ++ L +GK+PF
Sbjct: 175 RLPIKWM-SPESINFR----RFTTASDVWMFAVCMWEILSFGKQPF 215

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  120 bits (302), Expect = 5e-30
 Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 36/235 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHK-- 346
           ++  +GKG + EV      + +  VA KV        W             RE  I++  
Sbjct: 41  MVKQIGKGRYGEVWMG-KWRGE-KVAVKVFFTTEEASWF------------RETEIYQTV 86

Query: 347 ALDHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
            + H  ++           S      + +Y +   L  YLK   T+  +    +    VS
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVS 145

Query: 404 ALKYL------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            L +L       + KP + H DLK  NIL+ +   C    I D GL+     +    D  
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC---CIADLGLAVKFISDTNEVDIP 202

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISS--KVDVWSVGVIFYQCLYGKKPFGH 510
               ++  GT  Y+PPE      N     S    D++S G+I ++        G 
Sbjct: 203 P--NTR-VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  119 bits (301), Expect = 5e-30
 Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y+ L  LG+G ++ V+K         VA K  +L  + +E         A+RE ++ K
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL--EHEEGAPCT----AIREVSLLK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L H  +V L+D+   +  S   V EY D  DL  YL      I     +  + Q++  L
Sbjct: 56  DLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            Y +  K  V+H DLKP N+L+ E    GE+K+ DFGL++        P       ++  
Sbjct: 114 AYCHRQK--VLHRDLKPQNLLINER---GELKLADFGLARAKS----IPTK--TYDNEVV 162

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
            T WY PP+  +        S+++D+W VG IFY+ +   +P 
Sbjct: 163 -TLWYRPPDILLGST---DYSTQIDMWGVGCIFYE-MATGRPL 200

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (299), Expect = 2e-29
 Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 46/298 (15%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
              +  L  +G G F  V+ A D++    VA K    +     +K  + IK    E    
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK----EVRFL 108

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           + L HP  ++    +  +  ++  V+EYC G   D      K + E E  ++    +  L
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     +IH D+K GNILL+E    G +K+ DFG + +M   N         +    
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPAN---------SF--V 211

Query: 466 GT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
           GT YW + PE  +          KVDVWS+G+   +    K P  +             +
Sbjct: 212 GTPYW-MAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFN-------------M 256

Query: 525 KATEVQF--ANKPT-------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
            A    +  A   +        S   + F+ SCL    +DR     L +H ++    P
Sbjct: 257 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  118 bits (298), Expect = 2e-29
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 26/230 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +Y  L  +G+G F EV KA   K  + VA K   +  + KE         ALRE  I +
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPIT----ALREIKILQ 71

Query: 347 ALDHPRVVKLYDV-------FEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIV 398
            L H  VV L ++       +     S   V ++C+ HDL   L          E + ++
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVM 130

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             +++ L Y++  K  ++H D+K  N+L+T     G +K+ DFGL++             
Sbjct: 131 QMLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLA--KNSQPN 183

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             T++   T WY PPE  +  +        +D+W  G I  + ++ + P 
Sbjct: 184 RYTNRVV-TLWYRPPELLLGER---DYGPPIDLWGAGCIMAE-MWTRSPI 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (295), Expect = 2e-29
 Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 34/291 (11%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            + + +L  LG+G +  V+KA   +  + VA K   +  D +E  K         E +I 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK---------EISIM 78

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
           +  D P VVK Y  +  + + +  V+EYC    + D    ++KT+ E E  +I+   +  
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L+YL+ ++   IH D+K GNILL      G  K+ DFG++  + +        M   +  
Sbjct: 138 LEYLHFMR--KIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDT-------MAKRNTV 185

Query: 465 AGT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-FGHNQSQATILEENT 522
            GT +W + PE  V+ +     +   D+WS+G+   +   GK P    +  +A  +    
Sbjct: 186 IGTPFW-MAPE--VIQEIG--YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM---- 236

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
           I       F      S+    F++ CL    E R     L +H +++    
Sbjct: 237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  116 bits (294), Expect = 2e-29
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 35/224 (15%)

Query: 295 LGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LG G F  V +      K+Q  VA KV  L +  ++          +RE  I   LD+P 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEM----MREAQIMHQLDNPY 71

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +V+L  V    A +   V+E   G  L  +L   +  I       ++ QV   +KYL E 
Sbjct: 72  IVRLIGV--CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTY- 468
               +H DL   N+LL   +     KI+DFGLSK +  D+  Y        T++ AG + 
Sbjct: 130 N--FVHRDLAARNVLLVNRHYA---KISDFGLSKALGADDSYY--------TARSAGKWP 176

Query: 469 --WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
             WY  PEC        K SS+ DVWS GV  ++ L YG+KP+ 
Sbjct: 177 LKWY-APECINFR----KFSSRSDVWSYGVTMWEALSYGQKPYK 215

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 5e-29
 Identities = 71/308 (23%), Positives = 113/308 (36%), Gaps = 43/308 (13%)

Query: 281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
              +  D Y L  ++G G  + V  A+   ++  VA K   L K   +      +K    
Sbjct: 9   PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLK---- 62

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDG--------HDLDFYLKQHKTIAER 392
           E        HP +V  Y  F +  +    V++   G        H +     +   + E 
Sbjct: 63  EIQAMSQCHHPNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
              +I+ +V+  L+YL++     IH D+K GNILL E    G ++I DFG+S  +     
Sbjct: 122 TIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGD 176

Query: 453 NPDHGMDLTSQGAGT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
              + +  T    GT  W + PE   V +       K D+WS G+   +   G  P+   
Sbjct: 177 ITRNKVRKTF--VGTPCW-MAPE---VMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230

Query: 512 ----------QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS 561
                     Q+    LE     K    ++          +  I  CL    E R     
Sbjct: 231 PPMKVLMLTLQNDPPSLETGVQDKEMLKKY------GKSFRKMISLCLQKDPEKRPTAAE 284

Query: 562 LARHDYLQ 569
           L RH + Q
Sbjct: 285 LLRHKFFQ 292

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (292), Expect = 6e-29
 Identities = 50/232 (21%), Positives = 87/232 (37%), Gaps = 26/232 (11%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LGKG F +  K    +    +  K       + E+ +  +    L+E  + + L+HP V+
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKE---LIRFDEETQRTF----LKEVKVMRCLEHPNVL 70

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKP 413
           K   V   D      + EY  G  L   +K   +     +  S    + S + YL+ +  
Sbjct: 71  KFIGVLYKDKR-LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL-------TSQGAG 466
            +IH DL   N L+ E        + DFGL+++M +E   P+    L            G
Sbjct: 129 -IIHRDLNSHNCLVRENKNV---VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATI 517
             +++ PE             KVDV+S G++  + +        +       
Sbjct: 185 NPYWMAPEMINGRSY----DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (292), Expect = 1e-28
 Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 48/234 (20%)

Query: 291 LLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            + +LG G F  V+K        K +  VA K   L +              L E  +  
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEI----LDEAYVMA 72

Query: 347 ALDHPRVVKLYDVFEIDANSFCT------VLEYCDGHDLDFYLKQHK-TIAEREARSIVM 399
           ++D+P V +L  +        C       + +      L  Y+++HK  I  +   +  +
Sbjct: 73  SVDNPHVCRLLGI--------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   + YL + +  ++H DL   N+L+         KITDFGL+K++  E         
Sbjct: 125 QIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHV---KITDFGLAKLLGAEEK------- 172

Query: 460 LTSQGAGT----YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                 G      W    E  +        + + DVWS GV  ++ + +G KP+
Sbjct: 173 -EYHAEGGKVPIKWM-ALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPY 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  119 bits (300), Expect = 2e-28
 Identities = 75/327 (22%), Positives = 128/327 (39%), Gaps = 29/327 (8%)

Query: 224 LERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHP 283
           L +E   +          + +              G K    +    I   D +   +  
Sbjct: 279 LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRM 338

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            L+D +  LM+LGKG F +V  +         A K+  L KD     + + ++  + E  
Sbjct: 339 KLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKD--VVIQDDDVECTMVEKR 393

Query: 344 I-HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
           +       P + +L+  F+   +    V+EY +G DL ++++Q     E  A     ++ 
Sbjct: 394 VLALPGKPPFLTQLHSCFQ-TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             L +L      +I+ DLK  N++L      G IKI DFG+ K    EN         T 
Sbjct: 453 IGLFFLQSKG--IIYRDLKLDNVMLDSE---GHIKIADFGMCK----ENIWDG---VTTK 500

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
              GT  Y+ PE  ++   P   S  VD W+ GV+ Y+ L G+ PF             +
Sbjct: 501 TFCGTPDYIAPE--IIAYQPYGKS--VDWWAFGVLLYEMLAGQAPFEGEDEDELF---QS 553

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCL 549
           I++   V +    ++S EA    +  +
Sbjct: 554 IMEH-NVAY--PKSMSKEAVAICKGLM 577

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  115 bits (290), Expect = 2e-28
 Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 36/235 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIHK-- 346
           L   +GKG F EV +    + +  VA K+   +  + W             RE  I++  
Sbjct: 46  LQESIGKGRFGEVWRG-KWRGE-EVAVKIFSSREERSW------------FREAEIYQTV 91

Query: 347 ALDHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
            L H  ++        D  +      V +Y +   L  YL ++ T+       + +   S
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTAS 150

Query: 404 ALKYL------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
            L +L       + KP + H DLK  NIL+ +   C    I D GL+   D      D  
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC---CIADLGLAVRHDSATDTIDIA 207

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISS--KVDVWSVGVIFYQCLYGKKPFGH 510
               +   GT  Y+ PE      N     S  + D++++G++F++        G 
Sbjct: 208 P---NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (291), Expect = 3e-28
 Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 25/244 (10%)

Query: 273 NEDQSRFNNHPVLSDRYLLLMLLGKG--GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK 330
           N      ++       Y LL ++GKG      V+ A       YV  +   L     E  
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM- 69

Query: 331 KANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDG---HDLDFYLKQHK 387
               +     E ++ K  +HP +V     F I  N    V  +       DL   +  H 
Sbjct: 70  ----VTFLQGELHVSKLFNHPNIVPYRATF-IADNELWVVTSFMAYGSAKDL---ICTHF 121

Query: 388 T--IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              + E     I+  V+ AL Y++ +    +H  +K  +IL++     G++ ++    + 
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD---GKVYLSGLRSNL 176

Query: 446 VMDEENYNPDHGMDLTSQGAGT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
            M           D          W L PE  V+ +N     +K D++SVG+   +   G
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPW-LSPE--VLQQNLQGYDAKSDIYSVGITACELANG 233

Query: 505 KKPF 508
             PF
Sbjct: 234 HVPF 237

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  114 bits (288), Expect = 3e-28
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           S ++  L  LG G ++ V+K  +     YVA K  +L  D +E   +     A+RE ++ 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL--DSEEGTPST----AIREISLM 57

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT------IAEREARSIVM 399
           K L H  +V+LYDV   + N    V E+ D +DL  Y+           +     +    
Sbjct: 58  KELKHENIVRLYDVIHTE-NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++  L + +E K  ++H DLKP N+L+ +    G++K+ DFGL++        P +   
Sbjct: 116 QLLQGLAFCHENK--ILHRDLKPQNLLINKR---GQLKLGDFGLARAFG----IPVNTF- 165

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             S    T WY  P+  +  +     S+ +D+WS G I  + +   KP 
Sbjct: 166 --SSEVVTLWYRAPDVLMGSR---TYSTSIDIWSCGCILAE-MITGKPL 208

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  113 bits (284), Expect = 3e-28
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            +  +G G F  VH  +    +  VA K   + +    ++        + E  +   L H
Sbjct: 12  FVQEIGSGQFGLVHLGY-WLNKDKVAIK--TIREGAMSEEDF------IEEAEVMMKLSH 62

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLN 409
           P++V+LY V  ++    C V E+ +   L  YL+  +   A      + + V   + YL 
Sbjct: 63  PKLVQLYGVC-LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY- 468
           E    VIH DL   N L+ E  V    K++DFG+++ + ++ Y        TS     + 
Sbjct: 122 EAC--VIHRDLAARNCLVGENQVI---KVSDFGMTRFVLDDQY--------TSSTGTKFP 168

Query: 469 --WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             W   PE F       + SSK DVWS GV+ ++    GK P+
Sbjct: 169 VKWA-SPEVFSFS----RYSSKSDVWSFGVLMWEVFSEGKIPY 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  113 bits (284), Expect = 3e-28
 Identities = 57/230 (24%), Positives = 88/230 (38%), Gaps = 47/230 (20%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           LL  LG G F  V      K Q  VA K   + +    + +        +E      L H
Sbjct: 12  LLKELGSGQFGVVKLGK-WKGQYDVAVK--MIKEGSMSEDEF------FQEAQTMMKLSH 62

Query: 351 PRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVV 402
           P++VK Y V        C+       V EY     L  YL+ H   +   +   +   V 
Sbjct: 63  PKLVKFYGV--------CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             + +L   +   IH DL   N L+         K++DFG+++ + ++ Y         S
Sbjct: 115 EGMAFLESHQ--FIHRDLAARNCLVDRDLCV---KVSDFGMTRYVLDDQY--------VS 161

Query: 463 QGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                +   W   PE F       K SSK DVW+ G++ ++    GK P+
Sbjct: 162 SVGTKFPVKWS-APEVFHYF----KYSSKSDVWAFGILMWEVFSLGKMPY 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  116 bits (292), Expect = 3e-28
 Identities = 82/403 (20%), Positives = 130/403 (32%), Gaps = 101/403 (25%)

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VHQLNKDWKEDKKANYIKHA 338
                    Y    ++G G F  V++A        VA K V Q       DK+       
Sbjct: 47  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKR-----FK 94

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCT-----VLEYCDGHDL----DFYLKQHKTI 389
            RE  I + LDH  +V+L   F              VL+Y     +      Y +  +T+
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTL 153

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                +  + Q+  +L Y++     + H D+KP N+LL        +K+ DFG +K +  
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLVR 209

Query: 450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF- 508
              N        S    + +Y  PE           +S +DVWS G +  + L   +P  
Sbjct: 210 GEPN-------VSYIC-SRYYRAPELIF---GATDYTSSIDVWSAGCVLAE-LLLGQPIF 257

Query: 509 ----GHNQ-----------SQATILEENTILKATEVQFANK----------PTVSNEAKG 543
               G +Q           ++  I E N     TE +F             P    EA  
Sbjct: 258 PGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315

Query: 544 FIRSCLAYRKEDRIDVISLARHDYLQ---------------PP----------------- 571
                L Y    R+  +    H +                 P                  
Sbjct: 316 LCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLAT 375

Query: 572 --VPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQQS 612
             +P H R  A++S P   + AS     + G  +  +SA   +
Sbjct: 376 ILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASN 418

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (286), Expect = 5e-28
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 291 LLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD 349
           +  ++G G   EV      +  QR V   +  L   + E ++ ++    L E +I    D
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQFD 108

Query: 350 HPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHK-TIAEREARSIVMQV 401
           HP +++L  V         T       V EY +   LD +L+ H       +   ++  V
Sbjct: 109 HPNIIRLEGV--------VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
            + ++YL+++    +H DL   N+L+    VC   K++DFGLS+V++++          T
Sbjct: 161 GAGMRYLSDLG--YVHRDLAARNVLVDSNLVC---KVSDFGLSRVLEDDPDA-----AYT 210

Query: 462 SQGAG--TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           + G      W   PE           SS  DVWS GV+ ++ L YG++P+
Sbjct: 211 TTGGKIPIRWT-APEAIAFR----TFSSASDVWSFGVVMWEVLAYGERPY 255

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  113 bits (286), Expect = 7e-28
 Identities = 54/242 (22%), Positives = 104/242 (42%), Gaps = 32/242 (13%)

Query: 275 DQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY 334
           D           D Y L+  LG+G +SEV +A ++     V  K+ +  K          
Sbjct: 24  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--------- 74

Query: 335 IKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVL--EYCDGHDLDFYLKQHKTIAE 391
            K   RE  I + L   P ++ L D+   D  S    L  E+ +  D     +   T+ +
Sbjct: 75  -KKIKREIKILENLRGGPNIITLADIV-KDPVSRTPALVFEHVNNTDFKQLYQ---TLTD 129

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            + R  + +++ AL Y + +   ++H D+KP N+++   +   ++++ D+GL+     E 
Sbjct: 130 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLA-----EF 180

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           Y+P       +    + ++  PE  V   +       +D+WS+G +    ++ K+PF H 
Sbjct: 181 YHPGQEY---NVRVASRYFKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234

Query: 512 QS 513
             
Sbjct: 235 HD 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  117 bits (295), Expect = 9e-28
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 28/223 (12%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L   +G+G F +VH+            VA K         +  +  +    L+E    + 
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKNCTSDSVREKF----LQEALTMRQ 447

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALK 406
            DHP +VKL  V  I  N    ++E C   +L  +L+  K ++          Q+ +AL 
Sbjct: 448 FDHPHIVKLIGV--ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL   +   +H D+   N+L++  +     K+ DFGLS+ M++  Y       L  +   
Sbjct: 506 YLESKR--FVHRDIAARNVLVSSNDCV---KLGDFGLSRYMEDSTYYKASKGKLPIK--- 557

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             W   PE         + +S  DVW  GV  ++ L +G KPF
Sbjct: 558 --WM-APESINFR----RFTSASDVWMFGVCMWEILMHGVKPF 593

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  113 bits (284), Expect = 9e-28
 Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 32/286 (11%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
                  + +G+G    V  A +    R VA K+  L K  + +   N       E  I 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN-------EVVIM 96

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           +   H  VV++Y  + +       ++E+  G  L   +     + E +  ++   V+ AL
Sbjct: 97  RDYQHFNVVEMYKSYLVG-EELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQAL 154

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     VIH D+K  +ILLT     G +K++DFG    + ++       +       
Sbjct: 155 AYLHAQG--VIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKD-------VPKRKSLV 202

Query: 466 GT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-FGHNQSQATILEENTI 523
           GT YW + PE  V+ ++    +++VD+WS+G++  + + G+ P F  +  QA       +
Sbjct: 203 GTPYW-MAPE--VISRSL--YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----L 253

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             +   +  N   VS   + F+   L    ++R     L  H +L 
Sbjct: 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  115 bits (290), Expect = 1e-27
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 33/223 (14%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKAL 348
           L + LG+G F EV           VA K            K   +     L+E  + K L
Sbjct: 188 LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----------KPGTMSPEAFLQEAQVMKKL 236

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVVSALK 406
            H ++V+LY V  +       V EY     L  +LK       R  + + M  Q+ S + 
Sbjct: 237 RHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    G     +   
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIK--- 346

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             W   PE  + G    + + K DVWS G++  +    G+ P+
Sbjct: 347 --WT-APEAALYG----RFTIKSDVWSFGILLTELTTKGRVPY 382

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (282), Expect = 1e-27
 Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 32/286 (11%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
             +Y     +G+G    V+ A D+   + VA +   L +  K++   N       E  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-------EILVM 71

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           +   +P +V   D + +  +    V+EY  G  L   +     + E +  ++  + + AL
Sbjct: 72  RENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQAL 129

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++L+  +  VIH D+K  NILL      G +K+TDFG    +  E           S   
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE-------QSKRSTMV 177

Query: 466 GT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP-FGHNQSQATILEENTI 523
           GT YW + PE  VV +       KVD+WS+G++  + + G+ P    N  +A  L    I
Sbjct: 178 GTPYW-MAPE--VVTRKA--YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL----I 228

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                 +  N   +S   + F+  CL    E R     L +H +L+
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  113 bits (284), Expect = 1e-27
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 50/236 (21%)

Query: 291 LLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
              ++G G F EV+K        K++  VA K   L   + E ++ ++    L E  I  
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDF----LGEAGIMG 101

Query: 347 ALDHPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHK-TIAEREARSIV 398
              H  +++L  V         +       + EY +   LD +L++     +  +   ++
Sbjct: 102 QFSHHNIIRLEGV--------ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             + + +KYL  +    +H DL   NIL+    VC   K++DFGLS+V++++        
Sbjct: 154 RGIAAGMKYLANMN--YVHRDLAARNILVNSNLVC---KVSDFGLSRVLEDDPEA----- 203

Query: 459 DLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             T+ G      +P     PE         K +S  DVWS G++ ++ + YG++P+
Sbjct: 204 TYTTSGG----KIPIRWTAPEAISYR----KFTSASDVWSFGIVMWEVMTYGERPY 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  113 bits (285), Expect = 1e-27
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 39/226 (17%)

Query: 295 LGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +G G F EV      L  ++ ++  +  L   + E ++ ++    L E +I    DHP +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQFDHPNI 108

Query: 354 VKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSAL 405
           ++L  V         T       V EY +   LD +L++H       +   ++  + S +
Sbjct: 109 IRLEGV--------VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           KYL+++    +H DL   NIL+    VC   K++DFGL +V++++          T++G 
Sbjct: 161 KYLSDMG--YVHRDLAARNILINSNLVC---KVSDFGLGRVLEDDPEA-----AYTTRGG 210

Query: 466 G--TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                W   PE         K +S  DVWS G++ ++ + YG++P+
Sbjct: 211 KIPIRWT-SPEAIAYR----KFTSASDVWSYGIVLWEVMSYGERPY 251

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (280), Expect = 1e-27
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 27/220 (12%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            L  LG G F  V      + Q  VA K   + +    + +       + E  +   L H
Sbjct: 28  FLKELGTGQFGVVKYGK-WRGQYDVAIK--MIKEGSMSEDEF------IEEAKVMMNLSH 78

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLN 409
            ++V+LY V          + EY     L  YL++ +     ++   +   V  A++YL 
Sbjct: 79  EKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 410 EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYW 469
             +   +H DL   N L+ +  V    K++DFGLS+ + ++ Y    G     +     W
Sbjct: 138 SKQ--FLHRDLAARNCLVNDQGVV---KVSDFGLSRYVLDDEYTSSVGSKFPVR-----W 187

Query: 470 YLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             PPE  +      K SSK D+W+ GV+ ++    GK P+
Sbjct: 188 S-PPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  112 bits (282), Expect = 2e-27
 Identities = 81/327 (24%), Positives = 129/327 (39%), Gaps = 67/327 (20%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKH-----ALR 340
            +Y  +  +G+G + +V KA DLK   R+VA K  ++             +       +R
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG----------EEGMPLSTIR 60

Query: 341 EYNIHKAL---DHPRVVKLYDVF----EIDANSFCTVLEYCDGHDLDFYLKQHKT--IAE 391
           E  + + L   +HP VV+L+DV              V E+ D  DL  YL +     +  
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPT 119

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
              + ++ Q++  L +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   + 
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS---GQIKLADFGLARIYSFQ- 173

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                 M LTS    T WY  PE  ++       ++ VD+WSVG IF + ++ +KP    
Sbjct: 174 ------MALTSVVV-TLWYRAPE-VLLQS---SYATPVDLWSVGCIFAE-MFRRKPLFRG 221

Query: 512 QSQA---------------------TILEENTILKATEVQFANK-PTVSNEAKGFIRSCL 549
            S                         L        +          +    K  +  CL
Sbjct: 222 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

Query: 550 AYRKEDRIDVISLARHDYLQ-PPVPKH 575
            +    RI   S   H Y Q     K 
Sbjct: 282 TFNPAKRISAYSALSHPYFQDLERCKE 308

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (292), Expect = 2e-27
 Identities = 71/224 (31%), Positives = 102/224 (45%), Gaps = 35/224 (15%)

Query: 295 LGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           LG G F  V +      K+Q  VA KV       K+  +    +  +RE  I   LD+P 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV------LKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEI 411
           +V+L  V    A +   V+E   G  L  +L   +  I       ++ QV   +KYL E 
Sbjct: 398 IVRLIGV--CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGAGTY- 468
               +H +L   N+LL   +     KI+DFGLSK +  D+  Y        T++ AG + 
Sbjct: 456 N--FVHRNLAARNVLLVNRHYA---KISDFGLSKALGADDSYY--------TARSAGKWP 502

Query: 469 --WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFG 509
             WY  PEC        K SS+ DVWS GV  ++ L YG+KP+ 
Sbjct: 503 LKWY-APECINFR----KFSSRSDVWSYGVTMWEALSYGQKPYK 541

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  112 bits (281), Expect = 2e-27
 Identities = 57/226 (25%), Positives = 83/226 (36%), Gaps = 32/226 (14%)

Query: 291 LLMLLGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL 348
            +  LG+G F +V         +       V  L  D     ++ +     +E +I + L
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTL 90

Query: 349 DHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKY 407
            H  ++K      +  A S   V+EY     L  YL +H  I   +      Q+   + Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQGA 465
           L+      IH DL   N+LL    +    KI DFGL+K +    E Y          +  
Sbjct: 150 LHAQH--YIHRDLAARNVLLDNDRLV---KIGDFGLAKAVPEGHEYY--------RVRED 196

Query: 466 GTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKP 507
           G     WY  PEC        K     DVWS GV  Y+ L +    
Sbjct: 197 GDSPVFWY-APECLKEY----KFYYASDVWSFGVTLYELLTHCDSS 237

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  114 bits (286), Expect = 4e-27
 Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 38/250 (15%)

Query: 273 NEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKA 332
                R ++   + DRY +  L+G G +  V +A+D  E+R VA K     K  +  +  
Sbjct: 39  TASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDL 93

Query: 333 NYIKHALREYNIHKALDHPRVVKLYDVFE-IDANSFCT---VLEYCDGHDLDFYLKQHKT 388
              K  LRE  I   L+H  VVK+ D+    D   F     VLE  D  D     +    
Sbjct: 94  IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVY 152

Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD 448
           + E   ++++  ++  +KY++     ++H DLKP N L+   N    +K+ DFGL++ +D
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLV---NQDCSVKVCDFGLARTVD 207

Query: 449 EENYNPDHGMDLTSQGAG--------------------TYWYLPPECFVVGKNPPKISSK 488
                         +                       T WY  PE  +        +  
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL---LQENYTEA 264

Query: 489 VDVWSVGVIF 498
           +DVWS+G IF
Sbjct: 265 IDVWSIGCIF 274

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (278), Expect = 5e-27
 Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 36/230 (15%)

Query: 291 LLMLLGKGGFSEVHKA----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +  LG+G F +V               VA K   L  +   +  A+      +E  I +
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADL----KKEIEILR 78

Query: 347 ALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSA 404
            L H  +VK   +  E   N    ++E+     L  YL ++K  I  ++     +Q+   
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTS 462
           + YL   +   +H DL   N+L+   +     KI DFGL+K +  D+E Y        T 
Sbjct: 139 MDYLGSRQ--YVHRDLAARNVLVESEHQV---KIGDFGLTKAIETDKEYY--------TV 185

Query: 463 QGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           +        WY  PEC +      K     DVWS GV  ++ L Y     
Sbjct: 186 KDDRDSPVFWY-APECLMQS----KFYIASDVWSFGVTLHELLTYCDSDS 230

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  109 bits (276), Expect = 5e-27
 Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 41/227 (18%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           L+  LG G F EV   +       VA K  +      +          L E N+ K L H
Sbjct: 17  LVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDA--------FLAEANLMKQLQH 67

Query: 351 PRVVKLYDVFEIDANSFCT------VLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVV 402
            R+V+LY V         T      + EY +   L  +LK    I     + + M  Q+ 
Sbjct: 68  QRLVRLYAV--------VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             + ++ E     IH DL+  NIL+++   C   KI DFGL++++++  Y    G     
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPI 174

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           +     W   PE    G      + K DVWS G++  + + +G+ P+
Sbjct: 175 K-----WT-APEAINYG----TFTIKSDVWSFGILLTEIVTHGRIPY 211

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  111 bits (280), Expect = 5e-27
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 31/235 (13%)

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
                 L   Y+    +G G +  V  A D +    VA K     K  +  +   + K A
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRA 70

Query: 339 LREYNIHKALDHPRVVKLYDVF--EIDANSFCT---VLEYCDGHDLDFYLKQHKTIAERE 393
            RE  + K + H  V+ L DVF       +F     V+ +    DL   +      +E +
Sbjct: 71  YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK--FSEEK 127

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
            + +V Q++  LKY++     V+H DLKPGN+ + E   C E+KI DFGL++  D     
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED--C-ELKILDFGLARHADA---- 178

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                ++T     T WY  PE  +   +    +  VD+WSVG I  + L GK  F
Sbjct: 179 -----EMTGYVV-TRWYRAPEVIL---SWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  113 bits (284), Expect = 6e-27
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKAL 348
           L   LG G F EV  A    +   VA K            K   +     L E N+ K L
Sbjct: 192 LEKKLGAGQFGEVWMA-TYNKHTKVAVKTM----------KPGSMSVEAFLAEANVMKTL 240

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVVSALK 406
            H ++VKL+ V  +       + E+     L  +LK  +   +   + I    Q+   + 
Sbjct: 241 QHDKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           ++ +     IH DL+  NIL++   VC   KI DFGL++V+++  Y    G     +   
Sbjct: 299 FIEQRN--YIHRDLRAANILVSASLVC---KIADFGLARVIEDNEYTAREGAKFPIK--- 350

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             W   PE    G      + K DVWS G++  + + YG+ P+
Sbjct: 351 --WT-APEAINFG----SFTIKSDVWSFGILLMEIVTYGRIPY 386

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  112 bits (283), Expect = 6e-27
 Identities = 63/269 (23%), Positives = 112/269 (41%), Gaps = 37/269 (13%)

Query: 269 KRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE 328
           + ++ +     +    + D Y++  L+G+G +  V+ A+D   ++ VA K     K  + 
Sbjct: 12  ENLYFQGIKNVH----VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRM 62

Query: 329 DKKANYIKHALREYNIHKALDHPRVVKLYDVFE-IDANSFCT---VLEYCDGHDLDFYLK 384
            +     K  LRE  I   L    +++LYD+    D   F     VLE  D  DL    K
Sbjct: 63  FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK 121

Query: 385 QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
               + E   ++I+  ++    +++E    +IH DLKP N LL +   C  +K+ DFGL+
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD--C-SVKVCDFGLA 176

Query: 445 KVMDEENYNPDHGMDLTSQGAG---------------TYWYLPPECFVVGKNPPKISSKV 489
           + ++ E           ++  G               T WY  PE  +        +  +
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL---LQENYTKSI 233

Query: 490 DVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
           D+WS G IF + L   +   ++ +    L
Sbjct: 234 DIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 6e-27
 Identities = 73/306 (23%), Positives = 122/306 (39%), Gaps = 59/306 (19%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +  + L+ L+G G + +V+K   +K  +  A KV  +  D +E+     IK   +E N+ 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-----IK---QEINML 74

Query: 346 KAL-DHPRVVKLYDVFEIDANSFCT-----VLEYCDG---HDLDFYLKQHKTIAEREARS 396
           K    H  +   Y  F              V+E+C      DL     +  T+ E     
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAY 133

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
           I  +++  L +L++ K  VIH D+K  N+LLTE     E+K+ DFG+S  +D        
Sbjct: 134 ICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRT------ 182

Query: 457 GMDLTSQGAGT-YWYLPPECFVVGKNPPKIS---SKVDVWSVGVIFYQCLYGKKPFGHNQ 512
            +   +   GT YW + PE  V+  +    +    K D+WS+G+   +   G  P     
Sbjct: 183 -VGRRNTFIGTPYW-MAPE--VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-- 236

Query: 513 SQATILEENTILKATEVQF----ANKPTV-----SNEAKGFIRSCLAYRKEDRIDVISLA 563
                      +      F       P +     S + + FI SCL      R     L 
Sbjct: 237 -----------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285

Query: 564 RHDYLQ 569
           +H +++
Sbjct: 286 KHPFIR 291

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (275), Expect = 7e-27
 Identities = 38/310 (12%), Positives = 79/310 (25%), Gaps = 51/310 (16%)

Query: 282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
             + + RY LL+  G     +  +A D    R VA     ++         + ++  L  
Sbjct: 26  ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF--VDPQGVLP--DDVLQETLSR 81

Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
                 +D P V ++ DV    A     V E+  G  L          +   A   +  +
Sbjct: 82  TLRLSRIDKPGVARVLDVVHTRAGGLV-VAEWIRGGSLQEVADTS--PSPVGAIRAMQSL 138

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
            +A    +     V      P  + ++     G++ +                       
Sbjct: 139 AAAADAAHRA--GVALSIDHPSRVRVSID---GDVVLAYPA------------------- 174

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
                    +P             + + D+  +G   Y  L  + P      ++ +    
Sbjct: 175 --------TMPDA-----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215

Query: 522 TILKATEVQ-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSA 580
                  ++       +  +        +      R     L           +      
Sbjct: 216 RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

Query: 581 SSSAPVGHSP 590
              APV  +P
Sbjct: 276 IDEAPVSAAP 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (276), Expect = 7e-27
 Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            + +  L  +GKG F EV K  D + Q+ VA K+  L +   ED+  +  +    E  + 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQ----EITVL 74

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
              D P V K Y  + +       ++EY  G      L+    + E +  +I+ +++  L
Sbjct: 75  SQCDSPYVTKYYGSY-LKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGL 132

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+  K   IH D+K  N+LL+E    GE+K+ DFG++  + +            +   
Sbjct: 133 DYLHSEK--KIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDT-------QIKRNTFV 180

Query: 466 GT-YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH-NQSQATILEENTI 523
           GT +W + PE  V+ ++     SK D+WS+G+   +   G+ P    +  +   L    I
Sbjct: 181 GTPFW-MAPE--VIKQSA--YDSKADIWSLGITAIELARGEPPHSELHPMKVLFL----I 231

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            K            S   K F+ +CL      R     L +H ++ 
Sbjct: 232 PKNNPPTLEGN--YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  109 bits (274), Expect = 1e-26
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 47/231 (20%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
           +   LG G + EV++    K    VA K   L +D  E ++       L+E  + K + H
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEF------LKEAAVMKEIKH 68

Query: 351 PRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQH--KTIAEREARSIVMQV 401
           P +V+L  V        CT       + E+    +L  YL++   + ++      +  Q+
Sbjct: 69  PNLVQLLGV--------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
            SA++YL +     IH DL   N L+ E ++    K+ DFGLS++M  + Y        T
Sbjct: 121 SSAMEYLEKKN--FIHRDLAARNCLVGENHLV---KVADFGLSRLMTGDTY--------T 167

Query: 462 SQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           +     +   W   PE         K S K DVW+ GV+ ++   YG  P+
Sbjct: 168 AHAGAKFPIKW-TAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPY 213

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  111 bits (279), Expect = 1e-26
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 34/236 (14%)

Query: 287 DRYLLLML-LGKGGFSEVHKA--FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           D +      +G+G +  V+KA   D K+ +  A K         + +       A RE  
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK---------QIEGTGISMSACREIA 70

Query: 344 IHKALDHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFYLKQHKT---------IAERE 393
           + + L HP V+ L  VF   A      + +Y + HDL   +K H+          +    
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGM 129

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT-EGNVCGEIKITDFGLSKVMDEENY 452
            +S++ Q++  + YL+     V+H DLKP NIL+  EG   G +KI D G +++      
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----N 183

Query: 453 NPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           +P   +        T+WY  PE  +  +     +  +D+W++G IF + L   +P 
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAE-LLTSEPI 235

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  109 bits (275), Expect = 1e-26
 Identities = 62/252 (24%), Positives = 96/252 (38%), Gaps = 38/252 (15%)

Query: 291 LLMLLGKGGFSEVHKA----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +  LGKG F  V               VA K  QL +    D++ ++     RE  I K
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QL-QHSGPDQQRDF----QREIQILK 79

Query: 347 ALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSA 404
           AL    +VK   V +     S   V+EY     L  +L++H+  +          Q+   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTS 462
           ++YL   +   +H DL   NIL+         KI DFGL+K++  D++ Y          
Sbjct: 140 MEYLGSRR--CVHRDLAARNILVESEAHV---KIADFGLAKLLPLDKDYY--------VV 186

Query: 463 QGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF-GHNQSQATI 517
           +  G     WY  PE           S + DVWS GV+ Y+   Y  K      +    +
Sbjct: 187 REPGQSPIFWY-APESLSDN----IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

Query: 518 LEENTILKATEV 529
             E  +   + +
Sbjct: 242 GCERDVPALSRL 253

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/240 (23%), Positives = 95/240 (39%), Gaps = 33/240 (13%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK--AL 348
           LL L+G+G +  V+K   L E+  VA KV   +   +++           E NI++   +
Sbjct: 17  LLELIGRGRYGAVYKG-SLDER-PVAVKV--FSFANRQNFI--------NEKNIYRVPLM 64

Query: 349 DHPRVVKLY----DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
           +H  + +       V       +  V+EY     L  YL  H T     +  +   V   
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRG 123

Query: 405 LKYL-------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           L YL       +  KP + H DL   N+L+     C    I+DFGLS  +          
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC---VISDFGLSMRLTGNRLVRPGE 180

Query: 458 MDLTSQG-AGTYWYLPPECF---VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
            D  +    GT  Y+ PE     V  ++      +VD++++G+I+++           +S
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (273), Expect = 2e-26
 Identities = 56/228 (24%), Positives = 91/228 (39%), Gaps = 33/228 (14%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
              ++G+G F  V+      +  ++ + A K   LN+     + + +    L E  I K 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQF----LTEGIIMKD 82

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALK 406
             HP V+ L  +      S   VL Y    DL  +++        ++     +QV   +K
Sbjct: 83  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL   K   +H DL   N +L E       K+ DFGL++ M ++ Y         S    
Sbjct: 143 YLASKK--FVHRDLAARNCMLDEKFTV---KVADFGLARDMYDKEY--------YSVHNK 189

Query: 467 TYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           T   LP      E         K ++K DVWS GV+ ++ +  G  P+
Sbjct: 190 TGAKLPVKWMALESLQTQ----KFTTKSDVWSFGVLLWELMTRGAPPY 233

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  110 bits (277), Expect = 2e-26
 Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 34/233 (14%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI--KHALREY 342
           +  RY  L  +G+G +  V  A+D   +  VA K        K     +    +  LRE 
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--------KISPFEHQTYCQRTLREI 76

Query: 343 NIHKALDHPRVVKLYDVFEIDA----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
            I     H  ++ + D+              V +  +  DL   LK  + ++       +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFL 134

Query: 399 MQVVSALKYL---NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            Q++  LKY+   N     V+H DLKP N+LL     C ++KI DFGL++V D ++   D
Sbjct: 135 YQILRGLKYIHSAN-----VLHRDLKPSNLLLNTT--C-DLKICDFGLARVADPDH---D 183

Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           H   LT   A T WY  PE  +   N    +  +D+WSVG I  + L  +  F
Sbjct: 184 HTGFLTEYVA-TRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (282), Expect = 2e-26
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 45/230 (19%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKAL 348
           +   LG G + EV++    K    VA K            K + ++    L+E  + K +
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----------KEDTMEVEEFLKEAAVMKEI 273

Query: 349 DHPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQH--KTIAEREARSIVM 399
            HP +V+L  V        CT       + E+    +L  YL++   + ++      +  
Sbjct: 274 KHPNLVQLLGV--------CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+ SA++YL +     IH +L   N L+ E ++    K+ DFGLS++M  + Y    G  
Sbjct: 326 QISSAMEYLEKKN--FIHRNLAARNCLVGENHLV---KVADFGLSRLMTGDTYTAHAGAK 380

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
              +     W   PE         K S K DVW+ GV+ ++   YG  P+
Sbjct: 381 FPIK-----WT-APESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPY 420

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  108 bits (272), Expect = 2e-26
 Identities = 57/228 (25%), Positives = 86/228 (37%), Gaps = 34/228 (14%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           LL  LG G F  V +        +   VA K   L  D     +A      +RE N   +
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAM--DDFIREVNAMHS 77

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALK 406
           LDH  +++LY V  +       V E      L   L++H+            +QV   + 
Sbjct: 78  LDHRNLIRLYGV--VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTSQG 464
           YL   +   IH DL   N+LL   ++    KI DFGL + +  ++++Y          Q 
Sbjct: 136 YLESKR--FIHRDLAARNLLLATRDLV---KIGDFGLMRALPQNDDHY--------VMQE 182

Query: 465 AGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                  W   PE           S   D W  GV  ++   YG++P+
Sbjct: 183 HRKVPFAWC-APESLKTR----TFSHASDTWMFGVTLWEMFTYGQEPW 225

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (273), Expect = 2e-26
 Identities = 46/235 (19%), Positives = 86/235 (36%), Gaps = 39/235 (16%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNIH--K 346
           LL +  +G F  V KA       YVA K+   Q  + W+             EY ++   
Sbjct: 28  LLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQ------------NEYEVYSLP 73

Query: 347 ALDHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
            + H  +++     +   +       +  + +   L  +LK +  ++  E   I   +  
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMAR 132

Query: 404 ALKYL--------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            L YL        +  KP + H D+K  N+LL          I DFGL+   +       
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKFE-----AG 184

Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISS-KVDVWSVGVIFYQCLYGKKPFG 509
                T    GT  Y+ PE      N  + +  ++D++++G++ ++         
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  110 bits (276), Expect = 2e-26
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 30/235 (12%)

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            ++   +  RY  L  +G G    V  A+D   +R VA K     K  +  +   + K A
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRA 71

Query: 339 LREYNIHKALDHPRVVKLYDVF--EIDANSFCT---VLEYCDGHDLDFYLKQHKTIAERE 393
            RE  + K ++H  ++ L +VF  +     F     V+E  D  +L   ++         
Sbjct: 72  YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD--HER 128

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
              ++ Q++  +K+L+     +IH DLKP NI++     C  +KI DFGL++        
Sbjct: 129 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLARTAGTSFMM 183

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +          T +Y  PE  +           VD+WSVG I  + + G   F
Sbjct: 184 TPY--------VVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIKGGVLF 226

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (273), Expect = 3e-26
 Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 48/234 (20%)

Query: 291 LLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            + +LG G F  V+K        K +  VA K   L +              L E  +  
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEI----LDEAYVMA 72

Query: 347 ALDHPRVVKLYDVFEIDANSFCT------VLEYCDGHDLDFYLKQHK-TIAEREARSIVM 399
           ++D+P V +L  +        C       + +      L  Y+++HK  I  +   +  +
Sbjct: 73  SVDNPHVCRLLGI--------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   + YL + +  ++H DL   N+L+         KITDFGL+K++  E         
Sbjct: 125 QIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHV---KITDFGLAKLLGAEEK------- 172

Query: 460 LTSQGAGT----YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                 G      W    E  +        + + DVWS GV  ++ + +G KP+
Sbjct: 173 -EYHAEGGKVPIKWM-ALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPY 220

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (270), Expect = 4e-26
 Identities = 66/240 (27%), Positives = 95/240 (39%), Gaps = 37/240 (15%)

Query: 291 LLMLLGKGGFSEVHKA----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            L  LGKG F  V               VA K  +L +   E+   ++     RE  I K
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KL-QHSTEEHLRDF----EREIEILK 66

Query: 347 ALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSA 404
           +L H  +VK   V +     +   ++EY     L  YL++HK  I   +      Q+   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTS 462
           ++YL   +   IH DL   NIL+   N     KI DFGL+KV+  D+E +          
Sbjct: 127 MEYLGTKR--YIHRDLATRNILVENENRV---KIGDFGLTKVLPQDKEFF--------KV 173

Query: 463 QGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATIL 518
           +  G     WY  PE         K S   DVWS GV+ Y+   Y +K          ++
Sbjct: 174 KEPGESPIFWY-APESLTES----KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (279), Expect = 5e-26
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 33/223 (14%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA--LREYNIHKAL 348
           L + LG+G F EV           VA K            K   +     L+E  + K L
Sbjct: 271 LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL----------KPGTMSPEAFLQEAQVMKKL 319

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM--QVVSALK 406
            H ++V+LY V  +       V EY     L  +LK       R  + + M  Q+ S + 
Sbjct: 320 RHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y+  +    +H DL+  NIL+ E  VC   K+ DFGL++++++  Y    G     +   
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVC---KVADFGLARLIEDNEYTARQGAKFPIK--- 429

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             W   PE  + G    + + K DVWS G++  +    G+ P+
Sbjct: 430 --WT-APEAALYG----RFTIKSDVWSFGILLTELTTKGRVPY 465

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  108 bits (273), Expect = 5e-26
 Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 49/244 (20%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED--KKANYIKHALREY 342
           +S  + L  LLG+G +  V  A        VA K        K +   K  +    LRE 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREI 60

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-------HKTIAERE-- 393
            I K   H  ++ ++++   D+            +  + Y+ Q       H+ I+ +   
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFE----------NFNEVYIIQELMQTDLHRVISTQMLS 110

Query: 394 ---ARSIVMQVVSALKYL---NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM 447
               +  + Q + A+K L   N     VIH DLKP N+L+     C ++K+ DFGL++++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSN--C-DLKVCDFGLARII 162

Query: 448 DEENYNPDHGMDLTSQGAG---TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG 504
           DE   +        S       T WY  PE  +      K S  +DVWS G I  +    
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVML---TSAKYSRAMDVWSCGCILAELFLR 219

Query: 505 KKPF 508
           +  F
Sbjct: 220 RPIF 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 5e-26
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 33/224 (14%)

Query: 295 LGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP 351
           +GKG F  V+        + +   A K   L++  +  +   +    LRE  + + L+HP
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKS--LSRITEMQQVEAF----LREGLLMRGLNHP 82

Query: 352 RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNE 410
            V+ L  +          +L Y    DL  +++  +     ++  S  +QV   ++YL E
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
            K   +H DL   N +L E       K+ DFGL++ + +  Y         S     +  
Sbjct: 143 QK--FVHRDLAARNCMLDESFTV---KVADFGLARDILDREY--------YSVQQHRHAR 189

Query: 471 LP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           LP      E         + ++K DVWS GV+ ++ L  G  P+
Sbjct: 190 LPVKWTALESLQTY----RFTTKSDVWSFGVLLWELLTRGAPPY 229

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 6e-26
 Identities = 67/240 (27%), Positives = 95/240 (39%), Gaps = 37/240 (15%)

Query: 291 LLMLLGKGGFSEVHKA----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            L  LGKG F  V               VA K  +L +   E+   ++     RE  I K
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KL-QHSTEEHLRDF----EREIEILK 97

Query: 347 ALDHPRVVKLYDV-FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSA 404
           +L H  +VK   V +     +   ++EY     L  YL++HK  I   +      Q+   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM--DEENYNPDHGMDLTS 462
           ++YL   +   IH DL   NIL+   N     KI DFGL+KV+  D+E Y          
Sbjct: 158 MEYLGTKR--YIHRDLATRNILVENENRV---KIGDFGLTKVLPQDKEYY--------KV 204

Query: 463 QGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATIL 518
           +  G     WY  PE         K S   DVWS GV+ Y+   Y +K          ++
Sbjct: 205 KEPGESPIFWY-APESLTES----KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  108 bits (272), Expect = 7e-26
 Identities = 68/321 (21%), Positives = 107/321 (33%), Gaps = 53/321 (16%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VHQLNKDWKEDK---KANYIKHALR 340
           +   Y +   +  G +  V    D  E   VA K V     D +       +   K  LR
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 341 EYNIHKALDHPRVVKLYDVFEIDANSFCT----VLEYCDGHDLDFYLK-QHKTIAEREAR 395
           E  +     HP ++ L D+F             V E     DL   +  Q   I+ +  +
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137

Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
             +  ++  L  L+E    V+H DL PGNILL +     +I I DF L++    +     
Sbjct: 138 YFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN--N-DITICDFNLAREDTADANKTH 192

Query: 456 HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-G---HN 511
           +            WY  PE  +        +  VD+WS G +  +    K  F G   +N
Sbjct: 193 Y--------VTHRWYRAPELVM---QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241

Query: 512 Q-----------SQATILE----------ENTILKATEVQFANK-PTVSNEAKGFIRSCL 549
           Q               ++            N++       +    PT    A   I   L
Sbjct: 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKML 301

Query: 550 AYRKEDRIDVISLARHDYLQP 570
            +  + RI      RH Y + 
Sbjct: 302 EFNPQRRISTEQALRHPYFES 322

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  107 bits (270), Expect = 7e-26
 Identities = 46/233 (19%), Positives = 87/233 (37%), Gaps = 46/233 (19%)

Query: 291 LLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            L +LG G F  VHK          +  V  KV       ++       +          
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV------IEDKSGRQSFQAVTDHMLAIG 70

Query: 347 ALDHPRVVKLYDVFEIDANSFCT------VLEYCDGHDLDFYLKQHK-TIAEREARSIVM 399
           +LDH  +V+L  +        C       V +Y     L  +++QH+  +  +   +  +
Sbjct: 71  SLDHAHIVRLLGL--------CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q+   + YL E    ++H +L   N+LL   +     ++ DFG++ ++  ++        
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQV---QVADFGVADLLPPDDKQ------ 171

Query: 460 LTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                       W    E    G    K + + DVWS GV  ++ + +G +P+
Sbjct: 172 -LLYSEAKTPIKWM-ALESIHFG----KYTHQSDVWSYGVTVWELMTFGAEPY 218

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (272), Expect = 8e-26
 Identities = 70/248 (28%), Positives = 110/248 (44%), Gaps = 36/248 (14%)

Query: 272 HNEDQSRFNNHPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD 325
           H++++  F    +      + +RY  L  +G G +  V  AFD K    VA K     K 
Sbjct: 8   HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KL 62

Query: 326 WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF--EIDANSFCT---VLEYCDGHDLD 380
            +  +   + K   RE  + K + H  V+ L DVF        F     V       DL+
Sbjct: 63  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLN 121

Query: 381 FYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD 440
             +K  + + +   + ++ Q++  LKY++     +IH DLKP N+ + E   C E+KI D
Sbjct: 122 NIVK-CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED--C-ELKILD 175

Query: 441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           FGL++   +E         +T   A T WY  PE  +   N    +  VD+WSVG I  +
Sbjct: 176 FGLARHTADE---------MTGYVA-TRWYRAPEIML---NWMHYNQTVDIWSVGCIMAE 222

Query: 501 CLYGKKPF 508
            L G+  F
Sbjct: 223 LLTGRTLF 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (269), Expect = 2e-25
 Identities = 69/235 (29%), Positives = 107/235 (45%), Gaps = 30/235 (12%)

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
                 +   Y  L  +G G +  V  A D +    VA K     K ++  +   + K A
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRA 71

Query: 339 LREYNIHKALDHPRVVKLYDVF--EIDANSFCT---VLEYCDGHDLDFYLKQHKTIAERE 393
            RE  + K + H  V+ L DVF  +   + F     V+ +    DL   +K H+ + E  
Sbjct: 72  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMK-HEKLGEDR 129

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
            + +V Q++  L+Y++     +IH DLKPGN+ + E   C E+KI DFGL++  D E   
Sbjct: 130 IQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED--C-ELKILDFGLARQADSE--- 181

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                 +T     T WY  PE  +   N  + +  VD+WSVG I  + + GK  F
Sbjct: 182 ------MTGYVV-TRWYRAPEVIL---NWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 2e-25
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 33/228 (14%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
              ++G+G F  V+      +  ++ + A K   LN+     + + +    L E  I K 
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS--LNRITDIGEVSQF----LTEGIIMKD 146

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALK 406
             HP V+ L  +      S   VL Y    DL  +++        ++     +QV   +K
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           +L   K   +H DL   N +L E       K+ DFGL++ M ++ ++  H     +    
Sbjct: 207 FLASKK--FVHRDLAARNCMLDEKFTV---KVADFGLARDMYDKEFDSVHN---KTGAK- 257

Query: 467 TYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               LP      E         K ++K DVWS GV+ ++ +  G  P+
Sbjct: 258 ----LPVKWMALESLQTQ----KFTTKSDVWSFGVLLWELMTRGAPPY 297

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  108 bits (272), Expect = 2e-25
 Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 30/235 (12%)

Query: 279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
            ++   +  RY  L  +G G    V  A+D    R VA K     K  +  +   + K A
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRA 108

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDA-----NSFCTVLEYCDGHDLDFYLKQHKTIAERE 393
            RE  + K ++H  ++ L +VF              V+E  D  +L   ++         
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELD--HER 165

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
              ++ Q++  +K+L+     +IH DLKP NI++     C  +KI DFGL++        
Sbjct: 166 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD--C-TLKILDFGLARTAGTSFMM 220

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +          T +Y  PE  +           VD+WSVG I  + +  K  F
Sbjct: 221 TPY--------VVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILF 263

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  106 bits (267), Expect = 7e-25
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 44/247 (17%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
               H  ++ RY +L ++GKG F +V KA+D K  ++VA K+ + N+         + + 
Sbjct: 88  VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEK-------RFHRQ 139

Query: 338 ALREYNIHKAL------DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--I 389
           A  E  I + L      +   V+ + + F    N  C   E     +L   +K++K    
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENF-TFRNHICMTFELL-SMNLYELIKKNKFQGF 197

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
           +    R     ++  L  L++ +  +IH DLKP NILL +      IK+ DFG S    +
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRS-GIKVIDFGSSCYEHQ 254

Query: 450 ENYNPDHGMDLTSQGAGTY----WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
             Y              TY    +Y  PE  ++G    +    +D+WS+G I  + L G 
Sbjct: 255 RVY--------------TYIQSRFYRAPE-VILGA---RYGMPIDMWSLGCILAELLTGY 296

Query: 506 KPF-GHN 511
               G +
Sbjct: 297 PLLPGED 303

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 9e-25
 Identities = 54/237 (22%), Positives = 90/237 (37%), Gaps = 48/237 (20%)

Query: 291 LLMLLGKGGFSEVHKA-------FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
               LG+G F+++ K        +    +  V  KV  L+K  +   ++          +
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV--LDKAHRNYSES-----FFEAAS 64

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVV 402
           +   L H  +V  Y V  +  +    V E+     LD YLK++K  I       +  Q+ 
Sbjct: 65  MMSKLSHKHLVLNYGVC-VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE-----IKITDFGLSKVMDEENYNPDHG 457
           +A+ +L E    +IH ++   NILL             IK++D G+S  +  ++      
Sbjct: 124 AAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----- 176

Query: 458 MDLTSQGAGTY-----WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKPF 508
                           W  PPEC    KN   ++   D WS G   ++ C  G KP 
Sbjct: 177 ----------LQERIPWV-PPECIENPKN---LNLATDKWSFGTTLWEICSGGDKPL 219

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  105 bits (264), Expect = 1e-24
 Identities = 77/341 (22%), Positives = 119/341 (34%), Gaps = 71/341 (20%)

Query: 267 ELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VHQLNKD 325
             K I                 Y    ++G G F  V +A  ++    VA K V Q   D
Sbjct: 21  PNKVIKVLASDGKTGEQR-EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ---D 75

Query: 326 WKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF-----EIDANSFCTVLEYCDGHDL- 379
            K  K         RE  I + + HP VV L   F     + D      VLEY     + 
Sbjct: 76  -KRFK--------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVY 125

Query: 380 ---DFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI 436
                Y K  +T+     +  + Q++ +L Y++ I   + H D+KP N+LL      G +
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPP--SGVL 181

Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE-CFVVGKNPPKISSKVDVWSVG 495
           K+ DFG +K++     N        S    + +Y  PE  F         ++ +D+WS G
Sbjct: 182 KLIDFGSAKILIAGEPN-------VSYIC-SRYYRAPELIF----GATNYTTNIDIWSTG 229

Query: 496 VIFYQCLYGKKPF-----GHNQ-----------SQATILEENTILKATEVQFAN------ 533
            +  + L   +P      G +Q           S+  I   N      E +F        
Sbjct: 230 CVMAE-LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP--NYMEHKFPQIRPHPF 286

Query: 534 ----KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
               +P    +A   I   L Y    R+  I    H +   
Sbjct: 287 SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  105 bits (263), Expect = 1e-24
 Identities = 62/261 (23%), Positives = 98/261 (37%), Gaps = 50/261 (19%)

Query: 282 HPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYI 335
           HP          RY+L+  LG G FS V  A D+    +VA K+ + +K         Y 
Sbjct: 8   HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------YT 59

Query: 336 KHALREYNIHKAL-----------DHPRVVKLYDVFEIDANS---FCTVLEYCDGHDLDF 381
           + A  E  + + +               ++KL D F     +      V E   G +L  
Sbjct: 60  EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA 118

Query: 382 YLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC---GEI 436
            +K+  H+ I     + I  Q++  L Y+   +  +IH D+KP N+L+   +      +I
Sbjct: 119 LIKKYEHRGIPLIYVKQISKQLLLGLDYM-HRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV 496
           KI D G +   DE   N             T  Y  PE  V+   P       D+WS   
Sbjct: 178 KIADLGNACWYDEHYTNS----------IQTREYRSPE--VLLGAP--WGCGADIWSTAC 223

Query: 497 IFYQCLYGKKPF-GHNQSQAT 516
           + ++ + G   F        T
Sbjct: 224 LIFELITGDFLFEPDEGHSYT 244

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  104 bits (262), Expect = 2e-24
 Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 42/234 (17%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACK-VHQLNKDWKEDKKANYIKHALREYNIH 345
           DR+ +  + G+G F  V    +      VA K V Q       D +        RE  I 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-------DPR-----FRNRELQIM 70

Query: 346 KAL---DHPRVVKLYDVFEIDANS------FCTVLEYCDGHDL----DFYLKQHKTIAER 392
           + L    HP +V+L   F               V+EY     L      Y ++       
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPI 129

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENY 452
             +  + Q++ ++  L+     V H D+KP N+L+ E +  G +K+ DFG +K +     
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD--GTLKLCDFGSAKKLSPSEP 187

Query: 453 NPDHGMDLTSQGAGTYWYLPPE-CFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
           N        +    + +Y  PE  F         ++ VD+WSVG IF + + G+
Sbjct: 188 N-------VAYIC-SRYYRAPELIF----GNQHYTTAVDIWSVGCIFAEMMLGE 229

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (256), Expect = 2e-24
 Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 49/243 (20%)

Query: 291 LLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            +  LG+  F +V+K         ++ + VA K   L    +   +  +      E  + 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEF----RHEAMLR 66

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR---------- 395
             L HP VV L  V          +  YC   DL  +L      ++  +           
Sbjct: 67  ARLQHPNVVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 396 ------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                  +V Q+ + ++YL+     V+H DL   N+L+ +       KI+D GL + +  
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNV---KISDLGLFREVYA 180

Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
            +Y           G       W + PE  + G    K S   D+WS GV+ ++   YG 
Sbjct: 181 ADY-------YKLLGNSLLPIRW-MAPEAIMYG----KFSIDSDIWSYGVVLWEVFSYGL 228

Query: 506 KPF 508
           +P+
Sbjct: 229 QPY 231

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  103 bits (259), Expect = 4e-24
 Identities = 68/250 (27%), Positives = 102/250 (40%), Gaps = 42/250 (16%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
              N     DRY +  L+GKG F +V KA+D  EQ +VA K+ + NK         ++  
Sbjct: 45  IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKK-------AFLNQ 96

Query: 338 ALREYNIHKAL------DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT--I 389
           A  E  + + +          +V L   F    N  C V E    ++L   L+      +
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCLVFEML-SYNLYDLLRNTNFRGV 154

Query: 390 AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
           +    R    Q+ +AL +L   +  +IH DLKP NILL        IKI DFG S  + +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQLGQ 213

Query: 450 ENYNPDHGMDLTSQGAGTY----WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
             Y               Y    +Y  PE  ++G         +D+WS+G I  +   G+
Sbjct: 214 RIY--------------QYIQSRFYRSPE-VLLGM---PYDLAIDMWSLGCILVEMHTGE 255

Query: 506 KPF-GHNQSQ 514
             F G N+  
Sbjct: 256 PLFSGANEVD 265

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  103 bits (259), Expect = 4e-24
 Identities = 66/353 (18%), Positives = 124/353 (35%), Gaps = 93/353 (26%)

Query: 283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
              S +Y L   LG G F  V + FD++  +  A K     K  ++ +  N      RE 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRYKN------REL 51

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCT--------------------------------- 369
           +I K LDH  ++KL D F    +                                     
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 370 ----VLEY--CDGHD-LDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKP 422
               ++EY     H  L  +++  ++I        + Q+  A+ +++ +   + H D+KP
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKP 169

Query: 423 GNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP 482
            N+L+        +K+ DFG +K +     +        +    + +Y  PE  +     
Sbjct: 170 QNLLVNSK--DNTLKLCDFGSAKKLIPSEPS-------VAYIC-SRFYRAPELML---GA 216

Query: 483 PKISSKVDVWSVGVIFYQCLYGKKPF----GHNQ-----------SQATILEENTILKAT 527
            + +  +D+WS+G +F + + GK  F      +Q           ++  ++  N     T
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP--HYT 274

Query: 528 EVQFANKPTVS----------NEAKGFIRSCLAYRKEDRIDVISLARHDYLQP 570
           EV+F                 + A   +   L Y  + RI+      H +   
Sbjct: 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  102 bits (256), Expect = 5e-24
 Identities = 54/238 (22%), Positives = 82/238 (34%), Gaps = 44/238 (18%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L  +LGKG F  V +A    +      VA K+  L  D         I+  LRE    K 
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSD---IEEFLREAACMKE 81

Query: 348 LDHPRVVKLYDV-----FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARS------ 396
            DHP V KL  V      +        +L +    DL  +L   +               
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
            ++ +   ++YL+      IH DL   N +L E        + DFGLS+ +   +Y    
Sbjct: 142 FMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTV---CVADFGLSRKIYSGDYYRQG 196

Query: 457 GMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
                         LP      E           +   DVW+ GV  ++ +  G+ P+
Sbjct: 197 CASK----------LPVKWLALESLADN----LYTVHSDVWAFGVTMWEIMTRGQTPY 240

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  103 bits (258), Expect = 6e-24
 Identities = 61/248 (24%), Positives = 97/248 (39%), Gaps = 48/248 (19%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +  +Y L+  LGKG +  V K+ D +    VA K     K +   + +   +   RE  I
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMI 61

Query: 345 HKAL-DHPRVVKLYDVFEIDA-NSFCTVLEYCDGHDLDFYLKQHKTIA-----EREARSI 397
              L  H  +V L +V   D       V +Y +  DL      H  I          + +
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDL------HAVIRANILEPVHKQYV 114

Query: 398 VMQVVSALKYL---NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP 454
           V Q++  +KYL         ++H D+KP NILL     C  +K+ DFGLS+         
Sbjct: 115 VYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAE--C-HVKVADFGLSRSFVNIRRVT 166

Query: 455 DHGMDLTSQGAG--------------TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ 500
           ++     ++                 T WY  PE  +      K +  +D+WS+G I  +
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL---GSTKYTKGIDMWSLGCILGE 223

Query: 501 CLYGKKPF 508
            +   KP 
Sbjct: 224 -ILCGKPI 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  100 bits (252), Expect = 7e-24
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 41/225 (18%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA-LREYNIHKALD 349
           LL  +GKG F +V    D +  + VA K            K +    A L E ++   L 
Sbjct: 25  LLQTIGKGEFGDVMLG-DYRGNK-VAVKCI----------KNDATAQAFLAEASVMTQLR 72

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKY 407
           H  +V+L  V   +      V EY     L  YL+      +         + V  A++Y
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L       +H DL   N+L++E NV    K++DFGL+K    E  +            G 
Sbjct: 133 LEGNN--FVHRDLAARNVLVSEDNVA---KVSDFGLTK----EASSTQDT--------GK 175

Query: 468 Y---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
               W   PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 176 LPVKWT-APEALREK----KFSTKSDVWSFGILLWEIYSFGRVPY 215

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (254), Expect = 8e-24
 Identities = 50/237 (21%), Positives = 83/237 (35%), Gaps = 43/237 (18%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L  +LG+G F  V +     +      VA K   +  D    ++   I+  L E    K 
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQRE---IEEFLSEAACMKD 92

Query: 348 LDHPRVVKLYDV----FEIDANSFCTVLEYCDGHDLDFYLKQHK------TIAEREARSI 397
             HP V++L  V              +L +    DL  YL   +       I  +     
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           ++ +   ++YL+      +H DL   N +L +        + DFGLSK +   +Y     
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTV---CVADFGLSKKIYSGDYYRQGR 207

Query: 458 MDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
           +            +P      E           +SK DVW+ GV  ++    G  P+
Sbjct: 208 IAK----------MPVKWIAIESLADR----VYTSKSDVWAFGVTMWEIATRGMTPY 250

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 43/237 (18%)

Query: 291 LLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           +   LG+G F  V++      +K++      +  +N+     ++  +    L E ++ K 
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF----LNEASVMKE 84

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR----------SI 397
            +   VV+L  V          ++E     DL  YL+  +                   +
Sbjct: 85  FNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 398 VMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHG 457
             ++   + YLN  K   +H DL   N ++ E       KI DFG+++ + E +Y    G
Sbjct: 144 AGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV---KIGDFGMTRDIYETDYYRKGG 198

Query: 458 MDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             L          LP     PE    G      ++  DVWS GV+ ++     ++P+
Sbjct: 199 KGL----------LPVRWMSPESLKDG----VFTTYSDVWSFGVVLWEIATLAEQPY 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (258), Expect = 1e-23
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 35/222 (15%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHA-LREYNIHKALD 349
           LL  +GKG F +V    D +  + VA K            K +    A L E ++   L 
Sbjct: 197 LLQTIGKGEFGDVMLG-DYRGNK-VAVKCI----------KNDATAQAFLAEASVMTQLR 244

Query: 350 HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKY 407
           H  +V+L  V   +      V EY     L  YL+      +         + V  A++Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 408 LNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT 467
           L       +H DL   N+L++E NV    K++DFGL+K    E  +      L  +    
Sbjct: 305 LEGNN--FVHRDLAARNVLVSEDNVA---KVSDFGLTK----EASSTQDTGKLPVK---- 351

Query: 468 YWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            W   PE         K S+K DVWS G++ ++   +G+ P+
Sbjct: 352 -WT-APEALREK----KFSTKSDVWSFGILLWEIYSFGRVPY 387

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (252), Expect = 2e-23
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 49/242 (20%)

Query: 291 LLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           L   LG+G F +V  A        +++  VA K   L K+  E  + ++     RE  + 
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK--AL-KEASESARQDF----QREAELL 97

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR---------- 395
             L H  +V+ + V   +      V EY    DL+ +L+ H   A+  A           
Sbjct: 98  TMLQHQHIVRFFGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 396 -----SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
                ++  QV + + YL  +    +H DL   N L+ +G V    KI DFG+S+ +   
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVV---KIGDFGMSRDIYST 211

Query: 451 NYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKK 506
           +Y           G       W +PPE  +      K +++ DVWS GV+ ++   YGK+
Sbjct: 212 DY-------YRVGGRTMLPIRW-MPPESILYR----KFTTESDVWSFGVVLWEIFTYGKQ 259

Query: 507 PF 508
           P+
Sbjct: 260 PW 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 65/243 (26%), Positives = 96/243 (39%), Gaps = 50/243 (20%)

Query: 291 LLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           L   LG+G F +V  A        K++  VA K   L KD     + ++     RE  + 
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--AL-KDPTLAARKDF----QREAELL 71

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR---------- 395
             L H  +VK Y V   D +    V EY    DL+ +L+ H   A               
Sbjct: 72  TNLQHEHIVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 396 ------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE 449
                  I  Q+ S + YL       +H DL   N L+    +    KI DFG+S+ +  
Sbjct: 131 GLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLV---KIGDFGMSRDVYS 185

Query: 450 ENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGK 505
            +Y           G       W +PPE  +      K +++ DVWS GVI ++   YGK
Sbjct: 186 TDYY-------RVGGHTMLPIRW-MPPESIMYR----KFTTESDVWSFGVILWEIFTYGK 233

Query: 506 KPF 508
           +P+
Sbjct: 234 QPW 236

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 47/239 (19%)

Query: 291 LLMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           L+  LG G F EV++       +      VA K   L +   E  + ++    L E  I 
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDF----LMEALII 87

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR-------SIV 398
              +H  +V+   V  + +     ++E   G DL  +L++ +    + +         + 
Sbjct: 88  SKFNHQNIVRCIGVS-LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLT---EGNVCGEIKITDFGLSKVMDEENYNPD 455
             +    +YL E     IH D+   N LLT    G V    KI DFG+++ +   +Y   
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA---KIGDFGMARDIYRASYYRK 201

Query: 456 HGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
            G  +          LP     PE F+ G      +SK D WS GV+ ++    G  P+
Sbjct: 202 GGCAM----------LPVKWMPPEAFMEG----IFTSKTDTWSFGVLLWEIFSLGYMPY 246

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 97.3 bits (242), Expect = 7e-22
 Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 88/291 (30%)

Query: 282 HPV-----LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIK 336
           H V      + RY ++  LG G FS V  ++D++ +++VA KV +  +        +Y +
Sbjct: 27  HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--------HYTE 78

Query: 337 HALREYNIHKAL-----DHP---RVVKLYDVFEIDANS---FCTVLEYCDGHDLDFYLKQ 385
            AL E  + K++     + P    VV+L D F+I   +    C V E   GH L  ++ +
Sbjct: 79  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK 137

Query: 386 --HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV----------- 432
             ++ +     + I+ QV+  L YL+  K  +IH D+KP NILL+               
Sbjct: 138 SNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196

Query: 433 -----------------------------------CGEIKITDFGLSKVMDEENYNPDHG 457
                                                ++KI D G +  + +        
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ- 255

Query: 458 MDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
                    T  Y   E  V+  +    ++  D+WS   + ++   G   F
Sbjct: 256 ---------TRQYRSLE--VLIGSG--YNTPADIWSTACMAFELATGDYLF 293

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 43/237 (18%)

Query: 291 LLMLLGKGGFSEVHKA---FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
           L+  LG G F EV++        +   +   V  L +   E  + ++    L E  I   
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISK 130

Query: 348 LDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR-------SIVMQ 400
            +H  +V+   V  + +     +LE   G DL  +L++ +    + +         +   
Sbjct: 131 FNHQNIVRCIGVS-LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLT---EGNVCGEIKITDFGLSKVMDEENYNPDHG 457
           +    +YL E     IH D+   N LLT    G V    KI DFG+++ +    Y    G
Sbjct: 190 IACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA---KIGDFGMARDIYRAGYYRKGG 244

Query: 458 MDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPF 508
             +          LP     PE F+ G      +SK D WS GV+ ++    G  P+
Sbjct: 245 CAM----------LPVKWMPPEAFMEG----IFTSKTDTWSFGVLLWEIFSLGYMPY 287

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 61/253 (24%)

Query: 291 LLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            +  +G+G F  V +A        +    VA K   L ++   D +A++     RE  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADF----QREAALM 104

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR---------- 395
              D+P +VKL  V        C + EY    DL+ +L+                     
Sbjct: 105 AEFDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 396 --------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF 441
                          I  QV + + YL+E K   +H DL   N L+ E  V    KI DF
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVV---KIADF 218

Query: 442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGV 496
           GLS+ +   +Y    G D           +P     PE         + +++ DVW+ GV
Sbjct: 219 GLSRNIYSADYYKADGNDA----------IPIRWMPPESIFYN----RYTTESDVWAYGV 264

Query: 497 IFYQCL-YGKKPF 508
           + ++   YG +P+
Sbjct: 265 VLWEIFSYGLQPY 277

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 59/250 (23%), Positives = 87/250 (34%), Gaps = 53/250 (21%)

Query: 287 DRYLLLMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           DR  L   LG+G F +V +A           R VA K   L +     +        + E
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRAL----MSE 80

Query: 342 YNIHKALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR----- 395
             I   +  H  VV L             ++E+C   +L  YL+  +             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140

Query: 396 -----------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS 444
                          QV   +++L   K   IH DL   NILL+E NV    KI DFGL+
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVV---KICDFGLA 195

Query: 445 KVMDEENYNPDHGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFY 499
           + + ++      G             LP     PE           + + DVWS GV+ +
Sbjct: 196 RDIYKDPDYVRKGDAR----------LPLKWMAPETIFDR----VYTIQSDVWSFGVLLW 241

Query: 500 Q-CLYGKKPF 508
           +    G  P+
Sbjct: 242 EIFSLGASPY 251

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 30/222 (13%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV 353
           +LG+GGF +V+K   L +   VA K  +L    KE++          E  +     H  +
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVK--RL----KEERTQGGELQFQTEVEMISMAVHRNL 89

Query: 354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA------RSIVMQVVSALKY 407
           ++L   F +       V  Y     +   L   +    +        + I +     L Y
Sbjct: 90  LRLRG-FCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAY 146

Query: 408 L-NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           L +   P +IH D+K  NILL E     E  + DFGL+K+MD ++    H   +T+   G
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEF---EAVVGDFGLAKLMDYKD---TH---VTTAVRG 197

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
           T  ++ PE    G    K S K DV+  GV+  + + G++ F
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQRAF 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 60/239 (25%), Positives = 89/239 (37%), Gaps = 55/239 (23%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-------FDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
           D+  L   LG+G F +V  A          KE   VA K   L  D  E   ++     +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDL----V 88

Query: 340 REYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR--- 395
            E  + K +  H  ++ L      D      ++EY    +L  YL+  +      +    
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 396 -------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                        S   Q+   ++YL   K   IH DL   N+L+TE NV    KI DFG
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVM---KIADFG 202

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGV 496
           L++ ++  +Y        T+ G      LP     PE           + + DVWS GV
Sbjct: 203 LARDINNIDY-----YKKTTNGR-----LPVKWMAPEALFDR----VYTHQSDVWSFGV 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 59/248 (23%), Positives = 90/248 (36%), Gaps = 56/248 (22%)

Query: 291 LLMLLGKGGFSEVHKA-------FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           L   LG+G F +V  A          KE   VA K   L  D  E   ++     + E  
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDL----VSEME 138

Query: 344 IHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR------- 395
           + K +  H  ++ L      D      ++EY    +L  YL+  +      +        
Sbjct: 139 MMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 396 ---------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV 446
                    S   Q+   ++YL   K   IH DL   N+L+TE NV    KI DFGL++ 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVM---KIADFGLARD 252

Query: 447 MDEENYNPDHGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISSKVDVWSVGVIFYQ- 500
           ++  +Y                  LP     PE           + + DVWS GV+ ++ 
Sbjct: 253 INNIDYYKKTTNGR----------LPVKWMAPEALFDR----VYTHQSDVWSFGVLMWEI 298

Query: 501 CLYGKKPF 508
              G  P+
Sbjct: 299 FTLGGSPY 306

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 71/262 (27%)

Query: 287 DRYLLLMLLGKGGFSEVHKAF---DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
              +L   LG+G F +V KA          Y    V  L ++    +  +     L E+N
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFN 78

Query: 344 IHKALDHPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHKTIAEREAR- 395
           + K ++HP V+KLY          C+       ++EY     L  +L++ + +       
Sbjct: 79  VLKQVNHPHVIKLYGA--------CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130

Query: 396 -----------------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV 432
                                  S   Q+   ++YL E+K  ++H DL   NIL+ EG  
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRK 188

Query: 433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLP-----PECFVVGKNPPKISS 487
               KI+DFGLS+ + EE+          SQG      +P      E           ++
Sbjct: 189 M---KISDFGLSRDVYEEDS-----YVKRSQGR-----IPVKWMAIESLFDH----IYTT 231

Query: 488 KVDVWSVGVIFYQCL-YGKKPF 508
           + DVWS GV+ ++ +  G  P+
Sbjct: 232 QSDVWSFGVLLWEIVTLGGNPY 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 59/241 (24%), Positives = 87/241 (36%), Gaps = 63/241 (26%)

Query: 287 DRYLLLMLLGKGGFSEVHKA--FDLKEQRY---VACKVHQLNKDWKEDKKANYIKHALRE 341
           +       LG G F +V +A  F L ++     VA K   L      D+K       + E
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEAL----MSE 99

Query: 342 YNIHKALD-HPRVVKLYDVFEIDANSFCT-------VLEYCDGHDLDFYLKQHKTIAERE 393
             I   L  H  +V L           CT       + EYC   DL  +L++   + E +
Sbjct: 100 LKIMSHLGQHENIVNLLGA--------CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151

Query: 394 AR--------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT 439
                               QV   + +L       IH D+   N+LLT G+V    KI 
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA---KIG 206

Query: 440 DFGLS-KVMDEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVG 495
           DFGL+  +M++ NY          +G       W + PE           + + DVWS G
Sbjct: 207 DFGLARDIMNDSNY--------IVKGNARLPVKW-MAPESIFDC----VYTVQSDVWSYG 253

Query: 496 V 496
           +
Sbjct: 254 I 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 53/254 (20%), Positives = 93/254 (36%), Gaps = 50/254 (19%)

Query: 268 LKRIHNEDQSRFNNHPVLS-----DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQL 322
           +K+ H+    + N  P +      +      ++G+G F +V KA   K+   +   + ++
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 323 NKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF 381
            +   +D   ++      E  +   L  HP ++ L    E         +EY    +L  
Sbjct: 61  KEYASKDDHRDF----AGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLD 115

Query: 382 YLKQHKTIAEREAR----------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
           +L++ + +    A                      V   + YL++ +   IH DL   NI
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173

Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNP 482
           L+ E  V    KI DFGLS+   +E Y          +  G     W +  E        
Sbjct: 174 LVGENYVA---KIADFGLSR--GQEVY--------VKKTMGRLPVRW-MAIESLNYS--- 216

Query: 483 PKISSKVDVWSVGV 496
              ++  DVWS GV
Sbjct: 217 -VYTTNSDVWSYGV 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.5 bits (215), Expect = 9e-19
 Identities = 56/250 (22%), Positives = 84/250 (33%), Gaps = 54/250 (21%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           +R      LG G F +V +A             VA K   L       ++       + E
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREAL----MSE 76

Query: 342 YNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR----- 395
             +   L +H  +V L     I       + EYC   DL  +L++ +             
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 396 -------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                        S   QV   + +L       IH DL   NILLT G +    KI DFG
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT---KICDFG 190

Query: 443 LS-KVMDEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIF 498
           L+  + ++ NY          +G       W + PE           + + DVWS G+  
Sbjct: 191 LARDIKNDSNY--------VVKGNARLPVKW-MAPESIFNC----VYTFESDVWSYGIFL 237

Query: 499 YQ-CLYGKKP 507
           ++    G  P
Sbjct: 238 WELFSLGSSP 247

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 65/302 (21%), Positives = 93/302 (30%), Gaps = 61/302 (20%)

Query: 231 HIRELKR--IHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRIHNEDQSRFNNHPVLS-- 286
           H        I   +   FN        +   Y       L              P     
Sbjct: 5   HHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRW 64

Query: 287 ----DRYLLLMLLGKGGFSEVHKA-------FDLKEQRYVACKVHQLNKDWKEDKKANYI 335
               DR +L   LG+G F +V  A               VA K   L  D  E   ++  
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATEKDLSDL- 121

Query: 336 KHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREA 394
              + E  + K +  H  ++ L      D      ++EY    +L  YL+  +      +
Sbjct: 122 ---ISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYS 177

Query: 395 R----------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI 438
                            S   QV   ++YL   K   IH DL   N+L+TE NV    KI
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVM---KI 232

Query: 439 TDFGLS-KVMDEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSV 494
            DFGL+  +   + Y             G     W + PE           + + DVWS 
Sbjct: 233 ADFGLARDIHHIDYY--------KKTTNGRLPVKW-MAPEALFDR----IYTHQSDVWSF 279

Query: 495 GV 496
           GV
Sbjct: 280 GV 281

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 58/246 (23%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACK---------VHQLNKDWKEDKKANYIKHALREYNI 344
            +G+GGF  V+K + +     VA K           +L + +             +E  +
Sbjct: 38  KMGEGGFGVVYKGY-VNNTT-VAVKKLAAMVDITTEELKQQF------------DQEIKV 83

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-----------IAERE 393
                H  +V+L   F  D +  C V  Y     L   L                IA+  
Sbjct: 84  MAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYN 453
           A          + +L+E     IH D+K  NILL E       KI+DFGL++  ++    
Sbjct: 143 AN--------GINFLHE--NHHIHRDIKSANILLDEAF---TAKISDFGLARASEKFAQT 189

Query: 454 PDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
                 +TS+  GT  Y+ PE  + G+    I+ K D++S GV+  + + G      ++ 
Sbjct: 190 --V---MTSRIVGTTAYMAPEA-LRGE----ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 514 QATILE 519
              +L+
Sbjct: 240 PQLLLD 245

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 61/391 (15%), Positives = 117/391 (29%), Gaps = 124/391 (31%)

Query: 269 KRIHNEDQSRFNN-------------HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYV 315
              H+  +                    +L++ +L++  +G G F  V     +  ++Y 
Sbjct: 4   HHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYY 63

Query: 316 ACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-----DHPRVVKLYDVFEIDANSFCTV 370
           A KV + N          Y + A  E +I K +     ++  +VK +  F    +  C +
Sbjct: 64  AVKVVR-NIK-------KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHMCLI 114

Query: 371 LEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT 428
            E       +  + ++        + +   ++++ AL YL ++   + H DLKP NILL 
Sbjct: 115 FEPLGPSLYEI-ITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLD 171

Query: 429 EGNVCG----------------------EIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           +                            IK+ DFG       + +              
Sbjct: 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATFKSDYHG------------- 217

Query: 467 TY----WYLPPECFVV---GKNPPKISSKVDVWSVGVIFYQCLY---------------- 503
           +      Y  PE  V+   G +        D+WS G +  + LY                
Sbjct: 218 SIINTRQYRAPE--VILNLGWDVS-----SDMWSFGCVLAE-LYTGSLLFRTHEHMEHLA 269

Query: 504 ------GKKP---------------FGHNQSQATILEENTILKATEVQFANKPTVS---- 538
                    P                  ++ +    E  + + + +      P       
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329

Query: 539 NEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
                F+ S L      R     L +H +L+
Sbjct: 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 73/375 (19%), Positives = 123/375 (32%), Gaps = 101/375 (26%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIK 336
                  L +RY ++  LG+G F +V +  D    +  VA K+ + N          Y +
Sbjct: 10  VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVG-------KYRE 61

Query: 337 HALREYNIHKAL------DHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKT- 388
            A  E N+ K +      +    V + D F       C   E   G +  +F LK++   
Sbjct: 62  AARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-GHMCIAFELL-GKNTFEF-LKENNFQ 118

Query: 389 -IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG------------- 434
                  R +  Q+  AL++L+E +  + H DLKP NIL                     
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 435 ---EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY----WYLPPE-CFVVGKNPPKIS 486
               I++ DFG S   D E++              T      Y PPE    +G   P   
Sbjct: 177 KNTSIRVADFG-SATFDHEHHT-------------TIVATRHYRPPEVILELGWAQP--- 219

Query: 487 SKVDVWSVGVIFYQCLYGKKPF-GHNQSQ--ATILE------ENTILKATEVQF-----A 532
              DVWS+G I ++   G   F  H   +    + +       + I +  + ++      
Sbjct: 220 --CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGL 277

Query: 533 NKPTVSNEAK------------------------GFIRSCLAYRKEDRIDVISLARHDYL 568
                S++ +                          +R  L +    RI +     H + 
Sbjct: 278 VWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

Query: 569 QPPVPKHGRQSASSS 583
               P+      S +
Sbjct: 338 AGLTPEERSFHTSRN 352

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 53/243 (21%), Positives = 80/243 (32%), Gaps = 58/243 (23%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           +      +LG G F +V  A             VA K   L +     ++       + E
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSEREAL----MSE 98

Query: 342 YNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREAR----- 395
             +   L  H  +V L     +       + EYC   DL  YL+  +     +       
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 396 ------------------SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
                                 QV   +++L       +H DL   N+L+T G V    K
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVV---K 212

Query: 438 ITDFGLS-KVMDEENYNPDHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWS 493
           I DFGL+  +M + NY          +G       W + PE    G      + K DVWS
Sbjct: 213 ICDFGLARDIMSDSNY--------VVRGNARLPVKW-MAPESLFEG----IYTIKSDVWS 259

Query: 494 VGV 496
            G+
Sbjct: 260 YGI 262

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 67/266 (25%), Positives = 105/266 (39%), Gaps = 64/266 (24%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIK 336
              +  VLS RY ++  LG+G F +V +  D K   R+VA K+       K   +  Y +
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKI------VKNVDR--YCE 56

Query: 337 HALREYNIHKAL------DHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKT- 388
            A  E  + + L         R V++ + FE      C V E   G    DF +K++   
Sbjct: 57  AARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-HHGHICIVFELL-GLSTYDF-IKENGFL 113

Query: 389 -IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG------------- 434
                  R +  Q+  ++ +L+  K  + H DLKP NIL  + +                
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171

Query: 435 ---EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTY----WYLPPE-CFVVGKNPPKIS 486
              +IK+ DFG S   D+E+++             T      Y  PE    +G + P   
Sbjct: 172 INPDIKVVDFG-SATYDDEHHS-------------TLVSTRHYRAPEVILALGWSQP--- 214

Query: 487 SKVDVWSVGVIFYQCLYGKKPF-GHN 511
              DVWS+G I  +   G   F  H+
Sbjct: 215 --CDVWSIGCILIEYYLGFTVFPTHD 238

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 53/238 (22%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKV-----HQLNKDWKEDKKANYIKHALREYNIHKAL 348
           L+G G F +V+K   L++   VA K       Q  +++              E       
Sbjct: 46  LIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF------------ETEIETLSFC 92

Query: 349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL------------KQHKTIAEREARS 396
            HP +V L   F  + N    + +Y +  +L  +L            +Q   I    AR 
Sbjct: 93  RHPHLVSLIG-FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR- 150

Query: 397 IVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH 456
                   L YL+     +IH D+K  NILL E  V    KITDFG+SK   E   +  H
Sbjct: 151 -------GLHYLHT--RAIIHRDVKSINILLDENFVP---KITDFGISKKGTEL--DQTH 196

Query: 457 GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ 514
              L++   GT  Y+ PE F+ G    +++ K DV+S GV+ ++ L  +     +  +
Sbjct: 197 ---LSTVVKGTLGYIDPEYFIKG----RLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 76.1 bits (186), Expect = 4e-15
 Identities = 39/239 (16%), Positives = 68/239 (28%), Gaps = 56/239 (23%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV-HQLNKDWKEDKKANYIKHALREYNI 344
           +++      +G+G F EV +     +   VA K+      D          +  L E  I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 345 HKAL---------DHPRVVKLYDVF-----------------------------EIDANS 366
            K L              + L  V                                  + 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 367 FCTVLEYCD-GHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI 425
              VLE+   G DL+    +  +     A+SI+ Q+ ++L    E      H DL  GN+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSS--LATAKSILHQLTASLAVA-EASLRFEHRDLHWGNV 193

Query: 426 LLTEGNVCGEIKITDFGLSKVMDEENYN-----PDHGMDLTSQGAGTY---WYLPPECF 476
           LL +       K+      K     +        D+ +    +          +  + F
Sbjct: 194 LLKK---TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 15/161 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +RY L   +G G F +++   D+     VA K         E  K  +      E  I+K
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--------LECVKTKH-PQLHIESKIYK 59

Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
            +     +  +      + +    V+E   G  L D +    +  + +    +  Q++S 
Sbjct: 60  MMQGGVGIPTIRW-CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISR 117

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
           ++Y++      IH D+KP N L+  G     + I DFGL+K
Sbjct: 118 IEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 5e-11
 Identities = 60/339 (17%), Positives = 99/339 (29%), Gaps = 87/339 (25%)

Query: 170 TSTLHNGTDSATFLKPEPLPGMSSQEYYEADEILKLRQSALKKEDADLQLEMEKLERERN 229
           T+     TD  +      +           DE+  L    L     DL  E+       N
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----N 326

Query: 230 -LH---IRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRELKRI---------HNEDQ 276
                 I E  R   +  + ++N           +K+++  +L  I           E +
Sbjct: 327 PRRLSIIAESIR---DGLATWDN-----------WKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 277 SRFNNHPVLSD-----RYLLLMLLGKGGFSEV-------HKAFDLKEQR-YVACKVHQLN 323
             F+   V          LL ++      S+V       HK   +++Q       +  + 
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 324 KDWKEDKKANYIKHA--LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGH---- 377
            + K   +  Y  H   +  YNI K  D   ++  Y     D   F + + +   H    
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL----D-QYFYSHIGH---HLKNI 484

Query: 378 --------------DLDFYLKQ---HKTIAEREARSIVMQVVSALK-YLNEIKPPVIHYD 419
                         D  F L+Q   H + A   A   ++  +  LK Y   I      Y+
Sbjct: 485 EHPERMTLFRMVFLDFRF-LEQKIRHDSTA-WNASGSILNTLQQLKFYKPYICDNDPKYE 542

Query: 420 LKPGNI---LLTEGNVCGEIKITD---FGLSKVMDEENY 452
                I   L          K TD     L   M E+  
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLRIAL---MAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 1e-09
 Identities = 30/242 (12%), Positives = 71/242 (29%), Gaps = 60/242 (24%)

Query: 180 ATFLKPEPLPGM------SSQEYYEADEILKL--RQSALKKEDADLQLEMEKLERERNLH 231
           + F     +P +            +   ++    + S ++K+  +  + +  +  E  + 
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438

Query: 232 IRELKRIH-------NEDQSRFNNH--PVLSDSYL---IGYKNLHIRELKRIHNEDQSRF 279
           +     +H       N  ++  ++   P   D Y    IG+   H++ ++          
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH---HLKNIEH--------- 486

Query: 280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL 339
                  +R  L        F  V    D    R++  K+   +  W            L
Sbjct: 487 ------PERMTL--------FRMVF--LDF---RFLEQKIRHDSTAWNASGSILNTLQQL 527

Query: 340 REYNIHKALDHP---RVVKLYDVFEIDANSFCTVLEYCD------GHDLDFYLKQHKTIA 390
           + Y  +   + P   R+V     F           +Y D        + +   ++     
Sbjct: 528 KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587

Query: 391 ER 392
           +R
Sbjct: 588 QR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 3e-09
 Identities = 63/405 (15%), Positives = 124/405 (30%), Gaps = 109/405 (26%)

Query: 208 SALKKEDADLQLEMEKLERERNLHIRELKRIHNEDQSRFNNHPVLSDSYLIGYKNLHIRE 267
           S +K E     +       +R+       R++N++Q  F  + V         +     +
Sbjct: 96  SPIKTEQRQPSMMTRMYIEQRD-------RLYNDNQ-VFAKYNV--------SRLQPYLK 139

Query: 268 LKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGF------SEVHKAFDLKEQRYVACKVHQ 321
           L++   E +           + +L+   G  G        +V      K Q  +  K+  
Sbjct: 140 LRQALLELR---------PAKNVLID--GVLGSGKTWVALDV--CLSYKVQCKMDFKIF- 185

Query: 322 LNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDF 381
               W        +   L+  N  + +    + KL   ++ID N       +    D   
Sbjct: 186 ----W--------LN--LKNCNSPETVLEM-LQKLL--YQIDPN-------WTSRSDHSS 221

Query: 382 YLKQHKTIAEREARSIVM--QVVSALKYLNEIKPPVI--HYDL--KPGNILLTEGNVCGE 435
            +K      + E R ++      + L  L  ++       ++L  K   ILLT       
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK---ILLTTRF---- 274

Query: 436 IKITDFG-------LSKVMDEENYNPDHGMDLTSQGAGT-YWYLPPECFVVGKNPPKIS- 486
            ++TDF        +S         PD    L  +        LP E  V+  NP ++S 
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE--VLTTNPRRLSI 332

Query: 487 ---------------SKVDVWSVGVIFYQCLYGKKPFGHNQ--SQATILEENT-I-LKAT 527
                            V+   +  I    L   +P  + +   + ++   +  I     
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392

Query: 528 EVQFANKPT--VSNEAKGFIRSCLAYRKEDRIDVISLARHD-YLQ 569
            + + +     V        +  L  ++      IS+     YL+
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE-STISI--PSIYLE 434

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 3e-07
 Identities = 39/280 (13%), Positives = 83/280 (29%), Gaps = 56/280 (20%)

Query: 304 HKAFDLKEQRYVACK--VHQLNKDWKEDKKANYIKHALREYNIHKALDH-----PRVVKL 356
           H  F+  E +Y   K  +      + ++     ++   +     + +DH       V   
Sbjct: 6   HMDFETGEHQY-QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 357 YDVFEI----DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK 412
             +F              +E     +  F +   KT  E+   S++ +      Y+ +  
Sbjct: 65  LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT--EQRQPSMMTR-----MYIEQRD 117

Query: 413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD---HGMDLTSQGAGTYW 469
                  L   N +  + NV          L + + E     +    G+     G+G  W
Sbjct: 118 R------LYNDNQVFAKYNVSRLQPYLK--LRQALLELRPAKNVLIDGV----LGSGKTW 165

Query: 470 YLPPE-CF---VVGKNPPKISSKVDVW-SVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            +  + C    V  K   KI      W ++      C   +      Q     ++ N   
Sbjct: 166 -VALDVCLSYKVQCKMDFKIF-----WLNLK----NCNSPETVLEMLQKLLYQIDPN--W 213

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDR---I--DV 559
            +     +N     +  +  +R  L  +  +    +  +V
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV 253

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 34/168 (20%), Positives = 67/168 (39%), Gaps = 27/168 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             Y +   +G+G F  + +  +L   + VA K         E ++++       EY  +K
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--------FEPRRSDA-PQLRDEYRTYK 60

Query: 347 ALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVM 399
            L     +  +Y  F  +      V++   G  L+  L         KT+A         
Sbjct: 61  LLAGCTGIPNVYY-FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVA-----MAAK 113

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILL--TEGNVCGEIKITDFGLSK 445
           Q+++ ++ ++E    +++ D+KP N L+          I + DFG+ K
Sbjct: 114 QMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 27/167 (16%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA 347
            + +   +G G F E+    +L    YVA K+        E  K+        EY  +K 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRA-PQLHLEYRFYKQ 60

Query: 348 LDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVMQ 400
           L     + ++Y  F         VLE   G  L+            KT+       I +Q
Sbjct: 61  LGSGDGIPQVYY-FGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVL-----MIAIQ 113

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE--IKITDFGLSK 445
           ++S ++Y++     +I+ D+KP N L+       +  I I DF L+K
Sbjct: 114 LISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 34/117 (29%), Positives = 50/117 (42%), Gaps = 23/117 (19%)

Query: 396 SIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK-VMDEENYNP 454
               QV   +++L   K   IH DL   NILL+E NV    KI DFGL++ +  + +Y  
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVV---KICDFGLARDIYKDPDY-- 249

Query: 455 DHGMDLTSQGAGTY---WYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ-CLYGKKP 507
                   +G       W + PE           + + DVWS GV+ ++    G  P
Sbjct: 250 ------VRKGDARLPLKW-MAPETIFDR----VYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 38/179 (21%), Positives = 60/179 (33%), Gaps = 9/179 (5%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A D       A       K  KE    +  +  + E  I  
Sbjct: 22  DRLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 80

Query: 347 ALD-HPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
            +  H  VV L             ++E+C   +L  YL+  +       ++   +     
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTKGARFRQGK 139

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG-LSKVMDEENYNPDHGMDLTSQ 463
            Y+       I  DLK     +T           +   LS V +EE     +   LT +
Sbjct: 140 DYVGA-----IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLE 193

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 33/161 (20%), Positives = 73/161 (45%), Gaps = 15/161 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +++ L   +G G F E++   +++    VA K         E+ K  +    L E  I++
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKTKH-PQLLYESKIYR 57

Query: 347 AL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
            L     +  +   F ++ +    V++   G  L D +    + ++ +    +  Q+++ 
Sbjct: 58  ILQGGTGIPNVRW-FGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
           +++++      +H D+KP N L+  G    ++ I DFGL+K
Sbjct: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 24/173 (13%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI--- 344
           +++L   +G GGF  ++ AF   +    A  V ++     E ++   +   L+ Y     
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVAK 92

Query: 345 ---------HKALDHPRVVKLYD--VFEIDANSF-CTVLEYCDGHDLDFYLKQHKTIAER 392
                     K LD+  +   Y   + E    S+   V+E   G DL     Q+ T  + 
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151

Query: 393 EARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
               + ++++  L+Y++E +   +H D+K  N+LL   N   ++ + D+GLS 
Sbjct: 152 TVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN-PDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 20/188 (10%), Positives = 64/188 (34%), Gaps = 39/188 (20%)

Query: 284 VLSD----RYLLLMLLGKGGFSEVHKAFDL--------KEQRYVACKV-HQLNKDWKEDK 330
           VL+D    ++ L     +     +++A            +++  + K+  +  + + E  
Sbjct: 35  VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN 94

Query: 331 --KANYIKHALREYNIHKALDHPRVVKLYD-----------VFEIDANSFCTVLEYCDGH 377
             +       + ++    +     +                V      S  + L+    H
Sbjct: 95  FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH 154

Query: 378 DLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
            L       +++       +  +++ AL++L+E +   +H ++   NI +   +   ++ 
Sbjct: 155 VLSE-----RSVL-----QVACRLLDALEFLHENE--YVHGNVTAENIFVDPED-QSQVT 201

Query: 438 ITDFGLSK 445
           +  +G + 
Sbjct: 202 LAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 32/172 (18%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 288 RYLLLMLLGKGGFSEVHKAFDLKEQ-----RYVACKVH-----QLNKDWKEDKKANYIKH 337
            + + + +G+GGF  ++ A     +          KV       L  + K  ++A     
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK-PE 94

Query: 338 ALREYNIHKALDHPRVVKLYD--VFEIDANSF-CTVLEYCDGHDL-DFYLKQHKTIAERE 393
            ++++   + L +  V K +   + + +  S+   +++   G DL   Y    K  + + 
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKT 153

Query: 394 ARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
              + ++++  L+Y++E +   +H D+K  N+LL   N   ++ + D+GL+ 
Sbjct: 154 VLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKN-PDQVYLVDYGLAY 202

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 31/181 (17%), Positives = 62/181 (34%), Gaps = 33/181 (18%)

Query: 285 LSDRYLLLML---LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH---- 337
           L     +  +   +G+G  S V   +  ++      K H++     +  K          
Sbjct: 85  LVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143

Query: 338 -------ALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIA 390
                  A  E+   + L    V K+Y            ++E  D  +L     + +   
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAW-----EGNAVLMELIDAKEL----YRVRVEN 194

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
             E   ++++ V+   +       ++H DL   N+L++E  +     I DF  S  + EE
Sbjct: 195 PDEVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEEGIW----IIDFPQSVEVGEE 245

Query: 451 N 451
            
Sbjct: 246 G 246

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 21/113 (18%), Positives = 31/113 (27%), Gaps = 24/113 (21%)

Query: 376 GHDLDFYLKQHKTIAER----------EARSIVMQVVSALKYLNEIKPP----VIHYDLK 421
            + LD  L +   +             E  +          +L   KP       H DL 
Sbjct: 132 TNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191

Query: 422 PGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPE 474
             NI + +G V G     D G S   D+         D+          +  E
Sbjct: 192 DSNIFVKDGKVSG---FIDLGRSGRADKW-------YDIAFCVRSIREDIGEE 234

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 21/102 (20%), Positives = 44/102 (43%), Gaps = 18/102 (17%)

Query: 359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHY 418
           +F++D ++   ++ Y +G      ++ +  IA +    +         + N++    IH 
Sbjct: 406 IFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIV------GKLHKNDV----IHN 455

Query: 419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           DL   N +        ++ I DFGL K+ + +    D  +DL
Sbjct: 456 DLTTSNFIFD-----KDLYIIDFGLGKISNLDE---DKAVDL 489

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	627
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.23
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.5
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.34
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.08
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.99
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.95
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.87
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.74
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.73
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.7
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.24
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.62
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.78

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7e-60  Score=499.68  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=222.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|+++++||+|+||+||+|.++.+++.||||++.......       .+.+.+|+.+|+.++|||||+++++|. +.+
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~  144 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------RELLFNEVVIMRDYQHENVVEMYNSYL-VGD  144 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-------GGGGHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-------HHHHHHHHHHHHhCCCCCCCcEEEEEE-ECC
Confidence            357999999999999999999999999999999987543321       235788999999999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+||+|.+++.. ..+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~---g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD---GRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC---CCEEEecCcCce
Confidence            88999999999999998875 57999999999999999999999998  9999999999999987   699999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       ....+.+||+.|||||++.    ...|+.++||||||||||||++|++||........+.   .+..
T Consensus       219 ~~~~~~-------~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~  284 (346)
T 4fih_A          219 QVSKEV-------PRRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD  284 (346)
T ss_dssp             ECCSSS-------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH
T ss_pred             ecCCCC-------CcccccccCcCcCCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHc
Confidence            875432       2345669999999999983    5568999999999999999999999998765544332   2222


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....++.+..+|+++++||.+||++||++|||+.|+|+||||+..
T Consensus       285 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          285 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            3334455667899999999999999999999999999999999753

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.9e-60  Score=493.28  Aligned_cols=260  Identities=30%  Similarity=0.455  Sum_probs=221.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|+++.+++.||||++......    .....+.+.+|+++|+.|+|||||+++++|+ +.+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCE
Confidence            5799999999999999999999999999999998643221    1223457889999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||+||+|.+++...+.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+.
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~---g~vKl~DFGla~~  181 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED---MHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---SCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC---CCEEEEEcCCcee
Confidence            9999999999999999999999999999999999999999999998  9999999999999887   6999999999998


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.....     .....+.+||+.|||||++.    +..|+.++||||||||||+|++|++||...+....+...   . .
T Consensus       182 ~~~~~~-----~~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~-~  248 (311)
T 4aw0_A          182 LSPESK-----QARANSFVGTAQYVSPELLT----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI---I-K  248 (311)
T ss_dssp             CCTTTT-----CCCBCCCCSCGGGCCHHHHH----HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-H
T ss_pred             cCCCCC-----cccccCcccCcccCCHHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-c
Confidence            754321     12345679999999999995    446899999999999999999999999876554433221   1 1


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH------HHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS------LARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~e------lL~hp~~~~~  571 (627)
                      ..+.+  +..+|+++++||.+||++||++|||+.|      +++||||+..
T Consensus       249 ~~~~~--p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          249 LEYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             TCCCC--CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCCCC--CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            22333  4579999999999999999999999987      5899999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.4e-60  Score=501.28  Aligned_cols=259  Identities=23%  Similarity=0.426  Sum_probs=215.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|+++.+++.||||++.......     .....+.+|+.+|+.|+|||||+++++|+ +.+.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~-~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-----KEREESRREVAVLANMKHPNIVQYRESFE-ENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-----HHHHHHHHHHHHHHHCCCCCCCcEEEEEE-ECCE
Confidence            78999999999999999999999999999999987654321     22467899999999999999999999998 6678


Q ss_pred             EEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +|||||||+||+|.+++...  ..+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~---g~vKl~DFGla  172 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD---GTVQLGDFGIA  172 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT---CCEEECSTTEE
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC---CCEEEcccccc
Confidence            89999999999999999754  35799999999999999999999998  9999999999999987   69999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +.+....       ......+||+.|||||++.    +..|+.++||||||||||||++|+.||...+....+...   .
T Consensus       173 ~~~~~~~-------~~~~~~~GT~~YmAPE~l~----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~  238 (350)
T 4b9d_A          173 RVLNSTV-------ELARACIGTPYYLSPEICE----NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---I  238 (350)
T ss_dssp             SCCCHHH-------HHHHHHHSCCTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H
T ss_pred             eeecCCc-------ccccccCCCccccCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H
Confidence            8765321       2344568999999999984    556999999999999999999999999877655443322   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ...  ..+.+..+|+++++||.+||++||.+|||+.|+|+||||....
T Consensus       239 ~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          239 SGS--FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             cCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            111  1234567999999999999999999999999999999997543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.9e-59  Score=482.39  Aligned_cols=261  Identities=27%  Similarity=0.419  Sum_probs=217.0

Q ss_pred             CCCe-eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         286 SDRY-LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       286 ~~rY-~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      .++| ++.++||+|+||+||+|.+..++..||||++.......     ...+.+.+|+.+++.|+|||||+++++|+.. 
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            3455 77889999999999999999999999999987543221     2246789999999999999999999998642 


Q ss_pred             --CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 --ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 --~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                        ...+|||||||+||+|.+++...+.+++..++.|+.||+.||.|||+++++||||||||+||||+..+  +.+||+||
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~--g~vKl~DF  176 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT--GSVKIGDL  176 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT--SCEEECCT
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC--CCEEEEeC
Confidence              35689999999999999999999999999999999999999999999887899999999999998533  68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+....         ....+.+||+.|||||++.    + .|+.++||||||||||||+||+.||........+....
T Consensus       177 Gla~~~~~---------~~~~~~~GTp~YmAPE~~~----~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i  242 (290)
T 3fpq_A          177 GLATLKRA---------SFAKAVIGTPEFMAPEMYE----E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV  242 (290)
T ss_dssp             TGGGGCCT---------TSBEESCSSCCCCCGGGGG----T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred             cCCEeCCC---------CccCCcccCccccCHHHcC----C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH
Confidence            99986432         2245569999999999883    2 48999999999999999999999997665554443321


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                        .. .......+..+++++++||.+||+.||++|||+.++|+||||+.
T Consensus       243 --~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          243 --TS-GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --TT-TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --Hc-CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence              11 11111223457899999999999999999999999999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.7e-59  Score=479.36  Aligned_cols=259  Identities=31%  Similarity=0.527  Sum_probs=205.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|.+..+++.||||++.......    ......+.+|+.+++.++|||||+++++|+ +.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK----SDMQGRIEREISYLRLLRHPHIIKLYDVIK-SKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCE
Confidence            68999999999999999999999999999999987543321    223456889999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +||||||| +|+|.+++...+.+++.+++.|+.||+.||+|||+++  ||||||||+||||+.+   +++||+|||+|+.
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~---~~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH---LNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT---CCEEECCSSCC--
T ss_pred             EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC---CCEEEeecCCCee
Confidence            99999999 5799999998899999999999999999999999998  9999999999999987   6999999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      .....        ...+.+||+.|||||++.   ...+++.++|||||||+||+|++|+.||...+....+. .  + ..
T Consensus       162 ~~~~~--------~~~~~~GT~~Y~APE~~~---~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~-~--i-~~  226 (275)
T 3hyh_A          162 MTDGN--------FLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-N--I-SN  226 (275)
T ss_dssp             ---------------------CTTSCHHHHS---SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-H--H-HH
T ss_pred             cCCCC--------ccCCeeECcccCChhhhc---CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH-H--H-Hc
Confidence            65432        234568999999999984   23345689999999999999999999997765443321 1  1 11


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ..  +..+..+|+++++||.+||++||++|||+.|+++||||+...|
T Consensus       227 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          227 GV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             CC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence            22  2334579999999999999999999999999999999976544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-58  Score=500.87  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=222.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|+++++||+|+||+||+|.++.+++.||||++.......       .+.+.+|+.+|+.|+|||||+++++|. +.+
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~  221 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------RELLFNEVVIMRDYQHENVVEMYNSYL-VGD  221 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-------GGGHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-------HHHHHHHHHHHHhCCCCCCCceEEEEE-ECC
Confidence            467999999999999999999999999999999997654321       235789999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+||+|.+++.. ..+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~---g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD---GRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT---CCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC---CCEEEecCccce
Confidence            88999999999999998865 57999999999999999999999998  9999999999999987   699999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       ....+.+||+.|||||++.    ...|+.++||||||||||||++|++||........+.   .+..
T Consensus       296 ~~~~~~-------~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~  361 (423)
T 4fie_A          296 QVSKEV-------PRRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRD  361 (423)
T ss_dssp             ECCSSC-------CCBCCCEECTTTCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH
T ss_pred             ECCCCC-------ccccccccCcCcCCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHc
Confidence            875432       2245569999999999983    5568999999999999999999999998766544432   2223


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....+..+..+|+++++||.+||++||++|||+.|||+||||+..
T Consensus       362 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          362 NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            3334556667899999999999999999999999999999999753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-58  Score=479.56  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=211.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .++|++++.||+|+||+||+|.+.   .+++.||||++.........     ...+.+|+.+|+.++|||||+++++|+ 
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~-   96 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----RVRTKMERDILVEVNHPFIVKLHYAFQ-   96 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----CC------CCCCCCCCTTEECEEEEEE-
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----HHHHHHHHHHHHHCCCCCCCeEEEEEE-
Confidence            468999999999999999999875   46889999998654322111     124778999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|||||||+||+|.+++...+.+++.+++.|+.||+.||.|||+++  ||||||||+|||++.+   +++||+|||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~---g~vKl~DFG  171 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE---GHIKLTDFG  171 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT---SCEEEESSE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC---CCEEecccc
Confidence            56788999999999999999999999999999999999999999999998  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+......       ....+.+||+.|||||++.    ...|+.++||||||||||||++|+.||...+....+...  
T Consensus       172 la~~~~~~~-------~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--  238 (304)
T 3ubd_A          172 LSKESIDHE-------KKAYSFCGTVEYMAPEVVN----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--  238 (304)
T ss_dssp             EEEC------------CCCCSCCCCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred             cceeccCCC-------ccccccccCcccCCHHHhc----cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH--
Confidence            998754322       2234568999999999984    456899999999999999999999999876655443221  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                       .. .  .++.+..+|+++++||.+||++||++|||     ++|+++||||+..
T Consensus       239 -~~-~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          239 -LK-A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             -HH-C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -Hc-C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence             11 2  23344579999999999999999999998     6899999999753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-57  Score=480.17  Aligned_cols=260  Identities=21%  Similarity=0.284  Sum_probs=213.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .+.|.+.++||+|+||+||+|.++.+++.||||++.....            ..+|+.+++.|+|||||+++++|. +.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------------~~~E~~il~~l~HpnIV~l~~~~~-~~~  123 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------------RVEELVACAGLSSPRIVPLYGAVR-EGP  123 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------CTHHHHTTTTCCCTTBCCEEEEEE-ETT
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------------HHHHHHHHHhCCCCCCCcEEEEEE-ECC
Confidence            3579999999999999999999999999999999875432            246999999999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+||+|.++++..+.|++.+++.|+.||+.||.|||+++  ||||||||+||||+.+.  .++||+|||+|+
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g--~~vKl~DFGla~  199 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDG--SRAALCDFGHAL  199 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTS--CCEEECCCTTCE
T ss_pred             EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCC--CEEEEeeCCCCe
Confidence            88999999999999999999899999999999999999999999988  99999999999998763  269999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+.......  ........+||+.|||||++.    +..|+.++||||||||||||++|++||........+...   ..
T Consensus       200 ~~~~~~~~~--~~~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~  270 (336)
T 4g3f_A          200 CLQPDGLGK--SLLTGDYIPGTETHMAPEVVM----GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---AS  270 (336)
T ss_dssp             EC--------------CCCCCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HH
T ss_pred             EccCCCccc--ceecCCccccCccccCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---Hc
Confidence            876432211  111123458999999999984    456899999999999999999999999766554433222   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH-------------hccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA-------------RHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL-------------~hp~~~~~  571 (627)
                      ........++.+++++.+||.+||++||.+|||+.|++             +|||+...
T Consensus       271 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            11111234568999999999999999999999999984             68888643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-56  Score=480.26  Aligned_cols=270  Identities=25%  Similarity=0.407  Sum_probs=219.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  362 (627)
                      +.++|++++.||+|+||+||+|.+..+++.||||++......     ....+.+++|+.+|+.|+|||||+++++|..  
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-----VTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-----hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            568999999999999999999999999999999998644322     2234678899999999999999999998763  


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                         +.+.+|||||||+ |+|..++...+.+++.+++.|+.||+.||.|||+++  ||||||||+|||++.+   +.+||+
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~---~~~Ki~  200 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN---CELKIG  200 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---CCEEEC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC---CCEEEe
Confidence               2357899999997 579999998899999999999999999999999998  9999999999999987   699999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.+......   ......+.+||++|+|||++.   ....|+.++||||||||||||++|++||.+.+....+..
T Consensus       201 DFGla~~~~~~~~~---~~~~~~~~~GT~~Y~APEv~~---~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~  274 (398)
T 4b99_A          201 DFGMARGLCTSPAE---HQYFMTEYVATRWYRAPELML---SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL  274 (398)
T ss_dssp             CCTTCBCC----------CCCCCSSCCCCTTCCHHHHT---TCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred             ecceeeecccCccc---cccccccceeChHhcCHHHhc---CCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99999876543211   112345569999999999985   234689999999999999999999999987776655433


Q ss_pred             HHHHhhhhcc----------------ccCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKATEV----------------QFAN---------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~~----------------~~~~---------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..........                .++.         .+.+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus       275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            3222111110                0111         24578999999999999999999999999999999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-54  Score=464.53  Aligned_cols=268  Identities=22%  Similarity=0.325  Sum_probs=210.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYD  358 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~  358 (627)
                      |.+.++|++.++||+|+||+||+|.+.   .+++.||||++.....         ..++.+|+++|+.+ +|||||++++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---------PIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---------HHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---------HHHHHHHHHHHHHhcCCCCCceEEE
Confidence            457789999999999999999999875   4688999998854332         23577899999988 6999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +|. +.+.+|||||||+|++|.+++.   .+++.+++.|+.||+.||+|||++|  ||||||||+||||+.+.  +.+||
T Consensus        88 ~~~-~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~--~~~kl  159 (361)
T 4f9c_A           88 CFR-KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRL--KKYAL  159 (361)
T ss_dssp             EEE-ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTT--TEEEE
T ss_pred             EEE-ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCC--CeEEE
Confidence            998 6778999999999999999884   5999999999999999999999998  99999999999998764  68999


Q ss_pred             eecccccccccCCCCC---------------------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         439 TDFGLSKVMDEENYNP---------------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~---------------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      +|||+|+.........                     ..........+||++|+|||++.   ....|+.++||||+|||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~y~~~~DiWSlG~i  236 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT---KCPNQTTAIDMWSAGVI  236 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT---TCSCCCTHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc---CCCCCCCccchhhhHHH
Confidence            9999998765432100                     00011233458999999999985   23458999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHH-HHHhhh------------------------------------------------hc
Q psy4988         498 FYQCLYGKKPFGHNQSQATILEE-NTILKA------------------------------------------------TE  528 (627)
Q Consensus       498 L~elltG~~Pf~~~~~~~~~~~~-~~~~~~------------------------------------------------~~  528 (627)
                      ||||++|+.||....+....+.. ..+...                                                ..
T Consensus       237 l~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  316 (361)
T 4f9c_A          237 FLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHA  316 (361)
T ss_dssp             HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------------
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccc
Confidence            99999999999655544332221 110000                                                00


Q ss_pred             cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         529 VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       529 ~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .....+..+|++++|||++||++||++|||+.|+|+||||+.
T Consensus       317 ~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          317 TNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            112235678999999999999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-54  Score=452.16  Aligned_cols=264  Identities=21%  Similarity=0.305  Sum_probs=207.3

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .|++-.++|.+.++||+|+||+||+|.+.   ..||||++......     ....+.|.+|+.++++++|||||++++++
T Consensus        30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~-----~~~~~~f~~E~~il~~l~HpNIV~l~g~~  101 (307)
T 3omv_A           30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPT-----PEQFQAFRNEVAVLRKTRHVNILLFMGYM  101 (307)
T ss_dssp             CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCC-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45677789999999999999999999753   35999998654322     22356799999999999999999999987


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . + +.+|||||||+||+|.+++... ..+++.++..|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       102 ~-~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~---~~~Ki~  174 (307)
T 3omv_A          102 T-K-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG---LTVKIG  174 (307)
T ss_dssp             C-S-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT---EEEEEC
T ss_pred             E-C-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC---CcEEEe
Confidence            5 3 4578999999999999999754 57999999999999999999999988  9999999999999987   699999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.......     .......+||+.|||||++.... ...|+.++||||||||||||+||+.||.+......+..
T Consensus       175 DFGla~~~~~~~~-----~~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~  248 (307)
T 3omv_A          175 DFGLATVKSRWSG-----SQQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF  248 (307)
T ss_dssp             CCSSCBC-----------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             eccCceecccCCc-----ceeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            9999987654221     12234568999999999985332 34589999999999999999999999987665544432


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..............+..+++++.+||.+||+.||++|||+.+++.+
T Consensus       249 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          249 MVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            2111111111112345789999999999999999999999987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.1e-55  Score=453.91  Aligned_cols=261  Identities=23%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC-
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN-  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-  365 (627)
                      ++|++++.||+|+||+||+|.++.+++.||||++.....      ....+.+.+|+.+|+.|+|||||+++++|..... 
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR------ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            359999999999999999999999999999999875432      1224578899999999999999999999864332 


Q ss_pred             ----------eEEEEEeecCCCChHHHHHhccCc---CHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         366 ----------SFCTVLEYCDGHDLDFYLKQHKTI---AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       366 ----------~~~lV~E~~~gg~L~~~l~~~~~l---~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                                .+|||||||++++|.+++.....+   ++..++.|+.||+.||+|||+++  ||||||||+||||+.+  
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~--  154 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD--  154 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT--
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC--
Confidence                      478999999999999999876544   45678999999999999999998  9999999999999987  


Q ss_pred             ccceEEeecccccccccCCCCCC-----CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPD-----HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~-----~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                       +.+||+|||+|+.+........     .........+||+.|||||++.    +..|+.++||||||||||||++   |
T Consensus       155 -~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyell~---P  226 (299)
T 4g31_A          155 -DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH----GNSYSHKVDIFSLGLILFELLY---P  226 (299)
T ss_dssp             -CCEEECCCCCC--------------------------CCCTTSCHHHHT----TCCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             -CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc----CCCCCCHHHHHHHHHHHHHHcc---C
Confidence             6899999999998765432110     0011223458999999999984    5569999999999999999996   8


Q ss_pred             CCCCChHHHHHHHHHHhhhhccccC-CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         508 FGHNQSQATILEENTILKATEVQFA-NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       508 f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      |.........+..     .....++ .....++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus       227 f~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          227 FSTQMERVRTLTD-----VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             CSSHHHHHHHHHH-----HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             CCCccHHHHHHHH-----HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            8543222221111     1112221 12345678899999999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-53  Score=483.88  Aligned_cols=267  Identities=21%  Similarity=0.351  Sum_probs=220.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++-.++|.++++||+|+||+||+|.++.+++.||||++....... ............++.+++.++|||||+++++|+ 
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~-~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-  262 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-  262 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch-hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-
Confidence            455688999999999999999999999999999999986543211 122233334455678888999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|||||||+||+|..+|...+.|++..++.|+.||+.||.|||+++  ||||||||+||||+.+   |++||+|||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~---G~vKL~DFG  337 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH---GHVRISDLG  337 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT---SCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC---CCEEecccc
Confidence            67889999999999999999999999999999999999999999999998  9999999999999987   799999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+.+....         +.+.+||+.|||||++.   .+..|+.++||||||||||||++|++||......... ....
T Consensus       338 lA~~~~~~~---------~~t~~GTp~YmAPEvl~---~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~  404 (689)
T 3v5w_A          338 LACDFSKKK---------PHASVGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR  404 (689)
T ss_dssp             TCEECSSCC---------CCSCCSCGGGCCHHHHS---TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHH
T ss_pred             eeeecCCCC---------CCCccCCcCccCHHHHh---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH
Confidence            998775432         34569999999999985   2346899999999999999999999999654332211 1111


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      .....  .+..+..+|+++++||.+||++||.+|++     +.+|++||||...
T Consensus       405 ~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          405 MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            11122  23344579999999999999999999998     7999999999753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.9e-54  Score=445.89  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=209.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +-.++|.+.+.||+|+||+||+|.+.     .++..||||++....       ....+.|.+|+++|++|+|||||++++
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~il~~l~HpnIV~l~g   82 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------DNARKDFHREAELLTNLQHEHIVKFYG   82 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-------hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            44578999999999999999999865     368899999986432       123457899999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhc-------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQH-------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                      +|. +.+.+|||||||++|+|.++|...             ..|++.+++.|+.||+.||.|||+++  ||||||||+||
T Consensus        83 ~~~-~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NI  159 (299)
T 4asz_A           83 VCV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNC  159 (299)
T ss_dssp             EEC-SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             EEe-eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhE
Confidence            997 667788999999999999999764             36999999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      ||+.+   +.+||+|||+|+........     ......+||+.|||||++.    ...|+.++|||||||+||||+| |
T Consensus       160 Ll~~~---~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~----~~~~~~k~DVwS~Gvvl~Ellt~G  227 (299)
T 4asz_A          160 LVGEN---LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSLGVVLWEIFTYG  227 (299)
T ss_dssp             EECGG---GCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             EECCC---CcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHc----CCCCCchhhHHHHHHHHHHHHcCC
Confidence            99987   68999999999876543211     1223346999999999995    3459999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      +.||........+..   +....  ..+.+..+|+++.+||.+||+.||++|||+.+++  +||+
T Consensus       228 ~~Pf~~~~~~~~~~~---i~~~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          228 KQPWYQLSNNEVIEC---ITQGR--VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             CCTTTTSCHHHHHHH---HHHTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             CCCCCCCCHHHHHHH---HHcCC--CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            999987665443322   11211  2334567899999999999999999999999994  4553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=447.74  Aligned_cols=255  Identities=23%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +-.++|.+.++||+|+||+||+|.+.     .+++.||||++....       ....+.|.+|+++|++|+|||||++++
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------ESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            33467899999999999999999864     368999999985322       223467899999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhc---------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCC
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQH---------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG  423 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~  423 (627)
                      +|. +.+.+|||||||++|+|.+++...               ..+++.+++.|+.||+.||.|||+.+  ||||||||+
T Consensus       111 ~~~-~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~  187 (329)
T 4aoj_A          111 VCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATR  187 (329)
T ss_dssp             EEC-SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             EEE-ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHh
Confidence            997 667788999999999999999753               35999999999999999999999988  999999999


Q ss_pred             cEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh
Q psy4988         424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY  503 (627)
Q Consensus       424 NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt  503 (627)
                      ||||+.+   +.+||+|||+|+.+......     ......+||+.|||||++.    ...|+.++||||||||||||+|
T Consensus       188 NILl~~~---~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~----~~~~~~~sDvwS~Gvvl~Ellt  255 (329)
T 4aoj_A          188 NCLVGQG---LVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESIL----YRKFTTESDVWSFGVVLWEIFT  255 (329)
T ss_dssp             GEEEETT---TEEEECCCC---------------------CCCCGGGCCHHHHT----TCCCCHHHHHHHHHHHHHHHHT
T ss_pred             hEEECCC---CcEEEcccccceeccCCCcc-----eecCcccccccccChhhhc----CCCCCccccccchHHHHHHHHc
Confidence            9999987   59999999999976543221     2234568999999999984    5569999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         504 -GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       504 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       |+.||........+..   +....  ..+.+..+++++.+||.+||+.||++|||+.+|+.+
T Consensus       256 ~G~~Pf~~~~~~~~~~~---i~~g~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          256 YGKQPWYQLSNTEAIDC---ITQGR--ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             TSCCTTCSSCHHHHHHH---HHHTC--CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHH---HHcCC--CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence             9999987665543321   22222  334456789999999999999999999999999865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4e-53  Score=478.40  Aligned_cols=264  Identities=28%  Similarity=0.422  Sum_probs=223.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+++.||+|+||+||+|.++.+++.||||++.....       .....+.+|+.+|+.|+|||||+|+++|. 
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-  224 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------SDKETVRKEIQTMSVLRHPTLVNLHDAFE-  224 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------HHHHHHHHHHHHHHHTCCTTBCCEEEEEE-
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-------hhHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            3456899999999999999999999999999999999865432       11346789999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|||||||+||+|.+++.. .+.|++.+++.|+.||+.||.|||+++  ||||||||+||||+.+. .+.+||+||
T Consensus       225 ~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~-~~~vKl~DF  301 (573)
T 3uto_A          225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKR-SNELKLIDF  301 (573)
T ss_dssp             CSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSS-CCCEEECCC
T ss_pred             ECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCC-CCCEEEeec
Confidence            67889999999999999999864 468999999999999999999999998  99999999999998653 268999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.+....        .....+||+.|||||++.    +..|+.++||||||||||+|++|..||.+......+....
T Consensus       302 G~a~~~~~~~--------~~~~~~GT~~y~APEv~~----~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~  369 (573)
T 3uto_A          302 GLTAHLDPKQ--------SVKVTTGTAEFAAPEVAE----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK  369 (573)
T ss_dssp             SSCEECCTTS--------EEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             cceeEccCCC--------ceeeeEECccccCHHHhC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            9999875432        234558999999999984    5568999999999999999999999998776655443221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        .....+....+..+|+++++||++||++||.+|||+.|+|+||||++.
T Consensus       370 --~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          370 --SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             --TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             --hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence              111122223346799999999999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-53  Score=442.48  Aligned_cols=258  Identities=21%  Similarity=0.332  Sum_probs=211.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .++-.+.++++++||+|+||+||+|...     .+++.||||++......      ...+.|.+|+.++++++|||||++
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~------~~~~~f~~E~~il~~l~HpNIV~l   94 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG------PLREEFRHEAMLRARLQHPNVVCL   94 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh------HHHHHHHHHHHHHHhCCCCCCCCc
Confidence            3455678999999999999999999853     46789999998643221      123568999999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                      +++|. +...+|||||||++|+|.++|...                ..+++.++..|+.||+.||.|||+++  ||||||
T Consensus        95 ~g~~~-~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDL  171 (308)
T 4gt4_A           95 LGVVT-KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDL  171 (308)
T ss_dssp             EEEEC-SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             ceEEE-ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCc
Confidence            99997 566788999999999999999643                35899999999999999999999988  999999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      ||+||||+++   +.+||+|||+|+.+......     ......+||+.|||||++.    ...|+.++|||||||||||
T Consensus       172 K~~NILl~~~---~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~----~~~~s~ksDVwSfGvvl~E  239 (308)
T 4gt4_A          172 ATRNVLVYDK---LNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIM----YGKFSIDSDIWSYGVVLWE  239 (308)
T ss_dssp             SGGGEEECGG---GCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHH
T ss_pred             cccceEECCC---CCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHh----CCCCCccchhhhHHHHHHH
Confidence            9999999987   68999999999877543321     2244568999999999995    3459999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         501 CLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       501 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |+| |..||.+......+..   +..  ....+.+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       240 l~t~g~~Pf~~~~~~~~~~~---i~~--~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          240 VFSYGLQPYCGYSNQDVVEM---IRN--RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTTCCTTTTCCHHHHHHH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHH---HHc--CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            998 8999987665443321   111  12334556799999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-52  Score=445.90  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=214.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC-CceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH-PRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~  355 (627)
                      |++-.++|++.++||+|+||+||+|.+..+     ++.||||++......      ...+.+.+|+.+|++++| ||||+
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~------~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH------SEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh------HHHHHHHHHHHHHHHcCCCCcEEE
Confidence            456678999999999999999999987654     478999998644321      224578999999999975 89999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYD  419 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrD  419 (627)
                      ++++|..+.+.+|||||||++|+|.++|+..                ..+++.++..|+.||+.||.|||+++  |||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence            9999875667788999999999999999753                34899999999999999999999988  99999


Q ss_pred             ccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       420 LKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      |||+||||+.+   +.+||+|||+|+.+.....     ...+...+||+.|||||++.    ...|+.++|||||||+||
T Consensus       211 LK~~NILl~~~---~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~----~~~y~~ksDVwS~Gv~l~  278 (353)
T 4ase_A          211 LAARNILLSEK---NVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLW  278 (353)
T ss_dssp             CSGGGEEECGG---GCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHH
T ss_pred             cCccceeeCCC---CCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHh----cCCCCCcccEeehHHHHH
Confidence            99999999987   6899999999987654321     12234557999999999995    446999999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         500 QCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       500 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||++ |+.||.+......+...  +..  ...++.+..+++++.+||.+||+.||++|||+.+|++|
T Consensus       279 El~t~G~~Pf~~~~~~~~~~~~--i~~--g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          279 EIFSLGASPYPGVKIDEEFCRR--LKE--GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHTTTSCCSSTTCCCSHHHHHH--HHH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHH--HHc--CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            9997 99999876544444322  111  22334456789999999999999999999999999987

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-49  Score=419.07  Aligned_cols=268  Identities=26%  Similarity=0.437  Sum_probs=220.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||+||+|.+..+++.||||++......      .....+.+|+.+++.++|||||++++++. +.
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~   77 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------DCPENIKKEICINKMLNHENVVKFYGHRR-EG   77 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------CHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc------chHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            568999999999999999999999999999999998654321      11245788999999999999999999997 67


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+|||||++++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~---~~~kl~Dfg~a  152 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER---DNLKISDFGLA  152 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECCCTTC
T ss_pred             CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC---CCEEEEEeecc
Confidence            788999999999999999988889999999999999999999999988  9999999999999987   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +.+.....     .......+||+.|+|||++..   ...++.++|||||||+||+|++|+.||............   .
T Consensus       153 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~  221 (323)
T 3tki_A          153 TVFRYNNR-----ERLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---W  221 (323)
T ss_dssp             EECEETTE-----ECCBCSCCSCGGGSCHHHHHC---SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---H
T ss_pred             ceeccCCc-----ccccCCCccCcCccCcHHhcc---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---H
Confidence            87653321     122345589999999999852   233477999999999999999999999765544332221   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH  575 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~~  575 (627)
                      .........+..+++++.+||.+||..||.+|||+.|+++||||.......
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  272 (323)
T 3tki_A          222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (323)
T ss_dssp             HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCCC
T ss_pred             hcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccccc
Confidence            122233344567899999999999999999999999999999998765443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.4e-49  Score=415.81  Aligned_cols=262  Identities=29%  Similarity=0.441  Sum_probs=221.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .....++|++++.||+|+||.||+|.+..+++.||||++.....     .....+.+.+|+.+++.++|||||++++++.
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-----NPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34566789999999999999999999999999999999865432     1223467889999999999999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|+|||||++++|.+++...+.+++.+++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+||
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~---~~~kl~DF  158 (328)
T 3fe3_A           85 -TEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD---MNIKIADF  158 (328)
T ss_dssp             -CSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEECST
T ss_pred             -ECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC---CCEEEeec
Confidence             66788999999999999999998899999999999999999999999988  9999999999999887   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++..   ....+.++|||||||+||+|++|+.||............ 
T Consensus       159 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-  226 (328)
T 3fe3_A          159 GFSNEFTVGG--------KLDAFCGAPPYAAPELFQG---KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-  226 (328)
T ss_dssp             TCCGGGSSSC--------GGGTTSSSGGGCCHHHHHT---CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             cCceecCCCC--------ccccccCCcceeCcccccC---CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence            9998765322        2345689999999999852   233458999999999999999999999876544332211 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                         .  ...+..+..+++++.+||++||..||.+|||+.++++||||...
T Consensus       227 ---~--~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          227 ---L--RGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             ---H--HCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             ---H--hCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence               1  11233345689999999999999999999999999999999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-50  Score=419.57  Aligned_cols=263  Identities=19%  Similarity=0.249  Sum_probs=192.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      ..+|.+.++||+|+||+||+|.+  +|+.||||++.....      ..  ..+..|+.++..++|||||++++++..+..
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~------~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~   71 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE------RS--WFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH------HH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch------hh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence            35699999999999999999976  689999999853221      11  122346667788999999999999975442


Q ss_pred             ---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC------CCCEEeccccCCcEEecCCCcccce
Q psy4988         366 ---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI------KPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       366 ---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~------~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                         .+|||||||++|+|.+++.. ..+++..+..|+.|++.||.|||+.      .++||||||||+||||+.+   +++
T Consensus        72 ~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~---~~~  147 (303)
T 3hmm_A           72 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTC  147 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT---SCE
T ss_pred             CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC---CCE
Confidence               57899999999999999976 4799999999999999999999986      2349999999999999987   699


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK--NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      ||+|||+|+.........   .......+||+.|||||++....  ....|+.++||||||||||||+||..||......
T Consensus       148 Ki~DFGla~~~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~  224 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             EECCCTTCEEEETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             EEEeCCCCccccCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence            999999998775432110   01123458999999999985321  1124678999999999999999998876432211


Q ss_pred             -------------HHHHHHHHHhhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         515 -------------ATILEENTILKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       515 -------------~~~~~~~~~~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                                   ...+............++.   ....+..+.+||.+||+.||++|||+.++++.
T Consensus       225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                         0111111111111111211   11234578899999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-49  Score=420.92  Aligned_cols=271  Identities=28%  Similarity=0.424  Sum_probs=222.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++......... .......+.+|+.+++.++|||||+++++|. 
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-   85 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR-RGVCREEIEREVSILRQVLHPNIITLHDVYE-   85 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS-SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc-chhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-
Confidence            46788999999999999999999999999999999998765432110 0011246789999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-ccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-~g~vKL~DF  441 (627)
                      +...+|+|||||+|++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+.. ...+||+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            66788999999999999999998889999999999999999999999988  999999999999987631 127999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.    ...++.++||||||||||+|++|..||........+....
T Consensus       164 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~  231 (361)
T 2yab_A          164 GLAHEIEDGV--------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (361)
T ss_dssp             SSCEECCTTC--------CCCCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCceEcCCCC--------ccccCCCCccEECchHHc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9998765432        123458999999999984    4568999999999999999999999998766554432211


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ..........+..+++++++||.+||.+||.+|||+.++++||||...
T Consensus       232 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          232 --AVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             --TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             --hcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence              111111112235789999999999999999999999999999999853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=427.40  Aligned_cols=266  Identities=26%  Similarity=0.373  Sum_probs=222.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||+|++.......     .....+.+|+.+++.++|||||+++++|. +
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-----RDHQKLEREARICRLLKHPNIVRLHDSIS-E   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-----HHHHHHHHHHHHHHHCCBTTBCCEEEEEE-C
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCcCCCeEEEEEE-E
Confidence            46678999999999999999999999999999999987654322     22456889999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+|+|||||.|++|.+++.....+++..+..++.||+.||.|||+.+  ||||||||+|||++.+...+.+||+|||+
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            7788999999999999999999899999999999999999999999998  99999999999998654446899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.+....       ......+||+.|+|||++.    ...++.++||||||||||+|++|..||........+..  ..
T Consensus       160 a~~~~~~~-------~~~~~~~gt~~Y~APE~l~----~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~--i~  226 (444)
T 3soa_A          160 AIEVEGEQ-------QAWFGFAGTPGYLSPEVLR----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ--IK  226 (444)
T ss_dssp             CBCCCTTC-------CBCCCSCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HH
T ss_pred             eEEecCCC-------ceeecccCCcccCCHHHhc----CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH--HH
Confidence            98765432       1123458999999999984    45689999999999999999999999977655443322  11


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ........+.+..+++++++||.+||+.||.+|||+.++|+||||..
T Consensus       227 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          227 AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             hCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            22223333455689999999999999999999999999999999963

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-48  Score=404.90  Aligned_cols=260  Identities=24%  Similarity=0.410  Sum_probs=220.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.......       ...+.+|+.+++.++|||||+++++|. +.
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~   89 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-------KELIINEILVMRENKNPNIVNYLDSYL-VG   89 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-------HHHHHHHHHHHhcCCCCCCCeEeEEEE-EC
Confidence            5678999999999999999999999999999999986543321       235788999999999999999999998 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+|||||.+++|.+++... .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFC  163 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCTTC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC---CCEEEeeCCCc
Confidence            7788999999999999998764 7999999999999999999999988  9999999999999987   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       .....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+...   .
T Consensus       164 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~  229 (297)
T 3fxz_A          164 AQITPEQS-------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A  229 (297)
T ss_dssp             EECCSTTC-------CBCCCCSCGGGCCHHHHH----CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H
T ss_pred             eecCCccc-------ccCCccCCcCccChhhhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H
Confidence            87654321       233458999999999985    445899999999999999999999999776655443322   2


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ......+..+..++..+.+||.+||+.||.+|||+.++++||||....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            222333444567899999999999999999999999999999997543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-48  Score=417.46  Aligned_cols=267  Identities=27%  Similarity=0.370  Sum_probs=223.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|.
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----ARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            345678899999999999999999999999999999998754332     122456889999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|+|||||.+++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+...+.+||+||
T Consensus        99 -~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A           99 -EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             -eCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeec
Confidence             66788999999999999999988889999999999999999999999998  999999999999987644457999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.    ...++.++||||||||||+|++|..||........+... 
T Consensus       176 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-  242 (362)
T 2bdw_A          176 GLAIEVNDSE--------AWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-  242 (362)
T ss_dssp             TTCBCCTTCC--------SCCCSCSCTTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             CcceEecCCc--------ccccCCCCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence            9998765332        123458999999999984    446899999999999999999999999776544332211 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                       .........+.+..+++++.+||.+||..||.+||++.++|+||||..
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          243 -KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             -HHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             -HhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence             111112222334578999999999999999999999999999999963

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.7e-48  Score=408.44  Aligned_cols=260  Identities=30%  Similarity=0.465  Sum_probs=218.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -.++|.+++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++||||++++++|. +.
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-TH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CS
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh----hhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-eC
Confidence            346899999999999999999999999999999998643211    1122456889999999999999999999998 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+|||||+|++|..++.....+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||++
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---g~vkL~DFG~a  152 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD---GHIKITDFGLC  152 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC---CCEEEeeccch
Confidence            788999999999999999998889999999999999999999999988  9999999999999987   69999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||...........   + 
T Consensus       153 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---i-  217 (337)
T 1o6l_A          153 KEGISDG-------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---I-  217 (337)
T ss_dssp             BCSCCTT-------CCBCCCEECGGGCCGGGGS----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H-
T ss_pred             hhcccCC-------CcccccccChhhCChhhhc----CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH---H-
Confidence            8643221       1234568999999999984    44689999999999999999999999976654433211   1 


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      ......+  +..+++++.+||.+||+.||.+||     ++.++++||||...
T Consensus       218 ~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          218 LMEEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHCCCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HcCCCCC--CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            1122333  347899999999999999999999     99999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.9e-48  Score=396.66  Aligned_cols=264  Identities=25%  Similarity=0.443  Sum_probs=212.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|+++++||+|+||+||+|.+..+++.||||++.......     .....+.+|+.+++.++|||||+++++|. +...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-----GVPSSALREICLLKELKHKNIVRLHDVLH-SDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-----THHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-----CcchHHHHHHHHHhcCCCCCEeeEEeEEE-eCCE
Confidence            58999999999999999999999999999999987654322     12346789999999999999999999998 6678


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+|||||+++.+..+....+.+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN---GELKLANFGLARA  150 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEeeccccee
Confidence            8999999997655555566788999999999999999999999998  9999999999999987   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN-TILK  525 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~-~~~~  525 (627)
                      +....       .......||+.|+|||++.   ....++.++|||||||+||+|++|..||.........+... ....
T Consensus       151 ~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~  220 (292)
T 3o0g_A          151 FGIPV-------RCYSAEVVTLWYRPPDVLF---GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             CCSCC-------SCCCSCCSCGGGCCHHHHT---TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             cCCcc-------ccccCCccccCCcChHHHc---CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            65332       1233457899999999985   23348999999999999999999888864444433332221 1111


Q ss_pred             hh-cc----------------------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 AT-EV----------------------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~-~~----------------------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .. ..                      .....+.++.++.+||++||++||.+|||+.++++||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            00 00                      001123578999999999999999999999999999999854

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=416.06  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=214.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-.++|+++++||+|+||.||+|.+..+++.||||++......    .......+.+|+.++..+ +|||||+++++|. 
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~----~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL----QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc----chhHHHHHHHHHHHHHhccCCCceeeEEEEEE-
Confidence            4457899999999999999999999999999999998643221    122345678899999988 7999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|||||||+|++|..++.....+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +++||+|||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~---g~ikL~DFG  169 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE---GHCKLADFG  169 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC---CCEEEcccc
Confidence            66788999999999999999998899999999999999999999999998  9999999999999887   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||...+....+...  
T Consensus       170 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--  236 (353)
T 3txo_A          170 MCKEGICNG-------VTTATFCGTPDYIAPEILQ----EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--  236 (353)
T ss_dssp             TCBCSCC----------------CCGGGCCHHHHH----HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred             ceeecccCC-------ccccccCCCcCeEChhhcC----CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence            998643221       2234568999999999985    345889999999999999999999999876655433221  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV------ISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~------~elL~hp~~~~~  571 (627)
                        ......+  +..+++++.+||++||++||.+||++      .++++||||...
T Consensus       237 --~~~~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          237 --LNDEVVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             --HHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             --HcCCCCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence              1122333  34689999999999999999999999      899999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-48  Score=406.22  Aligned_cols=271  Identities=28%  Similarity=0.422  Sum_probs=221.7

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++......... .......+.+|+.+++.++|||||+++++|. 
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-   84 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR-RGVSREDIEREVSILKEIQHPNVITLHEVYE-   84 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence            35678899999999999999999999999999999998765432110 0001346789999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC-cccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN-VCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~-~~g~vKL~DF  441 (627)
                      +...+++|||||++++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+. ....+||+||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            66788999999999999999988889999999999999999999999988  99999999999998763 1237999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+....
T Consensus       163 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  230 (326)
T 2y0a_A          163 GLAHKIDFGN--------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS  230 (326)
T ss_dssp             TTCEECCTTS--------CCCCCCSCTTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             CCCeECCCCC--------ccccccCCcCcCCceeec----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            9998775332        123357999999999983    4568999999999999999999999998766554432221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..  ........+..++.++.+||++||+.||.+|||+.++++||||...
T Consensus       231 ~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          231 AV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             hc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            11  1111111224688999999999999999999999999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.1e-48  Score=417.40  Aligned_cols=263  Identities=26%  Similarity=0.414  Sum_probs=215.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-.++|.++++||+|+||.||+|.+..+++.||||++.......    ...+..+.+|..++..+ +|||||+++++|. 
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~----~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------CCHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC----HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-
Confidence            45678999999999999999999999999999999987543211    22234577899999876 8999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+|||||||+|++|..++...+.+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +++||+|||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~---g~ikL~DFG  198 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE---GHIKLTDYG  198 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCT
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC---CCEEEeecc
Confidence            67788999999999999999998899999999999999999999999998  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-------
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-------  515 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~-------  515 (627)
                      +|+......       ......+||+.|+|||++.    +..++.++|||||||+||||++|+.||.......       
T Consensus       199 la~~~~~~~-------~~~~~~~gt~~Y~aPE~l~----~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~  267 (396)
T 4dc2_A          199 MCKEGLRPG-------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  267 (396)
T ss_dssp             TCBCCCCTT-------CCBCCCCBCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCH
T ss_pred             eeeecccCC-------CccccccCCcccCCchhhc----CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhH
Confidence            998633221       2245568999999999984    4568999999999999999999999996432111       


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHhccCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV------ISLARHDYLQPP  571 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~------~elL~hp~~~~~  571 (627)
                      ..+..  ......+  ..+..++.++++||++||+.||.+||++      .++++||||...
T Consensus       268 ~~~~~--~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          268 DYLFQ--VILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             HHHHH--HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             HHHHH--HHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            11111  1112222  3345689999999999999999999984      899999999753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.7e-48  Score=413.89  Aligned_cols=266  Identities=25%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+++.||+|+||+||+|.+..+++.||||++.......        ..+.+|+.+++.++|||||+++++|. +
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~-~   87 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--------ENVQREIINHRSLRHPNIVRFKEVIL-T   87 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC--------HHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc--------HHHHHHHHHHHhCCCCCCCcEEEEEe-e
Confidence            35689999999999999999999999999999999986543221        24678999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+|||||.+++|..++...+.+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+.. +.+||+|||+
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~-~~~kl~Dfg~  164 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPA-PRLKICDFGY  164 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSS-CCEEECCCCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCC-ceEEEeecCc
Confidence            6788999999999999999988889999999999999999999999988  999999999999987632 3699999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKIS-SKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~-~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++......        .....+||+.|+|||++..    ..++ .++|||||||+||+|++|+.||..............
T Consensus       165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  232 (361)
T 3uc3_A          165 SKSSVLHS--------QPKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ  232 (361)
T ss_dssp             C-----------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred             cccccccC--------CCCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence            97543221        1233479999999999852    2344 459999999999999999999976544333322222


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      ........++....+++++.+||.+||.+||.+|||+.++++||||....+
T Consensus       233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            233344455666678999999999999999999999999999999975543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.4e-48  Score=401.72  Aligned_cols=268  Identities=26%  Similarity=0.460  Sum_probs=213.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .+.+.++|+++++||+|+||+||+|.+. +++.||||++.....     .......+.+|+.+++.++|||||+++++|.
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   89 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-----DEGIPSTAIREISLLKELHHPNIVSLIDVIH   89 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-----cchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence            4568899999999999999999999985 589999999864322     1223456789999999999999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                       +...+|+|||||++ +|..++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|
T Consensus        90 -~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~---~~~kl~D  162 (311)
T 3niz_A           90 -SERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD---GALKLAD  162 (311)
T ss_dssp             -CSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECC
T ss_pred             -cCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC---CCEEEcc
Confidence             66778899999996 666666544 56999999999999999999999988  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.+....       ......+||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+...
T Consensus       163 fg~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  232 (311)
T 3niz_A          163 FGLARAFGIPV-------RSYTHEVVTLWYRAPDVLM---GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI  232 (311)
T ss_dssp             CTTCEETTSCC-------C---CCCCCCTTCCHHHHT---TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred             CcCceecCCCc-------ccccCCcccCCcCCHHHhc---CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99998765322       1123347899999999985   2345899999999999999999999999876655544333


Q ss_pred             HHHhhhhcc-cc-----------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         521 NTILKATEV-QF-----------------------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       521 ~~~~~~~~~-~~-----------------------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ......... .+                       ...+.+++++.+||.+||++||.+|||+.++++||||+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            222211100 00                       01235788999999999999999999999999999998643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-48  Score=420.59  Aligned_cols=270  Identities=28%  Similarity=0.422  Sum_probs=224.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.++++||+|+||.||+|.+..+++.||||++........    .....+.+|+.+++.++|||||+++++|. 
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-  139 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR----SDSAFFWEERDIMAFANSPWVVQLFYAFQ-  139 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----CCCSTHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh----HHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            3456789999999999999999999999999999999864221111    11234778999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+|||||||+|++|..++.. ..+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +++||+|||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~---g~ikL~DFG  213 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS---GHLKLADFG  213 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC---CCEEEeccc
Confidence            67788999999999999999875 57999999999999999999999998  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+.+....      .......+||+.|+|||++........++.++|||||||+||||++|+.||...+....+..  .
T Consensus       214 ~a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--i  285 (410)
T 3v8s_A          214 TCMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--I  285 (410)
T ss_dssp             TCEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--H
T ss_pred             eeEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH--H
Confidence            998765432      11234568999999999986432223378899999999999999999999987665544322  1


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~~  571 (627)
                      ......+.++.+..++.++++||++||+.+|.+  |+++.+|++||||...
T Consensus       286 ~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          286 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            222234567777789999999999999999988  9999999999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-48  Score=413.30  Aligned_cols=268  Identities=26%  Similarity=0.429  Sum_probs=216.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++.........  ......+.+|+.+++.++|||||+++++|. +
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~   97 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP--GLSTEDLKREASICHMLKHPHIVELLETYS-S   97 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS--SCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-E
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc--cchHHHHHHHHHHHHhCCCCCCCcEEEEEE-e
Confidence            5678899999999999999999999999999999998643211100  001346889999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .+.+|||||||++++|.+++...    ..+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+.....+||+
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEe
Confidence            67889999999999998877543    35899999999999999999999988  9999999999999876544569999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.+....       ......+||+.|+|||++.    ...++.++||||||||||+|++|..||.....  .+..
T Consensus       176 Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~  242 (351)
T 3c0i_A          176 GFGVAIQLGESG-------LVAGGRVGTPHFMAPEVVK----REPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE  242 (351)
T ss_dssp             CCTTCEECCTTS-------CBCCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH
T ss_pred             cCcceeEecCCC-------eeecCCcCCcCccCHHHHc----CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH
Confidence            999998775432       1233458999999999984    44589999999999999999999999976432  2221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      . ............+..+++++.+||.+||..||.+|||+.++++||||..
T Consensus       243 ~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          243 G-IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             H-HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             H-HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            1 1111111112223578999999999999999999999999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-47  Score=402.97  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=218.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||+++++|. +..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh----hhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-eCC
Confidence            46799999999999999999999999999999998643211    1122456778999999999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+|||||+|++|..++.....+++..++.++.||+.||.|||+++  ||||||||+|||++.+   +.+||+|||+++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---g~~kL~Dfg~a~  154 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN---GHIKITDFGFAK  154 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT---SCEEECCCSSCE
T ss_pred             EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC---CCEEEeecCcce
Confidence            88999999999999999998889999999999999999999999988  9999999999999887   699999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .....          ....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   +..
T Consensus       155 ~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~  217 (318)
T 1fot_A          155 YVPDV----------TYTLCGTPDYIAPEVVS----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---ILN  217 (318)
T ss_dssp             ECSSC----------BCCCCSCTTTCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH
T ss_pred             ecCCc----------cccccCCccccCHhHhc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HHh
Confidence            76432          23458999999999984    45689999999999999999999999977655433321   111


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                       ....  .+..+++++.+||.+||..||.+||     ++.++++||||...
T Consensus       218 -~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          218 -AELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             -CCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             -CCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence             2223  3457899999999999999999999     99999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-48  Score=407.06  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=217.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++.....        ....+.+|+.+++.++|||||+++++|. +
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~   72 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--------DQVLVKKEISILNIARHRNILHLHESFE-S   72 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--------HHHHHHHHHHHHHHSCCTTBCCEEEEEE-E
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--------cHHHHHHHHHHHHhCCCCCCCeEeEEEe-c
Confidence            367899999999999999999999999999999999864321        1235778999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+++|||||++++|.+++... ..+++.+++.++.||+.||.|||+.+  |+||||||+|||++.+. .+.+||+|||
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~-~~~~kl~Dfg  149 (321)
T 1tki_A           73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRR-SSTIKIIEFG  149 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSS-CCCEEECCCT
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCC-CCCEEEEECC
Confidence            67889999999999999999765 47999999999999999999999988  99999999999998732 2689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+....        ......||+.|+|||++.    ...++.++|||||||+||+|++|..||........+.... 
T Consensus       150 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-  216 (321)
T 1tki_A          150 QARQLKPGD--------NFRLLFTAPEYYAPEVHQ----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-  216 (321)
T ss_dssp             TCEECCTTC--------EEEEEESCGGGSCHHHHT----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-
T ss_pred             CCeECCCCC--------ccccccCChhhcCcHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-
Confidence            998765421        123457999999999984    4457899999999999999999999998766554332211 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       ..........++.++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       217 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          217 -NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence             111111112235789999999999999999999999999999999754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=412.69  Aligned_cols=268  Identities=28%  Similarity=0.449  Sum_probs=221.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ..+..++|.+++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||+++++|.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV----ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc----cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            455678999999999999999999999999999999998643221    1122457889999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+|||||.|++|..++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+||
T Consensus        86 -~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~---g~vkL~DF  159 (384)
T 4fr4_A           86 -DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH---GHVHITDF  159 (384)
T ss_dssp             -CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCC
T ss_pred             -eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC---CCEEEecc
Confidence             66788999999999999999999889999999999999999999999998  9999999999999987   69999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++... .+..++.++||||||||||+|++|+.||.......... ..
T Consensus       160 G~a~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~-~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-~~  229 (384)
T 4fr4_A          160 NIAAMLPRET--------QITTMAGTKPYMAPEMFSSR-KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE-IV  229 (384)
T ss_dssp             TTCEECCTTC--------CBCCCCSCGGGCCGGGTCCC-SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-HH
T ss_pred             ceeeeccCCC--------ceeccCCCccccCCeeeccC-CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-HH
Confidence            9998765332        23456899999999998532 13458899999999999999999999996443322111 11


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-VISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-~~elL~hp~~~~~  571 (627)
                      ......  ....+..++.++.+||.+||+.||.+||+ +.+++.||||...
T Consensus       230 ~~~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          230 HTFETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            111112  23334578999999999999999999998 9999999999753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-47  Score=420.35  Aligned_cols=270  Identities=25%  Similarity=0.386  Sum_probs=221.3

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.++++||+|+||+||+|.+..+++.||||++.......    ......+.+|+.++..++|||||+++++|. 
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-  144 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK----RAETACFREERDVLVNGDSKWITTLHYAFQ-  144 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH----TTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence            456789999999999999999999999999999999986422111    111234778999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +...+|||||||+|++|..++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~---g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN---GHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC---CCEEEcch
Confidence            67788999999999999999987 578999999999999999999999988  9999999999999987   69999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG-KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      |+|+.+.....      ......+||+.|+|||++... .....|+.++|||||||+||||++|+.||...+....+...
T Consensus       220 Gla~~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i  293 (437)
T 4aw2_A          220 GSCLKLMEDGT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  293 (437)
T ss_dssp             TTCEECCTTSC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             hhhhhcccCCC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence            99987654321      123345899999999998521 01345889999999999999999999999876655444322


Q ss_pred             HHHhhhhccccCCC-CCCCHHHHHHHHHhhhcCcCC--CCCHHHHHhccCCCC
Q psy4988         521 NTILKATEVQFANK-PTVSNEAKGFIRSCLAYRKED--RIDVISLARHDYLQP  570 (627)
Q Consensus       521 ~~~~~~~~~~~~~~-~~vs~el~~LI~~cL~~dP~~--Rpt~~elL~hp~~~~  570 (627)
                        +.....+.++.. ..+++++++||++||+.+|.+  |+++.++++||||..
T Consensus       294 --~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          294 --MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             --HTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             --hhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence              111223344433 568999999999999998888  999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-47  Score=411.70  Aligned_cols=276  Identities=20%  Similarity=0.280  Sum_probs=217.9

Q ss_pred             ccCCCeeEEEEeccc--CceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         284 VLSDRYLLLMLLGKG--GFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G--~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ...++|+++++||+|  +||.||+|.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-----NEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-----hHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            356799999999999  9999999999999999999998754321     234567888999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                       +.+.+|+|||||++++|.+++...  ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~---~~~kl~  170 (389)
T 3gni_B           97 -ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD---GKVYLS  170 (389)
T ss_dssp             -ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEEC
T ss_pred             -ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC---CCEEEc
Confidence             667889999999999999999875  67999999999999999999999998  9999999999999877   699999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++....................+||+.|+|||++...  ...++.++||||||||||+|++|+.||........+..
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999876543221111111223345899999999998521  14589999999999999999999999976554443322


Q ss_pred             HHHHhh----------------------------------------hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH
Q psy4988         520 ENTILK----------------------------------------ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV  559 (627)
Q Consensus       520 ~~~~~~----------------------------------------~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~  559 (627)
                      ......                                        ......+.+..+++++.+||++||++||.+|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            110000                                        0000112334688999999999999999999999


Q ss_pred             HHHHhccCCCCCC
Q psy4988         560 ISLARHDYLQPPV  572 (627)
Q Consensus       560 ~elL~hp~~~~~~  572 (627)
                      .++|+||||....
T Consensus       329 ~ell~hp~f~~~~  341 (389)
T 3gni_B          329 STLLNHSFFKQIK  341 (389)
T ss_dssp             HHHTTSGGGGGC-
T ss_pred             HHHhcCHHHHHHh
Confidence            9999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-47  Score=404.88  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=216.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-.++|.+++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.++..+ +|||||+++++|. 
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC----SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc----chHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-
Confidence            3457899999999999999999999999999999998754321    123345678899999987 8999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+|+|||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +++||+|||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---g~~kL~DFG  155 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE---GHIKLTDYG  155 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCGG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC---CCEEEEecc
Confidence            66788999999999999999998889999999999999999999999988  9999999999999887   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-------H
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-------A  515 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-------~  515 (627)
                      +++......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||......       .
T Consensus       156 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  224 (345)
T 3a8x_A          156 MCKEGLRPG-------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  224 (345)
T ss_dssp             GCBCSCCTT-------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CH
T ss_pred             ccccccCCC-------CcccccCCCccccCccccC----CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccH
Confidence            998643221       1234568999999999984    456899999999999999999999999642111       1


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH------HHHHhccCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV------ISLARHDYLQPP  571 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~------~elL~hp~~~~~  571 (627)
                      ..+..  ........  .+..++.++.+||.+||+.||.+||++      .++++||||...
T Consensus       225 ~~~~~--~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          225 DYLFQ--VILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHHHH--HHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HHHHH--HHHcCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            11111  11112223  345789999999999999999999995      899999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=397.39  Aligned_cols=268  Identities=29%  Similarity=0.475  Sum_probs=213.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-------------------hHHHHHHHHHHHHHH
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-------------------KKANYIKHALREYNI  344 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-------------------~~~~~~~~~~~Ei~i  344 (627)
                      +..++|.+.+.||+|+||.||+|.+..+++.||||++.........                   ........+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            4568999999999999999999999999999999998755321110                   011224568899999


Q ss_pred             HhcCCCCceeEEeeEEeec-CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCC
Q psy4988         345 HKALDHPRVVKLYDVFEID-ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG  423 (627)
Q Consensus       345 l~~l~HpnIV~l~~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~  423 (627)
                      ++.++|||||++++++... ...+|+||||+++++|..++. ...+++..++.++.||+.||.|||+.+  ||||||||+
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~  166 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS  166 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence            9999999999999999742 567899999999999987643 457999999999999999999999998  999999999


Q ss_pred             cEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh
Q psy4988         424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY  503 (627)
Q Consensus       424 NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt  503 (627)
                      |||++.+   +.+||+|||+++.+....       .......||+.|+|||++.... ...++.++|||||||+||+|++
T Consensus       167 Nil~~~~---~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          167 NLLVGED---GHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETR-KIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             GEEECTT---SCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTC-CCEESHHHHHHHHHHHHHHHHH
T ss_pred             HEEECCC---CCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCC-CCCCCchhhhHhHHHHHHHHHH
Confidence            9999887   689999999998765432       1233458999999999984221 1124788999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       504 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      |+.||..........    ........++..+.+++++.+||.+||+.||.+|||+.++++||||.
T Consensus       236 g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          236 GQCPFMDERIMCLHS----KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SSCSSCCSSHHHHHH----HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CCCCCCCccHHHHHH----HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            999997654432221    12223345556678999999999999999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.4e-47  Score=387.14  Aligned_cols=266  Identities=27%  Similarity=0.371  Sum_probs=223.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++||||+++++++. +
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   76 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----ARDFQKLEREARICRKLQHPNIVRLHDSIQ-E   76 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-----HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-c
Confidence            4678999999999999999999999999999999998754332     223456889999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+++||||+.+++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+...+.+||+|||+
T Consensus        77 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           77 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            6778899999999999999988889999999999999999999999988  99999999999998765445699999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.......        ......||+.|+|||++.    ...++.++|||||||+||+|++|+.||............  .
T Consensus       155 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~  220 (284)
T 3kk8_A          155 AIEVNDSE--------AWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--K  220 (284)
T ss_dssp             CEECCSSC--------BCCCSCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H
T ss_pred             eEEcccCc--------cccCCCCCcCCcCchhhc----CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH--H
Confidence            98765432        123357999999999984    455899999999999999999999999776554433221  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........+.+..+++++.+||.+||..||.+|||+.++++||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          221 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             hccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            112222333445789999999999999999999999999999999754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-47  Score=405.37  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=220.2

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ....++|.+++.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||+++++|. 
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-  111 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-  111 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc----cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            34568899999999999999999999999999999998643211    1123456889999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+|||||||+|++|..++...+.+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---g~~kL~DFg  186 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCT
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC---CCEEEcccc
Confidence            66788999999999999999998889999999999999999999999988  9999999999999887   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+...          ....+||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   
T Consensus       187 ~a~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---  249 (350)
T 1rdq_E          187 FAKRVKGR----------TWTLCGTPEALAPEIIL----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK---  249 (350)
T ss_dssp             TCEECSSC----------BCCCEECGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             cceeccCC----------cccccCCccccCHHHhc----CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH---
Confidence            99876532          23458999999999984    45689999999999999999999999987655433221   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      +. .....  .+..++.++.+||.+||+.||.+||+     +.++++||||...
T Consensus       250 i~-~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          250 IV-SGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HH-HCCCC--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HH-cCCCC--CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            11 12223  34578999999999999999999998     9999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=404.87  Aligned_cols=266  Identities=29%  Similarity=0.388  Sum_probs=208.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ...+.++|.+.+.||+|+||.||+|.+..+++.||||++.....         .+.+.+|+.+++.++|||||+++++|.
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---------KKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---------HHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            45678899999999999999999999999999999999864321         235778999999999999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+++||||+++++|.+++.....+++.+++.++.||+.||.|||+.+  ||||||||+|||++.....+.+||+||
T Consensus       119 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          119 -TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             -cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccC
Confidence             66788999999999999999998889999999999999999999999988  999999999999986333378999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++......        .....+||+.|+|||++.    +..++.++|||||||+||+|++|..||........+....
T Consensus       196 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i  263 (349)
T 2w4o_A          196 GLSKIVEHQV--------LMKTVCGTPGYCAPEILR----GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI  263 (349)
T ss_dssp             C------------------------CGGGSCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred             ccccccCccc--------ccccccCCCCccCHHHhc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence            9998765322        123457999999999984    4468999999999999999999999997665554333221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                       .........+.+..++.++.+||++||..||++|||+.++++||||....
T Consensus       264 -~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          264 -LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             -HTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             -HhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence             11111122233467899999999999999999999999999999997543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-47  Score=406.38  Aligned_cols=262  Identities=24%  Similarity=0.403  Sum_probs=217.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||||++.......    ......+..|..++..+ +|||||+++++|.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH----TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh----hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            345688999999999999999999999999999999986432211    11234577899999876 8999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+|||||+|++|..++.....+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +++||+||
T Consensus        89 -~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---g~vkL~DF  162 (345)
T 1xjd_A           89 -TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD---GHIKIADF  162 (345)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCC
T ss_pred             -eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC---CCEEEeEC
Confidence             66788999999999999999998889999999999999999999999998  9999999999999987   69999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++......       ......+||+.|+|||++.    +..++.++|||||||+||+|++|..||........+... 
T Consensus       163 G~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-  230 (345)
T 1xjd_A          163 GMCKENMLGD-------AKTNTFCGTPDYIAPEILL----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-  230 (345)
T ss_dssp             TTCBCCCCTT-------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             hhhhhcccCC-------CcccCCCCCcccCChhhhc----CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence            9998643221       1234568999999999984    446899999999999999999999999776554333211 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHH-HHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI-SLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~-elL~hp~~~~~  571 (627)
                         ......+  +..++.++.+||.+||+.||.+||++. ++++||||...
T Consensus       231 ---~~~~~~~--p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          231 ---RMDNPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             ---HHCCCCC--CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ---HhCCCCC--CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence               1122233  346899999999999999999999998 99999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.3e-48  Score=407.22  Aligned_cols=262  Identities=30%  Similarity=0.493  Sum_probs=216.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||+++++|. +
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK----KSDMHMRVEREISYLKLLRHPHIIKLYDVIT-T   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc----chhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-e
Confidence            4567899999999999999999999999999999998643211    1112346789999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+++||||+ +++|.+++...+.+++.+++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~---~~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN---LNVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT---CCEEECCSSC
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC---CCEEEEEecc
Confidence            67788999999 5789898888889999999999999999999999998  9999999999999987   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.......        .....+||+.|+|||++.   .....+.++|||||||+||+|++|+.||.........      
T Consensus       155 s~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------  217 (336)
T 3h4j_B          155 SNIMTDGN--------FLKTSCGSPNYAAPEVIN---GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------  217 (336)
T ss_dssp             TBTTTTSB--------TTCCCTTSTTTSCGGGSC---CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------
T ss_pred             ceeccCCc--------ccccccCCcCcCCHHHHc---CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------
Confidence            98765432        234458999999999984   2223478999999999999999999999754332211      


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .......+..+..+++++.+||++||..||.+|||+.++++||||....+
T Consensus       218 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          218 KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            11111223344568999999999999999999999999999999976543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.7e-48  Score=409.09  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++.....           ...+|++++.++ +|||||+++++|.
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------~~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----------DPTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----------CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----------ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            3567889999999999999999999999999999999865432           134688888877 7999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC-cccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN-VCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~-~~g~vKL~D  440 (627)
                       +...+|+|||||.|++|.+++...+.+++..++.++.||+.||.|||+.+  ||||||||+|||+.++. ..+.+||+|
T Consensus        87 -~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~D  163 (342)
T 2qr7_A           87 -DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICD  163 (342)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEE
Confidence             67788999999999999999998889999999999999999999999998  99999999999986542 224699999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ--SQATIL  518 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~--~~~~~~  518 (627)
                      ||+++.+....       ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||....  ....+.
T Consensus       164 fg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~  232 (342)
T 2qr7_A          164 FGFAKQLRAEN-------GLLMTPCYTANFVAPEVLE----RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL  232 (342)
T ss_dssp             CTTCEECBCTT-------CCBCCSSCCSSCCCHHHHH----HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred             CCCcccCcCCC-------CceeccCCCccccCHHHhc----CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence            99998765432       1234458999999999984    3347889999999999999999999997532  222222


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .. ............+..+++++++||++||..||.+||++.++++||||..
T Consensus       233 ~~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          233 AR-IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HH-HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HH-HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            21 1111112222345679999999999999999999999999999999954

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.4e-47  Score=404.02  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=217.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +..++|.+++.||+|+||.||+|.+..+++.||||++.......    ......+.+|..++..+ +||||++++++|. 
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH----TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc----chHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-
Confidence            45678999999999999999999999999999999986432211    12245678899999988 7999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|||||||+|++|..++...+.+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +++||+|||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~---g~vkL~DFG  166 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE---GHIKIADFG  166 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC---CcEEEEeCC
Confidence            66788999999999999999998889999999999999999999999988  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++......       ......+||+.|+|||++.    ...++.++|||||||+||||++|+.||........+..   
T Consensus       167 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~---  232 (353)
T 2i0e_A          167 MCKENIWDG-------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---  232 (353)
T ss_dssp             TCBCCCCTT-------CCBCCCCSCGGGCCHHHHT----TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             cccccccCC-------cccccccCCccccChhhhc----CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH---
Confidence            998643221       1234568999999999984    45689999999999999999999999987655433221   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      +. .....+  +..++.++.+||.+||+.||.+||     ++.++++||||..
T Consensus       233 i~-~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          233 IM-EHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HH-HCCCCC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HH-hCCCCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            11 122333  357899999999999999999999     4699999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-47  Score=407.54  Aligned_cols=263  Identities=26%  Similarity=0.397  Sum_probs=218.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||+|++......       ....+.+|+.+++.++|||||+++++|. +
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~-~  119 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-------DKYTVKNEISIMNQLHHPKLINLHDAFE-D  119 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE-C
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-------hHHHHHHHHHHHHhCCCcCCCeEEEEEE-e
Confidence            3567899999999999999999999999999999998654321       1235789999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+|+|||||.+++|.+++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+. .+.+||+|||
T Consensus       120 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~-~~~vkL~DFG  196 (387)
T 1kob_A          120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKK-ASSVKIIDFG  196 (387)
T ss_dssp             SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTT-CCCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCC-CCceEEEecc
Confidence            77889999999999999998765 47999999999999999999999988  99999999999998542 2589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+....        .....+||+.|+|||++.    ...++.++||||||||||+|++|..||........+.... 
T Consensus       197 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-  263 (387)
T 1kob_A          197 LATKLNPDE--------IVKVTTATAEFAAPEIVD----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-  263 (387)
T ss_dssp             TCEECCTTS--------CEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-
T ss_pred             cceecCCCc--------ceeeeccCCCccCchhcc----CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            998765432        123347999999999984    4568999999999999999999999998765544332211 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       ..........+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       264 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          264 -RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -hCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence             111112223345789999999999999999999999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=391.59  Aligned_cols=266  Identities=28%  Similarity=0.477  Sum_probs=214.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||++++++|. +..
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-----DPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-----chHHHHHHHHHHHHHHhCCCCCccchhheee-cCC
Confidence            4789999999999999999999999999999998865432     1223456789999999999999999999997 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++|||||++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~  150 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH---SVIKLCDFGFAR  150 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCTTCE
T ss_pred             eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC---CCEEEeeCCCch
Confidence            78899999999999999988889999999999999999999999988  9999999999999887   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       ......+||+.|+|||++.   ....++.++|||||||+||+|++|..||........+........
T Consensus       151 ~~~~~~-------~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  220 (311)
T 4agu_A          151 LLTGPS-------DYYDDEVATRWYRSPELLV---GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG  220 (311)
T ss_dssp             ECC-------------------GGGCCHHHHH---TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             hccCcc-------cccCCCcCCccccChHHHh---cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc
Confidence            765332       1223457999999999985   234689999999999999999999999987766555443322211


Q ss_pred             hh---------------ccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         526 AT---------------EVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       526 ~~---------------~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ..               ....+          ..+.++.++.+||.+||++||.+|||+.++++||||....
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            00               00111          1146889999999999999999999999999999998643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.1e-47  Score=396.98  Aligned_cols=264  Identities=26%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||.||+|.+..+++.||||++.......      ....+.+|+.+++.++|||||+++++|. +.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------TPSTAIREISLMKELKHENIVRLYDVIH-TEN   76 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC------SCHHHHHHHHHHTTCCBTTBCCEEEEEC-CTT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc------cHHHHHHHHHHHHhcCCCCcceEEEEEE-ECC
Confidence            467999999999999999999999999999999987543211      1235778999999999999999999997 667


Q ss_pred             eEEEEEeecCCCChHHHHHhc------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .+|||||||+ ++|.+++...      ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~---~~~kl~  150 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR---GQLKLG  150 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEEC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC---CCEEEC
Confidence            8899999999 5898888654      35999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.+....       ......+||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+..
T Consensus       151 Dfg~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  220 (317)
T 2pmi_A          151 DFGLARAFGIPV-------NTFSSEVVTLWYRAPDVLM---GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL  220 (317)
T ss_dssp             CCSSCEETTSCC-------CCCCCCCSCCTTCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cCccceecCCCc-------ccCCCCcccccccCchHhh---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999998765321       1123447899999999985   234589999999999999999999999987766544433


Q ss_pred             HHHHhhhhc----------------------------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKATE----------------------------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~----------------------------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .........                            +.......++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          221 IFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             HHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence            222111000                            0001123578999999999999999999999999999999754


Q ss_pred             C
Q psy4988         572 V  572 (627)
Q Consensus       572 ~  572 (627)
                      .
T Consensus       301 ~  301 (317)
T 2pmi_A          301 Y  301 (317)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.6e-47  Score=390.53  Aligned_cols=261  Identities=28%  Similarity=0.457  Sum_probs=209.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||+||+|.+ .+++.||||++........     ....+.+|+.+++.++|||||++++++. +.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEG-----IPSTTIREISILKELKHSNIVKLYDVIH-TKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGC-----CCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccc-----cchhHHHHHHHHHhcCCCCEeeeeeEEc-cCCe
Confidence            6899999999999999999998 6789999999865432111     1245778999999999999999999997 5677


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+++
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~  148 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE---GELKIADFGLAR  148 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEECCTTHHH
T ss_pred             EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CCEEEeECcccc
Confidence            8899999996 888887654 68999999999999999999999988  9999999999999887   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+........
T Consensus       149 ~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  218 (288)
T 1ob3_A          149 AFGIPV-------RKYTHEIVTLWYRAPDVLM---GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG  218 (288)
T ss_dssp             HHCC----------------CCCTTCCHHHHT---TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccCccc-------cccccccccccccCchhee---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC
Confidence            765321       1123347899999999985   234589999999999999999999999987766555443322211


Q ss_pred             hhc-c-------------cc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         526 ATE-V-------------QF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       526 ~~~-~-------------~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ... .             .+         .....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            100 0             00         012357899999999999999999999999999999974

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.6e-47  Score=400.22  Aligned_cols=269  Identities=25%  Similarity=0.444  Sum_probs=209.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|+++++||+|+||+||+|.+..+++.||||++.....     .......+.+|+.+++.++|||||++++++. +
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-----EEGVPGTAIREVSLLKELQHRNIIELKSVIH-H  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------CHHHHHHGGGCCCTTBCCEEEEEE-E
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-----ccccchhHHHHHHHHHHcCCCCcceEEEEEe-c
Confidence            356789999999999999999999999999999999865432     1223456778999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vKL~DF  441 (627)
                      ...+|||||||++ +|..++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+.  ..+.+||+||
T Consensus       105 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcC
Confidence            6788999999995 99999998889999999999999999999999988  99999999999996431  1246999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....       ......+||+.|+|||++.   ....++.++|||||||+||+|++|..||........+....
T Consensus       182 g~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  251 (329)
T 3gbz_A          182 GLARAFGIPI-------RQFTHEIITLWYRPPEILL---GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF  251 (329)
T ss_dssp             THHHHHC------------------CCTTCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCccccCCcc-------cccCCCcCCccccCHHHhc---CCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence            9998765332       1123347899999999985   23458999999999999999999999998776655544332


Q ss_pred             HHhhhhc-cccC------C-----------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATE-VQFA------N-----------------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~-~~~~------~-----------------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ....... ..++      .                 ...+++++.+||.+||++||.+|||+.++|+||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            2211110 0000      0                 01278999999999999999999999999999999753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-47  Score=406.81  Aligned_cols=272  Identities=25%  Similarity=0.423  Sum_probs=206.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~  362 (627)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.+. |||||+++++|..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~   80 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-----NSTDAQRTFREIMILTELSGHENIVNLLNVLRA   80 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-----CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-----ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence            456899999999999999999999999999999998753321     1223456789999999997 9999999999974


Q ss_pred             cC-CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DA-NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~-~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +. ..+|+|||||+ ++|..++.. ..+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+||
T Consensus        81 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~---~~~kl~DF  153 (388)
T 3oz6_A           81 DNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE---CHVKVADF  153 (388)
T ss_dssp             TTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECCC
T ss_pred             CCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC---CCEEecCC
Confidence            33 46899999998 588888876 58999999999999999999999998  9999999999999987   68999999


Q ss_pred             ccccccccCCCCC--------------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         442 GLSKVMDEENYNP--------------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       442 Gla~~~~~~~~~~--------------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                      |+|+.+.......              ..........+||++|+|||++.   ....++.++||||||||||+|++|++|
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL---GSTKYTKGIDMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc---CCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence            9998764321100              00112234468999999999985   235689999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhhhhc-----------------------------------------cccCCCCCCCHHHHHHHH
Q psy4988         508 FGHNQSQATILEENTILKATE-----------------------------------------VQFANKPTVSNEAKGFIR  546 (627)
Q Consensus       508 f~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~vs~el~~LI~  546 (627)
                      |........+...........                                         .....+..+++++.+||.
T Consensus       231 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            987765544433221111000                                         001122367899999999


Q ss_pred             HhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         547 SCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       547 ~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +||++||.+|||+.++|+||||..
T Consensus       311 ~~L~~dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred             HhhccCcccCCCHHHHhCCHHHHH
Confidence            999999999999999999999974

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.5e-47  Score=397.44  Aligned_cols=263  Identities=29%  Similarity=0.451  Sum_probs=209.7

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      .+..++|.+++.||+|+||.||+|.+.   .+++.||||++.......   .......+.+|+.+++.++|||||+++++
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR---NAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------HHHHHHHCCCTTBCCEEEE
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            456689999999999999999999985   689999999986543211   11223457789999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      |. +.+.+|+|||||++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus        90 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~---~~~kl~  163 (327)
T 3a62_A           90 FQ-TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ---GHVKLT  163 (327)
T ss_dssp             EE-CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT---SCEEEC
T ss_pred             EE-cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC---CcEEEE
Confidence            98 56778899999999999999998889999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..
T Consensus       164 Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  232 (327)
T 3a62_A          164 DFGLCKESIHDG-------TVTHTFCGTIEYMAPEILM----RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK  232 (327)
T ss_dssp             CCSCC-----------------CTTSSCCTTSCHHHHT----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             eCCcccccccCC-------ccccccCCCcCccCHhhCc----CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999998654321       1234458999999999984    44588999999999999999999999987655443321


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      .   .. .  .+..++.++.++.+||.+||..||.+||     ++.++++||||...
T Consensus       233 i---~~-~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          233 I---LK-C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             H---HH-T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             H---Hh-C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            1   11 1  2233457899999999999999999999     89999999999753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-47  Score=420.98  Aligned_cols=266  Identities=31%  Similarity=0.470  Sum_probs=218.8

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ...+.++|++++.||+|+||+||+|.+..++..||||++.........     ...+.+|+.+++.++|||||+++++|.
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~  106 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----NSKLLEEVAVLKLLDHPNIMKLYDFFE  106 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----THHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            345677899999999999999999999999999999998754321111     245789999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+|||||.+++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.....+.+||+||
T Consensus       107 -~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          107 -DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             -eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEEC
Confidence             67788999999999999999988889999999999999999999999988  999999999999987644467999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.     ..++.++|||||||+||+|++|..||........+... 
T Consensus       184 G~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-  249 (494)
T 3lij_A          184 GLSAVFENQK--------KMKERLGTAYYIAPEVLR-----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-  249 (494)
T ss_dssp             TTCEECBTTB--------CBCCCCSCTTTCCHHHHT-----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             CCCeECCCCc--------cccccCCCcCeeCHHHHc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence            9998765432        123458999999999973     34899999999999999999999999876655443221 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                       .........+.+..+++++++||++||++||.+|||+.++|+||||..
T Consensus       250 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          250 -EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             -HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             -HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence             111122233445679999999999999999999999999999999964

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-47  Score=388.76  Aligned_cols=262  Identities=27%  Similarity=0.477  Sum_probs=212.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..++..||||++.......      ....+.+|+.+++.++||||++++++|. +
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~   91 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV------PMEQIEAEIEVLKSLDHPNIIKIFEVFE-D   91 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS------CHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch------hHHHHHHHHHHHHhCCCchHHhHHHhee-c
Confidence            46789999999999999999999999999999999987543211      1346788999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      ...+|+||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+...+.+||+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEE
Confidence            67889999999999999988543    67999999999999999999999988  9999999999999765444789999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++..+....        ......||+.|+|||++.     ..++.++|||||||+||+|++|+.||...........
T Consensus       170 Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~  236 (285)
T 3is5_A          170 DFGLAELFKSDE--------HSTNAAGTALYMAPEVFK-----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK  236 (285)
T ss_dssp             CCCCCCC------------------CTTGGGCCHHHHT-----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eeecceecCCcc--------cCcCcccccCcCChHHhc-----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence            999998765432        123457999999999973     3478999999999999999999999987654433221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .  ... ..........+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       237 ~--~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          237 A--TYK-EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             H--HHC-CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             h--ccC-CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            1  111 11111122357899999999999999999999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.7e-47  Score=398.71  Aligned_cols=275  Identities=25%  Similarity=0.378  Sum_probs=210.2

Q ss_pred             ccCCCeeEE-EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         284 VLSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~-~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      .+.++|.+. +.||+|+||.||+|.+..+++.||||++......       ....+.+|+.++.++ +||||++++++|.
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-------IRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-------CHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-------hHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            467889996 7899999999999999999999999998654321       124678899999885 7999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|+|||||++++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+.....+||+||
T Consensus        82 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           82 -EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             -ETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             -eCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence             56788999999999999999998889999999999999999999999998  999999999999998754346999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ------  514 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~------  514 (627)
                      |++..+.................+||+.|+|||++.... ....++.++|||||||+||+|++|+.||......      
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            999876432211111111123347999999999985210 0134788999999999999999999999754321      


Q ss_pred             --------HHHHHHHHHhhhhccccC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         515 --------ATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       515 --------~~~~~~~~~~~~~~~~~~--~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                              ..+..   ........++  .+..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          239 GEACPACQNMLFE---SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             --CCHHHHHHHHH---HHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             cccchhHHHHHHH---HHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                    11111   1111112222  124688999999999999999999999999999999854

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-47  Score=417.16  Aligned_cols=274  Identities=25%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.++++||+|+||+||+|.+..+++.||||++.....     .....+++.+|+.+++.++|||||+++++|...
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-----DLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-----CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            456899999999999999999999999999999999854322     122346788999999999999999999998532


Q ss_pred             ----CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 ----ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                          ...+|+||||+. ++|..++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       125 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~---~~~kl~  198 (458)
T 3rp9_A          125 DVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD---CSVKVC  198 (458)
T ss_dssp             CTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---CCEEEC
T ss_pred             CcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC---CCEeec
Confidence                256899999986 689999988889999999999999999999999998  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCC--------------------CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDH--------------------GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~--------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      |||+|+.+.........                    ........+||++|+|||++.   ....|+.++||||||||||
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~~DiwSlG~il~  275 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL---LQENYTEAIDVWSIGCIFA  275 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT---TCCCCCTHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh---CCCCCCcHhHHHHHHHHHH
Confidence            99999877533211000                    001234458999999999874   3446899999999999999


Q ss_pred             HHHh-----------CCCCCCCCCh--------------------HHHHHHHHHHhhhhc----------------c---
Q psy4988         500 QCLY-----------GKKPFGHNQS--------------------QATILEENTILKATE----------------V---  529 (627)
Q Consensus       500 ellt-----------G~~Pf~~~~~--------------------~~~~~~~~~~~~~~~----------------~---  529 (627)
                      ||++           |+++|.+...                    ...+.....++....                .   
T Consensus       276 elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~  355 (458)
T 3rp9_A          276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP  355 (458)
T ss_dssp             HHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSC
T ss_pred             HHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcC
Confidence            9998           6777754321                    011100000000000                0   


Q ss_pred             ------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         530 ------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       530 ------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                            .....+.+++++.+||++||.+||.+|||+.|+|+||||...
T Consensus       356 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence                  011234679999999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=394.07  Aligned_cols=269  Identities=26%  Similarity=0.453  Sum_probs=207.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDV  359 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~  359 (627)
                      .++.++|+++++||+|+||+||+|.+..+++.||||++..........  .....+.+|+.+++.+   +|||||+++++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~niv~~~~~   82 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG--GLPISTVREVALLRRLEAFEHPNVVRLMDV   82 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS--CCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc--ccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence            456789999999999999999999999999999999987543211100  0012345566666655   59999999999


Q ss_pred             EeecCC----eEEEEEeecCCCChHHHHHhccC--cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         360 FEIDAN----SFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       360 ~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      |.....    .+++||||+. ++|..++.....  +++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~---  156 (308)
T 3g33_A           83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG---  156 (308)
T ss_dssp             EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT---
T ss_pred             eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC---
Confidence            975443    5789999998 599999887654  999999999999999999999998  9999999999999887   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++.+....        .....+||+.|+|||++.    ...++.++|||||||+||+|++|+.||.....
T Consensus       157 ~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  224 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLL----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  224 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHH----TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred             CCEEEeeCccccccCCCc--------ccCCccccccccCchHHc----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            689999999998764321        123458999999999985    34589999999999999999999999987776


Q ss_pred             HHHHHHHHHHhhhhc-cccC--------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         514 QATILEENTILKATE-VQFA--------------------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~-~~~~--------------------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ...+........... ..++                    ..+.+++++.+||.+||++||.+|||+.++|+||||+..
T Consensus       225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            655443322211110 0010                    113678999999999999999999999999999999753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-47  Score=422.14  Aligned_cols=267  Identities=33%  Similarity=0.501  Sum_probs=222.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ...+.++|.++++||+|+||+||+|.+..+++.||||++.......     .....+.+|+.+++.++|||||++++++.
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~   91 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-----KDTSTILREVELLKKLDHPNIMKLFEILE   91 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-----hHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence            3457789999999999999999999999999999999986432111     11346889999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|+|||||.+++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.....+.+||+||
T Consensus        92 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           92 -DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEEC
Confidence             67788999999999999999988889999999999999999999999998  999999999999976544468999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.    + .++.++||||||||||+|++|..||........+... 
T Consensus       169 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-  234 (486)
T 3mwu_A          169 GLSTCFQQNT--------KMKDRIGTAYYIAPEVLR----G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-  234 (486)
T ss_dssp             SCTTTBCCC------------CCTTGGGGCCGGGGG----S-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             CcCeECCCCC--------ccCCCcCCCCCCCHHHhC----C-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence            9998765332        123458999999999984    2 4899999999999999999999999876654433221 


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       .........+.+..+|+++++||.+||++||.+|||+.++|+||||+..
T Consensus       235 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          235 -ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             -HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             -HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence             1122233445566899999999999999999999999999999999743

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-47  Score=416.95  Aligned_cols=261  Identities=30%  Similarity=0.457  Sum_probs=210.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|.++++||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||+++++|. +
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~  219 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-T  219 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH----C-------------CCCCCSCTTSCCEEEEEE-E
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh----hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-e
Confidence            456789999999999999999999999999999999864321    12223456788999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|||||||++++|..++.....+++..++.|+.||+.||.|||+ .+  ||||||||+||||+.+   +.+||+|||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~---~~~kl~DFG  294 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD---GHIKITDFG  294 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS---SCEEECCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC---CCEEEccCC
Confidence            67789999999999999999988899999999999999999999998 78  9999999999999987   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+......       ......+||+.|+|||++.    ...++.++||||||||||+|++|+.||...........   
T Consensus       295 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---  360 (446)
T 4ejn_A          295 LCKEGIKDG-------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---  360 (446)
T ss_dssp             CCCTTCC------------CCSSSCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             CceeccCCC-------cccccccCCccccCHhhcC----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---
Confidence            998643322       1234468999999999984    44589999999999999999999999976655433221   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                       ......  ..+..+++++.+||.+||.+||.+||     ++.++++||||...
T Consensus       361 -i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          361 -ILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             -HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -HHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence             111222  23456899999999999999999999     99999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=411.45  Aligned_cols=270  Identities=25%  Similarity=0.350  Sum_probs=218.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.++++||+|+||.||+|.+..+++.||||++......    ....+..+.+|+.++..++|||||+++++|. 
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~----~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-  131 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML----KRGEVSCFREERDVLVNGDRRWITQLHFAFQ-  131 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh----hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-
Confidence            35568899999999999999999999999999999998642211    1122345778999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|||||||+|++|..++... ..+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +++||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~---g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC---GHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC---CCEEEeec
Confidence            677889999999999999999875 48999999999999999999999988  9999999999999987   69999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccC---CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG---KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      |+++.+.....      ......+||+.|+|||++...   .....|+.++|||||||+||||++|+.||...+....+.
T Consensus       207 Gla~~~~~~~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          207 GSCLKLRADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             TTCEECCTTSC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             hhheeccCCCc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99987654321      112345899999999998521   113458999999999999999999999998766554432


Q ss_pred             HHHHHhhhhccccCC-CCCCCHHHHHHHHHhhhcCcCCC---CCHHHHHhccCCCCC
Q psy4988         519 EENTILKATEVQFAN-KPTVSNEAKGFIRSCLAYRKEDR---IDVISLARHDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~-~~~vs~el~~LI~~cL~~dP~~R---pt~~elL~hp~~~~~  571 (627)
                      ...  .......++. ...+++++++||++||+ +|.+|   +++.++++||||...
T Consensus       281 ~i~--~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          281 KIV--HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             HHH--THHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             HHH--hcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            221  1112233332 35789999999999999 99998   599999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.9e-47  Score=398.28  Aligned_cols=274  Identities=27%  Similarity=0.412  Sum_probs=222.9

Q ss_pred             ccccCCCCccCCCeeEE-EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCce
Q psy4988         276 QSRFNNHPVLSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRV  353 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~-~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI  353 (627)
                      ...|...+.+.++|.+. +.||+|+||.||+|.+..+++.||||++........     ....+.+|+.++..+. ||||
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~~i   91 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-----CRAEILHEIAVLELAKSCPRV   91 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-----CHHHHHHHHHHHHHTTTCTTB
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-----HHHHHHHHHHHHHhccCCCCE
Confidence            45566667788999998 899999999999999999999999999875432211     1346788999999994 6999


Q ss_pred             eEEeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       354 V~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      ++++++|. +...+|+|||||.+++|.+++...  ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+...
T Consensus        92 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           92 INLHEVYE-NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             CCEEEEEE-CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBT
T ss_pred             EEEEEEEE-eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCC
Confidence            99999997 677789999999999999988543  67999999999999999999999988  99999999999998743


Q ss_pred             cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy4988         432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN  511 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~  511 (627)
                      ..+.+||+|||+++.+....        .....+||+.|+|||++.    ...++.++|||||||+||+|++|+.||...
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHAC--------ELREIMGTPEYLAPEILN----YDPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             TBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcEEEeeCccccccCCcc--------ccccccCCcCccCCeeec----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            34789999999998765432        123357999999999984    456889999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       512 ~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....+......  ...........++.++.+||.+||..||.+|||+.++|+||||+..
T Consensus       237 ~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          237 DNQETYLNISQV--NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             SHHHHHHHHHHT--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             CchHHHHHHHhc--ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            665544332211  1222233345789999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-47  Score=397.73  Aligned_cols=270  Identities=28%  Similarity=0.447  Sum_probs=214.3

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||++++++
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA----RDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT----TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc----CCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            345688999999999999999999999999999999999865432    1233456788999999999999999999998


Q ss_pred             eecCC---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         361 EIDAN---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       361 ~~~~~---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      .....   .+|+|||||++++|.+++...+.+++.+++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~~~k  156 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT---NAVK  156 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT---SCEE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC---CCEE
Confidence            74432   35899999999999999998889999999999999999999999988  9999999999999887   5899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++.+......    .......+||+.|+|||++.    +..++.++|||||||+||+|++|+.||.........
T Consensus       157 l~Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  228 (311)
T 3ork_A          157 VMDFGIARAIADSGNS----VTQTAAVIGTAQYLSPEQAR----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA  228 (311)
T ss_dssp             ECCCSCC----------------------CCTTCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EeeccCcccccccccc----cccccccCcCcccCCHHHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9999999876543211    11233457999999999985    446899999999999999999999999876655443


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ....  .............++.++.+||.+||+.||.+||+..+++.|+|+.
T Consensus       229 ~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          229 YQHV--REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHH--HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHh--cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            2221  1111111122346899999999999999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-46  Score=404.27  Aligned_cols=260  Identities=32%  Similarity=0.497  Sum_probs=210.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHH-HhcCCCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-HKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIV~l~~~~~~  362 (627)
                      ...++|.+++.||+|+||.||+|.+..+++.||||++.......    ......+.+|..+ ++.++|||||+++++|. 
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~----~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------CCBCCCCCTTBCCEEEEEE-
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh----hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-
Confidence            44578999999999999999999999999999999987544322    1223456778777 57789999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+|||||||+|++|..++.....+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +++||+|||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~---g~ikL~DFG  184 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ---GHIVLTDFG  184 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEECCCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC---CCEEEeeCc
Confidence            66788999999999999999998889999999999999999999999988  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++......       ......+||+.|+|||++.    ...++.++|||||||+||||++|..||........+..   
T Consensus       185 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~---  250 (373)
T 2r5t_A          185 LCKENIEHN-------STTSTFCGTPEYLAPEVLH----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---  250 (373)
T ss_dssp             BCGGGBCCC-------CCCCSBSCCCCCCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH---
T ss_pred             cccccccCC-------CccccccCCccccCHHHhC----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH---
Confidence            998643322       1234568999999999984    45689999999999999999999999977655443321   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV----ISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~----~elL~hp~~~~  570 (627)
                      +.. ..  +...+.++.++.+||.+||+.||.+||++    .+++.||||..
T Consensus       251 i~~-~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          251 ILN-KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHH-SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHh-cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            111 12  22345789999999999999999999986    69999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-46  Score=399.63  Aligned_cols=268  Identities=22%  Similarity=0.357  Sum_probs=216.4

Q ss_pred             ccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-----C
Q psy4988         276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-----H  350 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-----H  350 (627)
                      ...+..+.++.++|.++++||+|+||+||+|.+..+++.||||++....        .....+..|+.+++.+.     |
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--------KYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--------HHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--------hhhhhhHHHHHHHHHhcccCCCC
Confidence            5567788899999999999999999999999999999999999985321        12345667999998886     9


Q ss_pred             CceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       351 pnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                      ||||+++++|. ..+.+||||||+ +++|.+++....  .+++..++.|+.||+.||.|||+.+  ||||||||+||||+
T Consensus        96 ~~iv~~~~~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  171 (360)
T 3llt_A           96 NNIVKYHGKFM-YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLD  171 (360)
T ss_dssp             GGBCCEEEEEE-ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES
T ss_pred             CCeecccceee-ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEc
Confidence            99999999998 567889999999 899999997654  5999999999999999999999988  99999999999998


Q ss_pred             CCC----------------------cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCC
Q psy4988         429 EGN----------------------VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKIS  486 (627)
Q Consensus       429 ~~~----------------------~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~  486 (627)
                      ...                      ..+.+||+|||+++.....          ....+||+.|+|||++.    +..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~  237 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVIL----NLGWD  237 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHT----TCCCC
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHc----CCCCC
Confidence            521                      1268999999999865432          23457999999999984    44689


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc----------------------cccCCC----------
Q psy4988         487 SKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE----------------------VQFANK----------  534 (627)
Q Consensus       487 ~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~----------  534 (627)
                      .++|||||||+||+|++|+.||........+...........                      ..++..          
T Consensus       238 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  317 (360)
T 3llt_A          238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV  317 (360)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHH
T ss_pred             CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhh
Confidence            999999999999999999999987665544332222111000                      001100          


Q ss_pred             --------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         535 --------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       535 --------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                              ...++++.+||.+||++||.+|||+.++|+||||+
T Consensus       318 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                    01247788999999999999999999999999995

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-47  Score=422.12  Aligned_cols=268  Identities=33%  Similarity=0.477  Sum_probs=224.8

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ....+.++|++.++||+|+||.||+|.+..+++.||||++.........    ....+.+|+.+++.++|||||+++++|
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~   95 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT----DKESLLREVQLLKQLDHPNIMKLYEFF   95 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS----CHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch----HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456788999999999999999999999999999999998654321111    134688999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +...+|+|||||.+++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.....+.+||+|
T Consensus        96 ~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           96 E-DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             E-CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             E-eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            8 67788999999999999999998899999999999999999999999998  99999999999997543347899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.+....        .....+||+.|+|||++.    + .++.++||||||||||+|++|..||........+...
T Consensus       173 fg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  239 (484)
T 3nyv_A          173 FGLSTHFEASK--------KMKDKIGTAYYIAPEVLH----G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV  239 (484)
T ss_dssp             TTHHHHBCCCC--------SHHHHTTGGGTCCHHHHH----T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eeeeEEccccc--------ccccCCCCccccCceeec----C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99998765432        123447999999999984    2 4889999999999999999999999876655443221


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                        .........+.+..+++++++||++||++||.+|||+.++|+||||+.
T Consensus       240 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          240 --EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             --HHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             --HcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence              112223334555689999999999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.7e-47  Score=420.29  Aligned_cols=273  Identities=30%  Similarity=0.480  Sum_probs=221.9

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh------HhHHHHHHHHHHHHHHHhcCCCCcee
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE------DKKANYIKHALREYNIHKALDHPRVV  354 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~------~~~~~~~~~~~~Ei~il~~l~HpnIV  354 (627)
                      ....+.++|.++++||+|+||+||+|.+..+++.||||++........      .........+.+|+.+++.++|||||
T Consensus        30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  109 (504)
T 3q5i_A           30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII  109 (504)
T ss_dssp             ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred             cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence            345678999999999999999999999999999999999875432110      00012245688999999999999999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      +++++|. +...+|||||||++++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+....
T Consensus       110 ~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          110 KLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             CEEEEEE-CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCS
T ss_pred             eEEEEEE-cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCc
Confidence            9999998 67788999999999999999988889999999999999999999999988  99999999999999875434


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      .+||+|||+++.+....        .....+||+.|+|||++.     ..++.++||||||||||+|++|..||......
T Consensus       187 ~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  253 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLK-----KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ  253 (504)
T ss_dssp             SEEECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHT-----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cEEEEECCCCEEcCCCC--------ccccccCCcCCCCHHHhc-----cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            79999999998765432        123457999999999983     34889999999999999999999999876655


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+....  ........+.+..+++++++||++||.+||.+|||+.++|+||||+..
T Consensus       254 ~~~~~i~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          254 DIIKKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             HHHHHHH--cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            4432211  111122233446799999999999999999999999999999999754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-46  Score=416.45  Aligned_cols=265  Identities=27%  Similarity=0.445  Sum_probs=222.6

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ...+..++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||++++++
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            455677899999999999999999999999999999999864321    1112345688999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +...+|+|||||++++|.+++...+.+++.+++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|
T Consensus        86 ~-~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~---~~vkL~D  159 (476)
T 2y94_A           86 S-TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH---MNAKIAD  159 (476)
T ss_dssp             E-CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT---CCEEECC
T ss_pred             E-ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC---CCeEEEe
Confidence            8 56788999999999999999998889999999999999999999999988  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.+....        .....+||+.|+|||++..   ...++.++|||||||+||+|++|..||........+.. 
T Consensus       160 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-  227 (476)
T 2y94_A          160 FGLSNMMSDGE--------FLRTSCGSPNYAAPEVISG---RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-  227 (476)
T ss_dssp             CSSCEECCTTC--------CBCCCCSCSTTCCHHHHTT---CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-
T ss_pred             ccchhhccccc--------cccccCCCcCeEChhhccC---CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-
Confidence            99998765432        2344589999999999852   23347899999999999999999999987655433221 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                        +.   ...+..+..+++++.+||++||..||.+|||+.++++||||....
T Consensus       228 --i~---~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          228 --IC---DGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             --HH---TTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             --Hh---cCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence              11   112334456899999999999999999999999999999997543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-47  Score=401.13  Aligned_cols=262  Identities=31%  Similarity=0.449  Sum_probs=194.2

Q ss_pred             CCCeeEE---EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEe
Q psy4988         286 SDRYLLL---MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~---~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~  361 (627)
                      .++|.+.   +.||+|+||.||+|.+..+++.||||++....          ...+.+|+.+++.+. |||||+++++|.
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~e~~~l~~l~~h~niv~~~~~~~   76 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----------EANTQKEITALKLCEGHPNIVKLHEVFH   76 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----------HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh----------hhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            4567765   77999999999999999999999999985321          234678999999997 999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+|||||||++++|.+++.....+++.+++.|+.||+.||.|||+.+  ||||||||+|||++.+.....+||+||
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Df  153 (325)
T 3kn6_A           77 -DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDF  153 (325)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCC
T ss_pred             -cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEecc
Confidence             67788999999999999999999899999999999999999999999988  999999999999987643348999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---HH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT---IL  518 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~---~~  518 (627)
                      |+++......       ......+||+.|+|||++.    ...++.++|||||||+||+|++|..||........   ..
T Consensus       154 g~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  222 (325)
T 3kn6_A          154 GFARLKPPDN-------QPLKTPCFTLHYAAPELLN----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV  222 (325)
T ss_dssp             TTCEECCC---------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred             ccceecCCCC-------CcccccCCCcCccCHHHhc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence            9998765432       1223457899999999984    45689999999999999999999999975432110   01


Q ss_pred             HHHHHhhhhcccc--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         519 EENTILKATEVQF--ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~~~~--~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ............+  ..+..+++++++||.+||++||.+|||+.++++||||+..
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            1111111111111  1224689999999999999999999999999999999753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-47  Score=396.85  Aligned_cols=263  Identities=27%  Similarity=0.491  Sum_probs=206.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+++.||+|+||+||+|.+..+++.||||++......      .....+.+|+.+++.++|||||++++++. +.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE------GAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------CCCCCCCHHHHSCCCCTTBCCEEEEEE-CSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhHHHHHHHHHhcCCCCCCeeeeEEe-eCCE
Confidence            6899999999999999999999999999999998643321      11123557999999999999999999997 6677


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+++
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~  148 (324)
T 3mtl_A           75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER---GELKLADFGLAR  148 (324)
T ss_dssp             EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT---CCEEECSSSEEE
T ss_pred             EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC---CCEEEccCcccc
Confidence            8899999985 777777654 56999999999999999999999988  9999999999999987   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       ......+||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+........
T Consensus       149 ~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  218 (324)
T 3mtl_A          149 AKSIPT-------KTYDNEVVTLWYRPPDILL---GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG  218 (324)
T ss_dssp             CC-------------------CGGGCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccCCc-------cccccccCcccccChhhhc---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            654322       1123347899999999985   234689999999999999999999999987766554433322211


Q ss_pred             hhc-c--------------cc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         526 ATE-V--------------QF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       526 ~~~-~--------------~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ... .              .+         ...+.+++++.+||.+||++||.+|||+.++|+||||....
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            110 0              00         11245789999999999999999999999999999998654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.7e-47  Score=417.65  Aligned_cols=261  Identities=25%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|++++.||+|+||+||+|++..+++.||||++.....     .....+.+.+|+.+++.++|||||+++++|...
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-----SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-----ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            356899999999999999999999999999999999864321     223356788999999999999999999999633


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|||||||+++ |...+.  ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus       134 ~~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~---~~~kl  205 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKI  205 (464)
T ss_dssp             CSTTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEE
T ss_pred             CccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC---CCEEE
Confidence            2     4679999999875 555553  35999999999999999999999998  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+|+......        .....+||++|+|||++.    +..|+.++||||||||||+|++|+.||.+.+....+.
T Consensus       206 ~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~  273 (464)
T 3ttj_A          206 LDFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN  273 (464)
T ss_dssp             CCCCCC-----CC--------CC----CCCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEEEeeeecCCCc--------ccCCCcccccccCHHHHc----CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999998765421        234458999999999985    4468999999999999999999999998776554443


Q ss_pred             HHHHHhhhhcc---------------ccCCC---------C------------CCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         519 EENTILKATEV---------------QFANK---------P------------TVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       519 ~~~~~~~~~~~---------------~~~~~---------~------------~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      ...........               ..+..         +            ..++++.+||.+||.+||.+|||+.|+
T Consensus       274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  353 (464)
T 3ttj_A          274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  353 (464)
T ss_dssp             HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            32221111000               00000         0            015789999999999999999999999


Q ss_pred             HhccCCC
Q psy4988         563 ARHDYLQ  569 (627)
Q Consensus       563 L~hp~~~  569 (627)
                      |+||||.
T Consensus       354 L~Hp~~~  360 (464)
T 3ttj_A          354 LQHPYIN  360 (464)
T ss_dssp             HTSTTTG
T ss_pred             hcChhhh
Confidence            9999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-46  Score=385.05  Aligned_cols=258  Identities=31%  Similarity=0.444  Sum_probs=215.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||.||+|.+..++..||||++.....    ........+.+|+.+++.++||||++++++|. +
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-D   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc----chhhHHHHHHHHHHHHHcCCCCCCcchhheEe-c
Confidence            345789999999999999999999999999999999864321    11222456889999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+++||||+++++|..++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~---~~~~l~Dfg~  155 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA---GELKIADFGW  155 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT---SCEEECSCCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC---CCEEEEeccc
Confidence            6778999999999999999998889999999999999999999999988  9999999999999887   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.......         .....||+.|+|||++.    ...++.++||||||++||+|++|..||............   
T Consensus       156 ~~~~~~~~---------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---  219 (279)
T 3fdn_A          156 SVHAPSSR---------RTDLCGTLDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---  219 (279)
T ss_dssp             ESCC-----------------CCCCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---
T ss_pred             cccCCccc---------ccccCCCCCccCHhHhc----cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---
Confidence            86544321         23347999999999984    456788999999999999999999999876554433221   


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                         ....+..+..+++++.+||.+||..||.+|||+.++++||||..
T Consensus       220 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          220 ---SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             ---HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             ---HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence               11233344568999999999999999999999999999999974

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-46  Score=408.05  Aligned_cols=261  Identities=30%  Similarity=0.459  Sum_probs=204.0

Q ss_pred             cCCCeeEE-EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHH-hcCCCCceeEEeeEEee
Q psy4988         285 LSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~-~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIV~l~~~~~~  362 (627)
                      +.++|.+. ++||+|+||+||+|.+..+++.||||++...            ..+.+|+.++ +.++|||||+++++|..
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            34556665 7999999999999999999999999998532            1356788877 45589999999999863


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                         +...+|||||||+|++|.+++....  .+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+...+.+|
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEE
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEE
Confidence               2456899999999999999998653  6999999999999999999999988  99999999999999753337899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++......        .....+||+.|+|||++.    ...++.++||||||||||+|++|+.||.........
T Consensus       205 l~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  272 (400)
T 1nxk_A          205 LTDFGFAKETTSHN--------SLTTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_dssp             ECCCTTCEECC-------------------CTTCCGGGSC----CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred             EEecccccccCCCC--------ccccCCCCCCccCHhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            99999998765321        123458999999999983    456899999999999999999999999755432110


Q ss_pred             --HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         518 --LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       518 --~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ..............+.+..++.++.+||++||..||.+|||+.++++||||...
T Consensus       273 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence              111111112222233456799999999999999999999999999999999643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.6e-46  Score=381.86  Aligned_cols=261  Identities=27%  Similarity=0.403  Sum_probs=215.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee---
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI---  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~---  362 (627)
                      ...|.+.+.||+|+||.||+|.+..++..||||++......     ......+.+|+.+++.++|||||+++++|..   
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-----HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            45689999999999999999999999999999998754322     2234678899999999999999999999864   


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+|+||||+++++|.+++.....+++..++.|+.||+.||.|||+.+++|+||||||+|||++...  +.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~--~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT--GSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT--SCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC--CCEEEeeCC
Confidence            245689999999999999999988899999999999999999999999776799999999999998433  689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++......         ......||+.|+|||++.     ..++.++|||||||+||+|++|+.||........+.....
T Consensus       178 ~~~~~~~~---------~~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  243 (290)
T 1t4h_A          178 LATLKRAS---------FAKAVIGTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT  243 (290)
T ss_dssp             GGGGCCTT---------SBEESCSSCCCCCGGGGG-----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred             Cccccccc---------ccccccCCcCcCCHHHHh-----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh
Confidence            99765432         123457999999999873     2488999999999999999999999987655544433211


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                         ............++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       244 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          244 ---SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence               111111223456789999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.8e-46  Score=406.90  Aligned_cols=275  Identities=25%  Similarity=0.412  Sum_probs=209.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++.....     .....+.+.+|+.+++.++|||||++++++...
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-----DLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-----ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            467899999999999999999999999999999999864321     222346788999999999999999999998744


Q ss_pred             C----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 A----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ~----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .    ..+||||||+++ +|..++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus        98 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~---~~~kL~  171 (432)
T 3n9x_A           98 DLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD---CSVKVC  171 (432)
T ss_dssp             CTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEEC
T ss_pred             CCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCC---CCEEEc
Confidence            3    568999999984 99999998888999999999999999999999998  9999999999999887   689999


Q ss_pred             ecccccccccCCCCCC---------------CCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy4988         440 DFGLSKVMDEENYNPD---------------HGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       440 DFGla~~~~~~~~~~~---------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG  504 (627)
                      |||+|+.+........               .........+||++|+|||++.   ....++.++||||||||||||++|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~~~~~~DiwSlG~il~ell~g  248 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL---LQENYTKSIDIWSTGCIFAELLNM  248 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHT---TCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh---cCCCCCcccccchHHHHHHHHHhc
Confidence            9999998754321100               0001234568999999999874   344689999999999999999985


Q ss_pred             CCC-----------CCCCCh-----------------HHHHHHHHHHhhh--------------------hccccC----
Q psy4988         505 KKP-----------FGHNQS-----------------QATILEENTILKA--------------------TEVQFA----  532 (627)
Q Consensus       505 ~~P-----------f~~~~~-----------------~~~~~~~~~~~~~--------------------~~~~~~----  532 (627)
                      ..|           |.+...                 ...+......+..                    .....+    
T Consensus       249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (432)
T 3n9x_A          249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLK  328 (432)
T ss_dssp             CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred             ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHH
Confidence            443           332210                 0111000000000                    000000    


Q ss_pred             -CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         533 -NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       533 -~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                       ..+.+++++.+||.+||.+||.+|||+.++|+||||....
T Consensus       329 ~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          329 QKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence             1146899999999999999999999999999999998643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.4e-46  Score=382.75  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=217.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..++..||+|++.......       ...+.+|+.+++.++||||++++++|. +
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   77 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-------VDRFKQEIEIMKSLDHPNIIRLYETFE-D   77 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-------HHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            35678999999999999999999999999999999986533211       346788999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+||||+++++|.+++.....+++..++.|+.||+.||.|||+.+  |+||||||+|||+..+...+.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            7788999999999999999988889999999999999999999999988  99999999999994433336899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +..+....        ......||+.|+|||++.    + .++.++|||||||++|+|++|..||.............. 
T Consensus       156 ~~~~~~~~--------~~~~~~~t~~y~aPE~~~----~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-  221 (277)
T 3f3z_A          156 AARFKPGK--------MMRTKVGTPYYVSPQVLE----G-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE-  221 (277)
T ss_dssp             CEECCTTS--------CBCCCCSCTTTCCHHHHT----T-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred             ceeccCcc--------chhccCCCCCccChHHhc----c-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-
Confidence            98765432        123457999999999983    2 388999999999999999999999987665544322211 


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       .........+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       222 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          222 -GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             -CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             -CCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence             11111111123688999999999999999999999999999999753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-46  Score=400.19  Aligned_cols=263  Identities=29%  Similarity=0.439  Sum_probs=209.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++.....     .....+.+.+|+.+++.++|||||+++++|..+
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-----SELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-----SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-----CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            457899999999999999999999999999999999854322     223356788999999999999999999999743


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~---~~~kl  169 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED---CELKI  169 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEE
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC---CCEEE
Confidence            2     3468999999 7899998876 67999999999999999999999998  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.....          ....+||++|+|||++..   ...++.++||||||||||+|++|+.||........+.
T Consensus       170 ~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~  236 (367)
T 1cm8_A          170 LDFGLARQADSE----------MTGYVVTRWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  236 (367)
T ss_dssp             CCCTTCEECCSS----------CCSSCSCGGGCCTHHHHT---TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             Eeeecccccccc----------cCcCcCCCCcCCHHHHhC---CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999876432          233478999999999862   2458999999999999999999999998776554443


Q ss_pred             HHHHHhhhhc------------------------ccc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         519 EENTILKATE------------------------VQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~------------------------~~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..........                        ..+ ...+.+++++.+||.+||.+||.+|||+.++|+||||...
T Consensus       237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            3222111000                        000 1124678999999999999999999999999999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-46  Score=393.08  Aligned_cols=271  Identities=28%  Similarity=0.421  Sum_probs=220.7

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++......... .......+.+|+.+++.++||||++++++|. 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-   85 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR-RGVSREEIEREVSILRQVLHHNVITLHDVYE-   85 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc-cchhHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence            35678899999999999999999999999999999998765432110 0001346789999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-ccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-~g~vKL~DF  441 (627)
                      +...+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+.. ...+||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            66788999999999999999998889999999999999999999999988  999999999999987631 117999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |++..+....        ......||+.|+|||++.    ...++.++|||||||+||+|++|..||........+....
T Consensus       164 g~~~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  231 (321)
T 2a2a_A          164 GLAHEIEDGV--------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (321)
T ss_dssp             TTCEECCTTC--------CCCCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             ccceecCccc--------cccccCCCCCccCccccc----CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9998765432        123347999999999984    4568999999999999999999999998766554432211


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..  ...........++.++.+||.+||..||.+|||+.++++||||...
T Consensus       232 ~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          232 SV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             hc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            11  0011111124688999999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.7e-46  Score=398.81  Aligned_cols=269  Identities=24%  Similarity=0.405  Sum_probs=221.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcch-hhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW-KEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~-~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +.++|.+.+.||.|+||.||+|.+..+++.||||++...... ...........+.+|+.+++.+ +||||++++++|. 
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-  170 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-  170 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe-
Confidence            446799999999999999999999999999999998765421 1222334456788999999999 7999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ....+|+||||+++++|.+++.....+++..++.|+.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~---~~ikl~DfG  245 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN---MQIRLSDFG  245 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECCCT
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC---CCEEEEecC
Confidence            66788999999999999999998889999999999999999999999988  9999999999999987   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCC--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK--NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ++..+....        .....+||+.|+|||++....  ....++.++|||||||+||+|++|..||........+...
T Consensus       246 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  317 (365)
T 2y7j_A          246 FSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI  317 (365)
T ss_dssp             TCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            998765432        123458999999999985331  1335888999999999999999999999766544332111


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                        .........+.+..++.++.+||.+||+.||.+|||+.++++||||+
T Consensus       318 --~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          318 --MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             --HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             --HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence              11111122233457889999999999999999999999999999996

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-47  Score=413.74  Aligned_cols=273  Identities=32%  Similarity=0.459  Sum_probs=211.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-hHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-KKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+.++|.+.+.||+|+||+||+|.+..+++.||||++......... ........+.+|+.++++++|||||+++++|. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4578999999999999999999999999999999998754322111 11222335788999999999999999999985 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                       ...+|+|||||++++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+.....+||+|||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence             4457899999999999999988889999999999999999999999988  9999999999999875434579999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+....        .....+||+.|+|||++... ....++.++|||||||+||+|++|..||........+.....
T Consensus       288 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~  358 (419)
T 3i6u_A          288 HSKILGETS--------LMRTLCGTPTYLAPEVLVSV-GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT  358 (419)
T ss_dssp             TTTSCC-------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH
T ss_pred             cceecCCCc--------cccccCCCCCccCceeeecC-CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh
Confidence            998765422        23445899999999998421 134578899999999999999999999976544333322111


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                       ..........+..+++++.+||.+||++||.+|||+.++++||||+.
T Consensus       359 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          359 -SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             -TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence             11111111223568999999999999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-46  Score=397.31  Aligned_cols=275  Identities=28%  Similarity=0.423  Sum_probs=216.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++.......  ........+.+|+.+++.++|||||+++++|. +.
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~  100 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ--INPKDVERIKTEVRLMKKLHHPNIARLYEVYE-DE  100 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CS
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc--cCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-cC
Confidence            4578999999999999999999999999999999986432111  11223467889999999999999999999997 67


Q ss_pred             CeEEEEEeecCCCChHHHHHh----------------------------------------ccCcCHHHHHHHHHHHHHH
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQ----------------------------------------HKTIAEREARSIVMQVVSA  404 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~i~~qi~~a  404 (627)
                      ..+|+|||||++++|.+++..                                        ...+++..++.|+.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            788999999999999998852                                        1234788899999999999


Q ss_pred             HHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCC
Q psy4988         405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPK  484 (627)
Q Consensus       405 L~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~  484 (627)
                      |.|||+.+  ||||||||+||||+.+.. ..+||+|||+++.+.......   ........||+.|+|||++...  ...
T Consensus       181 l~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~  252 (345)
T 3hko_A          181 LHYLHNQG--ICHRDIKPENFLFSTNKS-FEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTT--NES  252 (345)
T ss_dssp             HHHHHHTT--EECCCCCGGGEEESCSSS-CCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCS--SSC
T ss_pred             HHHHHHCC--ccccCCChhhEEEecCCC-ceEEEeeccccccccccCccc---cccccccCCCccccCchhhccC--CCC
Confidence            99999998  999999999999986531 389999999998765422110   1112345799999999998421  246


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         485 ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       485 ~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ++.++|||||||+||+|++|+.||........+...  .........+....+++++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--HhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            889999999999999999999999877665544322  112222222333458999999999999999999999999999


Q ss_pred             ccCCCCCC
Q psy4988         565 HDYLQPPV  572 (627)
Q Consensus       565 hp~~~~~~  572 (627)
                      ||||....
T Consensus       331 hp~~~~~~  338 (345)
T 3hko_A          331 HPWISQFS  338 (345)
T ss_dssp             SHHHHTTS
T ss_pred             ChhhccCh
Confidence            99997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=391.07  Aligned_cols=262  Identities=20%  Similarity=0.270  Sum_probs=205.5

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKL  356 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l  356 (627)
                      +.....++.++|+++++||+|+||+||+|.+..+++.||||++........     ....++.|+..+..+ +|||||++
T Consensus        48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~~~~~~~h~~iv~l  122 (311)
T 3p1a_A           48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-----DRARKLAEVGSHEKVGQHPCCVRL  122 (311)
T ss_dssp             TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-----HHHHHHHHHHHHHHhcCCCcEEEE
Confidence            334455677899999999999999999999999999999998754432211     123445565555544 89999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++|. +...+|||||||. ++|..++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.
T Consensus       123 ~~~~~-~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~---~~  195 (311)
T 3p1a_A          123 EQAWE-EGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR---GR  195 (311)
T ss_dssp             EEEEE-ETTEEEEEEECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG---GC
T ss_pred             EEEEE-eCCEEEEEEeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC---CC
Confidence            99997 6778899999995 5777777654 57999999999999999999999988  9999999999999877   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++......        ......||+.|+|||++.    + .++.++|||||||+||+|++|..||.......
T Consensus       196 ~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  262 (311)
T 3p1a_A          196 CKLGDFGLLVELGTAG--------AGEVQEGDPRYMAPELLQ----G-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ  262 (311)
T ss_dssp             EEECCCTTCEECC--------------CCCCCGGGCCGGGGG----T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH
T ss_pred             EEEccceeeeecccCC--------CCcccCCCccccCHhHhc----C-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            9999999998765432        123347999999999884    2 48899999999999999999977764432211


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .+       ............+++++.+||.+||+.||.+|||+.++++||||+.|
T Consensus       263 ~~-------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          263 QL-------RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP  311 (311)
T ss_dssp             HH-------TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred             HH-------hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence            11       11111111224688999999999999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-46  Score=379.76  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=209.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++........     ....+++|+.++..+ +||||++++++|. 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-   81 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-----DEQNALREVYAHAVLGQHSHVVRYFSAWA-   81 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-----HHHHHHHHHHHHHHSCSCTTBCCEEEEEE-
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeeee-
Confidence            356789999999999999999999999999999999875432221     234678899999999 9999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC-------
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN-------  431 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~-------  431 (627)
                      +.+.+++||||+++++|.+++...    ..+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+.       
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC----------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccc
Confidence            667888999999999999999765    67999999999999999999999988  99999999999998542       


Q ss_pred             ---------cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHH
Q psy4988         432 ---------VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL  502 (627)
Q Consensus       432 ---------~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ell  502 (627)
                               ....+||+|||++.......           ...||+.|+|||++.   ....++.++|||||||+||+|+
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQ---ENYTHLPKADIFALALTVVCAA  225 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHT---TCCTTHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhc---CCCCCCchhhHHHHHHHHHHHh
Confidence                     22479999999998765422           236999999999985   2335678999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         503 YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       503 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      +|.+||........+      ....  ....+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       226 ~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          226 GAEPLPRNGDQWHEI------RQGR--LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSSHHHHHH------HTTC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cCCCCCcchhHHHHH------HcCC--CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            999887544322111      1111  112235689999999999999999999999999999999854

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.8e-46  Score=393.78  Aligned_cols=269  Identities=25%  Similarity=0.396  Sum_probs=212.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      ..++|++++.||+|+||.||+|.+..+++.||||++........     ....+.+|+.+++.++|||||++++++... 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   89 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----FPITALREIKILQLLKHENVVNLIEICRTKA   89 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-----SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-----chHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence            45799999999999999999999999999999999865433211     123567899999999999999999998753 


Q ss_pred             ------CCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         364 ------ANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       364 ------~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                            .+.+|+|||||++ +|...+. ....+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+
T Consensus        90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~---~~~  163 (351)
T 3mi9_A           90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVL  163 (351)
T ss_dssp             -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCE
T ss_pred             cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC---CCE
Confidence                  3468899999996 5555554 4468999999999999999999999988  9999999999999987   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+++.+.......   .......+||+.|+|||++.   ....++.++|||||||+||+|++|..||........
T Consensus       164 kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  237 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLL---GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ  237 (351)
T ss_dssp             EECCCTTCEECCCCSSSS---CCCCCSSCSCGGGCCHHHHT---TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEccchhccccccccccc---ccccCCcccccCccCchhhc---CCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999998765332111   11223457899999999984   234588999999999999999999999988776655


Q ss_pred             HHHHHHHhhhhccc-cCCCC-------------------------CCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         517 ILEENTILKATEVQ-FANKP-------------------------TVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       517 ~~~~~~~~~~~~~~-~~~~~-------------------------~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +............. ++...                         ..++++.+||.+||++||.+|||+.++|+||||..
T Consensus       238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            44333222211111 11000                         02678999999999999999999999999999974

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-45  Score=388.18  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=214.5

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ..|...+.||+|+||.||+|.+..+++.||||++.......       ...+.+|+.+++.++|||||+++++|. ..+.
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~  116 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-------RELLFNEVVIMRDYQHFNVVEMYKSYL-VGEE  116 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS-------HHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH-------HHHHHHHHHHHHhCCCCCcceEEEEEE-ECCE
Confidence            35888899999999999999999999999999987543211       235788999999999999999999998 5667


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++..
T Consensus       117 ~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~  190 (321)
T 2c30_A          117 LWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD---GRVKLSDFGFCAQ  190 (321)
T ss_dssp             EEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC---CcEEEeeeeeeee
Confidence            8899999999999998865 57999999999999999999999988  9999999999999977   5899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +....       ......+||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..   +...
T Consensus       191 ~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~---~~~~  256 (321)
T 2c30_A          191 ISKDV-------PKRKSLVGTPYWMAPEVIS----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDS  256 (321)
T ss_dssp             CCSSS-------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS
T ss_pred             cccCc-------cccccccCCccccCHhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcC
Confidence            65432       1123458999999999984    45688999999999999999999999976655433321   2222


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ....+.....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       257 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          257 PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence            22233344568999999999999999999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-46  Score=420.76  Aligned_cols=266  Identities=25%  Similarity=0.415  Sum_probs=219.7

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ..++..++|.+.+.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++|||||+++++|
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK----KRKGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh----hhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            3456778999999999999999999999999999999998643211    111234678999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      . +.+.+|||||||+|++|..++....  .+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +++||
T Consensus       254 ~-~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~---g~vKL  327 (576)
T 2acx_A          254 E-TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH---GHIRI  327 (576)
T ss_dssp             E-CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---SCEEE
T ss_pred             e-eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC---CCeEE
Confidence            8 6678899999999999999998654  4999999999999999999999998  9999999999999987   69999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.+....        .....+||+.|+|||++.    ...++.++||||||||||+|++|+.||..........
T Consensus       328 ~DFGla~~~~~~~--------~~~~~~GT~~Y~APEvl~----~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~  395 (576)
T 2acx_A          328 SDLGLAVHVPEGQ--------TIKGRVGTVGYMAPEVVK----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE  395 (576)
T ss_dssp             CCCTTCEECCTTC--------CEECCCSCGGGCCHHHHT----TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred             EecccceecccCc--------cccccCCCccccCHHHHc----CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence            9999998765321        123458999999999984    4458999999999999999999999997654321111


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ............+  +..+++++++||.+||+.||.+||     ++.++++||||..
T Consensus       396 ~i~~~i~~~~~~~--p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          396 EVERLVKEVPEEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHhhcccccC--CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            1111122222233  357899999999999999999999     8999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-47  Score=398.89  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=214.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-hHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-KKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +.++|.+++.||+|+||.||+|.+..+++.||||++......... ........+.+|+.+++.++|||||+++++|. +
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-N  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-e
Confidence            557899999999999999999999999999999998765421110 00001224667999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCC-ChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGH-DLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg-~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+++||||+.++ +|..++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~---~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED---FTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---SCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC---CcEEEeecc
Confidence            77888999999766 99999999889999999999999999999999988  9999999999999987   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+....        .....+||+.|+|||++.   ....++.++|||||||+||+|++|..||.....         
T Consensus       176 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------  235 (335)
T 3dls_A          176 SAAYLERGK--------LFYTFCGTIEYCAPEVLM---GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------  235 (335)
T ss_dssp             TCEECCTTC--------CBCEECSCGGGCCHHHHT---TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred             cceECCCCC--------ceeccCCCccccChhhhc---CCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence            998765432        123457999999999985   223348899999999999999999999964211         


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                         ........+..+++++.+||.+||..||.+|||+.++++||||..+.
T Consensus       236 ---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          236 ---TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ---GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ---HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence               11122233456899999999999999999999999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.8e-46  Score=403.91  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++.....           ...+|+++++.++|||||+++++|... 
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            45579999999999999999999999999999998864322           133699999999999999999998532 


Q ss_pred             ----CCeEEEEEeecCCCChHHHHH----hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         364 ----ANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       364 ----~~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                          ...+++||||+++ +|..++.    ....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+.  +.
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~--~~  195 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDT--AV  195 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTT--TE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCC--Ce
Confidence                2246799999996 4544443    3568999999999999999999999988  99999999999999653  47


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++.+.....        ....+||++|+|||++.   ....++.++||||||||||||++|+.||.......
T Consensus       196 ~kl~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~  264 (420)
T 1j1b_A          196 LKLCDFGSAKQLVRGEP--------NVSYICSRYYRAPELIF---GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD  264 (420)
T ss_dssp             EEECCCTTCEECCTTCC--------CCSCCSCTTSCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEeccchhhhhcccCCC--------ceeeeeCCCcCCHHHHc---CCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            89999999987653321        23357899999999985   23368999999999999999999999998877665


Q ss_pred             HHHHHHHHhhh-------------hccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         516 TILEENTILKA-------------TEVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       516 ~~~~~~~~~~~-------------~~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .+.........             ....++          ..+.+++++.+||.+||++||.+|||+.++++||||..
T Consensus       265 ~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence            55443222110             011121          12457899999999999999999999999999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-46  Score=380.32  Aligned_cols=267  Identities=26%  Similarity=0.436  Sum_probs=219.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++......      .....+.+|+.+++.++||||+++++++. +.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   77 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------DCPENIKKEICINKMLNHENVVKFYGHRR-EG   77 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT------THHHHHHHHHHHHHTCCCTTBCCEEEEEE-ET
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch------hhhHHHHHHHHHHHhcCCCCceeeeeEEE-cC
Confidence            346799999999999999999999999999999998654321      12356788999999999999999999987 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~dfg~~  152 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER---DNLKISDFGLA  152 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC---CCEEEeeCCCc
Confidence            778899999999999999988788999999999999999999999988  9999999999999986   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....     ........||+.|+|||++..   ...++.++|||||||++|+|++|..||.............   
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---  221 (276)
T 2yex_A          153 TVFRYNNR-----ERLLNKMCGTLPYVAPELLKR---REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---  221 (276)
T ss_dssp             EECEETTE-----ECCBCCCCSCGGGCCGGGGTC---SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH---
T ss_pred             cccCCCcc-----hhcccCCccccCccChHHHhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh---
Confidence            87643221     112344579999999999842   2234778999999999999999999997655432222211   


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      .........+..+++++.+||.+||..||.+|||+.++++||||..+...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             hhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            11122233445789999999999999999999999999999999876544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.8e-46  Score=395.77  Aligned_cols=266  Identities=25%  Similarity=0.382  Sum_probs=218.7

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ....+..++|++++.||+|+||.||+|.+..++..||||++.....      ......+.+|+.+++.++|||||+++++
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~   99 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK------PAIRNQIIRELQVLHECNSPYIVGFYGA   99 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC------HHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence            3456778999999999999999999999999999999999875432      2234578899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      |. +.+.+|+|||||++++|.+++.....+++..++.|+.||+.||.|||+. +  ||||||||+||||+.+   +.+||
T Consensus       100 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~---~~~kl  173 (360)
T 3eqc_A          100 FY-SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR---GEIKL  173 (360)
T ss_dssp             EE-ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT---CCEEE
T ss_pred             EE-ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC---CCEEE
Confidence            98 5677889999999999999999888999999999999999999999985 7  9999999999999987   58999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||++..+....         .....||+.|+|||++.    ...++.++|||||||+||+|++|+.||..........
T Consensus       174 ~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  240 (360)
T 3eqc_A          174 CDFGVSGQLIDSM---------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  240 (360)
T ss_dssp             CCCCCCHHHHHHC-------------CCCCTTCCHHHHT----TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred             EECCCCccccccc---------ccCCCCCCCeECHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999997664321         23347999999999984    4568999999999999999999999997655433211


Q ss_pred             HHH--------------------------------------HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHH
Q psy4988         519 EEN--------------------------------------TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI  560 (627)
Q Consensus       519 ~~~--------------------------------------~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~  560 (627)
                      ...                                      ...............++.++.+||.+||.+||.+|||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  320 (360)
T 3eqc_A          241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  320 (360)
T ss_dssp             HHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             HhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence            100                                      000000111112235789999999999999999999999


Q ss_pred             HHHhccCCCC
Q psy4988         561 SLARHDYLQP  570 (627)
Q Consensus       561 elL~hp~~~~  570 (627)
                      ++++||||+.
T Consensus       321 ell~hp~~~~  330 (360)
T 3eqc_A          321 QLMVHAFIKR  330 (360)
T ss_dssp             HHHTSHHHHH
T ss_pred             HHhhChHhhc
Confidence            9999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=395.29  Aligned_cols=265  Identities=28%  Similarity=0.484  Sum_probs=209.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH--PRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~  361 (627)
                      +..++|.+++.||+|+||.||+|.+ .+++.||||++......     ......+.+|+.+++.++|  |||+++++++.
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-----hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            4567899999999999999999987 56899999998754322     2234578899999999986  99999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+||||| +.+++|.+++.....+++.+++.|+.||+.||.|||+.+  ||||||||+||||++    +.+||+||
T Consensus        80 -~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~~----~~~kl~DF  151 (343)
T 3dbq_A           80 -TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD----GMLKLIDF  151 (343)
T ss_dssp             -CSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET----TEEEECCC
T ss_pred             -eCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEEC----CcEEEeec
Confidence             6678899999 567899999999899999999999999999999999988  999999999999974    48999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCC-------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-------NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-------~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      |+++.+......     ......+||+.|+|||++....       ....++.++|||||||+||+|++|+.||......
T Consensus       152 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  226 (343)
T 3dbq_A          152 GIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  226 (343)
T ss_dssp             SSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             ccccccCccccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence            999876543211     1233458999999999985311       1256889999999999999999999999765443


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...+..  .. ........+...+.++.+||.+||..||.+|||+.++++||||+.
T Consensus       227 ~~~~~~--~~-~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          227 ISKLHA--II-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HHHHHH--HH-CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHH--Hh-cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            322211  11 112223334456789999999999999999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-46  Score=385.84  Aligned_cols=266  Identities=25%  Similarity=0.403  Sum_probs=214.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +.++.++|++++.||+|+||.||+|.+..+++.||||++......    .....+.+.+|+.+++.++||||+++++++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   81 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE----KEETLKRFEREVHNSSQLSHQNIVSMIDVDE   81 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC----CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc----cHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence            567889999999999999999999999999999999998654432    2334567889999999999999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        82 -~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~---~~~kl~Df  155 (294)
T 4eqm_A           82 -EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN---KTLKIFDF  155 (294)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEECCC
T ss_pred             -eCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CCEEEEeC
Confidence             66788999999999999999998889999999999999999999999988  9999999999999887   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+.....      ......+||+.|+|||++.    +..++.++|||||||+||+|++|+.||.............
T Consensus       156 g~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~  225 (294)
T 4eqm_A          156 GIAKALSETSL------TQTNHVLGTVQYFSPEQAK----GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI  225 (294)
T ss_dssp             SSSTTC-------------------CCSSCCHHHHH----TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH
T ss_pred             CCccccccccc------cccCccccCccccCHhHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence            99987654321      1223457999999999985    4457899999999999999999999998766544432211


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                       ..............+++.+.+||.+||+.||.+||+..+.+.+.|.
T Consensus       226 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          226 -QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             -SSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             -hccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence             1111111122345789999999999999999999966666666654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-46  Score=380.91  Aligned_cols=260  Identities=30%  Similarity=0.458  Sum_probs=218.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ....++|.+.+.||+|+||.||+|.+..+++.||||++......    .......+.+|+.+++.++||||+++++++. 
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   84 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE----KEGVEHQLRREIEIQSHLRHPNILRMYNYFH-   84 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc----hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-
Confidence            34567899999999999999999999999999999998643211    1112346788999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~Dfg  159 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK---GELKIADFG  159 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT---CCEEECCCT
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC---CCEEEeccc
Confidence            66788999999999999999998889999999999999999999999988  9999999999999877   589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++.......         .....||+.|+|||++.    ...++.++||||||+++|+|++|..||...........   
T Consensus       160 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---  223 (284)
T 2vgo_A          160 WSVHAPSLR---------RRTMCGTLDYLPPEMIE----GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR---  223 (284)
T ss_dssp             TCEECSSSC---------BCCCCSCGGGCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---
T ss_pred             ccccCcccc---------cccccCCCCcCCHHHhc----cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH---
Confidence            997654321         23347999999999984    44578999999999999999999999977654433211   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      +.   ...+..+..++.++.+||.+||..||.+||++.++++||||...
T Consensus       224 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          224 IV---NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HH---TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             Hh---ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            11   12233345789999999999999999999999999999999743

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-45  Score=379.17  Aligned_cols=261  Identities=31%  Similarity=0.458  Sum_probs=220.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +...++|.+.+.||+|+||.||+|.+..+++.||+|++.......    ......+.+|+.+++.++||||+++++++. 
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSMEISIHRSLAHQHVVGFHGFFE-   85 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC----HHHHHHHHHHHHHHHhCCCCCEeeeeeeec-
Confidence            356689999999999999999999999999999999986543221    223456888999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+++||||+++++|.+++.....+++.+++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~dfg  160 (294)
T 2rku_A           86 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED---LEVKIGDFG  160 (294)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECCCT
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC---CCEEEEecc
Confidence            66788999999999999999988889999999999999999999999988  9999999999999987   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++.......       .......||+.|+|||++.    ...++.++||||||++||+|++|+.||............  
T Consensus       161 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--  227 (294)
T 2rku_A          161 LATKVEYDG-------ERKKVLCGTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--  227 (294)
T ss_dssp             TCEECCSTT-------CCBCCCCSCCSSCCHHHHT----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred             CceecccCc-------cccccccCCCCcCCcchhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence            998765322       1123357999999999984    445788999999999999999999999876654433221  


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                        .  ...+..+..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus       228 --~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          228 --K--KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             --H--TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             --h--hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence              1  1123334578899999999999999999999999999999964

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-45  Score=378.79  Aligned_cols=273  Identities=26%  Similarity=0.425  Sum_probs=223.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcc--hhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD--WKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~--~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~  360 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++.....  ............+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            467899999999999999999999999999999999875532  111223344567889999999995 99999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +...+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        94 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~d  167 (298)
T 1phk_A           94 E-TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD---MNIKLTD  167 (298)
T ss_dssp             E-CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECC
T ss_pred             c-cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC---CcEEEec
Confidence            7 66788999999999999999998889999999999999999999999988  9999999999999887   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccC--CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG--KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      ||++..+....        ......||+.|+|||++...  .....++.++|||||||+||+|++|..||..........
T Consensus       168 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  239 (298)
T 1phk_A          168 FGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  239 (298)
T ss_dssp             CTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ccchhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence            99998765322        12345799999999987421  123457889999999999999999999997665443321


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .  ..........+.+..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       240 ~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          240 M--IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             H--HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             H--HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            1  111111222233457899999999999999999999999999999998654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.4e-46  Score=404.81  Aligned_cols=267  Identities=26%  Similarity=0.405  Sum_probs=210.5

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC------CCCcee
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL------DHPRVV  354 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIV  354 (627)
                      ....+.++|+++++||+|+||+||+|.+..+++.||||++.....        ....+.+|+.+++.+      +|+||+
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~~iv  162 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--------FHRQAAEEIRILEHLRKQDKDNTMNVI  162 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--------HHHHHHHHHHHHHHHHTTCTTSCSCBC
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--------hHHHHHHHHHHHHHHhhccccCCcCEE
Confidence            456788999999999999999999999999999999999864321        123456677776665      688999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                      +++++|. ....+|+||||+. ++|.+++....  .+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+..
T Consensus       163 ~~~~~~~-~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~  238 (429)
T 3kvw_A          163 HMLENFT-FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGR  238 (429)
T ss_dssp             CEEEEEE-ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTS
T ss_pred             EEEeecc-cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCC
Confidence            9999997 5678899999997 58888887653  5999999999999999999999998  999999999999998731


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ  512 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~  512 (627)
                       ..+||+|||+++.....          ....+||+.|+|||++.    +..++.++||||||||||+|++|.+||....
T Consensus       239 -~~vkL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          239 -SGIKVIDFGSSCYEHQR----------VYTYIQSRFYRAPEVIL----GARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             -CCEEECCCTTCEETTCC----------CCSSCSCGGGCCHHHHH----TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -cceEEeecccceecCCc----------ccccCCCCCccChHHHh----CCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence             23999999999765432          23358999999999985    3458999999999999999999999998777


Q ss_pred             hHHHHHHHHHHhhhhccc----------------cC-------------------------------------CCCCCCH
Q psy4988         513 SQATILEENTILKATEVQ----------------FA-------------------------------------NKPTVSN  539 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~----------------~~-------------------------------------~~~~vs~  539 (627)
                      ....+.............                ++                                     .....++
T Consensus       304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  383 (429)
T 3kvw_A          304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP  383 (429)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred             HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence            655543332221110000                00                                     0112478


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         540 EAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       540 el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      ++.+||++||++||.+|||+.|+|+||||+...+.
T Consensus       384 ~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred             HHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence            89999999999999999999999999999865443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=398.06  Aligned_cols=262  Identities=28%  Similarity=0.415  Sum_probs=209.2

Q ss_pred             cCCCeeE--EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         285 LSDRYLL--LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i--~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +.+.|.+  .+.||+|+||.||+|.+..+++.||||++.....       .....+.+|+.+++.++|||||+++++|. 
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-  156 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-------KDKEEVKNEISVMNQLDHANLIQLYDAFE-  156 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            3455665  6789999999999999999999999999875432       12346889999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|||||||++++|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+. .+.+||+||
T Consensus       157 ~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~-~~~~kl~DF  233 (373)
T 2x4f_A          157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRD-AKQIKIIDF  233 (373)
T ss_dssp             CSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETT-TTEEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCC-CCcEEEEeC
Confidence            667889999999999998888654 57999999999999999999999988  99999999999995322 158999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+++.+....        .....+||+.|+|||++.    ...++.++||||||||||+|++|..||........+....
T Consensus       234 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  301 (373)
T 2x4f_A          234 GLARRYKPRE--------KLKVNFGTPEFLAPEVVN----YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL  301 (373)
T ss_dssp             SSCEECCTTC--------BCCCCCSSCTTCCHHHHT----TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             CCceecCCcc--------ccccccCCCcEeChhhcc----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9998765432        123347999999999983    4568999999999999999999999998776554432221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .  .........+..+++++.+||.+||.+||.+|||+.++++||||...
T Consensus       302 ~--~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          302 A--CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             H--TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             h--ccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            1  11111222235789999999999999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-45  Score=391.87  Aligned_cols=268  Identities=26%  Similarity=0.441  Sum_probs=216.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++|||||++++++....
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH------QTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC------cHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            44899999999999999999999999999999999864221      223457889999999999999999999986432


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                          ..+|+||||+.+ +|..++.. ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|
T Consensus        99 ~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~---~~~kl~D  171 (364)
T 3qyz_A           99 IEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT---CDLKICD  171 (364)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECC
T ss_pred             ccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC---CCEEEEe
Confidence                468899999985 88888865 57999999999999999999999998  9999999999999887   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++........    .......+||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+...
T Consensus       172 fg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          172 FGLARVADPDHDH----TGFLTEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             CTTCEECCGGGCB----CCTTCCCCSCGGGCCHHHHH---TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             CcceEecCCCCCc----cccccccccccCCCCCHHhc---CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            9999876543211    11123458999999999875   2345889999999999999999999999877655544332


Q ss_pred             HHHhhhhc----------------cccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         521 NTILKATE----------------VQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       521 ~~~~~~~~----------------~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ........                ..++         ..+.+++++.+||.+||++||.+|||+.++|+||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence            21111100                0000         1146789999999999999999999999999999998653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-45  Score=388.34  Aligned_cols=261  Identities=31%  Similarity=0.445  Sum_probs=220.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++.......    ......+.+|+.+++.++||||++++++|. +
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~  112 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----PHQREKMSMEISIHRSLAHQHVVGFHGFFE-D  112 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            35678999999999999999999999999999999986543221    223456889999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      .+.+|+||||+.+++|.+++.....+++.+++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~---~~~kl~Dfg~  187 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED---LEVKIGDFGL  187 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT---CCEEECCCTT
T ss_pred             CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC---CCEEEeeccC
Confidence            6788999999999999999988889999999999999999999999988  9999999999999987   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.+....       .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+....  
T Consensus       188 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--  254 (335)
T 2owb_A          188 ATKVEYDG-------ERKKVLCGTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--  254 (335)
T ss_dssp             CEECCSTT-------CCBCCCCSCCSSCCHHHHH----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--
T ss_pred             ceecccCc-------ccccccCCCccccCHHHhc----cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--
Confidence            98765322       1123457999999999984    3457889999999999999999999998765544332211  


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ..  .+.....++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       255 --~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          255 --KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             --HT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             --cC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence              11  223345788999999999999999999999999999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.2e-46  Score=384.95  Aligned_cols=263  Identities=28%  Similarity=0.408  Sum_probs=216.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++.......       ...+.+|+.+++.++||||+++++++. +
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   77 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-------DSSLENEIAVLKKIKHENIVTLEDIYE-S   77 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------HHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-------hHHHHHHHHHHHhCCCCCeeehhhhcc-c
Confidence            45678999999999999999999999999999999987543211       235778999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||+......+.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            6788999999999999999988889999999999999999999999988  99999999999994332236899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +......         .....+||+.|+|||++.    ...++.++|||||||++|+|++|..||............  .
T Consensus       156 ~~~~~~~---------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--~  220 (304)
T 2jam_A          156 SKMEQNG---------IMSTACGTPGYVAPEVLA----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI--K  220 (304)
T ss_dssp             TCCCCCB---------TTHHHHSCCCBCCTTTBS----SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--H
T ss_pred             ceecCCC---------ccccccCCCCccChHHhc----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--H
Confidence            9764322         123346999999999984    456899999999999999999999999766544332211  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........+.+..+++++.+||.+||..||.+|||+.++++||||...
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            111122223446789999999999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.1e-46  Score=399.59  Aligned_cols=276  Identities=24%  Similarity=0.377  Sum_probs=211.2

Q ss_pred             hhhcccccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC
Q psy4988         270 RIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD  349 (627)
Q Consensus       270 ~~~~~~~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~  349 (627)
                      .+.......+..+.++.++|.++++||+|+||+||+|.+..+++.||||++....        .....+.+|+.+++.+.
T Consensus        20 ~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~   91 (397)
T 1wak_A           20 DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--------HYTETALDEIRLLKSVR   91 (397)
T ss_dssp             --CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--------cchHHHHHHHHHHHHHh
Confidence            3344445667778889999999999999999999999999999999999985321        22356788999998885


Q ss_pred             --------CCceeEEeeEEee---cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhC-CCCEE
Q psy4988         350 --------HPRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEI-KPPVI  416 (627)
Q Consensus       350 --------HpnIV~l~~~~~~---~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~-~~~Iv  416 (627)
                              ||||++++++|..   +...+||||||+.++.+..++... ..+++..++.|+.||+.||.|||+. +  ||
T Consensus        92 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--iv  169 (397)
T 1wak_A           92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--II  169 (397)
T ss_dssp             HSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EE
T ss_pred             hcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--Ee
Confidence                    7889999999863   445789999999654444444433 5799999999999999999999997 8  99


Q ss_pred             eccccCCcEEecCCC----------------------------------------------cccceEEeecccccccccC
Q psy4988         417 HYDLKPGNILLTEGN----------------------------------------------VCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       417 HrDLKP~NILl~~~~----------------------------------------------~~g~vKL~DFGla~~~~~~  450 (627)
                      ||||||+||||+.+.                                              ....+||+|||+++.....
T Consensus       170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~  249 (397)
T 1wak_A          170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH  249 (397)
T ss_dssp             CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred             cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence            999999999998652                                              0127999999999876532


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHh
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ------ATILEENTIL  524 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~------~~~~~~~~~~  524 (627)
                                ....+||+.|+|||++.    +..++.++||||||||||+|++|+.||......      ..+.......
T Consensus       250 ----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  315 (397)
T 1wak_A          250 ----------FTEDIQTRQYRSLEVLI----GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL  315 (397)
T ss_dssp             ----------SCSCCSCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHH
T ss_pred             ----------CccCCCCCcccCChhhc----CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhc
Confidence                      22347999999999985    345899999999999999999999999654421      1111111111


Q ss_pred             hhhc------------------------------------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         525 KATE------------------------------------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       525 ~~~~------------------------------------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ....                                    ..+.....++.++.+||.+||++||.+|||+.++|+||||
T Consensus       316 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          316 GKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence            0000                                    0001112345678999999999999999999999999999


Q ss_pred             C
Q psy4988         569 Q  569 (627)
Q Consensus       569 ~  569 (627)
                      .
T Consensus       396 ~  396 (397)
T 1wak_A          396 N  396 (397)
T ss_dssp             G
T ss_pred             c
Confidence            6

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.6e-46  Score=415.59  Aligned_cols=267  Identities=26%  Similarity=0.383  Sum_probs=218.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ..+..++|.+++.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++|||||+++++|.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            34566899999999999999999999999999999999864321    11122456889999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc----cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH----KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                       +...+|||||||+|++|..++...    ..+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +++|
T Consensus       256 -~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~---g~vk  329 (543)
T 3c4z_A          256 -TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD---GNVR  329 (543)
T ss_dssp             -CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---SCEE
T ss_pred             -eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC---CCEE
Confidence             667889999999999999998764    47999999999999999999999988  9999999999999987   6999


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++.+....       ......+||+.|+|||++.    +..++.++||||||||||||++|+.||.........
T Consensus       330 L~DFGla~~~~~~~-------~~~~~~~GT~~Y~APE~l~----~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~  398 (543)
T 3c4z_A          330 ISDLGLAVELKAGQ-------TKTKGYAGTPGFMAPELLL----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN  398 (543)
T ss_dssp             ECCCTTCEECCTTC-------CCBCCCCSCTTTSCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred             EeecceeeeccCCC-------cccccccCCccccChhhhc----CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence            99999998765432       1233458999999999984    456899999999999999999999999765321111


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      ............  ..+..+++++.+||++||+.||.+||+     +.++++||||...
T Consensus       399 ~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          399 KELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHhhccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            111111111222  234578999999999999999999996     5899999999853

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=378.63  Aligned_cols=258  Identities=31%  Similarity=0.505  Sum_probs=195.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||+++++++. +.+.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM----YKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-DSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-CSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh----hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-cCCe
Confidence            579999999999999999999999999999999864321    11122456889999999999999999999997 6778


Q ss_pred             EEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++||||+++++|..++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~---~~~kl~dfg~~~  160 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN---MNIKIADFGLAT  160 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT---CCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC---CCEEEEeeccee
Confidence            89999999999999999865 67999999999999999999999988  9999999999999887   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .......       ......||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+..      
T Consensus       161 ~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------  223 (278)
T 3cok_A          161 QLKMPHE-------KHYTLCGTPNYISPEIAT----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------  223 (278)
T ss_dssp             ECC---------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------
T ss_pred             eccCCCC-------cceeccCCCCcCCcchhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------
Confidence            7653221       122347999999999984    44578899999999999999999999976554332211      


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .....+..+..++.++.+||.+||..||.+|||+.++++||||...
T Consensus       224 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          224 VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            1111223345689999999999999999999999999999999754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-45  Score=397.23  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=208.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+.+.||+|+||+||+|.+..+++.||||++.....           ...+|+.+++.++|||||+++++|...
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----------~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----------YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----------hHHHHHHHHHHcCCCCccchhheeeec
Confidence            456799999999999999999999999999999998864432           123699999999999999999998532


Q ss_pred             -------------------------------------CCeEEEEEeecCCCChHHHHH----hccCcCHHHHHHHHHHHH
Q psy4988         364 -------------------------------------ANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVV  402 (627)
Q Consensus       364 -------------------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~  402 (627)
                                                           ...+++|||||++ +|...+.    ....+++..++.|+.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 3348899999995 6665554    457899999999999999


Q ss_pred             HHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCC
Q psy4988         403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNP  482 (627)
Q Consensus       403 ~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~  482 (627)
                      .||.|||+.+  |+||||||+|||++...  +.+||+|||+++.+....        ......||+.|+|||++.   ..
T Consensus       152 ~aL~~LH~~g--i~H~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~---~~  216 (383)
T 3eb0_A          152 RAVGFIHSLG--ICHRDIKPQNLLVNSKD--NTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELML---GA  216 (383)
T ss_dssp             HHHHHHHTTT--EECSCCCGGGEEEETTT--TEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHT---TC
T ss_pred             HHHHHHHHCc--CccCccCHHHEEEcCCC--CcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhc---CC
Confidence            9999999988  99999999999998433  689999999998765432        123347899999999985   23


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhh-------------ccccC----------CCCCCCH
Q psy4988         483 PKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKAT-------------EVQFA----------NKPTVSN  539 (627)
Q Consensus       483 ~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~vs~  539 (627)
                      ..++.++|||||||+||+|++|+.||........+..........             ...++          ....+++
T Consensus       217 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (383)
T 3eb0_A          217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS  296 (383)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred             CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH
Confidence            458999999999999999999999998877665554432221110             11111          1235789


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         540 EAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       540 el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ++.+||.+||.+||.+|||+.++++||||..
T Consensus       297 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            9999999999999999999999999999964

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.9e-46  Score=386.58  Aligned_cols=263  Identities=21%  Similarity=0.364  Sum_probs=204.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||.||+|.+..+++.||||++......      ...+.+.+|+.+++.++|||||+++++|....
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE------LAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT------THHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            346799999999999999999999999999999998754321      12356889999999999999999999986432


Q ss_pred             C--------------------------------------------------------eEEEEEeecCCCChHHHHHhcc-
Q psy4988         365 N--------------------------------------------------------SFCTVLEYCDGHDLDFYLKQHK-  387 (627)
Q Consensus       365 ~--------------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~-  387 (627)
                      .                                                        .+++|||||++++|.+++.... 
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence            2                                                        3789999999999999998754 


Q ss_pred             --CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCC-----Cccc
Q psy4988         388 --TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDH-----GMDL  460 (627)
Q Consensus       388 --~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~-----~~~~  460 (627)
                        ..++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++.+.........     ....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECCCTTCEECSCC--------------C
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC---CCEEEeecCcccccccchhhcccccccccccc
Confidence              3566678999999999999999988  9999999999999977   69999999999887654211000     0112


Q ss_pred             cccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccC-CCCCCCH
Q psy4988         461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFA-NKPTVSN  539 (627)
Q Consensus       461 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~vs~  539 (627)
                      ....+||+.|+|||++.    ...++.++|||||||+||+|++|..|+..   .......  .   ....++ .....++
T Consensus       233 ~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~--~---~~~~~~~~~~~~~~  300 (332)
T 3qd2_B          233 HTGQVGTKLYMSPEQIH----GNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITD--V---RNLKFPLLFTQKYP  300 (332)
T ss_dssp             CCSCC-CGGGSCHHHHH----CCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHH--H---HTTCCCHHHHHHCH
T ss_pred             ccccCCCcCccChHHhc----CCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHH--h---hccCCCcccccCCh
Confidence            23457999999999985    44689999999999999999998877621   1111111  1   111111 1124567


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         540 EAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       540 el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ++.+||.+||+.||.+|||+.++++||||+.
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            8899999999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.2e-46  Score=391.22  Aligned_cols=265  Identities=25%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|++++.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++||||++++++|. +.
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~   96 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-----KMVKKIAMREIKLLKQLRHENLVNLLEVCK-KK   96 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-----hHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cC
Confidence            457899999999999999999999999999999998654322     222356788999999999999999999998 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+++++|..++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~---~~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS---GVVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC---CcEEEEeCCCc
Confidence            788899999999999998888889999999999999999999999998  9999999999999887   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +.+....       .......||+.|+|||++.   ....++.++|||||||+||+|++|+.||........+.......
T Consensus       172 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (331)
T 4aaa_A          172 RTLAAPG-------EVYDDEVATRWYRAPELLV---GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL  241 (331)
T ss_dssp             -------------------CCCCCTTCCHHHHT---TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCc-------cccCCCcCCccccCccccc---CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            8765432       1223457999999999985   23468899999999999999999999998776655443322111


Q ss_pred             hh---------------hccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         525 KA---------------TEVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       525 ~~---------------~~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..               ....++          ..+.+++++.+||.+||+.||.+|||+.++|+||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            10               000011          12367899999999999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-45  Score=391.19  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=214.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++.......    ......+.+|+.+++.++|||||+++++|. +.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~  126 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-RE  126 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-EC
Confidence            4467999999999999999999999999999999987543322    233467889999999999999999999997 56


Q ss_pred             CeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      +.++||||||.| +|.+++. ....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+
T Consensus       127 ~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kL~DfG~  200 (348)
T 1u5q_A          127 HTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP---GLVKLGDFGS  200 (348)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT---TEEEECCCTT
T ss_pred             CeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC---CCEEEeeccC
Confidence            788899999985 6666664 4578999999999999999999999988  9999999999999987   6999999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.....           ...+||+.|+|||++... ....++.++||||||||||+|++|+.||........+...   
T Consensus       201 a~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---  265 (348)
T 1u5q_A          201 ASIMAPA-----------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---  265 (348)
T ss_dssp             CBSSSSB-----------CCCCSCGGGCCHHHHHTT-SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---
T ss_pred             ceecCCC-----------CcccCCcceeCHhhhccc-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---
Confidence            9875432           234799999999998532 2345889999999999999999999999776554433221   


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .... ........+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       266 ~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          266 AQNE-SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHSC-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            1111 1112234688999999999999999999999999999999654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-45  Score=376.45  Aligned_cols=266  Identities=28%  Similarity=0.458  Sum_probs=211.9

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ...+..++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||+++++++
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   80 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI----RSLDVVGKIKREIQNLKLFRHPHIIKLYQVI   80 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc----cchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence            345677899999999999999999999999999999999864321    1122345688999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      . +...+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|
T Consensus        81 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~~l~d  154 (276)
T 2h6d_A           81 S-TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH---MNAKIAD  154 (276)
T ss_dssp             E-CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT---SCEEECC
T ss_pred             e-cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC---CCEEEee
Confidence            7 66788899999999999999998889999999999999999999999998  9999999999999977   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++.......        ......||+.|+|||++..   ....+.++||||||+++|+|++|..||........... 
T Consensus       155 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-  222 (276)
T 2h6d_A          155 FGLSNMMSDGE--------FLRTSCGSPNYAAPEVISG---RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-  222 (276)
T ss_dssp             CCGGGCCCC---------------------CCTGGGTT---SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-
T ss_pred             cccccccCCCc--------ceecccCCccccCHHHHcC---CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-
Confidence            99998765432        1233478999999999842   22346899999999999999999999976554332211 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                         ....  .+..+..++.++.+||.+||+.||.+|||+.++++||||....+
T Consensus       223 ---~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          223 ---IRGG--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             ---HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             ---hhcC--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence               1111  22234568899999999999999999999999999999976543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.1e-46  Score=390.27  Aligned_cols=274  Identities=31%  Similarity=0.452  Sum_probs=214.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh-HhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE-DKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++........ .........+.+|+.+++.++||||+++++++. 
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-
Confidence            356789999999999999999999999999999999865432111 111222345788999999999999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +. .+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+|||++.+.....+||+|||
T Consensus        86 ~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           86 AE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             SS-SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             CC-ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            33 37899999999999999988889999999999999999999999988  9999999999999876433469999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+...        ......+||+.|+|||++... ....++.++|||||||+||+|++|..||........+.....
T Consensus       163 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  233 (322)
T 2ycf_A          163 HSKILGET--------SLMRTLCGTPTYLAPEVLVSV-GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT  233 (322)
T ss_dssp             TCEECCCC--------HHHHHHHSCCTTCCHHHHHHT-TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH
T ss_pred             cceecccc--------cccccccCCcCccCchhhccC-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH
Confidence            99876432        112334799999999997422 234588999999999999999999999976544322221111


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      . .........+..++.++.+||.+||..||.+||++.++++||||...
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          234 S-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             H-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             h-CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            1 10111111124688999999999999999999999999999999753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=391.17  Aligned_cols=268  Identities=26%  Similarity=0.442  Sum_probs=208.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.......  ........+.+|+.+++.++|||||+++++|. +.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~   84 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE--AKDGINRTALREIKLLQELSHPNIIGLLDAFG-HK   84 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CT
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch--hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-eC
Confidence            4578999999999999999999999999999999986433211  11222346789999999999999999999997 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ..+++||||+++ +|..++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~---~~~kl~Dfg~  158 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN---GVLKLADFGL  158 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---CCEEECCCGG
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC---CCEEEEeccc
Confidence            678899999996 788777654 47999999999999999999999998  9999999999999887   6899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      ++.+....       ......+||+.|+|||++.   ....++.++|||||||+||+|++|.+||........+......
T Consensus       159 a~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~  228 (346)
T 1ua2_A          159 AKSFGSPN-------RAYTHQVVTRWYRAPELLF---GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET  228 (346)
T ss_dssp             GSTTTSCC-------CCCCCSCCCCTTCCHHHHT---TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ceeccCCc-------ccCCcccccccccCchHhh---CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            98765432       1123457999999999985   2345889999999999999999999999877665554332221


Q ss_pred             hhhh-ccccCC---------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKAT-EVQFAN---------------------KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~-~~~~~~---------------------~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .... ...++.                     ...+++++.+||.+||..||.+|||+.|+++||||...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            1110 111110                     14567999999999999999999999999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-45  Score=377.19  Aligned_cols=265  Identities=24%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++..++|++++.||+|+||+||+|.+..+++.||||++.......     .....+.++..+++.++||||+++++++. 
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-   76 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-----EQKRLLMDLDISMRTVDCPFTVTFYGALF-   76 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-----HHHHHHHHHHHHHHhCCCCeEEEEeeeee-
Confidence            456789999999999999999999999999999999986543221     12233445555688899999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHH----hccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLK----QHKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +.+.+|+||||+++ +|.+++.    ....+++..++.|+.||+.||.|||+. +  |+||||||+|||++.+   +.+|
T Consensus        77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~---~~~k  150 (290)
T 3fme_A           77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL---GQVK  150 (290)
T ss_dssp             CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT---CCEE
T ss_pred             ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC---CCEE
Confidence            66778899999985 7766654    356899999999999999999999997 8  9999999999999986   5899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++.+.....        .....||+.|+|||++........++.++|||||||++|+|++|+.||.........
T Consensus       151 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  222 (290)
T 3fme_A          151 MCDFGISGYLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ  222 (290)
T ss_dssp             BCCC-----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH
T ss_pred             EeecCCccccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH
Confidence            999999987654321        223479999999999743224556899999999999999999999999764443333


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      +...  ...... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       223 ~~~~--~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          223 LKQV--VEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHH--HHSCCC-CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHH--hccCCC-CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            2221  111111 1223468999999999999999999999999999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-45  Score=382.84  Aligned_cols=260  Identities=24%  Similarity=0.440  Sum_probs=210.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeec
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEID  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~  363 (627)
                      ..++|+++++||+|+||.||+|.+..+++.||||++....          ...+.+|+.+++.+. ||||+++++++...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            3578999999999999999999999999999999985322          135788999999997 99999999999742


Q ss_pred             -CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 -ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 -~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                       ...+++||||+.+++|..++.   .+++..++.++.||+.||.|||+.+  ||||||||+||||+.+.  ..+||+|||
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~--~~~kl~Dfg  176 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWG  176 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT--TEEEECCCT
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCC--CEEEEEeCC
Confidence             566889999999999998874   4999999999999999999999988  99999999999998763  489999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-H
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE-N  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~  521 (627)
                      +++.+....        ......||+.|+|||++.   ....++.++|||||||+||+|++|+.||.........+.. .
T Consensus       177 ~a~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~  245 (330)
T 3nsz_A          177 LAEFYHPGQ--------EYNVRVASRYFKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  245 (330)
T ss_dssp             TCEECCTTC--------CCCSCCSCGGGCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred             CceEcCCCC--------ccccccccccccChhhhc---CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence            998765432        123347999999999985   2346899999999999999999999999655443322221 1


Q ss_pred             HHhhhh---------c----------------------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKAT---------E----------------------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~---------~----------------------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ......         .                      ........+++++.+||.+||++||.+|||+.++|+||||..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence            111000         0                      001112237999999999999999999999999999999986


Q ss_pred             CC
Q psy4988         571 PV  572 (627)
Q Consensus       571 ~~  572 (627)
                      ..
T Consensus       326 ~~  327 (330)
T 3nsz_A          326 VV  327 (330)
T ss_dssp             CC
T ss_pred             hc
Confidence            43

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.3e-46  Score=379.53  Aligned_cols=270  Identities=27%  Similarity=0.419  Sum_probs=216.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ++.++|.+.+.||+|+||.||+|.+..+++.||||++......... .......+.+|+.+++.++||||+++++++. +
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   79 (283)
T 3bhy_A            2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR-RGVSREEIEREVNILREIRHPNIITLHDIFE-N   79 (283)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS-SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc-cchHHHHHHHHHHHHHhCCCCCeeehhheec-C
Confidence            3567899999999999999999999999999999998765322111 0011346789999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC-cccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN-VCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~-~~g~vKL~DFG  442 (627)
                      ...+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+. ....+||+|||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            6778999999999999999988889999999999999999999999988  99999999999998763 12379999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+....        ......||+.|+|||++.    ...++.++||||||++||+|++|..||........+.....
T Consensus       158 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  225 (283)
T 3bhy_A          158 IAHKIEAGN--------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA  225 (283)
T ss_dssp             TCEECC----------------CCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             cceeccCCC--------cccccCCCcCccCcceec----CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence            998765432        123347999999999984    45688999999999999999999999987655443322111


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ............++.++.+||.+||..||.+||++.++++||||+..
T Consensus       226 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          226 --VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             --TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             --cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence              11111111224678999999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-45  Score=382.79  Aligned_cols=264  Identities=23%  Similarity=0.338  Sum_probs=207.6

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ...+..++|.+.+.||+|+||+||+|.+  +++.||||++......     ......+.+|+.++++++|||||+++++|
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-----AERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3456678999999999999999999975  6889999998654322     22345788999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      . +...+++|||||++++|.+++....   .+++..++.++.||+.||.|||+.+++||||||||+|||++.+   +.+|
T Consensus       104 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~---~~~k  179 (309)
T 3p86_A          104 T-QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK---YTVK  179 (309)
T ss_dssp             C-STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT---CCEE
T ss_pred             E-ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC---CcEE
Confidence            7 5667889999999999999998654   3999999999999999999999987779999999999999987   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++......       .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||........+
T Consensus       180 L~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~  248 (309)
T 3p86_A          180 VCDFGLSRLKASTF-------LSSKSAAGTPEWMAPEVLR----DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV  248 (309)
T ss_dssp             ECCCC------------------------CCTTSCHHHHT----TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             ECCCCCCccccccc-------cccccCCCCccccChhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999998654321       1123457999999999984    455889999999999999999999999876655443


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh--ccCCCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR--HDYLQP  570 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~--hp~~~~  570 (627)
                      ...    .........+..+++++.+||.+||..||.+|||+.++++  ++++..
T Consensus       249 ~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          249 AAV----GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHH----HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHH----HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            221    1122233445678999999999999999999999999987  566654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.3e-45  Score=422.85  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=219.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      +-.++|.++++||+|+||.||+|.+..+++.||||++.......    ...+..+..|..++..+ +||||+.++++|. 
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-  412 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-  412 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH----TTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc----HHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-
Confidence            34578999999999999999999999999999999986432211    12245678899999987 7999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +.+.+||||||++|++|..++...+.+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +++||+|||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~---g~ikL~DFG  487 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE---GHIKIADFG  487 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS---SCEEECCCT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC---CcEEEeecc
Confidence            66788999999999999999998899999999999999999999999998  9999999999999987   699999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+......       ......+||+.|+|||++.    ...|+.++||||||||||||++|+.||...+....+..   
T Consensus       488 la~~~~~~~-------~~~~~~~GT~~Y~APE~l~----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~---  553 (674)
T 3pfq_A          488 MCKENIWDG-------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---  553 (674)
T ss_dssp             TCEECCCTT-------CCBCCCCSCSSSCCHHHHT----CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---
T ss_pred             eeeccccCC-------cccccccCCCcccCHhhhc----CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH---
Confidence            998643322       1244568999999999984    45689999999999999999999999987655443321   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCH-----HHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDV-----ISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~-----~elL~hp~~~~~  571 (627)
                      +. ...+.  .+..+++++.+||++||++||.+||++     .+|++||||...
T Consensus       554 i~-~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          554 IM-EHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HH-SSCCC--CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HH-hCCCC--CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            11 12233  345799999999999999999999997     999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-45  Score=395.95  Aligned_cols=263  Identities=27%  Similarity=0.400  Sum_probs=196.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++|||||+++++|...
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-----SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            356899999999999999999999999999999999854321     122345788999999999999999999998632


Q ss_pred             -----CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 -----ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 -----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                           ...+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~---~~~kL  173 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED---CELKI  173 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---CCEEE
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC---CCEEE
Confidence                 24578999999 5788888865 67999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.....          ....+||++|+|||++..   ...++.++||||||||||+|++|+.||........+.
T Consensus       174 ~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~  240 (367)
T 2fst_X          174 LDFGLARHTADE----------MTGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  240 (367)
T ss_dssp             CC-------------------------CCCTTCCHHHHTT---CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eecccccccccc----------CCCcCcCcCccChHHHcC---CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999875432          233489999999999852   2468999999999999999999999998776554443


Q ss_pred             HHHHHhhhhc----------------cccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         519 EENTILKATE----------------VQFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~----------------~~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..........                ..++         ..+.+++++.+||.+||.+||.+|||+.++|+||||...
T Consensus       241 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          241 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            2222111100                0000         113578999999999999999999999999999999853

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=384.67  Aligned_cols=264  Identities=23%  Similarity=0.361  Sum_probs=207.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.++||+|+||+||+|.+..+++.||||++.......      ....+.+|+.+++.++|||||++++++...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------PVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------CHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc------hHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence            56789999999999999999999999999999999986433211      134577899999999999999999998743


Q ss_pred             C-CeEEEEEeecCCCChHHHHHhccC---cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe----cCCCcccc
Q psy4988         364 A-NSFCTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL----TEGNVCGE  435 (627)
Q Consensus       364 ~-~~~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl----~~~~~~g~  435 (627)
                      . ..+|||||||++++|.+++.....   +++..++.|+.||+.||.|||+.+  ||||||||+||||    +.+   +.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~---~~  154 (319)
T 4euu_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ---SV  154 (319)
T ss_dssp             TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC---EE
T ss_pred             CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC---ce
Confidence            3 368899999999999999986543   999999999999999999999988  9999999999998    433   58


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccC----CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG----KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN  511 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~  511 (627)
                      +||+|||+++.+....        .....+||+.|+|||++...    .....++.++||||||||||+|++|+.||...
T Consensus       155 ~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  226 (319)
T 4euu_A          155 YKLTDFGAARELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (319)
T ss_dssp             EEECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             EEEccCCCceecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999998765432        12334799999999987421    11356889999999999999999999999643


Q ss_pred             ChHHHHHH-HHHHhhhhc--------------c----ccCC----CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         512 QSQATILE-ENTILKATE--------------V----QFAN----KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       512 ~~~~~~~~-~~~~~~~~~--------------~----~~~~----~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ........ ...+.....              .    .++.    ...++..+.+||++||++||++|||+.|+|+||
T Consensus       227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            32211111 111111110              0    1111    123456789999999999999999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-44  Score=381.78  Aligned_cols=273  Identities=25%  Similarity=0.401  Sum_probs=214.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++||||+++++++..
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK------PLFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc------chHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            3577899999999999999999999999999999999854321      2234567899999999999999999998764


Q ss_pred             c----CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         363 D----ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       363 ~----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +    ...+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~---~~~kl  153 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN---CDLKV  153 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT---CCEEE
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC---CcEEE
Confidence            3    266889999998 588888876 57999999999999999999999988  9999999999999887   68999


Q ss_pred             eecccccccccCCCCCCC---CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         439 TDFGLSKVMDEENYNPDH---GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +|||+++.+.........   ........+||+.|+|||++.   ....++.++|||||||+||+|++|+.||.......
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML---TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHH---SCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeec---cCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999877543211100   001123357999999999875   23468999999999999999999999998776554


Q ss_pred             HHHHHHHHhhhhc--------------------cccC------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         516 TILEENTILKATE--------------------VQFA------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       516 ~~~~~~~~~~~~~--------------------~~~~------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      .+...........                    ..++      ..+.+++++.+||.+||..||.+|||+.++++||||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            4332221111000                    0000      1246889999999999999999999999999999998


Q ss_pred             CC
Q psy4988         570 PP  571 (627)
Q Consensus       570 ~~  571 (627)
                      ..
T Consensus       311 ~~  312 (353)
T 2b9h_A          311 TY  312 (353)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-45  Score=395.99  Aligned_cols=265  Identities=28%  Similarity=0.473  Sum_probs=209.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--CCceeEEeeEEee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~  362 (627)
                      ..++|.+++.||+|+||.||+|.+.. ++.||||++......     ......+.+|+.+++.+.  |||||++++++. 
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-  126 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-  126 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-----HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-----HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-
Confidence            34579999999999999999998765 899999998754321     223467889999999996  599999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      +...+||||| +.+++|.+++.....+++.+++.|+.||+.||.|||+.+  ||||||||+||||++    +.+||+|||
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~----~~~kl~DFG  199 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD----GMLKLIDFG  199 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEESS----SCEEECCCS
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEEC----CeEEEEecC
Confidence            5677899999 667899999998889999999999999999999999988  999999999999964    589999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCC-------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-------NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-------~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +++.+......     ......+||+.|+|||++....       ....++.++||||||||||+|++|+.||.......
T Consensus       200 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~  274 (390)
T 2zmd_A          200 IANQMQPDTTS-----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  274 (390)
T ss_dssp             SSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             ccccccCCCcc-----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence            99876543211     1233458999999999985311       12358999999999999999999999997654433


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..+..  +. .....+..+...+.++.+||.+||..||.+|||+.++++||||+..
T Consensus       275 ~~~~~--~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          275 SKLHA--II-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHH--HH-CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHH--Hh-CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            22221  11 1122223334568899999999999999999999999999999743

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.8e-45  Score=380.93  Aligned_cols=267  Identities=26%  Similarity=0.408  Sum_probs=212.8

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEE-cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC-----
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP-----  351 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~-~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp-----  351 (627)
                      .+..+.++.++|++.+.||+|+||.||+|.+ ..+++.||||++....        .....+.+|+.+++.++|+     
T Consensus         5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~   76 (339)
T 1z57_A            5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--------RYCEAARSEIQVLEHLNTTDPNST   76 (339)
T ss_dssp             TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--------HHHHHHHHHHHHHHHHHHHCTTCT
T ss_pred             eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--------chhHHHHHHHHHHHHhhhcCCCCc
Confidence            3456778899999999999999999999998 5689999999985321        2234567788888877654     


Q ss_pred             -ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         352 -RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       352 -nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                       +|++++++|. +.+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||+.+  ||||||||+|||++
T Consensus        77 ~~i~~~~~~~~-~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~  152 (339)
T 1z57_A           77 FRCVQMLEWFE-HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFV  152 (339)
T ss_dssp             TCBCCEEEEEE-ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES
T ss_pred             eeeEeeecccc-cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence             5999999998 567889999999 789999887765  6899999999999999999999988  99999999999998


Q ss_pred             CCCc----------------ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHH
Q psy4988         429 EGNV----------------CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVW  492 (627)
Q Consensus       429 ~~~~----------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVw  492 (627)
                      ....                .+.+||+|||+++.....          ....+||+.|+|||++.    ...++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~  218 (339)
T 1z57_A          153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVIL----ALGWSQPCDVW  218 (339)
T ss_dssp             CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHT----TSCCCTHHHHH
T ss_pred             ccccccccCCccccccccccCCCceEeeCcccccCccc----------cccccCCccccChHHhh----CCCCCcchhhH
Confidence            7421                257999999999875432          23347999999999984    44589999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc--------------------------------------cccCCC
Q psy4988         493 SVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE--------------------------------------VQFANK  534 (627)
Q Consensus       493 SlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~  534 (627)
                      ||||+||+|++|..||........+...........                                      ......
T Consensus       219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (339)
T 1z57_A          219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ  298 (339)
T ss_dssp             HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence            999999999999999987665544332222111000                                      000111


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         535 PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       535 ~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...++++.+||.+||+.||.+|||+.++++||||..
T Consensus       299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             hhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            234578999999999999999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.2e-45  Score=376.92  Aligned_cols=264  Identities=33%  Similarity=0.514  Sum_probs=218.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++........     ....+.+|+.+++.++||||+++++++. +
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   92 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----DTSTILREVELLKKLDHPNIMKLFEILE-D   92 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-----HHHHHHHHHHHHHhccCCCccEEEEEEe-C
Confidence            356789999999999999999999999999999999865432111     1346789999999999999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+++||||+.+++|.+++.....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+...+.+||+|||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            6788999999999999999988889999999999999999999999988  99999999999998764345899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +........        .....||+.|+|||++.    + .++.++||||||++||+|++|..||...........  ..
T Consensus       171 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~----~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~  235 (287)
T 2wei_A          171 STCFQQNTK--------MKDRIGTAYYIAPEVLR----G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR--VE  235 (287)
T ss_dssp             GGTBCCCSS--------CSCHHHHHTTCCHHHHT----T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH
T ss_pred             ceeecCCCc--------cccccCcccccChHHhc----C-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH--HH
Confidence            987653321        12236899999999983    2 378999999999999999999999977654433211  11


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ........+.+..+++++.+||.+||..||.+|||+.++++||||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            11122233344678999999999999999999999999999999964

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.3e-45  Score=392.06  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      ......+|.+.++||+|+||+||+|.+..++. ||||.+......           ..+|+.+++.++|||||+++++|.
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----------~~~E~~il~~l~h~niv~l~~~~~  102 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----------KNRELQIMRIVKHPNVVDLKAFFY  102 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----------CCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----------HHHHHHHHHhCCCCCcceEEEEEE
Confidence            44567789999999999999999999887766 788876543321           236999999999999999999986


Q ss_pred             ecC-----CeEEEEEeecCCCChHHHH---HhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         362 IDA-----NSFCTVLEYCDGHDLDFYL---KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       362 ~~~-----~~~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      ...     ..+|+|||||+++.+..+.   .....+++..++.|+.||+.||.|||+.+  ||||||||+||||+...  
T Consensus       103 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~--  178 (394)
T 4e7w_A          103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPS--  178 (394)
T ss_dssp             EESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTT--
T ss_pred             ecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCC--
Confidence            432     2378999999986554433   23568999999999999999999999988  99999999999998432  


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++.+.....        ....+||+.|+|||++.   ....++.++||||||||||+|++|+.||.....
T Consensus       179 ~~~kL~DFG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  247 (394)
T 4e7w_A          179 GVLKLIDFGSAKILIAGEP--------NVSYICSRYYRAPELIF---GATNYTTNIDIWSTGCVMAELMQGQPLFPGESG  247 (394)
T ss_dssp             TEEEECCCTTCEECCTTCC--------CCSSCSCGGGCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CcEEEeeCCCcccccCCCC--------CcccccCcCccCHHHHc---CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            6899999999987654321        23347899999999985   234589999999999999999999999988776


Q ss_pred             HHHHHHHHHHhhh-------------hccccC----------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         514 QATILEENTILKA-------------TEVQFA----------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       514 ~~~~~~~~~~~~~-------------~~~~~~----------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...+.........             ....++          ..+.+++++.+||.+||++||.+|||+.+++.||||..
T Consensus       248 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             HHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence            6555433222110             001111          12358899999999999999999999999999999986


Q ss_pred             C
Q psy4988         571 P  571 (627)
Q Consensus       571 ~  571 (627)
                      .
T Consensus       328 ~  328 (394)
T 4e7w_A          328 L  328 (394)
T ss_dssp             T
T ss_pred             h
Confidence            4

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=376.96  Aligned_cols=259  Identities=26%  Similarity=0.474  Sum_probs=211.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+++.||+|+||.||+|.+..+++.||||++.....         ...+.+|+.+++.++||||+++++++. +
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   95 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---------LQEIIKEISIMQQCDSPHVVKYYGSYF-K   95 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---------CHHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---------HHHHHHHHHHHHhCCCCCCccEEEEEE-e
Confidence            456889999999999999999999999999999999875432         235788999999999999999999997 5


Q ss_pred             CCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|+||||+++++|.+++. ....+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~dfg  170 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE---GHAKLADFG  170 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCT
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC---CCEEEeecc
Confidence            677889999999999999987 4568999999999999999999999988  9999999999999887   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      ++..+.....       ......||+.|+|||++.    ...++.++|||||||+||+|++|..||........+..   
T Consensus       171 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---  236 (314)
T 3com_A          171 VAGQLTDTMA-------KRNTVIGTPFWMAPEVIQ----EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM---  236 (314)
T ss_dssp             TCEECBTTBS-------CBCCCCSCGGGCCHHHHS----SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---
T ss_pred             cchhhhhhcc-------ccCccCCCCCccChhhcC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH---
Confidence            9987654321       123347999999999984    44588999999999999999999999976654433321   


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........+.....++.++.+||.+||..||.+|||+.++++||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            1222223333445678999999999999999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.6e-45  Score=376.37  Aligned_cols=272  Identities=23%  Similarity=0.397  Sum_probs=216.7

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .+.......++|++++.||+|+||.||+|.+..+++.||||++.....       .....+.+|+.+++.++||||++++
T Consensus        10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~   82 (302)
T 2j7t_A           10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-------EELEDYIVEIEILATCDHPYIVKLL   82 (302)
T ss_dssp             CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-------HHHHHHHHHHHHHhcCCCCCEeeee
Confidence            334455678899999999999999999999999999999999854321       1235688899999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +++. +.+.+++||||+++++|..++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+
T Consensus        83 ~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~  156 (302)
T 2j7t_A           83 GAYY-HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE---GDI  156 (302)
T ss_dssp             EEEE-CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT---SCE
T ss_pred             eeee-eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC---CCE
Confidence            9998 56678899999999999998865 467999999999999999999999988  9999999999999877   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccC-CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG-KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      ||+|||++.......       .......||+.|+|||++... .....++.++|||||||+||+|++|..||.......
T Consensus       157 kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  229 (302)
T 2j7t_A          157 RLADFGVSAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR  229 (302)
T ss_dssp             EECCCHHHHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             EEEECCCCccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            999999986533211       111234799999999987421 123457899999999999999999999998766544


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .+..   +.............++.++.+||.+||..||.+|||+.++++||||....
T Consensus       230 ~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          230 VLLK---IAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHH---HHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHH---HhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            3322   11222222333456889999999999999999999999999999998543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-44  Score=387.75  Aligned_cols=261  Identities=28%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++|||||+++++|....
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-----SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-----SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-----chhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            66899999999999999999999999999999999864332     1233567889999999999999999999997433


Q ss_pred             C-----eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 N-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 ~-----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .     .+|+||||+. ++|..++.  ..+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~---~~~kL~  186 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED---CELKIL  186 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEEEC
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC---CCEEEE
Confidence            2     2389999998 57777663  45999999999999999999999998  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.....          ....+||+.|+|||++..   ...++.++|||||||+||+|++|+.||........+..
T Consensus       187 Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          187 DFGLARHADAE----------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             STTCC------------------CTTCCCTTSCHHHHSC---CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ecCcccccccC----------cCCcccCccccCHHHhcC---CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999865432          233478999999999852   24689999999999999999999999987765554433


Q ss_pred             HHHHhhhhcc-------------------c------cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKATEV-------------------Q------FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~~-------------------~------~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..........                   .      ....+.+++++.+||++||++||.+|||+.++|+||||.+.
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            2221111000                   0      00124578999999999999999999999999999999854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-44  Score=387.47  Aligned_cols=270  Identities=27%  Similarity=0.389  Sum_probs=210.8

Q ss_pred             cccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CC----
Q psy4988         277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HP----  351 (627)
Q Consensus       277 ~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hp----  351 (627)
                      ..+.....+.++|.+.+.||+|+||+||+|.+..+++.||||++....        .....+.+|+.+++.+. |+    
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~  115 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--------AFLNQAQIEVRLLELMNKHDTEMK  115 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--------HHHHHHHHHHHHHHHHHHCSSGGG
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--------HHHHHHHHHHHHHHHHHhcccccc
Confidence            345667788899999999999999999999999999999999986332        12345667788777764 44    


Q ss_pred             -ceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEec
Q psy4988         352 -RVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLT  428 (627)
Q Consensus       352 -nIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~  428 (627)
                       +|++++++|. ..+.+||||||+++ +|.+++...  ..+++..++.|+.||+.||.|||.+..+||||||||+||||+
T Consensus       116 ~~iv~~~~~~~-~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~  193 (382)
T 2vx3_A          116 YYIVHLKRHFM-FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC  193 (382)
T ss_dssp             GGBCCEEEEEE-ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred             eeEEEeeeeec-cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence             5999999998 56788999999975 898888765  469999999999999999999996434499999999999996


Q ss_pred             CCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy4988         429 EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF  508 (627)
Q Consensus       429 ~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf  508 (627)
                      .+. .+.+||+|||+++.....          ....+||+.|+|||++.    +..++.++||||||||||+|++|+.||
T Consensus       194 ~~~-~~~~kL~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~pf  258 (382)
T 2vx3_A          194 NPK-RSAIKIVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLL----GMPYDLAIDMWSLGCILVEMHTGEPLF  258 (382)
T ss_dssp             STT-SCCEEECCCTTCEETTCC----------CCSSCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCC-CCcEEEEeccCceecccc----------cccccCCccccChHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            532 158999999999876432          23358999999999984    445899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhhhhcc--------------ccCC-------------------CCC-------------------
Q psy4988         509 GHNQSQATILEENTILKATEV--------------QFAN-------------------KPT-------------------  536 (627)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~-------------------~~~-------------------  536 (627)
                      ........+............              .++.                   ...                   
T Consensus       259 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  338 (382)
T 2vx3_A          259 SGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE  338 (382)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTC
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccccc
Confidence            877665544332221110000              0000                   000                   


Q ss_pred             ------CCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         537 ------VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       537 ------vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                            .++++.+||.+||++||++|||+.++|+||||...
T Consensus       339 ~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          339 SGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             ccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                  01478999999999999999999999999999753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=396.09  Aligned_cols=269  Identities=23%  Similarity=0.363  Sum_probs=191.4

Q ss_pred             ccCCCeeE-EEEecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLL-LMLLGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i-~~~LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+.+.|.+ .++||+|+||+||+|.+.  .+++.||||++.....         ...+.+|+.+++.++|||||+++++|
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~   87 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---------SMSACREIALLRELKHPNVISLQKVF   87 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---------CHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---------CHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            45567777 457999999999999966  5789999999864322         12477899999999999999999999


Q ss_pred             ee-cCCeEEEEEeecCCCChHHHHHhc---------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC
Q psy4988         361 EI-DANSFCTVLEYCDGHDLDFYLKQH---------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       361 ~~-~~~~~~lV~E~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~  430 (627)
                      .. +...+||||||+.+ +|..++...         ..+++..++.|+.||+.||.|||+.+  ||||||||+||||...
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~  164 (405)
T 3rgf_A           88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGE  164 (405)
T ss_dssp             EETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCS
T ss_pred             ecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecC
Confidence            53 45678999999985 676666532         24999999999999999999999998  9999999999999432


Q ss_pred             -CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         431 -NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       431 -~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                       ...+.+||+|||+++.+.....    ........+||+.|+|||++.   ....++.++||||||||||+|++|+.||.
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          165 GPERGRVKIADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLL---GARHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             STTTTCEEECCTTCCC--------------------CCCTTCCHHHHT---TCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCCcEEEEECCCceecCCCCc----ccccCCCceecCcccCchhhc---CCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence             1226899999999987654211    111233458999999999985   22458999999999999999999999996


Q ss_pred             CCChH---------HHHHHHHHHhhhhc-c---------------------cc----------CCCCCCCHHHHHHHHHh
Q psy4988         510 HNQSQ---------ATILEENTILKATE-V---------------------QF----------ANKPTVSNEAKGFIRSC  548 (627)
Q Consensus       510 ~~~~~---------~~~~~~~~~~~~~~-~---------------------~~----------~~~~~vs~el~~LI~~c  548 (627)
                      .....         ..+........... .                     .+          ......++++.+||.+|
T Consensus       238 ~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~  317 (405)
T 3rgf_A          238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL  317 (405)
T ss_dssp             CCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHH
T ss_pred             CccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHH
Confidence            54432         11111111110000 0                     00          01112367899999999


Q ss_pred             hhcCcCCCCCHHHHHhccCCCCC
Q psy4988         549 LAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       549 L~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      |++||.+|||+.++|+||||...
T Consensus       318 L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          318 LTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             ccCCcccCCCHHHHhcChhhccC
Confidence            99999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.8e-46  Score=399.14  Aligned_cols=256  Identities=16%  Similarity=0.212  Sum_probs=200.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHH---HHHhcCCCCceeEEe---
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY---NIHKALDHPRVVKLY---  357 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei---~il~~l~HpnIV~l~---  357 (627)
                      ...++|.+.+.||+|+||+||+|.+..+++.||||++........    ...+.+.+|+   .+++.++|||||+++   
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT----THHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch----HHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            346789999999999999999999999999999999875422111    1235678899   555666899999998   


Q ss_pred             ----eEEeecCC----------------eEEEEEeecCCCChHHHHHhccCcCH-------HHHHHHHHHHHHHHHHHHh
Q psy4988         358 ----DVFEIDAN----------------SFCTVLEYCDGHDLDFYLKQHKTIAE-------REARSIVMQVVSALKYLNE  410 (627)
Q Consensus       358 ----~~~~~~~~----------------~~~lV~E~~~gg~L~~~l~~~~~l~e-------~~~~~i~~qi~~aL~yLH~  410 (627)
                          +++.....                ..||||||| +|+|.+++.....+++       ..++.|+.||+.||.|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                66653321                378999999 5799999987665655       8888999999999999999


Q ss_pred             CCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccC-------CCCC
Q psy4988         411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG-------KNPP  483 (627)
Q Consensus       411 ~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~~~  483 (627)
                      .+  ||||||||+||||+.+   +.+||+|||+++....          .....+| +.|+|||++...       ....
T Consensus       225 ~~--ivHrDikp~NIll~~~---~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQR---GGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             TT--EECSCCCGGGEEECTT---CCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             CC--eecCCCCHHHEEEcCC---CCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccc
Confidence            98  9999999999999977   6899999999986432          1234478 999999998532       0012


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         484 KISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       484 ~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      .++.++|||||||+||+|++|+.||........          ....+.....+++++.+||.+||+.||.+|||+.+++
T Consensus       289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCCC------CC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             cCChhhhHHHHHHHHHHHHHCCCCCcccccccc----------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            589999999999999999999999965432211          1112233467899999999999999999999999999


Q ss_pred             hccCCCC
Q psy4988         564 RHDYLQP  570 (627)
Q Consensus       564 ~hp~~~~  570 (627)
                      +||||..
T Consensus       359 ~hp~f~~  365 (377)
T 3byv_A          359 ETPEYEQ  365 (377)
T ss_dssp             TSHHHHH
T ss_pred             hChHHHH
Confidence            9999963

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.4e-45  Score=389.27  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|...
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-----hHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            3568999999999999999999999999999999998653221     22345688999999999999999999998743


Q ss_pred             C-----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 A-----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .     ..+|+|||||++ +|..++.  ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||
T Consensus        97 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~---~~~kl  168 (371)
T 2xrw_A           97 KSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKI  168 (371)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEE
T ss_pred             cccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC---CCEEE
Confidence            3     368999999986 6777775  46999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++......        .....+||+.|+|||++.    +..++.++||||||||||+|++|+.||........+.
T Consensus       169 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  236 (371)
T 2xrw_A          169 LDFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN  236 (371)
T ss_dssp             CCCCC------------------------CTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEeeccccccccc--------ccCCceecCCccCHHHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999998764321        123458999999999984    4468999999999999999999999998766544332


Q ss_pred             HHHHHhhhh------------------ccc--------------cCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q psy4988         519 EENTILKAT------------------EVQ--------------FANK----PTVSNEAKGFIRSCLAYRKEDRIDVISL  562 (627)
Q Consensus       519 ~~~~~~~~~------------------~~~--------------~~~~----~~vs~el~~LI~~cL~~dP~~Rpt~~el  562 (627)
                      .........                  ...              ++..    ..++.++++||.+||++||.+|||+.++
T Consensus       237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  316 (371)
T 2xrw_A          237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  316 (371)
T ss_dssp             HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence            221110000                  000              0000    0125789999999999999999999999


Q ss_pred             HhccCCCC
Q psy4988         563 ARHDYLQP  570 (627)
Q Consensus       563 L~hp~~~~  570 (627)
                      |+||||..
T Consensus       317 l~hp~~~~  324 (371)
T 2xrw_A          317 LQHPYINV  324 (371)
T ss_dssp             HHSHHHHT
T ss_pred             hCCcchhh
Confidence            99999974

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-44  Score=379.04  Aligned_cols=271  Identities=21%  Similarity=0.328  Sum_probs=195.3

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCe---EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCcee
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQR---YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV  354 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV  354 (627)
                      .+....+..++|.+.+.||+|+||.||+|.+..++.   .||||++......     ......+.+|+.+++.++|||||
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv   88 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-----SSDIEEFLREAACMKEFDHPHVA   88 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-----------CHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-----HHHHHHHHHHHHHHHHCCCCcee
Confidence            344555778899999999999999999999887765   8999998643221     12246788999999999999999


Q ss_pred             EEeeEEeecCCe-----EEEEEeecCCCChHHHHHhcc------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCC
Q psy4988         355 KLYDVFEIDANS-----FCTVLEYCDGHDLDFYLKQHK------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG  423 (627)
Q Consensus       355 ~l~~~~~~~~~~-----~~lV~E~~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~  423 (627)
                      ++++++......     +++||||+.+++|..++....      .+++..++.|+.||+.||.|||+.+  ||||||||+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~  166 (323)
T 3qup_A           89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAAR  166 (323)
T ss_dssp             CCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             hhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcc
Confidence            999998743322     389999999999999986543      6999999999999999999999988  999999999


Q ss_pred             cEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh
Q psy4988         424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY  503 (627)
Q Consensus       424 NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt  503 (627)
                      ||||+.+   +.+||+|||+++.+......     .......+|+.|+|||++.    ...++.++|||||||++|+|++
T Consensus       167 NIli~~~---~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~  234 (323)
T 3qup_A          167 NCMLAED---MTVCVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLA----DNLYTVHSDVWAFGVTMWEIMT  234 (323)
T ss_dssp             GEEECTT---SCEEECCCCC----------------------CCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEEcCC---CCEEEeeccccccccccccc-----cccccccCcccccCchhhc----CCCCCCccchhhHHHHHHHHHh
Confidence            9999987   68999999999876543211     1122345788999999985    3458999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-------HHHHHhccCCCCCC
Q psy4988         504 -GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-------VISLARHDYLQPPV  572 (627)
Q Consensus       504 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-------~~elL~hp~~~~~~  572 (627)
                       |..||...........   +..  .........+++++.+||.+||+.||.+|||       +.+++.|+|+....
T Consensus       235 ~g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          235 RGQTPYAGIENAEIYNY---LIG--GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             TSCCTTTTCCGGGHHHH---HHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCccccChHHHHHH---Hhc--CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence             9999977655443321   111  1223445678999999999999999999999       77788899997643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=389.69  Aligned_cols=269  Identities=26%  Similarity=0.383  Sum_probs=212.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~  359 (627)
                      +-.++|.+++.||+|+||.||+|.+.   .+++.||||++.........   .....+.+|+.+++.+ +||||++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---KTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE---SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh---hHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            34578999999999999999999985   58999999998643211100   0112456799999999 69999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      |. +...+|||||||++++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       128 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kl~  201 (355)
T 1vzo_A          128 FQ-TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN---GHVVLT  201 (355)
T ss_dssp             EE-ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEES
T ss_pred             Ee-eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC---CcEEEe
Confidence            97 56778899999999999999998889999999999999999999999988  9999999999999887   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.+.....      ......+||+.|+|||++...  ...++.++||||||||||+|++|+.||...........
T Consensus       202 DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  273 (355)
T 1vzo_A          202 DFGLSKEFVADET------ERAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE  273 (355)
T ss_dssp             CSSEEEECCGGGG------GGGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred             eCCCCeecccCCC------CcccCcccCcCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence            9999987643221      122345799999999998521  23478899999999999999999999965432221111


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                      ......  ....+.+..++..+.+||.+||..||.+||     ++.++++||||...
T Consensus       274 ~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          274 ISRRIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHh--ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            111111  122334457899999999999999999999     99999999999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-44  Score=370.43  Aligned_cols=266  Identities=22%  Similarity=0.359  Sum_probs=214.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-c
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-D  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~  363 (627)
                      ..++|++++.||+|+||.||+|.+..+++.||||++......     ......+.+|+.+++.++||||+++++++.. +
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-----EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            457899999999999999999999999999999998754321     1224578899999999999999999998753 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc----CcCHHHHHHHHHHHHHHHHHHHhCC---CCEEeccccCCcEEecCCCcccce
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSALKYLNEIK---PPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~---~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      ...+++||||+++++|.+++....    .+++..++.++.||+.||.|||+.+   .+|+||||||+|||++.+   +.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~---~~~  155 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNV  155 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS---SCE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC---CCE
Confidence            567899999999999999987543    4999999999999999999999976   349999999999999976   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+++.+....       .......||+.|+|||++.    ...++.++|||||||+||+|++|..||........
T Consensus       156 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  224 (279)
T 2w5a_A          156 KLGDFGLARILNHDT-------SFAKTFVGTPYYMSPEQMN----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL  224 (279)
T ss_dssp             EECCCCHHHHC---C-------HHHHHHHSCCTTCCHHHHH----CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCchheeecccc-------ccccccCCCccccChHHhc----cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH
Confidence            999999998765321       1123347899999999985    34588999999999999999999999987654332


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      ...   +.....  ......++.++.+||.+||..||.+||++.++++|+|+..+.+.
T Consensus       225 ~~~---i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          225 AGK---IREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             HHH---HHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             HHH---Hhhccc--ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            211   111111  12334689999999999999999999999999999999876543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=373.66  Aligned_cols=267  Identities=25%  Similarity=0.418  Sum_probs=211.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-c
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-D  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~  363 (627)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++.......   .......+.+|+.+++.++||||+++++++.. +
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR---IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc---cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            4678999999999999999999999999999999986432111   11234578899999999999999999999842 4


Q ss_pred             CCeEEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ...+|+||||+.++ |.+++..  ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~---~~~kl~df  153 (305)
T 2wtk_C           80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG---GTLKISAL  153 (305)
T ss_dssp             --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECCC
T ss_pred             CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC---CcEEeecc
Confidence            45789999999987 6666654  457999999999999999999999988  9999999999999887   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |++........     ........||+.|+|||++...  ...++.++|||||||+||+|++|..||...........  
T Consensus       154 g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--  224 (305)
T 2wtk_C          154 GVAEALHPFAA-----DDTCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--  224 (305)
T ss_dssp             TTCEECCTTCS-----SCEECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--
T ss_pred             ccccccCcccc-----ccccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH--
Confidence            99987653211     1123345799999999998421  22347799999999999999999999987654433211  


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                        +.  ...+.....+++++.+||.+||..||.+|||+.++++||||....+
T Consensus       225 --i~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          225 --IG--KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             --HH--HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             --Hh--cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence              11  1123344578999999999999999999999999999999976443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-44  Score=384.35  Aligned_cols=263  Identities=23%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.......        ..+.+++..++.++|||||+++++|.....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--------NRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC--------CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc--------HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            468999999999999999999999999999999886543221        245678888888999999999999864322


Q ss_pred             ------eEEEEEeecCCCChHHH---HHhccCcCHHHHHHHHHHHHHHHHHHH--hCCCCEEeccccCCcEEecCCCccc
Q psy4988         366 ------SFCTVLEYCDGHDLDFY---LKQHKTIAEREARSIVMQVVSALKYLN--EIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       366 ------~~~lV~E~~~gg~L~~~---l~~~~~l~e~~~~~i~~qi~~aL~yLH--~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                            .+++||||++++.+..+   +.....+++..++.++.||+.||.|||  +.+  ||||||||+||||+...  +
T Consensus        94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~--~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEAD--G  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTT--T
T ss_pred             ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCC--C
Confidence                  37899999997533322   235568999999999999999999999  777  99999999999998732  6


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      .+||+|||+++.+.....        .....||+.|+|||++.   ....++.++|||||||+||+|++|+.||......
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  238 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--------NVAYICSRYYRAPELIF---GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA  238 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--------CCSTTSCGGGCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cEEEeeCCCceecCCCCC--------cccccCCcceeCHHHHc---CCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence            999999999987654321        23347899999999984   2345899999999999999999999999877665


Q ss_pred             HHHHHHHHHhhhh-------------cc-------------ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         515 ATILEENTILKAT-------------EV-------------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       515 ~~~~~~~~~~~~~-------------~~-------------~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..+..........             ..             .......+++++.+||.+||++||.+|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            5543332211100             00             001122367899999999999999999999999999999


Q ss_pred             CCC
Q psy4988         569 QPP  571 (627)
Q Consensus       569 ~~~  571 (627)
                      ...
T Consensus       319 ~~~  321 (360)
T 3e3p_A          319 DEL  321 (360)
T ss_dssp             GGG
T ss_pred             ccc
Confidence            754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=375.86  Aligned_cols=268  Identities=24%  Similarity=0.391  Sum_probs=211.3

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEee
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYD  358 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~  358 (627)
                      .......++|++.+.||+|+||.||+|.+..+++.||||++......        ...+.+|+.+++.+ +||||+++++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--------EEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--------THHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--------HHHHHHHHHHHHhccCCCCeeeeee
Confidence            34456788999999999999999999999999999999998654321        13577899999998 7999999999


Q ss_pred             EEeec-----CCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         359 VFEID-----ANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       359 ~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                      +|...     ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+ 
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-  165 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-  165 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-
Confidence            99753     46789999999999999999764  57999999999999999999999988  9999999999999876 


Q ss_pred             cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy4988         432 VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGH  510 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~  510 (627)
                        +.+||+|||++..+....       .......||+.|+|||++.... ....++.++|||||||+||+|++|..||..
T Consensus       166 --~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          166 --AEVKLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             --CCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --CCEEEeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              689999999998765321       1123347999999999985221 134588999999999999999999999976


Q ss_pred             CChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ......+..   +.. ..........++.++.+||.+||..||.+||++.++++||||...
T Consensus       237 ~~~~~~~~~---~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          237 MHPMRALFL---IPR-NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCHHHHHHH---HHH-SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             CcHHHHHHH---hhc-CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            655433321   111 111122245688999999999999999999999999999999753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-44  Score=381.74  Aligned_cols=271  Identities=23%  Similarity=0.354  Sum_probs=211.5

Q ss_pred             ccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCC-eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc--
Q psy4988         276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ-RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR--  352 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~-~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--  352 (627)
                      ......+..+.++|++.+.||+|+||.||+|.+..++ +.||||++....        .....+.+|+.+++.+.|++  
T Consensus         8 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~   79 (355)
T 2eu9_A            8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--------KYREAARLEINVLKKIKEKDKE   79 (355)
T ss_dssp             CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--------HHHHHHHHHHHHHHHHHHHCTT
T ss_pred             CcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--------cchhHHHHHHHHHHHHhhcCCC
Confidence            3445567788999999999999999999999998876 799999985321        12345677888888887655  


Q ss_pred             ----eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEE
Q psy4988         353 ----VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL  426 (627)
Q Consensus       353 ----IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NIL  426 (627)
                          |+.+++++. ....+||||||+. ++|..++...  ..+++..++.|+.||+.||.|||+.+  ||||||||+|||
T Consensus        80 ~~~~~~~~~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIl  155 (355)
T 2eu9_A           80 NKFLCVLMSDWFN-FHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENIL  155 (355)
T ss_dssp             SCSCBCCEEEEEE-ETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEE
T ss_pred             CceeEEEeeeeee-eCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence                999999887 5678889999995 5565665544  47999999999999999999999988  999999999999


Q ss_pred             ecCC----------------CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchh
Q psy4988         427 LTEG----------------NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVD  490 (627)
Q Consensus       427 l~~~----------------~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~D  490 (627)
                      |+..                ...+.+||+|||+++.....          ....+||+.|+|||++.    ...++.++|
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~D  221 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVIL----ELGWAQPCD  221 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHT----TCCCCTHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeee----cCCCCCccc
Confidence            9432                11268999999999865432          23347999999999984    456899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc--------------------------------------cccC
Q psy4988         491 VWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE--------------------------------------VQFA  532 (627)
Q Consensus       491 VwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~  532 (627)
                      ||||||+||+|++|..||........+...........                                      ....
T Consensus       222 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (355)
T 2eu9_A          222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML  301 (355)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCS
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccc
Confidence            99999999999999999987766554433222211100                                      0001


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       533 ~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .....+.++.+||.+||+.||.+|||+.++++||||....
T Consensus       302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             ccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            1122356899999999999999999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.2e-44  Score=383.01  Aligned_cols=257  Identities=23%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc-------CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCcee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL-------KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVV  354 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~-------~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV  354 (627)
                      .+..++|.+.+.||+|+||.||+|.+.       .++..||||++.....      ......+.+|+.+++.+ +|||||
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hpnIv  150 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHKNII  150 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB------HHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC------HHHHHHHHHHHHHHHHhcCCCCEe
Confidence            345689999999999999999999875       3567899999864322      22356789999999999 899999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEec
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIHY  418 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHr  418 (627)
                      +++++|. +.+.+|+||||+++++|.+++....                .+++.+++.|+.||+.||.|||+.+  ||||
T Consensus       151 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHr  227 (370)
T 2psq_A          151 NLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHR  227 (370)
T ss_dssp             CEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             eEEEEEc-cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence            9999997 5667889999999999999997643                4899999999999999999999988  9999


Q ss_pred             cccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         419 DLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       419 DLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      ||||+||||+.+   +.+||+|||+++.+......     .......+|+.|+|||++.    ...++.++|||||||+|
T Consensus       228 Dlkp~NIll~~~---~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~DvwslG~il  295 (370)
T 2psq_A          228 DLAARNVLVTEN---NVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLM  295 (370)
T ss_dssp             CCCGGGEEECTT---CCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHH----TCCCCHHHHHHHHHHHH
T ss_pred             ccchhhEEECCC---CCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhc----CCCCCcHHHHHHHHHHH
Confidence            999999999887   68999999999876543211     1233456889999999985    44689999999999999


Q ss_pred             HHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         499 YQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       499 ~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |||++ |..||........+..   +..  ......+..++.++.+||.+||..||.+|||+.+++++
T Consensus       296 ~ellt~g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          296 WEIFTLGGSPYPGIPVEELFKL---LKE--GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHTTSCCSSTTCCGGGHHHH---HHT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCHHHHHHH---Hhc--CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99998 9999976654433211   111  11233445789999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.1e-45  Score=385.71  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=213.2

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEE-----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCcee
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVV  354 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~-----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV  354 (627)
                      .+++..++|.+.+.||+|+||.||+|.     +..+++.||||++.....      ....+.+.+|+.++..+ +|||||
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC------HHHHHHHHHHHHHHHhhcCCccee
Confidence            345677899999999999999999998     556779999999864332      12245688999999999 799999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhccC----------------------------------------------
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT----------------------------------------------  388 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------------------------------------  388 (627)
                      +++++|..+...+++|||||++++|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999998666668899999999999999976543                                              


Q ss_pred             --------------------cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         389 --------------------IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       389 --------------------l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                                          +++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+++.+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK---NVVKICDFGLARDIY  244 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG---GCEEECCCGGGSCTT
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC---CcEEEEeccceeeec
Confidence                                999999999999999999999988  9999999999999876   689999999998764


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhh
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKAT  527 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  527 (627)
                      ....     ........||+.|+|||++.    ...++.++||||||||||+|++ |..||........+.....  .  
T Consensus       245 ~~~~-----~~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--~--  311 (359)
T 3vhe_A          245 KDPD-----YVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--E--  311 (359)
T ss_dssp             SCTT-----CEEC--CEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH--H--
T ss_pred             cccc-----chhccccCCCceeEChhhhc----CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH--c--
Confidence            3221     11233457899999999985    3458999999999999999998 9999977655444332211  1  


Q ss_pred             ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         528 EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       528 ~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ......+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            12233445689999999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.8e-45  Score=377.57  Aligned_cols=273  Identities=23%  Similarity=0.351  Sum_probs=194.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +.+..++|.+.+.||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++||||+++++++.
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC------QTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------CCCCCCCTTBCCEEEEEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc------chhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            45677899999999999999999999999999999998754321      122456789999999999999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHh--------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQ--------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~--------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                       +.+.+++||||+++++|.+++..        ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   
T Consensus        84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---  157 (303)
T 2vwi_A           84 -VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED---  157 (303)
T ss_dssp             -SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT---
T ss_pred             -ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC---
Confidence             55678899999999999999874        456999999999999999999999988  9999999999999887   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||++..+......  ..........||+.|+|||++..   ...++.++|||||||+||+|++|..||.....
T Consensus       158 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  232 (303)
T 2vwi_A          158 GSVQIADFGVSAFLATGGDI--TRNKVRKTFVGTPCWMAPEVMEQ---VRGYDFKADIWSFGITAIELATGAAPYHKYPP  232 (303)
T ss_dssp             CCEEECCCHHHHHCC-----------------CCCTTCCHHHHHH---HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             CCEEEEeccchheeccCCCc--cchhhhcccCCCccccCHHHhcc---ccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence            68999999999876532210  00112234579999999999852   13478899999999999999999999977655


Q ss_pred             HHHHHHHHHHhhhhc-----cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         514 QATILEENTILKATE-----VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~-----~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      .......... ....     ........++.++.+||.+||+.||.+||++.++++||||....
T Consensus       233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          233 MKVLMLTLQN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             GGHHHHHHTS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             hhHHHHHhcc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            4433221110 0000     01112346789999999999999999999999999999998543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-44  Score=383.37  Aligned_cols=271  Identities=23%  Similarity=0.339  Sum_probs=205.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchh----hHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK----EDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~----~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      .+.++|.+.+.||+|+||.||+|.+.. ++.||||++.......    ........+.+.+|+.+++.++|||||+++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            467899999999999999999998755 8999999885433211    11223445678999999999999999999999


Q ss_pred             Eee----cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         360 FEI----DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       360 ~~~----~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      |..    ....+|+||||+.+ +|..++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~---~  171 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN---N  171 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---C
T ss_pred             EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC---C
Confidence            853    23468999999995 66666654 457999999999999999999999998  9999999999999877   5


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      .+||+|||+++......        ......||+.|+|||++..   ...++.++|||||||++|+|++|+.||......
T Consensus       172 ~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          172 DITICDFNLAREDTADA--------NKTHYVTHRWYRAPELVMQ---FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             CEEECCTTC-----------------------CGGGCCHHHHTT---CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CEEEEecCccccccccc--------ccceecccceecCcHHhcC---CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            89999999997554322        1233579999999999852   245899999999999999999999999876655


Q ss_pred             HHHHHHHHHhhhhc--------------------ccc------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         515 ATILEENTILKATE--------------------VQF------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       515 ~~~~~~~~~~~~~~--------------------~~~------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      ..+...........                    ...      ...+.+++.+.+||.+||++||.+|||+.++++||||
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  320 (362)
T 3pg1_A          241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF  320 (362)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence            44332221111000                    000      1124578899999999999999999999999999999


Q ss_pred             CCCC
Q psy4988         569 QPPV  572 (627)
Q Consensus       569 ~~~~  572 (627)
                      ....
T Consensus       321 ~~~~  324 (362)
T 3pg1_A          321 ESLF  324 (362)
T ss_dssp             TTTC
T ss_pred             hhcc
Confidence            8653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.1e-45  Score=391.86  Aligned_cols=261  Identities=13%  Similarity=0.194  Sum_probs=193.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHH---HHHHhcCCCCceeEEe------
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE---YNIHKALDHPRVVKLY------  357 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~E---i~il~~l~HpnIV~l~------  357 (627)
                      ..|.+.+.||+|+||+||+|.+..+++.||||++.......    ......+.+|   +.+++. +|||||+++      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS----RSELERLHEATFAAARLLG-ESPEEARDRRRLLLP  136 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH----HHHHHHHHHHHHHHHHHHC-----------CBCCC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc----ccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEee
Confidence            45999999999999999999999999999999997654322    2223456667   455555 799988765      


Q ss_pred             -eEEeecC----------------CeEEEEEeecCCCChHHHHHhc-cCcCHHHH------HHHHHHHHHHHHHHHhCCC
Q psy4988         358 -DVFEIDA----------------NSFCTVLEYCDGHDLDFYLKQH-KTIAEREA------RSIVMQVVSALKYLNEIKP  413 (627)
Q Consensus       358 -~~~~~~~----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~------~~i~~qi~~aL~yLH~~~~  413 (627)
                       +++..++                ..+|||||||+ ++|.+++... ..+++..+      ..++.||+.||.|||+++ 
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-  214 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG-  214 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence             4444322                34789999999 8999999764 34555555      677799999999999988 


Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHH
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWS  493 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwS  493 (627)
                       ||||||||+||||+.+   +.+||+|||+++.....          .....+|+.|+|||++..+  ...++.++||||
T Consensus       215 -ivHrDikp~NIll~~~---~~~kL~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~--~~~~~~~~DiwS  278 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPD---GRLMLGDVSALWKVGTR----------GPASSVPVTYAPREFLNAS--TATFTHALNAWQ  278 (371)
T ss_dssp             -EEETTCSGGGEEECTT---SCEEECCGGGEEETTCE----------EEGGGSCGGGCCHHHHTCS--EEECCHHHHHHH
T ss_pred             -CccCcCCHHHEEECCC---CCEEEEecceeeecCCC----------ccCccCCcCCcChhhccCC--CCCcCccccHHH
Confidence             9999999999999987   68999999999876432          1133677999999998421  146899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHH---HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         494 VGVIFYQCLYGKKPFGHNQSQATILEEN---TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       494 lGviL~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      |||+||+|++|+.||.............   .........++.++.+++++.+||.+||++||++|||+.++++||||..
T Consensus       279 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            9999999999999997653321100000   0011123344555689999999999999999999999999999999964

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.5e-44  Score=372.49  Aligned_cols=266  Identities=28%  Similarity=0.493  Sum_probs=210.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc-CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL-KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~-~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~  359 (627)
                      ...++|.+++.||+|+||.||+|.+. .+++.||||++.........     ...+.+|+.+++.+   +||||++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-----CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            35588999999999999999999995 67899999998654321111     11345666666655   89999999999


Q ss_pred             Eee----cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         360 FEI----DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       360 ~~~----~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      |..    ....+++||||+. ++|..++....  .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~---  156 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS---  156 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC---
Confidence            862    3456889999999 59999887653  4999999999999999999999988  9999999999999887   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++.+....        ......||+.|+|||++.    ...++.++|||||||+||+|++|+.||.....
T Consensus       157 ~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  224 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CCEEEecCcccccccCCC--------CccccccccceeCHHHHh----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            689999999998764321        123457999999999984    44589999999999999999999999987766


Q ss_pred             HHHHHHHHHHhhhh-cccc--------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         514 QATILEENTILKAT-EVQF--------------------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       514 ~~~~~~~~~~~~~~-~~~~--------------------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                      ...+.......... ...+                    .....++.++.+||.+||..||.+|||+.++++||||....
T Consensus       225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            54443222111100 0000                    12246889999999999999999999999999999998543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.7e-44  Score=376.96  Aligned_cols=263  Identities=19%  Similarity=0.234  Sum_probs=205.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      ++.++|.+.+.||+|+||.||+|.+..+++.||||++......         ..+.+|+.+++.+ +||||+++++++. 
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~E~~~l~~l~~h~~i~~~~~~~~-   75 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---------PQLHLEYRFYKQLGSGDGIPQVYYFGP-   75 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---------CCHHHHHHHHHHHCSCTTSCCEEEEEE-
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---------HHHHHHHHHHHHhhCCCCCCEEEEEEe-
Confidence            5678999999999999999999999999999999998654321         2467899999999 9999999999987 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc--cceEEe
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC--GEIKIT  439 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~--g~vKL~  439 (627)
                      +...+++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+...  ..+||+
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           76 CGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             cCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEE
Confidence            567888999999 8999999986 468999999999999999999999988  9999999999999876310  129999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.+.................+||+.|+|||++.    +..++.++|||||||+||+|++|+.||...........
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~  228 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL----GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER  228 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHc----CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence            99999977544322111111234568999999999984    45689999999999999999999999976433222111


Q ss_pred             HHHHhhhh-ccccC-CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKAT-EVQFA-NKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~-~~~~~-~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...+.... ..... ....++ ++.+||.+||..||.+||++.++++
T Consensus       229 ~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          229 YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11111100 00000 012244 9999999999999999999998875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.5e-44  Score=369.76  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=215.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++.......      ....+.+|+.+++.++||||+++++++. +.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   92 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED------EIEDIQQEITVLSQCDSPYVTKYYGSYL-KD   92 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST------THHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH------HHHHHHHHHHHHHhCCCCCEeEEEEEEe-cC
Confidence            4567999999999999999999999999999999987543211      2356889999999999999999999997 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+|||++
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~---~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH---GEVKLADFGVA  166 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCTTC
T ss_pred             CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC---CCEEEeecccc
Confidence            778899999999999998865 67999999999999999999999988  9999999999999887   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+.....       ......||+.|+|||++.    ...++.++|||||||+||+|++|..||...........   +.
T Consensus       167 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~  232 (303)
T 3a7i_A          167 GQLTDTQI-------KRNTFVGTPFWMAPEVIK----QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IP  232 (303)
T ss_dssp             EECBTTBC-------CBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HH
T ss_pred             eecCcccc-------ccCccCCCcCccCHHHHh----cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hh
Confidence            87654321       123457999999999984    44688999999999999999999999976654433221   11


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...  .......++.++.+||.+||..||.+|||+.++++||||..
T Consensus       233 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          233 KNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             HSC--CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             cCC--CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            111  11233578999999999999999999999999999999964

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=375.15  Aligned_cols=268  Identities=31%  Similarity=0.494  Sum_probs=207.4

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.++|.+++.||+|+||.||+|.+..+++.||||++....       ....+.+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-------PQSVKHALREIKIIRRLDHDNIVKVFEILGP   79 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-------hHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence            357889999999999999999999999999999999986432       2234578899999999999999999998742


Q ss_pred             -------------cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC
Q psy4988         363 -------------DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       363 -------------~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~  429 (627)
                                   +...+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.+  |+||||||+|||++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  155 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINT  155 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEET
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcC
Confidence                         3467899999998 589988864 67999999999999999999999988  999999999999985


Q ss_pred             CCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         430 GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       430 ~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                      +.  +.+||+|||+++.+......    ........+|+.|+|||++..   ...++.++|||||||+||+|++|+.||.
T Consensus       156 ~~--~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          156 ED--LVLKIGDFGLARIMDPHYSH----KGHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             TT--TEEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CC--CeEEEccCccccccCCCccc----ccccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            43  58999999999876532111    111233468999999998852   3468999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhhh------------------hcccc------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         510 HNQSQATILEENTILKA------------------TEVQF------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       510 ~~~~~~~~~~~~~~~~~------------------~~~~~------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .......+.........                  .....      ...+.++.++.+||.+||+.||.+|||+.++++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            76654433221111000                  00000      0124689999999999999999999999999999


Q ss_pred             cCCCC
Q psy4988         566 DYLQP  570 (627)
Q Consensus       566 p~~~~  570 (627)
                      |||..
T Consensus       307 p~~~~  311 (320)
T 2i6l_A          307 PYMSI  311 (320)
T ss_dssp             HHHHT
T ss_pred             ccccc
Confidence            99974

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=376.93  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=209.9

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCC---eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~---~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      .++..++|.+.+.||+|+||.||+|.+..++   ..||||++.....      ......+.+|+.+++.++|||||++++
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT------ERQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3466789999999999999999999988654   4599999864322      222456889999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +|. +.+.+||||||+++++|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+|
T Consensus       118 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~---~~~k  191 (325)
T 3kul_A          118 VVT-RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN---LVCK  191 (325)
T ss_dssp             EEC-GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEE
T ss_pred             EEE-eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC---CCEE
Confidence            997 566788999999999999999754 68999999999999999999999988  9999999999999887   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQAT  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~  516 (627)
                      |+|||+++.+......    ........+|+.|+|||++.    ...++.++|||||||+||+|++ |..||........
T Consensus       192 l~Dfg~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  263 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDA----AYTTTGGKIPIRWTAPEAIA----FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV  263 (325)
T ss_dssp             ECCCSSCEECC----C----CEECC---CCGGGSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred             ECCCCcccccccCccc----eeeccCCCCcccccCHhHhc----CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999887543211    11223345788999999985    3458899999999999999998 9999977655443


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +...   .  .....+....+++++.+||.+||..||.+|||+.++++.
T Consensus       264 ~~~~---~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          264 ISSV---E--EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHH---H--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH---H--cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3221   1  123344556789999999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=373.52  Aligned_cols=259  Identities=20%  Similarity=0.303  Sum_probs=206.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+.++||+|+||+||+|.+..+++.||||++....       ......+.+|+.+++.++|||||+++++|. +..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~   80 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-------EETQRTFLKEVKVMRCLEHPNVLKFIGVLY-KDK   80 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETT
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-------HHHHHHHHHHHHHHHhCCCcCcccEEEEEe-cCC
Confidence            578999999999999999999999999999999874321       223457889999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+++||||+++++|.+++.. ...+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~---~~~kl~Dfg~~  155 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN---KNVVVADFGLA  155 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT---SCEEECCCTTC
T ss_pred             eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC---CCEEEeecccc
Confidence            78899999999999999987 568999999999999999999999988  9999999999999987   68999999999


Q ss_pred             cccccCCCCCCC-------CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         445 KVMDEENYNPDH-------GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       445 ~~~~~~~~~~~~-------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      +.+.........       ........+||+.|+|||++.    ...++.++|||||||+||+|++|..||.........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN----GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhc----CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            877544321110       001112457999999999984    456899999999999999999999998643322110


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .... ..  .......++.+++++.+||.+||+.||++|||+.++++
T Consensus       232 ~~~~-~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          232 FGLN-VR--GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             SSBC-HH--HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhhh-hh--ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            0000 00  00111223568889999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-44  Score=381.94  Aligned_cols=266  Identities=26%  Similarity=0.387  Sum_probs=190.1

Q ss_pred             CCCCccCCCeeEEE-EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         280 NNHPVLSDRYLLLM-LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       280 ~~~~~l~~rY~i~~-~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      .....+.++|.+++ +||+|+||.||+|.+..+++.||||++.....           ...+....++.+.||||+++++
T Consensus        21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----------HHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----------HHHHHHHHHHhcCCCChHHHHH
Confidence            34456889999965 69999999999999999999999999854211           0111223356779999999999


Q ss_pred             EEee---cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         359 VFEI---DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       359 ~~~~---~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      +|..   +...++||||||++++|.+++....  .+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+...
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~  167 (336)
T 3fhr_A           90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKD  167 (336)
T ss_dssp             EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTT
T ss_pred             HHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCC
Confidence            9864   2445889999999999999998754  6999999999999999999999988  9999999999999875444


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++......         ....+||+.|+|||++.    ...++.++|||||||+||+|++|..||.....
T Consensus       168 ~~~kl~Dfg~~~~~~~~~---------~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          168 AVLKLTDFGFAKETTQNA---------LQTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             CCEEECCCTTCEEC-----------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ceEEEeccccceeccccc---------cccCCCCcCccChhhhC----CCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            679999999998765322         23347899999999983    45688899999999999999999999965544


Q ss_pred             HHHHHHHHH--HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         514 QATILEENT--ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       514 ~~~~~~~~~--~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .........  .........+.+..+++++.+||.+||..||.+|||+.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          235 QAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            322111111  1111222333446789999999999999999999999999999999753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-43  Score=365.16  Aligned_cols=266  Identities=18%  Similarity=0.200  Sum_probs=209.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVF  360 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~  360 (627)
                      ..++.++|.+.+.||+|+||.||+|.+..+++.||||++......         ..+.+|+.+++.+ +|+||+++++++
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---------PQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            456789999999999999999999999999999999998643321         2467899999999 799999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIK  437 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vK  437 (627)
                      . +...+++||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+.  ..+.+|
T Consensus        76 ~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           76 Q-EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             E-ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             C-CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEE
Confidence            7 667888999999 899999998654 6999999999999999999999988  99999999999998752  123499


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--H
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ--A  515 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~--~  515 (627)
                      |+|||+++.+..................||+.|+|||++.    ...++.++|||||||+||+|++|+.||......  .
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  227 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK  227 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhc----CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH
Confidence            9999999987654322111112234568999999999984    455899999999999999999999999764322  1


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .....................+++++.+||.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          228 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            1111111111111111122468899999999999999999999999875

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=387.54  Aligned_cols=265  Identities=22%  Similarity=0.283  Sum_probs=213.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEE-----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~-----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .++..++|.+++.||+|+||+||+|.     +..+++.||||++......      .....+.+|+.+++.++|||||++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~  139 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE------QDELDFLMEALIISKFNHQNIVRC  139 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh------hhHHHHHHHHHHHHhCCCCCCCeE
Confidence            34667899999999999999999999     4567889999998543221      223468889999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhcc-------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~  429 (627)
                      +++|. +...+++|||||++++|.+++....       .+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.
T Consensus       140 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~  216 (367)
T 3l9p_A          140 IGVSL-QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTC  216 (367)
T ss_dssp             EEEEC-SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESC
T ss_pred             EEEEe-cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEec
Confidence            99997 5566789999999999999997653       5899999999999999999999998  999999999999996


Q ss_pred             CCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy4988         430 GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF  508 (627)
Q Consensus       430 ~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf  508 (627)
                      +.....+||+|||+++.+......     .......||+.|+|||++.    ...++.++|||||||+||+|++ |..||
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~DvwslG~il~ellt~g~~pf  287 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPY  287 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCCceEEECCCcccccccccccc-----ccCCCcCCcccEECHHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            543347999999999876443221     1123346899999999985    3458999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ........+..   +..  .........++.++.+||.+||+.||.+|||+.++++|.|+.
T Consensus       288 ~~~~~~~~~~~---i~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          288 PSKSNQEVLEF---VTS--GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCCHHHHHHH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHH---HHc--CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            87665443321   111  112333457899999999999999999999999999997753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.6e-44  Score=366.05  Aligned_cols=266  Identities=23%  Similarity=0.351  Sum_probs=211.3

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||||++...............+.+.+|+.+++.++||||+++++++. 
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   93 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-   93 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET-
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec-
Confidence            3567899999999999999999999999999999999866543322222222357889999999999999999999986 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc--ccceEEe
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV--CGEIKIT  439 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~--~g~vKL~  439 (627)
                      +..  ++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+++||||||||+|||++.+..  ...+||+
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            333  5899999999998887654 5799999999999999999999998767999999999999987531  1239999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.....          .....||+.|+|||++..  ....++.++|||||||+||+|++|+.||...........
T Consensus       172 Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  239 (287)
T 4f0f_A          172 DFGLSQQSVHS----------VSGLLGNFQWMAPETIGA--EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI  239 (287)
T ss_dssp             CCTTCBCCSSC----------EECCCCCCTTSCGGGSSC--SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred             CCCcccccccc----------ccccCCCccccCchhhcc--CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence            99999754321          234579999999998732  134578899999999999999999999976554333221


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..  .............+++++.+||.+||+.||.+|||+.++++.
T Consensus       240 ~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          240 NM--IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             HH--HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH--HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            11  112223334456789999999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.8e-44  Score=380.36  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=207.4

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC----------
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD----------  349 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~----------  349 (627)
                      ...+...++|.+.+.||+|+||+||+|.+..+++.||||++.....        ....+.+|+.+++.+.          
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~~~~   83 (373)
T 1q8y_A           12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------YTEAAEDEIKLLQRVNDADNTKEDSM   83 (373)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------HHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred             cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--------chhhhhHHHHHHHHhhcccccchhcc
Confidence            3344556899999999999999999999999999999999863221        2345678888888775          


Q ss_pred             -CCceeEEeeEEeecC---CeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccC
Q psy4988         350 -HPRVVKLYDVFEIDA---NSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKP  422 (627)
Q Consensus       350 -HpnIV~l~~~~~~~~---~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP  422 (627)
                       ||||++++++|....   ..+++||||+ +++|.+++...  ..+++..++.|+.||+.||.|||+. +  ||||||||
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp  160 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKP  160 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSG
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCh
Confidence             899999999987432   2688999999 78999998763  4699999999999999999999997 8  99999999


Q ss_pred             CcEEecCC---CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         423 GNILLTEG---NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       423 ~NILl~~~---~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      +||||+.+   ...+.+||+|||+++.....          ....+||+.|+|||++.    +..++.++|||||||+||
T Consensus       161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~  226 (373)
T 1q8y_A          161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLL----GAPWGCGADIWSTACLIF  226 (373)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHH----TCCCCTHHHHHHHHHHHH
T ss_pred             HHeEEeccCCCcCcceEEEcccccccccCCC----------CCCCCCCccccCcHHHh----CCCCCchHhHHHHHHHHH
Confidence            99999642   11248999999999876532          12347999999999985    345899999999999999


Q ss_pred             HHHhCCCCCCCCCh------HHHHHHHHHHhhhh------------------------------------ccccCCCCCC
Q psy4988         500 QCLYGKKPFGHNQS------QATILEENTILKAT------------------------------------EVQFANKPTV  537 (627)
Q Consensus       500 elltG~~Pf~~~~~------~~~~~~~~~~~~~~------------------------------------~~~~~~~~~v  537 (627)
                      +|++|+.||.....      ...+..........                                    ...+.....+
T Consensus       227 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (373)
T 1q8y_A          227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE  306 (373)
T ss_dssp             HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred             HHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcch
Confidence            99999999975432      11111111111000                                    0011122345


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         538 SNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       538 s~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      +.++.+||.+||+.||.+|||+.++|+||||.....
T Consensus       307 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             HHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence            678999999999999999999999999999986543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.7e-44  Score=366.27  Aligned_cols=265  Identities=25%  Similarity=0.422  Sum_probs=203.6

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      +.++|.+++.||+|+||.||+|.+..+++.||||++...        ......+.+|+.+++.++||||++++++|... 
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            456899999999999999999999999999999998532        12245688999999999999999999988632 


Q ss_pred             -----------CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC
Q psy4988         364 -----------ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN  431 (627)
Q Consensus       364 -----------~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~  431 (627)
                                 ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+ 
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-  152 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-  152 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-
Confidence                       35688999999999999999854 47899999999999999999999988  9999999999999877 


Q ss_pred             cccceEEeecccccccccCCCCC-------CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC
Q psy4988         432 VCGEIKITDFGLSKVMDEENYNP-------DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       432 ~~g~vKL~DFGla~~~~~~~~~~-------~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG  504 (627)
                        +.+||+|||+++.+.......       ...........||+.|+|||++.   ....++.++|||||||+||+|++ 
T Consensus       153 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          153 --RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD---GTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             --SCEEECCCCCCSCTTC-------------------------CTTSCHHHHT---SCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             --CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc---CCCCCcchhhHHHHHHHHHHHHh-
Confidence              689999999998765321000       00011223457999999999984   23358899999999999999998 


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        ||........+...   .......++  ....++..+.+||++||+.||.+|||+.++++||||...
T Consensus       227 --p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          227 --PFSTGMERVNILKK---LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             --CCSSHHHHHHHHHH---HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             --ccCCchhHHHHHHh---ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence              66433322222221   111112222  234677889999999999999999999999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=379.46  Aligned_cols=261  Identities=28%  Similarity=0.449  Sum_probs=208.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|.+.+.||+|+||.||+|.+..+++.||||++.....     .......+.+|+.+++.++||||+++++++....
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-----SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-----SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-----chHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            56899999999999999999999999999999999864322     1233457889999999999999999999997433


Q ss_pred             C-----eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 N-----SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 ~-----~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .     .+|+||||+. ++|..++.  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~---~~~kl~  168 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED---CELKIL  168 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT---CCEEEC
T ss_pred             ccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC---CcEEEe
Confidence            2     3589999998 47777664  35999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.....          .....||+.|+|||++..   ...++.++|||||||+||+|++|+.||........+..
T Consensus       169 Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  235 (353)
T 3coi_A          169 DFGLARHADAE----------MTGYVVTRWYRAPEVILS---WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  235 (353)
T ss_dssp             STTCTTC------------------CCSBCCSCHHHHSC---CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred             ecccccCCCCC----------ccccccCcCcCCHHHHhC---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999865432          223478999999999852   24688999999999999999999999987665443322


Q ss_pred             HHHHhhhh------------------------cccc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKAT------------------------EVQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~------------------------~~~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........                        ...+ ...+.+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            21111000                        0001 1234679999999999999999999999999999999854

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-43  Score=377.21  Aligned_cols=270  Identities=16%  Similarity=0.209  Sum_probs=205.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCC-----CeEEEEEEeecCcchhhHhHHHHH-----HHHHHHHHHHhcCCCCcee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKE-----QRYVACKVHQLNKDWKEDKKANYI-----KHALREYNIHKALDHPRVV  354 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~-----~~~VAVKii~~~~~~~~~~~~~~~-----~~~~~Ei~il~~l~HpnIV  354 (627)
                      ..++|.+.++||+|+||+||+|.+..+     ++.||||++......... .....     ..+++|+.+++.++|||||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHH-HHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHH-HHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            345999999999999999999998765     588999998755421111 11111     2355677888999999999


Q ss_pred             EEeeEEeec---CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCC
Q psy4988         355 KLYDVFEID---ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       355 ~l~~~~~~~---~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~  430 (627)
                      ++++++..+   ...+||||||| +++|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence            999998743   24578999999 99999999875 68999999999999999999999988  9999999999999832


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH  510 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~  510 (627)
                      . .+.+||+|||+++.+.................+||+.|+|||++.    +..++.++|||||||+||+|++|+.||..
T Consensus       189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          189 N-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN----GVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             C-TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             C-CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC----CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            1 268999999999887654332222222234456999999999984    45589999999999999999999999975


Q ss_pred             CChHHHHHHHHHHhhh------hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         511 NQSQATILEENTILKA------TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       511 ~~~~~~~~~~~~~~~~------~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ................      ....+ ....++.++.+||..||..||.+||++.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          264 NLKDPKYVRDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             GTTCHHHHHHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cccCHHHHHHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            4333332221111100      01111 22567899999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-43  Score=361.71  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=208.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+-.++|++.+.||+|+||.||+|.+. ++..||||++.......        ..+.+|+.++++++||||+++++++. 
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~~-   75 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--------EDFIEEAEVMMKLSHPKLVQLYGVCL-   75 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH--------HHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH--------HHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            355678999999999999999999876 57789999986543321        35788999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~~kl~Df  150 (269)
T 4hcu_A           76 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN---QVIKVSDF  150 (269)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG---GCEEECCT
T ss_pred             cCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC---CCEEeccc
Confidence            566788999999999999999654 56999999999999999999999988  9999999999999876   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.......      .......+|+.|+|||++.    ...++.++|||||||++|+|++ |..||............
T Consensus       151 g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~  220 (269)
T 4hcu_A          151 GMTRFVLDDQY------TSSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI  220 (269)
T ss_dssp             TGGGGBCCHHH------HSTTSTTCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred             ccccccccccc------ccccCcccccccCCHHHhc----CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            99987654321      1122346788999999984    3458999999999999999999 99999876654433221


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         ..  ......+..+++++.+||.+||+.||.+||++.++++|
T Consensus       221 ---~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          221 ---ST--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---HT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---hc--CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               11  12333445689999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2e-43  Score=359.25  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=208.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++..++|++++.||+|+||.||+|.+. ++..||||++.......        ..+.+|+.+++.++||||+++++++. 
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~~-   73 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE--------DEFFQEAQTMMKLSHPKLVKFYGVCS-   73 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH--------HHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH--------HHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence            456789999999999999999999765 67789999986543321        35788999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +...+++||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~~~l~Df  148 (268)
T 3sxs_A           74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD---LCVKVSDF  148 (268)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT---CCEEECCT
T ss_pred             cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC---CCEEEccC
Confidence            6677889999999999999997654 5999999999999999999999988  9999999999999887   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++........      .......+|+.|+|||++.    ...++.++|||||||++|+|++ |..||............
T Consensus       149 g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  218 (268)
T 3sxs_A          149 GMTRYVLDDQY------VSSVGTKFPVKWSAPEVFH----YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV  218 (268)
T ss_dssp             TCEEECCTTCE------EECCSCCCCGGGCCHHHHH----HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             ccceecchhhh------hcccCCCcCcccCCHHHHh----ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence            99987654321      1122335778899999984    3347889999999999999998 99999776655443221


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                         ..  ......+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       219 ---~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          219 ---SQ--GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---HT--TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---Hc--CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               11  12223345678999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-43  Score=368.09  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=211.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      +.+..++|.+.+.||+|+||.||+|.+.     .++..||||++.....      ....+.+.+|+.+++.++|||||++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~   91 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS------PSELRDLLSEFNVLKQVNHPHVIKL   91 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC------HHHHHHHHHHHHHHhhCCCCceeeE
Confidence            4456789999999999999999999884     4568999999864322      2234678899999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhccC------------------------cCHHHHHHHHHHHHHHHHHHHhCC
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT------------------------IAEREARSIVMQVVSALKYLNEIK  412 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~e~~~~~i~~qi~~aL~yLH~~~  412 (627)
                      ++++. +.+.+++||||+++++|.+++.....                        +++.+++.++.||+.||.|||+.+
T Consensus        92 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           92 YGACS-QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEEEC-SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEe-cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99987 56678899999999999999986543                        899999999999999999999988


Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHH
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVW  492 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVw  492 (627)
                        |+||||||+|||++.+   +.+||+|||+++.+.....     ........+|+.|+|||++.    ...++.++|||
T Consensus       171 --ivH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~  236 (314)
T 2ivs_A          171 --LVHRDLAARNILVAEG---RKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLF----DHIYTTQSDVW  236 (314)
T ss_dssp             --EECCCCSGGGEEEETT---TEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHH----HCEECHHHHHH
T ss_pred             --CcccccchheEEEcCC---CCEEEcccccccccccccc-----ceeccCCCCcccccChhhhc----CCCcCchhhHH
Confidence              9999999999999987   6899999999987654321     11123446789999999985    34588999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         493 SVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       493 SlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||||+||+|++ |..||...........   +..  ......+..+++++.+||.+||..||.+||++.+++++
T Consensus       237 slG~il~el~t~g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          237 SFGVLLWEIVTLGGNPYPGIPPERLFNL---LKT--GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHH---hhc--CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999 9999976655433211   111  11233445789999999999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=374.92  Aligned_cols=263  Identities=29%  Similarity=0.433  Sum_probs=203.1

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC----CCCceeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL----DHPRVVKL  356 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l----~HpnIV~l  356 (627)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||||++........ ........+.+|+.+++++    +||||+++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW-SPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc-ccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            345678899999999999999999999999999999999865432211 1111223456789999888    89999999


Q ss_pred             eeEEeecCCeEEEEEee-cCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEY-CDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++|. +.+.+++|||| +.+++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++...  +.
T Consensus       104 ~~~~~-~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~--~~  178 (312)
T 2iwi_A          104 LDWFE-TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRR--GC  178 (312)
T ss_dssp             EEEC------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTT--TE
T ss_pred             EEEEe-cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCC--Ce
Confidence            99987 45667899999 789999999998889999999999999999999999998  99999999999998332  68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++.+....         .....||+.|+|||++..   ....+.++|||||||+||+|++|+.||....   
T Consensus       179 ~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  243 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISR---HQYHALPATVWSLGILLYDMVCGDIPFERDQ---  243 (312)
T ss_dssp             EEECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHH---SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EEEEEcchhhhcccCc---------ccccCCcccccCceeeec---CCCCCccchHHHHHHHHHHHHHCCCCCCChH---
Confidence            9999999998775432         233479999999999853   2234568999999999999999999996421   


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                      .+.       ..  .......++.++.+||.+||+.||++|||+.++++||||+....
T Consensus       244 ~~~-------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          244 EIL-------EA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHH-------HT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHh-------hh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            111       11  22234578999999999999999999999999999999986543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-44  Score=374.77  Aligned_cols=266  Identities=28%  Similarity=0.427  Sum_probs=213.1

Q ss_pred             cccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--CCcee
Q psy4988         277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVV  354 (627)
Q Consensus       277 ~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV  354 (627)
                      ......+.+.++|++.+.||+|+||.||+|.+..+++.||||++.......... ......+.+|+.+++.+.  ||||+
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-CTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-hhhhhHHHHHHHHHHhhccCCCCce
Confidence            344556778999999999999999999999999999999999986543211000 001123567999999986  59999


Q ss_pred             EEeeEEeecCCeEEEEEeecCC-CChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      ++++++. +.+.+++||||+.+ ++|.+++.....+++..++.++.||+.||.|||+.+  ||||||||+||||+.+.  
T Consensus       112 ~~~~~~~-~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~--  186 (320)
T 3a99_A          112 RLLDWFE-RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR--  186 (320)
T ss_dssp             CEEEEEE-CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT--
T ss_pred             EEEEEEe-cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCC--
Confidence            9999998 66788899999986 899999998889999999999999999999999988  99999999999998433  


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++.+....         .....||+.|+|||++..   ...++.++|||||||+||+|++|+.||.... 
T Consensus       187 ~~~kL~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~~-  253 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-  253 (320)
T ss_dssp             TEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred             CCEEEeeCcccccccccc---------ccCCCCCccCCChHHhcc---CCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence            689999999998775432         233479999999999853   2334788999999999999999999996421 


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCC
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPV  572 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~  572 (627)
                        .+      ..   ........+++++.+||.+||..||.+|||+.++++||||....
T Consensus       254 --~~------~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          254 --EI------IR---GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --HH------HH---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --hh------hc---ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              11      11   11223457899999999999999999999999999999998654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6e-44  Score=376.98  Aligned_cols=270  Identities=21%  Similarity=0.412  Sum_probs=216.3

Q ss_pred             cCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHh----------HHHHHHHHHHHHHHHhcC
Q psy4988         279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDK----------KANYIKHALREYNIHKAL  348 (627)
Q Consensus       279 ~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~----------~~~~~~~~~~Ei~il~~l  348 (627)
                      +.....+.++|.+.+.||+|+||.||+|.+  +++.||||++..........          .......+.+|+.+++.+
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  100 (348)
T 2pml_X           23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI  100 (348)
T ss_dssp             ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred             hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence            344566778999999999999999999998  89999999986432111000          000114688999999999


Q ss_pred             CCCceeEEeeEEeecCCeEEEEEeecCCCChHHH------HHh--ccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEecc
Q psy4988         349 DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFY------LKQ--HKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYD  419 (627)
Q Consensus       349 ~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrD  419 (627)
                      +||||+++++++. +.+.+|+||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ .+  |+|||
T Consensus       101 ~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~d  177 (348)
T 2pml_X          101 KNEYCLTCEGIIT-NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRD  177 (348)
T ss_dssp             CCTTBCCCSEEEE-SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCC
T ss_pred             CCCCcceEEEEEe-eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecC
Confidence            9999999999997 66788999999999999988      655  5789999999999999999999999 88  99999


Q ss_pred             ccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCc-chhHHHHHHHH
Q psy4988         420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS-KVDVWSVGVIF  498 (627)
Q Consensus       420 LKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~-k~DVwSlGviL  498 (627)
                      |||+|||++.+   +.+||+|||++......         ......||+.|+|||++..   ...++. ++|||||||++
T Consensus       178 l~p~Nil~~~~---~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~---~~~~~~~~~Di~slG~il  242 (348)
T 2pml_X          178 VKPSNILMDKN---GRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSN---ESSYNGAKVDIWSLGICL  242 (348)
T ss_dssp             CCGGGEEECTT---SCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSS---CCCEEHHHHHHHHHHHHH
T ss_pred             CChHhEEEcCC---CcEEEeccccccccccc---------cccCCCCCcCccCchhhcC---CCCCCcchhhHHHHHHHH
Confidence            99999999887   58999999999876432         1234579999999999852   224555 99999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCC-----------------CCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q psy4988         499 YQCLYGKKPFGHNQSQATILEENTILKATEVQFAN-----------------KPTVSNEAKGFIRSCLAYRKEDRIDVIS  561 (627)
Q Consensus       499 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~vs~el~~LI~~cL~~dP~~Rpt~~e  561 (627)
                      |+|++|..||........+...   .......++.                 ...++.++.+||.+||+.||.+|||+.+
T Consensus       243 ~~l~~g~~pf~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          243 YVMFYNVVPFSLKISLVELFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             HHHHHSSCSSCCSSCSHHHHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHHhCCCCCCCCCcHHHHHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            9999999999876653333222   1111222221                 1568999999999999999999999999


Q ss_pred             HHhccCCCCC
Q psy4988         562 LARHDYLQPP  571 (627)
Q Consensus       562 lL~hp~~~~~  571 (627)
                      +++||||...
T Consensus       320 ~l~hp~f~~~  329 (348)
T 2pml_X          320 ALKHEWLADT  329 (348)
T ss_dssp             HHTSGGGTTC
T ss_pred             HhcCccccCC
Confidence            9999999754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=365.73  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +|....+||+|+||.||+|.+..+++.||||++.....       .....+.+|+.+++.++|||||+++++|. +...+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   94 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-------RYSQPLHEEIALHKHLKHKNIVQYLGSFS-ENGFI   94 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----------HHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-------HHHHHHHHHHHHHHhCCCCCEeeEeeEEE-eCCcE
Confidence            34444589999999999999999999999999865432       12346889999999999999999999997 56778


Q ss_pred             EEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++...  +.+||+|||++
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~--~~~kl~Dfg~~  170 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYS--GVLKISDFGTS  170 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT--CCEEECCTTTC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCC--CCEEEeecccc
Confidence            8999999999999999765   25679999999999999999999988  99999999999998733  68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ..+....       .......||+.|+|||++...  ...++.++|||||||+||+|++|+.||............... 
T Consensus       171 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-  240 (295)
T 2clq_A          171 KRLAGIN-------PCTETFTGTLQYMAPEIIDKG--PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-  240 (295)
T ss_dssp             EESCC------------CCCCCCGGGCCHHHHHHG--GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-
T ss_pred             cccCCCC-------CcccccCCCccccChhhhcCC--CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-
Confidence            8765322       112344799999999998532  123788999999999999999999999654333222111111 


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP  573 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~  573 (627)
                        .......+..+++++.+||.+||+.||.+||++.++++||||.....
T Consensus       241 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          241 --FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             --HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             --ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence              11222334578999999999999999999999999999999986543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.9e-44  Score=375.76  Aligned_cols=266  Identities=25%  Similarity=0.390  Sum_probs=190.1

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHH-HHhcCCCCceeEEeeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN-IHKALDHPRVVKLYDVF  360 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~  360 (627)
                      +.+..++|.+++.||+|+||.||+|.+..+++.||||++......      .....+.+|+. +++.++||||+++++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE------KEQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH------HHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc------hHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            345668999999999999999999999999999999998754321      11234555665 77888999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHh-----ccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCccc
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQ-----HKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      . +.+.+++||||+.+ +|..++..     ...+++..+..++.|++.||.|||+. +  |+||||||+|||++.+   +
T Consensus        91 ~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~---~  163 (327)
T 3aln_A           91 F-REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS---G  163 (327)
T ss_dssp             E-CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT---T
T ss_pred             E-eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC---C
Confidence            8 56788899999996 77776653     56899999999999999999999997 8  9999999999999877   6


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      .+||+|||+++.+.....        .....||+.|+|||++........++.++|||||||+||+|++|+.||......
T Consensus       164 ~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (327)
T 3aln_A          164 NIKLCDFGISGQLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV  235 (327)
T ss_dssp             EEEECCCSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---
T ss_pred             CEEEccCCCceecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH
Confidence            899999999987654321        223379999999999843223445889999999999999999999999764332


Q ss_pred             HHHHHHHHHhhhhcccc--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         515 ATILEENTILKATEVQF--ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~--~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ...+.  .........+  .....+++++.+||.+||..||.+|||+.++++||||..
T Consensus       236 ~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          236 FDQLT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             ----C--CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHH--HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            21111  1111111111  123468999999999999999999999999999999963

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-43  Score=366.21  Aligned_cols=262  Identities=25%  Similarity=0.346  Sum_probs=204.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      .+..++|++++.||+|+||+||+|.    +..+++.||||++....       ....+.+.+|+.+++.++|||||++++
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~   78 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-------EEHLRDFEREIEILKSLQHDNIVKYKG   78 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3567899999999999999999998    56789999999986432       223456889999999999999999999


Q ss_pred             EEeec-CCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         359 VFEID-ANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       359 ~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +|... ...+++|||||++++|.+++.... .+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~---~~~  153 (295)
T 3ugc_A           79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE---NRV  153 (295)
T ss_dssp             EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TEE
T ss_pred             EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC---CeE
Confidence            98532 345789999999999999997754 5999999999999999999999988  9999999999999987   589


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+++.+......    ........+|+.|+|||++.    ...++.++|||||||+||+|++|..||........
T Consensus       154 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~  225 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEF----FKVKEPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM  225 (295)
T ss_dssp             EECCCCSCC-----------------CTTCGGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH
T ss_pred             EEccCcccccccCCcce----eeeccCCCCccceeCcHHhc----CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH
Confidence            99999999876543211    11223346888999999985    34589999999999999999999999864322110


Q ss_pred             -----------HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         517 -----------ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       517 -----------~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                                 ...............+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          226 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                       000000011122234455678999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-43  Score=362.20  Aligned_cols=257  Identities=23%  Similarity=0.376  Sum_probs=209.4

Q ss_pred             cCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       279 ~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +..+.+..++|++++.||+|+||+||+|.+. ++..||||++.......        ..+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~   86 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--------DEFIEEAKVMMNLSHEKLVQLYG   86 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH--------HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH--------HHHHHHHHHHhcCCCCCEeeEEE
Confidence            4556677889999999999999999999765 67889999986543321        35788999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +|. +.+.+|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+|
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~---~~~k  160 (283)
T 3gen_A           87 VCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ---GVVK  160 (283)
T ss_dssp             EEC-SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT---SCEE
T ss_pred             EEe-cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC---CCEE
Confidence            997 66778899999999999999976 568999999999999999999999988  9999999999999977   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQAT  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~  516 (627)
                      |+|||+++.......      .......+|+.|+|||++.    ...++.++|||||||++|+|++ |+.||........
T Consensus       161 l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~  230 (283)
T 3gen_A          161 VSDFGLSRYVLDDEY------TSSVGSKFPVRWSPPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET  230 (283)
T ss_dssp             ECSTTGGGGBCCHHH------HSTTSTTSCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             Ecccccccccccccc------ccccCCccCcccCCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH
Confidence            999999987654321      1122335788999999985    3358999999999999999998 9999977655433


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...   +..  ......+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       231 ~~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          231 AEH---IAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHH---HHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHH---Hhc--ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            322   111  12233345678999999999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.6e-43  Score=361.16  Aligned_cols=264  Identities=19%  Similarity=0.228  Sum_probs=208.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++......         ..+.+|+.+++.+.|++++..+.++..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            4678999999999999999999999999999999998654321         2477899999999999988888877667


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+...+.+||+|||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            88889999999 8999999874 468999999999999999999999988  9999999999999522222689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ---ATILE  519 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~---~~~~~  519 (627)
                      +++.+..................||+.|+|||++.    +..++.++|||||||+||+|++|+.||......   ..+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             CcccccccccccccccccccccccccccCChhhhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            99887654322111112234558999999999984    455899999999999999999999999753321   11111


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ... .............+++++.+||.+||+.||.+|||+.++++
T Consensus       230 ~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          230 ISE-KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHH-HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcc-cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            100 00000000112468899999999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=375.76  Aligned_cols=274  Identities=19%  Similarity=0.244  Sum_probs=205.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHH----HHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKA----NYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      +..++|.+.+.||+|+||.||+|.+..   ++..||||++............    .....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            345799999999999999999999987   8899999998765432111111    011346789999999999999999


Q ss_pred             eeEEeec---CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         357 YDVFEID---ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       357 ~~~~~~~---~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      ++++..+   ...+|+||||| +++|.+++...+.+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+.. 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-  189 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP-  189 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST-
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC-
Confidence            9998742   56789999999 8999999988889999999999999999999999988  999999999999987632 


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+++.+..................||+.|+|||++.    +..++.++|||||||+||+|++|+.||.....
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK----GVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            38999999999887644322111112234558999999999985    44689999999999999999999999954322


Q ss_pred             HHH-HHHHH-HHhhhhc---cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         514 QAT-ILEEN-TILKATE---VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       514 ~~~-~~~~~-~~~~~~~---~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ... +.... .......   ..+.....++.++.+||.+||..||.+||++.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             ccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            221 11111 1111100   0111223688999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-43  Score=362.65  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .+.++..++|++.+.||+|+||.||+|.+..+   +..||||++.....      ......+.+|+.+++.++||||+++
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~   81 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------DSVREKFLQEALTMRQFDHPHIVKL   81 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCccceE
Confidence            34567889999999999999999999998654   56799998754321      2234578899999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ++++.  .+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.
T Consensus        82 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~  154 (281)
T 1mp8_A           82 IGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN---DC  154 (281)
T ss_dssp             EEEEC--SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TE
T ss_pred             EEEEc--cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC---CC
Confidence            99985  455779999999999999997654 7999999999999999999999988  9999999999999977   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQ  514 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~  514 (627)
                      +||+|||+++.+.....      .......+|+.|+|||++.    ...++.++|||||||+||+|++ |..||......
T Consensus       155 ~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~  224 (281)
T 1mp8_A          155 VKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN  224 (281)
T ss_dssp             EEECC-------------------------CCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEECccccccccCcccc------cccccCCCcccccChhhcc----cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence            99999999987754321      1123346788999999984    3458899999999999999996 99999776554


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..+..   +...  ...+.+..+++++.+||.+||..||.+|||+.+++++
T Consensus       225 ~~~~~---i~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          225 DVIGR---IENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             GHHHH---HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH---HHcC--CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43321   1111  1233456789999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=376.16  Aligned_cols=259  Identities=23%  Similarity=0.399  Sum_probs=212.9

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCc
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPR  352 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  352 (627)
                      .+.+..++|.+.+.||+|+||.||+|.+..       .+..||||++.....      ......+.+|+.+++.+ +|||
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hpn  136 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKHKN  136 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC------HHHHHHHHHHHHHHHHhcCCch
Confidence            356778999999999999999999999764       346899999864422      22345788999999999 8999


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      ||+++++|. +.+.+|+|||||++++|.+++....                .+++..++.|+.||+.||.|||+.+  ||
T Consensus       137 Iv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv  213 (382)
T 3tt0_A          137 IINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI  213 (382)
T ss_dssp             BCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             hhhheeeec-cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--Ee
Confidence            999999997 5667889999999999999998653                4999999999999999999999988  99


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      ||||||+||||+.+   +.+||+|||+++.+......     .......||+.|+|||++.    ...++.++|||||||
T Consensus       214 H~Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~  281 (382)
T 3tt0_A          214 HRDLAARNVLVTED---NVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGV  281 (382)
T ss_dssp             CSCCCGGGEEECTT---CCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHH----SCCCCHHHHHHHHHH
T ss_pred             cCCCCcceEEEcCC---CcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhc----CCCCCchhHHHHHHH
Confidence            99999999999987   58999999999876543211     1233457889999999985    456899999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         497 IFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       497 iL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +||+|++ |..||.......... .  +..  .........+++++.+||.+||..||.+|||+.+++++
T Consensus       282 il~ellt~g~~p~~~~~~~~~~~-~--~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          282 LLWEIFTLGGSPYPGVPVEELFK-L--LKE--GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHH-H--HHT--TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHH-H--HHc--CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999 999997665443321 1  111  12233446789999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-43  Score=363.10  Aligned_cols=266  Identities=20%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             cCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       279 ~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +...++..++|++.++||+|+||+||+|.+.   ..||||++......     ....+.+.+|+.+++.++||||+++++
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-----PQQLQAFKNEVGVLRKTRHVNILLFMG   87 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-----HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-----HHHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence            4556788999999999999999999999754   35999998655432     223457889999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      ++.  ...+++|||||.+++|.+++.. ...+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+|
T Consensus        88 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~---~~~k  160 (289)
T 3og7_A           88 YST--APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED---NTVK  160 (289)
T ss_dssp             EEC--SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT---TEEE
T ss_pred             ecc--CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC---CCEE
Confidence            654  4557899999999999999864 457999999999999999999999988  9999999999999987   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++.......     ........||+.|+|||++... ....++.++|||||||+||+|++|+.||........+
T Consensus       161 l~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  234 (289)
T 3og7_A          161 IGDFGLATEKSRWSG-----SHQFEQLSGSILWMAPEVIRMQ-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  234 (289)
T ss_dssp             ECCCC-----------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH
T ss_pred             Eccceeccccccccc-----cccccccCCCccccCchhhccc-CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH
Confidence            999999986543211     1122345799999999998422 2456888999999999999999999999876665554


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...................+++++.+||.+||..||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          235 IEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            333221111111111234688999999999999999999999999863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=371.05  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=209.7

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .+..++|.+.+.||+|+||.||+|.+.     .+++.||||++.....      ......+.+|+.+++.++||||++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            455688999999999999999999987     4568999999864322      22345788999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhc------------------------cCcCHHHHHHHHHHHHHHHHHHHhCCC
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQH------------------------KTIAEREARSIVMQVVSALKYLNEIKP  413 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qi~~aL~yLH~~~~  413 (627)
                      ++|. +.+.+|+||||+++++|.+++...                        ..+++.+++.|+.||+.||.|||+.+ 
T Consensus       117 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-  194 (343)
T 1luf_A          117 GVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-  194 (343)
T ss_dssp             EEEC-SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             EEEc-cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            9997 566788999999999999999763                        57999999999999999999999988 


Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHH
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWS  493 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwS  493 (627)
                       ||||||||+|||++.+   +.+||+|||+++.+......     .......||+.|+|||++.    ...++.++||||
T Consensus       195 -ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~s  261 (343)
T 1luf_A          195 -FVHRDLATRNCLVGEN---MVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIF----YNRYTTESDVWA  261 (343)
T ss_dssp             -CCCSCCSGGGEEECGG---GCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHH----HCCCCHHHHHHH
T ss_pred             -eecCCCCcceEEECCC---CeEEEeecCCCcccccCccc-----cccCCCcccceecChhhhc----cCCcCcccccHH
Confidence             9999999999999876   68999999999876543211     1123347899999999985    334899999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         494 VGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       494 lGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |||+||+|++ |..||...........   +...  .....+..++.++.+||.+||+.||.+|||+.+++++
T Consensus       262 lG~il~el~t~g~~p~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          262 YGVVLWEIFSYGLQPYYGMAHEEVIYY---VRDG--NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHHTTTCCTTTTSCHHHHHHH---HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCCcCCCCChHHHHHH---HhCC--CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9999999998 9999976655433221   1111  1123345789999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.1e-43  Score=360.42  Aligned_cols=265  Identities=19%  Similarity=0.232  Sum_probs=203.2

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||||++......         ..+.+|+.+++.+.|++++..+.++..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---------CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---------hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            4668999999999999999999999999999999986543321         2467899999999999988888877667


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ...+++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+||||+.+...+.+||+|||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            88889999999 8999999874 468999999999999999999999998  9999999999999422223689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA--TILEE  520 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~--~~~~~  520 (627)
                      +++.+..................||+.|+|||++.    ...++.++|||||||+||+|++|+.||.......  .....
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhc----CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            99987654322111112234568999999999984    4558999999999999999999999997543221  11111


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ................+++++.+||.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            00000011101112467899999999999999999999999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=373.04  Aligned_cols=259  Identities=15%  Similarity=0.187  Sum_probs=205.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC--------CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE--
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE--------QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK--  355 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~--------~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~--  355 (627)
                      .++|.+.+.||+|+||.||+|.+..+        ++.||||++...            ..+.+|+.+++.++|||||+  
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------------~~~~~E~~~l~~l~h~niv~~~  108 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------------GRLFNEQNFFQRAAKPLQVNKW  108 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------------STHHHHHHHHHHHCCHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------------chHHHHHHHHHHhcccchhhhh
Confidence            57999999999999999999999874        889999998643            24678999999999999988  


Q ss_pred             -------------EeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         356 -------------LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       356 -------------l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                                   +++++..+...+||||||+ +++|.+++...  ..+++..++.|+.||+.||.|||+.+  ||||||
T Consensus       109 ~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Di  185 (352)
T 2jii_A          109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNV  185 (352)
T ss_dssp             HHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCC
T ss_pred             hhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCC
Confidence                         5677765578889999999 89999999876  78999999999999999999999988  999999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      ||+|||++.+.. ..+||+|||+++.+..................||+.|+|||++.    +..++.++|||||||+||+
T Consensus       186 kp~NIl~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~e  260 (352)
T 2jii_A          186 TAENIFVDPEDQ-SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK----GCGPSRRSDLQSLGYCMLK  260 (352)
T ss_dssp             CGGGEEEETTEE-EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCC-ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc----cCCCCchhhHHHHHHHHHH
Confidence            999999997621 28999999999877654322111112234458999999999984    4468999999999999999


Q ss_pred             HHhCCCCCCCCC-hHHHHHHHHHHhhhhccccC----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         501 CLYGKKPFGHNQ-SQATILEENTILKATEVQFA----NKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       501 lltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |++|+.||.... ....+.............+.    .+..++.++.+||.+||..||.+|||+.++++
T Consensus       261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            999999997654 23333222222221211121    12357899999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-43  Score=364.57  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=200.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....    ........+.+|+.+++.++||||+++++++. +.
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-ID  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ET
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-eC
Confidence            45789999999999999999999999999999999864322    22334567889999999999999999999997 56


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|+||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~---~~~kl~Dfg~~  181 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD---DFAYLVDFGIA  181 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEECSCCC-
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC---CCEEEecCccC
Confidence            778899999999999999998889999999999999999999999988  9999999999999987   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      ........      .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||...... .+ .. .+.
T Consensus       182 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~-~~-~~~  248 (309)
T 2h34_A          182 SATTDEKL------TQLGNTVGTLYYMAPERFS----ESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VM-GA-HIN  248 (309)
T ss_dssp             ---------------------CCGGGCCGGGTC----C----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HH-HH-HHH
T ss_pred             cccccccc------ccccccCCCcCccCHHHHc----CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HH-HH-Hhc
Confidence            87654321      1123447999999999984    456888999999999999999999999765443 11 11 111


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-CHHHHHh
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-DVISLAR  564 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-t~~elL~  564 (627)
                      ..........+.++.++.+||.+||..||.+|| ++.+++.
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          249 QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            111112233457899999999999999999999 8888775

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-43  Score=380.12  Aligned_cols=258  Identities=23%  Similarity=0.353  Sum_probs=210.5

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+.+..++|.+.+.||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++|||||++++++
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP------PDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC------HHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC------HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345567899999999999999999999999999999999764321      22344688999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . +...+|||||||++++|.+++... ..+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+
T Consensus       182 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~---~~~kl~  255 (377)
T 3cbl_A          182 T-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK---NVLKIS  255 (377)
T ss_dssp             C-SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEEC
T ss_pred             e-cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC---CcEEEC
Confidence            7 556788999999999999999765 46999999999999999999999988  9999999999999887   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||+++......+..     ......+++.|+|||++.    ...++.++|||||||+||||++ |..||..........
T Consensus       256 DfG~s~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~  326 (377)
T 3cbl_A          256 DFGMSREEADGVYAA-----SGGLRQVPVKWTAPEALN----YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE  326 (377)
T ss_dssp             CGGGCEECTTSEEEC-----CSSCCEEEGGGSCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred             cCCCceecCCCceee-----cCCCCCCCcCcCCHhHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999998754332111     011123577899999985    3358899999999999999998 999997765543321


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                         .+..  ....+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       327 ---~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          327 ---FVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ---HHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---HHHc--CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               1111  2233445578999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.4e-43  Score=361.05  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=215.6

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .+..+++..++|.+.+.||+|+||.||+|.+..++..||||++.....        ....+.+|+.+++.++||||++++
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~   75 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------EVEEFLKEAAVMKEIKHPNLVQLL   75 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence            456677888999999999999999999999999999999999864332        134678999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++. +...+|+||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.
T Consensus        76 ~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~  149 (288)
T 3kfa_A           76 GVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN---HL  149 (288)
T ss_dssp             EEEC-SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG---GC
T ss_pred             EEEc-cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC---CC
Confidence            9987 667788999999999999999864  45999999999999999999999998  9999999999999876   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQ  514 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~  514 (627)
                      +||+|||++........      .......+|+.|+|||++.    ...++.++|||||||++|+|++ |..||......
T Consensus       150 ~~l~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~  219 (288)
T 3kfa_A          150 VKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  219 (288)
T ss_dssp             EEECCCCGGGTSCSSSS------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEEccCccceeccCCcc------ccccCCccccCcCChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999987654321      1222335788999999985    3458899999999999999999 99999766544


Q ss_pred             HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         515 ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       515 ~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .....   +.  .......+..+++++.+||++||..||.+|||+.++++
T Consensus       220 ~~~~~---~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          220 QVYEL---LE--KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             GHHHH---HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH---Hh--ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            33221   11  12233445678999999999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-43  Score=366.54  Aligned_cols=272  Identities=28%  Similarity=0.472  Sum_probs=210.8

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--CCceeE
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVVK  355 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~  355 (627)
                      .+....+..++|.+++.||+|+||.||+|.+. +++.||||++......     ......+.+|+.+++.+.  ||||++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-----NQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-----HHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-----ccchHHHHHHHHHHHhccccCCceEE
Confidence            34445566788999999999999999999875 5889999998754321     223457889999999997  599999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++++. +...+|+||| +.+++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||+++    +.
T Consensus        93 ~~~~~~-~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~----~~  164 (313)
T 3cek_A           93 LYDYEI-TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD----GM  164 (313)
T ss_dssp             EEEEEE-CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET----TE
T ss_pred             EEEEee-cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC----Ce
Confidence            999987 6677889999 567899999998889999999999999999999999988  999999999999975    58


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-------CCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-------NPPKISSKVDVWSVGVIFYQCLYGKKPF  508 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-------~~~~~~~k~DVwSlGviL~elltG~~Pf  508 (627)
                      +||+|||+++.+......     ......+||+.|+|||++....       ....++.++|||||||+||+|++|..||
T Consensus       165 ~kL~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             EEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEEeeccccccccCcccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            999999999876543211     1123447999999999985311       1246889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .........+..  .. ............+.++.+||.+||..||.+||++.++++||||+..
T Consensus       240 ~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          240 QQIINQISKLHA--II-DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             TTCCSHHHHHHH--HH-CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             hhHHHHHHHHHH--HH-hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            765443332211  11 1122223334568999999999999999999999999999999743

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-43  Score=371.11  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=210.4

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +++..++|.+.+.||+|+||.||+|.+.     .++..||||++.....      ......+.+|+.+++.+ +||||++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv~  113 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD------SSEREALMSELKMMTQLGSHENIVN  113 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC------HHHHHHHHHHHHHHHhhcCCCCeee
Confidence            4566789999999999999999999973     4677899999864321      12245688999999999 8999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhcc-----------------------CcCHHHHHHHHHHHHHHHHHHHhCC
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-----------------------TIAEREARSIVMQVVSALKYLNEIK  412 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~e~~~~~i~~qi~~aL~yLH~~~  412 (627)
                      +++++. +.+.+++|||||++++|.+++....                       .+++..++.|+.||+.||.|||+.+
T Consensus       114 ~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          114 LLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEe-eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999997 5667889999999999999997643                       3799999999999999999999988


Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHH
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVW  492 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVw  492 (627)
                        |+||||||+||||+.+   +.+||+|||++..+.....     ........||+.|+|||++.    ...++.++|||
T Consensus       193 --ivH~Dikp~NIll~~~---~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~  258 (344)
T 1rjb_A          193 --CVHRDLAARNVLVTHG---KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLF----EGIYTIKSDVW  258 (344)
T ss_dssp             --EEETTCSGGGEEEETT---TEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHH----HCCCCHHHHHH
T ss_pred             --cccCCCChhhEEEcCC---CcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhc----cCCCChhHhHH
Confidence              9999999999999977   6899999999987654321     12233446788999999985    34589999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         493 SVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       493 SlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ||||+||+|++ |..||........+...  +.  .......+..+++++.+||.+||..||.+|||+.++++|-
T Consensus       259 slG~il~el~t~g~~p~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          259 SYGILLWEIFSLGVNPYPGIPVDANFYKL--IQ--NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHH--HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCcHHHHHHH--Hh--cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            99999999998 99999776554443321  11  1223344556899999999999999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-43  Score=364.18  Aligned_cols=262  Identities=20%  Similarity=0.309  Sum_probs=196.5

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc--CCCCceeEEeeEE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA--LDHPRVVKLYDVF  360 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~~  360 (627)
                      ..+.++|++++.||+|+||+||+|.+  +++.||||++....          ...+.+|.+++..  ++||||+++++++
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----------~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----------EKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----------chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            46788999999999999999999976  68999999985321          1234556666655  8999999999986


Q ss_pred             eec---CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeccccCCcEEecC
Q psy4988         361 EID---ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN--------EIKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       361 ~~~---~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH--------~~~~~IvHrDLKP~NILl~~  429 (627)
                      ...   ...+|+||||+++++|.+++.. ..+++..++.|+.||+.||.|||        +.+  ||||||||+|||++.
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~  148 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKK  148 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECT
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcC
Confidence            532   3458899999999999999954 57999999999999999999999        777  999999999999997


Q ss_pred             CCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCC--CCCcchhHHHHHHHHHHHHhC---
Q psy4988         430 GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP--KISSKVDVWSVGVIFYQCLYG---  504 (627)
Q Consensus       430 ~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~--~~~~k~DVwSlGviL~elltG---  504 (627)
                      +   +.+||+|||+++.........   .......+||+.|+|||++.......  .++.++|||||||+||+|++|   
T Consensus       149 ~---~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~  222 (301)
T 3q4u_A          149 N---GQCCIADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS  222 (301)
T ss_dssp             T---SCEEECCCTTCEEEETTTTEE---ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             C---CCEEEeeCCCeeecccccccc---cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence            7   589999999998765432110   01123347999999999985321111  345799999999999999999   


Q ss_pred             -------CCCCCCCChHH---HHHHHHHHhhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 -------KKPFGHNQSQA---TILEENTILKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 -------~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                             ..||.......   ...............++.   ...+++++.+||.+||+.||.+|||+.++++.
T Consensus       223 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                   88885432211   111111111111111111   12356789999999999999999999999863

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-43  Score=356.71  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=198.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +..++|.+.+.||+|+||.||+|.+.  ++.||||++......   ......+.+.+|+.+++.++||||+++++++. +
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   77 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDE---DISQTIENVRQEAKLFAMLKHPNIIALRGVCL-K   77 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcc---cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-c
Confidence            34578999999999999999999864  899999997654321   11223456889999999999999999999997 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCC-CEEeccccCCcEEecCCCc-----ccceE
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKP-PVIHYDLKPGNILLTEGNV-----CGEIK  437 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~-~IvHrDLKP~NILl~~~~~-----~g~vK  437 (627)
                      .+.+++||||+++++|..++. ...+++..++.++.||+.||.|||+.+. +|+||||||+|||++....     .+.+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            667889999999999999885 4689999999999999999999999763 3889999999999986321     26899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+++.+....         .....||+.|+|||++.    ...++.++||||||+++|+|++|+.||.........
T Consensus       157 l~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~  223 (271)
T 3dtc_A          157 ITDFGLAREWHRTT---------KMSAAGAYAWMAPEVIR----ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA  223 (271)
T ss_dssp             ECCCCC----------------------CCGGGSCHHHHH----HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred             EccCCccccccccc---------ccCCCCccceeCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999998665322         12347999999999985    345899999999999999999999999876554433


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..    ........+....+++++.+||.+||..||.+|||+.++++|
T Consensus       224 ~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          224 YG----VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HH----HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hh----hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            22    112233344456789999999999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-43  Score=355.32  Aligned_cols=256  Identities=12%  Similarity=0.160  Sum_probs=207.4

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||||++.......     ...+.+.+|+.+++.++|||||++++++..
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-----RKSRDFNEECPRLRIFSHPNVLPVLGACQS   78 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-----HHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-----HHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence            355678999999999999999999874  8899999987543221     223568899999999999999999999874


Q ss_pred             c-CCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         363 D-ANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       363 ~-~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . ...+++||||+++++|.+++....  .+++..++.|+.||+.||.|||+.+++|+||||||+|||++.+   +.++|+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~---~~~~l~  155 (271)
T 3kmu_A           79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED---MTARIS  155 (271)
T ss_dssp             TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT---SCEEEE
T ss_pred             CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC---cceeEE
Confidence            3 267789999999999999998765  4899999999999999999999987779999999999999977   588999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++.....            ....||+.|+|||++.... ...++.++|||||||++|+|++|+.||...........
T Consensus       156 ~~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~  222 (271)
T 3kmu_A          156 MADVKFSFQS------------PGRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK  222 (271)
T ss_dssp             GGGSCCTTSC------------TTCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH
T ss_pred             eccceeeecc------------cCccCCccccChhhhccCC-CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH
Confidence            9988765322            2237899999999985321 22344589999999999999999999977655443322


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .  .  ........+..+++++.+||.+||+.||.+|||+.++++.
T Consensus       223 ~--~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          223 V--A--LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             H--H--HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H--H--hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1  1  1222333445789999999999999999999999999863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-43  Score=363.44  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=202.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCC-------eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ-------RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~-------~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      .+..++|.+.+.||+|+||.||+|.+..++       ..||||++.....       .....+.+|+.+++.++|||||+
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~   76 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-------NYSESFFEAASMMSKLSHKHLVL   76 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-------GGHHHHHHHHHHHHTSCCTTBCC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-------HHHHHHHHHHHHHHhCCCCCEeE
Confidence            456789999999999999999999998877       5799999854321       12346889999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccC-cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc-
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC-  433 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~-  433 (627)
                      +++++. +.+.+++||||+++++|.+++..... +++..++.|+.||+.||.|||+.+  ||||||||+|||++.+... 
T Consensus        77 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           77 NYGVCV-CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             EEEEEC-CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGG
T ss_pred             EEEEEE-eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccc
Confidence            999997 56667899999999999999987654 999999999999999999999988  9999999999999876421 


Q ss_pred             ----cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         434 ----GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       434 ----g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                          +.+||+|||++......           ....||+.|+|||++..   ...++.++|||||||+||+|++|..|+.
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIEN---PKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHC---GGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             ccccceeeeccCcccccccCc-----------cccCCcCcccCHHHhCC---CCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence                12999999999765322           22357899999999852   2458999999999999999999554443


Q ss_pred             CCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         510 HNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ............      ......+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       220 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          220 SALDSQRKLQFY------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TTSCHHHHHHHH------HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHh------hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            333322222111      11222334567899999999999999999999999987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-43  Score=364.58  Aligned_cols=259  Identities=20%  Similarity=0.313  Sum_probs=212.1

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEE-----cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFD-----LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~-----~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +.+..++|.+.+.||+|+||.||+|.+     ..+++.||||++......      .....+.+|+.+++.+ +||||++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~~h~~i~~   91 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL------TEREALMSELKVLSYLGNHMNIVN   91 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH------HHHHHHHHHHHHHhhcccCCCeee
Confidence            446678999999999999999999985     457889999998654321      1235688999999999 9999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhcc------------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------------TIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      ++++|. +.+.+++||||+++++|.+++....                  .+++..++.++.||+.||.|||+.+  |+|
T Consensus        92 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H  168 (313)
T 1t46_A           92 LLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH  168 (313)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             EEEEEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            999997 5667789999999999999997654                  4899999999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.+||+|||+++.+.....     ........||+.|+|||++.    ...++.++|||||||+
T Consensus       169 ~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~i  236 (313)
T 1t46_A          169 RDLAARNILLTHG---RITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGIF  236 (313)
T ss_dssp             SCCSGGGEEEETT---TEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHH
T ss_pred             CCCccceEEEcCC---CCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhc----CCCCChHHHHHHHHHH
Confidence            9999999999887   6899999999987654321     12233446788999999985    3458999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||+|++ |..||........+.....    ..........++.++.+||.+||..||.+|||+.+++++
T Consensus       237 l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          237 LWELFSLGSSPYPGMPVDSKFYKMIK----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTTTCCSSTTCCSSHHHHHHHH----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCCCCCCcccchhHHHHHhc----cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999998 9999976654443322211    112233445789999999999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=364.69  Aligned_cols=265  Identities=25%  Similarity=0.384  Sum_probs=196.4

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|.+++.||+|+||.||+|.+..+++.||||++.......     .....+.++..+++.++||||+++++++. +
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-~   95 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-----ENKRILMDLDVVLKSHDCPYIVQCFGTFI-T   95 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-----HHHHHHHHHHHHHHTTTCTTBCCEEEEEE-C
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-----HHHHHHHHHHHHHHhcCCCceeeEEEEEe-c
Confidence            34578999999999999999999999999999999987543321     11233445556788889999999999997 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhC-CCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEI-KPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~-~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      ...+|+||||+ ++.+..+... ...+++..++.++.||+.||.|||+. +  |+|+||||+|||++.+   +.+||+||
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~---~~~kl~df  169 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER---GQIKLCDF  169 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT---SCEEECCC
T ss_pred             CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC---CCEEEEEC
Confidence            67889999999 4556555543 56899999999999999999999985 8  9999999999999887   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      |++..+....        ......||+.|+|||++.... ....++.++|||||||+||+|++|+.||.........+..
T Consensus       170 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  241 (318)
T 2dyl_A          170 GISGRLVDDK--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK  241 (318)
T ss_dssp             TTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             CCchhccCCc--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence            9998765432        122347999999999984211 2345888999999999999999999999765444433322


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                        +.......++....++.++.+||.+||+.||.+||++.++++||||..
T Consensus       242 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          242 --VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             --HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             --HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence              222233344445578999999999999999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-43  Score=367.54  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=212.0

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEE-----cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFD-----LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~-----~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +.+..++|.+.+.||+|+||.||+|.+     ..+++.||||++.....      ......+.+|+.+++.+ +||||++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC------cHHHHHHHHHHHHHHhcccCCCeee
Confidence            345678999999999999999999985     35779999999864432      12235688999999999 7999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccC----------------cCHHHHHHHHHHHHHHHHHHHhCCCCEEecc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT----------------IAEREARSIVMQVVSALKYLNEIKPPVIHYD  419 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~----------------l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrD  419 (627)
                      +++++..+...+++|||||++++|.+++.....                +++..++.++.||+.||.|||+.+  |+|||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d  173 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  173 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence            999998666678899999999999999987543                899999999999999999999988  99999


Q ss_pred             ccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHH
Q psy4988         420 LKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFY  499 (627)
Q Consensus       420 LKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~  499 (627)
                      |||+|||++.+   +.+||+|||+++.+.....     ........||+.|+|||++.    ...++.++|||||||+||
T Consensus       174 ikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~  241 (316)
T 2xir_A          174 LAARNILLSEK---NVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLW  241 (316)
T ss_dssp             CSGGGEEECGG---GCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHH
T ss_pred             CccceEEECCC---CCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhc----cccccchhHHHHHHHHHH
Confidence            99999999876   6899999999987653221     11223346789999999985    345889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         500 QCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       500 ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +|++ |..||........+....  ..  .........+++++.+||.+||..||.+|||+.++++|
T Consensus       242 ~l~t~g~~p~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          242 EIFSLGASPYPGVKIDEEFCRRL--KE--GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHH--HH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCCcccchhHHHHHHh--cc--CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9998 999997665444433221  11  11233345689999999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.2e-43  Score=389.86  Aligned_cols=266  Identities=19%  Similarity=0.281  Sum_probs=207.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      +.+.++|.++++||+|+||.||+|.+..+++.||||++......         ..+.+|+.+++.|.|++++..+.+|..
T Consensus         3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---------CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            46789999999999999999999999999999999987654432         236789999999988666655555655


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +...+||||||| +++|.+++.. ...+++..++.|+.||+.||.|||+++  ||||||||+||||+.+...+.+||+||
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeC
Confidence            788889999999 8999999975 568999999999999999999999988  999999999999953222368999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT--ILE  519 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~--~~~  519 (627)
                      |+++.+.................+||+.|+|||++.    ...++.++||||||||||+|++|+.||........  .+.
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~  226 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE  226 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhc----CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence            999987654322221122234568999999999984    45689999999999999999999999976443211  111


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .................++.++.+||.+||..||.+||++.+|++
T Consensus       227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          227 KISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            111111111101112467899999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-43  Score=369.98  Aligned_cols=255  Identities=20%  Similarity=0.319  Sum_probs=200.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEE----EEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYV----ACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~V----AVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      +..++|.++++||+|+||+||+|.+..+++.|    |+|.+....      .....+.+.+|+.+++.++|||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   85 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT------SPKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc------CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            34578999999999999999999998887765    666553211      12234578899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      |. +. .+++|+||+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus        86 ~~-~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~---~~~kl  158 (327)
T 3poz_A           86 CL-TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP---QHVKI  158 (327)
T ss_dssp             EE-SS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET---TEEEE
T ss_pred             Ee-cC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC---CCEEE
Confidence            97 33 36799999999999999876 467999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+......     .......||+.|+|||++.    ...++.++|||||||+||+|++ |+.||.........
T Consensus       159 ~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  229 (327)
T 3poz_A          159 TDFGLAKLLGAEEKE-----YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             CCTTHHHHHTTTCC------------CCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             ccCcceeEccCCccc-----ccccCCCccccccChHHhc----cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence            999999887543211     1123346788999999985    3458999999999999999999 99999766554322


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      . .  +.  .....+....++.++.+||.+||+.||.+||++.+++.+
T Consensus       230 ~-~--~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          230 S-I--LE--KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             H-H--HH--TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             H-H--HH--cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            1 1  11  122344556789999999999999999999999999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-43  Score=370.24  Aligned_cols=261  Identities=20%  Similarity=0.243  Sum_probs=198.9

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      +-.++|++.++||+|+||+||+|.+.  ++.||||++.....        ....+.+|+.+++.++|||||++++++...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--------QSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--------HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            44578999999999999999999765  79999999854321        122455699999999999999999999754


Q ss_pred             C---CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC----------CCCEEeccccCCcEEecCC
Q psy4988         364 A---NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI----------KPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       364 ~---~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~----------~~~IvHrDLKP~NILl~~~  430 (627)
                      .   ..+|+|||||++++|.+++.. ..+++..++.|+.||+.||.|||+.          +  ||||||||+|||++.+
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC
Confidence            3   347899999999999999976 4699999999999999999999998          7  9999999999999887


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCC-CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN-PPKISSKVDVWSVGVIFYQCLYGKKPFG  509 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~~~~~k~DVwSlGviL~elltG~~Pf~  509 (627)
                         +.+||+|||+++.+......     ......+||+.|+|||++..... ...++.++|||||||+||+|++|+.||.
T Consensus       168 ---~~~kL~DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~  239 (322)
T 3soc_A          168 ---LTACIADFGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD  239 (322)
T ss_dssp             ---CCEEECCCTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred             ---CeEEEccCCcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence               68999999999877643221     11233579999999999853211 1345678899999999999999999996


Q ss_pred             CCChHHH--------------HHHHHHHhhhhccccC---CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         510 HNQSQAT--------------ILEENTILKATEVQFA---NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       510 ~~~~~~~--------------~~~~~~~~~~~~~~~~---~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .......              ..............++   .....+.++.+||.+||+.||.+|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5432110              0000000000000000   011234569999999999999999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-42  Score=358.67  Aligned_cols=263  Identities=21%  Similarity=0.331  Sum_probs=206.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      ......+|++++.||+|+||.||+|.    +..+++.||||++.....      ......+.+|+.+++.++||||++++
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG------GNHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc------chhHHHHHHHHHHHHhCCCCCeeeee
Confidence            34456779999999999999999998    677899999999864321      11235688999999999999999999


Q ss_pred             eEEeecC-CeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         358 DVFEIDA-NSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       358 ~~~~~~~-~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++..+. +.+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~  164 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE---HQ  164 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET---TE
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC---CC
Confidence            9987432 568899999999999999954 467999999999999999999999988  9999999999999887   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ-  514 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~-  514 (627)
                      +||+|||++..+.....    .........||..|+|||++.    ...++.++|||||||++|+|++|..||...... 
T Consensus       165 ~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  236 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKE----YYTVKDDRDSPVFWYAPECLM----QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF  236 (302)
T ss_dssp             EEECCCTTCEECCTTCC----EEECCCCTTCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             EEECcccccccccCCCc----ceeccCCCCCCccccCCeeec----CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence            99999999987754321    112233457899999999985    345788999999999999999999987422110 


Q ss_pred             ----------HHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         515 ----------ATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       515 ----------~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                                ...... ..........+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          237 LKMIGPTHGQMTVTRL-VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHCSCCGGGHHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hhccCCcccccCHHHH-HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                      000000 0111122234455678999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.5e-43  Score=364.59  Aligned_cols=260  Identities=20%  Similarity=0.328  Sum_probs=211.8

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCcee
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV  354 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV  354 (627)
                      ..+.+..++|.+.+.||+|+||.||+|.+.     .+++.||||++.....      ......+.+|+.+++.++||||+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~   91 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------MRERIEFLNEASVMKEFNCHHVV   91 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------HHHHHHHHHHHHHGGGCCCTTBC
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC------HHHHHHHHHHHHHHHhcCCCCEe
Confidence            345678899999999999999999999877     4678999999864332      12234688999999999999999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCc
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGN  424 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~N  424 (627)
                      ++++++. +.+.+++||||+++++|.+++...          ..+++..++.++.||+.||.|||+.+  |+||||||+|
T Consensus        92 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~N  168 (322)
T 1p4o_A           92 RLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARN  168 (322)
T ss_dssp             CEEEEEC-SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGG
T ss_pred             eeEEEEc-cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccce
Confidence            9999987 566778999999999999998753          35699999999999999999999988  9999999999


Q ss_pred             EEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-
Q psy4988         425 ILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-  503 (627)
Q Consensus       425 ILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-  503 (627)
                      ||++.+   +.+||+|||+++.......     ........||+.|+|||++.    ...++.++|||||||+||+|++ 
T Consensus       169 Ili~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~  236 (322)
T 1p4o_A          169 CMVAED---FTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATL  236 (322)
T ss_dssp             EEECTT---CCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCC---CeEEECcCccccccccccc-----cccccCCCCCCCccChhhhc----cCCCCchhhHHHHHHHHHHHHhc
Confidence            999987   6899999999987654321     11223346789999999985    3458899999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       504 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |..||...........   +..  .........++.++.+||.+||..||.+|||+.++++|
T Consensus       237 g~~p~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          237 AEQPYQGLSNEQVLRF---VME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             SCCTTTTSCHHHHHHH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccCCHHHHHHH---HHc--CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8999976654433211   111  11223345789999999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.7e-43  Score=367.77  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=208.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEE-----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAF-----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~-----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      ..+..++|.+.+.||+|+||.||+|.     +..+++.||||++.....      ......+.+|+.+++.++||||+++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------EQDELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc------hhhHHHHHHHHHHHhhCCCCCCCeE
Confidence            34677899999999999999999998     556788999999853322      1223468899999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc-------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH-------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~  429 (627)
                      ++++. +...+|+||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+  |+||||||+||||+.
T Consensus        99 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~  175 (327)
T 2yfx_A           99 IGVSL-QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTC  175 (327)
T ss_dssp             EEEEC-SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESC
T ss_pred             EEEEc-CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEec
Confidence            99997 556678999999999999999865       34899999999999999999999988  999999999999996


Q ss_pred             CCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q psy4988         430 GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPF  508 (627)
Q Consensus       430 ~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf  508 (627)
                      +.....+||+|||++..+......     .......||+.|+|||++.    ...++.++|||||||+||+|++ |..||
T Consensus       176 ~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~  246 (327)
T 2yfx_A          176 PGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPY  246 (327)
T ss_dssp             SSTTCCEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCcceEEECcccccccccccccc-----ccCCCcCCCcceeCHhHhc----CCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            543357999999999866443211     1123346899999999985    3458899999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ...........   +...  ........++..+.+||.+||..||.+||++.++++|.|+.
T Consensus       247 ~~~~~~~~~~~---~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          247 PSKSNQEVLEF---VTSG--GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TTCCHHHHHHH---HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcCHHHHHHH---HhcC--CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            77654433211   1111  12233457899999999999999999999999999998864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2e-42  Score=364.38  Aligned_cols=259  Identities=23%  Similarity=0.395  Sum_probs=209.6

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEc-------CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCc
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDL-------KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPR  352 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-------~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  352 (627)
                      .+.+..++|.+.+.||+|+||.||+|.+.       .++..||||++.....      ......+.+|+.+++.+ +|||
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~  102 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------EKDLSDLVSEMEMMKMIGKHKN  102 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC------HHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc------HHHHHHHHHHHHHHHHhhcCCC
Confidence            34566789999999999999999999976       4678899999864322      22345788999999999 8999


Q ss_pred             eeEEeeEEeecCCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         353 VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       353 IV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      |++++++|. +.+.+|+||||+++++|.+++....                .+++..++.++.||+.||.|||+.+  ||
T Consensus       103 iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv  179 (334)
T 2pvf_A          103 IINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI  179 (334)
T ss_dssp             BCCEEEEEC-SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             EeeEEEEEc-cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            999999987 5667889999999999999998654                3899999999999999999999988  99


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      ||||||+|||++.+   +.+||+|||+++.+.....     ........+|+.|+|||++.    ...++.++|||||||
T Consensus       180 H~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~  247 (334)
T 2pvf_A          180 HRDLAARNVLVTEN---NVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGV  247 (334)
T ss_dssp             CSCCSGGGEEECTT---CCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHH----HCEECHHHHHHHHHH
T ss_pred             CCCCccceEEEcCC---CCEEEcccccccccccccc-----ccccCCCCcccceeChHHhc----CCCcChHHHHHHHHH
Confidence            99999999999877   6899999999987654321     11223346789999999985    345889999999999


Q ss_pred             HHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         497 IFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       497 iL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +||+|++ |..||...........   +...  ........++.++.+||.+||..||.+|||+.+++++
T Consensus       248 il~ellt~g~~p~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          248 LMWEIFTLGGSPYPGIPVEELFKL---LKEG--HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHH---HHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCcCcCCHHHHHHH---HhcC--CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999 9999976654433211   1111  1233445789999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.6e-43  Score=368.88  Aligned_cols=255  Identities=21%  Similarity=0.288  Sum_probs=203.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeE----EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRY----VACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~----VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ...++|++++.||+|+||+||+|.+..+++.    ||+|++.......      ....+.+|+.+++.++|||||+++++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ------SFQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS------CBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH------HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            3457899999999999999999999888876    6667654322111      12346789999999999999999998


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +.  ...+++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus        84 ~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~---~~~kl  156 (325)
T 3kex_A           84 CP--GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP---SQVQV  156 (325)
T ss_dssp             EC--BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS---SCEEE
T ss_pred             Ec--CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC---CeEEE
Confidence            86  45578999999999999998764 68999999999999999999999998  9999999999999876   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+......     .......||+.|+|||++.    ...++.++|||||||+||+|++ |..||.........
T Consensus       157 ~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  227 (325)
T 3kex_A          157 ADFGVADLLPPDDKQ-----LLYSEAKTPIKWMALESIH----FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP  227 (325)
T ss_dssp             CSCSGGGGSCCCTTC-----CC-----CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred             CCCCcccccCccccc-----ccccCCCCcccccChHHhc----cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence            999999987543211     1233457888999999985    3458999999999999999999 99999766544332


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..   +...  ........++.++.+||.+||..||.+||++.++++|
T Consensus       228 ~~---~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          228 DL---LEKG--ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HH---HHTT--CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HH---HHcC--CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11   1111  2233344678899999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-42  Score=357.84  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=196.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++.......    ......+.+|+.+++.++||||++++++|. +
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~  103 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD----AKARADCIKEIDLLKQLNHPNVIKYYASFI-E  103 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-c
Confidence            34578999999999999999999999999999999986532211    223456889999999999999999999998 5


Q ss_pred             CCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .+.+++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~---~~~kl~  178 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT---GVVKLG  178 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEEC
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC---CCEEEE
Confidence            6778899999999999998864    456999999999999999999999988  9999999999999876   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||++..+.....       ......||+.|+|||++.    ...++.++|||||||+||+|++|..||.........+.
T Consensus       179 Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  247 (310)
T 2wqm_A          179 DLGLGRFFSSKTT-------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC  247 (310)
T ss_dssp             CC-------------------------CCSSCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH
T ss_pred             eccceeeecCCCc-------cccccCCCeeEeChHHhC----CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH
Confidence            9999987654321       123347899999999984    45689999999999999999999999965432221111


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .  ..............++.++.+||.+||..||.+|||+.+++++
T Consensus       248 ~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          248 K--KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             H--HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H--HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            1  1111111112235689999999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-42  Score=354.57  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-  362 (627)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++.....           .+.+|+.+++.++||||++++++|.. 
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----------KAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-----------GGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-----------HHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            456789999999999999999999999999999999865431           35679999999999999999998853 


Q ss_pred             --------------cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEE
Q psy4988         363 --------------DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL  426 (627)
Q Consensus       363 --------------~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NIL  426 (627)
                                    ....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+|+||||+|||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil  154 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF  154 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence                          134578999999999999999754  57999999999999999999999988  999999999999


Q ss_pred             ecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCC
Q psy4988         427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKK  506 (627)
Q Consensus       427 l~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~  506 (627)
                      ++.+   +.+||+|||++..+.....        .....||+.|+|||++.    ...++.++|||||||+||+|++|..
T Consensus       155 ~~~~---~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~~~  219 (284)
T 2a19_B          155 LVDT---KQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQIS----SQDYGKEVDLYALGLILAELLHVCD  219 (284)
T ss_dssp             EEET---TEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHH----CSCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred             EcCC---CCEEECcchhheecccccc--------ccccCCcccccChhhhc----cCCCcchhhhHHHHHHHHHHHhcCC
Confidence            9987   5899999999987654321        22347999999999985    4458899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         507 PFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       507 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ||...   ......   .  ...  .....++.++.+||.+||..||.+|||+.++++|.|..
T Consensus       220 ~~~~~---~~~~~~---~--~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          220 TAFET---SKFFTD---L--RDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             SHHHH---HHHHHH---H--HTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH---HHHHHH---h--hcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            98321   111110   1  111  12346889999999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-42  Score=363.11  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=208.5

Q ss_pred             CCCeeEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .++|++++.||+|+||.||+|.    +..+++.||||++....       ....+.+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-------PDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-------HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            4789999999999999999998    56789999999986432       122356889999999999999999999876


Q ss_pred             e-cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 I-DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~-~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . +...+|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~---~~~kl~  169 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE---AHVKIA  169 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET---TEEEEC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC---CCEEEc
Confidence            3 45668899999999999999976 457999999999999999999999988  9999999999999887   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH--
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI--  517 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~--  517 (627)
                      |||+++.+.....    .........||+.|+|||++.    ...++.++|||||||+||+|++|..||.........  
T Consensus       170 Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~  241 (327)
T 3lxl_A          170 DFGLAKLLPLDKD----YYVVREPGQSPIFWYAPESLS----DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM  241 (327)
T ss_dssp             CGGGCEECCTTCS----EEECSSCCCSCGGGSCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC
T ss_pred             ccccceecccCCc----cceeeccCCccccccCHHHhc----cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc
Confidence            9999987654321    111233457899999999985    345788999999999999999999999543321100  


Q ss_pred             --------HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 --------LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 --------~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                              ..............+....+++++.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                    000001111222344556789999999999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-42  Score=359.06  Aligned_cols=265  Identities=22%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             cccCCCCccCCCeeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce
Q psy4988         277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV  353 (627)
Q Consensus       277 ~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI  353 (627)
                      ..+....+..++|.+.+.||+|+||.||+|.+..   ++..||||++......     ......+.+|+.+++.++||||
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i   98 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-----QREIEEFLSEAACMKDFSHPNV   98 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-----HHHHHHHHHHHHHHHTCCCTTB
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-----hhHHHHHHHHHHHHhcCCCCCe
Confidence            3444555677899999999999999999998766   5668999998654321     2234578899999999999999


Q ss_pred             eEEeeEEeecCC----eEEEEEeecCCCChHHHHHh------ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCC
Q psy4988         354 VKLYDVFEIDAN----SFCTVLEYCDGHDLDFYLKQ------HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPG  423 (627)
Q Consensus       354 V~l~~~~~~~~~----~~~lV~E~~~gg~L~~~l~~------~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~  423 (627)
                      +++++++.....    .+++||||+.+++|..++..      ...+++..++.|+.||+.||.|||+.+  |+||||||+
T Consensus        99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~  176 (313)
T 3brb_A           99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAAR  176 (313)
T ss_dssp             CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGG
T ss_pred             eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcc
Confidence            999999874332    45899999999999999843      357999999999999999999999988  999999999


Q ss_pred             cEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh
Q psy4988         424 NILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY  503 (627)
Q Consensus       424 NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt  503 (627)
                      |||++.+   +.+||+|||+++.+......     .......+++.|+|||++.    ...++.++|||||||+||+|++
T Consensus       177 NIli~~~---~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~  244 (313)
T 3brb_A          177 NCMLRDD---MTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIAT  244 (313)
T ss_dssp             GEEECTT---SCEEECSCSCC---------------------CCGGGSCHHHHH----SSCCCHHHHHHHHHHHHHHHHT
T ss_pred             eEEEcCC---CcEEEeecCcceeccccccc-----CcccccCCCccccCchhhc----CCCccchhhhHHHHHHHHHHHh
Confidence            9999987   58999999999876543211     1123346788999999984    4468999999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         504 -GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       504 -G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       |..||...........   +...  ........+++++.+||.+||..||.+|||+.+++++
T Consensus       245 ~g~~p~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          245 RGMTPYPGVQNHEMYDY---LLHG--HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TSCCSSTTCCGGGHHHH---HHTT--CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCccCCHHHHHHH---HHcC--CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             9999976655443321   1111  1223345788999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-42  Score=363.55  Aligned_cols=259  Identities=21%  Similarity=0.331  Sum_probs=210.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCe-----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQR-----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~-----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +++..++|.+.+.||+|+||.||+|.+..++.     .||||++.....      ......+.+|+.+++.+ +|||||+
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~  114 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH------ADEKEALMSELKIMSHLGQHENIVN  114 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC------hHHHHHHHHHHHHHHhhcCCCCeee
Confidence            45667899999999999999999999877654     799999864432      12245688999999999 8999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc--------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEecccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLK  421 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLK  421 (627)
                      ++++|. +...+++|||||++++|.+++...              ..+++..++.++.||+.||.|||+.+  |||||||
T Consensus       115 ~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk  191 (333)
T 2i1m_A          115 LLGACT-HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVA  191 (333)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred             EEEEEe-cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcc
Confidence            999997 566788999999999999998753              35799999999999999999999988  9999999


Q ss_pred             CCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHH
Q psy4988         422 PGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC  501 (627)
Q Consensus       422 P~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~el  501 (627)
                      |+|||++.+   +.+||+|||+++.+.....     ........||+.|+|||++.    ...++.++|||||||+||+|
T Consensus       192 p~NIl~~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el  259 (333)
T 2i1m_A          192 ARNVLLTNG---HVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEI  259 (333)
T ss_dssp             GGGCEEEGG---GEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHH
T ss_pred             cceEEECCC---CeEEECccccccccccccc-----eeecCCCCCCccccCHHHhc----cCCCChHHHHHHHHHHHHHH
Confidence            999999876   6899999999987654321     11223346788999999985    34588999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         502 LY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       502 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ++ |..||........+....  .  .......+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       260 ~t~g~~p~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          260 FSLGLNPYPGILVNSKFYKLV--K--DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             TTTSCCSSTTCCSSHHHHHHH--H--HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCCCCcccchhHHHHHHH--h--cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            98 999997665444332211  1  122333445678999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-42  Score=386.14  Aligned_cols=257  Identities=22%  Similarity=0.359  Sum_probs=213.9

Q ss_pred             cCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       279 ~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +..+++..++|.+.++||+|+||.||+|.+..++..||||++......        ...+.+|+.+++.++|||||++++
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~  283 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKHPNLVQLLG  283 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--------hHHHHHHHHHHHhcCCCCEeeEEE
Confidence            445667778999999999999999999999999999999998644321        346889999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +|. +...+|||||||++++|.+++...  ..+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+
T Consensus       284 ~~~-~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~---~~~  357 (495)
T 1opk_A          284 VCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN---HLV  357 (495)
T ss_dssp             EEC-SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG---GCE
T ss_pred             EEe-cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC---CcE
Confidence            997 566788999999999999999864  46999999999999999999999988  9999999999999876   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~  515 (627)
                      ||+|||+++.+....+.      ......+++.|+|||++.    ...++.++|||||||+||||++ |..||.......
T Consensus       358 kl~DFG~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~  427 (495)
T 1opk_A          358 KVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  427 (495)
T ss_dssp             EECCTTCEECCTTCCEE------CCTTCCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEeecccceeccCCcee------ecCCCcCCcceeCHhHHh----cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999876543221      122335688999999985    3358899999999999999998 999997665443


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ....   +.  .....+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       428 ~~~~---~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          428 VYEL---LE--KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHH---HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHH---HH--cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            3211   11  12234445678999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-42  Score=349.96  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=207.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+-.++|.+.+.||+|+||.||+|.+. ++..||||++......        ...+.+|+.+++.++||||+++++++. 
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~-   73 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------EEDFIEEAEVMMKLSHPKLVQLYGVCL-   73 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--------HHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--------HHHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence            345678999999999999999999876 6788999998654321        135788999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~---~~~kl~df  148 (267)
T 3t9t_A           74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN---QVIKVSDF  148 (267)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG---GCEEECCT
T ss_pred             cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC---CCEEEccc
Confidence            566788999999999999999765 56999999999999999999999988  9999999999999876   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |++........      .......+|+.|+|||++.    ...++.++||||||++||+|++ |..||........... 
T Consensus       149 g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-  217 (267)
T 3t9t_A          149 GMTRFVLDDQY------TSSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-  217 (267)
T ss_dssp             TGGGGBCCHHH------HSTTSTTCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred             ccccccccccc------cccccccccccccChhhhc----CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-
Confidence            99987643221      1122346788999999984    3457899999999999999999 8999977655433221 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        +..  ......+..++.++.+||.+||..||.+||++.+++++
T Consensus       218 --i~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          218 --IST--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --HHT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --Hhc--CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              111  12223345688999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9e-43  Score=373.89  Aligned_cols=257  Identities=22%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      .+..++|.+.+.||+|+||.||+|.+.   .++..||||++.....      ....+.+.+|+.+++.++|||||+++++
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~  114 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT------EKQRRDFLGEASIMGQFDHPNIIRLEGV  114 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC------HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            455678999999999999999999876   4678899999864322      1234578899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +. +...++||||||++++|.+++.... .+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus       115 ~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~---~~~kl  188 (373)
T 2qol_A          115 VT-KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN---LVCKV  188 (373)
T ss_dssp             EC-SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEEE
T ss_pred             Ee-eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC---CCEEE
Confidence            97 5667889999999999999997654 7999999999999999999999988  9999999999999887   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+......    ........+|+.|+|||++.    ...++.++|||||||+||||++ |+.||........+
T Consensus       189 ~Dfg~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~  260 (373)
T 2qol_A          189 SDFGLGRVLEDDPEA----AYTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI  260 (373)
T ss_dssp             CCC--------------------------CTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH
T ss_pred             CcCccccccccCCcc----ceeccCCCcCCCccChhhhc----cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999877543211    01122235678999999985    3458999999999999999997 99999776554332


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..   +.  .....+....++.++.+||.+||+.||.+||++.++++
T Consensus       261 ~~---i~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          261 KA---VD--EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HH---HH--TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH---HH--cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            21   11  12234445678999999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-42  Score=377.45  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=206.4

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+.+..++|.+.+.||+|+||.||+|.+.  ++.||||++.....         .+.+.+|+.+++.++|||||++++++
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---------AQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT---------SHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH---------HHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            35567789999999999999999999764  78999999864321         24688999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccC--cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKT--IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      ..+...+|||||||++++|.+++...+.  +++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~---~~~kl  330 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED---NVAKV  330 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT---SCEEE
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC---CCEEE
Confidence            7555578999999999999999987643  799999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.....          .....+++.|+|||++.    ...++.++|||||||+||||++ |..||........+
T Consensus       331 ~DfG~a~~~~~~----------~~~~~~~~~y~aPE~~~----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~  396 (450)
T 1k9a_A          331 SDFGLTKEASST----------QDTGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  396 (450)
T ss_dssp             CCCTTCEECC----------------CCCTTTSCHHHHH----SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred             eeCCCccccccc----------ccCCCCCcceeCHHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999854321          12236789999999985    4458999999999999999998 99999766544333


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..   +..  ....+.+..+++++.+||.+||..||.+|||+.+++.
T Consensus       397 ~~---i~~--~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          397 PR---VEK--GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH---HHc--CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            21   111  1233445678999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=379.60  Aligned_cols=261  Identities=23%  Similarity=0.370  Sum_probs=203.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+.++||+|+||+||+|.+..+++.||||++.......      ....+.+|+.+++.++|||||++++++...
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   79 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------PVDVQMREFEVLKKLNHKNIVKLFAIEEET   79 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------CHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc------hHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence            56789999999999999999999999999999999986432211      134577899999999999999999998744


Q ss_pred             C-CeEEEEEeecCCCChHHHHHhccC---cCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEe----cCCCcccc
Q psy4988         364 A-NSFCTVLEYCDGHDLDFYLKQHKT---IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILL----TEGNVCGE  435 (627)
Q Consensus       364 ~-~~~~lV~E~~~gg~L~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl----~~~~~~g~  435 (627)
                      . ..+|+|||||++++|.+++.....   +++..++.|+.||+.||.|||+.+  ||||||||+|||+    +.+   +.
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~---~~  154 (396)
T 4eut_A           80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ---SV  154 (396)
T ss_dssp             TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC---EE
T ss_pred             CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc---ee
Confidence            3 367899999999999999976543   999999999999999999999988  9999999999998    433   57


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN----PPKISSKVDVWSVGVIFYQCLYGKKPFGHN  511 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~----~~~~~~k~DVwSlGviL~elltG~~Pf~~~  511 (627)
                      +||+|||+++.+....        .....+||+.|+|||++.....    ...++.++|||||||+||+|++|+.||...
T Consensus       155 ~kL~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~  226 (396)
T 4eut_A          155 YKLTDFGAARELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF  226 (396)
T ss_dssp             EEECCGGGCEECCCGG--------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred             EEEecCCCceEccCCC--------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            9999999998765432        1234579999999999742100    134678999999999999999999999532


Q ss_pred             Ch---HHHHHHHHHHhhhhc--------------c----ccCCC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         512 QS---QATILEENTILKATE--------------V----QFANK----PTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       512 ~~---~~~~~~~~~~~~~~~--------------~----~~~~~----~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..   ...++..  +.....              +    .++..    ..++..+.+||++||++||++||++.+++++
T Consensus       227 ~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          227 EGPRRNKEVMYK--IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCTTTCHHHHHH--HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchHHHHHH--HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            21   1122111  111110              0    11111    2345678899999999999999999998653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-42  Score=379.75  Aligned_cols=269  Identities=26%  Similarity=0.371  Sum_probs=197.9

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      ..+.+.|.+.++||+|+||+||.+ ...+++.||||++....          ...+.+|+.+++.+ +|||||++++++.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----------CDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            356788999999999999999876 45789999999885421          12467899999876 8999999999987


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCc-------CHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC---
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTI-------AEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN---  431 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l-------~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~---  431 (627)
                       +...+|||||||. ++|.+++......       ++..++.|+.||+.||.|||+.+  ||||||||+||||+.+.   
T Consensus        80 -~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~  155 (434)
T 2rio_A           80 -TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFT  155 (434)
T ss_dssp             -CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHH
T ss_pred             -cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccc
Confidence             6678899999997 5999999865433       33346789999999999999988  99999999999997541   


Q ss_pred             -------cccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC---CCCCCCcchhHHHHHHHHHHH
Q psy4988         432 -------VCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK---NPPKISSKVDVWSVGVIFYQC  501 (627)
Q Consensus       432 -------~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~~~~~~~k~DVwSlGviL~el  501 (627)
                             ....+||+|||+++.+.......   .......+||+.|+|||++....   ....++.++||||||||||+|
T Consensus       156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~el  232 (434)
T 2rio_A          156 ADQQTGAENLRILISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI  232 (434)
T ss_dssp             SCCTTCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccCCCceEEEEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHH
Confidence                   22489999999999876432110   01123457999999999985321   125689999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         502 LY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       502 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ++ |..||............ ...............+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       233 lt~g~~Pf~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          233 LSKGKHPFGDKYSRESNIIR-GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HTTSCCTTCSTTTHHHHHHH-TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HhCCCCCCCCchhhHHHHhc-CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            98 99999765443221110 0001111111112345689999999999999999999999999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.6e-42  Score=351.32  Aligned_cols=253  Identities=25%  Similarity=0.385  Sum_probs=207.6

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      ++.+..++|.+++.||+|+||.||+|.+. ++..||||++......        ...+.+|+.+++.++||||+++++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--------PDAFLAEANLMKQLQHQRLVRLYAVV   77 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--------HHHHHHHHHHHHhCCCcCcceEEEEE
Confidence            45677899999999999999999999864 6778999998644321        23578899999999999999999988


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .  .+.+++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||
T Consensus        78 ~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~~kl  150 (279)
T 1qpc_A           78 T--QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT---LSCKI  150 (279)
T ss_dssp             C--SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---SCEEE
T ss_pred             c--CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC---CCEEE
Confidence            6  345779999999999999987543  7999999999999999999999988  9999999999999876   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||++........      .......+++.|+|||++.    ...++.++|||||||+||+|++ |+.||........+
T Consensus       151 ~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  220 (279)
T 1qpc_A          151 ADFGLARLIEDNEY------TAREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI  220 (279)
T ss_dssp             CCCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             CCCcccccccCccc------ccccCCCCccCccChhhhc----cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence            99999987754321      1122346788999999984    3457899999999999999999 99999776554332


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ..   +..  .........++.++.+||.+||..||++|||+.++++
T Consensus       221 ~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          221 QN---LER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH---Hhc--ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            21   111  1223344578999999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.3e-42  Score=353.01  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=204.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcC---CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLK---EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~---~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      .+..++|.+.+.||+|+||.||+|.+..   ++..||||++.....      ......+.+|+.+++.++||||++++++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~   81 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT------LDNKEKFMSEAVIMKNLDHPHIVKLIGI   81 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC------HHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC------chHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            4567899999999999999999998654   345799999864422      1224578899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +. + +..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||
T Consensus        82 ~~-~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~kl  154 (281)
T 3cc6_A           82 IE-E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP---ECVKL  154 (281)
T ss_dssp             EC-S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET---TEEEE
T ss_pred             Ec-C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC---CcEEe
Confidence            86 3 3457999999999999999765 46999999999999999999999988  9999999999999987   58999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||++.........      ......+|+.|+|||++.    ...++.++|||||||+||+|++ |+.||.........
T Consensus       155 ~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~  224 (281)
T 3cc6_A          155 GDFGLSRYIEDEDYY------KASVTRLPIKWMSPESIN----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI  224 (281)
T ss_dssp             CCCCGGGCC---------------CCCCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred             CccCCCccccccccc------ccccCCCCcceeCchhhc----cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence            999999876543211      123346788999999984    3458899999999999999998 99999765544332


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..   +..  ....+....+++.+.+||.+||..||.+||++.+++++
T Consensus       225 ~~---~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          225 GV---LEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HH---HHH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH---Hhc--CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            11   111  12234455789999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.2e-42  Score=354.37  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=205.5

Q ss_pred             ccCCCeeEEE-EecccCceEEEEEEE--cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLM-LLGKGGFSEVHKAFD--LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~-~LG~G~fG~Vy~a~~--~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +..++|.+.+ .||+|+||.||+|.+  ..+++.||||++.....     .......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----DPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3457899998 999999999999954  56789999999864321     122345788999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      .  .+.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|
T Consensus        88 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~---~~~kl~D  160 (291)
T 1xbb_A           88 E--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ---HYAKISD  160 (291)
T ss_dssp             E--SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET---TEEEECC
T ss_pred             C--CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC---CcEEEcc
Confidence            4  4567899999999999999998888999999999999999999999988  9999999999999987   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILE  519 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  519 (627)
                      ||++..+......    ........+|+.|+|||++.    ...++.++|||||||+||+|++ |+.||...........
T Consensus       161 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  232 (291)
T 1xbb_A          161 FGLSKALRADENY----YKAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM  232 (291)
T ss_dssp             CTTCEECCTTCSE----EEC----CCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred             CCcceeeccCCCc----ccccccCCCCceeeChHHhc----cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999876543210    11122345789999999985    3347889999999999999999 9999987655433211


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                         +...  .....+..+++++.+||.+||+.||.+||++.++++
T Consensus       233 ---~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          233 ---LEKG--ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---HHTT--CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---HHcC--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               1111  122334578999999999999999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=363.06  Aligned_cols=255  Identities=21%  Similarity=0.322  Sum_probs=199.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEE----EEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYV----ACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~V----AVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      +..++|+++++||+|+||.||+|.+..+++.|    |+|.+......      .....+.+|+.+++.++|||||+++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------KANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC------CCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH------HHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            34678999999999999999999998888766    55554322111      113468899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      |. +. .+++|+||+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus        86 ~~-~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~---~~~kL  158 (327)
T 3lzb_A           86 CL-TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP---QHVKI  158 (327)
T ss_dssp             EE-SS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET---TEEEE
T ss_pred             Ee-cC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC---CCEEE
Confidence            97 33 37799999999999999876 457999999999999999999999988  9999999999999887   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+......     .......||+.|+|||++.    +..++.++|||||||+||+|++ |..||.........
T Consensus       159 ~DfG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  229 (327)
T 3lzb_A          159 TDFGLAKLLGAEEKE-----YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  229 (327)
T ss_dssp             CCTTC---------------------CCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             ccCcceeEccCcccc-----ccccCCCccccccCHHHHc----CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            999999876543211     1123346788999999985    3458999999999999999999 99999776554332


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..   +.  ....++....++.++.+||++||..||.+||++.++++.
T Consensus       230 ~~---~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          230 SI---LE--KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HH---HH--TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH---HH--cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11   11  122344556789999999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-42  Score=352.91  Aligned_cols=258  Identities=29%  Similarity=0.458  Sum_probs=208.6

Q ss_pred             ccCCCeeEEE-EecccCceEEEEEEEc--CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLM-LLGKGGFSEVHKAFDL--KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~-~LG~G~fG~Vy~a~~~--~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +..++|.+.+ .||+|+||.||+|.+.  .++..||||++.....      ......+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------KADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc------hhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            4467788887 9999999999999854  4688999999865422      22345788999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .  .+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+
T Consensus        80 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~---~~~kl~  152 (287)
T 1u59_A           80 Q--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR---HYAKIS  152 (287)
T ss_dssp             E--SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET---TEEEEC
T ss_pred             c--CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC---CCEEEC
Confidence            5  45588999999999999998654 56999999999999999999999988  9999999999999976   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||++..+......    ........||+.|+|||++.    ...++.++|||||||+||+|++ |+.||..........
T Consensus       153 Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  224 (287)
T 1u59_A          153 DFGLSKALGADDSY----YTARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA  224 (287)
T ss_dssp             CCTTCEECTTCSCE----ECCCCSSCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH
T ss_pred             cccceeeeccCcce----eeccccccccccccCHHHhc----cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            99999877543211    11123346789999999984    3458899999999999999998 999997765543321


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      .   +...  .....+..+++++.+||.+||..||.+||++.++++|.+
T Consensus       225 ~---i~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          225 F---IEQG--KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             H---HHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             H---HhcC--CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1   1111  122334578999999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-42  Score=360.63  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=204.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEE--EEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEe
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYV--ACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFE  361 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~V--AVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~  361 (627)
                      ..++|.+.+.||+|+||.||+|.+..++..+  |||++.....      ......+.+|+.+++.+ +||||+++++++.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc------hHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            3478999999999999999999999998866  8888753221      12235688999999999 8999999999997


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc----------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK----------------TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                       +.+.+|+||||+++++|.+++....                .+++..++.++.||+.||.|||+.+  |+||||||+||
T Consensus        97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI  173 (327)
T 1fvr_A           97 -HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI  173 (327)
T ss_dssp             -ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             -eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence             6678889999999999999997654                7999999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-C
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-G  504 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G  504 (627)
                      |++.+   +.+||+|||+++......        ......+++.|+|||++.    ...++.++|||||||+||+|++ |
T Consensus       174 l~~~~---~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g  238 (327)
T 1fvr_A          174 LVGEN---YVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLG  238 (327)
T ss_dssp             EECGG---GCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTS
T ss_pred             EEcCC---CeEEEcccCcCccccccc--------cccCCCCCccccChhhhc----cccCCchhcchHHHHHHHHHHcCC
Confidence            99876   689999999997543221        112336788999999984    3457899999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..||..........   .+..  .........+++++.+||.+||..||.+|||+.+++++
T Consensus       239 ~~pf~~~~~~~~~~---~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          239 GTPYCGMTCAELYE---KLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCTTTTCCHHHHHH---HGGG--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcHHHHHH---Hhhc--CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99997765543321   1111  12334455789999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-42  Score=351.71  Aligned_cols=257  Identities=20%  Similarity=0.263  Sum_probs=204.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCe---EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQR---YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      -.|.+.++||+|+||+||+|.+..++.   .||||++.....      ....+.+.+|+.+++.++|||||++++++...
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   94 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE------MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP   94 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence            357788999999999999999766544   799998754322      22346788999999999999999999999755


Q ss_pred             CCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      ....++||||+.+++|.+++.. ...+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+||+|||
T Consensus        95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~---~~~kl~Dfg  169 (298)
T 3pls_A           95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES---FTVKVADFG  169 (298)
T ss_dssp             SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT---CCEEECCTT
T ss_pred             CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC---CcEEeCcCC
Confidence            5665899999999999999976 467999999999999999999999988  9999999999999877   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++.+.......   ........+|+.|+|||++.    ...++.++|||||||++|+|++|..||........+.... 
T Consensus       170 ~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-  241 (298)
T 3pls_A          170 LARDILDREYYS---VQQHRHARLPVKWTALESLQ----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-  241 (298)
T ss_dssp             SSCTTTTGGGGC---SCCSSCTTCGGGGSCHHHHT----TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-
T ss_pred             CcccccCCcccc---cccCcCCCCCccccChhhhc----cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-
Confidence            998765432111   11233457899999999984    5568999999999999999999655543333333332211 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       .  .....+....+++++.+||.+||+.||.+|||+.++++.
T Consensus       242 -~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          242 -A--QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             -H--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -h--cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             1  112334455789999999999999999999999998863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-42  Score=360.08  Aligned_cols=259  Identities=21%  Similarity=0.313  Sum_probs=193.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc--CCCCceeEEeeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA--LDHPRVVKLYDV  359 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~  359 (627)
                      ...+.++|++.+.||+|+||.||+|.+.  ++.||||++.....          ..+.+|.+++..  ++||||++++++
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----------~~~~~e~~~~~~~~~~h~~i~~~~~~   99 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE----------ASWFRETEIYQTVLMRHENILGFIAA   99 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH----------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc----------chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence            4456789999999999999999999764  89999999853221          234455556554  489999999999


Q ss_pred             EeecC---CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC--------CCCEEeccccCCcEEec
Q psy4988         360 FEIDA---NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI--------KPPVIHYDLKPGNILLT  428 (627)
Q Consensus       360 ~~~~~---~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~--------~~~IvHrDLKP~NILl~  428 (627)
                      +....   ..+|+|||||++++|.+++.. ..+++..++.++.||+.||.|||+.        +  ||||||||+||||+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~  176 (337)
T 3mdy_A          100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK  176 (337)
T ss_dssp             EEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC
T ss_pred             EccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC
Confidence            87443   678999999999999999975 4799999999999999999999988        6  99999999999999


Q ss_pred             CCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCc------chhHHHHHHHHHHHH
Q psy4988         429 EGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISS------KVDVWSVGVIFYQCL  502 (627)
Q Consensus       429 ~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~------k~DVwSlGviL~ell  502 (627)
                      .+   +.+||+|||+++.+........   ......+||+.|+|||++...    .+..      ++|||||||+||||+
T Consensus       177 ~~---~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~DiwslG~il~el~  246 (337)
T 3mdy_A          177 KN---GTCCIADLGLAVKFISDTNEVD---IPPNTRVGTKRYMPPEVLDES----LNRNHFQSYIMADMYSFGLILWEVA  246 (337)
T ss_dssp             TT---SCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTC----CCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred             CC---CCEEEEeCCCceeecccccccc---CCCCCCccCcceeChhhcccc----cCCccccCccccchHHHHHHHHHHH
Confidence            77   6899999999987654321100   112245799999999998532    2333      499999999999999


Q ss_pred             hC----------CCCCCCCChHH---HHHHHHHHhhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         503 YG----------KKPFGHNQSQA---TILEENTILKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       503 tG----------~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +|          ..||.......   ...............++.   ...+++++.+||.+||+.||.+|||+.++++|
T Consensus       247 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            99          77775332211   111111111111111111   12466789999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=358.69  Aligned_cols=266  Identities=21%  Similarity=0.318  Sum_probs=204.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  362 (627)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....       .....+.+|+.+++.++||||+++++++..  
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-------QDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-------HHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            45789999999999999999999999999999998864321       224568899999999999999999999863  


Q ss_pred             -cCCeEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 -DANSFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 -~~~~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                       ....+++||||+.+++|.+++..    ...+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+|
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~---~~~k  174 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE---GQPV  174 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---SCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC---CCEE
Confidence             23468899999999999998875    467999999999999999999999988  9999999999999877   5899


Q ss_pred             EeecccccccccCCCCCCC--CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         438 ITDFGLSKVMDEENYNPDH--GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      |+|||++............  .........||+.|+|||++... ....++.++|||||||+||+|++|+.||.......
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccC-CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            9999998765421100000  00001123579999999998421 12236889999999999999999999994311110


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ..... ..  .....++....++.++.+||.+||+.||.+|||+.+++++-
T Consensus       254 ~~~~~-~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          254 DSVAL-AV--QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             SCHHH-HH--HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             chhhH-Hh--hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            00000 01  11334455567899999999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-42  Score=378.66  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=209.6

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ..+.+..++|.+.+.||+|+||+||+|.+. ++..||||++.....        ..+.+.+|+.+++.++|||||+++++
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--------SVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--------CHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--------cHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            345677889999999999999999999874 578899999865332        13468899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +.  ...+|||||||.+++|.+++...  ..+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+|
T Consensus       252 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~---~~~k  324 (454)
T 1qcf_A          252 VT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS---LVCK  324 (454)
T ss_dssp             EC--SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT---CCEE
T ss_pred             Ee--CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC---CcEE
Confidence            86  45678999999999999999754  37899999999999999999999988  9999999999999987   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQAT  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~  516 (627)
                      |+|||+++.+....+.      ......+|+.|+|||++.    ...++.++|||||||+||||++ |+.||........
T Consensus       325 l~DFG~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~  394 (454)
T 1qcf_A          325 IADFGLARVIEDNEYT------AREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV  394 (454)
T ss_dssp             ECSTTGGGGBCCHHHH------TTCSSSSCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EeeCCCceEcCCCcee------ccCCCcccccccCHHHhc----cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999876543211      112335788999999985    3458999999999999999998 9999987655443


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +..   +.  .....+.+..+++++.+||.+||..||.+|||+.+|+.
T Consensus       395 ~~~---i~--~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          395 IRA---LE--RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHH---HH--HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH---HH--cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            321   11  12334455678999999999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-42  Score=360.83  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=206.9

Q ss_pred             CCccCCCe-eEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         282 HPVLSDRY-LLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       282 ~~~l~~rY-~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      ..++.++| +++++||+|+||+||++.    +..+++.||||++.....      ......+.+|+.+++.++||||+++
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG------PQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC------hHHHHHHHHHHHHHHhCCCcchhhE
Confidence            34577777 999999999999998875    345789999999865422      2234568899999999999999999


Q ss_pred             eeEEeec-CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEID-ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ++++... ...+++||||+++++|.+++... .+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~---~~  172 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND---RL  172 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CC
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC---CC
Confidence            9999854 46788999999999999998764 5999999999999999999999988  9999999999999887   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++.+.....    .........||+.|+|||++.    ...++.++|||||||++|+|++|..||.......
T Consensus       173 ~kl~Dfg~a~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~  244 (318)
T 3lxp_A          173 VKIGDFGLAKAVPEGHE----YYRVREDGDSPVFWYAPECLK----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF  244 (318)
T ss_dssp             EEECCGGGCEECCTTCS----EEEC---CCCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             EEECCcccccccccccc----ccccccCCCCCceeeChHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence            99999999987754321    112233457899999999985    3457889999999999999999999996432211


Q ss_pred             -----------HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         516 -----------TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       516 -----------~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                                 ......... ......+....++.++.+||++||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          245 LELIGIAQGQMTVLRLTELL-ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHCSCCHHHHHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhcccccchhHHHHHHHH-hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                       111111111 112234455678999999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=361.11  Aligned_cols=264  Identities=24%  Similarity=0.344  Sum_probs=191.5

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEe-
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFE-  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~-  361 (627)
                      +...+|++.++||+|+||.||+|.+..+++.||||++.....       .....+.+|+.+++++. |||||++++++. 
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-------EKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-------HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-------HHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            345689999999999999999999999999999998854321       22346789999999996 999999999984 


Q ss_pred             ------ecCCeEEEEEeecCCCChHHHHHh---ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         362 ------IDANSFCTVLEYCDGHDLDFYLKQ---HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       362 ------~~~~~~~lV~E~~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                            .+...+++||||+. ++|.+++..   ...+++..++.|+.||+.||.|||+.+++||||||||+||||+.+  
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~--  174 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ--  174 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT--
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC--
Confidence                  24456889999997 578787754   467999999999999999999999977679999999999999987  


Q ss_pred             ccceEEeecccccccccCCCCCCC-----CccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDH-----GMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                       +.+||+|||+++.+.........     ........+||+.|+|||++... ....++.++|||||||+||+|++|..|
T Consensus       175 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          175 -GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-SNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             -SCEEBCCCTTCBCCSSCC-------------------------------CC-TTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             -CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-ccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence             58999999999876543211000     00111234699999999997322 244688999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         508 FGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       508 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      |........+        .....++....++..+.+||++||+.||.+|||+.++++|-+
T Consensus       253 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          253 FEDGAKLRIV--------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             C--------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CcchhHHHhh--------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9654332111        112234445567788999999999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-42  Score=359.81  Aligned_cols=259  Identities=20%  Similarity=0.338  Sum_probs=203.3

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCC----eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ----RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~----~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      .++..++|.+.+.||+|+||.||+|.+..++    ..||||++.....      ......+.+|+.+++.++|||||+++
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------EKQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3566789999999999999999999877653    4699999864322      12234688999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +++. +.+.++|||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+
T Consensus       113 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~---~~~  186 (333)
T 1mqb_A          113 GVIS-KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN---LVC  186 (333)
T ss_dssp             EEEC-SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCE
T ss_pred             EEEe-cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC---CcE
Confidence            9997 567788999999999999999764 67999999999999999999999988  9999999999999876   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~  515 (627)
                      ||+|||+++.+......    ........+|+.|+|||++.    ...++.++|||||||+||+|++ |..||.......
T Consensus       187 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~  258 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEA----TYTTSGGKIPIRWTAPEAIS----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE  258 (333)
T ss_dssp             EECCCCC---------------------CCCGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EECCCCcchhhcccccc----ccccCCCCccccccCchhcc----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999876543211    01122335788999999984    4458899999999999999998 999997665443


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ....   +.  ....++....++.++.+||.+||..||.+||++.+++++
T Consensus       259 ~~~~---~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          259 VMKA---IN--DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHH---HH--TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHH---HH--CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3211   11  122344456789999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.9e-43  Score=366.08  Aligned_cols=265  Identities=24%  Similarity=0.324  Sum_probs=207.0

Q ss_pred             cCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         279 FNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       279 ~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +.+.....++|.+.+.||+|+||.||+|.+ .+++.||||++.....       .....+.+|+.+++.++|||||++++
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~  102 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS-------QGIEEFETEIETLSFCRHPHLVSLIG  102 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS-------SHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh-------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            344456778999999999999999999985 5789999998764422       12346889999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhcc----CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCccc
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCG  434 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g  434 (627)
                      +|. +.+.+++||||+++++|.+++....    .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +
T Consensus       103 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~---~  176 (321)
T 2qkw_B          103 FCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN---F  176 (321)
T ss_dssp             ECC-CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT---C
T ss_pred             EEc-CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC---C
Confidence            987 5667889999999999999886543    5899999999999999999999988  9999999999999876   6


Q ss_pred             ceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         435 EIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       435 ~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      .+||+|||+++........     .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||......
T Consensus       177 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~  247 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQT-----HLSTVVKGTLGYIDPEYFI----KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR  247 (321)
T ss_dssp             CEEECCCTTCEECSSSSCC-----CCBCCCEEETTTCCHHHHH----HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS
T ss_pred             CEEEeeccccccccccccc-----ccccccCCCccccCHHHhc----CCCCCcccchHhHHHHHHHHHhCCCcccccCcH
Confidence            9999999999875432211     1223446899999999985    335889999999999999999999999654332


Q ss_pred             HHH--HHHH-HHhhhhc--------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         515 ATI--LEEN-TILKATE--------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       515 ~~~--~~~~-~~~~~~~--------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                      ...  .... .......        ......+.++..+.+||.+||+.||++|||+.++++|-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            111  0000 0000000        00011223567799999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.5e-42  Score=351.47  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +.+..++|++.+.||+|+||.||+|.+  +++.||||++....         ..+.+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---------TAQAFLAEASVMTQLRHSNLVQLLGVIV   84 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            455678999999999999999999976  48899999986432         1346889999999999999999999976


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .+.+.+++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~---~~~~l~  159 (278)
T 1byg_A           85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED---NVAKVS  159 (278)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT---SCEEEC
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC---CcEEEe
Confidence            55567889999999999999997654  3899999999999999999999988  9999999999999976   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||++......          .....+++.|+|||++.    ...++.++|||||||++|+|++ |..||..........
T Consensus       160 Dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  225 (278)
T 1byg_A          160 DFGLTKEASST----------QDTGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  225 (278)
T ss_dssp             CCCC----------------------CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             ecccccccccc----------ccCCCccccccCHHHhC----CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999865432          12236789999999985    3458899999999999999998 999997665443321


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   +..  .........+++++.+||.+||..||.+|||+.++++
T Consensus       226 ~---~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          226 R---VEK--GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             H---HTT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H---Hhc--CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            1   111  1223345678999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-42  Score=363.80  Aligned_cols=262  Identities=24%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .+..++|.+.+.||+|+||.||+|.+ .+++.||||++........      ...+.+|+.+++.++||||++++++|. 
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~-   97 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGG------ELQFQTEVEMISMAVHRNLLRLRGFCM-   97 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----C------CCHHHHHHHGGGTCCCTTBCCCCEEEC-
T ss_pred             HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchH------HHHHHHHHHHHHhccCCCccceEEEEe-
Confidence            35678899999999999999999974 5689999999864332111      125788999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhcc----CcCHHHHHHHHHHHHHHHHHHHhC---CCCEEeccccCCcEEecCCCcccc
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHK----TIAEREARSIVMQVVSALKYLNEI---KPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +...+++|||||.+++|.+++....    .+++..++.|+.||+.||.|||+.   +  ||||||||+|||++.+   +.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~---~~  172 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE---FE  172 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT---CC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC---CC
Confidence            5566789999999999999998653    499999999999999999999998   7  9999999999999987   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN----  511 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~----  511 (627)
                      +||+|||+++.+.....      .......||+.|+|||++.    ...++.++|||||||+||+|++|+.||...    
T Consensus       173 ~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDT------HVTTAVRGTIGHIAPEYLS----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN  242 (326)
T ss_dssp             EEECCCSSCEECCSSSS------CEECCCCSCGGGCCHHHHH----HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred             EEeccCccccccCcccc------cccccccCCcCccCHHHhc----cCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence            99999999987654321      2233456999999999985    334789999999999999999999999511    


Q ss_pred             ChHHHHHHH-HHHhhhhc--------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         512 QSQATILEE-NTILKATE--------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       512 ~~~~~~~~~-~~~~~~~~--------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      ......... ........        .........+.++.+||.+||+.||.+|||+.++++|-+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            110011000 00000000        001111233478999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-41  Score=352.08  Aligned_cols=256  Identities=23%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+|.+.+.||+|+||.||+|.+..+   ...||||++.....      ......+.+|+.+++.++||||+++++++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC------HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            45799999999999999999987654   34689998754322      2234578899999999999999999999765


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+.+  |+||||||+|||++.+   +.+||+||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~---~~~kl~Df  172 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK---FTVKVADF  172 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT---CCEEECSC
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC---CCEEECcc
Confidence            66778899999999999999975 456899999999999999999999988  9999999999999876   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+.......   ........||+.|+|||++.    ...++.++|||||||++|+|++ |.+||........... 
T Consensus       173 g~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-  244 (298)
T 3f66_A          173 GLARDMYDKEYYS---VHNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-  244 (298)
T ss_dssp             GGGCCCSCGGGCB---C-----CCBCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-
T ss_pred             cccccccccchhc---cccccCCCCCccccChHHhc----CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-
Confidence            9998765433211   11223346889999999984    3458899999999999999999 5666655444332211 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        +..  ......+..+++++.+||.+||..||.+|||+.++++
T Consensus       245 --~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          245 --LLQ--GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             --HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --Hhc--CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              111  1122334568899999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.3e-42  Score=357.06  Aligned_cols=240  Identities=30%  Similarity=0.468  Sum_probs=189.2

Q ss_pred             cCCCeeEE-EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHH-hcCCCCceeEEeeEEee
Q psy4988         285 LSDRYLLL-MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH-KALDHPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~-~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIV~l~~~~~~  362 (627)
                      +.++|.++ +.||+|+||.||+|.+..+++.||||++...            ..+.+|+.++ +.++||||++++++|..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            44556666 8899999999999999999999999998532            1356788887 66699999999999873


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhcc--CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                         +...+|+|||||++++|.+++....  .+++..++.|+.||+.||.|||+.+  |+||||||+|||++.....+.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~k  160 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILK  160 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEE
Confidence               2567899999999999999998754  6999999999999999999999988  99999999999999853336899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||++....                                 ...++.++|||||||+||+|++|+.||.........
T Consensus       161 l~Dfg~a~~~~---------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  207 (299)
T 3m2w_A          161 LTDFGFAKETT---------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  207 (299)
T ss_dssp             ECCCTTCEECT---------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred             Eeccccccccc---------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence            99999986532                                 123677899999999999999999999654332211


Q ss_pred             HHHHHHhhhhccccC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         518 LEENTILKATEVQFA--NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~--~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .............++  .+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          208 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            000000001111111  114689999999999999999999999999999999754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=351.33  Aligned_cols=246  Identities=25%  Similarity=0.371  Sum_probs=193.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      -.++|.+.+.||+|+||.||+|.+  .++.||||++....         ..+.+.+|+.++++++|||||++++++.   
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~---   71 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES---------ERKAFIVELRQLSRVNHPNIVKLYGACL---   71 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT---------HHHHHHHHHHHHHHCCCTTBCCEEEBCT---
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh---------HHHHHHHHHHHHhcCCCCCcCeEEEEEc---
Confidence            457899999999999999999976  47899999975321         1346889999999999999999999876   


Q ss_pred             CeEEEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHh---CCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNE---IKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~---~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      +.+|+||||+++++|.+++....   .+++..++.++.||+.||.|||+   .+  ||||||||+|||++.+.  ..+||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~--~~~kl  147 (307)
T 2eva_A           72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGG--TVLKI  147 (307)
T ss_dssp             TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTT--TEEEE
T ss_pred             CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCC--CEEEE
Confidence            23679999999999999998654   47899999999999999999999   56  99999999999998763  24899


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||++......          .....||+.|+|||++.    +..++.++|||||||+||+|++|+.||..........
T Consensus       148 ~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  213 (307)
T 2eva_A          148 CDFGTACDIQTH----------MTNNKGSAAWMAPEVFE----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI  213 (307)
T ss_dssp             CCCCC----------------------CCTTSSCHHHHT----CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH
T ss_pred             cccccccccccc----------cccCCCCCceEChhhhC----CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH
Confidence            999999765432          12336999999999984    4568999999999999999999999997543322111


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .. ...  .....+....++..+.+||.+||..||.+|||+.+++++
T Consensus       214 ~~-~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          214 MW-AVH--NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HH-HHH--TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-HHh--cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            11 111  112223345789999999999999999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=364.63  Aligned_cols=251  Identities=19%  Similarity=0.207  Sum_probs=194.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEE-----EEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC---CCcee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---HPRVV  354 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a-----~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV  354 (627)
                      .+..++|.+.++||+|+||+||+|     .+..+++.||||++.....          ..+.+|+.+++.+.   |+||+
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----------WEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----------HHHHHHHHHHHHSCGGGGGGBC
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----------hHHHHHHHHHHHhhhhhhhhhh
Confidence            455688999999999999999999     4677899999999864321          23556777777665   99999


Q ss_pred             EEeeEEeecCCeEEEEEeecCCCChHHHHHh-----ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecC
Q psy4988         355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ-----HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTE  429 (627)
Q Consensus       355 ~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~  429 (627)
                      .+++++. ..+.+|||||||++++|.+++..     ...+++..++.|+.||+.||.|||+.+  ||||||||+||||+.
T Consensus       131 ~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          131 KFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGN  207 (365)
T ss_dssp             CEEEEEE-CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECG
T ss_pred             hhheeee-cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecc
Confidence            9999997 56677899999999999999974     467999999999999999999999988  999999999999987


Q ss_pred             --------CCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHH
Q psy4988         430 --------GNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQC  501 (627)
Q Consensus       430 --------~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~el  501 (627)
                              +...+.+||+|||+|+.+.....     .......+||+.|+|||++.    +..++.++||||||||||+|
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el  278 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPK-----GTIFTAKCETSGFQCVEMLS----NKPWNYQIDYFGVAATVYCM  278 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCT-----TEEECCSSCTTSCCCHHHHT----TCCBSTHHHHHHHHHHHHHH
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCC-----CceeeeecCCCCCCChHHhc----CCCCCccccHHHHHHHHHHH
Confidence                    11126999999999986542211     12234568999999999984    44589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         502 LYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       502 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ++|+.||........        . ....+. ....++.+.+|+..||+.+|.+|++..+.+.+
T Consensus       279 ltg~~pf~~~~~~~~--------~-~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          279 LFGTYMKVKNEGGEC--------K-PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             HHSSCCCEEEETTEE--------E-ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             HhCCCccccCCCCce--------e-echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            999999954322110        0 011111 12356789999999999999999765555543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.3e-42  Score=353.90  Aligned_cols=277  Identities=23%  Similarity=0.326  Sum_probs=212.2

Q ss_pred             cccchHHHHHhhhcccccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHH
Q psy4988         260 YKNLHIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL  339 (627)
Q Consensus       260 ~~~~~~~el~~~~~~~~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~  339 (627)
                      ...+...++.++++.+..        ...|...+.||+|+||.||+|.+  +++.||||++........   ......+.
T Consensus        12 ~~~~~~~~l~~~~~~f~~--------~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~---~~~~~~~~   78 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDE--------RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT---EELKQQFD   78 (307)
T ss_dssp             CEECCHHHHHHHTTTTCC--------SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCT---TTHHHHHH
T ss_pred             CCcccHHHHHHHHccccc--------ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcch---HHHHHHHH
Confidence            456778888887765432        23355668899999999999975  688999999865432111   12245688


Q ss_pred             HHHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhc---cCcCHHHHHHHHHHHHHHHHHHHhCCCCEE
Q psy4988         340 REYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH---KTIAEREARSIVMQVVSALKYLNEIKPPVI  416 (627)
Q Consensus       340 ~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~~~Iv  416 (627)
                      +|+.+++.++||||+++++++. +.+.+++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+  |+
T Consensus        79 ~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~  155 (307)
T 2nru_A           79 QEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HI  155 (307)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             HHHHHHHhcCCCCeEEEEEEEe-cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--ee
Confidence            9999999999999999999987 566788999999999999998743   46999999999999999999999988  99


Q ss_pred             eccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHH
Q psy4988         417 HYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGV  496 (627)
Q Consensus       417 HrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGv  496 (627)
                      ||||||+|||++.+   +.+||+|||+++.......     ........||+.|+|||++.     ..++.++|||||||
T Consensus       156 H~dlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~-----~~~~~~~Dv~slG~  222 (307)
T 2nru_A          156 HRDIKSANILLDEA---FTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALR-----GEITPKSDIYSFGV  222 (307)
T ss_dssp             CSCCCGGGEEECTT---CCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHT-----TEECTHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCC---CcEEEeecccccccccccc-----cccccccCCCcCcCChHHhc-----CCCCccchhHHHHH
Confidence            99999999999876   6899999999987654221     12233457999999999873     23788999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc--------ccc-CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         497 IFYQCLYGKKPFGHNQSQATILEENTILKATE--------VQF-ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       497 iL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +||+|++|..||........+...........        ..+ ......+..+.+||.+||..||.+|||+.+++++
T Consensus       223 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          223 VLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999976543322111111111000        011 1122345779999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.1e-42  Score=351.38  Aligned_cols=259  Identities=22%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcC-CC--eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLK-EQ--RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~-~~--~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +..++|++.+.||+|+||.||+|.+.. ++  ..||||++......    .....+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS----QPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            345789999999999999999998643 33  36899987543221    123356788999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .. .. +++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+  |+|+||||+|||++.+   +.+||+
T Consensus        91 ~~-~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~---~~~kl~  163 (291)
T 1u46_A           91 LT-PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR---DLVKIG  163 (291)
T ss_dssp             CS-SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET---TEEEEC
T ss_pred             cc-CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC---CCEEEc
Confidence            73 33 77999999999999998764 67999999999999999999999988  9999999999999877   589999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||++..+.....    .........+|+.|+|||++.    ...++.++|||||||+||+|++ |..||........+.
T Consensus       164 Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  235 (291)
T 1u46_A          164 DFGLMRALPQNDD----HYVMQEHRKVPFAWCAPESLK----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH  235 (291)
T ss_dssp             CCTTCEECCC-CC----EEEC-----CCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             ccccccccccccc----chhhhccCCCCceeeCchhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH
Confidence            9999987654321    111223346888999999984    3457889999999999999999 999998765544332


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .    .......++....++.++.+||.+||..||.+|||+.+++++
T Consensus       236 ~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          236 K----IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             H----HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1    111223344556789999999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-41  Score=373.63  Aligned_cols=259  Identities=23%  Similarity=0.367  Sum_probs=206.2

Q ss_pred             CCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeE
Q psy4988         280 NNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDV  359 (627)
Q Consensus       280 ~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~  359 (627)
                      ..+++..++|++.++||+|+||.||+|.+.. +..||||++......        ...+.+|+.+++.++|||||+++++
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~  247 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAV  247 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3456677899999999999999999998764 467999998654321        2358899999999999999999999


Q ss_pred             EeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         360 FEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       360 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +. + +.+|||||||++++|.+++...  ..+++..+..++.||+.||.|||+++  ||||||||+|||++.+   +.+|
T Consensus       248 ~~-~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~---~~~k  320 (452)
T 1fmk_A          248 VS-E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN---LVCK  320 (452)
T ss_dssp             EC-S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG---GCEE
T ss_pred             Ec-C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC---CCEE
Confidence            86 3 5678999999999999999743  56999999999999999999999988  9999999999999876   6899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQAT  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~  516 (627)
                      |+|||+++.+....+.      ......+|+.|+|||++..    ..++.++|||||||+||||++ |+.||........
T Consensus       321 l~DfG~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  390 (452)
T 1fmk_A          321 VADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV  390 (452)
T ss_dssp             ECCCCTTC--------------------CCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred             ECCCccceecCCCcee------cccCCcccccccCHhHHhc----CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999876543221      1223357889999999853    358999999999999999999 9999987655443


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh--ccCCC
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR--HDYLQ  569 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~--hp~~~  569 (627)
                      +..   +.  .....+.+..+++++.+||.+||..||.+|||+.+++.  +.++.
T Consensus       391 ~~~---i~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          391 LDQ---VE--RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHH---HH--TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHH---HH--cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            321   11  12234455678999999999999999999999999986  35654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-42  Score=366.09  Aligned_cols=256  Identities=21%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      ..|.+.+.||+|+||.||+|.+..+   ...||||++.....      ......+.+|+.+++.++|||||++++++...
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  162 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  162 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC------SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence            4688999999999999999987643   34689998754222      12245788999999999999999999987655


Q ss_pred             CCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~---~~~kL~DFG  237 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK---FTVKVADFG  237 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEEECCC-
T ss_pred             CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC---CCEEEeecc
Confidence            66778999999999999999765 46899999999999999999999988  9999999999999887   689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEEN  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~  521 (627)
                      +++.+.......   ........+|+.|+|||++.    ...++.++|||||||+||+|++ |.+||...........  
T Consensus       238 ~a~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~--  308 (373)
T 3c1x_A          238 LARDMYDKEFDS---VHNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--  308 (373)
T ss_dssp             -----------------------CCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH--
T ss_pred             cccccccccccc---ccccCCCCCcccccChHHhc----CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH--
Confidence            998765432211   11122346788999999985    3458999999999999999999 7888865544332211  


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                       +...  .....+..++.++.+||.+||..||.+|||+.+++++
T Consensus       309 -~~~~--~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          309 -LLQG--RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHcC--CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1111  1223345689999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=356.60  Aligned_cols=269  Identities=21%  Similarity=0.306  Sum_probs=193.6

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHH--HHHHHHhcCCCCceeEEeeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHAL--REYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~--~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +..++|++++.||+|+||.||+|.+  +++.||||++.....          ..+.  .|+..+..++||||+++++++.
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----------~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----------QNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----------hhHHHHHHHHHHHhccCcchhhheeccc
Confidence            4568999999999999999999965  789999999864321          1233  3444455689999999997553


Q ss_pred             e----cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC---------CCCEEeccccCCcEEec
Q psy4988         362 I----DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI---------KPPVIHYDLKPGNILLT  428 (627)
Q Consensus       362 ~----~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---------~~~IvHrDLKP~NILl~  428 (627)
                      .    +...+|||||||++++|.+++... .+++..++.|+.||+.||.|||+.         +  ||||||||+||||+
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~  154 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK  154 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc
Confidence            2    234678999999999999999764 559999999999999999999998         7  99999999999999


Q ss_pred             CCCcccceEEeecccccccccCCCCCC-CCccccccCCCCCccCCccccccCCC---CCCCCcchhHHHHHHHHHHHHhC
Q psy4988         429 EGNVCGEIKITDFGLSKVMDEENYNPD-HGMDLTSQGAGTYWYLPPECFVVGKN---PPKISSKVDVWSVGVIFYQCLYG  504 (627)
Q Consensus       429 ~~~~~g~vKL~DFGla~~~~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~~---~~~~~~k~DVwSlGviL~elltG  504 (627)
                      .+   +.+||+|||+++.+........ .........+||+.|+|||++.....   ...++.++|||||||+||||++|
T Consensus       155 ~~---~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          155 ND---GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             TT---SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CC---CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence            87   6899999999987764322110 11112234579999999999852110   02456789999999999999999


Q ss_pred             CCCCCCCChHHH--------------HHHHHHHhh--hhcccc----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH-
Q psy4988         505 KKPFGHNQSQAT--------------ILEENTILK--ATEVQF----ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA-  563 (627)
Q Consensus       505 ~~Pf~~~~~~~~--------------~~~~~~~~~--~~~~~~----~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL-  563 (627)
                      ..||........              .........  .....+    .....+++++.+||.+||..||.+|||+.+++ 
T Consensus       232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            777633221100              000000010  011111    11223556899999999999999999999995 


Q ss_pred             -----hccCCCC
Q psy4988         564 -----RHDYLQP  570 (627)
Q Consensus       564 -----~hp~~~~  570 (627)
                           .++|.+.
T Consensus       312 ~L~~ll~~~~~~  323 (336)
T 3g2f_A          312 RMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHCCCC-
T ss_pred             HHHHHHHHHHhc
Confidence                 4677764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=351.32  Aligned_cols=262  Identities=24%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             CccCCCeeEEEEecccCceEEEEEE----EcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~----~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      ....++|++++.||+|+||.||+|.    +..+++.||||++.....       .....+.+|+.+++.++||||+++++
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~  109 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-------EHLRDFEREIEILKSLQHDNIVKYKG  109 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-------HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            3456789999999999999999998    466899999999864321       22456889999999999999999999


Q ss_pred             EEeecC-CeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         359 VFEIDA-NSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       359 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      ++.... ..+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   +.+
T Consensus       110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~---~~~  184 (326)
T 2w1i_A          110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE---NRV  184 (326)
T ss_dssp             EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET---TEE
T ss_pred             EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC---CcE
Confidence            886432 3678999999999999999875 46999999999999999999999988  9999999999999987   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA-  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~-  515 (627)
                      ||+|||+++.+.....    .........++..|+|||++.    ...++.++|||||||+||+|++|..||....... 
T Consensus       185 kL~Dfg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  256 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKE----YYKVKEPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM  256 (326)
T ss_dssp             EECCCTTCEECCSSCS----EEECSSCCSCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH
T ss_pred             EEecCcchhhcccccc----ccccccCCCCceeEECchhhc----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence            9999999987754321    011123346788999999985    3347889999999999999999999985321110 


Q ss_pred             ----------HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         516 ----------TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       516 ----------~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                                ................+....+++++.+||.+||..||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          257 RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      0000000001112233445678999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=379.75  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=210.5

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+++..++|++.++||+|+||.||+|.+.. +..||||++......        .+.+++|+.+++.++|||||++++++
T Consensus       261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            455677899999999999999999998764 467999998654321        23588999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      . + ..+|||||||.+++|.+++...  ..+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||
T Consensus       332 ~-~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~---~~~kl  404 (535)
T 2h8h_A          332 S-E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN---LVCKV  404 (535)
T ss_dssp             C-S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG---GCEEE
T ss_pred             e-e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC---CcEEE
Confidence            6 3 5678999999999999999743  56999999999999999999999988  9999999999999876   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATI  517 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~  517 (627)
                      +|||+++.+....+.      ......+++.|+|||++..    ..++.++|||||||+||||++ |+.||........+
T Consensus       405 ~DFG~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~  474 (535)
T 2h8h_A          405 ADFGLARLIEDNEYT------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  474 (535)
T ss_dssp             CCTTSTTTCCCHHHH------TTCSTTSCGGGSCHHHHHH----CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred             cccccceecCCCcee------cccCCcCcccccCHHHhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999876532211      1122357889999999853    358999999999999999999 99999776554433


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc--cCCC
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH--DYLQ  569 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h--p~~~  569 (627)
                      ..   +.  .....+....++.++.+||.+||..||++|||+.+|+..  .+|.
T Consensus       475 ~~---i~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          475 DQ---VE--RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HH---HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HH---HH--cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            21   11  122344456789999999999999999999999999864  5554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.7e-42  Score=373.10  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=195.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~  365 (627)
                      .+|.+.++||+|+||+||.. ...+++.||||++.....          ..+.+|+.+++.+ +|||||++++++. +..
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~----------~~~~~E~~~l~~l~~HpnIv~l~~~~~-~~~   91 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF----------SFADREVQLLRESDEHPNVIRYFCTEK-DRQ   91 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE----------EECHHHHHHHHHSCCCTTBCCEEEEEE-ETT
T ss_pred             EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH----------HHHHHHHHHHHhccCCCCcCeEEEEEe-cCC
Confidence            46999999999999997643 467899999999854321          1245799999999 7999999999987 677


Q ss_pred             eEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc--ccceEEeecc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV--CGEIKITDFG  442 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~--~g~vKL~DFG  442 (627)
                      .+|||||||.+ +|.+++.... .+++..++.|+.||+.||.|||+.+  ||||||||+||||+.++.  ...+||+|||
T Consensus        92 ~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           92 FQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            88999999984 8888887653 5666678899999999999999998  999999999999964321  2368899999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEEN  521 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~  521 (627)
                      +++.+......    .......+||+.|+|||++... ....++.++||||||||||+|++ |..||.........    
T Consensus       169 ~a~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~-~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----  239 (432)
T 3p23_A          169 LCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSED-CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----  239 (432)
T ss_dssp             EEECC----------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----
T ss_pred             ceeeccCCCcc----eeeccccCCCcCccChhhhhcc-cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----
Confidence            99877543211    1123445799999999998522 13457889999999999999999 99999654433221    


Q ss_pred             HHhhhhccc-cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQ-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~-~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ......... .......+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            111111111 1122334667899999999999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.8e-41  Score=383.79  Aligned_cols=252  Identities=28%  Similarity=0.442  Sum_probs=200.1

Q ss_pred             CeeEE-EEecccCceEEEEEEE--cCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         288 RYLLL-MLLGKGGFSEVHKAFD--LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       288 rY~i~-~~LG~G~fG~Vy~a~~--~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      .+.+. ++||+|+||+||+|.+  ..+++.||||++......     ......+.+|+.+++.++|||||++++++. + 
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~-  441 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----PALKDELLAEANVMQQLDNPYIVRMIGICE-A-  441 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-----GGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-S-
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-
Confidence            34443 4899999999999955  456789999998643221     122356889999999999999999999986 3 


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      ..++||||||.+++|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~---~~~kL~DFGla  516 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ---HYAKISDFGLS  516 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TEEEECCTTHH
T ss_pred             CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC---CCEEEEEcCCc
Confidence            457899999999999999998889999999999999999999999988  9999999999999987   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.+......    ........+|+.|+|||++.    ...++.++|||||||+||||++ |+.||...........   +
T Consensus       517 ~~~~~~~~~----~~~~~~~~~t~~y~APE~~~----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---i  585 (635)
T 4fl3_A          517 KALRADENY----YKAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---L  585 (635)
T ss_dssp             HHTTC-----------------CGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---H
T ss_pred             cccccCccc----cccccCCCCceeeeChhhhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H
Confidence            877543211    11123346788999999994    3458999999999999999998 9999987665443221   1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...  .....+..+++++.+||.+||..||++||++.+|++
T Consensus       586 ~~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          586 EKG--ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HTT--CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HcC--CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            111  223344578999999999999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=379.13  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=200.9

Q ss_pred             ccCCCeeEEE-EecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLM-LLGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~-~LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +..++|.+.+ .||+|+||.||+|.+..  ++..||||++......      .....+.+|+.+++.++|||||+++++|
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~E~~il~~l~hpniv~l~~~~  405 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK------ADTEEMMREAQIMHQLDNPYIVRLIGVC  405 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS------TTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh------HHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence            4456677776 89999999999998763  5678999998654221      1235688999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . + +.+|||||||.+++|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus       406 ~-~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~---~~vkL~  478 (613)
T 2ozo_A          406 Q-A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR---HYAKIS  478 (613)
T ss_dssp             E-S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TEEEEC
T ss_pred             c-c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC---CcEEEe
Confidence            7 3 4588999999999999999754 56999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||+++.+......    ........+|+.|+|||++.    ...++.++|||||||+||||++ |+.||........+.
T Consensus       479 DFGla~~~~~~~~~----~~~~~~~~~~~~y~APE~~~----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~  550 (613)
T 2ozo_A          479 DFGLSKALGADDSY----YTARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA  550 (613)
T ss_dssp             CCSTTTTCC------------------CCTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH
T ss_pred             eccCcccccCCCce----eeeccCCCCccceeCHhhhc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            99999876533211    11122335678999999985    3458999999999999999997 999998766554332


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      .   +...  ...+.+..+++++.+||.+||..||.+||++.++++
T Consensus       551 ~---i~~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          551 F---IEQG--KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             H---HHTT--CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             H---HHcC--CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1   1121  223344578999999999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.4e-41  Score=353.16  Aligned_cols=260  Identities=20%  Similarity=0.282  Sum_probs=198.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc--CCCCceeEEeeEEe
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA--LDHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIV~l~~~~~  361 (627)
                      .+.++|.+.+.||+|+||.||+|.+  +++.||||++....          ...+.+|++++..  ++||||+++++++.
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----------ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----------HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            4567899999999999999999986  58999999985321          1346778888877  79999999999987


Q ss_pred             ecC---CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHH--------hCCCCEEeccccCCcEEecCC
Q psy4988         362 IDA---NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLN--------EIKPPVIHYDLKPGNILLTEG  430 (627)
Q Consensus       362 ~~~---~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH--------~~~~~IvHrDLKP~NILl~~~  430 (627)
                      .+.   ..+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||        +.+  ||||||||+||||+.+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC
Confidence            444   278899999999999999976 47999999999999999999999        777  9999999999999887


Q ss_pred             CcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCC--CCCcchhHHHHHHHHHHHHhC----
Q psy4988         431 NVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPP--KISSKVDVWSVGVIFYQCLYG----  504 (627)
Q Consensus       431 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~--~~~~k~DVwSlGviL~elltG----  504 (627)
                         +.+||+|||++.........   .........||+.|+|||++.......  .++.++|||||||+||+|++|    
T Consensus       184 ---~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          184 ---GTCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             ---SCEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             ---CCEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence               58999999999876543210   000123457999999999985321111  233689999999999999999    


Q ss_pred             ------CCCCCCCChH----HHHHHHHHHhhhhccccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         505 ------KKPFGHNQSQ----ATILEENTILKATEVQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       505 ------~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                            ..||......    ..+. ...........++.   ...+++.+.+||.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHH-HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccccCccccCcCcccHHHHH-HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                  7898654321    1111 11111111111111   12345689999999999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=351.33  Aligned_cols=268  Identities=21%  Similarity=0.301  Sum_probs=206.1

Q ss_pred             cccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         277 SRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       277 ~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .....+++..++|.+.+.||+|+||.||+|.+..   .||||++........     ..+.+.+|+.+++.++||||+++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~   94 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNED-----QLKAFKREVMAYRQTRHENVVLF   94 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCC-----CCCCCCTTGGGGTTCCCTTBCCC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHH-----HHHHHHHHHHHHhcCCCCCEeEE
Confidence            3445667788999999999999999999998754   499999865432111     12346689999999999999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ++++. +...+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+  |+||||||+|||+++    +.
T Consensus        95 ~~~~~-~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~~----~~  167 (319)
T 2y4i_B           95 MGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN----GK  167 (319)
T ss_dssp             CEEEE-CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC------C
T ss_pred             EEEEe-cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEeC----CC
Confidence            99998 5667889999999999999997654 7999999999999999999999988  999999999999984    58


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-----NPPKISSKVDVWSVGVIFYQCLYGKKPFGH  510 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----~~~~~~~k~DVwSlGviL~elltG~~Pf~~  510 (627)
                      +||+|||+++........  ..........||+.|+|||++....     ....++.++|||||||+||+|++|+.||..
T Consensus       168 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          168 VVITDFGLFSISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             CEECCCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             EEEeecCCcccccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999998765422111  1112233447999999999985321     124578999999999999999999999987


Q ss_pred             CChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..........   ... .........++.++.+||.+||..||.+|||+.++++.
T Consensus       246 ~~~~~~~~~~---~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          246 QPAEAIIWQM---GTG-MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCHHHHHHHH---HTT-CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHh---ccC-CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            6554433221   111 11112233678899999999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.3e-42  Score=390.31  Aligned_cols=265  Identities=28%  Similarity=0.423  Sum_probs=205.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  362 (627)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.....      ......+.+|+.+++.++|||||++++++..  
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS------PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC------HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            44789999999999999999999999999999998764322      2234568899999999999999999998753  


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhcc---CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHK---TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                         +.+.+|+|||||++++|.+++....   .+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+.....+
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeE
Confidence               2566789999999999999998654   6999999999999999999999988  9999999999999976533469


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||++..+....        ......||+.|+|||++.    ...++.++|||||||+||+|++|..||........
T Consensus       164 KL~DFG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~----~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~  231 (676)
T 3qa8_A          164 KIIDLGYAKELDQGE--------LCTEFVGTLQYLAPELLE----QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ  231 (676)
T ss_dssp             EECSCCCCCBTTSCC--------CCCCCCSCCTTCSSCSSC----CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred             EEccccccccccccc--------ccccccCCcccCChHHhc----cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence            999999998765432        123458999999999984    45689999999999999999999999976433221


Q ss_pred             HHHH------HHHh--h--hhcccc----C----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         517 ILEE------NTIL--K--ATEVQF----A----NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       517 ~~~~------~~~~--~--~~~~~~----~----~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      +...      ....  .  .....+    +    ....+++++.+||.+||.+||.+|||+.+++.||||.
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence            1000      0000  0  000111    1    1223678999999999999999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-41  Score=362.81  Aligned_cols=253  Identities=18%  Similarity=0.216  Sum_probs=193.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC-Ccee---------E-
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH-PRVV---------K-  355 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV---------~-  355 (627)
                      ..|.+.++||+|+||+||+|.+..+++.||||++........    ...+.+.+|+.+++.+.| +|+.         . 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH----HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            358899999999999999999999999999999874433221    224568889999999977 2211         1 


Q ss_pred             -----------EeeEEeec----CCeEEEEEeecCCCChHHHHHh-------ccCcCHHHHHHHHHHHHHHHHHHHhCCC
Q psy4988         356 -----------LYDVFEID----ANSFCTVLEYCDGHDLDFYLKQ-------HKTIAEREARSIVMQVVSALKYLNEIKP  413 (627)
Q Consensus       356 -----------l~~~~~~~----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~~~  413 (627)
                                 ++.++...    ...++++|+++. ++|.+++..       ...+++..++.|+.||+.||.|||+.+ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-  231 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-  231 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence                       11111100    223567777664 788888741       346888999999999999999999988 


Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCC------CCCCCCc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK------NPPKISS  487 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~~~~~~~  487 (627)
                       ||||||||+||||+.+   +.+||+|||+++.....          ....+| +.|+|||++....      ....++.
T Consensus       232 -iiHrDiKp~NILl~~~---~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQR---GGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             -EECSCCCGGGEEECTT---CCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             -cccCCcccceEEEecC---CeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence             9999999999999987   58999999999875532          234478 9999999984221      3445788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccC
Q psy4988         488 KVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDY  567 (627)
Q Consensus       488 k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~  567 (627)
                      ++|||||||+||+|++|+.||........          ....+..+..+++++.+||.+||+.||.+||++.++++|||
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~  366 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  366 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            99999999999999999999976543221          12234455678999999999999999999999999999999


Q ss_pred             CCC
Q psy4988         568 LQP  570 (627)
Q Consensus       568 ~~~  570 (627)
                      |..
T Consensus       367 ~~~  369 (413)
T 3dzo_A          367 YEQ  369 (413)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-42  Score=364.62  Aligned_cols=256  Identities=18%  Similarity=0.215  Sum_probs=187.3

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh-HhHHHHHHHHHHHHHHHhcCC---------CCcee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE-DKKANYIKHALREYNIHKALD---------HPRVV  354 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~-~~~~~~~~~~~~Ei~il~~l~---------HpnIV  354 (627)
                      ..++|.+++.||+|+||+||+|.+  +++.||||++........ .........+.+|+.+++.++         |||||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            346799999999999999999987  789999999876532100 000111245677888877775         66666


Q ss_pred             EEeeEE-----------------ee------------cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHH
Q psy4988         355 KLYDVF-----------------EI------------DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL  405 (627)
Q Consensus       355 ~l~~~~-----------------~~------------~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL  405 (627)
                      ++++++                 ..            +...+|||||||++|++...+.. ..+++..++.|+.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            666554                 31            25778999999999966555533 6789999999999999999


Q ss_pred             HHHH-hCCCCEEeccccCCcEEecCCCc-----------------ccceEEeecccccccccCCCCCCCCccccccCCCC
Q psy4988         406 KYLN-EIKPPVIHYDLKPGNILLTEGNV-----------------CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGT  467 (627)
Q Consensus       406 ~yLH-~~~~~IvHrDLKP~NILl~~~~~-----------------~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt  467 (627)
                      .||| +.+  ||||||||+||||+.+..                 ...+||+|||+|+.+...            ..+||
T Consensus       175 ~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt  240 (336)
T 2vuw_A          175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFC  240 (336)
T ss_dssp             HHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECC
T ss_pred             HHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEe
Confidence            9999 888  999999999999997621                 128999999999876532            23799


Q ss_pred             CccCCccccccCCCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHhhhhccc----cCCCCCCCHHHH
Q psy4988         468 YWYLPPECFVVGKNPPKISSKVDVWSVGVI-FYQCLYGKKPFGHNQSQATILEENTILKATEVQ----FANKPTVSNEAK  542 (627)
Q Consensus       468 ~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi-L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~vs~el~  542 (627)
                      +.|+|||++.    +.. +.++|||||+++ +++++.|..||........+..  .+.......    .+.++.+++++.
T Consensus       241 ~~y~aPE~~~----g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~  313 (336)
T 2vuw_A          241 DVSMDEDLFT----GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTD--KMLKQMTFKTKCNTPAMKQIKRKIQ  313 (336)
T ss_dssp             CCTTCSGGGC----CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHH--HHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred             ecccChhhhc----CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHH--hhhhhhccCcccchhhhhhcCHHHH
Confidence            9999999984    222 789999998777 7788899999942111011111  111111111    111235788999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHH-hccCCC
Q psy4988         543 GFIRSCLAYRKEDRIDVISLA-RHDYLQ  569 (627)
Q Consensus       543 ~LI~~cL~~dP~~Rpt~~elL-~hp~~~  569 (627)
                      +||++||++|     |+.++| +||||+
T Consensus       314 dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          314 EFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHHHHhccC-----CHHHHHhcCCCcC
Confidence            9999999987     999999 999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-39  Score=374.47  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      ...+..++|.+.+.||+|+||.||+|.+..+   +..||||++.....      ......+.+|+.+++.++|||||+++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~  457 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS------DSVREKFLQEALTMRQFDHPHIVKLI  457 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3456678999999999999999999998653   56799998754321      22345788999999999999999999


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      +++.  .+.+|+|||||++++|.+++.... .+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+
T Consensus       458 ~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~---~~v  530 (656)
T 2j0j_A          458 GVIT--ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN---DCV  530 (656)
T ss_dssp             EEEC--SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TEE
T ss_pred             EEEe--cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC---CCE
Confidence            9985  345789999999999999998654 7999999999999999999999988  9999999999999987   689


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQA  515 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~  515 (627)
                      ||+|||+++.+.....      .......+|+.|+|||++.    ...++.++|||||||+||||++ |..||.......
T Consensus       531 kL~DFG~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             EECCCCCCCSCCC----------------CCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEecCCCeecCCCcc------eeccCCCCCcceeCHHHhc----CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999999987654321      1123346788999999985    3458999999999999999997 999998765544


Q ss_pred             HHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .+...   ...  ...+.++.+++++.+||.+||..||.+|||+.+++++
T Consensus       601 ~~~~i---~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          601 VIGRI---ENG--ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHH---HHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH---HcC--CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33221   111  2233456789999999999999999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-40  Score=382.23  Aligned_cols=250  Identities=21%  Similarity=0.273  Sum_probs=202.5

Q ss_pred             ccCCCCccCCCeeEEEEecccCceEEEEEEEcC-CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEE
Q psy4988         278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKL  356 (627)
Q Consensus       278 ~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l  356 (627)
                      .+..+.++.++|++.++||+|+||.||+|.+.. +++.||||++.....      ......+.+|+.+++.++|||||++
T Consensus        71 ~~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~  144 (681)
T 2pzi_A           71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD------AEAQAMAMAERQFLAEVVHPSIVQI  144 (681)
T ss_dssp             SSCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC------HHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred             CCCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC------HHHHHHHHHHHHHHHhcCCCCcCeE
Confidence            345567888999999999999999999999976 799999998754322      2234568899999999999999999


Q ss_pred             eeEEeecCCe----EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc
Q psy4988         357 YDVFEIDANS----FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV  432 (627)
Q Consensus       357 ~~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~  432 (627)
                      +++|......    +||||||++|++|..++..  .+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+  
T Consensus       145 ~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--  218 (681)
T 2pzi_A          145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--  218 (681)
T ss_dssp             EEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--
T ss_pred             eeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--
Confidence            9999754432    6899999999999988765  7999999999999999999999988  9999999999999874  


Q ss_pred             ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q psy4988         433 CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQ  512 (627)
Q Consensus       433 ~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~  512 (627)
                        .+||+|||+++.+...           ...+||+.|+|||++..+     ++.++||||||||||+|++|..||....
T Consensus       219 --~~kl~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~-----~~~~sDi~slG~~l~~l~~g~~~~~~~~  280 (681)
T 2pzi_A          219 --QLKLIDLGAVSRINSF-----------GYLYGTPGFQAPEIVRTG-----PTVATDIYTVGRTLAALTLDLPTRNGRY  280 (681)
T ss_dssp             --CEEECCCTTCEETTCC-----------SCCCCCTTTSCTTHHHHC-----SCHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred             --cEEEEecccchhcccC-----------CccCCCccccCHHHHcCC-----CCCceehhhhHHHHHHHHhCCCCCcccc
Confidence              7999999999876532           234799999999998532     3789999999999999999999985421


Q ss_pred             hHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         513 SQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       513 ~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                      ....           . .......+++.+.+||.+||++||.+||+..+++.|+|+.
T Consensus       281 ~~~~-----------~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          281 VDGL-----------P-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CSSC-----------C-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cccc-----------c-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            1100           0 0000012457899999999999999999999999998863

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-39  Score=337.36  Aligned_cols=238  Identities=14%  Similarity=0.133  Sum_probs=189.5

Q ss_pred             cccCCCC-ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         277 SRFNNHP-VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       277 ~~~~~~~-~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      ..+..+. ++.++|++.+.||+|+||.||+|.+..+++.||||++.......    ......+.+|+.+++.++|||||+
T Consensus        20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~hp~iv~   95 (286)
T 3uqc_A           20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP----DDVLQETLSRTLRLSRIDKPGVAR   95 (286)
T ss_dssp             CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC----HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC----HHHHHHHHHHHHHHhcCCCCCcce
Confidence            3445555 78899999999999999999999999999999999987543321    234567889999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++++. +.+.+|+|||||+|++|.+++...  ....++..|+.||+.||.|||+.+  ||||||||+||||+.+   +.
T Consensus        96 ~~~~~~-~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~---g~  167 (286)
T 3uqc_A           96 VLDVVH-TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID---GD  167 (286)
T ss_dssp             EEEEEE-ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT---SC
T ss_pred             eeEEEE-ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC---CC
Confidence            999998 567788999999999999998643  466678999999999999999998  9999999999999987   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+++|                           |++           .++.++|||||||+||+|++|+.||.......
T Consensus       168 ~kl~~~~---------------------------~~~-----------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~  209 (286)
T 3uqc_A          168 VVLAYPA---------------------------TMP-----------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS  209 (286)
T ss_dssp             EEECSCC---------------------------CCT-----------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred             EEEEecc---------------------------ccC-----------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence            8987543                           222           25789999999999999999999997655432


Q ss_pred             HHHHHHHHhhh-hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         516 TILEENTILKA-TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       516 ~~~~~~~~~~~-~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .+......... ........+.+++++.+||.+||+.||.+| |+.++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          210 GLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             hhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            11000000000 000001235689999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=5.5e-34  Score=321.87  Aligned_cols=193  Identities=15%  Similarity=0.072  Sum_probs=139.0

Q ss_pred             EecccCceEEEEEEEcCCCeEEEEEEeecCcch---hhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEeecCCeEEE
Q psy4988         294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW---KEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEIDANSFCT  369 (627)
Q Consensus       294 ~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~---~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~~l  369 (627)
                      .++.|++|.+..+.....|+.||||++.....+   .....+...+.+.+|+++|+++ .|+||++++++++ +...+||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-d~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-NAQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-CSSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-ECCEEEE
Confidence            356788888888888888999999998765322   2334455667899999999999 6999999999998 6778899


Q ss_pred             EEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccccccc
Q psy4988         370 VLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDE  449 (627)
Q Consensus       370 V~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~  449 (627)
                      |||||+|++|.++|...+.+++.   .|+.||+.||.|||++|  ||||||||+||||+.+   ++|||+|||+|+.+..
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d---g~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR---QHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT---SCEEECCCTTEESCC-
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC---CCEEEeecccCeeCCC
Confidence            99999999999999998888875   58899999999999999  9999999999999987   6999999999987654


Q ss_pred             CCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q psy4988         450 ENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKP  507 (627)
Q Consensus       450 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~P  507 (627)
                      ..       ....+.+||+.|+|||++.     ..+...+|+||+|+++|+|+++..+
T Consensus       392 ~~-------~~~~t~vGTp~YmAPE~l~-----g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC-------SWPTNLVQSFFVFVNELFA-----ENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---------CCSHHHHHHHHHHHHHHC----------------------CCCCTTHHH
T ss_pred             CC-------ccccCceechhhccHHHhC-----CCCCCcccccccccchhhhccccch
Confidence            32       1234568999999999984     2356789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.3e-28  Score=274.38  Aligned_cols=199  Identities=16%  Similarity=0.134  Sum_probs=144.4

Q ss_pred             eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchh-hHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEE
Q psy4988         290 LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWK-EDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFC  368 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~-~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~  368 (627)
                      ...++||+|+||.||+|  ...++.+++|......... ........+++.+|++++++++|||||++..++. +.+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccE
Confidence            44678999999999999  4567889999865533221 1222333567899999999999999995444443 344557


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccc
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD  448 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~  448 (627)
                      ||||||+|++|.+++..        +..|+.||+.||.|||+++  ||||||||+|||++.     .+||+|||+|+.+.
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~-----~~kL~DFGla~~~~  480 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK-----DLYIIDFGLGKISN  480 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS-----SEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC-----eEEEEECccCEECC
Confidence            99999999999999876        6789999999999999988  999999999999987     69999999999875


Q ss_pred             cCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q psy4988         449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF  508 (627)
Q Consensus       449 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf  508 (627)
                      ................+||+.|+|||++....  ..|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~--~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL--EGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH--HHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHH--HHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            42100000000123558999999999984211  23677889999999999888877776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.9e-24  Score=222.92  Aligned_cols=151  Identities=17%  Similarity=0.179  Sum_probs=117.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhH-----------hHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKED-----------KKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~-----------~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      ..|.+.+.||+|+||.||+|.+ .+++.||||++.........           ........+.+|+.+++.++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            4577889999999999999998 88999999998643211100           00013456889999999999  4 66


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      +++++..  +.+|+|||||+|++|.. +.      ...+..++.||+.||.|||+.+  ||||||||+|||++ +   +.
T Consensus       166 v~~~~~~--~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~---~~  230 (282)
T 1zar_A          166 VPKVYAW--EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E---EG  230 (282)
T ss_dssp             SCCEEEE--ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T---TE
T ss_pred             cCeEEec--cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C---Cc
Confidence            6666542  34579999999999987 32      2345679999999999999988  99999999999999 4   69


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCcccc
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECF  476 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l  476 (627)
                      +||+|||+|+.                    +..|.|||++
T Consensus       231 vkl~DFG~a~~--------------------~~~~~a~e~l  251 (282)
T 1zar_A          231 IWIIDFPQSVE--------------------VGEEGWREIL  251 (282)
T ss_dssp             EEECCCTTCEE--------------------TTSTTHHHHH
T ss_pred             EEEEECCCCeE--------------------CCCCCHHHHH
Confidence            99999999964                    3457899987

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=7.6e-21  Score=193.12  Aligned_cols=144  Identities=17%  Similarity=0.216  Sum_probs=108.3

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeE--EEEEEeecCcchhhH-----------------hHHHHHHHHHHHHHHHhcCC
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRY--VACKVHQLNKDWKED-----------------KKANYIKHALREYNIHKALD  349 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~--VAVKii~~~~~~~~~-----------------~~~~~~~~~~~Ei~il~~l~  349 (627)
                      |.+.+.||+|+||.||+|.+..+++.  ||||++.........                 ........+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998788999  999997543211000                 01112235788999999998


Q ss_pred             CCce--eEEeeEEeecCCeEEEEEeecCC-C----ChHHHHHhccCcCHHHHHHHHHHHHHHHHHHH-hCCCCEEecccc
Q psy4988         350 HPRV--VKLYDVFEIDANSFCTVLEYCDG-H----DLDFYLKQHKTIAEREARSIVMQVVSALKYLN-EIKPPVIHYDLK  421 (627)
Q Consensus       350 HpnI--V~l~~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH-~~~~~IvHrDLK  421 (627)
                      |++|  ..++++     ...+|||||+.+ |    .|..+...   +++..+..++.||+.+|.||| +.+  |||||||
T Consensus       129 ~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred             hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence            8764  333332     234699999953 3    66655432   346678899999999999999 888  9999999


Q ss_pred             CCcEEecCCCcccceEEeeccccccc
Q psy4988         422 PGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       422 P~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      |+|||++.     .++|+|||+|...
T Consensus       199 p~NILl~~-----~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID-----KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS-----SEEECCCTTCEET
T ss_pred             HHHEEEcC-----cEEEEECcccccC
Confidence            99999986     6899999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=2.6e-17  Score=175.73  Aligned_cols=147  Identities=19%  Similarity=0.186  Sum_probs=101.4

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcch----h-------hHhHHHH----HHHHHHHHHHHhcCCCCce
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDW----K-------EDKKANY----IKHALREYNIHKALDHPRV  353 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~----~-------~~~~~~~----~~~~~~Ei~il~~l~HpnI  353 (627)
                      |.|...||.|+||.||+|.+ .+|+.||||+++.....    .       .....+.    .....+|+..|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999987 46999999997643210    0       0000111    1123457777777755443


Q ss_pred             eEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-
Q psy4988         354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-  432 (627)
Q Consensus       354 V~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-  432 (627)
                      .-.. .+....  .+|||||++|..|..+.      ....+..++.||+.+|.|||+.|  ||||||||.||||+++.. 
T Consensus       176 ~vp~-p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          176 PVPE-PIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             SCCC-EEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECS
T ss_pred             CCCe-eeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCc
Confidence            2211 111122  25999999998875432      22355778999999999999988  999999999999987521 


Q ss_pred             ------ccceEEeeccccccc
Q psy4988         433 ------CGEIKITDFGLSKVM  447 (627)
Q Consensus       433 ------~g~vKL~DFGla~~~  447 (627)
                            ...+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                  014899999987544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=7.4e-12  Score=126.14  Aligned_cols=141  Identities=17%  Similarity=0.121  Sum_probs=106.4

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  365 (627)
                      +.|.+...++.|+++.||++..  .+..++||+........       ...+.+|+.+++.+. +..+.++++++. +.+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~   83 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT-------TYDVEREKDMMLWLEGKLPVPKVLHFER-HDG   83 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS-------TTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETT
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC-------HHHHHHHHHHHHHHhcCCCCCeEEEEEe-cCC
Confidence            4588899999999999999963  36789999975421100       113667888888874 677888888876 556


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK---------------------------------  412 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---------------------------------  412 (627)
                      ..|+||||++|.+|...+     .+......++.+++.+|..||+..                                 
T Consensus        84 ~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             ceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            778999999999987652     122334578899999999999811                                 


Q ss_pred             ------------------------CCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         413 ------------------------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       413 ------------------------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                                              ..++|+|++|.|||++++   +.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhcc
Confidence                                    239999999999999864   356799998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=7.9e-11  Score=117.57  Aligned_cols=137  Identities=18%  Similarity=0.092  Sum_probs=94.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCc--eeEEeeEEeecC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR--VVKLYDVFEIDA  364 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--IV~l~~~~~~~~  364 (627)
                      ..|.+....+.|..+.||++. ..++..|+||+.....          ...+.+|+.+++.+.+.+  +.+++.++. +.
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~----------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-~~   87 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA----------LNELQDEAARLSWLATTGVPCAAVLDVVT-EA   87 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-CS
T ss_pred             CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc----------chhhhHHHHHHHHHHhCCCCCCeEEEecc-CC
Confidence            345554444466679999985 4567789999865321          123567888888775434  455777766 44


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK--------------------------------  412 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--------------------------------  412 (627)
                      +..++||||++|.+|.  ..   ...   ...++.+++..|..||+..                                
T Consensus        88 ~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             CCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            5678999999998874  11   111   2356777788888888643                                


Q ss_pred             ------------------------CCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         413 ------------------------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       413 ------------------------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                                              ..++|+|++|.|||++.+   +.+.|+|||.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~  214 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV  214 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence                                    129999999999999865   3567999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=5.2e-10  Score=118.21  Aligned_cols=146  Identities=16%  Similarity=0.196  Sum_probs=103.4

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEee--cCcchhhHhHHHHHHHHHHHHHHHhcCC--CCceeEEeeEEeecC--
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQ--LNKDWKEDKKANYIKHALREYNIHKALD--HPRVVKLYDVFEIDA--  364 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~--~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~--  364 (627)
                      .++.|+.|.++.||++...  +..+++|+..  ......      ....+.+|+.+++.|.  +..+.+++.++....  
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLP------SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCC------cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            4677999999999998643  4577888754  221100      1124677999998886  456778888775321  


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI---------------------------------  411 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---------------------------------  411 (627)
                      ...|+||||++|..+.+.  ....++..+...++.+++..|..||+.                                 
T Consensus       114 g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             SSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             CCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            336799999999877431  123477888899999999999999973                                 


Q ss_pred             -----------------------CCCEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         412 -----------------------KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       412 -----------------------~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                                             ...+||+|++|.|||++.+.. ..+.|+||+.+..-
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence                                   135999999999999987632 24689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=8.4e-10  Score=113.89  Aligned_cols=190  Identities=19%  Similarity=0.188  Sum_probs=119.2

Q ss_pred             EEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCc--eeEEeeEEeecCC---e
Q psy4988         293 MLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPR--VVKLYDVFEIDAN---S  366 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-Hpn--IV~l~~~~~~~~~---~  366 (627)
                      +.|+.|.+..||++.     ..++||+....         .....+.+|+.+++.+. +..  +.+++.... +..   .
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~---------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~-~~~~~~~   90 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS---------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM-PSETYQM   90 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH---------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC-CCSSCSC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc---------chHHHHHHHHHHHHHHHhcCCCCCCceEeecC-CCCCCCc
Confidence            458999999999862     45788875321         12345778999887773 322  333443322 222   2


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK----------------------------------  412 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~----------------------------------  412 (627)
                      .|+||++++|..|.....  ..++..+...++.+++..|..||+..                                  
T Consensus        91 ~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             SCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             ceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            368999999988865432  35788888889999999999999621                                  


Q ss_pred             ----------------------CCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCcc
Q psy4988         413 ----------------------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY  470 (627)
Q Consensus       413 ----------------------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y  470 (627)
                                            +.++|+|++|.|||++.+. ...+.|+||+.+..-...       .++....... .-
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~-------~Dl~~~~~~~-~~  239 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPD-------NDFISLMEDD-EE  239 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTT-------HHHHTTCCTT-TS
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChH-------HHHHHHHhhc-cc
Confidence                                  2489999999999999741 146889999998754321       0111100000 00


Q ss_pred             CCccccc---c--CCCC-C----CCCcchhHHHHHHHHHHHHhCCCCC
Q psy4988         471 LPPECFV---V--GKNP-P----KISSKVDVWSVGVIFYQCLYGKKPF  508 (627)
Q Consensus       471 ~APE~l~---~--~~~~-~----~~~~k~DVwSlGviL~elltG~~Pf  508 (627)
                      ..|+.+.   .  +... +    ......+.|++++++|.+.+|..+|
T Consensus       240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2232211   0  0000 0    0112358999999999999999887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=5e-07  Score=93.36  Aligned_cols=140  Identities=14%  Similarity=0.100  Sum_probs=91.5

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCC---ceeEEeeEEeecCCeEE
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHP---RVVKLYDVFEIDANSFC  368 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIV~l~~~~~~~~~~~~  368 (627)
                      +..++.|....||+.     +..++||+-..         ......+.+|+.+++.|.+.   .|.+++.+.....+..+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~---------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~   89 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS---------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF   89 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS---------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC---------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence            455888888999987     45678887421         11234677899999988642   24455555533344567


Q ss_pred             EEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q psy4988         369 TVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK------------------------------------  412 (627)
Q Consensus       369 lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~------------------------------------  412 (627)
                      +||||++|..|....-  ..++..+...++.++...|..||+..                                    
T Consensus        90 ~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             EEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             EEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            9999999988865321  23445555555555555555555421                                    


Q ss_pred             ----------------------CCEEeccccCCcEEecCCCcccc-eEEeeccccccc
Q psy4988         413 ----------------------PPVIHYDLKPGNILLTEGNVCGE-IKITDFGLSKVM  447 (627)
Q Consensus       413 ----------------------~~IvHrDLKP~NILl~~~~~~g~-vKL~DFGla~~~  447 (627)
                                            +.+||+|++|.|||++.+...+. +.|+||+.+..-
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  24799999999999987211134 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=2.8e-06  Score=85.34  Aligned_cols=134  Identities=15%  Similarity=0.109  Sum_probs=90.6

Q ss_pred             ecccCc-eEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCCeEEEEEe
Q psy4988         295 LGKGGF-SEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDANSFCTVLE  372 (627)
Q Consensus       295 LG~G~f-G~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~~lV~E  372 (627)
                      +..|.. ..||+......+..+.||+.....          ...+.+|..+|+.|. +--|.+++.++. +.+..++|||
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----------~~~~~~E~~~l~~l~~~vPVP~v~~~~~-~~~~~~lvme  100 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV----------ANDVTDEMVRLNWLTAFMPLPTIKHFIR-TPDDAWLLTT  100 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH----------HHHHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC----------HhHHHHHHHHHHHhccCCCcCeEEEEEE-ECCeEEEEEE
Confidence            444544 469998777778889999854211          124667888887763 323556677766 4566779999


Q ss_pred             ecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q psy4988         373 YCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK----------------------------------------  412 (627)
Q Consensus       373 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~----------------------------------------  412 (627)
                      +++|.++.......    ......+..++...|..||...                                        
T Consensus       101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            99998887655431    1223345666666666676421                                        


Q ss_pred             ----------------CCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         413 ----------------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       413 ----------------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                                      +.+||+|+.+.|||++.+   +.+-|+||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~---~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG---KLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC---eEEEEEECccccc
Confidence                            127999999999999875   4567999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.23  E-value=1.6e-06  Score=92.71  Aligned_cols=83  Identities=18%  Similarity=0.143  Sum_probs=47.1

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcc-hhhHhHHHHHHHHHHHHHHHhcCCC--Cc-eeEEeeEEeecCCe
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD-WKEDKKANYIKHALREYNIHKALDH--PR-VVKLYDVFEIDANS  366 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~-~~~~~~~~~~~~~~~Ei~il~~l~H--pn-IV~l~~~~~~~~~~  366 (627)
                      -.+.||.|.++.||++.+..+++.|+||....... .... ......++..|+++++.+..  |. +.+++.+ .  ...
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~-~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~  109 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-WPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEM  109 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC-CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCc
Confidence            45789999999999997666678899997542211 0000 00011245668888776632  33 3345543 2  333


Q ss_pred             EEEEEeecCCC
Q psy4988         367 FCTVLEYCDGH  377 (627)
Q Consensus       367 ~~lV~E~~~gg  377 (627)
                      .++||||+++.
T Consensus       110 ~~lvmE~l~g~  120 (397)
T 2olc_A          110 AVTVMEDLSHL  120 (397)
T ss_dssp             TEEEECCCTTS
T ss_pred             cEEEEEeCCCc
Confidence            46999999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=6.1e-06  Score=86.55  Aligned_cols=84  Identities=11%  Similarity=0.032  Sum_probs=49.4

Q ss_pred             eEEEEe-cccCceEEEEEEEc--C----CCeEEEEEEeecCcc--hhhHhHHHHHHHHHHHHHHHhcCC-C--CceeEEe
Q psy4988         290 LLLMLL-GKGGFSEVHKAFDL--K----EQRYVACKVHQLNKD--WKEDKKANYIKHALREYNIHKALD-H--PRVVKLY  357 (627)
Q Consensus       290 ~i~~~L-G~G~fG~Vy~a~~~--~----~~~~VAVKii~~~~~--~~~~~~~~~~~~~~~Ei~il~~l~-H--pnIV~l~  357 (627)
                      ...+.| +.|....+|+....  .    ++..+++|+......  ....      ..+.+|+.+++.|. +  ..+.+++
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~   96 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVR   96 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEE
Confidence            345778 88999999987543  0    256788997543220  0000      12455666666553 2  2455666


Q ss_pred             eEEeecC--CeEEEEEeecCCCCh
Q psy4988         358 DVFEIDA--NSFCTVLEYCDGHDL  379 (627)
Q Consensus       358 ~~~~~~~--~~~~lV~E~~~gg~L  379 (627)
                      .++....  ...++||||++|..+
T Consensus        97 ~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           97 WIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             EEECSSTTTSSCEEEEECCCCBCC
T ss_pred             EEccCCCccCCceEEEEecCCCCh
Confidence            6654221  235689999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.88  E-value=0.0001  Score=76.03  Aligned_cols=42  Identities=26%  Similarity=0.314  Sum_probs=32.1

Q ss_pred             HHHHHHHHHh-----------CCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         401 VVSALKYLNE-----------IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       401 i~~aL~yLH~-----------~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +..++.+|+.           ....+||+|+++.|||++.+   +.+.|+||+.+.
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~lIDfe~a~  251 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN---EQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG---GCEEECCCTTCE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC---CcEEEEehhhcc
Confidence            4446666653           23469999999999999765   478999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00028  Score=73.07  Aligned_cols=76  Identities=17%  Similarity=0.055  Sum_probs=54.1

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeEEeecCCeE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD---HPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~~~~~  367 (627)
                      -.+.|+.|.+..+|+...  ++..++||+.....          ...+.+|+..|+.|.   ...|.+++.+.. .....
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-~~g~~  106 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY----------RSMFRAEADQLALLAKTNSINVPLVYGIGN-SQGHS  106 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-CSSEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc----------HHHHHHHHHHHHHHHhhCCCCcceEEEEee-cCCce
Confidence            357799999999999863  46678899865321          234667877777663   356777777665 44667


Q ss_pred             EEEEeecCCCCh
Q psy4988         368 CTVLEYCDGHDL  379 (627)
Q Consensus       368 ~lV~E~~~gg~L  379 (627)
                      ++||||++|..+
T Consensus       107 ~lvme~l~G~~~  118 (312)
T 3jr1_A          107 FLLLEALNKSKN  118 (312)
T ss_dssp             EEEEECCCCCCC
T ss_pred             EEEEEeccCCCC
Confidence            899999998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.00062  Score=73.10  Aligned_cols=80  Identities=13%  Similarity=0.105  Sum_probs=46.1

Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCC-CCCccCCccccccCCCCCCCCcchhH
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA-GTYWYLPPECFVVGKNPPKISSKVDV  491 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~-Gt~~Y~APE~l~~~~~~~~~~~k~DV  491 (627)
                      +.++|+|++|.|||++.+    .++|+||+.+..-...       .++..... -...|++|+...... ...-....++
T Consensus       232 ~~liHGDl~~~Nil~~~~----~~~lID~e~a~~G~p~-------~Dla~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~  299 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQD----STQVIDPEFSFYGPMG-------FDIGAYLGNLILAFFAQDGHATQE-NDRKEYKQWI  299 (420)
T ss_dssp             CEEECSCCSGGGEEECSS----CEEECCCTTCEEECHH-------HHHHHHHHHHHHHHHHGGGGCCSS-CCSHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCC----CCEEEeCcccccCchH-------HHHHHHHHHHHHHHHhcccccccc-cchHHHHHHH
Confidence            459999999999999875    3899999998753311       01111000 013356665542100 0011223455


Q ss_pred             HHHHHHHHHHHhC
Q psy4988         492 WSVGVIFYQCLYG  504 (627)
Q Consensus       492 wSlGviL~elltG  504 (627)
                      ..+...+|+.+.+
T Consensus       300 ~~~~~~~~~~y~~  312 (420)
T 2pyw_A          300 LRTIEQTWNLFNK  312 (420)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            6788888887754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.50  E-value=0.00065  Score=68.90  Aligned_cols=80  Identities=11%  Similarity=-0.046  Sum_probs=51.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC---CceeEEeeEEeec
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH---PRVVKLYDVFEID  363 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIV~l~~~~~~~  363 (627)
                      .+..-+..+|.|..+.||+.. ..+|+.|.||+.........       ..+.+|+..|+.|.-   --+.+++.+   +
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALD-------GLFRAEALGLDWLGRSFGSPVPQVAGW---D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCT-------THHHHHHHHHHHHTCSTTCCSCCEEEE---E
T ss_pred             CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchh-------hHHHHHHHHHHHHHhhCCCCcceEEec---c
Confidence            345667889999999999986 56789999998543221110       135568888776631   123444443   2


Q ss_pred             CCeEEEEEeecCCCCh
Q psy4988         364 ANSFCTVLEYCDGHDL  379 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L  379 (627)
                      ..  ++||||+.+...
T Consensus        84 ~~--~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 DR--TLAMEWVDERPP   97 (288)
T ss_dssp             TT--EEEEECCCCCCC
T ss_pred             Cc--eEEEEeecccCC
Confidence            22  489999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.34  E-value=0.00062  Score=69.54  Aligned_cols=29  Identities=28%  Similarity=0.237  Sum_probs=24.1

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .++|+|+.|.|||.++    +.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil~~~----~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFLDTG----ERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEEECS----SCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEEECC----CCEEEEecccccC
Confidence            4899999999999543    4789999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.08  E-value=0.0042  Score=60.43  Aligned_cols=122  Identities=16%  Similarity=0.145  Sum_probs=77.3

Q ss_pred             CChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHH-hCCCCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCC
Q psy4988         377 HDLDFYLKQH-KTIAEREARSIVMQVVSALKYLN-EIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNP  454 (627)
Q Consensus       377 g~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH-~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~  454 (627)
                      -+|.++|... .+|+|+++|.++.|.+.+|.-+- ...+  ..+=+-|..|+|..+   |.|.+.+ ..+.         
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~d---G~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRD---GAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETT---SCEEECC-C------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecC---Cceeccc-cccc---------
Confidence            3688888754 69999999999999999987762 1111  123344688888876   5666553 1110         


Q ss_pred             CCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhccccCCC
Q psy4988         455 DHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQFANK  534 (627)
Q Consensus       455 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  534 (627)
                                .....+.|||.+.     ...+.+.=|||||++||.-+-=..|=                       ...
T Consensus        98 ----------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE  139 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEE  139 (229)
T ss_dssp             -------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEE
T ss_pred             ----------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccc
Confidence                      1133467888752     34567889999999999887322221                       012


Q ss_pred             CCCCHHHHHHHHHhhhc
Q psy4988         535 PTVSNEAKGFIRSCLAY  551 (627)
Q Consensus       535 ~~vs~el~~LI~~cL~~  551 (627)
                      +.+|+.+..||..|..-
T Consensus       140 ~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          140 RELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ECCCHHHHHHHHHHTTC
T ss_pred             hhhCHHHHHHHHHHHhc
Confidence            46889999999999755

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.99  E-value=0.0031  Score=64.59  Aligned_cols=143  Identities=11%  Similarity=0.096  Sum_probs=73.8

Q ss_pred             eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-----CCCceeEEee--EEee
Q psy4988         290 LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-----DHPRVVKLYD--VFEI  362 (627)
Q Consensus       290 ~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~--~~~~  362 (627)
                      .-++.|+.|....||+... .++ .+++|+......  .       ..+..|+.++..|     .-|.++...+  .+..
T Consensus        25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~--~-------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~   93 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVE--K-------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE   93 (322)
T ss_dssp             EEEEEECC---EEEEEEEE-SSC-CEEEEEECC-----C-------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred             eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCC--H-------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence            4467788898899999864 334 577898754211  0       1233455555444     2344432211  0111


Q ss_pred             cCCeEEEEEeecCCCChH-----HH---------HHhc-cC--------cC---HHHHHH------------HHHHHHHH
Q psy4988         363 DANSFCTVLEYCDGHDLD-----FY---------LKQH-KT--------IA---EREARS------------IVMQVVSA  404 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~-----~~---------l~~~-~~--------l~---e~~~~~------------i~~qi~~a  404 (627)
                      ..+..++||+|++|..+.     .+         +... ..        ..   +.....            +...+...
T Consensus        94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~  173 (322)
T 2ppq_A           94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE  173 (322)
T ss_dssp             ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred             ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence            224567999999986431     10         1110 00        01   111000            01123445


Q ss_pred             HHHHHhC-----CCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         405 LKYLNEI-----KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       405 L~yLH~~-----~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +.+|+..     ...+||+|+.+.|||++.+   +.+.|+||+.+..
T Consensus       174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~---~~~~lIDf~~a~~  217 (322)
T 2ppq_A          174 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGD---ELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHCCCSSCEEEECSCCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred             HHHHHhhCcccCCcccCCCCCCccCEEEeCC---ceEEEecchhccC
Confidence            5566532     1259999999999999875   3457999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.95  E-value=0.0027  Score=65.61  Aligned_cols=35  Identities=20%  Similarity=0.275  Sum_probs=27.2

Q ss_pred             CCEEeccccCCcEEecCCCc-ccceEEeeccccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNV-CGEIKITDFGLSKVM  447 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~-~g~vKL~DFGla~~~  447 (627)
                      ..+||+|+.+.|||++.+.. .+.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            35999999999999986411 137899999988653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.92  E-value=0.0042  Score=63.79  Aligned_cols=29  Identities=24%  Similarity=0.243  Sum_probs=24.5

Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ..+||+|+++.|||++ +    .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~----~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D----GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S----SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C----CCEEEECCCCCc
Confidence            3589999999999998 3    589999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.87  E-value=0.0019  Score=69.66  Aligned_cols=74  Identities=19%  Similarity=0.147  Sum_probs=46.7

Q ss_pred             EEEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce-eEEeeEEee
Q psy4988         291 LLMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV-VKLYDVFEI  362 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-V~l~~~~~~  362 (627)
                      -++.|+.|-...||++....       ++..|++|+......         ...+.+|+.+++.|...+| .++++.+. 
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---------~~~li~E~~~l~~L~~~g~~P~l~~~~~-  146 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---------ESHLVAESVIFTLLSERHLGPKLYGIFS-  146 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---------HHHHHHHHHHHHHHHHTTSSSCEEEEET-
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---------HHHHHHHHHHHHHHHhCCCCCcEEEEeC-
Confidence            45678889889999997542       257889998732110         0124468777777642233 45666553 


Q ss_pred             cCCeEEEEEeecCCCC
Q psy4988         363 DANSFCTVLEYCDGHD  378 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~  378 (627)
                      +    .+|+||++|..
T Consensus       147 ~----g~v~e~l~G~~  158 (429)
T 1nw1_A          147 G----GRLEEYIPSRP  158 (429)
T ss_dssp             T----EEEECCCCEEE
T ss_pred             C----CEEEEEeCCcc
Confidence            2    27999998743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.74  E-value=0.0052  Score=66.92  Aligned_cols=76  Identities=24%  Similarity=0.253  Sum_probs=46.0

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce-eEEeeEEeecCCeEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV-VKLYDVFEIDANSFCT  369 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-V~l~~~~~~~~~~~~l  369 (627)
                      -++.|+.|-...+|++.....+..|++|+........       + ...+|+.++..|...++ .++++++.   +  .+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-------i-dR~~E~~vl~~L~~~gl~P~ll~~~~---~--G~  178 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-------I-NREREKKISCILYNKNIAKKIYVFFT---N--GR  178 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-------S-CHHHHHHHHHHHTTSSSBCCEEEEET---T--EE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-------c-CHHHHHHHHHHHHhcCCCCCEEEEeC---C--eE
Confidence            3567888888999999765445788899864321100       0 01368888887754444 45666552   2  25


Q ss_pred             EEeecCCCCh
Q psy4988         370 VLEYCDGHDL  379 (627)
Q Consensus       370 V~E~~~gg~L  379 (627)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.73  E-value=0.0026  Score=66.78  Aligned_cols=29  Identities=31%  Similarity=0.445  Sum_probs=24.4

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      .++|+|+++.|||++.+    .+.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~----~~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNK----CLRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-----CEEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCC----cEEEEEecCCCC
Confidence            59999999999999864    589999988753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.70  E-value=0.0032  Score=66.80  Aligned_cols=141  Identities=18%  Similarity=0.170  Sum_probs=76.8

Q ss_pred             EEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecC
Q psy4988         293 MLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDA  364 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~  364 (627)
                      +.|..|-...+|++....       ++..|++|+.....     ..   .....+|+.+++.|. +.-..++++++. + 
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-----~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~-~-  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-----QG---VDSLVLESVMFAILAERSLGPQLYGVFP-E-  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CC---HHHHHHHHHHHHHHHHTTSSCCEEEEET-T-
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-----ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcC-C-
Confidence            457777788899987532       35788899852211     00   123457888887663 222245566553 2 


Q ss_pred             CeEEEEEeecCCCChHH--------------HH---Hhc-----cCc--CHHHHHHHHHHHHH-----------------
Q psy4988         365 NSFCTVLEYCDGHDLDF--------------YL---KQH-----KTI--AEREARSIVMQVVS-----------------  403 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~--------------~l---~~~-----~~l--~e~~~~~i~~qi~~-----------------  403 (627)
                         .+||||++|..|..              .|   ...     ...  -+.++..++.++..                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               28999999855421              01   110     011  13455555544322                 


Q ss_pred             --HHHHHH----hC--CCCEEeccccCCcEEecCCC-cccceEEeecccccc
Q psy4988         404 --ALKYLN----EI--KPPVIHYDLKPGNILLTEGN-VCGEIKITDFGLSKV  446 (627)
Q Consensus       404 --aL~yLH----~~--~~~IvHrDLKP~NILl~~~~-~~g~vKL~DFGla~~  446 (627)
                        .+..|.    ..  ...++|+|+.+.|||++.+. ..+.+.|+||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              233332    22  12599999999999998751 124789999998863

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.24  E-value=0.043  Score=56.92  Aligned_cols=31  Identities=26%  Similarity=0.432  Sum_probs=26.5

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeeccccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVM  447 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~  447 (627)
                      .++|+|+.+.|||++.+   +.+.|+||+.+..-
T Consensus       207 ~~~HgD~~~~N~l~~~~---~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNE---ESIYIIDWDEPMLA  237 (339)
T ss_dssp             EEECSCCCGGGEEECGG---GCEEECCCSSCEEE
T ss_pred             eeEeCCCCcCCEEEeCC---CeEEEEECCCCeeC
Confidence            59999999999999865   47899999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.62  E-value=0.097  Score=56.19  Aligned_cols=76  Identities=12%  Similarity=0.084  Sum_probs=44.1

Q ss_pred             EEEEecccCceEEEEEEEcCC-------CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEee
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKE-------QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEI  362 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~-------~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~  362 (627)
                      -++.|..|-...+|++.....       +..|++++........        -...+|+.+++.|. +.-..++++.+. 
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~--------idR~~E~~~l~~L~~~gi~P~l~~~~~-  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF--------YDSKVELDVFRYLSNINIAPNIIADFP-  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC--------CCHHHHHHHHHHHHHTTSSCCEEEEET-
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh--------cCHHHHHHHHHHHHhcCCCCCEEEEcC-
Confidence            456677788889999875421       5788999854322110        01235666666653 212344444332 


Q ss_pred             cCCeEEEEEeecCCCCh
Q psy4988         363 DANSFCTVLEYCDGHDL  379 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L  379 (627)
                        +  ++||||++|..|
T Consensus       145 --~--~~I~efI~G~~l  157 (424)
T 3mes_A          145 --E--GRIEEFIDGEPL  157 (424)
T ss_dssp             --T--EEEEECCCSEEC
T ss_pred             --C--CEEEEEeCCccC
Confidence              2  478999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.92  E-value=0.64  Score=49.15  Aligned_cols=32  Identities=38%  Similarity=0.534  Sum_probs=24.8

Q ss_pred             EEeccccCCcEEecCC---CcccceEEeecccccc
Q psy4988         415 VIHYDLKPGNILLTEG---NVCGEIKITDFGLSKV  446 (627)
Q Consensus       415 IvHrDLKP~NILl~~~---~~~g~vKL~DFGla~~  446 (627)
                      ++|+|+.+.|||+..+   .....++|+||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999542   1125799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.78  E-value=3.1  Score=40.07  Aligned_cols=122  Identities=16%  Similarity=0.168  Sum_probs=80.4

Q ss_pred             HHHHHhcCCCCceeEEeeEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         341 EYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       341 Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                      |+.+|. ..||+++.. .+-+ +.+.+.|.++.-+.+.=+..   -..++..+.++++.+|+....+++.    -+|--|
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e-~eD~v~~~y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L  105 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTE-LRDSFQIHYDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT----RYTFVL  105 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEE-CSSEEEEEECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS----SEECCC
T ss_pred             HHHHHh-ccCCcccce-EEEE-cccEEEEEEEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC----ceEEEE
Confidence            444343 368888866 3333 55666666665442211111   2457889999999999998866654    489999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      .|+||+++.+   +.++|.-.|+-..+                        +|.         .++...=+-.+=|++..
T Consensus       106 ~P~NL~f~~~---~~p~i~~RGik~~l------------------------~P~---------~~~ee~fL~qyKAliia  149 (215)
T 4ann_A          106 APDELFFTRD---GLPIAKTRGLQNVV------------------------DPL---------PVSEAEFLTRYKALVIC  149 (215)
T ss_dssp             SGGGEEECTT---SCEEESCCEETTTB------------------------SCC---------CCCHHHHHHHHHHHHHH
T ss_pred             ecceEEEcCC---CCEEEEEccCccCC------------------------CCC---------CCCHHHHHHHHHHHHHH
Confidence            9999999998   58898877764322                        221         12222234467788889


Q ss_pred             HHhCCCCC
Q psy4988         501 CLYGKKPF  508 (627)
Q Consensus       501 lltG~~Pf  508 (627)
                      ++.++..|
T Consensus       150 ll~~K~~F  157 (215)
T 4ann_A          150 AFNEKQSF  157 (215)
T ss_dssp             HHCTTCCH
T ss_pred             HHcCCCCH
Confidence            99999988

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	627
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-66
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-63
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-63
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-63
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-62
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-60
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-60
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-59
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-59
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-59
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-58
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-58
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-56
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-55
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-54
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-53
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-51
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-51
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-48
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-48
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-47
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-47
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-46
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-45
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-45
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-44
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-44
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-41
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-40
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-37
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-34
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-22

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 6e-66
 Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 28/290 (9%)

Query: 284 VLSDRYL-LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
               R+L   + +G+G F  V+K  D +    VA    Q  K  K +++         E 
Sbjct: 5   SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-----RFKEEA 59

Query: 343 NIHKALDHPRVVKLYDVFEIDA---NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            + K L HP +V+ YD +E           V E      L  YLK+ K +  +  RS   
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++  L++L+   PP+IH DLK  NI +T     G +KI D GL+ +             
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPT--GSVKIGDLGLATLKRA---------S 168

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
                 GT  ++ PE +       K    VDV++ G+   +    + P+   Q+ A I  
Sbjct: 169 FAKAVIGTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 223

Query: 520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
               + +     +       E K  I  C+   K++R  +  L  H + Q
Sbjct: 224 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 1e-65
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 25/295 (8%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            D + ++  LG G F +V+KA + +     A KV  ++   +E+     ++  + E +I 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV--IDTKSEEE-----LEDYMVEIDIL 63

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSA 404
            + DHP +VKL D F    N+   ++E+C G  +D  + +  + + E + + +  Q + A
Sbjct: 64  ASCDHPNIVKLLDAFY-YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L YL++ K  +IH DLK GNIL T     G+IK+ DFG+S             +      
Sbjct: 123 LNYLHDNK--IIHRDLKAGNILFTLD---GDIKLADFGVSAKNTR-------TIQRRDSF 170

Query: 465 AGTYWYLPPECFVVGKNPPK-ISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
            GT +++ PE  +   +  +    K DVWS+G+   +    + P         +L+   I
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---I 227

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQ 578
            K+     A     S+  K F++ CL    + R     L +H ++     K  R+
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 4e-63
 Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 62/321 (19%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D +  +  LG G    V K         +A K+  ++ + K   +       +RE  +  
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL--IHLEIKPAIR----NQIIRELQVLH 59

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
             + P +V  Y  F          +E+ DG  LD  LK+   I E+    + + V+  L 
Sbjct: 60  ECNSPYIVGFYGAFY-SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL E K  ++H D+KP NIL+      GEIK+ DFG+S  + +          + +   G
Sbjct: 119 YLRE-KHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLID---------SMANSFVG 165

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE           S + D+WS+G+   +   G+ P     ++   L     ++ 
Sbjct: 166 TRSYMSPERLQGT----HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 527 TEVQFANKP--------------------------------------TVSNEAKGFIRSC 548
              +   +P                                        S E + F+  C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 549 LAYRKEDRIDVISLARHDYLQ 569
           L     +R D+  L  H +++
Sbjct: 282 LIKNPAERADLKQLMVHAFIK 302

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 6e-63
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 23/288 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + L+  LG+G + EV  A +   +  VA K+  ++      +  +  ++  +E  I+K
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI--VDM----KRAVDCPENIKKEICINK 58

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L+H  VVK Y       N     LEYC G +L   ++    + E +A+    Q+++ + 
Sbjct: 59  MLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+ I   + H D+KP N+LL E      +KI+DFGL+ V    N        L ++  G
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRE-----RLLNKMCG 167

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE     K     +  VDVWS G++    L G+ P+                K 
Sbjct: 168 TLPYVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKE 221

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
            +        + +     +   L      RI +  + +  +   P+ K
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (530), Expect = 7e-63
 Identities = 87/286 (30%), Positives = 133/286 (46%), Gaps = 25/286 (8%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D Y    +LG G FSEV  A D + Q+ VA K   + K   E K+         E  +
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC--IAKKALEGKE----GSMENEIAV 60

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
              + HP +V L D++E        +++   G +L   + +     ER+A  ++ QV+ A
Sbjct: 61  LHKIKHPNIVALDDIYE-SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           +KYL++    ++H DLKP N+L    +   +I I+DFGLSK+ D           + S  
Sbjct: 120 VKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--------SVLSTA 169

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
            GT  Y+ PE           S  VD WS+GVI Y  L G  PF ++++ A + E+  IL
Sbjct: 170 CGTPGYVAPEVL----AQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQ--IL 222

Query: 525 KAT-EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           KA  E        +S+ AK FIR  +    E R       +H ++ 
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (528), Expect = 1e-62
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 26/289 (8%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
              +  L  +G G F  V+ A D++    VA K   ++   K+  +    +  ++E    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK--MSYSGKQSNEK--WQDIIKEVRFL 69

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           + L HP  ++    +    ++   V+EYC G   D      K + E E  ++    +  L
Sbjct: 70  QKLRHPNTIQYRGCYL-REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     +IH D+K GNILL+E    G +K+ DFG + +M              +   
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP-----------ANSFV 172

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT +++ PE  ++  +  +   KVDVWS+G+   +    K P  +  + + +      + 
Sbjct: 173 GTPYWMAPEV-ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IA 227

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK 574
             E         S   + F+ SCL    +DR     L +H ++    P 
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 4e-62
 Identities = 80/283 (28%), Positives = 123/283 (43%), Gaps = 29/283 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + + +   LGKG F  V+ A + + +  +A KV  L K   + +KA       RE  I  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKV--LFKA--QLEKAGVEHQLRREVEIQS 61

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L HP +++LY  F  DA     +LEY     +   L++     E+   + + ++ +AL 
Sbjct: 62  HLRHPNILRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y +  +  VIH D+KP N+LL      GE+KI DFG S                     G
Sbjct: 121 YCHSKR--VIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRT---------TLCG 166

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  YLPPE             KVD+WS+GV+ Y+ L GK PF  N        + T  + 
Sbjct: 167 TLDYLPPEMI----EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRI 216

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           + V+F     V+  A+  I   L +    R  +  +  H ++ 
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  205 bits (522), Expect = 4e-62
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 21/288 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKV--HQLNKDWKEDKKANYIKHALREYNI 344
           + Y    +LG+G  S V +       +  A K+        +  ++     +  L+E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 345 HKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVS 403
            + +  HP +++L D +E     F  V +     +L  YL +  T++E+E R I+  ++ 
Sbjct: 63  LRKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
            +  L+++   ++H DLKP NILL +      IK+TDFG S  +D              +
Sbjct: 122 VICALHKLN--IVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGEK--------LRE 168

Query: 464 GAGTYWYLPPECFVVGK--NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
             GT  YL PE        N P    +VD+WS GVI Y  L G  PF H +    +    
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--RM 226

Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            +    +         S+  K  +   L  + + R        H + Q
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-60
 Identities = 64/288 (22%), Positives = 117/288 (40%), Gaps = 28/288 (9%)

Query: 286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
             +Y     +G+G    V+ A D+   + VA +   +N   +  K     +  + E  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ--MNLQQQPKK-----ELIINEILVM 71

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
           +   +P +V   D +    +    V+EY  G  L   +     + E +  ++  + + AL
Sbjct: 72  RENKNPNIVNYLDSYL-VGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQAL 129

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++L+  +  VIH D+K  NILL      G +K+TDFG    +  E           S   
Sbjct: 130 EFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQ-------SKRSTMV 177

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT +++ PE             KVD+WS+G++  + + G+ P+ +      +     I  
Sbjct: 178 GTPYWMAPEVVTRK----AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT 230

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVP 573
               +  N   +S   + F+  CL    E R     L +H +L+   P
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  202 bits (515), Expect = 3e-60
 Identities = 81/301 (26%), Positives = 120/301 (39%), Gaps = 27/301 (8%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y +   LG G F  VH+  +       A K   +    + DK     +   +E     
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF--VMTPHESDK-----ETVRKEIQTMS 78

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSAL 405
            L HP +V L+D FE D N    + E+  G +L   +  +H  ++E EA   + QV   L
Sbjct: 79  VLRHPTLVNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            +++E     +H DLKP NI+ T      E+K+ DFGL+  +D +               
Sbjct: 138 CHMHENN--YVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQS--------VKVTT 186

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  +  PE          +    D+WSVGV+ Y  L G  PFG      T+   N    
Sbjct: 187 GTAEFAAPEVA----EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL--RNVKSC 240

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP-PVPKHGRQSASSSA 584
              +  +    +S + K FIR  L      R+ +     H +L P   P    Q  SS  
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300

Query: 585 P 585
            
Sbjct: 301 T 301

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-59
 Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 27/284 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + +    +LG+G FS V  A +L   R  A K+ +     KE+K    + +  RE ++  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMS 63

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            LDHP  VKLY  F+ D       L Y    +L  Y+++  +  E   R    ++VSAL+
Sbjct: 64  RLDHPFFVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+     +IH DLKP NILL E      I+ITDFG +KV+      P+      +   G
Sbjct: 123 YLHG--KGIIHRDLKPENILLNED---MHIQITDFGTAKVLS-----PESKQARANSFVG 172

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILK 525
           T  Y+ PE               D+W++G I YQ + G  PF   N+            K
Sbjct: 173 TAQYVSPELL----TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQK 221

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             ++++        +A+  +   L      R+    +  +  L+
Sbjct: 222 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-59
 Identities = 57/290 (19%), Positives = 112/290 (38%), Gaps = 23/290 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +  +   +G G F  V+K    K    VA K+  +     +      ++    E  + +
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQ-----LQAFKNEVGVLR 59

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
              H  ++         A     V ++C+G  L  +L   +T     +   I  Q    +
Sbjct: 60  KTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL+     +IH DLK  NI L E      +KI DFGL+ V    + +         Q +
Sbjct: 118 DYLH--AKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRWSGS-----HQFEQLS 167

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           G+  ++ PE     ++    S + DV++ G++ Y+ + G+ P+ +  ++  I+       
Sbjct: 168 GSILWMAPEVIR-MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH-DYLQPPVPK 574
            +      +       K  +  CL  ++++R     +    + L   +PK
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  196 bits (500), Expect = 6e-59
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 22/289 (7%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
            LSDRY L  +LG GG SEVH A DL+  R VA KV  L  D   D    +     RE  
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKV--LRADLARDPS--FYLRFRREAQ 59

Query: 344 IHKALDHPRVVKLYDVFEID---ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
              AL+HP +V +YD  E +         V+EY DG  L   +     +  + A  ++  
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
              AL + ++    +IH D+KP NI+++       +K+ DFG+++ + +      + +  
Sbjct: 120 ACQALNFSHQ--NGIIHRDVKPANIMISA---TNAVKVMDFGIARAIADS----GNSVTQ 170

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
           T+   GT  YL PE          + ++ DV+S+G + Y+ L G+ PF  +   +     
Sbjct: 171 TAAVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--Y 224

Query: 521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
             + +      A    +S +    +   LA   E+R    +  R D ++
Sbjct: 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 6e-59
 Identities = 70/335 (20%), Positives = 125/335 (37%), Gaps = 36/335 (10%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L ++Y++   LG+G F  VH+  +   ++    K            K        +E +I
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--------KVKGTDQVLVKKEISI 54

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVS 403
                H  ++ L++ FE        + E+  G D+   +      + ERE  S V QV  
Sbjct: 55  LNIARHRNILHLHESFE-SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 404 ALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           AL++L+     + H+D++P NI+         IKI +FG ++ +         G +    
Sbjct: 114 ALQFLHSHN--IGHFDIRPENIIYQTRR-SSTIKIIEFGQARQL-------KPGDNFRLL 163

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
                +Y P            +S+  D+WS+G + Y  L G  PF    +Q  I  EN +
Sbjct: 164 FTAPEYYAPEVH-----QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII--ENIM 216

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH-------- 575
                        +S EA  F+   L   ++ R+      +H +L+  + +         
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

Query: 576 -GRQSASSSAPVGHSPASSGQNQNSGGASTQSSAV 609
             R+   +      +   S    + GGA      V
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-58
 Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 32/290 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + Y +L  +G G +    K     + + +  K        + +K     +  + E N+ +
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-----QMLVSEVNLLR 58

Query: 347 ALDHPRVVKLYDVF-EIDANSFCTVLEYCDGHDLDFYL----KQHKTIAEREARSIVMQV 401
            L HP +V+ YD   +    +   V+EYC+G DL   +    K+ + + E     ++ Q+
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 402 VSALKYL---NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
             ALK     ++    V+H DLKP N+ L        +K+ DFGL++++       +H  
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDFGLARIL-------NHDT 168

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                  GT +Y+ PE      N    + K D+WS+G + Y+      PF    SQ  + 
Sbjct: 169 SFAKAFVGTPYYMSPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELA 223

Query: 519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
            +  I +    +       S+E    I   L  +   R  V  +  +  +
Sbjct: 224 GK--IREGKFRRI--PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-58
 Identities = 84/302 (27%), Positives = 135/302 (44%), Gaps = 19/302 (6%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + D Y     LG G F+ V K  +       A K  +  +  K  ++    +   RE +I
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT-KSSRRGVSREDIEREVSI 66

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            K + HP V+ L++V+E +      +LE   G +L  +L + +++ E EA   + Q+++ 
Sbjct: 67  LKEIQHPNVITLHEVYE-NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVC-GEIKITDFGLSKVMDEENYNPDHGMDLTSQ 463
           + YL+     + H+DLKP NI+L + NV    IKI DFGL+  +D  N            
Sbjct: 126 VYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--------EFKN 175

Query: 464 GAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI 523
             GT  ++ PE      N   +  + D+WS+GVI Y  L G  PF  +  Q T+   N  
Sbjct: 176 IFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANVS 229

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHGRQSASSS 583
               E +       S  AK FIR  L    + R+ +    +H +++P   +    SA S 
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289

Query: 584 AP 585
             
Sbjct: 290 PQ 291

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  197 bits (501), Expect = 4e-58
 Identities = 81/363 (22%), Positives = 139/363 (38%), Gaps = 44/363 (12%)

Query: 270 RIHNEDQSRFNNHPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN 323
           + + +   ++   PV      + D Y +L  LG G F  VH+  +    R    K   +N
Sbjct: 6   KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--IN 63

Query: 324 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFY 382
             +  DK          E +I   L HP+++ L+D FE D      +LE+  G +L D  
Sbjct: 64  TPYPLDKYT-----VKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLSGGELFDRI 117

Query: 383 LKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
             +   ++E E  + + Q    LK+++E    ++H D+KP NI+         +KI DFG
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKK-ASSVKIIDFG 174

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           L+  ++ +        ++      T  +  PE      +   +    D+W++GV+ Y  L
Sbjct: 175 LATKLNPD--------EIVKVTTATAEFAAPEIV----DREPVGFYTDMWAIGVLGYVLL 222

Query: 503 YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL 562
            G  PF       T+  +N      E       +VS EAK FI++ L      R+ V   
Sbjct: 223 SGLSPFAGEDDLETL--QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

Query: 563 ARHDYLQ------------PPVPKHGRQSASSSAPVGHSPASSGQNQNSGGASTQSSAVQ 610
             H +L+                K  ++     A       + G+  N            
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEY 340

Query: 611 QSF 613
           Q +
Sbjct: 341 QIY 343

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-56
 Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 33/288 (11%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           L  +Y +  LLG GGF  V+    + +   VA K  + ++     +  N       E  +
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN-GTRVPMEVVL 60

Query: 345 HKALD--HPRVVKLYDVFEIDANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVMQV 401
            K +      V++L D F    +SF  +LE  +   DL  ++ +   + E  ARS   QV
Sbjct: 61  LKKVSSGFSGVIRLLDWF-ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           + A+++ +     V+H D+K  NIL+      GE+K+ DFG   ++ +  Y         
Sbjct: 120 LEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDFGSGALLKDTVYT-------- 167

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
               GT  Y PPE     +   +      VWS+G++ Y  + G  PF H         + 
Sbjct: 168 -DFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEH---------DE 214

Query: 522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
            I++    Q   +  VS+E +  IR CLA R  DR     +  H ++Q
Sbjct: 215 EIIRG---QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 4e-55
 Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 39/311 (12%)

Query: 278 RFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKH 337
           +   + ++ D  +   +LG G   +V + F+ + Q   A K+  L               
Sbjct: 3   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM--LQD----------CPK 50

Query: 338 ALREYNIH-KALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFYLKQH--KTIAE 391
           A RE  +H +A   P +V++ DV+E           V+E  DG +L   ++    +   E
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
           REA  I+  +  A++YL+ I   + H D+KP N+L T       +K+TDFG +K     N
Sbjct: 111 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
                          T +Y+ PE       P K     D+WS+GVI Y  L G  PF  N
Sbjct: 169 SLTTPCY--------TPYYVAPEVL----GPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216

Query: 512 QSQATILEENTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
              A      T ++  + +F N     VS E K  IR+ L      R+ +     H ++ 
Sbjct: 217 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

Query: 570 -----PPVPKH 575
                P  P H
Sbjct: 277 QSTKVPQTPLH 287

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 3e-54
 Identities = 70/311 (22%), Positives = 115/311 (36%), Gaps = 41/311 (13%)

Query: 291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH 350
            L  LG+G F+ V+KA D    + VA K   +    + + K    + ALRE  + + L H
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKK--IKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 351 PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE 410
           P ++ L D F    ++   V ++ +             +     ++ ++  +  L+YL++
Sbjct: 60  PNIIGLLDAFG-HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 411 IKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWY 470
               ++H DLKP N+LL E    G +K+ DFGL+K     N    H +        T WY
Sbjct: 119 --HWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAYTHQV-------VTRWY 166

Query: 471 LPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILKATEV 529
             PE              VD+W+VG I  + L       G +          T+   TE 
Sbjct: 167 RAPELL---FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223

Query: 530 QFANK---------------------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL 568
           Q+ +                          ++    I+    +    RI      +  Y 
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

Query: 569 Q-PPVPKHGRQ 578
              P P  G Q
Sbjct: 284 SNRPGPTPGCQ 294

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  186 bits (472), Expect = 7e-54
 Identities = 75/370 (20%), Positives = 138/370 (37%), Gaps = 52/370 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKD-WKEDKKANYIKHALREYNIH 345
           + + +  ++G+GGF EV+        +  A K   L+K   K  +      +     ++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 61

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
              D P +V +   F    +    +L+  +G DL ++L QH   +E + R    +++  L
Sbjct: 62  STGDCPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++++     V++ DLKP NILL E    G ++I+D GL+          D          
Sbjct: 121 EHMHN--RFVVYRDLKPANILLDE---HGHVRISDLGLAC---------DFSKKKPHASV 166

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT+ Y+ PE    G       S  D +S+G + ++ L G  PF  ++++           
Sbjct: 167 GTHGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRM 220

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS-----LARHDY------------- 567
              +      + S E +  +   L      R+  +      +    +             
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQK 280

Query: 568 LQPP-VPKHGRQSASSSAPVGH---------SPASSGQNQNSGGASTQSSAVQQSFATGL 617
             PP +P  G  +A+ +  +G              S Q        T S   QQ  A  +
Sbjct: 281 YPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETV 340

Query: 618 FSGMNASSSS 627
           F  +NA +  
Sbjct: 341 FDTINAETDR 350

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 5e-53
 Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 29/285 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI-H 345
           + ++L  +LGKG F +V  A   K  ++ A K   L KD         ++  + E  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDD--VECTMVEKRVLS 57

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSAL 405
            A +HP +  ++  F+    +   V+EY +G DL ++++         A     +++  L
Sbjct: 58  LAWEHPFLTHMFCTFQ-TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           ++L+     +++ DLK  NILL +    G IKI DFG+ K     +   +          
Sbjct: 117 QFLHSKG--IVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFC------- 164

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
           GT  Y+ PE         K +  VD WS GV+ Y+ L G+ PF          EE     
Sbjct: 165 GTPDYIAPEIL----LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELFHS 214

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS-LARHDYLQ 569
                      +  EAK  +        E R+ V   + +H   +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  178 bits (453), Expect = 1e-51
 Identities = 74/285 (25%), Positives = 121/285 (42%), Gaps = 30/285 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             + +L  LG G F  VH        RY A KV  L K+     K   ++H   E  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLK--QVEHTNDERLMLS 59

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            + HP +++++  F+ DA     +++Y +G +L   L++ +      A+    +V  AL+
Sbjct: 60  IVTHPFIIRMWGTFQ-DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+     +I+ DLKP NILL +    G IKITDFG +K + +  Y             G
Sbjct: 119 YLHS--KDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPDVTYTL----------CG 163

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  Y+ PE           +  +D WS G++ Y+ L G  PF  + +  T  +   IL A
Sbjct: 164 TPDYIAPEVVSTK----PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---ILNA 216

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
              +    P  + + K  +   +      R+  +     D    P
Sbjct: 217 ---ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 4e-51
 Identities = 51/294 (17%), Positives = 102/294 (34%), Gaps = 19/294 (6%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + +RY L   +G G F +++   D+     VA K+  +     +            E  I
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---------LHIESKI 55

Query: 345 HKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
           +K +     +        + +    V+E       D +    +  + +    +  Q++S 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           ++Y++      IH D+KP N L+  G     + I DFGL+K   +   +           
Sbjct: 116 IEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF--GHNQSQATILEENT 522
            GT  Y             + S + D+ S+G +      G  P+      ++    E  +
Sbjct: 174 TGTARYASINTH----LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKHG 576
             K +           +E   ++  C + R +D+ D   L      +    + G
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL--RQLFRNLFHRQG 281

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-50
 Identities = 70/321 (21%), Positives = 110/321 (34%), Gaps = 50/321 (15%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +Y  L  +G+G F EV KA   K  + VA K         E++K  +   ALRE  I +
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQ 64

Query: 347 ALDHPRVVKLYDVFEIDA-------NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            L H  VV L ++    A        S   V ++C+                 E + ++ 
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
            +++ L Y++  K  ++H D+K  N+L+T     G +K+ DFGL++       +  +   
Sbjct: 125 MLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKLADFGLARAFSLAKNSQPNRY- 178

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI-- 517
             +    T WY PPE  +           +D+W  G I  +          N  Q  +  
Sbjct: 179 --TNRVVTLWYRPPELLL---GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233

Query: 518 ------------------------LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRK 553
                                   LE     K               A   I   L    
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293

Query: 554 EDRIDVISLARHDYLQ-PPVP 573
             RID      HD+    P+P
Sbjct: 294 AQRIDSDDALNHDFFWSDPMP 314

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-50
 Identities = 68/280 (24%), Positives = 110/280 (39%), Gaps = 30/280 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
                +  +G G F  VH  + L + + VA K   + +    ++        + E  +  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKT--IREGAMSEE------DFIEEAEVMM 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSAL 405
            L HP++V+LY V   +    C V E+ +   L D+   Q    A      + + V   +
Sbjct: 56  KLSHPKLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            YL E    VIH DL   N L+ E      IK++DFG+++ + ++ Y    G        
Sbjct: 115 AYLEE--ACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGT------K 163

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK 525
               +  PE F       + SSK DVWS GV+ ++     K    N+S + ++E+  I  
Sbjct: 164 FPVKWASPEVFSFS----RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--IST 217

Query: 526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
              +        S      +  C   R EDR     L R 
Sbjct: 218 GFRLYK--PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-49
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 33/294 (11%)

Query: 284 VLSDRYLLLM---LLGKGGFSEVHKAF--DLKEQRYVACKVHQLNKDWKEDKKANYIKHA 338
           V  DR LL +    LG G F  V K +    K  + VA K+ +      E          
Sbjct: 1   VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-----NEANDPALKDEL 55

Query: 339 LREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIV 398
           L E N+ + LD+P +V++  + E +  S+  V+E  +   L+ YL+Q++ + ++    +V
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 113

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            QV   +KYL   +   +H DL   N+LL         KI+DFGLSK +  +        
Sbjct: 114 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENY----Y 164

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATI 517
              + G     +  PEC    K     SSK DVWS GV+ ++   YG+KP+   +     
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKF----SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

Query: 518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
                + K   +          E    +  C  Y  E+R    ++     L+  
Sbjct: 221 ---AMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELR--LRNY 267

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-49
 Identities = 73/313 (23%), Positives = 120/313 (38%), Gaps = 47/313 (15%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +  RY  L  +G+G +  V  A+D   +  VA K           +   Y +  LRE  I
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKK------ISPFEHQTYCQRTLREIKI 59

Query: 345 HKALDHPRVVKLYDVFE---IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
                H  ++ + D+     I+      ++ +  G DL   LK    ++       + Q+
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQI 118

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  LKY++     V+H DLKP N+LL       ++KI DFGL++V D ++ +        
Sbjct: 119 LRGLKYIHSAN--VLHRDLKPSNLLLNTT---CDLKICDFGLARVADPDHDH----TGFL 169

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI---- 517
           ++   T WY  PE  +  K   K    +D+WSVG I  + L  +  F        +    
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226

Query: 518 ----------LEENTILKATEVQFANK-----------PTVSNEAKGFIRSCLAYRKEDR 556
                     L     LKA     +             P   ++A   +   L +    R
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286

Query: 557 IDVISLARHDYLQ 569
           I+V     H YL+
Sbjct: 287 IEVEQALAHPYLE 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  170 bits (431), Expect = 7e-49
 Identities = 42/280 (15%), Positives = 95/280 (33%), Gaps = 21/280 (7%)

Query: 284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYN 343
           V+   Y +   +G+G F  + +  +L   + VA K            + +       EY 
Sbjct: 2   VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---------PRRSDAPQLRDEYR 52

Query: 344 IHKALDHPR-VVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            +K L     +  +Y   + +      V++       D      +  + +       Q++
Sbjct: 53  TYKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQML 111

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVC--GEIKITDFGLSKVMDEENYNPDHGMDL 460
           + ++ ++E    +++ D+KP N L+   N      I + DFG+ K   +           
Sbjct: 112 ARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE 520
               +GT  Y+            + S + D+ ++G +F   L G  P+   ++     + 
Sbjct: 170 KKNLSGTARYMSINTH----LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225

Query: 521 NTILKATEVQFANK--PTVSNEAKGFIRSCLAYRKEDRID 558
             I +  +     +       E   ++        +   D
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-48
 Identities = 55/281 (19%), Positives = 92/281 (32%), Gaps = 36/281 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
               LL  +GKG F +V        +  VA K           K     +  L E ++  
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI---------KNDATAQAFLAEASVMT 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSA 404
            L H  +V+L  V   +      V EY     L  YL+      +         + V  A
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           ++YL       +H DL   N+L++E       K++DFGL+K                  G
Sbjct: 116 MEYLE--GNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASST----------QDTG 160

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
                +  PE         K S+K DVWS G++ ++     +          ++    + 
Sbjct: 161 KLPVKWTAPEAL----REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VE 214

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
           K  ++               +++C       R   + L   
Sbjct: 215 KGYKMDAP--DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 4e-48
 Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 27/281 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
           +R  L   +G+G F +VH+   +  E   +A  +        +  +    +  L+E    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR----EKFLQEALTM 62

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
           +  DHP +VKL  V     N    ++E C   +L  F   +  ++          Q+ +A
Sbjct: 63  RQFDHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L YL       +H D+   N+L++       +K+ DFGLS+ M++  Y         S+G
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSS---NDCVKLGDFGLSRYMEDSTYY------KASKG 169

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
                ++ PE     +         DVW  GV  ++ L              ++    I 
Sbjct: 170 KLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IE 223

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
               +     P         +  C AY    R     L   
Sbjct: 224 NGERLPM--PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 5e-48
 Identities = 71/273 (26%), Positives = 115/273 (42%), Gaps = 26/273 (9%)

Query: 295 LGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVV 354
           LG G F  V +      ++ +   +  L +  ++       +  +RE  I   LD+P +V
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----TEEMMREAQIMHQLDNPYIV 72

Query: 355 KLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKP 413
           +L  V +  A +   V+E   G  L  +L   +  I       ++ QV   +KYL   + 
Sbjct: 73  RLIGVCQ--AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EK 128

Query: 414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPP 473
             +H DL   N+LL         KI+DFGLSK +  +    D      S G     +  P
Sbjct: 129 NFVHRDLAARNVLLVN---RHYAKISDFGLSKALGAD----DSYYTARSAGKWPLKWYAP 181

Query: 474 ECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTILKATEVQFA 532
           EC     N  K SS+ DVWS GV  ++ L YG+KP+   +    +     I +   ++  
Sbjct: 182 ECI----NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKRMECP 234

Query: 533 NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
             P    E    +  C  Y+ EDR D +++ + 
Sbjct: 235 --PECPPELYALMSDCWIYKWEDRPDFLTVEQR 265

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  167 bits (423), Expect = 9e-48
 Identities = 68/306 (22%), Positives = 113/306 (36%), Gaps = 45/306 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           ++Y  L  +G+G +  V+KA +       A K  +L K     +        +RE +I K
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-----EDEGIPSTTIREISILK 55

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +VKLYDV          V E+ D             +    A+S ++Q+++ + 
Sbjct: 56  ELKHSNIVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           Y ++    V+H DLKP N+L+      GE+KI DFGL++          H +        
Sbjct: 115 YCHD--RRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTL----- 164

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTILK 525
             WY  P+         K S+ +D+WSVG IF + + G   F G +++   +     +  
Sbjct: 165 --WYRAPDVL---MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

Query: 526 ATEVQFANK----------------------PTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
                + N                         +       +   L      RI      
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

Query: 564 RHDYLQ 569
            H Y +
Sbjct: 280 EHAYFK 285

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-47
 Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 32/274 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +   L+  LG G F EV   +       VA K   L +              L E N+ K
Sbjct: 13  ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKS--LKQGSMSPD------AFLAEANLMK 63

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK--TIAEREARSIVMQVVSA 404
            L H R+V+LY V   +      + EY +   L  +LK      +   +   +  Q+   
Sbjct: 64  QLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + ++ E     IH DL+  NIL+++       KI DFGL++++++  Y            
Sbjct: 122 MAFIEE--RNYIHRDLRAANILVSD---TLSCKIADFGLARLIEDNEYT------AREGA 170

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
                +  PE    G      + K DVWS G++  + +   +      +   +++   + 
Sbjct: 171 KFPIKWTAPEAINYGTF----TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LE 224

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
           +   +          E    +R C   R EDR  
Sbjct: 225 RGYRMVR--PDNCPEELYQLMRLCWKERPEDRPT 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-47
 Identities = 62/293 (21%), Positives = 108/293 (36%), Gaps = 34/293 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +   L + LG+G F EV           VA K   L       +        L+E  + K
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKT--LKPGTMSPE------AFLQEAQVMK 67

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSA 404
            L H ++V+LY V   +      V EY     L  +LK    K +   +   +  Q+ S 
Sbjct: 68  KLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + Y+   +   +H DL+  NIL+ E       K+ DFGL++++++  Y    G       
Sbjct: 126 MAYVE--RMNYVHRDLRAANILVGEN---LVCKVADFGLARLIEDNEYTARQGA------ 174

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
                +  PE  + G    + + K DVWS G++  +     +          +L++  + 
Sbjct: 175 KFPIKWTAPEAALYG----RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--VE 228

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR--HDYLQPPVPKH 575
           +   +     P         +  C     E+R     L     DY     P++
Sbjct: 229 RGYRMPC--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 8e-47
 Identities = 74/315 (23%), Positives = 121/315 (38%), Gaps = 48/315 (15%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + +  +  +G+G +  V+KA +      VA K  +      + +       A+RE ++ K
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLK 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKT-IAEREARSIVMQVVSAL 405
            L+HP +VKL DV     N    V E+       F      T I     +S + Q++  L
Sbjct: 57  ELNHPNIVKLLDVIH-TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
            + +     V+H DLKP N+L+      G IK+ DFGL++          H +       
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEV------- 163

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILEENTIL 524
            T WY  PE  +  K     S+ VD+WS+G IF + +  +  F G ++         T+ 
Sbjct: 164 VTLWYRAPEILLGCK---YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220

Query: 525 KATEVQFANK----------------------PTVSNEAKGFIRSCLAYRKEDRIDVISL 562
              EV +                         P +  + +  +   L Y    RI   + 
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

Query: 563 ARHDYLQP---PVPK 574
             H + Q    PVP 
Sbjct: 281 LAHPFFQDVTKPVPH 295

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-46
 Identities = 68/311 (21%), Positives = 114/311 (36%), Gaps = 45/311 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            +Y  L  +G+G +  V KA + +    VA K  +      +D        ALRE  + K
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLK 56

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
            L H  +V+L+DV          V E+CD     ++   +  +     +S + Q++  L 
Sbjct: 57  ELKHKNIVRLHDVLH-SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           + +     V+H DLKP N+L+      GE+K+ +FGL++                S    
Sbjct: 116 FCH--SRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPV-------RCYSAEVV 163

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE------- 519
           T WY PP+     K     S+ +D+WS G IF +     +P          L+       
Sbjct: 164 TLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

Query: 520 -----------------ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL 562
                               +  AT       P ++   +  +++ L      RI     
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

Query: 563 ARHDYLQPPVP 573
            +H Y     P
Sbjct: 281 LQHPYFSDFCP 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-46
 Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 21/279 (7%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             +  + +LG G F  V+K   + E   V   V    K+ +E       K  L E  +  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV--AIKELREATSPKANKEILDEAYVMA 66

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
           ++D+P V +L  +    +           G  LD+  +    I  +   +  +Q+   + 
Sbjct: 67  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL      ++H DL   N+L+        +KITDFGL+K++  E             G  
Sbjct: 126 YLE--DRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEY-----HAEGGKV 175

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
              ++  E  +        + + DVWS GV  ++ +            + I     IL+ 
Sbjct: 176 PIKWMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEK 228

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
            E +    P  + +    +  C     + R     L   
Sbjct: 229 GE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-46
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 27/285 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           + +  L LLGKG F +V    +    RY A K+  L K+    K  + + H + E  + +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAK--DEVAHTVTESRVLQ 60

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALK 406
              HP +  L   F+   +  C V+EY +G +L F+L + +   E  AR    ++VSAL+
Sbjct: 61  NTRHPFLTALKYAFQ-THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 407 YLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAG 466
           YL+     V++ D+K  N++L +    G IKITDFGL K    +               G
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDG-------ATMKTFCG 167

Query: 467 TYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA 526
           T  YL PE              VD W +GV+ Y+ + G+ PF +   +        ++  
Sbjct: 168 TPEYLAPEVL----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILM 219

Query: 527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP 571
            E++F    T+S EAK  +   L    + R+        + ++  
Sbjct: 220 EEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-45
 Identities = 65/286 (22%), Positives = 103/286 (36%), Gaps = 26/286 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
               LL  LG G F  V +  +D    + V+  V  L  D     +A  +   +RE N  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA--MDDFIREVNAM 65

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSA 404
            +LDH  +++LY V          V E      L D   K              +QV   
Sbjct: 66  HSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           + YL       IH DL   N+LL        +KI DFGL + + +     D    +    
Sbjct: 124 MGYLES--KRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQN----DDHYVMQEHR 174

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTI 523
              + +  PE           S   D W  GV  ++   YG++P+    + + IL +   
Sbjct: 175 KVPFAWCAPESLKTR----TFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHK--- 226

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ 569
           +     +         +    +  C A++ EDR   ++L   D+L 
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL--RDFLL 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 74/316 (23%), Positives = 118/316 (37%), Gaps = 55/316 (17%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           +   Y  L  +G G +  V  A D +    VA K   L + ++ +    + K A RE  +
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK--LYRPFQSEL---FAKRAYRELRL 70

Query: 345 HKALDHPRVVKLYDVFE-----IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVM 399
            K + H  V+ L DVF       D   F  V+ +         L +H+ + E   + +V 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGEDRIQFLVY 128

Query: 400 QVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMD 459
           Q++  L+Y++       H DLKPGN+ + E     E+KI DFGL++  D E         
Sbjct: 129 QMLKGLRYIHAAGII--HRDLKPGNLAVNED---CELKILDFGLARQADSE--------- 174

Query: 460 LTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE 519
             +    T WY  PE  +   N  + +  VD+WSVG I  + + GK  F  +     + E
Sbjct: 175 -MTGYVVTRWYRAPEVIL---NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230

Query: 520 ENTILKATEVQFANK-------------------------PTVSNEAKGFIRSCLAYRKE 554
              +      +F  +                            S  A   +   L    E
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290

Query: 555 DRIDVISLARHDYLQP 570
            R+       H Y + 
Sbjct: 291 QRVTAGEALAHPYFES 306

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-45
 Identities = 56/302 (18%), Positives = 109/302 (36%), Gaps = 44/302 (14%)

Query: 282 HPVLS-DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR 340
           +PVL  +      ++G+G F +V KA   K+   +   + ++ +   +D      +    
Sbjct: 4   YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAG 59

Query: 341 EYNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH------------- 386
           E  +   L  HP ++ L    E         +EY    +L  +L++              
Sbjct: 60  ELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 387 ---KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
               T++ ++       V   + YL++     IH DL   NIL+ E  V    KI DFGL
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYV---AKIADFGL 173

Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
           S+  +             + G     ++  E      N    ++  DVWS GV+ ++ + 
Sbjct: 174 SRGQEV--------YVKKTMGRLPVRWMAIESL----NYSVYTTNSDVWSYGVLLWEIVS 221

Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
                    + A + E+  + +   ++        +E    +R C   +  +R     + 
Sbjct: 222 LGGTPYCGMTCAELYEK--LPQGYRLEK--PLNCDDEVYDLMRQCWREKPYERPSFAQIL 277

Query: 564 RH 565
             
Sbjct: 278 VS 279

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-44
 Identities = 77/309 (24%), Positives = 131/309 (42%), Gaps = 30/309 (9%)

Query: 272 HNEDQSRFNNHP--VLSDRYLLLMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDW 326
           H    +    H   V  + + LL +LG G + +V     +      +  A KV  L K  
Sbjct: 7   HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV--LKKA- 63

Query: 327 KEDKKANYIKHALREYNIHKALDH-PRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQ 385
              +KA   +H   E  + + +   P +V L+  F+        +L+Y +G +L  +L Q
Sbjct: 64  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TETKLHLILDYINGGELFTHLSQ 122

Query: 386 HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK 445
            +   E E +  V ++V AL++L++    +I+ D+K  NILL      G + +TDFGLSK
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSN---GHVVLTDFGLSK 177

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
               +     +         GT  Y+ P+    G         VD WS+GV+ Y+ L G 
Sbjct: 178 EFVADETERAYDFC------GTIEYMAPDIVRGG--DSGHDKAVDWWSLGVLMYELLTGA 229

Query: 506 KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVI 560
            PF  +  + +  E +  +  +E  +     +S  AK  I+  L    + R+     D  
Sbjct: 230 SPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

Query: 561 SLARHDYLQ 569
            +  H + Q
Sbjct: 288 EIKEHLFFQ 296

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 56/275 (20%), Positives = 106/275 (38%), Gaps = 24/275 (8%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFD-LKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
               +  ++G G F EV      L  +R +   +  L   + E ++    +  L E +I 
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIM 81

Query: 346 KALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLD-FYLKQHKTIAEREARSIVMQVVSA 404
              DHP V+ L  V    +     + E+ +   LD F  +        +   ++  + + 
Sbjct: 82  GQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           +KYL       +H DL   NIL+         K++DFGLS+ ++++  +P +       G
Sbjct: 141 MKYLA--DMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTS--ALGG 193

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTI 523
                +  PE     K         DVWS G++ ++ + YG++P+    +Q  I   N I
Sbjct: 194 KIPIRWTAPEAIQYRKFTS----ASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---NAI 246

Query: 524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
            +  + +        +     +  C    +  R  
Sbjct: 247 EQ--DYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-44
 Identities = 56/274 (20%), Positives = 101/274 (36%), Gaps = 22/274 (8%)

Query: 294 LLGKGGFSEVHKAFDLK-EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPR 352
           ++G+G F  V+    L  + + + C V  LN+     +    +   L E  I K   HP 
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPN 89

Query: 353 VVKLYDVFEIDANSFCTVLEYCDGHDL-DFYLKQHKTIAEREARSIVMQVVSALKYLNEI 411
           V+ L  +      S   VL Y    DL +F   +      ++     +QV   +K+    
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF--LA 147

Query: 412 KPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYL 471
               +H DL   N +L E       K+ DFGL++ M ++ ++  H     +       ++
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTV---KVADFGLARDMYDKEFDSVHN---KTGAKLPVKWM 201

Query: 472 PPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATEVQF 531
             E         K ++K DVWS GV+ ++ +    P   + +   I     +L+   +  
Sbjct: 202 ALESL----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--LLQGRRLLQ 255

Query: 532 ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
                  +     +  C   + E R     L   
Sbjct: 256 PEY--CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  158 bits (401), Expect = 3e-44
 Identities = 62/317 (19%), Positives = 121/317 (38%), Gaps = 62/317 (19%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           D Y L+  LG+G +SEV +A ++     V  K+  L    K        K   RE  I +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKK--------KKIKREIKILE 84

Query: 347 AL-DHPRVVKLYDVFE-IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSA 404
            L   P ++ L D+ +   + +   V E+ +  D     + ++T+ + + R  + +++ A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYMYEILKA 141

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           L Y + +   ++H D+KP N+++   +   ++++ D+GL++                   
Sbjct: 142 LDYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHPGQEYNVR-------- 189

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
             + ++  PE      +       +D+WS+G +    ++ K+PF H       L     +
Sbjct: 190 VASRYFKGPELL---VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 525 KATEVQF--------------------------------ANKPTVSNEAKGFIRSCLAYR 552
             TE  +                                 N+  VS EA  F+   L Y 
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 553 KEDRIDVISLARHDYLQ 569
            + R+       H Y  
Sbjct: 307 HQSRLTAREAMEHPYFY 323

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  157 bits (398), Expect = 3e-44
 Identities = 62/274 (22%), Positives = 106/274 (38%), Gaps = 30/274 (10%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
               +   LG G + EV++    K    VA K   L +D  E      ++  L+E  + K
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTME------VEEFLKEAAVMK 68

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL--KQHKTIAEREARSIVMQVVSA 404
            + HP +V+L  V       F  + E+    +L  YL     + ++      +  Q+ SA
Sbjct: 69  EIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 405 LKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQG 464
           ++YL   K   IH DL   N L+ E      +K+ DFGLS++M  + Y         +  
Sbjct: 128 MEYLE--KKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYT------AHAGA 176

Query: 465 AGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL 524
                +  PE         K S K DVW+ GV+ ++              + + E   +L
Sbjct: 177 KFPIKWTAPESLAYN----KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LL 229

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
           +  + +         +    +R+C  +   DR  
Sbjct: 230 EK-DYRMERPEGCPEKVYELMRACWQWNPSDRPS 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 5e-44
 Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 32/281 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
                L  LG G F  V      + Q  VA K+  + +    +         + E  +  
Sbjct: 4   KDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKM--IKEGSMSED------EFIEEAKVMM 54

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL-KQHKTIAEREARSIVMQVVSAL 405
            L H ++V+LY V          + EY     L  YL +       ++   +   V  A+
Sbjct: 55  NLSHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113

Query: 406 KYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGA 465
           +YL       +H DL   N L+ +    G +K++DFGLS+ + ++ Y        +    
Sbjct: 114 EYLE--SKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLDDEYT------SSVGSK 162

Query: 466 GTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL-YGKKPFGHNQSQATILEENTIL 524
               + PPE  +      K SSK D+W+ GV+ ++    GK P+    +  T      I 
Sbjct: 163 FPVRWSPPEVLMYS----KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIA 215

Query: 525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
           +   +        S +    + SC   + ++R     L  +
Sbjct: 216 QGLRLYR--PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-44
 Identities = 72/310 (23%), Positives = 117/310 (37%), Gaps = 46/310 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKHALREYNIH 345
            +Y  +  +G+G + +V KA DLK   R+VA K   +     E+         +      
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGEEGMPLSTIREVAVLRHL 64

Query: 346 KALDHPRVVKLYDVFEIDA----NSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQ 400
           +  +HP VV+L+DV  +           V E+ D     +  K     +     + ++ Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  L +L+  +  V+H DLKP NIL+T     G+IK+ DFGL+++   +          
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSV---- 175

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF-GHNQSQATILE 519
                 T WY  PE  +        ++ VD+WSVG IF +    K  F G +        
Sbjct: 176 ----VVTLWYRAPEVLLQSS----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

Query: 520 ENTILKATEVQFANK--------------------PTVSNEAKGFIRSCLAYRKEDRIDV 559
            + I    E  +                         +    K  +  CL +    RI  
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

Query: 560 ISLARHDYLQ 569
            S   H Y Q
Sbjct: 288 YSALSHPYFQ 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 9e-44
 Identities = 56/304 (18%), Positives = 103/304 (33%), Gaps = 45/304 (14%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           +      +LG G F +V  A      +        + K  KE   ++  +  + E  +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV-KMLKEKADSSEREALMSELKMMT 95

Query: 347 AL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------------ 387
            L  H  +V L       +     + EYC   DL  YL+  +                  
Sbjct: 96  QLGSHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                 +   +      QV   +++L       +H DL   N+L+T G     +KI DFG
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHG---KVVKICDFG 209

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           L++ +  ++     G            ++ PE    G      + K DVWS G++ ++  
Sbjct: 210 LARDIMSDSNYVVRGN-----ARLPVKWMAPESLFEG----IYTIKSDVWSYGILLWEIF 260

Query: 503 -YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS 561
             G  P+      A   +   +++    +       + E    ++SC A+    R    +
Sbjct: 261 SLGVNPYPGIPVDANFYK---LIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 562 LARH 565
           L   
Sbjct: 317 LTSF 320

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-43
 Identities = 65/314 (20%), Positives = 107/314 (34%), Gaps = 57/314 (18%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
             Y    ++G G F  V++A        VA K    +K +K            RE  I +
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----------RELQIMR 68

Query: 347 ALDHPRVVKLYDVF-----EIDANSFCTVLEYCDG---HDLDFYLKQHKTIAEREARSIV 398
            LDH  +V+L   F     + D      VL+Y           Y +  +T+     +  +
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128

Query: 399 MQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGM 458
            Q+  +L Y++     + H D+KP N+LL        +K+ DFG +K +     N  +  
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLCDFGSAKQLVRGEPNVSYIC 184

Query: 459 DLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL 518
                    Y+  P   F         +S +DVWS G +  + L G+  F  +     ++
Sbjct: 185 S-------RYYRAPELIF----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

Query: 519 EENTIL-----------------------KATEVQFANKPTVSNEAKGFIRSCLAYRKED 555
           E   +L                       KA       +P    EA       L Y    
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293

Query: 556 RIDVISLARHDYLQ 569
           R+  +    H +  
Sbjct: 294 RLTPLEACAHSFFD 307

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (391), Expect = 4e-43
 Identities = 62/307 (20%), Positives = 109/307 (35%), Gaps = 54/307 (17%)

Query: 287 DRYLLLMLLGKGGFSEVHKA-----FDLKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           +    +  +G+G F  V +A        +    VA K+       KE+  A+      RE
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM------LKEEASADMQADFQRE 66

Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--------------- 386
             +    D+P +VKL  V  +     C + EY    DL+ +L+                 
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 387 ---------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK 437
                      ++  E   I  QV + + YL+E     +H DL   N L+ E      +K
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGEN---MVVK 180

Query: 438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI 497
           I DFGLS+ +   +Y            A    ++PPE         + +++ DVW+ GV+
Sbjct: 181 IADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESI----FYNRYTTESDVWAYGVV 231

Query: 498 FYQCLYGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI 557
            ++         +  +   ++    +     +          E    +R C +    DR 
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYY--VRDGNILACP--ENCPLELYNLMRLCWSKLPADRP 287

Query: 558 DVISLAR 564
              S+ R
Sbjct: 288 SFCSIHR 294

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 4e-43
 Identities = 52/301 (17%), Positives = 100/301 (33%), Gaps = 44/301 (14%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           ++   +L   +GKG F EV +     E+  VA K+    ++    ++A        E   
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREA--------EIYQ 50

Query: 345 HKALDHPRVVKLYDVFEIDANSF---CTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
              L H  ++        D  ++     V +Y +   L  YL ++  +       + +  
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALST 109

Query: 402 VSALKYL------NEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPD 455
            S L +L       + KP + H DLK  NIL+ +    G   I D GL+   D      D
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSAT---D 163

Query: 456 HGMDLTSQGAGTYWYLPPECF--VVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS 513
                 +   GT  Y+ PE     +     +   + D++++G++F++        G ++ 
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223

Query: 514 QATILEENTILKATEVQFANK----------------PTVSNEAKGFIRSCLAYRKEDRI 557
                 +      +  +                              +R C       R+
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 558 D 558
            
Sbjct: 284 T 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (386), Expect = 6e-42
 Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 30/308 (9%)

Query: 264 HIRELKRIHNEDQSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN 323
            + + K    +     + +    D++  +  LG G F  V      +   + A K+  L+
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LD 75

Query: 324 KDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYL 383
           K      K   I+H L E  I +A++ P +VKL      D ++   V+EY  G ++  +L
Sbjct: 76  KQKVVKLK--QIEHTLNEKRILQAVNFPFLVKLEF-SFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 384 KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL 443
           ++    +E  AR    Q+V   +YL+ +   +I+ DLKP N+L+   +  G I++TDFG 
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI---DQQGYIQVTDFGF 187

Query: 444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY 503
           +K +    +             GT   L PE           +  VD W++GV+ Y+   
Sbjct: 188 AKRVKGRTWTLC----------GTPEALAPEII----LSKGYNKAVDWWALGVLIYEMAA 233

Query: 504 GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA 563
           G  PF  +Q            K    +       S++ K  +R+ L      R   +   
Sbjct: 234 GYPPFFADQ------PIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287

Query: 564 RHDYLQPP 571
            +D     
Sbjct: 288 VNDIKNHK 295

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-41
 Identities = 50/276 (18%), Positives = 94/276 (34%), Gaps = 27/276 (9%)

Query: 287 DRYLLLMLLGKGGFSEVHKAF----DLKEQRYVACKVHQLNKDWKEDKKANYIKHALREY 342
                  ++G G F EV+K        K++  VA K   L   + E ++       L E 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQR----VDFLGEA 60

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
            I     H  +++L  V               +G    F  ++    +  +   ++  + 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
           + +KYL       +H DL   NIL+         K++DFGLS+V++++          TS
Sbjct: 121 AGMKYLAN--MNYVHRDLAARNILVNSN---LVCKVSDFGLSRVLEDDPEA----TYTTS 171

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT 522
            G     +  PE     K         DVWS G++ ++ +   +      S   +++   
Sbjct: 172 GGKIPIRWTAPEAISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMK--- 224

Query: 523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
                  +        +     +  C    +  R  
Sbjct: 225 -AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPK 259

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 9e-40
 Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 53/314 (16%)

Query: 285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNI 344
           + +RY  L  +G G +  V  AFD K    VA K   L++ ++    A   K   RE  +
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHA---KRTYRELRL 70

Query: 345 HKALDHPRVVKLYDVFE----IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQ 400
            K + H  V+ L DVF     ++  +   ++ +  G D    + + + + +   + ++ Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQ 129

Query: 401 VVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDL 460
           ++  LKY++     +IH DLKP N+ + E     E+KI DFGL++  D+E          
Sbjct: 130 ILRGLKYIHSAD--IIHRDLKPSNLAVNE---DCELKILDFGLARHTDDEMTGYVA---- 180

Query: 461 TSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF------------ 508
                 T WY  PE  +   N    +  VD+WSVG I  + L G+  F            
Sbjct: 181 ------TRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

Query: 509 ------------GHNQSQATILEENTILKATEVQFANK-PTVSNEAKGFIRSCLAYRKED 555
                           S++      ++ +  ++ FAN     +  A   +   L    + 
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

Query: 556 RIDVISLARHDYLQ 569
           RI       H Y  
Sbjct: 292 RITAAQALAHAYFA 305

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-39
 Identities = 65/324 (20%), Positives = 109/324 (33%), Gaps = 66/324 (20%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
            RY  L  +G G    V  A+D    R VA K   L++ ++      + K A RE  + K
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQT---HAKRAYRELVLMK 71

Query: 347 ALDHPRVVKLYDVFEI-----DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQV 401
            ++H  ++ L +VF       +      V+E  D +       +           ++ Q+
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQM 128

Query: 402 VSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLT 461
           +  +K+L+      IH DLKP NI++        +KI DFGL++              + 
Sbjct: 129 LCGIKHLHSAGI--IHRDLKPSNIVVKSD---CTLKILDFGLARTAGTS--------FMM 175

Query: 462 SQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN 521
           +    T +Y  PE              VD+WSVG I  + +  K  F          +  
Sbjct: 176 TPYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 522 TILKATEVQFANK------------------------------------PTVSNEAKGFI 545
             L     +F  K                                       +++A+  +
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 546 RSCLAYRKEDRIDVISLARHDYLQ 569
              L      RI V    +H Y+ 
Sbjct: 292 SKMLVIDPAKRISVDDALQHPYIN 315

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-39
 Identities = 53/296 (17%), Positives = 96/296 (32%), Gaps = 48/296 (16%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           +R      LG G F +V +A             VA K+  L       ++    +  + E
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM--LKPSAHLTER----EALMSE 76

Query: 342 YNIHKAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------- 387
             +   L +H  +V L             + EYC   DL  +L++ +             
Sbjct: 77  LKVLSYLGNHMNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 388 -----TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG 442
                 +   +  S   QV   + +L       IH DL   NILLT G +    KI DFG
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRIT---KICDFG 190

Query: 443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCL 502
           L++ +  ++        +         ++ PE           + + DVWS G+  ++  
Sbjct: 191 LARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVY----TFESDVWSYGIFLWELF 241

Query: 503 YGKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
                        +   +  ++K    +  +      E    +++C       R  
Sbjct: 242 SLGSSPYPGMPVDSKFYK--MIKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 6e-38
 Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 37/290 (12%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN-KDWKEDKKANYIKHALREYNIH 345
           DR +L   LG+G F +V  A  +   +    +V ++  K  K D     +   + E  + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 346 KAL-DHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------T 388
           K +  H  ++ L             ++EY    +L  YL+  +                 
Sbjct: 73  KMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMD 448
           ++ ++  S   QV   ++YL       IH DL   N+L+TE NV    KI DFGL++ + 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVM---KIADFGLARDIH 186

Query: 449 EENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPF 508
             +Y        T+ G     ++ PE           + + DVWS GV+ ++        
Sbjct: 187 HIDY-----YKKTTNGRLPVKWMAPEALFDR----IYTHQSDVWSFGVLLWEIFTLGGSP 237

Query: 509 GHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID 558
                   + +   + +   +        +NE    +R C       R  
Sbjct: 238 YPGVPVEELFKL--LKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQRPT 283

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-37
 Identities = 51/294 (17%), Positives = 105/294 (35%), Gaps = 40/294 (13%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFD-----LKEQRYVACKVHQLNKDWKEDKKANYIKHALRE 341
           ++  +   LG+G F  V++         + +  VA K   +N+     ++       L E
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT--VNEAASMRER----IEFLNE 73

Query: 342 YNIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------TIAE 391
            ++ K  +   VV+L  V          ++E     DL  YL+  +            + 
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 392 REARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEEN 451
            +   +  ++   + YLN      +H DL   N ++ E      +KI DFG+++ + E +
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAED---FTVKIGDFGMTRDIYETD 187

Query: 452 YNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHN 511
           Y          +G     ++ PE           ++  DVWS GV+ ++     +     
Sbjct: 188 Y-----YRKGGKGLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238

Query: 512 QSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
            S   +L    +++   +         +     +R C  Y  + R   + +   
Sbjct: 239 LSNEQVLRF--VMEGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 7e-37
 Identities = 52/295 (17%), Positives = 89/295 (30%), Gaps = 33/295 (11%)

Query: 287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK 346
           DR  L   LG+G F +V +A      +   C+   +    +    + +         +  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 347 ALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK----------------TIA 390
              H  VV L             ++E+C   +L  YL+  +                 + 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 391 EREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE 450
                    QV   +++L       IH DL   NILL+E      +KI DFGL++ + ++
Sbjct: 133 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKD 187

Query: 451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGH 510
                              ++ PE           + + DVWS GV+ ++          
Sbjct: 188 PDY-----VRKGDARLPLKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238

Query: 511 NQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH 565
                        LK    +       + E    +  C       R     L  H
Sbjct: 239 GVKIDEEFCR--RLKE-GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (327), Expect = 8e-34
 Identities = 66/352 (18%), Positives = 121/352 (34%), Gaps = 73/352 (20%)

Query: 282 HPV------LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANY- 334
           HP          RY+L+  LG G FS V  A D+    +VA K+ + +K + E  +    
Sbjct: 2   HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61

Query: 335 IKHALREYNI--HKALDHPRVVKLYDVFEI---DANSFCTVLEYCDGHDLDFYLK-QHKT 388
           +   + + +     ++    ++KL D F     +      V E    + L    K +H+ 
Sbjct: 62  LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121

Query: 389 IAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC---GEIKITDFGLSK 445
           I     + I  Q++  L Y++  +  +IH D+KP N+L+   +      +IKI D G + 
Sbjct: 122 IPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK 505
             DE   N             T  Y  PE  +            D+WS   + ++ + G 
Sbjct: 181 WYDEHYTNSI----------QTREYRSPEVLLGA----PWGCGADIWSTACLIFELITGD 226

Query: 506 KPFGHNQSQATILEENTILKATEV------------------------------------ 529
             F  ++  +   +++ I +  E+                                    
Sbjct: 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286

Query: 530 ------QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPKH 575
                 ++      + E   F+   L      R D   L  H +L+  +   
Sbjct: 287 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.4 bits (226), Expect = 6e-22
 Identities = 32/213 (15%), Positives = 67/213 (31%), Gaps = 44/213 (20%)

Query: 294 LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALR-----------EY 342
           L+G+G  S V   +  ++      K H++     +  K       L            E+
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 343 NIHKALDHPRVVKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVV 402
              + L    V K+Y            ++E           K+   +       ++  ++
Sbjct: 66  RALQKLQGLAVPKVYAWEG-----NAVLMELI-------DAKELYRVRVENPDEVLDMIL 113

Query: 403 SALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTS 462
             +         ++H DL   N+L++E      I I DF  S  + EE +      D+ +
Sbjct: 114 EEVAKFYH--RGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGEEGWREILERDVRN 167

Query: 463 QGAGTYWYLPPECFVVGKNPPKISSKVDVWSVG 495
                 ++         +      ++ D+ S  
Sbjct: 168 ---IITYF--------SR---TYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	627
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.26
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.68
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.77
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.53

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-59  Score=476.31  Aligned_cols=267  Identities=26%  Similarity=0.443  Sum_probs=222.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||+||+|.++.+++.||||++......      ...+.+.+|+.+++.++|||||+++++|. +.
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-~~   75 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------DCPENIKKEICINKMLNHENVVKFYGHRR-EG   75 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------CHHHHHHHHHTCCCTTBCCEEEEEE-ET
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHhCCCCCEeeEeeeec-cC
Confidence            457899999999999999999999999999999998754321      12346889999999999999999999998 66


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+|||||||++++|.+++.....+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~---~~~KL~DFG~a  150 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER---DNLKISDFGLA  150 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT---CCEEECCCTTC
T ss_pred             ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC---CCEEEccchhh
Confidence            788999999999999999988889999999999999999999999998  9999999999999987   58999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +.+.....     .......+||+.|+|||++.   ....++.++||||||||||+|++|+.||............   .
T Consensus       151 ~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~---~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~  219 (271)
T d1nvra_         151 TVFRYNNR-----ERLLNKMCGTLPYVAPELLK---RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---W  219 (271)
T ss_dssp             EECEETTE-----ECCBCCCCSCGGGSCTHHHH---CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---H
T ss_pred             eeeccCCc-----cccccceeeCcCccCHhHhc---CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---H
Confidence            98754321     12234568999999999985   2333567899999999999999999999765544333222   1


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCCCCC
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPPVPK  574 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~~~~  574 (627)
                      .........+..+|+++.+||.+||+.||++|||+.|+++||||+.+.++
T Consensus       220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            12223334456789999999999999999999999999999999877654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=463.83  Aligned_cols=254  Identities=31%  Similarity=0.455  Sum_probs=218.6

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|.++.+++.||||++.....    ........+.+|+.+++.++|||||+++++|. +.+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-ECCE
Confidence            679999999999999999999999999999999864321    11223456889999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|||||||++|+|..++.....+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+.
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~---~~~kl~DFG~a~~  155 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA---GELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEECCCCSCSC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC---CCEeecccceeee
Confidence            8999999999999999998899999999999999999999999988  9999999999999987   6899999999987


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      .....         ....+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||...+....+...    . 
T Consensus       156 ~~~~~---------~~~~~Gt~~Y~APE~~~----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~-  217 (263)
T d2j4za1         156 APSSR---------RTTLCGTLDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----S-  217 (263)
T ss_dssp             CCCCC---------CEETTEEGGGCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H-
T ss_pred             cCCCc---------ccccCCCCcccCHHHHc----CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----H-
Confidence            65321         23458999999999994    456899999999999999999999999876654433211    1 


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                       ...+..+..+|+++++||.+||++||.+|||+.|+|+||||.
T Consensus       218 -~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         218 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             -TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             -cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence             222334457899999999999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-57  Score=459.50  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=216.3

Q ss_pred             CCCe-eEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         286 SDRY-LLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       286 ~~rY-~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      .+|| ++.++||+|+||+||+|.+..+++.||||++.......     ...+.+.+|+++|++++|||||+++++|+.. 
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            4556 67789999999999999999999999999987543221     2245688999999999999999999998642 


Q ss_pred             --CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         364 --ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       364 --~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                        ...+|||||||++++|.+++.....+++.+++.|+.||+.||.|||+++++||||||||+||||+..+  +.+||+||
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~--~~~Kl~DF  159 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT--GSVKIGDL  159 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT--SCEEECCT
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCC--CCEEEeec
Confidence              45689999999999999999998999999999999999999999999887899999999999997543  68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.....         .....+||+.|+|||++.    + .|+.++||||||||||||++|+.||........+....
T Consensus       160 Gla~~~~~~---------~~~~~~GT~~Y~aPE~~~----~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i  225 (270)
T d1t4ha_         160 GLATLKRAS---------FAKAVIGTPEFMAPEMYE----E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV  225 (270)
T ss_dssp             TGGGGCCTT---------SBEESCSSCCCCCGGGGG----T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred             CcceeccCC---------ccCCcccCccccCHHHhC----C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH
Confidence            999865432         234568999999999883    2 48999999999999999999999997766555443321


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQ  569 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~  569 (627)
                        ... ......+..+++++++||.+||++||++|||+.|+|+||||+
T Consensus       226 --~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         226 --TSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             --TTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --HcC-CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence              111 111122345789999999999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-57  Score=472.27  Aligned_cols=266  Identities=29%  Similarity=0.426  Sum_probs=210.3

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      .+.+.++|++.+.||+|+||+||+|.+..+++.||||++......      .....+.+|+.+|+.++|||||+++++|.
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE------GKEGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh------hHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345789999999999999999999999999999999998754321      11245778999999999999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|||||||+|++|.+++...+.+++.+++.|+.||+.||.|||+++  ||||||||+|||+......+.+||+||
T Consensus        78 -~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          78 -SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             -ECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecc
Confidence             67788999999999999999999899999999999999999999999988  999999999999975433478999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+......        .....+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||...........  
T Consensus       155 G~a~~~~~~~--------~~~~~~GT~~y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~--  220 (307)
T d1a06a_         155 GLSKMEDPGS--------VLSTACGTPGYVAPEVLA----QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ--  220 (307)
T ss_dssp             --------------------------CTTSCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--
T ss_pred             ceeEEccCCC--------eeeeeeeCccccCcHHHc----CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence            9998765432        234458999999999984    45689999999999999999999999987655443321  


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..........+.++.+|+++.+||.+||++||.+|||+.|+++||||..
T Consensus       221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            1222223334455789999999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=466.66  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=219.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||+||+|.+..+++.||||++.......       .+.+.+|+.+++.++|||||+++++|. +.+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~   90 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-------KELIINEILVMRENKNPNIVNYLDSYL-VGD   90 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-------HHHHHHHHHHHHhCCCCCEeeEeEEEE-ECC
Confidence            468999999999999999999999999999999987543211       245889999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+|++|..++.. ..+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +++||+|||+|+
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~---~~vkl~DFG~a~  164 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD---GSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC---CcEeeccchhhe
Confidence            78999999999999988765 57999999999999999999999998  9999999999999877   689999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....       ......+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||........+..   +..
T Consensus       165 ~~~~~~-------~~~~~~~gt~~Y~aPE~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~  230 (293)
T d1yhwa1         165 QITPEQ-------SKRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT  230 (293)
T ss_dssp             ECCSTT-------CCBCCCCSCGGGCCHHHHS----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH
T ss_pred             eecccc-------ccccccccCCCccChhhhc----CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH---HHh
Confidence            875432       1234558999999999984    45689999999999999999999999977665544322   222


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .....+..+..+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       231 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            223344555679999999999999999999999999999999963

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=461.27  Aligned_cols=263  Identities=28%  Similarity=0.460  Sum_probs=221.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .|.|++++.||+|+||+||+|.+..+++.||||++......       ..+.+.+|+++|+.++|||||+++++|. +.+
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~   82 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-------ELEDYMVEIDILASCDHPNIVKLLDAFY-YEN   82 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-------GGGGTHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-------HHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCC
Confidence            36799999999999999999999999999999998754321       1346789999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .+|||||||++++|..++.. .+.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~---~~~Kl~DFG~a  157 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD---GDIKLADFGVS  157 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC---CCEEEEechhh
Confidence            88899999999999998765 467999999999999999999999998  9999999999999987   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGK-NPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +......       ......+||+.|+|||++.... ....|+.++|||||||+||+|++|+.||........+..   +
T Consensus       158 ~~~~~~~-------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~---i  227 (288)
T d2jfla1         158 AKNTRTI-------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---I  227 (288)
T ss_dssp             EECHHHH-------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---H
T ss_pred             hccCCCc-------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH---H
Confidence            8654321       1234568999999999985322 345689999999999999999999999987666554432   2


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......+..+..+|+++++||.+||+.||.+|||+.|+++||||+..
T Consensus       228 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            222223344456789999999999999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-57  Score=471.09  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=215.7

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++..|+|+++++||+|+||+||+|.+..+++.||||++......      .....+.+|+.+|+.++|||||+++++|. 
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-   74 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------AIRNQIIRELQVLHECNSPYIVGFYGAFY-   74 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT------THHHHHHHHGGGGGGCCCTTBCCEEEEEE-
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence            35678999999999999999999999999999999998754321      12346889999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|||||||+|++|.+++.+.+.+++..++.++.||+.||.|||+ ++  ||||||||+||||+.+   +++||+||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~---~~vkl~DF  149 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR---GEIKLCDF  149 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT---CCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC---CCEEEeeC
Confidence            667889999999999999999988999999999999999999999997 47  9999999999999887   69999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.+....         ..+.+||++|+|||++.    +..|+.++||||||||||||++|+.||...+.........
T Consensus       150 Gla~~~~~~~---------~~~~~GT~~Y~APEvl~----~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~  216 (322)
T d1s9ja_         150 GVSGQLIDSM---------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG  216 (322)
T ss_dssp             CCCHHHHHHT---------C---CCSSCCCCHHHHH----CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-
T ss_pred             CCccccCCCc---------cccccCCccccCchHHc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999775432         23458999999999995    4469999999999999999999999997654332211000


Q ss_pred             HHhh--------------------------------------hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         522 TILK--------------------------------------ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       522 ~~~~--------------------------------------~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      ....                                      ...........+|.++.+||.+||++||.+|||+.|+|
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L  296 (322)
T d1s9ja_         217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM  296 (322)
T ss_dssp             -----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            0000                                      00000001124689999999999999999999999999


Q ss_pred             hccCCCC
Q psy4988         564 RHDYLQP  570 (627)
Q Consensus       564 ~hp~~~~  570 (627)
                      +||||+.
T Consensus       297 ~Hpf~~~  303 (322)
T d1s9ja_         297 VHAFIKR  303 (322)
T ss_dssp             TSHHHHH
T ss_pred             hCHhhCc
Confidence            9999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=461.18  Aligned_cols=271  Identities=29%  Similarity=0.426  Sum_probs=224.3

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ..+.|+|++++.||+|+||+||+|.+..+++.||||++........ ......+.+.+|+.+|+.++|||||+++++|. 
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-   83 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS-RRGVSREDIEREVSILKEIQHPNVITLHEVYE-   83 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC-SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchh-hhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-
Confidence            3467899999999999999999999999999999999875433211 11112356889999999999999999999998 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCc-ccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNV-CGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~-~g~vKL~DF  441 (627)
                      +.+.+|||||||++++|.+++...+.+++..++.|+.||+.||+|||+.+  ||||||||+|||++.++. ...+||+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecch
Confidence            67888999999999999999998899999999999999999999999998  999999999999987642 236999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.+....        .....+||+.|+|||++.    ...++.++|||||||+||+|++|+.||...+....+....
T Consensus       162 G~a~~~~~~~--------~~~~~~~t~~y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~  229 (293)
T d1jksa_         162 GLAHKIDFGN--------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS  229 (293)
T ss_dssp             TTCEECTTSC--------BCSCCCCCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hhhhhcCCCc--------cccccCCCCcccCHHHHc----CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            9998875432        123458999999999984    4568999999999999999999999998766555442221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .  .........++.+|+++++||.+||+.||.+|||+.++++||||++.
T Consensus       230 ~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         230 A--VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             T--TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             h--cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            1  11111122235789999999999999999999999999999999854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=453.70  Aligned_cols=258  Identities=23%  Similarity=0.383  Sum_probs=203.7

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-cCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-DAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~  365 (627)
                      ++|++++.||+|+||+||+|.++.+++.||||++......     ....+.+.+|++++++++|||||+++++|.. ..+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-----EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-----HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence            6799999999999999999999999999999998755432     1224568899999999999999999998863 345


Q ss_pred             eEEEEEeecCCCChHHHHHh----ccCcCHHHHHHHHHHHHHHHHHHHhCC---CCEEeccccCCcEEecCCCcccceEE
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQ----HKTIAEREARSIVMQVVSALKYLNEIK---PPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      .+|||||||++|+|.+++..    ...+++..++.|+.||+.||.|||+.+   .+||||||||+||||+.+   +.+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl  155 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKL  155 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEE
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEE
Confidence            68899999999999998864    357999999999999999999999864   249999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+|+.+....       ......+||+.|+|||++.    ...|+.++||||||||||||++|+.||...+....+.
T Consensus       156 ~DFG~a~~~~~~~-------~~~~~~~gt~~Y~APE~l~----~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~  224 (269)
T d2java1         156 GDFGLARILNHDT-------SFAKAFVGTPYYMSPEQMN----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG  224 (269)
T ss_dssp             CCHHHHHHC------------------CCCSCCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eeccceeecccCC-------CccccCCCCcccCCHHHHc----CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH
Confidence            9999999875432       2234568999999999983    5568999999999999999999999998765544322


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                      .   +.....  ...+..+|+++.+||.+||+.||.+|||+.|+++|||+
T Consensus       225 ~---i~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         225 K---IREGKF--RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             H---HHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             H---HHcCCC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            1   111111  12345789999999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=459.26  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=217.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|++++.||+|+||+||+|.+..+++.||||++......    .......+.+|++++++++|||||+++++|. +.+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-CSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc----CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-ECC
Confidence            36799999999999999999999999999999998643221    1223456889999999999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+||+|.+++...+.+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+|+
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~---~~vkl~DFG~a~  156 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED---MHIQITDFGTAK  156 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---SCEEECCCTTCE
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC---ceEEecccccce
Confidence            88999999999999999999999999999999999999999999988  9999999999999987   689999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+......     ......+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||...+....+..   +. 
T Consensus       157 ~~~~~~~~-----~~~~~~~GT~~Y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~---i~-  223 (288)
T d1uu3a_         157 VLSPESKQ-----ARANSFVGTAQYVSPELLT----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK---II-  223 (288)
T ss_dssp             ECC---------------CCCCGGGCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH-
T ss_pred             ecccCCcc-----cccccccCCccccCceeec----cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH---HH-
Confidence            87543211     2234458999999999984    45689999999999999999999999987655443321   11 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH------HHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS------LARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~e------lL~hp~~~~~  571 (627)
                      ....  ..+..+++++++||++||+.||.+|||+.|      +++||||...
T Consensus       224 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         224 KLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             TTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             cCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            1222  334579999999999999999999999987      5789999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-56  Score=461.30  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=220.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||+|+||+||+|.+..+++.||||++.......    ....+.+.+|+.+|+.++|||||+++++|. +.+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~   88 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REH   88 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETT
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-ECC
Confidence            346999999999999999999999999999999987654322    233567899999999999999999999998 567


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||.+++|..++.....+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~---~~~Kl~DFG~a~  163 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP---GLVKLGDFGSAS  163 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT---TEEEECCCTTCB
T ss_pred             EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC---CCEEEeeccccc
Confidence            88999999999999888888889999999999999999999999998  9999999999999987   699999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .....           ...+||+.|+|||++... ....|+.++|||||||+||||++|..||........+...   ..
T Consensus       164 ~~~~~-----------~~~~GT~~Y~APE~~~~~-~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---~~  228 (309)
T d1u5ra_         164 IMAPA-----------NSFVGTPYWMAPEVILAM-DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ  228 (309)
T ss_dssp             SSSSB-----------CCCCSCGGGCCHHHHTTT-TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH
T ss_pred             ccCCC-----------CccccCccccCHHHHhcc-CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh
Confidence            75432           234899999999998532 2345899999999999999999999999876655443321   11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .. ........+|+++++||.+||++||.+|||+.++|+||||..
T Consensus       229 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         229 NE-SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             SC-CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CC-CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            11 122234568999999999999999999999999999999964

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-55  Score=465.28  Aligned_cols=263  Identities=28%  Similarity=0.425  Sum_probs=220.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|++++.||+|+||+||+|.+..+++.||||++.....       ...+.+.+|+.+|+.++|||||+++++|. +
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~   94 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------SDKETVRKEIQTMSVLRHPTLVNLHDAFE-D   94 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-------HHHHHHHHHHHHHHHTCCTTBCCEEEEEE-E
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-------hhHHHHHHHHHHHHhCCCCCCCcEEEEEE-E
Confidence            345799999999999999999999999999999999864432       12356889999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|||||||+||+|.+++. ..+.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+.. +.+||+|||
T Consensus        95 ~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~-~~vkL~DFG  171 (350)
T d1koaa2          95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRS-NELKLIDFG  171 (350)
T ss_dssp             TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTS-CCEEECCCT
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCC-CeEEEeecc
Confidence            678899999999999999985 4568999999999999999999999998  999999999999975432 689999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +|+.+....        .....+||+.|+|||++.    +..|+.++||||||||||+|++|+.||...+....+.... 
T Consensus       172 ~a~~~~~~~--------~~~~~~gT~~Y~aPEv~~----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-  238 (350)
T d1koaa2         172 LTAHLDPKQ--------SVKVTTGTAEFAAPEVAE----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-  238 (350)
T ss_dssp             TCEECCTTS--------CEEEECSCTTTCCHHHHH----TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred             hheeccccc--------ccceecCcccccCHHHHc----CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            998875432        234458999999999985    4568999999999999999999999998766554432221 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       ...........+.+|+++++||.+||++||++|||+.|+|+||||...
T Consensus       239 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         239 -SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             -HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             -hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             111112222335689999999999999999999999999999999854

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.2e-55  Score=463.03  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=220.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++++.||+|+||+||+|.+..+++.||||++......       ....+.+|+.+|+.|+|||||+++++|. +.
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~   98 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-------DKYTVKNEISIMNQLHHPKLINLHDAFE-DK   98 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE-CS
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEE-EC
Confidence            457899999999999999999999999999999998754321       1245788999999999999999999998 67


Q ss_pred             CeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      +.+|||||||+|++|.+++... ..|++.+++.|+.||+.||.|||+++  ||||||||+||||+... .+.+||+|||+
T Consensus        99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~-~~~vkL~DFGl  175 (352)
T d1koba_          99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKK-ASSVKIIDFGL  175 (352)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTT-CCCEEECCCTT
T ss_pred             CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccC-CCeEEEeeccc
Confidence            8889999999999998877654 47999999999999999999999988  99999999999998532 26899999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTI  523 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~  523 (627)
                      |+.+....        .....+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||.+......+....  
T Consensus       176 a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~--  241 (352)
T d1koba_         176 ATKLNPDE--------IVKVTTATAEFAAPEIVD----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--  241 (352)
T ss_dssp             CEECCTTS--------CEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred             ceecCCCC--------ceeeccCcccccCHHHHc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence            99876432        234458999999999984    5568999999999999999999999998766554432211  


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..........+..+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus       242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            111122223446799999999999999999999999999999999854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=460.65  Aligned_cols=258  Identities=29%  Similarity=0.457  Sum_probs=221.1

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||+|+||.||+|.++.+++.||||++.......    ...+..+.+|+.+|+.++|||||+++++|. +.+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----KDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----TTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC----HHHHHHHHHHHHHHHhCCCCCEEEEEeeec-ccc
Confidence            467999999999999999999999999999999986432211    123467889999999999999999999998 678


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|+|||||+||+|..++...+.+++..++.++.||+.||.|||+++  ||||||||+||||+.+   |.+||+|||+|+
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~---g~vkl~DFG~a~  153 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD---GHIKITDFGLCK  153 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCTTCB
T ss_pred             ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC---CCEEEeeccccc
Confidence            89999999999999999999999999999999999999999999998  9999999999999987   699999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       ......+||+.|+|||++.    +..|+.++||||||||||||++|++||...+....+..    ..
T Consensus       154 ~~~~~~-------~~~~~~~GT~~Y~aPE~~~----~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----i~  218 (337)
T d1o6la_         154 EGISDG-------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----IL  218 (337)
T ss_dssp             CSCCTT-------CCBCCCEECGGGCCGGGGS----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HH
T ss_pred             ccccCC-------cccccceeCHHHhhhhhcc----CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH----Hh
Confidence            765332       1234568999999999984    55689999999999999999999999987665443321    11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ...+  ..+..+|+++++||++||++||.+|+     ++.++++||||..
T Consensus       219 ~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         219 MEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCCC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            2223  33457999999999999999999999     4999999999975

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.2e-55  Score=447.14  Aligned_cols=270  Identities=26%  Similarity=0.419  Sum_probs=227.2

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh--HhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEe
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE--DKKANYIKHALREYNIHKALD-HPRVVKLYDVFE  361 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~--~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~  361 (627)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++........  .........+++|+.++++++ |||||+++++|.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            45899999999999999999999999999999999876643321  222344567889999999997 999999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +.+.+|||||||++++|.+++...+.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+||
T Consensus        81 -~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~---~~~kl~DF  154 (277)
T d1phka_          81 -TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD---MNIKLTDF  154 (277)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---CCEEECCC
T ss_pred             -cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC---CCeEEccc
Confidence             77889999999999999999999999999999999999999999999988  9999999999999877   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccC--CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVG--KNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |+++.+....        .....+||+.|+|||++...  .....++.++||||+|||||+|++|+.||.......... 
T Consensus       155 G~a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~-  225 (277)
T d1phka_         155 GFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-  225 (277)
T ss_dssp             TTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-
T ss_pred             hheeEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH-
Confidence            9999875432        12345899999999998532  134567899999999999999999999998776544321 


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                       ...........+....+|+++++||.+||++||.+|||+.|||+||||+.
T Consensus       226 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         226 -MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             -HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             -HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence             11222223334445689999999999999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-54  Score=452.34  Aligned_cols=255  Identities=27%  Similarity=0.472  Sum_probs=219.8

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|++++.||+|+||+||+|.++.+++.||||++......    .....+.+.+|+.+++.++|||||+++++|. +.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc----CHHHHHHHHHHHHHHHhccCcChhheeeeEe-eCCe
Confidence            5699999999999999999999999999999998643221    1223467889999999999999999999998 6788


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +|+|||||.|++|..++.....+++..++.++.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+.
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~---g~vkL~DFG~a~~  153 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN---GHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT---SCEEECCCSSCEE
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC---CCEEEecCccceE
Confidence            8999999999999999999999999999999999999999999988  9999999999999987   6999999999988


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +...          ....+||+.|+|||++.    +..|+.++|||||||+||+|++|+.||...+....+..   +.. 
T Consensus       154 ~~~~----------~~~~~Gt~~Y~APE~l~----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~~-  215 (316)
T d1fota_         154 VPDV----------TYTLCGTPDYIAPEVVS----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---ILN-  215 (316)
T ss_dssp             CSSC----------BCCCCSCTTTCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH-
T ss_pred             eccc----------cccccCcccccCHHHHc----CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH---HHc-
Confidence            7542          23458999999999983    55689999999999999999999999987665443322   111 


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                        ..+..++.+++++.+||.+||++||.+|+     |++++++||||+..
T Consensus       216 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         216 --AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence              12334467999999999999999999996     99999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-54  Score=459.47  Aligned_cols=264  Identities=20%  Similarity=0.346  Sum_probs=218.3

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.++++||+|+||.||+|.+..+++.||||++....... ...........+|+.+++.++|||||+++++|. +.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-~~~   80 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPD   80 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSS
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch-hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-ECC
Confidence            467999999999999999999999999999999986433211 122223334455688889999999999999998 667


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||+|++|..++.....+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+|||+|+
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~---g~iKl~DFGla~  155 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH---GHVRISDLGLAC  155 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS---SCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC---CcEEEeeeceee
Confidence            88999999999999999999999999999999999999999999988  9999999999999887   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+....         ....+||+.|+|||++.   .+..|+.++||||||||||+|++|+.||.......... ..  ..
T Consensus       156 ~~~~~~---------~~~~~GT~~y~APE~~~---~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~--~~  220 (364)
T d1omwa3         156 DFSKKK---------PHASVGTHGYMAPEVLQ---KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID--RM  220 (364)
T ss_dssp             ECSSSC---------CCSCCSCGGGCCHHHHS---TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HH--HH
T ss_pred             ecCCCc---------ccccccccccchhHHhh---cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HH--Hh
Confidence            765432         23458999999999985   24468999999999999999999999997654332221 11  11


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCC-----HHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRID-----VISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt-----~~elL~hp~~~~~  571 (627)
                      ........+..+|+++++||.+||++||.+|||     ++++++||||...
T Consensus       221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            122233445679999999999999999999999     7999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=454.45  Aligned_cols=262  Identities=23%  Similarity=0.364  Sum_probs=219.8

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.++|.+++.||+|+||+||+|.+..+++.||||++......        ...+.+|+.+|+.++|||||+++++|+ +
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--------~~~~~~Ei~il~~l~HpnIv~~~~~~~-~   72 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--------QVLVKKEISILNIARHRNILHLHESFE-S   72 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--------HHHHHHHHHHHHHSCCTTBCCEEEEEE-E
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--------HHHHHHHHHHHHhCCCCCCCeEEEEEE-E
Confidence            3678999999999999999999999999999999998654321        134778999999999999999999998 6


Q ss_pred             CCeEEEEEeecCCCChHHHHHhcc-CcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHK-TIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFG  442 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFG  442 (627)
                      .+.+|||||||+|++|.+++...+ .+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+.. ..+||+|||
T Consensus        73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~-~~ikl~DFG  149 (321)
T d1tkia_          73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRS-STIKIIEFG  149 (321)
T ss_dssp             TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSC-CCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCc-eEEEEcccc
Confidence            678899999999999999998765 7999999999999999999999988  999999999999986532 489999999


Q ss_pred             cccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q psy4988         443 LSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENT  522 (627)
Q Consensus       443 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~  522 (627)
                      +++......        .....+||+.|+|||.+.    ...|+.++||||||||||+|++|..||........+.... 
T Consensus       150 ~~~~~~~~~--------~~~~~~~t~~y~ape~~~----~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~-  216 (321)
T d1tkia_         150 QARQLKPGD--------NFRLLFTAPEYYAPEVHQ----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM-  216 (321)
T ss_dssp             TCEECCTTC--------EEEEEESCGGGSCHHHHT----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-
T ss_pred             hhhccccCC--------cccccccccccccchhcc----CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            998765322        234457999999999983    5568999999999999999999999998776654432211 


Q ss_pred             HhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                       .....+....++.+|+++++||.+||++||.+|||+.|+++||||...
T Consensus       217 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         217 -NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence             111111222235789999999999999999999999999999999754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-54  Score=457.12  Aligned_cols=256  Identities=28%  Similarity=0.403  Sum_probs=219.6

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .|+|++++.||+|+||+||+|.++.+++.||||++.....    ........+++|+.+|+.++|||||+++++|. +..
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc----cCHHHHHHHHHHHHHHHHcCCCcEeecccccc-ccc
Confidence            3789999999999999999999999999999999864322    11223457889999999999999999999998 677


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+++||||+.+++|..++...+.+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +++||+|||+|+
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~---g~ikL~DFG~a~  189 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ---GYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---SCEEECCCTTCE
T ss_pred             ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC---CCEEeeeceeee
Confidence            78899999999999999998899999999999999999999999998  9999999999999887   699999999999


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      .+...          ....+||+.|+|||++.    +..|+.++||||||||||+|++|+.||...+....+...   . 
T Consensus       190 ~~~~~----------~~~~~Gt~~Y~APE~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~-  251 (350)
T d1rdqe_         190 RVKGR----------TWTLCGTPEALAPEIIL----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---V-  251 (350)
T ss_dssp             ECSSC----------BCCCEECGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-
T ss_pred             ecccc----------cccccCccccCCHHHHc----CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH---h-
Confidence            87532          23458999999999984    456899999999999999999999999876554333211   1 


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~~  571 (627)
                        ...+..+..+++++.+||++||++||.+|+     |+.+|++||||...
T Consensus       252 --~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         252 --SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             --HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             --cCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence              122334467999999999999999999995     99999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=444.15  Aligned_cols=262  Identities=24%  Similarity=0.394  Sum_probs=211.0

Q ss_pred             EEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .+++||+|+||+||+|.+..+++.||||++......  .......+.+.+|+.+++.++|||||+++++|. +.+.+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-~~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS--EAKDGINRTALREIKLLQELSHPNIIGLLDAFG-HKSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CTTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh--hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCceeeh
Confidence            468899999999999999999999999998654321  112233456889999999999999999999998 56678899


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      ||||.++++..++.....+++.+++.|+.||+.||+|||+++  ||||||||+|||++.+   +.+||+|||+|+.....
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~---~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC---CccccccCccccccCCC
Confidence            999999888877777788999999999999999999999988  9999999999999987   68999999999876543


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhhhc-c
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKATE-V  529 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~  529 (627)
                      ..       .....+||+.|+|||++.   ....|+.++||||||||||||++|.+||......+.+........... .
T Consensus       154 ~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         154 NR-------AYTHQVVTRWYRAPELLF---GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             CC-------CCCCSCCCCTTCCHHHHT---TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cc-------cccceecChhhccHHHHc---cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            21       223458999999999985   344689999999999999999999999987776665544332221100 0


Q ss_pred             cc---------------C------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         530 QF---------------A------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       530 ~~---------------~------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      .+               +      ..+.+++++.+||.+||++||++|||+.|+|+||||+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            00               0      01357899999999999999999999999999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=453.16  Aligned_cols=262  Identities=30%  Similarity=0.462  Sum_probs=211.9

Q ss_pred             ccCCCeeEEE-EecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEe
Q psy4988         284 VLSDRYLLLM-LLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKA-LDHPRVVKLYDVFE  361 (627)
Q Consensus       284 ~l~~rY~i~~-~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIV~l~~~~~  361 (627)
                      .+.++|.++. +||+|+||+||+|.+..+++.||||++...            ..+.+|+.++.+ ++|||||+++++|+
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            3457798875 599999999999999999999999998532            235679988654 58999999999986


Q ss_pred             e---cCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccce
Q psy4988         362 I---DANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       362 ~---~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                      .   ....+|||||||+||+|.+++...  ..|++.+++.|+.||+.||+|||+++  ||||||||+|||++.+...+.+
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCE
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccc
Confidence            3   246689999999999999999864  47999999999999999999999998  9999999999999976555789


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQAT  516 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~  516 (627)
                      ||+|||+|+.......        ....+||+.|+|||++.    +..|+.++||||||||||+|+||+.||........
T Consensus       154 Kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~----~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~  221 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS--------LTTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  221 (335)
T ss_dssp             EECCCTTCEECCCCCC--------CCCCSCCCSSCCCCCCC----GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred             cccccceeeeccCCCc--------cccccCCcccCCcHHHc----CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence            9999999987764331        23458999999999984    45689999999999999999999999965544332


Q ss_pred             HHHHHHHhhhhccccCC--CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         517 ILEENTILKATEVQFAN--KPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~--~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ..............++.  +..+|+++++||++||++||++|||+.|+++||||...
T Consensus       222 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            22111112222223332  24689999999999999999999999999999999643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=442.27  Aligned_cols=257  Identities=29%  Similarity=0.449  Sum_probs=212.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--CCceeEEeeEEee
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVVKLYDVFEI  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~  362 (627)
                      +.++|++.++||+|+||+||+|.+..+++.||||++.......... .....++.+|+.++++++  |||||+++++|. 
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-   79 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-   79 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE-CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh-hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe-
Confidence            5689999999999999999999999999999999987543211100 001123568999999886  999999999998 


Q ss_pred             cCCeEEEEEeecCC-CChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDG-HDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~g-g~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +.+.+|+||||+.+ +++..++.....+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+.  +.+||+||
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~--~~vkl~DF  155 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR--GELKLIDF  155 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTT--TEEEECCC
T ss_pred             eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCC--CeEEECcc
Confidence            66788899999976 688888888889999999999999999999999988  99999999999998653  58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+......         ....+||+.|+|||++..   ...++.++|||||||+||+|++|+.||....   .+    
T Consensus       156 G~a~~~~~~~---------~~~~~GT~~y~aPE~~~~---~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~i----  216 (273)
T d1xwsa_         156 GSGALLKDTV---------YTDFDGTRVYSPPEWIRY---HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---EI----  216 (273)
T ss_dssp             TTCEECCSSC---------BCCCCSCGGGSCHHHHHH---SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---HH----
T ss_pred             ccceeccccc---------ccccccCCCcCCHHHHcC---CCCCCcccccccceeeehhHhhCCCCCCCch---HH----
Confidence            9998764322         344589999999999853   3345778999999999999999999996521   11    


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                        .. .  ....+..+|+++++||++||.+||++|||+.|+++||||+..
T Consensus       217 --~~-~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         217 --IR-G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             --HH-C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             --hh-c--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence              11 1  223345799999999999999999999999999999999754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=444.67  Aligned_cols=257  Identities=25%  Similarity=0.419  Sum_probs=216.9

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHh-cCCCCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHK-ALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~  365 (627)
                      |+|.+++.||+|+||+||+|.++.+++.||||++........    .....+++|+.++. .++|||||+++++|. +.+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~----~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----DDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----TCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh----HHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-cCC
Confidence            679999999999999999999999999999999865332111    22345677777765 689999999999998 677


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      .+|||||||++|+|..++.....+++.+++.++.||+.||.|||+++  ||||||||+|||++.+   +++||+|||+++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~---~~~kl~DFG~a~  151 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD---GHIKIADFGMCK  151 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT---SCEEECCCTTCB
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC---Cceeccccchhh
Confidence            89999999999999999999999999999999999999999999998  9999999999999987   699999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       ......+||+.|+|||++.    +..|+.++||||||||||+|++|+.||.+.+....+...    .
T Consensus       152 ~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----~  216 (320)
T d1xjda_         152 ENMLGD-------AKTNTFCGTPDYIAPEILL----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----R  216 (320)
T ss_dssp             CCCCTT-------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H
T ss_pred             hccccc-------ccccccCCCCCcCCHHHHc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH----H
Confidence            765332       2234458999999999994    456899999999999999999999999876655433221    1


Q ss_pred             hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHH-HHHhccCCCC
Q psy4988         526 ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVI-SLARHDYLQP  570 (627)
Q Consensus       526 ~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~-elL~hp~~~~  570 (627)
                      ....  ..+..+|+++.+||++||++||.+||++. ++++||||..
T Consensus       217 ~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         217 MDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             cCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            1222  33457899999999999999999999995 8999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=435.29  Aligned_cols=264  Identities=26%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      |+|+++++||+|+||+||+|.+..+++.||||++.....     .......+.+|++++++++|||||+++++|. +.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----TEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-----ChHHHHHHHHHHHHHHhCCCCcEEEeccccc-cccc
Confidence            689999999999999999999999999999999864322     1223457889999999999999999999998 6778


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|+|||||.++.+...... ...+++.+++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+||+|||+|+
T Consensus        76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~---~~~kl~DFG~a~  150 (298)
T d1gz8a_          76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE---GAIKLADFGLAR  150 (298)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEECSTTHHH
T ss_pred             eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc---CcceeccCCcce
Confidence            8999999987655554443 467999999999999999999999988  9999999999999877   589999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILK  525 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~  525 (627)
                      ......       .......||+.|+|||++.   ....++.++|||||||+||+|++|+.||...+....+........
T Consensus       151 ~~~~~~-------~~~~~~~gt~~y~apE~~~---~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~  220 (298)
T d1gz8a_         151 AFGVPV-------RTYTHEVVTLWYRAPEILL---GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG  220 (298)
T ss_dssp             HHCCCS-------BCTTCCBCCCTTCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eccCCc-------ccceeecccceeeehhhhc---cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            775432       2234458999999999875   344578899999999999999999999987766555443322111


Q ss_pred             hh-cc-------------ccC---------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         526 AT-EV-------------QFA---------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       526 ~~-~~-------------~~~---------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .. ..             .++         ..+.++.++++||++||.+||.+|||+.|+|+||||+..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            10 00             000         113578999999999999999999999999999999743

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=432.11  Aligned_cols=263  Identities=20%  Similarity=0.281  Sum_probs=207.1

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      |++-.++|.+.+.||+|+||+||+|...   ..||||++.......     ...+.+.+|+.++++++|||||++++++.
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~   74 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-----QQLQAFKNEVGVLRKTRHVNILLFMGYST   74 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-----THHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence            4566789999999999999999999643   359999986543322     12457889999999999999999999864


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                        .+.++||||||++|+|.+++... ..+++..+..|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|
T Consensus        75 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~---~~~Kl~D  147 (276)
T d1uwha_          75 --APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED---LTVKIGD  147 (276)
T ss_dssp             --SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT---SSEEECC
T ss_pred             --ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC---CCEEEcc
Confidence              34578999999999999999754 57999999999999999999999988  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+|+.......     .......+||+.|+|||++... ....|+.++|||||||+||||++|+.||........+...
T Consensus       148 FGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~-~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~  221 (276)
T d1uwha_         148 FGLATVKSRWSG-----SHQFEQLSGSILWMAPEVIRMQ-DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM  221 (276)
T ss_dssp             CCCSCC-----------------CCCCGGGCCHHHHTTC-SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred             ccceeeccccCC-----cccccccccCcccCCHHHHhcc-cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            999987654321     1223456899999999998532 2345899999999999999999999999876655444322


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .............+..+++++.+||.+||..||.+|||+.+++.+
T Consensus       222 ~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         222 VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            211111111122345789999999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.9e-52  Score=427.27  Aligned_cols=266  Identities=29%  Similarity=0.446  Sum_probs=211.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID  363 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~  363 (627)
                      .+.|+|++.+.||+|+||+||+|.+..+++.||||++......    .......+.+|+.+++.++|||||++++++..+
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            5789999999999999999999999999999999998754332    233456789999999999999999999998754


Q ss_pred             CC---eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         364 AN---SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       364 ~~---~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                      ..   .+|||||||+|++|..++...+.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.++|+|
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~---~~~~l~d  154 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT---NAVKVMD  154 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT---SCEEECC
T ss_pred             cCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc---ccceeeh
Confidence            32   47899999999999999999899999999999999999999999988  9999999999999987   5899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+++.......    ........+||+.|+|||++.    +..++.++||||||||||+|+||+.||........+...
T Consensus       155 ~~~~~~~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~  226 (277)
T d1o6ya_         155 FGIARAIADSGN----SVTQTAAVIGTAQYLSPEQAR----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH  226 (277)
T ss_dssp             CTTCEECC--------------------TTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             hhhhhhhccccc----cccccccccCcccccCHHHHc----CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence            999986654321    112234568999999999984    456899999999999999999999999877655443322


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYL  568 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~  568 (627)
                        +..........++.+|+++.+||.+||++||.+||+..+.+.|+|+
T Consensus       227 --~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         227 --VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             --HHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --HhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence              1111222223456799999999999999999999954444556664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.7e-52  Score=429.09  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=213.3

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      |+|.++++||+|+||+||+|.+. +++.||||++.......     ...+.+.+|+.++++++|||||+++++|. +.+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-----GIPSTTIREISILKELKHSNIVKLYDVIH-TKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG-----CCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh-----HHHHHHHHHHHHHHhCCCCcEEeeeeecc-cCCc
Confidence            68999999999999999999985 78999999986654321     12356889999999999999999999998 6677


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++||||+.++++..+....+.+++..++.|+.||+.||+|||+.+  ||||||||+||||+.+   +.+||+|||+|..
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~---~~~kl~DfG~a~~  149 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE---GELKIADFGLARA  149 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---SCEEECCTTHHHH
T ss_pred             eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC---CCEEeccccccee
Confidence            8899999999888888888889999999999999999999999988  9999999999999987   6899999999988


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......       ......|++.|+|||++.   ....++.++|||||||+||||++|+.||........+.........
T Consensus       150 ~~~~~~-------~~~~~~~~~~y~~pE~~~---~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (286)
T d1ob3a_         150 FGIPVR-------KYTHEIVTLWYRAPDVLM---GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT  219 (286)
T ss_dssp             HCC----------------CCCTTCCHHHHT---TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccCcc-------ccceecccchhhhHHHHh---CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            754321       123347899999999985   3446899999999999999999999999876655544332221111


Q ss_pred             hc--------------cc---------cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TE--------------VQ---------FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~--------------~~---------~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..              ..         ......+++++.|||++||++||++|||+.|+|+||||+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            00              00         0112457899999999999999999999999999999963

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-52  Score=428.65  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=216.6

Q ss_pred             ccccCCCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         276 QSRFNNHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       276 ~~~~~~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      ...|..+++-.++|++.+.||+|+||+||+|.+..+++.||||++......        .+.+.+|+.+|++++|||||+
T Consensus         6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------~~~~~~E~~il~~l~HpnIv~   77 (287)
T d1opja_           6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKHPNLVQ   77 (287)
T ss_dssp             STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--------HHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--------HHHHHHHHHHHHhCCCCCEec
Confidence            344556778889999999999999999999999999999999998643321        246889999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcc
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVC  433 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~  433 (627)
                      ++++|. +.+.++||||||++|+|..++...  ..+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   
T Consensus        78 ~~~~~~-~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~---  151 (287)
T d1opja_          78 LLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN---  151 (287)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG---
T ss_pred             CCccEe-eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC---
Confidence            999997 667788999999999999998754  57899999999999999999999988  9999999999999987   


Q ss_pred             cceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q psy4988         434 GEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQS  513 (627)
Q Consensus       434 g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~  513 (627)
                      +.+||+|||+|+.+.....      .......||+.|+|||++.    ...|+.++|||||||+||||++|..||.....
T Consensus       152 ~~~Kl~DFG~a~~~~~~~~------~~~~~~~g~~~y~aPE~~~----~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~  221 (287)
T d1opja_         152 HLVKVADFGLSRLMTGDTY------TAHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  221 (287)
T ss_dssp             GCEEECCCCCTTTCCSSSS------EEETTEEECGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CcEEEccccceeecCCCCc------eeeccccccccccChHHHc----CCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence            6899999999987754321      1223346899999999985    34589999999999999999997777654444


Q ss_pred             HHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         514 QATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       514 ~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...+...  +..  ....+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus       222 ~~~~~~~--i~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         222 LSQVYEL--LEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHH--HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHH--Hhc--CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            4443322  111  2334455679999999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=427.18  Aligned_cols=265  Identities=27%  Similarity=0.469  Sum_probs=210.1

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCC-CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC---CCCceeEEeeEE
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKE-QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL---DHPRVVKLYDVF  360 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~-~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIV~l~~~~  360 (627)
                      ..++|+++++||+|+||+||+|.+..+ ++.||||++.........     ...+.+|+.+++.|   +|||||+++++|
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~E~~~l~~l~~~~HpnIv~~~~~~   79 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----PLSTIREVAVLRHLETFEHPNVVRLFDVC   79 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----BCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-----HHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence            357999999999999999999999765 788999998654322111     12355677766655   899999999998


Q ss_pred             ee----cCCeEEEEEeecCCCChHHHHH-hccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccc
Q psy4988         361 EI----DANSFCTVLEYCDGHDLDFYLK-QHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGE  435 (627)
Q Consensus       361 ~~----~~~~~~lV~E~~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~  435 (627)
                      ..    ....++++||||.++++..... ....+++..++.|+.||+.||+|||+++  ||||||||+|||++.+   +.
T Consensus        80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~---~~  154 (305)
T d1blxa_          80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS---GQ  154 (305)
T ss_dssp             EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---CC
T ss_pred             cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC---CC
Confidence            53    2346889999999887765544 3467999999999999999999999988  9999999999999987   68


Q ss_pred             eEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q psy4988         436 IKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQA  515 (627)
Q Consensus       436 vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~  515 (627)
                      +||+|||+++......        .....+||+.|+|||++.    +..|+.++||||||||||||++|+.||...+...
T Consensus       155 ~kl~dfg~~~~~~~~~--------~~~~~~gT~~Y~APE~~~----~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~  222 (305)
T d1blxa_         155 IKLADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD  222 (305)
T ss_dssp             EEECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             eeecchhhhhhhcccc--------cCCCcccChhhcCcchhc----CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH
Confidence            9999999998654332        234568999999999984    4568999999999999999999999998776655


Q ss_pred             HHHHHHHHhhhh-ccc--------------------cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         516 TILEENTILKAT-EVQ--------------------FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       516 ~~~~~~~~~~~~-~~~--------------------~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .+.......... ...                    ......+++++++||.+||++||++|||+.|+|+||||+..
T Consensus       223 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            544332221110 000                    01234678999999999999999999999999999999753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-51  Score=426.32  Aligned_cols=259  Identities=21%  Similarity=0.377  Sum_probs=199.0

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCe---EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQR---YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~---~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      +..++|++.++||+|+||+||+|.+..+++   .||||.+.....      ....+.+.+|+.+|++++|||||+++++|
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT------EKQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC------HHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            446789999999999999999999887654   688888754332      12245789999999999999999999999


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      . +.+.+++|||||++|+|..++... +.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+
T Consensus        97 ~-~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~---~~~Kl~  170 (299)
T d1jpaa_          97 T-KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN---LVCKVS  170 (299)
T ss_dssp             C-SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEEEC
T ss_pred             e-eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC---CcEEEC
Confidence            7 567788999999999999988764 57999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||+|+.+........  ........||+.|+|||++.    ...++.++|||||||+||||++ |+.||........+.
T Consensus       171 DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~----~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~  244 (299)
T d1jpaa_         171 DFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQ----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN  244 (299)
T ss_dssp             CC-------------------------CGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             CcccceEccCCCCcce--eeecccccCCccccCHHHHh----cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999998765432111  01112246899999999985    4468999999999999999997 899998766544332


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .   +.  .....+.+..+++++.+||.+||+.||++|||+.+++++
T Consensus       245 ~---i~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         245 A---IE--QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             H---HH--TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             H---HH--cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            1   11  123445566799999999999999999999999998865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=420.50  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=209.3

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      +++-.++|++.+.||+|+||+||+|.+. ++..||||++......        .+.+.+|+.++++++|||||++++++.
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--------PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--------HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            4566789999999999999999999864 6789999998643321        235889999999999999999999875


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                       + +.++||||||++|+|.+++...  ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+
T Consensus        79 -~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~---~~~Kl~  151 (272)
T d1qpca_          79 -Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT---LSCKIA  151 (272)
T ss_dssp             -S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT---SCEEEC
T ss_pred             -c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc---cceeec
Confidence             3 4567999999999999877543  36999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.+.....      .......||+.|+|||++.    ...++.++|||||||+||||+||..||........+..
T Consensus       152 DFGla~~~~~~~~------~~~~~~~gt~~y~APE~~~----~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~  221 (272)
T d1qpca_         152 DFGLARLIEDNEY------TAREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ  221 (272)
T ss_dssp             CCTTCEECSSSCE------ECCTTCCCCTTTSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred             cccceEEccCCcc------ccccccCCcccccChHHHh----CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999998764321      1233457999999999985    34589999999999999999996555433333333322


Q ss_pred             HHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh--ccCCC
Q psy4988         520 ENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR--HDYLQ  569 (627)
Q Consensus       520 ~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~--hp~~~  569 (627)
                      .  +..  ....+.+..+++++.+||.+||+.||++|||+.++++  |+||.
T Consensus       222 ~--i~~--~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         222 N--LER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             H--HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHh--cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            2  111  2233445679999999999999999999999999998  78874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=430.47  Aligned_cols=259  Identities=22%  Similarity=0.351  Sum_probs=210.1

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCe-----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQR-----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~-----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +++-.++|++.++||+|+||+||+|.+..+++     .||||++.....      ......+.+|+.++.++ +|||||+
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~~HpnIv~  105 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD------SSEREALMSELKMMTQLGSHENIVN  105 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC------HHHHHHHHHHHHHHHHhcCCCcEeE
Confidence            34556899999999999999999999876543     699998754322      12235688999999998 8999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc-----------------------cCcCHHHHHHHHHHHHHHHHHHHhCC
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH-----------------------KTIAEREARSIVMQVVSALKYLNEIK  412 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~~l~e~~~~~i~~qi~~aL~yLH~~~  412 (627)
                      ++++|. +.+.+|||||||++|+|.+++...                       ..+++..++.|+.||+.||.|||+++
T Consensus       106 l~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         106 LLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEe-eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999998 667788999999999999999754                       24899999999999999999999988


Q ss_pred             CCEEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHH
Q psy4988         413 PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVW  492 (627)
Q Consensus       413 ~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVw  492 (627)
                        ||||||||+|||++.+   +.+||+|||+|+.......     .......+||+.|+|||++.    ...|+.++|||
T Consensus       185 --IiHRDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~----~~~~~~~~Diw  250 (325)
T d1rjba_         185 --CVHRDLAARNVLVTHG---KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLF----EGIYTIKSDVW  250 (325)
T ss_dssp             --EEETTCSGGGEEEETT---TEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHH----HCCCCHHHHHH
T ss_pred             --eeeccCchhccccccC---CeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHc----CCCCCcceecc
Confidence              9999999999999987   6999999999987654321     11233457899999999985    34589999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         493 SVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       493 SlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ||||+||||++ |+.||.+......+...  +.  ....++.+..+|+++.+||.+||+.||++|||+.+|++|
T Consensus       251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~--~~--~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         251 SYGILLWEIFSLGVNPYPGIPVDANFYKL--IQ--NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHH--HH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHhCCCCCCCCCCHHHHHHHH--Hh--cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999997 89999876555444322  11  123344556789999999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=415.96  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=217.5

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|+++++||+|+||+||+|.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|. +...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELKHKNIVRLHDVLH-SDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-----hHHHHHHHHHHHHHHhcCcCCEEeeccccc-cccc
Confidence            6899999999999999999999999999999998765432     223567889999999999999999999997 6778


Q ss_pred             EEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      +++|+||+.+++|..++...+.+++..++.++.|++.||+|||+++  ||||||||+|||++.+   +.+||+|||+|+.
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~---~~~kl~DFG~a~~  150 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN---GELKLANFGLARA  150 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT---CCEEECCCTTCEE
T ss_pred             eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC---Cceeeeecchhhc
Confidence            8899999999999999998899999999999999999999999988  9999999999999987   5899999999988


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      ......       ......+++.|+|||++.   ....++.++|||||||++|||++|+.||....+....+........
T Consensus       151 ~~~~~~-------~~~~~~~~~~~~~pe~~~---~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  220 (292)
T d1unla_         151 FGIPVR-------CYSAEVVTLWYRPPDVLF---GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             CCSCCS-------CCCSCCSCGGGCCHHHHT---TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccCCCc-------cceeeccccchhhhhHhc---cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence            764331       223346789999999885   2345789999999999999999999997555444433322111111


Q ss_pred             hc------------------------cccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         527 TE------------------------VQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       527 ~~------------------------~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ..                        ........+++++.+||++||++||.+|||++|+|+||||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             CCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            00                        001122457899999999999999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=424.70  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=212.0

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec--
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID--  363 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--  363 (627)
                      .++|+++++||+|+||+||+|.+..+++.||||++......     ......+.+|+.+|++++||||++++++|...  
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-----EGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-----TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-----hHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            48999999999999999999999999999999998654332     12235678999999999999999999998532  


Q ss_pred             -----CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         364 -----ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       364 -----~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                           .+.+|+|||||.++++..+......+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~---~~~kl  158 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD---GVLKL  158 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---SCEEE
T ss_pred             cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC---CcEEe
Confidence                 3457899999998888777777789999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+++.+.......   .......+||+.|+|||++.   ....|+.++|||||||+||||++|+.||........+.
T Consensus       159 ~dfg~~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~---~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~  232 (318)
T d3blha1         159 ADFGLARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLL---GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  232 (318)
T ss_dssp             CCCTTCEECCC--------CCCCCSCCSCGGGCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eecceeeecccccccc---cccccceecCHHHhhHHHHc---CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH
Confidence            9999998776443221   12233458999999999985   23468999999999999999999999998766555443


Q ss_pred             HHHHHhhhhcccc-CCC-------------------------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCC
Q psy4988         519 EENTILKATEVQF-ANK-------------------------PTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQP  570 (627)
Q Consensus       519 ~~~~~~~~~~~~~-~~~-------------------------~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~  570 (627)
                      ............. ...                         ...++++.+||.+||++||++|||+.|+|+||||+.
T Consensus       233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            3322221111000 000                         013678899999999999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=431.34  Aligned_cols=262  Identities=29%  Similarity=0.454  Sum_probs=208.5

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|+++++||+|+||+||+|.+..+++.||||++.....     .....+.+.+|+.+|+.++|||||+++++|....
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-----SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-----SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            67899999999999999999999999999999999864322     2234567899999999999999999999997433


Q ss_pred             -----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         365 -----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       365 -----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                           ..+||||||| +.+|..+++ ...+++..++.|+.||+.||.|||+++  ||||||||+|||++.+   +.+||+
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~---~~~kl~  163 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED---CELKIL  163 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEEC
T ss_pred             cccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc---cccccc
Confidence                 2578999999 456766654 468999999999999999999999998  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.....          ....+||+.|+|||++.   ....++.++|||||||+||+|++|++||...+....+..
T Consensus       164 Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~  230 (346)
T d1cm8a_         164 DFGLARQADSE----------MTGYVVTRWYRAPEVIL---NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  230 (346)
T ss_dssp             CCTTCEECCSS----------CCSSCSCGGGCCTHHHH---TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             cccceeccCCc----------cccccccccccCHHHHc---CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence            99999876542          23458999999999986   334678999999999999999999999987765544332


Q ss_pred             HHHHhhhh---------------------cc---c-cCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKAT---------------------EV---Q-FANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~~---------------------~~---~-~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........                     ..   . ......+++++.+||.+||++||.+|||+.|||+||||+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            22211100                     00   0 01124678999999999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=419.96  Aligned_cols=251  Identities=28%  Similarity=0.468  Sum_probs=201.4

Q ss_pred             EEecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeEEEE
Q psy4988         293 MLLGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       293 ~~LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      ++||+|+||+||+|.+..  +++.||||++.....     .....+.+++|+.+|++++|||||+++++|. + +.++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~-~~~~lv   85 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----DPALKDELLAEANVMQQLDNPYIVRMIGICE-A-ESWMLV   85 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S-SSEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-----CHHHHHHHHHHHHHHHhCCCCCCceEEEEec-c-CCEEEE
Confidence            469999999999998643  568899999854322     1223457899999999999999999999986 3 456799


Q ss_pred             EeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccccccC
Q psy4988         371 LEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEE  450 (627)
Q Consensus       371 ~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~  450 (627)
                      ||||++|+|.+++.....+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||+|+.+...
T Consensus        86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~---~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ---HYAKISDFGLSKALRAD  160 (277)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET---TEEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc---Ccccccchhhhhhcccc
Confidence            999999999999999899999999999999999999999988  9999999999999987   69999999999876543


Q ss_pred             CCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhhhhcc
Q psy4988         451 NYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTILKATEV  529 (627)
Q Consensus       451 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  529 (627)
                      ...    ........||+.|+|||++.    ...++.++|||||||+||||++ |+.||..........   .+...  .
T Consensus       161 ~~~----~~~~~~~~gt~~y~APE~l~----~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~---~i~~~--~  227 (277)
T d1xbba_         161 ENY----YKAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEKG--E  227 (277)
T ss_dssp             CSE----EEC----CCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHTT--C
T ss_pred             ccc----cccccccCCCceecCchhhc----CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH---HHHcC--C
Confidence            211    11233457999999999985    3458999999999999999997 899998765543321   12222  2


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH---hccCC
Q psy4988         530 QFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLA---RHDYL  568 (627)
Q Consensus       530 ~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL---~hp~~  568 (627)
                      ..+.+..+|+++.+||.+||+.||++|||+.+++   +|+|+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            3344567899999999999999999999999984   56554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=412.44  Aligned_cols=250  Identities=26%  Similarity=0.448  Sum_probs=195.5

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCC
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDAN  365 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~  365 (627)
                      .++|.+++.||+|+||+||+|.+. ++..||||++.......        +.+.+|+.++++++|||||+++++|. +.+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~--------~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~   73 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--------EDFIEEAEVMMKLSHPKLVQLYGVCL-EQA   73 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH--------HHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH--------HHHHHHHHHHHhcCCCCcccccceec-cCC
Confidence            368999999999999999999875 57789999986543221        35889999999999999999999997 556


Q ss_pred             eEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      .++||||||++|+|.+++... ..+++..++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||+|||++
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~---~~~Kl~DFGla  148 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN---QVIKVSDFGMT  148 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG---GCEEECSCC--
T ss_pred             ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC---CCeEecccchh
Confidence            788999999999999988654 57899999999999999999999988  9999999999999987   68999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHH
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYG-KKPFGHNQSQATILEENTI  523 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~  523 (627)
                      +.+......      ......||+.|+|||++.    ...|+.++|||||||+||||+++ .+||..... ..++..  +
T Consensus       149 ~~~~~~~~~------~~~~~~gt~~y~aPE~l~----~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~--i  215 (263)
T d1sm2a_         149 RFVLDDQYT------SSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVED--I  215 (263)
T ss_dssp             ----------------------CTTSCCHHHHT----TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHH--H
T ss_pred             eeccCCCce------eecceecCcccCChHHhc----CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHH--H
Confidence            877544321      123347999999999984    45689999999999999999995 555654443 333322  1


Q ss_pred             hhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         524 LKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       524 ~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ...  .....+..+++++.+||.+||+.||++|||+.++++|
T Consensus       216 ~~~--~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         216 STG--FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc--CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            111  2233445688999999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=427.26  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=209.5

Q ss_pred             CeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-----
Q psy4988         288 RYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI-----  362 (627)
Q Consensus       288 rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----  362 (627)
                      +|..+++||+|+||+||+|++..+++.||||++.....           .+.+|+.+|++++|||||+++++|..     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            69999999999999999999999999999999865432           13469999999999999999999853     


Q ss_pred             cCCeEEEEEeecCCCChHHHH---HhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         363 DANSFCTVLEYCDGHDLDFYL---KQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      +..++|||||||+++++..+.   .....+++.+++.|+.||+.||+|||+++  ||||||||+||||+.+.  ..+||+
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~--~~~kl~  165 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDT--AVLKLC  165 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTT--CCEEEC
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCC--CceeEe
Confidence            234578999999977544443   34568999999999999999999999988  99999999999998763  479999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++.+....        .....+||+.|+|||.+.   ....|+.++|||||||++|||++|+.||........+..
T Consensus       166 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~  234 (350)
T d1q5ka_         166 DFGSAKQLVRGE--------PNVSYICSRYYRAPELIF---GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE  234 (350)
T ss_dssp             CCTTCEECCTTS--------CCCSCCSCTTSCCHHHHT---TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred             cccchhhccCCc--------ccccccccccccChHHhh---cccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH
Confidence            999998775432        123458999999999875   345689999999999999999999999987776555443


Q ss_pred             HHHHhhh-------------hcccc----------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         520 ENTILKA-------------TEVQF----------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       520 ~~~~~~~-------------~~~~~----------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .......             ....+          ...+.+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus       235 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            3221110             00111          1234678999999999999999999999999999999754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=427.27  Aligned_cols=267  Identities=26%  Similarity=0.438  Sum_probs=211.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.+||+++++||+|+||+||+|.+..+++.||||++.....      ....+.+++|+.+|+.++|||||++++++..+.
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH------QTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC------hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            56899999999999999999999999999999999864322      233567899999999999999999999986432


Q ss_pred             ----CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         365 ----NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       365 ----~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                          ..+|+ ++|+.+++|.+++.. ..+++..++.|+.||+.||+|||+++  ||||||||+||||+.+   +.+||+|
T Consensus        80 ~~~~~~~~l-~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~---~~~kl~D  152 (345)
T d1pmea_          80 IEQMKDVYL-VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT---CDLKICD  152 (345)
T ss_dssp             TTTCCCEEE-EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT---CCEEECC
T ss_pred             ccccceEEE-EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC---CCEEEcc
Confidence                23444 556678999999875 47999999999999999999999998  9999999999999976   6999999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||+|+.........    ......+||+.|+|||++.   ....++.++||||+||++|+|++|+.||............
T Consensus       153 fG~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         153 FGLARVADPDHDHT----GFLTEYVATRWYRAPEIML---NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             CTTCEECCGGGCBC----CTTCCCCSCGGGCCGGGTT---TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cCceeeccCCCccc----eeeccccccceechHHHhh---cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            99998765543211    2234568999999999985   3446789999999999999999999999876654443322


Q ss_pred             HHHhhhhc----------------ccc---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATE----------------VQF---------ANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~----------------~~~---------~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........                ...         ...+.+++++++||.+||++||.+|||+.++|+||||...
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            21111000                000         0124678999999999999999999999999999999854

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=417.66  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=209.4

Q ss_pred             CCCeeEEEE-ecccCceEEEEEEEcC--CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLML-LGKGGFSEVHKAFDLK--EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~-LG~G~fG~Vy~a~~~~--~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .++|.+.+. ||+|+||+||+|.+..  ++..||||++.....      ....+.+.+|+++|++++|||||++++++. 
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-   79 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   79 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC------HHHHHHHHHHHHHHHhCCCCCEeeEeeeec-
Confidence            467888885 9999999999998754  456899999864332      223467899999999999999999999986 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      + +.+|||||||++|+|.+++... ..+++..+..|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+||
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~---~~~Kl~DF  153 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR---HYAKISDF  153 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET---TEEEECCC
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC---Cceeeccc
Confidence            3 4578999999999999987654 67999999999999999999999988  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+|+.+......    .......+||+.|+|||++.    ...++.++|||||||+||||++ |+.||........+.. 
T Consensus       154 Gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-  224 (285)
T d1u59a_         154 GLSKALGADDSY----YTARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-  224 (285)
T ss_dssp             TTCEECTTCSCE----ECCCCSSCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-
T ss_pred             hhhhcccccccc----cccccccccCccccChHHHh----CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence            999987643211    12233457999999999985    3458999999999999999997 9999987655433221 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH---HhccCCC
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISL---ARHDYLQ  569 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~el---L~hp~~~  569 (627)
                        +....  ..+.++.+++++.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       225 --i~~~~--~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         225 --IEQGK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --HHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHcCC--CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence              22222  234456799999999999999999999999888   5678763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-50  Score=422.38  Aligned_cols=258  Identities=24%  Similarity=0.435  Sum_probs=209.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeec-
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEID-  363 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~-  363 (627)
                      .|+|+++++||+|+||+||+|.++.+++.||||++....          .+++.+|+.+|+.+. ||||++++++|... 
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~  103 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKILENLRGGPNIITLADIVKDPV  103 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------HHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence            478999999999999999999999999999999985432          235788999999995 99999999999743 


Q ss_pred             CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccc
Q psy4988         364 ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGL  443 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGl  443 (627)
                      ...+++|||||.+++|..+.   +.+++.+++.|+.||+.||.|||+++  ||||||||+||||+.++  +.+||+|||+
T Consensus       104 ~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~--~~vkl~DFG~  176 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEH--RKLRLIDWGL  176 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT--TEEEECCGGG
T ss_pred             CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCC--Ceeeeccccc
Confidence            45688999999999987653   57999999999999999999999998  99999999999998753  4799999999


Q ss_pred             ccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HH
Q psy4988         444 SKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE-NT  522 (627)
Q Consensus       444 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~-~~  522 (627)
                      |+.+....        .....+||+.|+|||.+.   ....++.++|||||||++|+|++|+.||............ ..
T Consensus       177 a~~~~~~~--------~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~  245 (328)
T d3bqca1         177 AEFYHPGQ--------EYNVRVASRYFKGPELLV---DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  245 (328)
T ss_dssp             CEECCTTC--------CCCSCCSCGGGCCHHHHT---TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             ceeccCCC--------cccccccCccccCccccc---CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence            98775432        123458999999999985   2345799999999999999999999999765543322111 11


Q ss_pred             Hhhh---------h----------------------ccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         523 ILKA---------T----------------------EVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       523 ~~~~---------~----------------------~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ....         .                      .........+++++.+||++||++||.+|||+.|||+||||+..
T Consensus       246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            1000         0                      00111223578999999999999999999999999999999853

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=409.48  Aligned_cols=256  Identities=25%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      +++..++|++.+.||+|+||+||+|.+..+   +..||||++....      .......+.+|+.++++++|||||++++
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~l~~   75 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------SDSVREKFLQEALTMRQFDHPHIVKLIG   75 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            556778999999999999999999988764   3568888764322      1223457899999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      +|.  .+.+|+|||||++++|..++.. ...+++..++.++.||+.||.|||+.+  ||||||||+|||++.+   +.+|
T Consensus        76 ~~~--~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~---~~~K  148 (273)
T d1mp8a_          76 VIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN---DCVK  148 (273)
T ss_dssp             EEC--SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET---TEEE
T ss_pred             EEe--cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC---CcEE
Confidence            985  3567899999999999988754 457999999999999999999999988  9999999999999987   5899


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQAT  516 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~  516 (627)
                      |+|||+|+.+.....      .......||+.|+|||++.    ...++.++|||||||+||||++ |.+||........
T Consensus       149 l~DfG~a~~~~~~~~------~~~~~~~gt~~y~apE~l~----~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~  218 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV  218 (273)
T ss_dssp             ECC-------------------------CCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EccchhheeccCCcc------eeccceecCcccchhhHhc----cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999987654321      1234457899999999985    4458999999999999999997 8999987665544


Q ss_pred             HHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         517 ILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       517 ~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +..   +..  ....+.++.+|+++.+||.+||+.||.+|||+.+|++|
T Consensus       219 ~~~---i~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         219 IGR---IEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHH---HHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHH---HHc--CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            322   111  12334567899999999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=404.58  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=209.1

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCe
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANS  366 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  366 (627)
                      ++|+++++||+|+||+||+|.+ .+++.||||++.......        ..+++|+.++++++|||||+++++|. +.+.
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~--------~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~   73 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE--------DEFIEEAKVMMNLSHEKLVQLYGVCT-KQRP   73 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH--------HHHHHHHHHHHTCCCTTBCCEEEEEC-CSSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH--------HHHHHHHHHHHhcCCCceeeEEEEEe-eCCc
Confidence            5788899999999999999997 578899999987544321        35889999999999999999999997 5677


Q ss_pred             EEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         367 FCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       367 ~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +++|||||++|+|..++.. ...+++..++.|+.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||+++
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~---~~~kl~DfG~a~  148 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ---GVVKVSDFGLSR  148 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT---CCEEECCCSSCC
T ss_pred             eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC---CcEEECcchhhe
Confidence            8899999999999998654 467999999999999999999999988  9999999999999987   689999999998


Q ss_pred             ccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q psy4988         446 VMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       446 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      .+......      ......||+.|+|||++.    ...++.++|||||||++|||+| |+.||......+....   +.
T Consensus       149 ~~~~~~~~------~~~~~~~t~~y~aPE~~~----~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i~  215 (258)
T d1k2pa_         149 YVLDDEYT------SSVGSKFPVRWSPPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IA  215 (258)
T ss_dssp             BCSSSSCC------CCCCSCCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---HH
T ss_pred             eccCCCce------eecccCCCCCcCCcHHhc----CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---HH
Confidence            77654322      122347999999999985    3458999999999999999998 8999987765543321   22


Q ss_pred             hhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         525 KATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       525 ~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      ..  ...+.+..+++++.+||.+||+.||++|||+.++++|
T Consensus       216 ~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         216 QG--LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hC--CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            22  2334456788999999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=409.11  Aligned_cols=261  Identities=22%  Similarity=0.332  Sum_probs=206.9

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVF  360 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~  360 (627)
                      .+++-.++|++.+.||+|+||+||+|.+..+ ..||||++......        .+.+.+|+.++++++|||||+++++|
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--------~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--------PEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--------HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            3455668899999999999999999987655 67999998644321        13588999999999999999999998


Q ss_pred             eecCCeEEEEEeecCCCChHHHHHh--ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEE
Q psy4988         361 EIDANSFCTVLEYCDGHDLDFYLKQ--HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKI  438 (627)
Q Consensus       361 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL  438 (627)
                      . + +.+++|||||++|+|..++..  ...+++.+++.|+.||+.||.|||+.+  ||||||||+||||+.+   +.+||
T Consensus        82 ~-~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~---~~~kl  154 (285)
T d1fmka3          82 S-E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN---LVCKV  154 (285)
T ss_dssp             C-S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG---GCEEE
T ss_pred             e-c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC---CcEEE
Confidence            5 4 346799999999999988754  357999999999999999999999988  9999999999999987   68999


Q ss_pred             eecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q psy4988         439 TDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATIL  518 (627)
Q Consensus       439 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~  518 (627)
                      +|||+|+.+.....      .......||+.|+|||++.    ...++.++||||||||||||++|..||........++
T Consensus       155 ~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~----~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~  224 (285)
T d1fmka3         155 ADFGLARLIEDNEY------TARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL  224 (285)
T ss_dssp             CCCCTTC--------------------CCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred             cccchhhhccCCCc------eeeccccccccccChHHHh----CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999987654321      1123357999999999995    3458999999999999999999766665544444443


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh--ccCCCCC
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR--HDYLQPP  571 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~--hp~~~~~  571 (627)
                      ...  ..  ....+.+..+++++++||.+||+.||++||++.+|+.  |+||...
T Consensus       225 ~~i--~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         225 DQV--ER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHH--HT--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHH--Hh--cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            321  11  2234556789999999999999999999999999988  8999643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=405.94  Aligned_cols=258  Identities=20%  Similarity=0.306  Sum_probs=200.8

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcCCC----eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ----RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~----~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      ++-.+.|.+.++||+|+||+||+|.+..++    ..||||++......      .....+++|+.++++++|||||++++
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~E~~il~~l~H~nIv~~~g   76 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE------KQRVDFLGEAGIMGQFSHHNIIRLEG   76 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh------HHHHHHHHHHHHHHhcCCCCEeeeeE
Confidence            345578999999999999999999877654    57999998643321      22356889999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      ++. +...+++|||||.++++.+++... ..+++.++..|+.||+.||.|||+.+  ||||||||+||||+.+   +.+|
T Consensus        77 ~~~-~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~---~~~K  150 (283)
T d1mqba_          77 VIS-KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN---LVCK  150 (283)
T ss_dssp             EEC-SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEE
T ss_pred             EEe-cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC---CeEE
Confidence            987 667788999999999999887654 68999999999999999999999988  9999999999999987   6999


Q ss_pred             EeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q psy4988         438 ITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATI  517 (627)
Q Consensus       438 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~  517 (627)
                      |+|||+|+.+......    ........||+.|+|||++.    ...++.++|||||||+||||++|..||........+
T Consensus       151 l~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~l~----~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~  222 (283)
T d1mqba_         151 VSDFGLSRVLEDDPEA----TYTTSGGKIPIRWTAPEAIS----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV  222 (283)
T ss_dssp             ECCCCC---------------------CCCGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             EcccchhhcccCCCcc----ceEeccCCCCccccCHHHHc----cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH
Confidence            9999999887543211    11223347899999999984    446899999999999999999976665444444444


Q ss_pred             HHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         518 LEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       518 ~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      +..  +.  .....+.+..++.++.+||.+||..||++|||+.+|++
T Consensus       223 ~~~--i~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         223 MKA--IN--DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHH--HH--TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHH--Hh--ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            322  11  12334455678999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=420.03  Aligned_cols=263  Identities=27%  Similarity=0.399  Sum_probs=208.7

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeec-
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEID-  363 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  363 (627)
                      +.+||+++++||+|+||+||+|++..+++.||||++......     ....+.+.+|+.+|+.++|||||+++++|... 
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----IIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            368999999999999999999999999999999998654321     22245688999999999999999999998532 


Q ss_pred             ---CCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEee
Q psy4988         364 ---ANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITD  440 (627)
Q Consensus       364 ---~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~D  440 (627)
                         ....++||+|+.+++|.+++.. +.+++.+++.|+.||+.||.|||+++  ||||||||+|||++.+   +.+||+|
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~---~~~kl~d  164 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED---CELKILD  164 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---CCEEECC
T ss_pred             ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc---ccccccc
Confidence               2233466777889999998854 57999999999999999999999998  9999999999999987   6899999


Q ss_pred             cccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q psy4988         441 FGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEE  520 (627)
Q Consensus       441 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~  520 (627)
                      ||++......          .....||+.|+|||++.   ....++.++|||||||+||+|++|+.||...+........
T Consensus       165 fg~a~~~~~~----------~~~~~g~~~y~apE~~~---~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i  231 (348)
T d2gfsa1         165 FGLARHTDDE----------MTGYVATRWYRAPEIML---NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  231 (348)
T ss_dssp             C----CCTGG----------GSSSCHHHHTSCHHHHT---TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cchhcccCcc----------cccccccccccCchhhc---CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999765432          23458999999999875   3445789999999999999999999999876654443222


Q ss_pred             HHHhhhhc-------------------cccC------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         521 NTILKATE-------------------VQFA------NKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       521 ~~~~~~~~-------------------~~~~------~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      ........                   ...+      ....+++++++||++||++||.+|||+.|||+||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            11111000                   0000      123578999999999999999999999999999999853

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=410.99  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=201.6

Q ss_pred             CccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEE
Q psy4988         283 PVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKL  356 (627)
Q Consensus       283 ~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l  356 (627)
                      ++-.++|++.++||+|+||.||+|.+..     +++.||||++.....      ....+.+++|+.++.++ +|+|||.+
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C------HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------cHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            3556889999999999999999998754     457899999754322      12235677888888776 68999999


Q ss_pred             eeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccc
Q psy4988         357 YDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDL  420 (627)
Q Consensus       357 ~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDL  420 (627)
                      ++++..+...+++|||||++|+|.+++...                ..+++.+++.|+.||+.||.|||+++  ||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl  160 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL  160 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence            999876677789999999999999999753                24899999999999999999999988  999999


Q ss_pred             cCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHH
Q psy4988         421 KPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQ  500 (627)
Q Consensus       421 KP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~e  500 (627)
                      ||+||||+.+   +.+||+|||+|+........     ......+||+.|+|||++.    ...++.++|||||||+|||
T Consensus       161 Kp~NILl~~~---~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~----~~~~~~~sDiwS~Gvil~e  228 (299)
T d1ywna1         161 AARNILLSEK---NVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWE  228 (299)
T ss_dssp             CGGGEEECGG---GCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHH----HCCCCHHHHHHHHHHHHHH
T ss_pred             CccceeECCC---CcEEEccCcchhhccccccc-----cccCceeeCccccchhHhh----cCCCCcccceeehHHHHHH
Confidence            9999999876   69999999999876543211     2234568999999999985    3458999999999999999


Q ss_pred             HHhC-CCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         501 CLYG-KKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       501 lltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      |++| .+||........+....  ..  ...++.+..+++++.+||.+||+.||++|||+.++++|
T Consensus       229 llt~~~~p~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         229 IFSLGASPYPGVKIDEEFCRRL--KE--GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHTTSCCSSTTCCCSHHHHHHH--HH--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHH--hc--CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9986 56787655544433221  11  22334455789999999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=419.46  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=215.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEc---CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEe
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDL---KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH-PRVVKLYDVFE  361 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~---~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~  361 (627)
                      .++|++++.||+|+||+||+|.+.   .+++.||||++.........   ...+.+.+|+.++++++| |||+++++++.
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~---~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE---SSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch---HHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            478999999999999999999874   46899999998644321111   112357789999999976 89999999998


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                       +...+++|||||.+++|..++...+.+++..++.++.||+.||.|||+.+  ||||||||+||||+.+   +.+||+||
T Consensus       100 -~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~---~~vkL~DF  173 (322)
T d1vzoa_         100 -TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN---GHVVLTDF  173 (322)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT---SCEEESCS
T ss_pred             -cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC---CCEEEeec
Confidence             66788899999999999999999999999999999999999999999998  9999999999999987   68999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEEN  521 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~  521 (627)
                      |+|+.+.....      .......|++.|+|||.+...  ...++.++|||||||+||+|++|+.||.............
T Consensus       174 G~a~~~~~~~~------~~~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         174 GLSKEFVADET------ERAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             SEEEECCGGGG------GGGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             cchhhhccccc------ccccccccccccchhHHhhcC--CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99987654321      223445899999999998532  3357889999999999999999999997655433332221


Q ss_pred             HHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHhccCCCC
Q psy4988         522 TILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRI-----DVISLARHDYLQP  570 (627)
Q Consensus       522 ~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rp-----t~~elL~hp~~~~  570 (627)
                      ...  .....+.+..+|+++.+||.+||++||.+||     |++|+++||||+.
T Consensus       246 ~~~--~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         246 RRI--LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHH--HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             Hhc--ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            111  1223334457999999999999999999999     5899999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=409.03  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=200.0

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCe----EEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQR----YVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~----~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      ++|+++++||+|+||+||+|.+..+++    .||||.+.....      ....+.+.+|+.++++++|||||+++++|. 
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-   81 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------PKANKEILDEAYVMASVDNPHVCRLLGICL-   81 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            469999999999999999999988876    477776643211      122457899999999999999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      +. ..++||||+.+++|.+++.. ...+++..++.|+.||+.||.|||+++  ||||||||+||||+.+   +.+||+||
T Consensus        82 ~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~---~~~kl~DF  155 (317)
T d1xkka_          82 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP---QHVKITDF  155 (317)
T ss_dssp             SS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET---TEEEECCC
T ss_pred             cC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC---CCeEeecc
Confidence            43 45688999999999887765 468999999999999999999999988  9999999999999987   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+|+.+......     .......||+.|+|||++..    ..|+.++|||||||+||||+| |.+||......... ..
T Consensus       156 Gla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~----~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~  225 (317)
T d1xkka_         156 GLAKLLGAEEKE-----YHAEGGKVPIKWMALESILH----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI  225 (317)
T ss_dssp             SHHHHTTTTCC-------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HH
T ss_pred             ccceeccccccc-----ccccccccCccccChHHHhc----CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HH
Confidence            999987643321     12334478999999999853    358999999999999999998 89999766544332 11


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhcc
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARHD  566 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~hp  566 (627)
                        +..  ....+.++.+++++.+||.+||..||.+|||+.+++.|-
T Consensus       226 --i~~--~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         226 --LEK--GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             --HHH--TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --HHc--CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence              111  223445567999999999999999999999999999873

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=415.91  Aligned_cols=261  Identities=24%  Similarity=0.339  Sum_probs=200.4

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI--  362 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--  362 (627)
                      +.++|+++++||+|+||+||+|.+..+++.||||++......     ......+.+|+.+++.++|||||+++++|..  
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-----QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-----HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            458899999999999999999999999999999998754321     2234578899999999999999999999963  


Q ss_pred             ---cCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         363 ---DANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       363 ---~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                         +...+|+|||||.++++..+   ...+++..++.++.||+.||.|||++|  ||||||||+|||++.+   +.+||+
T Consensus        90 ~~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~---~~~kl~  161 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD---CTLKIL  161 (355)
T ss_dssp             STTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT---CCEEEC
T ss_pred             ccccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc---cceeee
Confidence               23678999999987655443   357999999999999999999999998  9999999999999987   589999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+++......        .....+||+.|+|||++.    +..++.++||||+||++|+|++|++||...+.......
T Consensus       162 df~~~~~~~~~~--------~~~~~~~t~~y~aPE~l~----~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~  229 (355)
T d2b1pa1         162 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_dssp             CCCC-----------------------CCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             chhhhhcccccc--------ccccccccccccChhhhc----CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence            999998765432        223457999999999984    45689999999999999999999999977665544332


Q ss_pred             HHHHhhhh------------------cccc--------------C----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q psy4988         520 ENTILKAT------------------EVQF--------------A----NKPTVSNEAKGFIRSCLAYRKEDRIDVISLA  563 (627)
Q Consensus       520 ~~~~~~~~------------------~~~~--------------~----~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL  563 (627)
                      ........                  ....              +    ....+++++.+||++||.+||++|||+.|||
T Consensus       230 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            21111000                  0000              0    0012467899999999999999999999999


Q ss_pred             hccCCCC
Q psy4988         564 RHDYLQP  570 (627)
Q Consensus       564 ~hp~~~~  570 (627)
                      +||||+.
T Consensus       310 ~Hpw~~~  316 (355)
T d2b1pa1         310 QHPYINV  316 (355)
T ss_dssp             TSTTTGG
T ss_pred             cCcccCC
Confidence            9999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-48  Score=403.20  Aligned_cols=269  Identities=19%  Similarity=0.216  Sum_probs=207.9

Q ss_pred             cCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC
Q psy4988         285 LSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA  364 (627)
Q Consensus       285 l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  364 (627)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++......         ..+.+|+++++.++|+|+|.++..+..+.
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---------PQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---------HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            568999999999999999999999999999999998654321         23678999999999888776666665678


Q ss_pred             CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccc
Q psy4988         365 NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLS  444 (627)
Q Consensus       365 ~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla  444 (627)
                      +.+++|||||+++.+..+......+++..+..++.||+.||+|||+++  ||||||||+|||++..+....+||+|||+|
T Consensus        76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcc
Confidence            889999999976544544555678999999999999999999999988  999999999999876544468999999999


Q ss_pred             cccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q psy4988         445 KVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTIL  524 (627)
Q Consensus       445 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~  524 (627)
                      +.+.................+||+.|+|||++.    +..++.++|||||||+||||++|+.||................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT----TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHh----CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            988755433222223345568999999999984    4568999999999999999999999997655443332211111


Q ss_pred             hh--hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH---HHhccCC
Q psy4988         525 KA--TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVIS---LARHDYL  568 (627)
Q Consensus       525 ~~--~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~e---lL~hp~~  568 (627)
                      ..  ..........+|+++.+||.+||..||++||++.+   +|+|+|.
T Consensus       230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            11  00001123468999999999999999999999875   5677764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=397.05  Aligned_cols=249  Identities=22%  Similarity=0.356  Sum_probs=199.7

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFE  361 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  361 (627)
                      |++-.++|++.+.||+|+||.||+|.+  .+..||||++.....         .+.+.+|+.++++++|||||+++++|.
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~   70 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT---------AQAFLAEASVMTQLRHSNLVQLLGVIV   70 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHH---------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345567899999999999999999986  478999999864321         245889999999999999999999886


Q ss_pred             ecCCeEEEEEeecCCCChHHHHHhc--cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEe
Q psy4988         362 IDANSFCTVLEYCDGHDLDFYLKQH--KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKIT  439 (627)
Q Consensus       362 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~  439 (627)
                      .+.+.+|||||||++|+|.+++...  ..+++..++.|+.||+.||.|||+.+  ||||||||+|||++.+   +.+||+
T Consensus        71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~---~~~kl~  145 (262)
T d1byga_          71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED---NVAKVS  145 (262)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT---SCEEEC
T ss_pred             ecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC---CCEeec
Confidence            4556688999999999999998654  35999999999999999999999988  9999999999999987   689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATIL  518 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~  518 (627)
                      |||+++.....          .....+|+.|+|||++..    ..++.++|||||||+||||++ |++||........+.
T Consensus       146 dfg~s~~~~~~----------~~~~~~~~~y~aPE~l~~----~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~  211 (262)
T d1byga_         146 DFGLTKEASST----------QDTGKLPVKWTAPEALRE----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  211 (262)
T ss_dssp             CCCC----------------------CCTTTSCHHHHHH----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred             ccccceecCCC----------CccccccccCCChHHHhC----CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            99999875432          233478999999999853    458999999999999999998 788887665554332


Q ss_pred             HHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         519 EENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       519 ~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .   +...  ...+.+..+++++.+||.+||..||.+|||+.+++++
T Consensus       212 ~---i~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         212 R---VEKG--YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             H---HTTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H---HHcC--CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            2   2222  2334455789999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-48  Score=403.17  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=207.3

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYD  358 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~  358 (627)
                      .-.++|++++.||+|+||+||+|.+.     .+++.||||++.....      ....+.+.+|+.+++.++|||||++++
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------ADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC------hHHHHHHHHHHHHHHhcCCCCccccee
Confidence            34678999999999999999999875     3568999999864332      223457899999999999999999999


Q ss_pred             EEeecCCeEEEEEeecCCCChHHHHHhcc------------------------CcCHHHHHHHHHHHHHHHHHHHhCCCC
Q psy4988         359 VFEIDANSFCTVLEYCDGHDLDFYLKQHK------------------------TIAEREARSIVMQVVSALKYLNEIKPP  414 (627)
Q Consensus       359 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------~l~e~~~~~i~~qi~~aL~yLH~~~~~  414 (627)
                      +|. +.+.+++||||+++++|.+++....                        .+++..++.|+.||+.||.|||+.+  
T Consensus        84 ~~~-~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--  160 (301)
T d1lufa_          84 VCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--  160 (301)
T ss_dssp             EEC-SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eec-cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--
Confidence            997 5677889999999999999986432                        4899999999999999999999988  


Q ss_pred             EEeccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHH
Q psy4988         415 VIHYDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSV  494 (627)
Q Consensus       415 IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSl  494 (627)
                      ||||||||+||||+.+   +.+||+|||+|+.+......     ......+||+.|+|||++.    ...|+.++|||||
T Consensus       161 ivHrDlKp~NILld~~---~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~----~~~~t~ksDVwS~  228 (301)
T d1lufa_         161 FVHRDLATRNCLVGEN---MVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIF----YNRYTTESDVWAY  228 (301)
T ss_dssp             CCCSCCSGGGEEECGG---GCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHH----HCCCCHHHHHHHH
T ss_pred             eEeeEEcccceEECCC---CcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHc----cCCCChhhhhccc
Confidence            9999999999999986   68999999999876543211     2234557999999999995    4568999999999


Q ss_pred             HHHHHHHHhCC-CCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         495 GVIFYQCLYGK-KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       495 GviL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      |||||||++|. +||......+.+..   +...  ...+.+..+++++.+||.+||+.||.+|||+.+|++
T Consensus       229 Gvvl~ell~~~~~p~~~~~~~e~~~~---v~~~--~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         229 GVVLWEIFSYGLQPYYGMAHEEVIYY---VRDG--NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHH---HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHccCCCCCCCCCHHHHHHH---HHcC--CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999985 57766655443322   1111  123345678999999999999999999999999965

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=397.43  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCC---CeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKE---QRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~---~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  362 (627)
                      .++|++++.||+|+||+||+|.+..+   ...||||++.....    ......+.+.+|+.++++++|||||+++++|. 
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-   81 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL----SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-   81 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence            35699999999999999999976543   34789998754332    12234567899999999999999999999996 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHh-ccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeec
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQ-HKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDF  441 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DF  441 (627)
                      + +.+++|||||++++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||||+.+   +.+||+||
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~---~~vkl~Df  155 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR---DLVKIGDF  155 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET---TEEEECCC
T ss_pred             e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc---cceeeccc
Confidence            4 356799999999999887654 457999999999999999999999988  9999999999999987   58999999


Q ss_pred             ccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q psy4988         442 GLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLY-GKKPFGHNQSQATILEE  520 (627)
Q Consensus       442 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~  520 (627)
                      |+++.+......    ........||+.|+|||++.    ...++.++|||||||+||||++ |..||...+....+.. 
T Consensus       156 Gl~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~----~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~-  226 (273)
T d1u46a_         156 GLMRALPQNDDH----YVMQEHRKVPFAWCAPESLK----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-  226 (273)
T ss_dssp             TTCEECCC-CCE----EEC-----CCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred             hhhhhcccCCCc----ceecCccccCcccCCHHHHh----CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH-
Confidence            999987543211    12233456889999999995    3458999999999999999997 8999987666554322 


Q ss_pred             HHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         521 NTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       521 ~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                        + ......++.+..+|+++.+||.+||..||++|||+.+|++
T Consensus       227 --i-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         227 --I-DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --H-HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --H-HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              1 1223344556789999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=401.69  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=202.2

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeE--EEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeEEeeEEee
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRY--VACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVKLYDVFEI  362 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~--VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~  362 (627)
                      .++|++.++||+|+||+||+|.+..++..  ||||.+.....      ....+.+.+|+++|+++ +|||||+++++|. 
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-   81 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------KDDHRDFAGELEVLCKLGHHPNIINLLGACE-   81 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------CHHHHHHHHHTTCCCCTTBCCEEEEEE-
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC------hHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-
Confidence            37899999999999999999999988876  55555432211      12245689999999998 7999999999997 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEE
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNIL  426 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NIL  426 (627)
                      +.+.+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+.+  ||||||||+|||
T Consensus        82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL  159 (309)
T d1fvra_          82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNIL  159 (309)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEE
Confidence            667889999999999999999654                57999999999999999999999988  999999999999


Q ss_pred             ecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCC-
Q psy4988         427 LTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK-  505 (627)
Q Consensus       427 l~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~-  505 (627)
                      ++.+   +.+||+|||+|+.......        .....||+.|+|||++.    ...++.++||||||||||||++|. 
T Consensus       160 ~~~~---~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~----~~~~~~~sDvwSfGvil~ell~~~~  224 (309)
T d1fvra_         160 VGEN---YVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGG  224 (309)
T ss_dssp             ECGG---GCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             EcCC---CceEEcccccccccccccc--------ccceecCCcccchHHhc----cCCCCccceeehhHHHHHHHHhcCC
Confidence            9987   5899999999986654321        22347899999999995    345899999999999999999975 


Q ss_pred             CCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         506 KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       506 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      +||...+... +...  +...  ..++.+..+++++++||.+||+.||++|||+.+|++|
T Consensus       225 ~p~~~~~~~~-~~~~--i~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         225 TPYCGMTCAE-LYEK--LPQG--YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CTTTTCCHHH-HHHH--GGGT--CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHH-HHHH--HHhc--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5676554333 3221  2222  2344556799999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=397.03  Aligned_cols=257  Identities=23%  Similarity=0.404  Sum_probs=206.8

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEcCCC-------eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCce
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDLKEQ-------RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRV  353 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~-------~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI  353 (627)
                      +++-.++|.+.+.||+|+||.||+|.+..++       ..||||++.....      ......+.+|+.++.++ +||||
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~e~~~l~~~~~HpnI   81 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------EKDLSDLISEMEMMKMIGKHKNI   81 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC------HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC------hHHHHHHHHHHHHHHHhcCCCeE
Confidence            5567889999999999999999999876654       4799999864432      22345688899999888 79999


Q ss_pred             eEEeeEEeecCCeEEEEEeecCCCChHHHHHhc----------------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         354 VKLYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------------KTIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       354 V~l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      |+++++|. +...+++|||||.+|+|.+++...                ..+++.+++.++.||+.||.|||+.+  |||
T Consensus        82 v~~~~~~~-~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivH  158 (299)
T d1fgka_          82 INLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH  158 (299)
T ss_dssp             CCEEEEEC-SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             Eecccccc-cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEe
Confidence            99999998 566788999999999999999754                35899999999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.+||+|||+++........     ......+||+.|+|||++.    ...|+.++||||||||
T Consensus       159 rDiKp~NiLl~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~----~~~y~~k~DiwS~Gvv  226 (299)
T d1fgka_         159 RDLAARNVLVTED---NVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVL  226 (299)
T ss_dssp             SCCSGGGEEECTT---CCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHH----HCCCCHHHHHHHHHHH
T ss_pred             eeecccceeecCC---CCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhc----CCCCCchhhhHHhHHH
Confidence            9999999999987   68999999999987654322     1234457999999999985    3468999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ||||++ |.+||........+ .  .+..  ...++.+..+++++.+||.+||++||.+|||+.+|++
T Consensus       227 l~ell~~g~~p~~~~~~~~~~-~--~i~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         227 LWEIFTLGGSPYPGVPVEELF-K--LLKE--GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTSCCSSTTCCHHHHH-H--HHHT--TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHH-H--HHHc--CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            999997 78899766554332 1  1222  2334455679999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=396.53  Aligned_cols=258  Identities=21%  Similarity=0.327  Sum_probs=209.6

Q ss_pred             CCccCCCeeEEEEecccCceEEEEEEEc-----CCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcC-CCCceeE
Q psy4988         282 HPVLSDRYLLLMLLGKGGFSEVHKAFDL-----KEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKAL-DHPRVVK  355 (627)
Q Consensus       282 ~~~l~~rY~i~~~LG~G~fG~Vy~a~~~-----~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIV~  355 (627)
                      +++-.++|++.++||+|+||.||+|.+.     .+++.||||++......      .....+.+|+.+++++ +|||||+
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~E~~~~~~l~~HpnIv~   91 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL------TEREALMSELKVLSYLGNHMNIVN   91 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH------HHHHHHHHHHHHHHhccCCCCEEE
Confidence            4566789999999999999999999853     46789999998654331      2235688999999999 6999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhcc------------------CcCHHHHHHHHHHHHHHHHHHHhCCCCEEe
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQHK------------------TIAEREARSIVMQVVSALKYLNEIKPPVIH  417 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qi~~aL~yLH~~~~~IvH  417 (627)
                      ++++|. +...++||||||++++|.+++....                  .+++..++.|+.||+.||.|||+++  |||
T Consensus        92 ~~g~~~-~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivH  168 (311)
T d1t46a_          92 LLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH  168 (311)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             EEEEEe-eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence            999997 5667889999999999999987543                  5899999999999999999999988  999


Q ss_pred             ccccCCcEEecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHH
Q psy4988         418 YDLKPGNILLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVI  497 (627)
Q Consensus       418 rDLKP~NILl~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGvi  497 (627)
                      |||||+|||++.+   +.+||+|||+++.+.....     .......+||+.|+|||++.    ...++.++|||||||+
T Consensus       169 rDLKp~NIl~~~~---~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DIwS~G~~  236 (311)
T d1t46a_         169 RDLAARNILLTHG---RITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGIF  236 (311)
T ss_dssp             SCCSGGGEEEETT---TEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHH
T ss_pred             ccccccccccccc---CcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhc----CCCCCCcccccchHHH
Confidence            9999999999887   6899999999997754321     12234458999999999985    3458999999999999


Q ss_pred             HHHHHh-CCCCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         498 FYQCLY-GKKPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       498 L~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ||||++ |.+||........+...  +..  ......+..+++++.+||.+||++||.+|||+.+|++
T Consensus       237 l~ellt~g~p~~~~~~~~~~~~~~--i~~--~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         237 LWELFSLGSSPYPGMPVDSKFYKM--IKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHTTTCCSSTTCCSSHHHHHH--HHH--TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHH--Hhc--CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999998 56666554444333221  111  2233344578999999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-47  Score=394.72  Aligned_cols=258  Identities=20%  Similarity=0.321  Sum_probs=209.6

Q ss_pred             CCCccCCCeeEEEEecccCceEEEEEEEcC-----CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeE
Q psy4988         281 NHPVLSDRYLLLMLLGKGGFSEVHKAFDLK-----EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVK  355 (627)
Q Consensus       281 ~~~~l~~rY~i~~~LG~G~fG~Vy~a~~~~-----~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~  355 (627)
                      .+++..++|.+.+.||+|+||+||+|.+..     +++.||||++......      .....+.+|+.++++++|||||+
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~   87 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM------RERIEFLNEASVMKEFNCHHVVR   87 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH------HHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh------HHHHHHHHHHHHHHHcCCCCEee
Confidence            356677999999999999999999998753     4678999998643321      12346889999999999999999


Q ss_pred             EeeEEeecCCeEEEEEeecCCCChHHHHHhc----------cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcE
Q psy4988         356 LYDVFEIDANSFCTVLEYCDGHDLDFYLKQH----------KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNI  425 (627)
Q Consensus       356 l~~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NI  425 (627)
                      ++++|. ..+.+++|||||.+|+|.+++...          ..+++..+..|+.||+.||.|||+.+  ||||||||+||
T Consensus        88 ~~~~~~-~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~Ni  164 (308)
T d1p4oa_          88 LLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNC  164 (308)
T ss_dssp             EEEEEC-SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGE
T ss_pred             eeeEEe-cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCce
Confidence            999997 566778999999999999988643          24689999999999999999999988  99999999999


Q ss_pred             EecCCCcccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCC
Q psy4988         426 LLTEGNVCGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGK  505 (627)
Q Consensus       426 Ll~~~~~~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~  505 (627)
                      ||+.+   +++||+|||+|+.+.....     ........||+.|+|||++.    ...++.++|||||||+||||++|.
T Consensus       165 Lld~~---~~~Kl~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~----~~~~~~~~Dv~S~G~il~El~t~~  232 (308)
T d1p4oa_         165 MVAED---FTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATLA  232 (308)
T ss_dssp             EECTT---CCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             eecCC---ceEEEeecccceeccCCcc-----eeeccceecccccCCHHHHc----cCCCCcccccccHHHHHHHHHhCC
Confidence            99987   5899999999987754321     12234457899999999985    345889999999999999999984


Q ss_pred             -CCCCCCChHHHHHHHHHHhhhhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         506 -KPFGHNQSQATILEENTILKATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       506 -~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                       +||........+ ..  +...  ...+.+..+++.+.+||.+||+.||.+|||+.+|++
T Consensus       233 ~~p~~~~~~~~~~-~~--i~~~--~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         233 EQPYQGLSNEQVL-RF--VMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCTTTTSCHHHHH-HH--HHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHH-HH--HHhC--CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             777665544433 21  2221  223345678999999999999999999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=390.59  Aligned_cols=253  Identities=22%  Similarity=0.312  Sum_probs=201.5

Q ss_pred             EEEEecccCceEEEEEEEcCCC---eEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecCCeE
Q psy4988         291 LLMLLGKGGFSEVHKAFDLKEQ---RYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDANSF  367 (627)
Q Consensus       291 i~~~LG~G~fG~Vy~a~~~~~~---~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  367 (627)
                      +.++||+|+||+||+|.+..++   ..||||++.....      ......+.+|+++|++++|||||++++++......+
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC------HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence            3678999999999999986643   4689998753322      223467999999999999999999999987566788


Q ss_pred             EEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         368 CTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       368 ~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++|||||++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+||||+.+   +.+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~---~~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK---FTVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT---CCEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC---CCEEEecccchhh
Confidence            9999999999999988754 46889999999999999999999988  9999999999999987   5899999999998


Q ss_pred             cccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhhh
Q psy4988         447 MDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILEENTILKA  526 (627)
Q Consensus       447 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~  526 (627)
                      +.......   ........||+.|+|||++.    ...++.++|||||||+||||++|..||........+...  +...
T Consensus       180 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~--i~~g  250 (311)
T d1r0pa_         180 MYDKEFDS---VHNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--LLQG  250 (311)
T ss_dssp             TTTTTCCC---TTCTTCSSCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH--HHTT
T ss_pred             cccccccc---ceecccccccccccChHHHh----cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH--HHcC
Confidence            76543221   11223457899999999985    345899999999999999999988888655444333222  1222


Q ss_pred             hccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         527 TEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       527 ~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                        .....+..+++++.+||.+||..||++||++.|+++|
T Consensus       251 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         251 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence              2333446789999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-46  Score=383.91  Aligned_cols=264  Identities=17%  Similarity=0.207  Sum_probs=206.1

Q ss_pred             ccCCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEee
Q psy4988         284 VLSDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDH-PRVVKLYDVFEI  362 (627)
Q Consensus       284 ~l~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~  362 (627)
                      ++.++|++.++||+|+||+||+|.+..+++.||||++......         ..+.+|+++++.|.| +||+.+++++. 
T Consensus         2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~e~~~~~~l~~~~~i~~~~~~~~-   71 (293)
T d1csna_           2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---------PQLRDEYRTYKLLAGCTGIPNVYYFGQ-   71 (293)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---------CCHHHHHHHHHHTTTCTTCCCEEEEEE-
T ss_pred             CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---------HHHHHHHHHHHHhcCCCCCCEEEEEee-
Confidence            5778999999999999999999999999999999997654321         135678888888865 89999999887 


Q ss_pred             cCCeEEEEEeecCCCChHHHHHhc-cCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCC--cccceEEe
Q psy4988         363 DANSFCTVLEYCDGHDLDFYLKQH-KTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGN--VCGEIKIT  439 (627)
Q Consensus       363 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~--~~g~vKL~  439 (627)
                      +...+++||||| +++|.+++... ..+++..+..|+.|++.||.|||+++  ||||||||+||||+...  ..+.+||+
T Consensus        72 ~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          72 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             cCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEc
Confidence            667788999999 57888887654 57999999999999999999999998  99999999999997532  23689999


Q ss_pred             ecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q psy4988         440 DFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQATILE  519 (627)
Q Consensus       440 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~~~~~~  519 (627)
                      |||+|+.+.................+||+.|+|||++.    +..++.++|||||||++|||++|+.||.+.........
T Consensus       149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~----~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~  224 (293)
T d1csna_         149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  224 (293)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             ccceeEEcccCccccceeecccCceEEchhhcCHHHhc----CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence            99999987654322222223344568999999999984    45689999999999999999999999975443322111


Q ss_pred             HHHHhh--hhccccCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHh
Q psy4988         520 ENTILK--ATEVQFANKPTVSNEAKGFIRSCLAYRKEDRIDVISLAR  564 (627)
Q Consensus       520 ~~~~~~--~~~~~~~~~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~  564 (627)
                      ...+..  ...........+|+++.+||..|+..+|.+||+++.+.+
T Consensus       225 ~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            111111  100000112468899999999999999999999877643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=384.53  Aligned_cols=263  Identities=20%  Similarity=0.267  Sum_probs=191.4

Q ss_pred             CCCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeecC-
Q psy4988         286 SDRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRVVKLYDVFEIDA-  364 (627)
Q Consensus       286 ~~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-  364 (627)
                      ..+|.+.+.||+|+||+||+|.+  +++.||||++.....      ..  .....|+..++.++|||||++++++..+. 
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~------~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~   71 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE------RS--WFREAEIYQTVMLRHENILGFIAADNKDNG   71 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH------HH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch------hH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence            45799999999999999999975  689999999853321      11  11224555667889999999999987544 


Q ss_pred             --CeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhC------CCCEEeccccCCcEEecCCCcccce
Q psy4988         365 --NSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEI------KPPVIHYDLKPGNILLTEGNVCGEI  436 (627)
Q Consensus       365 --~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~------~~~IvHrDLKP~NILl~~~~~~g~v  436 (627)
                        ..+|||||||++|+|.++++.. .+++..++.++.|++.||.|||+.      .++||||||||+||||+.+   +.+
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~---~~~  147 (303)
T d1vjya_          72 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTC  147 (303)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT---SCE
T ss_pred             cceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC---CCe
Confidence              3688999999999999999764 799999999999999999999974      1249999999999999887   699


Q ss_pred             EEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q psy4988         437 KITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKN--PPKISSKVDVWSVGVIFYQCLYGKKPFGHNQSQ  514 (627)
Q Consensus       437 KL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~--~~~~~~k~DVwSlGviL~elltG~~Pf~~~~~~  514 (627)
                      ||+|||+++.+.......   .......+||+.|+|||++.....  ...++.++|||||||+||||++|..||......
T Consensus       148 Kl~DFGl~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~  224 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             EECCCTTCEEEETTTTEE---CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             EEEecCccccccCCCcce---eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence            999999998875432110   112234589999999999842211  113677899999999999999999887432211


Q ss_pred             H-----------HHHHHHHHhhhhc--cccCC---CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHhc
Q psy4988         515 A-----------TILEENTILKATE--VQFAN---KPTVSNEAKGFIRSCLAYRKEDRIDVISLARH  565 (627)
Q Consensus       515 ~-----------~~~~~~~~~~~~~--~~~~~---~~~vs~el~~LI~~cL~~dP~~Rpt~~elL~h  565 (627)
                      .           .............  ..++.   ......++.+||.+||..||++|||+.||+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0           1111111111111  11111   11233568999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-44  Score=378.42  Aligned_cols=269  Identities=24%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             cCCCCccC-CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--------
Q psy4988         279 FNNHPVLS-DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--------  349 (627)
Q Consensus       279 ~~~~~~l~-~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--------  349 (627)
                      +..++++. +||+++++||+|+||+||+|.+..+++.||||++.....        ....+.+|+.+++.++        
T Consensus         4 ~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--------~~~~~~~Ei~~l~~l~~~~~~~~~   75 (362)
T d1q8ya_           4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------YTEAAEDEIKLLQRVNDADNTKED   75 (362)
T ss_dssp             CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------HHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred             CCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--------chHHHHHHHHHHHHhcchhhhhhh
Confidence            34456665 579999999999999999999999999999999864321        1234667887777664        


Q ss_pred             ---CCceeEEeeEEee-cCCeEEEEEeecCCCChHHHH---HhccCcCHHHHHHHHHHHHHHHHHHHh-CCCCEEecccc
Q psy4988         350 ---HPRVVKLYDVFEI-DANSFCTVLEYCDGHDLDFYL---KQHKTIAEREARSIVMQVVSALKYLNE-IKPPVIHYDLK  421 (627)
Q Consensus       350 ---HpnIV~l~~~~~~-~~~~~~lV~E~~~gg~L~~~l---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~~~IvHrDLK  421 (627)
                         |+|||++++++.. .....++||+++.........   .....+++..++.++.||+.||.|||+ .+  |||||||
T Consensus        76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlK  153 (362)
T d1q8ya_          76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIK  153 (362)
T ss_dssp             HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCS
T ss_pred             hcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCC
Confidence               6889999999864 334566777776655433322   234689999999999999999999997 77  9999999


Q ss_pred             CCcEEecCCCc---ccceEEeecccccccccCCCCCCCCccccccCCCCCccCCccccccCCCCCCCCcchhHHHHHHHH
Q psy4988         422 PGNILLTEGNV---CGEIKITDFGLSKVMDEENYNPDHGMDLTSQGAGTYWYLPPECFVVGKNPPKISSKVDVWSVGVIF  498 (627)
Q Consensus       422 P~NILl~~~~~---~g~vKL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~k~DVwSlGviL  498 (627)
                      |+||||+.+..   ...++|+|||.+......          ....+||+.|+|||++.    ...++.++||||+||+|
T Consensus       154 p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il  219 (362)
T d1q8ya_         154 PENVLMEIVDSPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLL----GAPWGCGADIWSTACLI  219 (362)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHH----TCCCCTHHHHHHHHHHH
T ss_pred             hhHeeeeccCcccccceeeEeecccccccccc----------cccccccccccChhhcc----ccCCCccccccchHHHH
Confidence            99999986421   125999999999865432          23458999999999985    34589999999999999


Q ss_pred             HHHHhCCCCCCCCChH------HHHHHHHHHhhhh------------------------------------ccccCCCCC
Q psy4988         499 YQCLYGKKPFGHNQSQ------ATILEENTILKAT------------------------------------EVQFANKPT  536 (627)
Q Consensus       499 ~elltG~~Pf~~~~~~------~~~~~~~~~~~~~------------------------------------~~~~~~~~~  536 (627)
                      ++|++|+.||......      ..+......+...                                    ...+.....
T Consensus       220 ~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
T d1q8ya_         220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD  299 (362)
T ss_dssp             HHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHH
T ss_pred             HHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcc
Confidence            9999999999643321      1111111110000                                    001111223


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHhccCCCCC
Q psy4988         537 VSNEAKGFIRSCLAYRKEDRIDVISLARHDYLQPP  571 (627)
Q Consensus       537 vs~el~~LI~~cL~~dP~~Rpt~~elL~hp~~~~~  571 (627)
                      .++++.+||.+||++||.+|||+.|||+||||+..
T Consensus       300 ~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             HHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence            56789999999999999999999999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=2.7e-25  Score=213.39  Aligned_cols=142  Identities=21%  Similarity=0.253  Sum_probs=110.3

Q ss_pred             eeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhh-----------HhHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy4988         289 YLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKE-----------DKKANYIKHALREYNIHKALDHPRVVKLY  357 (627)
Q Consensus       289 Y~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~-----------~~~~~~~~~~~~Ei~il~~l~HpnIV~l~  357 (627)
                      |.+.++||+|+||+||+|.+. +++.||||+++.......           .........+.+|+.++.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568899999999999999874 789999998754321100           01112234456789999999999999988


Q ss_pred             eEEeecCCeEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCCCCEEeccccCCcEEecCCCcccceE
Q psy4988         358 DVFEIDANSFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIKPPVIHYDLKPGNILLTEGNVCGEIK  437 (627)
Q Consensus       358 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~~~IvHrDLKP~NILl~~~~~~g~vK  437 (627)
                      ++..   .  ++||||+++..+.       .+++..+..++.||+.+|.|||+++  ||||||||+|||++++    .++
T Consensus        81 ~~~~---~--~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~----~~~  142 (191)
T d1zara2          81 AWEG---N--AVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE----GIW  142 (191)
T ss_dssp             EEET---T--EEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT----EEE
T ss_pred             EecC---C--EEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC----CEE
Confidence            7532   2  5899999986543       3566777899999999999999988  9999999999999864    589


Q ss_pred             Eeeccccccccc
Q psy4988         438 ITDFGLSKVMDE  449 (627)
Q Consensus       438 L~DFGla~~~~~  449 (627)
                      |+|||+|+....
T Consensus       143 liDFG~a~~~~~  154 (191)
T d1zara2         143 IIDFPQSVEVGE  154 (191)
T ss_dssp             ECCCTTCEETTS
T ss_pred             EEECCCcccCCC
Confidence            999999987643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.26  E-value=2e-06  Score=83.50  Aligned_cols=142  Identities=17%  Similarity=0.125  Sum_probs=86.2

Q ss_pred             CCeeEEEEecccCceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeecCC
Q psy4988         287 DRYLLLMLLGKGGFSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD-HPRVVKLYDVFEIDAN  365 (627)
Q Consensus       287 ~rY~i~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~  365 (627)
                      ..|++.+..+-++.+.||+..  .++..+.||+.........       ..+.+|..++..+. +--+.+++.++. +.+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~-------~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~   83 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTT-------YDVEREKDMMLWLEGKLPVPKVLHFER-HDG   83 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTST-------TCHHHHHHHHHHHTTTSCCCCEEEEEE-ETT
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccch-------hhHHHHHHHHHHHhccCCCCcEEEEEe-cCC
Confidence            356666665555667899874  4556677887653322111       12456777766553 323455566655 456


Q ss_pred             eEEEEEeecCCCChHHHHHhccCcCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q psy4988         366 SFCTVLEYCDGHDLDFYLKQHKTIAEREARSIVMQVVSALKYLNEIK---------------------------------  412 (627)
Q Consensus       366 ~~~lV~E~~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---------------------------------  412 (627)
                      ..++||++++|..+......     ......++.++...|..||+..                                 
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             ceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            67799999999877543321     1112233444445555555321                                 


Q ss_pred             ------------------------CCEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         413 ------------------------PPVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       413 ------------------------~~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                                              ..++|+|+.|.|||++++   +.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC---ceEEEeechhccc
Confidence                                    127999999999999875   3556999988753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.12  E-value=1.3e-06  Score=91.10  Aligned_cols=79  Identities=19%  Similarity=0.196  Sum_probs=45.7

Q ss_pred             EEEecccCceEEEEEEEcCCCeEEEEEEeecC-----cchhhHhHHHHHHHHHHHHHHHhcCC---CCceeEEeeEEeec
Q psy4988         292 LMLLGKGGFSEVHKAFDLKEQRYVACKVHQLN-----KDWKEDKKANYIKHALREYNIHKALD---HPRVVKLYDVFEID  363 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~~~~~VAVKii~~~-----~~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIV~l~~~~~~~  363 (627)
                      .+.||.|....||++.+..+++.|+||.-...     ..|...     +.+...|+.+|+.+.   ...+.+++.+   +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~-----~~R~~~E~~~L~~~~~~~p~~vP~v~~~---d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLT-----IDRARIESSALIRQGEHVPHLVPRVFYS---D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCC-----TTHHHHHHHHHHHHHTTCGGGSCCEEEE---E
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCC-----HHHHHHHHHHHHHhhhhCCCCcceEEEE---c
Confidence            46799999999999988777889999963211     111111     123445666666542   2345555543   2


Q ss_pred             CCeEEEEEeecCCCC
Q psy4988         364 ANSFCTVLEYCDGHD  378 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~  378 (627)
                      ....++|||++++..
T Consensus       103 ~~~~~lvmE~L~~~~  117 (392)
T d2pula1         103 TEMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTTEEEECCCTTSE
T ss_pred             CCCCEEEEeccCCcc
Confidence            334458999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.74  E-value=2.9e-05  Score=74.66  Aligned_cols=74  Identities=16%  Similarity=0.040  Sum_probs=45.3

Q ss_pred             EecccC-ceEEEEEEEcCCCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCC--CCceeEEeeEEeecCCeEEEE
Q psy4988         294 LLGKGG-FSEVHKAFDLKEQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALD--HPRVVKLYDVFEIDANSFCTV  370 (627)
Q Consensus       294 ~LG~G~-fG~Vy~a~~~~~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIV~l~~~~~~~~~~~~lV  370 (627)
                      .+..|. -+.||+.. ..++..+.||+......          ..+..|+.+++.+.  .-.+.+++.+.. +.+..++|
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~-~~~~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL----------NELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT----------SCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEE
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH----------hHHHHHHHHHHHHHhcCCCCCceeeecc-cccceEEE
Confidence            344444 46899886 45667788897543321          12445666665542  223556666655 55667799


Q ss_pred             EeecCCCCh
Q psy4988         371 LEYCDGHDL  379 (627)
Q Consensus       371 ~E~~~gg~L  379 (627)
                      |+|++|.++
T Consensus        85 ~~~i~G~~~   93 (255)
T d1nd4a_          85 LGEVPGQDL   93 (255)
T ss_dssp             EECCSSEET
T ss_pred             EEeeecccc
Confidence            999998655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.68  E-value=0.0025  Score=63.51  Aligned_cols=28  Identities=29%  Similarity=0.392  Sum_probs=23.1

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeecccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSKV  446 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~~  446 (627)
                      ++||+|+.|.|||++++     ..|+||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~-----~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG-----PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS-----EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC-----ceEEechhccc
Confidence            58999999999999753     35899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.77  E-value=0.014  Score=59.33  Aligned_cols=74  Identities=20%  Similarity=0.194  Sum_probs=46.6

Q ss_pred             EEEecccCceEEEEEEEcC-------CCeEEEEEEeecCcchhhHhHHHHHHHHHHHHHHHhcCCCCce-eEEeeEEeec
Q psy4988         292 LMLLGKGGFSEVHKAFDLK-------EQRYVACKVHQLNKDWKEDKKANYIKHALREYNIHKALDHPRV-VKLYDVFEID  363 (627)
Q Consensus       292 ~~~LG~G~fG~Vy~a~~~~-------~~~~VAVKii~~~~~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-V~l~~~~~~~  363 (627)
                      ++.|+.|--=.+|++....       ..+.|.+++...... .        ....+|..+++.+.-.+| .+++++|.  
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~--------idr~~E~~i~~~ls~~gl~Pkll~~~~--  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E--------SHLVAESVIFTLLSERHLGPKLYGIFS--  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H--------HHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-h--------hHHHHHHHHHHHHHhCCCCCeEEEEcC--
Confidence            4678888889999987543       346788887642211 1        123467777777642233 46676653  


Q ss_pred             CCeEEEEEeecCCCCh
Q psy4988         364 ANSFCTVLEYCDGHDL  379 (627)
Q Consensus       364 ~~~~~lV~E~~~gg~L  379 (627)
                       +  .+|+||++|..|
T Consensus       116 -~--g~I~efi~g~~l  128 (395)
T d1nw1a_         116 -G--GRLEEYIPSRPL  128 (395)
T ss_dssp             -T--EEEECCCCEEEC
T ss_pred             -C--ceEEEEeccccC
Confidence             2  478999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.53  E-value=0.066  Score=52.01  Aligned_cols=29  Identities=28%  Similarity=0.318  Sum_probs=25.1

Q ss_pred             CEEeccccCCcEEecCCCcccceEEeeccccc
Q psy4988         414 PVIHYDLKPGNILLTEGNVCGEIKITDFGLSK  445 (627)
Q Consensus       414 ~IvHrDLKP~NILl~~~~~~g~vKL~DFGla~  445 (627)
                      +|||+|+.++|||++.+   ...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~---~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGD---ELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETT---EEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccc---cceeEecccccc
Confidence            59999999999999976   345799999885